Citrus Sinensis ID: 006055

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660---
Protein Sequence
MAMQMQIESQNIFLLLLLIISTFSFSFSDLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPLQDCGTKASLVVPSTPSGTDEISHGEKEKKKLSGGAIAGIVIGSVIGFLLILLILLILCRKKSNRNTRSVDITSLKQQEVEIVDDKAVGEMDNGYSVAAAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQPDDLDNISSR
Secondary Structure (PSIPRED)
cccccccHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHcccccccccccccccccccEEEEccccEEEEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccccccHHHHHcccccccEEcccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccEEcccccccccccccHHHHHHHHHHHcccccccccccccccccccccEEEEccccccccHHHHHHccccEEcccccccEEEEEEccccEEEEEEcccccccHHHHHHHHHHHcccccccccccEEEEEcccEEEEEEcccccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccEEEcccccEEEccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHcccccccccccccHHHHHHHHHHHcccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHccccccccccccccccccEEEEEccccEEEEEEccccccccccHccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccHHHcccccEEEccccEEEEEcccHHcccccEEEccccccccccccccccccccccccccccccccccccccccccccEEEEEEcccccccHHHHHHHEEEcccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccEEEcccccccccHHHHHHHHHHHcccccccEEEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHcccccEEEEEEEEEccccEEEEEEccccccHHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHccccEEccccccccEEcccccccEHccccHHHHcccccccccccccccccEccccccccHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHccHHHHccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MAMQMQIESQNIFLLLLLIISTFSFSFSDLSSDRAALLALRSSVGGRTLLWNvyeaspckwagveceqNRVTMlrlpgvalsgqiplgilgnltsLRTLSLRFNSLtsqlpsdlascSNLRNLylqgnhfsgevPLFLVGLHHLVRLNLatnnfsgeipsgfknLTKLKTLFLEnnrlsgsipgfddvlpnlqqlnvsnnllngsipkrfqtfgsnsflgnslcgkplqdcgtkaslvvpstpsgtdeishgekekkklsggaiAGIVIGSVIGFLLILLILLILCRkksnrntrsvditslkqqeveivddkavgemdnGYSVAAAAAAAMVGigngngktqvnsnvngaTKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDkiegvgavnhenlVPLRAYYYSMDEKLLVYDYLTMGSLSAllhgnkgagrtplNWEMRSLIALGAARGIEYlhaqgpnvshgnikssnilltksyearvsdfglahlvgpsstpnrvagyrapevtdpckvsqkadvYSFGVLLLELLtgkapthallneegvdlprwVQSIvkdewtsevfDLELLRYQNVEEEMVQLLQLAIDcsaqypdnrpsMSEVIKRIEelhpsstqghhglqpddldnissr
Flexible Loop (DISEMBL)
MAMQMQIESQNIFLLLLLIISTFSFSFSDLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPLQDCGTKASLVVpstpsgtdeishgekekkklsgGAIAGIVIGSVIGFLLILLILLILCRKksnrntrsvditslkqqeveiVDDKAVGEMDNGYSVAAAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAvkrlkdvtiserefkdkiegvgavnhenlVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAqgpnvshgniKSSNILLTKSYEARVSDFGLAhlvgpsstpnrvAGYRApevtdpckvsqKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELhpsstqghhglqpddldnissr
Low Complexity Region (SEG)
MAMQMQIESQNifllllliistfsfsfsdlssdraallalrssVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGfknltklktlflennRLSGSIPGFDDvlpnlqqlnvsnnllnGSIPKRFQTFGSNSFLGNSLCGKPLQDCGTKASLVVPSTPSGTDEISHGEKEKKKLsggaiagivigsvigFllillillilCRKKSNRNTRSVDITSLKQQEVEIVDDKAVGEMDNGYSVaaaaaaaMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQPDDLDNISSR
Disordered region (IsUnstruct)
*********QNIFLLLLLIISTFSFSFSDLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPLQDCGTK**************************GGAIAGIVIGSVIGFLLILLILLILCRKKS******VDITSLKQQEVEIVDDKAVGEMDNGYSVAAAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP*****RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQ****************************************
Disordered Region (DISOPRED)
************FLLLLLIISTFSFSFSDLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCG***************************************AGIVIGSVIGFLLILLILLILC***********************************************************************FGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI**REFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPT********VDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR**************************
Disordered Region (DISEMBL)
MAMQMQIESQNIFLLLLLIISTFSFSFSDLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPLQDCGTKASLVV********************SGGAIAGIVIGSVIGFLLILLILLILCRKKSNRNTRSVDITSLKQQEVEIVDDKAVGEMDNGYSVAAAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP********LQPDDLDNISSR
Disordered Region (DISPRO)
**MQMQIESQNIFLLLLLIISTFSFSFSDLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPLQDCGTKASLVVPSTPSGTDEISHGEKEKKKLSGGAIAGIVIGSVIGFLLILLILLILCRKK*****************VEIVDDKAVGEMDNGYSVAAAAAAAMVGIGN**************TKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH*********************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAMQMQIESQNIFLLLLLIISTFSFSFSDLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPLQDCGTKASLVVPSTPSGTDEISHGEKEKKKLSGGAIAGIVIGSVIGFLLILLILLILCRKKSNRNTRSVDITSLKQQEVEIVDDKAVGEMDNGYSVAAAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQPDDLDNISSR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	663	2.2.26 [Sep-21-2011]
Q9LP77	655	Probable inactive recepto	yes	no	0.912	0.923	0.676	0.0
Q9LVI6	647	Probable inactive recepto	no	no	0.898	0.921	0.647	0.0
Q9FMD7	625	Probable inactive recepto	no	no	0.907	0.963	0.526	1e-180
Q9M8T0	627	Probable inactive recepto	no	no	0.926	0.979	0.515	1e-175
O48788	658	Probable inactive recepto	no	no	0.900	0.907	0.503	1e-152
Q9LVM0	654	Probable inactive recepto	no	no	0.891	0.903	0.482	1e-151
Q9C9Y8	640	Probable inactive recepto	no	no	0.903	0.935	0.466	1e-143
Q9FHK7	640	Probable leucine-rich rep	no	no	0.888	0.920	0.441	1e-129
Q9SUQ3	638	Probable inactive recepto	no	no	0.876	0.910	0.423	1e-128
Q9M9C5	670	Probable leucine-rich rep	no	no	0.867	0.858	0.447	1e-123

>sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1

 Score =  831 bits (2147), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 424/627 (67%), Positives = 511/627 (81%), Gaps = 22/627 (3%)

Query: 29  DLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLG 88
           DL++DR ALL+LRS+VGGRT  WN+ + SPC WAGV+CE NRVT LRLPGVALSG IP G
Sbjct: 32  DLNADRTALLSLRSAVGGRTFRWNIKQTSPCNWAGVKCESNRVTALRLPGVALSGDIPEG 91

Query: 89  ILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN 148
           I GNLT LRTLSLR N+L+  LP DL++ SNLR+LYLQGN FSGE+P  L  L HLVRLN
Sbjct: 92  IFGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSLSHLVRLN 151

Query: 149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPK 208
           LA+N+F+GEI SGF NLTKLKTLFLENN+LSGSIP  D  LP L Q NVSNN LNGSIPK
Sbjct: 152 LASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPDLD--LP-LVQFNVSNNSLNGSIPK 208

Query: 209 RFQTFGSNSFLGNSLCGKPLQDCGTKASLVVPSTPSG-------TDEISHGEKEKKKLSG 261
             Q F S+SFL  SLCGKPL+ C  + +  VPS P+        + E S  +K+K KLSG
Sbjct: 209 NLQRFESDSFLQTSLCGKPLKLCPDEET--VPSQPTSGGNRTPPSVEGSEEKKKKNKLSG 266

Query: 262 GAIAGIVIGSVIGFLLILLILLILCRKKSNRNTRSVDITSLKQQEVEIVDDKAVGEMDNG 321
           GAIAGIVIG V+GF LI+LIL++LCRKKSN+ +R+VDI+++KQQE EI  DK   +  N 
Sbjct: 267 GAIAGIVIGCVVGFALIVLILMVLCRKKSNKRSRAVDISTIKQQEPEIPGDKEAVDNGNV 326

Query: 322 YSVAAAAAAAMVGIGNGNGKTQVNSNVNG-ATKKLVFFGNAARVFDLEDLLRASAEVLGK 380
           YSV+AAAAAAM G    NGK    S  NG ATKKLVFFGNA +VFDLEDLLRASAEVLGK
Sbjct: 327 YSVSAAAAAAMTG----NGKA---SEGNGPATKKLVFFGNATKVFDLEDLLRASAEVLGK 379

Query: 381 GTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEK 440
           GTFGTAYKAVL+  T+VAVKRLKDV ++++EFK+KIE VGA++HENLVPLRAYY+S DEK
Sbjct: 380 GTFGTAYKAVLDAVTVVAVKRLKDVMMADKEFKEKIELVGAMDHENLVPLRAYYFSRDEK 439

Query: 441 LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKS 500
           LLVYD++ MGSLSALLHGN+GAGR+PLNW++RS IA+GAARG++YLH+QG + SHGNIKS
Sbjct: 440 LLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQGTSTSHGNIKS 499

Query: 501 SNILLTKSYEARVSDFGLAHLVGPSST-PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLL 559
           SNILLTKS++A+VSDFGLA LVG S+T PNR  GYRAPEVTDP +VSQK DVYSFGV+LL
Sbjct: 500 SNILLTKSHDAKVSDFGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLL 559

Query: 560 ELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMV-QLLQLAI 618
           EL+TGKAP+++++NEEGVDLPRWV+S+ +DEW  EVFD ELL     EEEM+ +++QL +
Sbjct: 560 ELITGKAPSNSVMNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGL 619

Query: 619 DCSAQYPDNRPSMSEVIKRIEELHPSS 645
           +C++Q+PD RP MSEV++++E L P S
Sbjct: 620 ECTSQHPDQRPEMSEVVRKMENLRPYS 646

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1

 Score =  781 bits (2018), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 409/632 (64%), Positives = 488/632 (77%), Gaps = 36/632 (5%)

Query: 29  DLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLG 88
           DL++D++ALL+ RS+VGGRTLLW+V + SPC W GV C+  RVT LRLPG  LSG IP G
Sbjct: 30  DLAADKSALLSFRSAVGGRTLLWDVKQTSPCNWTGVLCDGGRVTALRLPGETLSGHIPEG 89

Query: 89  ILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN 148
           I GNLT LRTLSLR N LT  LP DL SCS+LR LYLQGN FSGE+P  L  L +LVRLN
Sbjct: 90  IFGNLTQLRTLSLRLNGLTGSLPLDLGSCSDLRRLYLQGNRFSGEIPEVLFSLSNLVRLN 149

Query: 149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPK 208
           LA N FSGEI SGFKNLT+LKTL+LENN+LSGS+    D+  +L Q NVSNNLLNGSIPK
Sbjct: 150 LAENEFSGEISSGFKNLTRLKTLYLENNKLSGSL---LDLDLSLDQFNVSNNLLNGSIPK 206

Query: 209 RFQTFGSNSFLGNSLCGKPLQDCGTKASLVVPSTP------SGTDEISHGEKEKKKLSGG 262
             Q F S+SF+G SLCGKPL  C  + +  VPS P       GT E S  +K++KKLSGG
Sbjct: 207 SLQKFDSDSFVGTSLCGKPLVVCSNEGT--VPSQPISVGNIPGTVEGSEEKKKRKKLSGG 264

Query: 263 AIAGIVIGSVIGFLLILLILLILCRKKSNRNTRSVDITSLKQQEVEIVDDKAVGEMD--- 319
           AIAGIVIG V+G  LI++IL++L RKK N  TR++D+ ++K  EVEI  +KA  E     
Sbjct: 265 AIAGIVIGCVVGLSLIVMILMVLFRKKGNERTRAIDLATIKHHEVEIPGEKAAVEAPENR 324

Query: 320 ---NGYSVAAAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAE 376
              N YS +A  A             +VNS+     KKLVFFGNA +VFDLEDLLRASAE
Sbjct: 325 SYVNEYSPSAVKA------------VEVNSS---GMKKLVFFGNATKVFDLEDLLRASAE 369

Query: 377 VLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           VLGKGTFGTAYKAVL+  T+VAVKRLKDVT+++REFK+KIE VGA++HENLVPLRAYYYS
Sbjct: 370 VLGKGTFGTAYKAVLDAVTLVAVKRLKDVTMADREFKEKIEVVGAMDHENLVPLRAYYYS 429

Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
            DEKLLVYD++ MGSLSALLHGNKGAGR PLNWE+RS IALGAARG++YLH+Q P  SHG
Sbjct: 430 GDEKLLVYDFMPMGSLSALLHGNKGAGRPPLNWEVRSGIALGAARGLDYLHSQDPLSSHG 489

Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSS-TPNRVAGYRAPEVTDPCKVSQKADVYSFG 555
           N+KSSNILLT S++ARVSDFGLA LV  SS TPNR  GYRAPEVTDP +VSQKADVYSFG
Sbjct: 490 NVKSSNILLTNSHDARVSDFGLAQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSFG 549

Query: 556 VLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ---NVEEEMVQ 612
           V+LLELLTGKAP+++++NEEG+DL RWV S+ ++EW +EVFD EL+  +   +VEEEM +
Sbjct: 550 VVLLELLTGKAPSNSVMNEEGMDLARWVHSVAREEWRNEVFDSELMSIETVVSVEEEMAE 609

Query: 613 LLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS 644
           +LQL IDC+ Q+PD RP M EV++RI+EL  S
Sbjct: 610 MLQLGIDCTEQHPDKRPVMVEVVRRIQELRQS 641

Arabidopsis thaliana (taxid: 3702)

>sp|Q9FMD7|Y5659_ARATH Probable inactive receptor kinase At5g16590 OS=Arabidopsis thaliana GN=At5g16590 PE=1 SV=1

 Score =  632 bits (1631), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 333/633 (52%), Positives = 434/633 (68%), Gaps = 31/633 (4%)

Query: 11  NIFLLLLLIISTFSFSFSDLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNR 70
           ++F   + ++S  S    DL +DR AL+ALR  V GR LLWN+  A PC W GV+CE  R
Sbjct: 10  SVFFFFICLVSVTS----DLEADRRALIALRDGVHGRPLLWNL-TAPPCTWGGVQCESGR 64

Query: 71  VTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHF 130
           VT LRLPGV LSG +P+ I GNLT L TLS RFN+L   LP D A+ + LR LYLQGN F
Sbjct: 65  VTALRLPGVGLSGPLPIAI-GNLTKLETLSFRFNALNGPLPPDFANLTLLRYLYLQGNAF 123

Query: 131 SGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLP 190
           SGE+P FL  L +++R+NLA NNF G IP    + T+L TL+L++N+L+G IP   ++  
Sbjct: 124 SGEIPSFLFTLPNIIRINLAQNNFLGRIPDNVNSATRLATLYLQDNQLTGPIP---EIKI 180

Query: 191 NLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPLQDCGTKASLVVPSTPSGTDEIS 250
            LQQ NVS+N LNGSIP         +FLGN LCGKPL  C        P   +G   ++
Sbjct: 181 KLQQFNVSSNQLNGSIPDPLSGMPKTAFLGNLLCGKPLDAC--------PVNGTGNGTVT 232

Query: 251 HGEKEKK-KLSGGAIAGIVIGSVIGFLLILLILLILCRKKSNRNTRSVDITSLKQQEVEI 309
            G K K  KLS GAI GIVIG  +  L++ LI+  LCRKK             K+Q V+ 
Sbjct: 233 PGGKGKSDKLSAGAIVGIVIGCFVLLLVLFLIVFCLCRKKK------------KEQVVQS 280

Query: 310 VDDKAVGEMDNGYSVAAAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLED 369
              +A     +  +VA  +      + NG  +  V+ N    +K L FF  +   FDL+ 
Sbjct: 281 RSIEAAPVPTSSAAVAKESNGPPAVVANGASENGVSKNPAAVSKDLTFFVKSFGEFDLDG 340

Query: 370 LLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVP 429
           LL+ASAEVLGKGTFG++YKA  + G +VAVKRL+DV + E+EF++K++ +G+++H NLV 
Sbjct: 341 LLKASAEVLGKGTFGSSYKASFDHGLVVAVKRLRDVVVPEKEFREKLQVLGSISHANLVT 400

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           L AYY+S DEKL+V++Y++ GSLSALLHGNKG+GR+PLNWE R+ IALGAAR I YLH++
Sbjct: 401 LIAYYFSRDEKLVVFEYMSRGSLSALLHGNKGSGRSPLNWETRANIALGAARAISYLHSR 460

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKA 549
               SHGNIKSSNILL++S+EA+VSD+ LA ++ P+STPNR+ GYRAPEVTD  K+SQKA
Sbjct: 461 DATTSHGNIKSSNILLSESFEAKVSDYCLAPMISPTSTPNRIDGYRAPEVTDARKISQKA 520

Query: 550 DVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ-NVEE 608
           DVYSFGVL+LELLTGK+PTH  L+EEGVDLPRWV SI + +  S+VFD EL RYQ +  E
Sbjct: 521 DVYSFGVLILELLTGKSPTHQQLHEEGVDLPRWVSSITEQQSPSDVFDPELTRYQSDSNE 580

Query: 609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            M++LL + I C+ QYPD+RP+M EV + IEE+
Sbjct: 581 NMIRLLNIGISCTTQYPDSRPTMPEVTRLIEEV 613

Might be involved in early recognition of growth promoting fungi. Appears to be specific for P.indica.

Arabidopsis thaliana (taxid: 3702)

>sp|Q9M8T0|Y3288_ARATH Probable inactive receptor kinase At3g02880 OS=Arabidopsis thaliana GN=At3g02880 PE=1 SV=1

 Score =  616 bits (1588), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 335/650 (51%), Positives = 437/650 (67%), Gaps = 36/650 (5%)

Query: 1   MAMQMQIESQNIFLLLLLIISTFSFSFSDLSSDRAALLALRSSVGGRTLLWNVYEASPCK 60
           M  + ++    +FL +  + +  S    DL SDR ALLA+R+SV GR LLWN+  +SPC 
Sbjct: 1   MKYKRKLSLSVVFLFVFYLAAVTS----DLESDRRALLAVRNSVRGRPLLWNMSASSPCN 56

Query: 61  WAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNL 120
           W GV C+  RVT LRLPG  L G +P+G +GNLT L+TLSLRFNSL+  +PSD ++   L
Sbjct: 57  WHGVHCDAGRVTALRLPGSGLFGSLPIGGIGNLTQLKTLSLRFNSLSGPIPSDFSNLVLL 116

Query: 121 RNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSG 180
           R LYLQGN FSGE+P  L  L  ++R+NL  N FSG IP    + T+L TL+LE N+LSG
Sbjct: 117 RYLYLQGNAFSGEIPSLLFTLPSIIRINLGENKFSGRIPDNVNSATRLVTLYLERNQLSG 176

Query: 181 SIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPLQDCGTKASLVVP 240
            IP  +  LP LQQ NVS+N LNGSIP    ++   +F GN+LCGKPL  C  +      
Sbjct: 177 PIP--EITLP-LQQFNVSSNQLNGSIPSSLSSWPRTAFEGNTLCGKPLDTCEAE------ 227

Query: 241 STPSGTD----EISHGEKEKKKLSGGAIAGIVIGSVIGFLLILLILLILCRKKSNRNTRS 296
            +P+G D         +K+  KLS GAI GIVIG V+G LL+LLIL  LCRK+       
Sbjct: 228 -SPNGGDAGGPNTPPEKKDSDKLSAGAIVGIVIGCVVGLLLLLLILFCLCRKR------- 279

Query: 297 VDITSLKQQEVEIVDDKAVGEMDNGYSVAAAAAAAMVGIGNGNGKTQVNSNVNGATKKLV 356
                  ++E  +        +    S AA     +V +         +  VN   K L 
Sbjct: 280 -------KKEENVPSRNVEAPVAAATSSAAIPKETVVVVPPAKATGSESGAVN---KDLT 329

Query: 357 FFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKI 416
           FF  +   FDL+ LL+ASAEVLGKGT G++YKA  E G +VAVKRL+DV + E+EF++++
Sbjct: 330 FFVKSFGEFDLDGLLKASAEVLGKGTVGSSYKASFEHGLVVAVKRLRDVVVPEKEFRERL 389

Query: 417 EGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIA 476
             +G+++H NLV L AYY+S DEKLLV++Y++ GSLSA+LHGNKG GRTPLNWE R+ IA
Sbjct: 390 HVLGSMSHANLVTLIAYYFSRDEKLLVFEYMSKGSLSAILHGNKGNGRTPLNWETRAGIA 449

Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRA 536
           LGAAR I YLH++    SHGNIKSSNILL+ SYEA+VSD+GLA ++  +S PNR+ GYRA
Sbjct: 450 LGAARAISYLHSRDGTTSHGNIKSSNILLSDSYEAKVSDYGLAPIISSTSAPNRIDGYRA 509

Query: 537 PEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF 596
           PE+TD  K+SQKADVYSFGVL+LELLTGK+PTH  LNEEGVDLPRWVQS+ + +  S+V 
Sbjct: 510 PEITDARKISQKADVYSFGVLILELLTGKSPTHQQLNEEGVDLPRWVQSVTEQQTPSDVL 569

Query: 597 DLELLRYQ-NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
           D EL RYQ    E +++LL++ + C+AQ+PD+RPSM+EV + IEE+  SS
Sbjct: 570 DPELTRYQPEGNENIIRLLKIGMSCTAQFPDSRPSMAEVTRLIEEVSHSS 619

Arabidopsis thaliana (taxid: 3702)

>sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1

 Score =  540 bits (1390), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 314/624 (50%), Positives = 409/624 (65%), Gaps = 27/624 (4%)

Query: 28  SDLSSDRAALLALRSSVGGRTLL-WNVYEASPCKWAGVECEQNRVTM--LRLPGVALSGQ 84
           S+ ++++ ALL     +     L WN  +++ C W GVEC  N+ ++  LRLPG  L GQ
Sbjct: 23  SESTAEKQALLTFLQQIPHENRLQWNESDSA-CNWVGVECNSNQSSIHSLRLPGTGLVGQ 81

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
           IP G LG LT LR LSLR N L+ Q+PSD ++ ++LR+LYLQ N FSGE P     L++L
Sbjct: 82  IPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGEFPTSFTQLNNL 141

Query: 145 VRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNG 204
           +RL++++NNF+G IP    NLT L  LFL NN  SG++P    +   L   NVSNN LNG
Sbjct: 142 IRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLP---SISLGLVDFNVSNNNLNG 198

Query: 205 SIPKRFQTFGSNSFLGN-SLCGKPLQDCGTKASLVVPS-TPSGTDEISHGEKEKKKLSGG 262
           SIP     F + SF GN  LCG PL+ C  K+  V PS +PS  +  +    +K KLS  
Sbjct: 199 SIPSSLSRFSAESFTGNVDLCGGPLKPC--KSFFVSPSPSPSLINPSNRLSSKKSKLSKA 256

Query: 263 AIAGIVIGSVIGFLLILLILLILCRKKSNRNTRSVDITSLKQQEVEIVDDKAVGEMDNGY 322
           AI  I++ S +  LL+L +LL LC +K     R  +    KQ +   V  + V       
Sbjct: 257 AIVAIIVASALVALLLLALLLFLCLRKR----RGSNEARTKQPKPAGVATRNVDLPPGAS 312

Query: 323 SVAAAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGKGT 382
           S          G+G   G+T+ N        KLVF       FDLEDLLRASAEVLGKG+
Sbjct: 313 SSKEEVTGTSSGMG---GETERN--------KLVFTEGGVYSFDLEDLLRASAEVLGKGS 361

Query: 383 FGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLL 442
            GT+YKAVLE GT V VKRLKDV  S++EF+ ++E VG + H N++PLRAYYYS DEKLL
Sbjct: 362 VGTSYKAVLEEGTTVVVKRLKDVMASKKEFETQMEVVGKIKHPNVIPLRAYYYSKDEKLL 421

Query: 443 VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSN 502
           V+D++  GSLSALLHG++G+GRTPL+W+ R  IA+ AARG+ +LH     V HGNIK+SN
Sbjct: 422 VFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGLAHLHVSAKLV-HGNIKASN 480

Query: 503 ILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELL 562
           ILL  + +  VSD+GL  L   SS PNR+AGY APEV +  KV+ K+DVYSFGVLLLELL
Sbjct: 481 ILLHPNQDTCVSDYGLNQLFSNSSPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELL 540

Query: 563 TGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSA 622
           TGK+P  A L EEG+DLPRWV S+V++EWT+EVFD+EL+RY N+EEEMVQLLQ+A+ C +
Sbjct: 541 TGKSPNQASLGEEGIDLPRWVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVS 600

Query: 623 QYPDNRPSMSEVIKRIEELHPSST 646
             PD RP M EV++ IE+++ S T
Sbjct: 601 TVPDQRPVMQEVLRMIEDVNRSET 624

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1

 Score =  534 bits (1376), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 312/647 (48%), Positives = 412/647 (63%), Gaps = 56/647 (8%)

Query: 16  LLLIISTF-SFSFSDLSSDRAALLALRSSVGG-RTLLWNVYEASPCKWAGVECEQN--RV 71
            L + +TF S++ +DL+SDR ALLA  +SV   R L WN        W GV C  +   V
Sbjct: 30  FLFVTTTFCSYAIADLNSDRQALLAFAASVPHLRRLNWNSTNHICKSWVGVTCTSDGTSV 89

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS 131
             LRLPG+ L G IP   LG L SLR LSLR N L+  LP D+ S  +L  +YLQ N+FS
Sbjct: 90  HALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHNNFS 149

Query: 132 GEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPN 191
           GEVP F+     L  L+L+ N+F+G+IP+ F+NL +L  L L+NN+LSG +P  D V  +
Sbjct: 150 GEVPSFVS--RQLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPNLDTV--S 205

Query: 192 LQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSL-CGKPLQDCGTKASLVVPSTPSGTDEIS 250
           L++LN+SNN LNGSIP     F S+SF GN+L CG PLQ C T +       PS T  IS
Sbjct: 206 LRRLNLSNNHLNGSIPSALGGFPSSSFSGNTLLCGLPLQPCATSSP-----PPSLTPHIS 260

Query: 251 --------HGEKEKKKLSGGAIAGIVIGSVIGFLLILLILLILCRKKSNRNTRSVDITSL 302
                   H E  K+KL    I  I  G     LLI +I+L  C KK ++   S+     
Sbjct: 261 TPPLPPFPHKEGSKRKLHVSTIIPIAAGGAALLLLITVIILCCCIKKKDKREDSI----- 315

Query: 303 KQQEVEIVDDKAVGEMDNGYSVAAAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAA 362
              +V+ + +KA  E                    G+G  +   N      KLVFF   +
Sbjct: 316 --VKVKTLTEKAKQEF-------------------GSGVQEPEKN------KLVFFNGCS 348

Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAV 422
             FDLEDLLRASAEVLGKG++GTAYKAVLE  T V VKRLK+V   +REF+ ++E +  V
Sbjct: 349 YNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVAAGKREFEQQMEIISRV 408

Query: 423 -NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR 481
            NH ++VPLRAYYYS DEKL+V DY   G+LS+LLHGN+G+ +TPL+W+ R  I L AA+
Sbjct: 409 GNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLLHGNRGSEKTPLDWDSRVKITLSAAK 468

Query: 482 GIEYLHAQG-PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVT 540
           GI +LHA G P  SHGNIKSSN+++ +  +A +SDFGL  L+     P R AGYRAPEV 
Sbjct: 469 GIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISDFGLTPLMAVPIAPMRGAGYRAPEVM 528

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL 600
           +  K + K+DVYSFGVL+LE+LTGK+P  +   ++ VDLPRWVQS+V++EWTSEVFD+EL
Sbjct: 529 ETRKHTHKSDVYSFGVLILEMLTGKSPVQSPSRDDMVDLPRWVQSVVREEWTSEVFDIEL 588

Query: 601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ 647
           +R+QN+EEEMVQ+LQ+A+ C AQ P+ RP+M +V++ IEE+  S ++
Sbjct: 589 MRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMIEEIRVSDSE 635

Arabidopsis thaliana (taxid: 3702)

>sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1

 Score =  510 bits (1314), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 304/651 (46%), Positives = 394/651 (60%), Gaps = 52/651 (7%)

Query: 12  IFLLLLLIISTFSFSF--SDLSSDRAALLALRSSVG-GRTLLWNVYEASPCKWAGVECEQ 68
           I   L L+++TF      +D+ SD+ ALL   S V   R L WN        W G+ C +
Sbjct: 5   IAAFLFLLVTTFVSRCLSADIESDKQALLEFASLVPHSRKLNWNSTIPICASWTGITCSK 64

Query: 69  N--RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQ 126
           N  RVT LRLPG  L G +P      L +LR +SLR N L   +PS + S   +R+LY  
Sbjct: 65  NNARVTALRLPGSGLYGPLPEKTFEKLDALRIISLRSNHLQGNIPSVILSLPFIRSLYFH 124

Query: 127 GNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFD 186
            N+FSG +P  L   H LV L+L+ N+ SG IP+  +NLT+L  L L+NN LSG IP   
Sbjct: 125 ENNFSGTIPPVLS--HRLVNLDLSANSLSGNIPTSLQNLTQLTDLSLQNNSLSGPIP--- 179

Query: 187 DVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNS-LCGKPLQDCGTKASLVVPS---- 241
           ++ P L+ LN+S N LNGS+P   ++F ++SF GNS LCG PL  C    +   PS    
Sbjct: 180 NLPPRLKYLNLSFNNLNGSVPSSVKSFPASSFQGNSLLCGAPLTPCPENTTAPSPSPTTP 239

Query: 242 -TPSGTDEISHGEKEKKKLSGGAIAGIVIGSVIGFLLILLILLILCRKKSNRNTRSVDIT 300
               GT  I  G   KK LS GAI GI +G  +   +IL I+ + C KK +         
Sbjct: 240 TEGPGTTNIGRG-TAKKVLSTGAIVGIAVGGSVLLFIILAIITLCCAKKRDGGQ------ 292

Query: 301 SLKQQEVEIVDDKAVGEMDNGYSVAAAAAAAMVGIGNGNGKTQVNSNVNGATK-KLVFFG 359
                     D  AV +   G S               N   +  S V  A K KLVFF 
Sbjct: 293 ----------DSTAVPKAKPGRS--------------DNKAEEFGSGVQEAEKNKLVFFE 328

Query: 360 NAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGV 419
            ++  FDLEDLLRASAEVLGKG++GT YKA+LE GT V VKRLK+V   +REF+ ++E V
Sbjct: 329 GSSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVAAGKREFEQQMEAV 388

Query: 420 GAVN-HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG 478
           G ++ H N+ PLRAYY+S DEKLLVYDY   G+ S LLHGN   GR  L+WE R  I L 
Sbjct: 389 GRISPHVNVAPLRAYYFSKDEKLLVYDYYQGGNFSMLLHGNNEGGRAALDWETRLRICLE 448

Query: 479 AARGIEYLH-AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-TPNRVAGYRA 536
           AARGI ++H A G  + HGNIKS N+LLT+     VSDFG+A L+   +  P+R  GYRA
Sbjct: 449 AARGISHIHSASGAKLLHGNIKSPNVLLTQELHVCVSDFGIAPLMSHHTLIPSRSLGYRA 508

Query: 537 PEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF 596
           PE  +  K +QK+DVYSFGVLLLE+LTGKA      +EE VDLP+WVQS+V++EWT EVF
Sbjct: 509 PEAIETRKHTQKSDVYSFGVLLLEMLTGKAAGKTTGHEEVVDLPKWVQSVVREEWTGEVF 568

Query: 597 DLELLRYQ-NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
           D+EL++ Q NVEEEMVQ+LQ+A+ C +++PD+RPSM EV+  +EE+ PS +
Sbjct: 569 DVELIKQQHNVEEEMVQMLQIAMACVSKHPDSRPSMEEVVNMMEEIRPSGS 619

Arabidopsis thaliana (taxid: 3702)

>sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1

 Score =  463 bits (1192), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 285/645 (44%), Positives = 385/645 (59%), Gaps = 56/645 (8%)

Query: 14  LLLLLIISTFSFSFSDLSSDRAALLALRSSVGGRTLL-WNVYEASPCKWAGVECEQN--- 69
              LL+ +T     +DL+SD  ALL   +SV     L WN   +    W G+ C+++   
Sbjct: 13  FFFLLLAATAVLVSADLASDEQALLNFAASVPHPPKLNWNKNLSLCSSWIGITCDESNPT 72

Query: 70  -RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGN 128
            RV  +RLPGV L G IP   LG L +L+ LSLR NSL   LPSD+ S  +L  LYLQ N
Sbjct: 73  SRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEYLYLQHN 132

Query: 129 HFSGEVPLFLVGL--HHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFD 186
           +FSGE+    +      LV L+L+ N+ SG IPSG +NL+++  L+L+NN   G I   D
Sbjct: 133 NFSGELTTNSLPSISKQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDGPIDSLD 192

Query: 187 DVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSL-CGKPLQDCGTKASLVVPST--P 243
             LP+++ +N+S N L+G IP+  +     SF+GNSL CG PL  C   A  + PS+  P
Sbjct: 193 --LPSVKVVNLSYNNLSGPIPEHLKKSPEYSFIGNSLLCGPPLNACSGGA--ISPSSNLP 248

Query: 244 SGTDEISHGEKEKKKLSGGAIAGIVIGSVIGFLLILLILLILCRKKSNRNTRSVDITSLK 303
               E  H  + ++  S   I  IV+G  +  L + ++ L+   KK+ +           
Sbjct: 249 RPLTENLHPVRRRQ--SKAYIIAIVVGCSVAVLFLGIVFLVCLVKKTKK----------- 295

Query: 304 QQEVEIVDDKAVGEMDNGYSVAAAAAAAMVGIGNGNGKTQVNSNVNGATK-KLVFFGNAA 362
                   ++  GE              M G+ N        S V    K KL FF    
Sbjct: 296 --------EEGGGE---------GVRTQMGGV-NSKKPQDFGSGVQDPEKNKLFFFERCN 337

Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAV 422
             FDLEDLL+ASAEVLGKG+FGTAYKAVLE  T V VKRL++V  S++EF+ ++E VG +
Sbjct: 338 HNFDLEDLLKASAEVLGKGSFGTAYKAVLEDTTAVVVKRLREVVASKKEFEQQMEIVGKI 397

Query: 423 N-HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR 481
           N H N VPL AYYYS DEKLLVY Y+T GSL  ++HGN+G     ++WE R  IA G ++
Sbjct: 398 NQHSNFVPLLAYYYSKDEKLLVYKYMTKGSLFGIMHGNRG--DRGVDWETRMKIATGTSK 455

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNRVAGYRAPEVT 540
            I YLH+      HG+IKSSNILLT+  E  +SD  L  L   P+ TP R  GY APEV 
Sbjct: 456 AISYLHSL--KFVHGDIKSSNILLTEDLEPCLSDTSLVTLFNLPTHTP-RTIGYNAPEVI 512

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAP-THALLNEEGV--DLPRWVQSIVKDEWTSEVFD 597
           +  +VSQ++DVYSFGV++LE+LTGK P T   L +E V  DLPRWV+S+V++EWT+EVFD
Sbjct: 513 ETRRVSQRSDVYSFGVVILEMLTGKTPLTQPGLEDERVVIDLPRWVRSVVREEWTAEVFD 572

Query: 598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH 642
           +ELL++QN+EEEMVQ+LQLA+ C A+ P++RP M EV + IE++ 
Sbjct: 573 VELLKFQNIEEEMVQMLQLALACVARNPESRPKMEEVARMIEDVR 617

Probable leucine-rich repeat receptor-like protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SUQ3|Y4374_ARATH Probable inactive receptor kinase At4g23740 OS=Arabidopsis thaliana GN=At4g23740 PE=1 SV=1

 Score =  457 bits (1177), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 273/645 (42%), Positives = 373/645 (57%), Gaps = 64/645 (9%)

Query: 28  SDLSSDRAALLALRSSVG-GRTLLWNVYEASPCKWAGVECEQN--RVTMLRLPGVALSGQ 84
           SD   D+ ALL   + +   R+L WN        W GV C Q+  R+  +RLPGV L+GQ
Sbjct: 24  SDPLEDKRALLEFLTIMQPTRSLNWNETSQVCNIWTGVTCNQDGSRIIAVRLPGVGLNGQ 83

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
           IP   +  L++LR LSLR N ++ + P D     +L  LYLQ N+ SG +PL      +L
Sbjct: 84  IPPNTISRLSALRVLSLRSNLISGEFPKDFVELKDLAFLYLQDNNLSGPLPLDFSVWKNL 143

Query: 145 VRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNL-LN 203
             +NL+ N F+G IPS    L ++++L L NN LSG IP    VL +LQ +++SNN  L 
Sbjct: 144 TSVNLSNNGFNGTIPSSLSRLKRIQSLNLANNTLSGDIPDLS-VLSSLQHIDLSNNYDLA 202

Query: 204 GSIPKRFQTFGSNSFLGNSLCGKPLQDCGTKASLVVPSTPSGTDEISHGEKEKKKLSGGA 263
           G IP   + F  +S+ G  +        G   +LV P  PS   E +H +  K +  G +
Sbjct: 203 GPIPDWLRRFPFSSYTGIDIIPP-----GGNYTLVTPPPPS---EQTHQKPSKARFLGLS 254

Query: 264 IAGIVIGSVIGFLLI---LLILLILC--RKKSNRNTRSVDITSLKQQEVEIVDDKAVGEM 318
               ++  +   +++   L  +L +C  R+K  R    +    L Q++  +  +K V  M
Sbjct: 255 ETVFLLIVIAVSIVVITALAFVLTVCYVRRKLRRGDGVISDNKL-QKKGGMSPEKFVSRM 313

Query: 319 DNGYSVAAAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEVL 378
           ++                                 +L FF      FDLEDLLRASAEVL
Sbjct: 314 ED------------------------------VNNRLSFFEGCNYSFDLEDLLRASAEVL 343

Query: 379 GKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMD 438
           GKGTFGT YKAVLE  T VAVKRLKDV   +R+F+ ++E +G + HEN+V L+AYYYS D
Sbjct: 344 GKGTFGTTYKAVLEDATSVAVKRLKDVAAGKRDFEQQMEIIGGIKHENVVELKAYYYSKD 403

Query: 439 EKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP-NVSHGN 497
           EKL+VYDY + GS+++LLHGN+G  R PL+WE R  IA+GAA+GI  +H +    + HGN
Sbjct: 404 EKLMVYDYFSRGSVASLLHGNRGENRIPLDWETRMKIAIGAAKGIARIHKENNGKLVHGN 463

Query: 498 IKSSNILLTKSYEARVSDFGLAHLVGPSSTP-NRVAGYRAPEVTDPCKVSQKADVYSFGV 556
           IKSSNI L       VSD GL  ++ P + P +R AGYRAPEVTD  K SQ +DVYSFGV
Sbjct: 464 IKSSNIFLNSESNGCVSDLGLTAVMSPLAPPISRQAGYRAPEVTDTRKSSQLSDVYSFGV 523

Query: 557 LLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQL 616
           +LLELLTGK+P H    +E + L RWV S+V++EWT+EVFD+ELLRY N+EEEMV++LQ+
Sbjct: 524 VLLELLTGKSPIHTTAGDEIIHLVRWVHSVVREEWTAEVFDIELLRYTNIEEEMVEMLQI 583

Query: 617 AIDCSAQYPDNRPSMSEVIKRIE-------------ELHPSSTQG 648
           A+ C  +  D RP MS++++ IE             EL P S  G
Sbjct: 584 AMSCVVKAADQRPKMSDLVRLIENVGNRRTSIEPEPELKPKSENG 628

Arabidopsis thaliana (taxid: 3702)

>sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1

 Score =  443 bits (1139), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 282/630 (44%), Positives = 378/630 (60%), Gaps = 55/630 (8%)

Query: 38  LALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLR 97
             L +   G+   WN    +PC+W GV C +NRVT L L  + L+G I    L +LTSLR
Sbjct: 38  FKLTADSTGKLNSWNT-TTNPCQWTGVSCNRNRVTRLVLEDINLTGSI--SSLTSLTSLR 94

Query: 98  TLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGE 157
            LSL+ N+L+  +P +L++ + L+ L+L  N FSG  P  +  L  L RL+L+ NNFSG+
Sbjct: 95  VLSLKHNNLSGPIP-NLSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRLDLSFNNFSGQ 153

Query: 158 IPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNS 217
           IP    +LT L TL LE+NR SG IP  +  L +LQ  NVS N  NG IP     F  + 
Sbjct: 154 IPPDLTDLTHLLTLRLESNRFSGQIPNIN--LSDLQDFNVSGNNFNGQIPNSLSQFPESV 211

Query: 218 FLGN-SLCGKPLQDCG--------------TKAS-LVVPST-PSGTDEISHGEKEKK--K 258
           F  N SLCG PL  C                KAS L  P T PS    I  G+K     +
Sbjct: 212 FTQNPSLCGAPLLKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTSIHGGDKSNNTSR 271

Query: 259 LSGGAIAGIVIGSVIGFLLILLILLILCRKKSNRNTRSVDITSLKQQEVEIVDDKAVGEM 318
           +S  ++  I++G  I    + L+L     ++   N         K++  +I++ + +   
Sbjct: 272 ISTISLIAIILGDFIILSFVSLLLYYCFWRQYAVN---------KKKHSKILEGEKIVYS 322

Query: 319 DNGYSVAAAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEVL 378
            N Y  +              GK             +VFF    R F+LEDLLRASAE+L
Sbjct: 323 SNPYPTSTQNNNNQNQQVGDKGK-------------MVFF-EGTRRFELEDLLRASAEML 368

Query: 379 GKGTFGTAYKAVLEMGTIVAVKRLKD-VTIS-EREFKDKIEGVGAVNHENLVPLRAYYYS 436
           GKG FGTAYKAVLE G  VAVKRLKD VT++ ++EF+ ++E +G + H NLV L+AYY++
Sbjct: 369 GKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFA 428

Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN--VS 494
            +EKLLVYDY+  GSL  LLHGN+G GRTPL+W  R  IA GAARG+ ++H       ++
Sbjct: 429 REEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLT 488

Query: 495 HGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSF 554
           HG+IKS+N+LL +S  ARVSDFGL+ +  PS T  +  GYRAPE+ D  K +QK+DVYSF
Sbjct: 489 HGDIKSTNVLLDRSGNARVSDFGLS-IFAPSQTVAKSNGYRAPELIDGRKHTQKSDVYSF 547

Query: 555 GVLLLELLTGKAPTHALLNEEG--VDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQ 612
           GVLLLE+LTGK P        G  VDLPRWVQS+V++EWT+EVFDLEL+RY+++EEEMV 
Sbjct: 548 GVLLLEILTGKCPNMVETGHSGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVG 607

Query: 613 LLQLAIDCSAQYPDNRPSMSEVIKRIEELH 642
           LLQ+A+ C+A   D+RP M  V+K IE++ 
Sbjct: 608 LLQIAMACTAVAADHRPKMGHVVKLIEDIR 637

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	663
255585468	661	ATP binding protein, putative [Ricinus c	0.948	0.951	0.740	0.0
224135633	652	predicted protein [Populus trichocarpa]	0.963	0.980	0.725	0.0
359491530	672	PREDICTED: probable inactive receptor ki	0.930	0.918	0.711	0.0
224118602	608	predicted protein [Populus trichocarpa]	0.911	0.993	0.761	0.0
449439475	663	PREDICTED: probable inactive receptor ki	0.944	0.944	0.727	0.0
449510935	694	PREDICTED: probable inactive receptor ki	0.944	0.902	0.727	0.0
357521691	706	Atypical receptor-like kinase MARK [Medi	0.945	0.888	0.703	0.0
356524700	649	PREDICTED: probable inactive receptor ki	0.929	0.949	0.696	0.0
356512960	656	PREDICTED: probable inactive receptor ki	0.920	0.929	0.706	0.0
4008006	645	receptor-like protein kinase [Arabidopsi	0.912	0.937	0.676	0.0

>gi|255585468|ref|XP_002533427.1| ATP binding protein, putative [Ricinus communis] gi|223526727|gb|EEF28958.1| ATP binding protein, putative [Ricinus communis]

 Score =  930 bits (2403), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 483/652 (74%), Positives = 538/652 (82%), Gaps = 23/652 (3%)

Query: 26  SFSDLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQI 85
           S  DL++DRAALL LRSSVGGRTL WN+ + SPC WAGV CE NRVT+LRLPGVALSGQ+
Sbjct: 19  SKPDLAADRAALLKLRSSVGGRTLFWNITQQSPCSWAGVACEGNRVTVLRLPGVALSGQL 78

Query: 86  PLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLV 145
           P GI  NLT LRTLSLR N+L   LPSDL SC+NLRNLYLQGN FSGE+P FL GLH LV
Sbjct: 79  PEGIFANLTQLRTLSLRLNALNGHLPSDLGSCTNLRNLYLQGNMFSGEIPEFLFGLHDLV 138

Query: 146 RLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGS 205
           RLNL  NNF+GEI   F N T+L+TLFLENNRLSGS+P  D  L  L+Q NVSNNLLNGS
Sbjct: 139 RLNLGENNFTGEISPSFGNFTRLRTLFLENNRLSGSVP--DLKLDKLEQFNVSNNLLNGS 196

Query: 206 IPKRFQTFGSNSFLGNSLCGKPLQDCGTKASLVVPSTPSGTDEISHGEKEKKKLSGGAIA 265
           IP+R   F  +SFLGNSLCG+PL  C   +++VVPSTP  TDE  +G K KK LS GAIA
Sbjct: 197 IPERLHLFDPSSFLGNSLCGQPLASCSGNSNVVVPSTP--TDEAGNGGK-KKNLSAGAIA 253

Query: 266 GIVIGSVIGFLLILLILLILCRKKSNRNTRSVDITSLKQQEVEIVDDKAVGEMDNGYS-- 323
           GIVIGS++G  LI+LIL+ LCRKK ++ +RS+DI S+KQQE+ +  +K +GE++NG    
Sbjct: 254 GIVIGSIVGLFLIVLILMFLCRKKGSKKSRSIDIASIKQQELAMPGEKPIGEVENGSGGG 313

Query: 324 ----------VAAAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRA 373
                     VAAAAAAAMVG G           VNG  KKLVFFG AARVFDLEDLLRA
Sbjct: 314 YGNGNGNGYSVAAAAAAAMVGHGK---GGAAGGEVNGG-KKLVFFGKAARVFDLEDLLRA 369

Query: 374 SAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAY 433
           SAEVLGKGTFGTAYKAVLEMGT+VAVKRLKDVTI+EREFK+KIE VGA++HE+LVPLRAY
Sbjct: 370 SAEVLGKGTFGTAYKAVLEMGTVVAVKRLKDVTITEREFKEKIETVGALDHESLVPLRAY 429

Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
           Y+S DEKLLVYDY+ MGSLSALLHGNKG GRTPLNWE+RS IALGAARGI+Y+H+QGPNV
Sbjct: 430 YFSRDEKLLVYDYMPMGSLSALLHGNKGGGRTPLNWEIRSGIALGAARGIQYIHSQGPNV 489

Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYS 553
           SHGNIKSSNILLT+SYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDP KVSQKADVYS
Sbjct: 490 SHGNIKSSNILLTQSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPRKVSQKADVYS 549

Query: 554 FGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQL 613
           FGVLLLELLTGK PTHALLNEEGVDLPRWVQSIV++EWTSEVFDLELLRYQNVEEEMVQL
Sbjct: 550 FGVLLLELLTGKPPTHALLNEEGVDLPRWVQSIVREEWTSEVFDLELLRYQNVEEEMVQL 609

Query: 614 LQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQPD--DLDNISSR 663
           LQL IDC+AQYPDNRPSMSEV  RIEEL  SS +     +PD  DLD+ SSR
Sbjct: 610 LQLGIDCAAQYPDNRPSMSEVTNRIEELRRSSIREDQDPEPDVVDLDDSSSR 661

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224135633|ref|XP_002322122.1| predicted protein [Populus trichocarpa] gi|222869118|gb|EEF06249.1| predicted protein [Populus trichocarpa]

 Score =  922 bits (2382), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 480/662 (72%), Positives = 544/662 (82%), Gaps = 23/662 (3%)

Query: 12  IFLLLLLIISTFSFSFSDLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRV 71
           +F   +LI+S       +LS D +ALL+LRS+V GRTLLWNV   SPC W GV+CEQNRV
Sbjct: 4   VFFTSILILSIQPSLPKNLSPDHSALLSLRSAVHGRTLLWNVSLQSPCSWTGVKCEQNRV 63

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS 131
           T+LRLPG AL+G+IPLGI  NLT LRTLSLR N+LT  LP DL++C +LRNLYLQGN FS
Sbjct: 64  TVLRLPGFALTGEIPLGIFSNLTQLRTLSLRLNALTGNLPQDLSNCKSLRNLYLQGNLFS 123

Query: 132 GEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPN 191
           GE+P FL  L  LVRLNLA NNF+GEI  GF N T+L+TLFLE+N L+GS+P  D  L  
Sbjct: 124 GEIPDFLFSLKDLVRLNLAENNFTGEISPGFDNFTRLRTLFLEDNLLTGSLP--DLKLEK 181

Query: 192 LQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPLQDC-GTKASLVVPSTPSGTDEIS 250
           L+Q NVSNNLLNGSIP  F+ FG +SF G SLCGKPL DC  +  ++VVPSTP+G     
Sbjct: 182 LKQFNVSNNLLNGSIPDTFKGFGPSSFGGTSLCGKPLPDCKDSGGAIVVPSTPNGG---- 237

Query: 251 HGEKEKKKLSGGAIAGIVIGSVIGFLLILLILLILCRKKSNRNTRSVDITSLKQQEVEIV 310
            G+ ++KKLSGGAIAGIVIGS++G LLI++IL+ LCRK S+  +RS+DI S+KQQE+EI 
Sbjct: 238 -GQGKRKKLSGGAIAGIVIGSIVGLLLIVMILMFLCRKNSSNKSRSIDIASIKQQEMEIQ 296

Query: 311 DDKAVGEMDNGY------SVAAAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARV 364
            DK + E +NG       SVAAAAAAAMVG G G     +NS   G  KKLVFFG A RV
Sbjct: 297 GDKPIVEAENGGGYGNGYSVAAAAAAAMVGNGKGG---DLNS---GGAKKLVFFGKAPRV 350

Query: 365 FDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNH 424
           FDLEDLLRASAEVLGKGTFGTAYKAVLEMGT+VAVKRL+DVTISE EF++KIE VGA++H
Sbjct: 351 FDLEDLLRASAEVLGKGTFGTAYKAVLEMGTVVAVKRLRDVTISEIEFREKIETVGAMDH 410

Query: 425 ENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
           ENLVPLRAYYYS DEKLLVYDY++MGSLSALLHGNKGAGR PLNWE+RS IAL AARGIE
Sbjct: 411 ENLVPLRAYYYSRDEKLLVYDYMSMGSLSALLHGNKGAGRAPLNWEIRSGIALAAARGIE 470

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCK 544
           YLH+QGPNVSHGNIKSSNILLT+SY+ARVSDFGLAHLVGP STPNRVAGYRAPEVTDP K
Sbjct: 471 YLHSQGPNVSHGNIKSSNILLTQSYDARVSDFGLAHLVGPPSTPNRVAGYRAPEVTDPRK 530

Query: 545 VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ 604
           VSQKADVYSFGVLLLELLTGKAP HALLNEEGVDLPRWVQSIV++EWTSEVFDLELLRYQ
Sbjct: 531 VSQKADVYSFGVLLLELLTGKAPAHALLNEEGVDLPRWVQSIVREEWTSEVFDLELLRYQ 590

Query: 605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQPD---DLDNIS 661
           NVEEEMVQLLQL IDC+AQYPDNRPSMS V +RIEEL  SS + HHG QP+   D D+ S
Sbjct: 591 NVEEEMVQLLQLGIDCAAQYPDNRPSMSAVTRRIEELCRSSLREHHGPQPEPSNDADDNS 650

Query: 662 SR 663
           SR
Sbjct: 651 SR 652

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359491530|ref|XP_002279127.2| PREDICTED: probable inactive receptor kinase At1g48480-like [Vitis vinifera]

 Score =  896 bits (2315), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 456/641 (71%), Positives = 523/641 (81%), Gaps = 24/641 (3%)

Query: 28  SDLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPL 87
           SDL++DR ALL LR  V GRTLLWNV + SPC WAGV+CE+NRV  LRLPG +L+G+IP 
Sbjct: 51  SDLAADRTALLGLRKVVSGRTLLWNVSQDSPCLWAGVKCEKNRVVGLRLPGCSLTGKIPA 110

Query: 88  GILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL 147
           GI+GNLT LR LSLR N+L   LPSDL SC++LRNLYL GN FSGE+P  L GL  +VRL
Sbjct: 111 GIIGNLTELRVLSLRMNALEGPLPSDLGSCADLRNLYLFGNAFSGEIPASLFGLTKIVRL 170

Query: 148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
           NLA NN SGEI + F  LT+LKTL+L+ N LSGSIP   D+   L Q NVS NLL G +P
Sbjct: 171 NLAANNLSGEISTDFNKLTRLKTLYLQENILSGSIP---DLTLKLDQFNVSFNLLKGEVP 227

Query: 208 KRFQTFGSNSFLGNSLCGKPLQDCGTKASLVVPSTPSGTDEISHGEKEKKKLSGGAIAGI 267
              ++  +++FLGNS+CG PL+ C     ++VP              +K KLSGGAIAGI
Sbjct: 228 AALRSMPASAFLGNSMCGTPLKSCSGGNDIIVPKN-----------DKKHKLSGGAIAGI 276

Query: 268 VIGSVIGFLLILLILLILCRKKSNRNTRSVDITSLKQQEVEIVDDKAVGEMDNG--YSVA 325
           VIGSV+GF+LIL+IL +LC KK  + T +VD+ ++K  EVEI  +K +GE++NG  YSVA
Sbjct: 277 VIGSVVGFVLILIILFVLCGKKRGKKTSAVDVAAVKHSEVEIQGEKPIGEVENGNGYSVA 336

Query: 326 AAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGT 385
           AAAAAAM G GN  G        NG  K+LVFFGNAARVFDLEDLLRASAEVLGKGTFGT
Sbjct: 337 AAAAAAMTGNGNAKGDMS-----NGGAKRLVFFGNAARVFDLEDLLRASAEVLGKGTFGT 391

Query: 386 AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYD 445
           AYKA+LEMGT+VAVKRLKDVTISE EF++KIEGVGA++HE+LVPLRAYYYS DEKLLVYD
Sbjct: 392 AYKAILEMGTVVAVKRLKDVTISENEFREKIEGVGAMDHEHLVPLRAYYYSRDEKLLVYD 451

Query: 446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL 505
           Y+ MGSLSALLHGNKGAGRTPLNWE+RS IALGAARGIEYLH+QGP+VSHGNIKSSNILL
Sbjct: 452 YMPMGSLSALLHGNKGAGRTPLNWEIRSGIALGAARGIEYLHSQGPSVSHGNIKSSNILL 511

Query: 506 TKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGK 565
           TKSY+ARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDP KVSQKADVYSFGVL+LELLTGK
Sbjct: 512 TKSYDARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPRKVSQKADVYSFGVLILELLTGK 571

Query: 566 APTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYP 625
           APTHA+LNEEGVDLPRWVQSIV++EWTSEVFDLELLRYQNVEEEMVQLLQLAIDC+AQYP
Sbjct: 572 APTHAILNEEGVDLPRWVQSIVREEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCTAQYP 631

Query: 626 DNRPSMSEVIKRIEELHPSSTQGHHGLQPD---DLDNISSR 663
           D RP +SEV KRIEEL  SS + +   QPD   D+D++SSR
Sbjct: 632 DKRPPISEVTKRIEELCRSSLREYQDPQPDPVNDVDDLSSR 672

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224118602|ref|XP_002317861.1| predicted protein [Populus trichocarpa] gi|222858534|gb|EEE96081.1| predicted protein [Populus trichocarpa]

 Score =  880 bits (2275), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 472/620 (76%), Positives = 529/620 (85%), Gaps = 16/620 (2%)

Query: 29  DLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLG 88
           DLS+D +ALL LRS+V GRTLLWN    +PC W GV CEQNRVT+LRLPG AL+G+IPLG
Sbjct: 1   DLSADHSALLTLRSAVLGRTLLWNTSLPTPCSWTGVSCEQNRVTVLRLPGFALTGEIPLG 60

Query: 89  ILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN 148
           I  NLT LRTLSLR N+L+ +LP DLA+C +LRNLYLQGN FSGE+P FL GL  LVRLN
Sbjct: 61  IFSNLTELRTLSLRLNALSGKLPQDLANCKSLRNLYLQGNLFSGEIPDFLFGLKDLVRLN 120

Query: 149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPK 208
           L  NNF+GEI +GF N  +L+TLFLE+N LSGS+P  D  L  L+Q NVSNNLLNGSIP 
Sbjct: 121 LGENNFTGEISTGFGNFIRLRTLFLEDNSLSGSLP--DLKLEKLEQFNVSNNLLNGSIPD 178

Query: 209 RFQTFGSNSFLGNSLCGKPLQDC-GTKASLVVPSTPSGTDEISHGEKEKKKLSGGAIAGI 267
           RF+ FG +SF G SLCGKPL  C G   S+VVPS P+G      GE ++KKLSGGAIAGI
Sbjct: 179 RFKGFGISSFGGTSLCGKPLPGCDGVPRSIVVPSRPNG-----GGEGKRKKLSGGAIAGI 233

Query: 268 VIGSVIGFLLILLILLILCRKKSNRNTRSVDITSLKQQEVEIVDDKAVGEMDNG--YSVA 325
           VIGS++G LLIL+IL+ LCRKKS+  +RS+DI S+KQQE+EI   K + E++NG  YSVA
Sbjct: 234 VIGSIMGLLLILMILMFLCRKKSSSKSRSIDIASVKQQEMEIQVGKPIVEVENGGGYSVA 293

Query: 326 AAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGT 385
           AAAAAAMVG G G     +NS   G  KKLVFFG A+RVFDLEDLLRASAEVLGKGTFGT
Sbjct: 294 AAAAAAMVGNGKGG---DLNS---GDGKKLVFFGKASRVFDLEDLLRASAEVLGKGTFGT 347

Query: 386 AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYD 445
           AYKAVLEMGT+VAVKRLKDVTISEREF++KIE VGA++HENLVPLRAYYYS DEKLLVYD
Sbjct: 348 AYKAVLEMGTVVAVKRLKDVTISEREFREKIETVGAMDHENLVPLRAYYYSGDEKLLVYD 407

Query: 446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL 505
           Y++MGSLSALLHGN+GAGRTPLNWE+RS IALGAARGIEYLH+QGPNVSHGNIKSSNILL
Sbjct: 408 YMSMGSLSALLHGNRGAGRTPLNWEIRSGIALGAARGIEYLHSQGPNVSHGNIKSSNILL 467

Query: 506 TKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGK 565
           T+SY+ARVSDFGLA LVGP STPNRVAGYRAPEVTDP KVSQKADVYSFGVLLLELLTGK
Sbjct: 468 TQSYDARVSDFGLARLVGPPSTPNRVAGYRAPEVTDPGKVSQKADVYSFGVLLLELLTGK 527

Query: 566 APTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYP 625
           APTHALLNEEGVDLPRWVQSIV++EWTSEVFDLELLRYQNVEEEMVQLLQL IDC+AQYP
Sbjct: 528 APTHALLNEEGVDLPRWVQSIVREEWTSEVFDLELLRYQNVEEEMVQLLQLGIDCAAQYP 587

Query: 626 DNRPSMSEVIKRIEELHPSS 645
           DNRPSMSEV +RI+EL  SS
Sbjct: 588 DNRPSMSEVTRRIDELCRSS 607

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449439475|ref|XP_004137511.1| PREDICTED: probable inactive receptor kinase At1g48480-like [Cucumis sativus]

 Score =  877 bits (2265), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 470/646 (72%), Positives = 532/646 (82%), Gaps = 20/646 (3%)

Query: 29  DLSSDRAALLALRSSVGGRTLL-WNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPL 87
           DL+SDR ALLALRS+VGGRTLL WNV + + C W G++CE NRVT+LRLPG AL G +P+
Sbjct: 27  DLASDRTALLALRSAVGGRTLLLWNVTDQNTCSWPGIQCEDNRVTVLRLPGAALFGPLPV 86

Query: 88  GILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL 147
           GI GNLT LRTLSLR N+L+ QLPSDL++C NLRNLYLQGN FSG +P FL  L  LVRL
Sbjct: 87  GIFGNLTHLRTLSLRLNALSGQLPSDLSACINLRNLYLQGNEFSGLIPDFLFQLPDLVRL 146

Query: 148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
           NLA+NNFSGEI SGF NLT+LKTLFLE N LSGSIP   D+   L Q NVSNN LNGS+P
Sbjct: 147 NLASNNFSGEISSGFNNLTRLKTLFLEKNHLSGSIP---DLKIPLDQFNVSNNQLNGSVP 203

Query: 208 KRFQTFGSNSFLGNSLCGKPLQDCGTKASLVVPSTPSGTDEISHGEKEKKKLSGGAIAGI 267
           K  Q+F S+SFLGNSLCG PL+ C     LVVP+   G +    G   KKKL+GGAIAGI
Sbjct: 204 KGLQSFSSSSFLGNSLCGGPLEAC--SGDLVVPTGEVGNN---GGSGHKKKLAGGAIAGI 258

Query: 268 VIGSVIGFLLILLILLILCRKKSNRNTRSVDITSLKQQEVEIVDDKAVGEMDNG-YS--- 323
           VIGSV+ F+LIL+IL++LCRKKS + T SVD+ ++K  EVEI   K  GE++NG YS   
Sbjct: 259 VIGSVLAFVLILVILMLLCRKKSAKKTSSVDVATVKNPEVEIQGSKPPGEIENGGYSNGY 318

Query: 324 ---VAAAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGK 380
                AAA A+   +  G  K +V++N  G TKKLVFFGNAARVFDLEDLLRASAEVLGK
Sbjct: 319 TVPATAAAVASAATVAAGTAKGEVSANGTG-TKKLVFFGNAARVFDLEDLLRASAEVLGK 377

Query: 381 GTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEK 440
           GTFGTAYKAVLE+G++VAVKRLKDVTI+EREF++KIE VG+++HE+LVPLRAYY+S DEK
Sbjct: 378 GTFGTAYKAVLEVGSVVAVKRLKDVTITEREFREKIEAVGSMDHESLVPLRAYYFSRDEK 437

Query: 441 LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKS 500
           LLVYDY+ MGSLSALLHGNKGAGRTPLNWE+RS IALGAARGIEYLH+QGPNVSHGNIKS
Sbjct: 438 LLVYDYMAMGSLSALLHGNKGAGRTPLNWEIRSGIALGAARGIEYLHSQGPNVSHGNIKS 497

Query: 501 SNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLE 560
           SNILLTKSY+ARVSDFGLAHLVGP STP RVAGYRAPEVTDP KVS KADVYSFGVLLLE
Sbjct: 498 SNILLTKSYDARVSDFGLAHLVGPPSTPTRVAGYRAPEVTDPRKVSHKADVYSFGVLLLE 557

Query: 561 LLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDC 620
           LLTGKAPTH+LLNEEGVDLPRWVQS+V++EWTSEVFDLELLRYQNVEEEMVQLLQLA+DC
Sbjct: 558 LLTGKAPTHSLLNEEGVDLPRWVQSVVREEWTSEVFDLELLRYQNVEEEMVQLLQLAVDC 617

Query: 621 SAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQPD---DLDNISSR 663
           +AQYPD RPSMSEV KRIEEL  SS       QPD   D D+ SSR
Sbjct: 618 AAQYPDKRPSMSEVTKRIEELRQSSLHEAVNPQPDAAHDSDDASSR 663

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449510935|ref|XP_004163815.1| PREDICTED: probable inactive receptor kinase At1g48480-like [Cucumis sativus]

 Score =  876 bits (2263), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 470/646 (72%), Positives = 532/646 (82%), Gaps = 20/646 (3%)

Query: 29  DLSSDRAALLALRSSVGGRTLL-WNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPL 87
           DL+SDR ALLALRS+VGGRTLL WNV + + C W G++CE NRVT+LRLPG AL G +P+
Sbjct: 58  DLASDRTALLALRSAVGGRTLLLWNVTDQNTCSWPGIQCEDNRVTVLRLPGAALFGPLPV 117

Query: 88  GILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL 147
           GI GNLT LRTLSLR N+L+ QLPSDL++C NLRNLYLQGN FSG +P FL  L  LVRL
Sbjct: 118 GIFGNLTHLRTLSLRLNALSGQLPSDLSACINLRNLYLQGNEFSGLIPDFLFQLPDLVRL 177

Query: 148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
           NLA+NNFSGEI SGF NLT+LKTLFLE N LSGSIP   D+   L Q NVSNN LNGS+P
Sbjct: 178 NLASNNFSGEISSGFNNLTRLKTLFLEKNHLSGSIP---DLKIPLDQFNVSNNQLNGSVP 234

Query: 208 KRFQTFGSNSFLGNSLCGKPLQDCGTKASLVVPSTPSGTDEISHGEKEKKKLSGGAIAGI 267
           K  Q+F S+SFLGNSLCG PL+ C     LVVP+   G +    G   KKKL+GGAIAGI
Sbjct: 235 KGLQSFSSSSFLGNSLCGGPLEAC--SGDLVVPTGEVGNN---GGSGHKKKLAGGAIAGI 289

Query: 268 VIGSVIGFLLILLILLILCRKKSNRNTRSVDITSLKQQEVEIVDDKAVGEMDNG-YS--- 323
           VIGSV+ F+LIL+IL++LCRKKS + T SVD+ ++K  EVEI   K  GE++NG YS   
Sbjct: 290 VIGSVLAFVLILVILMLLCRKKSAKKTSSVDVATVKNPEVEIQGSKPPGEIENGGYSNGY 349

Query: 324 ---VAAAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGK 380
                AAA A+   +  G  K +V++N  G TKKLVFFGNAARVFDLEDLLRASAEVLGK
Sbjct: 350 TVPATAAAVASAATVAAGTAKGEVSANGTG-TKKLVFFGNAARVFDLEDLLRASAEVLGK 408

Query: 381 GTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEK 440
           GTFGTAYKAVLE+G++VAVKRLKDVTI+EREF++KIE VG+++HE+LVPLRAYY+S DEK
Sbjct: 409 GTFGTAYKAVLEVGSVVAVKRLKDVTITEREFREKIEAVGSMDHESLVPLRAYYFSRDEK 468

Query: 441 LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKS 500
           LLVYDY+ MGSLSALLHGNKGAGRTPLNWE+RS IALGAARGIEYLH+QGPNVSHGNIKS
Sbjct: 469 LLVYDYMAMGSLSALLHGNKGAGRTPLNWEIRSGIALGAARGIEYLHSQGPNVSHGNIKS 528

Query: 501 SNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLE 560
           SNILLTKSY+ARVSDFGLAHLVGP STP RVAGYRAPEVTDP KVS KADVYSFGVLLLE
Sbjct: 529 SNILLTKSYDARVSDFGLAHLVGPPSTPTRVAGYRAPEVTDPRKVSHKADVYSFGVLLLE 588

Query: 561 LLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDC 620
           LLTGKAPTH+LLNEEGVDLPRWVQS+V++EWTSEVFDLELLRYQNVEEEMVQLLQLA+DC
Sbjct: 589 LLTGKAPTHSLLNEEGVDLPRWVQSVVREEWTSEVFDLELLRYQNVEEEMVQLLQLAVDC 648

Query: 621 SAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQPD---DLDNISSR 663
           +AQYPD RPSMSEV KRIEEL  SS       QPD   D D+ SSR
Sbjct: 649 AAQYPDKRPSMSEVTKRIEELRQSSLHEAVNPQPDAAHDSDDASSR 694

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357521691|ref|XP_003631134.1| Atypical receptor-like kinase MARK [Medicago truncatula] gi|355525156|gb|AET05610.1| Atypical receptor-like kinase MARK [Medicago truncatula]

 Score =  863 bits (2231), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 450/640 (70%), Positives = 515/640 (80%), Gaps = 13/640 (2%)

Query: 28  SDLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPL 87
           +DL S RAALL LRSSVGGRTL WN    SPC WAGV+C+ NRV  L LPGVALSGQIP 
Sbjct: 71  ADLDSQRAALLTLRSSVGGRTLFWNATNQSPCNWAGVQCDHNRVVELHLPGVALSGQIPT 130

Query: 88  GILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL 147
           GI  NLT LRTLSLRFN+LT  LPSDLASC NLRNLY+Q N  SG++P FL  L  +VRL
Sbjct: 131 GIFSNLTHLRTLSLRFNALTGSLPSDLASCVNLRNLYIQRNLLSGQIPDFLFTLPDMVRL 190

Query: 148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
           N+  NNFSG I + F N T+LKTLFLENN LSGSIP F      L Q NVSNN+LNGS+P
Sbjct: 191 NMGFNNFSGPISTSFNNFTRLKTLFLENNHLSGSIPQFKAF--TLDQFNVSNNVLNGSVP 248

Query: 208 KRFQTFGSNSFLGNSLCGKPLQDCGTKASLVVPSTPSGTDEISHGEKEKKKLSGGAIAGI 267
              QTF  +SFLGNSLCG+PL  C   A+    S+P   D+ +   K K KLSGGAIAGI
Sbjct: 249 VNLQTFSQDSFLGNSLCGRPLSLCPGTATDA--SSPFSADDGNIKNKNKNKLSGGAIAGI 306

Query: 268 VIGSVIGFLLILLILLILCRKKSNRNTRSVDITSLKQQEVEIVDDKAVGEMDN---GYSV 324
           VIGSV+G LL++ +L+ LCR KS++NT +VD+ ++K  E E+  DK++ +++N   GYS 
Sbjct: 307 VIGSVVGLLLLVFLLIFLCRNKSSKNTSAVDVATIKHPESELPHDKSISDLENNGNGYST 366

Query: 325 AAAAAAAMVGIGNGNGKTQVNSNVNGAT----KKLVFFGNAARVFDLEDLLRASAEVLGK 380
            +AAAAA   +     K + N N N A     KKLVFFGNAAR FDLEDLLRASAEVLGK
Sbjct: 367 TSAAAAAAAAVAVS--KVEANGNGNTAAAVGAKKLVFFGNAARAFDLEDLLRASAEVLGK 424

Query: 381 GTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEK 440
           GTFGTAYKAVLE G +VAVKRLKDVTI+E+EF++KIE VGA++H++LVPLRAYY+S DEK
Sbjct: 425 GTFGTAYKAVLESGPVVAVKRLKDVTITEKEFREKIEAVGAIDHQSLVPLRAYYFSRDEK 484

Query: 441 LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKS 500
           LLVYDY++MGSLSALLHGNKGAGRTPLNWEMRS IALGAA+GIEYLH+QGPNVSHGNIKS
Sbjct: 485 LLVYDYMSMGSLSALLHGNKGAGRTPLNWEMRSGIALGAAKGIEYLHSQGPNVSHGNIKS 544

Query: 501 SNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLE 560
           SNILLTKSY+ARVSDFGLA LVGPSSTPNRVAGYRAPEVTD  KVSQKADVYSFGVLLLE
Sbjct: 545 SNILLTKSYDARVSDFGLAQLVGPSSTPNRVAGYRAPEVTDARKVSQKADVYSFGVLLLE 604

Query: 561 LLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDC 620
           LLTGKAPTHALLNEEGVDLPRWVQS+V++EWTSEVFDLELLRYQNVEEEMVQLLQLA+DC
Sbjct: 605 LLTGKAPTHALLNEEGVDLPRWVQSVVREEWTSEVFDLELLRYQNVEEEMVQLLQLAVDC 664

Query: 621 SAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQPDDLDNI 660
           +AQYPD RPSMSEV++ IEEL  SS + +      D ++I
Sbjct: 665 AAQYPDKRPSMSEVVRSIEELRRSSLKENQDQIQHDHNDI 704

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356524700|ref|XP_003530966.1| PREDICTED: probable inactive receptor kinase At1g48480-like isoform 1 [Glycine max] gi|356524702|ref|XP_003530967.1| PREDICTED: probable inactive receptor kinase At1g48480-like isoform 2 [Glycine max]

 Score =  858 bits (2216), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 442/635 (69%), Positives = 509/635 (80%), Gaps = 19/635 (2%)

Query: 29  DLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLG 88
           DL+S+RAALLALRS+VGGRTL WN    SPC WAGV+CE + V  L LPGVALSG+IP+G
Sbjct: 23  DLASERAALLALRSAVGGRTLFWNATRESPCNWAGVQCEHDHVVELHLPGVALSGEIPVG 82

Query: 89  ILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN 148
           I GNLT LRTLSLRFN+L   LPSDLASC NLRNLY+Q N  SG++P FL     LVRLN
Sbjct: 83  IFGNLTQLRTLSLRFNALRGSLPSDLASCVNLRNLYIQRNLLSGQIPPFLFDFADLVRLN 142

Query: 149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPK 208
           L  NNFSG  P+ F +LT+LKTLFLENN+LSG IP  D +   L Q NVS+NLLNGS+P 
Sbjct: 143 LGFNNFSGPFPTAFNSLTRLKTLFLENNQLSGPIPDLDKL--TLDQFNVSDNLLNGSVPL 200

Query: 209 RFQTFGSNSFLGNSLCGKPLQDCGTKASLVVPSTPSGTDEISHGEKEKKKLSGGAIAGIV 268
           + Q F  +SFLGNSLCG+PL  C    +  +    +  D  ++    K KLSGGAIAGIV
Sbjct: 201 KLQAFPPDSFLGNSLCGRPLSLCPGDVADPLSVDNNAKDSNTN---NKSKLSGGAIAGIV 257

Query: 269 IGSVIGFLLILLILLILCRKKSNRNTRSVDITSLKQQEVE--IVDDKAVGEMDNGYSVAA 326
           +GSV+  LL++ + + LCR KS +NT +VDI ++K  E E  ++ DK V +++NG   A 
Sbjct: 258 VGSVVFLLLLVFLFIFLCRNKSAKNTSAVDIATVKHPETESKVLADKGVSDVENGAGHAN 317

Query: 327 A-AAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGT 385
             +A A V +GNG  K        G  KKLVFFGNAAR FDLEDLLRASAEVLGKGTFGT
Sbjct: 318 GNSAVAAVAVGNGGSKA-----AEGNAKKLVFFGNAARAFDLEDLLRASAEVLGKGTFGT 372

Query: 386 AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYD 445
           AYKAVLE G +VAVKRLKDVTISE+EF++KIE VGA++HE+LVPLRAYY+S DEKLLVYD
Sbjct: 373 AYKAVLEAGPVVAVKRLKDVTISEKEFREKIEAVGAMDHESLVPLRAYYFSRDEKLLVYD 432

Query: 446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL 505
           Y++MGSLSALLHGNKGAGRTPLNWE+RS IALGAARGIEYLH++GPNVSHGNIKSSNILL
Sbjct: 433 YMSMGSLSALLHGNKGAGRTPLNWEVRSGIALGAARGIEYLHSRGPNVSHGNIKSSNILL 492

Query: 506 TKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGK 565
           TKSY+ARVSDFGLAHLV PSSTPNRVAGYRAPEVTDP KVSQK DVYSFGVLLLELLTGK
Sbjct: 493 TKSYDARVSDFGLAHLVSPSSTPNRVAGYRAPEVTDPRKVSQKVDVYSFGVLLLELLTGK 552

Query: 566 APTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYP 625
           APTHALLNEEGVDLPRWVQS+V++EWTSEVFDLELLRYQNVEEEMVQLLQLA+DC+AQYP
Sbjct: 553 APTHALLNEEGVDLPRWVQSVVREEWTSEVFDLELLRYQNVEEEMVQLLQLAVDCAAQYP 612

Query: 626 DNRPSMSEVIKRIEELHPSSTQGHHGLQPDDLDNI 660
           D RPSMSEV++RI+EL  SS      L+ +D D I
Sbjct: 613 DMRPSMSEVVRRIQELRRSS------LKEEDQDQI 641

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356512960|ref|XP_003525182.1| PREDICTED: probable inactive receptor kinase At1g48480-like [Glycine max]

 Score =  848 bits (2191), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 439/621 (70%), Positives = 508/621 (81%), Gaps = 11/621 (1%)

Query: 28  SDLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPL 87
           +DL+S+RAALL+LRSSVGGRTL WN    SPC WAGV+CE   V  L LPGVALSG+IP+
Sbjct: 28  ADLASERAALLSLRSSVGGRTLFWNATRDSPCNWAGVQCEHGHVVELHLPGVALSGEIPV 87

Query: 88  GILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL 147
           GI GNLT LRTLSLRFN+L   LPSDLASC NLRNLY+Q N  +G++P FL  L  LVRL
Sbjct: 88  GIFGNLTQLRTLSLRFNALRGSLPSDLASCVNLRNLYIQRNLLTGQIPPFLFHLPDLVRL 147

Query: 148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
           N+  NNFSG  PS F NLT+LKTLFLENN+LSG IP  + +   L Q NVS+NLLNGS+P
Sbjct: 148 NMGFNNFSGPFPSAFNNLTRLKTLFLENNQLSGPIPDLNKL--TLDQFNVSDNLLNGSVP 205

Query: 208 KRFQTFGSNSFLGNSLCGKPLQDCGTKASLVVPSTPSGTDEISHGEKEKKKLSGGAIAGI 267
            + QTF  +SFLGNSLCG+PL  C     +  P +     + ++ + +K KLSGGAIAGI
Sbjct: 206 LKLQTFPQDSFLGNSLCGRPLSLC--PGDVADPLSVDNNAKGNNNDNKKNKLSGGAIAGI 263

Query: 268 VIGSVIGFLLILLILLILCRKKSNRNTRSVDITSLKQQEVE--IVDDKAVGEMDNG-YSV 324
           V+GSV+  LL++ +L+ LCR KS +NT +VDI ++K  E E  ++ DK V +++NG ++ 
Sbjct: 264 VVGSVVFLLLLVFLLIFLCRNKSAKNTSAVDIATVKHPETESEVLADKGVSDVENGGHAN 323

Query: 325 AAAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFG 384
              A A++  +  GNG     S   G  KKLVFFGNAAR FDLEDLLRASAEVLGKGTFG
Sbjct: 324 VNPAIASVAAVAAGNG----GSKAEGNAKKLVFFGNAARAFDLEDLLRASAEVLGKGTFG 379

Query: 385 TAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVY 444
           TAYKAVLE G +VAVKRLKDVTISE+EFK+KIE VGA++HE+LVPLRAYY+S DEKLLVY
Sbjct: 380 TAYKAVLEAGPVVAVKRLKDVTISEKEFKEKIEAVGAMDHESLVPLRAYYFSRDEKLLVY 439

Query: 445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNIL 504
           DY+ MGSLSALLHGNKGAGRTPLNWE+RS IALGAARGIEYLH++GPNVSHGNIKSSNIL
Sbjct: 440 DYMPMGSLSALLHGNKGAGRTPLNWEVRSGIALGAARGIEYLHSRGPNVSHGNIKSSNIL 499

Query: 505 LTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTG 564
           LTKSY+ARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDP KVSQ ADVYSFGVLLLELLTG
Sbjct: 500 LTKSYDARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPRKVSQMADVYSFGVLLLELLTG 559

Query: 565 KAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQY 624
           KAPTHALLNEEGVDLPRWVQS+V++EWTSEVFDLELLRYQNVEEEMVQLLQLA+DC+AQY
Sbjct: 560 KAPTHALLNEEGVDLPRWVQSVVREEWTSEVFDLELLRYQNVEEEMVQLLQLAVDCAAQY 619

Query: 625 PDNRPSMSEVIKRIEELHPSS 645
           PD RPSMSEV++ I+EL  SS
Sbjct: 620 PDKRPSMSEVVRSIQELRRSS 640

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|4008006|gb|AAC95351.1| receptor-like protein kinase [Arabidopsis thaliana]

 Score =  831 bits (2147), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 424/627 (67%), Positives = 510/627 (81%), Gaps = 22/627 (3%)

Query: 29  DLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLG 88
           DL++DR ALL+LRS+VGGRT  WN+ + SPC WAGV+CE NRVT LRLPGVALSG IP G
Sbjct: 22  DLNADRTALLSLRSAVGGRTFRWNIKQTSPCNWAGVKCESNRVTALRLPGVALSGDIPEG 81

Query: 89  ILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN 148
           I GNLT LRTLSLR N+L+  LP DL++ SNLR+LYLQGN FSGE+P  L  L HLVRLN
Sbjct: 82  IFGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSLSHLVRLN 141

Query: 149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPK 208
           LA+N+F+GEI SGF NLTKLKTLFLENN+LSGSIP  D  LP L Q NVSNN LNGSIPK
Sbjct: 142 LASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPDLD--LP-LVQFNVSNNSLNGSIPK 198

Query: 209 RFQTFGSNSFLGNSLCGKPLQDCGTKASLVVPSTPSG-------TDEISHGEKEKKKLSG 261
             Q F S+SFL  SLCGKPL+ C  + +  VPS P+        + E S  +K+K KLSG
Sbjct: 199 NLQRFESDSFLQTSLCGKPLKLCPDEET--VPSQPTSGGNRTPPSVEGSEEKKKKNKLSG 256

Query: 262 GAIAGIVIGSVIGFLLILLILLILCRKKSNRNTRSVDITSLKQQEVEIVDDKAVGEMDNG 321
           GAIAGIVIG V+GF LI+LIL++LCRKKSN+ +R+VDI+++KQQE EI  DK   +  N 
Sbjct: 257 GAIAGIVIGCVVGFALIVLILMVLCRKKSNKRSRAVDISTIKQQEPEIPGDKEAVDNGNV 316

Query: 322 YSVAAAAAAAMVGIGNGNGKTQVNSNVNG-ATKKLVFFGNAARVFDLEDLLRASAEVLGK 380
           YSV+AAAAAAM G    NGK    S  NG ATKKLVFFGNA +VFDLEDLLRASAEVLGK
Sbjct: 317 YSVSAAAAAAMTG----NGKA---SEGNGPATKKLVFFGNATKVFDLEDLLRASAEVLGK 369

Query: 381 GTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEK 440
           GTFGTAYKAVL+  T+VAVKRLKDV ++++EFK+KIE VGA++HENLVPLRAYY+S DEK
Sbjct: 370 GTFGTAYKAVLDAVTVVAVKRLKDVMMADKEFKEKIELVGAMDHENLVPLRAYYFSRDEK 429

Query: 441 LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKS 500
           LLVYD++ MGSLSALLHGN+GAGR+PLNW++RS IA+GAARG+ YLH+QG + SHGNIKS
Sbjct: 430 LLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLNYLHSQGTSTSHGNIKS 489

Query: 501 SNILLTKSYEARVSDFGLAHLVGPSST-PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLL 559
           SNILLTKS++A+VSDFGLA LVG S+T PNR  GYRAPEVTDP +VSQK DVYSFGV+LL
Sbjct: 490 SNILLTKSHDAKVSDFGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLL 549

Query: 560 ELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMV-QLLQLAI 618
           EL+TGKAP+++++NEEGVDLPRWV+S+ +DEW  EVFD ELL     EEEM+ +++QL +
Sbjct: 550 ELITGKAPSNSVMNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGL 609

Query: 619 DCSAQYPDNRPSMSEVIKRIEELHPSS 645
           +C++Q+PD RP MSEV++++E L P S
Sbjct: 610 ECTSQHPDQRPEMSEVVRKMENLRPYS 636

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	663
TAIR|locus:2198090	655	RKL1 "receptor-like kinase 1"	0.889	0.900	0.598	3.7e-183
TAIR|locus:2088500	647	RLK902 "receptor-like kinase 9	0.885	0.907	0.584	1.6e-173
TAIR|locus:2075502	627	AT3G02880 [Arabidopsis thalian	0.447	0.473	0.615	1.5e-138
TAIR|locus:2043858	658	AT2G26730 [Arabidopsis thalian	0.458	0.462	0.609	6.8e-132
TAIR|locus:2161308	654	AT5G58300 [Arabidopsis thalian	0.463	0.469	0.574	2.2e-122
TAIR|locus:2077898	640	AT3G08680 [Arabidopsis thalian	0.482	0.5	0.553	2.6e-117
TAIR|locus:2202359	670	AT1G68400 [Arabidopsis thalian	0.458	0.453	0.568	5.4e-115
TAIR|locus:2128414	638	AT4G23740 [Arabidopsis thalian	0.446	0.463	0.567	1.4e-112
TAIR|locus:2156784	640	RUL1 "REDUCED IN LATERAL GROWT	0.458	0.475	0.547	5.7e-107
TAIR|locus:2174190	625	LRR1 [Arabidopsis thaliana (ta	0.811	0.860	0.433	7.5e-105

TAIR|locus:2198090 RKL1 "receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1777 (630.6 bits), Expect = 3.7e-183, P = 3.7e-183
 Identities = 366/612 (59%), Positives = 443/612 (72%)

Query:    44 VGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRF 103
             VGGRT  WN+ + SPC WAGV+CE NRVT LRLPGVALSG IP GI GNLT LRTLSLR 
Sbjct:    47 VGGRTFRWNIKQTSPCNWAGVKCESNRVTALRLPGVALSGDIPEGIFGNLTQLRTLSLRL 106

Query:   104 NSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGXX 163
             N+L+  LP DL++ SNLR+LYLQGN FSGE+P  L  L HLVRLNLA+N+F+GEI SG  
Sbjct:   107 NALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSLSHLVRLNLASNSFTGEISSGFT 166

Query:   164 XXXXXXXXXXXXXRLSGSIPGFDDXXXXXXXXXXXXXXXXGSIPKRFQTFGSNSFLGNSL 223
                          +LSGSIP  D                 GSIPK  Q F S+SFL  SL
Sbjct:   167 NLTKLKTLFLENNQLSGSIPDLD---LPLVQFNVSNNSLNGSIPKNLQRFESDSFLQTSL 223

Query:   224 CGKPLQDCGTKASLVVPSTP-SGTD------EISHGEKEKKKLXXXXXXXXXXXXXXXFX 276
             CGKPL+ C  + +  VPS P SG +      E S  +K+K KL               F 
Sbjct:   224 CGKPLKLCPDEET--VPSQPTSGGNRTPPSVEGSEEKKKKNKLSGGAIAGIVIGCVVGFA 281

Query:   277 XXXXXXXXXCRKKSNRNTRSVDITSLKQQEVEIVDDKAVGEMDNGYSVXXXXXXXMVGIG 336
                      CRKKSN+ +R+VDI+++KQQE EI  DK   +  N YSV       M G  
Sbjct:   282 LIVLILMVLCRKKSNKRSRAVDISTIKQQEPEIPGDKEAVDNGNVYSVSAAAAAAMTG-- 339

Query:   337 NGNGKTQVNSNVNG-ATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT 395
               NGK    S  NG ATKKLVFFGNA +VFDLEDLLRASAEVLGKGTFGTAYKAVL+  T
Sbjct:   340 --NGKA---SEGNGPATKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVT 394

Query:   396 IVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSAL 455
             +VAVKRLKDV ++++EFK+KIE VGA++HENLVPLRAYY+S DEKLLVYD++ MGSLSAL
Sbjct:   395 VVAVKRLKDVMMADKEFKEKIELVGAMDHENLVPLRAYYFSRDEKLLVYDFMPMGSLSAL 454

Query:   456 LHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSD 515
             LHGN+GAGR+PLNW++RS IA+GAARG++YLH+QG + SHGNIKSSNILLTKS++A+VSD
Sbjct:   455 LHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQGTSTSHGNIKSSNILLTKSHDAKVSD 514

Query:   516 FGLAHLVGPSST-PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNE 574
             FGLA LVG S+T PNR  GYRAPEVTDP +VSQK DVYSFGV+LLEL+TGKAP+++++NE
Sbjct:   515 FGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLLELITGKAPSNSVMNE 574

Query:   575 EGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMV-QLLQLAIDCSAQYPDNRPSMSE 633
             EGVDLPRWV+S+ +DEW  EVFD ELL     EEEM+ +++QL ++C++Q+PD RP MSE
Sbjct:   575 EGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLECTSQHPDQRPEMSE 634

Query:   634 VIKRIEELHPSS 645
             V++++E L P S
Sbjct:   635 VVRKMENLRPYS 646

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005774 "vacuolar membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2088500 RLK902 "receptor-like kinase 902" [Arabidopsis thaliana (taxid:3702)]

 Score = 1686 (598.6 bits), Expect = 1.6e-173, P = 1.6e-173
 Identities = 357/611 (58%), Positives = 420/611 (68%)

Query:    44 VGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRF 103
             VGGRTLLW+V + SPC W GV C+  RVT LRLPG  LSG IP GI GNLT LRTLSLR 
Sbjct:    45 VGGRTLLWDVKQTSPCNWTGVLCDGGRVTALRLPGETLSGHIPEGIFGNLTQLRTLSLRL 104

Query:   104 NSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGXX 163
             N LT  LP DL SCS+LR LYLQGN FSGE+P  L  L +LVRLNLA N FSGEI SG  
Sbjct:   105 NGLTGSLPLDLGSCSDLRRLYLQGNRFSGEIPEVLFSLSNLVRLNLAENEFSGEISSGFK 164

Query:   164 XXXXXXXXXXXXXRLSGSIPGFDDXXXXXXXXXXXXXXXXGSIPKRFQTFGSNSFLGNSL 223
                          +LSGS+   D                 GSIPK  Q F S+SF+G SL
Sbjct:   165 NLTRLKTLYLENNKLSGSLLDLD---LSLDQFNVSNNLLNGSIPKSLQKFDSDSFVGTSL 221

Query:   224 CGKPLQDCGTKASLVVPSTP------SGTDEISHGEKEKKKLXXXXXXXXXXXXXXXFXX 277
             CGKPL  C  + +  VPS P       GT E S  +K++KKL                  
Sbjct:   222 CGKPLVVCSNEGT--VPSQPISVGNIPGTVEGSEEKKKRKKLSGGAIAGIVIGCVVGLSL 279

Query:   278 XXXXXXXXCRKKSNRNTRSVDITSLKQQEVEIVDDKAVGEMDNGYSVXXXXXXXMVGIGN 337
                      RKK N  TR++D+ ++K  EVEI  +KA  E     S         V    
Sbjct:   280 IVMILMVLFRKKGNERTRAIDLATIKHHEVEIPGEKAAVEAPENRSYVNEYSPSAVKA-- 337

Query:   338 GNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIV 397
                  +VNS+     KKLVFFGNA +VFDLEDLLRASAEVLGKGTFGTAYKAVL+  T+V
Sbjct:   338 ----VEVNSS---GMKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTLV 390

Query:   398 AVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLH 457
             AVKRLKDVT+++REFK+KIE VGA++HENLVPLRAYYYS DEKLLVYD++ MGSLSALLH
Sbjct:   391 AVKRLKDVTMADREFKEKIEVVGAMDHENLVPLRAYYYSGDEKLLVYDFMPMGSLSALLH 450

Query:   458 GNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFG 517
             GNKGAGR PLNWE+RS IALGAARG++YLH+Q P  SHGN+KSSNILLT S++ARVSDFG
Sbjct:   451 GNKGAGRPPLNWEVRSGIALGAARGLDYLHSQDPLSSHGNVKSSNILLTNSHDARVSDFG 510

Query:   518 LAHLVGPSST-PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEG 576
             LA LV  SST PNR  GYRAPEVTDP +VSQKADVYSFGV+LLELLTGKAP+++++NEEG
Sbjct:   511 LAQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSFGVVLLELLTGKAPSNSVMNEEG 570

Query:   577 VDLPRWVQSIVKDEWTSEVFDLELLRYQ---NVEEEMVQLLQLAIDCSAQYPDNRPSMSE 633
             +DL RWV S+ ++EW +EVFD EL+  +   +VEEEM ++LQL IDC+ Q+PD RP M E
Sbjct:   571 MDLARWVHSVAREEWRNEVFDSELMSIETVVSVEEEMAEMLQLGIDCTEQHPDKRPVMVE 630

Query:   634 VIKRIEELHPS 644
             V++RI+EL  S
Sbjct:   631 VVRRIQELRQS 641

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2075502 AT3G02880 [Arabidopsis thaliana (taxid:3702)]

 Score = 956 (341.6 bits), Expect = 1.5e-138, Sum P(2) = 1.5e-138
 Identities = 184/299 (61%), Positives = 238/299 (79%)

Query:   349 NGATKK-LVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI 407
             +GA  K L FF  +   FDL+ LL+ASAEVLGKGT G++YKA  E G +VAVKRL+DV +
Sbjct:   321 SGAVNKDLTFFVKSFGEFDLDGLLKASAEVLGKGTVGSSYKASFEHGLVVAVKRLRDVVV 380

Query:   408 SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPL 467
              E+EF++++  +G+++H NLV L AYY+S DEKLLV++Y++ GSLSA+LHGNKG GRTPL
Sbjct:   381 PEKEFRERLHVLGSMSHANLVTLIAYYFSRDEKLLVFEYMSKGSLSAILHGNKGNGRTPL 440

Query:   468 NWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST 527
             NWE R+ IALGAAR I YLH++    SHGNIKSSNILL+ SYEA+VSD+GLA ++  +S 
Sbjct:   441 NWETRAGIALGAARAISYLHSRDGTTSHGNIKSSNILLSDSYEAKVSDYGLAPIISSTSA 500

Query:   528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIV 587
             PNR+ GYRAPE+TD  K+SQKADVYSFGVL+LELLTGK+PTH  LNEEGVDLPRWVQS+ 
Sbjct:   501 PNRIDGYRAPEITDARKISQKADVYSFGVLILELLTGKSPTHQQLNEEGVDLPRWVQSVT 560

Query:   588 KDEWTSEVFDLELLRYQ-NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
             + +  S+V D EL RYQ    E +++LL++ + C+AQ+PD+RPSM+EV + IEE+  SS
Sbjct:   561 EQQTPSDVLDPELTRYQPEGNENIIRLLKIGMSCTAQFPDSRPSMAEVTRLIEEVSHSS 619

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046658 "anchored to plasma membrane" evidence=IDA

GO:0005618 "cell wall" evidence=IDA

GO:0009505 "plant-type cell wall" evidence=IDA

GO:0016020 "membrane" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0005829 "cytosol" evidence=RCA

GO:0009506 "plasmodesma" evidence=IDA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0052541 "plant-type cell wall cellulose metabolic process" evidence=RCA

GO:0052546 "cell wall pectin metabolic process" evidence=RCA

TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)]

 Score = 946 (338.1 bits), Expect = 6.8e-132, Sum P(2) = 6.8e-132
 Identities = 187/307 (60%), Positives = 236/307 (76%)

Query:   342 TQVNSNVNGATK--KLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAV 399
             T  +S + G T+  KLVF       FDLEDLLRASAEVLGKG+ GT+YKAVLE GT V V
Sbjct:   319 TGTSSGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVV 378

Query:   400 KRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGN 459
             KRLKDV  S++EF+ ++E VG + H N++PLRAYYYS DEKLLV+D++  GSLSALLHG+
Sbjct:   379 KRLKDVMASKKEFETQMEVVGKIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGS 438

Query:   460 KGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA 519
             +G+GRTPL+W+ R  IA+ AARG+ +LH     V HGNIK+SNILL  + +  VSD+GL 
Sbjct:   439 RGSGRTPLDWDNRMRIAITAARGLAHLHVSAKLV-HGNIKASNILLHPNQDTCVSDYGLN 497

Query:   520 HLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDL 579
              L   SS PNR+AGY APEV +  KV+ K+DVYSFGVLLLELLTGK+P  A L EEG+DL
Sbjct:   498 QLFSNSSPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDL 557

Query:   580 PRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE 639
             PRWV S+V++EWT+EVFD+EL+RY N+EEEMVQLLQ+A+ C +  PD RP M EV++ IE
Sbjct:   558 PRWVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIE 617

Query:   640 ELHPSST 646
             +++ S T
Sbjct:   618 DVNRSET 624

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0040007 "growth" evidence=RCA

TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)]

 Score = 908 (324.7 bits), Expect = 2.2e-122, Sum P(2) = 2.2e-122
 Identities = 178/310 (57%), Positives = 234/310 (75%)

Query:   341 KTQVNSNVNGATK-KLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAV 399
             K +  S V    K KLVFF   +  FDLEDLLRASAEVLGKG++GTAYKAVLE  T V V
Sbjct:   326 KQEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVV 385

Query:   400 KRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHG 458
             KRLK+V   +REF+ ++E +  V NH ++VPLRAYYYS DEKL+V DY   G+LS+LLHG
Sbjct:   386 KRLKEVAAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLLHG 445

Query:   459 NKGAGRTPLNWEMRSLIALGAARGIEYLHAQG-PNVSHGNIKSSNILLTKSYEARVSDFG 517
             N+G+ +TPL+W+ R  I L AA+GI +LHA G P  SHGNIKSSN+++ +  +A +SDFG
Sbjct:   446 NRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISDFG 505

Query:   518 LAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGV 577
             L  L+     P R AGYRAPEV +  K + K+DVYSFGVL+LE+LTGK+P  +   ++ V
Sbjct:   506 LTPLMAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQSPSRDDMV 565

Query:   578 DLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR 637
             DLPRWVQS+V++EWTSEVFD+EL+R+QN+EEEMVQ+LQ+A+ C AQ P+ RP+M +V++ 
Sbjct:   566 DLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRM 625

Query:   638 IEELHPSSTQ 647
             IEE+  S ++
Sbjct:   626 IEEIRVSDSE 635

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)]

 Score = 881 (315.2 bits), Expect = 2.6e-117, Sum P(2) = 2.6e-117
 Identities = 182/329 (55%), Positives = 234/329 (71%)

Query:   336 GNGNGKTQ-VNSNVNGATK-KLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEM 393
             G  + K +   S V  A K KLVFF  ++  FDLEDLLRASAEVLGKG++GT YKA+LE 
Sbjct:   303 GRSDNKAEEFGSGVQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAILEE 362

Query:   394 GTIVAVKRLKDVTISEREFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLLVYDYLTMGSL 452
             GT V VKRLK+V   +REF+ ++E VG ++ H N+ PLRAYY+S DEKLLVYDY   G+ 
Sbjct:   363 GTTVVVKRLKEVAAGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLVYDYYQGGNF 422

Query:   453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH-AQGPNVSHGNIKSSNILLTKSYEA 511
             S LLHGN   GR  L+WE R  I L AARGI ++H A G  + HGNIKS N+LLT+    
Sbjct:   423 SMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQELHV 482

Query:   512 RVSDFGLAHLVGPSST-PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
              VSDFG+A L+   +  P+R  GYRAPE  +  K +QK+DVYSFGVLLLE+LTGKA    
Sbjct:   483 CVSDFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKAAGKT 542

Query:   571 LLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ-NVEEEMVQLLQLAIDCSAQYPDNRP 629
               +EE VDLP+WVQS+V++EWT EVFD+EL++ Q NVEEEMVQ+LQ+A+ C +++PD+RP
Sbjct:   543 TGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSRP 602

Query:   630 SMSEVIKRIEELHPSST---QGHHGLQPD 655
             SM EV+  +EE+ PS +    G+    P+
Sbjct:   603 SMEEVVNMMEEIRPSGSGPGSGNRASSPE 631

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009505 "plant-type cell wall" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)]

 Score = 858 (307.1 bits), Expect = 5.4e-115, Sum P(2) = 5.4e-115
 Identities = 179/315 (56%), Positives = 232/315 (73%)

Query:   342 TQVNSNVN---GATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVA 398
             TQ N+N N   G   K+VFF    R F+LEDLLRASAE+LGKG FGTAYKAVLE G  VA
Sbjct:   330 TQNNNNQNQQVGDKGKMVFFEGTRR-FELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVA 388

Query:   399 VKRLKD-VTIS-EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALL 456
             VKRLKD VT++ ++EF+ ++E +G + H NLV L+AYY++ +EKLLVYDY+  GSL  LL
Sbjct:   389 VKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLL 448

Query:   457 HGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV--SHGNIKSSNILLTKSYEARVS 514
             HGN+G GRTPL+W  R  IA GAARG+ ++H     +  +HG+IKS+N+LL +S  ARVS
Sbjct:   449 HGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVS 508

Query:   515 DFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNE 574
             DFGL+ +  PS T  +  GYRAPE+ D  K +QK+DVYSFGVLLLE+LTGK P       
Sbjct:   509 DFGLS-IFAPSQTVAKSNGYRAPELIDGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGH 567

Query:   575 EG--VDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMS 632
              G  VDLPRWVQS+V++EWT+EVFDLEL+RY+++EEEMV LLQ+A+ C+A   D+RP M 
Sbjct:   568 SGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMG 627

Query:   633 EVIKRIEELHPSSTQ 647
              V+K IE++    ++
Sbjct:   628 HVVKLIEDIRGGGSE 642

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2128414 AT4G23740 [Arabidopsis thaliana (taxid:3702)]

 Score = 868 (310.6 bits), Expect = 1.4e-112, Sum P(2) = 1.4e-112
 Identities = 169/298 (56%), Positives = 217/298 (72%)

Query:   346 SNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDV 405
             S +     +L FF      FDLEDLLRASAEVLGKGTFGT YKAVLE  T VAVKRLKDV
Sbjct:   311 SRMEDVNNRLSFFEGCNYSFDLEDLLRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKDV 370

Query:   406 TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRT 465
                +R+F+ ++E +G + HEN+V L+AYYYS DEKL+VYDY + GS+++LLHGN+G  R 
Sbjct:   371 AAGKRDFEQQMEIIGGIKHENVVELKAYYYSKDEKLMVYDYFSRGSVASLLHGNRGENRI 430

Query:   466 PLNWEMRSLIALGAARGIEYLHAQGPN-VSHGNIKSSNILLTKSYEARVSDFGLAHLVGP 524
             PL+WE R  IA+GAA+GI  +H +    + HGNIKSSNI L       VSD GL  ++ P
Sbjct:   431 PLDWETRMKIAIGAAKGIARIHKENNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVMSP 490

Query:   525 SSTP-NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWV 583
              + P +R AGYRAPEVTD  K SQ +DVYSFGV+LLELLTGK+P H    +E + L RWV
Sbjct:   491 LAPPISRQAGYRAPEVTDTRKSSQLSDVYSFGVVLLELLTGKSPIHTTAGDEIIHLVRWV 550

Query:   584 QSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
              S+V++EWT+EVFD+ELLRY N+EEEMV++LQ+A+ C  +  D RP MS++++ IE +
Sbjct:   551 HSVVREEWTAEVFDIELLRYTNIEEEMVEMLQIAMSCVVKAADQRPKMSDLVRLIENV 608

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2156784 RUL1 "REDUCED IN LATERAL GROWTH1" [Arabidopsis thaliana (taxid:3702)]

 Score = 808 (289.5 bits), Expect = 5.7e-107, Sum P(2) = 5.7e-107
 Identities = 173/316 (54%), Positives = 222/316 (70%)

Query:   332 MVGIGNGNGKTQVNSNVNGATK-KLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAV 390
             M G+ N        S V    K KL FF      FDLEDLL+ASAEVLGKG+FGTAYKAV
Sbjct:   307 MGGV-NSKKPQDFGSGVQDPEKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYKAV 365

Query:   391 LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLLVYDYLTM 449
             LE  T V VKRL++V  S++EF+ ++E VG +N H N VPL AYYYS DEKLLVY Y+T 
Sbjct:   366 LEDTTAVVVKRLREVVASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVYKYMTK 425

Query:   450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY 509
             GSL  ++HGN+G     ++WE R  IA G ++ I YLH+      HG+IKSSNILLT+  
Sbjct:   426 GSLFGIMHGNRGD--RGVDWETRMKIATGTSKAISYLHSL--KFVHGDIKSSNILLTEDL 481

Query:   510 EARVSDFGLAHLVG-PSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP- 567
             E  +SD  L  L   P+ TP R  GY APEV +  +VSQ++DVYSFGV++LE+LTGK P 
Sbjct:   482 EPCLSDTSLVTLFNLPTHTP-RTIGYNAPEVIETRRVSQRSDVYSFGVVILEMLTGKTPL 540

Query:   568 THALLNEEGV--DLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYP 625
             T   L +E V  DLPRWV+S+V++EWT+EVFD+ELL++QN+EEEMVQ+LQLA+ C A+ P
Sbjct:   541 TQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALACVARNP 600

Query:   626 DNRPSMSEVIKRIEEL 641
             ++RP M EV + IE++
Sbjct:   601 ESRPKMEEVARMIEDV 616

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005618 "cell wall" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:2000605 "positive regulation of secondary growth" evidence=IMP

GO:0010089 "xylem development" evidence=RCA

GO:0044036 "cell wall macromolecule metabolic process" evidence=RCA

TAIR|locus:2174190 LRR1 [Arabidopsis thaliana (taxid:3702)]

 Score = 1038 (370.5 bits), Expect = 7.5e-105, P = 7.5e-105
 Identities = 247/570 (43%), Positives = 326/570 (57%)

Query:    91 GNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLA 150
             G +T+LR   +    L+  LP  + + + L  L  + N  +G +P     L  L  L L 
Sbjct:    63 GRVTALRLPGV---GLSGPLPIAIGNLTKLETLSFRFNALNGPLPPDFANLTLLRYLYLQ 119

Query:   151 TNNFSGEIPSGXXXXXXXXXXXXXXXRLSGSIPGFDDXXXXXXXXXXXXXXXXGSIPK-- 208
              N FSGEIPS                   G IP   +                G IP+  
Sbjct:   120 GNAFSGEIPSFLFTLPNIIRINLAQNNFLGRIPDNVNSATRLATLYLQDNQLTGPIPEIK 179

Query:   209 -RFQTFG--SNSFLGN---SLCGKP----LQD--CGTKASLVVPSTPSGTDEISHGEKEK 256
              + Q F   SN   G+    L G P    L +  CG K     P   +G   ++ G K K
Sbjct:   180 IKLQQFNVSSNQLNGSIPDPLSGMPKTAFLGNLLCG-KPLDACPVNGTGNGTVTPGGKGK 238

Query:   257 K-KLXXXXXXXXXXXXXXXFXXXXXXXXXXCRKKSNRNTRSVDITSLKQQEVEIVDDKAV 315
               KL                          CRKK       V   S++   V      AV
Sbjct:   239 SDKLSAGAIVGIVIGCFVLLLVLFLIVFCLCRKKKKEQV--VQSRSIEAAPVP-TSSAAV 295

Query:   316 GEMDNGYSVXXXXXXXMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASA 375
              +  NG             + NG  +  V+ N    +K L FF  +   FDL+ LL+ASA
Sbjct:   296 AKESNGPPAV---------VANGASENGVSKNPAAVSKDLTFFVKSFGEFDLDGLLKASA 346

Query:   376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
             EVLGKGTFG++YKA  + G +VAVKRL+DV + E+EF++K++ +G+++H NLV L AYY+
Sbjct:   347 EVLGKGTFGSSYKASFDHGLVVAVKRLRDVVVPEKEFREKLQVLGSISHANLVTLIAYYF 406

Query:   436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
             S DEKL+V++Y++ GSLSALLHGNKG+GR+PLNWE R+ IALGAAR I YLH++    SH
Sbjct:   407 SRDEKLVVFEYMSRGSLSALLHGNKGSGRSPLNWETRANIALGAARAISYLHSRDATTSH 466

Query:   496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFG 555
             GNIKSSNILL++S+EA+VSD+ LA ++ P+STPNR+ GYRAPEVTD  K+SQKADVYSFG
Sbjct:   467 GNIKSSNILLSESFEAKVSDYCLAPMISPTSTPNRIDGYRAPEVTDARKISQKADVYSFG 526

Query:   556 VLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN-VEEEMVQLL 614
             VL+LELLTGK+PTH  L+EEGVDLPRWV SI + +  S+VFD EL RYQ+   E M++LL
Sbjct:   527 VLILELLTGKSPTHQQLHEEGVDLPRWVSSITEQQSPSDVFDPELTRYQSDSNENMIRLL 586

Query:   615 QLAIDCSAQYPDNRPSMSEVIKRIEELHPS 644
              + I C+ QYPD+RP+M EV + IEE+  S
Sbjct:   587 NIGISCTTQYPDSRPTMPEVTRLIEEVSRS 616

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009505 "plant-type cell wall" evidence=IDA

GO:0009610 "response to symbiotic fungus" evidence=IEP

GO:0016020 "membrane" evidence=IDA

GO:0005829 "cytosol" evidence=RCA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9LP77	Y1848_ARATH	No assigned EC number	0.6762	0.9125	0.9236	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	663
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-46
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-37
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-36
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-36
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-35
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-34
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-34
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-32
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-28
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-27
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-25
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-23
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-21
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-21
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-21
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-20
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-19
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-19
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-19
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	9e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-18
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-17
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-17
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-16
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-16
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-16
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-16
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-15
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-15
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-15
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-14
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-13
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-13
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-13
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-13
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-13
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-12
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-11
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	8e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	9e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	9e-11
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-10
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-10
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-10
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-10
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-10
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	7e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-09
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-09
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-09
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-08
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	8e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	9e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-07
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	5e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	7e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	8e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-06
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-06
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-06
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-06
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-06
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	9e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-05
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-05
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-05
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-05
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-05
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	8e-05
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-04
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	8e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	9e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.001
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	0.001
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.001
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	0.001
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.001
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.001
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	0.002
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.002
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	0.003
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	0.003
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.003
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.003
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	0.003
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.004
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  175 bits (444), Expect = 8e-46
 Identities = 169/633 (26%), Positives = 270/633 (42%), Gaps = 91/633 (14%)

Query: 66  CEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLA---------- 115
           C    +  L L   +L G+IP   LG   SLR + L+ NS + +LPS+            
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKS-LGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDI 435

Query: 116 SCSNLRN--------------LYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG 161
           S +NL+               L L  N F G +P    G   L  L+L+ N FSG +P  
Sbjct: 436 SNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRK 494

Query: 162 FKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLG- 220
             +L++L  L L  N+LSG IP        L  L++S+N L+G IP  F      S L  
Sbjct: 495 LGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL 554

Query: 221 --NSLCGKPLQDCGTKASLVVPSTPSGTDEISHGEKEKKKLSGGAIAGIVIGSVIGFLLI 278
             N L G+  ++ G   SLV  +       ISH        S GA   I   +V G + +
Sbjct: 555 SQNQLSGEIPKNLGNVESLVQVN-------ISHNHLHGSLPSTGAFLAINASAVAGNIDL 607

Query: 279 L----LILLILCRKKSNRNTRSVDITSLKQQEVEIVDDKAVGEMDNGYSVAAAAAAAMVG 334
                   L  C++     +    IT                      ++ A    A+V 
Sbjct: 608 CGGDTTSGLPPCKRVRKTPSWWFYITC---------------------TLGAFLVLALVA 646

Query: 335 IGNGNGKTQVNSNV------NGATKKLVFFGNAARVFDLEDLLRASAE--VLGKGTFGTA 386
            G    + + N  +      +G  +   F    ++   + D+L +  E  V+ +G  G +
Sbjct: 647 FGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGAS 706

Query: 387 YKAVLEMGTI-VAVKRLKDV-TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVY 444
           YK       +   VK + DV +I   E  D    +G + H N+V L     S     L++
Sbjct: 707 YKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIH 762

Query: 445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ-GPNVSHGNIKSSNI 503
           +Y+   +LS +L          L+WE R  IA+G A+ + +LH +  P V  GN+    I
Sbjct: 763 EYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKI 814

Query: 504 LLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT 563
           ++    E  +    L  L+   +     + Y APE  +   +++K+D+Y FG++L+ELLT
Sbjct: 815 IIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLT 873

Query: 564 GKAPTHAL--LNEEGVDLPRWVQSIVK-DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDC 620
           GK+P  A   ++   V+  R+  S    D W       ++   QN   E+V+++ LA+ C
Sbjct: 874 GKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN---EIVEVMNLALHC 930

Query: 621 SAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQ 653
           +A  P  RP  ++V+K +E    SS+    GL+
Sbjct: 931 TATDPTARPCANDVLKTLESASRSSSSCVTGLK 963

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  136 bits (346), Expect = 7e-37
 Identities = 68/193 (35%), Positives = 101/193 (52%), Gaps = 15/193 (7%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLK--DVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
           LG+G FGT Y A   + G  VA+K +K  D +    E   +IE +  +NH N+V L   +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
              +   LV +Y   GSL  LL  N+G     L+ +    I L    G+EYLH+ G  + 
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEG----KLSEDEILRILLQILEGLEYLHSNG--II 114

Query: 495 HGNIKSSNILLTK-SYEARVSDFGLAHLVG-PSSTPNRVAG---YRAPEV-TDPCKVSQK 548
           H ++K  NILL   + + +++DFGL+ L+    S    + G   Y APEV       S+K
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 549 ADVYSFGVLLLEL 561
           +D++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  137 bits (348), Expect = 1e-36
 Identities = 74/277 (26%), Positives = 115/277 (41%), Gaps = 38/277 (13%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPLR 431
           E LG+G+FG  Y A   + G +VA+K +K   I +   +   E +     + H N+V L 
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILRE-IKILKKLKHPNIVRLY 63

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
             +   D+  LV +Y   G L  LL          L+ +            +EYLH++G 
Sbjct: 64  DVFEDEDKLYLVMEYCEGGDLFDLLKKRG-----RLSEDEARFYLRQILSALEYLHSKG- 117

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVSQK 548
            + H ++K  NILL +    +++DFGLA  + P        G   Y APEV       + 
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176

Query: 549 ADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE 608
            D++S GV+L ELLTGK P                + I K +              ++  
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLL-----ELFKKIGKPKPPFP------PPEWDISP 225

Query: 609 EMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
           E   L++  L  D     P+ R +  E ++     HP
Sbjct: 226 EAKDLIRKLLVKD-----PEKRLTAEEALQ-----HP 252

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  136 bits (345), Expect = 3e-36
 Identities = 74/201 (36%), Positives = 101/201 (50%), Gaps = 16/201 (7%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGA---VNHENLVPLR 431
             LG G+FGT YKA     G IVAVK LK  +   ++ +     +     ++H N+V L 
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
             +   D   LV +Y   G L   L         PL+ +    IAL   RG+EYLH+ G 
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLSRGG-----PLSEDEAKKIALQILRGLEYLHSNG- 118

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVT-DPCKVS 546
            + H ++K  NILL ++   +++DFGLA  L+  SS+     G   Y APEV        
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 547 QKADVYSFGVLLLELLTGKAP 567
            K DV+S GV+L ELLTGK P
Sbjct: 178 PKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  132 bits (335), Expect = 6e-35
 Identities = 78/277 (28%), Positives = 130/277 (46%), Gaps = 38/277 (13%)

Query: 376 EVLGKGTFGTAYKAVLEM-----GTIVAVKRLKDVTISE--REFKDKIEGVGAVNHENLV 428
           + LG+G FG  YK  L+         VAVK LK+    +   EF  +   +  ++H N+V
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L       +   +V +Y+  G L + L  N+      L+       AL  ARG+EYL +
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGMEYLES 120

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG----YR--APEVTDP 542
           +  N  H ++ + N L+ ++   ++SDFGL+  +       R  G     R  APE    
Sbjct: 121 K--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YRKRGGKLPIRWMAPESLKE 177

Query: 543 CKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL 601
            K + K+DV+SFGVLL E+ T G+ P   + NEE   +  ++++              L 
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---VLEYLKN-----------GYRLP 223

Query: 602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
           +  N   E+  L+     C A+ P++RP+ SE+++ +
Sbjct: 224 QPPNCPPELYDLML---QCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  132 bits (334), Expect = 1e-34
 Identities = 81/278 (29%), Positives = 135/278 (48%), Gaps = 39/278 (14%)

Query: 376 EVLGKGTFGTAYKAVLEM-----GTIVAVKRLKDVTISE--REFKDKIEGVGAVNHENLV 428
           + LG+G FG  YK  L+       T VAVK LK+    E   EF ++   +  ++H N+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L       +   +V +Y+  G L   L  +       L  +    +AL  A+G+EYL +
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLES 120

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEVTD 541
           +  N  H ++ + N L+T++   ++SDFGL+  +       R  G       + APE   
Sbjct: 121 K--NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY-YRKRGGGKLPIKWMAPESLK 177

Query: 542 PCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL 600
             K + K+DV+SFGVLL E+ T G+ P   + NEE ++L       ++D          L
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEL-------LED-------GYRL 223

Query: 601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
            R +N  +E+ +L+     C A  P++RP+ SE+++ +
Sbjct: 224 PRPENCPDELYELMLQ---CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  131 bits (333), Expect = 1e-34
 Identities = 77/277 (27%), Positives = 130/277 (46%), Gaps = 37/277 (13%)

Query: 376 EVLGKGTFGTAYKAVLEMG-----TIVAVKRLKDVTISE--REFKDKIEGVGAVNHENLV 428
           + LG+G FG  YK  L+         VAVK LK+    +   EF  +   +  ++H N+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L       +  ++V +Y+  G L   L  N+      L+       AL  ARG+EYL +
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLES 121

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG----YR--APEVTDP 542
           +  N  H ++ + N L+ ++   ++SDFGL+  +       +V G     R  APE    
Sbjct: 122 K--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YKVKGGKLPIRWMAPESLKE 178

Query: 543 CKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL 601
            K + K+DV+SFGVLL E+ T G+ P   + N E   +  +++               L 
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE---VLEYLKK-----------GYRLP 224

Query: 602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
           +  N   E+ +L+     C A+ P++RP+ SE+++ +
Sbjct: 225 KPPNCPPELYKLML---QCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  125 bits (316), Expect = 3e-32
 Identities = 76/284 (26%), Positives = 130/284 (45%), Gaps = 42/284 (14%)

Query: 376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLKDVTISE--REFKDKIEGVGAVNHENLVP 429
           + LG+G FG  YK  L+      T VAVK LK+    E  ++F  +   +  + H N+V 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGA----GRTPLNWEMRSLIALGAARGIEY 485
           L       +   LV +Y+  G L   L  ++       ++ L+ +     A+  A+G+EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST---------PNRVAGYRA 536
           L ++     H ++ + N L+ +    ++SDFGL+  V              P R   + A
Sbjct: 121 LASK--KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR---WMA 175

Query: 537 PEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV 595
           PE       + K+DV+SFGVLL E+ T G  P   L NEE   +  +++           
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYLRK---------- 222

Query: 596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE 639
               L + +   +E+ +L+     C    P++RP+ SE+++R+E
Sbjct: 223 -GYRLPKPEYCPDELYELML---SCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  124 bits (313), Expect = 6e-32
 Identities = 63/199 (31%), Positives = 97/199 (48%), Gaps = 11/199 (5%)

Query: 376 EVLGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRAY 433
           E +GKG FG  YKA     G  VA+K +K  +  ++E     I+ +    H N+V     
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
           Y   DE  +V ++ + GSL  LL          L     + +     +G+EYLH+    +
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLLKSTNQ----TLTESQIAYVCKELLKGLEYLHSN--GI 119

Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVSQKAD 550
            H +IK++NILLT   E ++ DFGL+  +  +   N + G   + APEV +      KAD
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKAD 179

Query: 551 VYSFGVLLLELLTGKAPTH 569
           ++S G+  +EL  GK P  
Sbjct: 180 IWSLGITAIELAEGKPPYS 198

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 2e-28
 Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 21/207 (10%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKD---KIEGVGAVNHENLVPLR 431
           +++G+G FG  YK + LE G  VA+K++    I E   K    +I+ +  + H N+V   
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA---RGIEYLHA 488
               + D   ++ +Y   GSL  ++         P      SL+A+      +G+ YLH 
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKF-----GPFP---ESLVAVYVYQVLQGLAYLHE 117

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPCK 544
           QG  V H +IK++NIL TK    +++DFG+A  L   S     V G   + APEV +   
Sbjct: 118 QG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG 175

Query: 545 VSQKADVYSFGVLLLELLTGKAPTHAL 571
            S  +D++S G  ++ELLTG  P + L
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDL 202

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  109 bits (275), Expect = 8e-27
 Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 31/210 (14%)

Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLR 431
           E+LG+G+FG+ Y A+ +  G ++AVK ++    SE E    + +I  + ++ H N+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62

Query: 432 AYYYSMDEK----LLVY-DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA---RGI 483
            YY S  ++    L ++ +Y++ GSLS+LL          L  E   +I         G+
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-----KLP-E--PVIRKYTRQILEGL 114

Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR---VAG---YRAP 537
            YLH+ G  + H +IK +NIL+      +++DFG A  +G   T      V G   + AP
Sbjct: 115 AYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Query: 538 EVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           EV    +  + AD++S G  ++E+ TGK P
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  110 bits (276), Expect = 6e-25
 Identities = 64/160 (40%), Positives = 87/160 (54%), Gaps = 4/160 (2%)

Query: 70  RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNH 129
            + +L L G  L G+IP   L NLTSL  L+L  N L  Q+P +L    +L+ +YL  N+
Sbjct: 165 SLKVLDLGGNVLVGKIP-NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNN 223

Query: 130 FSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVL 189
            SGE+P  + GL  L  L+L  NN +G IPS   NL  L+ LFL  N+LSG IP     L
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283

Query: 190 PNLQQLNVSNNLLNGSIPK---RFQTFGSNSFLGNSLCGK 226
             L  L++S+N L+G IP+   + Q         N+  GK
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGK 323

Length = 968

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  103 bits (257), Expect = 8e-24
 Identities = 75/281 (26%), Positives = 121/281 (43%), Gaps = 30/281 (10%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE----FKDKIEGVGAVNHE-NLVPL 430
             LG+G+FG  Y A      +VA+K L     S+ +    F  +I+ + ++NH  N+V L
Sbjct: 6   RKLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
             ++       LV +Y+  GSL  LL      G    +  +  L  +     +EYLH++G
Sbjct: 64  YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI--LSALEYLHSKG 121

Query: 491 PNVSHGNIKSSNILLTKSY-EARVSDFGLAHLVGPSSTPNRV----------AGYRAPEV 539
             + H +IK  NILL +     ++ DFGLA L+    + + +           GY APEV
Sbjct: 122 --IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179

Query: 540 ---TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF 596
                    S  +D++S G+ L ELLTG  P     N       + ++ I++    S   
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS--QTLKIILELPTPSLAS 237

Query: 597 DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR 637
            L     + + +    LL+  +      P NR S S  +  
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAK---DPKNRLSSSSDLSH 275

Length = 384

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  100 bits (252), Expect = 1e-23
 Identities = 76/289 (26%), Positives = 123/289 (42%), Gaps = 40/289 (13%)

Query: 378 LGKGTFGTAYKAVLE-----MGTIVAVKRLK--DVTISEREFKDKIEGVGAVNHENLVPL 430
           LG+G FG       +      G  VAVK L          +F+ +IE +  ++HEN+V  
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 431 RAYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
           +        +   L+ +YL  GSL   L  +    R  +N +   L +    +G++YL +
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLGS 127

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR-------APEVTD 541
           Q     H ++ + NIL+      ++SDFGLA ++        V           APE   
Sbjct: 128 QR--YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185

Query: 542 PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL-EL 600
             K S  +DV+SFGV L EL T   P+             +++ I   +    V  L EL
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPSQ-------SPPAEFLRMIGIAQGQMIVTRLLEL 238

Query: 601 L-------RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH 642
           L       R  +  +E+  L++L   C    P +RPS +++I  ++ L 
Sbjct: 239 LKEGERLPRPPSCPDEVYDLMKL---CWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 71/216 (32%), Positives = 110/216 (50%), Gaps = 30/216 (13%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVK--RLKDVTISE-REFKDKIEGVGAVNHENLVPLRAY 433
           +G GTFG  Y AV L+ G ++AVK  R++D      +E  D+++ +  + H NLV     
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---- 63

Query: 434 YYSM---DEKLLVY-DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           YY +    EK+ ++ +Y + G+L  LL      GR  L+  +  +  L    G+ YLH+ 
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEELLEH----GRI-LDEHVIRVYTLQLLEGLAYLHSH 118

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP-----NRVAG---YRAPEVTD 541
           G  + H +IK +NI L  +   ++ DFG A  +  ++T        +AG   Y APEV  
Sbjct: 119 G--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 542 PCKVSQK---ADVYSFGVLLLELLTGKAPTHALLNE 574
             K       AD++S G ++LE+ TGK P   L NE
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 95.4 bits (238), Expect = 8e-22
 Identities = 65/273 (23%), Positives = 113/273 (41%), Gaps = 28/273 (10%)

Query: 368 EDLLRASAEVLGKGTFGTAYKAVL-EMGTIVAVKRLK--DVTISEREFKDKIEGVGAVNH 424
            DL R    VLG+G+ G  YK      G I A+K++         ++   +++ + +   
Sbjct: 1   SDLERVK--VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCES 58

Query: 425 ENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
             +V     +Y   E  +V +Y+  GSL+ LL          +   + + IA    +G++
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG-----KIPEPVLAYIARQILKGLD 113

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR----VAGYRAPEVT 540
           YLH +  ++ H +IK SN+L+    E +++DFG++ ++  +            Y +PE  
Sbjct: 114 YLHTK-RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI 172

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL 600
                S  AD++S G+ LLE   GK P    L          +Q+I              
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFP---FLPPGQPSFFELMQAICDGP-------PPS 222

Query: 601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSE 633
           L  +    E    +     C  + P  RPS +E
Sbjct: 223 LPAEEFSPEFRDFISA---CLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 15/210 (7%)

Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLK-DVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G FG  ++ + +    VA+K LK D  + +++F+ +++ +  + H++L+ L A    
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPNVS 494
            +   ++ + +  GSL A L   +G         + SLI +    A G+ YL  Q  N  
Sbjct: 74  GEPVYIITELMEKGSLLAFLRSPEGQ-----VLPVASLIDMACQVAEGMAYLEEQ--NSI 126

Query: 495 HGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAGYR--APEVTDPCKVSQKAD 550
           H ++ + NIL+ +    +V+DFGLA L+      + ++   Y+  APE       S K+D
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSD 186

Query: 551 VYSFGVLLLELLT-GKAPTHALLNEEGVDL 579
           V+SFG+LL E+ T G+ P   + N E  D 
Sbjct: 187 VWSFGILLYEMFTYGQVPYPGMNNHEVYDQ 216

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 31/209 (14%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK-----DVTISEREFKDKIEGVGAVNHENLVP 429
           + +G GT+G  YKA  +  G +VA+K +K     D  I ++E    I  +    H N+V 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQE----ISMLKECRHPNIVA 64

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
               Y   D+  +V +Y   GSL  +        R PL+    + +     +G+ YLH  
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQDIYQ----VTRGPLSELQIAYVCRETLKGLAYLHET 120

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--------TPNRVAGYRAPEVT- 540
           G    H +IK +NILLT+  + +++DFG++  +  +         TP     + APEV  
Sbjct: 121 G--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPY----WMAPEVAA 174

Query: 541 --DPCKVSQKADVYSFGVLLLELLTGKAP 567
                    K D+++ G+  +EL   + P
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 98.0 bits (244), Expect = 4e-21
 Identities = 55/128 (42%), Positives = 74/128 (57%), Gaps = 1/128 (0%)

Query: 81  LSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVG 140
           LSG+IP  I G LTSL  L L +N+LT  +PS L +  NL+ L+L  N  SG +P  +  
Sbjct: 224 LSGEIPYEI-GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282

Query: 141 LHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
           L  L+ L+L+ N+ SGEIP     L  L+ L L +N  +G IP     LP LQ L + +N
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342

Query: 201 LLNGSIPK 208
             +G IPK
Sbjct: 343 KFSGEIPK 350

Length = 968

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 93.1 bits (232), Expect = 4e-21
 Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 19/209 (9%)

Query: 364 VFDLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAV 422
           VFD+        E LG+G++G+ YKA+  E G +VA+K +  V    +E   +I  +   
Sbjct: 4   VFDIL-------EKLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQC 55

Query: 423 NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
           +   +V     Y+   +  +V +Y   GS+S ++   K   +T L  E  + I     +G
Sbjct: 56  DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM---KITNKT-LTEEEIAAILYQTLKG 111

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPE 538
           +EYLH+      H +IK+ NILL +  +A+++DFG++  L    +  N V G   + APE
Sbjct: 112 LEYLHSN--KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPE 169

Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           V      + KAD++S G+  +E+  GK P
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 92.8 bits (231), Expect = 5e-21
 Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 16/198 (8%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
             +GKG FG         G  VAVK LKD + + + F  +   +  + H NLV L     
Sbjct: 12  ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
             +   +V +Y+  GSL   L   +  GR  +    +   AL    G+EYL  +  N  H
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK--NFVH 125

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKAD 550
            ++ + N+L+++   A+VSDFGLA      ++  + +G     + APE     K S K+D
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSD 181

Query: 551 VYSFGVLLLELLT-GKAP 567
           V+SFG+LL E+ + G+ P
Sbjct: 182 VWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 92.4 bits (230), Expect = 7e-21
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 15/206 (7%)

Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG  +       T VAVK LK  T+S   F  + + +  + H+ LV L A     
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73

Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPNVSH 495
           +   +V +Y++ GSL   L    G G+      +  L+ + A  A G+ YL ++  N  H
Sbjct: 74  EPIYIVTEYMSKGSLLDFLK--SGEGK---KLRLPQLVDMAAQIAEGMAYLESR--NYIH 126

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKAD 550
            ++ + NIL+ ++   +++DFGLA L+       R        + APE  +  + + K+D
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSD 186

Query: 551 VYSFGVLLLELLT-GKAPTHALLNEE 575
           V+SFG+LL E++T G+ P   + N E
Sbjct: 187 VWSFGILLTEIVTYGRVPYPGMTNRE 212

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 92.4 bits (229), Expect = 7e-21
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 14/208 (6%)

Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   S 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 72

Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y++ GSL   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 73  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA------YVERMNYVHR 126

Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 187 WSFGILLTELTTKGRVPYPGMVNREVLD 214

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 90.6 bits (226), Expect = 2e-20
 Identities = 75/288 (26%), Positives = 134/288 (46%), Gaps = 62/288 (21%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKR--LKDVTISEREF-KDKIEGVGAVNHENLVPLR 431
           + +GKG+FG  Y       G +  +K   L +++  ERE   ++++ +  +NH N++   
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII--- 62

Query: 432 AYYYSMDEK---LLVYDYLTMGSLSALLHGNKGAGRTP-----LNWEMRSLIALGAARGI 483
            YY S +EK    +V +Y   G LS  +   K  G+       L+W ++  +AL      
Sbjct: 63  KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL------ 116

Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--------TPNRVAGYR 535
           +YLH++   + H +IK  NI LT +   ++ DFG++ ++  +         TP     Y 
Sbjct: 117 KYLHSR--KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPY----YL 170

Query: 536 APEVTDPCKV---SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT 592
           +PE+   C+    + K+D++S G +L EL T K P       EG +L      I+K ++ 
Sbjct: 171 SPEL---CQNKPYNYKSDIWSLGCVLYELCTLKHPF------EGENLLELALKILKGQYP 221

Query: 593 --SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
                +  EL         +V  L L  D     P+ RPS++++++  
Sbjct: 222 PIPSQYSSEL-------RNLVSSL-LQKD-----PEERPSIAQILQSP 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 89.8 bits (223), Expect = 5e-20
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 15/206 (7%)

Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG  ++ +    T VAVK LK  T+  ++F  + + +  + H  L+ L A     
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73

Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPNVSH 495
           +   +V + +  GSL   L G  G        ++  LI + A  A G+ YL AQ  N  H
Sbjct: 74  EPIYIVTELMKYGSLLEYLQGGAGR-----ALKLPQLIDMAAQVASGMAYLEAQ--NYIH 126

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKAD 550
            ++ + N+L+ ++   +V+DFGLA ++       R        + APE     + S K+D
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186

Query: 551 VYSFGVLLLELLT-GKAPTHALLNEE 575
           V+SFG+LL E++T G+ P   + N E
Sbjct: 187 VWSFGILLTEIVTYGRMPYPGMTNAE 212

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 93.8 bits (233), Expect = 1e-19
 Identities = 49/149 (32%), Positives = 79/149 (53%), Gaps = 6/149 (4%)

Query: 67  EQNRVTMLRLPGVALSGQIPLGIL--GNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLY 124
           + N +T+L L    L+G+IP G+   GNL  L   S   NSL  ++P  L +C +LR + 
Sbjct: 354 KHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFS---NSLEGEIPKSLGACRSLRRVR 410

Query: 125 LQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPG 184
           LQ N FSGE+P     L  +  L+++ NN  G I S   ++  L+ L L  N+  G +P 
Sbjct: 411 LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPD 470

Query: 185 FDDVLPNLQQLNVSNNLLNGSIPKRFQTF 213
                  L+ L++S N  +G++P++  + 
Sbjct: 471 SFGS-KRLENLDLSRNQFSGAVPRKLGSL 498

Length = 968

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 87.9 bits (218), Expect = 3e-19
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 27/208 (12%)

Query: 377 VLGKGTFGTAYKAV----LEMGTI-VAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVP 429
           VLG G FGT YK V     E   I VA+K L++ T   + +E  D+   + +V+H ++V 
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 430 LRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGA--GRTPLNWEMRSLIALGAARGIEYL 486
           L      +  ++ L+   + +G L   +  +K     +  LNW       +  A+G+ YL
Sbjct: 74  L--LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR------APEVT 540
             +   + H ++ + N+L+      +++DFGLA L+          G +      A E  
Sbjct: 126 EEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 541 DPCKVSQKADVYSFGVLLLELLT-GKAP 567
                + K+DV+S+GV + EL+T G  P
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 83/295 (28%), Positives = 130/295 (44%), Gaps = 54/295 (18%)

Query: 378 LGKGTFGTAYKAVLEM----------GTIVAVKRLKDVTISE-REFKDKIEGVGAVNHEN 426
           LGKG FG+     +E+          G +VAVK+L+  T    R+F+ +IE + ++ H+N
Sbjct: 12  LGKGNFGS-----VELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDN 66

Query: 427 LVPLRAYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
           +V  +   YS   +   LV +YL  GSL   L  +    R  L+     L A    +G+E
Sbjct: 67  IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGME 122

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV----------GPSSTPNRVAGY 534
           YL ++     H ++ + NIL+      ++ DFGL  ++           P  +P  +  Y
Sbjct: 123 YLGSK--RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP--IFWY 178

Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVDLPRWVQSIVKDE 590
            APE     K S  +DV+SFGV+L EL T      +P    +   G D     Q IV   
Sbjct: 179 -APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG--QMIV--- 232

Query: 591 WTSEVFDLELL----RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
                  +ELL    R         ++  +  +C    P  RPS SE+  ++E +
Sbjct: 233 ----YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 87.5 bits (218), Expect = 5e-19
 Identities = 80/309 (25%), Positives = 127/309 (41%), Gaps = 74/309 (23%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGA-----------VN 423
           E LG+GT+G  YKA   + G IVA+K+++          ++ EG+ +           + 
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKIR--------LDNEEEGIPSTALREISLLKELK 56

Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWE---MRSLIALGAA 480
           H N+V L    ++  +  LV++Y  M  L   L    G      N     M  L+     
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP--LSPNLIKSIMYQLL----- 108

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG---PSSTPNRVA-GYRA 536
           RG+ Y H+    + H ++K  NIL+ +    +++DFGLA   G    + T   V   YRA
Sbjct: 109 RGLAYCHSH--RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRA 166

Query: 537 PEVTDPCKV-SQKADVYSFGVLLLELLTGKAPTHA------------LL---NEE---GV 577
           PE+    K  S   D++S G +  E++TGK                 +L    EE   GV
Sbjct: 167 PEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226

Query: 578 D-LPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEV 634
             LP +       ++  +  +  L     ++ E + LL   L  +     P  R S  E 
Sbjct: 227 TKLPDY--KPTFPKFPPKDLEKVL---PRLDPEGIDLLSKMLQYN-----PAKRISAKEA 276

Query: 635 IKRIEELHP 643
           +K     HP
Sbjct: 277 LK-----HP 280

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 87.0 bits (215), Expect = 5e-19
 Identities = 67/247 (27%), Positives = 122/247 (49%), Gaps = 29/247 (11%)

Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG  + A     T VAVK +K  ++S   F  +   +  + H+ LV L A   + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVTK 72

Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPNVSH 495
           +   ++ +++  GSL   L  ++G  + PL      LI   A  A G+ ++  +  N  H
Sbjct: 73  EPIYIITEFMAKGSLLDFLKSDEG-SKQPLP----KLIDFSAQIAEGMAFIEQR--NYIH 125

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKAD 550
            +++++NIL++ S   +++DFGLA ++  +    R        + APE  +    + K+D
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185

Query: 551 VYSFGVLLLELLT-GKAPTHALLN-------EEGVDLPRWVQSIVKDEWTSEVFDLELLR 602
           V+SFG+LL+E++T G+ P   + N       E G  +PR       +    E++++ +  
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR------PENCPEELYNIMMRC 239

Query: 603 YQNVEEE 609
           ++N  EE
Sbjct: 240 WKNRPEE 246

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 86.7 bits (215), Expect = 5e-19
 Identities = 74/275 (26%), Positives = 125/275 (45%), Gaps = 36/275 (13%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVK--RLKDVTISEREFKDKIEGVGAVNHENLVPLRAY 433
           E +GKG FG  YK VL+  T VAVK  R       +R+F  + E +   +H N+V L   
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
                   +V + +  GSL   L   K         +M    +L AA G+EYL ++  N 
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQM----SLDAAAGMEYLESK--NC 114

Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAH-----LVGPSSTPNRVA-GYRAPEVTDPCKVSQ 547
            H ++ + N L+ ++   ++SDFG++      +   S    ++   + APE  +  + + 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 548 KADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD--LELLRYQ 604
           ++DV+S+G+LL E  + G  P   + N++                T E  +    +   Q
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQ----------------TRERIESGYRMPAPQ 218

Query: 605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE 639
              EE+ +L+     C A  P+NRPS SE+   ++
Sbjct: 219 LCPEEIYRLMLQ---CWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 26/211 (12%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK----DVTISE--REFKDKIEGVGAVNHENLV 428
           E+LG G+FG+ Y+ + L+ G   AVK +       T  E  ++ + +I  +  + H N+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 429 PLRAYYYSM--DEKLLVY-DYLTMGSLSALLHGNKGAGRTPL-NWEMRSLIALGAARGIE 484
               Y  +   ++ L ++ + +  GSL+ LL    G+   P+     R ++      G+E
Sbjct: 66  ---QYLGTEREEDNLYIFLELVPGGSLAKLL-KKYGSFPEPVIRLYTRQILL-----GLE 116

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTD 541
           YLH +  N  H +IK +NIL+  +   +++DFG+A  V   S      G   + APEV  
Sbjct: 117 YLHDR--NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174

Query: 542 PCKV-SQKADVYSFGVLLLELLTGKAPTHAL 571
                   AD++S G  +LE+ TGK P   L
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 86.6 bits (214), Expect = 7e-19
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 16/206 (7%)

Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG  +       T VAVK LK  T+S   F ++ + +  + H+ LV L A   S 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYA-VVSE 72

Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPNVSH 495
           +   +V +Y++ GSL   L    G GR     ++ +L+ + A  A G+ Y+     N  H
Sbjct: 73  EPIYIVTEYMSKGSLLDFL--KDGEGR---ALKLPNLVDMAAQVAAGMAYIERM--NYIH 125

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKAD 550
            +++S+NIL+      +++DFGLA L+  +    R        + APE     + + K+D
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 551 VYSFGVLLLELLT-GKAPTHALLNEE 575
           V+SFG+LL EL+T G+ P   + N E
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMNNRE 211

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 86.2 bits (213), Expect = 9e-19
 Identities = 70/261 (26%), Positives = 127/261 (48%), Gaps = 32/261 (12%)

Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG  +       T VAVK LK  T+S + F ++   +  + H+ LV L A     
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73

Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPNVSH 495
           +   ++ +Y+  GSL   L  ++G G+  L      LI   A  A G+ Y+  +  N  H
Sbjct: 74  EPIYIITEYMAKGSLLDFLKSDEG-GKVLLP----KLIDFSAQIAEGMAYIERK--NYIH 126

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKAD 550
            +++++N+L+++S   +++DFGLA ++  +    R        + APE  +    + K+D
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186

Query: 551 VYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           V+SFG+LL E++T GK P   + N +       V S ++  +        + R +N  +E
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGY-------RMPRMENCPDE 232

Query: 610 MVQLLQLAIDCSAQYPDNRPS 630
           +  +++    C  +  + RP+
Sbjct: 233 LYDIMKT---CWKEKAEERPT 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 85.9 bits (212), Expect = 1e-18
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 14/205 (6%)

Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+    F  + + +  + H+ LVPL A   S 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYA-VVSE 72

Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +++  GSL   L    G   + P   +M + IA G A  IE +     N  H 
Sbjct: 73  EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY-IERM-----NYIHR 126

Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+  +   +++DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 552 YSFGVLLLELLT-GKAPTHALLNEE 575
           +SFG+LL EL+T G+ P   ++N E
Sbjct: 187 WSFGILLTELVTKGRVPYPGMVNRE 211

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 24/202 (11%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE-------REFKDKIEGVGAVNHENLVP 429
           +G+GT+G  YKA     G IVA+K++K    SE       RE K   E    +NH N++ 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKE----LNHPNIIK 62

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           L   +    +  LV++++    L  L+       +  L   +         +G+ + H+ 
Sbjct: 63  LLDVFRHKGDLYLVFEFMDT-DLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHSH 117

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP--NRVAG--YRAPEVTDPCKV 545
              + H ++K  N+L+      +++DFGLA   G    P  + V    YRAPE+    K 
Sbjct: 118 --GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 546 -SQKADVYSFGVLLLELLTGKA 566
            S   D++S G +  ELL+ + 
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRP 197

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 85.4 bits (211), Expect = 2e-18
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 12/207 (5%)

Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           +G G FG  +         VA+K +++  +SE +F ++ + +  ++H  LV L       
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71

Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGN 497
               LV++++  G LS  L   +G         M     L    G+ YL +   NV H +
Sbjct: 72  SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGM----CLDVCEGMAYLESS--NVIHRD 125

Query: 498 IKSSNILLTKSYEARVSDFGLAHLV----GPSSTPNRV-AGYRAPEVTDPCKVSQKADVY 552
           + + N L+ ++   +VSDFG+   V      SST  +    + +PEV    K S K+DV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185

Query: 553 SFGVLLLELLT-GKAPTHALLNEEGVD 578
           SFGVL+ E+ + GK P     N E V+
Sbjct: 186 SFGVLMWEVFSEGKTPYENRSNSEVVE 212

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 68/213 (31%), Positives = 101/213 (47%), Gaps = 28/213 (13%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAY 433
           EV+G+GT+G  YKA   + G +VA+K +  +   E E K++   +    NH N+    A 
Sbjct: 12  EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI----AT 67

Query: 434 YYSM----------DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
           +Y            D+  LV +    GS++ L+ G +  G+  L  E  + I     RG+
Sbjct: 68  FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-RLKEEWIAYILRETLRGL 126

Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGL-AHLVGPSSTPNRVAG---YRAPEV 539
            YLH     V H +IK  NILLTK+ E ++ DFG+ A L       N   G   + APEV
Sbjct: 127 AYLHEN--KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184

Query: 540 -----TDPCKVSQKADVYSFGVLLLELLTGKAP 567
                        ++DV+S G+  +EL  GK P
Sbjct: 185 IACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 28/225 (12%)

Query: 376 EVLGKGTFGTAYKAVLEMG------TIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENL 427
             LG+G FG  +              +VAVK LK+     + ++F+ + E +    HEN+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALL--HG-------NKGAGRTPLNWEMRSLIALG 478
           V         D  ++V++Y+  G L+  L  HG       +  +    L       IA+ 
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR--- 535
            A G+ YL +Q  +  H ++ + N L+      ++ DFG++  V  ++   RV G+    
Sbjct: 131 IASGMVYLASQ--HFVHRDLATRNCLVGYDLVVKIGDFGMSRDV-YTTDYYRVGGHTMLP 187

Query: 536 ----APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
                PE     K + ++DV+SFGV+L E+ T GK P + L NEE
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 77/273 (28%), Positives = 125/273 (45%), Gaps = 38/273 (13%)

Query: 377 VLGKGTFGTA--YKAVLEMGTIVAVKRLKDVTISEREFKD---KIEGVGAVNHENLVPLR 431
           VLGKG FG A  Y+   E  ++V  K +    +SE+E +D   +I  +  + H N++   
Sbjct: 7   VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNII--- 62

Query: 432 AYYYS-MDEKLLV--YDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
           AYY   MD+  L+   +Y   G+L   +   KG        EM           + Y+H 
Sbjct: 63  AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIHK 119

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-STPNRVAG---YRAPEVTDPCK 544
            G  + H +IK+ NI LTK+   ++ DFG++ ++G   S    V G   Y +PE+    K
Sbjct: 120 AG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK 177

Query: 545 VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ 604
            + K+D+++ G +L ELLT K         +  +    V  IV+  +T  V       Y 
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTF------DATNPLNLVVKIVQGNYTPVV-----SVYS 226

Query: 605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR 637
               E++ L+        Q P+ RP+  EV+ +
Sbjct: 227 ---SELISLVH---SLLQQDPEKRPTADEVLDQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 85.3 bits (212), Expect = 3e-18
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 25/204 (12%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVG-------AVNHENL 427
           E +G+G  G  YKA     G  VA+K+++ +       K   E +           H N+
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMR-LR------KQNKELIINEILIMKDCKHPNI 77

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           V     Y   DE  +V +Y+  GSL+ ++  N       +N    + +     +G+EYLH
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLH 133

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-STPNRVAG---YRAPEVTDPC 543
           +Q  NV H +IKS NILL+K    +++DFG A  +    S  N V G   + APEV    
Sbjct: 134 SQ--NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK 191

Query: 544 KVSQKADVYSFGVLLLELLTGKAP 567
               K D++S G++ +E+  G+ P
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 88.4 bits (219), Expect = 4e-18
 Identities = 66/220 (30%), Positives = 99/220 (45%), Gaps = 42/220 (19%)

Query: 15  LLLLIISTFSFSFSDLSSDRAALL-ALRSSVG---GRTLLWNVYEASPCKWAGVECEQ-N 69
            L+ ++     +FS L ++   LL + +SS+         WN   A  C W G+ C   +
Sbjct: 11  YLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNS-SADVCLWQGITCNNSS 69

Query: 70  RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGN 128
           RV  + L G  +SG+I   I   L  ++T++L  N L+  +P D+  + S+LR       
Sbjct: 70  RVVSIDLSGKNISGKISSAIFR-LPYIQTINLSNNQLSGPIPDDIFTTSSSLR------- 121

Query: 129 HFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDV 188
                             LNL+ NNF+G IP G   +  L+TL L NN LSG IP     
Sbjct: 122 -----------------YLNLSNNNFTGSIPRGS--IPNLETLDLSNNMLSGEIPNDIGS 162

Query: 189 LPNLQQLNVSNNLLNGSIPK--------RFQTFGSNSFLG 220
             +L+ L++  N+L G IP          F T  SN  +G
Sbjct: 163 FSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVG 202

Length = 968

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 12/207 (5%)

Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG  +         VA+K +++  +SE +F ++ + +  ++H NLV L       
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71

Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGN 497
               +V +Y+  G L   L   KG   T    +M           +EYL + G    H +
Sbjct: 72  RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM----CSDVCEAMEYLESNG--FIHRD 125

Query: 498 IKSSNILLTKSYEARVSDFGLAHLV----GPSSTPNRV-AGYRAPEVTDPCKVSQKADVY 552
           + + N L+ +    +VSDFGLA  V      SS   +    +  PEV D  + S K+DV+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185

Query: 553 SFGVLLLELLT-GKAPTHALLNEEGVD 578
           SFGVL+ E+ + GK P     N E V+
Sbjct: 186 SFGVLMWEVFSEGKMPYERFSNSEVVE 212

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 83.0 bits (205), Expect = 1e-17
 Identities = 69/264 (26%), Positives = 124/264 (46%), Gaps = 35/264 (13%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           + LG G FG  +       T VA+K LK  ++S   F  +   +  + H  LV L A   
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV- 70

Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPNV 493
           + +   ++ +Y+  GSL   L   +G  +  +N     LI + A  A G+ ++  +  N 
Sbjct: 71  TQEPIYIITEYMENGSLVDFLKTPEGI-KLTIN----KLIDMAAQIAEGMAFIERK--NY 123

Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQK 548
            H +++++NIL++++   +++DFGLA L+  +    R        + APE  +    + K
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 549 ADVYSFGVLLLELLT-GKAPTHALLNEEGV-DLPRWVQSIVKDEWTSEVFDLELLRYQNV 606
           +DV+SFG+LL E++T G+ P   + N E + +L R  +    D    E+++L        
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL-------- 235

Query: 607 EEEMVQLLQLAIDCSAQYPDNRPS 630
              M         C  + P+ RP+
Sbjct: 236 ---MRL-------CWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 86.4 bits (214), Expect = 2e-17
 Identities = 64/192 (33%), Positives = 90/192 (46%), Gaps = 11/192 (5%)

Query: 70  RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNH 129
           R+ +L+L     SG+IP   LG   +L  L L  N+LT ++P  L S  NL  L L  N 
Sbjct: 333 RLQVLQLWSNKFSGEIPKN-LGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNS 391

Query: 130 FSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVL 189
             GE+P  L     L R+ L  N+FSGE+PS F  L  +  L + NN L G I      +
Sbjct: 392 LEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDM 451

Query: 190 PNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPLQDCGTKASLVVPSTPSGTDEI 249
           P+LQ L+++ N   G +P    +FGS          + L     + S  VP       E+
Sbjct: 452 PSLQMLSLARNKFFGGLP---DSFGSKRL-------ENLDLSRNQFSGAVPRKLGSLSEL 501

Query: 250 SHGEKEKKKLSG 261
              +  + KLSG
Sbjct: 502 MQLKLSENKLSG 513

Length = 968

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 67/199 (33%), Positives = 107/199 (53%), Gaps = 20/199 (10%)

Query: 376 EVLGKGTFGTAYKAVLE---MGTIVAVKRLK-DVTISEREFKDKIEGVGAVNHENLVPLR 431
           E++G+G FG    AVL+    G  VAVK +K DVT   + F ++   +  ++H+NLV L 
Sbjct: 12  EIIGEGEFG----AVLQGEYTGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLL 65

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
                 +   +V + ++ G+L   L   +  GR  ++       +L  A G+EYL ++  
Sbjct: 66  GVILH-NGLYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLESK-- 119

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV--AGYRAPEVTDPCKVSQKA 549
            + H ++ + NIL+++   A+VSDFGLA  VG     N      + APE     K S K+
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVKWTAPEALKHKKFSSKS 178

Query: 550 DVYSFGVLLLELLT-GKAP 567
           DV+S+GVLL E+ + G+AP
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 17/200 (8%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
           E +GKG+FG  YKA+      +VA+K + D+  +E E +D  + +  ++      +  YY
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65

Query: 435 YSM--DEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            S     KL ++ +Y   GS   LL          L+    + I      G+EYLH +G 
Sbjct: 66  GSFLKGSKLWIIMEYCGGGSCLDLLK------PGKLDETYIAFILREVLLGLEYLHEEG- 118

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPCKVSQ 547
              H +IK++NILL++  + +++DFG++  L    S  N   G   + APEV       +
Sbjct: 119 -KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177

Query: 548 KADVYSFGVLLLELLTGKAP 567
           KAD++S G+  +EL  G+ P
Sbjct: 178 KADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 80.3 bits (199), Expect = 1e-16
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 33/209 (15%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLK--------DVTISEREFKDKIEGVGAVNHENLV 428
           +G+GT+G  YKA   + G +VA+K+++         +T + RE    I+ +  + H N+V
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPIT-AIRE----IKLLQKLRHPNIV 61

Query: 429 PLRAYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWE--MRSLIALGAARGIE 484
            L+    S  +    +V++Y+    L+ LL  +     T    +  M+ L+      G++
Sbjct: 62  RLKEIVTSKGKGSIYMVFEYMDH-DLTGLLD-SPEVKFTESQIKCYMKQLL-----EGLQ 114

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG--YRAPEV 539
           YLH+ G  + H +IK SNIL+      +++DFGLA      ++    NRV    YR PE+
Sbjct: 115 YLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172

Query: 540 TDPCKVSQKA-DVYSFGVLLLELLTGKAP 567
                      D++S G +L EL  GK  
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELFLGKPI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 75/276 (27%), Positives = 131/276 (47%), Gaps = 39/276 (14%)

Query: 378 LGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +     VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73

Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  +N  +   +A   +  +EYL  +  N  H 
Sbjct: 74  EPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK--NFIHR 128

Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 188

Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL-----ELLRYQN 605
           ++FGVLL E+ T G +P        G+DL             S+V++L      + R + 
Sbjct: 189 WAFGVLLWEIATYGMSPY------PGIDL-------------SQVYELLEKGYRMERPEG 229

Query: 606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
              ++ +L++    C    P +RPS +E+ +  E +
Sbjct: 230 CPPKVYELMR---ACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 80/283 (28%), Positives = 125/283 (44%), Gaps = 48/283 (16%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGA---VNHENLVPLR 431
           EV+G G     Y A+ L     VA+KR+ D+   +    +  + V A    NH N+V   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVV--- 62

Query: 432 AYYYSM---DEKLLVYDYLTMGSLSALL-HGNKGAGRTPLNWEMRSLIAL---GAARGIE 484
            YY S    DE  LV  YL+ GSL  ++       G         ++IA       +G+E
Sbjct: 63  KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD------EAIIATVLKEVLKGLE 116

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGL-AHLVGPSSTPNRV----AG---YRA 536
           YLH+ G    H +IK+ NILL +    +++DFG+ A L        +V     G   + A
Sbjct: 117 YLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174

Query: 537 PEVTDPCK-VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLP--RWVQSIVKDEWTS 593
           PEV +       KAD++SFG+  +EL TG AP            P  + +   ++++  S
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYS--------KYPPMKVLMLTLQNDPPS 226

Query: 594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK 636
                +  +Y     +M+ L      C  + P  RP+  E++K
Sbjct: 227 LETGADYKKYSKSFRKMISL------CLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 78/291 (26%), Positives = 128/291 (43%), Gaps = 45/291 (15%)

Query: 362 ARVFDLED--LLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLK-DVTISEREFKDKIE 417
           A +F  +D   L      +G G+FG  Y A  +    +VA+K++      S  +++D I+
Sbjct: 5   AELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK 64

Query: 418 GVG---AVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL 474
            V     + H N +  +  Y       LV +Y  +GS S +L  +K     PL     + 
Sbjct: 65  EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY-CLGSASDILEVHK----KPLQEVEIAA 119

Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGY 534
           I  GA +G+ YLH+      H +IK+ NILLT+    +++DFG A LV P+++      +
Sbjct: 120 ICHGALQGLAYLHSH--ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYW 177

Query: 535 RAPEV---TDPCKVSQKADVYSFGVLLLELLTGKAP------THALLNEEGVDLPRWVQS 585
            APEV    D  +   K DV+S G+  +EL   K P        AL +    D P    +
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP----T 233

Query: 586 IVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK 636
           +  ++W+               +     +     C  + P +RPS  E++K
Sbjct: 234 LSSNDWS---------------DYFRNFVDS---CLQKIPQDRPSSEELLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 71/222 (31%), Positives = 105/222 (47%), Gaps = 31/222 (13%)

Query: 359 GNAARVFDLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRL-----KD-VTISE-R 410
           G    V + E L R     +G+GT+G  Y+A     G IVA+K++     +D + IS  R
Sbjct: 1   GRCRSVTEFEKLNR-----IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR 55

Query: 411 EFKDKIEGVGAVNHENLVPLR--AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLN 468
           E    I  +  + H N+V L+       +D   LV +Y     L++LL        TP +
Sbjct: 56  E----ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMP----TPFS 106

Query: 469 WEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP---S 525
                 + L   RG++YLH     + H ++K SN+LLT     +++DFGLA   G     
Sbjct: 107 ESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164

Query: 526 STPNRVA-GYRAPEVTDPCKVSQKA-DVYSFGVLLLELLTGK 565
            TP  V   YRAPE+   C     A D+++ G +L ELL  K
Sbjct: 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 39/211 (18%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE----------REFKDKIEGVGAVNHEN 426
           LG+GT+   YKA   E G IVA+K++K     E          RE K   E    + H N
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQE----LKHPN 63

Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLN---WEMRSLIALGAARGI 483
           ++ L   +       LV++++    L  ++  +K    TP +   + + +L      RG+
Sbjct: 64  IIGLLDVFGHKSNINLVFEFME-TDLEKVIK-DKSIVLTPADIKSYMLMTL------RGL 115

Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRA 536
           EYLH+    + H ++K +N+L+      +++DFGLA   G   +PNR          YRA
Sbjct: 116 EYLHSN--WILHRDLKPNNLLIASDGVLKLADFGLARSFG---SPNRKMTHQVVTRWYRA 170

Query: 537 PEVTDPCKV-SQKADVYSFGVLLLELLTGKA 566
           PE+    +      D++S G +  ELL    
Sbjct: 171 PELLFGARHYGVGVDMWSVGCIFAELLLRVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 55/234 (23%)

Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRL-----------KDVTISEREFKDKIEGVGAVN 423
           +++G+G+F T   A   E     A+K L           K V I E+E   ++ G     
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKI-EKEVLTRLNG----- 60

Query: 424 HENLVPLRAYYYSM--DEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA 480
           H  ++ L   YY+   +E L  V +Y   G L   +          L+ +     A    
Sbjct: 61  HPGIIKL---YYTFQDEENLYFVLEYAPNGELLQYIRKYGS-----LDEKCTRFYAAEIL 112

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV--------- 531
             +EYLH++G  + H ++K  NILL K    +++DFG A ++ P+S+P            
Sbjct: 113 LALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 532 ---------------AGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
                          A Y +PE+ +     + +D+++ G ++ ++LTGK P   
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 67/256 (26%), Positives = 113/256 (44%), Gaps = 43/256 (16%)

Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENL 427
           E LG+G FG  YK  L         T VA+K LK+      ++EF+ + E +  + H N+
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALL-----HGNKGAG------RTPLNWEMRSLIA 476
           V L           ++++YL  G L   L     H + GA       ++ L+      IA
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR- 535
           +  A G+EYL +   +  H ++ + N L+ +    ++SDFGL+  +  S+   RV     
Sbjct: 131 IQIAAGMEYLSSH--HFVHRDLAARNCLVGEGLTVKISDFGLSRDI-YSADYYRVQSKSL 187

Query: 536 ------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE------------- 575
                  PE     K + ++D++SFGV+L E+ + G  P +   N+E             
Sbjct: 188 LPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPC 247

Query: 576 GVDLPRWVQSIVKDEW 591
             D P  V +++ + W
Sbjct: 248 PEDCPARVYALMIECW 263

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 82.2 bits (203), Expect = 4e-16
 Identities = 59/156 (37%), Positives = 77/156 (49%), Gaps = 4/156 (2%)

Query: 74  LRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGE 133
           L L    LSG+IP  I G+ +SL+ L L  N L  ++P+ L + ++L  L L  N   G+
Sbjct: 145 LDLSNNMLSGEIPNDI-GSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQ 203

Query: 134 VPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQ 193
           +P  L  +  L  + L  NN SGEIP     LT L  L L  N L+G IP     L NLQ
Sbjct: 204 IPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQ 263

Query: 194 QLNVSNNLLNGSIPKR---FQTFGSNSFLGNSLCGK 226
            L +  N L+G IP      Q   S     NSL G+
Sbjct: 264 YLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE 299

Length = 968

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 21/210 (10%)

Query: 366 DLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAV-- 422
           DLE L       LG G  G   K +    G I+AVK ++ + I+E   K  +  +  +  
Sbjct: 2   DLEYL-----GELGAGNSGVVSKVLHRPTGKIMAVKTIR-LEINEAIQKQILRELDILHK 55

Query: 423 -NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR 481
            N   +V     +Y+  +  +  +Y+  GSL  +L   +  GR P    +   IA+   +
Sbjct: 56  CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPE--RILGKIAVAVLK 111

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAP 537
           G+ YLH +   + H ++K SNIL+    + ++ DFG++  LV  +S      G   Y AP
Sbjct: 112 GLTYLHEK-HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV--NSLAKTFVGTSSYMAP 168

Query: 538 EVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           E       S K+D++S G+ L+EL TG+ P
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 78.3 bits (193), Expect = 4e-16
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 23/208 (11%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGV------GAVNHENLVP 429
             +GKG+FG  +K V +    V    +K + +S+   +++ E +        ++   ++ 
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYA--MKQIDLSKMNRREREEAIDEARVLAKLDSSYII- 62

Query: 430 LRAYYYSMDEKLLVY---DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
              YY S  +K  +    +Y   G L  LL   +G    PL  +      +    G+ +L
Sbjct: 63  --RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHL 117

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-PNRVAG---YRAPEVTDP 542
           H++   + H +IKS N+ L      ++ D G+A L+  ++   N + G   Y +PE+ + 
Sbjct: 118 HSK--KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED 175

Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHA 570
              ++K+DV++ GV+L E  TGK P  A
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 68/285 (23%), Positives = 121/285 (42%), Gaps = 42/285 (14%)

Query: 377 VLGKGTFGTAYKAVL------EMGTIVAVKRL--KDVTISEREFKDKIEGVGAVNHENLV 428
            LG+G FG  + A           T+V VK L        + EF+ +++    ++H+N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRT----PLNWEMRSLIALGAARGIE 484
            L       +   ++ +Y  +G L   L   K         PL+ + +  +    A G++
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--------HLVGPSSTPNRVAGYRA 536
           +L        H ++ + N L++   E +VS   L+        + +  +  P R   + A
Sbjct: 132 HLSNA--RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR---WLA 186

Query: 537 PEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV 595
           PE       S K+DV+SFGVL+ E+ T G+ P + L +EE ++               + 
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN-------------RLQA 233

Query: 596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE 640
             LEL   +     + +L+     C A  P +RPS SE++  + E
Sbjct: 234 GKLELPVPEGCPSRLYKLMT---RCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 79.4 bits (195), Expect = 4e-16
 Identities = 71/269 (26%), Positives = 125/269 (46%), Gaps = 31/269 (11%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G+FG  Y A  +    +VA+K++    K      ++   +++ +  + H N +  + 
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
            Y       LV +Y  +GS S LL  +K     PL     + I  GA +G+ YLH+   N
Sbjct: 93  CYLREHTAWLVMEY-CLGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSH--N 145

Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEV---TDPCKVSQKA 549
           + H +IK+ NILLT+  + +++DFG A +  P+++      + APEV    D  +   K 
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKV 205

Query: 550 DVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           DV+S G+  +EL   K P   L N   +     +  I ++E  +    L+   + +    
Sbjct: 206 DVWSLGITCIELAERKPP---LFNMNAMSA---LYHIAQNESPT----LQSNEWSDYFRN 255

Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
            V        C  + P +RP+  E++K +
Sbjct: 256 FVD------SCLQKIPQDRPTSEELLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 78.0 bits (192), Expect = 6e-16
 Identities = 68/270 (25%), Positives = 117/270 (43%), Gaps = 33/270 (12%)

Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG            VA+K +K+ ++SE EF ++ + +  ++HE LV L       
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71

Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYLHAQGPNVSH 495
               +V +Y++ G L   L   +  G+     +   L+ +      G+ YL ++     H
Sbjct: 72  RPIYIVTEYMSNGCLLNYL---REHGKRF---QPSQLLEMCKDVCEGMAYLESK--QFIH 123

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKAD 550
            ++ + N L+      +VSDFGL+  V      + V       +  PEV    K S K+D
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183

Query: 551 VYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           V++FGVL+ E+ + GK P     N E V+  +  Q             L L R     E+
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERFNNSETVE--KVSQG------------LRLYRPHLASEK 229

Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIE 639
           +  ++     C  +  + RP+  +++  IE
Sbjct: 230 VYAIM---YSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 78.0 bits (192), Expect = 9e-16
 Identities = 81/296 (27%), Positives = 123/296 (41%), Gaps = 52/296 (17%)

Query: 376 EVLGKGTFGTAYKAVL--------EMGTIVAVKRLK-DVTISERE-FKDKIEGVGAVNHE 425
            VLG+G FG   K  L          G +VAVK LK +        +K +I  +  + HE
Sbjct: 10  RVLGEGHFG---KVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66

Query: 426 NLVPLRAYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
           N+V  +        K   L+ +Y+ +GSL   L  +K      LN     L A     G+
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEGM 120

Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRA 536
            YLH+Q  +  H ++ + N+LL      ++ DFGLA  V       RV         + A
Sbjct: 121 AYLHSQ--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178

Query: 537 PEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPR--WVQSI-VKDEWTS 593
            E     K S  +DV+SFGV L ELLT      +         P   + + I  K    +
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQS---------PPKKFEEMIGPKQGQMT 229

Query: 594 EVFDLELL-------RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH 642
            V  +ELL         +N  +E+  L++   +C       RP+   +I  ++E+H
Sbjct: 230 VVRLIELLERGMRLPCPKNCPQEVYILMK---NCWETEAKFRPTFRSLIPILKEMH 282

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 28/212 (13%)

Query: 377 VLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDK----------IEGVGAVNHE 425
           ++G G+FG+ Y  +    G ++AVK+++  ++S      K          I  +  + HE
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           N+V         D   +  +Y+  GS++ALL+ N GA    L   +R+ +     +G+ Y
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETL---VRNFVR-QILKGLNY 121

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR---------- 535
           LH +G  + H +IK +NIL+      ++SDFG++  +  +S   +  G R          
Sbjct: 122 LHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179

Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           APEV      ++KAD++S G L++E+LTGK P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 15/205 (7%)

Query: 371 LRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLK-DVTISEREFKDKIEGVG---AVNHE 425
           L +    +G G+FG  Y A  +    +VA+K++      S  +++D I+ V     + H 
Sbjct: 16  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75

Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           N +  R  Y       LV +Y  +GS S LL  +K     PL     + +  GA +G+ Y
Sbjct: 76  NTIQYRGCYLREHTAWLVMEY-CLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAY 130

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEV---TDP 542
           LH+   N+ H ++K+ NILL++    ++ DFG A ++ P++       + APEV    D 
Sbjct: 131 LHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDE 188

Query: 543 CKVSQKADVYSFGVLLLELLTGKAP 567
            +   K DV+S G+  +EL   K P
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 28/218 (12%)

Query: 376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLK-DVTISER-EFKDKIEGVGAVNHENLVP 429
           +V+G G FG  ++ +L+M       VA+K LK   T  +R +F  +   +G  +H N++ 
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI----EY 485
           L          +++ +Y+  G+L   L  + G        E  S   +G  RGI    +Y
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDG--------EFSSYQLVGMLRGIAAGMKY 122

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPE 538
           L     N  H ++ + NIL+  + E +VSDFGL+ ++   P  T     G     + APE
Sbjct: 123 LSDM--NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180

Query: 539 VTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
                K +  +DV+SFG+++ E+++ G+ P   + N E
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 76.7 bits (188), Expect = 2e-15
 Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 16/213 (7%)

Query: 366 DLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHE 425
           D E+L     E +GKG+FG  +K +      V   ++ D+  +E E +D  + +  ++  
Sbjct: 1   DPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 426 NLVPLRAYY--YSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
           +   +  YY  Y  D KL ++ +YL  GS   LL         PL+    + I     +G
Sbjct: 60  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKG 113

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPE 538
           ++YLH++     H +IK++N+LL++  E +++DFG+A  L       N   G   + APE
Sbjct: 114 LDYLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171

Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHAL 571
           V        KAD++S G+  +EL  G+ P   L
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 54/199 (27%), Positives = 100/199 (50%), Gaps = 9/199 (4%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGV---GAVNHENLVPLRAY 433
           LGKG++G+ YK   L      A+K +   ++S++E +D +  +    +VNH N++  +  
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
           +   ++  +V +Y   G LS  +   +   R  +  +    I +   RG++ LH Q   +
Sbjct: 68  FLDGNKLCIVMEYAPFGDLSKAIS-KRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ--KI 124

Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVTDPCKVSQKADV 551
            H ++KS+NILL  +   ++ D G++ ++  +    ++    Y APEV      S K+D+
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDI 184

Query: 552 YSFGVLLLELLTGKAPTHA 570
           +S G LL E+ T   P  A
Sbjct: 185 WSLGCLLYEMATFAPPFEA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 76.8 bits (190), Expect = 2e-15
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 36/209 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK------DVTISEREFKD--KIEGVGAVNHEN 426
           + LG GTFG+ Y A   E G +VA+K++K      +  ++ RE K   K+       H N
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-----EHPN 59

Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWE-MRSLIALGAARGIEY 485
           +V L+  +   DE   V++Y+  G+L  L+   KG    P +   +RS+I     +G+ +
Sbjct: 60  IVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKG---KPFSESVIRSII-YQILQGLAH 114

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-------STPNRVAGYRAPE 538
           +H  G    H ++K  N+L++     +++DFGLA  +          ST  R   YRAPE
Sbjct: 115 IHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST--R--WYRAPE 168

Query: 539 V--TDPCKVSQKADVYSFGVLLLELLTGK 565
           +        S   D+++ G ++ EL T +
Sbjct: 169 ILLRSTS-YSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 77.0 bits (189), Expect = 3e-15
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 15/198 (7%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G+FG  Y A       +VAVK++    K      ++   +++ +  + H N +  + 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
            Y       LV +Y  +GS S LL  +K     PL     + I  GA +G+ YLH+   N
Sbjct: 89  CYLKEHTAWLVMEY-CLGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSH--N 141

Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEV---TDPCKVSQKA 549
           + H +IK+ NILLT+  + +++DFG A    P+++      + APEV    D  +   K 
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKV 201

Query: 550 DVYSFGVLLLELLTGKAP 567
           DV+S G+  +EL   K P
Sbjct: 202 DVWSLGITCIELAERKPP 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 79/300 (26%), Positives = 129/300 (43%), Gaps = 55/300 (18%)

Query: 377 VLGKGTFGTAYKAV------LEMGTIVAVKRLKDVTISEREFKD---KIEGVGAVNHENL 427
            LG+G FG   KA           T VAVK LK+   S  E +D   +   +  VNH ++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDLLSEFNLLKQVNHPHV 65

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLH-------------GNKGA------GRTPLN 468
           + L          LL+ +Y   GSL + L              GN+ +          L 
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 469 WEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSST 527
                  A   +RG++YL      + H ++ + N+L+ +  + ++SDFGL+  V    S 
Sbjct: 126 MGDLISFAWQISRGMQYLAEM--KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 528 PNRVAG-----YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPR 581
             R  G     + A E       + ++DV+SFGVLL E++T G  P   +        P 
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI-------APE 236

Query: 582 WVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            + +++K  +  E       R +N  EEM  L+   + C  Q PD RP+ +++ K +E++
Sbjct: 237 RLFNLLKTGYRME-------RPENCSEEMYNLM---LTCWKQEPDKRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 74.9 bits (185), Expect = 5e-15
 Identities = 67/216 (31%), Positives = 95/216 (43%), Gaps = 44/216 (20%)

Query: 378 LGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVGA-------VNHENLVP 429
           LGKG+FG       +  G + A+K LK   I +R    ++E           +NH  +V 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR---KEVEHTLTERNILSRINHPFIVK 57

Query: 430 LRAYYYSM--DEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR----- 481
           L   +Y+   +EKL LV +Y   G L + L                   +   AR     
Sbjct: 58  L---HYAFQTEEKLYLVLEYAPGGELFSHL-------------SKEGRFSEERARFYAAE 101

Query: 482 ---GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---Y 534
               +EYLH+ G  + + ++K  NILL      +++DFGLA  L    S  N   G   Y
Sbjct: 102 IVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159

Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
            APEV       +  D +S GVLL E+LTGK P +A
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 74.7 bits (184), Expect = 7e-15
 Identities = 59/214 (27%), Positives = 87/214 (40%), Gaps = 31/214 (14%)

Query: 377 VLGKGTFGTAYK----------AVLEM--GTIVAVKRLKDVTISEREFKDKIEGVGAVNH 424
           V+GKG FG              A+  M     V    +++V ++ER    ++      NH
Sbjct: 7   VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNV-LNERRILQEL------NH 59

Query: 425 ENLVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
             LV L  Y +  +E + LV D L  G L    H ++   +   + E            +
Sbjct: 60  PFLVNLW-YSFQDEENMYLVVDLLLGGDLR--YHLSQ---KVKFSEEQVKFWICEIVLAL 113

Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVT 540
           EYLH++   + H +IK  NILL +     ++DF +A  V P +     +G   Y APEV 
Sbjct: 114 EYLHSK--GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVL 171

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNE 574
                S   D +S GV   E L GK P       
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT 205

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 75.0 bits (184), Expect = 7e-15
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 28/226 (12%)

Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKDVTISER-EFKDKIEGVGAVNHENLVPL 430
           LG+G FG  + A        +   +VAVK LK+ + S R +F+ + E +  + H+++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 431 RAYYYSMDEKLLVYDYLTMGSL----------SALLHGNKGAGRTPLNWEMRSLIALGAA 480
                     L+V++Y+  G L          + +L G +      L       IA   A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------- 533
            G+ YL     +  H ++ + N L+ +    ++ DFG++  +  S+   RV G       
Sbjct: 133 SGMVYL--ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTMLPIR 189

Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +  PE     K + ++D++SFGV+L E+ T GK P + L N E ++
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 74.3 bits (183), Expect = 9e-15
 Identities = 69/275 (25%), Positives = 121/275 (44%), Gaps = 39/275 (14%)

Query: 378 LGKGTFGTAYKAVLEMGTI----VAVKRLKDVTIS--EREFKDKIEGVGAVNHENLVPLR 431
           LG G FG+  K V  M +     VAVK LK   I+  ++EF  +   +  ++H  +V L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKG-AGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                 +  +LV +   +G L   L   +                A   A G+ YL ++ 
Sbjct: 63  GVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESK- 114

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV--AG-----YRAPEVTDPC 543
            +  H ++ + N+LL   ++A++SDFG++  +G  S   R   AG     + APE  +  
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173

Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY 603
           K S K+DV+S+GV L E  +  A  +  +  +G ++   ++S              L R 
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEM--KGAEVIAMLES-----------GERLPRP 220

Query: 604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
           +   +E+  ++     C    P++RP+ SE+    
Sbjct: 221 EECPQEIYSIML---SCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 77.6 bits (191), Expect = 1e-14
 Identities = 62/188 (32%), Positives = 93/188 (49%), Gaps = 6/188 (3%)

Query: 70  RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNH 129
            +  L L    L GQIP   LG + SL+ + L +N+L+ ++P ++   ++L +L L  N+
Sbjct: 189 SLEFLTLASNQLVGQIPRE-LGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNN 247

Query: 130 FSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVL 189
            +G +P  L  L +L  L L  N  SG IP    +L KL +L L +N LSG IP     L
Sbjct: 248 LTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQL 307

Query: 190 PNLQQLNVSNNLLNGSIPKRFQTFGSNSFL---GNSLCGKPLQDCGTKASLVV--PSTPS 244
            NL+ L++ +N   G IP    +      L    N   G+  ++ G   +L V   ST +
Sbjct: 308 QNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNN 367

Query: 245 GTDEISHG 252
            T EI  G
Sbjct: 368 LTGEIPEG 375

Length = 968

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 16/197 (8%)

Query: 378 LGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFK-DKIEGVGAVNHENLVPLRAYYY 435
           +G+G+ G    A  +  G  VAVK++       RE   +++  +   +HEN+V +   Y 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
             DE  +V ++L  G+L+ ++        T +N E  + + L   R + YLH QG  V H
Sbjct: 90  VGDELWVVMEFLEGGALTDIV------THTRMNEEQIATVCLSVLRALSYLHNQG--VIH 141

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR--VAG---YRAPEVTDPCKVSQKAD 550
            +IKS +ILLT     ++SDFG    V     P R  + G   + APEV        + D
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVS-KEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200

Query: 551 VYSFGVLLLELLTGKAP 567
           ++S G++++E++ G+ P
Sbjct: 201 IWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 57/197 (28%), Positives = 100/197 (50%), Gaps = 16/197 (8%)

Query: 378 LGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFK-DKIEGVGAVNHENLVPLRAYYY 435
           +G+G+ G    A ++  G +VAVK++       RE   +++  +    HEN+V +   Y 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
             DE  +V ++L  G+L+ ++        T +N E  + + L   + +  LHAQG  V H
Sbjct: 88  VGDELWVVMEFLEGGALTDIV------THTRMNEEQIAAVCLAVLKALSVLHAQG--VIH 139

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR--VAG---YRAPEVTDPCKVSQKAD 550
            +IKS +ILLT     ++SDFG    V     P R  + G   + APE+        + D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198

Query: 551 VYSFGVLLLELLTGKAP 567
           ++S G++++E++ G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 75/283 (26%), Positives = 124/283 (43%), Gaps = 41/283 (14%)

Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEG--VGAVNHENLVP 429
            V+GKG FG  Y   L          AVK L  +T  E   +   EG  +   +H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 430 LRAYYYSMD-EKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYL 486
           L       +   L+V  Y+  G L    +  +     P    ++ LI  G   A+G+EYL
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDL---RNFIRSETHNP---TVKDLIGFGLQVAKGMEYL 114

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--TPNRVAGYRAP------E 538
            ++     H ++ + N +L +S+  +V+DFGLA  +      + +   G + P      E
Sbjct: 115 ASK--KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172

Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                K + K+DV+SFGVLL EL+T  AP +  ++   +                 V+ L
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI----------------TVYLL 216

Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           +  R    E     L ++ + C    P+ RP+ SE++ RIE++
Sbjct: 217 QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 76.0 bits (187), Expect = 3e-14
 Identities = 53/149 (35%), Positives = 79/149 (53%), Gaps = 4/149 (2%)

Query: 81  LSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVG 140
           LSG+IP  ++  L +L  L L  N+ T ++P  L S   L+ L L  N FSGE+P  L  
Sbjct: 296 LSGEIP-ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGK 354

Query: 141 LHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
            ++L  L+L+TNN +GEIP G  +   L  L L +N L G IP       +L+++ + +N
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414

Query: 201 LLNGSIPKRFQTFGSNSFL---GNSLCGK 226
             +G +P  F       FL    N+L G+
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGR 443

Length = 968

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 27/206 (13%)

Query: 376 EVLGKGTFGTAYKA-VLEMGTIVAVKRLKDV-------TISEREFKDKIEGVGAVNHENL 427
            V+G+G +G   K      G IVA+K+ K+          + RE    ++ +  + HEN+
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALRE----VKVLRQLRHENI 62

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           V L+  +       LV++Y+   +L  LL  + G G  P    +RS I     + I Y H
Sbjct: 63  VNLKEAFRRKGRLYLVFEYVER-TLLELLEASPG-GLPPD--AVRSYI-WQLLQAIAYCH 117

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN---RVAG--YRAPE--VT 540
           +   N+ H +IK  NIL+++S   ++ DFG A  +           VA   YRAPE  V 
Sbjct: 118 SH--NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG 175

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKA 566
           D     +  DV++ G ++ ELL G+ 
Sbjct: 176 DT-NYGKPVDVWAIGCIMAELLDGEP 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 73.1 bits (180), Expect = 4e-14
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 35/206 (16%)

Query: 378 LGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISE-------REFKDKIEGVGAVNHENLVP 429
           +G+G  G  +KA   E G  VA+K++    +         RE    I+ + A  H  +V 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALRE----IKALQACQHPYVVK 63

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWE-----MRSLIALGAARGIE 484
           L   +      +LV +Y+    LS +L         PL        MR L+     +G+ 
Sbjct: 64  LLDVFPHGSGFVLVMEYM-PSDLSEVLRDE----ERPLPEAQVKSYMRMLL-----KGVA 113

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG--YRAPEV 539
           Y+HA G  + H ++K +N+L++     +++DFGLA L          ++VA   YRAPE+
Sbjct: 114 YMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171

Query: 540 TDPC-KVSQKADVYSFGVLLLELLTG 564
                K     D+++ G +  ELL G
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 61/239 (25%), Positives = 109/239 (45%), Gaps = 37/239 (15%)

Query: 362 ARVFDLEDLLRASAEVLGKGTFGTAYKAVL--EMGTI---VAVKRLKDVTISE--REFKD 414
           AR+    +L +   ++LG G FGT +K +   E  +I   VA+K ++D +  +  +E  D
Sbjct: 1   ARILKETELRKL--KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITD 58

Query: 415 KIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGA--GRTPLNWEMR 472
            +  +G+++H  +V L         +L V     +GSL   +  ++ +   +  LNW   
Sbjct: 59  HMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNW--- 114

Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA 532
               +  A+G+ YL      + H N+ + NILL      +++DFG+A L+ P        
Sbjct: 115 ---CVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK---- 165

Query: 533 GYRAPEVTDPCK-----------VSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDL 579
            Y   E   P K            + ++DV+S+GV + E+++ G  P   +   E  DL
Sbjct: 166 -YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL 223

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 72.0 bits (177), Expect = 6e-14
 Identities = 67/279 (24%), Positives = 125/279 (44%), Gaps = 36/279 (12%)

Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKD-VTISER-EFKDKIEGVGAVNHENLVP 429
           +V+G G FG   +  L++       VA+K LK   +  +R +F  +   +G  +H N++ 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           L          +++ +Y+  GSL   L  N G             +  G A G++YL   
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYLSEM 125

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------YRAPEVTDPC 543
             N  H ++ + NIL+  +   +VSDFGL+  +  S       G      + APE     
Sbjct: 126 --NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183

Query: 544 KVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR 602
           K +  +DV+SFG+++ E+++ G+ P   + N++       V   V+D +          R
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGY----------R 226

Query: 603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
                +    L QL +DC  +  + RP+ S+++  ++++
Sbjct: 227 LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 72.1 bits (176), Expect = 7e-14
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 28/212 (13%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
           E++G GT+G  YK   ++ G + A+K +      E E K +I  +   +H   +   A Y
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI---ATY 68

Query: 435 YS---------MDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
           Y          MD++L LV ++   GS++ L+   KG     L  E  + I     RG+ 
Sbjct: 69  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLS 125

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFG----LAHLVGPSSTPNRVAGYRAPEVT 540
           +LH     V H +IK  N+LLT++ E ++ DFG    L   VG  +T      + APEV 
Sbjct: 126 HLHQH--KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183

Query: 541 ----DP-CKVSQKADVYSFGVLLLELLTGKAP 567
               +P      K+D++S G+  +E+  G  P
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 71.6 bits (175), Expect = 7e-14
 Identities = 59/195 (30%), Positives = 94/195 (48%), Gaps = 10/195 (5%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           + +GKG FG         G  VAVK +K+   + + F  +   +  + H NLV L     
Sbjct: 12  QTIGKGEFGDVMLGDYR-GNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 436 SMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
                L +V +Y+  GSL   L   +  GR+ L  +     +L     +EYL A   N  
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN--NFV 124

Query: 495 HGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-AGYRAPEVTDPCKVSQKADVYS 553
           H ++ + N+L+++   A+VSDFGL      +    ++   + APE     K S K+DV+S
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 184

Query: 554 FGVLLLELLT-GKAP 567
           FG+LL E+ + G+ P
Sbjct: 185 FGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 27/204 (13%)

Query: 380 KGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVGA--------VNHENLVPL 430
           KG FG+ Y A     G   A+K LK    S+   K+++  V A             +  L
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKK---SDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
              + S D   LV +YL  G  ++L+   K  G  P +W  +  IA     G+E LH +G
Sbjct: 63  YYSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDW-AKQYIA-EVVLGVEDLHQRG 117

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAH--LVGP--SSTPNRVAGYRAPEVTDPCKVS 546
             + H +IK  N+L+ ++   +++DFGL+   L       TP+    Y APE        
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD----YLAPETILGVGDD 171

Query: 547 QKADVYSFGVLLLELLTGKAPTHA 570
           + +D +S G ++ E L G  P HA
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHA 195

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 71.6 bits (175), Expect = 8e-14
 Identities = 70/273 (25%), Positives = 125/273 (45%), Gaps = 35/273 (12%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEG--VGAVNHENLVPLRAY 433
           E+LGKG FG  +K  L+  T VAVK  K+    E + K   E   +   +H N+V L   
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI--ALGAARGIEYLHAQGP 491
                   +V + +  G   + L   K   +T      + L+  AL AA G+ YL ++  
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDELKT------KQLVKFALDAAAGMAYLESK-- 112

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHL----VGPSSTPNRVA-GYRAPEVTDPCKVS 546
           N  H ++ + N L+ ++   ++SDFG++      +  SS   ++   + APE  +  + S
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172

Query: 547 QKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN 605
            ++DV+S+G+LL E  + G  P   + N++              E   + + +     Q 
Sbjct: 173 SESDVWSYGILLWETFSLGVCPYPGMTNQQA------------REQVEKGYRMSCP--QK 218

Query: 606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
             +++ +++Q    C    P+NRP  SE+ K +
Sbjct: 219 CPDDVYKVMQ---RCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 71.9 bits (176), Expect = 8e-14
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 30/212 (14%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVG---AVNHENLV 428
           EVLGKG +GT Y  +   G ++AVK++     +V  +E+E++   E V    ++ H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 429 PLRAYYYS-MDEKLL--VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
               Y  + +D+  +    +++  GS+S++L+   G    P+  +    I      G+ Y
Sbjct: 66  ---QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFCKYTKQI----LDGVAY 117

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH---LVGPSSTPNRVAG-------YR 535
           LH     V H +IK +N++L  +   ++ DFG A     VG   T + +         + 
Sbjct: 118 LHNN--CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175

Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           APEV +     +K+D++S G  + E+ TGK P
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 72.3 bits (178), Expect = 9e-14
 Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 47/222 (21%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL-----KD---VTISEREFKDKIEGVGAVNHENLV 428
           LG+GTFG  YKA  ++ G +VA+K++     KD   +T + RE    I+ +  + H N+V
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPIT-ALRE----IKILKKLKHPNVV 70

Query: 429 PL--RAYYYSMDEK------LLVYDYLTMGS-LSALLHGNKGAGRTPLNWEMRSLIALGA 479
           PL   A       K       +V  Y  M   LS LL          L         L  
Sbjct: 71  PLIDMAVERPDKSKRKRGSVYMVTPY--MDHDLSGLLENP----SVKLTESQIKCYMLQL 124

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG----- 533
             GI YLH    ++ H +IK++NIL+      +++DFGLA    GP   P    G     
Sbjct: 125 LEGINYLHEN--HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182

Query: 534 ---------YRAPE-VTDPCKVSQKADVYSFGVLLLELLTGK 565
                    YR PE +    + +   D++  G +  E+ T +
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 26/203 (12%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRL------KDVT-ISEREFKDKIEGVGAVNHENL 427
            ++G+G++G   K    E G IVA+K+       K V  I+ RE    I  +  + HENL
Sbjct: 7   GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMRE----IRMLKQLRHENL 62

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           V L   +       LV++++    L  L     G     L+            RGIE+ H
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCH 117

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH-LVGPS-STPNRVAG--YRAPE--VTD 541
           +   N+ H +IK  NIL+++S   ++ DFG A  L  P     + VA   YRAPE  V D
Sbjct: 118 SH--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGD 175

Query: 542 PCKVSQKADVYSFGVLLLELLTG 564
             K  +  D+++ G L+ E+LTG
Sbjct: 176 T-KYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 21/208 (10%)

Query: 377 VLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREF----KDKIEGVGAVNHENLVPLRA 432
           VLGKGT+G  Y A  ++ T V +  +K++   +  +     ++I     + H N+V    
Sbjct: 15  VLGKGTYGIVY-AARDLSTQVRIA-IKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA--RGIEYLHAQG 490
                    +  + +  GSLSALL    G    PL    +++I        G++YLH   
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRSKWG----PLKDNEQTIIFYTKQILEGLKYLHDN- 127

Query: 491 PNVSHGNIKSSNILL-TKSYEARVSDFG----LAHLVGPSSTPNRVAGYRAPEVTD--PC 543
             + H +IK  N+L+ T S   ++SDFG    LA +   + T      Y APEV D  P 
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186

Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHAL 571
                AD++S G  ++E+ TGK P   L
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPFIEL 214

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 72.2 bits (178), Expect = 1e-13
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 39/214 (18%)

Query: 377 VLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEG---------VGAVNHEN 426
            +G G +G    AV    G  VA+K++ +V      F D I+          +  + HEN
Sbjct: 7   PIGSGAYGVVCSAVDKRTGRKVAIKKISNV------FDDLIDAKRILREIKLLRHLRHEN 60

Query: 427 LVPLRA-----YYYSMDEKLLVYDYLTMGS-LSALLHGNKGAGRTPLNWEMRSLIALGAA 480
           ++ L            ++  +V +   M + L  ++   +     PL  +          
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTEL--METDLHKVIKSPQ-----PLTDDHIQYFLYQIL 113

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR-----VAG-- 533
           RG++YLH+   NV H ++K SNIL+  + + ++ DFGLA  V P           V    
Sbjct: 114 RGLKYLHSA--NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 534 YRAPEV-TDPCKVSQKADVYSFGVLLLELLTGKA 566
           YRAPE+     + ++  D++S G +  ELLT K 
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 60/224 (26%), Positives = 86/224 (38%), Gaps = 43/224 (19%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKD--KIEGVG-------------A 421
           LG+GT+G   KA     G IVA+K++K + IS    KD   +   G              
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 422 VNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR 481
           + HEN++ L   Y   D   LV D +    L  ++       +  L       I L    
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILN 130

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH------LVGPSS--------- 526
           G+  LH       H ++  +NI +      +++DFGLA            S         
Sbjct: 131 GLNVLHKW--YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 527 --TPNRVA-GYRAPEV-TDPCKVSQKADVYSFGVLLLELLTGKA 566
             T   V   YRAPE+     K     D++S G +  ELLTGK 
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232

Length = 335

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 16/197 (8%)

Query: 378 LGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISEREFK-DKIEGVGAVNHENLVPLRAYYY 435
           +G+G+ G    A     G  VAVK++       RE   +++  +    H N+V + + Y 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
             DE  +V ++L  G+L+ ++        T +N E  + + L   + + +LHAQG  V H
Sbjct: 87  VGDELWVVMEFLEGGALTDIV------THTRMNEEQIATVCLAVLKALSFLHAQG--VIH 138

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR--VAG---YRAPEVTDPCKVSQKAD 550
            +IKS +ILLT     ++SDFG    V     P R  + G   + APEV        + D
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPEVISRLPYGTEVD 197

Query: 551 VYSFGVLLLELLTGKAP 567
           ++S G++++E++ G+ P
Sbjct: 198 IWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 29/267 (10%)

Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG  +         VA+K + +  +SE +F ++ + +  ++H  LV L       
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71

Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGN 497
               +V +++  G L   L   +G     L+ +M   +      G+EYL     +  H +
Sbjct: 72  KPLYIVTEFMENGCLLNYLRQRQGK----LSKDMLLSMCQDVCEGMEYLERN--SFIHRD 125

Query: 498 IKSSNILLTKSYEARVSDFGLAHLV-----GPSSTPNRVAGYRAPEVTDPCKVSQKADVY 552
           + + N L++ +   +VSDFG+   V       SS       +  PEV +  K S K+DV+
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185

Query: 553 SFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMV 611
           SFGVL+ E+ T GK P     N E V            E  S  F L    Y+     M 
Sbjct: 186 SFGVLMWEVFTEGKMPFEKKSNYEVV------------EMISRGFRL----YRPKLASM- 228

Query: 612 QLLQLAIDCSAQYPDNRPSMSEVIKRI 638
            + ++   C  + P+ RP+ +E+++ I
Sbjct: 229 TVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 79/296 (26%), Positives = 129/296 (43%), Gaps = 75/296 (25%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKD---KIEGVGAVNHENLVPL-RA 432
           LG G FG  YKA   E G   A K ++    SE E +D   +I+ +    H N+V L  A
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQ--IESEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 433 YYYSMDEKLLVY-DYLTMGSLSAL-LHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
           Y+Y  + KL +  ++   G+L ++ L   +G     + +  R ++       + +LH+  
Sbjct: 71  YFY--ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML-----EALNFLHSH- 122

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHL-----------VGPSSTPNRVAGYRAPEV 539
             V H ++K+ NILLT   + +++DFG++             +G   TP     + APEV
Sbjct: 123 -KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIG---TPY----WMAPEV 174

Query: 540 TDPCKVSQ------KADVYSFGVLLLELLTGKAPTHA------LLNEEGVDLPRWVQSIV 587
              C+  +      KAD++S G+ L+EL   + P H       LL     + P   Q   
Sbjct: 175 VA-CETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQP-- 231

Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP 643
             +W+S   D                  L   C  + PD+RP+ +E++K     HP
Sbjct: 232 -SKWSSSFNDF-----------------LKS-CLVKDPDDRPTAAELLK-----HP 263

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 15/203 (7%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY- 434
           E +GKG+FG  YK +      V   ++ D+  +E E +D  + +  ++  +   +  YY 
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69

Query: 435 -YSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
            Y    KL ++ +YL  GS   LL         PL     + I     +G++YLH++   
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLKPG------PLEETYIATILREILKGLDYLHSE--R 121

Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPCKVSQK 548
             H +IK++N+LL++  + +++DFG+A  L       N   G   + APEV        K
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181

Query: 549 ADVYSFGVLLLELLTGKAPTHAL 571
           AD++S G+  +EL  G+ P   L
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 29/207 (14%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE-------REFKDKIEGVGAVNHENL 427
           E +G+GT+G  YKA     G +VA+K+++  T +E       RE    I  +  +NH N+
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 61

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           V L    ++ ++  LV+++L    L   +  +  +G  PL      L  L   +G+ + H
Sbjct: 62  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSG-IPLPLIKSYLFQL--LQGLAFCH 117

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEVT 540
           +    V H ++K  N+L+      +++DFGLA   G    P R          YRAPE+ 
Sbjct: 118 SH--RVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYTHEVVTLWYRAPEIL 172

Query: 541 DPCKV-SQKADVYSFGVLLLELLTGKA 566
             CK  S   D++S G +  E++T +A
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRA 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 28/212 (13%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
           EV+G GT+G  YK   ++ G + A+K +      E E K +I  +   +H   +   A Y
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNI---ATY 78

Query: 435 YSM----------DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
           Y            D+  LV ++   GS++ L+   KG     L  +  + I     RG+ 
Sbjct: 79  YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLA 135

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFG----LAHLVGPSSTPNRVAGYRAPEVT 540
           +LHA    V H +IK  N+LLT++ E ++ DFG    L   VG  +T      + APEV 
Sbjct: 136 HLHAH--KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193

Query: 541 ----DP-CKVSQKADVYSFGVLLLELLTGKAP 567
               +P      ++D++S G+  +E+  G  P
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 62/232 (26%), Positives = 105/232 (45%), Gaps = 28/232 (12%)

Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVTISER--EFKDKIEGVGAVNHENLV 428
           E LG+  FG  YK  L     +   +VA+K LKD+   ++  EF+ +   +  ++H N+V
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL-----HGNKGAGRTPLNWEMRSL-------IA 476
            L           ++++YL  G L   L     H + G           SL       IA
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----TPNRVA 532
           +  A G+EYL +      H ++ + NIL+ +    ++SD GL+  +  +      P  + 
Sbjct: 131 IQIAAGMEYLSSH--FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 533 GYR--APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPR 581
             R   PE     K S  +D++SFGV+L E+ + G  P +   N+E +++ R
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 70.7 bits (174), Expect = 3e-13
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 28/202 (13%)

Query: 381 GTFGTAYKAV-LEMGTIVAVKRLK--------DVTISEREFKDKIEGVGAVNHENLVPLR 431
           GT+G  Y+A   + G IVA+K+LK         +T S RE    I  +  + H N+V ++
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPIT-SLRE----INILLKLQHPNIVTVK 70

Query: 432 AYYY--SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
                 ++D+  +V +Y+    L +L+   K         E++ L+ L    G+ +LH  
Sbjct: 71  EVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS---EVKCLM-LQLLSGVAHLHDN 125

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG---PSSTPNRVA-GYRAPEVT-DPCK 544
              + H ++K+SN+LL      ++ DFGLA   G      T   V   YRAPE+     +
Sbjct: 126 W--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKE 183

Query: 545 VSQKADVYSFGVLLLELLTGKA 566
            S   D++S G +  ELLT K 
Sbjct: 184 YSTAIDMWSVGCIFAELLTKKP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 70.5 bits (172), Expect = 3e-13
 Identities = 64/224 (28%), Positives = 107/224 (47%), Gaps = 26/224 (11%)

Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKDVTISER-EFKDKIEGVGAVNHENLVPL 430
           LG+G FG  + A        +   +VAVK LKD + + R +F  + E +  + HE++V  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALL--HG------NKGAGRTPLNWEMRSLIALGAARG 482
                  D  ++V++Y+  G L+  L  HG       +G     L       IA   A G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YR 535
           + YL +Q  +  H ++ + N L+ ++   ++ DFG++  V  S+   RV G       + 
Sbjct: 133 MVYLASQ--HFVHRDLATRNCLVGENLLVKIGDFGMSRDV-YSTDYYRVGGHTMLPIRWM 189

Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVD 578
            PE     K + ++DV+S GV+L E+ T GK P + L N E ++
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 54/214 (25%), Positives = 105/214 (49%), Gaps = 31/214 (14%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK-DVTISERE----------FKDKIEGVGAVN 423
           E++GKGT+G  Y A+ +  G ++AVK+++   TI+ R            + +IE +  ++
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWE--MRSLIALGAAR 481
           H N+V    +  + +   +  +Y+  GS+ + L       RT   +E  +          
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-------RTYGRFEEQLVRFFTEQVLE 119

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL---VGPSSTPNRVAG---YR 535
           G+ YLH++G  + H ++K+ N+L+      ++SDFG++     +  +     + G   + 
Sbjct: 120 GLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177

Query: 536 APEV--TDPCKVSQKADVYSFGVLLLELLTGKAP 567
           APEV  +     S K D++S G ++LE+  G+ P
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 41/224 (18%)

Query: 366 DLEDLLRASAEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNH 424
           DL+DL       +G+G FGT  K +    GTI+AVKR++  T+ E+E K  +  +  V  
Sbjct: 5   DLKDL-----GEIGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEKEQKRLLMDLDVVMR 58

Query: 425 ENLVPLRAYYYS--------------MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWE 470
            +  P    +Y               MD        +++      ++      ++ +  E
Sbjct: 59  SSDCPYIVKFYGALFREGDCWICMELMD--------ISLDKFYKYVYEVL---KSVIPEE 107

Query: 471 MRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPN 529
           +   IA+   + + YL  +   + H ++K SNILL ++   ++ DFG++  LV  S    
Sbjct: 108 ILGKIAVATVKALNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD-SIAKT 165

Query: 530 RVAG---YRAPEVTDPCKVSQ---KADVYSFGVLLLELLTGKAP 567
           R AG   Y APE  DP        ++DV+S G+ L E+ TGK P
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 52/253 (20%), Positives = 114/253 (45%), Gaps = 47/253 (18%)

Query: 400 KRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKL----LVYDYLTMGSLSAL 455
           K L D+T +E      I+ +  ++  N++ +  +   + + L    L+ +Y T G L  +
Sbjct: 59  KVLIDITENE------IKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREV 112

Query: 456 LHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSD 515
           L   K      L+++ +  +A+   +G+  L+    N  + N+ S + L+T++Y+ ++  
Sbjct: 113 LDKEKD-----LSFKTKLDMAIDCCKGLYNLYKY-TNKPYKNLTSVSFLVTENYKLKIIC 166

Query: 516 FGLAHL--VGPSSTPNRVAGYRAPEVTDPC--KVSQKADVYSFGVLLLELLTGKAPTHAL 571
            GL  +    P    N +  Y + ++ +    + + K D+YS GV+L E+ TGK P    
Sbjct: 167 HGLEKILSSPPFKNVNFMV-YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF--- 222

Query: 572 LNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM----VQLLQLAID-CSAQYPD 626
              E +              T E++D  L+  +N   ++       ++  ++ C++    
Sbjct: 223 ---ENLT-------------TKEIYD--LIINKNNSLKLPLDCPLEIKCIVEACTSHDSI 264

Query: 627 NRPSMSEVIKRIE 639
            RP++ E++  + 
Sbjct: 265 KRPNIKEILYNLS 277

Length = 283

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 70.0 bits (171), Expect = 5e-13
 Identities = 70/232 (30%), Positives = 114/232 (49%), Gaps = 25/232 (10%)

Query: 376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLK-DVTISEREFKDKI--EGVGAVNHEN--LVP 429
           +VLGKG+FG    A L+  G   AVK LK DV + + + +  +  + V A+  EN  L  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           L   + + +    V ++L  G L  + H  +  GR  L     +  A     G+++LH++
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDL--MFH-IQDKGRFDL--YRATFYAAEIVCGLQFLHSK 115

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLA--HLVGPS--STPNRVAGYRAPEVTDPCKV 545
           G  + + ++K  N++L +    +++DFG+   ++ G +  ST      Y APE+    K 
Sbjct: 116 G--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY 173

Query: 546 SQKADVYSFGVLLLELLTGKAPTHA-----LLNEEGVD---LPRWVQSIVKD 589
           +   D +SFGVLL E+L G++P H      L     VD    PRW+    KD
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKD 225

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 69.6 bits (170), Expect = 8e-13
 Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 35/237 (14%)

Query: 376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLK-DVTISEREFKDKIEGVG--------AVNHE 425
           ++LGKG+FG  + A L+      A+K LK DV + +    D +E           A  H 
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD----DDVECTMVEKRVLSLAWEHP 56

Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
            L  L   + + +    V +YL  G L  + H          +    +  A     G+++
Sbjct: 57  FLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCH---KFDLPRATFYAAEIICGLQF 111

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--HLVGPSSTPNRVAG---YRAPEVT 540
           LH++G  + + ++K  NILL      +++DFG+   +++G + T     G   Y APE+ 
Sbjct: 112 LHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT-CTFCGTPDYIAPEIL 168

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVD--------LPRWVQSIVKD 589
              K +   D +SFGVLL E+L G++P H    EE            PRW+    KD
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKD 225

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 21/209 (10%)

Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAY 433
           E +GKGT+G  YK   +  G++ AVK L  ++  + E + +   + ++ NH N+V     
Sbjct: 28  ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87

Query: 434 YYSMDEKL-----LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
           +Y  D+ +     LV +    GS++ L+ G    G+  L+  M S I  GA  G+++LH 
Sbjct: 88  FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR-LDEAMISYILYGALLGLQHLHN 146

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGL-AHLVGPSSTPNRVAG---YRAPEVTDPCK 544
               + H ++K +NILLT     ++ DFG+ A L       N   G   + APEV   C+
Sbjct: 147 N--RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI-ACE 203

Query: 545 ------VSQKADVYSFGVLLLELLTGKAP 567
                    + DV+S G+  +EL  G  P
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPP 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 64/227 (28%), Positives = 106/227 (46%), Gaps = 29/227 (12%)

Query: 378 LGKGTFGTAYKA------VLEMGTIVAVKRLKDVTISER-EFKDKIEGVGAVNHENLVPL 430
           LG+G FG  + A        +   +VAVK LKD T++ R +F+ + E +  + HE++V  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLH-----------GNKGAGRTPLNWEMRSLIALGA 479
                  D  ++V++Y+  G L+  L            G     +  L       IA   
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------ 533
           A G+ YL +Q  +  H ++ + N L+  +   ++ DFG++  V  S+   RV G      
Sbjct: 133 ASGMVYLASQ--HFVHRDLATRNCLVGANLLVKIGDFGMSRDV-YSTDYYRVGGHTMLPI 189

Query: 534 -YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVD 578
            +  PE     K + ++DV+SFGV+L E+ T GK P   L N E ++
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 71/293 (24%), Positives = 125/293 (42%), Gaps = 50/293 (17%)

Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKD-VTISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+         E  T VAVK + +  ++ ER EF ++   +      ++V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLH-----GNKGAGRTPLNWEMRSLIALGA--ARG 482
           L          L+V + +  G L + L           GR P    ++ +I + A  A G
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT--LQEMIQMAAEIADG 131

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAG 533
           + YL+A+     H ++ + N ++   +  ++ DFG+   +         G    P R   
Sbjct: 132 MAYLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186

Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWT 592
           + APE       +  +D++SFGV+L E+ +  + P   L NE+       V   V D   
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLKFVMDGGY 239

Query: 593 SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHPS 644
                  L +  N  E +  L+++   C    P  RP+  E++  + ++LHPS
Sbjct: 240 -------LDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDLHPS 282

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 16/209 (7%)

Query: 366 DLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHE 425
           D E+L     E +GKG+FG  +K +      V   ++ D+  +E E +D  + +  ++  
Sbjct: 1   DPEELF-TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 426 NLVPLRAYY--YSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
           +   +  YY  Y    KL ++ +YL  GS   LL         P +    + +     +G
Sbjct: 60  DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG------PFDEFQIATMLKEILKG 113

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPE 538
           ++YLH++     H +IK++N+LL++  + +++DFG+A  L       N   G   + APE
Sbjct: 114 LDYLHSE--KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171

Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           V        KAD++S G+  +EL  G+ P
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 80/277 (28%), Positives = 122/277 (44%), Gaps = 44/277 (15%)

Query: 378 LGKGTFGTAY----KAVLEMGT---IVAVKRL-KDVTISER-EFKDKIEGVGAVNHENLV 428
           LG G FG  Y      +L  G+    VAVK L K  T  E+ EF  +   +   NH N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL--IALGAARGIEYL 486
            L       + + ++ + +  G L + L   +     P    ++ L  I L  A+G  YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 487 HAQGPNVSHGNIKSSNILLT-KSYEAR----VSDFGLAHLVGPSSTPNRVAGYR------ 535
             +  +  H ++ + N L++ K Y+A     + DFGLA  +   S   R  G        
Sbjct: 123 --EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-YKSDYYRKEGEGLLPVRW 179

Query: 536 -APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTS 593
            APE     K + ++DV+SFGVL+ E+LT G+ P  AL N+E       V   V      
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-------VLQHVTAGG-- 230

Query: 594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPS 630
                 L + +N  +++ QL+     C AQ P  RP+
Sbjct: 231 -----RLQKPENCPDKIYQLMTN---CWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 69.8 bits (171), Expect = 2e-12
 Identities = 66/264 (25%), Positives = 103/264 (39%), Gaps = 74/264 (28%)

Query: 36  ALLALRSSVGGRTLL-WNVYEASPC-----KWAGVECEQNRVT-MLRLPGVALSGQIPLG 88
           AL  L+SS+G      WN     PC      W+G +C+ +       + G+ L  Q    
Sbjct: 376 ALQTLKSSLGLPLRFGWN---GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQ---- 428

Query: 89  ILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN 148
                            L   +P+D++   +L+++ L GN   G +P  L  +  L  L+
Sbjct: 429 ----------------GLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLD 472

Query: 149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPK 208
           L+ N+F+G IP     LT L+ L L  N LSG +P             +   LL+ +   
Sbjct: 473 LSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPA-----------ALGGRLLHRAS-- 519

Query: 209 RFQTFGSNSFLGNSLCGKP-LQDCGTKASLVVPSTPSGTDEISHGEKEKKKLSGGAIAGI 267
               F  N+     LCG P L+ CG                  H       LS GA  GI
Sbjct: 520 --FNFTDNA----GLCGIPGLRACG-----------------PH-------LSVGAKIGI 549

Query: 268 VIGSVIGFLLILLILLILCRKKSN 291
             G  + FL +++  +   +++ N
Sbjct: 550 AFGVSVAFLFLVICAMCWWKRRQN 573

Length = 623

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 35/229 (15%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK------DVTISEREFKDKIEGVGAVNHENLV 428
           E++G+G +G  Y+   +  G +VA+K +       DV+  +RE    +  +      N+ 
Sbjct: 7   ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVA-LLSQLRQSQPPNIT 65

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
                Y       ++ +Y   GS+  L+     AG  P+  +  S+I       ++Y+H 
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGSVRTLMK----AG--PIAEKYISVIIREVLVALKYIHK 119

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--------TPNRVAGYRAPEV- 539
            G  V H +IK++NIL+T +   ++ DFG+A L+  +S        TP     + APEV 
Sbjct: 120 VG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPY----WMAPEVI 173

Query: 540 TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK 588
           T+      KAD++S G+ + E+ TG  P ++      VD  R +  I K
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPP-YS-----DVDAFRAMMLIPK 216

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 66/284 (23%), Positives = 117/284 (41%), Gaps = 50/284 (17%)

Query: 378 LGKGTFGTAYKAVLEMGTIVA---VKRLKD-VTISER-EFKDKIEGVGAVNHENLVPLRA 432
           +G G FG         G   A   VK L+   T  E+  F  +++    +NH N++    
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
                   LLV ++  +G L   L  N+G        ++   +A   A G+ +LH    +
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--D 120

Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---------TPNRVAGYRAPEVTD-- 541
             H ++   N  LT     ++ D+GLA    P            P R   + APE+ +  
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR---WLAPELVEIR 177

Query: 542 -----PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF 596
                P   ++K++++S GV + EL T     +  L++E V     ++ +V+++      
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-----LKQVVREQ------ 226

Query: 597 DLEL------LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEV 634
           D++L      L+Y +   E++Q   L        P+ RP+  EV
Sbjct: 227 DIKLPKPQLDLKYSDRWYEVMQFCWLD-------PETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 37/215 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRL-------KDVTISE----REFKDKIEGVGAVN 423
           E +G+G  GT Y A+ +  G  VA+K++       K++ I+E    RE K          
Sbjct: 25  EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK---------- 74

Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
           H N+V     Y   DE  +V +YL  GSL+ ++        T ++    + +     + +
Sbjct: 75  HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQAL 128

Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----STPNRVAGYRAPEV 539
           E+LH+    V H +IKS NILL      +++DFG    + P     ST      + APEV
Sbjct: 129 EFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186

Query: 540 TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNE 574
                   K D++S G++ +E++ G+ P    LNE
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPP---YLNE 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 67.4 bits (164), Expect = 4e-12
 Identities = 74/281 (26%), Positives = 132/281 (46%), Gaps = 45/281 (16%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKD---KIEGVGAVNHENLVPLRAY 433
           LG G FG  YKA   E G + A K ++  T SE E +D   +IE +   NH  +V L   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYMVEIEILATCNHPYIVKLLGA 77

Query: 434 YYSMDEKLLVYDYLTMGSLSA-LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
           +Y   +  ++ ++   G++ A +L  ++G     +    R ++       ++YLH+    
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML-----EALQYLHSM--K 130

Query: 493 VSHGNIKSSNILLTKSYEARVSDFGL-AHLVGPSSTPNRVAG---YRAPEVTDPCKVSQ- 547
           + H ++K+ N+LLT   + +++DFG+ A  V      +   G   + APEV   C+  + 
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVV-MCETMKD 189

Query: 548 -----KADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR 602
                KAD++S G+ L+E+   + P H L      +  R +  I K E  +      L +
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHEL------NPMRVLLKIAKSEPPT------LSQ 237

Query: 603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP 643
                 E    L+ A+D   ++P+ RPS +++++     HP
Sbjct: 238 PSKWSMEFRDFLKTALD---KHPETRPSAAQLLE-----HP 270

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 67.1 bits (163), Expect = 4e-12
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 17/205 (8%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFK-DKIEGVGAVNHENLVPLRAY 433
           E +G+G  GT + A+ +  G  VA+K++      ++E   ++I  +  + + N+V     
Sbjct: 25  EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
           +   DE  +V +YL  GSL+ ++        T ++    + +     + +E+LHA    V
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVV------TETCMDEAQIAAVCRECLQALEFLHAN--QV 136

Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----STPNRVAGYRAPEVTDPCKVSQKA 549
            H +IKS N+LL      +++DFG    + P     ST      + APEV        K 
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196

Query: 550 DVYSFGVLLLELLTGKAPTHALLNE 574
           D++S G++ +E++ G+ P    LNE
Sbjct: 197 DIWSLGIMAIEMVEGEPP---YLNE 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 66.8 bits (163), Expect = 5e-12
 Identities = 65/294 (22%), Positives = 122/294 (41%), Gaps = 54/294 (18%)

Query: 376 EVLGKGTFGTAYKAVL--EMGTI--VAVKRLKDVTISEREFKDKI-EGV--GAVNHENLV 428
           ++LG+G FG+  +  L  + G+   VAVK +K    +  E ++ + E       +H N++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 429 PLRAYYYSMDEK------LLVYDYLTMGSL-SALLHGNKGAGRTPLNWEMRSLIALGAAR 481
            L    +           +++  ++  G L S LL+   G     L  +      +  A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTD 541
           G+EYL  +  N  H ++ + N +L +     V+DFGL+  +           YR   +  
Sbjct: 125 GMEYLSNR--NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY------YRQGRIAK 176

Query: 542 -PCK-----------VSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVK 588
            P K            + K+DV++FGV + E+ T G+ P   + N E  D  R    + +
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ 236

Query: 589 -DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            ++   E++DL           M         C    P +RP+ +++ + +E +
Sbjct: 237 PEDCLDELYDL-----------MYS-------CWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 63/275 (22%), Positives = 128/275 (46%), Gaps = 28/275 (10%)

Query: 378 LGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFK----DKIEGVGAVNHENLVPLRA 432
           +G+G F   Y+A   + G  VA+K+++   + + + +     +I+ +  +NH N++   A
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 433 YYYSMDEKLLVYDYLTMGSLSALL-HGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +   +E  +V +    G LS ++ H  K     P     +  + L +A  +E++H++  
Sbjct: 70  SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LEHMHSR-- 125

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-PNRVAG---YRAPEVTDPCKVSQ 547
            V H +IK +N+ +T +   ++ D GL       +T  + + G   Y +PE       + 
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 185

Query: 548 KADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE 607
           K+D++S G LL E+   ++P +     + ++L    + I       E  D   L   +  
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYG----DKMNLYSLCKKI-------EQCDYPPLPSDHYS 234

Query: 608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH 642
           EE+ QL+ + I+     P+ RP ++ V    + +H
Sbjct: 235 EELRQLVNMCINPD---PEKRPDITYVYDVAKRMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 66.2 bits (162), Expect = 7e-12
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 26/203 (12%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDV-------TISEREFKDKIEGVGAVNHENLVP 429
           +G+G++G  +K    E G IVA+K+  +         I+ RE    I  +  + H NLV 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALRE----IRMLKQLKHPNLVN 64

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           L   +    +  LV++Y     L+ L    +G     +   +   I     + + + H  
Sbjct: 65  LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-----VPEHLIKKIIWQTLQAVNFCHKH 119

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST--PNRVAG--YRAPE--VTDPC 543
             N  H ++K  NIL+TK  + ++ DFG A ++        + VA   YRAPE  V D  
Sbjct: 120 --NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD-T 176

Query: 544 KVSQKADVYSFGVLLLELLTGKA 566
           +     DV++ G +  ELLTG+ 
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 65.7 bits (160), Expect = 9e-12
 Identities = 66/285 (23%), Positives = 130/285 (45%), Gaps = 45/285 (15%)

Query: 376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLKDVTISE---REFKDKIEGVGAVNHENLV 428
           EV+G G FG   +  L++       VA+K LK    +E   R+F  +   +G  +H N++
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYL 486
            L          +++ +++  G+L + L  N G       + +  L+ +  G A G++YL
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDG------QFTVIQLVGMLRGIAAGMKYL 122

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH-LVGPSSTPNRVAG--------YRAP 537
                N  H ++ + NIL+  +   +VSDFGL+  L   +S P   +         + AP
Sbjct: 123 SEM--NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 538 EVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF 596
           E     K +  +DV+S+G+++ E+++ G+ P   + N++ ++      +I +D       
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN------AIEQDYRLPPPM 234

Query: 597 DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           D               L QL +DC  +  + RP   +++  ++++
Sbjct: 235 DCP-----------TALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 73/263 (27%), Positives = 122/263 (46%), Gaps = 39/263 (14%)

Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKD---KIEGVGAVNHENLVPL-RAY 433
           LG G FG  YKA  +   ++A  ++ D T SE E +D   +I+ + + +H N+V L  A+
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVID-TKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
           YY  +  +L+ ++   G++ A++         PL      ++       + YLH     +
Sbjct: 72  YYENNLWILI-EFCAGGAVDAVML----ELERPLTEPQIRVVCKQTLEALNYLHEN--KI 124

Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGY------RAPEVTDPCKVSQ 547
            H ++K+ NIL T   + +++DFG++     + T  R   +       APEV   C+ S+
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVV-MCETSK 181

Query: 548 ------KADVYSFGVLLLELLTGKAPTH------ALLNEEGVDLPRWVQSIVKDEWTSEV 595
                 KADV+S G+ L+E+   + P H       LL     + P   Q      W+SE 
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQP---SRWSSEF 238

Query: 596 FD-LELLRYQNVEEE--MVQLLQ 615
            D L+    +NV+      QLLQ
Sbjct: 239 KDFLKKCLEKNVDARWTTTQLLQ 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.4 bits (162), Expect = 9e-12
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 20/206 (9%)

Query: 376 EVLGKGTFGTAY--KAVL--EMGTIVAVKRLKDVTISERE-FKDKIEG--VGAVNHENLV 428
           +VLG+G+FG  +  + +   + G + A+K LK  T+  R+  + K+E   +  VNH  +V
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 429 PLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            L  Y +  + KL L+ D+L  G L   L          + + +  L     A  +++LH
Sbjct: 62  KLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL-----ALALDHLH 115

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPC 543
           + G  + + ++K  NILL +    +++DFGL+   +          G   Y APEV +  
Sbjct: 116 SLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 173

Query: 544 KVSQKADVYSFGVLLLELLTGKAPTH 569
             +Q AD +SFGVL+ E+LTG  P  
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLPFQ 199

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 66.0 bits (161), Expect = 9e-12
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 39/215 (18%)

Query: 377 VLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE-FK----DKIEGVGAVNHENLVPL 430
            +G+GT+G  YKA   + G +VA+K+++    +E+E F      +I+ +  +NH N+V L
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVR--LDNEKEGFPITAIREIKILRQLNHRNIVNL 71

Query: 431 RAYYY----SMDEK------LLVYDYLT---MGSL-SALLHGNKGAGRTPLNWEMRSLIA 476
           +        ++D K       LV++Y+    MG L S L+H ++   ++     M+ L+ 
Sbjct: 72  KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS----FMKQLL- 126

Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTP--NRVAG 533
                G+ Y H +  N  H +IK SNILL    + +++DFGLA L     S P  N+V  
Sbjct: 127 ----EGLNYCHKK--NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180

Query: 534 --YRAPE-VTDPCKVSQKADVYSFGVLLLELLTGK 565
             YR PE +    +     DV+S G +L EL T K
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 67/229 (29%), Positives = 104/229 (45%), Gaps = 33/229 (14%)

Query: 377 VLGKGTFGTAYKAVL-EMGTIVAVKRL-KDVTISEREFKDKIEGVG--------AVNHEN 426
           VLGKG+FG    A L     + AVK L KDV + +    D +E           A  H  
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD----DDVECTMTEKRVLALAGKHPF 57

Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI-ALGAARGIEY 485
           L  L + + + D    V +Y+  G L  + H  + +GR     E R+   A     G+++
Sbjct: 58  LTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQR-SGRFD---EPRARFYAAEIVLGLQF 111

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTD 541
           LH +G  + + ++K  N+LL      +++DFG+    +    T +   G   Y APE+  
Sbjct: 112 LHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILS 169

Query: 542 PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE 590
                   D ++ GVLL E+L G++P       EG D     QSI++DE
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPF------EGDDEDELFQSILEDE 212

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 76/294 (25%), Positives = 124/294 (42%), Gaps = 51/294 (17%)

Query: 370 LLRASAEVLGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISEREFKDKIEG--V 419
           LLRA    LG G FG  Y+ +         E+   VAVK L +    + E    +E   +
Sbjct: 10  LLRA----LGHGAFGEVYEGLYRGRDGDAVELQ--VAVKTLPESCSEQDESDFLMEALIM 63

Query: 420 GAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI--AL 477
              NH+N+V L    +    + ++ + +  G L + L  N+     P +  M+ L+  A 
Sbjct: 64  SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123

Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARV---SDFGLAHLVGPSSTPNRVAGY 534
             A+G +YL        H +I + N LLT     RV   +DFG+A  +  +S   +  G 
Sbjct: 124 DVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK--GG 179

Query: 535 RA--------PEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQS 585
           RA        PE       + K DV+SFGVLL E+ + G  P     N+E ++       
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME------- 232

Query: 586 IVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE 639
                     F     R    +     + ++  DC    P++RP+ + +++RI+
Sbjct: 233 ----------FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 24/199 (12%)

Query: 378 LGKGTFGTAYKAVLEM-GTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G FG    A  ++ G  VA+K++        +++R +++ ++ +  + HEN++ L  
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE-LKLLKHLRHENIISLSD 76

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
            + S  E +    Y     L   LH    +   PL  +          RG++Y+H+ G  
Sbjct: 77  IFISPLEDI----YFVTELLGTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAG-- 128

Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLA-----HLVGPSSTPNRVAGYRAPEVTDPC-KVS 546
           V H ++K SNIL+ ++ + ++ DFGLA      + G  ST      YRAPE+     K  
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----YRAPEIMLTWQKYD 184

Query: 547 QKADVYSFGVLLLELLTGK 565
            + D++S G +  E+L GK
Sbjct: 185 VEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 69/237 (29%), Positives = 108/237 (45%), Gaps = 37/237 (15%)

Query: 377 VLGKGTFGTAYKAVLEMGT--IVAVKRLK----------DVTISEREFKDKIEGVGAVNH 424
           VLGKG+FG    A L+ GT    A+K LK          + T+ ER    ++  + A  H
Sbjct: 2   VLGKGSFGKVMLAELK-GTNEFFAIKALKKDVVLEDDDVECTMVER----RVLAL-AWEH 55

Query: 425 ENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
             L  L   + + +    V +YL  G L   +   + +GR           A     G++
Sbjct: 56  PFLTHLFCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDE--ARARFYAAEIICGLQ 110

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA----HLVGPSSTPNRVAGYRAPEVT 540
           +LH +G  + + ++K  N+LL K    +++DFG+     +  G +ST      Y APE+ 
Sbjct: 111 FLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL 168

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVD--------LPRWVQSIVKD 589
              K ++  D +SFGVLL E+L G++P H    +E  D         PRW+    KD
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKD 225

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 65.5 bits (159), Expect = 2e-11
 Identities = 66/233 (28%), Positives = 108/233 (46%), Gaps = 27/233 (11%)

Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVL--EMGTI---VAVKRLKDVT--ISEREFKDK 415
           R+    +L R   +VLG G FGT YK +   E  T+   VA+K L + T   +  EF D+
Sbjct: 2   RILKETELKRV--KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDE 59

Query: 416 IEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKG--AGRTPLNWEMRS 473
              + +++H +LV L     S   +L V   +  G L   +H +K     +  LNW    
Sbjct: 60  ALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW---- 114

Query: 474 LIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG 533
              +  A+G+ YL  +   + H ++ + N+L+      +++DFGLA L+          G
Sbjct: 115 --CVQIAKGMMYLEER--RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 170

Query: 534 YRAP------EVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDL 579
            + P      E     K + ++DV+S+GV + EL+T G  P   +   E  DL
Sbjct: 171 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL 223

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 75/300 (25%), Positives = 133/300 (44%), Gaps = 64/300 (21%)

Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTISEREFKDKI------EGVGAVN 423
           + LG+G FG   KA           + VAVK LKD   +E++  D +      + +G   
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD-DATEKDLSDLVSEMEMMKMIG--K 74

Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG--------RTPL-NWEMRSL 474
           H+N++ L           +V +Y   G+L   L   +  G        R P      + L
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 475 I--ALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA 532
           +  A   ARG+E+L ++     H ++ + N+L+T+ +  +++DFGLA  +      + + 
Sbjct: 135 VSFAYQVARGMEFLASK--KCIHRDLAARNVLVTEDHVMKIADFGLARDI------HHID 186

Query: 533 GYR------------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDL 579
            YR            APE       + ++DV+SFGVLL E+ T G +P   +  EE   L
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246

Query: 580 PRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE 639
            +            E + +E  + QN  +E+  L++   DC  + P  RP+  ++++ ++
Sbjct: 247 LK------------EGYRME--KPQNCTQELYHLMR---DCWHEVPSQRPTFKQLVEDLD 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 33/225 (14%)

Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISEREFKDKIEGVGA 421
              DL DL       +G GT G  YK    + G ++AVK++       +E   +I     
Sbjct: 10  YPADLNDLENLGE--IGSGTCGQVYKMRFKKTGHVMAVKQM--RRTGNKEENKRI----- 60

Query: 422 VNHENLVPLRAYYYSMDEKLLV--YDYLT--------MGSLSALLHGNKGAGRTPLNWEM 471
                L+ L     S D   +V  Y Y          M  +S  L       + P+  ++
Sbjct: 61  -----LMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDI 115

Query: 472 RSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV 531
              + +   + + YL  +   V H ++K SNILL  S   ++ DFG++  +  S    R 
Sbjct: 116 LGKMTVAIVKALHYLK-EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS 174

Query: 532 AG---YRAPEVTDPCKVSQK----ADVYSFGVLLLELLTGKAPTH 569
           AG   Y APE  DP   + K    ADV+S G+ L+EL TG+ P  
Sbjct: 175 AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 73/280 (26%), Positives = 122/280 (43%), Gaps = 49/280 (17%)

Query: 378 LGKGTFGTAYKAVLEM---GTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
           LG G FGT  K + +M      VAVK LK+   ++   KD++     V  +   P   Y 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNP---YI 58

Query: 435 YSM------DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYL 486
             M      +  +LV +   +G L+  L  NK       +   +++  L    + G++YL
Sbjct: 59  VRMIGICEAESWMLVMELAELGPLNKFLQKNK-------HVTEKNITELVHQVSMGMKYL 111

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEV 539
                N  H ++ + N+LL   + A++SDFGL+  +G      +          + APE 
Sbjct: 112 EET--NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169

Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
            +  K S K+DV+SFGVL+ E  + G+ P   +   +G ++ + ++S  + E        
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM---KGNEVTQMIESGERMECP------ 220

Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
                Q    EM  L++L   C     D RP  + V  R+
Sbjct: 221 -----QRCPPEMYDLMKL---CWTYGVDERPGFAVVELRL 252

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 70/289 (24%), Positives = 125/289 (43%), Gaps = 57/289 (19%)

Query: 377 VLGKGTFGTAYKAVLEM----GTIVAVKRLKDVTISE---REFKDKIEGVGAVNHENLVP 429
           V+G G FG      L++       VA+K LK    +E   R+F  +   +G  +H N++ 
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLK-AGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYLH 487
           L          ++V +Y+  GSL A L  + G       + +  L+ +  G A G++YL 
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG------QFTVIQLVGMLRGIASGMKYLS 123

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEVT 540
             G    H ++ + NIL+  +   +VSDFGL+ ++   P +      G     + APE  
Sbjct: 124 DMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181

Query: 541 DPCKVSQKADVYSFGVLLLELLT-GKAPTHALLN-------EEGVDLPRWVQSIVKDEWT 592
              K +  +DV+S+G+++ E+++ G+ P   + N       EEG  LP  +         
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDC------- 234

Query: 593 SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
                               L QL +DC  +  + RP   +++  +++L
Sbjct: 235 -----------------PAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 43/149 (28%), Positives = 78/149 (52%), Gaps = 14/149 (9%)

Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
           H+N+V +   Y   +E  ++ ++L  G+L+ ++       +T LN E  + +     + +
Sbjct: 77  HQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV------SQTRLNEEQIATVCESVLQAL 130

Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR--VAG---YRAPE 538
            YLH+QG  V H +IKS +ILLT     ++SDFG    +     P R  + G   + APE
Sbjct: 131 CYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYWMAPE 187

Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           V        + D++S G++++E++ G+ P
Sbjct: 188 VISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 75/291 (25%), Positives = 135/291 (46%), Gaps = 60/291 (20%)

Query: 376 EVLGKGTFGTAYKAVLEMGTI---VAVKRLKDVTISE--REFKDKIEGVGAVN-HENLVP 429
           +V+G+G FG   KA ++   +    A+KR+K+    +  R+F  ++E +  +  H N++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 430 L------RAYYYSMDEKLLVYDYLTMGSLSALLHGNKG---------AGRTPLNWEMRSL 474
           L      R Y Y      L  +Y   G+L   L  ++          A  T      + L
Sbjct: 73  LLGACEHRGYLY------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 475 IALGA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--HLVGPSSTPNR 530
           +   A  ARG++YL  +     H ++ + NIL+ ++Y A+++DFGL+    V    T  R
Sbjct: 127 LHFAADVARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 184

Query: 531 V-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAP----THALLNEEGVDLPRWVQ 584
           +   + A E  +    +  +DV+S+GVLL E+++ G  P    T A L E+   LP+   
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK---LPQG-- 239

Query: 585 SIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVI 635
                      + LE  +  N ++E+  L++    C  + P  RPS ++++
Sbjct: 240 -----------YRLE--KPLNCDDEVYDLMR---QCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 79/291 (27%), Positives = 120/291 (41%), Gaps = 46/291 (15%)

Query: 378 LGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISER--EFKDKIEGVGAVNHENL 427
           LG+G FG   K  L          G  VAVK LK  +      + K +IE +  + HEN+
Sbjct: 12  LGEGHFG---KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 428 VPLRAYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           V  +            L+ ++L  GSL   L  NK      +N + +   A+   +G++Y
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK----INLKQQLKYAVQICKGMDY 124

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPE 538
           L ++     H ++ + N+L+   ++ ++ DFGL   +        V         + APE
Sbjct: 125 LGSR--QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182

Query: 539 VTDPCKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
                K    +DV+SFGV L ELLT      +P    L   G   P   Q  V    T  
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIG---PTHGQMTV----TRL 235

Query: 595 VFDLE----LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           V  LE    L R  N  EE+ QL++    C    P  R +   +I+  E +
Sbjct: 236 VRVLEEGKRLPRPPNCPEEVYQLMR---KCWEFQPSKRTTFQNLIEGFEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 35/209 (16%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE-------REFKDKIEGVGAVNHENL 427
           E +G+GT+G  YKA     G IVA+K+++  T  E       RE    I  +  +NH N+
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIRE----ISLLKELNHPNI 60

Query: 428 VPLRAYYYSMDEKL-LVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIE 484
           V L    +S + KL LV+++L +  L   +      G     +   +  L+     +GI 
Sbjct: 61  VRLLDVVHS-ENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLL-----QGIA 113

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAP 537
           Y H+    V H ++K  N+L+ +    +++DFGLA   G    P R          YRAP
Sbjct: 114 YCHSH--RVLHRDLKPQNLLIDREGALKLADFGLARAFG---VPVRTYTHEVVTLWYRAP 168

Query: 538 EVTDPCK-VSQKADVYSFGVLLLELLTGK 565
           E+    +  S   D++S G +  E++  +
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 64.2 bits (157), Expect = 5e-11
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 25/204 (12%)

Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGA---------VNHE 425
             +G G +G    A   + G  VA+K+L       R F+  I              ++HE
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLS------RPFQSAIHAKRTYRELRLLKHMDHE 74

Query: 426 NLVPLRAYYYSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
           N++ L   +          D YL    + A L  N       L+ +    +     RG++
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADL--NNIVKCQKLSDDHIQFLVYQILRGLK 132

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-D 541
           Y+H+ G  + H ++K SNI + +  E ++ DFGLA       T   VA   YRAPE+  +
Sbjct: 133 YIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLN 189

Query: 542 PCKVSQKADVYSFGVLLLELLTGK 565
               +Q  D++S G ++ ELLTGK
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 24/207 (11%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLK-----DVTISEREFKDKIEGVGAVNHENLVPLR 431
           +G GT+G  YKA  L  G + AVK +K     D ++ ++E    I  V    H N+V   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQE----IFMVKECKHCNIVAYF 72

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
             Y S ++  +  +Y   GSL  + H        PL+    + +     +G+ YLH++G 
Sbjct: 73  GSYLSREKLWICMEYCGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSKGK 127

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR----VAGYRAPEVTDPCK--- 544
              H +IK +NILLT + + +++DFG+A  +  +    +       + APEV    K   
Sbjct: 128 --MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 545 VSQKADVYSFGVLLLELLTGKAPTHAL 571
            +Q  D+++ G+  +EL   + P   L
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDL 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 63.2 bits (154), Expect = 7e-11
 Identities = 35/101 (34%), Positives = 61/101 (60%), Gaps = 10/101 (9%)

Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG 533
           IA+   + +EYLH++  +V H ++K SN+L+ ++ + ++ DFG++ +LV  S      AG
Sbjct: 108 IAVSIVKALEYLHSK-LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD-SVAKTIDAG 165

Query: 534 ---YRAPEVTDPCKVSQ----KADVYSFGVLLLELLTGKAP 567
              Y APE  +P    +    K+DV+S G+ ++EL TG+ P
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 70/293 (23%), Positives = 120/293 (40%), Gaps = 53/293 (18%)

Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLKD-VTISERE-FKDKIEGVGAVNHENL 427
           E LG+  FG  YK  L      E    VA+K LKD      RE FK +      + H N+
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALL---HGNKGAGRTPLNWEMRSL--------IA 476
           V L           +++ Y +   L   L     +   G T  +  ++S         I 
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH---------LVGPSST 527
              A G+E+L +   +V H ++ + N+L+      ++SD GL           L+G S  
Sbjct: 131 TQIAAGMEFLSSH--HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188

Query: 528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSI 586
           P R   + +PE     K S  +D++S+GV+L E+ + G  P     N++ +++ R  Q +
Sbjct: 189 PIR---WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL 245

Query: 587 -VKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
              D+  + V+                   L ++C  ++P  RP   ++  R+
Sbjct: 246 PCPDDCPAWVY------------------TLMLECWNEFPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 67/276 (24%), Positives = 116/276 (42%), Gaps = 47/276 (17%)

Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEG--VGAVNHENLVPLRA 432
           E +G+G FG  +   L    T VAVK  ++    + + K   E   +   +H N+V L  
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYLHAQG 490
                    +V + +  G     L   +G        +++ LI +   AA G+EYL ++ 
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLR-TEGP-----RLKVKELIQMVENAAAGMEYLESK- 113

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGL---------AHLVGPSSTPNRVAGYRAPEVTD 541
            +  H ++ + N L+T+    ++SDFG+         A   G    P +   + APE  +
Sbjct: 114 -HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK---WTAPEALN 169

Query: 542 PCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD--L 598
             + S ++DV+SFG+LL E  + G  P   L N++                T E  +  +
Sbjct: 170 YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ----------------TREAIEQGV 213

Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEV 634
            L   +   + + +L++    C    P  RPS S V
Sbjct: 214 RLPCPELCPDAVYRLME---RCWEYDPGQRPSFSTV 246

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 8e-11
 Identities = 61/224 (27%), Positives = 96/224 (42%), Gaps = 48/224 (21%)

Query: 379 GKGTFGTAYKAVL---EMGTIVAVKRLKDVTISEREFKDKIEGVG-------------AV 422
           G+GT+G  YKA     + G   A+K+ K          DK +  G              +
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFK---------GDKEQYTGISQSACREIALLREL 59

Query: 423 NHENLVPLR-AYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEM-RSLI--AL 477
            HEN+V L   +    D+ + L++DY     L  ++  ++ A R  +   M +SL+   L
Sbjct: 60  KHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118

Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEAR----VSDFGLAHLVGPSSTP----N 529
               G+ YLH+    V H ++K +NIL+      R    + D GLA L      P    +
Sbjct: 119 ---NGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173

Query: 530 RVA---GYRAPEVTDPCKVSQKA-DVYSFGVLLLELLTGKAPTH 569
            V     YRAPE+    +   KA D+++ G +  ELLT +    
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 63.2 bits (153), Expect = 8e-11
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 17/205 (8%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFK-DKIEGVGAVNHENLVPLRAY 433
           E +G+G  GT Y A+ +  G  VA++++      ++E   ++I  +    + N+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
           Y   DE  +V +YL  GSL+ ++        T ++    + +     + +E+LH+    V
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHSN--QV 137

Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGP-SSTPNRVAG---YRAPEVTDPCKVSQKA 549
            H +IKS NILL      +++DFG    + P  S  + + G   + APEV        K 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 550 DVYSFGVLLLELLTGKAPTHALLNE 574
           D++S G++ +E++ G+ P    LNE
Sbjct: 198 DIWSLGIMAIEMIEGEPP---YLNE 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 62.9 bits (153), Expect = 9e-11
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 25/205 (12%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK----DVTISE--REFKDKIEGVGAVNHENLV 428
           E LG+GT+ T YK      G IVA+K +     + T S   RE    I  +  + HEN+V
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIRE----ISLMKELKHENIV 61

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L    ++ ++ +LV++Y+    L   +  HG +GA     N        L   +GI + 
Sbjct: 62  RLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGA--LDPNTVKSFTYQL--LKGIAFC 116

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSST-PNRVAG--YRAPEVTDP 542
           H     V H ++K  N+L+ K  E +++DFGLA   G P +T  N V    YRAP+V   
Sbjct: 117 HENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLG 174

Query: 543 CKV-SQKADVYSFGVLLLELLTGKA 566
            +  S   D++S G ++ E++TG+ 
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRP 199

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 63.5 bits (155), Expect = 9e-11
 Identities = 62/233 (26%), Positives = 107/233 (45%), Gaps = 38/233 (16%)

Query: 365 FDLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKD----VTISEREFKD-KIEG 418
           FD+    +   E +G G +G    A+    G  VA+K++       T+++R  ++ KI  
Sbjct: 1   FDVGSRYKPI-ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKI-- 57

Query: 419 VGAVNHENLVPLRAYYYS----MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL 474
           +    H+N++ +R           +  +V D L    L  ++H ++     PL  E    
Sbjct: 58  LRHFKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQ-----PLTEEHIRY 111

Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR---- 530
                 RG++Y+H+   NV H ++K SN+L+ +  E R+ DFG+A  +  S T ++    
Sbjct: 112 FLYQLLRGLKYIHSA--NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169

Query: 531 --VAG--YRAPEV--TDPCKVSQKADVYSFGVLLLE------LLTGKAPTHAL 571
             VA   YRAPE+  + P + +   D++S G +  E      L  GK   H L
Sbjct: 170 EYVATRWYRAPELLLSLP-EYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL 221

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 62.5 bits (152), Expect = 9e-11
 Identities = 67/284 (23%), Positives = 127/284 (44%), Gaps = 46/284 (16%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDK----IEGVGAVNHENLVPLRA 432
           +GKG F   YKA+ L  G +VA+K+++   + + + +      I+ +  ++H N++   A
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRT---PLNWEMRSLIALGAARGIEYLHAQ 489
            +   +E  +V +    G LS ++   K   R       W+    +       +E++H++
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHMHSK 125

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGL----------AH-LVGPSSTPNRVAGYRAPE 538
              + H +IK +N+ +T +   ++ D GL          AH LVG   TP     Y +PE
Sbjct: 126 --RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG---TPY----YMSPE 176

Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                  + K+D++S G LL E+   ++P +     + ++L    + I K ++      L
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLYSLCKKIEKCDYPP----L 228

Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH 642
               Y        +L  L   C    P+ RP +S V++  +E+H
Sbjct: 229 PADHYSE------ELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.5 bits (152), Expect = 9e-11
 Identities = 66/288 (22%), Positives = 112/288 (38%), Gaps = 59/288 (20%)

Query: 378 LGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISER----------EFKDKIEGVGAVNHEN 426
           LG+GTF   YK VL     +  V   ++V++  +           F +    +  ++H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 427 LVPLRAYYYSM--DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
           LV L   Y     DE ++V +Y+  G L   LH  K      L+W++   +A   A  + 
Sbjct: 63  LVKL---YGVCVRDENIMVEEYVKFGPLDVFLHREKNN--VSLHWKL--DVAKQLASALH 115

Query: 485 YLHAQGPNVSHGNIKSSNILLTK-------SYEARVSDFGLAHLVGPSSTPNRVAGYRAP 537
           YL  +   + HGN+   NIL+ +           ++SD G+   V           + AP
Sbjct: 116 YLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAP 173

Query: 538 EV--TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           E        ++  AD +SFG  LLE+ + G+ P   L + E                   
Sbjct: 174 ECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE------------------- 214

Query: 595 VFDLELLRYQNV----EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
               +   YQ+       +  +L  L   C    P  RPS   +++ +
Sbjct: 215 ----KERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 24/212 (11%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV--TISERE-----FKDKIEGVGAVNHENL 427
           + LG G F + Y+A  ++ GT++AVK++  V  T SE+E      + +I  +  +NH ++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           + +           L  +++  GS+S LL          +      L+     RG+ YLH
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL-----RGLSYLH 120

Query: 488 AQGPNVSHGNIKSSNILL-TKSYEARVSDFGLA-----HLVGPSSTPNRVAG---YRAPE 538
                + H ++K +N+L+ +     R++DFG A        G      ++ G   + APE
Sbjct: 121 EN--QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           V    +  +  DV+S G +++E+ T K P +A
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 58/210 (27%), Positives = 85/210 (40%), Gaps = 39/210 (18%)

Query: 378 LGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISEREFKDKI----EGVGAVNHENLVPLRA 432
           LG G FG      V       A+K +K   I E   ++ I    E +   NH  +V L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 433 YYYSMDEKLLVY---DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
            +   D+K  +Y   +Y   G L  +L      G     +  R  IA       EYLH +
Sbjct: 61  TFK--DKKY-IYMLMEYCLGGELWTILRDR---GLFD-EYTARFYIA-CVVLAFEYLHNR 112

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-------TPNRVAGYRAPEVTDP 542
              + + ++K  N+LL  +   ++ DFG A  +           TP     Y APE+   
Sbjct: 113 --GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTP----EYVAPEI--- 163

Query: 543 CKVSQK-----ADVYSFGVLLLELLTGKAP 567
             +  K      D +S G+LL ELLTG+ P
Sbjct: 164 --ILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 34/218 (15%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN------HENLV 428
           E +GKG+FGT  K      G I+  K +    ++E+E   K + V  VN      H N+V
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE---KQQLVSEVNILRELKHPNIV 62

Query: 429 PLRAYY---YSMDEKLL--VYDYLTMGSLSALL-HGNKGAGRTPLN--WEMRSLIALGAA 480
               YY        + L  V +Y   G L+ L+    K          W + + + L   
Sbjct: 63  ---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--------TPNRVA 532
                    G  V H ++K +NI L  +   ++ DFGLA ++G  S        TP    
Sbjct: 120 E-CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY--- 175

Query: 533 GYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
            Y +PE  +     +K+D++S G L+ EL     P  A
Sbjct: 176 -YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFK-DKIEGVGAVNHENLVPLRAY 433
           E +G+G  GT Y A+ +  G  VA+K++      ++E   ++I  +    + N+V     
Sbjct: 25  EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
           Y   DE  +V +YL  GSL+ ++        T ++    + +     + +++LH+    V
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALDFLHSN--QV 136

Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----STPNRVAGYRAPEVTDPCKVSQKA 549
            H +IKS NILL      +++DFG    + P     ST      + APEV        K 
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196

Query: 550 DVYSFGVLLLELLTGKAPTHALLNE 574
           D++S G++ +E++ G+ P    LNE
Sbjct: 197 DIWSLGIMAIEMVEGEPP---YLNE 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 63/285 (22%), Positives = 111/285 (38%), Gaps = 45/285 (15%)

Query: 376 EVLGKGTFGTAYKAVLEMG--TIVAVKRL--------KDVTISEREFKDKIEGVGAV--- 422
           E LG G FG  YK   +     ++A+K +        KD    ++   D +  V  +   
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 423 -NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLN---WEMRSLIALG 478
             H N+V     +   D   +V D +    L    +  K   +       W +   + L 
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YR 535
               + YLH +   + H ++  +NI+L +  +  ++DFGLA    P S    V G   Y 
Sbjct: 126 ----LRYLHKE-KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180

Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV 595
            PE+       +KADV++FG +L ++ T + P ++       ++      IV+       
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS------TNMLSLATKIVEAV----- 229

Query: 596 FDLELLRYQNVEEEMV-QLLQLAID-CSAQYPDNRPSMSEVIKRI 638
                  Y+ + E M  + +   I  C     + RP + +V   I
Sbjct: 230 -------YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 70/260 (26%), Positives = 117/260 (45%), Gaps = 37/260 (14%)

Query: 378 LGKGTFGTAYKAVLEMGTI---VAVKRLKDVTISEREFKDKIEGVGAVNHE--NLVPLRA 432
           LG G FG   K V +M      VA+K LK+    E+  +D++     + H+  N   +R 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 433 YYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
                 E L LV +  + G L+  L G K         E+   +++G    ++YL  +G 
Sbjct: 61  IGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG----MKYL--EGK 114

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP--SSTPNRVAG-----YRAPEVTDPCK 544
           N  H ++ + N+LL   + A++SDFGL+  +G   S    R AG     + APE  +  K
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 545 VSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDL-------------PRWVQSIVKDE 590
            S ++DV+S+G+ + E  + G+ P   +   E +               P  + +++KD 
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDC 234

Query: 591 WTSEVFDLELLRYQNVEEEM 610
           W  +  D     +  VEE M
Sbjct: 235 WIYKWED--RPNFAKVEERM 252

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 2e-10
 Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 10/93 (10%)

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR-----VAG-- 533
           RG++Y+H    NV H ++K SN+LL  + + ++ DFGLA +  P           VA   
Sbjct: 117 RGLKYIH--SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 534 YRAPEVTDPCKVSQKA-DVYSFGVLLLELLTGK 565
           YRAPE+    K   KA D++S G +L E+L+ +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 15/200 (7%)

Query: 377 VLGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISEREFK----DKIEGVGAVNHENLVPLR 431
           VLGKG FG      V   G + A K+L+   I +R+ +    ++ + +  VN   +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI-ALGAARGIEYLHAQG 490
             Y + D   LV   +  G L   ++    AG      E R++  A     G+E LH + 
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE----EGRAVFYAAEICCGLEDLHQE- 121

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVA--GYRAPEVTDPCKVSQ 547
             + + ++K  NILL      R+SD GLA H+    +   RV   GY APEV    + + 
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180

Query: 548 KADVYSFGVLLLELLTGKAP 567
             D ++ G LL E++ G++P
Sbjct: 181 SPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 26/209 (12%)

Query: 376 EVLGKGTFGTAYKAVLE--MGTI--VAVKRLKDVTISE--REFKDKIEGVGAVNHENLVP 429
           + LG G+FG   +       G +  VAVK LK   +S+   +F  +   + +++HENL+ 
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLI- 59

Query: 430 LRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLN--WEMRSLIALGAARGIEYL 486
            R Y   +   L +V +   +GSL   L  +   G   ++   +     A+  A G+ YL
Sbjct: 60  -RLYGVVLTHPLMMVTELAPLGSLLDRLRKDA-LGHFLISTLCDY----AVQIANGMRYL 113

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-----STPNRVA--GYRAPEV 539
            ++     H ++ + NILL    + ++ DFGL   +  +        +      + APE 
Sbjct: 114 ESK--RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171

Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAP 567
                 S  +DV+ FGV L E+ T G+ P
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 38/217 (17%)

Query: 378 LGKGTFGTAYKAVLEM-GTIVAVKRL-KDVTISEREFKDKIEGVGAVNHENLVPLRA--- 432
           + KG +G  + A  +  G I A+K + K   I + +          V  E  +  +A   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVD-------QVLTERDILSQAQSP 53

Query: 433 ----YYYSM--DEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
                YYS    + L LV +YL  G L++LL  N G+    L+ ++  +        +EY
Sbjct: 54  YVVKLYYSFQGKKNLYLVMEYLPGGDLASLLE-NVGS----LDEDVARIYIAEIVLALEY 108

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA---------HLVGPSSTPNRVAG--- 533
           LH+ G  + H ++K  NIL+  +   +++DFGL+         +L        R+ G   
Sbjct: 109 LHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166

Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           Y APEV      S+  D +S G +L E L G  P H 
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 14/201 (6%)

Query: 373 ASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE----REFKDKIEGVGAVNHENL 427
            S + +G G +G+   A+    G  VA+K+L     SE    R +++ +  +  + HEN+
Sbjct: 18  TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRE-LTLLKHMQHENV 76

Query: 428 VPLRAYYYSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           + L   + S        D YL M  +   L    G    PL+ +    +      G++Y+
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG---HPLSEDKVQYLVYQMLCGLKYI 133

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-YRAPEVT-DPCK 544
           H+ G  + H ++K  N+ + +  E ++ DFGLA       T   V   YRAPEV  +   
Sbjct: 134 HSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMH 191

Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ E+LTGK
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 64/273 (23%), Positives = 122/273 (44%), Gaps = 42/273 (15%)

Query: 377 VLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLRA 432
           V+G+G FG  +         +V +K++    +++ E    +++ + +  ++H N++    
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII---E 63

Query: 433 YYYS--MDEKL-LVYDYLTMGSLSALLHGNKGA---GRTPLNWEMRSLIALGAARGIEYL 486
           YY +   D+ L +V +Y   G+L+  +     +     T L++ ++ L+AL         
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH-------- 115

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDP 542
           H     + H ++K+ NILL K     ++ DFG++ ++   S    V G   Y +PE+ + 
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG 175

Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR 602
              +QK+D+++ G +L EL + K         E  +LP  V  I      S  F     R
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAF------EAANLPALVLKI-----MSGTFAPISDR 224

Query: 603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVI 635
           Y         L QL +      P  RP +S+++
Sbjct: 225 YSP------DLRQLILSMLNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 17/204 (8%)

Query: 377 VLGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISEREFK----DKIEGVGAVNHENLVPLR 431
           VLGKG FG      V   G + A KRL+   I +R+ +    ++ + +  VN + +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLH--GNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
             Y + D   LV   +  G L   ++  GN G        E     A     G+E LH +
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-----FEEERALFYAAEILCGLEDLHRE 121

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVA--GYRAPEVTDPCKVS 546
             N  + ++K  NILL      R+SD GLA  +    S   RV   GY APEV +  + +
Sbjct: 122 --NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYT 179

Query: 547 QKADVYSFGVLLLELLTGKAPTHA 570
              D +  G L+ E++ G++P   
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 62.2 bits (151), Expect = 4e-10
 Identities = 45/136 (33%), Positives = 67/136 (49%), Gaps = 17/136 (12%)

Query: 442 LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSS 501
           LV DY   G L   +       RT    E   L+ +     + ++H++  ++ H +IKS+
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEA-GLLFIQVLLAVHHVHSK--HMIHRDIKSA 172

Query: 502 NILLTKSYEARVSDFGLAHL--------VGPS--STPNRVAGYRAPEVTDPCKVSQKADV 551
           NILL  +   ++ DFG + +        VG +   TP     Y APE+      S+KAD+
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY----YVAPEIWRRKPYSKKADM 228

Query: 552 YSFGVLLLELLTGKAP 567
           +S GVLL ELLT K P
Sbjct: 229 FSLGVLLYELLTLKRP 244

Length = 496

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 61.1 bits (149), Expect = 4e-10
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 33/205 (16%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE--------RE--FKDKIEGVGAVNHEN 426
           +G+G +GT YKA  L  G  VA+K+++ V +SE        RE     ++E   +  H N
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVR-VPLSEEGIPLSTLREIALLKQLE---SFEHPN 62

Query: 427 LVPLR--AYYYSMDEKL---LVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGA 479
           +V L    +    D +L   LV++++    L+  L      G     +   MR L+    
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLL---- 117

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--TPNRVA-GYRA 536
            RG+++LH+    + H ++K  NIL+T   + +++DFGLA +       T   V   YRA
Sbjct: 118 -RGVDFLHSH--RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRA 174

Query: 537 PEVTDPCKVSQKADVYSFGVLLLEL 561
           PEV      +   D++S G +  EL
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 20/205 (9%)

Query: 377 VLGKGTFGTA----YKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           V+G+G+FG A    +    +   +  ++  K  +  E   K+ +  +  + H N+V  + 
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVL-LAKMKHPNIVAFKE 65

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKG---AGRTPLNWEMRSLIALGAARGIEYLHAQ 489
            + +     +V +Y   G L   +   +G      T L W ++  +      G++++H +
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK 119

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNRVAG---YRAPEVTDPCKV 545
              V H +IKS NI LT++ + ++ DFG A L+  P +      G   Y  PE+ +    
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPY 177

Query: 546 SQKADVYSFGVLLLELLTGKAPTHA 570
           + K+D++S G +L EL T K P  A
Sbjct: 178 NNKSDIWSLGCILYELCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 28/208 (13%)

Query: 378 LGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKD---KIEGVGAVNHENLVPL 430
           +G+G+FG   KA+L    E G    +K +    +S +E ++   ++  +  + H N+V  
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKG---AGRTPLNWEMRSLIALGAARGIEYLH 487
           +  +       +V DY   G L   ++  +G        L+W ++  +AL         H
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK--------H 116

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA----GYRAPEVTDPC 543
                + H +IKS NI LTK    ++ DFG+A ++  +    R       Y +PE+ +  
Sbjct: 117 VHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENR 176

Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHAL 571
             + K+D+++ G +L E+ T K   HA 
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLK---HAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 60.6 bits (147), Expect = 5e-10
 Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 15/200 (7%)

Query: 377 VLGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISEREFK----DKIEGVGAVNHENLVPLR 431
           VLGKG FG      V   G + A K+L+   I +R+ +    ++ + +  VN   +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI-ALGAARGIEYLHAQG 490
             Y + D   LV   +  G L   ++ N G        E R++  A     G+E LH + 
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIY-NMGNPGFD---EERAVFYAAEITCGLEDLHRE- 121

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVA--GYRAPEVTDPCKVSQ 547
             + + ++K  NILL      R+SD GLA  +    +   RV   GY APEV    + + 
Sbjct: 122 -RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTF 180

Query: 548 KADVYSFGVLLLELLTGKAP 567
             D +  G L+ E++ GK+P
Sbjct: 181 SPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 60.6 bits (147), Expect = 5e-10
 Identities = 70/286 (24%), Positives = 123/286 (43%), Gaps = 47/286 (16%)

Query: 377 VLGKGTFG-----TAYKAVLEMGTI-VAVKRLKDVT-ISEREF---KDKI-EGVGAVNHE 425
            LG G FG     TAY        + VAVK LK     SERE    + KI   +G  NHE
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG--NHE 99

Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           N+V L          L++ +Y   G L   L   +    + L  E     +   A+G+ +
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAF 156

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAGYRA 536
           L ++  N  H ++ + N+LLT     ++ DFGLA  +         G +  P +   + A
Sbjct: 157 LASK--NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK---WMA 211

Query: 537 PEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV 595
           PE    C  + ++DV+S+G+LL E+ + G  P   +  +           ++K+ +    
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKEGY---- 261

Query: 596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
               + + ++   E+  +++    C    P  RP+  ++++ I + 
Sbjct: 262 ---RMAQPEHAPAEIYDIMK---TCWDADPLKRPTFKQIVQLIGKQ 301

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 6e-10
 Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 39/213 (18%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL------KDVTISEREFKDKIEGVGAVNHENLVPL 430
           LG+G FG  Y    ++ G  +AVK++       +        + +I+ +  + HE +V  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV-- 67

Query: 431 RAYYYSM--DEKLLVY-DYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEY 485
             YY  +  DE L ++ +Y+  GS+   L  +G        L   +          G+EY
Sbjct: 68  -QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-------ALTETVTRKYTRQILEGVEY 119

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--------HLVGPSS---TPNRVAGY 534
           LH+    + H +IK +NIL   +   ++ DFG +           G  S   TP     +
Sbjct: 120 LHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY----W 173

Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
            +PEV       +KADV+S G  ++E+LT K P
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 21/209 (10%)

Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAY 433
           E +GKGT+G  +K + +  G+  AVK L  +   + E + +   + A+ +H N+V     
Sbjct: 24  ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 434 YYSMDEK-----LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
           YY  D K      LV +    GS++ L+ G    G   +   + + I   A  G+++LH 
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER-MEEPIIAYILHEALMGLQHLHV 142

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGL-AHLVGPSSTPNRVAG---YRAPEVTDPCK 544
                 H ++K +NILLT     ++ DFG+ A L       N   G   + APEV   C+
Sbjct: 143 N--KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI-ACE 199

Query: 545 ------VSQKADVYSFGVLLLELLTGKAP 567
                    + DV+S G+  +EL  G  P
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDGDPP 228

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 60.1 bits (146), Expect = 7e-10
 Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 38/212 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGA-----------VN 423
           E +G+GT+GT +KA   E   IVA+KR++          D  EGV +           + 
Sbjct: 6   EKIGEGTYGTVFKAKNRETHEIVALKRVR--------LDDDDEGVPSSALREICLLKELK 57

Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
           H+N+V L    +S  +  LV++Y     L        G     +   ++S +     +G+
Sbjct: 58  HKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEI---VKSFM-FQLLKGL 112

Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRA 536
            + H+   NV H ++K  N+L+ K+ E +++DFGLA   G    P R          YR 
Sbjct: 113 AFCHSH--NVLHRDLKPQNLLINKNGELKLADFGLARAFG---IPVRCYSAEVVTLWYRP 167

Query: 537 PEVTDPCKV-SQKADVYSFGVLLLELLTGKAP 567
           P+V    K+ S   D++S G +  EL     P
Sbjct: 168 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 60.5 bits (147), Expect = 9e-10
 Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 32/229 (13%)

Query: 377 VLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKI-------EGVGAVNHE 425
           VLG+G FG   K +L    + G + A+K LK   I  R+  + +       E   +  H 
Sbjct: 6   VLGRGHFG---KVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62

Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
            LV L A + + D    V +Y   G L  ++H +      P      + + LG    ++Y
Sbjct: 63  FLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLG----LQY 116

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTD 541
           LH     + + ++K  N+LL      +++DFGL    +G     +   G   + APEV  
Sbjct: 117 LHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT 174

Query: 542 PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE 590
               ++  D +  GVL+ E+L G++P      EE  D      SIV DE
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD------SIVNDE 217

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 9e-10
 Identities = 67/287 (23%), Positives = 124/287 (43%), Gaps = 47/287 (16%)

Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKD-VTISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+ +       E  T VA+K + +  ++ ER EF ++   +   N  ++V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNK-----GAGRTPLNWEMRSLIALGAARGIE 484
           L     +    L+V + +  G L + L   +       G  P   +    +A   A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAGYR 535
           YL A+     H ++ + N ++ +    ++ DFG+   +         G    P R   + 
Sbjct: 134 YLAAK--KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---WM 188

Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           APE       + K+DV+SFGV+L E+ T  + P   L NEE +                 
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF--------------- 233

Query: 595 VFDLELLRY-QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE 640
           V D   L   +N  +++++L+++   C    P  RP+  E++  +++
Sbjct: 234 VIDGGHLDLPENCPDKLLELMRM---CWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 67/294 (22%), Positives = 125/294 (42%), Gaps = 50/294 (17%)

Query: 378 LGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG    A          +    VAVK LKD   +E++  D +  +  +     H+
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHK 81

Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG-----------RTPLNWEMRSL 474
           N++ L           ++ +Y + G+L   L   +  G              + ++    
Sbjct: 82  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141

Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-----PSSTPN 529
                ARG+EYL +Q     H ++ + N+L+T++   +++DFGLA  V        +T  
Sbjct: 142 CTYQVARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVL+ E+ T G +P   +  EE   L +    + 
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 259

Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P +RP+  ++++ ++ +
Sbjct: 260 KP--------------ANCTNELYMMMR---DCWHAIPSHRPTFKQLVEDLDRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 60.1 bits (145), Expect = 1e-09
 Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 16/195 (8%)

Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY A+LE    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL-MKCVNHKNIIGLLNVF 92

Query: 435 YSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
                     D Y+ M  + A L       +  L+ E  S +      GI++LH+ G  +
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG--I 147

Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQKAD 550
            H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       +  D
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207

Query: 551 VYSFGVLLLELLTGK 565
           ++S G ++ E++ G 
Sbjct: 208 IWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 21/207 (10%)

Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEG-----VGAVNHENLVP 429
           +V+GKG+FG    A  +  G+  AVK L+  TI +++ ++ I       +  + H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 430 LRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRS-LIALGAARGIEYLH 487
           L  Y +   EKL  V DY+  G L   L       R     E R+   A   A  I YLH
Sbjct: 61  LH-YSFQTAEKLYFVLDYVNGGELFFHLQ------RERCFLEPRARFYAAEVASAIGYLH 113

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTDPC 543
           +   N+ + ++K  NILL       ++DFGL    V P  T +   G   Y APEV    
Sbjct: 114 SL--NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKE 171

Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHA 570
              +  D +  G +L E+L G  P ++
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYS 198

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 52/218 (23%)

Query: 378 LGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISER-EFKDKIEGVGAVN----HENLVPLR 431
           LG+G  G+  K  L   G I A   LK +T     + + +I     +N       +V   
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFA---LKTITTDPNPDLQKQILRELEINKSCKSPYIV--- 62

Query: 432 AYYYS-MDEK----LLVYDYLTMGSLSALLH---------GNKGAGRTPLNWEMRSLIAL 477
            YY + +DE      +  +Y   GSL ++           G K  G+          IA 
Sbjct: 63  KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK----------IAE 112

Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG--- 533
              +G+ YLH++   + H +IK SNILLT+  + ++ DFG++  LV      N +AG   
Sbjct: 113 SVLKGLSYLHSR--KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV------NSLAGTFT 164

Query: 534 ----YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
               Y APE       S  +DV+S G+ LLE+   + P
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 61/275 (22%), Positives = 127/275 (46%), Gaps = 28/275 (10%)

Query: 378 LGKGTFGTAYKAVLEMG-TIVAVKRLKDVTISEREFKD----KIEGVGAVNHENLVPLRA 432
           +G+G F   Y+A   +    VA+K+++   + + + +     +I+ +  +NH N++    
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGR-TPLNWEMRSLIALGAARGIEYLHAQGP 491
            +   +E  +V +    G LS ++   K   R  P     +  + L +A  +E++H++  
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--VEHMHSR-- 125

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-PNRVAG---YRAPEVTDPCKVSQ 547
            V H +IK +N+ +T +   ++ D GL       +T  + + G   Y +PE       + 
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 185

Query: 548 KADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE 607
           K+D++S G LL E+   ++P +     + ++L    Q I       E  D   L  ++  
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYG----DKMNLFSLCQKI-------EQCDYPPLPTEHYS 234

Query: 608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH 642
           E++ +L+ +   C    PD RP +  V +  +++H
Sbjct: 235 EKLRELVSM---CIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 70/279 (25%), Positives = 131/279 (46%), Gaps = 47/279 (16%)

Query: 376 EVLGKGTFGTAYKAVLEMGT---IVAVKRLKDVTISEREF-KDKIEGVGAVNHENLVPLR 431
           + +G+G+FG  Y A  +  +   ++    L  + + E+E  K ++  +  + H N+V   
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV--- 62

Query: 432 AYYYSMDEK---LLVYDYLTMGSLSALLHGNKGAGRTP---LNWEMRSLIALGAARGIEY 485
            ++ S  E     +V +Y   G L   ++  +G   +    L+W ++  I+LG    +++
Sbjct: 63  TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ--ISLG----LKH 116

Query: 486 LHAQGPNVSHGNIKSSNILLTKS-YEARVSDFGLAHLVGPSSTPNRV-AG---YRAPEVT 540
           +H +   + H +IKS NI L+K+   A++ DFG+A  +  S        G   Y +PE+ 
Sbjct: 117 IHDR--KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC 174

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW--TSEVFDL 598
                + K D++S G +L EL T K P       EG +L + V  I +  +   S  F  
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPF------EGNNLHQLVLKICQGYFAPISPNFSR 228

Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR 637
           +L         + QL +++       P +RPS++ ++KR
Sbjct: 229 DL------RSLISQLFKVS-------PRDRPSITSILKR 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 24/207 (11%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLK-----DVTISEREFKDKIEGVGAVNHENLVPLR 431
           +G GT+G  YKA  +  G + A+K +K     D  + ++E    I  +    H N+V   
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQE----IIMMKDCKHSNIVAYF 72

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
             Y   D+  +  ++   GSL  + H        PL+    + ++    +G+ YLH++G 
Sbjct: 73  GSYLRRDKLWICMEFCGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR----VAGYRAPEVTDPCK--- 544
              H +IK +NILLT +   +++DFG++  +  +    +       + APEV    +   
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 545 VSQKADVYSFGVLLLELLTGKAPTHAL 571
            +Q  D+++ G+  +EL   + P   L
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDL 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 35/210 (16%)

Query: 377 VLGKGTFGTAYKAVL--EMGT--IVAVKRLK-DVTISEREF-----KDKIEGVGAVNHEN 426
           VLGKG+FG   K +L    GT  + A+K LK DV I + +      + ++  +       
Sbjct: 7   VLGKGSFG---KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP-F 62

Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNK-GAGRTPLNWEMRSLIALGAARGIEY 485
           L  L + + +MD    V +Y+  G L  + H  + G  + P         A   A G+ +
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEP----HAVFYAAEIAIGLFF 116

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--HLVGPSST------PNRVAGYRAP 537
           LH++G  + + ++K  N++L      +++DFG+   ++ G  +T      P+    Y AP
Sbjct: 117 LHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPD----YIAP 170

Query: 538 EVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           E+       +  D ++FGVLL E+L G+ P
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 16/195 (8%)

Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY AVL+    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 29  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL-MKCVNHKNIISLLNVF 85

Query: 435 YSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
                     D YL M  + A L       +  L+ E  S +      GI++LH+ G  +
Sbjct: 86  TPQKSLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG--I 140

Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQKAD 550
            H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       +  D
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 200

Query: 551 VYSFGVLLLELLTGK 565
           ++S G ++ E++  K
Sbjct: 201 IWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 70/282 (24%), Positives = 123/282 (43%), Gaps = 44/282 (15%)

Query: 376 EVLGKGTFGTAYKAVL-EMG-------TIVAVKRLKDVTISERE-FKDKIEGVGAVNHEN 426
           E LG+GTF   +K +  E+G       T V +K L     +  E F +    +  ++H++
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           LV         DE ++V +Y+  GSL   L  NK      ++W++   +A   A  + +L
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNL--INISWKLE--VAKQLAWALHFL 116

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEA--------RVSDFGLAHLVGPSSTPNRVAGYRAPE 538
             +G  ++HGN+ + N+LL +  +         ++SD G++  V P         +  PE
Sbjct: 117 EDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174

Query: 539 -VTDPCKVSQKADVYSFGVLLLELLTG-KAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF 596
            + +P  +S  AD +SFG  L E+ +G   P  AL +++ +        +   +WT    
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWT---- 230

Query: 597 DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
                       E+  L+     C    PD RPS   +I+ +
Sbjct: 231 ------------ELANLIN---QCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 69/290 (23%), Positives = 132/290 (45%), Gaps = 43/290 (14%)

Query: 374 SAEVLGKGTFGTAYKAVLEMGTI-----VAVKRLKD----VTISEREFKDKIEGVGAVNH 424
            +++L +GTFG  +  +L          V VK +KD    + ++    ++     G ++H
Sbjct: 10  LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVT-LLLQESCLLYG-LSH 67

Query: 425 ENLVP-LRAYYYSMDEKLLVYDYLTMGSLSALL----HGNKGAGRTPLNWEMRSLIALGA 479
           +N++P L       +   ++Y Y+  G+L   L     G     +     ++  + A+  
Sbjct: 68  QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM-AIQI 126

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS------TPNRVAG 533
           A G+ YLH +G  V H +I + N ++ +  + +++D  L+  + P          NR   
Sbjct: 127 ACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184

Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWT 592
           + A E     + S  +DV+SFGVLL EL+T G+ P         +D P  + + +KD + 
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP------YVEID-PFEMAAYLKDGY- 236

Query: 593 SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH 642
                  L +  N  +E+  ++     C A  P+ RPS S++++ + + H
Sbjct: 237 ------RLAQPINCPDELFAVMAC---CWALDPEERPSFSQLVQCLTDFH 277

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 67/289 (23%), Positives = 123/289 (42%), Gaps = 51/289 (17%)

Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKD-VTISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+ +       E  T VA+K + +  ++ ER EF ++   +   N  ++V 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALL-------HGNKGAGRTPLNWEMRSLIALGAARG 482
           L          L++ + +T G L + L         N       L   ++  +A   A G
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ--MAGEIADG 131

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAG 533
           + YL+A      H ++ + N ++ + +  ++ DFG+   +         G    P R   
Sbjct: 132 MAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186

Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWT 592
           + +PE       +  +DV+SFGV+L E+ T  + P   + NE+ +               
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF------------- 233

Query: 593 SEVFDLELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE 640
             V +  LL +  N  + + +L+++   C    P  RPS  E+I  I+E
Sbjct: 234 --VMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 58.3 bits (142), Expect = 3e-09
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 51/217 (23%)

Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVK--------RLKDV--TISEREFKDKIEGVGAVNH 424
           + LG G+FG          G   A+K        +LK V   ++E+    +I  + ++ H
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEK----RI--LQSIRH 60

Query: 425 ENLVPLRAYYYSMDEKLL--VYDYLTMGSLSALLHGNKGAGRTPLNWEM--RSLIALGAA 480
             LV    Y    D+  L  V +Y+  G L + L   + +GR P        + + L   
Sbjct: 61  PFLV--NLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPVARFYAAQVVLA-- 113

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----TPNRVAGYR 535
             +EYLH+   ++ + ++K  N+LL      +++DFG A  V   +     TP     Y 
Sbjct: 114 --LEYLHSL--DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPE----YL 165

Query: 536 APEVTDPCKVSQK-----ADVYSFGVLLLELLTGKAP 567
           APE+     +  K      D ++ G+L+ E+L G  P
Sbjct: 166 APEI-----ILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 15/197 (7%)

Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYY 434
           LG G  G   K   +   ++  ++L  + I      +   +++ +   N   +V     +
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
           YS  E  +  +++  GSL  +L   K A R P   E+   +++   RG+ YL  +   + 
Sbjct: 73  YSDGEISICMEHMDGGSLDQVL---KEAKRIP--EEILGKVSIAVLRGLAYLREKH-QIM 126

Query: 495 HGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPCKVSQKAD 550
           H ++K SNIL+    E ++ DFG++  L+   S  N   G   Y +PE       S ++D
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQSD 184

Query: 551 VYSFGVLLLELLTGKAP 567
           ++S G+ L+EL  G+ P
Sbjct: 185 IWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 27/202 (13%)

Query: 445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNIL 504
           +++  GSL  +    K  G  P+  E+   IA+    G+ YL+     + H +IK SNIL
Sbjct: 83  EFMDCGSLDRIY---KKGG--PIPVEILGKIAVAVVEGLTYLYNV-HRIMHRDIKPSNIL 136

Query: 505 LTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPCKVSQKADVYSFGVLLLE 560
           +    + ++ DFG++  L+  +S  +   G   Y +PE     K + K+DV+S G+ ++E
Sbjct: 137 VNSRGQIKLCDFGVSGELI--NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIE 194

Query: 561 LLTGKAP-THALLNEEGVDLP----RWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQ 615
           L  GK P   + ++++G D P      +Q IV++        L    +     + V    
Sbjct: 195 LALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR----LPSSDFPEDLRDFVDA-- 248

Query: 616 LAIDCSAQYPDNRPSMSEVIKR 637
               C  + P  RP+  ++   
Sbjct: 249 ----CLLKDPTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 67/233 (28%), Positives = 99/233 (42%), Gaps = 37/233 (15%)

Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLK-DVTISEREFKDKIEGVG--------AVNHE 425
            VLGKG+FG    A L E G + AVK LK DV + +    D +E           A NH 
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD----DDVECTMTEKRILSLARNHP 56

Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRS-LIALGAARGIE 484
            L  L   + + D    V +++  G L  + H  K         E R+   A      + 
Sbjct: 57  FLTQLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFD----EARARFYAAEITSALM 110

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA----HLVGPSSTPNRVAGYRAPEVT 540
           +LH +G  + + ++K  N+LL      +++DFG+          +ST      Y APE+ 
Sbjct: 111 FLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL 168

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHA---------LLNEEGVDLPRWVQ 584
                    D ++ GVLL E+L G AP  A         +LN+E V  P W+ 
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYPTWLS 220

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 54/221 (24%), Positives = 104/221 (47%), Gaps = 17/221 (7%)

Query: 376 EVLGKGTFGTAYKA-VLEMGTIVAVKRLK-DVTIS-EREFKDKIEGVGAVNHENLVPLRA 432
           E+LG G  GT YKA  L    I+AVK +  D+T+  +++   ++E +   +   ++    
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
            ++  +   +  +++  GSL           + P +   R  IA+   +G+ YL      
Sbjct: 67  AFFVENRISICTEFMDGGSLDVY-------RKIPEHVLGR--IAVAVVKGLTYL--WSLK 115

Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVTDPCKVSQKAD 550
           + H ++K SN+L+    + ++ DFG++  +  S     V    Y APE     +    +D
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSD 175

Query: 551 VYSFGVLLLELLTGKAPTHALLNEEGVDLP-RWVQSIVKDE 590
           V+S G+  +EL  G+ P   +   +G  +P + +Q IV ++
Sbjct: 176 VWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED 216

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 58.0 bits (141), Expect = 5e-09
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 28/207 (13%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKD----VTISEREFKDKIEGVGAVNHENLVPLRA 432
           LGKG +G  +KA+      +VA+K++ D     T ++R F++ +      +H N+V L  
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74

Query: 433 YYYSMDEK--LLVYDYLTMGS-LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              + ++K   LV++Y  M + L A++  N       L    +  I     + ++Y+H+ 
Sbjct: 75  VIKAENDKDIYLVFEY--METDLHAVIRANI------LEDVHKRYIMYQLLKALKYIHSG 126

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR-------VAG--YRAPEVT 540
             NV H ++K SNILL      +++DFGLA  +               VA   YRAPE+ 
Sbjct: 127 --NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEIL 184

Query: 541 DPCKVSQKA-DVYSFGVLLLELLTGKA 566
                  K  D++S G +L E+L GK 
Sbjct: 185 LGSTRYTKGVDMWSVGCILGEMLLGKP 211

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 57.1 bits (138), Expect = 6e-09
 Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 19/201 (9%)

Query: 378 LGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISERE------FKDKIEGVGAVNHENLVPL 430
           LGKG FG      V   G + A K+L    + +R+       + KI  +  V+   +V L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKI--LEKVSSRFIVSL 58

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI-ALGAARGIEYLHAQ 489
              + + D+  LV   +  G L   ++     G      E R++  A     G+E+LH +
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP----EARAIFYAAQIICGLEHLHQR 114

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVA--GYRAPEVTDPCKVS 546
              + + ++K  N+LL      R+SD GLA  L G      R    GY APEV       
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYD 172

Query: 547 QKADVYSFGVLLLELLTGKAP 567
              D ++ G  L E++ G++P
Sbjct: 173 FSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 65/301 (21%), Positives = 124/301 (41%), Gaps = 65/301 (21%)

Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKD--VTISEREFKDKIEGVGAVNHENLVP 429
           +G+G FG  ++A        E  T+VAVK LK+      + +F+ +   +   +H N+V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNK-----------------GAGRTPLNWEMR 472
           L           L+++Y+  G L+  L                     G    PL+   +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH---------LVG 523
             IA   A G+ YL  +     H ++ + N L+ ++   +++DFGL+             
Sbjct: 133 LCIAKQVAAGMAYLSER--KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASE 190

Query: 524 PSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRW 582
             + P R   +  PE     + + ++DV+++GV+L E+ + G  P + + +EE       
Sbjct: 191 NDAIPIR---WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE------- 240

Query: 583 VQSIVKDEWTSEVFDLELLRYQNV----EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
           V   V+D               NV    +   ++L  L   C ++ P +RPS + + + +
Sbjct: 241 VIYYVRD--------------GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286

Query: 639 E 639
           +
Sbjct: 287 Q 287

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 25/208 (12%)

Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKG--AGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L +   +  G L   +  +K     +  LNW       +  A+G+ YL
Sbjct: 73  RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 125

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 126 EER--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183

Query: 541 DPCKVSQKADVYSFGVLLLELLT-GKAP 567
                + ++DV+S+GV + EL+T G  P
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 24/198 (12%)

Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    A+  VL  G  VAVK+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 33  AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVL-LKCVNHKNIISLLNVF 89

Query: 435 Y---SMDEKLLVYDYLTM--GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
               S++E   VY  + +   +L  ++H         L+ E  S +      GI++LH+ 
Sbjct: 90  TPQKSLEEFQDVYLVMELMDANLCQVIH-------MELDHERMSYLLYQMLCGIKHLHSA 142

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAGY-RAPEVTDPCKVS 546
           G  + H ++K SNI++      ++ DFGLA     +   TP  V  Y RAPEV       
Sbjct: 143 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYK 200

Query: 547 QKADVYSFGVLLLELLTG 564
           +  D++S G ++ EL+ G
Sbjct: 201 ENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 15/197 (7%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE----REFKDKIEGVGAVNHENLVPLRA 432
           +G G +GT   A+    G  VA+K+L     SE    R +++ +  +  + HEN++ L  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRE-LRLLKHMKHENVIGL-L 80

Query: 433 YYYSMDEKLLVYD--YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
             ++ D  L  +   YL M  +   L   K      L+ +    +     +G++Y+HA G
Sbjct: 81  DVFTPDLSLDRFHDFYLVMPFMGTDL--GKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG 138

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-YRAPEVT-DPCKVSQK 548
             + H ++K  N+ + +  E ++ DFGLA       T   V   YRAPEV  +    +Q 
Sbjct: 139 --IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQT 196

Query: 549 ADVYSFGVLLLELLTGK 565
            D++S G ++ E+LTGK
Sbjct: 197 VDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 64/220 (29%), Positives = 95/220 (43%), Gaps = 52/220 (23%)

Query: 378 LGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAV----------NH 424
           LG+G +G    A  A       VA+K++ +V      F  KI    A+           H
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNV------FSKKILAKRALRELKLLRHFRGH 61

Query: 425 ENLVPLRAYYYSMD-------EKLLVYDYLTMGSLSALLHGNKGAGRTPL-NWEMRSLIA 476
           +N+  L    Y MD        +L +Y+ L    L  ++   +     PL +   +S I 
Sbjct: 62  KNITCL----YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ-----PLTDAHFQSFI- 111

Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--- 533
                G++Y+H+   NV H ++K  N+L+    E ++ DFGLA   G S  P   AG   
Sbjct: 112 YQILCGLKYIHSA--NVLHRDLKPGNLLVNADCELKICDFGLAR--GFSENPGENAGFMT 167

Query: 534 -------YRAPEVTDPCKVSQKA-DVYSFGVLLLELLTGK 565
                  YRAPE+    +   KA DV+S G +L ELL  K
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 64/208 (30%), Positives = 95/208 (45%), Gaps = 28/208 (13%)

Query: 377 VLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISEREFKD----KIEG--VGAVNHEN 426
           VLGKG +G  ++     G     I A+K LK  TI  R  KD    K E   + AV H  
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-RNQKDTAHTKAERNILEAVKHPF 61

Query: 427 LVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA-ARGIE 484
           +V L  Y +    KL L+ +YL+ G L   L       R  +  E  +   L   +  +E
Sbjct: 62  IVDL-IYAFQTGGKLYLILEYLSGGELFMHLE------REGIFMEDTACFYLSEISLALE 114

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--HLVGPSSTPNRVAG---YRAPEV 539
           +LH QG  + + ++K  NILL      +++DFGL    +   + T +   G   Y APE+
Sbjct: 115 HLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT-HTFCGTIEYMAPEI 171

Query: 540 TDPCKVSQKADVYSFGVLLLELLTGKAP 567
                  +  D +S G L+ ++LTG  P
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 49/197 (24%), Positives = 94/197 (47%), Gaps = 15/197 (7%)

Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYY 434
           LG G  G  +K   +   ++  ++L  + I      +   +++ +   N   +V     +
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
           YS  E  +  +++  GSL  +L   K AGR P   ++   +++   +G+ YL  +   + 
Sbjct: 73  YSDGEISICMEHMDGGSLDQVL---KKAGRIP--EQILGKVSIAVIKGLTYLREKH-KIM 126

Query: 495 HGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPCKVSQKAD 550
           H ++K SNIL+    E ++ DFG++  L+   S  N   G   Y +PE       S ++D
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQSD 184

Query: 551 VYSFGVLLLELLTGKAP 567
           ++S G+ L+E+  G+ P
Sbjct: 185 IWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 48/219 (21%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV--TISE-----REFK--------DKIEGV 419
           EV+GKG++G    A+    G  VA+K++ DV   +S+     RE K        D +E  
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE-- 63

Query: 420 GAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA 479
             + H  L P R  +  +        Y+    + + LH    A    L  E         
Sbjct: 64  --IKHIMLPPSRREFKDI--------YVVFELMESDLHQVIKAN-DDLTPEHHQFFLYQL 112

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP------NRVAG 533
            R ++Y+H    NV H ++K  NIL     + ++ DFGLA  V  + TP      + VA 
Sbjct: 113 LRALKYIHTA--NVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVAT 169

Query: 534 --YRAPEVTDPC-----KVSQKADVYSFGVLLLELLTGK 565
             YRAPE+   C     K +   D++S G +  E+LTGK
Sbjct: 170 RWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 52/295 (17%)

Query: 378 LGKGTFGTAYKAVLEMG---------TIVAVKRLKDVTISEREFKDKIEGVGAVN----H 424
           LG+G FG    A   +G         T VAVK LK    +E++  D I  +  +     H
Sbjct: 26  LGEGCFGQVVMAE-AIGLDKEKPNRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMIGKH 83

Query: 425 ENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG--------RTPL-NWEMRSLI 475
           +N++ L           ++ +Y + G+L   L   +  G        + P      + L+
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 476 --ALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA----HLVGPSSTPN 529
             A   ARG+EYL ++     H ++ + N+L+T+    +++DFGLA    H+     T N
Sbjct: 144 SCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 530 -RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSI 586
            R+   + APE       + ++DV+SFGVLL E+ T G +P   +  EE   L +    +
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM 261

Query: 587 VKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 262 DKP--------------SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 19/202 (9%)

Query: 377 VLGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISEREFK----DKIEGVGAVNHENLVPLR 431
           VLGKG FG      V   G + A K+L+   I +R+ +    ++   +  VN   +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLH--GNKGAGRTPLNWEMRSLI-ALGAARGIEYLHA 488
             Y + D   LV   +  G L   ++  GN G        E R++  A     G+E L  
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD------EQRAIFYAAELCCGLEDLQR 120

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-PNRVA--GYRAPEVTDPCKV 545
           +   + + ++K  NILL      R+SD GLA  +    T   RV   GY APEV +  K 
Sbjct: 121 E--RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY 178

Query: 546 SQKADVYSFGVLLLELLTGKAP 567
           +   D +  G L+ E++ G++P
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 28/206 (13%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE-------REFKDKIEGVGAVNHENL 427
           E +G+GT+G  YK    + G IVA+K+++  +  E       RE    I  +  + H N+
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIRE----ISLLKELQHPNI 61

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           V L+          L++++L+M  L   L              ++S +     +GI + H
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAEL-VKSYL-YQILQGILFCH 118

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEV- 539
           ++   V H ++K  N+L+      +++DFGLA   G    P RV         YRAPEV 
Sbjct: 119 SR--RVLHRDLKPQNLLIDNKGVIKLADFGLARAFG---IPVRVYTHEVVTLWYRAPEVL 173

Query: 540 TDPCKVSQKADVYSFGVLLLELLTGK 565
               + S   D++S G +  E+ T K
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 18/203 (8%)

Query: 378 LGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVP-LRAYYY 435
           LGKG +G+ YK +    G  +A+K ++ + + E +F   I  +  + H+ + P +  +Y 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIR-LELDESKFNQIIMEL-DILHKAVSPYIVDFYG 66

Query: 436 SMDEKLLVY---DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
           +   +  VY   +Y+  GSL  L  G       P +   R  I     +G+++L  +  N
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEE-HN 123

Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPN-RVAGYRAPE------VTDPCK 544
           + H ++K +N+L+  + + ++ DFG++ +LV   +  N     Y APE            
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPT 183

Query: 545 VSQKADVYSFGVLLLELLTGKAP 567
            + ++DV+S G+ +LE+  G+ P
Sbjct: 184 YTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 61/203 (30%), Positives = 87/203 (42%), Gaps = 21/203 (10%)

Query: 377 VLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEG-----VGAVNHENLVPL 430
           V+GKG+FG    A     G   AVK L+   I +++ +  I       +  V H  LV L
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 431 RAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRS-LIALGAARGIEYLHA 488
             Y +   +KL  V DY+  G L   L   +     P   E R+   A   A  + YLH 
Sbjct: 62  H-YSFQTADKLYFVLDYVNGGELFFHLQRER---SFP---EPRARFYAAEIASALGYLH- 113

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTDPCK 544
              N+ + ++K  NILL       ++DFGL    +  S T +   G   Y APEV     
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP 172

Query: 545 VSQKADVYSFGVLLLELLTGKAP 567
             +  D +  G +L E+L G  P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 64/288 (22%), Positives = 122/288 (42%), Gaps = 44/288 (15%)

Query: 377 VLGKGTFGTAYKAVLEM----GTIVAVKRLK-DVTISE--REFKDKIEGVGAVNHENLVP 429
           +LGKG FG+  +A L+        VAVK LK D+  S    EF  +   +   +H N++ 
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 430 LRAYYYSMDEK------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI--ALGAAR 481
           L         K      +++  ++  G L   L  ++  G  P    +++L+   +  A 
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR-IGEEPFTLPLQTLVRFMIDIAS 124

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP---- 537
           G+EYL ++  N  H ++ + N +L ++    V+DFGL+  +       +    + P    
Sbjct: 125 GMEYLSSK--NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182

Query: 538 ---EVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTS 593
               + D    +  +DV++FGV + E++T G+ P   + N E          ++K     
Sbjct: 183 ALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSE------IYNYLIKGN--- 232

Query: 594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
                   R +   + +  + +L   C +  P  RPS   +  ++E +
Sbjct: 233 --------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 33/228 (14%)

Query: 378 LGKGTFGTAY--------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG           K        VAVK LKD   ++++  D +  +  +     H+
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKD-DATDKDLSDLVSEMEMMKMIGKHK 78

Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG--------RTP---LNWEMRSL 474
           N++ L           ++ +Y + G+L   L   +  G        + P   L ++    
Sbjct: 79  NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138

Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-----PSSTPN 529
            A   ARG+EYL +Q     H ++ + N+L+T+    +++DFGLA  V        +T  
Sbjct: 139 CAYQVARGMEYLASQ--KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
           R+   + APE       + ++DV+SFGVLL E+ T G +P   +  EE
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 3e-08
 Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 25/202 (12%)

Query: 378 LGKGTFGTAYKA---------VLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLV 428
           +G GTFG  +            L++  I  V RLK     E+   ++   +  V+H  ++
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLK----QEQHVHNEKRVLKEVSHPFII 64

Query: 429 PLRAYYYSMDEKLL--VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
             R ++   D++ L  + +Y+  G L + L   + +GR   +       A      +EYL
Sbjct: 65  --RLFWTEHDQRFLYMLMEYVPGGELFSYL---RNSGR--FSNSTGLFYASEIVCALEYL 117

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAGYRAPEVTDPCKV 545
           H++   + + ++K  NILL K    +++DFG A  L   + T      Y APEV      
Sbjct: 118 HSK--EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGH 175

Query: 546 SQKADVYSFGVLLLELLTGKAP 567
           ++  D ++ G+L+ E+L G  P
Sbjct: 176 NKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 42/138 (30%), Positives = 72/138 (52%), Gaps = 12/138 (8%)

Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
           +YS  E  +  +++  GSL  +L   K AGR P N   +  I++   RG+ YL  +   +
Sbjct: 68  FYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGK--ISIAVLRGLTYLREK-HKI 121

Query: 494 SHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPCKVSQKA 549
            H ++K SNIL+    E ++ DFG++  L+   S  N   G   Y +PE       + ++
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYTVQS 179

Query: 550 DVYSFGVLLLELLTGKAP 567
           D++S G+ L+E+  G+ P
Sbjct: 180 DIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 34/89 (38%), Positives = 52/89 (58%), Gaps = 6/89 (6%)

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPE 538
           RG++Y+H+ G  + H ++K SN+ + +  E R+ DFGLA       T   VA   YRAPE
Sbjct: 129 RGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT-GYVATRWYRAPE 185

Query: 539 VT-DPCKVSQKADVYSFGVLLLELLTGKA 566
           +  +    +Q  D++S G ++ ELL GKA
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKA 214

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 33/228 (14%)

Query: 378 LGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG   +A          +    VAVK LKD   ++++  D I  +  +     H+
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKD-NATDKDLADLISEMELMKLIGKHK 78

Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG-----------RTPLNWEMRSL 474
           N++ L           ++ +Y   G+L   L   +  G              L+++    
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV------GPSSTP 528
            A   ARG+EYL ++     H ++ + N+L+T+    +++DFGLA  V        +S  
Sbjct: 139 CAYQVARGMEYLESR--RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
                + APE       + ++DV+SFG+L+ E+ T G +P   +  EE
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 54.6 bits (131), Expect = 6e-08
 Identities = 65/227 (28%), Positives = 110/227 (48%), Gaps = 33/227 (14%)

Query: 377 VLGKGTFGTAYKAVLEMGT--IVAVKRLK-DVTISEREFKDKI--EGVGAVNHEN--LVP 429
           VLGKG+FG    A  + GT  + A+K LK DV I + + +  +  + V A++ +   L  
Sbjct: 7   VLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQ 65

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           L + + +MD    V +Y+  G L   ++  +  GR           A   A G+ +LH++
Sbjct: 66  LHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSK 120

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAH---LVGPSS-----TPNRVAGYRAPEVTD 541
           G  + + ++K  N++L      +++DFG+       G ++     TP+    Y APE+  
Sbjct: 121 G--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD----YIAPEIIA 174

Query: 542 PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK 588
                +  D ++FGVLL E+L G+AP       EG D     QSI++
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPF------EGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 54.4 bits (131), Expect = 6e-08
 Identities = 60/214 (28%), Positives = 88/214 (41%), Gaps = 36/214 (16%)

Query: 377 VLGKGTFGTAYKA---------------VLEMGTIVAVKRLKDVTISEREFKDKIEGVGA 421
           VLG G +G  +                 VL+  TIV   +  + T +ER+  + +     
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRC-- 64

Query: 422 VNHENLVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA 480
                LV L  Y +  D KL L+ DY+  G L   L+  +    +    E+R  IA    
Sbjct: 65  ---PFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLYQREHFTES----EVRVYIA-EIV 115

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST--PNRVAG---YR 535
             +++LH  G  + + +IK  NILL       ++DFGL+               G   Y 
Sbjct: 116 LALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173

Query: 536 APEV--TDPCKVSQKADVYSFGVLLLELLTGKAP 567
           APEV         +  D +S GVL  ELLTG +P
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 54.7 bits (132), Expect = 6e-08
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 23/202 (11%)

Query: 377 VLGKGTFGT---AYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVP 429
            +G G  G    AY  V   G  VA+K+L    ++VT ++R +++ +  +  VNH+N++ 
Sbjct: 23  PIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVL-MKLVNHKNIIG 79

Query: 430 LRAYYY---SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           L   +    S++E   VY  L M  + A L       +  L+ E  S +      GI++L
Sbjct: 80  LLNVFTPQKSLEEFQDVY--LVMELMDANLCQ---VIQMDLDHERMSYLLYQMLCGIKHL 134

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--TPNRVAG-YRAPEVTDPC 543
           H+ G  + H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV    
Sbjct: 135 HSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 192

Query: 544 KVSQKADVYSFGVLLLELLTGK 565
              +  D++S G ++ E++ G 
Sbjct: 193 GYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 54.2 bits (130), Expect = 7e-08
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 26/206 (12%)

Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRL-KDVTISEREFKDKIEG---VGAVNHENL 427
           ++LGKGTFG   K +L      G   A+K L K+V I++ E    +     +    H  L
Sbjct: 1   KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEY 485
             L+  + + D    V +Y   G L    H      R  +  E R+    GA     +EY
Sbjct: 58  TALKYAFQTHDRLCFVMEYANGGEL--FFH----LSRERVFTEERARF-YGAEIVSALEY 110

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTD 541
           LH++  +V + +IK  N++L K    +++DFGL    +   +T     G   Y APEV +
Sbjct: 111 LHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 168

Query: 542 PCKVSQKADVYSFGVLLLELLTGKAP 567
                +  D +  GV++ E++ G+ P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 54.7 bits (131), Expect = 8e-08
 Identities = 57/269 (21%), Positives = 122/269 (45%), Gaps = 47/269 (17%)

Query: 311 DDKAVGEMDNGYSVAAAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDL 370
           +DK + E +  ++  A          + + +  +++++N +  K    GN          
Sbjct: 31  NDKKLDEEERSHNNNAG--------EDEDEEKMIDNDINRSPNKSYKLGN---------- 72

Query: 371 LRASAEVLGKGTFGTAYKAV-LEMGTIVAVKR-LKDVTISEREFKDKIEGVGAVNHENLV 428
                 ++G G+FG  Y+A+ ++    VA+K+ L+D     RE       +  +NH N++
Sbjct: 73  ------IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNHINII 122

Query: 429 PLRAYYYS----MDEKLL----VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA 480
            L+ YYY+     +EK +    V +++       + H  +     PL   +  L +    
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPL--FLVKLYSYQLC 180

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLT-KSYEARVSDFGLA-HLVGPSSTPNRVAG--YRA 536
           R + Y+H++   + H ++K  N+L+   ++  ++ DFG A +L+    + + +    YRA
Sbjct: 181 RALAYIHSK--FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRA 238

Query: 537 PEVT-DPCKVSQKADVYSFGVLLLELLTG 564
           PE+       +   D++S G ++ E++ G
Sbjct: 239 PELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 54.5 bits (131), Expect = 9e-08
 Identities = 43/154 (27%), Positives = 66/154 (42%), Gaps = 30/154 (19%)

Query: 422 VNHENLVPLRAYYYSMDEKLLV--------YDYLTMGSLSALLHGNKGAGRTPLNWEMRS 473
           VNH +++ ++    S     +V        Y YLT  S              PL  +   
Sbjct: 114 VNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS-------------RPLPIDQAL 160

Query: 474 LIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR--V 531
           +I      G+ YLHAQ   + H ++K+ NI +    +  + D G A    P   P    +
Sbjct: 161 IIEKQILEGLRYLHAQ--RIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGL 216

Query: 532 AGY---RAPEVTDPCKVSQKADVYSFGVLLLELL 562
           AG     APEV    K + KAD++S G++L E+L
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 54.1 bits (130), Expect = 9e-08
 Identities = 55/236 (23%), Positives = 96/236 (40%), Gaps = 37/236 (15%)

Query: 376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVPL 430
           E LG G+FG    A  +  G   A+K LK   I + +    +    ++    +H  +V +
Sbjct: 24  ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLN----WEMRSLIALGAARGIEYL 486
              +   +    + +++  G L   L   + AGR P +    +    ++A       EYL
Sbjct: 84  MCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYHAELVLAF------EYL 134

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----TPNRVAGYRAPEVTD 541
           H++  ++ + ++K  N+LL      +V+DFG A  V   +     TP     Y APEV  
Sbjct: 135 HSK--DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPE----YLAPEVIQ 188

Query: 542 PCKVSQKADVYSFGVLLLELLTGKAP--------THALLNEEGVDLPRWVQSIVKD 589
                +  D ++ GVLL E + G  P         +  +    +  P W     +D
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARD 244

Length = 329

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 15/199 (7%)

Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVK--RLKDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           E LG+G++ T YK   ++ G +VA+K  RL++   +      +   +  + H N+V L  
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
             ++ +   LV++Y+    L   +  + G G  P N +   L      RG+ Y+H +   
Sbjct: 71  IIHTKETLTLVFEYVHT-DLCQYMDKHPG-GLHPENVK---LFLFQLLRGLSYIHQR--Y 123

Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSST-PNRVAG--YRAPEV-TDPCKVSQ 547
           + H ++K  N+L++ + E +++DFGLA     PS T  N V    YR P+V     + S 
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 548 KADVYSFGVLLLELLTGKA 566
             D++  G + +E++ G A
Sbjct: 184 CLDMWGVGCIFVEMIQGVA 202

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 23/216 (10%)

Query: 358 FGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKI 416
           FG A    +LE L        G+G++ T YK +  + G +VA+K +   T     F    
Sbjct: 1   FGAATSYLNLEKL--------GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR 52

Query: 417 EG--VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL 474
           E   +  + H N+V L    ++ +    V++Y+    L+  +  + G G  P N     L
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPG-GLHPYNVR---L 107

Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR--- 530
                 RG+ Y+H Q  ++ H ++K  N+L++   E +++DFGLA     PS T +    
Sbjct: 108 FMFQLLRGLAYIHGQ--HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV 165

Query: 531 VAGYRAPEV-TDPCKVSQKADVYSFGVLLLELLTGK 565
              YR P+V       S   D++  G + +E+L G+
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 60/234 (25%), Positives = 107/234 (45%), Gaps = 35/234 (14%)

Query: 376 EVLGKGTFGTAY-------KAVLEMGT--------IVAVKRLK-DVTISER-EFKDKIEG 418
           E LG+G FG  +          L  G         +VAVK L+ DVT + R +F  +I+ 
Sbjct: 11  EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70

Query: 419 VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL---- 474
           +  + + N++ L     S D   ++ +Y+  G L+  L   +          + S+    
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 475 ---IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV 531
              +A+  A G++YL +   N  H ++ + N L+   Y  +++DFG++  +  S    R+
Sbjct: 131 LLYMAVQIASGMKYLASL--NFVHRDLATRNCLVGNHYTIKIADFGMSRNL-YSGDYYRI 187

Query: 532 AG-------YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGV 577
            G       + A E     K +  +DV++FGV L E+ T  K   ++LL++E V
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 25/219 (11%)

Query: 377 VLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVP 429
           VLG G FGT YK +       +   VA+K L++ T   + +E  D+   +  V    +  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKG--AGRTPLNWEMRSLIALGAARGIEYLH 487
           L     +   +L V   +  G L   +  NK     +  LNW       +  A+G+ YL 
Sbjct: 74  LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYL- 125

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVTD 541
            +   + H ++ + N+L+      +++DFGLA L+    T     G + P      E   
Sbjct: 126 -EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 542 PCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDL 579
             + + ++DV+S+GV + EL+T G  P   +   E  DL
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL 223

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 62/237 (26%), Positives = 100/237 (42%), Gaps = 32/237 (13%)

Query: 378 LGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISEREFKDKIEGV-------GAVNHENLVP 429
           +G+G +G  + A   + G IVA+KR+K   +      +++  V            E LV 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLL---FKLNEVRHVLTERDILTTTKSEWLVK 65

Query: 430 LRAYYYSMDEKLLVY---DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIA-LGAARGIEY 485
           L    Y+  +   +Y   +Y+  G    LL+ N G          R  +A +  A  ++ 
Sbjct: 66  L---LYAFQDDEYLYLAMEYVPGGDFRTLLN-NLGVLS---EDHARFYMAEMFEA--VDA 116

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDP 542
           LH  G    H ++K  N L+  S   +++DFGL+   G  +  N V G   Y APEV   
Sbjct: 117 LHELG--YIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTYANSVVGSPDYMAPEVLRG 172

Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHA-LLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                  D +S G +L E L G  P      NE   +L  W +++ +  +    F+L
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNL 229

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 62/220 (28%), Positives = 91/220 (41%), Gaps = 31/220 (14%)

Query: 376 EVLGKGTFGTAYKA------------VLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
           +V+GKG+FG    A            VL+   I+  K  K + +SER    K      V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHI-MSERNVLLK-----NVK 54

Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRS-LIALGAARG 482
           H  LV L   + + D+   V DY+  G L   L       R     E R+   A   A  
Sbjct: 55  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ------RERCFLEPRARFYAAEIASA 108

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPE 538
           + YLH+   N+ + ++K  NILL       ++DFGL    +  + T +   G   Y APE
Sbjct: 109 LGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPE 166

Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVD 578
           V       +  D +  G +L E+L G  P ++    E  D
Sbjct: 167 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 22/204 (10%)

Query: 378 LGKGTFGTAYKAVLEMGTI--VAVKRLKDVTISEREFKDKI----EGVGAVNHENLVPLR 431
           LG G+FG    A  +      VA+KR +   I +++  D +    + +  +NH   V L 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
             +       LV +++  G     L  NK   R P   ++    A       EYL  Q  
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNK---RFPN--DVGCFYAAQIVLIFEYL--QSL 150

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----TPNRVAGYRAPEVTDPCKVS 546
           N+ + ++K  N+LL K    +++DFG A +V   +     TP     Y APE+       
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPE----YIAPEILLNVGHG 206

Query: 547 QKADVYSFGVLLLELLTGKAPTHA 570
           + AD ++ G+ + E+L G  P +A
Sbjct: 207 KAADWWTLGIFIYEILVGCPPFYA 230

Length = 340

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 32/212 (15%)

Query: 378 LGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHEN---------- 426
           +GKGTFG  Y+    +   I A+K L     S++E   K E    +   N          
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVL-----SKKEIVAKKEVAHTIGERNILVRTLLDES 55

Query: 427 --LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA-ARGI 483
             +V L+  + +  +  LV DY++ G L    H  K  GR     E R+   +      +
Sbjct: 56  PFIVGLKFSFQTDSDLYLVTDYMSGGEL--FWHLQK-EGRFS---EDRAKFYIAELVLAL 109

Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEV 539
           E+LH    ++ + ++K  NILL  +    + DFGL+   +  + T N   G   Y APEV
Sbjct: 110 EHLHKY--DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEV 167

Query: 540 T-DPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             D    ++  D +S GVL+ E+  G +P +A
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 22/204 (10%)

Query: 378 LGKGTFGTAYKA--VLEMGTIVAVKRLKDVTISEREFKDKIEGVGAV------NHENLVP 429
           +G+G +G  +KA  +   G  VA+KR++  T  E      I  V  +       H N+V 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 430 L----RAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
           L           + KL LV++++    L+  L      G      E    +     RG++
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLD 124

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA---GYRAPEVTD 541
           +LH+    V H ++K  NIL+T S + +++DFGLA +         V     YRAPEV  
Sbjct: 125 FLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 182

Query: 542 PCKVSQKADVYSFGVLLLELLTGK 565
               +   D++S G +  E+   K
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 23/201 (11%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 83

Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 137

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +    + H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 138 SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 194

Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 195 YNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 18/199 (9%)

Query: 377 VLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKD----KIEGVGAVNHENLVPLR 431
           V+G+G +G   K    E   IVA+K+ KD   +E E K+    +++ +  +  EN+V L+
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELK 66

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
             +    +  LV++Y+    L  L     G     +   +  LI     + I + H    
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLI-----KAIHWCHKN-- 119

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR---VAG--YRAPEVTDPCKVS 546
           ++ H +IK  N+L++ +   ++ DFG A  +   S  N    VA   YR+PE+       
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179

Query: 547 QKADVYSFGVLLLELLTGK 565
           +  D++S G +L EL  G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 57/230 (24%), Positives = 102/230 (44%), Gaps = 24/230 (10%)

Query: 373 ASAEVLGKGTFGTAYKAVL---EMGTIVAVKRLKDVTISEREFKDKIEGVGAV---NHEN 426
           A  + LG+G FG+  +  L   +    VAVK +K    +  E +D +     +   +H N
Sbjct: 2   ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61

Query: 427 LVPLRAYYYSMDEK------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA- 479
           ++ L        E       +++  ++  G L + L  ++  G  P     + L+     
Sbjct: 62  VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR-LGDCPQYLPTQMLVKFMTD 120

Query: 480 -ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG--- 533
            A G+EYL ++  +  H ++ + N +L ++    V+DFGL+  +  G      R+A    
Sbjct: 121 IASGMEYLSSK--SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178

Query: 534 -YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPR 581
            + A E       + K+DV+SFGV + E+ T G+ P   + N E  D  R
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR 228

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 37/232 (15%)

Query: 376 EVLGKGTFGTAYKAVLEMGT--IVAVKRLK----------DVTISEREFKDKIEGVGAVN 423
           +VLGKG+FG    A L+ GT  + A+K LK          D T++E+    +I  + A  
Sbjct: 1   KVLGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEK----RILALAA-K 54

Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRS-LIALGAARG 482
           H  L  L   + + D    V +Y+  G L   +  ++         E RS   A      
Sbjct: 55  HPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD------EPRSRFYAAEVTLA 108

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPE 538
           + +LH  G  V + ++K  NILL      +++DFG+    +    T     G   Y APE
Sbjct: 109 LMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166

Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE 590
           +    +     D ++ GVL+ E++ G+ P  A  NE+  DL    +SI+ D+
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNED--DL---FESILHDD 212

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 28/206 (13%)

Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLK----DVTISEREFKDKIEGVGAVNHENLVPL 430
           E +G+GT+G  YKA   +    +A+K+++    D  +     ++ I  +  + H N+V L
Sbjct: 8   EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIRE-ISLLKEMQHGNIVRL 66

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTP-----LNWEMRSLIALGAARGIEY 485
           +   +S     LV++YL +  L   +  +    + P       +++         RGI Y
Sbjct: 67  QDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQI--------LRGIAY 117

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLAHLVG-PSST-PNRVAG--YRAPEV- 539
            H+    V H ++K  N+L+ +   A +++DFGLA   G P  T  + V    YRAPE+ 
Sbjct: 118 CHSH--RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL 175

Query: 540 TDPCKVSQKADVYSFGVLLLELLTGK 565
                 S   D++S G +  E++  K
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 8/91 (8%)

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YR 535
           RG++YLH     + H +IK  N+L+  +   ++ DFGLA +  P  + +         YR
Sbjct: 114 RGLKYLH--SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYR 171

Query: 536 APEVTDPCK-VSQKADVYSFGVLLLELLTGK 565
           APE+    +  +   D++S G +  ELL  +
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 52.9 bits (127), Expect = 5e-07
 Identities = 40/106 (37%), Positives = 57/106 (53%), Gaps = 16/106 (15%)

Query: 143 HLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLP---NLQQLNVSN 199
            +V ++L+  N SG+I S    L  ++T+ L NN+LSG IP  DD+     +L+ LN+SN
Sbjct: 70  RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIP--DDIFTTSSSLRYLNLSN 127

Query: 200 NLLNGSIPKRFQTFGSNSFL------GNSLCGKPLQDCGTKASLVV 239
           N   GSIP+     GS   L       N L G+   D G+ +SL V
Sbjct: 128 NNFTGSIPR-----GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKV 168

Length = 968

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 52.1 bits (125), Expect = 5e-07
 Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 51/229 (22%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKR------------LKDVTISEREFKDKI----EGVG 420
           LG G+ G  + AV  +    VAVK+            L+++ I  R   D I    E +G
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 421 AVNHE------NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL 474
               +      +L  L + Y       +V +Y+     + L  G       PL+ E   L
Sbjct: 73  PSGSDLTEDVGSLTELNSVY-------IVQEYMETDLANVLEQG-------PLSEEHARL 118

Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEARVSDFGLAHLVGPS-------S 526
                 RG++Y+H+   NV H ++K +N+ + T+    ++ DFGLA +V P        S
Sbjct: 119 FMYQLLRGLKYIHSA--NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176

Query: 527 TPNRVAGYRAPE-VTDPCKVSQKADVYSFGVLLLELLTGK---APTHAL 571
                  YR+P  +  P   ++  D+++ G +  E+LTGK   A  H L
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 52.0 bits (125), Expect = 5e-07
 Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 13/93 (13%)

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR-------VAG 533
           RG++Y+H+   NV H ++K SN+LL  + + ++ DFGLA     +S              
Sbjct: 119 RGLKYIHSA--NVLHRDLKPSNLLLNANCDLKICDFGLAR---TTSEKGDFMTEYVVTRW 173

Query: 534 YRAPEVTDPCKVSQKA-DVYSFGVLLLELLTGK 565
           YRAPE+   C     A DV+S G +  ELL  K
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 46.2 bits (110), Expect = 5e-07
 Identities = 18/41 (43%), Positives = 22/41 (53%), Gaps = 4/41 (9%)

Query: 30 LSSDRAALLALRSSV----GGRTLLWNVYEASPCKWAGVEC 66
          L+ DR ALLA +SS+     G    WN   + PC W GV C
Sbjct: 1  LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 25/213 (11%)

Query: 378 LGKGTFGTAYKAVLEMGTI---VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
           +G+GT+G  YKA  + G      A+K+++   IS    ++ I  +  + H N++ L+  +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE-IALLRELKHPNVIALQKVF 67

Query: 435 YSMDEK--LLVYDYLTMGSLSAL-LHGNKGAGRTPLNWEMRSLIA---LGAARGIEYLHA 488
            S  ++   L++DY        +  H    A + P+    RS++         GI YLHA
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLP-RSMVKSLLYQILDGIHYLHA 126

Query: 489 QGPNVSHGNIKSSNILLT----KSYEARVSDFGLAHLVGPSSTPNR-------VAGYRAP 537
               V H ++K +NIL+     +    +++D G A L      P            YRAP
Sbjct: 127 NW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 538 EVTDPCKVSQKA-DVYSFGVLLLELLTGKAPTH 569
           E+    +   KA D+++ G +  ELLT +   H
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.8 bits (124), Expect = 6e-07
 Identities = 47/191 (24%), Positives = 89/191 (46%), Gaps = 35/191 (18%)

Query: 463 GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV 522
            + PL  E     +   ARG+E+L ++     H ++ + NILL+++   ++ DFGLA  +
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDI 223

Query: 523 ---------GPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHAL- 571
                    G +  P +   + APE       + ++DV+SFGVLL E+ + G +P   + 
Sbjct: 224 YKDPDYVRKGDARLPLK---WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280

Query: 572 LNEEGVD-LPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPS 630
           ++EE    L    +    +  T E++                   + +DC    P++RP+
Sbjct: 281 IDEEFCRRLKEGTRMRAPEYATPEIY------------------SIMLDCWHNNPEDRPT 322

Query: 631 MSEVIKRIEEL 641
            SE+++ + +L
Sbjct: 323 FSELVEILGDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 51.2 bits (123), Expect = 6e-07
 Identities = 49/185 (26%), Positives = 87/185 (47%), Gaps = 20/185 (10%)

Query: 395 TIVAVKRLK-DVTISER-EFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL 452
            +VAVK L+ D + + R +F  +++ +  ++  N+  L           ++ +Y+  G L
Sbjct: 47  VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106

Query: 453 SALLH------GNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT 506
           +  L                L++     +A   A G+ YL +   N  H ++ + N L+ 
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL--NFVHRDLATRNCLVG 164

Query: 507 KSYEARVSDFGLAHLVGPSSTPNRVAGYRAP--------EVTDPCKVSQKADVYSFGVLL 558
           K+Y  +++DFG++  +  SS   RV G RAP        E     K + K+DV++FGV L
Sbjct: 165 KNYTIKIADFGMSRNL-YSSDYYRVQG-RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTL 222

Query: 559 LELLT 563
            E+LT
Sbjct: 223 WEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 51.9 bits (124), Expect = 7e-07
 Identities = 51/156 (32%), Positives = 75/156 (48%), Gaps = 26/156 (16%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L NL +L+ L L FN L+  LP  L++ SNL NL L GN  S ++P  +  L  L  L+L
Sbjct: 159 LRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDL 216

Query: 150 A----------------------TNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDD 187
           +                      +NN   ++P    NL+ L+TL L NN++S SI     
Sbjct: 217 SNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS-SISSL-G 274

Query: 188 VLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSL 223
            L NL++L++S N L+ ++P           L N L
Sbjct: 275 SLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLL 310

Length = 394

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 51.4 bits (123), Expect = 7e-07
 Identities = 42/170 (24%), Positives = 80/170 (47%), Gaps = 29/170 (17%)

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-------- 531
           A+G+ +L ++  N  H ++ + NILLT     ++ DFGLA  +   S  N V        
Sbjct: 224 AKGMSFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS--NYVVKGNARLP 279

Query: 532 AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDE 590
             + APE    C  + ++DV+S+G+LL E+ + G +P        G+ +      ++K+ 
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY------PGMPVDSKFYKMIKEG 333

Query: 591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE 640
           +        +L  +    EM  +++    C    P  RP+  ++++ IE+
Sbjct: 334 Y-------RMLSPECAPSEMYDIMK---SCWDADPLKRPTFKQIVQLIEQ 373

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 51.2 bits (122), Expect = 8e-07
 Identities = 47/190 (24%), Positives = 85/190 (44%), Gaps = 35/190 (18%)

Query: 464 RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV- 522
           +  L  E     +   A+G+E+L ++     H ++ + NILL+++   ++ DFGLA  + 
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIY 230

Query: 523 --------GPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHAL-L 572
                   G +  P +   + APE       + ++DV+SFGVLL E+ + G +P   + +
Sbjct: 231 KDPDYVRKGDARLPLK---WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 287

Query: 573 NEEGV-DLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSM 631
           +EE    L    +    D  T E++                  Q  +DC    P  RP+ 
Sbjct: 288 DEEFCRRLKEGTRMRAPDYTTPEMY------------------QTMLDCWHGEPSQRPTF 329

Query: 632 SEVIKRIEEL 641
           SE+++ +  L
Sbjct: 330 SELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 51.2 bits (122), Expect = 8e-07
 Identities = 57/233 (24%), Positives = 102/233 (43%), Gaps = 30/233 (12%)

Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLK-DVTISEREFKDKIEG---VGAVNHENL 427
           ++LGKGTFG   K +L      G   A+K LK +V I++ E    +     +    H  L
Sbjct: 1   KLLGKGTFG---KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
             L+  + + D    V +Y+  G L   L   +        +    +++      ++YLH
Sbjct: 58  TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVS-----ALDYLH 112

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTDPC 543
           +    + + ++K  N++L K    +++DFGL    +  ++T     G   Y APEV +  
Sbjct: 113 SG--KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDN 170

Query: 544 KVSQKADVYSFGVLLLELLTGKAP----THALLNE----EGVDLPRWVQSIVK 588
              +  D +  GV++ E++ G+ P     H  L E    E +  PR + +  K
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAK 223

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 51.2 bits (122), Expect = 8e-07
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 25/213 (11%)

Query: 378 LGKGTFGTAYKAVLEMG---TIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
           +G+GT+G  YKA  + G      A+K+++   IS    ++ I  +  + H N++ L+  +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACRE-IALLRELKHPNVISLQKVF 67

Query: 435 YS-MDEKL-LVYDYLTMGSLSAL-LHGNKGAGRTPLNWE---MRSLIALGAARGIEYLHA 488
            S  D K+ L++DY        +  H    A + P+      ++SL+      GI YLHA
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL-YQILDGIHYLHA 126

Query: 489 QGPNVSHGNIKSSNILLT----KSYEARVSDFGLAHLVGPSSTPNR-------VAGYRAP 537
               V H ++K +NIL+     +    +++D G A L      P            YRAP
Sbjct: 127 NW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 538 EVTDPCKVSQKA-DVYSFGVLLLELLTGKAPTH 569
           E+    +   KA D+++ G +  ELLT +   H
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 38/113 (33%), Positives = 61/113 (53%), Gaps = 3/113 (2%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L  LT+L +L L  N++T   P      SNL+ L L  N     +P  L  L +L  L+L
Sbjct: 112 LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDL 170

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL 202
           + N+ S ++P    NL+ L  L L  N++S  +P   ++L  L++L++SNN +
Sbjct: 171 SFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI 221

Length = 394

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 5/89 (5%)

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEV 539
           G+E++H +   V + ++K +NILL +    R+SD GLA           V   GY APEV
Sbjct: 109 GLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV 166

Query: 540 TDP-CKVSQKADVYSFGVLLLELLTGKAP 567
                     AD +S G +L +LL G +P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 50.2 bits (121), Expect = 1e-06
 Identities = 53/215 (24%), Positives = 83/215 (38%), Gaps = 47/215 (21%)

Query: 423 NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
           ++ N + L     ++   +L+ DY+  G L  LL   +G             I       
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK-KEGKLSEAEV----KKIIRQLVEA 121

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARV--SDFGLAHLVGPSSTPNRVAGYRAPE-- 538
           +  LH    N+ H +IK  N+L  +  + R+   D+GL  ++G  S  +    Y +PE  
Sbjct: 122 LNDLHKH--NIIHNDIKLENVLYDR-AKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKI 178

Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                 VS   D ++ GVL  ELLTGK P      +E  D               E  DL
Sbjct: 179 KGHNYDVS--FDWWAVGVLTYELLTGKHPF-----KEDED---------------EELDL 216

Query: 599 E-LLRYQ------------NVEEEMVQLLQLAIDC 620
           E LL+ Q            N  + +  +L+  I+ 
Sbjct: 217 ESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINY 251

Length = 267

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 31/209 (14%)

Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-------H 424
           ++LGKGTFG   K +L      G   A+K LK   I     KD++      N       H
Sbjct: 1   KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNSRH 54

Query: 425 ENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARG 482
             L  L+  + + D    V +Y   G L    H      R  +  E R+    GA     
Sbjct: 55  PFLTALKYSFQTHDRLCFVMEYANGGEL--FFH----LSRERVFSEDRARF-YGAEIVSA 107

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPE 538
           ++YLH++  NV + ++K  N++L K    +++DFGL    +   +T     G   Y APE
Sbjct: 108 LDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166

Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           V +     +  D +  GV++ E++ G+ P
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 17/202 (8%)

Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRL-KDVTISEREFKDKIEG----VGAVNHENLVP 429
           +V+GKG+FG    A  ++ G   AVK L K + ++ +E K  +      +  V H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           L   + + ++   V D++  G L    H  +   R+      R   A   A  + YLH+ 
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGEL--FFHLQRE--RSFPEPRARFYAA-EIASALGYLHSI 115

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTDPCKV 545
             N+ + ++K  NILL       ++DFGL    +  S T     G   Y APEV      
Sbjct: 116 --NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173

Query: 546 SQKADVYSFGVLLLELLTGKAP 567
               D +  G +L E+L G  P
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 67/286 (23%), Positives = 130/286 (45%), Gaps = 52/286 (18%)

Query: 376 EVLGKGTFGTAYKAVLEMGTI---VAVKRLKDVTIS--EREFKDKIEGVGAV-NHENLVP 429
           +V+G+G FG   +A+++   +    A+K LK+       R+F  ++E +  + +H N++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 430 L------RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGR---TPLNWEMRSLI--ALG 478
           L      R Y Y   E     + L     S +L  +    +   T      + L+  A  
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG----- 533
            A G++YL  +     H ++ + N+L+ ++  ++++DFGL+   G      +  G     
Sbjct: 128 VATGMQYLSEK--QFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRLPVR 183

Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAP----THALLNEEGVDLPRWVQSIVK 588
           + A E  +    + K+DV+SFGVLL E+++ G  P    T A L E+   LP        
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK---LP-------- 232

Query: 589 DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEV 634
                + + +E  + +N ++E+ +L++    C    P  RP  +++
Sbjct: 233 -----QGYRME--KPRNCDDEVYELMR---QCWRDRPYERPPFAQI 268

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 37/216 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKR--------------LKDVTI----SEREFKDKI 416
           E +G+GT+G  YKA     G +VA+K+              L+++++    SE  +  ++
Sbjct: 7   EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66

Query: 417 EGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIA 476
             V  V  +N  P    Y       LV++YL    L   +  N      PL  +      
Sbjct: 67  LDVEHVEEKNGKPS--LY-------LVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFM 116

Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEA-RVSDFGL--AHLVGPSSTPNRVAG 533
               +G+ + H  G  V H ++K  N+L+ K     +++D GL  A  +   S  + +  
Sbjct: 117 YQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVT 174

Query: 534 --YRAPEV-TDPCKVSQKADVYSFGVLLLELLTGKA 566
             YRAPEV       S   D++S G +  E+   + 
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 50.1 bits (119), Expect = 1e-06
 Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 27/215 (12%)

Query: 376 EVLGKGTFGTAYKAVLEMGTI---VAVKRLKDVTIS--EREFKDKIEGVGAV-NHENLVP 429
           +V+G+G FG   KA ++   +    A+KR+K+       R+F  ++E +  + +H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 430 L------RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGR---TPLNWEMRSLI--ALG 478
           L      R Y Y   E     + L     S +L  +        T      + L+  A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG----- 533
            ARG++YL  +     H ++ + NIL+ ++Y A+++DFGL+   G      +  G     
Sbjct: 121 VARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR 176

Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAP 567
           + A E  +    +  +DV+S+GVLL E+++ G  P
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 19/157 (12%)

Query: 422 VNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR 481
           V+H +L  +        E ++V +++  G L   L   KG  R P+ W++   +A   A 
Sbjct: 73  VSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKI--TVAQQLAS 128

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEA-------RVSDFGLAHLVGPSSTPNRVA-- 532
            + YL  +  N+ HGN+ + NILL +   A       ++SD G++      S   RV   
Sbjct: 129 ALSYL--EDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERVERI 184

Query: 533 GYRAPE-VTDPCKVSQKADVYSFGVLLLEL-LTGKAP 567
            + APE V     +S  AD +SFG  LLE+   G+ P
Sbjct: 185 PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP 221

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 49/172 (28%), Positives = 70/172 (40%), Gaps = 30/172 (17%)

Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSL----SALLHGNKGAGRTPLNWEMRSLIALGAAR 481
           N+V L  Y  S D   LV  +   G L    S  L+  +   +    W    ++AL A  
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK---RWAAEMVVALDA-- 100

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-YRAPEVT 540
               LH +G  +   ++  +NILL      +++ F     V  S     V   Y APEV 
Sbjct: 101 ----LHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVG 154

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKA---------PTHALLNEEGVDLPRWV 583
              + ++  D +S G +L ELLTGK           TH  LN     +P WV
Sbjct: 155 GISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLN-----IPEWV 201

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 26/206 (12%)

Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRL-KDVTISEREFKDKIEG---VGAVNHENL 427
           ++LGKGTFG   K +L      G   A+K L K+V I++ E    +     +    H  L
Sbjct: 1   KLLGKGTFG---KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEY 485
             L+  + + D    V +Y   G L    H      R  +  E R+    GA     + Y
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGEL--FFH----LSRERVFSEDRARF-YGAEIVSALGY 110

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTD 541
           LH+   +V + ++K  N++L K    +++DFGL    +   +T     G   Y APEV +
Sbjct: 111 LHSC--DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 168

Query: 542 PCKVSQKADVYSFGVLLLELLTGKAP 567
                +  D +  GV++ E++ G+ P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 47/201 (23%), Positives = 91/201 (45%), Gaps = 17/201 (8%)

Query: 377 VLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVG-----AVNHENLVPL 430
           V+G+G++       L+    I A+K +K   +++ E  D ++        A NH  LV L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
            + + +      V +Y+  G L  + H  +   +  L  E     +   +  + YLH +G
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDL--MFHMQR---QRKLPEEHARFYSAEISLALNYLHERG 116

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTDPCKVS 546
             + + ++K  N+LL      +++D+G+    + P  T +   G   Y APE+       
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174

Query: 547 QKADVYSFGVLLLELLTGKAP 567
              D ++ GVL+ E++ G++P
Sbjct: 175 FSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 69/269 (25%), Positives = 110/269 (40%), Gaps = 46/269 (17%)

Query: 378 LGKGTFGTAYKA-VLEMGTIVAVKRL----------KDVTISEREFKDKIEGVGAVNHEN 426
           LGKG FG      V   G + A K+L          + + + E+E  +K      VN   
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEK------VNSPF 54

Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLH--GNKGAGRTPLNWEMRSLIALGA--ARG 482
           +V L   + S     LV   +  G L   ++  G +G        EM  +I   A    G
Sbjct: 55  IVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-------EMERVIHYSAQITCG 107

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVA--GYRAPEV 539
           I +LH+    + + ++K  N+LL      R+SD GLA  L    +   R    GY APE+
Sbjct: 108 ILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEI 165

Query: 540 TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE 599
                 S   D ++ G  + E++ G+ P      +E V      +  ++DE   E     
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH--KEKVAKEELKRRTLEDEVKFE----- 218

Query: 600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNR 628
              +QN  EE   + +L +   A+ P++R
Sbjct: 219 ---HQNFTEESKDICRLFL---AKKPEDR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 25/201 (12%)

Query: 378 LGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKD-----KIEGVGAVNHENLVPLR 431
           LG+GT+ T YK   ++   +VA   LK++ +   E        ++  +  + H N+V L 
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVA---LKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLH--GNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              ++     LV++YL    L   L   GN       +N     L      RG+ Y H +
Sbjct: 71  DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNS------INMHNVKLFLFQLLRGLNYCHRR 123

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSST-PNRVAG--YRAPEV-TDPCK 544
              V H ++K  N+L+ +  E +++DFGLA     P+ T  N V    YR P++      
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTD 181

Query: 545 VSQKADVYSFGVLLLELLTGK 565
            S + D++  G +  E+ TG+
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 44/171 (25%), Positives = 81/171 (47%), Gaps = 29/171 (16%)

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-------- 531
           A+G+++L ++  N  H ++ + N+LLT    A++ DFGLA  +   S  N V        
Sbjct: 222 AQGMDFLASK--NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS--NYVVKGNARLP 277

Query: 532 AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDE 590
             + APE    C  + ++DV+S+G+LL E+ + GK+P   +L    V+       +VK  
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL----VN--SKFYKMVKRG 331

Query: 591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           +     D           E+  ++++   C    P  RP+ S++ + I+  
Sbjct: 332 YQMSRPDFAPP-------EIYSIMKM---CWNLEPTERPTFSQISQLIQRQ 372

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 53/195 (27%), Positives = 87/195 (44%), Gaps = 53/195 (27%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE-------REFKDKIEGVGAVNHENLVP 429
           +G+GTFG  +KA   +   IVA+K++      E       RE    I+ +  + HEN+V 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALRE----IKILQLLKHENVVN 75

Query: 430 L--------------RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI 475
           L              +  +Y      LV+++     L+ LL  NK    T    E++ ++
Sbjct: 76  LIEICRTKATPYNRYKGSFY------LVFEFCEH-DLAGLLS-NKNVKFTLS--EIKKVM 125

Query: 476 ALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP------- 528
            +    G+ Y+H     + H ++K++NIL+TK    +++DFGLA      S         
Sbjct: 126 KM-LLNGLYYIHRN--KILHRDMKAANILITKDGILKLADFGLAR---AFSLSKNSKPNR 179

Query: 529 --NRVAG--YRAPEV 539
             NRV    YR PE+
Sbjct: 180 YTNRVVTLWYRPPEL 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 31/213 (14%)

Query: 375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRL----------KDVTISEREFKDKIEGVGAVN 423
            ++LG+G FG  Y    ++ G  +A K++          K+V+  E E    I+ +  + 
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECE----IQLLKNLQ 62

Query: 424 HENLVPLRAYYYSMDEKLLV--YDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR 481
           HE +V          EK L    +Y+  GS+   L        +      R ++      
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL-----E 117

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA---HLVGPSSTPNR-VAG---Y 534
           G+ YLH     + H +IK +NIL   +   ++ DFG +     +  S T  R V G   +
Sbjct: 118 GMSYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175

Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
            +PEV       +KADV+S G  ++E+LT K P
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 33/209 (15%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKR---------LKDVTISEREFKDKIEGVGAVNHENL 427
           +G G +GT YKA     G  VA+K          L   T+ E     ++E   A +H N+
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLE---AFDHPNI 64

Query: 428 VPLRAYYYSM--DEKL---LVYDYLTMGSLSALLHGNKGAGRTPLNW---EMRSLIALGA 479
           V L     +   D +    LV++++    L   L      G  P       MR  +    
Sbjct: 65  VRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPG-LPAETIKDLMRQFL---- 118

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG--PSSTPNRVA-GYRA 536
            RG+++LHA    + H ++K  NIL+T   + +++DFGLA +     + TP  V   YRA
Sbjct: 119 -RGLDFLHAN--CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 537 PEVTDPCKVSQKADVYSFGVLLLELLTGK 565
           PEV      +   D++S G +  E+   K
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 59/223 (26%), Positives = 105/223 (47%), Gaps = 25/223 (11%)

Query: 377 VLGKGTFGTAYKAVLE-MGTIVAVKRLK-DVTISEREFKDKI--EGVGAVNHEN--LVPL 430
           VLGKG+FG    A  +    + A+K LK DV I + + +  +  + V A+  +   L  L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNK-GAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
            + + ++D    V +Y+  G L  + H  + G  + P         A   + G+ +LH +
Sbjct: 67  HSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEP----QAVFYAAEISVGLFFLHRR 120

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLA--HLVGPSSTPN--RVAGYRAPEVTDPCKV 545
           G  + + ++K  N++L      +++DFG+   H+V   +T        Y APE+      
Sbjct: 121 G--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY 178

Query: 546 SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK 588
            +  D +++GVLL E+L G+ P       +G D     QSI++
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPF------DGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 59/273 (21%), Positives = 115/273 (42%), Gaps = 41/273 (15%)

Query: 377 VLGKGTFGTAYKAVLEMGT----IVAVKRLKD--VTISEREFKDKIEGVGAVNHENLVPL 430
           +LG G FG   +  L++ +     VA+  L+        R F  +   +G  +H N+V L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKG---AGRTPLNWEMRSLIALGAARGIEYLH 487
                  +  ++V +Y++ G+L + L  ++G   AG      ++  ++  G A G++YL 
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAG------QLMGMLP-GLASGMKYLS 124

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFG-----LAHLVGPSSTPNRVAGYRAPEVTDP 542
             G    H  + +  +L+      ++S F       +  +  + +      + APE    
Sbjct: 125 EMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182

Query: 543 CKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL 601
              S  +DV+SFG+++ E+++ G+ P   +  ++       V   V+D          L 
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVED-------GFRLP 228

Query: 602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEV 634
             +N       L QL +DC  +    RP  S++
Sbjct: 229 APRNCPN---LLHQLMLDCWQKERGERPRFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 49.2 bits (117), Expect = 4e-06
 Identities = 39/124 (31%), Positives = 67/124 (54%), Gaps = 18/124 (14%)

Query: 464 RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV- 522
           ++PL  E     +   ARG+E+L ++     H ++ + NILL+++   ++ DFGLA  + 
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASR--KCIHRDLAARNILLSENNVVKICDFGLARDIY 225

Query: 523 --------GPSSTPNRVAGYRAPE-VTDPCKVSQKADVYSFGVLLLELLT-GKAPTHAL- 571
                   G +  P +   + APE + D    +Q +DV+SFGVLL E+ + G +P   + 
Sbjct: 226 KDPDYVRKGSARLPLK---WMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQ 281

Query: 572 LNEE 575
           +NEE
Sbjct: 282 INEE 285

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 26/204 (12%)

Query: 378 LGKGTFGTAYKAVLEMGT--IVAVKRLKDVTISEREFKDKIEG----VGAVNHENLVPLR 431
           +GKG+FG   + V +  T  I A+K ++   I  R            +  VN   +VPL+
Sbjct: 1   IGKGSFGKVMQ-VRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLN----WEMRSLIALGAARGIEYLH 487
             + S ++  LV  ++  G L    H  +  GR  L+    +    L AL      E LH
Sbjct: 60  FSFQSPEKLYLVLAFINGGEL---FHHLQREGRFDLSRARFYTAELLCAL------ENLH 110

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTDPC 543
               NV + ++K  NILL       + DFGL  L +      N   G   Y APE+    
Sbjct: 111 KF--NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH 168

Query: 544 KVSQKADVYSFGVLLLELLTGKAP 567
             ++  D ++ GVLL E+LTG  P
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 48.4 bits (115), Expect = 4e-06
 Identities = 63/270 (23%), Positives = 120/270 (44%), Gaps = 31/270 (11%)

Query: 377 VLGKGTFG-TAYKAVLEMGTIVAVKRLKDVTISEREFK---DKIEGVGAVNHENLVPLRA 432
           V+GKG++G  +       G    +K+L     S RE K    + + +  + H N+V  R 
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 433 YYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +   D  L +V  +   G L   L   KG    P N  +   + +  A  ++YLH +  
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGK-LLPENQVVEWFVQIAMA--LQYLHEK-- 121

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP----SSTPNRVAGYRAPEVTDPCKVSQ 547
           ++ H ++K+ N+ LT++   +V D G+A ++      +ST      Y +PE+      + 
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNY 181

Query: 548 KADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE 607
           K+DV++ G  + E+ T K   HA       D+   V  I++ +      D          
Sbjct: 182 KSDVWALGCCVYEMATLK---HAF---NAKDMNSLVYRIIEGKLPPMPKDY--------S 227

Query: 608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR 637
            E+ +L+   +   ++ P+ RPS+  ++++
Sbjct: 228 PELGELIATML---SKRPEKRPSVKSILRQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 48.4 bits (115), Expect = 5e-06
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 25/200 (12%)

Query: 378 LGKGTFGTAY-----KAVLEMGTIVAVKRLKDVTISEREFKDKIEG------VGAVNHEN 426
           LGKG+FGT Y     KAV E      +K LK++ + E    + ++       +  ++H  
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEE----RLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63

Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRT-PLNWEMRSLIALGAARGIEY 485
           +V   A +   D   ++ +Y     L   L   K  G+T   N      I L    G+ Y
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL--LLGVHY 121

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----STPNRVAGYRAPEVTD 541
           +H +   + H ++K+ NI L  +   ++ DFG++ L+  S    +T      Y +PE   
Sbjct: 122 MHQR--RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK 178

Query: 542 PCKVSQKADVYSFGVLLLEL 561
                 K+D++S G +L E+
Sbjct: 179 HQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 48.7 bits (116), Expect = 5e-06
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 25/203 (12%)

Query: 378 LGKGTFGTAYKAVLE-MGTIVAVKRL---KDVTISEREFKDKIEGVGAVNHENLVPLRAY 433
           +G G  GT YK +    G + A+K +    + T+  R+   +IE +  VNH N+V     
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTV-RRQICREIEILRDVNHPNVVKCHDM 140

Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
           +    E  ++ +++  GSL          G    + +  + +A     GI YLH +  ++
Sbjct: 141 FDHNGEIQVLLEFMDGGSLE---------GTHIADEQFLADVARQILSGIAYLHRR--HI 189

Query: 494 SHGNIKSSNILLTKSYEARVSDFG----LAHLVGPSSTPNRVAGYRAPE-----VTDPCK 544
            H +IK SN+L+  +   +++DFG    LA  + P ++      Y +PE     +     
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAY 249

Query: 545 VSQKADVYSFGVLLLELLTGKAP 567
                D++S GV +LE   G+ P
Sbjct: 250 DGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 43.7 bits (104), Expect = 5e-06
 Identities = 20/60 (33%), Positives = 29/60 (48%)

Query: 119 NLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRL 178
           NL++L L  N  +        GL +L  L+L+ NN +   P  F  L  L++L L  N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 39/145 (26%), Positives = 61/145 (42%), Gaps = 26/145 (17%)

Query: 442 LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSS 501
           +V +Y+  G  + LL   K  G   L  +M  +        +EYLH  G  + H ++K  
Sbjct: 78  MVMEYVEGGDCATLL---KNIG--ALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPD 130

Query: 502 NILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------------------YRAPEVTDP 542
           N+L+T     +++DFGL+ +   S T N   G                   Y APEV   
Sbjct: 131 NLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR 190

Query: 543 CKVSQKADVYSFGVLLLELLTGKAP 567
               +  D ++ G++L E L G  P
Sbjct: 191 QGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 48.0 bits (114), Expect = 7e-06
 Identities = 52/219 (23%), Positives = 94/219 (42%), Gaps = 25/219 (11%)

Query: 378 LGKGTFGTAYKAVLEMG---TIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G FG      +  G     V VK L+       + +F ++ +   ++ H NL+    
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL--IALGAARGIEYLHAQG 490
               +   LLV ++  +G L   L   + A    +  +  +L  +A   A G+ +LH   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKA--ELMTPDPTTLQRMACEIALGLLHLHKN- 119

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---TPNRV---AGYRAPEVTDP-- 542
            N  H ++   N LLT     ++ D+GL+H         TP+++     + APE+ D   
Sbjct: 120 -NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 543 -----CKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
                   +++++V+S GV + EL   G  P   L +E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ 217

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 47.7 bits (114), Expect = 8e-06
 Identities = 46/220 (20%), Positives = 86/220 (39%), Gaps = 32/220 (14%)

Query: 369 DLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFK---DKIEGVGAVNHE 425
           +LL    +           K      T+VAVK++   + S+ + K    +I     + H 
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59

Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIAL---GAA 480
           N++P    +    E  +V   +  GS   LL  H  +G             IA       
Sbjct: 60  NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL--------AIAFILKDVL 111

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH-----------LVGPSSTPN 529
             ++Y+H++G    H ++K+S+ILL+   +  +S    +            +     +  
Sbjct: 112 NALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169

Query: 530 RVAGYRAPEV--TDPCKVSQKADVYSFGVLLLELLTGKAP 567
           +   + +PEV   +    ++K+D+YS G+   EL  G  P
Sbjct: 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 46.2 bits (110), Expect = 9e-06
 Identities = 33/107 (30%), Positives = 43/107 (40%), Gaps = 13/107 (12%)

Query: 464 RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG 523
             PLN E    + L     +  LH Q         KS NILLT      +   G      
Sbjct: 11  GRPLNEEEIWAVCLQCLGALRELHRQA--------KSGNILLTWD--GLLKLDGSVAFKT 60

Query: 524 PSSTPNRVAGY-RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTH 569
           P    +R   Y  APEV      ++KAD+YS G+ L E L  + P +
Sbjct: 61  PEQ--SRPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYN 105

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 48.1 bits (114), Expect = 9e-06
 Identities = 47/201 (23%), Positives = 91/201 (45%), Gaps = 17/201 (8%)

Query: 377 VLGKGTFGTAYKAVLEMG-TIVAVKRLKDVTISEREFKDKIEGVGAVNHEN-----LVPL 430
           V+G+G++       L+    I A+K +K   + + E  D ++    V  +      LV L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
            + + +     LV +Y+  G L  + H  +   +  L  E     A      + +LH +G
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDL--MFHMQR---QRKLPEEHARFYAAEICIALNFLHERG 116

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTDPCKVS 546
             + + ++K  N+LL      +++D+G+    +GP  T +   G   Y APE+    +  
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174

Query: 547 QKADVYSFGVLLLELLTGKAP 567
              D ++ GVL+ E++ G++P
Sbjct: 175 FSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.5 bits (101), Expect = 1e-05
 Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 1/61 (1%)

Query: 70  RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNH 129
            +  L L    L+  IP G    L +L+ L L  N+LTS  P   +   +LR+L L GN+
Sbjct: 1   NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 130 F 130
            
Sbjct: 60  L 60

Length = 60

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 5/89 (5%)

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEV 539
           G+E++H +   V + ++K +NILL +    R+SD GLA           V   GY APEV
Sbjct: 109 GLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV 166

Query: 540 TDP-CKVSQKADVYSFGVLLLELLTGKAP 567
                     AD +S G +L +LL G +P
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 37/216 (17%)

Query: 375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRL----------KDVTISEREFKDKIEGVGAVN 423
            ++LG+G FG  Y     + G  +AVK++          K+V   E E    I+ +  + 
Sbjct: 7   GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECE----IQLLKNLR 62

Query: 424 HENLVPLRAYYYSM----DEKLLVY-DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG 478
           H+ +V    YY  +    ++KL ++ +Y+  GS+   L               R ++   
Sbjct: 63  HDRIV---QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL--- 116

Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG----PSSTPNRVAG- 533
             +G+ YLH     + H +IK +NIL   +   ++ DFG +  +       +    V G 
Sbjct: 117 --QGVSYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172

Query: 534 --YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
             + +PEV       +KADV+S    ++E+LT K P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 40/161 (24%), Positives = 78/161 (48%), Gaps = 9/161 (5%)

Query: 413 KDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMR 472
           + ++  + A +H  +V     + S D+ LL+ +Y + G L+  +   +     P      
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIK-QRLKEHLPFQEYEV 171

Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA 532
            L+       ++ +H++   + H ++KS+NI L  +   ++ DFG +     S + +  +
Sbjct: 172 GLLFYQIVLALDEVHSR--KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229

Query: 533 G------YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
                  Y APE+ +  + S+KAD++S GV+L ELLT   P
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 57/215 (26%), Positives = 88/215 (40%), Gaps = 36/215 (16%)

Query: 376 EVLGKGTFGTAY---------------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVG 420
           +VLG G +G  +                 VL+  TIV   +  + T +ER+  + I    
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--- 62

Query: 421 AVNHENLVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA 479
                 LV L  Y +  D KL L+ DY+  G L   L     + R     +   + +   
Sbjct: 63  --QSPFLVTLH-YAFQTDTKLHLILDYINGGELFTHL-----SQRERFKEQEVQIYSGEI 114

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH--LVGPSSTPNRVAG---Y 534
              +E+LH  G  + + +IK  NILL  +    ++DFGL+               G   Y
Sbjct: 115 VLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172

Query: 535 RAPEVTDPCKV--SQKADVYSFGVLLLELLTGKAP 567
            AP++         +  D +S GVL+ ELLTG +P
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 47/225 (20%)

Query: 376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISERE------------FKDKIEGVGAV 422
           + LG+G++ T YK   +  G +VA   LK++ +   E             KD       +
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVA---LKEIRLEHEEGAPFTAIREASLLKD-------L 60

Query: 423 NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAA 480
            H N+V L    ++     LV++YL    L   +   G    G +  N     L      
Sbjct: 61  KHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG---GLSMHNVR---LFLFQLL 113

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSST-PNRVAG--YRA 536
           RG+ Y H +   V H ++K  N+L+++  E +++DFGLA     PS T  N V    YR 
Sbjct: 114 RGLAYCHQR--RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRP 171

Query: 537 PEV----TDPCKVSQKADVYSFGVLLLELLTGKA--PTHALLNEE 575
           P+V    T+    S   D++  G +  E+ TG+   P    + ++
Sbjct: 172 PDVLLGSTE---YSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.1 bits (112), Expect = 3e-05
 Identities = 31/108 (28%), Positives = 47/108 (43%), Gaps = 24/108 (22%)

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-------------------HLV 522
            IEY+H++G  V H ++K  NILL    E  + D+G A                      
Sbjct: 125 TIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 523 GPSSTPNRVAG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
              + P ++ G   Y APE       S+  D+Y+ GV+L ++LT   P
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 51/199 (25%), Positives = 91/199 (45%), Gaps = 21/199 (10%)

Query: 378 LGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKD-----KIEGVGAVNHENLVPLR 431
           LG+GT+ T +K   ++   +VA   LK++ +   E        ++  +  + H N+V L 
Sbjct: 13  LGEGTYATVFKGRSKLTENLVA---LKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLH 69

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
              ++     LV++YL       L +         +   M  L+     RG+ Y H +  
Sbjct: 70  DIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLL-----RGLSYCHKR-- 122

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSST-PNRVAG--YRAPEV-TDPCKVS 546
            + H ++K  N+L+ +  E +++DFGLA     P+ T  N V    YR P+V     + S
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 547 QKADVYSFGVLLLELLTGK 565
              D++  G +L E+ TG+
Sbjct: 183 TPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 45.7 bits (109), Expect = 3e-05
 Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 64/219 (29%)

Query: 378 LGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----------HEN 426
           +G+GTF    KA   + G   A+K +K        FK  +E V  +           H N
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKH------FKS-LEQVNNLREIQALRRLSPHPN 59

Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLS---ALLHGN-----KGAGRTPLN-----WEMRS 473
           ++        + E  +++D  T G L+    L+  N     KG  + PL        M  
Sbjct: 60  IL-------RLIE--VLFDRKT-GRLALVFELMDMNLYELIKGR-KRPLPEKRVKSYMYQ 108

Query: 474 LIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP----- 528
           L+     + ++++H  G  + H +IK  NIL+ K    +++DFG     G  S P     
Sbjct: 109 LL-----KSLDHMHRNG--IFHRDIKPENILI-KDDILKLADFGSCR--GIYSKPPYTEY 158

Query: 529 --NRVAGYRAPE--VTDPCKVSQKADVYSFGVLLLELLT 563
              R   YRAPE  +TD      K D+++ G +  E+L+
Sbjct: 159 ISTR--WYRAPECLLTDG-YYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.4 bits (98), Expect = 4e-05
 Identities = 26/62 (41%), Positives = 34/62 (54%), Gaps = 4/62 (6%)

Query: 143 HLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG-FDDVLPNLQQLNVSNN 200
           +L  L+L +NN    IP G FK L  LK L L  N L+   P  F   LP+L+ L++S N
Sbjct: 1   NLKSLDL-SNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSG-LPSLRSLDLSGN 58

Query: 201 LL 202
            L
Sbjct: 59  NL 60

Length = 60

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 23/209 (11%)

Query: 375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKD------KIEGVGAVNHENL 427
            ++LG+G FG  Y     + G  +AVK+++    S    K+      +I+ +  + HE +
Sbjct: 7   GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI 66

Query: 428 VPLRAYYYSMDEKLL--VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           V          E+ L    +++  GS+   L               R ++      G+ Y
Sbjct: 67  VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL-----EGVSY 121

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFG----LAHLVGPSSTPNRVAG---YRAPE 538
           LH+    + H +IK +NIL       ++ DFG    L  +    +    V G   + +PE
Sbjct: 122 LHSN--MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           V       +KAD++S G  ++E+LT K P
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 45.1 bits (107), Expect = 6e-05
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 25/215 (11%)

Query: 376 EVLGKGTFGTAYKAV---LEMGTI-VAVKRLK-DVTISERE-FKDKIEGVGAVNHENLVP 429
             +G+G FG  Y+ V    E   I VAVK  K   + S RE F  +   +   +H ++V 
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNW-EMRSLI--ALGAARGIEYL 486
           L     + +   +V +   +G L + L  NK          ++ SLI  +   +  + YL
Sbjct: 72  LIGVI-TENPVWIVMELAPLGELRSYLQVNK-------YSLDLASLILYSYQLSTALAYL 123

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTD 541
                   H +I + N+L++     ++ DFGL+  +   S      G     + APE  +
Sbjct: 124 E--SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181

Query: 542 PCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
             + +  +DV+ FGV + E+L  G  P   + N +
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 44.8 bits (106), Expect = 8e-05
 Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 14/94 (14%)

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--------HLVGPSSTPNRVAG 533
           G+E+LH +   + + ++K  N+LL      R+SD GLA           G + TP    G
Sbjct: 109 GLEHLHQR--RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP----G 162

Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           + APE+    +     D ++ GV L E++  + P
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 44.6 bits (105), Expect = 9e-05
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 39/210 (18%)

Query: 376 EVLGKGTFGTAYKAVLEMG-TIVAVKRLKDVTISEREFKD-----KIEGVGAVNHENLVP 429
           E LG+GT+ T +K   ++   +VA   LK++ +   E        ++  +  + H N+V 
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVA---LKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68

Query: 430 LRAYYYSMDEKLLVYDYLTM---------GSLSALLHGNKGAGRTPLNWEMRSLIALGAA 480
           L    ++     LV++YL           G++ ++ H  K             +      
Sbjct: 69  LHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSM-HNVK-------------IFLYQIL 114

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSST-PNRVAG--YRA 536
           RG+ Y H +   V H ++K  N+L+ +  E +++DFGLA     P+ T  N V    YR 
Sbjct: 115 RGLAYCHRR--KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 172

Query: 537 PEV-TDPCKVSQKADVYSFGVLLLELLTGK 565
           P+V     + S + D++  G +  E+ +G+
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 44.4 bits (105), Expect = 1e-04
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 32/215 (14%)

Query: 377 VLGKGTFGTAYKAVLEMGT--IVAVKRLKDVTISERE----FKDKIEGVGAVNHENLVPL 430
           ++G+G FG   + V E  T  I A+K +K   +  +E    F+++ + +   N   +  L
Sbjct: 8   LVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
           +  +   D   LV +Y   G L +LL+  +       + +M           I  +H  G
Sbjct: 67  QYAFQDKDNLYLVMEYQPGGDLLSLLNRYED----QFDEDMAQFYLAELVLAIHSVHQMG 122

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLA-------HLVG--PSSTPNRVAGYRAPEV-- 539
               H +IK  N+L+ ++   +++DFG A        +    P  TP+    Y APEV  
Sbjct: 123 --YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD----YIAPEVLT 176

Query: 540 ---TDP-CKVSQKADVYSFGVLLLELLTGKAPTHA 570
               D       + D +S GV+  E++ G++P H 
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 39/108 (36%), Positives = 54/108 (50%), Gaps = 19/108 (17%)

Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-----GPSST-- 527
           I  GA RG+ YLH  G    H NIK+S+IL+  S +  VS  GL+HL      G  +   
Sbjct: 106 ILFGALRGLNYLHQNG--YIHRNIKASHILI--SGDGLVSLSGLSHLYSLVRNGQKAKVV 161

Query: 528 ---PN---RVAGYRAPEV--TDPCKVSQKADVYSFGVLLLELLTGKAP 567
              P     V  + +PE+   D    + K+D+YS G+   EL TG+ P
Sbjct: 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 55/195 (28%), Positives = 71/195 (36%), Gaps = 73/195 (37%)

Query: 434 YYSMDEK---LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIA-LGAARGIEYLHAQ 489
           YYS  +K     V DY+  G + +LL    G     L    R  IA L  A  IE +H  
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLI-RLGIFEEDL---ARFYIAELTCA--IESVHKM 120

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGL------------------------------- 518
           G    H +IK  NIL+ +    +++DFGL                               
Sbjct: 121 G--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 519 ----------------------AH-LVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFG 555
                                 AH LVG   TPN    Y APEV      +Q  D +S G
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVG---TPN----YIAPEVLLRTGYTQLCDWWSVG 231

Query: 556 VLLLELLTGKAPTHA 570
           V+L E+L G+ P  A
Sbjct: 232 VILYEMLVGQPPFLA 246

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 44.8 bits (106), Expect = 2e-04
 Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 49/229 (21%)

Query: 392 EMGTIVAVKRLK-DVTISERE---FKDKIEGVGAVNHENLVPLRAYYYSMDEKLL-VYDY 446
             G  VA+K L+ D    E +   F+ +      + H N+V L     +    L  V++Y
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 447 LTMGSLSALLHGNKGA------GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKS 500
           +   +L  +L    GA      GR  L    + L AL  A      H QG  + H ++K 
Sbjct: 61  VPGRTLREVL-AADGALPAGETGRLML----QVLDALACA------HNQG--IVHRDLKP 107

Query: 501 SNILLTKS---YEARVSDFGLAHLVGPS---------STPNRVAG---YRAPEVTDPCKV 545
            NI+++++     A+V DFG+  L  P          +    V G   Y APE      V
Sbjct: 108 QNIMVSQTGVRPHAKVLDFGIGTL-LPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV 166

Query: 546 SQKADVYSFGVLLLELLTGK-----APTHAL----LNEEGVDLPRWVQS 585
           +  +D+Y++G++ LE LTG+     A    +    L+   V LP W+  
Sbjct: 167 TPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAG 215

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 47/175 (26%), Positives = 78/175 (44%), Gaps = 31/175 (17%)

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-------HLVGPSSTPNRVA 532
           ARG+E+L ++  N  H ++ + N+LL +    ++ DFGLA       + V   ST   V 
Sbjct: 247 ARGMEFLASK--NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK 304

Query: 533 GYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGV--DLPRWVQSIVKD 589
            + APE       +  +DV+S+G+LL E+ + G  P   ++ +      +    +    D
Sbjct: 305 -WMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPD 363

Query: 590 EWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS 644
             T EV+D+           MV+       C    P+ RPS   +   +E L PS
Sbjct: 364 HATQEVYDI-----------MVK-------CWNSEPEKRPSFLHLSDIVESLLPS 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 37/218 (16%)

Query: 376 EVLGKGTFGTAYKAVLEMGT---IVAVKRLKDVTISERE----FKDKIEGVGAVNHEN-L 427
           +V+G+G FG    AV+++     + A+K L    + +R     F+++ + +  VN +N  
Sbjct: 7   KVIGRGAFGEV--AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL--VNGDNQW 62

Query: 428 VPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLN----WEMRSLIALGAARG 482
           +    Y +  +  L LV DY   G L  LL  +K   R P +    +    +IA+ +   
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFG-LAHLVGPSSTPNRVA----GYRAP 537
           + Y+H         +IK  NIL+  +   R++DFG    L+   +  + VA     Y +P
Sbjct: 121 LHYVHR--------DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 172

Query: 538 EVTDPC-----KVSQKADVYSFGVLLLELLTGKAPTHA 570
           E+         K   + D +S GV + E+L G+ P +A
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 43.8 bits (104), Expect = 2e-04
 Identities = 59/238 (24%), Positives = 86/238 (36%), Gaps = 63/238 (26%)

Query: 377 VLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLV----- 428
           V+G+G FG          + G + A+K L+   + +R        +  V  E  +     
Sbjct: 8   VIGRGAFGEVWLVRDK--DTGQVYAMKVLRKSDMIKRNQ------IAHVRAERDILADAD 59

Query: 429 -P--LRAYYYSMDEKLL--VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIA-LGAARG 482
            P  ++ YY   DE+ L  V +Y+  G L  LL   K     P     R  IA L  A  
Sbjct: 60  SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLI-RKD--VFPEET-ARFYIAELVLA-- 113

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--------------HLVGPSSTP 528
           ++ +H  G    H +IK  NIL+      +++DFGL                        
Sbjct: 114 LDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 529 NR----------------VAG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           N                   G   Y APEV        + D +S GV+L E+L G  P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.1 bits (102), Expect = 4e-04
 Identities = 64/248 (25%), Positives = 98/248 (39%), Gaps = 68/248 (27%)

Query: 374 SAEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGA-------VNHE 425
           S +V+G+G FG        + G I A+K+L+    SE   K+++  V A        ++ 
Sbjct: 5   SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRK---SEMLEKEQVAHVRAERDILAEADNP 61

Query: 426 NLVPLRAYYYSMDEKL---LVYDYLTMGSLSALLHGNKGAGRTPLNWEM-RSLIALGAAR 481
            +V L   YYS  ++    L+ +YL  G +  LL       +     E  R  IA     
Sbjct: 62  WVVKL---YYSFQDENYLYLIMEYLPGGDMMTLL-----MKKDTFTEEETRFYIA-ETIL 112

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGL------AH--------------- 520
            I+ +H  G    H +IK  N+LL      ++SDFGL      +H               
Sbjct: 113 AIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170

Query: 521 LVGPSSTP------------NRVA---------GYRAPEVTDPCKVSQKADVYSFGVLLL 559
            +   S P            NR A          Y APEV      +++ D +S GV++ 
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230

Query: 560 ELLTGKAP 567
           E+L G  P
Sbjct: 231 EMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 35/214 (16%)

Query: 376 EVLGKGTFGTAY---------------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVG 420
           +VLG G +G  +                 VL+   +V   +  + T +ER   + +    
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR--- 62

Query: 421 AVNHENLVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA 479
                 LV L  Y +  + KL L+ DY++ G +   L+         + +    +I    
Sbjct: 63  --QSPFLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIIL--- 116

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH--LVGPSSTPNRVAG---Y 534
              +E+LH  G  + + +IK  NILL       ++DFGL+   L           G   Y
Sbjct: 117 --ALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172

Query: 535 RAPEVTDPCKVSQKA-DVYSFGVLLLELLTGKAP 567
            APE+        KA D +S G+L+ ELLTG +P
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 66/270 (24%), Positives = 121/270 (44%), Gaps = 46/270 (17%)

Query: 396 IVAVKRLK-DVTISER-EFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS 453
           +VAVK L+ D   + R +F  +I+ +  +   N++ L A   + D   ++ +Y+  G L+
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 454 ALL--HGNKGAG----RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK 507
             L  H  + A        +++     +A   A G++YL +   N  H ++ + N L+ K
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL--NFVHRDLATRNCLVGK 165

Query: 508 SYEARVSDFGLAH---------LVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLL 558
           +Y  +++DFG++          + G +  P R   + + E     K +  +DV++FGV L
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR---WMSWESILLGKFTTASDVWAFGVTL 222

Query: 559 LELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQ----- 612
            E+LT  K   ++ L++E        Q I   E T E F     R Q  +  + +     
Sbjct: 223 WEILTLCKEQPYSQLSDE--------QVI---ENTGEFF-----RDQGRQVYLPKPALCP 266

Query: 613 --LLQLAIDCSAQYPDNRPSMSEVIKRIEE 640
             L +L + C  +    RPS  E+   + E
Sbjct: 267 DSLYKLMLSCWRRNAKERPSFQEIHATLLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 41.9 bits (98), Expect = 8e-04
 Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 38/225 (16%)

Query: 371 LRASAE------VLGKGTFGTA----YKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVG 420
           LR  AE      V+G+G FG      +K+  ++  +  + + + +  S+  F  +   + 
Sbjct: 38  LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 421 AVNHENLVPLRAYYYSMDEKLL--VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG 478
           A  +   V ++ +Y   D++ L  V +Y+  G L  L+       +    +    ++AL 
Sbjct: 98  AFANSPWV-VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALD 156

Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-----STPNRVAG 533
           A   + ++H         ++K  N+LL KS   +++DFG    +         T      
Sbjct: 157 AIHSMGFIHR--------DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208

Query: 534 YRAPEVTDPCKVSQKADVY--------SFGVLLLELLTGKAPTHA 570
           Y +PEV      SQ  D Y        S GV L E+L G  P +A
Sbjct: 209 YISPEVLK----SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.8 bits (98), Expect = 9e-04
 Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 12/86 (13%)

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNR--VAG---YRA 536
           I+Y+H +G  + H +IK+ N+L+    +  + DFG A    G  STP    +AG     A
Sbjct: 273 IDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNA 330

Query: 537 PEVT--DPCKVSQKADVYSFGVLLLE 560
           PEV   DP   +   D++S G+++ E
Sbjct: 331 PEVLAGDP--YTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 26/162 (16%)

Query: 423 NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAA 480
           NH N+VP RA + + +E  +V  ++  GS   L+  H   G     + +     I  G  
Sbjct: 57  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY-----ILQGVL 111

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR---------- 530
           + ++Y+H  G    H ++K+S+IL+  S + +V   GL   +   +   R          
Sbjct: 112 KALDYIHHMG--YVHRSVKASHILI--SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKY 167

Query: 531 ---VAGYRAPEV--TDPCKVSQKADVYSFGVLLLELLTGKAP 567
              V  + +PEV   +      K+D+YS G+   EL  G  P
Sbjct: 168 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 41.7 bits (98), Expect = 0.001
 Identities = 64/235 (27%), Positives = 97/235 (41%), Gaps = 58/235 (24%)

Query: 371 LRASAE------VLGKGTFGTAYKAVLEMGT--IVAVKRLKDVTISERE----FKDKIEG 418
           LR  AE      V+G+G FG   + V    +  + A+K L    + +R     F ++ + 
Sbjct: 38  LRMKAEDFDVIKVIGRGAFG-EVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI 96

Query: 419 VGAVNHENLVPLRAYYYSMDEKLL--VYDYLTMGSLSALLHGNKGAGRTPLNWE----MR 472
           +   N E +V L  +Y   D+K L  V +Y+  G L  L+         P  W       
Sbjct: 97  MAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKWARFYTAE 150

Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDF---------GLAHLVG 523
            ++AL A      +H+ G    H ++K  N+LL KS   +++DF         G+     
Sbjct: 151 VVLALDA------IHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT 202

Query: 524 PSSTPNRVAGYRAPEVTDPCKVSQKADVY--------SFGVLLLELLTGKAPTHA 570
              TP+    Y +PEV      SQ  D Y        S GV L E+L G  P +A
Sbjct: 203 AVGTPD----YISPEVL----KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 29/105 (27%), Positives = 48/105 (45%), Gaps = 14/105 (13%)

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-TPNRVAGY----- 534
           R I+YLH     + H +IK+ NI +    +  + DFG A    P     N+  G+     
Sbjct: 193 RAIQYLHEN--RIIHRDIKAENIFINHPGDVCLGDFGAACF--PVDINANKYYGWAGTIA 248

Query: 535 -RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVD 578
             APE+          D++S G++L E+ T      +L  ++G+D
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH---DSLFEKDGLD 290

Length = 391

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 45/201 (22%), Positives = 92/201 (45%), Gaps = 17/201 (8%)

Query: 377 VLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTISEREFKDKIEGVGAV-----NHENLVPL 430
           V+G+G++       L+    I A+K +K   +++ E  D ++    V     NH  LV L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
            + + +      V ++++ G L  + H  +   +  L  E     +   +  + +LH +G
Sbjct: 62  HSCFQTESRLFFVIEFVSGGDL--MFHMQR---QRKLPEEHARFYSAEISLALNFLHERG 116

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTDPCKVS 546
             + + ++K  N+LL      +++D+G+    + P  T +   G   Y APE+       
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYG 174

Query: 547 QKADVYSFGVLLLELLTGKAP 567
              D ++ GVL+ E++ G++P
Sbjct: 175 FSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 29/214 (13%)

Query: 376 EVLGKGTFGTAYKAVLEMGT---IVAVKRLKDVTISERE----FKDKIEGVGAVNHENLV 428
           +V+G+G FG    AV++M     I A+K L    + +R     F+++   +  VN +   
Sbjct: 7   KVIGRGAFGEV--AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVL--VNGDCQW 62

Query: 429 PLRAYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
               +Y   DE    LV DY   G L  LL  +K   R P   +M           I  +
Sbjct: 63  ITTLHYAFQDENYLYLVMDYYVGGDLLTLL--SKFEDRLP--EDMARFYIAEMVLAIHSI 118

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDP---- 542
           H    +  H +IK  N+LL  +   R++DFG    +    T         P+   P    
Sbjct: 119 HQL--HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176

Query: 543 ------CKVSQKADVYSFGVLLLELLTGKAPTHA 570
                  K   + D +S GV + E+L G+ P +A
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 40.7 bits (96), Expect = 0.001
 Identities = 59/236 (25%), Positives = 88/236 (37%), Gaps = 55/236 (23%)

Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGA-------VNHENL 427
           ++LGKG  G  +   L   G + A+K L    + +R   +K++ V         ++H  L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKR---NKVKRVLTEQEILATLDHPFL 63

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR---GIE 484
             L A + +     LV DY   G L  LL       R P       +    AA     +E
Sbjct: 64  PTLYASFQTETYLCLVMDYCPGGELFRLLQ------RQPGKCLSEEVARFYAAEVLLALE 117

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA------------HLVGPSSTPNRVA 532
           YLH  G  + + ++K  NILL +S    +SDF L+             L   S   +  +
Sbjct: 118 YLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175

Query: 533 G---------------------YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
                                 Y APEV          D ++ G+LL E+L G  P
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 35.9 bits (84), Expect = 0.002
 Identities = 16/38 (42%), Positives = 21/38 (55%), Gaps = 2/38 (5%)

Query: 94  TSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS 131
           T+L TL L  N +T  LP  L++  NL  L L GN  +
Sbjct: 1   TNLETLDLSNNQITD-LPP-LSNLPNLETLDLSGNKIT 36

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 40.5 bits (95), Expect = 0.002
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 35/217 (16%)

Query: 376 EVLGKGTFGTAYKAVLEM---GTIVAVKRL-------KDVTISEREFKDKIEGVGAVNHE 425
           +V+G+G FG    AV++M   G + A+K L       +  T   RE +D +     VN +
Sbjct: 7   KVIGRGAFGEV--AVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVL-----VNGD 59

Query: 426 NLVPLRAYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
                  +Y   DE    LV DY   G L  LL  +K   R P   +M           I
Sbjct: 60  RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLPE--DMARFYLAEMVLAI 115

Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFG-LAHLVGPSSTPNRVA----GYRAPE 538
           + +H  G    H +IK  N+LL K+   R++DFG    L+   +  + VA     Y +PE
Sbjct: 116 DSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173

Query: 539 VTDPC-----KVSQKADVYSFGVLLLELLTGKAPTHA 570
           +         +   + D +S GV + E+L G+ P +A
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 35.5 bits (83), Expect = 0.003
 Identities = 15/37 (40%), Positives = 25/37 (67%), Gaps = 2/37 (5%)

Query: 166 TKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL 202
           T L+TL L NN+++  +P   + LPNL+ L++S N +
Sbjct: 1   TNLETLDLSNNQIT-DLPPLSN-LPNLETLDLSGNKI 35

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 39.9 bits (93), Expect = 0.003
 Identities = 49/210 (23%), Positives = 97/210 (46%), Gaps = 32/210 (15%)

Query: 396 IVAVKRLK-DVTISER-EFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS 453
           +VAVK L+ D   + R +F  +++ +  +   N++ L       D   ++ +Y+  G L+
Sbjct: 48  LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 454 ALL----------HGNKG---AGRTP-LNWEMRSLIALGAARGIEYLHAQGPNVSHGNIK 499
             L          +GN     A   P +++     +AL  A G++YL +   N  H ++ 
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--NFVHRDLA 165

Query: 500 SSNILLTKSYEARVSDFGLAH---------LVGPSSTPNRVAGYRAPEVTDPCKVSQKAD 550
           + N L+ ++   +++DFG++          + G +  P R   + A E     K +  +D
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR---WMAWECILMGKFTTASD 222

Query: 551 VYSFGVLLLELLT--GKAPTHALLNEEGVD 578
           V++FGV L E+L    + P   L +E+ ++
Sbjct: 223 VWAFGVTLWEILMLCKEQPYGELTDEQVIE 252

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 60/244 (24%), Positives = 91/244 (37%), Gaps = 63/244 (25%)

Query: 374 SAEVLGKGTFGTA-YKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           S +V+G+G FG        + G + A+K L+   + E+E       VG +  E  + + A
Sbjct: 5   SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE------QVGHIRAERDILVEA 58

Query: 433 -------YYYSMDEKL---LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
                   +YS  +KL   L+ ++L  G +  LL       +  L  E            
Sbjct: 59  DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL-----MKKDTLTEEETQFYIAETVLA 113

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGL------AHLVG---------PSS- 526
           I+ +H  G    H +IK  N+LL      ++SDFGL      AH            PS  
Sbjct: 114 IDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171

Query: 527 --------------TPNR---------VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT 563
                           NR            Y APEV      ++  D +S GV++ E+L 
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231

Query: 564 GKAP 567
           G  P
Sbjct: 232 GYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 40.1 bits (93), Expect = 0.003
 Identities = 43/179 (24%), Positives = 80/179 (44%), Gaps = 28/179 (15%)

Query: 400 KRLKDVTISEREFKDKIEGVGAVNHENLVPLR------AYYYSMDEKLLVYDYLTMGSLS 453
           KR+K  + +  + +++I  +G +NHEN++ +       A  Y + +K   YD+      S
Sbjct: 198 KRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQK---YDF---DLYS 251

Query: 454 ALLHGNKGAGRTPLNWEMRSLIA-LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEAR 512
            +          PL  + R+++  L  A  +EY+H +   + H +IK  NI L    +  
Sbjct: 252 FMYDEAFDWKDRPLLKQTRAIMKQLLCA--VEYIHDK--KLIHRDIKLENIFLNCDGKIV 307

Query: 513 VSDFGLAHLVGPSSTPNRVAGY--------RAPEVTDPCKVSQKADVYSFGVLLLELLT 563
           + DFG A    P         Y         +PE+       +  D++S G++LL++L+
Sbjct: 308 LGDFGTAM---PFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 40/218 (18%)

Query: 376 EVLGKGTFGTA----YKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
           +V+G+G FG      +K+  ++  +  + + + +  S+  F  +   + A  +   V ++
Sbjct: 49  KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-VQ 107

Query: 432 AYYYSMDEKLL--VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
            +    D+K L  V +Y+  G L  L+       +    +    ++AL A      +H+ 
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDA------IHSM 161

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFG---------LAHLVGPSSTPNRVAGYRAPEVT 540
           G  + H ++K  N+LL K    +++DFG         +        TP+    Y +PEV 
Sbjct: 162 G--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPD----YISPEVL 215

Query: 541 DPCKVSQKADVY--------SFGVLLLELLTGKAPTHA 570
                SQ  D Y        S GV L E+L G  P +A
Sbjct: 216 K----SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 39.6 bits (92), Expect = 0.004
 Identities = 32/107 (29%), Positives = 55/107 (51%), Gaps = 16/107 (14%)

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNR 530
           A G+E+L ++  N  H ++ + N+L+ +    ++ DFGLA  +         G +  P +
Sbjct: 249 ANGMEFLASK--NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306

Query: 531 VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHAL-LNEE 575
              + APE       +  +DV+SFG+LL E+ T G  P   L +NE+
Sbjct: 307 ---WMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 40.1 bits (93), Expect = 0.004
 Identities = 36/134 (26%), Positives = 56/134 (41%), Gaps = 35/134 (26%)

Query: 482 GIEYLH--AQGPN---VSHGNIKSSNILLTKSYE-----------------ARVSDFGLA 519
            + Y H    GPN   V H ++K  NI L+                     A++ DFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189

Query: 520 HLVGPSSTPNRVAG---YRAPEVT--DPCKVSQKADVYSFGVLLLELLTGKAPTHALLN- 573
             +G  S  +   G   Y +PE+   +      K+D+++ G ++ EL +GK P H   N 
Sbjct: 190 KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249

Query: 574 -------EEGVDLP 580
                  + G DLP
Sbjct: 250 SQLISELKRGPDLP 263

Length = 1021

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	663
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.98
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.98
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.98
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.98
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.98
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.84
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.82
PLN03150	623	hypothetical protein; Provisional	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.8
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.8
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.79
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.76
PRK10345	210	hypothetical protein; Provisional	99.75
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.71
PRK14879	211	serine/threonine protein kinase; Provisional	99.71
smart00090	237	RIO RIO-like kinase.	99.7
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.68
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.68
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.68
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.67
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.6
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.59
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.59
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.59
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.58
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.58
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.56
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.56
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.51
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.49
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.45
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.45
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.42
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.4
PLN03150	623	hypothetical protein; Provisional	99.39
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.39
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.36
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.32
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.25
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.23
KOG1243	690	consensus Protein kinase [General function predict	99.21
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.2
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.2
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.19
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.19
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.18
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.17
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.14
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.14
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.13
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.12
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.09
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.09
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.98
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.98
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.96
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.96
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.95
KOG3087	229	consensus Serine/threonine protein kinase [General	98.94
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.94
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.92
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.9
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.89
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.88
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.87
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.86
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.85
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.84
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.81
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.77
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.75
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.68
COG4248	637	Uncharacterized protein with protein kinase and he	98.68
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.64
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.56
PRK09902	216	hypothetical protein; Provisional	98.5
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.48
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.48
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.46
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.44
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.44
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.41
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.41
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.37
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.34
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.24
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.23
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.1
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.05

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.5e-60  Score=569.84  Aligned_cols=275  Identities=29%  Similarity=0.501  Sum_probs=219.2

Q ss_pred             cCHHHHHHHh--hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccE
Q 006055          365 FDLEDLLRAS--AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKL  441 (663)
Q Consensus       365 ~~~~~l~~~~--~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  441 (663)
                      ++.+++....  .++||+|+||.||+|.. .+|..||||+++.....   ..+|++.+++++||||++++++|.+.+..+
T Consensus       683 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~  759 (968)
T PLN00113        683 ITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAY  759 (968)
T ss_pred             hhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence            4445544433  45899999999999995 67999999998754322   234688899999999999999999999999


Q ss_pred             EEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-CcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          442 LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG-PNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       442 lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                      +||||+++|+|.++++.        ++|..+.+|+.|+|+|++|||..+ ++|+||||||+||+++.++.+++. ||...
T Consensus       760 lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~  830 (968)
T PLN00113        760 LIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG  830 (968)
T ss_pred             EEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence            99999999999999962        789999999999999999999653 569999999999999999988876 66665


Q ss_pred             ccCCCCCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          521 LVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       521 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                      .........++.+|+|||++.+..++.++|||||||++|||+||+.||+.... ....+..|++..........++|+.+
T Consensus       831 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  909 (968)
T PLN00113        831 LLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSI  909 (968)
T ss_pred             ccccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccc
Confidence            54444444567889999999999999999999999999999999999965432 23456777765554444444555544


Q ss_pred             hcc-cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCCCC
Q 006055          601 LRY-QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGL  652 (663)
Q Consensus       601 ~~~-~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~  652 (663)
                      ... ....++..++.+++.+||+.||++||||+||+++|+++.........+.
T Consensus       910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~~~  962 (968)
T PLN00113        910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVTGL  962 (968)
T ss_pred             cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccccccCc
Confidence            221 2234567788999999999999999999999999999977655555443

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-54  Score=450.23  Aligned_cols=281  Identities=42%  Similarity=0.701  Sum_probs=249.4

Q ss_pred             CCcccCHHHHHHHh-----hcccccccceEEEEEEecCCcEEEEEEecCcccC-HHHHHHHHHHhhcCCCCCcccceEEE
Q 006055          361 AARVFDLEDLLRAS-----AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS-EREFKDKIEGVGAVNHENLVPLRAYY  434 (663)
Q Consensus       361 ~~~~~~~~~l~~~~-----~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~  434 (663)
                      ..+.|++.++..||     .++||+|+||.||+|.+.+|+.||||++...... .++|..|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            34679999999998     4699999999999999999999999998876544 77899999999999999999999999


Q ss_pred             EecC-ccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-CcceecCCCCCCEEEcCCCceE
Q 006055          435 YSMD-EKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG-PNVSHGNIKSSNILLTKSYEAR  512 (663)
Q Consensus       435 ~~~~-~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-~~iiHrdlk~~Nill~~~~~~k  512 (663)
                      .+.+ +.+||||||++|+|.++|+.....   +++|.+|++||.++|+||+|||+.+ |+||||||||+|||+|+++.+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            9998 499999999999999999975532   7899999999999999999999987 7899999999999999999999


Q ss_pred             EeccccccccCC-CCC---C-CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHH
Q 006055          513 VSDFGLAHLVGP-SST---P-NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIV  587 (663)
Q Consensus       513 l~Dfg~a~~~~~-~~~---~-~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  587 (663)
                      |+|||+|+.... ...   . .+|.||+||||+..+..++|+|||||||+++|++||+.|.+.........+..|+...+
T Consensus       218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            999999976654 322   1 68889999999999999999999999999999999999988765444556999999999


Q ss_pred             hhcccccccchhhhcccCh-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          588 KDEWTSEVFDLELLRYQNV-EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       588 ~~~~~~~~~d~~~~~~~~~-~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      .+....+++|+.+...... .+++.++.+++.+|++.+|++||+|.||+++|+.+...
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            9989999999998643333 26888899999999999999999999999999776544

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=387.84  Aligned_cols=260  Identities=34%  Similarity=0.494  Sum_probs=213.0

Q ss_pred             ccCHHHHHHHhhcccccccceEEEEEEecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecC-c
Q 006055          364 VFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMD-E  439 (663)
Q Consensus       364 ~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  439 (663)
                      .++..++.  ..+.||+|+||+||+|.++....||||++.....+   .+.|.+|+.+|.+++|||||+++|+|.+.. .
T Consensus        37 ~i~~~~l~--~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~  114 (362)
T KOG0192|consen   37 EIDPDELP--IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGS  114 (362)
T ss_pred             ecChHHhh--hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            34555553  35669999999999999984444999999876433   458999999999999999999999999887 7


Q ss_pred             cEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC-ceEEecccc
Q 006055          440 KLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY-EARVSDFGL  518 (663)
Q Consensus       440 ~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~-~~kl~Dfg~  518 (663)
                      .++|||||++|+|.++++..   ....+++..+++++.|||+|+.|||+++| ||||||||+|||++.++ ++||+|||+
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCcc
Confidence            99999999999999999874   23469999999999999999999999985 99999999999999998 999999999


Q ss_pred             ccccCCC---C-CCCCCccccCccccC--CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccc
Q 006055          519 AHLVGPS---S-TPNRVAGYRAPEVTD--PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT  592 (663)
Q Consensus       519 a~~~~~~---~-~~~~~~~y~aPE~~~--~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  592 (663)
                      ++.....   . ...+|..|||||++.  ...|++|+||||||+++|||+||+.||.....      ...+..+..... 
T Consensus       191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~-  263 (362)
T KOG0192|consen  191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGL-  263 (362)
T ss_pred             ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCC-
Confidence            9877642   2 246788899999999  56899999999999999999999999975432      222222222221 


Q ss_pred             ccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          593 SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       593 ~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                               +...+..+...+..++.+||..||++||++.|++..|+.+....
T Consensus       264 ---------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  264 ---------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             ---------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence                     11112235567888889999999999999999999999775543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-46  Score=367.12  Aligned_cols=253  Identities=28%  Similarity=0.390  Sum_probs=211.0

Q ss_pred             cCHHHHHHHhhcccccccceEEEEEEe-cCCcEEEEEEecCc--ccCHHHHHHHHHHhhcCCCCCcccceEEEEecC-cc
Q 006055          365 FDLEDLLRASAEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV--TISEREFKDKIEGVGAVNHENLVPLRAYYYSMD-EK  440 (663)
Q Consensus       365 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~  440 (663)
                      +++.|+.+  .+.||+|..|+|||+.+ .+++.+|+|.+...  ....+++.+|+++++..+||+||+++|.|.... +.
T Consensus        76 i~~~dle~--~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i  153 (364)
T KOG0581|consen   76 ISLSDLER--LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI  153 (364)
T ss_pred             cCHHHhhh--hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence            56667633  57899999999999995 57899999999543  233678999999999999999999999999988 49


Q ss_pred             EEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCcceecCCCCCCEEEcCCCceEEeccccc
Q 006055          441 LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA-QGPNVSHGNIKSSNILLTKSYEARVSDFGLA  519 (663)
Q Consensus       441 ~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a  519 (663)
                      .++||||++|+|++++...+     .+++....+|+.+|++||.|||+ ++  ||||||||+|||++..|++||||||.+
T Consensus       154 sI~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS  226 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVS  226 (364)
T ss_pred             EeehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEecccccc
Confidence            99999999999999998643     48999999999999999999996 55  999999999999999999999999999


Q ss_pred             cccCCC--CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          520 HLVGPS--STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       520 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                      +.+...  .+..||..|||||.+.+..|+.++||||||+.++|+.+|+.||... .....+..+.+..+..+..+     
T Consensus       227 ~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~-~~~~~~~~~Ll~~Iv~~ppP-----  300 (364)
T KOG0581|consen  227 GILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP-NPPYLDIFELLCAIVDEPPP-----  300 (364)
T ss_pred             HHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc-CCCCCCHHHHHHHHhcCCCC-----
Confidence            877654  4566888999999999999999999999999999999999999764 12223444444444433211     


Q ss_pred             hhhhcccChH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          598 LELLRYQNVE-EEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       598 ~~~~~~~~~~-~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                            ..+. .+..++..++-.|+++||.+||+++|+++|=
T Consensus       301 ------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp  336 (364)
T KOG0581|consen  301 ------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP  336 (364)
T ss_pred             ------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence                  1112 3566788889999999999999999999863

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-45  Score=376.80  Aligned_cols=256  Identities=29%  Similarity=0.432  Sum_probs=217.9

Q ss_pred             cCHHHHHHHhhcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEE
Q 006055          365 FDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVY  444 (663)
Q Consensus       365 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  444 (663)
                      ++.+++  ...+.||+|-||+||.|.++....||+|.++........|.+|+.+|++|+|+|||+++++|..++..+|||
T Consensus       203 i~r~~l--~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  203 IPREEL--KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             ecHHHH--HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            444444  446789999999999999998889999999988888899999999999999999999999999988999999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      |||+.|+|.++|+...   ...+.....+.++.|||+|++||++++  +|||||.++||||+++..+||+|||+|+....
T Consensus       281 E~m~~GsLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARLIGD  355 (468)
T ss_pred             EecccCcHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccccCC
Confidence            9999999999998632   345888999999999999999999998  99999999999999999999999999996554


Q ss_pred             CCCCC-----CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          525 SSTPN-----RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       525 ~~~~~-----~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                      +....     ....|.|||.+....++.|+|||||||+|+||+| |+.||....+      .+.+..+-+..        
T Consensus       356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn------~ev~~~le~Gy--------  421 (468)
T KOG0197|consen  356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN------EEVLELLERGY--------  421 (468)
T ss_pred             CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH------HHHHHHHhccC--------
Confidence            43322     2334999999999999999999999999999999 9999876543      23333332222        


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                         +.+.+..++..+.++|..||+.+|++|||++.+...|+++...
T Consensus       422 ---Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  422 ---RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             ---cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence               2233455777899999999999999999999999999988654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-44  Score=341.55  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=207.5

Q ss_pred             hhcccccccceEEEEEE-ecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceE-EEEecCc-cEEEEEcc
Q 006055          374 SAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRA-YYYSMDE-KLLVYDYL  447 (663)
Q Consensus       374 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~lv~ey~  447 (663)
                      ..++||+|.||+||++. ..+|..||.|.++-...+   ......|+.++++++|||||++++ .+.++.+ ..+||||+
T Consensus        23 Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c  102 (375)
T KOG0591|consen   23 ILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELC  102 (375)
T ss_pred             HHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhh
Confidence            45789999999999998 788999999999855444   456889999999999999999998 4555555 78999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCc--ceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN--VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~--iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      ..|+|..+++..+ .....+++..+++++.|++.||.++|..-|.  |+||||||.||+++.+|.+||+|||++++....
T Consensus       103 ~~GDLsqmIk~~K-~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~  181 (375)
T KOG0591|consen  103 DAGDLSQMIKHFK-KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK  181 (375)
T ss_pred             cccCHHHHHHHHH-hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcch
Confidence            9999999997654 2355699999999999999999999985444  999999999999999999999999999998765


Q ss_pred             C----CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhh
Q 006055          526 S----TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL  601 (663)
Q Consensus       526 ~----~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  601 (663)
                      .    +..||+.||+||.++...|+.|+||||+||++|||+.-++||.+.      ++....+.+.+....         
T Consensus       182 ~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qgd~~---------  246 (375)
T KOG0591|consen  182 TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQGDYP---------  246 (375)
T ss_pred             hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcCCCC---------
Confidence            4    356899999999999999999999999999999999999999753      455555554444221         


Q ss_pred             cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       602 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                       .-..+.++.++.+++..|+..||+.||+.-.+++.+.
T Consensus       247 -~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  247 -PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             -CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence             0112456778999999999999999999655555543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-43  Score=366.27  Aligned_cols=239  Identities=26%  Similarity=0.424  Sum_probs=205.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc----ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV----TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      +++||+|||+.||+++. .+|+.||+|++.+.    ....+...+||++.+.|+|||||+++++|++.+..|+|.|+|.+
T Consensus        23 g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~  102 (592)
T KOG0575|consen   23 GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHR  102 (592)
T ss_pred             eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCC
Confidence            57899999999999995 88999999999763    33456789999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      ++|..+++.     +.++++.++..+..||+.||.|||+++  |+|||||-.|++++++.++||+|||+|..+....   
T Consensus       103 ~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk  175 (592)
T KOG0575|consen  103 GSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK  175 (592)
T ss_pred             ccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence            999999984     346999999999999999999999998  9999999999999999999999999999887442   


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       +..||+.|+|||++....++..+||||+||++|-|+.|++||+..      ++.+....+...++            ..
T Consensus       176 ~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk------~vkety~~Ik~~~Y------------~~  237 (592)
T KOG0575|consen  176 KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK------TVKETYNKIKLNEY------------SM  237 (592)
T ss_pred             ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc------hHHHHHHHHHhcCc------------cc
Confidence             345788899999999999999999999999999999999999642      23333444433322            22


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      +.....+..++|.++++.+|.+|||+++|+.+=
T Consensus       238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~  270 (592)
T KOG0575|consen  238 PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP  270 (592)
T ss_pred             ccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence            234445677888899999999999999999853

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.2e-44  Score=352.87  Aligned_cols=243  Identities=28%  Similarity=0.447  Sum_probs=197.3

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccC--------HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS--------EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~--------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  445 (663)
                      .+.||+|+||.|-+|. .++|+.||||++++....        ...+.+|+++|++++|||||+++++|..++..|+|||
T Consensus       177 ~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE  256 (475)
T KOG0615|consen  177 SKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLE  256 (475)
T ss_pred             eeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEE
Confidence            5789999999999998 678999999999754221        2346799999999999999999999999999999999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC---CceEEecccccccc
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS---YEARVSDFGLAHLV  522 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~---~~~kl~Dfg~a~~~  522 (663)
                      |+++|+|.+.+-..+     .+.+..-..+++|++.|+.|||++|  |+||||||+|||+..+   ..+||+|||+|+..
T Consensus       257 ~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  257 YVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             EecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            999999999887544     3667777889999999999999999  9999999999999766   67999999999998


Q ss_pred             CCCC---CCCCCccccCccccCCCC---CCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccccccc
Q 006055          523 GPSS---TPNRVAGYRAPEVTDPCK---VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF  596 (663)
Q Consensus       523 ~~~~---~~~~~~~y~aPE~~~~~~---~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  596 (663)
                      +...   +..||+.|.|||++.+..   +..++|+||+||++|-+++|.+||......     ....+++.+..+...  
T Consensus       330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~-----~sl~eQI~~G~y~f~--  402 (475)
T KOG0615|consen  330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD-----PSLKEQILKGRYAFG--  402 (475)
T ss_pred             ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC-----ccHHHHHhcCccccc--
Confidence            7543   445889999999997654   344789999999999999999999764322     122333443333211  


Q ss_pred             chhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          597 DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       597 d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                            .....+...+..+++.+++..||++|||+.|+++|
T Consensus       403 ------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  403 ------PLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             ------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                  11123345567778889999999999999999984

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-42  Score=340.02  Aligned_cols=189  Identities=29%  Similarity=0.420  Sum_probs=170.3

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      +.||+|+||+||+|+ .+++..||||.+......   .+.+..|+.+++.++|||||++++++..++..+||||||.+|+
T Consensus        16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGD   95 (429)
T KOG0595|consen   16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGD   95 (429)
T ss_pred             hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCC
Confidence            459999999999999 456899999999766433   3557899999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC------CceEEeccccccccCCC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS------YEARVSDFGLAHLVGPS  525 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~------~~~kl~Dfg~a~~~~~~  525 (663)
                      |.++++..+     .+++......+.|+|.||++||+++  ||||||||.||||+..      -.+||+|||+|+.+.+.
T Consensus        96 Ls~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen   96 LSDYIRRRG-----RLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            999999754     5899999999999999999999998  9999999999999865      45899999999999876


Q ss_pred             CC---CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccc
Q 006055          526 ST---PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHAL  571 (663)
Q Consensus       526 ~~---~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~  571 (663)
                      ..   ..|++-|||||++....|+.|+|+||+|+++|++++|+.||+..
T Consensus       169 ~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  169 SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            43   45677799999999999999999999999999999999999853

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.4e-42  Score=374.93  Aligned_cols=251  Identities=28%  Similarity=0.443  Sum_probs=212.1

Q ss_pred             hcccccccceEEEEEEe------cCCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|.||+||+|+.      ++.+.||||.+++...  ...+|++|+++++.++|||||+++|.|.+++..++|+||
T Consensus       491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEY  570 (774)
T KOG1026|consen  491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEY  570 (774)
T ss_pred             hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEe
Confidence            56899999999999983      2356799999997743  468899999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCCC-----C----CCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccc
Q 006055          447 LTMGSLSALLHGNKGA-----G----RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFG  517 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~-----~----~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg  517 (663)
                      |..|||.++|+.....     .    +.+++-.+.+.||.|||.|++||-++.  ++||||..+|+||.++..|||+|||
T Consensus       571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~l~VKIsDfG  648 (774)
T KOG1026|consen  571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGENLVVKISDFG  648 (774)
T ss_pred             cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccceEEEecccc
Confidence            9999999999754321     1    334899999999999999999999997  9999999999999999999999999


Q ss_pred             cccccCCCCCCC------CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhc
Q 006055          518 LAHLVGPSSTPN------RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDE  590 (663)
Q Consensus       518 ~a~~~~~~~~~~------~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  590 (663)
                      +++..=..+.+.      -...|||||.+..+++++++|||||||+|||+++ |+.||.+..+++       |-..++.+
T Consensus       649 LsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VIe~i~~g  721 (774)
T KOG1026|consen  649 LSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VIECIRAG  721 (774)
T ss_pred             cchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HHHHHHcC
Confidence            998754433322      2346999999999999999999999999999999 999998876654       22222222


Q ss_pred             ccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       591 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      ..          ..-++.++.++.+|+..||...|++||+++||-..|+.....
T Consensus       722 ~l----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  722 QL----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             Cc----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            21          234567788999999999999999999999999999987554

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.1e-42  Score=326.54  Aligned_cols=254  Identities=25%  Similarity=0.335  Sum_probs=195.8

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .++|+|+||.||+++. .+|+.||||++...+.+   .+-..+|++++++++|+|+|.++++|......+|||||++..-
T Consensus         8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv   87 (396)
T KOG0593|consen    8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV   87 (396)
T ss_pred             hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence            5799999999999994 56999999999776543   4567899999999999999999999999999999999999855


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccC-CCCC---
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSST---  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~-~~~~---  527 (663)
                      |.++-+..     ..++.....+++.|+++|+.|+|+++  +|||||||+||||+.++.+||||||+|+... +.+.   
T Consensus        88 L~eLe~~p-----~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD  160 (396)
T KOG0593|consen   88 LHELERYP-----NGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD  160 (396)
T ss_pred             HHHHHhcc-----CCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence            55544332     34888999999999999999999998  9999999999999999999999999999887 4433   


Q ss_pred             CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCC--------ChHHHHHHHHhhcc-c-----
Q 006055          528 PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGV--------DLPRWVQSIVKDEW-T-----  592 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~-~-----  592 (663)
                      ...|..|+|||.+.+ ..|+..+||||+||++.||++|.+-|.+.++-+..        ++...-++++..+. .     
T Consensus       161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l  240 (396)
T KOG0593|consen  161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL  240 (396)
T ss_pred             hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence            235667999999987 68999999999999999999999998765432210        11111122222111 0     


Q ss_pred             ccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          593 SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       593 ~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .+.-+++.++. .......-+++++..|++.||++|++-+|++.+
T Consensus       241 P~~~~~epLe~-k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  241 PEPEHPEPLER-KYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             CCCCCccchhh-hcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            11111111100 011223357889999999999999999999865

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=334.58  Aligned_cols=231  Identities=27%  Similarity=0.352  Sum_probs=194.7

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .++||+|+||+||.++ ..+++.+|+|.+++...    ..+....|..++..++||.||+++-.|.+.+.+|+|+||+.|
T Consensus        30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~G  109 (357)
T KOG0598|consen   30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNG  109 (357)
T ss_pred             eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCC
Confidence            4789999999999999 55699999999987633    245688999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----  525 (663)
                      |.|..+|+.+.     .+++..+..++.+|+.||.|||+++  ||||||||+|||+|.+|+++|+|||+++.....    
T Consensus       110 GeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t  182 (357)
T KOG0598|consen  110 GELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDAT  182 (357)
T ss_pred             ccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhcccCCCcc
Confidence            99999998644     5889989999999999999999999  999999999999999999999999999865433    


Q ss_pred             CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          526 STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       526 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      .+..||+.|||||++.+..|+..+|.||+|+++|||++|.+||..      .+...+.+.+.+.....         .+ 
T Consensus       183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~------~~~~~~~~~I~~~k~~~---------~p-  246 (357)
T KOG0598|consen  183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA------EDVKKMYDKILKGKLPL---------PP-  246 (357)
T ss_pred             ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC------ccHHHHHHHHhcCcCCC---------CC-
Confidence            223577889999999999999999999999999999999999964      45556666666554110         01 


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRP  629 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RP  629 (663)
                       .-...+..+++.+.+..||++|.
T Consensus       247 -~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  247 -GYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -ccCCHHHHHHHHHHhccCHHHhc
Confidence             11223456667789999999995

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=342.06  Aligned_cols=256  Identities=23%  Similarity=0.358  Sum_probs=201.4

Q ss_pred             HhhcccccccceEEEEEE-ecCCcEEEEEEecCcccC--HHHHHHHHHHhhcCC-CCCcccceEEEEecC-ccEEEEEcc
Q 006055          373 ASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS--EREFKDKIEGVGAVN-HENLVPLRAYYYSMD-EKLLVYDYL  447 (663)
Q Consensus       373 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~lv~ey~  447 (663)
                      .+.++||.|+||+||+|+ ..+|..||||+++.....  +-.-.+|+..+++++ |||||++.+.+.+.+ ..++|||||
T Consensus        13 ~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M   92 (538)
T KOG0661|consen   13 TVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM   92 (538)
T ss_pred             HHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh
Confidence            346789999999999999 778999999999876444  334568999999998 999999999998888 899999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST  527 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  527 (663)
                      +. +|+++++..    ...+++..+..|+.||++||+|+|++|  +.|||+||+|||+.....+||+|||+||.......
T Consensus        93 d~-NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   93 DC-NLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVRSKPP  165 (538)
T ss_pred             hh-hHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEecccccccccccCCC
Confidence            87 999999864    357999999999999999999999999  99999999999999999999999999998865432


Q ss_pred             ---CCCCccccCccccC-CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh----cccc-----c
Q 006055          528 ---PNRVAGYRAPEVTD-PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD----EWTS-----E  594 (663)
Q Consensus       528 ---~~~~~~y~aPE~~~-~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~-----~  594 (663)
                         +..|..|+|||++. ...|+.+.||||+|||++|+.+-++-|.+..+.+.  +.. +-.++..    .+.+     .
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq--i~K-Ic~VLGtP~~~~~~eg~~La~  242 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ--IYK-ICEVLGTPDKDSWPEGYNLAS  242 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH--HHH-HHHHhCCCccccchhHHHHHH
Confidence               34566799999974 56789999999999999999999999876433210  111 1111111    1111     0


Q ss_pred             ccchhhhccc------ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          595 VFDLELLRYQ------NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       595 ~~d~~~~~~~------~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      .+...+....      -......+.++++.+|+..||++|||+.|++++-
T Consensus       243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            0111111100      0123567888999999999999999999999864

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-41  Score=345.97  Aligned_cols=240  Identities=25%  Similarity=0.375  Sum_probs=201.6

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccC-HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS-EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .++||+|+.|.||.|. ..+++.||||++....+. ++-+.+|+.+|+..+|+|||.+++.|...++.|+|||||++|+|
T Consensus       278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL  357 (550)
T KOG0578|consen  278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL  357 (550)
T ss_pred             hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence            3679999999999998 667899999999877555 45578999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----CCC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----STP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----~~~  528 (663)
                      .+++...      .+++.++..|+.++++||+|||.++  |+|||||.+|||++.+|.+||+|||++......    .+.
T Consensus       358 TDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~Tm  429 (550)
T KOG0578|consen  358 TDVVTKT------RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTM  429 (550)
T ss_pred             hhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeeccccccCccccc
Confidence            9999754      3899999999999999999999999  999999999999999999999999999876554    345


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .||+.|||||+.....|+.|+||||||++++||+.|.+||-..      +....+.-+...+.      +   .....+.
T Consensus       430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE------~PlrAlyLIa~ng~------P---~lk~~~k  494 (550)
T KOG0578|consen  430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE------NPLRALYLIATNGT------P---KLKNPEK  494 (550)
T ss_pred             cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC------ChHHHHHHHhhcCC------C---CcCCccc
Confidence            6899999999999999999999999999999999999998531      11111111111111      1   1122334


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....+.+++.+|+..|+++||++.|+++|
T Consensus       495 lS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  495 LSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             cCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            45567777789999999999999999986

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=9.2e-40  Score=335.37  Aligned_cols=257  Identities=17%  Similarity=0.320  Sum_probs=206.4

Q ss_pred             cccCHHHHHHHhhcccccccceEEEEEEecCCcEEEEEEecCcccCH----HHHHHHHHHhhcCCCCCcccceEEEEe--
Q 006055          363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISE----REFKDKIEGVGAVNHENLVPLRAYYYS--  436 (663)
Q Consensus       363 ~~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~----~~~~~e~~~l~~l~h~niv~l~~~~~~--  436 (663)
                      +.++.+++.......||+|++|.||+|.. +|+.||||.++......    +.+.+|+.++.+++||||+++++++.+  
T Consensus        13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~   91 (283)
T PHA02988         13 KCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV   91 (283)
T ss_pred             eecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence            34566666555557899999999999998 58999999997654332    567799999999999999999999877  


Q ss_pred             --cCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCcceecCCCCCCEEEcCCCceEE
Q 006055          437 --MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ-GPNVSHGNIKSSNILLTKSYEARV  513 (663)
Q Consensus       437 --~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~iiHrdlk~~Nill~~~~~~kl  513 (663)
                        ....++||||+++|+|.++++..     ..+++.....++.+++.||.|||+. +  ++||||||+||++++++.+||
T Consensus        92 ~~~~~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl  164 (283)
T PHA02988         92 DDLPRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKI  164 (283)
T ss_pred             cCCCceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEE
Confidence              34678999999999999999753     2588999999999999999999985 5  789999999999999999999


Q ss_pred             eccccccccCCCC-CCCCCccccCccccCC--CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhc
Q 006055          514 SDFGLAHLVGPSS-TPNRVAGYRAPEVTDP--CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE  590 (663)
Q Consensus       514 ~Dfg~a~~~~~~~-~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  590 (663)
                      +|||+++...... ...++..|+|||++.+  ..++.++|||||||++|||++|+.||....      .......+....
T Consensus       165 ~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~------~~~~~~~i~~~~  238 (283)
T PHA02988        165 ICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT------TKEIYDLIINKN  238 (283)
T ss_pred             cccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhcC
Confidence            9999998654432 2346778999999976  678999999999999999999999996432      222333332222


Q ss_pred             ccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       591 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      ...          ..+......+.+++.+||+.||++|||++|+++.|+.+..
T Consensus       239 ~~~----------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        239 NSL----------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             CCC----------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            110          0111234568888999999999999999999999998753

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=333.52  Aligned_cols=247  Identities=26%  Similarity=0.409  Sum_probs=197.0

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC-HHHHHHHHHHhhcCCCCCcccceEEEEecC--ccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS-EREFKDKIEGVGAVNHENLVPLRAYYYSMD--EKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ey~~~g  450 (663)
                      .+.||+|+||+||++.. ++|+..|||.+...... .+.+.+|+.++.+++|||||+.+|.....+  ..++.|||+++|
T Consensus        22 ~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~G  101 (313)
T KOG0198|consen   22 GKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGG  101 (313)
T ss_pred             hccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCC
Confidence            57899999999999995 45999999998655211 456899999999999999999999865555  588999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC-CCceEEeccccccccCC-----
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK-SYEARVSDFGLAHLVGP-----  524 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~-~~~~kl~Dfg~a~~~~~-----  524 (663)
                      +|.+++....+    .+++..+++.+.||++||.|||+++  |+||||||+|||++. ++.+||+|||+++....     
T Consensus       102 sL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~  175 (313)
T KOG0198|consen  102 SLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS  175 (313)
T ss_pred             cHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence            99999987542    4899999999999999999999998  999999999999999 79999999999987653     


Q ss_pred             --CCCCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhh
Q 006055          525 --SSTPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL  601 (663)
Q Consensus       525 --~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  601 (663)
                        .....+|+.|||||++..+ ....++||||+||++.||+||+.||...     .....++-.+.......        
T Consensus       176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P--------  242 (313)
T KOG0198|consen  176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLP--------  242 (313)
T ss_pred             cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCC--------
Confidence              1234578889999999853 3335899999999999999999999753     11122222222221111        


Q ss_pred             cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       602 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                        ..+.....+..+++.+|+..+|++|||++|++++.....
T Consensus       243 --~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  243 --EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             --CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence              112224446677888999999999999999999876543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=326.83  Aligned_cols=251  Identities=22%  Similarity=0.319  Sum_probs=199.9

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCc--ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV--TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .++||.|..++||+|. .+.++.||||++.-.  ..+-..+.+|+..|+.++||||++++..|..+...|+||.||.+|+
T Consensus        31 ~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS  110 (516)
T KOG0582|consen   31 QEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGS  110 (516)
T ss_pred             EEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCc
Confidence            5789999999999999 777899999998654  2334789999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC------
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS------  525 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~------  525 (663)
                      +.+++...-   ...+++..+..|.+++++||.|||++|  .||||||+.||||+.+|.+||+|||....+...      
T Consensus       111 ~ldIik~~~---~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~  185 (516)
T KOG0582|consen  111 LLDIIKTYY---PDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVT  185 (516)
T ss_pred             HHHHHHHHc---cccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeE
Confidence            999998644   234899999999999999999999999  999999999999999999999999987655432      


Q ss_pred             --CCCCCCccccCccccC--CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhh
Q 006055          526 --STPNRVAGYRAPEVTD--PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL  601 (663)
Q Consensus       526 --~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  601 (663)
                        .+..+++.|||||+++  ...|+.|+||||||++..||.+|..||.....      .+.+-..+++..+.- . ....
T Consensus       186 rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tLqn~pp~~-~-t~~~  257 (516)
T KOG0582|consen  186 RFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTLQNDPPTL-L-TSGL  257 (516)
T ss_pred             eeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhcCCCCCc-c-cccC
Confidence              2335778899999954  35799999999999999999999999975321      111112222221100 0 0000


Q ss_pred             cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       602 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      ...........+.+++..|+.+||.+|||+++++++=
T Consensus       258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~  294 (516)
T KOG0582|consen  258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA  294 (516)
T ss_pred             ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence            1111223345788889999999999999999998753

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-40  Score=334.95  Aligned_cols=248  Identities=28%  Similarity=0.406  Sum_probs=196.5

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEec--CccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSM--DEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ey~~  448 (663)
                      .++||+|+||.||+|+ ..+|+.||+|++....   .......+||.+|++|.||||+++.+..++.  ...|||||||+
T Consensus       122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd  201 (560)
T KOG0600|consen  122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD  201 (560)
T ss_pred             HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence            4789999999999999 7889999999987543   2356678999999999999999999999887  67899999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCC
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP  528 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  528 (663)
                      . ||.-++...    ...++..++.-++.|++.||+|||.++  |+|||||.+|||||.+|.+||+|||+|+++......
T Consensus       202 h-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~  274 (560)
T KOG0600|consen  202 H-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA  274 (560)
T ss_pred             c-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence            8 999888753    346899999999999999999999999  999999999999999999999999999988766533


Q ss_pred             C-----CCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHh------hccccccc
Q 006055          529 N-----RVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK------DEWTSEVF  596 (663)
Q Consensus       529 ~-----~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~  596 (663)
                      .     .|..|.|||++.|. .|+..+|+||.||||.||++|++.|.+..+      +..+..+++      +.++. ..
T Consensus       275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE------veQl~kIfklcGSP~e~~W~-~~  347 (560)
T KOG0600|consen  275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE------VEQLHKIFKLCGSPTEDYWP-VS  347 (560)
T ss_pred             ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH------HHHHHHHHHHhCCCChhccc-cc
Confidence            2     34559999999875 699999999999999999999999976433      222333321      11111 00


Q ss_pred             chh---hhcc-c----C----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          597 DLE---LLRY-Q----N----VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       597 d~~---~~~~-~----~----~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      +..   .... .    .    ........++|+..++..||.+|.|+.++++
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            110   0000 0    0    1112345677888999999999999999987

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=339.35  Aligned_cols=239  Identities=23%  Similarity=0.350  Sum_probs=199.7

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCccc----CHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI----SEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      ++.||+|+|++||+|. ..+++.||||++.+...    -.+.+..|-+.|.+| .||.|++|+-.|.+...+|+|+||++
T Consensus        78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~  157 (604)
T KOG0592|consen   78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP  157 (604)
T ss_pred             hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence            5789999999999999 66799999999876522    234577888889999 89999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--  526 (663)
                      +|+|.++++..+     .+++...+.++.+|+.||+|||++|  ||||||||+|||+|+|+++||.|||.|+.+.+..  
T Consensus       158 nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  158 NGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             CCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence            999999998764     4899999999999999999999999  9999999999999999999999999998765421  


Q ss_pred             ---------------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc
Q 006055          527 ---------------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW  591 (663)
Q Consensus       527 ---------------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  591 (663)
                                     +..||..|.+||++.....+..+|+|+|||++|.|+.|++||.+..      -....+.++.-.+
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N------eyliFqkI~~l~y  304 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN------EYLIFQKIQALDY  304 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc------HHHHHHHHHHhcc
Confidence                           1236777999999999999999999999999999999999997532      2223333332221


Q ss_pred             cccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          592 TSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       592 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                                  ..++..+....+|+.+.+..||.+|+|.+|+.+|-
T Consensus       305 ------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  305 ------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             ------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence                        11222234566777799999999999999998875

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-39  Score=342.42  Aligned_cols=252  Identities=25%  Similarity=0.399  Sum_probs=197.2

Q ss_pred             hcccccccceEEEEEEe------cCCcEEEEEEecCccc--CHHHHHHHHHHhhcC-CCCCcccceEEEEecC-ccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAV-NHENLVPLRAYYYSMD-EKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~~lv~  444 (663)
                      .++||+|+||.||+|..      .+++.||||+++....  ....+.+|+.++..+ +||||++++++|...+ ..++||
T Consensus        12 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~   91 (338)
T cd05102          12 GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIV   91 (338)
T ss_pred             eeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEE
Confidence            57899999999999973      2357899999875422  235688999999999 8999999999987654 478999


Q ss_pred             EccCCCChhHhhccCCCC---------------------------------------------------------CCCCC
Q 006055          445 DYLTMGSLSALLHGNKGA---------------------------------------------------------GRTPL  467 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~---------------------------------------------------------~~~~l  467 (663)
                      ||+++|+|.++++.....                                                         ...++
T Consensus        92 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  171 (338)
T cd05102          92 EFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPL  171 (338)
T ss_pred             ecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCC
Confidence            999999999998753210                                                         12358


Q ss_pred             CHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC------CCCCCccccCccccC
Q 006055          468 NWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS------TPNRVAGYRAPEVTD  541 (663)
Q Consensus       468 ~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~  541 (663)
                      ++..+..++.||++||+|||+.+  |+||||||+|||++.++.+||+|||+++......      ...++..|+|||++.
T Consensus       172 ~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  249 (338)
T cd05102         172 TMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIF  249 (338)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhh
Confidence            88999999999999999999998  9999999999999999999999999998653321      122345699999999


Q ss_pred             CCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHc
Q 006055          542 PCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDC  620 (663)
Q Consensus       542 ~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C  620 (663)
                      +..++.++|||||||++|||++ |..||......      ..+...+......          ..+.....++.+++.+|
T Consensus       250 ~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~------~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~c  313 (338)
T cd05102         250 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN------EEFCQRLKDGTRM----------RAPENATPEIYRIMLAC  313 (338)
T ss_pred             cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHHhcCCCC----------CCCCCCCHHHHHHHHHH
Confidence            8889999999999999999997 99999653211      1111112111110          01112334688899999


Q ss_pred             cCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          621 SAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       621 ~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      |..||++|||+.|+++.|+++...
T Consensus       314 l~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         314 WQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             ccCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=337.87  Aligned_cols=250  Identities=29%  Similarity=0.417  Sum_probs=201.5

Q ss_pred             hhcccccccceEEEEEEecCCcEEEEEEecCcccCH---HHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          374 SAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISE---REFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       374 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      ..+.||+|+||+||+|.|.  -.||||.++.....+   +.|+.|+..+++-+|.||+-+.|||..+.. .+|+.+|++-
T Consensus       396 l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGs  472 (678)
T KOG0193|consen  396 LGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGS  472 (678)
T ss_pred             ccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCc
Confidence            3689999999999999985  358999998765443   679999999999999999999999998877 9999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC-----
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-----  525 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~-----  525 (663)
                      +|+.++|..+    ..++......||.|||+|+.|||.++  |||||||+.||++.+++.|||+|||++..-..-     
T Consensus       473 SLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q  546 (678)
T KOG0193|consen  473 SLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQ  546 (678)
T ss_pred             hhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccceeeeeeeccccc
Confidence            9999999654    56899999999999999999999998  999999999999999999999999999654321     


Q ss_pred             -CCCCCCccccCccccCC---CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhh
Q 006055          526 -STPNRVAGYRAPEVTDP---CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL  601 (663)
Q Consensus       526 -~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  601 (663)
                       ....+...|||||++..   ..|++.+||||||+|+|||++|..||.. ...+..        ++.-+...-..|..  
T Consensus       547 ~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqI--------ifmVGrG~l~pd~s--  615 (678)
T KOG0193|consen  547 LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQI--------IFMVGRGYLMPDLS--  615 (678)
T ss_pred             cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhhe--------EEEecccccCccch--
Confidence             12234456999999864   3589999999999999999999999973 222100        00000100111111  


Q ss_pred             cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       602 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                        .....+.+++.+|+..||..++++||.+.+|+..|+++....
T Consensus       616 --~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  616 --KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             --hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence              122345668888889999999999999999999999987744

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.4e-39  Score=305.70  Aligned_cols=251  Identities=23%  Similarity=0.364  Sum_probs=200.6

Q ss_pred             hhcccccccceEEEEEE-ecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          374 SAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       374 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      ..++||+|.||.||+|. .++|+.||||+++..+..   .....+|++.++.++|+||+.++++|...+...+|+|||+.
T Consensus         6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t   85 (318)
T KOG0659|consen    6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT   85 (318)
T ss_pred             hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc
Confidence            35789999999999999 678999999999866433   45678999999999999999999999999999999999987


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCC-
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP-  528 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-  528 (663)
                       +|+.+++...    ..+.-.....++.++.+|++|||.+.  |+||||||.|+|++.+|.+||+|||+|+..++.... 
T Consensus        86 -dLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~  158 (318)
T KOG0659|consen   86 -DLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ  158 (318)
T ss_pred             -cHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence             9999998643    46888999999999999999999998  999999999999999999999999999998765332 


Q ss_pred             ---CCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHh-------hcccc--cc
Q 006055          529 ---NRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK-------DEWTS--EV  595 (663)
Q Consensus       529 ---~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~--~~  595 (663)
                         ..|..|.|||.+.| +.|+..+||||.||++.||+-|.+-|.+..+      .+.+..+++       +.|++  ..
T Consensus       159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD------idQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD------IDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch------HHHHHHHHHHcCCCCcccCcccccc
Confidence               24566999999876 4689999999999999999999887765432      222222222       11111  11


Q ss_pred             cchhhhc-cc------ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          596 FDLELLR-YQ------NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       596 ~d~~~~~-~~------~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .|..... .+      -......+.++++..++..||.+|+|+.|++++
T Consensus       233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1111101 11      112334567899999999999999999999985

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=349.81  Aligned_cols=247  Identities=24%  Similarity=0.469  Sum_probs=211.2

Q ss_pred             hcccccccceEEEEEEecC----CcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLEM----GTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .++||.|-||+||+|.++-    ...||||.++...  ....+|..|..+|+++.||||++|.|+.+..+..++|+|||+
T Consensus       634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyME  713 (996)
T KOG0196|consen  634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYME  713 (996)
T ss_pred             EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhh
Confidence            5799999999999999542    3569999999763  335789999999999999999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCC
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP  528 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  528 (663)
                      +|+|+.+|+.+.+    .+.+.+..-+..+||.|+.||-+++  ++||||.++|||++.+..+|++|||+++...++...
T Consensus       714 NGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~  787 (996)
T KOG0196|consen  714 NGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  787 (996)
T ss_pred             CCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence            9999999997653    4899999999999999999999998  999999999999999999999999999988655422


Q ss_pred             -CCC------ccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          529 -NRV------AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       529 -~~~------~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                       ..+      ..|.|||.+..++++..+||||||+||||.++ |..||..+.+.+      .++. +.+++         
T Consensus       788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd------VIka-Ie~gy---------  851 (996)
T KOG0196|consen  788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD------VIKA-IEQGY---------  851 (996)
T ss_pred             cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH------HHHH-HHhcc---------
Confidence             122      34999999999999999999999999999988 999998766533      1111 11211         


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                       +.+.+.+++..|.+|++.||++|-.+||++.|++.+|..+.-+
T Consensus       852 -RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  852 -RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             -CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence             3345667888999999999999999999999999999887544

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1e-39  Score=333.97  Aligned_cols=238  Identities=24%  Similarity=0.390  Sum_probs=205.0

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccCH---HHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE---REFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||.||||+ ..+.+.||+|.+.+....+   +.+.+|+++++.++|||||.++++|+...+.++|+||+.+ 
T Consensus         7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-   85 (808)
T KOG0597|consen    7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-   85 (808)
T ss_pred             HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-
Confidence            4679999999999999 5678999999997765444   4588999999999999999999999999999999999987 


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC---
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST---  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~---  527 (663)
                      +|..++....     .++++.+..|+.++..||.|||+.+  |+|||+||.|||++..+.+|+||||+|+.+.....   
T Consensus        86 ~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt  158 (808)
T KOG0597|consen   86 DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT  158 (808)
T ss_pred             hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence            9999998543     5899999999999999999999998  99999999999999999999999999998877543   


Q ss_pred             -CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          528 -PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       528 -~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                       ..||+-|||||...+..|+..+|+||+||++||+.+|++||...      .+...++.+..+..            ..+
T Consensus       159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~v------------~~p  220 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDPV------------KPP  220 (808)
T ss_pred             eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCCC------------CCc
Confidence             35888899999999999999999999999999999999999752      23444444443321            122


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      ......+..++...+.+||.+|.|..+++.|=
T Consensus       221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp  252 (808)
T KOG0597|consen  221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGHP  252 (808)
T ss_pred             ccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence            34556778888899999999999999998764

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=334.76  Aligned_cols=254  Identities=22%  Similarity=0.303  Sum_probs=206.3

Q ss_pred             hhcccccccceEEEEEEecCCcEEEEEEecCc--ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          374 SAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDV--TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       374 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      ..++||+|-||+|.+++...+.+||||+++..  ....++|.+|+++|.+++||||++++|+|..++..++|+|||++|+
T Consensus       542 ~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGD  621 (807)
T KOG1094|consen  542 FKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGD  621 (807)
T ss_pred             hhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence            37899999999999999988899999999865  3345899999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCCCC-
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR-  530 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-  530 (663)
                      |.+++......   .+.-..-.+|+.|||.|++||.+..  ++||||.++|+|+|.++++||+|||+++-+-..+.... 
T Consensus       622 LnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq  696 (807)
T KOG1094|consen  622 LNQFLSAHELP---TAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ  696 (807)
T ss_pred             HHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence            99999865321   1345566779999999999999997  99999999999999999999999999986654443322 


Q ss_pred             -----CccccCccccCCCCCCCcchhhhHHHHHHHHHh--CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          531 -----VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT--GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       531 -----~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                           ...|||||.+..++++.++|||+||+++||+++  ...||....++.   .++-........... .+      .
T Consensus       697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~-~~------l  766 (807)
T KOG1094|consen  697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQ-VV------L  766 (807)
T ss_pred             cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCcc-ee------c
Confidence                 256999999999999999999999999999887  788997655432   111111111111111 00      1


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                      ..+.-++..+.+++.+||..+.++||+++++...|.+..
T Consensus       767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            123446678899999999999999999999999998753

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=362.16  Aligned_cols=259  Identities=26%  Similarity=0.403  Sum_probs=211.4

Q ss_pred             hcccccccceEEEEEEec--CCc----EEEEEEecCc--ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE--MGT----IVAVKRLKDV--TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~--~g~----~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      ...||+|.||.||.|...  +|.    .||||.++..  .....+|.+|..+|+.++|||||+++|+|.+....++++||
T Consensus       697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ley  776 (1025)
T KOG1095|consen  697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEY  776 (1025)
T ss_pred             eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehh
Confidence            468999999999999944  343    4999999876  44567899999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          447 LTMGSLSALLHGNKG--AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      |++|+|..+|+..+.  .+...+.....+.++.|||+|+.||++++  +|||||..+|+||+....+||+|||+|+..-.
T Consensus       777 M~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~  854 (1025)
T KOG1095|consen  777 MEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIADFGLARDIYD  854 (1025)
T ss_pred             cccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcccchhHhhhh
Confidence            999999999987532  22456899999999999999999999997  99999999999999999999999999995433


Q ss_pred             CCCC-C-----CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          525 SSTP-N-----RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       525 ~~~~-~-----~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                      .+.+ .     -...|||||.+..+.++.|+|||||||++||++| |..||....+.+      .+..+...+       
T Consensus       855 ~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~------v~~~~~~gg-------  921 (1025)
T KOG1095|consen  855 KDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE------VLLDVLEGG-------  921 (1025)
T ss_pred             chheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH------HHHHHHhCC-------
Confidence            2221 1     1245999999999999999999999999999999 888987644322      111222222       


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCCCC
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGL  652 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~  652 (663)
                          +.+.+..++..+.++|.+||+.+|++||++..+++.+..+...........
T Consensus       922 ----RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~  972 (1025)
T KOG1095|consen  922 ----RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGP  972 (1025)
T ss_pred             ----ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcccc
Confidence                223455677789999999999999999999999999988766654433333

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-39  Score=340.18  Aligned_cols=239  Identities=24%  Similarity=0.360  Sum_probs=204.5

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCc-cc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV-TI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~-~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      ++.||.|+.|.|-.|+ ..+|+.+|||++.+. +.   ....+.+|+-+|+.++|||++++++.|++..++|+|.||+++
T Consensus        17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g   96 (786)
T KOG0588|consen   17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG   96 (786)
T ss_pred             cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence            5679999999999999 578999999999765 22   246789999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC--
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST--  527 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--  527 (663)
                      |.|++++-..+     ++++....+.+.||+.|+.|+|..+  |+||||||+|+|+|..+.+||+|||+|..-.++..  
T Consensus        97 GELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLe  169 (786)
T KOG0588|consen   97 GELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLE  169 (786)
T ss_pred             chhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCCcccc
Confidence            99999987644     5888999999999999999999998  99999999999999999999999999988776643  


Q ss_pred             -CCCCccccCccccCCCCC-CCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          528 -PNRVAGYRAPEVTDPCKV-SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       528 -~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       ..|.+.|.|||++++..| +.++||||.|||||.|+||+.||++      .++...+..+.+..            ++.
T Consensus       170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD------dNir~LLlKV~~G~------------f~M  231 (786)
T KOG0588|consen  170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD------DNIRVLLLKVQRGV------------FEM  231 (786)
T ss_pred             ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC------ccHHHHHHHHHcCc------------ccC
Confidence             345566999999999887 5689999999999999999999974      34444444444432            223


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      +.....+..+|+.+|+..||++|.|++||.+|-
T Consensus       232 Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  232 PSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             CCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence            344455778888899999999999999999964

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-40  Score=335.53  Aligned_cols=239  Identities=26%  Similarity=0.427  Sum_probs=200.6

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhHh
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSAL  455 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~~  455 (663)
                      +-||.|+.|-||+|+++ ++.||||+++.-+      ..+|+-|++|+|+||+.+.|+|....-+++|||||..|-|..+
T Consensus       130 eWlGSGaQGAVF~Grl~-netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V  202 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH-NETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV  202 (904)
T ss_pred             hhhccCcccceeeeecc-CceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence            56999999999999988 7899999875422      3467789999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC---CCCCc
Q 006055          456 LHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST---PNRVA  532 (663)
Q Consensus       456 l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~---~~~~~  532 (663)
                      |+..     .++.-.....+..+||.|+.|||.+.  |||||||+-||||..+..+||+|||-++......+   ..+|.
T Consensus       203 Lka~-----~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTV  275 (904)
T KOG4721|consen  203 LKAG-----RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTV  275 (904)
T ss_pred             Hhcc-----CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhH
Confidence            9864     35788888899999999999999997  99999999999999999999999999988766543   34778


Q ss_pred             cccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHH
Q 006055          533 GYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQ  612 (663)
Q Consensus       533 ~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  612 (663)
                      .|||||++....+++|+||||||||||||+||..||.......          ++..      +....+..+.++.++..
T Consensus       276 aWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----------IIwG------VGsNsL~LpvPstcP~G  339 (904)
T KOG4721|consen  276 AWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----------IIWG------VGSNSLHLPVPSTCPDG  339 (904)
T ss_pred             hhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----------eEEe------ccCCcccccCcccCchH
Confidence            8999999999999999999999999999999999996432110          0100      01111223445677778


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          613 LLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       613 l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      +.-|+++||...|..||++.+++.||+-..+.
T Consensus       340 fklL~Kqcw~sKpRNRPSFrqil~HldIa~pe  371 (904)
T KOG4721|consen  340 FKLLLKQCWNSKPRNRPSFRQILLHLDIASPE  371 (904)
T ss_pred             HHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence            88889999999999999999999999866543

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=340.23  Aligned_cols=250  Identities=30%  Similarity=0.433  Sum_probs=205.1

Q ss_pred             hcccccccceEEEEEEecC--C--cE-EEEEEecCc----ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLEM--G--TI-VAVKRLKDV----TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~--g--~~-vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  445 (663)
                      .++||+|+||.||+|.++.  +  .. ||||..+..    ....++|.+|.++|+.++|||||+++|++...+..++|||
T Consensus       162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE  241 (474)
T KOG0194|consen  162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME  241 (474)
T ss_pred             cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence            3789999999999999543  2  23 899998852    2235789999999999999999999999999999999999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      +|.||+|.++|+..++    .++..++.+++.++|.||+|||+++  +|||||-++|+|++.++.+||+|||+++.-...
T Consensus       242 l~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~  315 (474)
T KOG0194|consen  242 LCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY  315 (474)
T ss_pred             ecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence            9999999999997653    5899999999999999999999998  999999999999999999999999998765422


Q ss_pred             CCC----CCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          526 STP----NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       526 ~~~----~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                      ...    .-...|+|||.+....++.++|||||||++||+.+ |..||.+..      ..+....+..+++...      
T Consensus       316 ~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~------~~~v~~kI~~~~~r~~------  383 (474)
T KOG0194|consen  316 VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK------NYEVKAKIVKNGYRMP------  383 (474)
T ss_pred             eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC------HHHHHHHHHhcCccCC------
Confidence            111    12356999999999999999999999999999999 888986543      2233333334333221      


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST  646 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~  646 (663)
                          .+...+.++..++.+||..+|++||+|.++.+.++.+.....
T Consensus       384 ----~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  384 ----IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             ----CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                122344567778889999999999999999999999866644

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=333.92  Aligned_cols=237  Identities=25%  Similarity=0.357  Sum_probs=197.0

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCc-----c-cCHHHHHHHHHHhhcCC-CCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV-----T-ISEREFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~-----~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.|+.|. ..+|+.||+|.+...     . ...+.+.+|+.+++.++ ||||+++++++......++||||
T Consensus        22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy  101 (370)
T KOG0583|consen   22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY  101 (370)
T ss_pred             eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence            4679999999999998 567899999976553     1 12456778999999999 99999999999999999999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC-CceEEeccccccccC-C
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS-YEARVSDFGLAHLVG-P  524 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~-~~~kl~Dfg~a~~~~-~  524 (663)
                      +.+|+|.+++....     .+.+....+++.|++.|++|||+++  |+||||||+|||+|.+ +++||+|||++.... .
T Consensus       102 ~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~  174 (370)
T KOG0583|consen  102 CSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAISPGE  174 (370)
T ss_pred             cCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccccCCC
Confidence            99999999998622     4788999999999999999999999  9999999999999999 999999999999883 3


Q ss_pred             C---CCCCCCccccCccccCCCC-CC-CcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          525 S---STPNRVAGYRAPEVTDPCK-VS-QKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       525 ~---~~~~~~~~y~aPE~~~~~~-~~-~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                      .   .+..|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.      .+.......+.....        
T Consensus       175 ~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d------~~~~~l~~ki~~~~~--------  240 (370)
T KOG0583|consen  175 DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD------SNVPNLYRKIRKGEF--------  240 (370)
T ss_pred             CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC------ccHHHHHHHHhcCCc--------
Confidence            2   3456788899999999877 75 789999999999999999999976      233333333332221        


Q ss_pred             hhcccChHHH-HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          600 LLRYQNVEEE-MVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       600 ~~~~~~~~~~-~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                          ..+... ..++..++.+|+..||.+|+|+.|+++
T Consensus       241 ----~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  241 ----KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ----cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                111111 457788888999999999999999994

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=346.36  Aligned_cols=248  Identities=23%  Similarity=0.308  Sum_probs=203.2

Q ss_pred             hcccccccceEEEEEEecCC-cEEEEEEecCc-ccCHHHHHHHHHHhhcCC-CCCcccceE-EEEe------cCccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLEMG-TIVAVKRLKDV-TISEREFKDKIEGVGAVN-HENLVPLRA-YYYS------MDEKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g-~~vavK~l~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~-~~~~------~~~~~lv~  444 (663)
                      .++|.+|||+.||.|....+ ..||+|++-.. +..-+.+.+|+++|+.|+ |+|||.+++ ....      .-+.+|.|
T Consensus        42 ~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLm  121 (738)
T KOG1989|consen   42 EKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLM  121 (738)
T ss_pred             EEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeeh
Confidence            57899999999999996555 99999998655 334577899999999996 999999999 3321      23578999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      |||.+|+|-+++....   ...|++.++++|+.++|+|+++||...|||||||||-+||||+.++..||||||.|.....
T Consensus       122 EyC~gg~Lvd~mn~Rl---q~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~  198 (738)
T KOG1989|consen  122 EYCKGGSLVDFMNTRL---QTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL  198 (738)
T ss_pred             hhccCCcHHHHHHHHH---hccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence            9999999999997543   2349999999999999999999999999999999999999999999999999999965433


Q ss_pred             CC-------------CCCCCccccCcccc---CCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHh
Q 006055          525 SS-------------TPNRVAGYRAPEVT---DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK  588 (663)
Q Consensus       525 ~~-------------~~~~~~~y~aPE~~---~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  588 (663)
                      ..             ....|+.|+|||.+   .+..+++|+|||+|||+||-|+....||+....               
T Consensus       199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------------  263 (738)
T KOG1989|consen  199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------------  263 (738)
T ss_pred             CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------------
Confidence            22             12357779999987   466789999999999999999999999975311               


Q ss_pred             hcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          589 DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                          ..+++-.+ .++....+...+.+||..||+.||++||++-+|++.+.++....
T Consensus       264 ----laIlng~Y-~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  264 ----LAILNGNY-SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             ----eeEEeccc-cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                11222111 22333567888999999999999999999999999999886554

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-39  Score=305.55  Aligned_cols=237  Identities=22%  Similarity=0.290  Sum_probs=195.5

Q ss_pred             cCHHHHHHHhhcccccccceEEEEEE-ecCCcEEEEEEecCcccC----HHHHHHHHHHhhcCCCCCcccceEEEEecCc
Q 006055          365 FDLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPLRAYYYSMDE  439 (663)
Q Consensus       365 ~~~~~l~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  439 (663)
                      +.+++..  +...||.|+||+|.+++ ..+|..+|+|++.....-    .+...+|..+++.+.||.++++++.|.+...
T Consensus        41 ~~l~dfe--~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~  118 (355)
T KOG0616|consen   41 YSLQDFE--RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN  118 (355)
T ss_pred             cchhhhh--heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence            5666663  35789999999999999 456899999999765322    3457789999999999999999999999999


Q ss_pred             cEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccc
Q 006055          440 KLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA  519 (663)
Q Consensus       440 ~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a  519 (663)
                      .++||||+++|.|.++++...     .+++.+++.+|.+|+.||+|||+.+  |++|||||+|||+|.+|.+||.|||+|
T Consensus       119 lymvmeyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFA  191 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFA  191 (355)
T ss_pred             EEEEEeccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccce
Confidence            999999999999999998644     5899999999999999999999998  999999999999999999999999999


Q ss_pred             cccCCCC-CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          520 HLVGPSS-TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       520 ~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                      +.+.... +..||+.|+|||++.+..+...+|.|||||++|||+.|.+||.....      ......++....       
T Consensus       192 K~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY~KI~~~~v-------  258 (355)
T KOG0616|consen  192 KRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIYEKILEGKV-------  258 (355)
T ss_pred             EEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHHHHHHhCcc-------
Confidence            9886653 34589999999999999999999999999999999999999976432      334444443321       


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCC
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNR  628 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~R  628 (663)
                           ..+.....++.+++...++.|-.+|
T Consensus       259 -----~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 -----KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -----cCCcccCHHHHHHHHHHHhhhhHhh
Confidence                 1122222345566667777777777

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7e-39  Score=298.00  Aligned_cols=253  Identities=25%  Similarity=0.369  Sum_probs=204.3

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecC-----ccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMD-----EKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~ey~  447 (663)
                      .+.||+|||+-||.++ ..++..+|+|++.... .+.+..++|++..++++|||+++++++...+.     +.|++++|.
T Consensus        26 ~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy  105 (302)
T KOG2345|consen   26 QRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYY  105 (302)
T ss_pred             eeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehh
Confidence            4679999999999999 7789999999998764 45678899999999999999999999875433     489999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC--
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--  525 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~--  525 (663)
                      ..|+|.+.+...... ...+++...+.|+.+|++||.+||+..|+++||||||.|||+.+++.+++.|||.++...-.  
T Consensus       106 ~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~  184 (302)
T KOG2345|consen  106 KRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIE  184 (302)
T ss_pred             ccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEee
Confidence            999999998765432 34689999999999999999999999999999999999999999999999999998765321  


Q ss_pred             -----------CCCCCCccccCccccCC---CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc
Q 006055          526 -----------STPNRVAGYRAPEVTDP---CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW  591 (663)
Q Consensus       526 -----------~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  591 (663)
                                 .....|.-|.|||.+.-   ...++++|||||||++|+|+.|..||+.... .|..+.-          
T Consensus       185 ~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSlaL----------  253 (302)
T KOG2345|consen  185 GSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLAL----------  253 (302)
T ss_pred             chHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEEE----------
Confidence                       11234666999999854   4678999999999999999999999986544 2222111          


Q ss_pred             cccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          592 TSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       592 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                        .+....+ ..+........+.+++..|++.||.+||++.+++.++..+.
T Consensus       254 --Av~n~q~-s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  254 --AVQNAQI-SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             --eeecccc-ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence              1111111 12222236678889999999999999999999999988763

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.3e-38  Score=326.02  Aligned_cols=254  Identities=22%  Similarity=0.325  Sum_probs=195.4

Q ss_pred             hcccccccceEEEEEEecC-----------------CcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLEM-----------------GTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYY  435 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~  435 (663)
                      .++||+|+||.||++.+++                 +..||+|.+.....  ...++.+|++++.+++||||+++++++.
T Consensus        10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   89 (304)
T cd05096          10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCV   89 (304)
T ss_pred             eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence            4679999999999997532                 34799999875422  2457899999999999999999999999


Q ss_pred             ecCccEEEEEccCCCChhHhhccCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCC
Q 006055          436 SMDEKLLVYDYLTMGSLSALLHGNKG--------------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSS  501 (663)
Q Consensus       436 ~~~~~~lv~ey~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~  501 (663)
                      +.+..++||||+++|+|.+++.....              .....++|....+++.||+.||.|||+.+  |+||||||+
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--ivH~dlkp~  167 (304)
T cd05096          90 DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATR  167 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--ccccCcchh
Confidence            99999999999999999999864321              11235788999999999999999999998  999999999


Q ss_pred             CEEEcCCCceEEeccccccccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh--CCCCCccccC
Q 006055          502 NILLTKSYEARVSDFGLAHLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT--GKAPTHALLN  573 (663)
Q Consensus       502 Nill~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt--g~~p~~~~~~  573 (663)
                      |||++.++.+||+|||+++.......      ...+..|+|||++.+..++.++||||||+++|||++  +..||.....
T Consensus       168 Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  247 (304)
T cd05096         168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD  247 (304)
T ss_pred             heEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCH
Confidence            99999999999999999986543321      223556999999988889999999999999999987  5567764321


Q ss_pred             CCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          574 EEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                      .   .....+.......... ..      ...+...+..+.+++.+||..||++|||++||.+.|++
T Consensus       248 ~---~~~~~~~~~~~~~~~~-~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         248 E---QVIENAGEFFRDQGRQ-VY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             H---HHHHHHHHHhhhcccc-cc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            1   1122222211111000 00      00112234578899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=324.44  Aligned_cols=238  Identities=25%  Similarity=0.389  Sum_probs=197.6

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      ++||+|.||.||+|. .++++.||+|++....  ....++++|+.++..++++||.++++.|..+...+++|||+.+|++
T Consensus        19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv   98 (467)
T KOG0201|consen   19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV   98 (467)
T ss_pred             hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence            579999999999999 6789999999987653  3356899999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----CCC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----STP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----~~~  528 (663)
                      .+.+....     .+++.....|..++..|+.|||.++  .+|||||+.|||+..+|.+|++|||.+..+...    .+.
T Consensus        99 ~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tf  171 (467)
T KOG0201|consen   99 LDLLKSGN-----ILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTF  171 (467)
T ss_pred             hhhhccCC-----CCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhhccccc
Confidence            99998644     3467777778889999999999998  999999999999999999999999999776543    445


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .+|+.|||||++....|+.|+||||||++.+||.+|.+|+.........-+       +.+.     .-|.     ....
T Consensus       172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------Ipk~-----~PP~-----L~~~  234 (467)
T KOG0201|consen  172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------IPKS-----APPR-----LDGD  234 (467)
T ss_pred             cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------ccCC-----CCCc-----cccc
Confidence            688899999999998999999999999999999999999865432110000       0000     0000     1114


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....+.+++..|+.+||+.||++.+++++
T Consensus       235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  235 FSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            45568888889999999999999999875

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-38  Score=294.50  Aligned_cols=250  Identities=24%  Similarity=0.325  Sum_probs=206.2

Q ss_pred             cccCHHHHHHHhhcccccccceEEEEEE-ecCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEec
Q 006055          363 RVFDLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSM  437 (663)
Q Consensus       363 ~~~~~~~l~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  437 (663)
                      ..++++++  ..++.||+|-||.||.|. .+++-.||+|++.+..    ..+.++.+|+++-+.|+||||++++++|.+.
T Consensus        17 ~~~~l~df--eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~   94 (281)
T KOG0580|consen   17 KTWTLDDF--EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS   94 (281)
T ss_pred             cccchhhc--cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence            34666666  447899999999999999 5678899999997653    2367899999999999999999999999999


Q ss_pred             CccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccc
Q 006055          438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFG  517 (663)
Q Consensus       438 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg  517 (663)
                      ...||++||...|+++..|+...   ...+++.....+..|+|.|+.|+|..+  ||||||||+|+|++.++..||+|||
T Consensus        95 ~riyLilEya~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfG  169 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFG  169 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCC
Confidence            99999999999999999998544   235778888889999999999999987  9999999999999999999999999


Q ss_pred             cccccCCC--CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccc
Q 006055          518 LAHLVGPS--STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV  595 (663)
Q Consensus       518 ~a~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  595 (663)
                      .+......  .+..+|..|.+||...+..++..+|+|++|++.||++.|.+||.....+      +..+.+.+..    .
T Consensus       170 wsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~------etYkrI~k~~----~  239 (281)
T KOG0580|consen  170 WSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS------ETYKRIRKVD----L  239 (281)
T ss_pred             ceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH------HHHHHHHHcc----c
Confidence            98665422  3345777799999999999999999999999999999999999764421      1122222111    1


Q ss_pred             cchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       596 ~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .+        ++....+..+++.+|+..+|.+|.+..|++++
T Consensus       240 ~~--------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  240 KF--------PSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             cC--------CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            11        12233466788889999999999999999985

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9.9e-38  Score=333.09  Aligned_cols=249  Identities=24%  Similarity=0.417  Sum_probs=197.0

Q ss_pred             hcccccccceEEEEEEe------cCCcEEEEEEecCccc--CHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  445 (663)
                      .++||+|+||.||+|..      .++..||||+++....  ..+.+.+|+.++..+ +||||++++++|.+....++|||
T Consensus        40 ~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E  119 (375)
T cd05104          40 GKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITE  119 (375)
T ss_pred             hheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeeh
Confidence            67899999999999963      2466899999875432  245688999999999 89999999999999999999999


Q ss_pred             ccCCCChhHhhccCCCC---------------------------------------------------------------
Q 006055          446 YLTMGSLSALLHGNKGA---------------------------------------------------------------  462 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~---------------------------------------------------------------  462 (663)
                      |+++|+|.++++.....                                                               
T Consensus       120 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (375)
T cd05104         120 YCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDV  199 (375)
T ss_pred             hccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceeccccc
Confidence            99999999998653210                                                               


Q ss_pred             -------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC------CC
Q 006055          463 -------GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST------PN  529 (663)
Q Consensus       463 -------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~  529 (663)
                             ....++|..+..++.||+.||.|||+.+  |+||||||+|||+++++.+||+|||+++.......      ..
T Consensus       200 ~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~  277 (375)
T cd05104         200 TSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR  277 (375)
T ss_pred             HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCC
Confidence                   1125789999999999999999999998  99999999999999999999999999986643321      12


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .+..|+|||.+.+..++.++|||||||++|||++ |..||.......     .. ...+.......          .+..
T Consensus       278 ~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-----~~-~~~~~~~~~~~----------~~~~  341 (375)
T cd05104         278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-----KF-YKMIKEGYRML----------SPEC  341 (375)
T ss_pred             CCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-----HH-HHHHHhCccCC----------CCCC
Confidence            2346999999999899999999999999999998 888886532111     11 11122211100          0111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                      ...++.+++.+|+..||++||++.||+++|++.
T Consensus       342 ~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         342 APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            234688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4e-38  Score=329.64  Aligned_cols=237  Identities=22%  Similarity=0.289  Sum_probs=192.8

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      ++||+|+||.||++.. .+|+.||+|.++....    ....+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999984 5789999999875421    2245778999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----C
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----S  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----~  526 (663)
                      +|.+++....     .+++.....++.||+.||+|||+.+  |+||||||+||+++.++.+||+|||+++.....    .
T Consensus        81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  153 (323)
T cd05571          81 ELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK  153 (323)
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence            9999987532     5889999999999999999999998  999999999999999999999999998754222    1


Q ss_pred             CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+.....            ..+
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~------~~~~~~~~~~~~~------------~~p  215 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HEKLFELILMEEI------------RFP  215 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC------HHHHHHHHHcCCC------------CCC
Confidence            2346778999999999899999999999999999999999996421      1122222211110            011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                      .....++.+++.+|+..||++||     ++.+++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            12334677888899999999999     79998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.6e-37  Score=312.43  Aligned_cols=241  Identities=25%  Similarity=0.385  Sum_probs=199.3

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|+||.||++.++++..+|+|.++........+.+|+++++.++||||+++++++......++||||+++|+|.+
T Consensus         9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~   88 (256)
T cd05114           9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN   88 (256)
T ss_pred             eeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHH
Confidence            36799999999999998888899999988666667889999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-----CC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~~  529 (663)
                      +++...    ..+++..+..++.+++.||.|||+.+  |+||||||+||++++++.+||+|||.++.......     ..
T Consensus        89 ~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05114          89 YLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAK  162 (256)
T ss_pred             HHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCC
Confidence            997533    24889999999999999999999998  99999999999999999999999999876543221     12


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      ++..|+|||++.+..++.++||||||+++|||++ |+.||....      ....+..+.......   .        +..
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~------~~~~~~~i~~~~~~~---~--------~~~  225 (256)
T cd05114         163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS------NYEVVEMISRGFRLY---R--------PKL  225 (256)
T ss_pred             CchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHHCCCCCC---C--------CCC
Confidence            2346999999988889999999999999999999 899986432      222233322221110   0        111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      ...++.+++.+||..+|++||+++|+++.|
T Consensus       226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            234678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-38  Score=320.60  Aligned_cols=242  Identities=32%  Similarity=0.534  Sum_probs=190.1

Q ss_pred             hcccccccceEEEEEEec-----CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVLE-----MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||.|.||.||+|.+.     .+..|+||.++....  ..+.+.+|++.+++++||||++++|++...+..++||||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            367999999999999976     367899999965422  2578999999999999999999999999888899999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-  526 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-  526 (663)
                      ++|+|.++++...   ...+++..+..|+.|||+||.|||+.+  ++|+||+++||+++.++.+||+|||+++...... 
T Consensus        84 ~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   84 PGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc---ccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence            9999999998752   345899999999999999999999998  9999999999999999999999999998773221 


Q ss_pred             -----CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          527 -----TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       527 -----~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                           .......|+|||.+....++.++||||||+++|||++ |+.||...      +.......+..... .       
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~------~~~~~~~~~~~~~~-~-------  224 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY------DNEEIIEKLKQGQR-L-------  224 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS------CHHHHHHHHHTTEE-T-------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc------cccccccccccccc-c-------
Confidence                 1224456999999988889999999999999999999 77887543      22233333322211 1       


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                         .........+.+++..||+.+|++||+++++++.|
T Consensus       225 ---~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 ---PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ---TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ---eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence               11122344688899999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.5e-37  Score=314.60  Aligned_cols=244  Identities=22%  Similarity=0.378  Sum_probs=196.6

Q ss_pred             hcccccccceEEEEEEec----CCcEEEEEEecCcccC--HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLE----MGTIVAVKRLKDVTIS--EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|.+.    .+..||+|.++.....  ...+.+|+.++..++||||+++++++...+..++||||++
T Consensus        10 ~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   89 (266)
T cd05064          10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMS   89 (266)
T ss_pred             eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCC
Confidence            467999999999999743    4678999998765322  3568899999999999999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-  527 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  527 (663)
                      +|+|.+++....    ..+++..++.++.|++.||+|||+.+  ++||||||+||+++.++.++++|||.+........ 
T Consensus        90 ~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~  163 (266)
T cd05064          90 NGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY  163 (266)
T ss_pred             CCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence            999999997532    35899999999999999999999998  99999999999999999999999998765432211 


Q ss_pred             ----CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          528 ----PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       528 ----~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                          ...+..|+|||.+.+..++.++|||||||++||+++ |+.||.....      ...+..+ .+...          
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~------~~~~~~~-~~~~~----------  226 (266)
T cd05064         164 TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG------QDVIKAV-EDGFR----------  226 (266)
T ss_pred             cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHH-HCCCC----------
Confidence                123456999999998899999999999999999775 9999965321      1222222 11110          


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                      ...+...+..+.+++.+||..+|++||+++|+.+.|.++
T Consensus       227 ~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            011223445688899999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-37  Score=320.55  Aligned_cols=244  Identities=23%  Similarity=0.271  Sum_probs=195.2

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||++. ..+|+.||||.+....    .....+.+|+.++..++|+|++++++++.+.+..++||||+++
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05631           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG   84 (285)
T ss_pred             EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence            3679999999999998 4679999999986542    2234578899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++....   ...+++..+..++.|++.||+|||+.+  |+||||||+|||+++++.+||+|||++.......   
T Consensus        85 g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05631          85 GDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR  159 (285)
T ss_pred             CcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence            99998876432   235899999999999999999999998  9999999999999999999999999998754332   


Q ss_pred             CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||.......   ....+........           ....
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~-----------~~~~  225 (285)
T cd05631         160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV---KREEVDRRVKEDQ-----------EEYS  225 (285)
T ss_pred             CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch---hHHHHHHHhhccc-----------ccCC
Confidence            2346778999999999999999999999999999999999997543211   1111111111100           0111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPS-----MSEVIKR  637 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt-----~~ev~~~  637 (663)
                      .....++.+++.+|+..||++||+     ++|++++
T Consensus       226 ~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         226 EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            123346778899999999999997     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.3e-37  Score=313.10  Aligned_cols=245  Identities=28%  Similarity=0.425  Sum_probs=201.0

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .+.||+|+||.||+|.. ++++.||+|.++.......++.+|+++++.++|+||+++++++......++||||+++++|.
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   90 (263)
T cd05052          11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL   90 (263)
T ss_pred             eeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHH
Confidence            46799999999999994 46899999998866555678899999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-----C
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----P  528 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~  528 (663)
                      +++....   ...+++..++.++.|++.||+|||+.+  ++||||||+||++++++.+||+|||++........     .
T Consensus        91 ~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~  165 (263)
T cd05052          91 DYLRECN---RQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  165 (263)
T ss_pred             HHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCC
Confidence            9987533   245899999999999999999999998  99999999999999999999999999987654321     1


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..+..|+|||++.+..++.++|||||||++|||++ |..||...      +.......... ...          ...+.
T Consensus       166 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~------~~~~~~~~~~~-~~~----------~~~~~  228 (263)
T cd05052         166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK-GYR----------MERPE  228 (263)
T ss_pred             CCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHHHC-CCC----------CCCCC
Confidence            12456999999998889999999999999999998 89998642      22222222211 110          01112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                      ..+.++.+++.+|+..+|++||++.+++++|+++
T Consensus       229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            2345688899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-38  Score=311.33  Aligned_cols=238  Identities=24%  Similarity=0.375  Sum_probs=202.8

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccC----HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|.||.|-+|. ...|+.||||.+++....    --.+.+|+++|..++||||+.++++|.+.+...+||||..+
T Consensus        58 ~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~  137 (668)
T KOG0611|consen   58 TETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASG  137 (668)
T ss_pred             HHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCC
Confidence            5679999999999998 578999999999876433    24588999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |.|++++....     .+++.....++.||..|+.|+|.++  ++|||||-+|||+|.++++||+|||++..+....   
T Consensus       138 GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq  210 (668)
T KOG0611|consen  138 GELYDYISERG-----SLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ  210 (668)
T ss_pred             ccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhccccHHH
Confidence            99999998644     5899999999999999999999998  9999999999999999999999999998887654   


Q ss_pred             CCCCCccccCccccCCCCC-CCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 TPNRVAGYRAPEVTDPCKV-SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      +..+++-|.+||++++..| +..+|.||+||+||-|+.|..||++      .+....++++-...+.+         .. 
T Consensus       211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG------~Dhk~lvrQIs~GaYrE---------P~-  274 (668)
T KOG0611|consen  211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG------RDHKRLVRQISRGAYRE---------PE-  274 (668)
T ss_pred             HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC------chHHHHHHHhhcccccC---------CC-
Confidence            3446666999999999887 5679999999999999999999965      44555666655544311         11 


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                         .+.+.--+|++|+..+|++|.|+++|..|-
T Consensus       275 ---~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  275 ---TPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             ---CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence               122445677899999999999999999875

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-37  Score=311.51  Aligned_cols=245  Identities=27%  Similarity=0.425  Sum_probs=202.1

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|++|.||+|...+++.||+|.++......+++.+|+.++++++|+|++++++++...+..++||||+++++|.+
T Consensus        11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   90 (261)
T cd05068          11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLE   90 (261)
T ss_pred             EEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHH
Confidence            46899999999999998778899999998766667889999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC--CCC--
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST--PNR--  530 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~--  530 (663)
                      ++....   ...+++..+..++.+++.|+.|||+.+  |+||||||+||++++++.+||+|||+++.......  ..+  
T Consensus        91 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  165 (261)
T cd05068          91 YLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAK  165 (261)
T ss_pred             HHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCc
Confidence            997543   235899999999999999999999998  99999999999999999999999999987653321  111  


Q ss_pred             -CccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          531 -VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       531 -~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                       ...|+|||++.+..++.++||||||++++||++ |+.||....      .......+. ....          ......
T Consensus       166 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------~~~~~~~~~-~~~~----------~~~~~~  228 (261)
T cd05068         166 FPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT------NAEVLQQVD-QGYR----------MPCPPG  228 (261)
T ss_pred             CceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHH-cCCC----------CCCCCc
Confidence             236999999998889999999999999999999 999986432      111111111 1110          011122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                      ....+.+++.+|+..+|++||+++++++.|+++
T Consensus       229 ~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         229 CPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            345788899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.2e-37  Score=316.62  Aligned_cols=248  Identities=27%  Similarity=0.432  Sum_probs=198.7

Q ss_pred             hcccccccceEEEEEEecC------CcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLEM------GTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|....      ...||+|.++....  ....+.+|+..+..++||||+++++++......+++|||
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~   89 (283)
T cd05048          10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEY   89 (283)
T ss_pred             hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEec
Confidence            5789999999999998532      25799999875432  245688999999999999999999999988899999999


Q ss_pred             cCCCChhHhhccCCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEec
Q 006055          447 LTMGSLSALLHGNKGAGR-----------TPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSD  515 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~D  515 (663)
                      +++|+|.+++........           ..+++.....++.|++.||.|||+.+  ++||||||+||++++++.+||+|
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~~~~~~L~d  167 (283)
T cd05048          90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISD  167 (283)
T ss_pred             CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcCCCcEEECC
Confidence            999999999975432111           45889999999999999999999998  99999999999999999999999


Q ss_pred             cccccccCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHh
Q 006055          516 FGLAHLVGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVK  588 (663)
Q Consensus       516 fg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  588 (663)
                      ||+++......      ...++..|+|||++.+..++.++|||||||++|||++ |..||.....      ......+. 
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~------~~~~~~i~-  240 (283)
T cd05048         168 FGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN------QEVIEMIR-  240 (283)
T ss_pred             CcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHH-
Confidence            99997653322      1223456999999988889999999999999999998 9999865322      11222211 


Q ss_pred             hcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          589 DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                      .....          ..+...+.++.+++.+||+.||++||++.||+++|+.+
T Consensus       241 ~~~~~----------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         241 SRQLL----------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             cCCcC----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            11111          11233456788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.8e-37  Score=311.46  Aligned_cols=245  Identities=24%  Similarity=0.422  Sum_probs=201.1

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .++||+|+||.||+|...++..||+|.+.......+.+.+|+.+++.++|+||+++++++.+.+..++||||+++|+|.+
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   90 (261)
T cd05072          11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLD   90 (261)
T ss_pred             eeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHH
Confidence            46899999999999998888999999987665566789999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-----CC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~~  529 (663)
                      +++...   ...+++..+..++.+++.||+|||+.+  ++||||||+||++++++.++|+|||+++.......     ..
T Consensus        91 ~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  165 (261)
T cd05072          91 FLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAK  165 (261)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCc
Confidence            997543   235788999999999999999999998  99999999999999999999999999987654221     12


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      ++..|+|||++.+..++.++|||||||++|||++ |+.||.....      ......+ ......          +....
T Consensus       166 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~------~~~~~~~-~~~~~~----------~~~~~  228 (261)
T cd05072         166 FPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN------SDVMSAL-QRGYRM----------PRMEN  228 (261)
T ss_pred             cceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH------HHHHHHH-HcCCCC----------CCCCC
Confidence            3456999999988888999999999999999998 9999864321      1111111 111110          11112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                      ...++.+++.+|+..+|++||+++++.+.|+++
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         229 CPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            334678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.1e-37  Score=319.63  Aligned_cols=241  Identities=24%  Similarity=0.326  Sum_probs=192.1

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccC----HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      ..+||+|+||+||+|+ ..+|..+|+|++++...-    .+.+..|..+|....+|.||+++-.|.+.+.+||||||++|
T Consensus       146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG  225 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG  225 (550)
T ss_pred             heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence            4789999999999999 557999999999877432    35688899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC-----
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP-----  524 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~-----  524 (663)
                      |++..+|....     .+++......+.+++.|++-+|+.|  +|||||||+|+|||..|++||+|||++.....     
T Consensus       226 GD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~  298 (550)
T KOG0605|consen  226 GDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE  298 (550)
T ss_pred             ccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence            99999998643     6889999999999999999999999  99999999999999999999999999842100     


Q ss_pred             -----------------C--C---------------------------CCCCCccccCccccCCCCCCCcchhhhHHHHH
Q 006055          525 -----------------S--S---------------------------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLL  558 (663)
Q Consensus       525 -----------------~--~---------------------------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl  558 (663)
                                       .  .                           +..||+.|||||++.+..|+..+|+||+|||+
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im  378 (550)
T KOG0605|consen  299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM  378 (550)
T ss_pred             hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence                             0  0                           01256669999999999999999999999999


Q ss_pred             HHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCC---HHHHH
Q 006055          559 LELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPS---MSEVI  635 (663)
Q Consensus       559 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt---~~ev~  635 (663)
                      |||+.|.+||......      ...+.+..-..        -+.++...+...+..++|.+|+. ||++|.-   ++||.
T Consensus       379 yEmLvGyPPF~s~tp~------~T~rkI~nwr~--------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK  443 (550)
T KOG0605|consen  379 YEMLVGYPPFCSETPQ------ETYRKIVNWRE--------TLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK  443 (550)
T ss_pred             HHHHhCCCCCCCCCHH------HHHHHHHHHhh--------hccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence            9999999999864322      22222221110        00111122233566777788887 9999975   66666


Q ss_pred             HH
Q 006055          636 KR  637 (663)
Q Consensus       636 ~~  637 (663)
                      +|
T Consensus       444 ~H  445 (550)
T KOG0605|consen  444 KH  445 (550)
T ss_pred             cC
Confidence            54

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.5e-37  Score=331.43  Aligned_cols=251  Identities=24%  Similarity=0.384  Sum_probs=197.1

Q ss_pred             hhcccccccceEEEEEEe------cCCcEEEEEEecCcccC--HHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEE
Q 006055          374 SAEVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTIS--EREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVY  444 (663)
Q Consensus       374 ~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  444 (663)
                      ..+.||+|+||.||+|..      .++..||||+++.....  ...+.+|+++++.+ +|+||++++++|......++||
T Consensus        42 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~  121 (374)
T cd05106          42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVIT  121 (374)
T ss_pred             ehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeH
Confidence            467899999999999873      23457999999764322  34688999999999 8999999999999999999999


Q ss_pred             EccCCCChhHhhccCCC---------------------------------------------------------------
Q 006055          445 DYLTMGSLSALLHGNKG---------------------------------------------------------------  461 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~---------------------------------------------------------------  461 (663)
                      ||+++|+|.++++....                                                               
T Consensus       122 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (374)
T cd05106         122 EYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEE  201 (374)
T ss_pred             hhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchh
Confidence            99999999999864210                                                               


Q ss_pred             --CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC------CCCCcc
Q 006055          462 --AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST------PNRVAG  533 (663)
Q Consensus       462 --~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~  533 (663)
                        ....++++....+++.||+.||.|||+.+  |+||||||+||++++++.+||+|||+++.......      ..++..
T Consensus       202 ~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~  279 (374)
T cd05106         202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK  279 (374)
T ss_pred             ccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccc
Confidence              01235788999999999999999999998  99999999999999999999999999976543221      122346


Q ss_pred             ccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHH
Q 006055          534 YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQ  612 (663)
Q Consensus       534 y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  612 (663)
                      |+|||++.+..++.++|||||||++|||++ |+.||.......      .............          .+.....+
T Consensus       280 y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~~~~~----------~~~~~~~~  343 (374)
T cd05106         280 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRGYQMS----------RPDFAPPE  343 (374)
T ss_pred             eeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHcccCcc----------CCCCCCHH
Confidence            999999988889999999999999999997 999997532211      1111111111000          00112346


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          613 LLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       613 l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                      +.+++.+||..||++|||+.+|++.|+++.
T Consensus       344 l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         344 IYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            788899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-37  Score=307.95  Aligned_cols=255  Identities=27%  Similarity=0.396  Sum_probs=196.5

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhc--CCCCCcccceEEEEec----CccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGA--VNHENLVPLRAYYYSM----DEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~~lv~ey~~  448 (663)
                      .+.||+|.||+||+|.|+ |+.||||+|...+  ++.+.+|.++++.  ++|+||..+++.=..+    .+++||++|.+
T Consensus       216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe  292 (513)
T KOG2052|consen  216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE  292 (513)
T ss_pred             EEEecCccccceeecccc-CCceEEEEecccc--hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence            468999999999999998 9999999997543  4556666666554  6999999999874322    35799999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-----cC-CcceecCCCCCCEEEcCCCceEEecccccccc
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA-----QG-PNVSHGNIKSSNILLTKSYEARVSDFGLAHLV  522 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-----~~-~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~  522 (663)
                      +|||+|+|...      .++....++++..+|.||+|||.     +| |.|.|||||+.|||+..++...|+|+|+|...
T Consensus       293 ~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h  366 (513)
T KOG2052|consen  293 HGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  366 (513)
T ss_pred             CCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence            99999999853      48999999999999999999994     34 88999999999999999999999999999766


Q ss_pred             CCCC--------CCCCCccccCccccCCCC------CCCcchhhhHHHHHHHHHhC----------CCCCccccCCCCCC
Q 006055          523 GPSS--------TPNRVAGYRAPEVTDPCK------VSQKADVYSFGVLLLELLTG----------KAPTHALLNEEGVD  578 (663)
Q Consensus       523 ~~~~--------~~~~~~~y~aPE~~~~~~------~~~~~Dv~slGvvl~elltg----------~~p~~~~~~~~~~~  578 (663)
                      ....        ...||..|||||++...-      --..+||||||+|+||+.-+          +.||++....+ ..
T Consensus       367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D-Ps  445 (513)
T KOG2052|consen  367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD-PS  445 (513)
T ss_pred             cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC-CC
Confidence            5442        234677899999986532      12358999999999999863          34666544332 11


Q ss_pred             hHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          579 LPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       579 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      ..+ ++.+    .-.+.+.|.+.+.....+.+..+.+++..||..+|..|-|+-.+.+.|.++...
T Consensus       446 ~ee-MrkV----VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  446 FEE-MRKV----VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             HHH-Hhcc----eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            111 1111    111122233334445567889999999999999999999999999999988653

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=324.32  Aligned_cols=235  Identities=23%  Similarity=0.292  Sum_probs=190.6

Q ss_pred             cccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          378 LGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       378 lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      ||+|+||.||++.. .+++.||+|.++...    .....+.+|++++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999995 468899999986532    2235678899999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----CC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----TP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~~  528 (663)
                      .+++....     .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++......    ..
T Consensus        81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  153 (312)
T cd05585          81 FHHLQREG-----RFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF  153 (312)
T ss_pred             HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence            99997532     4889999999999999999999998  9999999999999999999999999997643221    23


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .++..|+|||++.+..++.++|||||||++|||++|+.||...      +.......+.....            ..+..
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~------~~~~~~~~~~~~~~------------~~~~~  215 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE------NVNEMYRKILQEPL------------RFPDG  215 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC------CHHHHHHHHHcCCC------------CCCCc
Confidence            4677899999999989999999999999999999999999642      22233333332211            01112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPS---MSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt---~~ev~~~  637 (663)
                      ...++.+++.+|+..||++||+   +.|++.+
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            2345778888999999999985   5666554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-38  Score=321.98  Aligned_cols=238  Identities=20%  Similarity=0.228  Sum_probs=195.2

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|.. .+|+.||+|.+....    .....+.+|+++++.++||||+++++++.+....++||||+++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   85 (291)
T cd05612           6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPG   85 (291)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCC
Confidence            36799999999999995 468999999986432    1245688899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-CC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-TP  528 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~  528 (663)
                      |+|.+++....     .+++.....++.|++.||+|||+++  |+||||||+||+++.++.+||+|||+++...... ..
T Consensus        86 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~  158 (291)
T cd05612          86 GELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL  158 (291)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCCcccc
Confidence            99999997532     4889999999999999999999998  9999999999999999999999999998765432 23


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .++..|+|||++.+..++.++|||||||++|||++|+.||...      +.......+.....            ..+..
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~------~~~~~~~~i~~~~~------------~~~~~  220 (291)
T cd05612         159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD------NPFGIYEKILAGKL------------EFPRH  220 (291)
T ss_pred             cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCc------------CCCcc
Confidence            4677899999999888999999999999999999999999643      22222333322211            00111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPS-----MSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt-----~~ev~~~  637 (663)
                      ....+.+++.+|+..||.+||+     ++|++++
T Consensus       221 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         221 LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            2335778888999999999995     8888876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-37  Score=309.42  Aligned_cols=258  Identities=26%  Similarity=0.414  Sum_probs=195.0

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhh--cCCCCCcccceEEEEecC----ccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVG--AVNHENLVPLRAYYYSMD----EKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~----~~~lv~ey~~~  449 (663)
                      ++||+|+||.||||.+. ++.||||++...  ....|..|-++++  .++|+||++++++-....    +++||+||.+.
T Consensus       216 eli~~Grfg~V~KaqL~-~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k  292 (534)
T KOG3653|consen  216 ELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK  292 (534)
T ss_pred             HHhhcCccceeehhhcc-CceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence            67999999999999987 699999998643  3456777777755  469999999999865444    78999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------CcceecCCCCCCEEEcCCCceEEecccccccc
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG-------PNVSHGNIKSSNILLTKSYEARVSDFGLAHLV  522 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-------~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~  522 (663)
                      |+|.++|..+      .++|....+|+..+++||+|||+.-       |+|+|||||+.||||..|+++.|+|||+|..+
T Consensus       293 GsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~  366 (534)
T KOG3653|consen  293 GSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL  366 (534)
T ss_pred             CcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence            9999999864      4899999999999999999999632       78999999999999999999999999999887


Q ss_pred             CCCCC------CCCCccccCccccCCCC-CC-----CcchhhhHHHHHHHHHhCCCCCcc--------ccCCC---CCCh
Q 006055          523 GPSST------PNRVAGYRAPEVTDPCK-VS-----QKADVYSFGVLLLELLTGKAPTHA--------LLNEE---GVDL  579 (663)
Q Consensus       523 ~~~~~------~~~~~~y~aPE~~~~~~-~~-----~~~Dv~slGvvl~elltg~~p~~~--------~~~~~---~~~~  579 (663)
                      .+...      ..||..|||||++.+.. ..     .+.||||+|.|+|||+++...++.        .++.+   ...+
T Consensus       367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~  446 (534)
T KOG3653|consen  367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL  446 (534)
T ss_pred             cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence            65432      44778899999987642 11     358999999999999997654431        11111   1122


Q ss_pred             HHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 006055          580 PRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ  647 (663)
Q Consensus       580 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~  647 (663)
                      .+.-.-+.++..-..+.|     ...-...+..+.+.+..||+.||+.|.|+.=|-+.+.++....+.
T Consensus       447 e~mq~~VV~kK~RP~~p~-----~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  447 EEMQELVVRKKQRPKIPD-----AWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             HHHHHHHHhhccCCCChh-----hhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence            222222222222111111     111124456778888899999999999999999999988665543

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.7e-37  Score=325.55  Aligned_cols=237  Identities=21%  Similarity=0.290  Sum_probs=192.9

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      +.||+|+||.||++. ..+|+.||+|.+....    .....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            369999999999998 4578999999987542    22356788999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----C
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----S  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----~  526 (663)
                      +|.+++....     .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.....    .
T Consensus        81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  153 (328)
T cd05593          81 ELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK  153 (328)
T ss_pred             CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence            9999886532     5889999999999999999999998  999999999999999999999999998764322    1


Q ss_pred             CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+.....            ..+
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~------~~~~~~~~~~~~~------------~~p  215 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HEKLFELILMEDI------------KFP  215 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC------HHHHHHHhccCCc------------cCC
Confidence            2346778999999998889999999999999999999999996422      1222222211110            001


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                      .....++.+++.+|+..||++||     ++.|++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            12234677888899999999997     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.9e-37  Score=324.56  Aligned_cols=237  Identities=23%  Similarity=0.295  Sum_probs=192.1

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      +.||+|+||.||++.. .+|+.||+|.++...    .....+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3699999999999984 578999999987542    12345678999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----  526 (663)
                      +|..++....     .+++..+..++.|++.||.|||+++  |+||||||+|||++.++.+||+|||+++......    
T Consensus        81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  153 (323)
T cd05595          81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK  153 (323)
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence            9999886532     4889999999999999999999998  9999999999999999999999999987543221    


Q ss_pred             CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+.....            ..+
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~------~~~~~~~~~~~~~------------~~p  215 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HERLFELILMEEI------------RFP  215 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHhcCCC------------CCC
Confidence            2346778999999998889999999999999999999999996432      1122222221110            001


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                      .....++.+++.+|+..||++||     ++.+++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            12234677888899999999998     88888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-37  Score=325.66  Aligned_cols=238  Identities=21%  Similarity=0.272  Sum_probs=194.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|.. .+|+.||+|.++...    .....+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus        23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  102 (329)
T PTZ00263         23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVG  102 (329)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCC
Confidence            46899999999999995 468999999987542    1235688999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-CC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-TP  528 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~  528 (663)
                      |+|.+++....     .+++.....++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++...... ..
T Consensus       103 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  175 (329)
T PTZ00263        103 GELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL  175 (329)
T ss_pred             ChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCCCccee
Confidence            99999997532     4788899999999999999999998  9999999999999999999999999998765432 23


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+.....     .  .     +..
T Consensus       176 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~~~i~~~~~-----~--~-----p~~  237 (329)
T PTZ00263        176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT------PFRIYEKILAGRL-----K--F-----PNW  237 (329)
T ss_pred             cCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC------HHHHHHHHhcCCc-----C--C-----CCC
Confidence            46778999999999889999999999999999999999996421      1222222222110     0  0     011


Q ss_pred             HHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPS-----MSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt-----~~ev~~~  637 (663)
                      ...++.+++.+|+..||++||+     +++++.|
T Consensus       238 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        238 FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            2235678888999999999997     6888765

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.2e-37  Score=326.97  Aligned_cols=238  Identities=22%  Similarity=0.349  Sum_probs=187.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .++||+|+||.||+|.. .+|+.||||.+.....  ....+.+|+++++.++|+||+++++++...+..++||||+++|+
T Consensus        79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  158 (353)
T PLN00034         79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS  158 (353)
T ss_pred             hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence            47899999999999994 4789999999865432  24678899999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----CC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----ST  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----~~  527 (663)
                      |.+..         ...+.....++.||+.||.|||+.+  |+||||||+|||+++++.+||+|||+++.....    ..
T Consensus       159 L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  227 (353)
T PLN00034        159 LEGTH---------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNS  227 (353)
T ss_pred             ccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecccccccccc
Confidence            86532         2456778889999999999999998  999999999999999999999999999865432    22


Q ss_pred             CCCCccccCccccCC-----CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          528 PNRVAGYRAPEVTDP-----CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~-----~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                      ..++..|+|||++..     ...+.++|||||||++|||++|+.||......   +.......+.....           
T Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~-----------  293 (353)
T PLN00034        228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG---DWASLMCAICMSQP-----------  293 (353)
T ss_pred             cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---cHHHHHHHHhccCC-----------
Confidence            356778999998743     23456899999999999999999999732211   11111111111100           


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .........++.+++.+||..||++||++.|++++
T Consensus       294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00111234468888999999999999999999996

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2e-37  Score=299.51  Aligned_cols=249  Identities=25%  Similarity=0.316  Sum_probs=194.9

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEe--cCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYS--MDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ey~~  448 (663)
                      .+.|++|+||.||+|+ .++++.||+|+++-....   .--..+||.++.+.+|||||.+..+...  -+..|+|||||+
T Consensus        81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E  160 (419)
T KOG0663|consen   81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE  160 (419)
T ss_pred             HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence            5789999999999999 668999999999765322   2346799999999999999999998764  356899999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-  527 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  527 (663)
                      . +|..+++..+    +++...+..-+..|+++|++|||...  |+|||||++|+|++..|.+||+|||+|+.++.... 
T Consensus       161 h-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~  233 (419)
T KOG0663|consen  161 H-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP  233 (419)
T ss_pred             h-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence            8 9999998654    56888999999999999999999999  99999999999999999999999999999987632 


Q ss_pred             ---CCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHh------hcccccccc
Q 006055          528 ---PNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK------DEWTSEVFD  597 (663)
Q Consensus       528 ---~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~d  597 (663)
                         ...|..|.|||.+.+. .|++..|+||+|||+.||+++++-|.+..+.+      .+..+++      +..+.....
T Consensus       234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d------Ql~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID------QLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH------HHHHHHHHhCCCccccCCCccc
Confidence               2346679999998775 68999999999999999999999987654322      2222221      111111111


Q ss_pred             hhhh------c---------ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          598 LELL------R---------YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       598 ~~~~------~---------~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....      .         +.... ....-++++...+..||.+|.|++|.+++
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhcc
Confidence            1100      0         00000 12445677788999999999999999984

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=9.3e-37  Score=320.49  Aligned_cols=255  Identities=22%  Similarity=0.296  Sum_probs=195.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||.||++.. .+|..||+|.+....  .....+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   89 (331)
T cd06649          10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS   89 (331)
T ss_pred             EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCc
Confidence            36799999999999995 468899999987542  224578999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--CCC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--TPN  529 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~  529 (663)
                      |.+++....     .+++..+..++.+++.||.|||+.+ .|+||||||+||+++.++.+||+|||+++......  ...
T Consensus        90 L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  163 (331)
T cd06649          90 LDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV  163 (331)
T ss_pred             HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEcCCCcEEEccCcccccccccccccCC
Confidence            999997533     4789999999999999999999853 39999999999999999999999999997654332  234


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccc-----------------
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT-----------------  592 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------------  592 (663)
                      ++..|+|||++.+..++.++|||||||++|||++|+.||......+   +...+.........                 
T Consensus       164 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd06649         164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPRPRPPGRPV  240 (331)
T ss_pred             CCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcccccccccc
Confidence            6778999999998889999999999999999999999996422110   00000000000000                 


Q ss_pred             ----------c---cccch---hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          593 ----------S---EVFDL---ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       593 ----------~---~~~d~---~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                                .   +..+.   .............++.+++.+||..||++|||++|++++-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         241 SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             cccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                      0   00000   0000000112345788999999999999999999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.1e-37  Score=323.71  Aligned_cols=244  Identities=18%  Similarity=0.290  Sum_probs=193.0

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      ++||+|+||.||++.. .+++.||||.++....    ....+..|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            3699999999999984 5689999999975422    234577889998888 799999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC-C---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP-S---  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~-~---  525 (663)
                      |+|.+++....     .+++..+..++.|++.||.|||+++  |+||||||+||+++.++.+||+|||+++.... .   
T Consensus        81 g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~  153 (329)
T cd05588          81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT  153 (329)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence            99999886432     4899999999999999999999998  99999999999999999999999999875321 1   


Q ss_pred             CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCC--CCChHHHHHHHHhhcccccccchhhhcc
Q 006055          526 STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEE--GVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       526 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||+.....+  ......+....+......          
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------  223 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR----------  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC----------
Confidence            12346778999999999899999999999999999999999997532221  112223332222221110          


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPS------MSEVIKR  637 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt------~~ev~~~  637 (663)
                       .+.....++.+++.+|+..||++||+      +++++++
T Consensus       224 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         224 -IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence             01122345778888999999999997      6777764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-37  Score=309.55  Aligned_cols=251  Identities=25%  Similarity=0.344  Sum_probs=195.4

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccC---------------HHHHHHHHHHhhcCCCCCcccceEEEEec-
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS---------------EREFKDKIEGVGAVNHENLVPLRAYYYSM-  437 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---------------~~~~~~e~~~l~~l~h~niv~l~~~~~~~-  437 (663)
                      ...||+|.||.|-+|. ..+++.||+|++.+....               -+...+||.+|++++|||||+|+++..++ 
T Consensus       102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~  181 (576)
T KOG0585|consen  102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE  181 (576)
T ss_pred             hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc
Confidence            5679999999999999 567999999998653211               24788999999999999999999998765 


Q ss_pred             -CccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecc
Q 006055          438 -DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDF  516 (663)
Q Consensus       438 -~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Df  516 (663)
                       +..|||+|||..|.+...=..     ...+...++++++.++..||+|||.++  ||||||||+|+||+++|++||+||
T Consensus       182 s~~~YlVley~s~G~v~w~p~d-----~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~VKIsDF  254 (576)
T KOG0585|consen  182 SDKLYLVLEYCSKGEVKWCPPD-----KPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGTVKISDF  254 (576)
T ss_pred             cCceEEEEEeccCCccccCCCC-----cccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCcEEeecc
Confidence             468999999998876443211     122899999999999999999999998  999999999999999999999999


Q ss_pred             ccccccCCC---------CCCCCCccccCccccCCCC----CCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHH
Q 006055          517 GLAHLVGPS---------STPNRVAGYRAPEVTDPCK----VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWV  583 (663)
Q Consensus       517 g~a~~~~~~---------~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~  583 (663)
                      |.+......         ....||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||-+...      ....
T Consensus       255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~------~~l~  328 (576)
T KOG0585|consen  255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE------LELF  328 (576)
T ss_pred             ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH------HHHH
Confidence            998765322         1245888899999987732    35678999999999999999999965321      2222


Q ss_pred             HHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCCCCC
Q 006055          584 QSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQ  653 (663)
Q Consensus       584 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~  653 (663)
                      ..+..+         .+ .++...+...++.+++.+++.+||++|.+..+|..     +++......+.+
T Consensus       329 ~KIvn~---------pL-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~-----Hpwvt~~g~~~~  383 (576)
T KOG0585|consen  329 DKIVND---------PL-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL-----HPWVTRDGDSPQ  383 (576)
T ss_pred             HHHhcC---------cc-cCCCcccccHHHHHHHHHHhhcChhheeehhhhee-----cceeccCCCCCc
Confidence            222221         11 22233345567888889999999999999999988     455555544443

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-36  Score=307.72  Aligned_cols=242  Identities=24%  Similarity=0.357  Sum_probs=198.7

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|+||+||+|...++..+|+|.++........+.+|+.++.+++||||+++++++.+....++||||+.+|+|.+
T Consensus         9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   88 (256)
T cd05113           9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN   88 (256)
T ss_pred             eeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHH
Confidence            36799999999999998777789999988666667789999999999999999999999998888999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-----CC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~~  529 (663)
                      +++...    ..+++..++.++.+|+.||.|||+.+  ++|+||||+||++++++.+||+|||.++.......     ..
T Consensus        89 ~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05113          89 YLREHG----KRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK  162 (256)
T ss_pred             HHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCc
Confidence            997533    25899999999999999999999998  99999999999999999999999999876543321     12


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      ++..|+|||++.+..++.++||||||+++|||++ |+.||.....      ......+......           .....
T Consensus       163 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~-----------~~~~~  225 (256)
T cd05113         163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN------SETVEKVSQGLRL-----------YRPHL  225 (256)
T ss_pred             cChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHHhcCCCC-----------CCCCC
Confidence            3346999999988889999999999999999998 9999864321      1222222221111           00111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                      ....+.+++.+||..+|++||++.++++.|+
T Consensus       226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            2357888999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-37  Score=323.18  Aligned_cols=246  Identities=20%  Similarity=0.228  Sum_probs=196.8

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|... +++.||||+++...    .....+.+|++++..++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g   85 (333)
T cd05600           6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG   85 (333)
T ss_pred             EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence            367999999999999954 58999999987542    1235688899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC-CCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-STP  528 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~-~~~  528 (663)
                      |+|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++..... ...
T Consensus        86 ~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~  158 (333)
T cd05600          86 GDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV  158 (333)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCc
Confidence            99999997532     4789999999999999999999998  999999999999999999999999999866542 234


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+.....   .+.... .......
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~---~~~~~~-~~~~~~~  228 (333)
T cd05600         159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST------PNETWENLKYWKE---TLQRPV-YDDPRFN  228 (333)
T ss_pred             ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC------HHHHHHHHHhccc---cccCCC-CCccccc
Confidence            57788999999999899999999999999999999999996532      1111222211110   000000 0000012


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...++.+++.+|+..+|++||+++|++++
T Consensus       229 ~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         229 LSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            34567788889999999999999999986

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.8e-36  Score=307.23  Aligned_cols=245  Identities=25%  Similarity=0.439  Sum_probs=201.9

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .++||+|+||.||+|...++..+|+|.+..... ....+..|+.+++.++|+||+++++++.+.+..++||||+++|+|.
T Consensus        11 ~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   90 (261)
T cd05148          11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL   90 (261)
T ss_pred             hhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHH
Confidence            578999999999999988899999999876644 4567899999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC----CC
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST----PN  529 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~----~~  529 (663)
                      ++++...   ...+++..+..++.+++.||.|||+.+  |+||||||+||++++++.+||+|||.+........    ..
T Consensus        91 ~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~  165 (261)
T cd05148          91 AFLRSPE---GQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK  165 (261)
T ss_pred             HHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCccccccCCC
Confidence            9997643   235899999999999999999999998  99999999999999999999999999976643321    12


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .+..|+|||.+....++.++||||||+++|+|++ |+.||.....      ......+... ..          ......
T Consensus       166 ~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~-~~----------~~~~~~  228 (261)
T cd05148         166 IPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN------HEVYDQITAG-YR----------MPCPAK  228 (261)
T ss_pred             CceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHHhC-Cc----------CCCCCC
Confidence            3456999999988889999999999999999998 8999864321      1122222211 10          011122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                      ....+.+++.+|+..||++|||++++++.|+.+
T Consensus       229 ~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         229 CPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.7e-37  Score=320.95  Aligned_cols=237  Identities=25%  Similarity=0.314  Sum_probs=191.9

Q ss_pred             cccccccceEEEEEEe----cCCcEEEEEEecCcc-----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVT-----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      +.||+|+||.||++..    .+++.||||.++...     .....+..|+++++.++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999984    358899999987532     1234577899999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      +++|+|.+++....     .+.+..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            99999999987533     4778888899999999999999998  9999999999999999999999999987543222


Q ss_pred             ----CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          527 ----TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       527 ----~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                          ...++..|+|||++.+..++.++|||||||++|||++|+.||....      ....+..+.....           
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~------~~~~~~~~~~~~~-----------  217 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN------RKKTIDKILKGKL-----------  217 (323)
T ss_pred             CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC------HHHHHHHHHcCCC-----------
Confidence                1246778999999998888999999999999999999999996422      2222233222211           


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                       ..+.....++.+++.+|+..+|++||     ++++++++
T Consensus       218 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         218 -NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence             00111234577888899999999999     88888774

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-36  Score=307.05  Aligned_cols=241  Identities=26%  Similarity=0.418  Sum_probs=198.1

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|+||.||++.++++..+|+|.+.........+.+|+++++.++|+||+++++++......++||||+++++|.+
T Consensus         9 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   88 (256)
T cd05059           9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLN   88 (256)
T ss_pred             hhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHH
Confidence            56799999999999998878899999987666667788999999999999999999999998899999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC--C---C
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST--P---N  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~---~  529 (663)
                      +++...    ..+++..+..++.|++.|+.|||+.+  ++||||||+||++++++.+||+|||.++.......  .   .
T Consensus        89 ~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  162 (256)
T cd05059          89 YLRERK----GKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTK  162 (256)
T ss_pred             HHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceecccccccccCCCC
Confidence            997533    25899999999999999999999998  99999999999999999999999999976643221  1   1


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .+..|+|||++.+..++.++||||||+++|||++ |+.||+.....      .....+. ...     .     ......
T Consensus       163 ~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~-~~~-----~-----~~~~~~  225 (256)
T cd05059         163 FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS------EVVESVS-AGY-----R-----LYRPKL  225 (256)
T ss_pred             CCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH------HHHHHHH-cCC-----c-----CCCCCC
Confidence            2346999999998889999999999999999999 89998643211      1111111 110     0     001112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      .+.++.+++.+|+..+|++|||+.|+++.|
T Consensus       226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            345788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-37  Score=320.14  Aligned_cols=241  Identities=23%  Similarity=0.360  Sum_probs=208.9

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCc-cEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDE-KLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ey~~~  449 (663)
                      .+++|+|+||.++... ..+++.|++|.+.....+   ++...+|+.++++++|||||.+.+.|.+++. .++||+|++|
T Consensus         9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eG   88 (426)
T KOG0589|consen    9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEG   88 (426)
T ss_pred             hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCC
Confidence            4789999999999988 446889999998766443   3457899999999999999999999999888 8999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |++.+.+...+   ...+++.....++.|++.|+.|||+..  |+|||||+.||+++.+..|||+|||+|+.+.+..   
T Consensus        89 g~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a  163 (426)
T KOG0589|consen   89 GDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLA  163 (426)
T ss_pred             CCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCchhhh
Confidence            99999998766   346899999999999999999999887  9999999999999999999999999999988764   


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       +..+|+.||+||.+.+..|..|+|||||||++|||++-+++|.+      .++...+..+.+...           .+-
T Consensus       164 ~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a------~~m~~Li~ki~~~~~-----------~Pl  226 (426)
T KOG0589|consen  164 STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA------SNMSELILKINRGLY-----------SPL  226 (426)
T ss_pred             heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc------cchHHHHHHHhhccC-----------CCC
Confidence             45688999999999999999999999999999999999999965      345555555544431           223


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      +..+..++..++..|+..+|+.||++.+++.+
T Consensus       227 p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  227 PSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            45566788899999999999999999999986

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.4e-36  Score=306.17  Aligned_cols=244  Identities=27%  Similarity=0.430  Sum_probs=199.3

Q ss_pred             hhcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          374 SAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       374 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      ..+.||+|+||.||+|..+++..||+|.+.........+.+|+.++++++|+|++++++++. ....+++|||+++++|.
T Consensus        10 ~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~   88 (260)
T cd05070          10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLL   88 (260)
T ss_pred             hhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHH
Confidence            35789999999999999888889999999876666778999999999999999999999874 46689999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-----C
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----P  528 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~  528 (663)
                      ++++...   ...+++..+..++.+++.||.|||+.+  |+||||||+||++++++.++|+|||++........     .
T Consensus        89 ~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05070          89 DFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA  163 (260)
T ss_pred             HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCC
Confidence            9997533   235899999999999999999999998  99999999999999999999999999977644321     1


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      .++..|+|||++.+..++.++||||||+++|||++ |..||....      .......+.. ...          .....
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~------~~~~~~~~~~-~~~----------~~~~~  226 (260)
T cd05070         164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN------NREVLEQVER-GYR----------MPCPQ  226 (260)
T ss_pred             CCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHHc-CCC----------CCCCC
Confidence            23346999999988889999999999999999999 888986422      1122222211 110          01112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                      .....+.+++.+|+..+|++|||++++.+.|++
T Consensus       227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         227 DCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            234568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.1e-36  Score=305.81  Aligned_cols=244  Identities=28%  Similarity=0.431  Sum_probs=198.8

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .++||+|+||.||+|...++..||+|.++......+.+.+|+++++.++|+||+++++++. ....++||||+++|+|.+
T Consensus        11 ~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~   89 (262)
T cd05071          11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLD   89 (262)
T ss_pred             eeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHH
Confidence            4679999999999999777778999999876666778999999999999999999999874 456899999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-----CC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~~  529 (663)
                      +++...   ...+++..+..++.+++.||.|||+.+  ++||||||+||++++++.++|+|||.++.......     ..
T Consensus        90 ~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~  164 (262)
T cd05071          90 FLKGEM---GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK  164 (262)
T ss_pred             HHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCc
Confidence            997532   235789999999999999999999998  99999999999999999999999999976644321     12


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      ++..|+|||+..+..++.++||||||+++|||++ |+.||.....      ......+.. ..          ......+
T Consensus       165 ~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~------~~~~~~~~~-~~----------~~~~~~~  227 (262)
T cd05071         165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVER-GY----------RMPCPPE  227 (262)
T ss_pred             ccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh------HHHHHHHhc-CC----------CCCCccc
Confidence            3446999999988889999999999999999999 8888864321      111111111 10          0011223


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                      ....+.+++.+|++.+|++||+++++++.|++.
T Consensus       228 ~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         228 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            455788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.6e-38  Score=308.50  Aligned_cols=260  Identities=23%  Similarity=0.301  Sum_probs=192.4

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCc-----cEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDE-----KLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~~lv~ey~~  448 (663)
                      .+++|+|+||.||+|. ..+++.||||+.-...   +.-.+|+++|+.+.|||||++.-+|....+     ..+|||||+
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~---r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP  105 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK---RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP  105 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCC---CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence            4789999999999999 5567999999875432   233578999999999999999988865332     358999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC-CceEEeccccccccCCCCC
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS-YEARVSDFGLAHLVGPSST  527 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~~  527 (663)
                      . +|.++++.... ....++...+.-+..|+.+||.|||+.+  |+||||||.|+|+|.+ |.+||||||.|+...++..
T Consensus       106 ~-tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep  181 (364)
T KOG0658|consen  106 E-TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP  181 (364)
T ss_pred             H-HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence            8 99999885321 1234677777889999999999999998  9999999999999976 8999999999998866543


Q ss_pred             ---CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccc----------
Q 006055          528 ---PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTS----------  593 (663)
Q Consensus       528 ---~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------  593 (663)
                         ...+..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+...   .+....+-.++.-...+          
T Consensus       182 niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~---~dQL~eIik~lG~Pt~e~I~~mn~~y~  258 (364)
T KOG0658|consen  182 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS---VDQLVEIIKVLGTPTREDIKSMNPNYT  258 (364)
T ss_pred             ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH---HHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence               345666999999876 5699999999999999999999999976322   11111111111110000          


Q ss_pred             cccchhhhccc----ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH--HhhCCC
Q 006055          594 EVFDLELLRYQ----NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI--EELHPS  644 (663)
Q Consensus       594 ~~~d~~~~~~~----~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L--~~~~~~  644 (663)
                      +...+.+....    .......+.++++.+++..+|.+|.++.|++.+=  .++++.
T Consensus       259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            11111111111    1123345788999999999999999999998753  455544

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.1e-37  Score=321.42  Aligned_cols=244  Identities=18%  Similarity=0.303  Sum_probs=191.6

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      +.||+|+||.||+|.. .+++.||+|.++....    ....+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            3699999999999994 5688999999875421    234577888887766 899999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----  525 (663)
                      |+|..++....     .+++..+..++.|++.||.|||+++  |+||||||+||+++.++.+||+|||+++.....    
T Consensus        81 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~  153 (329)
T cd05618          81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT  153 (329)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence            99998886532     4889999999999999999999998  999999999999999999999999998754221    


Q ss_pred             CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCC--CCChHHHHHHHHhhcccccccchhhhcc
Q 006055          526 STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEE--GVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       526 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||.......  ......++...+.....           
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----------  222 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----------  222 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-----------
Confidence            12346778999999999999999999999999999999999996432221  11222232222222111           


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPS------MSEVIKR  637 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt------~~ev~~~  637 (663)
                      ..+.....++.+++.+|+..||++||+      +.++++|
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            011122346778888999999999998      4677664

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-37  Score=303.29  Aligned_cols=260  Identities=21%  Similarity=0.349  Sum_probs=195.1

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCc---ccCHHHHHHHHHHhhcCCCCCcccceEEEEe-----cCccEEEEEc
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV---TISEREFKDKIEGVGAVNHENLVPLRAYYYS-----MDEKLLVYDY  446 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~ey  446 (663)
                      +.||+|+||.|+.|. ..+|+.||+|++...   ....+.-.+|+++++.++|+||+.+.+.+..     -++.|+|+|+
T Consensus        28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el  107 (359)
T KOG0660|consen   28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL  107 (359)
T ss_pred             ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence            679999999999999 567999999998744   3446778899999999999999999998754     3567999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC-
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-  525 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~-  525 (663)
                      |+. +|..+++.+.     .++....+.+.+|+++||.|+|+.+  |+||||||+|+|++.+...||+|||+|+..... 
T Consensus       108 Met-DL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  108 MET-DLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             Hhh-HHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeeccccC
Confidence            965 9999998643     4899999999999999999999998  999999999999999999999999999988542 


Q ss_pred             -----CCCCCCccccCccccC-CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChH---------HH--------
Q 006055          526 -----STPNRVAGYRAPEVTD-PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLP---------RW--------  582 (663)
Q Consensus       526 -----~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~---------~~--------  582 (663)
                           .....|..|.|||++. ...|+...||||.||++.||++|+.-|.+...-+...+.         ..        
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence                 1123455699999974 467999999999999999999999998753221100000         00        


Q ss_pred             HHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhCCCCCC
Q 006055          583 VQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR--IEELHPSSTQ  647 (663)
Q Consensus       583 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~--L~~~~~~~~~  647 (663)
                      ++..++...........- .++   ......++++.+|+..||.+|+|++|+++|  |...+....+
T Consensus       260 ar~yi~slp~~p~~~f~~-~fp---~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dE  322 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSS-IFP---NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDE  322 (359)
T ss_pred             HHHHHHhCCCCCCCCHHH-HcC---CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccC
Confidence            011111100000000000 011   122346677779999999999999999986  3555444433

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.3e-36  Score=325.63  Aligned_cols=251  Identities=24%  Similarity=0.378  Sum_probs=198.1

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCccc--CHHHHHHHHHHhhcCC-CCCcccceEEEEecCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  445 (663)
                      .++||+|+||.||+|...      .+..||||+++....  ....+.+|+++++++. ||||++++++|.+....++|||
T Consensus        42 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E  121 (400)
T cd05105          42 GRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITE  121 (400)
T ss_pred             hheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEE
Confidence            578999999999999842      234799999975422  2457899999999996 9999999999999999999999


Q ss_pred             ccCCCChhHhhccCCCC---------------------------------------------------------------
Q 006055          446 YLTMGSLSALLHGNKGA---------------------------------------------------------------  462 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~---------------------------------------------------------------  462 (663)
                      |+++|+|.++++.....                                                               
T Consensus       122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (400)
T cd05105         122 YCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYS  201 (400)
T ss_pred             ecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhh
Confidence            99999999988653210                                                               


Q ss_pred             ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEe
Q 006055          463 ----------------------------GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVS  514 (663)
Q Consensus       463 ----------------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~  514 (663)
                                                  ....+++..+..++.|++.||.|||+.+  |+||||||+||++++++.+||+
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~~~~~~kL~  279 (400)
T cd05105         202 DIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQGKIVKIC  279 (400)
T ss_pred             hcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEeCCCEEEEE
Confidence                                        0124788899999999999999999998  9999999999999999999999


Q ss_pred             ccccccccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHH
Q 006055          515 DFGLAHLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV  587 (663)
Q Consensus       515 Dfg~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  587 (663)
                      |||+++.......      ..++..|+|||.+.+..++.++|||||||++|||++ |..||.......      ......
T Consensus       280 DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~------~~~~~~  353 (400)
T cd05105         280 DFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS------TFYNKI  353 (400)
T ss_pred             eCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH------HHHHHH
Confidence            9999986543221      223456999999988889999999999999999997 999986532111      111111


Q ss_pred             hhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      .....          .........++.+++.+||..+|++||++.+|.++|+++.+
T Consensus       354 ~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         354 KSGYR----------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             hcCCC----------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            11110          01112334578899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.1e-36  Score=313.44  Aligned_cols=256  Identities=20%  Similarity=0.242  Sum_probs=192.6

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||+||++..+ +++.||||+++....   ..+.+.+|+++++.++||||+++++++...+..++||||++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (287)
T cd07848           6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKN   85 (287)
T ss_pred             EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCC
Confidence            367999999999999964 688999999875422   2456789999999999999999999999999999999999998


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----  526 (663)
                      .+..+....     ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++......    
T Consensus        86 ~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          86 MLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence            776554321     24889999999999999999999998  9999999999999999999999999998764322    


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCC---------ChHHHHHHHHhhccccccc
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGV---------DLPRWVQSIVKDEWTSEVF  596 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~  596 (663)
                       ...++..|+|||++.+..++.++|||||||++|||++|+.||......+..         ....+..............
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07848         159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR  238 (287)
T ss_pred             cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence             123567799999998888999999999999999999999999753221100         0000000000000000000


Q ss_pred             chhhhccc-----ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          597 DLELLRYQ-----NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       597 d~~~~~~~-----~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .+......     .......++.+++.+|++.||++|||++|+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000000     011134568899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.2e-36  Score=308.64  Aligned_cols=247  Identities=24%  Similarity=0.399  Sum_probs=198.8

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCcccC--HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVTIS--EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|...      ++..||||.++.....  .+.+.+|++++..++|+||+++++++......++||||
T Consensus        10 ~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   89 (280)
T cd05049          10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEY   89 (280)
T ss_pred             HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEec
Confidence            467999999999999853      3478999998765333  46899999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccc
Q 006055          447 LTMGSLSALLHGNKG---------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFG  517 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg  517 (663)
                      +++|+|.++++....         .....+++.....++.+++.|+.|||+.+  ++||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~kl~d~g  167 (280)
T cd05049          90 MEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFG  167 (280)
T ss_pred             CCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCCeEEECCcc
Confidence            999999999975421         12345889999999999999999999998  9999999999999999999999999


Q ss_pred             cccccCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhc
Q 006055          518 LAHLVGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDE  590 (663)
Q Consensus       518 ~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  590 (663)
                      +++......      ....+..|+|||++.+..++.++|||||||++|||++ |+.||.....      ...+..+. ..
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~------~~~~~~~~-~~  240 (280)
T cd05049         168 MSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN------EEVIECIT-QG  240 (280)
T ss_pred             cceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHH-cC
Confidence            997653321      1223456999999999999999999999999999998 9999864321      12222221 11


Q ss_pred             ccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       591 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                      ....          ........+.+++.+||..||++||+++||++.|++
T Consensus       241 ~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         241 RLLQ----------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             CcCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            1100          011234568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.2e-36  Score=306.41  Aligned_cols=243  Identities=25%  Similarity=0.428  Sum_probs=199.6

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .++||+|+||.||+|..++++.||+|.+.........+.+|+.++++++|+|++++++++ ..+..++||||+++|+|.+
T Consensus        11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~~~~L~~   89 (260)
T cd05067          11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMENGSLVD   89 (260)
T ss_pred             eeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCCCCCHHH
Confidence            468999999999999988899999999987777778899999999999999999999986 4567899999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-----CC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~~  529 (663)
                      ++....   ...+++..+..++.+++.||+|||+.+  ++||||||+||++++++.++|+|||++........     ..
T Consensus        90 ~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  164 (260)
T cd05067          90 FLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAK  164 (260)
T ss_pred             HHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCc
Confidence            987543   235899999999999999999999998  99999999999999999999999999976653221     12


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      ++..|+|||++.+..++.++||||||+++|||++ |+.||....      ....+...... ...          .....
T Consensus       165 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~~~~~~~~~-~~~----------~~~~~  227 (260)
T cd05067         165 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT------NPEVIQNLERG-YRM----------PRPDN  227 (260)
T ss_pred             ccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC------hHHHHHHHHcC-CCC----------CCCCC
Confidence            3456999999988889999999999999999999 999996432      12222221111 100          01112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                      ...++.+++.+|+..+|++||+++++.+.|+.
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         228 CPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            23468889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.8e-37  Score=322.55  Aligned_cols=238  Identities=22%  Similarity=0.235  Sum_probs=193.3

Q ss_pred             hcccccccceEEEEEEecC--CcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLEM--GTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~--g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|....  +..||+|.+....    .....+.+|+.++..++||||+++++++.+....++||||++
T Consensus        35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~  114 (340)
T PTZ00426         35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI  114 (340)
T ss_pred             EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCC
Confidence            4689999999999998543  3689999986432    223567889999999999999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-C
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-T  527 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~  527 (663)
                      +|+|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++...... .
T Consensus       115 ~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~~  187 (340)
T PTZ00426        115 GGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT  187 (340)
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCeecCCCcce
Confidence            999999997543     4889999999999999999999998  9999999999999999999999999998765432 3


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+..... .           .+.
T Consensus       188 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~------~~~~~~~i~~~~~-~-----------~p~  249 (340)
T PTZ00426        188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE------PLLIYQKILEGII-Y-----------FPK  249 (340)
T ss_pred             ecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC------HHHHHHHHhcCCC-C-----------CCC
Confidence            357788999999998889999999999999999999999996431      1122222222110 0           001


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                      .....+.+++.+|++.||++|+     +++|++++
T Consensus       250 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        250 FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            1123466788899999999995     89998876

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-37  Score=317.91  Aligned_cols=247  Identities=23%  Similarity=0.384  Sum_probs=207.3

Q ss_pred             HhhcccccccceEEEEEEecC---C--cEEEEEEecCc--ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEE
Q 006055          373 ASAEVLGKGTFGTAYKAVLEM---G--TIVAVKRLKDV--TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYD  445 (663)
Q Consensus       373 ~~~~~lg~G~~g~Vy~~~~~~---g--~~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  445 (663)
                      ...++||+|-||.||+|...+   |  -.||||..+..  ..+.+.|.+|..+|+.++|||||+++|.|.+ ...++|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence            446789999999999998432   3  35889988764  2346789999999999999999999999975 57899999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      .++-|.|..+|+.++    ..++......+++||+.||+|||+..  .+||||..+|||+.....+||+|||+++.+...
T Consensus       471 L~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  471 LAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             cccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            999999999998765    34888899999999999999999997  999999999999999999999999999998877


Q ss_pred             CCCCCCc-----cccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          526 STPNRVA-----GYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       526 ~~~~~~~-----~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                      .....+.     .|||||.++-++++.++|||.|||++||++. |..||.+..+.+..-       .+..+         
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-------~iEnG---------  608 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-------HIENG---------  608 (974)
T ss_pred             chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-------EecCC---------
Confidence            6554443     3999999999999999999999999999998 999998765543110       00000         


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                       .+.+.++.++..|..++.+||+.+|.+||++.|+...|.++.+
T Consensus       609 -eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  609 -ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             -CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence             0234456677789999999999999999999999999988765

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.1e-37  Score=322.43  Aligned_cols=237  Identities=22%  Similarity=0.285  Sum_probs=191.5

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      +.||+|+||.||++. ..+|+.||+|.++...    .....+..|++++..++||||+++++++......++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            369999999999998 4578999999987542    12345678999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA-QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----  525 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----  525 (663)
                      +|.+++....     .+++..+..++.||+.||.|||+ .+  |+||||||+|||++.++.+||+|||+++.....    
T Consensus        81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  153 (325)
T cd05594          81 ELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM  153 (325)
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence            9999886532     58999999999999999999997 67  999999999999999999999999998754322    


Q ss_pred             CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          526 STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       526 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+.....            ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~------~~~~~~~i~~~~~------------~~  215 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HEKLFELILMEEI------------RF  215 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC------HHHHHHHHhcCCC------------CC
Confidence            12346778999999998899999999999999999999999996422      1122222211110            00


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                      +.....++.+++.+|+..||++|+     ++.+++++
T Consensus       216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            111234677888899999999996     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.1e-36  Score=312.14  Aligned_cols=243  Identities=20%  Similarity=0.257  Sum_probs=192.0

Q ss_pred             cccccceEEEEEEe-cCCcEEEEEEecCcccC----HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          378 LGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       378 lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      ||+|+||+||++.. .+|+.||+|.+......    ...+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999984 57899999998654221    24567899999999999999999999998999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC----C
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST----P  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~----~  528 (663)
                      .+++..... ....+++..+..++.||+.||.|||+.+  |+||||||+||+++.++.+||+|||++........    .
T Consensus        81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence            988754321 2345899999999999999999999998  99999999999999999999999999976544322    2


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .++..|+|||++.+..++.++|||||||++|||++|+.||.......  .............            ......
T Consensus       158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~------------~~~~~~  223 (280)
T cd05608         158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRILNDS------------VTYPDK  223 (280)
T ss_pred             CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch--hHHHHHHhhcccC------------CCCccc
Confidence            46678999999999999999999999999999999999997532211  1111111111100            011122


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                      ...++.+++.+|++.||++||     ++++++++
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            345678888999999999999     77778774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.5e-37  Score=316.48  Aligned_cols=250  Identities=20%  Similarity=0.264  Sum_probs=190.2

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .++||+|+||.||+|.. .+++.||+|.++...  .....+.+|+.+++.++||||+++++++......++||||+++ +
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~   88 (288)
T cd07871          10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-D   88 (288)
T ss_pred             eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-C
Confidence            36799999999999984 468999999986542  2345678999999999999999999999988889999999985 9


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----C
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----T  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~  527 (663)
                      |.+++....    ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++......    .
T Consensus        89 l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~  162 (288)
T cd07871          89 LKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN  162 (288)
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccC
Confidence            998886432    24788999999999999999999998  9999999999999999999999999997653322    2


Q ss_pred             CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh---c---ccccccch--
Q 006055          528 PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD---E---WTSEVFDL--  598 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~d~--  598 (663)
                      ..++..|+|||.+.+ ..++.++||||+||++|||++|+.||.....      ...+..+...   .   ....+.+.  
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV------KEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCChHHhhccccchh
Confidence            335677999999865 5688999999999999999999999965322      1111111110   0   00000000  


Q ss_pred             ----hhhcc--cC----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          599 ----ELLRY--QN----VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       599 ----~~~~~--~~----~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                          .....  ..    ......+..+++.+|+..||.+|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                00000  00    00113456788999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-36  Score=306.01  Aligned_cols=244  Identities=25%  Similarity=0.443  Sum_probs=197.9

Q ss_pred             hcccccccceEEEEEEec----CCcEEEEEEecCcccC--HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLE----MGTIVAVKRLKDVTIS--EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||+||+|.+.    +...||||.++.....  ...+.+|+..++.++||||+++++++...+..++||||++
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   88 (266)
T cd05033           9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYME   88 (266)
T ss_pred             eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCC
Confidence            468999999999999864    2468999998754322  4578899999999999999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-  527 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  527 (663)
                      +++|.+++....    ..+++..+..++.|++.|+.|||+.+  |+||||||+||++++++.++|+|||+++....... 
T Consensus        89 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd05033          89 NGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT  162 (266)
T ss_pred             CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence            999999997543    25899999999999999999999998  99999999999999999999999999987752211 


Q ss_pred             -----CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhh
Q 006055          528 -----PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL  601 (663)
Q Consensus       528 -----~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  601 (663)
                           ...+..|+|||.+.+..++.++||||||+++|||++ |..||.....      ......+ .....         
T Consensus       163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~-~~~~~---------  226 (266)
T cd05033         163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN------QDVIKAV-EDGYR---------  226 (266)
T ss_pred             eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH------HHHHHHH-HcCCC---------
Confidence                 122356999999998889999999999999999998 9999854321      1111111 11110         


Q ss_pred             cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       602 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                       .+.....+..+.+++.+|++.+|++||+++||+++|+++
T Consensus       227 -~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         227 -LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             011122345688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.8e-36  Score=304.18  Aligned_cols=242  Identities=24%  Similarity=0.358  Sum_probs=194.2

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      +.||+|+||.||+|.. .+++.||+|.+....  .....+.+|+++++.++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4699999999999995 579999999876542  2246789999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCC----
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP----  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~----  528 (663)
                      .++++...    ..+++..++.++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++.........    
T Consensus        81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            99997432    34789999999999999999999998  999999999999999999999999998765432111    


Q ss_pred             --CCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          529 --NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       529 --~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                        .....|+|||.+.+..++.++||||||+++|||++ |..||......      . ..........          ...
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~------~-~~~~~~~~~~----------~~~  217 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ------Q-TREAIEQGVR----------LPC  217 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH------H-HHHHHHcCCC----------CCC
Confidence              11235999999998889999999999999999998 88888643211      1 1111111100          011


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                      .......+.+++.+|+..+|++|||+.||.++|++
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            12234578889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7.9e-37  Score=319.38  Aligned_cols=237  Identities=24%  Similarity=0.317  Sum_probs=190.1

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      ++||+|+||.||+|.. .+++.||||.++...    .....+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999995 468999999987532    2234567788888766 799999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----  525 (663)
                      |+|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++.....    
T Consensus        81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~  153 (320)
T cd05590          81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT  153 (320)
T ss_pred             chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence            99999887533     4889999999999999999999998  999999999999999999999999998754222    


Q ss_pred             CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          526 STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       526 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+......            .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~------~~~~~~~i~~~~~~------------~  215 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN------EDDLFEAILNDEVV------------Y  215 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC------HHHHHHHHhcCCCC------------C
Confidence            12346778999999998889999999999999999999999996432      22233333222110            0


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSM------SEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~------~ev~~~  637 (663)
                      +.....++.+++.+|++.||++||++      ++++++
T Consensus       216 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         216 PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            11123467788889999999999998      666554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.7e-37  Score=302.21  Aligned_cols=259  Identities=22%  Similarity=0.332  Sum_probs=199.0

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCC-cccceEEEEecC------ccEEEE
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHEN-LVPLRAYYYSMD------EKLLVY  444 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------~~~lv~  444 (663)
                      ++||+|+||+||+|+ ..+|+.||+|++.-...   -+....+|+.+++.++|+| |+++++++...+      ..++||
T Consensus        17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf   96 (323)
T KOG0594|consen   17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF   96 (323)
T ss_pred             HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence            569999999999999 66799999999875533   2455789999999999999 999999998877      678999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||++. +|..++......+ ..++...++.++.|+++||+|||+++  |+||||||.||||+++|.+||+|||+|+...-
T Consensus        97 e~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i  172 (323)
T KOG0594|consen   97 EFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGLARAFSI  172 (323)
T ss_pred             Eeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence            99987 9999997654221 34667889999999999999999998  99999999999999999999999999987653


Q ss_pred             CC----CCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHh-------hccc
Q 006055          525 SS----TPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK-------DEWT  592 (663)
Q Consensus       525 ~~----~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~  592 (663)
                      ..    ....|..|.|||++.+. .|+...||||+||++.||++++..|.+..+      ......+.+       +.|.
T Consensus       173 p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se------~~ql~~If~~lGtP~e~~Wp  246 (323)
T KOG0594|consen  173 PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE------IDQLFRIFRLLGTPNEKDWP  246 (323)
T ss_pred             CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH------HHHHHHHHHHcCCCCccCCC
Confidence            22    22355669999999876 689999999999999999999999987554      122222221       1121


Q ss_pred             ccc----cchhhhcccChHHH----H---HHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhCCC
Q 006055          593 SEV----FDLELLRYQNVEEE----M---VQLLQLAIDCSAQYPDNRPSMSEVIKR--IEELHPS  644 (663)
Q Consensus       593 ~~~----~d~~~~~~~~~~~~----~---~~l~~l~~~C~~~dP~~RPt~~ev~~~--L~~~~~~  644 (663)
                      ...    .+............    .   .+..+++.+|++.+|.+|.|++.+++|  +.++...
T Consensus       247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence            111    01111111111111    1   367888999999999999999999997  5555333

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.3e-36  Score=317.84  Aligned_cols=252  Identities=25%  Similarity=0.400  Sum_probs=196.1

Q ss_pred             hhcccccccceEEEEEEe------cCCcEEEEEEecCcccC--HHHHHHHHHHhhcC-CCCCcccceEEEEec-CccEEE
Q 006055          374 SAEVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTIS--EREFKDKIEGVGAV-NHENLVPLRAYYYSM-DEKLLV  443 (663)
Q Consensus       374 ~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~~lv  443 (663)
                      ..++||+|+||.||+|..      .+++.||+|+++.....  .+.+.+|+.++.++ +|+||++++++|... ...+++
T Consensus        11 i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v   90 (337)
T cd05054          11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVI   90 (337)
T ss_pred             hhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEE
Confidence            357899999999999963      23578999998754322  34577899999999 899999999988654 457899


Q ss_pred             EEccCCCChhHhhccCCCC--------------------------------------------------------CCCCC
Q 006055          444 YDYLTMGSLSALLHGNKGA--------------------------------------------------------GRTPL  467 (663)
Q Consensus       444 ~ey~~~gsL~~~l~~~~~~--------------------------------------------------------~~~~l  467 (663)
                      |||+++|+|.+++......                                                        ...++
T Consensus        91 ~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  170 (337)
T cd05054          91 VEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPL  170 (337)
T ss_pred             EecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCC
Confidence            9999999999998643210                                                        01368


Q ss_pred             CHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC------CCCCccccCccccC
Q 006055          468 NWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST------PNRVAGYRAPEVTD  541 (663)
Q Consensus       468 ~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~y~aPE~~~  541 (663)
                      +|..+..++.||+.||.|||+.+  |+||||||+||++++++.++|+|||+++.......      ..++..|+|||++.
T Consensus       171 ~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  248 (337)
T cd05054         171 TLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIF  248 (337)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhc
Confidence            99999999999999999999998  99999999999999999999999999987543221      12345699999999


Q ss_pred             CCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHc
Q 006055          542 PCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDC  620 (663)
Q Consensus       542 ~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C  620 (663)
                      +..++.++|||||||++|||++ |..||......+      .....+......          ..+.....++.+++.+|
T Consensus       249 ~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~----------~~~~~~~~~~~~l~~~c  312 (337)
T cd05054         249 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRM----------RAPEYATPEIYSIMLDC  312 (337)
T ss_pred             CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCC----------CCCccCCHHHHHHHHHH
Confidence            9999999999999999999998 999986532111      111111111100          01112334688999999


Q ss_pred             cCCCCCCCCCHHHHHHHHHhhCC
Q 006055          621 SAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       621 ~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      |..+|++||++.|++++|+++.+
T Consensus       313 l~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         313 WHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             ccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.2e-36  Score=315.71  Aligned_cols=246  Identities=23%  Similarity=0.395  Sum_probs=195.7

Q ss_pred             hcccccccceEEEEEEec-CCc----EEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGT----IVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||+|+||.||+|.+. +|+    .||+|.++...  ...+++.+|+.+++.++||||++++++|... ..++|+||+
T Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~   90 (316)
T cd05108          12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM   90 (316)
T ss_pred             eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecC
Confidence            367999999999999853 344    48999987542  2346788999999999999999999998764 578999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST  527 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  527 (663)
                      ++|+|.++++...    ..+++...+.++.||+.||+|||+.+  |+||||||+||+++.++.+||+|||+++.......
T Consensus        91 ~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  164 (316)
T cd05108          91 PFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK  164 (316)
T ss_pred             CCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccccccccccCCCc
Confidence            9999999997543    34789999999999999999999998  99999999999999999999999999987654322


Q ss_pred             C------CCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          528 P------NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       528 ~------~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                      .      ..+..|+|||++.+..++.++|||||||++|||++ |+.||+...      ...+ ..+......        
T Consensus       165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~------~~~~-~~~~~~~~~--------  229 (316)
T cd05108         165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP------ASEI-SSILEKGER--------  229 (316)
T ss_pred             ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC------HHHH-HHHHhCCCC--------
Confidence            1      12346999999999899999999999999999998 999986432      1111 122221110        


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                        ......+..++.+++.+||..+|++||++.+++..+..+...
T Consensus       230 --~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         230 --LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence              011112334678899999999999999999999999887544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=6.2e-36  Score=303.17  Aligned_cols=243  Identities=26%  Similarity=0.408  Sum_probs=197.3

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|+||.||+|....+..+|+|.+.........+.+|+.+++.++|+|++++++++. ....++||||+++|+|.+
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~   89 (260)
T cd05069          11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLD   89 (260)
T ss_pred             eeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHH
Confidence            3579999999999999877778999998766556678899999999999999999998874 456899999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-----CC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~~  529 (663)
                      +++...   ...+++..+..++.+++.||.|||+.+  ++||||||+||++++++.++|+|||.++.......     ..
T Consensus        90 ~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  164 (260)
T cd05069          90 FLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAK  164 (260)
T ss_pred             HHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCc
Confidence            997533   235789999999999999999999998  99999999999999999999999999976643321     12


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      ++..|+|||+..+..++.++||||||+++|||++ |+.||.....      ......+. .....          .....
T Consensus       165 ~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~~-~~~~~----------~~~~~  227 (260)
T cd05069         165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN------REVLEQVE-RGYRM----------PCPQG  227 (260)
T ss_pred             cchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHH-cCCCC----------CCCcc
Confidence            3456999999988889999999999999999999 8999864321      11111111 11100          11122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                      .+..+.+++.+|+..+|++||++++|++.|++
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            34568888999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.4e-36  Score=309.98  Aligned_cols=251  Identities=25%  Similarity=0.386  Sum_probs=200.2

Q ss_pred             hcccccccceEEEEEEe------cCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||+|+||.||++..      .++..+|+|.+.... .....+.+|++++.+++||||+++++++......++||||+
T Consensus        10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   89 (288)
T cd05093          10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM   89 (288)
T ss_pred             ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcC
Confidence            46799999999999974      235679999887543 23457899999999999999999999999999999999999


Q ss_pred             CCCChhHhhccCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccc
Q 006055          448 TMGSLSALLHGNKG--------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA  519 (663)
Q Consensus       448 ~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a  519 (663)
                      ++++|.+++.....        .....+++..+..++.|++.||+|||+.+  ++||||||+||++++++.+||+|||++
T Consensus        90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~  167 (288)
T cd05093          90 KHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMS  167 (288)
T ss_pred             CCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCcEEeccCCcc
Confidence            99999999875331        12335899999999999999999999998  999999999999999999999999999


Q ss_pred             cccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhccc
Q 006055          520 HLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWT  592 (663)
Q Consensus       520 ~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  592 (663)
                      +.......      ..++..|+|||++.+..++.++|||||||++|||++ |..||.....      ......+......
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~------~~~~~~i~~~~~~  241 (288)
T cd05093         168 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NEVIECITQGRVL  241 (288)
T ss_pred             ccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCcC
Confidence            76533221      123456999999998889999999999999999998 8999864321      1122222221110


Q ss_pred             ccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          593 SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       593 ~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                       .          .......++.+++.+|+..+|.+|||++|+.+.|+.+...
T Consensus       242 -~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         242 -Q----------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             -C----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence             0          0111234688999999999999999999999999998644

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-36  Score=318.65  Aligned_cols=237  Identities=22%  Similarity=0.299  Sum_probs=190.6

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      ++||+|+||.||+|.. .+++.||+|.++...    .....+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            3699999999999995 458899999987542    1234567788888765 899999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|..++....     .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++......   
T Consensus        81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  153 (321)
T cd05591          81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT  153 (321)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence            99999886532     4889999999999999999999998  9999999999999999999999999987543221   


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       ...++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+......            .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~------~~~~~~~i~~~~~~------------~  215 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN------EDDLFESILHDDVL------------Y  215 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC------HHHHHHHHHcCCCC------------C
Confidence             2236778999999998889999999999999999999999996532      22233333222110            0


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRP-------SMSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RP-------t~~ev~~~  637 (663)
                      +.....++.+++.+|+..||++||       ++++++++
T Consensus       216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            111234677888899999999999       78888765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=9.1e-37  Score=319.89  Aligned_cols=244  Identities=18%  Similarity=0.290  Sum_probs=193.5

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      ++||+|+||+||++.. .+++.||+|+++....    ..+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            3699999999999994 5688999999976422    234577888888887 699999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC-C---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP-S---  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~-~---  525 (663)
                      |+|..++....     .+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||+++.... .   
T Consensus        81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  153 (327)
T cd05617          81 GDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT  153 (327)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence            99999886432     4899999999999999999999998  99999999999999999999999999875322 1   


Q ss_pred             CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          526 STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       526 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||.........+...++..........           .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------~  222 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR-----------I  222 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC-----------C
Confidence            12346778999999999999999999999999999999999997644333333333333332221110           0


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSM------SEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~------~ev~~~  637 (663)
                      +......+.+++.+|+..||++||++      +++++|
T Consensus       223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            11122356788889999999999984      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.9e-36  Score=307.39  Aligned_cols=239  Identities=24%  Similarity=0.342  Sum_probs=188.4

Q ss_pred             cccccccceEEEEEEecC-------------CcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEecCccE
Q 006055          376 EVLGKGTFGTAYKAVLEM-------------GTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKL  441 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~-------------g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  441 (663)
                      +.||+|+||.||+|.+.+             ...||+|.+..... ....+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998432             23589998765432 2356888899999999999999999999999999


Q ss_pred             EEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc-------eEEe
Q 006055          442 LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE-------ARVS  514 (663)
Q Consensus       442 lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~-------~kl~  514 (663)
                      +||||+++|+|..+++...    ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.       ++++
T Consensus        81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeC
Confidence            9999999999999887432    35899999999999999999999998  999999999999987664       8999


Q ss_pred             ccccccccCCCCCCCCCccccCccccC-CCCCCCcchhhhHHHHHHHHH-hCCCCCccccCCCCCChHHHHHHHHhhccc
Q 006055          515 DFGLAHLVGPSSTPNRVAGYRAPEVTD-PCKVSQKADVYSFGVLLLELL-TGKAPTHALLNEEGVDLPRWVQSIVKDEWT  592 (663)
Q Consensus       515 Dfg~a~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slGvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  592 (663)
                      |||++..........++..|+|||++. +..++.++|||||||++|||+ +|..|+......      . ......... 
T Consensus       155 d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~-~~~~~~~~~-  226 (262)
T cd05077         155 DPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA------E-KERFYEGQC-  226 (262)
T ss_pred             CCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh------H-HHHHHhcCc-
Confidence            999997765554555677899999986 466889999999999999998 588887542111      1 001111100 


Q ss_pred             ccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          593 SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       593 ~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                                 ........++.+++.+||..||++||++.+++++++
T Consensus       227 -----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         227 -----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             -----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence                       001112346788999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.8e-36  Score=304.47  Aligned_cols=251  Identities=21%  Similarity=0.316  Sum_probs=201.2

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|.. .+++.||||.++....    ....+.+|+++++.++|||++++++++.+....++|+||+++
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   86 (267)
T cd08228           7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADA   86 (267)
T ss_pred             eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCC
Confidence            36799999999999994 5789999998764321    234688899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++..... ....+++.....++.+++.||.|||+.+  ++||||||+||+++.++.++|+|||++.......   
T Consensus        87 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~  163 (267)
T cd08228          87 GDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA  163 (267)
T ss_pred             CcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccchhHHH
Confidence            999998864321 1235788999999999999999999998  9999999999999999999999999988765432   


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       ...++..|+|||.+.+..++.++||||||+++|||++|+.||....    .....+...+......          ...
T Consensus       164 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~----~~~~~~~~~~~~~~~~----------~~~  229 (267)
T cd08228         164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLFSLCQKIEQCDYP----------PLP  229 (267)
T ss_pred             hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc----ccHHHHHHHHhcCCCC----------CCC
Confidence             2345667999999988888999999999999999999999985421    1222222222111110          011


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                      .......+.+++.+||..+|++||+++||++.+++++
T Consensus       230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            1234456888999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.6e-36  Score=333.62  Aligned_cols=243  Identities=21%  Similarity=0.254  Sum_probs=195.1

Q ss_pred             hcccccccceEEEEEEe-cC-CcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EM-GTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~-g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||.||+|.. .+ ++.||+|.+..... ....+.+|+.+++.++||||+++++++...+..++||||+++|+
T Consensus        72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~  151 (478)
T PTZ00267         72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGD  151 (478)
T ss_pred             EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCC
Confidence            46899999999999984 33 67888887654322 23567889999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-----
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----  526 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-----  526 (663)
                      |.++++... ....++++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++......     
T Consensus       152 L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~  228 (478)
T PTZ00267        152 LNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA  228 (478)
T ss_pred             HHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccc
Confidence            999886422 12346889999999999999999999998  9999999999999999999999999998764321     


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       ...++.+|+|||++.+..++.++|||||||++|||++|+.||...      +....+..+......           ..
T Consensus       229 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~------~~~~~~~~~~~~~~~-----------~~  291 (478)
T PTZ00267        229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP------SQREIMQQVLYGKYD-----------PF  291 (478)
T ss_pred             cccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCC-----------CC
Confidence             223677899999999989999999999999999999999999642      222333333222111           01


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      +.....++.+++.+|+..||++||++++++.+
T Consensus       292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            11233467888999999999999999998753

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.8e-36  Score=303.46  Aligned_cols=240  Identities=26%  Similarity=0.380  Sum_probs=192.7

Q ss_pred             ccccccceEEEEEEe---cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          377 VLGKGTFGTAYKAVL---EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       377 ~lg~G~~g~Vy~~~~---~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .||+|+||.||+|.+   .++..+|+|+++.....   .+++.+|+.+++.++|+||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999964   35789999998754322   457889999999999999999999875 45678999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC---
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST---  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~---  527 (663)
                      +|.+++...     ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++.......   
T Consensus        81 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            999999643     24889999999999999999999998  99999999999999999999999999987654322   


Q ss_pred             ----CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          528 ----PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       528 ----~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                          ..++..|+|||.+....++.++|||||||++|||++ |+.||.....      ..+...+..... ..        
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~i~~~~~-~~--------  218 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG------NEVTQMIESGER-ME--------  218 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHCCCC-CC--------
Confidence                112346999999988888999999999999999998 9999965321      122222211111 00        


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                        .+.....++.+++.+||..||++||++.+|++.|++.
T Consensus       219 --~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         219 --CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             --CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence              1112334678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-37  Score=321.24  Aligned_cols=240  Identities=25%  Similarity=0.334  Sum_probs=194.5

Q ss_pred             ccCHHHHHHHhhcccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHhhcC-CCCCcccceEEEEec
Q 006055          364 VFDLEDLLRASAEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGVGAV-NHENLVPLRAYYYSM  437 (663)
Q Consensus       364 ~~~~~~l~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  437 (663)
                      .++++++  ....+||+|.||+|+++.. .+++.+|||.+++...    .-+..+.|.+++... +||.++.++.+|...
T Consensus       364 ~~~l~~F--~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~  441 (694)
T KOG0694|consen  364 PLTLDDF--RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK  441 (694)
T ss_pred             cccccce--EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence            3444444  2357899999999999994 5689999999987632    234566777776665 699999999999999


Q ss_pred             CccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccc
Q 006055          438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFG  517 (663)
Q Consensus       438 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg  517 (663)
                      ++.++||||+.||++..+.+.      ..+++..+..++..|+.||.|||+++  |||||||-+|||+|.+|++||+|||
T Consensus       442 ~~l~fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFG  513 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFG  513 (694)
T ss_pred             CeEEEEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEecccc
Confidence            999999999999996666653      34899999999999999999999999  9999999999999999999999999


Q ss_pred             cccccC-CC---CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccc
Q 006055          518 LAHLVG-PS---STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTS  593 (663)
Q Consensus       518 ~a~~~~-~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (663)
                      +++... .+   .+..||+.|||||++.+..|+..+|.|||||+||||+.|..||.+..++      +....++.+..  
T Consensus       514 lcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe------e~FdsI~~d~~--  585 (694)
T KOG0694|consen  514 LCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE------EVFDSIVNDEV--  585 (694)
T ss_pred             cccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHhcCCC--
Confidence            998754 22   2334788899999999999999999999999999999999999865432      23333333321  


Q ss_pred             cccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCH
Q 006055          594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSM  631 (663)
Q Consensus       594 ~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~  631 (663)
                                ..+.....+.+.++.+.+.++|++|.-+
T Consensus       586 ----------~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  586 ----------RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ----------CCCCcccHHHHHHHHHHhccCcccccCC
Confidence                      1223345577888889999999999876

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-36  Score=319.43  Aligned_cols=254  Identities=22%  Similarity=0.354  Sum_probs=187.6

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecC-----ccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMD-----EKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e  445 (663)
                      .++||+|+||.||+|. ..+|+.||||++....   .....+.+|+++++.++||||+++++++....     ..++|||
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e   84 (338)
T cd07859           5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE   84 (338)
T ss_pred             EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence            4689999999999999 4578999999987532   22356889999999999999999999886432     4799999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+. ++|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++.....
T Consensus        85 ~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          85 LME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             cCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            996 68999886432     4899999999999999999999998  999999999999999999999999999764322


Q ss_pred             C-------CCCCCccccCccccCC--CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCC---------CChHHHHHHHH
Q 006055          526 S-------TPNRVAGYRAPEVTDP--CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEG---------VDLPRWVQSIV  587 (663)
Q Consensus       526 ~-------~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~---------~~~~~~~~~~~  587 (663)
                      .       ...++..|+|||++.+  ..++.++|||||||++|||++|+.||........         .....+...+.
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            1       1236677999999866  5788999999999999999999999965321100         00000000000


Q ss_pred             hhcccccccchhhh-cccCh----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          588 KDEWTSEVFDLELL-RYQNV----EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       588 ~~~~~~~~~d~~~~-~~~~~----~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .. .....+..-.. .....    ......+.+++.+|+..||++|||++|++++
T Consensus       237 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         237 NE-KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hh-hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00 00000000000 00000    0123456789999999999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-37  Score=316.70  Aligned_cols=249  Identities=27%  Similarity=0.427  Sum_probs=213.3

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .++||.|.||.||.|.|+ -.-.||||.++.....-.+|..|..+|+.++|||+|+++|+|......|+|+|||..|+|.
T Consensus       272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLL  351 (1157)
T KOG4278|consen  272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLL  351 (1157)
T ss_pred             eeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHH
Confidence            579999999999999975 3678999999988888899999999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCCC----
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN----  529 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~----  529 (663)
                      ++|+.+.   +..++-...+.+|.||+.|++||..+.  +|||||..+|.|+.++..+|++|||+++++..+..+.    
T Consensus       352 dYLRecn---r~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGA  426 (1157)
T KOG4278|consen  352 DYLRECN---RSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGA  426 (1157)
T ss_pred             HHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCc
Confidence            9999765   455777888999999999999999987  9999999999999999999999999999986554321    


Q ss_pred             -CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          530 -RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       530 -~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                       ..+.|.|||-+....++.|+|||+|||+|||+.| |..||.+      .++.+ +...+..++          +...++
T Consensus       427 KFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG------idlSq-VY~LLEkgy----------RM~~Pe  489 (1157)
T KOG4278|consen  427 KFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQ-VYGLLEKGY----------RMDGPE  489 (1157)
T ss_pred             cCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC------ccHHH-HHHHHhccc----------cccCCC
Confidence             2345999999998899999999999999999999 8888854      34333 333333333          223455


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                      .++..+.++++.||..+|.+||++.|+-+.++.+....
T Consensus       490 GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  490 GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence            67778999999999999999999999999998875543

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.8e-36  Score=308.73  Aligned_cols=244  Identities=23%  Similarity=0.263  Sum_probs=192.3

Q ss_pred             cccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          378 LGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       378 lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      ||+|+||.||++.. .+|+.||+|.+....    ...+.+..|+++++.++||||+++++++.+..+.++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999984 569999999986432    1234566799999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---CCC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---TPN  529 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---~~~  529 (663)
                      .+++....   ...+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++.......   ...
T Consensus        81 ~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  155 (277)
T cd05607          81 KYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA  155 (277)
T ss_pred             HHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence            98886433   345889999999999999999999998  9999999999999999999999999987664432   234


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE  609 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  609 (663)
                      ++..|+|||++.+..++.++||||+||++|||++|+.||......  ...............     ..      .....
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~-----~~------~~~~~  222 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRTLEDEV-----KF------EHQNF  222 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHhhcccc-----cc------ccccC
Confidence            667899999998888999999999999999999999999653221  111111111111110     00      00123


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       610 ~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                      ..++.+++.+|+..||++||+++|+++.+.
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            346788889999999999999977664443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.1e-36  Score=307.78  Aligned_cols=247  Identities=26%  Similarity=0.413  Sum_probs=195.3

Q ss_pred             hcccccccceEEEEEEe-----cCCcEEEEEEecCcccC--HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVTIS--EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||+|+||.||+|..     .++..||+|.++.....  ...+.+|+++++.++||||+++++++......++||||+
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   89 (283)
T cd05090          10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL   89 (283)
T ss_pred             eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcC
Confidence            46899999999999984     35688999998754322  357889999999999999999999999999999999999


Q ss_pred             CCCChhHhhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEec
Q 006055          448 TMGSLSALLHGNKG------------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSD  515 (663)
Q Consensus       448 ~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~D  515 (663)
                      ++|+|.+++.....            .....+++.....++.+++.||.|||+.+  |+||||||+||++++++.+||+|
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~~~~~kl~d  167 (283)
T cd05090          90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQLHVKISD  167 (283)
T ss_pred             CCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcCCCcEEecc
Confidence            99999999853221            11235789999999999999999999998  99999999999999999999999


Q ss_pred             cccccccCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHh
Q 006055          516 FGLAHLVGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVK  588 (663)
Q Consensus       516 fg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  588 (663)
                      ||+++......      ....+..|+|||++.+..++.++||||||+++|||++ |..||.....      ......+..
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~  241 (283)
T cd05090         168 LGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN------QEVIEMVRK  241 (283)
T ss_pred             ccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHc
Confidence            99997654322      1223456999999988889999999999999999998 9889864221      111111111


Q ss_pred             hcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          589 DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                      ... .          ........++.+++.+|+..||++||++.++.++|..
T Consensus       242 ~~~-~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         242 RQL-L----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             CCc-C----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            111 0          0111223467888899999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.9e-36  Score=305.32  Aligned_cols=248  Identities=23%  Similarity=0.350  Sum_probs=193.0

Q ss_pred             hcccccccceEEEEEEecC-Cc--EEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEec------CccEE
Q 006055          375 AEVLGKGTFGTAYKAVLEM-GT--IVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSM------DEKLL  442 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~-g~--~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l  442 (663)
                      .+.||+|+||.||+|.... +.  .||+|.++....   ..+.+.+|+++++.++|+||+++++++...      ...++
T Consensus         4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   83 (272)
T cd05075           4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV   83 (272)
T ss_pred             ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence            4679999999999999653 33  699998875422   235688899999999999999999987532      24689


Q ss_pred             EEEccCCCChhHhhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccc
Q 006055          443 VYDYLTMGSLSALLHGNK-GAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL  521 (663)
Q Consensus       443 v~ey~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~  521 (663)
                      ||||+++|+|.+++.... ......+++.....++.|++.||.|||+.+  |+||||||+||++++++.+||+|||+++.
T Consensus        84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  161 (272)
T cd05075          84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKK  161 (272)
T ss_pred             EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCcccc
Confidence            999999999998874322 112345899999999999999999999998  99999999999999999999999999987


Q ss_pred             cCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          522 VGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       522 ~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                      ......      ...+..|+|||+..+..++.++||||||+++|||++ |+.||.....      ......+......  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~~~--  233 (272)
T cd05075         162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN------SEIYDYLRQGNRL--  233 (272)
T ss_pred             cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHcCCCC--
Confidence            644321      123456999999998889999999999999999999 8888864211      1222222111110  


Q ss_pred             ccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       595 ~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                               .........+.+++.+||..+|++|||++|+++.|+++
T Consensus       234 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         234 ---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                     01112334678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.9e-36  Score=315.88  Aligned_cols=236  Identities=24%  Similarity=0.310  Sum_probs=185.7

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhc-CCCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGA-VNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      ++||+|+||.||+|.. .+++.||+|.++...    ...+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999995 468899999987542    122345556666654 4899999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++....     .+++.....++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++......   
T Consensus        81 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  153 (316)
T cd05592          81 GDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA  153 (316)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence            99999987532     4888999999999999999999998  9999999999999999999999999997543221   


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       ...++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+.....            ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~------~~~~~~~i~~~~~------------~~  215 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED------EDELFDSILNDRP------------HF  215 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCCC------------CC
Confidence             2346778999999998889999999999999999999999996532      1222222221110            00


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMS-EVIK  636 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~-ev~~  636 (663)
                      +.....++.+++.+|++.+|++||++. ++.+
T Consensus       216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            111234567888899999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.2e-36  Score=316.68  Aligned_cols=237  Identities=25%  Similarity=0.303  Sum_probs=188.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHH---hhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEG---VGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|.. .+|+.||||.++...    ...+.+.+|+++   ++.++||||+++++++...+..++||||
T Consensus         4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~   83 (324)
T cd05589           4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY   83 (324)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence            36799999999999984 568999999997542    112445566554   4567899999999999999999999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC-
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-  525 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~-  525 (663)
                      +++|+|..+++..      .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++..... 
T Consensus        84 ~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          84 AAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             CCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            9999999888642      4899999999999999999999998  999999999999999999999999998754322 


Q ss_pred             ---CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          526 ---STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       526 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                         ....++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+......          
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~------~~~~~~~i~~~~~~----------  219 (324)
T cd05589         156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD------EEEVFDSIVNDEVR----------  219 (324)
T ss_pred             CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCC----------
Confidence               12346778999999999889999999999999999999999996432      22222222222110          


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                        .+......+.+++.+|+..||++||     ++.+++++
T Consensus       220 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         220 --YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             --CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence              1112234577889999999999999     56676664

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.2e-36  Score=308.32  Aligned_cols=247  Identities=22%  Similarity=0.364  Sum_probs=195.0

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|...      ++..||+|.+.....  ...++.+|+.+++.++||||+++++++......++||||
T Consensus        11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~   90 (277)
T cd05062          11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL   90 (277)
T ss_pred             eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEec
Confidence            467999999999998743      356899999864322  245688999999999999999999999988999999999


Q ss_pred             cCCCChhHhhccCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccc
Q 006055          447 LTMGSLSALLHGNKGA-----GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL  521 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~  521 (663)
                      +++|+|.++++.....     ....+++..+..++.|++.||.|||+.+  ++||||||+||++++++.++|+|||+++.
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~~l~dfg~~~~  168 (277)
T cd05062          91 MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRD  168 (277)
T ss_pred             CCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCEEECCCCCccc
Confidence            9999999998753211     1234688999999999999999999998  99999999999999999999999999875


Q ss_pred             cCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          522 VGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       522 ~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                      ......      ..++..|+|||++.+..++.++|||||||++|||++ |..||....      .......+..... ..
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~------~~~~~~~~~~~~~-~~  241 (277)
T cd05062         169 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS------NEQVLRFVMEGGL-LD  241 (277)
T ss_pred             cCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHHcCCc-CC
Confidence            533221      223556999999998889999999999999999999 788885432      1222222221111 00


Q ss_pred             ccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       595 ~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                                ........+.+++.+|+..+|++|||+.|++++|++
T Consensus       242 ----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         242 ----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             ----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence                      011233468889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.2e-36  Score=315.39  Aligned_cols=236  Identities=24%  Similarity=0.321  Sum_probs=187.4

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhc-CCCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGA-VNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      +.||+|+||+||+|.. .+++.||||.++...    .....+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            3699999999999995 458899999987542    223456667777765 5999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----  525 (663)
                      |+|.+++...     ..+++.....++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++.....    
T Consensus        81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05619          81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT  153 (316)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence            9999998753     24789999999999999999999998  999999999999999999999999998753221    


Q ss_pred             CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          526 STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       526 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+.....            ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~------~~~~~~~i~~~~~------------~~  215 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD------EEELFQSIRMDNP------------CY  215 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCC------------CC
Confidence            12346778999999998889999999999999999999999996532      1122222211110            00


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMS-EVIK  636 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~-ev~~  636 (663)
                      +.....++.+++.+|+..||++||++. ++.+
T Consensus       216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            111234567888899999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.7e-36  Score=321.05  Aligned_cols=249  Identities=20%  Similarity=0.236  Sum_probs=190.0

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .+.||+|+||.||++. ..+++.||+|...     ...+.+|+++++.++||||+++++++......++|+||+. ++|.
T Consensus        97 ~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~  170 (391)
T PHA03212         97 LETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLY  170 (391)
T ss_pred             EEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHH
Confidence            4689999999999999 4578999999753     2457889999999999999999999999999999999986 6898


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC-----CCC
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-----STP  528 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~-----~~~  528 (663)
                      .++....     .+++..++.++.||+.||.|||+++  |+||||||+||+++.++.+||+|||+++.....     ...
T Consensus       171 ~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~  243 (391)
T PHA03212        171 CYLAAKR-----NIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW  243 (391)
T ss_pred             HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccc
Confidence            8886432     4789999999999999999999998  999999999999999999999999999754321     123


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCC-ChHHHHHHHHhhcc--ccc-ccc-------
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGV-DLPRWVQSIVKDEW--TSE-VFD-------  597 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~--~~~-~~d-------  597 (663)
                      .++..|+|||++.+..++.++|||||||++|||++|+.||.......+. +....+..++....  ..+ ..+       
T Consensus       244 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~  323 (391)
T PHA03212        244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDE  323 (391)
T ss_pred             cCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHH
Confidence            4678899999999888999999999999999999999887543221111 11111111111000  000 000       


Q ss_pred             ------------hh-hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          598 ------------LE-LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       598 ------------~~-~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                                  +. ...+....+...++.+++.+|+..||++|||++|+++
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        324 IYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                        00 0000111233557889999999999999999999997

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.1e-36  Score=310.72  Aligned_cols=258  Identities=27%  Similarity=0.350  Sum_probs=195.4

Q ss_pred             hcccccccceEEEEEE-----ecCCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecC--ccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAV-----LEMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMD--EKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-----~~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e  445 (663)
                      .+.||+|+||+||++.     ..++..||+|.++....  ....+.+|+++++.++||||+++++++...+  ..++|||
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   88 (283)
T cd05080           9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME   88 (283)
T ss_pred             ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEec
Confidence            3679999999998764     24678999999876432  3567889999999999999999999886543  4789999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+++|+|.+++...      .+++..+..++.|++.||.|||+.+  |+||||||+||++++++.++|+|||+++.....
T Consensus        89 ~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          89 YVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             CCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            99999999999743      3899999999999999999999998  999999999999999999999999999876543


Q ss_pred             CC-------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          526 ST-------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       526 ~~-------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                      ..       ..++..|+|||.+....++.++||||||++++||++|+.|+......- .+...............+..+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhhc
Confidence            21       123445999999988889999999999999999999999986432110 0000000000000000000000


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                      .. ..+.....+.++.+++.+||..+|++|||++++++.|+++.
T Consensus       240 ~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         240 GM-RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CC-CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            00 01112233457889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.6e-36  Score=308.28  Aligned_cols=250  Identities=26%  Similarity=0.406  Sum_probs=199.9

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCcccC-HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVTIS-EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||+|+||.||+++..      ++..+++|.++..... .+.+.+|++.+++++|+||+++++++......++||||+
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   89 (291)
T cd05094          10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM   89 (291)
T ss_pred             eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence            357999999999999742      3567999998755332 467899999999999999999999999999999999999


Q ss_pred             CCCChhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecc
Q 006055          448 TMGSLSALLHGNKG-----------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDF  516 (663)
Q Consensus       448 ~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Df  516 (663)
                      ++++|.+++.....           .....+++..++.++.+++.||.|||+++  |+||||||+||+++.++.++|+||
T Consensus        90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df  167 (291)
T cd05094          90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDF  167 (291)
T ss_pred             CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCcEEECCC
Confidence            99999999975321           11234899999999999999999999998  999999999999999999999999


Q ss_pred             ccccccCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhh
Q 006055          517 GLAHLVGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKD  589 (663)
Q Consensus       517 g~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  589 (663)
                      |++.......      ...++..|+|||++.+..++.++||||||+++|||++ |+.||.....      ...+... ..
T Consensus       168 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------~~~~~~~-~~  240 (291)
T cd05094         168 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN------TEVIECI-TQ  240 (291)
T ss_pred             CcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHH-hC
Confidence            9997654322      1223456999999998889999999999999999999 9999865321      1122211 11


Q ss_pred             cccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          590 EWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       590 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      .....          .....+..+.+++.+||..+|++||++++|+++|+++..
T Consensus       241 ~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         241 GRVLE----------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             CCCCC----------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            11111          011234568899999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.9e-36  Score=309.47  Aligned_cols=238  Identities=24%  Similarity=0.326  Sum_probs=186.4

Q ss_pred             ccccccceEEEEEEecC-------------------------CcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccc
Q 006055          377 VLGKGTFGTAYKAVLEM-------------------------GTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPL  430 (663)
Q Consensus       377 ~lg~G~~g~Vy~~~~~~-------------------------g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l  430 (663)
                      .||+|+||.||+|.+..                         ...||+|.+..... ....+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999997421                         13589998865432 23568888999999999999999


Q ss_pred             eEEEEecCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC-
Q 006055          431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY-  509 (663)
Q Consensus       431 ~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~-  509 (663)
                      +++|.+....++||||+++|+|..++....    ..+++..+..++.||++||+|||+.+  |+||||||+||+++.++ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCc
Confidence            999999999999999999999999987532    24789999999999999999999998  99999999999998654 


Q ss_pred             ------ceEEeccccccccCCCCCCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHH-hCCCCCccccCCCCCChHH
Q 006055          510 ------EARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELL-TGKAPTHALLNEEGVDLPR  581 (663)
Q Consensus       510 ------~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~ell-tg~~p~~~~~~~~~~~~~~  581 (663)
                            .+|++|||.+..........++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+   .  
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~--  230 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE---K--  230 (274)
T ss_pred             ccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---H--
Confidence                  379999999866544444455677999998865 56789999999999999995 6999986532211   1  


Q ss_pred             HHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          582 WVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       582 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                        ........            ..+.....++.+++.+||..+|++|||++++++.|+
T Consensus       231 --~~~~~~~~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 --ERFYEKKH------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             --HHHHHhcc------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence              11111100            001112236788999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.8e-36  Score=306.01  Aligned_cols=247  Identities=23%  Similarity=0.349  Sum_probs=196.3

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCcccC--HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVTIS--EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|...      ++..||+|+++.....  ...+.+|+.++..++||||+++++++......++++||
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~   89 (283)
T cd05091          10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSY   89 (283)
T ss_pred             HHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEc
Confidence            568999999999999853      3578999998754322  35688999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEec
Q 006055          447 LTMGSLSALLHGNKG-----------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSD  515 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~D  515 (663)
                      +.+++|.+++.....           .....+++..+..++.|++.||.|||+.+  |+||||||+||++++++.+||+|
T Consensus        90 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~kl~D  167 (283)
T cd05091          90 CSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISD  167 (283)
T ss_pred             CCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecCCCceEecc
Confidence            999999999853210           11235889999999999999999999998  99999999999999999999999


Q ss_pred             cccccccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHh
Q 006055          516 FGLAHLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVK  588 (663)
Q Consensus       516 fg~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  588 (663)
                      ||+++.......      ...+..|+|||++.+..++.++|||||||++|||++ |..||....      ...+...+..
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------~~~~~~~i~~  241 (283)
T cd05091         168 LGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS------NQDVIEMIRN  241 (283)
T ss_pred             cccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHHc
Confidence            999876543221      223457999999988889999999999999999998 888886421      2223332222


Q ss_pred             hcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          589 DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                      ....           ..+...+..+.+++.+|++.+|++||+++||++.|+.
T Consensus       242 ~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         242 RQVL-----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             CCcC-----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            2110           1112344567889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.2e-36  Score=315.40  Aligned_cols=236  Identities=24%  Similarity=0.294  Sum_probs=186.8

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhc-CCCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGA-VNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      ++||+|+||.||+|.. .+|+.||+|.++...    .....+..|..++.. .+||||+++++++.+.+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            3699999999999995 468999999987542    223456667777765 4899999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----  525 (663)
                      |+|.+++....     .+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||+++.....    
T Consensus        81 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05620          81 GDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA  153 (316)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence            99999887532     4788999999999999999999998  999999999999999999999999998753221    


Q ss_pred             CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          526 STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       526 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+.....       .     .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~------~~~~~~~~~~~~~-------~-----~  215 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD------EDELFESIRVDTP-------H-----Y  215 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCC-------C-----C
Confidence            12346778999999999899999999999999999999999996432      1122222211110       0     0


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMS-EVIK  636 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~-ev~~  636 (663)
                      +.....++.+++.+|++.||++||++. ++.+
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         216 PRWITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            111233567888899999999999984 5653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-35  Score=303.57  Aligned_cols=248  Identities=22%  Similarity=0.355  Sum_probs=196.5

Q ss_pred             hcccccccceEEEEEEecC----CcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCc------cE
Q 006055          375 AEVLGKGTFGTAYKAVLEM----GTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDE------KL  441 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~  441 (663)
                      .+.||+|+||.||+|....    +..||+|+++.....   ...+.+|++.++.++|+||+++++++...+.      .+
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   83 (273)
T cd05035           4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM   83 (273)
T ss_pred             ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence            4679999999999998532    378999998754332   3468899999999999999999999876554      68


Q ss_pred             EEEEccCCCChhHhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          442 LVYDYLTMGSLSALLHGNKG-AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       442 lv~ey~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                      +|+||+++|+|..++..... .....+++.....++.|++.||.|||+.+  ++||||||+||++++++.+||+|||+++
T Consensus        84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~  161 (273)
T cd05035          84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSK  161 (273)
T ss_pred             EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCcccee
Confidence            99999999999998854321 12346899999999999999999999998  9999999999999999999999999998


Q ss_pred             ccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccc
Q 006055          521 LVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTS  593 (663)
Q Consensus       521 ~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (663)
                      .......      ...+..|+|||++.+..++.++|||||||++|||++ |..||.....      ............. 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~~~-  234 (273)
T cd05035         162 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN------HEIYDYLRHGNRL-  234 (273)
T ss_pred             eccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCCC-
Confidence            7654322      122346999999988889999999999999999999 8888864321      1222222211110 


Q ss_pred             cccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       594 ~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                                ..+.....++.+++.+|+..||++||++.|+++.|+++
T Consensus       235 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         235 ----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                      11122345788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.2e-37  Score=319.60  Aligned_cols=233  Identities=27%  Similarity=0.333  Sum_probs=189.1

Q ss_pred             cccccccceEEEEEEe----cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      +.||+|+||.||++..    .+|+.||+|+++....   ....+..|++++++++||||+++++++.+....++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4699999999999874    3689999999975422   23457789999999999999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--  526 (663)
                      +|+|.+++...     ..+++..+..++.||+.||.|||+.+  |+||||||+||+++.++.+||+|||+++......  
T Consensus        82 ~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~  154 (318)
T cd05582          82 GGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK  154 (318)
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence            99999998643     24899999999999999999999998  9999999999999999999999999997654331  


Q ss_pred             --CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          527 --TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                        ...++..|+|||.+.+..++.++|||||||++|||++|+.||....      .......+.....            .
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~------~~~~~~~i~~~~~------------~  216 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD------RKETMTMILKAKL------------G  216 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC------HHHHHHHHHcCCC------------C
Confidence              2236778999999998888999999999999999999999996421      1222222222111            0


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSE  633 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~e  633 (663)
                      .+......+.+++.+|++.||++||++.+
T Consensus       217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            11112345778888999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.2e-36  Score=300.27  Aligned_cols=241  Identities=25%  Similarity=0.387  Sum_probs=195.1

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      ++||+|+||.||+|...+++.||+|.+.....  ....+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36999999999999988899999999875432  2346889999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-----C
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----P  528 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~  528 (663)
                      +++....    ..+++..+..++.+++.||.|||+.+  ++||||||+||++++++.+||+|||++........     .
T Consensus        81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            9986532    24789999999999999999999998  99999999999999999999999999875433211     1


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      .....|+|||++.+..++.++||||||+++||+++ |..||.....      ......+ ......          ....
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~------~~~~~~~-~~~~~~----------~~~~  217 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN------QQAREQV-EKGYRM----------SCPQ  217 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHH-HcCCCC----------CCCC
Confidence            22346999999998889999999999999999998 9999864321      1111111 111100          0011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                      ....++.+++.+|+..+|++||++.|+++.|.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            23457888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.1e-36  Score=314.98  Aligned_cols=190  Identities=23%  Similarity=0.358  Sum_probs=165.7

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .++||+|+||.||++... +++.+|+|.++....  ....+.+|+++++.++|+||++++++|.+.+..++||||+++|+
T Consensus        10 ~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   89 (333)
T cd06650          10 ISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS   89 (333)
T ss_pred             eccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCc
Confidence            468999999999999954 688999998865422  23568899999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--CCC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--TPN  529 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~  529 (663)
                      |.+++....     .+++.....++.+++.||.|||+.+ .|+||||||+||+++.++.+||+|||++.......  ...
T Consensus        90 L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~  163 (333)
T cd06650          90 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV  163 (333)
T ss_pred             HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcC-CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccCC
Confidence            999997532     4788999999999999999999752 39999999999999999999999999997654322  234


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCcc
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA  570 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~  570 (663)
                      ++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       164 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             CCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            67789999999988899999999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6.3e-36  Score=320.18  Aligned_cols=251  Identities=24%  Similarity=0.346  Sum_probs=197.9

Q ss_pred             hhcccccccceEEEEEEec------CCcEEEEEEecCcccC--HHHHHHHHHHhhcCC-CCCcccceEEEEecCccEEEE
Q 006055          374 SAEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVTIS--EREFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLLVY  444 (663)
Q Consensus       374 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  444 (663)
                      ..+.||+|+||.||+|.+.      .++.||||+++.....  ...+.+|++++.++. ||||++++++|......++||
T Consensus        41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~  120 (401)
T cd05107          41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT  120 (401)
T ss_pred             hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence            4678999999999999853      3468999999765322  346889999999997 999999999999999999999


Q ss_pred             EccCCCChhHhhccCCC---------------------------------------------------------------
Q 006055          445 DYLTMGSLSALLHGNKG---------------------------------------------------------------  461 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~---------------------------------------------------------------  461 (663)
                      ||+++|+|.++++....                                                               
T Consensus       121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (401)
T cd05107         121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK  200 (401)
T ss_pred             eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence            99999999999975421                                                               


Q ss_pred             ------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCce
Q 006055          462 ------------------------------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEA  511 (663)
Q Consensus       462 ------------------------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~  511 (663)
                                                    .....+++...+.++.|++.||.|||+.+  |+||||||+|||+++++.+
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl~~~~~~  278 (401)
T cd05107         201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLICEGKLV  278 (401)
T ss_pred             hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEEeCCCEE
Confidence                                          01134788889999999999999999987  9999999999999999999


Q ss_pred             EEeccccccccCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHH
Q 006055          512 RVSDFGLAHLVGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQ  584 (663)
Q Consensus       512 kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  584 (663)
                      ||+|||+++......      ...++..|+|||.+.+..++.++|||||||++|||++ |..||.....      .....
T Consensus       279 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~------~~~~~  352 (401)
T cd05107         279 KICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM------NEQFY  352 (401)
T ss_pred             EEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc------hHHHH
Confidence            999999998653221      1223456999999988889999999999999999998 8889864321      11111


Q ss_pred             HHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          585 SIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       585 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                      ..+......          ..+.....++.+++.+||..+|++||+++|+++.|+++.
T Consensus       353 ~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         353 NAIKRGYRM----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            111111100          011122346888889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=309.66  Aligned_cols=244  Identities=25%  Similarity=0.299  Sum_probs=194.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .++||+|+||+||++.. .+++.||||.+.....    ....+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05605           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG   84 (285)
T ss_pred             EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence            36799999999999994 5789999999865422    234577899999999999999999999998999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC--
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST--  527 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--  527 (663)
                      |+|.+++....   ...+++..+..++.|++.||.|||+.+  |+||||||+||++++++.++|+|||+++.......  
T Consensus        85 ~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  159 (285)
T cd05605          85 GDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR  159 (285)
T ss_pred             CcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccc
Confidence            99998886432   235899999999999999999999998  99999999999999999999999999987643322  


Q ss_pred             -CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          528 -PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       528 -~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                       ..++..|+|||++.+..++.++||||+||++|||++|+.||......   .....+...+....           ....
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~-----------~~~~  225 (285)
T cd05605         160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK---VKREEVERRVKEDQ-----------EEYS  225 (285)
T ss_pred             cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh---hHHHHHHHHhhhcc-----------cccC
Confidence             24567799999999888999999999999999999999999753211   11111111111100           0111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                      ......+.+++.+|+..||++||     ++++++++
T Consensus       226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            22344678889999999999999     88898775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.5e-36  Score=309.89  Aligned_cols=252  Identities=23%  Similarity=0.378  Sum_probs=200.0

Q ss_pred             hhcccccccceEEEEEEe--------cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEE
Q 006055          374 SAEVLGKGTFGTAYKAVL--------EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLL  442 (663)
Q Consensus       374 ~~~~lg~G~~g~Vy~~~~--------~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  442 (663)
                      ..+.||+|+||.||+|..        .++..||+|.+....  ...+.+.+|+.++..+ +||||+++++++......++
T Consensus        19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   98 (304)
T cd05101          19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV   98 (304)
T ss_pred             ecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEE
Confidence            457899999999999973        134579999987542  2246788999999999 89999999999999999999


Q ss_pred             EEEccCCCChhHhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCce
Q 006055          443 VYDYLTMGSLSALLHGNKGA-----------GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEA  511 (663)
Q Consensus       443 v~ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~  511 (663)
                      ||||+++|+|.+++......           ....+++..+..++.||+.||.|||+.+  |+||||||+||++++++.+
T Consensus        99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nili~~~~~~  176 (304)
T cd05101          99 IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENNVM  176 (304)
T ss_pred             EEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEEEcCCCcE
Confidence            99999999999999754221           1235889999999999999999999998  9999999999999999999


Q ss_pred             EEeccccccccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHH
Q 006055          512 RVSDFGLAHLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQ  584 (663)
Q Consensus       512 kl~Dfg~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  584 (663)
                      ||+|||+++.......      ...+..|+|||++.+..++.++||||||+++|||++ |..||...      ....+..
T Consensus       177 kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~------~~~~~~~  250 (304)
T cd05101         177 KIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI------PVEELFK  250 (304)
T ss_pred             EECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC------CHHHHHH
Confidence            9999999987643221      123456999999988889999999999999999998 78887542      2222322


Q ss_pred             HHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          585 SIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       585 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      .+..... .          .........+.+++.+||..+|++|||+.|+++.|+++..-
T Consensus       251 ~~~~~~~-~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         251 LLKEGHR-M----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             HHHcCCc-C----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            2211110 0          01122345688889999999999999999999999987554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.1e-36  Score=311.68  Aligned_cols=250  Identities=23%  Similarity=0.361  Sum_probs=188.9

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||.||+|... +++.||||.+....  .....+.+|+.+++.++||||+++++++.+....++||||+. ++
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~   88 (303)
T cd07869          10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TD   88 (303)
T ss_pred             eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cC
Confidence            367999999999999954 68999999987542  223567889999999999999999999999999999999996 58


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----CC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----ST  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----~~  527 (663)
                      |.+++....    ..+++..+..++.|++.||+|||+.+  |+||||||+||++++++.+||+|||+++.....    ..
T Consensus        89 l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  162 (303)
T cd07869          89 LCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN  162 (303)
T ss_pred             HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence            888776432    34788899999999999999999998  999999999999999999999999998754322    12


Q ss_pred             CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHh---hc----ccc----cc
Q 006055          528 PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK---DE----WTS----EV  595 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~----~~~----~~  595 (663)
                      ..++..|+|||++.+ ..++.++||||+||++|||++|+.||....+     ....+..+..   ..    +..    ..
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD-----IQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc-----HHHHHHHHHHHhCCCChhhccchhhccc
Confidence            335677999999865 4578899999999999999999999975321     1111111110   00    000    00


Q ss_pred             cchhhh---cccChH------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          596 FDLELL---RYQNVE------EEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       596 ~d~~~~---~~~~~~------~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      +++...   ......      .....+.+++.+|+..||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000000   000000      11245678889999999999999999987

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.7e-36  Score=315.15  Aligned_cols=237  Identities=23%  Similarity=0.307  Sum_probs=190.6

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      +.||+|+||+||++.. .+++.||||.++...    .....+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999985 458899999987542    2234567788888877 799999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+||++++++.+||+|||+++......   
T Consensus        81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  153 (318)
T cd05570          81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT  153 (318)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence            99999887532     4899999999999999999999998  9999999999999999999999999987532221   


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       ...++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+.....            ..
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~------~~~~~~~i~~~~~------------~~  215 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD------EDELFQSILEDEV------------RY  215 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC------HHHHHHHHHcCCC------------CC
Confidence             1235677999999999999999999999999999999999996432      1222222221111            00


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSM-----SEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~-----~ev~~~  637 (663)
                      +......+.+++.+|+..||++||++     .+++++
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            11223467888899999999999999     888764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7e-36  Score=302.29  Aligned_cols=241  Identities=24%  Similarity=0.376  Sum_probs=191.8

Q ss_pred             ccccccceEEEEEEec---CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          377 VLGKGTFGTAYKAVLE---MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       377 ~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .||+|+||.||+|.+.   .+..||+|.+.....  ..+.+.+|+.++++++|+||+++++++. ....++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999753   356799999875432  2356889999999999999999999875 457899999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC----
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST----  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~----  527 (663)
                      |.+++....    ..+++..+++++.|++.||.|||+++  ++||||||+||+++.++.+||+|||+++.......    
T Consensus        81 L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            999987432    35899999999999999999999998  99999999999999999999999999976543321    


Q ss_pred             ---CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          528 ---PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       528 ---~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                         ...+..|+|||.+.+..++.++||||||+++||+++ |..||.....      ......+... ...          
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~-~~~----------  217 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG------PEVMSFIEQG-KRL----------  217 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHHHCC-CCC----------
Confidence               112346999999988888999999999999999996 9999965321      1222221111 100          


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                      ..+.....++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            11122345778899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.2e-36  Score=316.64  Aligned_cols=232  Identities=25%  Similarity=0.299  Sum_probs=184.8

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHH-HhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIE-GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      +.||+|+||+||+|.. .+|+.||+|.+.....    ..+.+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            3699999999999995 5799999999865321    1234445544 46789999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++....     .+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++......   
T Consensus        81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (323)
T cd05575          81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT  153 (323)
T ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence            99999987532     4788999999999999999999998  9999999999999999999999999987542221   


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       ...++..|+|||++.+..++.++|||||||++|||++|+.||...      +.......+......            .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~------~~~~~~~~i~~~~~~------------~  215 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR------DTAEMYDNILNKPLR------------L  215 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC------CHHHHHHHHHcCCCC------------C
Confidence             123677899999999988999999999999999999999999642      222233333222110            0


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMS  632 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~  632 (663)
                      .......+.+++.+|++.||++||++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         216 KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            011234677888899999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-35  Score=302.48  Aligned_cols=248  Identities=23%  Similarity=0.383  Sum_probs=194.3

Q ss_pred             cccccccceEEEEEEec-CCc--EEEEEEecCcc--cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVLE-MGT--IVAVKRLKDVT--ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~-~g~--~vavK~l~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      ++||+|+||.||+|... ++.  .+|+|.++...  .....+.+|++++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            46999999999999964 343  46888887532  2345788999999999 899999999999999999999999999


Q ss_pred             CChhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccc
Q 006055          450 GSLSALLHGNKG-----------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGL  518 (663)
Q Consensus       450 gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~  518 (663)
                      |+|.++++....           .....+++..+..++.|++.||+|||+.+  ++||||||+||++++++.+||+|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCCCC
Confidence            999999975431           11234789999999999999999999998  99999999999999999999999999


Q ss_pred             ccccCCCC---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          519 AHLVGPSS---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       519 a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                      +.......   ....+..|+|||++....++.++||||||++++||++ |..||....      ..............  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~------~~~~~~~~~~~~~~--  230 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYEKLPQGYRL--  230 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC------HHHHHHHHhCCCCC--
Confidence            86432211   1122446999999988889999999999999999997 999985421      11222222111100  


Q ss_pred             ccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       595 ~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                               ........++.+++.+|+..+|.+|||+.|+++.|+++.
T Consensus       231 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         231 ---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                     011122346789999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-38  Score=297.49  Aligned_cols=242  Identities=23%  Similarity=0.385  Sum_probs=206.1

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .++||+|+||.||+|. .++|+++|+|.+.. ..+-.++.+|+.+|++.+.|++|++||.|....+.++|||||..|+..
T Consensus        38 ~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiS  116 (502)
T KOG0574|consen   38 VGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSIS  116 (502)
T ss_pred             HHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHH
Confidence            4679999999999998 56799999999865 345678999999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC----CCCCC
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP----SSTPN  529 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~----~~~~~  529 (663)
                      ++++...    .++.+..+..++...++||+|||...  -||||||+.|||++.+|.+||+|||.|..+..    ..+..
T Consensus       117 DI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVI  190 (502)
T KOG0574|consen  117 DIMRARR----KPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVI  190 (502)
T ss_pred             HHHHHhc----CCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccc
Confidence            9998543    57999999999999999999999986  89999999999999999999999999976533    34567


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE  609 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  609 (663)
                      +|+-|||||++..-.|..++||||+|++..||..|++||.........               --+.......+..+++.
T Consensus       191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---------------FMIPT~PPPTF~KPE~W  255 (502)
T KOG0574|consen  191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---------------FMIPTKPPPTFKKPEEW  255 (502)
T ss_pred             cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee---------------EeccCCCCCCCCChHhh
Confidence            889999999999999999999999999999999999999764332210               00111111234556777


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       610 ~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      ..++-+++++|+-++|++|-|+.++++|-
T Consensus       256 S~~F~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  256 SSEFNDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             hhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence            88999999999999999999999988763

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.2e-35  Score=302.28  Aligned_cols=251  Identities=22%  Similarity=0.332  Sum_probs=201.3

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||++. ..+|+.+|||.+.....    ...++.+|+.+++.++|+||+++++++.+.+..+++|||+++
T Consensus         7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~   86 (267)
T cd08229           7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA   86 (267)
T ss_pred             hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCC
Confidence            4679999999999999 46799999998865322    235788999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC--
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST--  527 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--  527 (663)
                      ++|.+++..... ....+++..+..++.+++.||.|||+.+  ++|+||||+||+++.++.++|+|||++........  
T Consensus        87 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd08229          87 GDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA  163 (267)
T ss_pred             CCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccCCccc
Confidence            999999864321 2345899999999999999999999998  99999999999999999999999999876644322  


Q ss_pred             --CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          528 --PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       528 --~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                        ..++..|+|||++.+..++.++||||||+++|+|++|..||.....    ........+.....      +.    ..
T Consensus       164 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~------~~----~~  229 (267)
T cd08229         164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQCDY------PP----LP  229 (267)
T ss_pred             ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhhhhcCCC------CC----CC
Confidence              2356679999999888889999999999999999999999864221    11122111111100      00    01


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                      .......+.+++.+|+..+|++|||+.+|++.++++.
T Consensus       230 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         230 SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            1224457888899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-36  Score=301.95  Aligned_cols=244  Identities=26%  Similarity=0.423  Sum_probs=201.5

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .++||+|+||.||+|..+++..||||.+.......+++.+|+.+++.++|+|++++++++......++||||+++++|.+
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   90 (261)
T cd05034          11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD   90 (261)
T ss_pred             eeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHH
Confidence            46799999999999998888899999998777777889999999999999999999999988889999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-----CCC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----TPN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-----~~~  529 (663)
                      ++....   ...+++..+..++.+++.|+.|||+.+  ++|+||||+||++++++.+||+|||.++......     ...
T Consensus        91 ~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  165 (261)
T cd05034          91 FLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAK  165 (261)
T ss_pred             HHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccC
Confidence            997643   235899999999999999999999998  9999999999999999999999999997765321     112


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .+..|+|||.+.+..++.++||||||++++||++ |+.||....      .......+.....           ......
T Consensus       166 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~------~~~~~~~~~~~~~-----------~~~~~~  228 (261)
T cd05034         166 FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT------NREVLEQVERGYR-----------MPRPPN  228 (261)
T ss_pred             CCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCC-----------CCCCCC
Confidence            3346999999998889999999999999999998 999985422      1112222211100           001111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                      .+.++.+++.+|+..+|++||+++++++.|+.
T Consensus       229 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         229 CPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            24468889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.2e-36  Score=305.71  Aligned_cols=247  Identities=25%  Similarity=0.383  Sum_probs=195.7

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|...      .+..||+|.+.....  ....+.+|+.+++.++|+||+++++++.+....++||||
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   90 (277)
T cd05036          11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL   90 (277)
T ss_pred             eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence            367999999999999964      367899998865432  245689999999999999999999999998999999999


Q ss_pred             cCCCChhHhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC---ceEEeccccccc
Q 006055          447 LTMGSLSALLHGNKG--AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY---EARVSDFGLAHL  521 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~---~~kl~Dfg~a~~  521 (663)
                      +++++|.++++....  .....++|..+..++.||+.||+|||+.+  ++||||||+||+++.++   .+||+|||+++.
T Consensus        91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~  168 (277)
T cd05036          91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARD  168 (277)
T ss_pred             CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEeccCccccc
Confidence            999999999975432  12235899999999999999999999998  99999999999998765   599999999986


Q ss_pred             cCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          522 VGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       522 ~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                      ......      ......|+|||++.+..++.++|||||||++|||++ |..||.....      ...+..+......  
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~------~~~~~~~~~~~~~--  240 (277)
T cd05036         169 IYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN------QEVMEFVTGGGRL--  240 (277)
T ss_pred             cCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHcCCcC--
Confidence            633221      112346999999998889999999999999999997 9999864322      1222222211110  


Q ss_pred             ccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       595 ~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                               ..+...+..+.+++.+|+..+|++||++.+|+++|++
T Consensus       241 ---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         241 ---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence                     0112234568889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1e-35  Score=300.75  Aligned_cols=243  Identities=27%  Similarity=0.422  Sum_probs=195.8

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEe-cCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS-MDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ey~~~gsL~  453 (663)
                      .+.||+|+||.||++... |..||+|.++... ..+.+.+|+.++++++|+|++++++++.. ....++||||+++|+|.
T Consensus        11 ~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~   88 (256)
T cd05082          11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV   88 (256)
T ss_pred             eeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHH
Confidence            468999999999999876 8889999986533 35678899999999999999999997654 45689999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-CCCCCc
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-TPNRVA  532 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~  532 (663)
                      ++++...   ...+++..+..++.+++.||+|||+++  ++||||||+||++++++.+||+|||+++...... ....+.
T Consensus        89 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  163 (256)
T cd05082          89 DYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV  163 (256)
T ss_pred             HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceeccccCCCCccce
Confidence            9987543   235889999999999999999999998  9999999999999999999999999987654332 223445


Q ss_pred             cccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHH
Q 006055          533 GYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMV  611 (663)
Q Consensus       533 ~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  611 (663)
                      .|+|||++.+..++.++|||||||++|||++ |+.||...      +.......+.. .....          .....+.
T Consensus       164 ~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~------~~~~~~~~~~~-~~~~~----------~~~~~~~  226 (256)
T cd05082         164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI------PLKDVVPRVEK-GYKMD----------APDGCPP  226 (256)
T ss_pred             eecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHhc-CCCCC----------CCCCCCH
Confidence            7999999988889999999999999999998 99998532      22222222211 11111          1112345


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          612 QLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       612 ~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                      .+.+++.+|+..+|++|||+.++++.|+++
T Consensus       227 ~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         227 VVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            678889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.6e-36  Score=306.49  Aligned_cols=248  Identities=23%  Similarity=0.310  Sum_probs=188.1

Q ss_pred             ccccccceEEEEEEec---CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          377 VLGKGTFGTAYKAVLE---MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       377 ~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .||+|+||.||+|...   ++..+|+|.++....  ....+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            5899999999999854   346799998875532  23578889999999999999999999999889999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-----
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----  526 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-----  526 (663)
                      |.++++..........++..+..++.|++.|++|||+.+  ++||||||+||+++.++.+||+|||.++......     
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~  159 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP  159 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence            999997644323345678888899999999999999998  9999999999999999999999999997543322     


Q ss_pred             -CCCCCccccCccccCCC-------CCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          527 -TPNRVAGYRAPEVTDPC-------KVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~-------~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                       ...++..|+|||++.+.       .++.++||||||+++|||++ |+.||......+      ........ ......+
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~-~~~~~~~  232 (269)
T cd05087         160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ------VLTYTVRE-QQLKLPK  232 (269)
T ss_pred             CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH------HHHHHhhc-ccCCCCC
Confidence             12234569999998642       35789999999999999996 999996532211      11111111 0011111


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                      +..     .......+.+++..|+ .+|++|||++||++.|+
T Consensus       233 ~~~-----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         233 PRL-----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             Ccc-----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111     0112235667888999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.1e-35  Score=302.68  Aligned_cols=246  Identities=22%  Similarity=0.353  Sum_probs=192.5

Q ss_pred             hcccccccceEEEEEEe-cCCc----EEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGT----IVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||+|+||+||+|.+ .+|+    .+++|.+.....  ...++..|+..++.++||||+++++++. ....++++||+
T Consensus        12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~   90 (279)
T cd05111          12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLS   90 (279)
T ss_pred             ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeC
Confidence            47899999999999985 3454    477887754321  2356778888899999999999999875 45578999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST  527 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  527 (663)
                      ++|+|.++++...    ..+++..+..++.||+.||.|||+.+  ++||||||+||++++++.+||+|||+++.......
T Consensus        91 ~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T cd05111          91 PLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK  164 (279)
T ss_pred             CCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence            9999999997543    35899999999999999999999998  99999999999999999999999999986543221


Q ss_pred             ------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          528 ------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       528 ------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                            ..++..|+|||++.+..++.++||||||+++|||++ |+.||.....       ......+.......  .   
T Consensus       165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~--~---  232 (279)
T cd05111         165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-------HEVPDLLEKGERLA--Q---  232 (279)
T ss_pred             ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCcCC--C---
Confidence                  123456999999988889999999999999999998 9999865321       11112222111100  0   


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                           ......++.+++.+||..+|++|||+.|+++.|..+...
T Consensus       233 -----~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         233 -----PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             -----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence                 111234567888899999999999999999999887643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6e-36  Score=302.80  Aligned_cols=238  Identities=26%  Similarity=0.408  Sum_probs=190.9

Q ss_pred             cccccccceEEEEEEecCCc-----------EEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEE
Q 006055          376 EVLGKGTFGTAYKAVLEMGT-----------IVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVY  444 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  444 (663)
                      +.||+|+||.||+|...+..           .|++|.+.........+.+|+.+++.++||||+++++++.. ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            46999999999999965432           58888876554436789999999999999999999999988 7889999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC-------ceEEeccc
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY-------EARVSDFG  517 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~-------~~kl~Dfg  517 (663)
                      ||+++|+|.+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++       .+||+|||
T Consensus        80 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          80 EYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999997543    25889999999999999999999998  99999999999999888       79999999


Q ss_pred             cccccCCCCCCCCCccccCccccCCC--CCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          518 LAHLVGPSSTPNRVAGYRAPEVTDPC--KVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       518 ~a~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                      ++..........+...|+|||++.+.  .++.++||||||++++||++ |..||......      .+..... ...  .
T Consensus       154 ~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~------~~~~~~~-~~~--~  224 (259)
T cd05037         154 IPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS------EKERFYQ-DQH--R  224 (259)
T ss_pred             cccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch------hHHHHHh-cCC--C
Confidence            99876654444556679999999876  78899999999999999999 57777553211      1111111 000  0


Q ss_pred             ccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       595 ~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                      .      ..    .....+.+++.+|+..+|++|||+.|+++.|+
T Consensus       225 ~------~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         225 L------PM----PDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             C------CC----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0      00    01157888999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-35  Score=300.02  Aligned_cols=245  Identities=29%  Similarity=0.435  Sum_probs=199.9

Q ss_pred             cccccccceEEEEEEecC----CcEEEEEEecCcccC--HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVLEM----GTIVAVKRLKDVTIS--EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      +.||+|+||.||+|....    +..||+|.++.....  .+.+.+|++.+..++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999543    889999999866443  57889999999999999999999999998899999999999


Q ss_pred             CChhHhhccCCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          450 GSLSALLHGNKGA----GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       450 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      ++|.+++......    ....+++..+..++.+++.||+|||+.+  ++||||||+||+++.++.+||+|||.+......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEcccccccccccc
Confidence            9999999864210    1246899999999999999999999998  999999999999999999999999999877553


Q ss_pred             C------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          526 S------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       526 ~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                      .      ...++..|+|||.+....++.++||||+|+++|||++ |..||....      .......+.....       
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~~~~~~~~~-------  225 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS------NEEVLEYLRKGYR-------  225 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHHcCCC-------
Confidence            2      2234567999999988889999999999999999999 699986541      1222222221110       


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                          ...+.....++.+++.+|+..+|++||++.|++++|+
T Consensus       226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 ----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                0111223457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=8.9e-36  Score=307.59  Aligned_cols=249  Identities=24%  Similarity=0.395  Sum_probs=198.0

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCcccC--HHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVTIS--EREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  445 (663)
                      .+.||+|+||.||++...      ....+|+|.+......  ...+.+|++++.++ +|+||+++++++......+++||
T Consensus        17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e   96 (293)
T cd05053          17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVE   96 (293)
T ss_pred             eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEE
Confidence            468999999999999853      2468999998754322  34688899999999 89999999999999999999999


Q ss_pred             ccCCCChhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEe
Q 006055          446 YLTMGSLSALLHGNKG-----------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVS  514 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~  514 (663)
                      |+++|+|.++++....           .....+++..+..++.|++.||.|||+.+  |+||||||+||++++++.+||+
T Consensus        97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~~~~~~kL~  174 (293)
T cd05053          97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDHVMKIA  174 (293)
T ss_pred             eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEEcCCCeEEeC
Confidence            9999999999864320           12346899999999999999999999998  9999999999999999999999


Q ss_pred             ccccccccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHH
Q 006055          515 DFGLAHLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV  587 (663)
Q Consensus       515 Dfg~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  587 (663)
                      |||+++.......      ...+..|+|||++.+..++.++|||||||++|||++ |..||....      .........
T Consensus       175 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~~~~~~~~~  248 (293)
T cd05053         175 DFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------VEELFKLLK  248 (293)
T ss_pred             ccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC------HHHHHHHHH
Confidence            9999987654321      113356999999988889999999999999999998 989985422      112111111


Q ss_pred             hhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                      ....           ..........+.+++.+|+..+|++|||++|+++.|+++.
T Consensus       249 ~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         249 EGYR-----------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             cCCc-----------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            1110           0111223446888999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-35  Score=300.25  Aligned_cols=242  Identities=26%  Similarity=0.392  Sum_probs=194.6

Q ss_pred             cccccccceEEEEEEec--C--CcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVLE--M--GTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~--~--g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      ++||+|+||.||+|...  +  +..+|+|.+.....  ..+.+.+|+.+++.+.|+|++++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999742  2  36899999876544  4567899999999999999999999875 4568999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN  529 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  529 (663)
                      |+|.+++....     .+++..+..++.|++.||.|||+.+  ++||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            99999997533     5899999999999999999999998  9999999999999999999999999998664432211


Q ss_pred             -------CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhh
Q 006055          530 -------RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL  601 (663)
Q Consensus       530 -------~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  601 (663)
                             ++..|+|||.+.+..++.++||||||+++|||++ |..||.....      ......+. .....        
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~------~~~~~~~~-~~~~~--------  217 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG------AEVIAMLE-SGERL--------  217 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHH-cCCcC--------
Confidence                   1245999999998889999999999999999998 9999865321      12222111 11110        


Q ss_pred             cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       602 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                        ..+......+.+++.+|+..+|++||++.++++.|+++.
T Consensus       218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence              111223356788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.8e-36  Score=320.94  Aligned_cols=189  Identities=23%  Similarity=0.355  Sum_probs=165.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||++.. .+++.||+|++.....    ....+.+|+.++..++|+||+++++.+.+....++||||+++
T Consensus         6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~g   85 (363)
T cd05628           6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG   85 (363)
T ss_pred             eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCC
Confidence            36899999999999984 5689999999875421    234678899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----  525 (663)
                      |+|.+++....     .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++.....    
T Consensus        86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          86 GDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            99999997532     4889999999999999999999998  999999999999999999999999998754321    


Q ss_pred             -----------------------------------CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCcc
Q 006055          526 -----------------------------------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA  570 (663)
Q Consensus       526 -----------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~  570 (663)
                                                         ....+|..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                               012467789999999998999999999999999999999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-36  Score=321.13  Aligned_cols=241  Identities=22%  Similarity=0.324  Sum_probs=195.2

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||+|.. .+|+.||||+++...    .....+.+|++++..++|+||+++++++.+.+..++||||+++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   85 (350)
T cd05573           6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG   85 (350)
T ss_pred             EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence            36799999999999995 479999999987542    2345688999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||++.......   
T Consensus        86 ~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          86 GDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            9999999754     25889999999999999999999998  9999999999999999999999999997654332   


Q ss_pred             ------------------------------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCC
Q 006055          527 ------------------------------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEG  576 (663)
Q Consensus       527 ------------------------------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~  576 (663)
                                                    ...++..|+|||++.+..++.++|||||||++|||++|+.||....    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~----  234 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT----  234 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC----
Confidence                                          2236677999999999999999999999999999999999996532    


Q ss_pred             CChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 006055          577 VDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPS-MSEVIKR  637 (663)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt-~~ev~~~  637 (663)
                        .......+....  ...      ..+.......++.+++.+|+. ||++||+ ++|++++
T Consensus       235 --~~~~~~~i~~~~--~~~------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 --LQETYNKIINWK--ESL------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             --HHHHHHHHhccC--Ccc------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence              112222222100  000      000011134467788889997 9999999 9999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.5e-36  Score=329.47  Aligned_cols=243  Identities=24%  Similarity=0.314  Sum_probs=194.6

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecC--------ccEE
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMD--------EKLL  442 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------~~~l  442 (663)
                      .+.||+|+||+||+|. ..+|+.||||.+......   ...+.+|+..+..++|+|++++++.+....        ..++
T Consensus        37 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~l  116 (496)
T PTZ00283         37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIAL  116 (496)
T ss_pred             EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEE
Confidence            4689999999999998 567999999998755333   346788999999999999999887765432        2579


Q ss_pred             EEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccccc
Q 006055          443 VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV  522 (663)
Q Consensus       443 v~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~  522 (663)
                      ||||+++|+|.++++.... ....+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus       117 V~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~vkL~DFGls~~~  193 (496)
T PTZ00283        117 VLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLGDFGFSKMY  193 (496)
T ss_pred             EEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCEEEEecccCeec
Confidence            9999999999999875332 2346899999999999999999999998  999999999999999999999999999865


Q ss_pred             CCC------CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccccccc
Q 006055          523 GPS------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF  596 (663)
Q Consensus       523 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  596 (663)
                      ...      ....++..|+|||++.+..++.++|||||||++|||++|+.||...      +....+.........    
T Consensus       194 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~------~~~~~~~~~~~~~~~----  263 (496)
T PTZ00283        194 AATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE------NMEEVMHKTLAGRYD----  263 (496)
T ss_pred             cccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHhcCCCC----
Confidence            432      1234677899999999989999999999999999999999999642      233333333322111    


Q ss_pred             chhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          597 DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       597 d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                             ..+.....++.+++.+||..||++||++.+++++
T Consensus       264 -------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        264 -------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             -------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                   0111233467888999999999999999999875

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.1e-36  Score=320.03  Aligned_cols=241  Identities=22%  Similarity=0.288  Sum_probs=192.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||++.. .+++.||+|.+....    .....+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus        48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~g  127 (370)
T cd05596          48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPG  127 (370)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCC
Confidence            46899999999999994 568999999986532    2234578899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.++++..      .++......++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.......   
T Consensus       128 g~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~  199 (370)
T cd05596         128 GDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR  199 (370)
T ss_pred             CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence            9999998743      3778888899999999999999998  9999999999999999999999999997664321   


Q ss_pred             --CCCCCccccCccccCCC----CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          527 --TPNRVAGYRAPEVTDPC----KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~----~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                        ...++..|+|||++.+.    .++.++|||||||++|||++|+.||....      .......+........      
T Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~i~~~~~~~~------  267 (370)
T cd05596         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKIMDHKNSLT------  267 (370)
T ss_pred             CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC------HHHHHHHHHcCCCcCC------
Confidence              23467789999998653    47889999999999999999999996532      2222333322111000      


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDN--RPSMSEVIKR  637 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~--RPt~~ev~~~  637 (663)
                        .+.......++.+++.+|+..+|++  ||+++|++++
T Consensus       268 --~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         268 --FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             --CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence              1111123446778888999999988  9999999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.5e-35  Score=303.79  Aligned_cols=251  Identities=25%  Similarity=0.385  Sum_probs=200.0

Q ss_pred             hcccccccceEEEEEEecC-----CcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEe-cCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLEM-----GTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYS-MDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|....     +..|++|++.....  ....+.+|+.+++.++|+|++++++++.. ....++++||
T Consensus        11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~   90 (280)
T cd05043          11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPY   90 (280)
T ss_pred             eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEc
Confidence            4689999999999999765     78899999875422  24568899999999999999999998876 4678999999


Q ss_pred             cCCCChhHhhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccC
Q 006055          447 LTMGSLSALLHGNKGA---GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG  523 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~  523 (663)
                      +++|+|.+++......   ....+++..+..++.+++.||.|||+.+  ++||||||+||++++++.+||+|||+++.+.
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl~d~g~~~~~~  168 (280)
T cd05043          91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLF  168 (280)
T ss_pred             CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEECCCCCccccc
Confidence            9999999998754321   1246899999999999999999999998  9999999999999999999999999998664


Q ss_pred             CCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhccccccc
Q 006055          524 PSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF  596 (663)
Q Consensus       524 ~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  596 (663)
                      +..      ...++..|+|||++.+..++.++||||||+++||+++ |+.||....      ...+... ......    
T Consensus       169 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~~~~~-~~~~~~----  237 (280)
T cd05043         169 PMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID------PFEMAAY-LKDGYR----  237 (280)
T ss_pred             CCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC------HHHHHHH-HHcCCC----
Confidence            332      1223456999999988889999999999999999999 999996532      1122211 111110    


Q ss_pred             chhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          597 DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       597 d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                            .......+.++.+++.+||..+|++|||+.|+++.|+++...
T Consensus       238 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         238 ------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             ------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence                  001112234678899999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.9e-36  Score=306.65  Aligned_cols=239  Identities=28%  Similarity=0.415  Sum_probs=188.7

Q ss_pred             cccccccceEEEEEEecC--------CcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          376 EVLGKGTFGTAYKAVLEM--------GTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      +.||+|+||+||+|....        ...||+|.+..... ..+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998532        23488888765432 245688899999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc--------eEEecccc
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE--------ARVSDFGL  518 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~--------~kl~Dfg~  518 (663)
                      +++|+|.++++...    ..+++..+..++.||+.||.|||+.+  |+||||||+||+++.++.        ++++|||.
T Consensus        81 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccccc
Confidence            99999999997543    25889999999999999999999998  999999999999987765        69999999


Q ss_pred             ccccCCCCCCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCC-CCCccccCCCCCChHHHHHHHHhhccccccc
Q 006055          519 AHLVGPSSTPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGK-APTHALLNEEGVDLPRWVQSIVKDEWTSEVF  596 (663)
Q Consensus       519 a~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  596 (663)
                      +..........++..|+|||++.+ ..++.++||||||+++|||++|. .|+.....      .... ......      
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~------~~~~-~~~~~~------  221 (258)
T cd05078         155 SITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS------QKKL-QFYEDR------  221 (258)
T ss_pred             ccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH------HHHH-HHHHcc------
Confidence            887766555567778999999976 45788999999999999999985 55533211      1111 111110      


Q ss_pred             chhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          597 DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       597 d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                            ...+.....++.+++.+|++.+|++|||++++++.|+
T Consensus       222 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 ------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  0001112246788999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.4e-35  Score=302.01  Aligned_cols=244  Identities=24%  Similarity=0.450  Sum_probs=197.2

Q ss_pred             hcccccccceEEEEEEec-CC---cEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MG---TIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|... ++   ..+|+|.++....  ....+..|+++++.++|+|++++.+++...+..++||||++
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (268)
T cd05063          10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME   89 (268)
T ss_pred             eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCC
Confidence            468999999999999854 33   3799999865422  24578899999999999999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCC
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP  528 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  528 (663)
                      +++|.++++...    ..+++..+..++.+++.|++|||+.+  ++||||||+||++++++.+||+|||++.........
T Consensus        90 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  163 (268)
T cd05063          90 NGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG  163 (268)
T ss_pred             CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence            999999997532    35899999999999999999999998  999999999999999999999999999766433211


Q ss_pred             -------CCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          529 -------NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       529 -------~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                             .....|+|||++....++.++|||||||++|||++ |+.||.....      ......+....          
T Consensus       164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------~~~~~~i~~~~----------  227 (268)
T cd05063         164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------HEVMKAINDGF----------  227 (268)
T ss_pred             ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHHhcCC----------
Confidence                   11235999999988889999999999999999998 9999964321      22222222111          


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                       ..+...+...++.+++.+|+..+|++||++.+|++.|+++
T Consensus       228 -~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 -RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             1111223345788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.5e-35  Score=306.62  Aligned_cols=254  Identities=21%  Similarity=0.370  Sum_probs=197.9

Q ss_pred             hcccccccceEEEEEEec-CCc--EEEEEEecCcc--cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGT--IVAVKRLKDVT--ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~--~vavK~l~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .++||+|+||.||+|..+ ++.  .+++|.++...  ...+.+.+|++++.++ +||||+++++++......++|+||++
T Consensus         7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~   86 (297)
T cd05089           7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP   86 (297)
T ss_pred             eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence            457999999999999864 343  47888887432  2245788999999999 79999999999998889999999999


Q ss_pred             CCChhHhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccc
Q 006055          449 MGSLSALLHGNKGA-----------GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFG  517 (663)
Q Consensus       449 ~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg  517 (663)
                      +|+|.++++.....           ....+++..+..++.|++.||+|||+.+  |+||||||+||++++++.+||+|||
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg  164 (297)
T cd05089          87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLASKIADFG  164 (297)
T ss_pred             CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCeEEECCcC
Confidence            99999999753211           1135889999999999999999999998  9999999999999999999999999


Q ss_pred             cccccCCCCC---CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccc
Q 006055          518 LAHLVGPSST---PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTS  593 (663)
Q Consensus       518 ~a~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (663)
                      ++........   ...+..|+|||++.+..++.++|||||||++|||++ |..||....      ........... .. 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~------~~~~~~~~~~~-~~-  236 (297)
T cd05089         165 LSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT------CAELYEKLPQG-YR-  236 (297)
T ss_pred             CCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhcC-CC-
Confidence            9864332111   112345999999988889999999999999999997 999996432      12222222111 00 


Q ss_pred             cccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 006055          594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ  647 (663)
Q Consensus       594 ~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~  647 (663)
                               ..........+.+++.+|+..+|.+||+++++++.|+++......
T Consensus       237 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         237 ---------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence                     001112334678899999999999999999999999988765433

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.3e-36  Score=319.33  Aligned_cols=242  Identities=21%  Similarity=0.312  Sum_probs=193.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||++.. .+|+.||+|.++....    ..+.+.+|+.+++.++|+||+++++++.+.+..++||||+++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   85 (330)
T cd05601           6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG   85 (330)
T ss_pred             EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCC
Confidence            36799999999999984 5789999999976432    345688999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC--
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST--  527 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--  527 (663)
                      |+|.+++....    ..+++.....++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++........  
T Consensus        86 ~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          86 GDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence            99999997642    35899999999999999999999998  99999999999999999999999999987654321  


Q ss_pred             ---CCCCccccCccccC------CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          528 ---PNRVAGYRAPEVTD------PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       528 ---~~~~~~y~aPE~~~------~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                         ..++..|+|||++.      ...++.++|||||||++|||++|+.||....      .......+.......     
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~------~~~~~~~i~~~~~~~-----  228 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT------SAKTYNNIMNFQRFL-----  228 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC------HHHHHHHHHcCCCcc-----
Confidence               24677899999986      4567889999999999999999999996432      122233332211100     


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                         ..+.......++.+++..|+. +|++||++++++++
T Consensus       229 ---~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         229 ---KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence               011111123456777788997 99999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.4e-35  Score=304.03  Aligned_cols=242  Identities=23%  Similarity=0.366  Sum_probs=192.5

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .++||+|+||.||+|. ..+++.||+|.+.....  ....+.+|++++.+++||||+++++++...+..++||||+++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   85 (279)
T cd06619           6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS   85 (279)
T ss_pred             eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCC
Confidence            3679999999999998 46789999999865422  24568899999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--CCC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--TPN  529 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~  529 (663)
                      |..+.         .+++.....++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||++.......  ...
T Consensus        86 l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~  154 (279)
T cd06619          86 LDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV  154 (279)
T ss_pred             hHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence            97653         2678888999999999999999998  9999999999999999999999999997654432  234


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCC-hHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVD-LPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      ++..|+|||++.+..++.++||||||+++|+|++|+.||.......... ........... ....     .    ....
T Consensus       155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~-----~----~~~~  224 (279)
T cd06619         155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-DPPV-----L----PVGQ  224 (279)
T ss_pred             CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-CCCC-----C----CCCc
Confidence            6677999999998889999999999999999999999997643322211 11111111111 0000     0    0111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...++.+++.+|+..+|++||+++|++++
T Consensus       225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         225 FSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            23467888999999999999999999985

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-35  Score=305.09  Aligned_cols=252  Identities=29%  Similarity=0.454  Sum_probs=193.8

Q ss_pred             hcccccccceEEEEEEe-----cCCcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEec--CccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSM--DEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ey  446 (663)
                      .+.||+|+||.||++..     .++..||+|.++.... ..+.+.+|+++++.++||||+++++++...  ...++||||
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   88 (284)
T cd05081           9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY   88 (284)
T ss_pred             eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEe
Confidence            46799999999999974     3588999999875532 245788999999999999999999987543  457899999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      +++|+|.+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||++++++.+||+|||+++......
T Consensus        89 ~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  162 (284)
T cd05081          89 LPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLPQDK  162 (284)
T ss_pred             cCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence            99999999997532    24899999999999999999999998  9999999999999999999999999998764432


Q ss_pred             CC-------CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCC---------CCCChHHHHHHHHhhc
Q 006055          527 TP-------NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNE---------EGVDLPRWVQSIVKDE  590 (663)
Q Consensus       527 ~~-------~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~---------~~~~~~~~~~~~~~~~  590 (663)
                      ..       .....|+|||++.+..++.++|||||||+++||++|..|+......         .+..............
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05081         163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN  242 (284)
T ss_pred             cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence            21       1123499999998888999999999999999999988775432110         0000000011111110


Q ss_pred             ccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       591 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                      .          ..........++.+++.+||..+|++|||++||++.|+.+.
T Consensus       243 ~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         243 G----------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             C----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            0          00111223456889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.7e-35  Score=299.25  Aligned_cols=242  Identities=25%  Similarity=0.376  Sum_probs=195.7

Q ss_pred             cccccccceEEEEEEecC--Cc--EEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVLEM--GT--IVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~--g~--~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      ++||+|++|.||+|.+.+  ++  .||+|.+.....  ..+.+.+|+..+++++|+||+++++++.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998543  33  699999876644  35678999999999999999999999988 888999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC--
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST--  527 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--  527 (663)
                      |+|.+++.....   ..+++.....++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||+++.......  
T Consensus        80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999976431   45899999999999999999999998  99999999999999999999999999987654211  


Q ss_pred             -----CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhh
Q 006055          528 -----PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL  601 (663)
Q Consensus       528 -----~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  601 (663)
                           ..++.+|+|||++.+..++.++|||||||+++||++ |+.||....      .......+......         
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------~~~~~~~~~~~~~~---------  219 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS------GSQILKKIDKEGER---------  219 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHhcCCc---------
Confidence                 224457999999998889999999999999999999 999986432      12222222211110         


Q ss_pred             cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       602 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                       .......+..+.+++.+|+..+|++||++.|+++.|.
T Consensus       220 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         220 -LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence             0111223457888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.7e-35  Score=299.04  Aligned_cols=241  Identities=25%  Similarity=0.433  Sum_probs=198.2

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|+||.||++.+.+++.+|+|.++........+.+|+++++.++|||++++++++......++||||+++++|.+
T Consensus         9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   88 (256)
T cd05112           9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSD   88 (256)
T ss_pred             EeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHH
Confidence            46799999999999998778899999988766667889999999999999999999999999899999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-----CC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~~  529 (663)
                      +++...    ..+++..+..++.+++.|+.|||+.+  ++||||||+||+++.++.++|+|||.++.......     ..
T Consensus        89 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05112          89 YLRAQR----GKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTK  162 (256)
T ss_pred             HHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCc
Confidence            997543    24789999999999999999999998  99999999999999999999999999876543221     12


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .+.+|+|||++.+..++.++||||||+++|||++ |+.||....      ....+...... .  ....+        ..
T Consensus       163 ~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------~~~~~~~~~~~-~--~~~~~--------~~  225 (256)
T cd05112         163 FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS------NSEVVETINAG-F--RLYKP--------RL  225 (256)
T ss_pred             cchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC------HHHHHHHHhCC-C--CCCCC--------CC
Confidence            3457999999998889999999999999999998 999986422      11222222111 0  00011        11


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      ....+.+++.+|+..+|++|||++|++++|
T Consensus       226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         226 ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            234688899999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=298.80  Aligned_cols=244  Identities=28%  Similarity=0.447  Sum_probs=200.2

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|+||.||+|... |+.||+|.++......+.+.+|+.+++.++|+|++++++++.+....++||||+++++|.+
T Consensus        11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   89 (256)
T cd05039          11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVD   89 (256)
T ss_pred             eeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHH
Confidence            468999999999999876 8899999998765556789999999999999999999999998889999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-CCCCcc
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-PNRVAG  533 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~  533 (663)
                      ++....   ...+++..+..++.|++.||.|||+.+  ++||||||+||+++.++.+||+|||.++....... ......
T Consensus        90 ~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  164 (256)
T cd05039          90 YLRSRG---RAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK  164 (256)
T ss_pred             HHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEcccccccccccccccCCCccc
Confidence            997543   235899999999999999999999998  99999999999999999999999999987643322 223456


Q ss_pred             ccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHH
Q 006055          534 YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQ  612 (663)
Q Consensus       534 y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  612 (663)
                      |+|||++.+..++.++||||||++++||++ |..||....      ... +...........          .+...+.+
T Consensus       165 ~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~-~~~~~~~~~~~~----------~~~~~~~~  227 (256)
T cd05039         165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKD-VVPHVEKGYRME----------APEGCPPE  227 (256)
T ss_pred             ccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC------HHH-HHHHHhcCCCCC----------CccCCCHH
Confidence            999999988888999999999999999997 999986431      111 111111111100          11123456


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          613 LLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       613 l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                      +.+++.+|+..+|++|||++|++++|+.+
T Consensus       228 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         228 VYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             HHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            78899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.9e-35  Score=299.75  Aligned_cols=244  Identities=27%  Similarity=0.400  Sum_probs=189.5

Q ss_pred             cccccccceEEEEEEec----CCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEe-cCccEEEEEccC
Q 006055          376 EVLGKGTFGTAYKAVLE----MGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYS-MDEKLLVYDYLT  448 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ey~~  448 (663)
                      +.||+|+||.||+|...    ++..||+|++....  .....+.+|+.+++.++|||++++++++.. +...++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            36999999999999853    24679999886432  224578889999999999999999998764 445789999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--  526 (663)
                      +|+|.++++...    ..+++..+..++.+++.||.|||+.+  ++||||||+||++++++.+||+|||+++......  
T Consensus        81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            999999997533    23677888899999999999999998  9999999999999999999999999997543211  


Q ss_pred             ------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhC-CCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          527 ------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTG-KAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       527 ------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                            ....+..|+|||++.+..++.++|||||||++|||++| ..||...      +..............       
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~------~~~~~~~~~~~~~~~-------  221 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------DSFDITVYLLQGRRL-------  221 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHHhcCCCC-------
Confidence                  11234569999999888899999999999999999995 4555432      122222222211110       


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                          ......+..+.+++.+||..+|++||++.|+++.|+++.
T Consensus       222 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         222 ----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             ----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                001112346888999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.1e-35  Score=308.49  Aligned_cols=253  Identities=23%  Similarity=0.384  Sum_probs=197.1

Q ss_pred             hcccccccceEEEEEEec-CCc--EEEEEEecCcc--cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGT--IVAVKRLKDVT--ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~--~vavK~l~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|..+ ++.  .+|+|.++...  .....+.+|++++.++ +|+||+++++++...+..++||||++
T Consensus        12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   91 (303)
T cd05088          12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   91 (303)
T ss_pred             eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence            468999999999999954 454  46888776432  2345788999999999 89999999999999999999999999


Q ss_pred             CCChhHhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccc
Q 006055          449 MGSLSALLHGNKGA-----------GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFG  517 (663)
Q Consensus       449 ~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg  517 (663)
                      +|+|.++++.....           ....+++..++.++.|++.|++|||+.+  |+||||||+|||++.++.+||+|||
T Consensus        92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~~~~kl~dfg  169 (303)
T cd05088          92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFG  169 (303)
T ss_pred             CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCCCcEEeCccc
Confidence            99999999754311           1235889999999999999999999998  9999999999999999999999999


Q ss_pred             cccccCCCCC---CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccc
Q 006055          518 LAHLVGPSST---PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTS  593 (663)
Q Consensus       518 ~a~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (663)
                      +++.......   ...+..|+|||++.+..++.++|||||||++|||+| |..||.....      ......... ... 
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~~~~-~~~-  241 (303)
T cd05088         170 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKLPQ-GYR-  241 (303)
T ss_pred             cCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhc-CCc-
Confidence            9864322111   112446999999988888999999999999999998 9999864321      111211111 100 


Q ss_pred             cccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006055          594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST  646 (663)
Q Consensus       594 ~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~  646 (663)
                               .........++.+++.+|+..+|++||++++++++|+++.....
T Consensus       242 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         242 ---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence                     00111123467889999999999999999999999998765544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.1e-36  Score=322.62  Aligned_cols=242  Identities=24%  Similarity=0.313  Sum_probs=187.9

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||+|. ..+++.||||++.....    ....+.+|++++..++|+||+++++++.+.+..++||||+++
T Consensus         6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g   85 (381)
T cd05626           6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG   85 (381)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence            3679999999999998 45689999999975422    234688999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----  525 (663)
                      |+|.+++....     .+++.....++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++.....    
T Consensus        86 g~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          86 GDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            99999987533     4788899999999999999999998  999999999999999999999999997532100    


Q ss_pred             -----------------------------------------------CCCCCCccccCccccCCCCCCCcchhhhHHHHH
Q 006055          526 -----------------------------------------------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLL  558 (663)
Q Consensus       526 -----------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl  558 (663)
                                                                     ....++..|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il  238 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence                                                           012366779999999988899999999999999


Q ss_pred             HHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHH--ccCCCCCCCCCHHHHHH
Q 006055          559 LELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAID--CSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       559 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~--C~~~dP~~RPt~~ev~~  636 (663)
                      |||++|+.||......      .....+......     .........   ..++.+++.+  |+..+|..||+++|+++
T Consensus       239 ~elltG~~Pf~~~~~~------~~~~~i~~~~~~-----~~~~~~~~~---s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         239 FEMLVGQPPFLAPTPT------ETQLKVINWENT-----LHIPPQVKL---SPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             HHHHhCCCCCcCCCHH------HHHHHHHccccc-----cCCCCCCCC---CHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            9999999999753211      111111110000     000011111   2244455545  66777778999999998


Q ss_pred             H
Q 006055          637 R  637 (663)
Q Consensus       637 ~  637 (663)
                      |
T Consensus       305 h  305 (381)
T cd05626         305 H  305 (381)
T ss_pred             C
Confidence            6

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.4e-35  Score=298.67  Aligned_cols=251  Identities=22%  Similarity=0.356  Sum_probs=202.1

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|... +|+.||+|.++...    ...+.+.+|++++++++|+|++++++++...+..++||||+++
T Consensus         7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   86 (267)
T cd08224           7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADA   86 (267)
T ss_pred             eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCC
Confidence            367999999999999965 89999999886432    1245788999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++.... .....+++..+..++.+++.||.|||+.+  |+||||||+||+++.++.++|+|||+++......   
T Consensus        87 ~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~  163 (267)
T cd08224          87 GDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA  163 (267)
T ss_pred             CCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccCCCccc
Confidence            99999986432 12345899999999999999999999998  9999999999999999999999999987654332   


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       ...++..|+|||++.+..++.++|||||||++|+|++|+.||....    .+............. ..         ..
T Consensus       164 ~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~-~~---------~~  229 (267)
T cd08224         164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEKCDY-PP---------LP  229 (267)
T ss_pred             ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhcCCC-CC---------CC
Confidence             1235667999999988889999999999999999999999985421    222222222211110 00         01


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                      .......+.+++.+|+..+|++|||+.+|+++|++++
T Consensus       230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            1133456788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-36  Score=320.74  Aligned_cols=241  Identities=22%  Similarity=0.284  Sum_probs=190.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||+|.. .+|+.||||++....    .....+.+|++++..++||||+++++++.+....++||||+++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~   85 (364)
T cd05599           6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG   85 (364)
T ss_pred             EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence            36899999999999995 468999999997542    1234578899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++....     .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++......   
T Consensus        86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          86 GDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             cHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            99999997532     4899999999999999999999998  9999999999999999999999999986542210   


Q ss_pred             ---------------------------------------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCC
Q 006055          527 ---------------------------------------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP  567 (663)
Q Consensus       527 ---------------------------------------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p  567 (663)
                                                             ...+|..|+|||++....++.++|||||||++|||++|..|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence                                                   12367789999999988999999999999999999999999


Q ss_pred             CccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 006055          568 THALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPS---MSEVIKR  637 (663)
Q Consensus       568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt---~~ev~~~  637 (663)
                      |....      .......+........     .....   ....++.+++.+|+. +|.+|++   ++|++++
T Consensus       239 f~~~~------~~~~~~~i~~~~~~~~-----~~~~~---~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         239 FCSDN------PQETYRKIINWKETLQ-----FPDEV---PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCC------HHHHHHHHHcCCCccC-----CCCCC---CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            96432      1222222221110000     00001   122355667778885 8999998   9988875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.5e-35  Score=308.13  Aligned_cols=251  Identities=24%  Similarity=0.385  Sum_probs=198.7

Q ss_pred             hcccccccceEEEEEEec--------CCcEEEEEEecCcc--cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEE
Q 006055          375 AEVLGKGTFGTAYKAVLE--------MGTIVAVKRLKDVT--ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLV  443 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  443 (663)
                      .+.||+|+||.||++...        ++..+|+|.++...  ....++..|++++..+ +|+||+++++++......++|
T Consensus        23 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  102 (307)
T cd05098          23 GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI  102 (307)
T ss_pred             eeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            578999999999999742        23579999987542  2235688899999999 799999999999999999999


Q ss_pred             EEccCCCChhHhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceE
Q 006055          444 YDYLTMGSLSALLHGNKGA-----------GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEAR  512 (663)
Q Consensus       444 ~ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~k  512 (663)
                      |||+++|+|.++++.....           ....+++..++.++.|++.||+|||+.+  ++||||||+||++++++.+|
T Consensus       103 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~~~~~~k  180 (307)
T cd05098         103 VEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMK  180 (307)
T ss_pred             EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheEEcCCCcEE
Confidence            9999999999999754321           1235899999999999999999999998  99999999999999999999


Q ss_pred             EeccccccccCCCC----CC--CCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHH
Q 006055          513 VSDFGLAHLVGPSS----TP--NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQS  585 (663)
Q Consensus       513 l~Dfg~a~~~~~~~----~~--~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  585 (663)
                      |+|||.++......    ..  ..+..|+|||++.+..++.++|||||||++|||++ |..||...      ........
T Consensus       181 L~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~------~~~~~~~~  254 (307)
T cd05098         181 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------PVEELFKL  254 (307)
T ss_pred             ECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC------CHHHHHHH
Confidence            99999987654321    11  12346999999988889999999999999999998 88888532      12222222


Q ss_pred             HHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          586 IVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      + .....          ...+.....++.+++.+|+..+|++|||+.||++.|+++.+.
T Consensus       255 ~-~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         255 L-KEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             H-HcCCC----------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            1 11111          011122345778899999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.3e-35  Score=302.45  Aligned_cols=248  Identities=22%  Similarity=0.319  Sum_probs=186.9

Q ss_pred             ccccccceEEEEEEecC---CcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          377 VLGKGTFGTAYKAVLEM---GTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       377 ~lg~G~~g~Vy~~~~~~---g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .||+|+||.||+|...+   ...+|+|.+.....  ....+.+|++.++.++|+||+++++++......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            59999999999997433   45788888764422  23568889999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-----
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----  526 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-----  526 (663)
                      |.+++...........++.....++.||+.||+|||+.+  |+||||||+||++++++.+||+|||++.......     
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK  159 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence            999997654332334578888999999999999999998  9999999999999999999999999987543321     


Q ss_pred             -CCCCCccccCccccCC-------CCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          527 -TPNRVAGYRAPEVTDP-------CKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                       ...++..|+|||+...       ..++.++|||||||++|||++ |..||....+.      ........... ....+
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~~-~~~~~  232 (269)
T cd05042         160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQD-IKLPK  232 (269)
T ss_pred             CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhccC-ccCCC
Confidence             1223456999998642       356789999999999999999 77888643211      11112222111 11111


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                      +     .........+.+++..|+ .||++|||++||++.|.
T Consensus       233 ~-----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         233 P-----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             C-----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1     111223345667778898 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.9e-36  Score=314.44  Aligned_cols=232  Identities=25%  Similarity=0.306  Sum_probs=183.7

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHH-HhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIE-GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      ++||+|+||.||+|.. .+|+.||+|.+.....    ....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999995 4689999999865421    1234455544 57889999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|...+...     ..+++.....++.||+.||.|||+.+  |+||||||+||+++.++.+||+|||+++......   
T Consensus        81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (321)
T cd05603          81 GELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT  153 (321)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence            9999888643     24788888999999999999999998  9999999999999999999999999987532221   


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       ...++..|+|||++.+..++.++|||||||++|||++|+.||...      +.......+.....            ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~------~~~~~~~~i~~~~~------------~~  215 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR------DVSQMYDNILHKPL------------QL  215 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC------CHHHHHHHHhcCCC------------CC
Confidence             123677899999999888999999999999999999999999642      22223333222110            00


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMS  632 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~  632 (663)
                      +.....++.+++.+|++.||.+||+..
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         216 PGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            112234677888899999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.5e-35  Score=305.43  Aligned_cols=250  Identities=27%  Similarity=0.406  Sum_probs=197.8

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|...      ....+|+|.+.....  ....+.+|+.+++.++||||+++++++......++|+||
T Consensus         5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (290)
T cd05045           5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY   84 (290)
T ss_pred             cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence            467999999999999842      235789998865432  235688999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC
Q 006055          447 LTMGSLSALLHGNKG-------------------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK  507 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~  507 (663)
                      +.+|+|.+++.....                   .....+++..++.++.|++.||.|||+.+  |+||||||+||++++
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~nill~~  162 (290)
T cd05045          85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAE  162 (290)
T ss_pred             cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhheEEEcC
Confidence            999999999864321                   11245889999999999999999999998  999999999999999


Q ss_pred             CCceEEeccccccccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChH
Q 006055          508 SYEARVSDFGLAHLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLP  580 (663)
Q Consensus       508 ~~~~kl~Dfg~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~  580 (663)
                      ++.+||+|||+++.......      ...+..|+|||++.+..++.++||||||++++||++ |..||....      ..
T Consensus       163 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------~~  236 (290)
T cd05045         163 GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA------PE  236 (290)
T ss_pred             CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC------HH
Confidence            99999999999976533211      123456999999988889999999999999999998 999986432      11


Q ss_pred             HHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          581 RWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       581 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      ... ........          .........++.+++.+|++.+|++||++.|+++.|+++..
T Consensus       237 ~~~-~~~~~~~~----------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         237 RLF-NLLKTGYR----------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHH-HHHhCCCC----------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            211 11211110          01112233468889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9e-38  Score=289.45  Aligned_cols=241  Identities=24%  Similarity=0.327  Sum_probs=195.4

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCc---ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV---TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .++||+|.|+.||+.. .++|+.+|+|++...   ..+-+++.+|+.+-+.++||||+++...+.+....++|||+|.++
T Consensus        16 ~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~   95 (355)
T KOG0033|consen   16 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG   95 (355)
T ss_pred             HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccch
Confidence            4679999999999987 668999999987644   234578899999999999999999999999999999999999999


Q ss_pred             ChhH-hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC---CCceEEeccccccccCCCC
Q 006055          451 SLSA-LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK---SYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       451 sL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~---~~~~kl~Dfg~a~~~~~~~  526 (663)
                      +|.. ++++      ..+++...-..+.||++||.|+|..+  |+|||+||+|+++..   ..-+||+|||+|..+..+.
T Consensus        96 dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~  167 (355)
T KOG0033|consen   96 ELFEDIVAR------EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE  167 (355)
T ss_pred             HHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence            9954 4443      24678888899999999999999998  999999999999953   3358999999999988543


Q ss_pred             C---CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          527 T---PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       527 ~---~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                      .   ..+|++|||||++....|+..+|||+.||++|-|+.|..||.+..      -....+++++..     +|..-..+
T Consensus       168 ~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~------~~rlye~I~~g~-----yd~~~~~w  236 (355)
T KOG0033|consen  168 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED------QHRLYEQIKAGA-----YDYPSPEW  236 (355)
T ss_pred             ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc------HHHHHHHHhccc-----cCCCCccc
Confidence            3   457899999999999999999999999999999999999997532      233444444433     22222233


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....++   ..+++.+|+..||.+|.|+.|.++|
T Consensus       237 ~~is~~---Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  237 DTVTPE---AKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             CcCCHH---HHHHHHHHhccChhhhccHHHHhCC
Confidence            334444   4556669999999999999998873

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.8e-35  Score=304.83  Aligned_cols=251  Identities=23%  Similarity=0.315  Sum_probs=186.6

Q ss_pred             hcccccccceEEEEEEe-c-CCcEEEEEEecCccc---CHHHHHHHHHHhhcC---CCCCcccceEEEEe-----cCccE
Q 006055          375 AEVLGKGTFGTAYKAVL-E-MGTIVAVKRLKDVTI---SEREFKDKIEGVGAV---NHENLVPLRAYYYS-----MDEKL  441 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~~~~  441 (663)
                      .+.||+|+||+||+|.. . +|+.||+|.++....   ....+.+|+.+++.+   +||||++++++|..     ....+
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~   85 (290)
T cd07862           6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   85 (290)
T ss_pred             eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence            36799999999999985 3 478899999865421   234566677776655   79999999999853     34578


Q ss_pred             EEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccc
Q 006055          442 LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL  521 (663)
Q Consensus       442 lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~  521 (663)
                      +||||+. ++|.+++....   ...+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        86 lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          86 LVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             EEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            9999997 59999887533   234899999999999999999999998  99999999999999999999999999987


Q ss_pred             cCCCC---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhc-------c
Q 006055          522 VGPSS---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE-------W  591 (663)
Q Consensus       522 ~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~  591 (663)
                      .....   ...++..|+|||.+.+..++.++|||||||++|||++|+.||......      ..+..+....       +
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~------~~~~~i~~~~~~~~~~~~  233 (290)
T cd07862         160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV------DQLGKILDVIGLPGEEDW  233 (290)
T ss_pred             ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH------HHHHHHHHHhCCCChhhc
Confidence            65432   234567799999998888999999999999999999999999753221      1122221110       0


Q ss_pred             cccc-cchhhh---cccCh----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          592 TSEV-FDLELL---RYQNV----EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       592 ~~~~-~d~~~~---~~~~~----~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .... ......   .....    ......+.+++.+|++.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            0000 000000   00000    1123456788999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.3e-35  Score=306.88  Aligned_cols=254  Identities=21%  Similarity=0.342  Sum_probs=196.1

Q ss_pred             hcccccccceEEEEEEecC-----------------CcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLEM-----------------GTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYY  435 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~  435 (663)
                      .+.||+|+||.||+|....                 +..||+|.+....  ...+.+.+|++++++++|||++++++++.
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   89 (296)
T cd05051          10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT   89 (296)
T ss_pred             cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            4689999999999988432                 3468999987543  23467889999999999999999999999


Q ss_pred             ecCccEEEEEccCCCChhHhhccCCCC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC
Q 006055          436 SMDEKLLVYDYLTMGSLSALLHGNKGA------GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY  509 (663)
Q Consensus       436 ~~~~~~lv~ey~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~  509 (663)
                      .....++||||+++++|.+++......      ....+++..++.++.|++.||.|||+.+  |+||||||+||+++.++
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~Nili~~~~  167 (296)
T cd05051          90 VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNY  167 (296)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhceeecCCC
Confidence            999999999999999999999764421      1236899999999999999999999998  99999999999999999


Q ss_pred             ceEEeccccccccCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh--CCCCCccccCCCCCChHH
Q 006055          510 EARVSDFGLAHLVGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT--GKAPTHALLNEEGVDLPR  581 (663)
Q Consensus       510 ~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt--g~~p~~~~~~~~~~~~~~  581 (663)
                      .++|+|||+++......      ....+..|+|||++.+..++.++|||||||++|||++  +..||......   ....
T Consensus       168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~---~~~~  244 (296)
T cd05051         168 TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ---QVIE  244 (296)
T ss_pred             ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH---HHHH
Confidence            99999999987653322      1223457999999988889999999999999999998  67777543211   1111


Q ss_pred             HHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          582 WVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       582 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                      .+............       .......+.++.+++.+|++.||++|||+.|+++.|++
T Consensus       245 ~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         245 NAGHFFRDDGRQIY-------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HHHhcccccccccc-------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            11111111000000       01112233578999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.4e-36  Score=313.93  Aligned_cols=235  Identities=24%  Similarity=0.273  Sum_probs=184.7

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHH-HhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIE-GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      +.||+|+||+||+|.. .+++.||+|.+.....    ....+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            3699999999999995 4678899999875421    2233444443 56788999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----  525 (663)
                      |+|.+++....     .+.+.....++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++.....    
T Consensus        81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~  153 (325)
T cd05602          81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT  153 (325)
T ss_pred             CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence            99999997532     4678888889999999999999998  999999999999999999999999998754322    


Q ss_pred             CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          526 STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       526 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+.....            ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~~------------~~  215 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN------TAEMYDNILNKPL------------QL  215 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC------HHHHHHHHHhCCc------------CC
Confidence            12346778999999999899999999999999999999999996422      2222222222110            00


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVI  635 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~  635 (663)
                      .......+.+++.+|++.+|.+||++.+.+
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            112234577888899999999999987443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=9.7e-36  Score=302.93  Aligned_cols=244  Identities=24%  Similarity=0.361  Sum_probs=192.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.++..++||||+++++++...+..++||||+++++|
T Consensus        14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L   93 (267)
T cd06646          14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL   93 (267)
T ss_pred             hheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcH
Confidence            46799999999999994 678999999987543 2345688899999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----CC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----TP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~~  528 (663)
                      .++++..     ..+++..+..++.|++.||.|||+.+  |+||||||+||++++++.++|+|||+++......    ..
T Consensus        94 ~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd06646          94 QDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF  166 (267)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeecccccccCcc
Confidence            9998743     24789999999999999999999998  9999999999999999999999999998664322    22


Q ss_pred             CCCccccCccccC---CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          529 NRVAGYRAPEVTD---PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       529 ~~~~~y~aPE~~~---~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      .++..|+|||.+.   ...++.++|||||||++|||++|+.||......+..      .......     +.+.  ....
T Consensus       167 ~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~------~~~~~~~-----~~~~--~~~~  233 (267)
T cd06646         167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMSKSN-----FQPP--KLKD  233 (267)
T ss_pred             ccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh------eeeecCC-----CCCC--CCcc
Confidence            3556799999874   344678999999999999999999998643211100      0000000     0000  0011


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      .......+.+++.+|+..+|++||++++++++|
T Consensus       234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            112345788899999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7.6e-36  Score=313.86  Aligned_cols=242  Identities=22%  Similarity=0.264  Sum_probs=190.2

Q ss_pred             hcccccccceEEEEEEe----cCCcEEEEEEecCcc-----cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVT-----ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  444 (663)
                      .+.||+|+||.||++..    .+++.||+|.+....     ...+.+..|+.++..+ +|+||+++++++......++||
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (332)
T cd05614           5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL   84 (332)
T ss_pred             EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence            46899999999999874    368899999986532     1234678899999999 5899999999999889999999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+++|+|.+++....     .+++.....++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++....
T Consensus        85 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          85 DYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence            9999999999987532     4889999999999999999999998  99999999999999999999999999976533


Q ss_pred             CC-----CCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          525 SS-----TPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       525 ~~-----~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                      ..     ...++..|+|||++.+. .++.++|||||||++|||++|+.||.......  ........+....       +
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~~~~~~~~~~-------~  228 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN--TQSEVSRRILKCD-------P  228 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC--CHHHHHHHHhcCC-------C
Confidence            22     12467789999999765 47889999999999999999999996432211  1111111221111       0


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                      .     ........+.+++.+|+..||++||     ++++++++
T Consensus       229 ~-----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         229 P-----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             C-----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            0     0111234567888899999999999     77788765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.9e-35  Score=297.17  Aligned_cols=241  Identities=23%  Similarity=0.348  Sum_probs=197.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|++|.||+|.. .+++.|++|.+....   .....+.+|+++++.++|||++++++++.+....++||||++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd08529           5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG   84 (256)
T ss_pred             eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCC
Confidence            36799999999999995 468999999986432   23567889999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC---
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST---  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~---  527 (663)
                      +|.++++...   ...+++..+..++.+++.||.|||+.+  ++||||||+||+++.++.++|+|||+++.......   
T Consensus        85 ~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          85 DLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             cHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence            9999997642   235889999999999999999999998  99999999999999999999999999887654322   


Q ss_pred             -CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          528 -PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       528 -~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                       ..++..|+|||+..+..++.++||||||++++||++|+.||.....      ............ .          ...
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-~----------~~~  222 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ------GALILKIIRGVF-P----------PVS  222 (256)
T ss_pred             ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCC-C----------CCc
Confidence             2355679999999988899999999999999999999999964321      111222221110 0          011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ......+.+++.+|+..+|++||++.+++++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1334578899999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2e-35  Score=310.88  Aligned_cols=252  Identities=24%  Similarity=0.372  Sum_probs=199.6

Q ss_pred             HhhcccccccceEEEEEEec--------CCcEEEEEEecCccc--CHHHHHHHHHHhhcC-CCCCcccceEEEEecCccE
Q 006055          373 ASAEVLGKGTFGTAYKAVLE--------MGTIVAVKRLKDVTI--SEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKL  441 (663)
Q Consensus       373 ~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  441 (663)
                      ...+.||+|+||.||+|...        .+..||+|.++....  ..+++.+|++++.++ +|+||++++++|......+
T Consensus        15 ~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   94 (334)
T cd05100          15 TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY   94 (334)
T ss_pred             eecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceE
Confidence            34678999999999999732        123689998875422  245788999999999 8999999999999988999


Q ss_pred             EEEEccCCCChhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc
Q 006055          442 LVYDYLTMGSLSALLHGNKG-----------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE  510 (663)
Q Consensus       442 lv~ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~  510 (663)
                      ++|||+++|+|.+++.....           .....++|..+..++.|++.||.|||+.+  |+||||||+||++++++.
T Consensus        95 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nill~~~~~  172 (334)
T cd05100          95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDNV  172 (334)
T ss_pred             EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCc
Confidence            99999999999999875321           12345899999999999999999999998  999999999999999999


Q ss_pred             eEEeccccccccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHH
Q 006055          511 ARVSDFGLAHLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWV  583 (663)
Q Consensus       511 ~kl~Dfg~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~  583 (663)
                      +||+|||+++.......      ...+..|+|||++.+..++.++||||||+++|||++ |..||...      +.....
T Consensus       173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~------~~~~~~  246 (334)
T cd05100         173 MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI------PVEELF  246 (334)
T ss_pred             EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC------CHHHHH
Confidence            99999999986543221      112345999999998889999999999999999998 88888542      222333


Q ss_pred             HHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          584 QSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       584 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      ..+..... .          ..+.....++.+++.+|++.+|++||++.|+++.|+++..
T Consensus       247 ~~~~~~~~-~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         247 KLLKEGHR-M----------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HHHHcCCC-C----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            22221111 0          1111234468899999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.2e-36  Score=315.59  Aligned_cols=234  Identities=23%  Similarity=0.283  Sum_probs=185.5

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCcc----cCHHHHHHHHH-HhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT----ISEREFKDKIE-GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~----~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      +.||+|+||+||+|. ..+|+.||+|++....    .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            369999999999998 4579999999986542    12234555554 46779999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----  525 (663)
                      |+|..++...     ..+++..+..++.||+.||.|||+.+  |+||||||+|||+++++.+||+|||+++.....    
T Consensus        81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  153 (325)
T cd05604          81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT  153 (325)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence            9999888643     25889999999999999999999998  999999999999999999999999998753221    


Q ss_pred             CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          526 STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       526 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||...      +.......+......   +         
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~------~~~~~~~~~~~~~~~---~---------  215 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR------DVAEMYDNILHKPLV---L---------  215 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC------CHHHHHHHHHcCCcc---C---------
Confidence            1233677899999999989999999999999999999999999642      222223333222110   0         


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEV  634 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev  634 (663)
                      .......+.+++.+|+..+|++||++.+.
T Consensus       216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~  244 (325)
T cd05604         216 RPGASLTAWSILEELLEKDRQRRLGAKED  244 (325)
T ss_pred             CCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence            01123456788889999999999988643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-37  Score=312.98  Aligned_cols=243  Identities=28%  Similarity=0.407  Sum_probs=200.4

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCc-ccC-H--HHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV-TIS-E--REFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~-~~~-~--~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      ..||.|+||-||-|. .++.++||||++... .++ +  .++.+|+..+..++|||+|.+.|+|......|||||||-| 
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG-  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-
Confidence            469999999999999 678899999998754 232 2  4689999999999999999999999999999999999965 


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCCCC
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR  530 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  530 (663)
                      +-.|++.-.+    .++.+..+..|+.+.+.||+|||+++  .||||||+.|||+++.|.|||+|||.|....+..+..|
T Consensus       111 SAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFvG  184 (948)
T KOG0577|consen  111 SASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSFVG  184 (948)
T ss_pred             cHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCchhcccC
Confidence            8888775433    36888999999999999999999998  99999999999999999999999999999999999999


Q ss_pred             CccccCccccC---CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          531 VAGYRAPEVTD---PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       531 ~~~y~aPE~~~---~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      |+.|||||++.   .+.|+-|+||||+|++..||...++|+-.+..      ...+..+.++.       .+.+   ...
T Consensus       185 TPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSALYHIAQNe-------sPtL---qs~  248 (948)
T KOG0577|consen  185 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE-------SPTL---QSN  248 (948)
T ss_pred             CccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHHHHHHHhcC-------CCCC---CCc
Confidence            99999999974   45799999999999999999999999643211      11111222221       1111   123


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                      +....+.+++..|+++-|++|||.+++++|-.-.
T Consensus       249 eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~  282 (948)
T KOG0577|consen  249 EWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVL  282 (948)
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhc
Confidence            4556677888899999999999999999875433

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8.7e-36  Score=312.19  Aligned_cols=238  Identities=22%  Similarity=0.277  Sum_probs=188.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCC-CcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHE-NLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|.. .+++.||||++....    .....+..|.+++..++|+ +|+++++++.+.+..++||||++
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   84 (324)
T cd05587           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN   84 (324)
T ss_pred             EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence            36799999999999995 457899999987542    2235677888899988765 57888899988899999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--  526 (663)
                      +|+|.+++....     .+++..+..++.|++.||.|||+++  |+||||||+|||++.++.+||+|||+++......  
T Consensus        85 ~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          85 GGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence            999999987532     4789999999999999999999998  9999999999999999999999999987532211  


Q ss_pred             --CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          527 --TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                        ...++..|+|||++.+..++.++||||+||++|||++|+.||....      .......+.....            .
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~------~~~~~~~i~~~~~------------~  219 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED------EDELFQSIMEHNV------------S  219 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCCC------------C
Confidence              2236778999999999889999999999999999999999996432      1222222221110            0


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSM-----SEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~-----~ev~~~  637 (663)
                      .+.....++.+++.+|+..||++|++.     +++.++
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         220 YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            011123467788889999999999986     566554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.4e-35  Score=301.00  Aligned_cols=246  Identities=23%  Similarity=0.388  Sum_probs=195.2

Q ss_pred             hcccccccceEEEEEEe-cCCc----EEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGT----IVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .++||+|+||+||+|.+ .+|+    .||+|.++....  ....+.+|+.++..++|+||+++++++.. ...++++||+
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~   90 (279)
T cd05109          12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLM   90 (279)
T ss_pred             eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcC
Confidence            36899999999999984 4454    489999875422  24678899999999999999999999875 4578999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST  527 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  527 (663)
                      ++|+|.++++...    ..+++..++.++.|++.||.|||+.+  |+||||||+||++++++.+||+|||+++.......
T Consensus        91 ~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~  164 (279)
T cd05109          91 PYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET  164 (279)
T ss_pred             CCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence            9999999997533    35899999999999999999999998  99999999999999999999999999987643322


Q ss_pred             ------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          528 ------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       528 ------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                            ...+..|+|||...+..++.++|||||||++|||++ |..||+.....   .+.    ..+.....        
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~----~~~~~~~~--------  229 (279)
T cd05109         165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIP----DLLEKGER--------  229 (279)
T ss_pred             eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHHCCCc--------
Confidence                  122456999999988889999999999999999998 89998643211   111    11111110        


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                        .........++.+++.+||..||++||++.|+++.|+++...
T Consensus       230 --~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         230 --LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             --CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence              001112344678899999999999999999999999888544

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.6e-35  Score=305.39  Aligned_cols=246  Identities=24%  Similarity=0.397  Sum_probs=196.3

Q ss_pred             hcccccccceEEEEEEe------cCCcEEEEEEecCcccC--HHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTIS--EREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  445 (663)
                      .+.||+|+||.||++..      .++..||||.++.....  .+.+.+|+++++++ +|+||+++++++...+..++|||
T Consensus        40 ~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e  119 (302)
T cd05055          40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE  119 (302)
T ss_pred             cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEE
Confidence            57899999999999973      23558999998754322  35688999999999 79999999999999999999999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+++|+|.++++...   ...+++..+..++.+++.||.|||+.+  |+|+||||+||+++.++.++++|||+++.....
T Consensus       120 ~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  194 (302)
T cd05055         120 YCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLARDIMND  194 (302)
T ss_pred             cCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCCcccccccCC
Confidence            999999999997533   223899999999999999999999998  999999999999999999999999999765432


Q ss_pred             CC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          526 ST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       526 ~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                      ..      ..++..|+|||.+.+..++.++|||||||++|||++ |..||.....      ..............     
T Consensus       195 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~------~~~~~~~~~~~~~~-----  263 (302)
T cd05055         195 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV------DSKFYKLIKEGYRM-----  263 (302)
T ss_pred             CceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc------hHHHHHHHHcCCcC-----
Confidence            21      123456999999988889999999999999999998 9999864321      11111111111100     


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                           ........++.+++.+|+..+|++|||+.|+++.|+++
T Consensus       264 -----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         264 -----AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                 00111234688899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.1e-35  Score=302.79  Aligned_cols=247  Identities=23%  Similarity=0.371  Sum_probs=195.8

Q ss_pred             hcccccccceEEEEEEe------cCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .++||+|+||.||++..      .++..+|+|.++... .....+.+|+++++.++|+||+++++++......++||||+
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   89 (280)
T cd05092          10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM   89 (280)
T ss_pred             ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecC
Confidence            46899999999999963      246689999887543 23467999999999999999999999999988999999999


Q ss_pred             CCCChhHhhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccc
Q 006055          448 TMGSLSALLHGNKG----------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFG  517 (663)
Q Consensus       448 ~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg  517 (663)
                      ++|+|.++++....          .....+++..+..++.|++.|++|||+.+  ++||||||+||++++++.+||+|||
T Consensus        90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~~~~kL~dfg  167 (280)
T cd05092          90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFG  167 (280)
T ss_pred             CCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCCCCEEECCCC
Confidence            99999999875421          11235899999999999999999999998  9999999999999999999999999


Q ss_pred             cccccCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhc
Q 006055          518 LAHLVGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDE  590 (663)
Q Consensus       518 ~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  590 (663)
                      ++.......      ....+..|+|||++.+..++.++|||||||++|||++ |+.||.....      ...+.......
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~  241 (280)
T cd05092         168 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN------TEAIECITQGR  241 (280)
T ss_pred             ceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH------HHHHHHHHcCc
Confidence            997654321      1123456999999998889999999999999999998 8999864321      11122211111


Q ss_pred             ccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       591 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                      ..           ..+...+..+.+++.+||..||++||+++||++.|++
T Consensus       242 ~~-----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         242 EL-----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             cC-----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            10           0111233467788999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.6e-35  Score=297.62  Aligned_cols=243  Identities=23%  Similarity=0.439  Sum_probs=197.4

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|+||.||++....+..+|+|.++........+.+|+++++.++|+|++++++++.+ ...+++|||+++|+|.+
T Consensus        11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~   89 (260)
T cd05073          11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLD   89 (260)
T ss_pred             EeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHH
Confidence            46899999999999998778899999987655556778999999999999999999999877 77899999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-----CC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~~  529 (663)
                      ++....   ...+++..+..++.+++.||.|||+.+  ++||||||+||+++.++.+||+|||.+........     ..
T Consensus        90 ~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  164 (260)
T cd05073          90 FLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK  164 (260)
T ss_pred             HHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCc
Confidence            997543   235789999999999999999999998  99999999999999999999999999876543221     12


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      ++..|+|||++....++.++|+|||||++|++++ |+.||....      .......+ ......          .....
T Consensus       165 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~------~~~~~~~~-~~~~~~----------~~~~~  227 (260)
T cd05073         165 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS------NPEVIRAL-ERGYRM----------PRPEN  227 (260)
T ss_pred             ccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC------HHHHHHHH-hCCCCC----------CCccc
Confidence            2345999999988889999999999999999999 899986432      11111111 111110          11122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                      ...++.+++.+|+..+|++||++.++.+.|+.
T Consensus       228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         228 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            34568888999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3e-35  Score=302.28  Aligned_cols=250  Identities=22%  Similarity=0.303  Sum_probs=199.0

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||+||++.. .+|+.||+|.+....  ...+.+.+|+++++.++||||+++++++......++||||+++++
T Consensus        10 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   89 (284)
T cd06620          10 ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGS   89 (284)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCC
Confidence            57899999999999994 468999999876442  235678999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--CC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ-GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--TP  528 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--~~  528 (663)
                      |.++++...     .+++.....++.+++.||.|||+. +  ++||||||+||++++++.++|+|||++.......  ..
T Consensus        90 L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~~  162 (284)
T cd06620          90 LDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF  162 (284)
T ss_pred             HHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchhhhccCcc
Confidence            999987532     489999999999999999999974 5  9999999999999999999999999987543222  23


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCC-----CChHHHHHHHHhhcccccccchhhhcc
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEG-----VDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                      .++..|+|||++.+..++.++|||||||++|+|++|+.||......+.     ..+..++.........          .
T Consensus       163 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~  232 (284)
T cd06620         163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP----------R  232 (284)
T ss_pred             ccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC----------C
Confidence            456779999999888889999999999999999999999986443211     1122222222221100          0


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                      ....+...++.+++.+|+..||++|||++|++++.--+
T Consensus       233 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~  270 (284)
T cd06620         233 LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI  270 (284)
T ss_pred             CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            00112345688899999999999999999999975443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=8.7e-36  Score=317.18  Aligned_cols=241  Identities=20%  Similarity=0.279  Sum_probs=189.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||++.. .+++.||+|.+....    .....+.+|+.+++.++||||+++++++.++...++||||+++
T Consensus        48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g  127 (370)
T cd05621          48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG  127 (370)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCC
Confidence            46799999999999995 468899999986532    2245688999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++...      .+++.....++.||+.||+|||+.+  |+||||||+|||+++++.+||+|||++.......   
T Consensus       128 g~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~  199 (370)
T cd05621         128 GDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR  199 (370)
T ss_pred             CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence            9999999643      3788899999999999999999998  9999999999999999999999999998764322   


Q ss_pred             --CCCCCccccCccccCCC----CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          527 --TPNRVAGYRAPEVTDPC----KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~----~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                        ...++..|+|||++.+.    .++.++||||+||++|||++|+.||....      .......+........      
T Consensus       200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~------~~~~~~~i~~~~~~~~------  267 (370)
T cd05621         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS------LVGTYSKIMDHKNSLN------  267 (370)
T ss_pred             cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCcccC------
Confidence              23477889999998654    37789999999999999999999996432      2222333322111000      


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDN--RPSMSEVIKR  637 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~--RPt~~ev~~~  637 (663)
                        .+........+.+++..|+..++.+  ||+++|+++|
T Consensus       268 --~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         268 --FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             --CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence              1111122335566777888755544  8999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.4e-35  Score=300.44  Aligned_cols=244  Identities=25%  Similarity=0.462  Sum_probs=195.4

Q ss_pred             hcccccccceEEEEEEec-CC---cEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MG---TIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g---~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|... ++   ..||||.++...  ....+|..|+.+++.++||||+++++++.+....++||||++
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~   88 (269)
T cd05065           9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME   88 (269)
T ss_pred             EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence            468999999999999954 33   369999987542  224679999999999999999999999999899999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCC
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP  528 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  528 (663)
                      +|+|.+++....    ..+++..+..++.|++.||.|||+.+  ++||||||+||+++.++.+||+|||++.........
T Consensus        89 ~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~  162 (269)
T cd05065          89 NGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD  162 (269)
T ss_pred             CCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence            999999997533    24899999999999999999999998  999999999999999999999999998765432211


Q ss_pred             ------CC---CccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          529 ------NR---VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       529 ------~~---~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                            .+   +..|+|||++.+..++.++|||||||++|||++ |..||.....      ......+... .       
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~------~~~~~~i~~~-~-------  228 (269)
T cd05065         163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN------QDVINAIEQD-Y-------  228 (269)
T ss_pred             cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH------HHHHHHHHcC-C-------
Confidence                  11   235999999998889999999999999999887 9999864321      1111111111 0       


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                         ..+...+.+..+.+++.+|+..+|++||+++++++.|+++
T Consensus       229 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 ---RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ---cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence               0111123345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-35  Score=303.21  Aligned_cols=247  Identities=24%  Similarity=0.381  Sum_probs=196.4

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|...      .+..||+|.+.....  ....+.+|+.++..++|+||+++++++......++||||
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   90 (277)
T cd05032          11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMEL   90 (277)
T ss_pred             EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEec
Confidence            468999999999999853      247899999875432  235688999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccc
Q 006055          447 LTMGSLSALLHGNKGA-----GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL  521 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~  521 (663)
                      +++|+|.+++......     ....++|..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++.
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~kl~dfg~~~~  168 (277)
T cd05032          91 MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRD  168 (277)
T ss_pred             CCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCEEECCcccchh
Confidence            9999999998753321     1234789999999999999999999998  99999999999999999999999999876


Q ss_pred             cCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          522 VGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       522 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                      .....      ...++..|+|||.+.+..++.++|||||||++||+++ |..||.....      ........ ......
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------~~~~~~~~-~~~~~~  241 (277)
T cd05032         169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN------EEVLKFVI-DGGHLD  241 (277)
T ss_pred             hccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH------HHHHHHHh-cCCCCC
Confidence            54322      1223567999999988889999999999999999998 8999864221      11122111 111100


Q ss_pred             ccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       595 ~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                                .+.....++.+++.+|+..+|++|||+.|+++.|++
T Consensus       242 ----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         242 ----------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             ----------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence                      111224578899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-35  Score=311.71  Aligned_cols=253  Identities=25%  Similarity=0.376  Sum_probs=194.8

Q ss_pred             HhhcccccccceEEEEEEe------cCCcEEEEEEecCcccC--HHHHHHHHHHhhcC-CCCCcccceEEEEecC-ccEE
Q 006055          373 ASAEVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTIS--EREFKDKIEGVGAV-NHENLVPLRAYYYSMD-EKLL  442 (663)
Q Consensus       373 ~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~~l  442 (663)
                      ...+.||+|+||.||+|..      .+++.||||+++.....  ...+.+|+.++.++ +|+||+++++++...+ ..++
T Consensus        10 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~l   89 (343)
T cd05103          10 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV   89 (343)
T ss_pred             cccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEE
Confidence            3467899999999999973      35789999999754322  35688899999999 6899999999887654 5789


Q ss_pred             EEEccCCCChhHhhccCCCC------------------------------------------------------------
Q 006055          443 VYDYLTMGSLSALLHGNKGA------------------------------------------------------------  462 (663)
Q Consensus       443 v~ey~~~gsL~~~l~~~~~~------------------------------------------------------------  462 (663)
                      ||||+++|+|.++++.....                                                            
T Consensus        90 v~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (343)
T cd05103          90 IVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQE  169 (343)
T ss_pred             EEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhh
Confidence            99999999999998653210                                                            


Q ss_pred             --CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC------CCCCccc
Q 006055          463 --GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST------PNRVAGY  534 (663)
Q Consensus       463 --~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~y  534 (663)
                        ....+++..+..++.|++.||+|||+.+  |+||||||+||++++++.+||+|||++........      ..++..|
T Consensus       170 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y  247 (343)
T cd05103         170 DLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  247 (343)
T ss_pred             hhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcce
Confidence              0124788899999999999999999998  99999999999999999999999999976532211      1234469


Q ss_pred             cCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHH
Q 006055          535 RAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQL  613 (663)
Q Consensus       535 ~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l  613 (663)
                      +|||.+.+..++.++||||||+++|||++ |..||......      ..............          .+.....++
T Consensus       248 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~~~----------~~~~~~~~~  311 (343)
T cd05103         248 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEGTRMR----------APDYTTPEM  311 (343)
T ss_pred             ECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------HHHHHHHhccCCCC----------CCCCCCHHH
Confidence            99999988889999999999999999997 89998643211      11111111111000          001122367


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          614 LQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       614 ~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      .+++..||..+|++|||+.|++++|+.+.+
T Consensus       312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.2e-35  Score=302.05  Aligned_cols=251  Identities=26%  Similarity=0.390  Sum_probs=195.1

Q ss_pred             hhcccccccceEEEEEEe-----cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEec--CccEEEE
Q 006055          374 SAEVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSM--DEKLLVY  444 (663)
Q Consensus       374 ~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  444 (663)
                      ..+.||+|+||.||++..     .++..||+|.++...  .....+.+|+.+++.++|||++++++++...  ...++||
T Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (284)
T cd05079           8 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM   87 (284)
T ss_pred             hceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEE
Confidence            346799999999999973     357899999987542  2245789999999999999999999998775  5678999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+++++|.+++....    ..+++..+..++.+++.||.|||+.+  ++||||||+||+++.++.++|+|||+++....
T Consensus        88 e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          88 EFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCcccccccc
Confidence            9999999999986432    24899999999999999999999998  99999999999999999999999999986643


Q ss_pred             CCC-------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCC--------CC-CChHHHHHHHHh
Q 006055          525 SST-------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNE--------EG-VDLPRWVQSIVK  588 (663)
Q Consensus       525 ~~~-------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~--------~~-~~~~~~~~~~~~  588 (663)
                      ...       ..++..|+|||++.+..++.++||||||+++|||++++.|.......        .+ ......+.. ..
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  240 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV-LE  240 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH-HH
Confidence            321       12334599999998888999999999999999999987765321110        00 011111111 11


Q ss_pred             hcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          589 DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                      ...          ..+........+.+++.+|++.+|++|||++++++.|+++
T Consensus       241 ~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         241 EGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            110          0111122345788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1e-35  Score=311.45  Aligned_cols=238  Identities=22%  Similarity=0.291  Sum_probs=188.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|.. .+++.||+|.++....    ....+..|..++..+ +|++|+++++++.+.+..++||||++
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   84 (323)
T cd05616           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN   84 (323)
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence            36799999999999985 4678999999875421    223456677777766 58899999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--  526 (663)
                      +|+|.+++....     .+++..+..++.|++.||+|||+.+  |+||||||+|||+++++.+||+|||+++......  
T Consensus        85 ~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          85 GGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence            999999886532     4889999999999999999999998  9999999999999999999999999997543221  


Q ss_pred             --CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          527 --TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                        ...++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+.....            .
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~------~~~~~~~i~~~~~------------~  219 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED------EDELFQSIMEHNV------------A  219 (323)
T ss_pred             cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCC------------C
Confidence              2346778999999999999999999999999999999999996432      1222222222111            0


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSM-----SEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~-----~ev~~~  637 (663)
                      .+.....++.+++.+|++.||++|++.     .++.++
T Consensus       220 ~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         220 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            011223467788889999999999984     566543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.3e-35  Score=306.79  Aligned_cols=239  Identities=25%  Similarity=0.357  Sum_probs=194.0

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      +.||+|+||.||+|.. .+++.||+|.+..... ....+.+|+.+++.++|+|++++++++....+.++||||+++++|.
T Consensus        26 ~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~  105 (296)
T cd06654          26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT  105 (296)
T ss_pred             EEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHH
Confidence            5799999999999984 5689999999875432 3467889999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----CCC
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----TPN  529 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~~~  529 (663)
                      ++++..      .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++.......    ...
T Consensus       106 ~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~  177 (296)
T cd06654         106 DVVTET------CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV  177 (296)
T ss_pred             HHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhccccccccCccc
Confidence            998642      3789999999999999999999998  9999999999999999999999999987654332    224


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE  609 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  609 (663)
                      ++..|+|||.+.+..++.++|||||||++|+|++|+.||......      ........... ..        .......
T Consensus       178 ~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~------~~~~~~~~~~~-~~--------~~~~~~~  242 (296)
T cd06654         178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGT-PE--------LQNPEKL  242 (296)
T ss_pred             CCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH------HhHHHHhcCCC-CC--------CCCcccc
Confidence            566799999998888899999999999999999999999643211      11111111110 00        0111223


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          610 MVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       610 ~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...+.+++.+|+..+|++||+++|++++
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         243 SAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            3467888999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.2e-35  Score=322.82  Aligned_cols=250  Identities=18%  Similarity=0.293  Sum_probs=184.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEec--------CccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM--------DEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~~~~lv~e  445 (663)
                      .++||+|+||.||+|.. .+++.||||++....   ....+|+.+++.++||||+++++++...        ...++|||
T Consensus        71 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE  147 (440)
T PTZ00036         71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME  147 (440)
T ss_pred             eEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEe
Confidence            46899999999999995 568999999885432   3345799999999999999999987532        13568999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC-ceEEeccccccccCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY-EARVSDFGLAHLVGP  524 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~-~~kl~Dfg~a~~~~~  524 (663)
                      |+++ +|.+++..... ....+++.....++.||+.||.|||+.+  |+||||||+|||++.++ .+||+|||+++....
T Consensus       148 ~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  223 (440)
T PTZ00036        148 FIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA  223 (440)
T ss_pred             cCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence            9985 77776653211 1345899999999999999999999998  99999999999999665 699999999986643


Q ss_pred             CC---CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh---cccc----
Q 006055          525 SS---TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD---EWTS----  593 (663)
Q Consensus       525 ~~---~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~----  593 (663)
                      ..   ...++..|+|||++.+ ..++.++|||||||++|||++|+.||......      ..+..+++.   ....    
T Consensus       224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~------~~~~~i~~~~~~p~~~~~~~  297 (440)
T PTZ00036        224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV------DQLVRIIQVLGTPTEDQLKE  297 (440)
T ss_pred             CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHHhCCCCHHHHHH
Confidence            32   2346777999999865 46899999999999999999999999753221      111111110   0000    


Q ss_pred             ---cccchhh-------hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          594 ---EVFDLEL-------LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       594 ---~~~d~~~-------~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                         ...+..+       .....+.....++.+++.+|+..||.+|||+.|+++|
T Consensus       298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence               0000000       0000011123568899999999999999999999975

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.1e-35  Score=305.55  Aligned_cols=194  Identities=25%  Similarity=0.378  Sum_probs=158.8

Q ss_pred             hcccccccceEEEEEEec---CCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEec--CccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE---MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM--DEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ey~~~  449 (663)
                      +.+||+|+||+||+|...   +++.||+|.++.... ...+.+|+.+++.++||||+++++++...  ...++||||+.+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH   84 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence            357999999999999854   568899999875433 34578899999999999999999988653  457899999875


Q ss_pred             CChhHhhccCCC----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEE----cCCCceEEeccccccc
Q 006055          450 GSLSALLHGNKG----AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHL  521 (663)
Q Consensus       450 gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill----~~~~~~kl~Dfg~a~~  521 (663)
                       +|.+++.....    .....+++..+..++.||+.||.|||+.+  |+||||||+|||+    +.++.+||+|||+++.
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence             88887753221    12235899999999999999999999998  9999999999999    4567899999999987


Q ss_pred             cCCCC-------CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCcccc
Q 006055          522 VGPSS-------TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALL  572 (663)
Q Consensus       522 ~~~~~-------~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~  572 (663)
                      .....       ...++..|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            64321       2235677999999876 457899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-36  Score=319.25  Aligned_cols=241  Identities=22%  Similarity=0.282  Sum_probs=188.4

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||++. ..+|+.||||.+.....    ..+.+.+|++++..++||||+++++++.+....++||||+++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g   85 (377)
T cd05629           6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG   85 (377)
T ss_pred             eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence            3689999999999998 45789999999865321    235678899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----  525 (663)
                      |+|.+++....     .+++.....++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.....    
T Consensus        86 g~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          86 GDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            99999997532     4788899999999999999999998  999999999999999999999999998632110    


Q ss_pred             -----------------------------------------------CCCCCCccccCccccCCCCCCCcchhhhHHHHH
Q 006055          526 -----------------------------------------------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLL  558 (663)
Q Consensus       526 -----------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl  558 (663)
                                                                     ....++.+|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  238 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM  238 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence                                                           012367779999999988899999999999999


Q ss_pred             HHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCC---CCHHHHH
Q 006055          559 LELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNR---PSMSEVI  635 (663)
Q Consensus       559 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~R---Pt~~ev~  635 (663)
                      |||++|+.||.....      ......+.....  ..      ..+.......++.+++.+|+. +|.+|   +++.|++
T Consensus       239 ~elltG~~Pf~~~~~------~~~~~~i~~~~~--~~------~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l  303 (377)
T cd05629         239 FECLIGWPPFCSENS------HETYRKIINWRE--TL------YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK  303 (377)
T ss_pred             hhhhcCCCCCCCCCH------HHHHHHHHccCC--cc------CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence            999999999964321      122222221100  00      001111123356677778887 66664   6999998


Q ss_pred             HH
Q 006055          636 KR  637 (663)
Q Consensus       636 ~~  637 (663)
                      ++
T Consensus       304 ~h  305 (377)
T cd05629         304 SH  305 (377)
T ss_pred             cC
Confidence            86

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.5e-35  Score=307.38  Aligned_cols=255  Identities=23%  Similarity=0.391  Sum_probs=199.6

Q ss_pred             hhcccccccceEEEEEEec--------CCcEEEEEEecCcccC--HHHHHHHHHHhhcC-CCCCcccceEEEEecCccEE
Q 006055          374 SAEVLGKGTFGTAYKAVLE--------MGTIVAVKRLKDVTIS--EREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLL  442 (663)
Q Consensus       374 ~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  442 (663)
                      ..+.||+|+||.||++...        +...+|+|.++.....  ...+..|++++..+ +||||+++++++......++
T Consensus        16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   95 (314)
T cd05099          16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV   95 (314)
T ss_pred             eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEE
Confidence            4678999999999999732        2457999998754322  35688899999999 69999999999998888999


Q ss_pred             EEEccCCCChhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCce
Q 006055          443 VYDYLTMGSLSALLHGNKG-----------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEA  511 (663)
Q Consensus       443 v~ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~  511 (663)
                      ||||+++|+|.+++.....           .....+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+
T Consensus        96 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~~~~~~  173 (314)
T cd05099          96 IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVM  173 (314)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEEEcCCCcE
Confidence            9999999999999975321           11245899999999999999999999998  9999999999999999999


Q ss_pred             EEeccccccccCCCCC----C--CCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHH
Q 006055          512 RVSDFGLAHLVGPSST----P--NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQ  584 (663)
Q Consensus       512 kl~Dfg~a~~~~~~~~----~--~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  584 (663)
                      ||+|||.++.......    .  ..+..|+|||.+.+..++.++||||||+++|||++ |..||....      ......
T Consensus       174 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~------~~~~~~  247 (314)
T cd05099         174 KIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP------VEELFK  247 (314)
T ss_pred             EEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC------HHHHHH
Confidence            9999999986643221    1  12245999999988889999999999999999999 888885421      112222


Q ss_pred             HHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 006055          585 SIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ  647 (663)
Q Consensus       585 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~  647 (663)
                      .+ ......          ..+.....++.+++.+|+..+|++|||+.|+++.|.++......
T Consensus       248 ~~-~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~  299 (314)
T cd05099         248 LL-REGHRM----------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE  299 (314)
T ss_pred             HH-HcCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence            11 111110          01112334677899999999999999999999999988654433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.6e-35  Score=302.19  Aligned_cols=242  Identities=24%  Similarity=0.393  Sum_probs=191.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcC-CCCCcccceEEEEec------CccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAYYYSM------DEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|.. .+++.||+|.+.........+..|+.++.++ +|+|++++++++...      ...++||||
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~   90 (272)
T cd06637          11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF   90 (272)
T ss_pred             HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence            46799999999999984 5689999999976665667889999999998 799999999998753      357899999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      +++|+|.+++....   ...+++..+..++.|++.|+.|||+.+  |+||||||+||++++++.++|+|||++.......
T Consensus        91 ~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~  165 (272)
T cd06637          91 CGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV  165 (272)
T ss_pred             CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCceeccccc
Confidence            99999999987533   245889999999999999999999998  9999999999999999999999999997654321


Q ss_pred             ----CCCCCccccCccccC-----CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          527 ----TPNRVAGYRAPEVTD-----PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       527 ----~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                          ...++..|+|||++.     ...++.++|||||||++|||++|+.||......     ... ...... .....  
T Consensus       166 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~-~~~~~~-~~~~~--  236 (272)
T cd06637         166 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RAL-FLIPRN-PAPRL--  236 (272)
T ss_pred             ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHH-HHHhcC-CCCCC--
Confidence                234566799999985     335788999999999999999999999643211     011 011110 00000  


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                             .......++.+++.+|+..+|.+|||+.|++++
T Consensus       237 -------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         237 -------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             -------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                   011223467888999999999999999999873

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.5e-35  Score=301.43  Aligned_cols=252  Identities=27%  Similarity=0.393  Sum_probs=199.5

Q ss_pred             hcccccccceEEEEEEec-----CCcEEEEEEecCcccC--HHHHHHHHHHhhcCCCCCcccceEEEEe--cCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLE-----MGTIVAVKRLKDVTIS--EREFKDKIEGVGAVNHENLVPLRAYYYS--MDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  445 (663)
                      .+.||+|+||.||++.+.     ++..||||.++.....  ...+.+|+++++.++|+||+++++++..  ....++|||
T Consensus         9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   88 (284)
T cd05038           9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME   88 (284)
T ss_pred             heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEe
Confidence            367999999999999853     3789999999866543  6789999999999999999999999877  557899999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+++++|.+++....    ..+++..+..++.+++.||+|||+.+  ++||||||+||+++.++.++|+|||.+......
T Consensus        89 ~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05038          89 YLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVLPED  162 (284)
T ss_pred             cCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence            999999999997543    24899999999999999999999998  999999999999999999999999999876532


Q ss_pred             CC-------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCC--------ChHHHHHHHHhhc
Q 006055          526 ST-------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGV--------DLPRWVQSIVKDE  590 (663)
Q Consensus       526 ~~-------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~  590 (663)
                      ..       ......|+|||...+..++.++||||||++++||++|+.|+.........        .........+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05038         163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG  242 (284)
T ss_pred             CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC
Confidence            21       11234599999998888999999999999999999999998653221100        0011111111111


Q ss_pred             ccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       591 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                      .          ..........++.+++.+|+..+|++|||+.||+++|+.+.
T Consensus       243 ~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         243 E----------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             C----------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            0          01111223457889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.2e-35  Score=305.13  Aligned_cols=254  Identities=23%  Similarity=0.364  Sum_probs=194.9

Q ss_pred             hcccccccceEEEEEEec-----------------CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLE-----------------MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYY  435 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-----------------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~  435 (663)
                      .+.||+|+||.||++...                 ++..||+|.+.....  ....+.+|+.+++.++|+||+++++++.
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   89 (296)
T cd05095          10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI   89 (296)
T ss_pred             eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            467999999999998532                 245799999875422  2467899999999999999999999999


Q ss_pred             ecCccEEEEEccCCCChhHhhccCCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC
Q 006055          436 SMDEKLLVYDYLTMGSLSALLHGNKG------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY  509 (663)
Q Consensus       436 ~~~~~~lv~ey~~~gsL~~~l~~~~~------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~  509 (663)
                      .....++||||+++|+|.+++.....      .....+++.....++.|++.||+|||+.+  ++||||||+||++++++
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Nili~~~~  167 (296)
T cd05095          90 TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNY  167 (296)
T ss_pred             cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheEEEcCCC
Confidence            99999999999999999999875431      11235788999999999999999999998  99999999999999999


Q ss_pred             ceEEeccccccccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh--CCCCCccccCCCCCChHH
Q 006055          510 EARVSDFGLAHLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT--GKAPTHALLNEEGVDLPR  581 (663)
Q Consensus       510 ~~kl~Dfg~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt--g~~p~~~~~~~~~~~~~~  581 (663)
                      .++|+|||+++.......      ...+..|+|||...+..++.++|||||||++|||++  |..||......+   ...
T Consensus       168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~---~~~  244 (296)
T cd05095         168 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ---VIE  244 (296)
T ss_pred             CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH---HHH
Confidence            999999999976543221      122356999999888889999999999999999998  778886432211   111


Q ss_pred             HHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          582 WVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       582 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                      ............. .      ......+...+.+++.+||+.||++||++.||++.|++
T Consensus       245 ~~~~~~~~~~~~~-~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         245 NTGEFFRDQGRQV-Y------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHhhccccc-c------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1111111110000 0      01112233578899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.9e-35  Score=299.72  Aligned_cols=245  Identities=28%  Similarity=0.403  Sum_probs=194.4

Q ss_pred             ccccccceEEEEEEecC-------CcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          377 VLGKGTFGTAYKAVLEM-------GTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       377 ~lg~G~~g~Vy~~~~~~-------g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .||+|+||.||+|...+       +..+|+|.+....  .....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            69999999999998542       2579999886543  33567889999999999999999999999989999999999


Q ss_pred             CCCChhHhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC-----ceEEecccccc
Q 006055          448 TMGSLSALLHGNKGA--GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY-----EARVSDFGLAH  520 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~-----~~kl~Dfg~a~  520 (663)
                      ++|+|.++++.....  ....+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++     .++++|||+++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            999999999753211  2334789999999999999999999998  99999999999999887     89999999987


Q ss_pred             ccCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccc
Q 006055          521 LVGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTS  593 (663)
Q Consensus       521 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (663)
                      ......      ....+..|+|||++.+..++.++|||||||++|||++ |+.||.....      ......+.....  
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~------~~~~~~~~~~~~--  231 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN------QEVLQHVTAGGR--  231 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH------HHHHHHHhcCCc--
Confidence            653321      1223467999999998889999999999999999998 9999864321      111111111110  


Q ss_pred             cccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       594 ~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                               .......+..+.+++.+|+..+|++||+++++++.|++
T Consensus       232 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         232 ---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                     01112234567889999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.9e-35  Score=303.89  Aligned_cols=243  Identities=26%  Similarity=0.313  Sum_probs=193.3

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcccC----HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      +.||+|+||+||++.. .+++.||||.+......    ...+.+|+.+++.++|+|++++++.+.+.+..++||||+++|
T Consensus         6 ~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~   85 (285)
T cd05630           6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG   85 (285)
T ss_pred             EEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCC
Confidence            5799999999999984 57899999998654221    345778999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC---
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST---  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~---  527 (663)
                      +|.+++....   ...+++..+..++.|++.||.|||+.+  |+||||||+||++++++.++|+|||++........   
T Consensus        86 ~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05630          86 DLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG  160 (285)
T ss_pred             cHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence            9999886432   235889999999999999999999998  99999999999999999999999999876543322   


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..++..|+|||++.+..++.++||||||+++|||++|+.||.......  . .......... ..          .....
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~--~-~~~~~~~~~~-~~----------~~~~~  226 (285)
T cd05630         161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--K-REEVERLVKE-VQ----------EEYSE  226 (285)
T ss_pred             CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc--h-HHHHHhhhhh-hh----------hhcCc
Confidence            346778999999998889999999999999999999999997532211  0 0011111100 00          00111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPS-----MSEVIKR  637 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt-----~~ev~~~  637 (663)
                      ....++.+++.+|+..||++|||     ++|++++
T Consensus       227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            22345778888999999999999     8888884

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-35  Score=297.01  Aligned_cols=240  Identities=22%  Similarity=0.299  Sum_probs=193.0

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc------CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI------SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||+|++|.||++.. .++++||+|.+.....      ..+.+.+|++++++++||||+++++++.+.+..++|+||+
T Consensus         7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   86 (263)
T cd06625           7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM   86 (263)
T ss_pred             cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence            46899999999999984 5689999999864321      1246888999999999999999999999999999999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-  526 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-  526 (663)
                      ++++|.+++....     .+++.....++.+++.||.|||+.+  |+||||+|+||++++++.++|+|||+++...... 
T Consensus        87 ~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          87 PGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS  159 (263)
T ss_pred             CCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence            9999999987532     4788999999999999999999998  9999999999999999999999999987654321 


Q ss_pred             ------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          527 ------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       527 ------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                            ...++..|+|||++.+..++.++||||||+++|||++|+.||.....      .............        
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~--------  225 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQPTN--------  225 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch------HHHHHHHhccCCC--------
Confidence                  12245569999999998899999999999999999999999864311      1111111111110        


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                        ...+......+.+++.+|+..+|++|||+.|++++
T Consensus       226 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 --PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence              01112234467888899999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5e-35  Score=297.77  Aligned_cols=244  Identities=25%  Similarity=0.448  Sum_probs=195.9

Q ss_pred             hcccccccceEEEEEEec-C---CcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLE-M---GTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~---g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|... +   +..+|+|.++....  ..+.+..|+.++..++||||+++++++...+..++||||++
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (267)
T cd05066           9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME   88 (267)
T ss_pred             eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence            468999999999999853 2   34799999875432  24578999999999999999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCC
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP  528 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  528 (663)
                      +++|.+++....    ..+++..+..++.|++.||.|||+.+  ++||||||+||+++.++.++++|||++.........
T Consensus        89 ~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd05066          89 NGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  162 (267)
T ss_pred             CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence            999999997543    34799999999999999999999998  999999999999999999999999999876543211


Q ss_pred             -------CCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          529 -------NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       529 -------~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                             ..+..|+|||++.+..++.++|+||||+++||+++ |+.||......      .....+. +...        
T Consensus       163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~------~~~~~~~-~~~~--------  227 (267)
T cd05066         163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ------DVIKAIE-EGYR--------  227 (267)
T ss_pred             eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH------HHHHHHh-CCCc--------
Confidence                   11345999999998889999999999999999887 99998653211      1111111 1110        


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                        .+.....+..+.+++.+|+..+|++||++.++++.|+++
T Consensus       228 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 --LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence              011112344678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.5e-35  Score=302.35  Aligned_cols=247  Identities=22%  Similarity=0.376  Sum_probs=196.4

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|...      ++..||+|.+.....  ..+++.+|+.+++.++|||++++++++......++||||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   89 (288)
T cd05050          10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEY   89 (288)
T ss_pred             cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEec
Confidence            467999999999999853      478899999875432  246788999999999999999999999998899999999


Q ss_pred             cCCCChhHhhccCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC
Q 006055          447 LTMGSLSALLHGNKG-----------------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY  509 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~  509 (663)
                      +++|+|.+++.....                 .....+++..++.++.|++.||.|||+.+  ++||||||+||++++++
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~nil~~~~~  167 (288)
T cd05050          90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENM  167 (288)
T ss_pred             CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHhheEecCCC
Confidence            999999999974321                 11235789999999999999999999998  99999999999999999


Q ss_pred             ceEEeccccccccCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHH
Q 006055          510 EARVSDFGLAHLVGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRW  582 (663)
Q Consensus       510 ~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~  582 (663)
                      .++|+|||+++......      ....+..|+|||.+.+..++.++|||||||++|||++ |..||...      .....
T Consensus       168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~------~~~~~  241 (288)
T cd05050         168 VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM------AHEEV  241 (288)
T ss_pred             ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------CHHHH
Confidence            99999999987653321      1123446999999988889999999999999999998 88888542      12222


Q ss_pred             HHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          583 VQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       583 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                      ...+..... .          ........++.+++.+|+..+|++|||+.|+++.|++
T Consensus       242 ~~~~~~~~~-~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         242 IYYVRDGNV-L----------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHHhcCCC-C----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            222221111 0          0111234568889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.8e-36  Score=319.26  Aligned_cols=241  Identities=22%  Similarity=0.283  Sum_probs=187.8

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|. ..+++.||||.+....    .....+.+|++++..++|+||+++++.+.+.+..++||||+++
T Consensus         6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~   85 (376)
T cd05598           6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG   85 (376)
T ss_pred             EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCC
Confidence            3679999999999999 4568999999986532    2245688999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC-----
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP-----  524 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~-----  524 (663)
                      |+|.+++....     .+++.....++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++.....     
T Consensus        86 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          86 GDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            99999997532     4788888999999999999999998  99999999999999999999999999753210     


Q ss_pred             ------------------------------------------CCCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHH
Q 006055          525 ------------------------------------------SSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELL  562 (663)
Q Consensus       525 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ell  562 (663)
                                                                .....++..|+|||++.+..++.++|||||||++|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence                                                      00123677899999999989999999999999999999


Q ss_pred             hCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 006055          563 TGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRP---SMSEVIKR  637 (663)
Q Consensus       563 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RP---t~~ev~~~  637 (663)
                      +|+.||.....      ......+.....  ..   .   .+.......++.+++.+|+ .+|++|+   ++.|++++
T Consensus       239 ~G~~Pf~~~~~------~~~~~~i~~~~~--~~---~---~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         239 VGQPPFLADTP------AETQLKVINWET--TL---H---IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hCCCCCCCCCH------HHHHHHHhccCc--cc---c---CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            99999965321      111111111100  00   0   0000112234555666665 5999999   89999886

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-35  Score=294.10  Aligned_cols=241  Identities=28%  Similarity=0.440  Sum_probs=195.4

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      ++||+|+||.||++...+++.||+|.+.....  ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            36999999999999976699999999876533  3467899999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC------
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST------  527 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------  527 (663)
                      +++....    ..+++.....++.+++.||.|||+.+  ++||||||+||+++.++.+||+|||.+........      
T Consensus        81 ~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            9997532    24789999999999999999999998  99999999999999999999999999976542211      


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ...+..|+|||.+.+..++.++||||||+++|||++ |..||.....      ...... .....          .....
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~------~~~~~~-~~~~~----------~~~~~  217 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN------QQTRER-IESGY----------RMPAP  217 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH------HHHHHH-HhcCC----------CCCCC
Confidence            112345999999988889999999999999999999 8888854321      111111 11110          00111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                      ...+.++.+++.+|+..+|++|||+.|+++.|+
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            223457888999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.9e-35  Score=297.27  Aligned_cols=241  Identities=25%  Similarity=0.403  Sum_probs=196.3

Q ss_pred             hcccccccceEEEEEEecC-CcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .+.||+|+||.||+|...+ ++.||+|.+..... ...+.+|+++++.++|+|++++++++.+....++++||+++++|.
T Consensus         8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~   86 (256)
T cd06612           8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVS   86 (256)
T ss_pred             hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHH
Confidence            4579999999999999654 89999999876533 678999999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----CCC
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----TPN  529 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~~~  529 (663)
                      +++....    ..+++..+..++.+++.|+.|||+.+  ++||||+|+||+++.++.++|+|||++.......    ...
T Consensus        87 ~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  160 (256)
T cd06612          87 DIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI  160 (256)
T ss_pred             HHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCcccccccc
Confidence            9986432    35899999999999999999999998  9999999999999999999999999988765432    123


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE  609 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  609 (663)
                      ++..|+|||++.+..++.++||||||+++++|++|+.||.......      ....+. .....        ........
T Consensus       161 ~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~--------~~~~~~~~  225 (256)
T cd06612         161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR------AIFMIP-NKPPP--------TLSDPEKW  225 (256)
T ss_pred             CCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh------hhhhhc-cCCCC--------CCCchhhc
Confidence            5667999999998889999999999999999999999997532211      000000 00000        01112223


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          610 MVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       610 ~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ..++.+++.+|++.+|++|||++|++++
T Consensus       226 ~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         226 SPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            3567889999999999999999999873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.5e-36  Score=282.88  Aligned_cols=243  Identities=25%  Similarity=0.359  Sum_probs=199.3

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcc---cC--H----HHHHHHHHHhhcC-CCCCcccceEEEEecCccEEE
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT---IS--E----REFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLV  443 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~--~----~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  443 (663)
                      .+.||+|..++|-+.. .++|..+|+|++....   .+  .    +.-.+|+.+++++ .||+|+.+.++|..+...++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            4679999999998877 5678999999986431   11  1    3456789999987 799999999999999999999


Q ss_pred             EEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccC
Q 006055          444 YDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG  523 (663)
Q Consensus       444 ~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~  523 (663)
                      +|.|+.|.|.|+|...     ..+++....+|+.|+..|++|||...  |+||||||+|||+|++.++||+|||++....
T Consensus       102 Fdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen  102 FDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             hhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEeccceeeccC
Confidence            9999999999999853     46899999999999999999999998  9999999999999999999999999999988


Q ss_pred             CCCC---CCCCccccCccccCC------CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          524 PSST---PNRVAGYRAPEVTDP------CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       524 ~~~~---~~~~~~y~aPE~~~~------~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                      ++..   ..||+||+|||.+..      ..|+..+|+||+||++|-|+.|.+||....      -.-.++.++...+.  
T Consensus       175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------QmlMLR~ImeGkyq--  246 (411)
T KOG0599|consen  175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------QMLMLRMIMEGKYQ--  246 (411)
T ss_pred             CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------HHHHHHHHHhcccc--
Confidence            7753   458999999998753      468889999999999999999999997532      12233444443321  


Q ss_pred             ccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       595 ~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                         .   ..++-.+......+++.+|+..||.+|.|++|+++|=
T Consensus       247 ---F---~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  247 ---F---RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             ---c---CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence               1   1122234455677788899999999999999999864

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.9e-35  Score=301.36  Aligned_cols=248  Identities=21%  Similarity=0.357  Sum_probs=195.2

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .++||+|+||.||+|..+      .+..||+|.+.....  ....+.+|+..++.++|+||+++++++.+....++||||
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   90 (288)
T cd05061          11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMEL   90 (288)
T ss_pred             eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeC
Confidence            468999999999998743      255899998865432  234678899999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccc
Q 006055          447 LTMGSLSALLHGNKG-----AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL  521 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~  521 (663)
                      +++|+|.++++....     .....+++..+..++.|++.||.|||+.+  |+||||||+||++++++.++|+|||+++.
T Consensus        91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~~~L~Dfg~~~~  168 (288)
T cd05061          91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRD  168 (288)
T ss_pred             CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCcEEECcCCcccc
Confidence            999999999975321     11244678888999999999999999998  99999999999999999999999999976


Q ss_pred             cCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          522 VGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       522 ~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                      ......      ..++..|+|||.+.+..++.++|||||||++|||++ |..||....      ..+....+....... 
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~------~~~~~~~~~~~~~~~-  241 (288)
T cd05061         169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS------NEQVLKFVMDGGYLD-  241 (288)
T ss_pred             ccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCCCC-
Confidence            533221      122456999999988889999999999999999998 788886422      122222222111110 


Q ss_pred             ccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       595 ~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                                ........+.+++.+|++.+|++|||+.++++.|++.
T Consensus       242 ----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         242 ----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             ----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                      1112235788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.8e-35  Score=332.24  Aligned_cols=253  Identities=23%  Similarity=0.257  Sum_probs=197.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .++||+|+||.||+|.. .+|+.||+|++.....    ..+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus         7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eG   86 (932)
T PRK13184          7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG   86 (932)
T ss_pred             EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCC
Confidence            36899999999999995 4689999999875421    245788999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccC
Q 006055          450 GSLSALLHGNKG------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG  523 (663)
Q Consensus       450 gsL~~~l~~~~~------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~  523 (663)
                      |+|.+++.....      ......++..+..++.||++||+|||+.+  |+||||||+||+++.++.+||+|||+++...
T Consensus        87 GSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~  164 (932)
T PRK13184         87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGAAIFKK  164 (932)
T ss_pred             CCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCcceecc
Confidence            999999864211      11234677888999999999999999998  9999999999999999999999999997652


Q ss_pred             CC----------------------CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHH
Q 006055          524 PS----------------------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPR  581 (663)
Q Consensus       524 ~~----------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~  581 (663)
                      ..                      ....++..|+|||++.+..++.++|||||||++|||+||+.||.......   ...
T Consensus       165 ~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k---i~~  241 (932)
T PRK13184        165 LEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK---ISY  241 (932)
T ss_pred             cccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh---hhh
Confidence            10                      01236778999999999999999999999999999999999996522111   100


Q ss_pred             HHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHhhCCC
Q 006055          582 WVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRP-SMSEVIKRIEELHPS  644 (663)
Q Consensus       582 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RP-t~~ev~~~L~~~~~~  644 (663)
                             ..   ...++..  .....+.+..+.+++.+|+..||++|| +++++.+.|+.....
T Consensus       242 -------~~---~i~~P~~--~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        242 -------RD---VILSPIE--VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             -------hh---hccChhh--ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence                   00   0001100  001122344677889999999999995 678888888877544

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.6e-35  Score=317.54  Aligned_cols=241  Identities=22%  Similarity=0.293  Sum_probs=185.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .++||+|+||+||+|.. .+++.||+|.+.....    ....+.+|+++++.++|+||+++++++.+.+..++||||+++
T Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g   85 (382)
T cd05625           6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG   85 (382)
T ss_pred             EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence            36899999999999994 5689999999875422    234688899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----  525 (663)
                      |+|.+++....     .+++.....++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.....    
T Consensus        86 g~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          86 GDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            99999987532     4788889999999999999999998  999999999999999999999999997532100    


Q ss_pred             -----------------------------------------------CCCCCCccccCccccCCCCCCCcchhhhHHHHH
Q 006055          526 -----------------------------------------------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLL  558 (663)
Q Consensus       526 -----------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl  558 (663)
                                                                     ....++..|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                           012356779999999998999999999999999


Q ss_pred             HHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCC---HHHHH
Q 006055          559 LELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPS---MSEVI  635 (663)
Q Consensus       559 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt---~~ev~  635 (663)
                      |||++|+.||.....      ......+.......     .......   ...++.+++.+++ .+|++|++   ++|++
T Consensus       239 ~elltG~~Pf~~~~~------~~~~~~i~~~~~~~-----~~p~~~~---~s~~~~~li~~l~-~~p~~R~~~~~~~ei~  303 (382)
T cd05625         239 YEMLVGQPPFLAQTP------LETQMKVINWQTSL-----HIPPQAK---LSPEASDLIIKLC-RGPEDRLGKNGADEIK  303 (382)
T ss_pred             HHHHhCCCCCCCCCH------HHHHHHHHccCCCc-----CCCCccc---CCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence            999999999965321      11111221111000     0001111   1223445555554 49999997   88887


Q ss_pred             HH
Q 006055          636 KR  637 (663)
Q Consensus       636 ~~  637 (663)
                      +|
T Consensus       304 ~h  305 (382)
T cd05625         304 AH  305 (382)
T ss_pred             cC
Confidence            64

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.3e-35  Score=308.95  Aligned_cols=253  Identities=20%  Similarity=0.294  Sum_probs=190.0

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||.||+|.. .+++.||+|.++...  .....+.+|++++++++||||+++++++..++..++||||+++ +
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~   89 (309)
T cd07872          11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-D   89 (309)
T ss_pred             EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-C
Confidence            36799999999999984 468899999987542  2345678899999999999999999999999999999999985 8


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----C
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----T  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~  527 (663)
                      |.+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++......    .
T Consensus        90 l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  163 (309)
T cd07872          90 LKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN  163 (309)
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence            888876432    34788999999999999999999998  9999999999999999999999999997643322    2


Q ss_pred             CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc---cc------cccc
Q 006055          528 PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW---TS------EVFD  597 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~------~~~d  597 (663)
                      ..++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+   ....+........   ..      ...+
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07872         164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED---ELHLIFRLLGTPTEETWPGISSNDEFKN  240 (309)
T ss_pred             ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence            235667999998865 457889999999999999999999996532211   1111111100000   00      0000


Q ss_pred             hhhhcc------cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          598 LELLRY------QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       598 ~~~~~~------~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ......      ........++.+++.+|+..||++|||++|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            000000      0001123457789999999999999999999983

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.9e-35  Score=301.55  Aligned_cols=243  Identities=24%  Similarity=0.290  Sum_probs=192.5

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      ++||+|+||+||++.. .+++.||+|.+.....    ....+.+|+++++.++|+|++++.+++..++..++||||++++
T Consensus         6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (285)
T cd05632           6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGG   85 (285)
T ss_pred             EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCc
Confidence            5799999999999984 5789999999865432    2345778999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---C
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---T  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---~  527 (663)
                      +|.+++....   ...+++..+..++.|++.||.|||+.+  |+||||||+||++++++.++|+|||++.......   .
T Consensus        86 ~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05632          86 DLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG  160 (285)
T ss_pred             cHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence            9998886432   235899999999999999999999998  9999999999999999999999999987654322   2


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..++..|+|||++.+..++.++|+||||+++|||++|+.||.......  ........ .....  .         ....
T Consensus       161 ~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--~~~~~~~~-~~~~~--~---------~~~~  226 (285)
T cd05632         161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--KREEVDRR-VLETE--E---------VYSA  226 (285)
T ss_pred             CCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHh-hhccc--c---------ccCc
Confidence            345677999999998889999999999999999999999997532111  00011111 11100  0         0011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPS-----MSEVIKR  637 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt-----~~ev~~~  637 (663)
                      ....++.+++..|++.||++||+     +++++++
T Consensus       227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         227 KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            22345678888999999999999     6677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.4e-35  Score=314.88  Aligned_cols=249  Identities=22%  Similarity=0.337  Sum_probs=189.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecC-----ccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMD-----EKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e  445 (663)
                      .+.||+|+||.||++.. .+|+.||||++....   ...+.+.+|+++++.++|+||+++++++....     ..++|+|
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e   84 (372)
T cd07853           5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE   84 (372)
T ss_pred             cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence            46799999999999994 579999999986542   23467889999999999999999999998766     7899999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+. ++|.+++...     ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++.....
T Consensus        85 ~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          85 LMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             ccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            997 5788877542     35899999999999999999999998  999999999999999999999999999865432


Q ss_pred             CC-----CCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHh---hcccc---
Q 006055          526 ST-----PNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK---DEWTS---  593 (663)
Q Consensus       526 ~~-----~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~---  593 (663)
                      ..     ..++..|+|||++.+. .++.++|||||||++|||++|+.||......      ..+..+..   .....   
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~g~~~~~~~~  230 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI------QQLDLITDLLGTPSLEAMR  230 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH------HHHHHHHHHcCCCCHHHHH
Confidence            21     2346679999998774 4788999999999999999999999753221      11111110   00000   


Q ss_pred             ------------cccchh-hh-cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          594 ------------EVFDLE-LL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       594 ------------~~~d~~-~~-~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                                  ....+. .. ......+...++.+++.+|+..||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                        000000 00 000011123467889999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.2e-35  Score=313.04  Aligned_cols=191  Identities=32%  Similarity=0.436  Sum_probs=168.1

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccCHHHHHHHHHHhhcCC-C-----CCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-H-----ENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .++||+|+||.|-+|. .++++.||||+++....--.+-..|+.+|..++ |     -|+|++++||...++.+||+|.+
T Consensus       191 ~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL  270 (586)
T KOG0667|consen  191 LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL  270 (586)
T ss_pred             EEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh
Confidence            4689999999999999 667999999999987666667788999999986 4     38999999999999999999988


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC--ceEEeccccccccCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY--EARVSDFGLAHLVGPS  525 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~--~~kl~Dfg~a~~~~~~  525 (663)
                      .. +|+++++.+.   ...++....+.++.||+.||.+||+.+  |||+||||+||||.+-.  .+||+|||.+.+....
T Consensus       271 ~~-NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~  344 (586)
T KOG0667|consen  271 ST-NLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR  344 (586)
T ss_pred             hh-hHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccccccCCc
Confidence            66 9999998765   456999999999999999999999998  99999999999997544  6999999999877654


Q ss_pred             C-CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccc
Q 006055          526 S-TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHAL  571 (663)
Q Consensus       526 ~-~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~  571 (663)
                      . +...+..|+|||++.+..|+.+.||||||||+.||++|.+.|.+.
T Consensus       345 vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~  391 (586)
T KOG0667|consen  345 VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD  391 (586)
T ss_pred             ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence            3 334455699999999999999999999999999999998877654

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5.2e-35  Score=306.78  Aligned_cols=250  Identities=22%  Similarity=0.315  Sum_probs=188.9

Q ss_pred             cccccc--cceEEEEEE-ecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKG--TFGTAYKAV-LEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G--~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      ++||+|  +|++||++. ..+|+.||+|++......   ...+.+|+++++.++||||++++++|..++..++||||+++
T Consensus         4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~   83 (327)
T cd08227           4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY   83 (327)
T ss_pred             hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence            579999  789999998 467999999998754322   34677899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----  525 (663)
                      |+|.+++....   ...+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++++||+........    
T Consensus        84 ~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          84 GSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            99999986432   124889999999999999999999998  999999999999999999999999865432111    


Q ss_pred             -------CCCCCCccccCccccCC--CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccccccc
Q 006055          526 -------STPNRVAGYRAPEVTDP--CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF  596 (663)
Q Consensus       526 -------~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  596 (663)
                             ....++..|+|||++.+  ..++.++|||||||++|||++|+.||.......      ......... .....
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~-~~~~~  231 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ------MLLEKLNGT-VPCLL  231 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH------HHHHHhcCC-ccccc
Confidence                   11123455999999875  458899999999999999999999997532111      000000000 00000


Q ss_pred             c-------------------hhh----------------hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          597 D-------------------LEL----------------LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       597 d-------------------~~~----------------~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      +                   ...                ...........++.+++.+|+..||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            0                   000                0000111234578899999999999999999999984

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-35  Score=304.89  Aligned_cols=254  Identities=21%  Similarity=0.319  Sum_probs=192.8

Q ss_pred             hcccccccceEEEEEEecC---------------CcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEec
Q 006055          375 AEVLGKGTFGTAYKAVLEM---------------GTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSM  437 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~---------------g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  437 (663)
                      .+.||+|+||.||++....               ...||+|.++....  ....+.+|++++++++|+|++++++++...
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   89 (295)
T cd05097          10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD   89 (295)
T ss_pred             hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence            4679999999999987532               23589999875422  235688999999999999999999999999


Q ss_pred             CccEEEEEccCCCChhHhhccCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc
Q 006055          438 DEKLLVYDYLTMGSLSALLHGNKG-------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE  510 (663)
Q Consensus       438 ~~~~lv~ey~~~gsL~~~l~~~~~-------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~  510 (663)
                      ...++||||+++++|.+++.....       .....+++..++.++.+++.||.|||+.+  ++||||||+||++++++.
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nill~~~~~  167 (295)
T cd05097          90 DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYT  167 (295)
T ss_pred             CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhEEEcCCCc
Confidence            999999999999999999864321       11124789999999999999999999998  999999999999999999


Q ss_pred             eEEeccccccccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh--CCCCCccccCCCCCChHHH
Q 006055          511 ARVSDFGLAHLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT--GKAPTHALLNEEGVDLPRW  582 (663)
Q Consensus       511 ~kl~Dfg~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt--g~~p~~~~~~~~~~~~~~~  582 (663)
                      +||+|||++........      ..++..|+|||++.+..++.++|||||||+++||++  +..||......+   ....
T Consensus       168 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~---~~~~  244 (295)
T cd05097         168 IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ---VIEN  244 (295)
T ss_pred             EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH---HHHH
Confidence            99999999976543221      122456999999988889999999999999999998  566775432211   1111


Q ss_pred             HHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          583 VQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       583 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                      ..............       ......+..+.+++.+|++.+|++||++++|++.|++
T Consensus       245 ~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         245 TGEFFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHhhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            11111110000000       0011123478899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.1e-35  Score=300.91  Aligned_cols=243  Identities=23%  Similarity=0.358  Sum_probs=192.3

Q ss_pred             hhcccccccceEEEEEEec-CCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          374 SAEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       374 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      ..+.||+|+||.||++... ++..+|+|.+.... .....+.+|+++++.++|||++++++++...+..++||||+++++
T Consensus         9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~   88 (282)
T cd06643           9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA   88 (282)
T ss_pred             HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCc
Confidence            3567999999999999954 57889999886543 234568889999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----CC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----ST  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----~~  527 (663)
                      |..++....    .++++..+..++.|++.||.|||+.+  ++||||||+||+++.++.+||+|||++......    ..
T Consensus        89 l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (282)
T cd06643          89 VDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  162 (282)
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence            999886422    35899999999999999999999998  999999999999999999999999998654332    12


Q ss_pred             CCCCccccCccccC-----CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          528 PNRVAGYRAPEVTD-----PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       528 ~~~~~~y~aPE~~~-----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                      ..++..|+|||++.     +..++.++|||||||++|||++|+.||....      ....+.......... .       
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~------~~~~~~~~~~~~~~~-~-------  228 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN------PMRVLLKIAKSEPPT-L-------  228 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC------HHHHHHHHhhcCCCC-C-------
Confidence            33566799999974     3456789999999999999999999986432      111122222111110 0       


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                       ........++.+++.+||..+|++||++++++++
T Consensus       229 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         229 -AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0111233467888999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.4e-35  Score=307.49  Aligned_cols=232  Identities=21%  Similarity=0.275  Sum_probs=185.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCC-CCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||+||+|.. .+|+.||+|.+....    .....+..|..++..+. |++|+++++++.+.+..++||||++
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~   84 (323)
T cd05615           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN   84 (323)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence            36799999999999984 568999999987542    12345777888888875 5677889999988889999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--  526 (663)
                      +|+|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++......  
T Consensus        85 ~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          85 GGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence            999999987532     4899999999999999999999998  9999999999999999999999999987543221  


Q ss_pred             --CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          527 --TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                        ...++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+.....            .
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~------~~~~~~~i~~~~~------------~  219 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED------EDELFQSIMEHNV------------S  219 (323)
T ss_pred             ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCC------------C
Confidence              2336778999999998889999999999999999999999996532      1222233322211            0


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSM  631 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~  631 (663)
                      .+.....++.+++.+|+..+|.+|++.
T Consensus       220 ~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         220 YPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            011223467788889999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.4e-34  Score=294.59  Aligned_cols=247  Identities=21%  Similarity=0.308  Sum_probs=185.1

Q ss_pred             ccccccceEEEEEEecCC---cEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          377 VLGKGTFGTAYKAVLEMG---TIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       377 ~lg~G~~g~Vy~~~~~~g---~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .||+|+||.||++...++   ..+++|.++...  ...+.+.+|+..++.++||||++++++|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999985433   346677665432  234678999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC------
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS------  525 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~------  525 (663)
                      |.++++..... ....++.....++.||+.||+|||+.+  ++||||||+|||++.++.+||+|||++......      
T Consensus        82 L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99999754321 234677788899999999999999998  999999999999999999999999998643211      


Q ss_pred             CCCCCCccccCccccCC-------CCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          526 STPNRVAGYRAPEVTDP-------CKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       526 ~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                      ....++..|+|||++..       ..++.++||||||+++|||++ |..||....      ....+..+..+.. ....+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~------~~~~~~~~~~~~~-~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS------DREVLNHVIKDQQ-VKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHhhcc-cccCC
Confidence            12234567999998743       235778999999999999997 566775322      1222333322211 12222


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                      +...     ......+.+++..|| .+|++||+++||++.|.
T Consensus       232 ~~~~-----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLE-----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccC-----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2211     112345677888999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.3e-35  Score=313.02  Aligned_cols=242  Identities=20%  Similarity=0.284  Sum_probs=189.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||++.. .+++.||+|.+....    .....+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus        48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g  127 (371)
T cd05622          48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG  127 (371)
T ss_pred             EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence            46899999999999995 468899999986432    1234578899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++...      .++...+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++......   
T Consensus       128 g~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~  199 (371)
T cd05622         128 GDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR  199 (371)
T ss_pred             CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCccc
Confidence            9999998743      3788888999999999999999998  9999999999999999999999999998764322   


Q ss_pred             --CCCCCccccCccccCCC----CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          527 --TPNRVAGYRAPEVTDPC----KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~----~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                        ...++..|+|||++...    .++.++|||||||++|||++|+.||...      +.......+........      
T Consensus       200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~------~~~~~~~~i~~~~~~~~------  267 (371)
T cd05622         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD------SLVGTYSKIMNHKNSLT------  267 (371)
T ss_pred             ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC------CHHHHHHHHHcCCCccc------
Confidence              23477889999998653    3788999999999999999999999642      22223333332211111      


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDN--RPSMSEVIKRI  638 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~--RPt~~ev~~~L  638 (663)
                        .+........+.+++..|+..++.+  ||+++|++++.
T Consensus       268 --~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         268 --FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             --CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence              1111123345667778899744433  78999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.4e-35  Score=315.24  Aligned_cols=251  Identities=19%  Similarity=0.199  Sum_probs=188.4

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .+.||+|+||.||++... .++.||||....     ..+.+|++++++++|+||+++++++......++||||+. ++|.
T Consensus       174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~  247 (461)
T PHA03211        174 HRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLY  247 (461)
T ss_pred             EEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHH
Confidence            467999999999999954 588999996432     346789999999999999999999999999999999995 6898


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC------C
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS------T  527 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~------~  527 (663)
                      +++....    ..++|..++.|+.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++......      .
T Consensus       248 ~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  321 (461)
T PHA03211        248 TYLGARL----RPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG  321 (461)
T ss_pred             HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence            8886432    35899999999999999999999998  9999999999999999999999999997654321      1


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCC-CCCChHHHHHHHHhhccc--cccc---chhh-
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNE-EGVDLPRWVQSIVKDEWT--SEVF---DLEL-  600 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~--~~~~---d~~~-  600 (663)
                      ..++..|+|||++.+..++.++|||||||++|||++|..|+-..... ........+.+++.....  .+..   ...+ 
T Consensus       322 ~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~  401 (461)
T PHA03211        322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLV  401 (461)
T ss_pred             cCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHH
Confidence            23677899999999999999999999999999999988765332211 111111112222211100  0000   0000 


Q ss_pred             ---h--------------cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          601 ---L--------------RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       601 ---~--------------~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                         .              .+........++.+++.+|++.||.+|||+.|++++
T Consensus       402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        402 SQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence               0              000000112357788999999999999999999984

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.3e-35  Score=303.13  Aligned_cols=239  Identities=25%  Similarity=0.358  Sum_probs=193.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||.||++.. .+++.||+|.+.... .....+.+|+.+++.++|+|++++++++......++||||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  103 (297)
T cd06656          24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL  103 (297)
T ss_pred             eeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCH
Confidence            46799999999999994 679999999987543 3346688899999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----CC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----TP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~~  528 (663)
                      .+++...      .+++..+..++.+++.||.|||+.+  ++||||||+||+++.++.++|+|||++.......    ..
T Consensus       104 ~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  175 (297)
T cd06656         104 TDVVTET------CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  175 (297)
T ss_pred             HHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcc
Confidence            9998642      3788999999999999999999998  9999999999999999999999999987654432    12


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .++..|+|||.+.+..++.++|||||||++|+|++|+.||.........      ....... ..        ....+..
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~------~~~~~~~-~~--------~~~~~~~  240 (297)
T cd06656         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG-TP--------ELQNPER  240 (297)
T ss_pred             cCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe------eeeccCC-CC--------CCCCccc
Confidence            3566799999999888899999999999999999999999653221100      0000000 00        0011122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      ....+.+++.+|+..+|++||+++++++
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         241 LSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            3345678888999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6e-35  Score=290.49  Aligned_cols=242  Identities=25%  Similarity=0.328  Sum_probs=196.4

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccC----HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|.-|+||+++.+ ++..+|+|++.+....    -...+.|-++|+.+.||.+..+|+.+..++..++|||||+|
T Consensus        82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG  161 (459)
T KOG0610|consen   82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG  161 (459)
T ss_pred             HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence            468999999999999965 4689999999765332    24567788999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC-----
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP-----  524 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~-----  524 (663)
                      |+|..+++.+.+   ..+++..+..++.+|+-||+|||..|  ||+|||||+||||-++|++.|+||.++.....     
T Consensus       162 GdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~  236 (459)
T KOG0610|consen  162 GDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV  236 (459)
T ss_pred             ccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence            999999998763   46899999999999999999999999  99999999999999999999999998732100     


Q ss_pred             ----------------------------CCC---------------------------CCCCccccCccccCCCCCCCcc
Q 006055          525 ----------------------------SST---------------------------PNRVAGYRAPEVTDPCKVSQKA  549 (663)
Q Consensus       525 ----------------------------~~~---------------------------~~~~~~y~aPE~~~~~~~~~~~  549 (663)
                                                  ...                           ..||-.|+|||++.+...+..+
T Consensus       237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAV  316 (459)
T KOG0610|consen  237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAV  316 (459)
T ss_pred             ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchh
Confidence                                        000                           0123349999999999999999


Q ss_pred             hhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCC
Q 006055          550 DVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRP  629 (663)
Q Consensus       550 Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RP  629 (663)
                      |+|+|||++|||+.|+.||.+...++      -+.+++...          +.++...+.+..+.+||++.+.+||.+|.
T Consensus       317 DWWtfGIflYEmLyG~TPFKG~~~~~------Tl~NIv~~~----------l~Fp~~~~vs~~akDLIr~LLvKdP~kRl  380 (459)
T KOG0610|consen  317 DWWTFGIFLYEMLYGTTPFKGSNNKE------TLRNIVGQP----------LKFPEEPEVSSAAKDLIRKLLVKDPSKRL  380 (459)
T ss_pred             hHHHHHHHHHHHHhCCCCcCCCCchh------hHHHHhcCC----------CcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence            99999999999999999998755433      122222221          12222224456778888999999999999


Q ss_pred             C----HHHHHHH
Q 006055          630 S----MSEVIKR  637 (663)
Q Consensus       630 t----~~ev~~~  637 (663)
                      -    +.||.+|
T Consensus       381 g~~rGA~eIK~H  392 (459)
T KOG0610|consen  381 GSKRGAAEIKRH  392 (459)
T ss_pred             ccccchHHhhcC
Confidence            8    7787765

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.1e-35  Score=304.16  Aligned_cols=254  Identities=21%  Similarity=0.295  Sum_probs=193.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||.||++.. .++..+|+|.++....  ....+.+|++++.+++||||+++++++.++++.++||||+++++
T Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~   85 (308)
T cd06615           6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS   85 (308)
T ss_pred             EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCc
Confidence            46799999999999984 4688999998865422  23568899999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCcceecCCCCCCEEEcCCCceEEeccccccccCCC--CCC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ-GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STP  528 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~--~~~  528 (663)
                      |.++++..     ..+++..+..++.|++.||.|||+. +  ++||||||+||+++.++.+||+|||++......  ...
T Consensus        86 L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  158 (308)
T cd06615          86 LDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  158 (308)
T ss_pred             HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccccccccccC
Confidence            99999753     2478999999999999999999974 5  999999999999999999999999998765432  223


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccc---------------
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTS---------------  593 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------------  593 (663)
                      .++..|+|||.+.+..++.++||||||+++|||++|+.||.......   ...+...........               
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (308)
T cd06615         159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPPDSPR  235 (308)
T ss_pred             CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCCCCccc
Confidence            45667999999988888999999999999999999999986432111   111100000000000               


Q ss_pred             -----cccchhhh---cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          594 -----EVFDLELL---RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       594 -----~~~d~~~~---~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                           +..+....   ..........++.+++.+|+..+|++|||++|++++-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                 00000000   0000011334688999999999999999999999863

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-35  Score=299.99  Aligned_cols=245  Identities=32%  Similarity=0.453  Sum_probs=193.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHH---HHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISER---EFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~---~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||+||++.. .+++.||+|.+........   ...+|+..++.++||||+++++++......++||||++++
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~   83 (260)
T PF00069_consen    4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG   83 (260)
T ss_dssp             EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred             eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence            36899999999999995 4567999999987644332   2345999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC----CC
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP----SS  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~----~~  526 (663)
                      +|.+++...     ..+++..+..++.|+++||.|||+.+  |+||||||+||++++++.++|+|||.+.....    ..
T Consensus        84 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~  156 (260)
T PF00069_consen   84 SLQDYLQKN-----KPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN  156 (260)
T ss_dssp             BHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred             ccccccccc-----cccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccc
Confidence            999999722     34899999999999999999999998  99999999999999999999999999975311    12


Q ss_pred             CCCCCccccCccccC-CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 TPNRVAGYRAPEVTD-PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~-~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      ...++..|+|||.+. +..++.++||||+|+++++|++|..||......   +..............     .   ....
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~---~~~~~~~~~~~~~~~-----~---~~~~  225 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD---DQLEIIEKILKRPLP-----S---SSQQ  225 (260)
T ss_dssp             SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH---HHHHHHHHHHHTHHH-----H---HTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccch---hhhhhhhhccccccc-----c---cccc
Confidence            234667799999998 788899999999999999999999999754110   111111111111000     0   0001


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .......+.+++.+|++.||++||++.+++++
T Consensus       226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  226 SREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11112578899999999999999999999873

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.1e-35  Score=299.40  Aligned_cols=238  Identities=24%  Similarity=0.364  Sum_probs=193.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||.||+|.. .+++.||+|.+....  ...+.+.+|++++++++||||+++++++......++||||+++++
T Consensus         9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (277)
T cd06642           9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS   88 (277)
T ss_pred             HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCc
Confidence            46799999999999984 568899999887442  223578899999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC----
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST----  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~----  527 (663)
                      |.+++...      .+++..+..++.+++.|+.|||+.+  ++|+||+|+||++++++.++++|||++........    
T Consensus        89 L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          89 ALDLLKPG------PLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             HHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence            99998642      4789999999999999999999998  99999999999999999999999999976543321    


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..++..|+|||++.+..++.++||||||++++||++|+.|+.......      ....+ .....          .....
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------~~~~~-~~~~~----------~~~~~  223 (277)
T cd06642         161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR------VLFLI-PKNSP----------PTLEG  223 (277)
T ss_pred             ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh------HHhhh-hcCCC----------CCCCc
Confidence            234567999999998889999999999999999999999986432111      11111 11100          00112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .....+.+++.+|+..+|++||++.+++++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         224 QYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            234567889999999999999999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-36  Score=317.34  Aligned_cols=253  Identities=25%  Similarity=0.398  Sum_probs=208.6

Q ss_pred             HHHHHHhhcccccccceEEEEEEe-cCCc----EEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCcc
Q 006055          368 EDLLRASAEVLGKGTFGTAYKAVL-EMGT----IVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEK  440 (663)
Q Consensus       368 ~~l~~~~~~~lg~G~~g~Vy~~~~-~~g~----~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  440 (663)
                      +|....-.++||+|+||+||+|.| +.|+    +||+|.+....  ....++.+|+..|.+++|||+++++|+|.... .
T Consensus       694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~  772 (1177)
T KOG1025|consen  694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L  772 (1177)
T ss_pred             hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence            344444467999999999999984 4443    68999887653  33678999999999999999999999997765 8


Q ss_pred             EEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          441 LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       441 ~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                      .||++||+.|.|.++++..+    ..+-....+.|..|||+|+.|||.+.  ++||||-++|||+..-..+||.|||+++
T Consensus       773 qlvtq~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~  846 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAK  846 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhh
Confidence            89999999999999998755    35778889999999999999999998  9999999999999999999999999999


Q ss_pred             ccCCCCCCCC------CccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccc
Q 006055          521 LVGPSSTPNR------VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTS  593 (663)
Q Consensus       521 ~~~~~~~~~~------~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (663)
                      ...+......      .+.|||-|.+....|+.++|||||||++||++| |..|++....++.       ...++.+.  
T Consensus       847 ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-------~dlle~ge--  917 (1177)
T KOG1025|consen  847 LLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-------PDLLEKGE--  917 (1177)
T ss_pred             ccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-------hHHHhccc--
Confidence            9887654332      234999999999999999999999999999999 9999987654332       22222211  


Q ss_pred             cccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       594 ~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                              +...++-+..++..++.+||..|++.||+++++...+.++...
T Consensus       918 --------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  918 --------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             --------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence                    1234455677899999999999999999999999999887543

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.6e-35  Score=303.47  Aligned_cols=239  Identities=25%  Similarity=0.378  Sum_probs=194.2

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      +.||.|+||.||+|. ..+|+.||+|.+..... ....+.+|++.++.++|||++++++++...+..++|+||+++++|.
T Consensus        25 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  104 (296)
T cd06655          25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT  104 (296)
T ss_pred             EEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHH
Confidence            579999999999998 46799999999865432 3567889999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC----CC
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST----PN  529 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~----~~  529 (663)
                      +++...      .+++..+..++.+++.|+.|||+.+  ++||||||+||+++.++.+||+|||++........    ..
T Consensus       105 ~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  176 (296)
T cd06655         105 DVVTET------CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV  176 (296)
T ss_pred             HHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcC
Confidence            998642      4899999999999999999999998  99999999999999999999999999876544321    23


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE  609 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  609 (663)
                      ++..|+|||.+.+..++.++|||||||++|+|++|+.||.....      ......+.... ...        .......
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~------~~~~~~~~~~~-~~~--------~~~~~~~  241 (296)
T cd06655         177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNG-TPE--------LQNPEKL  241 (296)
T ss_pred             CCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcC-Ccc--------cCCcccC
Confidence            56679999999988899999999999999999999999965321      11111111111 000        0111223


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          610 MVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       610 ~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...+.+++.+||..||++||++.+++++
T Consensus       242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         242 SPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             CHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            3467788899999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.2e-35  Score=308.35  Aligned_cols=182  Identities=23%  Similarity=0.288  Sum_probs=156.5

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .+.||+|+||.||+|... +++.||+|.....     ....|+.++++++|+||+++++++......++|+||+. ++|.
T Consensus        71 ~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~  144 (357)
T PHA03209         71 IKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLY  144 (357)
T ss_pred             EEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHH
Confidence            468999999999999954 5788999975432     23568899999999999999999999999999999985 5888


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---CCCC
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---TPNR  530 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---~~~~  530 (663)
                      +++....    ..+++..+..|+.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++......   ...+
T Consensus       145 ~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~g  218 (357)
T PHA03209        145 TYLTKRS----RPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAG  218 (357)
T ss_pred             HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccCcccccccc
Confidence            8886432    35899999999999999999999998  9999999999999999999999999997543222   2346


Q ss_pred             CccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCC
Q 006055          531 VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPT  568 (663)
Q Consensus       531 ~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~  568 (663)
                      +..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       219 t~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            77899999999989999999999999999999965554

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1e-34  Score=295.98  Aligned_cols=246  Identities=24%  Similarity=0.369  Sum_probs=195.5

Q ss_pred             hcccccccceEEEEEEecC----CcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLEM----GTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .++||+|+||.||+|...+    ...||+|......  ...+.+.+|+.+++.++|||++++++++.+ +..++||||++
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~   89 (270)
T cd05056          11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAP   89 (270)
T ss_pred             eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCC
Confidence            4689999999999998543    2468999876543  224578999999999999999999998865 56789999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-  527 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  527 (663)
                      +|+|.+++....    ..+++..+..++.+++.||.|||+.+  ++||||||+||+++.++.+||+|||+++....... 
T Consensus        90 ~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  163 (270)
T cd05056          90 LGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY  163 (270)
T ss_pred             CCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeecccccce
Confidence            999999997532    24899999999999999999999998  99999999999999999999999999976543321 


Q ss_pred             ----CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          528 ----PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       528 ----~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                          ......|+|||.+....++.++||||||++++|+++ |..||......      .....+......          
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~~~~~~~----------  227 (270)
T cd05056         164 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN------DVIGRIENGERL----------  227 (270)
T ss_pred             ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHcCCcC----------
Confidence                112346999999988889999999999999999996 99999653221      111111111111          


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                       ..+.....++.+++.+|+..+|++|||+.++++.|+++...
T Consensus       228 -~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         228 -PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence             01122344688889999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.2e-36  Score=311.73  Aligned_cols=240  Identities=25%  Similarity=0.406  Sum_probs=193.9

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEec--Cc-ccC--HHHHHHHHHHhhcCCCCCcccceEEEEecCc--cEEEEEcc
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLK--DV-TIS--EREFKDKIEGVGAVNHENLVPLRAYYYSMDE--KLLVYDYL  447 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~--~~-~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ey~  447 (663)
                      ++||+|+|-+||+|.. .+|-.||=-.++  +. ...  ...|..|+.+|+.|+|||||+++.+|.+...  .-+|+|.+
T Consensus        46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~  125 (632)
T KOG0584|consen   46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF  125 (632)
T ss_pred             hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence            5799999999999994 457777632222  11 222  3679999999999999999999999988765  67899999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC-CCceEEeccccccccCCC-
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK-SYEARVSDFGLAHLVGPS-  525 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~-~~~~kl~Dfg~a~~~~~~-  525 (663)
                      ..|+|..|+.+.+     .++......|+.||++||.|||++.|||||||||.+||+|+. .|.+||+|.|+|+..... 
T Consensus       126 TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  126 TSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             cCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            9999999998754     478889999999999999999999999999999999999975 579999999999987654 


Q ss_pred             -CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          526 -STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       526 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                       ....||+.|||||... ..|.+.+||||||++++||+|+..||..-     .+..++.+.+...-.+..+...     .
T Consensus       201 aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-----~n~AQIYKKV~SGiKP~sl~kV-----~  269 (632)
T KOG0584|consen  201 AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-----TNPAQIYKKVTSGIKPAALSKV-----K  269 (632)
T ss_pred             cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-----CCHHHHHHHHHcCCCHHHhhcc-----C
Confidence             3357999999999987 77999999999999999999999999642     3445555555544332221110     0


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                        .   .++.++|.+|+.. ..+|||+.|++++
T Consensus       270 --d---Pevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  270 --D---PEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             --C---HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence              0   1466778899999 9999999999974

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.1e-34  Score=293.19  Aligned_cols=241  Identities=22%  Similarity=0.321  Sum_probs=194.7

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||.||++.. .+++.+|+|.++...  ...+.+.+|+.+++.++|+|++++++++.+....++||||+++|+
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   84 (255)
T cd08219           5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD   84 (255)
T ss_pred             EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence            46899999999999994 468999999986432  234678889999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----C
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----T  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~  527 (663)
                      |.+++....   ...+++.....++.+++.||.|||+.+  |+|+||||+||++++++.++++|||.++......    .
T Consensus        85 l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (255)
T cd08219          85 LMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT  159 (255)
T ss_pred             HHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence            999886433   234788999999999999999999998  9999999999999999999999999997664322    2


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..++..|+|||++.+..++.++|+||||+++|+|++|+.||...      +.......+..... ..          ...
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~------~~~~~~~~~~~~~~-~~----------~~~  222 (255)
T cd08219         160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN------SWKNLILKVCQGSY-KP----------LPS  222 (255)
T ss_pred             ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC------CHHHHHHHHhcCCC-CC----------CCc
Confidence            34566799999998888999999999999999999999999642      12222222222111 00          011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .....+.+++.+||..||++||++.|++..
T Consensus       223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         223 HYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            223457788999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.8e-35  Score=325.03  Aligned_cols=252  Identities=23%  Similarity=0.273  Sum_probs=182.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCCC------CCcccceEEEEec-CccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNH------ENLVPLRAYYYSM-DEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~~-~~~~lv~ey  446 (663)
                      .++||+|+||+||+|.. .+++.||||+++........+..|+.++..++|      .+++++++++... .+.++|||+
T Consensus       134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~  213 (467)
T PTZ00284        134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPK  213 (467)
T ss_pred             EEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEec
Confidence            46899999999999984 568899999997543334456667777766654      4588888888764 467899998


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCcceecCCCCCCEEEcCCC----------------
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ-GPNVSHGNIKSSNILLTKSY----------------  509 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~iiHrdlk~~Nill~~~~----------------  509 (663)
                      + +++|.+++...     ..+++..+..|+.||+.||.|||++ +  |+||||||+|||++.++                
T Consensus       214 ~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~  285 (467)
T PTZ00284        214 Y-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDPC  285 (467)
T ss_pred             c-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence            7 66888888643     2589999999999999999999974 7  99999999999998765                


Q ss_pred             ceEEeccccccccCCC-CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHh
Q 006055          510 EARVSDFGLAHLVGPS-STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK  588 (663)
Q Consensus       510 ~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  588 (663)
                      .+||+|||.+...... ....++..|+|||++.+..++.++|||||||++|||++|+.||+.....+   ....+...+.
T Consensus       286 ~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~---~~~~i~~~~g  362 (467)
T PTZ00284        286 RVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE---HLHLMEKTLG  362 (467)
T ss_pred             eEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHcC
Confidence            4999999988654332 23457788999999999999999999999999999999999997532211   1111111100


Q ss_pred             h---cc------------------cccccchhhh----cccChH--HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          589 D---EW------------------TSEVFDLELL----RYQNVE--EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       589 ~---~~------------------~~~~~d~~~~----~~~~~~--~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .   .+                  .....++...    ......  .....+.+++.+|+..||++|||++|+++|
T Consensus       363 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        363 RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH  438 (467)
T ss_pred             CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence            0   00                  0000011000    000000  012457799999999999999999999983

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-35  Score=295.81  Aligned_cols=248  Identities=23%  Similarity=0.333  Sum_probs=205.4

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      +.||+|-|+.|-+|+ .-+|.+||||++.+...   +...+.+|++.|+.++|||||++|++.......|||+|.-++|+
T Consensus        24 kTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GD  103 (864)
T KOG4717|consen   24 KTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGD  103 (864)
T ss_pred             hhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCch
Confidence            459999999999998 66899999999987643   45789999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEE-cCCCceEEeccccccccCCCCCCCC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEARVSDFGLAHLVGPSSTPNR  530 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~~~~~  530 (663)
                      |++++-...    ..+.+....+++.||..|+.|+|+..  ++||||||+||.+ .+-|-+||.|||++-.+.++.....
T Consensus       104 l~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T  177 (864)
T KOG4717|consen  104 LFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT  177 (864)
T ss_pred             HHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc
Confidence            999986543    35899999999999999999999997  9999999999876 4567899999999988887765444


Q ss_pred             ---CccccCccccCCCCCCC-cchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          531 ---VAGYRAPEVTDPCKVSQ-KADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       531 ---~~~y~aPE~~~~~~~~~-~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                         ...|-|||++.+..|+. .+||||+||+||-|++|+.||+...+.+.      +..++...            +.-+
T Consensus       178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET------LTmImDCK------------YtvP  239 (864)
T KOG4717|consen  178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET------LTMIMDCK------------YTVP  239 (864)
T ss_pred             ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh------hhhhhccc------------ccCc
Confidence               44499999999988764 57999999999999999999987655442      22222222            2334


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCCCC
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGL  652 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~  652 (663)
                      .....+..++|..|+..||++|.+.+|++.     ..|.+....++
T Consensus       240 shvS~eCrdLI~sMLvRdPkkRAslEeI~s-----~~Wlq~~D~~~  280 (864)
T KOG4717|consen  240 SHVSKECRDLIQSMLVRDPKKRASLEEIVS-----TSWLQAGDRGL  280 (864)
T ss_pred             hhhhHHHHHHHHHHHhcCchhhccHHHHhc-----cccccCCCCCc
Confidence            556677888889999999999999999987     45554444433

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.4e-35  Score=312.54  Aligned_cols=248  Identities=19%  Similarity=0.215  Sum_probs=189.7

Q ss_pred             hcccccccceEEEEEEec---CCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE---MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||.||++...   .+..||||.+...    +...+|+++++.++||||+++++++......++||||+. ++
T Consensus        97 ~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~  171 (392)
T PHA03207         97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CD  171 (392)
T ss_pred             EEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CC
Confidence            468999999999999743   4678999987653    345689999999999999999999999999999999986 58


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-----
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----  526 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-----  526 (663)
                      |.+++...     ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||++.......     
T Consensus       172 l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~  244 (392)
T PHA03207        172 LFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC  244 (392)
T ss_pred             HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccc
Confidence            88888432     35899999999999999999999998  9999999999999999999999999997654332     


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh---ccccccc------
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD---EWTSEVF------  596 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~------  596 (663)
                       ...++..|+|||++.+..++.++|||||||++|||++|+.||........   ...+..+.+.   .......      
T Consensus       245 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~l~~i~~~~~~~~~~~~~~~~~~~  321 (392)
T PHA03207        245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS---SSQLRSIIRCMQVHPLEFPQNGSTNL  321 (392)
T ss_pred             cccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCc---HHHHHHHHHHhccCccccCCccchhH
Confidence             12467789999999998999999999999999999999999976433221   1111111111   0000000      


Q ss_pred             -------chhhhc-ccCh-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          597 -------DLELLR-YQNV-----EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       597 -------d~~~~~-~~~~-----~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                             ...... ....     .....++.+++.+|+..||++|||+.|++.+
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                   000000 0000     0113457788899999999999999999985

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.3e-35  Score=297.16  Aligned_cols=240  Identities=23%  Similarity=0.372  Sum_probs=192.1

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccC-------HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS-------EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||+|+||+||+|...+|+.+|||.++.....       ...+.+|+++++.++|+||+++++++.+....++||||+
T Consensus         5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (265)
T cd06631           5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV   84 (265)
T ss_pred             cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence            4679999999999999888999999988643211       245888999999999999999999999999999999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC--
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--  525 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~--  525 (663)
                      ++++|.+++....     .+++..+..++.|++.||+|||+.+  |+|+||+|+||++++++.++|+|||++......  
T Consensus        85 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          85 PGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL  157 (265)
T ss_pred             CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence            9999999997532     4789999999999999999999998  999999999999999999999999998754221  


Q ss_pred             --------CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          526 --------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       526 --------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                              ....++..|+|||++.+..++.++||||||+++++|++|+.||.....     ... ...+.......    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~-~~~~~~~~~~~----  227 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-----LAA-MFYIGAHRGLM----  227 (265)
T ss_pred             cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-----HHH-HHHhhhccCCC----
Confidence                    112356679999999988899999999999999999999999964321     111 11111100000    


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      +     ........++.+++.+|+..+|++||++.|+++
T Consensus       228 ~-----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         228 P-----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             C-----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0     011123446788889999999999999999986

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-35  Score=309.10  Aligned_cols=236  Identities=23%  Similarity=0.261  Sum_probs=182.1

Q ss_pred             cccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHhhcC---CCCCcccceEEEEecCccEEEEEccCC
Q 006055          378 LGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGVGAV---NHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       378 lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      ||+|+||+||+|.. .+|+.||||++.....    ....+..|..++...   +||||+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999994 5689999999865321    112344556665554   799999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++....     .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++......   
T Consensus        81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~  153 (330)
T cd05586          81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT  153 (330)
T ss_pred             ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence            99999887532     4889999999999999999999998  9999999999999999999999999987543221   


Q ss_pred             -CCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          527 -TPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                       ...++..|+|||++.+. .++.++|||||||++|||++|+.||...      +.......+.....       .+..  
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~------~~~~~~~~i~~~~~-------~~~~--  218 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE------DTQQMYRNIAFGKV-------RFPK--  218 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC------CHHHHHHHHHcCCC-------CCCC--
Confidence             23467789999998754 4789999999999999999999999642      12222222221110       0000  


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRP----SMSEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RP----t~~ev~~~  637 (663)
                        .....++.+++.+|+..||++||    +++|++++
T Consensus       219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence              01233567788899999999998    56666653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.5e-35  Score=296.38  Aligned_cols=243  Identities=22%  Similarity=0.356  Sum_probs=191.2

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||.||+|. ..+++.||+|.++.... ....+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus        14 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L   93 (267)
T cd06645          14 IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL   93 (267)
T ss_pred             HHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcH
Confidence            4679999999999998 45689999999875432 234678899999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----CCC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----STP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----~~~  528 (663)
                      .+++....     .+++.....++.|++.|+.|||+.+  ++|+||||+||+++.++.++|+|||++......    ...
T Consensus        94 ~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd06645          94 QDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF  166 (267)
T ss_pred             HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccc
Confidence            99986432     4889999999999999999999998  999999999999999999999999998765432    123


Q ss_pred             CCCccccCccccC---CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          529 NRVAGYRAPEVTD---PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       529 ~~~~~y~aPE~~~---~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      .++..|+|||++.   ...++.++|||||||++|||++|+.||.......      .+.............       ..
T Consensus       167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~------~~~~~~~~~~~~~~~-------~~  233 (267)
T cd06645         167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR------ALFLMTKSNFQPPKL-------KD  233 (267)
T ss_pred             cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh------hHHhhhccCCCCCcc-------cc
Confidence            4667799999874   4457889999999999999999999985432111      010111111100000       00


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .......+.+++.+|+..+|++||++++++++
T Consensus       234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            01123457788999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=8.8e-35  Score=303.69  Aligned_cols=193  Identities=25%  Similarity=0.381  Sum_probs=157.8

Q ss_pred             hcccccccceEEEEEEec---CCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEe--cCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE---MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS--MDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ey~~~  449 (663)
                      +.+||+|+||+||+|...   ++..||+|.+..... ...+.+|+++++.++||||+++++++..  ....++||||+.+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            357999999999999854   457899999875433 3457889999999999999999999854  4557899999875


Q ss_pred             CChhHhhccCCC----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEE----cCCCceEEeccccccc
Q 006055          450 GSLSALLHGNKG----AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHL  521 (663)
Q Consensus       450 gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill----~~~~~~kl~Dfg~a~~  521 (663)
                       +|.+++.....    .....+++..+..++.|++.||.|||+.+  |+||||||+||++    +.++.+||+|||+++.
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence             78777653211    12345889999999999999999999998  9999999999999    5667899999999987


Q ss_pred             cCCCC-------CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccc
Q 006055          522 VGPSS-------TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHAL  571 (663)
Q Consensus       522 ~~~~~-------~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~  571 (663)
                      .....       ...++..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            64332       1235667999999876 45789999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-34  Score=293.47  Aligned_cols=245  Identities=24%  Similarity=0.398  Sum_probs=196.1

Q ss_pred             hcccccccceEEEEEEec-CCc----EEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGT----IVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||+|+||.||+|..+ +|+    .||+|.+.....  ....+.+|+..+++++|+|++++++++.. ...++||||+
T Consensus        12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   90 (279)
T cd05057          12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLM   90 (279)
T ss_pred             cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecC
Confidence            478999999999999853 343    589998865532  24578899999999999999999999987 7889999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST  527 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  527 (663)
                      ++|+|.++++...    ..+++..+..++.|++.||+|||+.+  ++||||||+||++++++.+||+|||+++.......
T Consensus        91 ~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~  164 (279)
T cd05057          91 PLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK  164 (279)
T ss_pred             CCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence            9999999997543    24899999999999999999999988  99999999999999999999999999987654322


Q ss_pred             C------CCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          528 P------NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       528 ~------~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                      .      ..+..|+|||.+....++.++|+||||++++|+++ |+.||+...      ...+...+.....         
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~~~~~~~~~~~---------  229 (279)
T cd05057         165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP------AVEIPDLLEKGER---------  229 (279)
T ss_pred             ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC------HHHHHHHHhCCCC---------
Confidence            1      12345999999988888999999999999999998 999996532      1222222211110         


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                        ...+..+..++.+++.+||..+|++||++.++++.|+++..
T Consensus       230 --~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 --LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence              00111123467788899999999999999999999998744

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=9.9e-35  Score=308.71  Aligned_cols=254  Identities=24%  Similarity=0.321  Sum_probs=187.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecC------ccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMD------EKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  444 (663)
                      .+.||+|+||.||++.. .+|+.||||.+....   .....+.+|+.+++.++||||+++++++....      ..++||
T Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  105 (359)
T cd07876          26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM  105 (359)
T ss_pred             EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEE
Confidence            46899999999999984 568999999986542   22456788999999999999999999986543      468999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+++ +|.+.++.       .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++....
T Consensus       106 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876         106 ELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             eCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            99976 66666642       3788889999999999999999998  99999999999999999999999999976543


Q ss_pred             CC---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCC---------CCChHHH-------HHH
Q 006055          525 SS---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEE---------GVDLPRW-------VQS  585 (663)
Q Consensus       525 ~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~---------~~~~~~~-------~~~  585 (663)
                      ..   ...++..|+|||.+.+..++.++|||||||++|||++|+.||......+         +.....+       +..
T Consensus       176 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (359)
T cd07876         176 NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN  255 (359)
T ss_pred             CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence            22   2345677999999999999999999999999999999999997532110         0000000       000


Q ss_pred             HHhhcccccccchh--hhccc------ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          586 IVKDEWTSEVFDLE--LLRYQ------NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       586 ~~~~~~~~~~~d~~--~~~~~------~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      ..............  ...+.      .......++.+++.+|+..||++|||+.|++++-
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence            00000000000000  00000      0001234678899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.1e-34  Score=290.83  Aligned_cols=241  Identities=27%  Similarity=0.447  Sum_probs=193.4

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|+||.||++.. +++.||+|.++... ....+.+|+.++..++|||++++++++.. +..++||||+++++|.+
T Consensus        11 ~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~   87 (254)
T cd05083          11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVN   87 (254)
T ss_pred             eeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCCCCCHHH
Confidence            46899999999999875 58889999986532 34678899999999999999999999865 45799999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-CCCCCcc
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-TPNRVAG  533 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~  533 (663)
                      ++....   ...+++..+..++.|++.||.|||+.+  ++||||||+||+++.++.+||+|||++....... .......
T Consensus        88 ~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  162 (254)
T cd05083          88 FLRTRG---RALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK  162 (254)
T ss_pred             HHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCCce
Confidence            997543   235789999999999999999999998  9999999999999999999999999987654322 2223456


Q ss_pred             ccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHH
Q 006055          534 YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQ  612 (663)
Q Consensus       534 y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  612 (663)
                      |+|||++.+..++.++||||||+++|||++ |+.||....      .......+. .....          ......+..
T Consensus       163 y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------~~~~~~~~~-~~~~~----------~~~~~~~~~  225 (254)
T cd05083         163 WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS------LKEVKECVE-KGYRM----------EPPEGCPAD  225 (254)
T ss_pred             ecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC------HHHHHHHHh-CCCCC----------CCCCcCCHH
Confidence            999999988889999999999999999998 999986432      122222221 11100          011223456


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          613 LLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       613 l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                      +.+++.+|+..+|++||+++++++.|++
T Consensus       226 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         226 VYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            7889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.3e-34  Score=290.80  Aligned_cols=242  Identities=27%  Similarity=0.383  Sum_probs=198.1

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .++||+|+||.||.+. ..+++.+++|.+....   ...+.+.+|++++++++|+||+++++++.+.+..+++|||+++|
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (256)
T cd08221           5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGG   84 (256)
T ss_pred             eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCC
Confidence            3689999999999988 5668999999986543   22456889999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----  526 (663)
                      +|.+++....   ...+++..+..++.+++.||.|||+.+  ++||||+|+||++++++.+||+|||++.......    
T Consensus        85 ~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          85 TLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             cHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence            9999997543   235899999999999999999999998  9999999999999999999999999997664433    


Q ss_pred             CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ...++..|+|||+..+..++.++||||||++++||++|..||...      +....+..+.......           ..
T Consensus       160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~------~~~~~~~~~~~~~~~~-----------~~  222 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT------NPLNLVVKIVQGNYTP-----------VV  222 (256)
T ss_pred             ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHcCCCCC-----------Cc
Confidence            233566799999998888899999999999999999999998642      2223333333221111           01


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      .....++.+++.+|+..+|++||+++|+++++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            22344678888999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.7e-35  Score=312.06  Aligned_cols=241  Identities=20%  Similarity=0.273  Sum_probs=187.0

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||++.. .+++.||+|.+....    .....+.+|+.++..++|+||+++++.+.+.+..++||||+++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g   85 (360)
T cd05627           6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG   85 (360)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence            36799999999999985 568999999987532    1235678899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----  525 (663)
                      |+|.+++....     .+++.....++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++.....    
T Consensus        86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          86 GDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             ccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            99999997532     4889999999999999999999998  999999999999999999999999998644211    


Q ss_pred             -----------------------------------CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCcc
Q 006055          526 -----------------------------------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA  570 (663)
Q Consensus       526 -----------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~  570 (663)
                                                         ....++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                               012367789999999999999999999999999999999999964


Q ss_pred             ccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 006055          571 LLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPS---MSEVIKR  637 (663)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt---~~ev~~~  637 (663)
                      ..      .......+.....  . +.  ......   ...++.+++.+|+ .||++|++   ++|+++|
T Consensus       239 ~~------~~~~~~~i~~~~~--~-~~--~p~~~~---~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         239 ET------PQETYRKVMNWKE--T-LV--FPPEVP---ISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CC------HHHHHHHHHcCCC--c-ee--cCCCCC---CCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            32      1222222221110  0 00  000111   1234555555655 49999985   6777765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.1e-34  Score=295.28  Aligned_cols=243  Identities=26%  Similarity=0.350  Sum_probs=189.2

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      ..||+|+||.||+|. ..+++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++...+..++|+||+++++|.
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   93 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS   93 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence            479999999999999 45678999998875532 3467899999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC-CCceEEeccccccccCCCC----CC
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK-SYEARVSDFGLAHLVGPSS----TP  528 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~----~~  528 (663)
                      ++++....  ....++..+..++.|++.||.|||+.+  |+||||||+||+++. ++.++|+|||.+.......    ..
T Consensus        94 ~~l~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  169 (268)
T cd06624          94 ALLRSKWG--PLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF  169 (268)
T ss_pred             HHHHHhcc--cCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccC
Confidence            99975321  111278888999999999999999998  999999999999986 6789999999987654321    12


Q ss_pred             CCCccccCccccCCC--CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          529 NRVAGYRAPEVTDPC--KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~--~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      .++..|+|||++.+.  .++.++||||||+++|+|++|+.||.......   ...+.......       .     ...+
T Consensus       170 ~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~~-------~-----~~~~  234 (268)
T cd06624         170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFKI-------H-----PEIP  234 (268)
T ss_pred             CCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhcc-------C-----CCCC
Confidence            356779999998654  37889999999999999999999986432111   00000000000       0     0011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .....++.+++.+|+..+|++|||+.|++++
T Consensus       235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            1233467788899999999999999999874

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.9e-35  Score=298.96  Aligned_cols=246  Identities=25%  Similarity=0.382  Sum_probs=190.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcC-CCCCcccceEEEEe-----cCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAYYYS-----MDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----~~~~~lv~ey~  447 (663)
                      .+.||+|+||.||++.. .+++.+|+|.+.........+..|+.++..+ +|+|++++++++..     .+..++||||+
T Consensus        23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  102 (286)
T cd06638          23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELC  102 (286)
T ss_pred             eeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeec
Confidence            36799999999999984 5689999999876544456788999999999 69999999998853     34579999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-  526 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-  526 (663)
                      ++++|.++++.... ....+++..+..++.|++.||.|||+.+  |+||||||+||++++++.+||+|||+++...... 
T Consensus       103 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  179 (286)
T cd06638         103 NGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL  179 (286)
T ss_pred             CCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEEEccCCceeecccCCC
Confidence            99999998864321 1245789999999999999999999998  9999999999999999999999999987654322 


Q ss_pred             ---CCCCCccccCccccCC-----CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          527 ---TPNRVAGYRAPEVTDP-----CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       527 ---~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                         ...++..|+|||++..     ..++.++||||+||++|||++|+.||......      ..+...... ......  
T Consensus       180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~------~~~~~~~~~-~~~~~~--  250 (286)
T cd06638         180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM------RALFKIPRN-PPPTLH--  250 (286)
T ss_pred             ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh------HHHhhcccc-CCCccc--
Confidence               2346677999999753     44788999999999999999999998653211      111111000 000000  


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                            .+.....++.+++.+|+..||++|||+.|++++.
T Consensus       251 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         251 ------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             ------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence                  1111234678899999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.3e-34  Score=298.51  Aligned_cols=246  Identities=25%  Similarity=0.400  Sum_probs=193.5

Q ss_pred             hcccccccceEEEEEEe-cCCc----EEEEEEecCcccC--HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGT----IVAVKRLKDVTIS--EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||+|+||.||+|.+ .+|.    .||+|.+......  ..++.+|+.+++.++||||++++++|... ..++++||+
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~   90 (303)
T cd05110          12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM   90 (303)
T ss_pred             ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence            46899999999999984 3454    5788988654322  34688999999999999999999998654 567999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST  527 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  527 (663)
                      ++|+|.+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||++++++.+||+|||+++.......
T Consensus        91 ~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~  164 (303)
T cd05110          91 PHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK  164 (303)
T ss_pred             CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccccccccCccc
Confidence            9999999987533    24789999999999999999999998  99999999999999999999999999986543221


Q ss_pred             ------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          528 ------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       528 ------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                            ...+..|+|||++.+..++.++||||||+++|||++ |+.||.....       .............       
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~-------  230 (303)
T cd05110         165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-------REIPDLLEKGERL-------  230 (303)
T ss_pred             ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCCCCC-------
Confidence                  112456999999998889999999999999999998 8999864321       1111222211100       


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                         .........+.+++..||..+|++||+++++++.|+++...
T Consensus       231 ---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         231 ---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence               00111234678889999999999999999999999987544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-34  Score=304.65  Aligned_cols=248  Identities=25%  Similarity=0.328  Sum_probs=186.4

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEec------CccEEEE
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSM------DEKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~  444 (663)
                      .+.||+|+||.||+|. ..+++.||||.+.....   ..+.+.+|+++++.++||||+++++++...      ...++++
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~   99 (343)
T cd07878          20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT   99 (343)
T ss_pred             heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence            4679999999999998 45788999999875422   235677899999999999999999987543      3468999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      |++ +++|.+++...      .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++....
T Consensus       100 ~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878         100 NLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            987 67998888632      4899999999999999999999998  99999999999999999999999999987654


Q ss_pred             CC-CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhc--cccccc---c
Q 006055          525 SS-TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE--WTSEVF---D  597 (663)
Q Consensus       525 ~~-~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~---d  597 (663)
                      .. ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.....      ...+..+....  ...+..   .
T Consensus       171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07878         171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY------IDQLKRIMEVVGTPSPEVLKKIS  244 (343)
T ss_pred             CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHHHhCCCCHHHHHhcc
Confidence            32 2346777999999876 5688999999999999999999999964221      11111111000  000000   0


Q ss_pred             --------hhhhcccC------hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          598 --------LELLRYQN------VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       598 --------~~~~~~~~------~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                              ..+.....      .......+.+++.+|+..||++|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                    00000000      00112246788999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.4e-34  Score=298.66  Aligned_cols=242  Identities=24%  Similarity=0.359  Sum_probs=191.2

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||.||+|.. .+++.||+|.+..... ..+.+.+|+.+++.++|+|++++++++..+...++||||+++++|
T Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l   96 (292)
T cd06644          17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV   96 (292)
T ss_pred             hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcH
Confidence            46799999999999995 4589999999875432 245688899999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----CCC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----STP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----~~~  528 (663)
                      ..++....    ..+++..+..++.|++.|+.|||+.+  ++||||||+||+++.++.+||+|||++......    ...
T Consensus        97 ~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  170 (292)
T cd06644          97 DAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF  170 (292)
T ss_pred             HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceecccccccccee
Confidence            98876432    34899999999999999999999998  999999999999999999999999998654322    122


Q ss_pred             CCCccccCccccC-----CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          529 NRVAGYRAPEVTD-----PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       529 ~~~~~y~aPE~~~-----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                      .++..|+|||++.     ...++.++|||||||++|||++|+.||.....      ...+......... .        .
T Consensus       171 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~-~--------~  235 (292)
T cd06644         171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSEPP-T--------L  235 (292)
T ss_pred             cCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCCCc-c--------C
Confidence            3566799999984     34467889999999999999999999864321      1111121111110 0        0


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ........++.+++.+|+..+|++||+++|++++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1112233467888999999999999999999874

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.7e-34  Score=292.20  Aligned_cols=239  Identities=25%  Similarity=0.404  Sum_probs=191.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC----------HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS----------EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLV  443 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  443 (663)
                      ...||+|++|.||+|.. .+++.||+|.+......          .+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (267)
T cd06628           5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF   84 (267)
T ss_pred             cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEE
Confidence            35799999999999984 46899999988654211          14578899999999999999999999999999999


Q ss_pred             EEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccC
Q 006055          444 YDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG  523 (663)
Q Consensus       444 ~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~  523 (663)
                      |||+++++|.+++....     .+++..+..++.+++.||+|||+.+  ++||||+|+||++++++.++|+|||.++...
T Consensus        85 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          85 LEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             EEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            99999999999997532     4788999999999999999999998  9999999999999999999999999987664


Q ss_pred             CCC----------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccc
Q 006055          524 PSS----------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTS  593 (663)
Q Consensus       524 ~~~----------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (663)
                      ...          ...++..|+|||.+.+..++.++||||||+++|+|++|+.||.....      ...+......    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~----  227 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ------LQAIFKIGEN----  227 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH------HHHHHHHhcc----
Confidence            211          12245679999999888889999999999999999999999975321      1111111110    


Q ss_pred             cccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       594 ~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                        ..+     ..+......+.+++.+||+.||++||++.|++++
T Consensus       228 --~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         228 --ASP-----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             --CCC-----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence              000     1112234567888889999999999999999873

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.7e-35  Score=300.74  Aligned_cols=251  Identities=24%  Similarity=0.312  Sum_probs=186.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc---cCHHHHHHHHHHhhcC---CCCCcccceEEEEec-----CccEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT---ISEREFKDKIEGVGAV---NHENLVPLRAYYYSM-----DEKLL  442 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~~~~l  442 (663)
                      .+.||+|+||+||+|.. .+|+.||+|.++...   .....+.+|+.++..+   +||||+++++++...     ...++
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l   84 (288)
T cd07863           5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL   84 (288)
T ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence            36799999999999984 468999999987532   1234556677766655   799999999988642     34689


Q ss_pred             EEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccccc
Q 006055          443 VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV  522 (663)
Q Consensus       443 v~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~  522 (663)
                      ||||+.+ +|.+++....   ...+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++..
T Consensus        85 v~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          85 VFEHVDQ-DLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             EEccccc-CHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCccccc
Confidence            9999985 8988886533   234899999999999999999999998  999999999999999999999999999876


Q ss_pred             CCCC---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHh-------hccc
Q 006055          523 GPSS---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK-------DEWT  592 (663)
Q Consensus       523 ~~~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~  592 (663)
                      ....   ...++..|+|||++.+..++.++||||+||++|||++|+.||......      .....+..       ..+.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~------~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA------DQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH------HHHHHHHHHhCCCChhhCc
Confidence            5432   233567799999998888999999999999999999999998643211      11111111       0000


Q ss_pred             cc------ccchhhhc--ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          593 SE------VFDLELLR--YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       593 ~~------~~d~~~~~--~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ..      .+......  .....+...++.+++.+|+..||++|||+.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00      00000000  00001223467789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4e-34  Score=289.16  Aligned_cols=241  Identities=22%  Similarity=0.325  Sum_probs=193.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecC-ccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMD-EKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ey~~~  449 (663)
                      .+.||+|++|.||++.. .+++.||+|++.....   ..+.+.+|++++++++|+|++++++.+...+ ..++||||+++
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~   84 (257)
T cd08223           5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEG   84 (257)
T ss_pred             EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCC
Confidence            46799999999999994 4578999999865432   2356888999999999999999998876443 57899999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      ++|.+++....   ...+++..+..++.+++.|++|||+.+  ++||||||+||+++.++.++|+|||++.......   
T Consensus        85 ~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          85 GDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             CcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence            99999997533   235899999999999999999999998  9999999999999999999999999997664322   


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       ...++..|+|||++.+..++.++||||||++++||++|+.||...      +.......+.... ..          ..
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~------~~~~~~~~~~~~~-~~----------~~  222 (257)
T cd08223         160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK------DMNSLVYRIIEGK-LP----------PM  222 (257)
T ss_pred             ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC------CHHHHHHHHHhcC-CC----------CC
Confidence             223566799999999988999999999999999999999998642      2222322222211 10          01


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ......++.+++.+|+..+|++|||+.+++++
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            12234568889999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.7e-34  Score=291.66  Aligned_cols=238  Identities=23%  Similarity=0.362  Sum_probs=194.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||.||+|.. .+++.||+|.+....  .....+.+|+.+++.++|+||+++++++.+....++||||+++|+
T Consensus         9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (277)
T cd06640           9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS   88 (277)
T ss_pred             hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCc
Confidence            35799999999999995 468999999987542  224578899999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC----
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST----  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~----  527 (663)
                      |.+++...      ++++.....++.+++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++........    
T Consensus        89 L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          89 ALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence            99998642      3788899999999999999999998  99999999999999999999999999976543221    


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..++..|+|||++.+..++.++|+|||||++|||++|+.||......      .....+ ....          ......
T Consensus       161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------~~~~~~-~~~~----------~~~~~~  223 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM------RVLFLI-PKNN----------PPTLTG  223 (277)
T ss_pred             ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH------hHhhhh-hcCC----------CCCCch
Confidence            23456699999998888899999999999999999999998653211      111111 0000          011123


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .....+.+++.+||..+|++||++++++++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         224 EFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            455678899999999999999999999886

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-34  Score=292.95  Aligned_cols=239  Identities=25%  Similarity=0.378  Sum_probs=194.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||.|+||.||+|.. .+++.||+|.+....  .....+.+|+++++.++|+|++++++++.+....++|+||+++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   85 (274)
T cd06609           6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS   85 (274)
T ss_pred             hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCc
Confidence            35799999999999995 468999999986543  223568899999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----C
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----T  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~  527 (663)
                      |.++++..      .+++..+..++.|++.|+.|||+.+  ++||||+|+||++++++.++|+|||+++......    .
T Consensus        86 L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          86 CLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            99999743      5899999999999999999999998  9999999999999999999999999998775432    2


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..++..|+|||++.+..++.++||||||+++|||++|+.||.....      ......+. ........+      .   
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~------~~~~~~~~-~~~~~~~~~------~---  221 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP------MRVLFLIP-KNNPPSLEG------N---  221 (274)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch------HHHHHHhh-hcCCCCCcc------c---
Confidence            3355679999999988899999999999999999999999964321      11111111 111111000      0   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....++.+++.+|+..+|++|||+++++++
T Consensus       222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         222 KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            033467788899999999999999999884

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.5e-35  Score=301.23  Aligned_cols=240  Identities=23%  Similarity=0.335  Sum_probs=193.1

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCc-ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV-TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      ..||+|+||.||++.. .+++.||+|.+... ....+.+.+|+.++..++|||++++++++...+..++|+||+++++|.
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~  106 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT  106 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence            4699999999999984 46899999998654 233567889999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----CCC
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----TPN  529 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~~~  529 (663)
                      +++..      ..+++..+..++.|++.||.|||+.+  ++||||||+||+++.++.+||+|||++.......    ...
T Consensus       107 ~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~  178 (297)
T cd06659         107 DIVSQ------TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV  178 (297)
T ss_pred             HHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence            98754      24789999999999999999999998  9999999999999999999999999987554321    233


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE  609 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  609 (663)
                      ++..|+|||++.+..++.++|||||||+++||++|+.||.....      ...+..+. ......        .......
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~-~~~~~~--------~~~~~~~  243 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP------VQAMKRLR-DSPPPK--------LKNAHKI  243 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHh-ccCCCC--------ccccCCC
Confidence            56679999999888899999999999999999999999964221      11111111 110000        0001112


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       610 ~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      ...+.+++.+|+..+|++||+++|++++-
T Consensus       244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~~  272 (297)
T cd06659         244 SPVLRDFLERMLTREPQERATAQELLDHP  272 (297)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence            34577888899999999999999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-34  Score=287.41  Aligned_cols=244  Identities=25%  Similarity=0.391  Sum_probs=195.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||.||+|.. .+++.+|+|.+..... ..+.+.+|+++++.++|||++++++++.+....+++|||+++++|
T Consensus         8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l   87 (262)
T cd06613           8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL   87 (262)
T ss_pred             EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcH
Confidence            36799999999999995 4688999999876532 356789999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----CC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----TP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~~  528 (663)
                      .+++....    ..+++..+..++.|++.||.|||+.+  |+|+||||+||++++++.+||+|||.+.......    ..
T Consensus        88 ~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  161 (262)
T cd06613          88 QDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF  161 (262)
T ss_pred             HHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhhhccccc
Confidence            99987532    35889999999999999999999998  9999999999999999999999999987654322    22


Q ss_pred             CCCccccCccccCCC---CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          529 NRVAGYRAPEVTDPC---KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~---~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      .++..|+|||.+.+.   .++.++||||||+++|||++|+.||......      ..............       ....
T Consensus       162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~------~~~~~~~~~~~~~~-------~~~~  228 (262)
T cd06613         162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM------RALFLISKSNFPPP-------KLKD  228 (262)
T ss_pred             cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCCCc-------cccc
Confidence            345669999998776   7889999999999999999999999653211      11111111110000       0111


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ......++.+++.+|+..+|++|||+++|+.+
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             hhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            22345578899999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.1e-34  Score=289.90  Aligned_cols=241  Identities=21%  Similarity=0.337  Sum_probs=197.0

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||.||++. ..+|+.||+|.+....   ...+++.+|+.+++.++||||+++++++.+.+..++||||++++
T Consensus         5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd08218           5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG   84 (256)
T ss_pred             EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCC
Confidence            3689999999999998 4578999999986542   22357889999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----  526 (663)
                      +|.+++....   ...+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.++.++|+|||++.......    
T Consensus        85 ~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          85 DLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            9999987533   234789999999999999999999998  9999999999999999999999999997664432    


Q ss_pred             CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ...++..|+|||+..+..++.++|+|||||++++|++|+.||...      +....+..+......           ...
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~------~~~~~~~~~~~~~~~-----------~~~  222 (256)
T cd08218         160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG------NMKNLVLKIIRGSYP-----------PVS  222 (256)
T ss_pred             hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC------CHHHHHHHHhcCCCC-----------CCc
Confidence            123566799999999888999999999999999999999998642      223333333322211           011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .....++.+++.+|++.+|++||++.||+++
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             ccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            2234468889999999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-34  Score=298.33  Aligned_cols=244  Identities=26%  Similarity=0.401  Sum_probs=191.1

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcC-CCCCcccceEEEEecC-----ccEEEEEccC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAYYYSMD-----EKLLVYDYLT  448 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----~~~lv~ey~~  448 (663)
                      +.||+|+||.||++.. .+++.+|+|.+.........+.+|+.++.++ +|||++++++++...+     ..++||||++
T Consensus        28 ~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~  107 (291)
T cd06639          28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCN  107 (291)
T ss_pred             EEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECC
Confidence            5799999999999995 5689999999876554567788899999988 8999999999987543     4799999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--  526 (663)
                      +|+|.++++.... ....+++..++.++.|++.||.|||+.+  ++||||||+||++++++.+||+|||++.......  
T Consensus       108 ~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~  184 (291)
T cd06639         108 GGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR  184 (291)
T ss_pred             CCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEeecccchhccccccc
Confidence            9999998864221 1235899999999999999999999998  9999999999999999999999999987654322  


Q ss_pred             --CCCCCccccCccccCCC-----CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          527 --TPNRVAGYRAPEVTDPC-----KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                        ...++..|+|||++...     .++.++|||||||++|||++|+.||.....      ...+..+.+. .....    
T Consensus       185 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~------~~~~~~~~~~-~~~~~----  253 (291)
T cd06639         185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP------VKTLFKIPRN-PPPTL----  253 (291)
T ss_pred             ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH------HHHHHHHhcC-CCCCC----
Confidence              23356679999997543     367899999999999999999999864321      1111111111 11111    


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                          .........+.+++.+|+..+|++||++.|++++
T Consensus       254 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         254 ----LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             ----CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                1112234468889999999999999999999874

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.2e-35  Score=302.07  Aligned_cols=251  Identities=22%  Similarity=0.313  Sum_probs=189.0

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCc--ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV--TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      +.||+|+||.||+|.. .+++.||+|.++..  ......+.+|+.+++.++||||+++++++......++||||++ ++|
T Consensus        12 ~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l   90 (301)
T cd07873          12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDL   90 (301)
T ss_pred             eEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCH
Confidence            6799999999999985 46899999998644  2234567889999999999999999999999999999999997 589


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----CC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----TP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~~  528 (663)
                      .+++....    ..+++.....++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++.......    ..
T Consensus        91 ~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  164 (301)
T cd07873          91 KQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNE  164 (301)
T ss_pred             HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccccc
Confidence            88886532    24789999999999999999999998  9999999999999999999999999997643321    22


Q ss_pred             CCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh---cccccccc------h
Q 006055          529 NRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD---EWTSEVFD------L  598 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d------~  598 (663)
                      .++..|+|||.+.+. .++.++|||||||++|||++|+.||......+   ....+......   .....+.+      .
T Consensus       165 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (301)
T cd07873         165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEEFKSY  241 (301)
T ss_pred             ceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhcccccccc
Confidence            346679999998653 57889999999999999999999997532111   11111111000   00000000      0


Q ss_pred             hhhcc--c----ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          599 ELLRY--Q----NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       599 ~~~~~--~----~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      .....  .    ........+.+++.+|+..||.+|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000  0    00112345778899999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.6e-35  Score=300.88  Aligned_cols=240  Identities=25%  Similarity=0.372  Sum_probs=192.2

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      ...||+|+||.||++.. .++..||||.+.... ...+.+.+|+..++.++|+|++++++.+...+..++||||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            35799999999999984 468999999986543 2345688999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----CC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----TP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~~  528 (663)
                      .+++...      .+++..+..++.+|+.||.|||+.+  |+||||||+||++++++.++|+|||++.......    ..
T Consensus       107 ~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  178 (292)
T cd06658         107 TDIVTHT------RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL  178 (292)
T ss_pred             HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence            9988532      3789999999999999999999998  9999999999999999999999999987553322    12


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .++..|+|||++.+..++.++||||||+++|||++|+.||.....      ...+.. +........        .....
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~-~~~~~~~~~--------~~~~~  243 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP------LQAMRR-IRDNLPPRV--------KDSHK  243 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HHhcCCCcc--------ccccc
Confidence            356679999999888899999999999999999999999864211      111111 111110000        01112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....+.+++.+|+..||++|||++|++++
T Consensus       244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         244 VSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            23357778889999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-35  Score=305.44  Aligned_cols=244  Identities=24%  Similarity=0.382  Sum_probs=201.7

Q ss_pred             hhcccccccceEEEEEEec--CCc--EEEEEEecCcccC--HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          374 SAEVLGKGTFGTAYKAVLE--MGT--IVAVKRLKDVTIS--EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       374 ~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      ..|+||+|.||.|++|.|.  +|+  .||||.++.....  -.+|.+|+..|.+|+|+|++++||...+ ....+|||.+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            3678999999999999975  343  5899999876443  4789999999999999999999999887 6788999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST  527 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  527 (663)
                      +.|+|.+.|+...   ...+.......++.|||.|+.||..++  +|||||..+|+|+-....+||+|||+.+-++....
T Consensus       193 plGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             ccchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            9999999998722   345788889999999999999999998  99999999999999999999999999998876543


Q ss_pred             CC-------CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          528 PN-------RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       528 ~~-------~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                      ..       ....|+|||.+....++.++|||+|||++|||+| |..||-+..      -..+++.+-..          
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~------g~qIL~~iD~~----------  331 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR------GIQILKNIDAG----------  331 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC------HHHHHHhcccc----------
Confidence            22       1234999999999999999999999999999999 888986532      12222222111          


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                       .+...+..+.+++.+++..||..+|++|||+..+.+.+-.
T Consensus       332 -erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  332 -ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             -ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence             1233455678899999999999999999999999865543

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.3e-34  Score=305.54  Aligned_cols=253  Identities=23%  Similarity=0.284  Sum_probs=187.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEec------CccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSM------DEKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~  444 (663)
                      .+.||+|+||.||++.. ..++.||||++.....   ....+.+|+.+++.++||||+++++++...      ...++||
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  101 (355)
T cd07874          22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM  101 (355)
T ss_pred             EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEh
Confidence            46799999999999984 4689999999875422   235677899999999999999999988643      2468999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+++ ++.+.+..       .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++....
T Consensus       102 e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~  171 (355)
T cd07874         102 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_pred             hhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence            99975 67766642       3788899999999999999999998  99999999999999999999999999987654


Q ss_pred             CC---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCC---------CChHH-------HHHH
Q 006055          525 SS---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEG---------VDLPR-------WVQS  585 (663)
Q Consensus       525 ~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~---------~~~~~-------~~~~  585 (663)
                      ..   ...++..|+|||++.+..++.++|||||||++|||++|+.||......+.         .....       .+..
T Consensus       172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (355)
T cd07874         172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_pred             ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence            32   23467789999999998899999999999999999999999965321100         00000       0000


Q ss_pred             HHhhccc-ccccchhhhc-------ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          586 IVKDEWT-SEVFDLELLR-------YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       586 ~~~~~~~-~~~~d~~~~~-------~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....... .....+....       .........++.+++.+|+..||++|||+.|++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            0000000 0000000000       00001123467889999999999999999999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5e-34  Score=298.71  Aligned_cols=245  Identities=24%  Similarity=0.360  Sum_probs=201.9

Q ss_pred             cccccccceEEEEEEec-CCcEEEEEEecCccc----CHHHHHHHHHHhhcCC-CCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTI----SEREFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      +.||+|.||.||++..+ +|+.+|+|.+.+...    +...+.+|+.+|+++. |||||.+.+.|.+....++|||++.+
T Consensus        41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~G  120 (382)
T KOG0032|consen   41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEG  120 (382)
T ss_pred             hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCC
Confidence            67999999999999954 599999999976533    3468999999999998 99999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC----CceEEeccccccccCCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS----YEARVSDFGLAHLVGPS  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~----~~~kl~Dfg~a~~~~~~  525 (663)
                      |.|.+.+...      .+++.....++.+++.|+.|||+.|  |+||||||+|+|+...    +.+|++|||++......
T Consensus       121 GeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~  192 (382)
T KOG0032|consen  121 GELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG  192 (382)
T ss_pred             chHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence            9999998754      2899999999999999999999998  9999999999999643    47999999999988773


Q ss_pred             C---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          526 S---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       526 ~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                      .   ...++++|+|||++....|+..+||||+||++|.|++|..||.+.....      ....+....+     +.....
T Consensus       193 ~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~------~~~~i~~~~~-----~f~~~~  261 (382)
T KOG0032|consen  193 ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE------IFLAILRGDF-----DFTSEP  261 (382)
T ss_pred             ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH------HHHHHHcCCC-----CCCCCC
Confidence            2   3458889999999999999999999999999999999999998654321      1113333322     111112


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ  647 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~  647 (663)
                      +   ........+++..|+..||.+|+|+.++++|     +|...
T Consensus       262 w---~~is~~akd~i~~ll~~dp~~R~ta~~~L~H-----pWi~~  298 (382)
T KOG0032|consen  262 W---DDISESAKDFIRKLLEFDPRKRLTAAQALQH-----PWIKS  298 (382)
T ss_pred             c---cccCHHHHHHHHHhcccCcccCCCHHHHhcC-----ccccC
Confidence            2   2334456677779999999999999999994     66544

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.1e-34  Score=305.54  Aligned_cols=247  Identities=21%  Similarity=0.298  Sum_probs=187.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEec------CccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSM------DEKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~  444 (663)
                      .+.||+|+||.||++.. ..++.||||++....   .....+.+|+.+++.++||||+++++++...      ...++||
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~  108 (364)
T cd07875          29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM  108 (364)
T ss_pred             EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEE
Confidence            46899999999999984 568999999987542   2245678899999999999999999987543      3469999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+++ +|.+.+..       .+++..+..++.|++.||.|||+++  |+||||||+||+++.++.+||+|||+++....
T Consensus       109 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         109 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             eCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            99975 77777642       3788899999999999999999998  99999999999999999999999999987654


Q ss_pred             CC---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHh-------------
Q 006055          525 SS---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK-------------  588 (663)
Q Consensus       525 ~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------------  588 (663)
                      ..   ...++..|+|||++.+..++.++|||||||++|||++|+.||.....      ...+..++.             
T Consensus       179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~  252 (364)
T cd07875         179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH------IDQWNKVIEQLGTPCPEFMKKL  252 (364)
T ss_pred             CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHhcCCCCHHHHHhh
Confidence            32   23467789999999999999999999999999999999999965321      111111111             


Q ss_pred             ---------hcccccccchh-hhc---cc----ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          589 ---------DEWTSEVFDLE-LLR---YQ----NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       589 ---------~~~~~~~~d~~-~~~---~~----~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                               ........... ...   .+    .......++.+++.+|+..||++|||+.|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                     00000000000 000   00    000123467889999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-34  Score=301.31  Aligned_cols=244  Identities=22%  Similarity=0.298  Sum_probs=186.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||++.. .+++.||+|.+....    ...+.+.+|+.++..++|+||+++++++.+....++||||+++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g   85 (331)
T cd05597           6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVG   85 (331)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCC
Confidence            36799999999999994 568999999986432    2235588899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC--
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST--  527 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--  527 (663)
                      |+|.+++....    ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++........  
T Consensus        86 ~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          86 GDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             CcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence            99999996532    24788999999999999999999998  99999999999999999999999999876543321  


Q ss_pred             ---CCCCccccCccccCC-----CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          528 ---PNRVAGYRAPEVTDP-----CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       528 ---~~~~~~y~aPE~~~~-----~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                         ..++..|+|||++..     ..++.++|||||||++|||++|+.||...      +.......+......... .  
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~------~~~~~~~~i~~~~~~~~~-~--  230 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE------SLVETYGKIMNHKEHFQF-P--  230 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC------CHHHHHHHHHcCCCcccC-C--
Confidence               236778999999863     45788999999999999999999999642      222222232221110000 0  


Q ss_pred             hhcccChHHHHHHHHHHHHHcc--CCCCCCCCCHHHHHHH
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCS--AQYPDNRPSMSEVIKR  637 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~--~~dP~~RPt~~ev~~~  637 (663)
                          .........+.+++.+|+  ..++..||++++++++
T Consensus       231 ----~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         231 ----PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ----CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                000112234455555654  4445558999999987

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1e-33  Score=288.88  Aligned_cols=248  Identities=23%  Similarity=0.373  Sum_probs=193.0

Q ss_pred             hcccccccceEEEEEEec----CCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecC------ccE
Q 006055          375 AEVLGKGTFGTAYKAVLE----MGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMD------EKL  441 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~  441 (663)
                      .+.||+|+||.||+|.+.    +++.||||.++.....   .+++.+|+++++.++||||+++++++...+      ..+
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   83 (273)
T cd05074           4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM   83 (273)
T ss_pred             hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence            357999999999999843    4689999998765322   356888999999999999999999886543      236


Q ss_pred             EEEEccCCCChhHhhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          442 LVYDYLTMGSLSALLHGNK-GAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       442 lv~ey~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                      +++||+.+|+|.+++.... ......+++.....++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||+++
T Consensus        84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg~~~  161 (273)
T cd05074          84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSK  161 (273)
T ss_pred             EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECcccccc
Confidence            8899999999998875322 122335789999999999999999999998  9999999999999999999999999998


Q ss_pred             ccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccc
Q 006055          521 LVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTS  593 (663)
Q Consensus       521 ~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (663)
                      .......      ......|++||.+....++.++||||||+++|||++ |+.||.....      ......+.......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~~~~  235 (273)
T cd05074         162 KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN------SEIYNYLIKGNRLK  235 (273)
T ss_pred             cccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH------HHHHHHHHcCCcCC
Confidence            6543221      123346999999988888999999999999999999 8888864321      11111111111100


Q ss_pred             cccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       594 ~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                                 ........+.+++.+|+..+|++||++.|+++.|+++
T Consensus       236 -----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         236 -----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                       0112335788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=307.66  Aligned_cols=242  Identities=26%  Similarity=0.392  Sum_probs=194.8

Q ss_pred             ccccccceEEEEEE-ecCCcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          377 VLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       377 ~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      +||+|.||+||-|+ ..+...+|||.+..... ...-+.+||..-+.++|+|||+++|.+.+....-+.||.++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            79999999999999 45567899999875533 23568899999999999999999999999998999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc-CCCceEEeccccccccCCC----CCCC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT-KSYEARVSDFGLAHLVGPS----STPN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~-~~~~~kl~Dfg~a~~~~~~----~~~~  529 (663)
                      +|+..-+  +..-++.+.-.+.+||++||.|||+..  |+|||||-+|||++ -.|.+||+|||-++.+..-    .+..
T Consensus       662 LLrskWG--PlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT  737 (1226)
T KOG4279|consen  662 LLRSKWG--PLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT  737 (1226)
T ss_pred             HHHhccC--CCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence            9986543  222377888889999999999999997  99999999999995 6789999999988765432    2345


Q ss_pred             CCccccCccccCC--CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          530 RVAGYRAPEVTDP--CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       530 ~~~~y~aPE~~~~--~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ||..|||||++..  +.|+..+|||||||++.||.||++||........    .    .++-+    ++.   ...+.++
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA----A----MFkVG----myK---vHP~iPe  802 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA----A----MFKVG----MYK---VHPPIPE  802 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH----h----hhhhc----cee---cCCCCcH
Confidence            6777999999965  4688999999999999999999999976543210    0    01111    110   0123355


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      +...+...++.+|+.+||..||++.++++.
T Consensus       803 elsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             HHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            667788899999999999999999999873

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5e-34  Score=293.18  Aligned_cols=251  Identities=24%  Similarity=0.307  Sum_probs=189.9

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      +.||+|++|.||+|.. .+++.||+|.++....   ..+.+.+|+.++..++|||++++++++.++...++||||++ ++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~   84 (285)
T cd07861           6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MD   84 (285)
T ss_pred             eEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CC
Confidence            5799999999999995 4689999999865422   24678899999999999999999999999999999999998 68


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----C
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----T  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~  527 (663)
                      |.+++.....  ...+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++.......    .
T Consensus        85 l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (285)
T cd07861          85 LKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH  160 (285)
T ss_pred             HHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccC
Confidence            9888865331  245899999999999999999999998  9999999999999999999999999987654322    1


Q ss_pred             CCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhc--cc-------ccccc
Q 006055          528 PNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE--WT-------SEVFD  597 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~-------~~~~d  597 (663)
                      ..++..|+|||++.+. .++.++|||||||+++||++|+.||......      ..........  ..       ....+
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI------DQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHHHhCCCChhhhhcchhhHH
Confidence            2345679999988654 4688999999999999999999999753211      1111100000  00       00000


Q ss_pred             hh--hhcc--c----ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          598 LE--LLRY--Q----NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       598 ~~--~~~~--~----~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ..  ....  .    .......++.+++.+|+..||++|||+++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            00  0000  0    001123466789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=296.56  Aligned_cols=242  Identities=26%  Similarity=0.384  Sum_probs=192.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||.||++.. .++..||+|.+..... ..+.+.+|++++++++|+|++++++++..+...++||||+++++|
T Consensus        10 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   89 (280)
T cd06611          10 IGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGAL   89 (280)
T ss_pred             HHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcH
Confidence            46799999999999995 4689999999865432 245788999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----CC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----TP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~~  528 (663)
                      .+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||.+.......    ..
T Consensus        90 ~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  163 (280)
T cd06611          90 DSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF  163 (280)
T ss_pred             HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhccccccccee
Confidence            99987532    35899999999999999999999998  9999999999999999999999999886543321    22


Q ss_pred             CCCccccCccccC-----CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          529 NRVAGYRAPEVTD-----PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       529 ~~~~~y~aPE~~~-----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                      .++..|+|||.+.     ...++.++||||||+++|||++|+.||....      ....+........ ..        .
T Consensus       164 ~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~-~~--------~  228 (280)
T cd06611         164 IGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN------PMRVLLKILKSEP-PT--------L  228 (280)
T ss_pred             ecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC------HHHHHHHHhcCCC-CC--------c
Confidence            3567799999974     3346778999999999999999999996532      1122222211110 00        0


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ........++.+++.+|+..+|++||++++++++
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            1111233467788999999999999999999885

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.1e-34  Score=292.63  Aligned_cols=252  Identities=21%  Similarity=0.324  Sum_probs=192.0

Q ss_pred             cccccccceEEEEEEec-CCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      ..||+|+||.||+|..+ +|+.||+|++....   ...+.+.+|+.+++.++|+|++++++++......++||||++++.
T Consensus         7 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   86 (286)
T cd07847           7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTV   86 (286)
T ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccH
Confidence            57999999999999965 68999999986542   224568899999999999999999999999999999999999998


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----C
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----T  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~  527 (663)
                      |..++...     ..+++..+..++.|++.||.|||+.+  ++||||||+||+++.++.++|+|||++.......    .
T Consensus        87 l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          87 LNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             HHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            88877542     24899999999999999999999998  9999999999999999999999999998765433    1


Q ss_pred             CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh------------ccccc
Q 006055          528 PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD------------EWTSE  594 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~  594 (663)
                      ..++..|+|||++.+ ..++.++||||||++++||++|+.||......+   ...........            .+...
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD---QLYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChHHhhhccccccccc
Confidence            234566999999866 457889999999999999999999997533211   00001110000            00000


Q ss_pred             ccchhhhcccC----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          595 VFDLELLRYQN----VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       595 ~~d~~~~~~~~----~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...+.......    .......+.+++.+|+..+|++||++.|++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            00000000000    01124567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.1e-34  Score=324.03  Aligned_cols=249  Identities=19%  Similarity=0.297  Sum_probs=191.2

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEec--CccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSM--DEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ey~~  448 (663)
                      .+.||+|+||+||+|.. .++..||+|.+......   ...+..|+.++..++||||++++++|.+.  ...++||||++
T Consensus        18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~   97 (1021)
T PTZ00266         18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCD   97 (1021)
T ss_pred             EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCC
Confidence            46899999999999994 56788999998754322   45688999999999999999999988654  45789999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CcceecCCCCCCEEEcCC---------------
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG-----PNVSHGNIKSSNILLTKS---------------  508 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-----~~iiHrdlk~~Nill~~~---------------  508 (663)
                      +|+|.+++..... ....+++..++.|+.||+.||.|||+.+     .+|+||||||+||||+.+               
T Consensus        98 gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~n  176 (1021)
T PTZ00266         98 AGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN  176 (1021)
T ss_pred             CCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccC
Confidence            9999999875321 1235899999999999999999999854     249999999999999642               


Q ss_pred             --CceEEeccccccccCCCC---CCCCCccccCccccCC--CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHH
Q 006055          509 --YEARVSDFGLAHLVGPSS---TPNRVAGYRAPEVTDP--CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPR  581 (663)
Q Consensus       509 --~~~kl~Dfg~a~~~~~~~---~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~  581 (663)
                        ..+||+|||++.......   ...+++.|+|||++.+  ..++.++|||||||++|||++|+.||....     ....
T Consensus       177 g~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~-----~~~q  251 (1021)
T PTZ00266        177 GRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN-----NFSQ  251 (1021)
T ss_pred             CCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC-----cHHH
Confidence              348999999998765432   2346788999999854  457899999999999999999999996421     2222


Q ss_pred             HHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhh
Q 006055          582 WVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK--RIEEL  641 (663)
Q Consensus       582 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~--~L~~~  641 (663)
                      .+.. +....     +  +    .......++.+++..||..+|++||++.|+++  .+..+
T Consensus       252 li~~-lk~~p-----~--l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        252 LISE-LKRGP-----D--L----PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             HHHH-HhcCC-----C--C----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            2222 11111     0  0    01112346788999999999999999999995  34444

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.1e-34  Score=302.75  Aligned_cols=244  Identities=20%  Similarity=0.265  Sum_probs=187.8

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .++||+|+||+||++..+ +++.||+|.+....    .....+.+|+.++..++|+||+++++++.+....++||||+++
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~   85 (332)
T cd05623           6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVG   85 (332)
T ss_pred             EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCC
Confidence            367999999999999954 57889999986432    1234578899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.++++...    ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++.......   
T Consensus        86 g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          86 GDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             CcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence            99999997532    24889999999999999999999998  9999999999999999999999999987543322   


Q ss_pred             --CCCCCccccCccccC-----CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          527 --TPNRVAGYRAPEVTD-----PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                        ...++..|+|||++.     ...++.++|||||||++|||++|+.||...      +.......+.........    
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~------~~~~~~~~i~~~~~~~~~----  229 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE------SLVETYGKIMNHKERFQF----  229 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC------CHHHHHHHHhCCCccccC----
Confidence              134677899999986     345788999999999999999999999642      223333333322110000    


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCC--CCCCCHHHHHHH
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYP--DNRPSMSEVIKR  637 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP--~~RPt~~ev~~~  637 (663)
                         .........++.+++.+|+..++  ..|++++|++++
T Consensus       230 ---p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         230 ---PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ---CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence               01111223455666667665444  447899999887

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.3e-34  Score=287.57  Aligned_cols=242  Identities=29%  Similarity=0.446  Sum_probs=196.2

Q ss_pred             hcccccccceEEEEEEecC-----CcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVLEM-----GTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||+|+||.||++...+     +..||+|.+.....  ..+.+.+|++++..++|+||+++++++.+.+..+++|||+
T Consensus         4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~   83 (258)
T smart00219        4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM   83 (258)
T ss_pred             cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence            3679999999999999643     38899999976543  3568999999999999999999999999989999999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST  527 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  527 (663)
                      ++++|.+++.....   ..+++..+..++.|++.||+|||+.+  ++||||||+||++++++.++|+|||+++.......
T Consensus        84 ~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       84 EGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             CCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            99999999975431   12899999999999999999999998  99999999999999999999999999977654321


Q ss_pred             -----CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhh
Q 006055          528 -----PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL  601 (663)
Q Consensus       528 -----~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  601 (663)
                           ..++..|+|||.+.+..++.++||||+|+++++|++ |..||...      +.......+......         
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~------~~~~~~~~~~~~~~~---------  223 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM------SNEEVLEYLKKGYRL---------  223 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHhcCCCC---------
Confidence                 124467999999988889999999999999999998 78887642      222222222221110         


Q ss_pred             cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       602 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                        ........++.+++.+|+..+|++|||+.|+++.|
T Consensus       224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 --PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              01112345788899999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.1e-33  Score=294.08  Aligned_cols=241  Identities=27%  Similarity=0.400  Sum_probs=192.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc-c---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-I---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|.. .+|+.||+|.+.... .   ..+.+.+|+++++.++|||+++++++|.+.+..++||||+. 
T Consensus        20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-   98 (307)
T cd06607          20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-   98 (307)
T ss_pred             heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-
Confidence            36799999999999985 468999999986432 1   12468899999999999999999999999999999999997 


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN  529 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  529 (663)
                      |++.+++....    ..+++..+..++.|++.||.|||+.+  |+||||+|+||++++++.++|+|||++..........
T Consensus        99 g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~~  172 (307)
T cd06607          99 GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV  172 (307)
T ss_pred             CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCCCCcc
Confidence            57777765332    24899999999999999999999998  9999999999999999999999999998776655556


Q ss_pred             CCccccCccccC---CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          530 RVAGYRAPEVTD---PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       530 ~~~~y~aPE~~~---~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ++..|+|||++.   ...++.++||||||+++|||++|+.||....      ............. .         ....
T Consensus       173 ~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~------~~~~~~~~~~~~~-~---------~~~~  236 (307)
T cd06607         173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNDS-P---------TLSS  236 (307)
T ss_pred             CCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc------HHHHHHHHhcCCC-C---------CCCc
Confidence            777899999874   3567889999999999999999999985421      1111111111110 0         0011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      ......+.+++.+||..+|++||++.+++.+.
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             hhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            22445688999999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.3e-34  Score=289.90  Aligned_cols=247  Identities=22%  Similarity=0.342  Sum_probs=193.0

Q ss_pred             hcccccccceEEEEEEecC--CcEEEEEEecCcc--------c---CHHHHHHHHHHhhc-CCCCCcccceEEEEecCcc
Q 006055          375 AEVLGKGTFGTAYKAVLEM--GTIVAVKRLKDVT--------I---SEREFKDKIEGVGA-VNHENLVPLRAYYYSMDEK  440 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~--g~~vavK~l~~~~--------~---~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~  440 (663)
                      .+.||+|+||.||+|....  ++.+|+|.+....        .   ...++.+|+.++.+ ++||||+++++++.+....
T Consensus         5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   84 (269)
T cd08528           5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL   84 (269)
T ss_pred             hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence            3579999999999999654  7889999875321        1   12446678887764 7999999999999999999


Q ss_pred             EEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCcceecCCCCCCEEEcCCCceEEeccccc
Q 006055          441 LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA-QGPNVSHGNIKSSNILLTKSYEARVSDFGLA  519 (663)
Q Consensus       441 ~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a  519 (663)
                      ++||||+++++|.+++..... ....+++..++.++.|++.||.|||+ .+  ++||||||+||+++.++.+||+|||.+
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~  161 (269)
T cd08528          85 YIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLA  161 (269)
T ss_pred             EEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEecccce
Confidence            999999999999998854221 12458899999999999999999996 55  999999999999999999999999999


Q ss_pred             cccCCCC---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccccccc
Q 006055          520 HLVGPSS---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF  596 (663)
Q Consensus       520 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  596 (663)
                      .......   ...++..|+|||.+.+..++.++||||||+++|||++|+.||...      +.......+...... .. 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~------~~~~~~~~~~~~~~~-~~-  233 (269)
T cd08528         162 KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST------NMLSLATKIVEAVYE-PL-  233 (269)
T ss_pred             eecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc------CHHHHHHHHhhccCC-cC-
Confidence            8765442   233566799999999888999999999999999999999998642      122222222211110 00 


Q ss_pred             chhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          597 DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       597 d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                              ........+.+++.+|++.||++||++.|+.+++++
T Consensus       234 --------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         234 --------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             --------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence                    001223467888899999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.9e-34  Score=292.38  Aligned_cols=245  Identities=19%  Similarity=0.346  Sum_probs=192.7

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||.||++... +|+.||+|.++....  ....+.+|++++++++|+||+++++++...+..++||||+++++
T Consensus         6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (286)
T cd06622           6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGS   85 (286)
T ss_pred             hhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCC
Confidence            468999999999999954 799999998865422  23568899999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--CC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ-GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--TP  528 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--~~  528 (663)
                      |.++++...  ....+++..+..++.+++.||.|||+. +  |+||||||+||+++.++.+||+|||++.......  ..
T Consensus        86 l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  161 (286)
T cd06622          86 LDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN  161 (286)
T ss_pred             HHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCCccccC
Confidence            999987532  123589999999999999999999974 6  9999999999999999999999999997654332  23


Q ss_pred             CCCccccCccccCCC------CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          529 NRVAGYRAPEVTDPC------KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~------~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                      .++.+|+|||++.+.      .++.++|||||||++|||++|+.||.....   ......+..+... ..          
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~-~~----------  227 (286)
T cd06622         162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFAQLSAIVDG-DP----------  227 (286)
T ss_pred             CCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHHHHHHHhhc-CC----------
Confidence            356679999998554      347899999999999999999999964321   1111111111111 00          


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...+.....++.+++.+|+..+|++||++++++.+
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         228 PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            01112244567788899999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.3e-34  Score=295.28  Aligned_cols=242  Identities=25%  Similarity=0.385  Sum_probs=189.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcC-CCCCcccceEEEEe------cCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAYYYS------MDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|.. .+++.+|+|.+.........+..|+.++.++ +|+|++++++++..      ....+++|||
T Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~  100 (282)
T cd06636          21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF  100 (282)
T ss_pred             heeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence            46799999999999995 5689999999876554556788899999888 79999999999853      3467999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC-
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-  525 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~-  525 (663)
                      +++|+|.+++....   ...+++..+..++.|++.|+.|||+.+  |+||||||+||++++++.++|+|||++...... 
T Consensus       101 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~  175 (282)
T cd06636         101 CGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV  175 (282)
T ss_pred             CCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcchhhhhccc
Confidence            99999999987543   234788889999999999999999998  999999999999999999999999998755322 


Q ss_pred             ---CCCCCCccccCccccC-----CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          526 ---STPNRVAGYRAPEVTD-----PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       526 ---~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                         ....++..|+|||.+.     ...++.++|||||||++|||++|+.||.......      ........ ...    
T Consensus       176 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~------~~~~~~~~-~~~----  244 (282)
T cd06636         176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR------ALFLIPRN-PPP----  244 (282)
T ss_pred             cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh------hhhhHhhC-CCC----
Confidence               1233566799999875     3457889999999999999999999996532111      00000000 000    


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                           .........++.+++.+||..||.+|||+.|++++
T Consensus       245 -----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         245 -----KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             -----CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                 00111234578889999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.3e-34  Score=289.65  Aligned_cols=246  Identities=26%  Similarity=0.405  Sum_probs=194.2

Q ss_pred             cccccccceEEEEEEec------CCcEEEEEEecCcccC--HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          376 EVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVTIS--EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      ..||+|+||.||+|..+      +.+.|++|.+......  ...+.+|++++++++|+||+++++++.+....++||||+
T Consensus        11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   90 (275)
T cd05046          11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYT   90 (275)
T ss_pred             eeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEec
Confidence            57999999999999853      3467999988654332  467899999999999999999999999888999999999


Q ss_pred             CCCChhHhhccCCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccC
Q 006055          448 TMGSLSALLHGNKGA----GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG  523 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~  523 (663)
                      ++|+|.++++.....    ....+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++++|||++....
T Consensus        91 ~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~  168 (275)
T cd05046          91 DLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKDVY  168 (275)
T ss_pred             CCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEcccccccccC
Confidence            999999999754311    1225899999999999999999999998  9999999999999999999999999986543


Q ss_pred             CCC-----CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          524 PSS-----TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       524 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                      ...     ....+..|+|||.+.+...+.++||||||+++|+|++ |..||.....      ...+.........     
T Consensus       169 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~------~~~~~~~~~~~~~-----  237 (275)
T cd05046         169 NSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD------EEVLNRLQAGKLE-----  237 (275)
T ss_pred             cccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch------HHHHHHHHcCCcC-----
Confidence            221     1123445999999988888899999999999999999 7888854321      1122222111110     


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                           ..........+.+++.+|+..+|++||++.|++++|.
T Consensus       238 -----~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         238 -----LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                 0011123346888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2e-34  Score=302.78  Aligned_cols=244  Identities=22%  Similarity=0.284  Sum_probs=188.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||++.. .+++.||+|.+....    .....+.+|+.++..++|+||+++++++.+.+..++||||+++
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~g   85 (331)
T cd05624           6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVG   85 (331)
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence            36799999999999995 468899999986532    1234578899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC--
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST--  527 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--  527 (663)
                      |+|.++++...    ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  
T Consensus        86 g~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          86 GDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             CcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence            99999997532    24789999999999999999999998  99999999999999999999999999976654322  


Q ss_pred             ---CCCCccccCccccCC-----CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          528 ---PNRVAGYRAPEVTDP-----CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       528 ---~~~~~~y~aPE~~~~-----~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                         ..++.+|+|||++.+     ..++.++|||||||++|||++|+.||....      .......+......   +.  
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~---~~--  228 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHEER---FQ--  228 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC------HHHHHHHHHcCCCc---cc--
Confidence               246778999999875     457889999999999999999999996421      22222222221100   00  


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDN--RPSMSEVIKR  637 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~--RPt~~ev~~~  637 (663)
                      .  .....+...++.+++.+|+..++++  |+++++++++
T Consensus       229 ~--p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 F--PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             C--CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            0  0111122345667777887765544  5688888876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-34  Score=292.59  Aligned_cols=245  Identities=28%  Similarity=0.423  Sum_probs=192.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcC-CCCCcccceEEEEecC------ccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAYYYSMD------EKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------~~~lv~ey  446 (663)
                      .+.||+|++|.||+|.. .+++.+++|.+.........+.+|+++++++ +|+||+++++++....      ..++||||
T Consensus        11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~   90 (275)
T cd06608          11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMEL   90 (275)
T ss_pred             eeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEc
Confidence            46799999999999996 4688999999887665567899999999998 7999999999997654      37999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      +++++|.++++.... ....+++..+..++.|++.||.|||+.+  ++|+||+|+||++++++.++|+|||++.......
T Consensus        91 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~  167 (275)
T cd06608          91 CGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL  167 (275)
T ss_pred             CCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCccceecccch
Confidence            999999999865321 1245899999999999999999999998  9999999999999999999999999987654322


Q ss_pred             ----CCCCCccccCccccCC-----CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          527 ----TPNRVAGYRAPEVTDP-----CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       527 ----~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                          ...++..|+|||++..     ..++.++||||||+++++|++|+.||.....      ......+... ....   
T Consensus       168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-~~~~---  237 (275)
T cd06608         168 GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP------MRALFKIPRN-PPPT---  237 (275)
T ss_pred             hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch------HHHHHHhhcc-CCCC---
Confidence                2335667999998753     3467889999999999999999999964211      1111111111 0000   


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                           .........++.+++.+|+..||++|||++|++++
T Consensus       238 -----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         238 -----LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             -----CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                 11122244578889999999999999999999873

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.1e-34  Score=286.26  Aligned_cols=241  Identities=20%  Similarity=0.347  Sum_probs=194.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||.||++.. .+++.+|||.+.....   ....+.+|+++++.++|||++++++.+...+..++||||++++
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd08220           5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGG   84 (256)
T ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCC
Confidence            36799999999999984 5789999999865432   2457889999999999999999999999889999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC-ceEEeccccccccCCCCC--
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY-EARVSDFGLAHLVGPSST--  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~--  527 (663)
                      +|.+++....   ...+++..+..++.+++.|+.|||+++  ++||||||+||++++++ .+||+|||.+........  
T Consensus        85 ~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          85 TLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             CHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence            9999997543   235799999999999999999999998  99999999999998654 589999999987654322  


Q ss_pred             -CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          528 -PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       528 -~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                       ..++..|+|||.+.+..++.++||||||+++++|++|+.||...      +....+..+...... .          ..
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~------~~~~~~~~~~~~~~~-~----------~~  222 (256)
T cd08220         160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA------NLPALVLKIMSGTFA-P----------IS  222 (256)
T ss_pred             ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC------chHHHHHHHHhcCCC-C----------CC
Confidence             33566799999999888899999999999999999999998642      222222222221110 0          11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .....++.+++.+||..+|++|||++|++++
T Consensus       223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            1234467889999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=8.2e-34  Score=288.67  Aligned_cols=239  Identities=21%  Similarity=0.306  Sum_probs=185.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc------CHHHHHHHHHHhhcCCCCCcccceEEEEec--CccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI------SEREFKDKIEGVGAVNHENLVPLRAYYYSM--DEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  445 (663)
                      .+.||+|+||.||+|.. .+++.||+|.+.....      ....+.+|+.+++.++||||+++++++.+.  ...++++|
T Consensus         7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e   86 (266)
T cd06651           7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME   86 (266)
T ss_pred             cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence            46899999999999985 5689999998864321      124578899999999999999999988753  45789999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+++++|.+++....     .+++.....++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++.....
T Consensus        87 ~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd06651          87 YMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  159 (266)
T ss_pred             CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence            999999999997532     4788999999999999999999998  999999999999999999999999998765321


Q ss_pred             C-------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          526 S-------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       526 ~-------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                      .       ...++.+|+|||++.+..++.++|||||||++|||++|+.||....      ....+........     .+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~------~~~~~~~~~~~~~-----~~  228 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE------AMAAIFKIATQPT-----NP  228 (266)
T ss_pred             cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc------hHHHHHHHhcCCC-----CC
Confidence            1       1235667999999998889999999999999999999999996431      1111111111110     01


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .     .+......+..++ .|+..+|++||+++||+++
T Consensus       229 ~-----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         229 Q-----LPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             C-----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            0     0111223344554 6888999999999999873

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-33  Score=291.26  Aligned_cols=253  Identities=23%  Similarity=0.288  Sum_probs=194.7

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecC--ccEEEEEccCCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMD--EKLLVYDYLTMG  450 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ey~~~g  450 (663)
                      +.||.|++|.||++.. .+++.+|+|.+.....  ....+.+|+++++.++||||++++++|.+..  ..++||||++++
T Consensus         7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~   86 (287)
T cd06621           7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGG   86 (287)
T ss_pred             EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCC
Confidence            6799999999999995 4689999999875432  3467889999999999999999999986543  579999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--CC
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--TP  528 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--~~  528 (663)
                      +|.+++..... ....+++.....++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        87 ~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  163 (287)
T cd06621          87 SLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTF  163 (287)
T ss_pred             CHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeeccccccccccccccc
Confidence            99988764221 2345788999999999999999999998  9999999999999999999999999987654322  22


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .++..|+|||.+.+..++.++||||+|+++|+|++|+.||+...... ............ .......+.    ......
T Consensus       164 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~----~~~~~~  237 (287)
T cd06621         164 TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVN-MPNPELKDE----PGNGIK  237 (287)
T ss_pred             cCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHhc-CCchhhccC----CCCCCc
Confidence            35667999999998889999999999999999999999997653211 111121111111 000000000    000012


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....+.+++.+|++.+|++|||+.|++++
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             hHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            34568899999999999999999999983

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.9e-34  Score=294.61  Aligned_cols=240  Identities=25%  Similarity=0.350  Sum_probs=193.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||.||++.. .+++.||+|.+.... .....+.+|+.+++.++|||++++++++...+..++|+||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L  103 (293)
T cd06647          24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL  103 (293)
T ss_pred             eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcH
Confidence            36799999999999984 568899999986442 3346788999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC----C
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST----P  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~----~  528 (663)
                      .+++...      .+++..+..++.+++.||.|||+.+  ++||||||+||+++.++.++|+|||++........    .
T Consensus       104 ~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~  175 (293)
T cd06647         104 TDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  175 (293)
T ss_pred             HHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceecccccccccccc
Confidence            9998743      3788999999999999999999998  99999999999999999999999998876544322    2


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .++..|+|||.+....++.++||||||+++|++++|+.||......+.      +........         ........
T Consensus       176 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~------~~~~~~~~~---------~~~~~~~~  240 (293)
T cd06647         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGT---------PELQNPEK  240 (293)
T ss_pred             cCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh------eeehhcCCC---------CCCCCccc
Confidence            345669999999888889999999999999999999999975322110      000000000         00111122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....+.+++.+||..+|++||++.+++.+
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         241 LSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            33467788999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.4e-34  Score=290.09  Aligned_cols=243  Identities=23%  Similarity=0.365  Sum_probs=193.6

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCccc-------CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI-------SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||++. ..+++.||+|.+.....       ..+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~   84 (268)
T cd06630           5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW   84 (268)
T ss_pred             cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence            4679999999999998 46799999999864321       135688999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC-ceEEeccccccccCCC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY-EARVSDFGLAHLVGPS  525 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~-~~kl~Dfg~a~~~~~~  525 (663)
                      +++++|.+++....     ++++..+..++.|++.||.|||+.+  ++||||||+||+++.++ .+||+|||.+......
T Consensus        85 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          85 MAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             cCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            99999999997532     5789999999999999999999998  99999999999998776 5999999998766432


Q ss_pred             C--------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          526 S--------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       526 ~--------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                      .        ...++..|+|||.+.+..++.++||||+|+++++|++|+.||.....   ................     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~-----  229 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH---SNHLALIFKIASATTA-----  229 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---cchHHHHHHHhccCCC-----
Confidence            1        12245679999999888889999999999999999999999964321   1111111111111110     


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                           .........++.+++.+|+..+|++||++.|++++
T Consensus       230 -----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         230 -----PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             -----CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                 11112334578889999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.5e-34  Score=289.42  Aligned_cols=244  Identities=23%  Similarity=0.395  Sum_probs=190.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc---C--------HHHHHHHHHHhhcCCCCCcccceEEEEecCccEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---S--------EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLL  442 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~--------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  442 (663)
                      .+.||+|+||.||+|.. .+|+.||+|.++....   .        .+.+.+|+.+++.++|+|++++++++...+..++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (272)
T cd06629           6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI   85 (272)
T ss_pred             cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence            46899999999999984 5689999998753210   0        1357889999999999999999999999999999


Q ss_pred             EEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccccc
Q 006055          443 VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV  522 (663)
Q Consensus       443 v~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~  522 (663)
                      ||||+++|+|.++++..     ..+++..+..++.|++.||.|||+.+  ++||||+|+||+++.++.++++|||+++..
T Consensus        86 v~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~~~  158 (272)
T cd06629          86 FLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKS  158 (272)
T ss_pred             EEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence            99999999999999754     25889999999999999999999998  999999999999999999999999999765


Q ss_pred             CCCC------CCCCCccccCccccCCCC--CCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          523 GPSS------TPNRVAGYRAPEVTDPCK--VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       523 ~~~~------~~~~~~~y~aPE~~~~~~--~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                      ....      ...++..|+|||.+....  ++.++|+||||++++|+++|..||.....     ... ......... ..
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~-~~~~~~~~~-~~  231 (272)
T cd06629         159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAA-MFKLGNKRS-AP  231 (272)
T ss_pred             cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHH-HHHhhcccc-CC
Confidence            4321      123566799999987654  78899999999999999999999853211     111 111111100 00


Q ss_pred             ccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       595 ~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .+..     .........+.+++.+|+..+|++||++++|+++
T Consensus       232 ~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         232 PIPP-----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cCCc-----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            0000     0111234577888899999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.4e-33  Score=292.80  Aligned_cols=245  Identities=27%  Similarity=0.409  Sum_probs=195.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc-cC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-IS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||++.. .++..||+|.+.... ..   ...+.+|+++++.++|+|++++++++.+....++||||+. 
T Consensus        30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  108 (317)
T cd06635          30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-  108 (317)
T ss_pred             hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-
Confidence            46799999999999994 568999999986432 11   3468889999999999999999999999999999999997 


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN  529 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  529 (663)
                      |+|.+++....    .++++..+..++.+++.|+.|||+.+  |+||||+|+||+++.++.++|+|||++..........
T Consensus       109 g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  182 (317)
T cd06635         109 GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV  182 (317)
T ss_pred             CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCCccccc
Confidence            48877775432    34899999999999999999999998  9999999999999999999999999998776655566


Q ss_pred             CCccccCccccC---CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          530 RVAGYRAPEVTD---PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       530 ~~~~y~aPE~~~---~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ++..|+|||++.   ...++.++|||||||++|||++|+.||....      .......+......          ....
T Consensus       183 ~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~------~~~~~~~~~~~~~~----------~~~~  246 (317)
T cd06635         183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNESP----------TLQS  246 (317)
T ss_pred             CCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHhccCC----------CCCC
Confidence            777899999973   4567889999999999999999999986421      11111222211110          0111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                      ......+.+++.+|+..+|++||++.++++++..+.
T Consensus       247 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            223346788888999999999999999999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.5e-34  Score=292.73  Aligned_cols=239  Identities=22%  Similarity=0.287  Sum_probs=185.1

Q ss_pred             ccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHh---hcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          377 VLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGV---GAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       377 ~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      +||+|+||.||++.. .+++.+|+|.+.....    ....+.+|..++   ...+|||++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999995 5689999998865422    123344454433   34479999999999998889999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--  526 (663)
                      +|+|.+++....     .+++.....++.|++.||.|||+.+  |+||||||+||++++++.++|+|||++.......  
T Consensus        81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~  153 (279)
T cd05633          81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH  153 (279)
T ss_pred             CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceeccccCcc
Confidence            999999887532     4899999999999999999999998  9999999999999999999999999987554322  


Q ss_pred             CCCCCccccCccccC-CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 TPNRVAGYRAPEVTD-PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~-~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      ...++..|+|||.+. +..++.++|||||||++|||++|..||.......    ...+......      ..     ...
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~------~~-----~~~  218 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMTLT------VN-----VEL  218 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC----HHHHHHHhhc------CC-----cCC
Confidence            234677899999986 4567899999999999999999999997542211    1111111100      00     011


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                      +.....++.+++.+|+..||++||     +++|+++|
T Consensus       219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            122345678888999999999999     69999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8.3e-34  Score=291.23  Aligned_cols=244  Identities=23%  Similarity=0.390  Sum_probs=187.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc--CHHHHHHHHHH-hhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI--SEREFKDKIEG-VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||.||++.. .+|+.||+|+++....  ....+..|+.. ++..+|||++++++++......++||||++ |
T Consensus         6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~   84 (283)
T cd06617           6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T   84 (283)
T ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence            35799999999999995 4699999999876532  23455556664 666799999999999999999999999997 6


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC--
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ-GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST--  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--  527 (663)
                      +|.++++..... ...+++..++.++.|++.||+|||++ +  ++||||||+||+++.++.+||+|||+++.......  
T Consensus        85 ~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (283)
T cd06617          85 SLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKT  161 (283)
T ss_pred             cHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            888887643222 24689999999999999999999987 6  99999999999999999999999999976543221  


Q ss_pred             -CCCCccccCccccCC----CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          528 -PNRVAGYRAPEVTDP----CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       528 -~~~~~~y~aPE~~~~----~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                       ..++..|+|||.+.+    ..++.++|+|||||++|||++|+.||.....     ....+........ ..     .  
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~-~~-----~--  228 (283)
T cd06617         162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-----PFQQLKQVVEEPS-PQ-----L--  228 (283)
T ss_pred             cccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-----CHHHHHHHHhcCC-CC-----C--
Confidence             235667999998865    4468899999999999999999999864211     1111112111110 00     0  


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                        .......++.+++.+|+..+|++||++++++++
T Consensus       229 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         229 --PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              011234568889999999999999999999873

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.1e-34  Score=293.97  Aligned_cols=239  Identities=24%  Similarity=0.371  Sum_probs=193.7

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|++|.||++.. .+++.+|+|++.... ...+.+.+|+.+++.++|+|++++++++...+..++|+||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L  103 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL  103 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence            36899999999999984 578999999886443 2345688999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----CC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----TP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~~  528 (663)
                      .+++...      .+++..+..++.+++.||+|||+.+  |+||||+|+||+++.++.++|+|||.+.......    ..
T Consensus       104 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648         104 TDIVTHT------RMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             HHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence            9998752      3789999999999999999999998  9999999999999999999999999887543321    12


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .++..|+|||.+.+..++.++||||||++++||++|+.||...      +........... .....        .....
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~------~~~~~~~~~~~~-~~~~~--------~~~~~  240 (285)
T cd06648         176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE------PPLQAMKRIRDN-LPPKL--------KNLHK  240 (285)
T ss_pred             cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC------CHHHHHHHHHhc-CCCCC--------ccccc
Confidence            3566799999998888999999999999999999999998642      112222222211 10000        01111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      ....+.+++.+|+..+|++||++.++++
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         241 VSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            3346888999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-33  Score=286.04  Aligned_cols=239  Identities=26%  Similarity=0.360  Sum_probs=192.4

Q ss_pred             cccccccceEEEEEEec-CCcEEEEEEecCccc------CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTI------SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      +.||+|+||.||+|... +++.|++|.+.....      ..+.+.+|+.+++.++|+|++++++++.+....++|+||++
T Consensus         6 ~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (258)
T cd06632           6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVP   85 (258)
T ss_pred             ceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecC
Confidence            67999999999999965 799999998864321      23568899999999999999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--  526 (663)
                      +++|.+++....     .+++..+..++.+++.|+.|||+.+  ++|+||+|+||+++.++.+||+|||.+.......  
T Consensus        86 ~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~  158 (258)
T cd06632          86 GGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA  158 (258)
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceeccccccc
Confidence            999999997532     4789999999999999999999998  9999999999999999999999999987654432  


Q ss_pred             -CCCCCccccCccccCCCC-CCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          527 -TPNRVAGYRAPEVTDPCK-VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                       ...++..|+|||.+.... ++.++|+||||+++|+|++|+.||.....      ..............          .
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~----------~  222 (258)
T cd06632         159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELP----------P  222 (258)
T ss_pred             cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccCC----------C
Confidence             233566799999987766 88999999999999999999999965321      11111111101000          0


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ........+.+++.+|+..+|++||++++++.+
T Consensus       223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            011223467788889999999999999999863

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7e-34  Score=288.76  Aligned_cols=246  Identities=24%  Similarity=0.360  Sum_probs=197.7

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||.||++... +++.||+|++....  ...+.+.+|+++++.++||||+++++++......++|+||+++++
T Consensus         6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (265)
T cd06605           6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGS   85 (265)
T ss_pred             HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCc
Confidence            367999999999999954 68999999987653  234678899999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--CC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA-QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--TP  528 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--~~  528 (663)
                      |.+++....    ..+++.....++.+++.|+.|||+ .+  ++||||||+||++++++.++|+|||.+.......  ..
T Consensus        86 L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  159 (265)
T cd06605          86 LDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF  159 (265)
T ss_pred             HHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcc
Confidence            999997542    358889999999999999999999 77  9999999999999999999999999987654321  23


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .++..|+|||++.+..++.++||||||+++++|++|+.||...... .......++......... .         ....
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~-~---------~~~~  228 (265)
T cd06605         160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEPPPR-L---------PSGK  228 (265)
T ss_pred             cCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCCCCC-C---------Chhh
Confidence            4566799999999889999999999999999999999999654221 112222332222211100 0         0111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...++.+++.+|+..+|++|||+.|++.+
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         229 FSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             cCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            44568889999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.3e-34  Score=294.68  Aligned_cols=250  Identities=25%  Similarity=0.353  Sum_probs=191.0

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .++||+|+||.||+|..+ +++.||+|++.....   ..+.+.+|+++++.++||||+++++++......++||||++++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (286)
T cd07846           6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT   85 (286)
T ss_pred             eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCcc
Confidence            367999999999999965 589999999865422   2456889999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC---
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST---  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~---  527 (663)
                      +|.++.....     .+++..+..++.|++.||.|||+.+  ++||||+|+||++++++.++|+|||++........   
T Consensus        86 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07846          86 VLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT  158 (286)
T ss_pred             HHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence            9988776422     3899999999999999999999998  99999999999999999999999999876543321   


Q ss_pred             -CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhc-cc----------cc
Q 006055          528 -PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE-WT----------SE  594 (663)
Q Consensus       528 -~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~----------~~  594 (663)
                       ..++..|+|||++.+ ..++.++||||||++++||++|+.||.....      ......+.... ..          ..
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD------IDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch------HHHHHHHHHHhCCCchhhHHHhccch
Confidence             234566999999875 3467899999999999999999999864321      11111111000 00          00


Q ss_pred             ----ccchhhhcc----cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          595 ----VFDLELLRY----QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       595 ----~~d~~~~~~----~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                          ...+.....    .........+.+++.+|+..+|++||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence                000000000    0011234568889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.1e-33  Score=290.67  Aligned_cols=250  Identities=23%  Similarity=0.313  Sum_probs=189.4

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      +.||+|++|.||+|.. .+|+.||||+++....   ....+.+|++++++++||||+++++++.+.+..++||||+. ++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~   84 (284)
T cd07860           6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QD   84 (284)
T ss_pred             eeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cC
Confidence            5799999999999985 4689999998865422   23578899999999999999999999999999999999996 58


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC----
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST----  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~----  527 (663)
                      |.+++....   ...+++..+..++.+++.||+|||+.+  ++||||+|+||++++++.+||+|||++........    
T Consensus        85 l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (284)
T cd07860          85 LKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH  159 (284)
T ss_pred             HHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence            998886533   235899999999999999999999998  99999999999999999999999999876543321    


Q ss_pred             CCCCccccCccccCCCC-CCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhc-ccccccch-------
Q 006055          528 PNRVAGYRAPEVTDPCK-VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE-WTSEVFDL-------  598 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~-------  598 (663)
                      ..++..|+|||++.+.. ++.++||||||+++|||+||+.||......      .......... .......+       
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI------DQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHHHhCCCChhhhhhhhHHHH
Confidence            22456799999886644 588899999999999999999999643211      1111111100 00000000       


Q ss_pred             ---hhh--cccCh----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          599 ---ELL--RYQNV----EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       599 ---~~~--~~~~~----~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                         ...  .....    .....++.+++.+|++.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence               000  00000    1122456788999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.4e-33  Score=288.66  Aligned_cols=238  Identities=25%  Similarity=0.387  Sum_probs=193.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||.||+|.. .+++.||+|.+.....  ..+.+.+|++.+.+++||||+++++++......++||||+++++
T Consensus         9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   88 (277)
T cd06641           9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS   88 (277)
T ss_pred             heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCc
Confidence            46799999999999984 5689999998764422  23578899999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----C
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----T  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~  527 (663)
                      |.+++...      .+++.....++.+++.|+.|||+.+  ++|+||||+||+++.++.++|+|||++.......    .
T Consensus        89 l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06641          89 ALDLLEPG------PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence            99998642      4789999999999999999999998  9999999999999999999999999987654322    1


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..++..|+|||++.+...+.++|+|||||++++|++|..||.....      ......+..... .          ....
T Consensus       161 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~-~----------~~~~  223 (277)
T cd06641         161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP------MKVLFLIPKNNP-P----------TLEG  223 (277)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch------HHHHHHHhcCCC-C----------CCCc
Confidence            2356679999999888889999999999999999999999864221      111111111110 0          0111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....++.+++.+|+..+|++||++.+++++
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         224 NYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            233467788899999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-33  Score=286.57  Aligned_cols=238  Identities=22%  Similarity=0.265  Sum_probs=193.1

Q ss_pred             cccccceEEEEEEec-CCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          378 LGKGTFGTAYKAVLE-MGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       378 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      ||.|+||.||++... +++.||+|.+....    ...+.+.+|+.+++.++||||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999954 58999999986542    2346789999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---CCC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---TPN  529 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---~~~  529 (663)
                      .+++....     .+++..+..++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+|||+++......   ...
T Consensus        81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~  153 (262)
T cd05572          81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC  153 (262)
T ss_pred             HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccccc
Confidence            99997532     4789999999999999999999998  9999999999999999999999999998765432   223


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE  609 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  609 (663)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|..||.....    +.......+......          ...+...
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~----------~~~~~~~  219 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDILKGNGK----------LEFPNYI  219 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHhccCCC----------CCCCccc
Confidence            56679999999888889999999999999999999999975432    122222222211100          0111112


Q ss_pred             HHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006055          610 MVQLLQLAIDCSAQYPDNRPS-----MSEVIK  636 (663)
Q Consensus       610 ~~~l~~l~~~C~~~dP~~RPt-----~~ev~~  636 (663)
                      ..++.+++.+||..+|++||+     ++|+++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            457889999999999999999     677766

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.2e-33  Score=287.14  Aligned_cols=247  Identities=27%  Similarity=0.413  Sum_probs=196.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||.|+||+||+|.. .++..+|+|++....  ...+.+.+|++.++.++|+|++++++.+...+..++|+||+++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~   85 (267)
T cd06610           6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS   85 (267)
T ss_pred             eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence            46799999999999994 468899999986543  235678999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCC---
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---  528 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~---  528 (663)
                      |.++++....  ...+++.....++.|++.||.|||+.+  ++||||||+||++++++.++|+|||++.........   
T Consensus        86 l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~  161 (267)
T cd06610          86 LLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK  161 (267)
T ss_pred             HHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccc
Confidence            9999975321  235899999999999999999999998  999999999999999999999999998766543221   


Q ss_pred             -----CCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          529 -----NRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       529 -----~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                           .++..|+|||++... .++.++|+|||||+++||++|+.||......      ............      ....
T Consensus       162 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~~~~~~------~~~~  229 (267)
T cd06610         162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM------KVLMLTLQNDPP------SLET  229 (267)
T ss_pred             ccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh------hhHHHHhcCCCC------CcCC
Confidence                 356679999998776 7889999999999999999999999653221      111111111110      0000


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ..........+.+++.+|+..||++||+++|++++
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            11112334567888999999999999999999874

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.8e-34  Score=292.49  Aligned_cols=241  Identities=27%  Similarity=0.410  Sum_probs=196.6

Q ss_pred             cccccccceEEEEEEec-CCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      +.||+|++|.||++... +++.||+|.+.........+.+|+++++.++|+|++++++++......++|+||+++++|.+
T Consensus        25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  104 (286)
T cd06614          25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD  104 (286)
T ss_pred             HhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHH
Confidence            57999999999999965 68999999987654456778999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----CCCCC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----STPNR  530 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----~~~~~  530 (663)
                      ++....    ..+++..+..++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++......    ....+
T Consensus       105 ~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  178 (286)
T cd06614         105 IITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVG  178 (286)
T ss_pred             HHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccC
Confidence            998642    35899999999999999999999998  999999999999999999999999988655432    12235


Q ss_pred             CccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHH
Q 006055          531 VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM  610 (663)
Q Consensus       531 ~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  610 (663)
                      +..|+|||++.+..++.++||||||+++|+|++|+.||.....      ......+.... ...        ........
T Consensus       179 ~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~~--------~~~~~~~~  243 (286)
T cd06614         179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP------LRALFLITTKG-IPP--------LKNPEKWS  243 (286)
T ss_pred             CcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcC-CCC--------CcchhhCC
Confidence            6679999999888889999999999999999999999864211      11111111111 000        11111234


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          611 VQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       611 ~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ..+.+++.+|++.+|.+||++.+++++
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         244 PEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            568889999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.6e-33  Score=285.73  Aligned_cols=242  Identities=24%  Similarity=0.317  Sum_probs=193.7

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEec--CccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSM--DEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ey~~~  449 (663)
                      +.||.|+||.||++. ..+|+.||+|.+......   .+.+..|+++++.++|+|++++++++...  ...+++|||+++
T Consensus         6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~   85 (265)
T cd08217           6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG   85 (265)
T ss_pred             eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence            579999999999998 457899999998754322   35678899999999999999999987643  457899999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-----hcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH-----AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH-----~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ++|.+++..... ....+++..++.++.+++.||.|||     +.+  ++|+||||+||++++++.+||+|||++.....
T Consensus        86 ~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~  162 (265)
T cd08217          86 GDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLAKILGH  162 (265)
T ss_pred             CCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEecccccccccC
Confidence            999999875321 2346899999999999999999999     666  99999999999999999999999999987654


Q ss_pred             CCC----CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          525 SST----PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       525 ~~~----~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                      ...    ..++..|+|||.+.+..++.++|+||||+++++|++|+.||....      .......+. .....       
T Consensus       163 ~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~-~~~~~-------  228 (265)
T cd08217         163 DSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN------QLQLASKIK-EGKFR-------  228 (265)
T ss_pred             CcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC------HHHHHHHHh-cCCCC-------
Confidence            332    345667999999998889999999999999999999999997532      112222211 11110       


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                         ........++.+++.+|+..+|++||++++|+++
T Consensus       229 ---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 ---RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ---CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence               1112334578899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=273.31  Aligned_cols=256  Identities=24%  Similarity=0.365  Sum_probs=194.6

Q ss_pred             CCCcccCHHHHHHHhhcccccccceEEEEEEe-cCCcEEEEEEecCccc--CHHHHHHHHHHhhcC-CCCCcccceEEEE
Q 006055          360 NAARVFDLEDLLRASAEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAV-NHENLVPLRAYYY  435 (663)
Q Consensus       360 ~~~~~~~~~~l~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~  435 (663)
                      +....-++.|+..  ...||.|+.|.|+++.. .+|...|||.+.....  ..+.+...++++..- .+|.||+.+|||.
T Consensus        84 g~r~~~dindl~~--l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi  161 (391)
T KOG0983|consen   84 GQRYQADINDLEN--LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI  161 (391)
T ss_pred             CcccccChHHhhh--HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence            3344567777733  46799999999999995 4689999999976533  235566667766554 4899999999999


Q ss_pred             ecCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEec
Q 006055          436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSD  515 (663)
Q Consensus       436 ~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~D  515 (663)
                      .+...++.||.|.. -++.++..-.    .++++...-++...+..||.||.++. .|+|||+||+|||+|+.|.+|+||
T Consensus       162 ~n~dV~IcMelMs~-C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCD  235 (391)
T KOG0983|consen  162 TNTDVFICMELMST-CAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCD  235 (391)
T ss_pred             eCchHHHHHHHHHH-HHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeec
Confidence            99999999998865 4566665433    35888888899999999999998774 499999999999999999999999


Q ss_pred             cccccccCCCCCCC---CCccccCccccCCC---CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh
Q 006055          516 FGLAHLVGPSSTPN---RVAGYRAPEVTDPC---KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD  589 (663)
Q Consensus       516 fg~a~~~~~~~~~~---~~~~y~aPE~~~~~---~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  589 (663)
                      ||++..+-++....   +-+.|||||.+...   .|+.++||||||+.++||.||+.||..-..    + .+.+..++.+
T Consensus       236 FGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t----d-Fe~ltkvln~  310 (391)
T KOG0983|consen  236 FGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT----D-FEVLTKVLNE  310 (391)
T ss_pred             ccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc----c-HHHHHHHHhc
Confidence            99998776554333   44459999999654   688899999999999999999999965221    1 1222233332


Q ss_pred             cccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          590 EWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       590 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      +.      +.+..   ......++.+++..|+.+|+.+||...++++|
T Consensus       311 eP------P~L~~---~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  311 EP------PLLPG---HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CC------CCCCc---ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            21      11111   11145578888889999999999999999875

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=294.23  Aligned_cols=241  Identities=25%  Similarity=0.331  Sum_probs=192.9

Q ss_pred             cccccccceEEEEEEec-CCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      +.||+|+||.||++... +++.||+|.+.....    ..+.+..|++++..++|+||+++++.+.+....++||||+.++
T Consensus         7 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   86 (316)
T cd05574           7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGG   86 (316)
T ss_pred             eeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCC
Confidence            57999999999999954 589999999876532    2356888999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----  526 (663)
                      +|.+++....   ...+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.++|+|||++.......    
T Consensus        87 ~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  161 (316)
T cd05574          87 ELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS  161 (316)
T ss_pred             CHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence            9999987533   245899999999999999999999998  9999999999999999999999999986543211    


Q ss_pred             -----------------------------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCC
Q 006055          527 -----------------------------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGV  577 (663)
Q Consensus       527 -----------------------------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~  577 (663)
                                                   ...++..|+|||++.+..++.++||||||+++|+|++|+.||......   
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---  238 (316)
T cd05574         162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD---  238 (316)
T ss_pred             cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH---
Confidence                                         112455699999999888999999999999999999999999643211   


Q ss_pred             ChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCC----HHHHHHH
Q 006055          578 DLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPS----MSEVIKR  637 (663)
Q Consensus       578 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt----~~ev~~~  637 (663)
                         .....+.....          ...........+.+++.+|+..+|++||+    ++|++++
T Consensus       239 ---~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         239 ---ETFSNILKKEV----------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             ---HHHHHHhcCCc----------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence               11111111110          01111114457888999999999999999    7777663

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.3e-33  Score=292.21  Aligned_cols=249  Identities=23%  Similarity=0.315  Sum_probs=191.0

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC------HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS------EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||+|+||.||+|.. .+|+.||||.+......      ...+..|+++++.++|+||+++++++.+....++||||+
T Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   84 (298)
T cd07841           5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM   84 (298)
T ss_pred             eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc
Confidence            35799999999999995 46899999998755322      345778999999999999999999999988999999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST  527 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  527 (663)
                       +|+|.+++....    ..+++..+..++.||++||.|||+++  |+||||||+||+++.++.++|+|||+++.......
T Consensus        85 -~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          85 -ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             -CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence             889999997532    25899999999999999999999998  99999999999999999999999999987654321


Q ss_pred             ----CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhc-------c----
Q 006055          528 ----PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE-------W----  591 (663)
Q Consensus       528 ----~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~----  591 (663)
                          ...+..|+|||.+.+ ..++.++|||||||+++||++|..||......      .....+....       +    
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI------DQLGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH------HHHHHHHHHcCCCchhhhhhcc
Confidence                224556999998854 45788999999999999999998777643211      1111111100       0    


Q ss_pred             -cccccchhhhcc----cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          592 -TSEVFDLELLRY----QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       592 -~~~~~d~~~~~~----~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                       ............    .........+.+++.+|+..+|++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence             000000000000    001123457889999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.4e-34  Score=292.85  Aligned_cols=250  Identities=25%  Similarity=0.305  Sum_probs=188.7

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      +.||+|+||.||+|.. .+|+.||+|.++....   ....+.+|+++++.++|+|++++++++.+....++|+||+++ +
T Consensus         6 ~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~   84 (284)
T cd07839           6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-D   84 (284)
T ss_pred             EEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-C
Confidence            5799999999999995 4799999999865322   235678899999999999999999999999999999999974 8


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----C
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----T  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~  527 (663)
                      |.+++....    ..+++..+..++.||++||.|||+.+  |+||||||+||+++.++.+||+|||+++......    .
T Consensus        85 l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          85 LKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence            888776432    24899999999999999999999998  9999999999999999999999999998654332    1


Q ss_pred             CCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccc---------ccccc
Q 006055          528 PNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT---------SEVFD  597 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~d  597 (663)
                      ..++..|+|||++.+. .++.++|||||||++|||++|+.|+.....     .......+......         ....+
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-----VDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC-----HHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence            2345679999998664 468899999999999999999998643211     11111111110000         00000


Q ss_pred             hhh-hcc-------cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          598 LEL-LRY-------QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       598 ~~~-~~~-------~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ... ...       ........++.+++.+|+..||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            000 000       0011223567788999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=282.15  Aligned_cols=249  Identities=21%  Similarity=0.343  Sum_probs=190.9

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCccc--CHHHHHHHHHH-hhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI--SEREFKDKIEG-VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      ..||.|+||+|+|.. .+.|+..|||++.....  ..+++..|.+. ++.-+.||||+++|.+..+...|+.||.|.- |
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-S  148 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-S  148 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-h
Confidence            579999999999987 56799999999987644  34567788876 4455899999999999999999999999975 7


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC--C-
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST--P-  528 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~-  528 (663)
                      |+.+...-.......+++...-.|+..+..||.||.+.- +|||||+||+|||+|..|.+||||||++..+..+-.  . 
T Consensus       149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~d  227 (361)
T KOG1006|consen  149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVD  227 (361)
T ss_pred             HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhc
Confidence            765543211122345888888889989999999998764 699999999999999999999999999876654321  1 


Q ss_pred             CCCccccCccccCC--CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          529 NRVAGYRAPEVTDP--CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       529 ~~~~~y~aPE~~~~--~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      .|-..|||||.+..  ..|+.++||||+|++|||+.||+.||..+.     +..+.+.++.....+.-.      .....
T Consensus       228 aGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gdpp~l~------~~~~~  296 (361)
T KOG1006|consen  228 AGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGDPPILL------FDKEC  296 (361)
T ss_pred             cCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCCCCeec------Ccccc
Confidence            23334999999964  358899999999999999999999997643     233344444333221111      11122


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .+....+..++..|+.+|-..||...++.++
T Consensus       297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            3455678889999999999999999998764

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=9e-34  Score=287.68  Aligned_cols=241  Identities=27%  Similarity=0.417  Sum_probs=192.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||.||++.. .+++.||+|.++....   ..+.+..|+++++.++|+||+++++++...+..++|+||++++
T Consensus         5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (264)
T cd06626           5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG   84 (264)
T ss_pred             eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCC
Confidence            36799999999999985 4789999999876544   3467899999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC---
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST---  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~---  527 (663)
                      +|.++++...     .+++..+..++.+++.||.|||+.+  |+|+||+|+||++++++.+||+|||++........   
T Consensus        85 ~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          85 TLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             cHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            9999997532     4788999999999999999999998  99999999999999999999999999977644322   


Q ss_pred             -----CCCCccccCccccCCCC---CCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          528 -----PNRVAGYRAPEVTDPCK---VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       528 -----~~~~~~y~aPE~~~~~~---~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                           ..++..|+|||++.+..   ++.++||||||++++|+++|+.||.....     .......+.. ..     .+.
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-----~~~~~~~~~~-~~-----~~~  226 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-----EFQIMFHVGA-GH-----KPP  226 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-----hHHHHHHHhc-CC-----CCC
Confidence                 23456799999998766   78899999999999999999999964321     1111111111 00     000


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      .   +........+.+++.+|++.+|++||+++|++.
T Consensus       227 ~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         227 I---PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             C---CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0   011112345678888999999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=7.8e-34  Score=292.29  Aligned_cols=248  Identities=23%  Similarity=0.353  Sum_probs=188.2

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCC-CCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||.||++.. .+++.||+|.+....  .....+.+|+.++.++. |+||+++++++..+...+++|||+.. 
T Consensus         9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-   87 (288)
T cd06616           9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-   87 (288)
T ss_pred             HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence            46899999999999984 568999999987543  23456888999999996 99999999999998899999999875 


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ-GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      ++.++...........+++.....++.+++.||+|||+. +  ++||||||+||+++.++.+||+|||+++......   
T Consensus        88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  165 (288)
T cd06616          88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT  165 (288)
T ss_pred             CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHHhccCCccc
Confidence            554433210001124589999999999999999999975 6  9999999999999999999999999997654322   


Q ss_pred             CCCCCccccCccccCCC---CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          527 TPNRVAGYRAPEVTDPC---KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~---~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                      ...++..|+|||++.+.   .++.++|||||||++|||++|+.||....     .....+.........      .+ ..
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~~~------~~-~~  233 (288)
T cd06616         166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGDPP------IL-SN  233 (288)
T ss_pred             cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCCCC------cC-CC
Confidence            23456679999998765   68899999999999999999999996432     111111111111100      00 01


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ........++.+++.+|+..+|++|||++||+++
T Consensus       234 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1112244578889999999999999999999985

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-34  Score=297.08  Aligned_cols=248  Identities=21%  Similarity=0.389  Sum_probs=192.5

Q ss_pred             HHHHHHHhhcccccccceEEEEEEecCCcEEEEEEecCccc---CHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEE
Q 006055          367 LEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI---SEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLL  442 (663)
Q Consensus       367 ~~~l~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  442 (663)
                      +..-++...++||+||.+.||++...+.+.||+|++.....   .-..|..|+..|.++ .|.+||++++|-..+...|+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            33333445678999999999999988889999998764432   346799999999999 58999999999999999999


Q ss_pred             EEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccccc
Q 006055          443 VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV  522 (663)
Q Consensus       443 v~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~  522 (663)
                      ||||=+ .+|..+|+....   ....| .+..+..|++.|+.++|++|  |||.||||.|+|+- .|.+||+|||+|...
T Consensus       438 vmE~Gd-~DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  438 VMECGD-IDLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLKLIDFGIANAI  509 (677)
T ss_pred             Eeeccc-ccHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEEeeeechhccc
Confidence            999654 499999986542   33445 77789999999999999999  99999999999985 469999999999988


Q ss_pred             CCCCC------CCCCccccCccccCCC-----------CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHH
Q 006055          523 GPSST------PNRVAGYRAPEVTDPC-----------KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQS  585 (663)
Q Consensus       523 ~~~~~------~~~~~~y~aPE~~~~~-----------~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~  585 (663)
                      .++.+      ..||..||+||.+...           .++.++||||+||+||+|+.|+.||....+       .|.+ 
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~aK-  581 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIAK-  581 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHHH-
Confidence            77643      4588889999988542           256789999999999999999999965321       1111 


Q ss_pred             HHhhcccccccchhh-hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          586 IVKDEWTSEVFDLEL-LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       586 ~~~~~~~~~~~d~~~-~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                            ...+.|+.- ..++... ...+++++++.|+..||++||+..|++++
T Consensus       582 ------l~aI~~P~~~Iefp~~~-~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  582 ------LHAITDPNHEIEFPDIP-ENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ------HHhhcCCCccccccCCC-CchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                  111222210 0111111 11238999999999999999999999985

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.3e-33  Score=285.55  Aligned_cols=234  Identities=21%  Similarity=0.276  Sum_probs=185.6

Q ss_pred             cccccceEEEEEE-ecCCcEEEEEEecCcccCHHHHHHHHHHhhc-CCCCCcccceEEEEecCccEEEEEccCCCChhHh
Q 006055          378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGA-VNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSAL  455 (663)
Q Consensus       378 lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~~  455 (663)
                      ||+|+||.||++. ..++..+|+|.+........    |+..... .+|+|++++++++...+..++||||+++|+|.++
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~   99 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL   99 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence            6999999999998 45789999999875433221    1222211 2799999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC-ceEEeccccccccCCCCCCCCCccc
Q 006055          456 LHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY-EARVSDFGLAHLVGPSSTPNRVAGY  534 (663)
Q Consensus       456 l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~y  534 (663)
                      +....     .+++..+..++.|+++||.|||+.+  ++||||||+||+++.++ .++|+|||+++.........++..|
T Consensus       100 l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y  172 (267)
T PHA03390        100 LKKEG-----KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDY  172 (267)
T ss_pred             HHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCCCcc
Confidence            97532     5899999999999999999999998  99999999999999998 9999999999877666556678889


Q ss_pred             cCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHH
Q 006055          535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLL  614 (663)
Q Consensus       535 ~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~  614 (663)
                      +|||++.+..++.++||||||+++|||++|+.||...... ..+...+.... ..    .        ..........+.
T Consensus       173 ~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~~----~--------~~~~~~~~~~~~  238 (267)
T PHA03390        173 FSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ-QK----K--------LPFIKNVSKNAN  238 (267)
T ss_pred             cChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh-cc----c--------CCcccccCHHHH
Confidence            9999999888999999999999999999999999743221 11222222111 00    0        011112344678


Q ss_pred             HHHHHccCCCCCCCCC-HHHHHH
Q 006055          615 QLAIDCSAQYPDNRPS-MSEVIK  636 (663)
Q Consensus       615 ~l~~~C~~~dP~~RPt-~~ev~~  636 (663)
                      +++.+|++.+|++||+ ++|+++
T Consensus       239 ~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        239 DFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHHHHhccChhhCCchHHHHhc
Confidence            8888999999999996 699886

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=290.00  Aligned_cols=253  Identities=23%  Similarity=0.316  Sum_probs=192.6

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||.||+|... +++.||+|.++...   ...+.+.+|+++++.++|+||+++++++...+..++||||++++
T Consensus         6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~   85 (288)
T cd07833           6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERT   85 (288)
T ss_pred             EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCC
Confidence            367999999999999954 68899999987542   22467899999999999999999999999999999999999987


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----  526 (663)
                      .+..+....     ..+++..+..++.+++.||.|||+.+  ++||||+|+||++++++.+||+|||++.......    
T Consensus        86 ~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          86 LLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL  158 (288)
T ss_pred             HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence            777666432     24789999999999999999999998  9999999999999999999999999987765432    


Q ss_pred             -CCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh------------ccc
Q 006055          527 -TPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD------------EWT  592 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~  592 (663)
                       ...++..|+|||++.+. .++.++||||||+++|+|++|+.||......   +...........            ...
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI---DQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHhhhcccCccc
Confidence             12345669999999887 7889999999999999999999998643211   000000010000            000


Q ss_pred             -----ccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          593 -----SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       593 -----~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                           ....+..............++.+++.+|+..+|++||++++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence                 000000000000111225678899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.2e-33  Score=283.70  Aligned_cols=241  Identities=23%  Similarity=0.334  Sum_probs=194.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||.||++.. .+|..||+|.+....   ...+.+.+|+++++.++|+|++++++++......++|+||++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (257)
T cd08225           5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG   84 (257)
T ss_pred             EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence            36799999999999995 468999999986542   23456889999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc-eEEeccccccccCCCCC--
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE-ARVSDFGLAHLVGPSST--  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~-~kl~Dfg~a~~~~~~~~--  527 (663)
                      +|.+++....   ...+++..+..++.+++.||.|||+.+  ++|+||||+||++++++. +||+|||.+........  
T Consensus        85 ~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          85 DLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            9999997543   235799999999999999999999998  999999999999998864 69999999976654322  


Q ss_pred             --CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          528 --PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       528 --~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                        ..++..|+|||+..+..++.++|+||||++++||++|+.||...      +...++........ ..          .
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~-~~----------~  222 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN------NLHQLVLKICQGYF-AP----------I  222 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHHHHhcccC-CC----------C
Confidence              23566799999998888899999999999999999999998642      22333333222211 00          0


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ......++.+++.+|+..+|++|||+.|++++
T Consensus       223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         223 SPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            11223467888899999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.5e-33  Score=293.08  Aligned_cols=251  Identities=23%  Similarity=0.314  Sum_probs=189.5

Q ss_pred             cccccc--cceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKG--TFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G--~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      +.||+|  +||+||++.. .+|+.||+|.+......   .+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356776  9999999995 57999999998754332   35688899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++....   ...+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.++++||+.+.......   
T Consensus        84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            99999987543   234889999999999999999999998  9999999999999999999999998653321110   


Q ss_pred             --------CCCCCccccCccccCCC--CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhc------
Q 006055          527 --------TPNRVAGYRAPEVTDPC--KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE------  590 (663)
Q Consensus       527 --------~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------  590 (663)
                              ....+..|+|||++.+.  .++.++|||||||++|||++|+.||.......      .+.......      
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~  232 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ------MLLQKLKGPPYSPLD  232 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH------HHHHHhcCCCCCCcc
Confidence                    01123459999998763  47889999999999999999999997532110      000000000      


Q ss_pred             ------------------------------ccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          591 ------------------------------WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       591 ------------------------------~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                                                    ......+. .............+.+++.+|+..||++|||++|++++-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSE-RLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             ccccchhhhhhccchhhhhcccccchhccccccccccc-cccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence                                          00000000 001112234566789999999999999999999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.4e-34  Score=295.05  Aligned_cols=242  Identities=20%  Similarity=0.271  Sum_probs=190.0

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      +.||+|+||.||++.. .+++.||+|.+.....    ....+.+|+++++.++||||+++++.+......++||||++++
T Consensus         7 ~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~   86 (305)
T cd05609           7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGG   86 (305)
T ss_pred             eEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence            6799999999999995 4578999999875421    2346788999999999999999999999988999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC-----
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-----  525 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~-----  525 (663)
                      +|.+++....     .+++..+..++.+++.||.|||+.+  ++||||||+||+++.++.+||+|||+++.....     
T Consensus        87 ~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          87 DCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            9999996532     4889999999999999999999998  999999999999999999999999998642110     


Q ss_pred             --------------CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc
Q 006055          526 --------------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW  591 (663)
Q Consensus       526 --------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  591 (663)
                                    ....++..|+|||++....++.++|+||||+++|||++|+.||...      +...+.........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~------~~~~~~~~~~~~~~  233 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD------TPEELFGQVISDDI  233 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhccc
Confidence                          0112455699999998888999999999999999999999999642      12222222221110


Q ss_pred             cccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          592 TSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       592 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                          ..+.     .......++.+++.+|++.+|++||++.++.+.|+
T Consensus       234 ----~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         234 ----EWPE-----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             ----CCCC-----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence                0000     00123446788999999999999999655555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=290.48  Aligned_cols=251  Identities=22%  Similarity=0.333  Sum_probs=188.3

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|++|.||+|..+ +++.||+|.+.....  ....+.+|+++++.++|+||+++++++.+.+..++||||+.+ +
T Consensus        10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~   88 (291)
T cd07844          10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-D   88 (291)
T ss_pred             EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-C
Confidence            367999999999999954 689999999865422  234567899999999999999999999999999999999985 9


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----CC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----ST  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----~~  527 (663)
                      |.+++....    ..+++.....++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++.....    ..
T Consensus        89 L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (291)
T cd07844          89 LKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN  162 (291)
T ss_pred             HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence            999887543    25789999999999999999999998  999999999999999999999999998754321    11


Q ss_pred             CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHh---hccccc---------
Q 006055          528 PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK---DEWTSE---------  594 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~---------  594 (663)
                      ...+..|+|||++.+ ..++.++||||+|+++|||++|+.||.....     ....+..+..   ......         
T Consensus       163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD-----VEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc-----HHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            234566999999865 4578899999999999999999999964321     1111111100   000000         


Q ss_pred             -------cc-chhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          595 -------VF-DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       595 -------~~-d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                             .. ...............++.+++.+|+..+|++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                   00 00000000000112567789999999999999999998863

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=283.34  Aligned_cols=253  Identities=26%  Similarity=0.370  Sum_probs=207.7

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEe-cCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYS-MDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  445 (663)
                      ..++-+|.||.||+|.|+      +.+.|-||.++...  ..-..+..|--.+..+.|||+..+.+.+.+ .+..+++|.
T Consensus       289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~  368 (563)
T KOG1024|consen  289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP  368 (563)
T ss_pred             hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence            457899999999999754      34557778776542  223457778778888899999999999865 456799999


Q ss_pred             ccCCCChhHhhccCCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccccc
Q 006055          446 YLTMGSLSALLHGNKG---AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV  522 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~  522 (663)
                      ++.-|+|..+|+..++   .+.+.+.-.+...++.|++.|++|||+++  |||.||..+|.+||+...+||+|-.+++..
T Consensus       369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~LqVkltDsaLSRDL  446 (563)
T KOG1024|consen  369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQLQVKLTDSALSRDL  446 (563)
T ss_pred             ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhheeEEeccchhcccc
Confidence            9999999999984432   34566788888999999999999999999  999999999999999999999999999988


Q ss_pred             CCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccc
Q 006055          523 GPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV  595 (663)
Q Consensus       523 ~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  595 (663)
                      .+.+      +.++...||+||.+....|+..+|||||||++|||+| |+.|+.+..       +..+...+++++    
T Consensus       447 FP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID-------PfEm~~ylkdGy----  515 (563)
T KOG1024|consen  447 FPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID-------PFEMEHYLKDGY----  515 (563)
T ss_pred             CcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC-------HHHHHHHHhccc----
Confidence            7753      4556677999999999999999999999999999999 999985432       223444455543    


Q ss_pred             cchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006055          596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST  646 (663)
Q Consensus       596 ~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~  646 (663)
                            +..++..++.+++.++..||+..|++||+++|++.-|.++..+.+
T Consensus       516 ------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt  560 (563)
T KOG1024|consen  516 ------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT  560 (563)
T ss_pred             ------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence                  233455678899999999999999999999999999999876654

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=288.45  Aligned_cols=239  Identities=25%  Similarity=0.388  Sum_probs=191.2

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCC---CCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVN---HENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|.. .+++.||+|.+....  ....++.+|+.+++.++   |||++++++++......++||||++
T Consensus         6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06917           6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE   85 (277)
T ss_pred             hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence            36799999999999994 678999999986542  23456888999998886   9999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-  527 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  527 (663)
                      +++|.++++..      .+++.....++.+++.||.|||+.+  |+||||+|+||++++++.++|+|||++........ 
T Consensus        86 ~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06917          86 GGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK  157 (277)
T ss_pred             CCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence            99999998642      4889999999999999999999998  99999999999999999999999999987654322 


Q ss_pred             ---CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          528 ---PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       528 ---~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                         ..++..|+|||++.+ ..++.++|+||||+++|+|++|+.||.....      ......+ .....     +.+   
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~------~~~~~~~-~~~~~-----~~~---  222 (277)
T cd06917         158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA------FRAMMLI-PKSKP-----PRL---  222 (277)
T ss_pred             cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh------hhhhhcc-ccCCC-----CCC---
Confidence               235567999999865 4468899999999999999999999965321      1111110 00000     000   


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                       .......++.+++.+|+..||++||++.|++++
T Consensus       223 -~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         223 -EDNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             -CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence             001134568889999999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.9e-33  Score=283.49  Aligned_cols=239  Identities=21%  Similarity=0.259  Sum_probs=186.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc---cC---HHHHHHHHHHhhcCCCCCcccceEEEEec--CccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT---IS---EREFKDKIEGVGAVNHENLVPLRAYYYSM--DEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  445 (663)
                      .+.||+|+||.||++.. .+|+.||+|.+....   ..   ...+.+|+.++++++||||+++++++.+.  ...++|||
T Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e   86 (265)
T cd06652           7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME   86 (265)
T ss_pred             eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence            46899999999999985 568999999875321   11   24678899999999999999999988764  34679999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+++++|.+++....     .+++.....++.+++.||.|||+.+  ++|+||||+||+++.++.++|+|||.++.....
T Consensus        87 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          87 HMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             ecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence            999999999987432     4788889999999999999999998  999999999999999999999999998754321


Q ss_pred             -------CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          526 -------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       526 -------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                             ....++..|+|||.+.+..++.++||||||+++|||++|+.||.....      ...+........       
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~-------  226 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQPT-------  226 (265)
T ss_pred             cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch------HHHHHHHhcCCC-------
Confidence                   112355679999999888889999999999999999999999964211      111111111100       


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                         ....+......+.+++.+|+ .+|++||+++|++++
T Consensus       227 ---~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~  261 (265)
T cd06652         227 ---NPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRH  261 (265)
T ss_pred             ---CCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence               01112233446677778888 489999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.2e-33  Score=283.56  Aligned_cols=242  Identities=25%  Similarity=0.377  Sum_probs=198.5

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|++|.||+|... +++.||||++.....  ....+.+|+..+..++|+|++++++++......++||||+++++
T Consensus         6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (264)
T cd06623           6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS   85 (264)
T ss_pred             eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence            368999999999999955 599999999876532  35779999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC---
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA-QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST---  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~---  527 (663)
                      |.+++...     ..+++..+..++.|+++|+.|||+ .+  ++||||+|+||+++.++.++|+|||.+........   
T Consensus        86 L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          86 LADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            99999753     358999999999999999999999 88  99999999999999999999999999987654332   


Q ss_pred             -CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          528 -PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       528 -~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                       ..++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....   .........+..... .          ...
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~~-~----------~~~  224 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ---PSFFELMQAICDGPP-P----------SLP  224 (264)
T ss_pred             ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc---cCHHHHHHHHhcCCC-C----------CCC
Confidence             2345679999999988899999999999999999999999965432   112222222221110 0          011


Q ss_pred             HH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          607 EE-EMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       607 ~~-~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .. ....+.+++.+|+..+|++||++.|++++
T Consensus       225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            11 34578889999999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3e-33  Score=288.32  Aligned_cols=238  Identities=21%  Similarity=0.261  Sum_probs=192.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||++.. .+++.||+|.++....    ....+.+|++++++++||||+++++++.+....++||||+++
T Consensus         6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   85 (290)
T cd05580           6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG   85 (290)
T ss_pred             EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCC
Confidence            36799999999999995 4689999999865421    235688899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-CC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-TP  528 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~  528 (663)
                      ++|.++++..     ..+++..+..++.|++.||.|||+.+  ++||||+|+||+++.++.+||+|||+++...... ..
T Consensus        86 ~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~  158 (290)
T cd05580          86 GELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL  158 (290)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCC
Confidence            9999999754     25889999999999999999999998  9999999999999999999999999998765442 23


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .++..|+|||.+.+...+.++||||||+++|+|++|+.||....      .......+.....            ..+..
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~------------~~~~~  220 (290)
T cd05580         159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN------PIQIYEKILEGKV------------RFPSF  220 (290)
T ss_pred             CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhcCCc------------cCCcc
Confidence            45677999999988888899999999999999999999986432      1111112111110            00111


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                      ....+.+++.+|+..+|++||     +++|++++
T Consensus       221 ~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         221 FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence            234677888899999999999     77777754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-34  Score=274.64  Aligned_cols=261  Identities=23%  Similarity=0.383  Sum_probs=198.5

Q ss_pred             CHHHHHHHhhcccccccceEEEEEE-ecCCcEEEEEEecCc-ccCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEE
Q 006055          366 DLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV-TISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLL  442 (663)
Q Consensus       366 ~~~~l~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  442 (663)
                      .++|+..-+.+.||+|+|+.|-.++ +.+|..||||++.+. ......+.+|++++... .|+||+.++++|.+++..||
T Consensus        74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL  153 (463)
T KOG0607|consen   74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL  153 (463)
T ss_pred             hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence            3567777788999999999999888 788999999999766 45578889999999888 59999999999999999999


Q ss_pred             EEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc---eEEeccccc
Q 006055          443 VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLA  519 (663)
Q Consensus       443 v~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~---~kl~Dfg~a  519 (663)
                      |||.|.+|.|..+++..+     .+++.++.++..+||.||.+||.+|  |.||||||+|||-.....   +|||||.++
T Consensus       154 VfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLg  226 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLG  226 (463)
T ss_pred             EEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccc
Confidence            999999999999998644     6899999999999999999999999  999999999999876554   899999887


Q ss_pred             cccCCC--C---------CCCCCccccCccccC-----CCCCCCcchhhhHHHHHHHHHhCCCCCccccCC-CCCC---h
Q 006055          520 HLVGPS--S---------TPNRVAGYRAPEVTD-----PCKVSQKADVYSFGVLLLELLTGKAPTHALLNE-EGVD---L  579 (663)
Q Consensus       520 ~~~~~~--~---------~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~-~~~~---~  579 (663)
                      .-....  .         +..++..|||||+..     ...|+.++|.||+|||+|-|+.|..||.+.=.. .|.+   .
T Consensus       227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~  306 (463)
T KOG0607|consen  227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV  306 (463)
T ss_pred             cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence            543211  1         123445599999863     346889999999999999999999999864321 1211   1


Q ss_pred             HHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          580 PRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       580 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      ....++.+-+...+..+..+...+..+..+.+   +++...+..|+.+|.++.+++.
T Consensus       307 Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eak---dlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  307 CRVCQNKLFESIQEGKYEFPDKDWAHISSEAK---DLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cHHHHHHHHHHHhccCCcCChhhhHHhhHHHH---HHHHHHHhccHHhhhhhhhccC
Confidence            12222222111111112222222333344444   4455666799999999999987

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.5e-33  Score=286.99  Aligned_cols=253  Identities=23%  Similarity=0.322  Sum_probs=192.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||.||+|.. .+|+.||||++.....   ....+.+|+.+++.++|||++++++++......++||||+ ++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~   83 (286)
T cd07832           5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PS   83 (286)
T ss_pred             EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CC
Confidence            36799999999999995 5789999999875432   2467899999999999999999999999999999999999 99


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----  526 (663)
                      +|.+++....    ..+++..+..++.||+.||.|||+.+  ++|+||||+||+++.++.++|+|||++.......    
T Consensus        84 ~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          84 DLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence            9999987533    35899999999999999999999998  9999999999999999999999999998765432    


Q ss_pred             -CCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccc------ccccch
Q 006055          527 -TPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT------SEVFDL  598 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~d~  598 (663)
                       ...++..|+|||.+.+. .++.++||||+|++++||++|..||....+.   .....+.........      .+..+.
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCcchh
Confidence             23356679999998654 4688999999999999999998877543211   111111111000000      000000


Q ss_pred             hhhc---------ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          599 ELLR---------YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       599 ~~~~---------~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....         .....+....+.+++.+|+..+|++||++++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000         00001223678889999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.3e-33  Score=287.13  Aligned_cols=240  Identities=22%  Similarity=0.267  Sum_probs=188.7

Q ss_pred             cccccceEEEEEE-ecCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       378 lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      ||+|+||+||++. ..+|+.||+|.+....    .....+..|+++++.++|||++++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            6999999999998 4568999999986532    2244567899999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---CCC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---TPN  529 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---~~~  529 (663)
                      .+++....   ...+++..+..++.|++.||.|||+.+  ++||||+|+||++++++.++|+|||.+.......   ...
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  155 (277)
T cd05577          81 KYHIYNVG---EPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA  155 (277)
T ss_pred             HHHHHHcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence            99987543   235899999999999999999999998  9999999999999999999999999987654322   223


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE  609 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  609 (663)
                      ++..|+|||++.+..++.++||||||+++++|++|+.||.......  ..........     ..       ........
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~-----~~-------~~~~~~~~  221 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV--EKEELKRRTL-----EM-------AVEYPDKF  221 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc--cHHHHHhccc-----cc-------cccCCccC
Confidence            4567999999988889999999999999999999999996533211  1111110000     00       00011122


Q ss_pred             HHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006055          610 MVQLLQLAIDCSAQYPDNRP-----SMSEVIK  636 (663)
Q Consensus       610 ~~~l~~l~~~C~~~dP~~RP-----t~~ev~~  636 (663)
                      ...+.+++.+|++.+|++||     ++.+++.
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            34677888999999999999     6666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-33  Score=283.34  Aligned_cols=240  Identities=23%  Similarity=0.255  Sum_probs=186.2

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcccC----HHHHHHHHHH-hhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS----EREFKDKIEG-VGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      +.||+|+||.||+|.. .+|+.||||.+......    ...+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4699999999999985 56899999998654221    1233444443 4455899999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN  529 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  529 (663)
                      ++|.++++...     .+++..+..++.|++.||.|||+.+  ++||||+|+||+++.++.++|+|||+++.........
T Consensus        82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  154 (260)
T cd05611          82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV  154 (260)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccccccCC
Confidence            99999997532     4788999999999999999999998  9999999999999999999999999998665444445


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE  609 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  609 (663)
                      ++..|+|||.+.+..++.++||||||+++|||++|..||....      .......+......     .   ........
T Consensus       155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~-----~---~~~~~~~~  220 (260)
T cd05611         155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET------PDAVFDNILSRRIN-----W---PEEVKEFC  220 (260)
T ss_pred             CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhcccC-----C---CCcccccC
Confidence            6777999999988888999999999999999999999996422      11222222111100     0   00011123


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          610 MVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       610 ~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      ...+.+++.+|+..+|++||++.++.+
T Consensus       221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         221 SPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             CHHHHHHHHHHccCCHHHccCCCcHHH
Confidence            456888999999999999997754444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.2e-33  Score=286.00  Aligned_cols=240  Identities=24%  Similarity=0.305  Sum_probs=194.8

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||++... +++.||+|.+....    ...+.+.+|++++++++||||+++++++.+....++|+||+.+
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   84 (258)
T cd05578           5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLG   84 (258)
T ss_pred             EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCC
Confidence            368999999999999954 69999999987542    2346788999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      ++|.+++...     .++++.....++.++++||.|||+.+  ++|+||+|+||++++++.++|+|||.+.......   
T Consensus        85 ~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  157 (258)
T cd05578          85 GDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT  157 (258)
T ss_pred             CCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCcccc
Confidence            9999999753     25889999999999999999999998  9999999999999999999999999987765442   


Q ss_pred             CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|+.||......    ...++.......           ....+
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~-----------~~~~~  222 (258)
T cd05578         158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQETA-----------DVLYP  222 (258)
T ss_pred             ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhccc-----------cccCc
Confidence            233556699999998888999999999999999999999999754321    112221111110           01111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH--HHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSM--SEVIK  636 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~--~ev~~  636 (663)
                      ......+.+++.+|+..||.+||++  +|+++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             ccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            2234578889999999999999999  66553

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.8e-33  Score=282.78  Aligned_cols=242  Identities=29%  Similarity=0.452  Sum_probs=197.7

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|++|.||++... +++.+++|++..... ....+.+|++.++.++|+|++++++++......++++||+++++|
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   84 (253)
T cd05122           5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL   84 (253)
T ss_pred             eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence            367999999999999964 789999999976543 457899999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---CCC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---TPN  529 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---~~~  529 (663)
                      .+++....    ..+++..+..++.+++.||.|||+.+  ++||||+|+||++++++.++|+|||.+.......   ...
T Consensus        85 ~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  158 (253)
T cd05122          85 KDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV  158 (253)
T ss_pred             HHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence            99987542    35899999999999999999999988  9999999999999999999999999998776543   334


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE  609 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  609 (663)
                      ++..|+|||++.+..++.++||||||+++++|++|+.||.....      ......... ......        ......
T Consensus       159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~~~--------~~~~~~  223 (253)
T cd05122         159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP------MKALFKIAT-NGPPGL--------RNPEKW  223 (253)
T ss_pred             cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch------HHHHHHHHh-cCCCCc--------Cccccc
Confidence            56679999999888889999999999999999999999864321      111111111 110110        011112


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          610 MVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       610 ~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...+.+++.+|+..||++|||+.|++++
T Consensus       224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         224 SDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            3468889999999999999999999874

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.4e-33  Score=290.98  Aligned_cols=239  Identities=25%  Similarity=0.387  Sum_probs=192.1

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .+||+|+||.||++.. .+|+.||+|.+.... .....+.+|+.+++.++|+|++++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            5799999999999985 578999999886432 23456889999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----CCC
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----TPN  529 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~~~  529 (663)
                      +++...      .+++.....++.|++.|++|||+.+  ++||||||+||++++++.++|+|||++.......    ...
T Consensus       106 ~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~  177 (292)
T cd06657         106 DIVTHT------RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV  177 (292)
T ss_pred             HHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence            988532      3789999999999999999999998  9999999999999999999999999887554322    123


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE  609 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  609 (663)
                      ++.+|+|||++.+..++.++|+||||+++|||++|+.||.....      ...+... .......        .......
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~------~~~~~~~-~~~~~~~--------~~~~~~~  242 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMI-RDNLPPK--------LKNLHKV  242 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH-HhhCCcc--------cCCcccC
Confidence            56679999999888889999999999999999999999864211      1111111 1111100        0011122


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          610 MVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       610 ~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...+.+++.+|+..+|.+||++.+++++
T Consensus       243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         243 SPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             CHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            3457788889999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-35  Score=300.19  Aligned_cols=242  Identities=24%  Similarity=0.364  Sum_probs=194.5

Q ss_pred             hcccccccceEEEEEEecC-CcEEEEEEecCc-ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDV-TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      ...||.|+||.||+|..++ +-..|.|.+... ...-.+|.-||+++....||+||++++.|+-.+.++++.|||.||-.
T Consensus        37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV  116 (1187)
T KOG0579|consen   37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV  116 (1187)
T ss_pred             HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence            4468999999999999654 444566666533 22346789999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccC----CCCCC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG----PSSTP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~----~~~~~  528 (663)
                      +.++-.-.    .++.+.++..++++++.||.|||++.  |||||||+.|||++-+|.++|+|||.+....    ..++.
T Consensus       117 DaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsF  190 (1187)
T KOG0579|consen  117 DAIMLELG----RVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSF  190 (1187)
T ss_pred             hHHHHHhc----cccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHHhhhccc
Confidence            98876432    46999999999999999999999998  9999999999999999999999999875432    34667


Q ss_pred             CCCccccCccccCC-----CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          529 NRVAGYRAPEVTDP-----CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       529 ~~~~~y~aPE~~~~-----~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                      .||++|||||+.+.     ..|+.++||||||++|.||..+.+|-....      ....+-.+.+.. +..        .
T Consensus       191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln------pMRVllKiaKSe-PPT--------L  255 (1187)
T KOG0579|consen  191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKIAKSE-PPT--------L  255 (1187)
T ss_pred             cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc------hHHHHHHHhhcC-CCc--------c
Confidence            89999999998753     568999999999999999999999975432      222222222211 111        1


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      -.+......+.+++.+|+.+||..||++.++++|
T Consensus       256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            2345566678888999999999999999999875

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.4e-33  Score=287.99  Aligned_cols=250  Identities=22%  Similarity=0.310  Sum_probs=186.2

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      +.||+|+||.||+|.. .+|+.||+|.+....  .....+.+|+.+++.++|+||+++++++......++||||+. +++
T Consensus        11 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l   89 (291)
T cd07870          11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDL   89 (291)
T ss_pred             EEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCH
Confidence            5799999999999984 568999999986542  223467889999999999999999999999889999999996 677


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----CC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----TP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~~  528 (663)
                      .+++....    ..+.+..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++......    ..
T Consensus        90 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  163 (291)
T cd07870          90 AQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE  163 (291)
T ss_pred             HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCc
Confidence            77665322    24678888899999999999999998  9999999999999999999999999987543221    12


Q ss_pred             CCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh----------------cc
Q 006055          529 NRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD----------------EW  591 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------------~~  591 (663)
                      .++..|+|||++.+. .++.++|||||||++|||++|+.||+.....     ...+......                .+
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07870         164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-----FEQLEKIWTVLGVPTEDTWPGVSKLPNY  238 (291)
T ss_pred             cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-----HHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence            346679999998753 4788999999999999999999999753221     1111111000                00


Q ss_pred             cccccc----hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          592 TSEVFD----LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       592 ~~~~~d----~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ..+...    ...............+.+++.+|+..||.+|||++|++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            000000    0000000000113467788899999999999999999863

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=8.4e-33  Score=287.52  Aligned_cols=243  Identities=25%  Similarity=0.366  Sum_probs=192.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|.. .+++.+|+|.+....    .....+.+|+++++.++|+|++++++++......++||||+. 
T Consensus        20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-   98 (308)
T cd06634          20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-   98 (308)
T ss_pred             HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-
Confidence            46799999999999994 468899999986431    123467789999999999999999999999999999999997 


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN  529 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  529 (663)
                      |++.+++....    ..+++..+..++.+++.|+.|||+.+  ++||||||+||+++.++.++|+|||++....+.....
T Consensus        99 ~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  172 (308)
T cd06634          99 GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV  172 (308)
T ss_pred             CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCccccc
Confidence            58888775432    34789999999999999999999998  9999999999999999999999999998776655556


Q ss_pred             CCccccCccccC---CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          530 RVAGYRAPEVTD---PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       530 ~~~~y~aPE~~~---~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ++..|+|||++.   ...++.++|||||||++|||++|+.||.....      .............          ....
T Consensus       173 ~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~----------~~~~  236 (308)
T cd06634         173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNESP----------ALQS  236 (308)
T ss_pred             CCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH------HHHHHHHhhcCCC----------CcCc
Confidence            777899999974   34578899999999999999999999854211      1111111111110          0011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                      ......+.+++.+||..+|++||++++++++-..
T Consensus       237 ~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~  270 (308)
T cd06634         237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  270 (308)
T ss_pred             ccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence            1234567888999999999999999999986443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-33  Score=291.01  Aligned_cols=259  Identities=23%  Similarity=0.301  Sum_probs=190.0

Q ss_pred             cccccccceEEEEEEec---CCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEec--CccEEEEEc
Q 006055          376 EVLGKGTFGTAYKAVLE---MGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSM--DEKLLVYDY  446 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ey  446 (663)
                      ++||+|+||.||+|...   +++.||+|.+....    .....+.+|+.++..++||||+++++++.+.  ...++||||
T Consensus         6 ~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   85 (316)
T cd07842           6 GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDY   85 (316)
T ss_pred             EEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeC
Confidence            57999999999999954   48999999987632    1235678899999999999999999999887  779999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC----CCceEEecccccccc
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK----SYEARVSDFGLAHLV  522 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~----~~~~kl~Dfg~a~~~  522 (663)
                      +++ +|.+++..........+++.....++.|++.||.|||+.+  |+||||||+||+++.    ++.+||+|||+++..
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~  162 (316)
T cd07842          86 AEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF  162 (316)
T ss_pred             CCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCcccccc
Confidence            985 7777765433222346889999999999999999999998  999999999999999    899999999999865


Q ss_pred             CCCCC-------CCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHH---HHHHHHhh--
Q 006055          523 GPSST-------PNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPR---WVQSIVKD--  589 (663)
Q Consensus       523 ~~~~~-------~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~---~~~~~~~~--  589 (663)
                      .....       ..++..|+|||.+.+. .++.++|||||||+++||++|+.||.............   .+..+...  
T Consensus       163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  242 (316)
T cd07842         163 NAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLG  242 (316)
T ss_pred             CCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhC
Confidence            43221       2345679999987664 57889999999999999999999997644322111000   00000000  


Q ss_pred             -cc---------cccccc----hhhhcc--cChH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          590 -EW---------TSEVFD----LELLRY--QNVE-------EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       590 -~~---------~~~~~d----~~~~~~--~~~~-------~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                       ..         ..+...    ......  ....       ....++.+++.+|++.||++|||+.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         243 TPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             CCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             00         000000    000000  0000       223468899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.2e-33  Score=286.39  Aligned_cols=249  Identities=25%  Similarity=0.272  Sum_probs=189.7

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEec--CccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSM--DEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|..+ +++.+|+|.++.....   ...+.+|+.++.+++||||+++++++...  ...++||||+.
T Consensus        10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~   89 (293)
T cd07843          10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE   89 (293)
T ss_pred             hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence            467999999999999964 6899999998754322   34567899999999999999999999877  78999999998


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--  526 (663)
                      + +|.+++....    ..+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||++.......  
T Consensus        90 ~-~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  162 (293)
T cd07843          90 H-DLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP  162 (293)
T ss_pred             c-CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence            5 9999887533    25899999999999999999999998  9999999999999999999999999998765431  


Q ss_pred             --CCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhc-------------
Q 006055          527 --TPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE-------------  590 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------------  590 (663)
                        ...++..|+|||.+.+. .++.++|+||||++++||++|+.||......      .....+....             
T Consensus       163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI------DQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHHhCCCchHHHHHhhc
Confidence              22345679999998764 4688999999999999999999999753211      1111111000             


Q ss_pred             -------ccccccchhhhcccChHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          591 -------WTSEVFDLELLRYQNVEE-EMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       591 -------~~~~~~d~~~~~~~~~~~-~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                             .........+ ....... ....+.+++.+|+..+|++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         237 LPGAKKKTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             cchhcccccccccchhh-hccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                   0000000000 0000000 24567788999999999999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.8e-33  Score=286.79  Aligned_cols=254  Identities=22%  Similarity=0.250  Sum_probs=188.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCC-CCCcccceEEEEecCc-----cEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVN-HENLVPLRAYYYSMDE-----KLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----~~lv~  444 (663)
                      .+.||+|+||.||+|.. .+|+.||+|.++....   ....+.+|+.+++.++ |+||+++++++...+.     .++||
T Consensus         6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~   85 (295)
T cd07837           6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF   85 (295)
T ss_pred             eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence            36799999999999995 4689999998765422   2357888999999995 6999999999877665     79999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC-CCceEEeccccccccC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK-SYEARVSDFGLAHLVG  523 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~-~~~~kl~Dfg~a~~~~  523 (663)
                      ||+++ +|.+++..........+++..++.++.||+.||.|||+.+  |+||||||+||+++. ++.+||+|||+++...
T Consensus        86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~  162 (295)
T cd07837          86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS  162 (295)
T ss_pred             eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeecccceecC
Confidence            99986 8988886543222346899999999999999999999998  999999999999998 8899999999987653


Q ss_pred             CCC----CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhc-cc-----
Q 006055          524 PSS----TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE-WT-----  592 (663)
Q Consensus       524 ~~~----~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~-----  592 (663)
                      ...    ...++..|+|||++.+ ..++.++||||||+++|||++|..||.....      ......+.... ..     
T Consensus       163 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~------~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         163 IPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE------LQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             CCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHHHhCCCChhhC
Confidence            321    1234566999998865 4578899999999999999999999964321      11111111100 00     


Q ss_pred             ccccchh----hh--ccc----ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          593 SEVFDLE----LL--RYQ----NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       593 ~~~~d~~----~~--~~~----~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....+..    ..  ...    .......++.+++.+|+..+|++||+++|++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0000000    00  000    001234567889999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.1e-32  Score=287.52  Aligned_cols=252  Identities=19%  Similarity=0.250  Sum_probs=186.9

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      ++.+|.|+++.||++.. +++.||||++....   ...+.+.+|++.++.++|+||+++++++.+.+..+++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455555655555554 69999999987542   234678999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-----
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----  526 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-----  526 (663)
                      |.++++...   ...+++.....++.|++.||.|||+++  |+||||||+||+++.++.+||+|||.+.......     
T Consensus        86 l~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          86 CEDLLKTHF---PEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             HHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            999997532   234788999999999999999999998  9999999999999999999999999886543211     


Q ss_pred             ------CCCCCccccCccccCC--CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccc------
Q 006055          527 ------TPNRVAGYRAPEVTDP--CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT------  592 (663)
Q Consensus       527 ------~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  592 (663)
                            ...++..|+|||++..  ..++.++|||||||+++||++|+.||.......     ...... .....      
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-----~~~~~~-~~~~~~~~~~~  234 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-----MLLEKV-RGTVPCLLDKS  234 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHH-hccCccccccC
Confidence                  1224456999999865  357889999999999999999999997532110     011110 00000      


Q ss_pred             ---------cc----ccchhh---hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          593 ---------SE----VFDLEL---LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       593 ---------~~----~~d~~~---~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                               ..    ..+...   ...........++.+++.+||..||++|||++|++++-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence                     00    000000   00111122345688899999999999999999999853

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-33  Score=285.84  Aligned_cols=251  Identities=25%  Similarity=0.314  Sum_probs=190.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|++|.||+|.. .+|+.||+|++.....   ....+.+|+++++.++|||++++++++.+....+++|||++ +
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~   82 (283)
T cd07835           4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L   82 (283)
T ss_pred             heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence            36799999999999985 5799999999875422   23568889999999999999999999999999999999995 6


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----  526 (663)
                      +|.+++....   ...+++..+..++.|+++||.|||+.+  ++||||+|+||+++.++.++|+|||++.......    
T Consensus        83 ~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  157 (283)
T cd07835          83 DLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT  157 (283)
T ss_pred             CHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence            8999987543   135899999999999999999999998  9999999999999999999999999997654321    


Q ss_pred             CCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhc-cccccc--------
Q 006055          527 TPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE-WTSEVF--------  596 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--------  596 (663)
                      ...++..|+|||++.+. .++.++||||||+++|+|++|+.||......      .....+.+.. ......        
T Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI------DQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCCChHHhhhhhhch
Confidence            12245679999987654 4688999999999999999999999643211      1111111100 000000        


Q ss_pred             ch--hhhc--ccC----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          597 DL--ELLR--YQN----VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       597 d~--~~~~--~~~----~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      +.  ....  ...    .......+.+++.+|++.+|++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00  0000  000    11123467889999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8.8e-33  Score=283.39  Aligned_cols=252  Identities=20%  Similarity=0.268  Sum_probs=187.5

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCccc--CHHHHHHHHHHhhcCC-CCCcccceEEEEec--CccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVN-HENLVPLRAYYYSM--DEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|. ..+++.||+|+++....  ......+|+.++.++. |+|++++++++.+.  +..++||||++
T Consensus         4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~   83 (282)
T cd07831           4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD   83 (282)
T ss_pred             EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence            3579999999999999 45789999999876422  2334557888888885 99999999999887  78999999997


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-  527 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  527 (663)
                       |+|.+.+....    ..+++..+..++.|++.||.|||+.+  ++||||||+||+++. +.+||+|||+++....... 
T Consensus        84 -~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          84 -MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             -ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence             58888876432    35899999999999999999999998  999999999999999 9999999999986643322 


Q ss_pred             --CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc--------ccccc
Q 006055          528 --PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW--------TSEVF  596 (663)
Q Consensus       528 --~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~  596 (663)
                        ..++..|+|||++.. ..++.++|||||||++|||++|+.||......   +...+.........        .....
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhhcccccc
Confidence              235667999997644 55788999999999999999999999653211   11111111110000        00000


Q ss_pred             chhhhc--c----cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          597 DLELLR--Y----QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       597 d~~~~~--~----~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      +.....  .    .........+.+++.+|+..+|++||++++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            000000  0    0012335678999999999999999999999874

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.7e-33  Score=284.43  Aligned_cols=239  Identities=23%  Similarity=0.279  Sum_probs=184.0

Q ss_pred             ccccccceEEEEEEe-cCCcEEEEEEecCcccC----HHHHHHHHH---HhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          377 VLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS----EREFKDKIE---GVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       377 ~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      +||+|+||.||+|.. .+++.||+|.+......    ...+..|..   .++...|||++++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999984 56899999998654211    222334433   3445689999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC--C
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--S  526 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~--~  526 (663)
                      +|+|.+++...     ..+++..+..++.|++.|+.|||+.+  |+||||||+||+++.++.++|+|||++......  .
T Consensus        81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~  153 (278)
T cd05606          81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH  153 (278)
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCccCCc
Confidence            99999988643     25899999999999999999999998  999999999999999999999999998755332  2


Q ss_pred             CCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 TPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      ...++..|+|||.+.+. .++.++||||+|+++|||++|+.||.......   ......... .      ...     ..
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~-~------~~~-----~~  218 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTL-T------MAV-----EL  218 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc---hHHHHHHhh-c------cCC-----CC
Confidence            23466779999998754 68899999999999999999999997542211   111100000 0      000     01


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                      +.....++.+++.+|+..+|++||     ++.+++++
T Consensus       219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            111245678888899999999999     99999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.7e-32  Score=285.83  Aligned_cols=240  Identities=27%  Similarity=0.413  Sum_probs=190.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|.. .+|+.||+|.+.....    ....+.+|+++++.++|||++++++++.+....++||||+. 
T Consensus        26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  104 (313)
T cd06633          26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-  104 (313)
T ss_pred             ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence            46799999999999984 5689999999864322    12467889999999999999999999999999999999996 


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN  529 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  529 (663)
                      |++.+++....    .++++..+..++.|++.|+.|||+.+  ++||||||+||++++++.+||+|||++..........
T Consensus       105 ~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~  178 (313)
T cd06633         105 GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV  178 (313)
T ss_pred             CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccCCCCCcc
Confidence            57877775432    35899999999999999999999998  9999999999999999999999999987665544555


Q ss_pred             CCccccCccccC---CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          530 RVAGYRAPEVTD---PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       530 ~~~~y~aPE~~~---~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ++..|+|||++.   ...++.++|||||||++|||++|..||.....      ...+.......... .         ..
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~~~~-~---------~~  242 (313)
T cd06633         179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNDSPT-L---------QS  242 (313)
T ss_pred             ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCCC-C---------Cc
Confidence            677899999984   35678899999999999999999999864321      11222221111100 0         01


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ......+.+++.+|++.+|++||++.+++.+
T Consensus       243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         243 NEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1122357788889999999999999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-33  Score=294.06  Aligned_cols=258  Identities=21%  Similarity=0.317  Sum_probs=190.1

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEec-----CccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSM-----DEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|. ..+|+.||+|.+....  .....+.+|+.+++.++|+||+++++++...     ...++|+||
T Consensus        10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~   89 (336)
T cd07849          10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL   89 (336)
T ss_pred             EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence            3689999999999998 4578999999986432  2345678899999999999999999987644     347899999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      +.+ +|.+++...      .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++......
T Consensus        90 ~~~-~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          90 MET-DLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             ccc-CHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            975 888887642      4899999999999999999999998  9999999999999999999999999987654321


Q ss_pred             C-------CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccc---cc
Q 006055          527 T-------PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTS---EV  595 (663)
Q Consensus       527 ~-------~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~  595 (663)
                      .       ..++..|+|||.+.+ ..++.++||||+||++|+|++|+.||......   .....+.........+   .+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCHHHHHHh
Confidence            1       234667999998654 56788999999999999999999999642110   0011111111100000   00


Q ss_pred             cchh-------hh--ccc----ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhCCC
Q 006055          596 FDLE-------LL--RYQ----NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR--IEELHPS  644 (663)
Q Consensus       596 ~d~~-------~~--~~~----~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~--L~~~~~~  644 (663)
                      .+..       ..  ...    .......++.+++.+|++.+|++|||+.|++++  ++.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence            0000       00  000    001224568899999999999999999999997  5555433

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.4e-33  Score=281.78  Aligned_cols=239  Identities=23%  Similarity=0.343  Sum_probs=190.9

Q ss_pred             cccccceEEEEEEec-CCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          378 LGKGTFGTAYKAVLE-MGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       378 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      ||+|+||.||++... +|+.+|+|.+.....    ....+.+|++++++++|+|++++++.+......++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999965 599999999875432    345788899999999999999999999998999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC------
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS------  526 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~------  526 (663)
                      .+++....     .+++..+..++.|++.||.|||+.+  ++||||+|+||++++++.++|+|||++.......      
T Consensus        81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            99997532     5899999999999999999999998  9999999999999999999999999987643321      


Q ss_pred             ------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          527 ------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       527 ------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                            ...++..|+|||.......+.++||||||++++|+++|+.||....      .............     .   
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~~~-----~---  219 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET------PEEIFQNILNGKI-----E---  219 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhcCCc-----C---
Confidence                  1224556999999988888999999999999999999999996432      1222222211110     0   


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                        ..........+.+++.+|+..+|++|||+.++.+.|+
T Consensus       220 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         220 --WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             --CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence              0001112456788899999999999999955555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=321.76  Aligned_cols=241  Identities=27%  Similarity=0.377  Sum_probs=193.0

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      +..||.|.||.||.|. ..+|...|||.++-..   ..-+...+|+.++..++|||+|+++|+=.+++..++.||||++|
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            5689999999999999 7789999999876432   22356889999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----  526 (663)
                      +|.+++...+     ..++.....+..|++.|++|||++|  ||||||||.||+++.+|.+|++|||.|.......    
T Consensus      1320 sLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1320 SLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred             cHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence            9999997543     3567777788899999999999999  9999999999999999999999999998765542    


Q ss_pred             ----CCCCCccccCccccCCC---CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          527 ----TPNRVAGYRAPEVTDPC---KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       527 ----~~~~~~~y~aPE~~~~~---~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                          ...||+-|||||++.+.   +...++||||+|||+.||+||+.||....++     ...+-.+-...         
T Consensus      1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-----~aIMy~V~~gh--------- 1458 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-----WAIMYHVAAGH--------- 1458 (1509)
T ss_pred             HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-----hHHHhHHhccC---------
Confidence                13477889999999663   4566789999999999999999999754321     11111111111         


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                        .++.++....+-.+++.+|+..||++|.++.|++++-
T Consensus      1459 --~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1459 --KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             --CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence              1122233444556777799999999999999888753

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-33  Score=310.82  Aligned_cols=257  Identities=18%  Similarity=0.181  Sum_probs=178.8

Q ss_pred             hcccccccceEEEEEEecC--CcEEEEE------------------EecCcccCHHHHHHHHHHhhcCCCCCcccceEEE
Q 006055          375 AEVLGKGTFGTAYKAVLEM--GTIVAVK------------------RLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY  434 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~--g~~vavK------------------~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  434 (663)
                      .+.||+|+||+||++..+.  +..+++|                  .++........+.+|+++++.++|+||+++++++
T Consensus       153 i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  232 (501)
T PHA03210        153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEIL  232 (501)
T ss_pred             EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEEE
Confidence            4689999999999987432  2222222                  1111122235678999999999999999999999


Q ss_pred             EecCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEe
Q 006055          435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVS  514 (663)
Q Consensus       435 ~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~  514 (663)
                      ...+..++|+|++. ++|.+++..................|+.|++.||.|||+++  |+||||||+|||++.++.+||+
T Consensus       233 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~~~~vkL~  309 (501)
T PHA03210        233 RSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCDGKIVLG  309 (501)
T ss_pred             EECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEE
Confidence            99999999999986 47777765432111122345567789999999999999998  9999999999999999999999


Q ss_pred             ccccccccCCCC-----CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh
Q 006055          515 DFGLAHLVGPSS-----TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD  589 (663)
Q Consensus       515 Dfg~a~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  589 (663)
                      |||+++......     ...++..|+|||++.+..++.++|||||||++|||++|..++.....   .+....+..++..
T Consensus       310 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~---~~~~~~~~~~~~~  386 (501)
T PHA03210        310 DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG---GKPGKQLLKIIDS  386 (501)
T ss_pred             eCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCC---CCHHHHHHHHHHh
Confidence            999998765432     23467789999999999999999999999999999998764432111   1111111111110


Q ss_pred             c--ccccccchh-----------hh-cccChH------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          590 E--WTSEVFDLE-----------LL-RYQNVE------EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       590 ~--~~~~~~d~~-----------~~-~~~~~~------~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .  ...++.+..           .. ......      ....++.+++.+|+..||++|||+.|++++
T Consensus       387 ~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        387 LSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             cccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            0  000000000           00 000000      112356777889999999999999999975

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.4e-33  Score=288.79  Aligned_cols=243  Identities=24%  Similarity=0.389  Sum_probs=186.8

Q ss_pred             hhcccccccceEEEEEEecC-CcEEEEEEecCccc--CHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCC
Q 006055          374 SAEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTI--SEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       374 ~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      ..+.||+|+||.||+|...+ ++.||||.++....  ....+..|+..+.+. .|+||+++++++.+....++||||+.+
T Consensus        19 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   98 (296)
T cd06618          19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST   98 (296)
T ss_pred             eeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc
Confidence            35789999999999999654 89999999975432  234566677766666 599999999999999999999999864


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ-GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-  527 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  527 (663)
                       ++.+++....    ..+++..+..++.+++.|+.|||+. +  |+||||+|+||++++++.+||+|||++........ 
T Consensus        99 -~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~  171 (296)
T cd06618          99 -CLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK  171 (296)
T ss_pred             -CHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccchhccCCCcc
Confidence             7777765422    2589999999999999999999974 6  99999999999999999999999999876543222 


Q ss_pred             --CCCCccccCccccCCCC----CCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhh
Q 006055          528 --PNRVAGYRAPEVTDPCK----VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL  601 (663)
Q Consensus       528 --~~~~~~y~aPE~~~~~~----~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  601 (663)
                        ..++..|+|||++.+..    ++.++||||||+++|||++|+.||.....     .............. .       
T Consensus       172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~-~-------  238 (296)
T cd06618         172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-----EFEVLTKILQEEPP-S-------  238 (296)
T ss_pred             cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-----HHHHHHHHhcCCCC-C-------
Confidence              23456799999987654    78899999999999999999999964211     11122222221110 0       


Q ss_pred             cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       602 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                       .........++.+++.+|+..||++||++++++++
T Consensus       239 -~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         239 -LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             00011233467888999999999999999999876

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.3e-33  Score=286.07  Aligned_cols=252  Identities=25%  Similarity=0.322  Sum_probs=191.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|++|.||+|.. .+|+.||||.++...  .....+.+|+++++.++|+|++++++++.+.+..++||||+++ +
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~   83 (284)
T cd07836           5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D   83 (284)
T ss_pred             eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence            36799999999999996 468999999987542  2345677899999999999999999999999999999999985 8


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----C
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----T  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~  527 (663)
                      |.+++.....  ...+++..+..++.|++.||.|||+.+  ++||||||+||++++++.++|+|||+++......    .
T Consensus        84 l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (284)
T cd07836          84 LKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN  159 (284)
T ss_pred             HHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence            8888764331  245899999999999999999999998  9999999999999999999999999997654321    2


Q ss_pred             CCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc------cc-----cc
Q 006055          528 PNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW------TS-----EV  595 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~-----~~  595 (663)
                      ..++..|++||.+.+. .++.++||||||+++|+|++|+.||......      .....+.....      ..     ..
T Consensus       160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE------DQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHHHhCCCChhhHHHHhcCch
Confidence            2346679999988654 5688999999999999999999999753221      11111111000      00     00


Q ss_pred             cchhhhc------ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          596 FDLELLR------YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       596 ~d~~~~~------~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .......      ..........+.+++.+|++.||.+||+++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0000000      00011224567889999999999999999999863

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.4e-32  Score=277.56  Aligned_cols=240  Identities=26%  Similarity=0.373  Sum_probs=196.6

Q ss_pred             cccccccceEEEEEEec-CCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEec--CccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSM--DEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ey~~~  449 (663)
                      +.||+|++|.||+|... +++.|++|.+....   ...+.+.+|++.+++++|+||+++++.+...  ...++|+||+++
T Consensus         6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~   85 (260)
T cd06606           6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG   85 (260)
T ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCC
Confidence            67999999999999965 79999999987654   2356788999999999999999999999888  789999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC--
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST--  527 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--  527 (663)
                      ++|.+++....     .+++..+..++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+|||.+........  
T Consensus        86 ~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          86 GSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence            99999997532     5899999999999999999999998  99999999999999999999999999987655432  


Q ss_pred             ----CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          528 ----PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       528 ----~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                          ..++..|+|||...+...+.++||||||+++++|++|..||....     +....+.........          .
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~----------~  223 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEP----------P  223 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCC----------c
Confidence                335567999999988889999999999999999999999997533     111111111110000          0


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ..+......+.+++.+|+..+|++||++.|++++
T Consensus       224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            1112224578888999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.8e-33  Score=289.44  Aligned_cols=252  Identities=23%  Similarity=0.289  Sum_probs=184.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecCc--------cEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDE--------KLL  442 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--------~~l  442 (663)
                      .+.||+|+||.||+|.. .+++.||||.+....   .....+.+|++++++++||||+++++++...+.        .++
T Consensus        17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l   96 (310)
T cd07865          17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL   96 (310)
T ss_pred             EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence            36799999999999995 468999999886432   223456789999999999999999999876544        399


Q ss_pred             EEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccccc
Q 006055          443 VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV  522 (663)
Q Consensus       443 v~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~  522 (663)
                      ||||+.+ +|.+++....    ..+++.....++.|++.||.|||+.+  ++|+||||+||+++.++.+||+|||++...
T Consensus        97 v~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          97 VFEFCEH-DLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             EEcCCCc-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence            9999975 8888876432    24899999999999999999999998  999999999999999999999999999765


Q ss_pred             CCCCC--------CCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccc
Q 006055          523 GPSST--------PNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTS  593 (663)
Q Consensus       523 ~~~~~--------~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (663)
                      .....        ..++..|+|||++.+. .++.++||||||+++|||++|+.||......   .....+..... ....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~---~~~~~~~~~~~-~~~~  245 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ---HQLTLISQLCG-SITP  245 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhC-CCCh
Confidence            43211        1234569999988664 3688999999999999999999998653211   11111111110 0000


Q ss_pred             ccc----chh------hhcc--cChH------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          594 EVF----DLE------LLRY--QNVE------EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       594 ~~~----d~~------~~~~--~~~~------~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ++.    +..      ....  ....      .....+.+++.+|+..||++|||++|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            000    000      0000  0000      012356789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-34  Score=286.05  Aligned_cols=238  Identities=23%  Similarity=0.276  Sum_probs=191.1

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCc----ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV----TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      ..+||+|+||.||-.. -.+|+.+|.|++.+.    ...+.....|-.++.+++.+.||.+--.|...+..++|+..|.+
T Consensus       190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG  269 (591)
T KOG0986|consen  190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG  269 (591)
T ss_pred             eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence            3589999999999988 456999999988654    33456678899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC--
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST--  527 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--  527 (663)
                      |+|.-++....   ...+++...+.++.+|+.||++||+.+  |++|||||+|||+|+.|+++|+|.|+|..+.....  
T Consensus       270 GDLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~  344 (591)
T KOG0986|consen  270 GDLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR  344 (591)
T ss_pred             CceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEecCCCCccc
Confidence            99998886543   345899999999999999999999998  99999999999999999999999999998876543  


Q ss_pred             -CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          528 -PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       528 -~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                       ..||.||||||++++..|+...|.||+||++|||+.|+.||..-.+..  +-.+.-+.+..+        +    ....
T Consensus       345 ~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--k~eEvdrr~~~~--------~----~ey~  410 (591)
T KOG0986|consen  345 GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--KREEVDRRTLED--------P----EEYS  410 (591)
T ss_pred             cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh--hHHHHHHHHhcc--------h----hhcc
Confidence             368999999999999999999999999999999999999997643221  000111111111        0    0112


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSM  631 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~  631 (663)
                      +....+..++....+.+||++|.--
T Consensus       411 ~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  411 DKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             cccCHHHHHHHHHHHccCHHHhccC
Confidence            2334455566667889999998643

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.2e-32  Score=277.93  Aligned_cols=243  Identities=24%  Similarity=0.344  Sum_probs=196.9

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .++||+|+||.||++. ..+++.+|+|.+.....   ....+.+|+++++.++|+||+++++++.+....++||||++++
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (256)
T cd08530           5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG   84 (256)
T ss_pred             eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCC
Confidence            3679999999999998 45789999999875432   2346778999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--CC
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--TP  528 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--~~  528 (663)
                      +|.+++.... .....+++..+..++.+++.||.|||+.+  ++|+||+|+||++++++.+||+|||+++......  ..
T Consensus        85 ~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~  161 (256)
T cd08530          85 DLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ  161 (256)
T ss_pred             CHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccCCcccc
Confidence            9999986532 12345899999999999999999999998  9999999999999999999999999998765442  22


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .++..|+|||...+..++.++|+||||++++||++|+.||....      .......+.... ..          .....
T Consensus       162 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~~-~~----------~~~~~  224 (256)
T cd08530         162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS------MQDLRYKVQRGK-YP----------PIPPI  224 (256)
T ss_pred             cCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhcCC-CC----------CCchh
Confidence            35667999999998888999999999999999999999996432      111111111111 00          11123


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...++.+++.+|+..+|++||++.|++++
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         225 YSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             hCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            44578899999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-34  Score=270.19  Aligned_cols=246  Identities=23%  Similarity=0.311  Sum_probs=193.8

Q ss_pred             HHhhcccccccceEEEEEE-ecCCcEEEEEEecCcccCHHHHHHHHHHhh-cCCCCCcccceEEEEe----cCccEEEEE
Q 006055          372 RASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVG-AVNHENLVPLRAYYYS----MDEKLLVYD  445 (663)
Q Consensus       372 ~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~----~~~~~lv~e  445 (663)
                      ....++||-|-.|.|-... ..+|+++|+|++.+..    ...+|++.-- .-.|||||.++++|.+    ..-+++|||
T Consensus        64 ~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE  139 (400)
T KOG0604|consen   64 SISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME  139 (400)
T ss_pred             eehhhhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence            3345799999999999887 5679999999987643    3456666533 3379999999998754    344689999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC---CCceEEecccccccc
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK---SYEARVSDFGLAHLV  522 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~---~~~~kl~Dfg~a~~~  522 (663)
                      .|++|.|.+.++...   ...+++..+..|..||+.|+.|||+..  |.||||||+|+|...   |..+||+|||+|+..
T Consensus       140 ~meGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t  214 (400)
T KOG0604|consen  140 CMEGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET  214 (400)
T ss_pred             cccchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEeccccccccc
Confidence            999999999998654   567999999999999999999999998  999999999999964   446899999999877


Q ss_pred             CCC---CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          523 GPS---STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       523 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                      ...   .+...|+.|.|||++...+|+...|+||+||++|-|+.|.+||+...   +..+..-++..+..+.    ++..
T Consensus       215 ~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h---g~aispgMk~rI~~gq----y~FP  287 (400)
T KOG0604|consen  215 QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---GLAISPGMKRRIRTGQ----YEFP  287 (400)
T ss_pred             CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC---CccCChhHHhHhhccC----ccCC
Confidence            643   23457888999999999999999999999999999999999998643   3333333443333332    1111


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      .   ++-...+++..++++..+..+|.+|.|++|++.
T Consensus       288 ~---pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  288 E---PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             C---hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            1   122334556667788999999999999999998

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-32  Score=281.95  Aligned_cols=249  Identities=22%  Similarity=0.305  Sum_probs=192.9

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      +.||+|++|.||++.. .+|+.+|+|.+.....   ....+.+|++++++++|+||+++++++......++|+||+++ +
T Consensus         5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~   83 (283)
T cd05118           5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D   83 (283)
T ss_pred             eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence            5799999999999985 5789999999876533   246788899999999999999999999999999999999975 8


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----C
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----T  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~  527 (663)
                      +.+++....    ..+++..+..++.+++.||.|||+.+  |+|+||||+||++++++.++|+|||.+.......    .
T Consensus        84 l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~  157 (283)
T cd05118          84 LYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH  157 (283)
T ss_pred             HHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence            888886532    35899999999999999999999998  9999999999999999999999999997765543    1


Q ss_pred             CCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHh---hcc---cccccc---
Q 006055          528 PNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK---DEW---TSEVFD---  597 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~---~~~~~d---  597 (663)
                      ..++..|+|||.+.+. .++.++||||||+++|+|++|+.||......      ..+..+..   ...   .....+   
T Consensus       158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI------DQLFKIFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHcCCCchHhcccchhhhh
Confidence            2345569999998776 7889999999999999999999998643211      11111110   000   000000   


Q ss_pred             ---hhhhc------ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          598 ---LELLR------YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       598 ---~~~~~------~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                         .....      .........++.+++.+|+..||.+||++++++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence               00000      00112345678899999999999999999999873

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-32  Score=282.04  Aligned_cols=248  Identities=24%  Similarity=0.330  Sum_probs=190.8

Q ss_pred             cccccccceEEEEEEec-CCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEec--CccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSM--DEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ey~~~  449 (663)
                      +.||+|+||.||+|... +|+.+|+|++....   .....+.+|+++++.++|+|++++++++.+.  ...++||||+++
T Consensus         5 ~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~   84 (287)
T cd07840           5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH   84 (287)
T ss_pred             EEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc
Confidence            57999999999999955 58999999997652   2245688999999999999999999999887  789999999985


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                       +|.+++....    ..+++..+..++.+++.||+|||+.+  ++|+||||+||++++++.+||+|||++.......   
T Consensus        85 -~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          85 -DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             -cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence             8988886532    35899999999999999999999998  9999999999999999999999999998765442   


Q ss_pred             --CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh---cccc---cccc
Q 006055          527 --TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD---EWTS---EVFD  597 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~---~~~d  597 (663)
                        ....+..|+|||.+.+ ..++.++||||||++++||++|+.||.....      ...+..+...   ....   ...+
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE------LEQLEKIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhCCCchhhcccccc
Confidence              1224556999998764 4578899999999999999999999965321      1111111110   0000   0000


Q ss_pred             -------------hhhhcccChHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          598 -------------LELLRYQNVEE-EMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       598 -------------~~~~~~~~~~~-~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                                   ..... ..... +...+.+++.+|+..+|++||++++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         232 LPWFENLKPKKPYKRRLR-EFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             chhhhhccccccchhHHH-HHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                         00000 00011 25678899999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9e-33  Score=309.56  Aligned_cols=257  Identities=26%  Similarity=0.383  Sum_probs=205.9

Q ss_pred             cCHHHHHHHhhcccccccceEEEEEEec----C----CcEEEEEEecCccc--CHHHHHHHHHHhhcC-CCCCcccceEE
Q 006055          365 FDLEDLLRASAEVLGKGTFGTAYKAVLE----M----GTIVAVKRLKDVTI--SEREFKDKIEGVGAV-NHENLVPLRAY  433 (663)
Q Consensus       365 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~----~----g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~  433 (663)
                      ++.+.+  ...+.||+|.||.|++|...    .    ...||||.++....  ..+.+..|+++|+.+ +|+|++.++|+
T Consensus       293 ~~~~~l--~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  293 IPRENL--KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             echhhc--cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            344444  34559999999999999832    1    45799999987643  357899999999998 69999999999


Q ss_pred             EEecCccEEEEEccCCCChhHhhccCC---CCC------C--CCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCC
Q 006055          434 YYSMDEKLLVYDYLTMGSLSALLHGNK---GAG------R--TPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSN  502 (663)
Q Consensus       434 ~~~~~~~~lv~ey~~~gsL~~~l~~~~---~~~------~--~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~N  502 (663)
                      |......++|+||+..|+|.++++..+   ...      .  ..+.....+.++.|||.|++||++..  ++||||..+|
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRN  448 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARN  448 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhh
Confidence            999899999999999999999998765   111      1  24889999999999999999999997  9999999999


Q ss_pred             EEEcCCCceEEeccccccccCCCCCC--CC-----CccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCC
Q 006055          503 ILLTKSYEARVSDFGLAHLVGPSSTP--NR-----VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNE  574 (663)
Q Consensus       503 ill~~~~~~kl~Dfg~a~~~~~~~~~--~~-----~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~  574 (663)
                      ||++++..+||+|||+|+...+....  .+     ...|||||.+....++.|+|||||||++||++| |..||.+... 
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-  527 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-  527 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-
Confidence            99999999999999999976554322  11     234999999999999999999999999999999 8888864210 


Q ss_pred             CCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          575 EGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                          ....++ .++++.          +...+..+..++.++++.||+.+|++||++.|+++.++..
T Consensus       528 ----~~~l~~-~l~~G~----------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  528 ----TEELLE-FLKEGN----------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             ----HHHHHH-HHhcCC----------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence                111111 233322          1223445567888999999999999999999999999885

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-32  Score=280.30  Aligned_cols=251  Identities=23%  Similarity=0.274  Sum_probs=189.7

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccC---HHHHHHHHHHhhcC---CCCCcccceEEEEecCc-----cEE
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTIS---EREFKDKIEGVGAV---NHENLVPLRAYYYSMDE-----KLL  442 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----~~l  442 (663)
                      .+.||+|+||.||+|+.+ +++.||+|+++.....   ...+.+|+.++.++   +|+|++++++++...+.     .++
T Consensus         4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l   83 (287)
T cd07838           4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL   83 (287)
T ss_pred             EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence            367999999999999965 4899999998744222   34566777766555   69999999999988776     899


Q ss_pred             EEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccccc
Q 006055          443 VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV  522 (663)
Q Consensus       443 v~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~  522 (663)
                      +|||+.+ +|.+++....   ...+++..+..++.|++.||.|||+.+  ++|+||+|+||++++++.+||+|||.+...
T Consensus        84 ~~e~~~~-~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          84 VFEHVDQ-DLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             Eehhccc-CHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCcceec
Confidence            9999975 8988887543   235899999999999999999999998  999999999999999999999999999776


Q ss_pred             CCCCC---CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc-------c
Q 006055          523 GPSST---PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW-------T  592 (663)
Q Consensus       523 ~~~~~---~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~  592 (663)
                      .....   ..++..|+|||++.+..++.++|||||||++|||++|+.||.....      ......+.....       .
T Consensus       158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07838         158 SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE------ADQLDKIFDVIGLPSEEEWP  231 (287)
T ss_pred             cCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh------HHHHHHHHHHcCCCChHhcC
Confidence            54322   2245669999999988899999999999999999999999875322      122222221100       0


Q ss_pred             cccc-chh-hhc--c----cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          593 SEVF-DLE-LLR--Y----QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       593 ~~~~-d~~-~~~--~----~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .... ... ...  .    ....+....+.+++.+|+..||++||+++|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            0000 000 000  0    0012234567889999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.1e-32  Score=284.69  Aligned_cols=246  Identities=15%  Similarity=0.216  Sum_probs=174.2

Q ss_pred             hcccccccceEEEEEEecC----CcEEEEEEecCcccC---H---------HHHHHHHHHhhcCCCCCcccceEEEEecC
Q 006055          375 AEVLGKGTFGTAYKAVLEM----GTIVAVKRLKDVTIS---E---------REFKDKIEGVGAVNHENLVPLRAYYYSMD  438 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~---~---------~~~~~e~~~l~~l~h~niv~l~~~~~~~~  438 (663)
                      .++||+|+||.||+|...+    +..+|+|........   +         .....+...+..+.|+|++++++++....
T Consensus        17 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~   96 (294)
T PHA02882         17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKR   96 (294)
T ss_pred             eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEec
Confidence            4679999999999999654    345666653221110   1         11223334456779999999999766543


Q ss_pred             ----ccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEe
Q 006055          439 ----EKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVS  514 (663)
Q Consensus       439 ----~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~  514 (663)
                          ..++++|++.. ++.+.+....     ..++.....|+.|++.||+|||+.+  |+||||||+|||++.++.++|+
T Consensus        97 ~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~~~~~l~  168 (294)
T PHA02882         97 CRMYYRFILLEKLVE-NTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGNNRGYII  168 (294)
T ss_pred             CCceEEEEEEehhcc-CHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCcEEEE
Confidence                23677777654 6666654321     2567888999999999999999998  9999999999999999999999


Q ss_pred             ccccccccCCCC-----------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHH
Q 006055          515 DFGLAHLVGPSS-----------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWV  583 (663)
Q Consensus       515 Dfg~a~~~~~~~-----------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~  583 (663)
                      |||+++......           ...++..|+|||++.+..++.++|||||||+++||++|+.||.......  ......
T Consensus       169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~~~~~~  246 (294)
T PHA02882        169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--NLIHAA  246 (294)
T ss_pred             EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--HHHHHh
Confidence            999997653211           1236777999999999999999999999999999999999997642211  111100


Q ss_pred             HHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          584 QSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       584 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      .    ......+.....    ........+.+++..|+..+|++||+++++++.+
T Consensus       247 ~----~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        247 K----CDFIKRLHEGKI----KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             H----HHHHHHhhhhhh----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            0    000011110100    1112345688888999999999999999999876

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.9e-33  Score=293.07  Aligned_cols=260  Identities=21%  Similarity=0.328  Sum_probs=192.5

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCc---ccCHHHHHHHHHHhhcCCCCCcccceEEEEec-----CccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV---TISEREFKDKIEGVGAVNHENLVPLRAYYYSM-----DEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e  445 (663)
                      .+.||+|+||+||+|. ..+++.||||.+...   ......+.+|+.+++.++|+||+++++++...     ...++|||
T Consensus        10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e   89 (337)
T cd07858          10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE   89 (337)
T ss_pred             EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence            3579999999999998 457899999998653   22345677899999999999999999987644     34799999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+. ++|.+++...     ..+++.....++.|++.||.|||+.+  ++||||||+||+++.++.+||+|||+++.....
T Consensus        90 ~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          90 LMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             CCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            996 6898888643     24899999999999999999999998  999999999999999999999999999866433


Q ss_pred             C----CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc---cccccc
Q 006055          526 S----TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW---TSEVFD  597 (663)
Q Consensus       526 ~----~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d  597 (663)
                      .    ...++..|+|||.+.. ..++.++|||||||++|+|++|+.||.....   ...............   ...+.+
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY---VHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCChHHhhhcCc
Confidence            1    2235567999998764 4688999999999999999999999964311   000110111000000   000000


Q ss_pred             hhh-------hc--cc----ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhCCCC
Q 006055          598 LEL-------LR--YQ----NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR--IEELHPSS  645 (663)
Q Consensus       598 ~~~-------~~--~~----~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~--L~~~~~~~  645 (663)
                      ...       ..  ..    .......++.+++.+|+..+|++|||++|++++  ++.+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~  301 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS  301 (337)
T ss_pred             hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence            000       00  00    011234567899999999999999999999998  66665443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.8e-33  Score=289.53  Aligned_cols=250  Identities=26%  Similarity=0.323  Sum_probs=187.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEec--CccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSM--DEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|.. .+|+.||+|.++.....   ...+.+|+.++++++|+|++++++++.+.  +..++||||+.
T Consensus        12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   91 (309)
T cd07845          12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE   91 (309)
T ss_pred             eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence            36799999999999995 56999999998644221   33567899999999999999999998765  45799999997


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-  527 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  527 (663)
                      + +|.+++....    ..+++..+..++.|++.||.|||+.+  ++||||||+||++++++.+||+|||++........ 
T Consensus        92 ~-~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~  164 (309)
T cd07845          92 Q-DLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP  164 (309)
T ss_pred             C-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence            5 8888886432    35899999999999999999999998  99999999999999999999999999987654321 


Q ss_pred             ---CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc------cc----
Q 006055          528 ---PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW------TS----  593 (663)
Q Consensus       528 ---~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~----  593 (663)
                         ...+..|+|||.+.+ ..++.++||||+||++|||++|+.||.....      ...+..+.....      ..    
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07845         165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE------IEQLDLIIQLLGTPNESIWPGFSD  238 (309)
T ss_pred             CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHhcCCCChhhchhhhc
Confidence               123556999999865 4578899999999999999999999964321      112221111000      00    


Q ss_pred             ----cccchhhhcccCh----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          594 ----EVFDLELLRYQNV----EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       594 ----~~~d~~~~~~~~~----~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                          ..+..........    ......+.+++.+|+..||++|||++|++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                0000000000000    1124566789999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.6e-33  Score=286.33  Aligned_cols=251  Identities=22%  Similarity=0.280  Sum_probs=186.7

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|++|.||+|.. .+|+.||+|.+.....   ..+.+.+|++++++++|+|++++++++.+....++||||++ +
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~   85 (294)
T PLN00009          7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-L   85 (294)
T ss_pred             EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-c
Confidence            35799999999999995 4789999999865422   23568899999999999999999999999999999999996 4


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC-CCceEEeccccccccCCCC---
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK-SYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      +|.+++....   ...+++.....++.||+.||+|||+.+  ++||||+|+||+++. ++.+||+|||++.......   
T Consensus        86 ~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~  160 (294)
T PLN00009         86 DLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF  160 (294)
T ss_pred             cHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence            8888775432   234678888899999999999999998  999999999999985 5579999999997654321   


Q ss_pred             -CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh--cccccc-------
Q 006055          527 -TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD--EWTSEV-------  595 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-------  595 (663)
                       ...++..|+|||++.+ ..++.++||||||+++|+|++|+.||......      ..+......  ......       
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI------DELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCCChhhccccccc
Confidence             2234567999998865 45788999999999999999999999653211      111111100  000000       


Q ss_pred             cchh--hhc--ccC----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          596 FDLE--LLR--YQN----VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       596 ~d~~--~~~--~~~----~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .+..  ...  ...    ......++.+++.+|+..+|++||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000  000  000    01123457889999999999999999999973

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-32  Score=274.98  Aligned_cols=238  Identities=28%  Similarity=0.461  Sum_probs=194.5

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|++|.||++... +++.||+|.+.....   ....+.+|++++.+++|+|++++++++.+....++||||++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (254)
T cd06627           5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG   84 (254)
T ss_pred             eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence            468999999999999854 688999999976643   3457899999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC---
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST---  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~---  527 (663)
                      +|.+++...     ..+++..+..++.+++.||.|||+.+  |+||||||+||+++.++.++|+|||.+........   
T Consensus        85 ~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (254)
T cd06627          85 SLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA  157 (254)
T ss_pred             cHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence            999998753     35899999999999999999999998  99999999999999999999999999987655432   


Q ss_pred             -CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          528 -PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       528 -~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                       ..++..|+|||...+..++.++||||+|+++++|++|+.||.....     ..... .......           ....
T Consensus       158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~-~~~~~~~-----------~~~~  220 (254)
T cd06627         158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALF-RIVQDDH-----------PPLP  220 (254)
T ss_pred             ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHH-HHhccCC-----------CCCC
Confidence             2356679999999888888999999999999999999999864321     11111 1111100           0011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      ......+.+++.+|+..+|++||++.|++.
T Consensus       221 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         221 EGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            122346778889999999999999999986

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.5e-33  Score=268.42  Aligned_cols=261  Identities=23%  Similarity=0.281  Sum_probs=193.0

Q ss_pred             hcccccccceEEEEEEec---C--CcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEe-cCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLE---M--GTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYS-MDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~---~--g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  445 (663)
                      ...||+|+||.||+|.-.   +  ...+|+|+++.....   .....+|+..++.++|||++.+..++.+ +...+++||
T Consensus        29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fd  108 (438)
T KOG0666|consen   29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFD  108 (438)
T ss_pred             cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEeh
Confidence            467999999999999622   2  237999999865221   2456789999999999999999999877 677899999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC----CceEEeccccccc
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS----YEARVSDFGLAHL  521 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~----~~~kl~Dfg~a~~  521 (663)
                      |.+. +|..+++-........++-.+...|..||+.|+.|||+.-  |+||||||.|||+..+    |.+||+|+|+++.
T Consensus       109 YAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~  185 (438)
T KOG0666|consen  109 YAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADLGLARL  185 (438)
T ss_pred             hhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecccHHHH
Confidence            9998 9999987655544567899999999999999999999998  9999999999999888    8999999999998


Q ss_pred             cCCCC-------CCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCC---ChHHHHHHHHhh-
Q 006055          522 VGPSS-------TPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGV---DLPRWVQSIVKD-  589 (663)
Q Consensus       522 ~~~~~-------~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~-  589 (663)
                      +...-       ....|..|.|||.+.+. .|+...||||.||++.||+|-++-|......-..   --...+.+++.- 
T Consensus       186 ~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vL  265 (438)
T KOG0666|consen  186 FNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVL  265 (438)
T ss_pred             hhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHc
Confidence            76532       22346679999999875 5788899999999999999999888754221111   112223333221 


Q ss_pred             --cccccccchhh-------------hcccC--hHHH-------HHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          590 --EWTSEVFDLEL-------------LRYQN--VEEE-------MVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       590 --~~~~~~~d~~~-------------~~~~~--~~~~-------~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                        ....++.+...             .....  ....       ...-+++..+++..||.+|.|+++++++.
T Consensus       266 G~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  266 GTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             CCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence              00011111000             00000  0000       11256788899999999999999999864

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.4e-32  Score=289.37  Aligned_cols=251  Identities=25%  Similarity=0.299  Sum_probs=188.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCH---------------HHHHHHHHHhhcCCCCCcccceEEEEecC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISE---------------REFKDKIEGVGAVNHENLVPLRAYYYSMD  438 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---------------~~~~~e~~~l~~l~h~niv~l~~~~~~~~  438 (663)
                      .+.||+|+||+||+|.. .+++.||||.++......               ..+.+|+++++.++|+||+++++++...+
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            45799999999999994 469999999986542211               24778999999999999999999999999


Q ss_pred             ccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccc
Q 006055          439 EKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGL  518 (663)
Q Consensus       439 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~  518 (663)
                      ..++||||+. |+|.+++...     ..+++.....++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||.
T Consensus        94 ~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             cEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEECCccc
Confidence            9999999997 5999988643     24889999999999999999999998  99999999999999999999999999


Q ss_pred             ccccCCC------------------CCCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCCh
Q 006055          519 AHLVGPS------------------STPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDL  579 (663)
Q Consensus       519 a~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~  579 (663)
                      ++.....                  ....++..|+|||++.+. .++.++|||||||++|||++|+.||......+   .
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~---~  242 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---Q  242 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence            9765511                  011235569999998764 46889999999999999999999996532211   1


Q ss_pred             HHHHHHHHhhc----ccccccchhhh-----cccC----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          580 PRWVQSIVKDE----WTSEVFDLELL-----RYQN----VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       580 ~~~~~~~~~~~----~~~~~~d~~~~-----~~~~----~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      ...+.......    +......+...     ....    ......++.+++.+|++.+|++||+++|++.
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            11111111100    00000000000     0000    0112456788999999999999999999998

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.4e-32  Score=287.93  Aligned_cols=255  Identities=23%  Similarity=0.357  Sum_probs=188.4

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCc---ccCHHHHHHHHHHhhcC-CCCCcccceEEEEec--CccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDV---TISEREFKDKIEGVGAV-NHENLVPLRAYYYSM--DEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~~lv~ey~  447 (663)
                      .+.||+|+||.||+|... +|+.+|||++...   ......+.+|+.++.++ +|+||+++++++...  ...++||||+
T Consensus        12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~   91 (337)
T cd07852          12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM   91 (337)
T ss_pred             hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence            467999999999999954 6899999988643   12234577899999999 999999999998654  3579999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST  527 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  527 (663)
                      + ++|.+++...      .++|..+..++.||+.||.|||+.+  |+||||||+||+++.++.+||+|||+++.......
T Consensus        92 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          92 E-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE  162 (337)
T ss_pred             c-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence            7 5999988642      4789999999999999999999998  99999999999999999999999999976543221


Q ss_pred             ---------CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHH----------
Q 006055          528 ---------PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIV----------  587 (663)
Q Consensus       528 ---------~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----------  587 (663)
                               ..++..|+|||++.+ ..++.++||||||+++|+|++|+.||......+   ....+....          
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN---QLEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHH
Confidence                     124567999998754 457889999999999999999999996432211   000000000          


Q ss_pred             -hhcccccccc----hhhhc-ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhh
Q 006055          588 -KDEWTSEVFD----LELLR-YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR--IEEL  641 (663)
Q Consensus       588 -~~~~~~~~~d----~~~~~-~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~--L~~~  641 (663)
                       .........+    ..... .........++.+++.+|+..+|++|||+.+++++  +..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence             0000000000    00000 00001134578899999999999999999999986  4444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.1e-33  Score=292.62  Aligned_cols=253  Identities=20%  Similarity=0.340  Sum_probs=188.1

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEe----cCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYS----MDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|. ..+|+.||+|++....   ...+.+.+|+.+++.++||||+++++++..    ....++||||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~   89 (334)
T cd07855          10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL   89 (334)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence            3579999999999999 4569999999987542   234567789999999999999999998753    3457999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      +. |+|.+++....     .+++..+..++.||+.||.|||+.+  |+||||||+||++++++.+||+|||++.......
T Consensus        90 ~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          90 ME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             hh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            96 58999886432     4899999999999999999999998  9999999999999999999999999997654321


Q ss_pred             --------CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHh---------
Q 006055          527 --------TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK---------  588 (663)
Q Consensus       527 --------~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------  588 (663)
                              ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......   ....+.....         
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~---~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH---QLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH---HHHHHHHHhCCChhHhhhh
Confidence                    1234566999999765 457899999999999999999999996532110   0000000000         


Q ss_pred             --hcccccccch-hhhcccC----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          589 --DEWTSEVFDL-ELLRYQN----VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       589 --~~~~~~~~d~-~~~~~~~----~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                        ........+. .......    ......++.+++.+|++.+|++||++++++.+-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence              0000000000 0000000    112346788999999999999999999999854

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.4e-32  Score=288.59  Aligned_cols=253  Identities=23%  Similarity=0.314  Sum_probs=187.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEec------CccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSM------DEKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~  444 (663)
                      .+.||+|+||.||+|.. .+|+.||+|.+....   .....+.+|+.++++++|+||+++++++...      ...++||
T Consensus        21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~  100 (353)
T cd07850          21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM  100 (353)
T ss_pred             EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence            36799999999999994 579999999986532   2234677899999999999999999988643      3469999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+.+ +|.+.+..       .+++.....++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||+++....
T Consensus       101 e~~~~-~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850         101 ELMDA-NLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             eccCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            99965 88888753       2788889999999999999999998  99999999999999999999999999987654


Q ss_pred             CCC---CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCC---------CCChHHHHH-------H
Q 006055          525 SST---PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEE---------GVDLPRWVQ-------S  585 (663)
Q Consensus       525 ~~~---~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~---------~~~~~~~~~-------~  585 (663)
                      ...   ..++..|+|||.+.+..++.++|||||||++|+|++|+.||.......         +.....+..       .
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (353)
T cd07850         171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN  250 (353)
T ss_pred             CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence            322   235667999999999899999999999999999999999996432100         000000000       0


Q ss_pred             HHhhcccc------cccchhhhc---ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          586 IVKDEWTS------EVFDLELLR---YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       586 ~~~~~~~~------~~~d~~~~~---~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ........      ..+......   .........++.+++.+|+..||++|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000000      000000000   00011234567899999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.8e-32  Score=274.29  Aligned_cols=242  Identities=23%  Similarity=0.363  Sum_probs=197.2

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      +.||+|+||.||++.. .++..||+|++.....   ..+.+.+|++.++.++|+|++++++.+......++|+||+++++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~   85 (258)
T cd08215           6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGD   85 (258)
T ss_pred             eeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCc
Confidence            5799999999999995 4689999999876532   35678899999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----C
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----T  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~  527 (663)
                      |.+++..... ....+++..+..++.+++.||.|||+.+  ++|+||+|+||++++++.++|+|||.+.......    .
T Consensus        86 L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  162 (258)
T cd08215          86 LSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT  162 (258)
T ss_pred             HHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCcceecc
Confidence            9999976421 1246899999999999999999999998  9999999999999999999999999997765442    1


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..++..|+|||...+..++.++|+||+|+++++|++|+.||....      ............. ..          .+.
T Consensus       163 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~~~-~~----------~~~  225 (258)
T cd08215         163 VVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKILKGQY-PP----------IPS  225 (258)
T ss_pred             eeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHhcCCC-CC----------CCC
Confidence            234566999999988889999999999999999999999986432      2222222222111 00          011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .....+.+++.+|+..+|++|||+.|++++
T Consensus       226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         226 QYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            233467888999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-32  Score=279.92  Aligned_cols=257  Identities=24%  Similarity=0.366  Sum_probs=190.9

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCccc--CHHHHHHHHHHhhcCC-CCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|++|+||+|... +++.||+|++.....  ......+|+..+.+++ |+|++++++++.+....++||||+ +|
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~   82 (283)
T cd07830           4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG   82 (283)
T ss_pred             heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence            367999999999999964 588999999876533  2334567889999998 999999999999999999999999 78


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC---
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST---  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~---  527 (663)
                      +|.+++....   ...+++..+..++.|++.||.|||+.+  ++|+||+|+||++++++.++|+|||.++.......   
T Consensus        83 ~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          83 NLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             CHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence            9999887543   235899999999999999999999998  99999999999999999999999999987654322   


Q ss_pred             CCCCccccCccccC-CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCC----------CChHHHHHHHHhhccccccc
Q 006055          528 PNRVAGYRAPEVTD-PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEG----------VDLPRWVQSIVKDEWTSEVF  596 (663)
Q Consensus       528 ~~~~~~y~aPE~~~-~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~  596 (663)
                      ..++..|+|||++. ...++.++|+||||++++||++|+.||......+.          .....|.............+
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            23456799999874 45578899999999999999999999865321100          00000111110000000000


Q ss_pred             chhhhc--ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          597 DLELLR--YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       597 d~~~~~--~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ......  .........++.+++.+|+..+|++|||++|++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000000  00001113568899999999999999999999874

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.5e-32  Score=283.79  Aligned_cols=254  Identities=22%  Similarity=0.327  Sum_probs=189.2

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecC------ccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMD------EKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  444 (663)
                      .+.||+|+||.||+|.. .+|+.||||++.....   ....+.+|+.+++.++|+||+++++++....      ..++|+
T Consensus        20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   99 (342)
T cd07879          20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM   99 (342)
T ss_pred             EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence            46899999999999994 5799999999875422   2356789999999999999999999986543      358999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+.. +|.+++.       ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++....
T Consensus       100 e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~  169 (342)
T cd07879         100 PYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHADA  169 (342)
T ss_pred             ccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence            99975 7776653       24789999999999999999999998  99999999999999999999999999976543


Q ss_pred             CCC-CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc-c---------
Q 006055          525 SST-PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW-T---------  592 (663)
Q Consensus       525 ~~~-~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~---------  592 (663)
                      ... ..++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....      ...+..++.... .         
T Consensus       170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~  243 (342)
T cd07879         170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY------LDQLTQILKVTGVPGPEFVQKLE  243 (342)
T ss_pred             CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHhcCCCCHHHHHHhc
Confidence            322 234567999999866 4578899999999999999999999975321      111111111000 0         


Q ss_pred             ----ccccch-hhhcccC----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhCCC
Q 006055          593 ----SEVFDL-ELLRYQN----VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR--IEELHPS  644 (663)
Q Consensus       593 ----~~~~d~-~~~~~~~----~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~--L~~~~~~  644 (663)
                          ...+.. .......    ......++.+++.+|+..||++||+++|++.+  ++.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence                000000 0000000    01123457789999999999999999999976  7777654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=9e-33  Score=292.02  Aligned_cols=260  Identities=23%  Similarity=0.310  Sum_probs=194.1

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCc--ccCHHHHHHHHHHhhcCCCCCcccceEEEEec------CccEEEEEc
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV--TISEREFKDKIEGVGAVNHENLVPLRAYYYSM------DEKLLVYDY  446 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ey  446 (663)
                      +.||+|+||.||+++ ..+|+.||||.+...  ....+...+|++++++++|+|||++++.=.+.      ....+||||
T Consensus        19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEy   98 (732)
T KOG4250|consen   19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEY   98 (732)
T ss_pred             hhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEee
Confidence            579999999999999 678999999998764  23356678999999999999999999875443      356899999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc--CCCc--eEEecccccccc
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT--KSYE--ARVSDFGLAHLV  522 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~--~~~~--~kl~Dfg~a~~~  522 (663)
                      |.+|||+..|....  +...+++.+.+.+..+++.||.|||+++  |+||||||.||++-  .+|.  -||+|||.|+..
T Consensus        99 C~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   99 CSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             cCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            99999999998654  4567999999999999999999999998  99999999999983  3343  699999999999


Q ss_pred             CCCCC---CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccc--c
Q 006055          523 GPSST---PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV--F  596 (663)
Q Consensus       523 ~~~~~---~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  596 (663)
                      .++..   ..||..|.+||.... ..|+..+|.|||||++||.+||..||..........-..|.  +........+  .
T Consensus       175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~--~~tkkp~~v~i~~  252 (732)
T KOG4250|consen  175 DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH--IITKKPSGVAIGA  252 (732)
T ss_pred             CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh--hhccCCCceeEee
Confidence            87653   457888999999984 78899999999999999999999999765433221112221  1111111000  0


Q ss_pred             chhhh---------c--ccChHHHHHHHHHHHHHccCCCCCCCC--CHHHHHHHHHhh
Q 006055          597 DLELL---------R--YQNVEEEMVQLLQLAIDCSAQYPDNRP--SMSEVIKRIEEL  641 (663)
Q Consensus       597 d~~~~---------~--~~~~~~~~~~l~~l~~~C~~~dP~~RP--t~~ev~~~L~~~  641 (663)
                      +.+..         +  ..........+.+....++..+|++|.  ...+....+..|
T Consensus       253 ~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  253 QEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             ecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            11000         0  011123344556666677778888888  555555555443

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8e-32  Score=283.07  Aligned_cols=256  Identities=23%  Similarity=0.344  Sum_probs=196.2

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecC-----ccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMD-----EKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e  445 (663)
                      .+.||+|++|.||+|... +++.||+|++....   ...+.+.+|+++++.++|+||+++++++....     ..++|||
T Consensus         5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e   84 (330)
T cd07834           5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE   84 (330)
T ss_pred             eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence            367999999999999954 58999999987643   23467889999999999999999999987765     7899999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+++ +|.+++....     .+++..+..++.+++.||.|||+.+  |+||||||+||+++.++.++|+|||++......
T Consensus        85 ~~~~-~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          85 LMET-DLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             chhh-hHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            9984 8988886432     6899999999999999999999998  999999999999999999999999999876544


Q ss_pred             C-------CCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc--c---
Q 006055          526 S-------TPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW--T---  592 (663)
Q Consensus       526 ~-------~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~---  592 (663)
                      .       ...++..|+|||.+.+. .++.++||||||+++++|++|+.||.....      ......+.....  .   
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~  230 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY------IDQLNLIVEVLGTPSEED  230 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH------HHHHHHHHHhcCCCChhH
Confidence            2       12245569999999887 789999999999999999999999965321      111111111000  0   


Q ss_pred             ---------ccccch-hhhc----ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhCCC
Q 006055          593 ---------SEVFDL-ELLR----YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR--IEELHPS  644 (663)
Q Consensus       593 ---------~~~~d~-~~~~----~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~--L~~~~~~  644 (663)
                               ...+.. ....    ..........+.+++.+||+.+|++||++++++++  ++.+...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                     000000 0000    00011134567889999999999999999999996  6666554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.8e-32  Score=278.72  Aligned_cols=242  Identities=23%  Similarity=0.291  Sum_probs=189.0

Q ss_pred             hcccccccceEEEEEEe----cCCcEEEEEEecCcc-----cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVT-----ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  444 (663)
                      .+.||+|+||.||++..    .+|+.||+|++....     ...+.+.+|+.++..+ +|+||+++++++......++||
T Consensus         5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (290)
T cd05613           5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL   84 (290)
T ss_pred             eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence            36799999999999985    368999999987532     1245678899999999 5899999999998888899999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+++++|.+++....     .+++.....++.|++.||.|||+.+  ++||||||+||+++.++.+||+|||+++....
T Consensus        85 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          85 DYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            9999999999987532     4788899999999999999999998  99999999999999999999999999976543


Q ss_pred             CC-----CCCCCccccCccccCCC--CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          525 SS-----TPNRVAGYRAPEVTDPC--KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       525 ~~-----~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                      ..     ...++..|+|||.+...  .++.++||||||+++|+|++|+.||.....  ......+.........      
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~------  229 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE--KNSQAEISRRILKSEP------  229 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc--cccHHHHHHHhhccCC------
Confidence            22     12356679999998653  467899999999999999999999864221  1122222222222111      


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                            .........+.+++.+|+..+|++||     ++++++.+
T Consensus       230 ------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         230 ------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             ------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                  01112234677888899999999997     67777664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.1e-32  Score=283.40  Aligned_cols=254  Identities=24%  Similarity=0.349  Sum_probs=187.8

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEe-cCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYS-MDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|. ..+|+.||+|++....   ...+.+.+|++++..++|||++++++++.. ....++|+||+. 
T Consensus        15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~~-   93 (328)
T cd07856          15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLG-   93 (328)
T ss_pred             EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehhc-
Confidence            3689999999999998 4579999999886432   234678889999999999999999999866 456889999984 


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-CC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-TP  528 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~  528 (663)
                      ++|.++++..      .+++.....++.|++.||.|||+.+  |+||||+|+||++++++.++|+|||.+....... ..
T Consensus        94 ~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  165 (328)
T cd07856          94 TDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY  165 (328)
T ss_pred             cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCCCcCCC
Confidence            5899888642      3788888899999999999999998  9999999999999999999999999997654432 23


Q ss_pred             CCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCC---------CChHHHHHHHHhhcccccccch
Q 006055          529 NRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEG---------VDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       529 ~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                      .++..|+|||++.+ ..++.++||||||+++|+|++|+.||........         ....++................
T Consensus       166 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (328)
T cd07856         166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSL  245 (328)
T ss_pred             cccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhc
Confidence            35667999998765 5688999999999999999999999964321000         0001111111000000000000


Q ss_pred             hhhcccCh----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          599 ELLRYQNV----EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       599 ~~~~~~~~----~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ........    .....++.+++.+|+..+|++||++++++.+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         246 PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000    1123578889999999999999999999885

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-32  Score=273.31  Aligned_cols=239  Identities=20%  Similarity=0.268  Sum_probs=187.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc------cCHHHHHHHHHHhhcCCCCCcccceEEEEec--CccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT------ISEREFKDKIEGVGAVNHENLVPLRAYYYSM--DEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  445 (663)
                      .+.||+|+||.||+|.. .+++.||+|.+....      .....+.+|++++++++|+||+++++++.+.  ...++|+|
T Consensus         7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e   86 (264)
T cd06653           7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE   86 (264)
T ss_pred             eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence            46899999999999994 569999999875321      1234688899999999999999999998764  34789999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+++++|.+++....     .+++.....++.+++.||.|||+.+  ++|+||||+||+++.++.++|+|||+++.....
T Consensus        87 ~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          87 YMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTI  159 (264)
T ss_pred             eCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence            999999999987432     4788899999999999999999998  999999999999999999999999999765321


Q ss_pred             -------CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          526 -------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       526 -------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                             ....++..|+|||++.+...+.++|+|||||+++||++|+.||.....      ...+.........      
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~------  227 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAIFKIATQPTK------  227 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHHHHHHHcCCCC------
Confidence                   112356679999999988889999999999999999999999964211      1111111111100      


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                          ...+......+.+++.+|+. +|.+||+..+++.|
T Consensus       228 ----~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         228 ----PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             ----CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence                01122234567788889998 57999999988764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-32  Score=272.49  Aligned_cols=234  Identities=28%  Similarity=0.339  Sum_probs=190.2

Q ss_pred             cccccceEEEEEEec-CCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          378 LGKGTFGTAYKAVLE-MGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       378 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      ||+|+||.||++... +++.+|+|.+.....    ....+..|+++++.++|+|++++++.+......++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999954 589999999876532    235788999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----CCC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----STP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----~~~  528 (663)
                      .+++....     .+++.....++.|++.|+.|||+.+  ++|+||+|+||+++.++.++|+|||.+......    ...
T Consensus        81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (250)
T cd05123          81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF  153 (250)
T ss_pred             HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence            99997542     4899999999999999999999988  999999999999999999999999999776543    123


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .++..|+|||...+...+.++|+||||+++|+|++|+.||.....      ......+.....            .....
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~~------------~~~~~  215 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILKDPL------------RFPEF  215 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcCCC------------CCCCC
Confidence            356679999999888889999999999999999999999964321      222222222110            11111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCH---HHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSM---SEVIK  636 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~---~ev~~  636 (663)
                      ....+.+++.+|+..||++||++   +++.+
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence            23467888999999999999999   55543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.4e-32  Score=274.83  Aligned_cols=242  Identities=22%  Similarity=0.294  Sum_probs=188.9

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc------cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT------ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||+|+||.||++... .+..+++|.++...      .....+..|+.+++.++|||++++++++.+.+..++||||+
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (260)
T cd08222           5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYC   84 (260)
T ss_pred             eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeC
Confidence            367999999999999854 34556666655321      12345677899999999999999999999888999999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-  526 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-  526 (663)
                      ++++|.++++.... ....+++..++.++.|++.||.|||+.+  ++|+||||+||++++ +.++|+|||+++...... 
T Consensus        85 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~  160 (260)
T cd08222          85 EGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD  160 (260)
T ss_pred             CCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCCCcc
Confidence            99999998875321 2346899999999999999999999998  999999999999975 569999999987664332 


Q ss_pred             ---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          527 ---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       527 ---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                         ...++..|+|||...+..++.++|+||||+++++|++|..||...      ..............           .
T Consensus       161 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~-----------~  223 (260)
T cd08222         161 LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ------NFLSVVLRIVEGPT-----------P  223 (260)
T ss_pred             cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHHHHHcCCC-----------C
Confidence               233566799999998888889999999999999999999998532      12222222221110           0


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ........++.+++.+|+..+|++||++.|++++
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         224 SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            1112344578889999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.9e-33  Score=306.99  Aligned_cols=239  Identities=23%  Similarity=0.322  Sum_probs=176.5

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEec---------------
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSM---------------  437 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------------  437 (663)
                      ++||+||||.||+++. -||+.||||++.-..  .....+.+|+..+++|+|||||+++..|.+.               
T Consensus       485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~  564 (1351)
T KOG1035|consen  485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE  564 (1351)
T ss_pred             HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence            6899999999999994 489999999987653  3346688999999999999999988655110               


Q ss_pred             --------------------------------------------------------------------------------
Q 006055          438 --------------------------------------------------------------------------------  437 (663)
Q Consensus       438 --------------------------------------------------------------------------------  437 (663)
                                                                                                      
T Consensus       565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~  644 (1351)
T KOG1035|consen  565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD  644 (1351)
T ss_pred             hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence                                                                                            


Q ss_pred             ------------------------CccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcc
Q 006055          438 ------------------------DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV  493 (663)
Q Consensus       438 ------------------------~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~i  493 (663)
                                              ...|+-||||+...+.++++.+...    -.-...++++.+|++||.|+|++|  |
T Consensus       645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIlEGLaYIH~~g--i  718 (1351)
T KOG1035|consen  645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREILEGLAYIHDQG--I  718 (1351)
T ss_pred             chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHHHHHHHHHhCc--e
Confidence                                    0014667888887777777654311    035677889999999999999999  9


Q ss_pred             eecCCCCCCEEEcCCCceEEeccccccccC----C------------------CCCCCCCccccCccccCCC---CCCCc
Q 006055          494 SHGNIKSSNILLTKSYEARVSDFGLAHLVG----P------------------SSTPNRVAGYRAPEVTDPC---KVSQK  548 (663)
Q Consensus       494 iHrdlk~~Nill~~~~~~kl~Dfg~a~~~~----~------------------~~~~~~~~~y~aPE~~~~~---~~~~~  548 (663)
                      |||||||.||++|+++.+||+|||+|+...    .                  .....||.-|+|||++.+.   .|+.|
T Consensus       719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K  798 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK  798 (1351)
T ss_pred             eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence            999999999999999999999999998721    0                  0112356669999999765   49999


Q ss_pred             chhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCC
Q 006055          549 ADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNR  628 (663)
Q Consensus       549 ~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~R  628 (663)
                      +|+||+|||++||+.   ||....+     -...+.+ +++..+...-       ....+....-.+++.++++.||.+|
T Consensus       799 iDmYSLGIVlFEM~y---PF~TsME-----Ra~iL~~-LR~g~iP~~~-------~f~~~~~~~e~slI~~Ll~hdP~kR  862 (1351)
T KOG1035|consen  799 IDMYSLGIVLFEMLY---PFGTSME-----RASILTN-LRKGSIPEPA-------DFFDPEHPEEASLIRWLLSHDPSKR  862 (1351)
T ss_pred             hhhHHHHHHHHHHhc---cCCchHH-----HHHHHHh-cccCCCCCCc-------ccccccchHHHHHHHHHhcCCCccC
Confidence            999999999999985   5654222     1122222 1222221110       0112233345678889999999999


Q ss_pred             CCHHHHHH
Q 006055          629 PSMSEVIK  636 (663)
Q Consensus       629 Pt~~ev~~  636 (663)
                      ||+.|++.
T Consensus       863 PtA~eLL~  870 (1351)
T KOG1035|consen  863 PTATELLN  870 (1351)
T ss_pred             CCHHHHhh
Confidence            99999987

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.4e-32  Score=281.21  Aligned_cols=253  Identities=24%  Similarity=0.296  Sum_probs=187.2

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecC----------cc
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMD----------EK  440 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~  440 (663)
                      .+.||+|+||.||+|... +|+.||+|.++...   .....+.+|+++++.++|||++++++++.+..          ..
T Consensus        12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   91 (302)
T cd07864          12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF   91 (302)
T ss_pred             eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcE
Confidence            468999999999999964 68999999986542   23456788999999999999999999987654          68


Q ss_pred             EEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          441 LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       441 ~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                      ++|+||+++ ++...+...    ...+++..+..++.|++.||.|||+.+  |+||||||+||++++++.+||+|||.+.
T Consensus        92 ~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~  164 (302)
T cd07864          92 YLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLAR  164 (302)
T ss_pred             EEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeCcccccc
Confidence            999999986 777776543    235899999999999999999999998  9999999999999999999999999998


Q ss_pred             ccCCCCC-----CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          521 LVGPSST-----PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       521 ~~~~~~~-----~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                      .......     ...+..|+|||.+.+ ..++.++|||||||+++||++|+.||.....   ......+...........
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~  241 (302)
T cd07864         165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE---LAQLELISRLCGSPCPAV  241 (302)
T ss_pred             cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCChhh
Confidence            6643321     123556999998764 3568899999999999999999999964221   111111111111100000


Q ss_pred             ---cc--------chhhhc----ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          595 ---VF--------DLELLR----YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       595 ---~~--------d~~~~~----~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                         +.        +.....    .......+..+.+++.+|+..+|++||++++++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               00        000000    00001124567889999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.7e-33  Score=288.14  Aligned_cols=238  Identities=21%  Similarity=0.325  Sum_probs=194.3

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      ...||+|.|+.|.+|. ..++..||+|.+.+....   ...+.+|+++|..++|||||+++.+.......++||||+.+|
T Consensus        61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~g  140 (596)
T KOG0586|consen   61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGG  140 (596)
T ss_pred             eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCc
Confidence            3579999999999999 456999999999876433   245889999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---C
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---T  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---~  527 (663)
                      .+++++....     .........++.|+..|++|||+++  |+|||||++||||+.+.++||+|||++.++....   +
T Consensus       141 e~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt  213 (596)
T KOG0586|consen  141 ELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQT  213 (596)
T ss_pred             hhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeecccccccc
Confidence            9999998654     2445778889999999999999998  9999999999999999999999999999887653   3


Q ss_pred             CCCCccccCccccCCCCC-CCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          528 PNRVAGYRAPEVTDPCKV-SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ..+++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++..-      ...-..++...+            .-+
T Consensus       214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l------k~Lr~rvl~gk~------------rIp  275 (596)
T KOG0586|consen  214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL------KELRPRVLRGKY------------RIP  275 (596)
T ss_pred             cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc------ccccchheeeee------------ccc
Confidence            446677999999999775 6789999999999999999999975321      111111111111            001


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .-...+..+++++.+..+|.+|++++++.++
T Consensus       276 ~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  276 FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            1112355677779999999999999999875

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.6e-32  Score=282.19  Aligned_cols=250  Identities=24%  Similarity=0.291  Sum_probs=183.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecC--------ccEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMD--------EKLL  442 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------~~~l  442 (663)
                      .++||+|+||.||+|.. .+++.||+|++.....   ....+.+|+++++.++|+||+++++++.+..        ..++
T Consensus        13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l   92 (311)
T cd07866          13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM   92 (311)
T ss_pred             EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence            35799999999999995 4689999999864322   2346778999999999999999999875543        3589


Q ss_pred             EEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccccc
Q 006055          443 VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV  522 (663)
Q Consensus       443 v~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~  522 (663)
                      |+||+.. ++...+....    ..+++..+..++.|+++||.|||+.+  |+||||||+||++++++.++|+|||+++..
T Consensus        93 v~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          93 VTPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             EEecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCccchhc
Confidence            9999875 7777776432    35899999999999999999999998  999999999999999999999999999765


Q ss_pred             CCCCC---------------CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHH
Q 006055          523 GPSST---------------PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSI  586 (663)
Q Consensus       523 ~~~~~---------------~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  586 (663)
                      .....               ..++..|+|||.+.+ ..++.++|||||||++|||++|+.||......      .....+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~------~~~~~~  239 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI------DQLHLI  239 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH
Confidence            43211               112455999998765 45788999999999999999999998643221      111111


Q ss_pred             Hhhc---cc---------ccccc-hhhhcc-cC----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          587 VKDE---WT---------SEVFD-LELLRY-QN----VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       587 ~~~~---~~---------~~~~d-~~~~~~-~~----~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....   ..         ....+ ...... ..    .......+.+++.+|+..+|++|||+.|++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            1100   00         00000 000000 00    01122567889999999999999999999863

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.2e-32  Score=278.19  Aligned_cols=245  Identities=22%  Similarity=0.255  Sum_probs=191.1

Q ss_pred             hcccccccceEEEEEEe----cCCcEEEEEEecCcc-----cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVT-----ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  444 (663)
                      .+.||+|+||.||++..    .+++.||||.++...     ...+.+.+|+.++.++ +|+||+++++.+......++||
T Consensus         5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   84 (288)
T cd05583           5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL   84 (288)
T ss_pred             EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence            36799999999999874    357899999987532     1235678899999999 5999999999998888999999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+++|+|.+++...     ..+++.....++.|+++||.|||+.+  ++||||||+||+++.++.++|+|||+++....
T Consensus        85 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          85 DYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             ecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            999999999998643     24789999999999999999999988  99999999999999999999999999876543


Q ss_pred             CCC-----CCCCccccCccccCCCC--CCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          525 SST-----PNRVAGYRAPEVTDPCK--VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       525 ~~~-----~~~~~~y~aPE~~~~~~--~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                      ...     ..++..|+|||...+..  .+.++||||||++++||++|..||......  .......+......       
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~-------  228 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKSK-------  228 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHccC-------
Confidence            221     23466799999987654  678999999999999999999998642111  11112222211111       


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                           ..........+.+++.+|++.+|++|||+.++.+.|+.
T Consensus       229 -----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         229 -----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                 00111123467788899999999999999888776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.98  E-value=2.9e-31  Score=280.13  Aligned_cols=254  Identities=24%  Similarity=0.340  Sum_probs=189.1

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecC------ccEEEE
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMD------EKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  444 (663)
                      .+.||+|+||.||++. ..+|+.||||++......   ...+.+|+++++.++||||+++++++....      ..++||
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~   99 (343)
T cd07880          20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM   99 (343)
T ss_pred             EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence            3679999999999998 557999999998653222   356789999999999999999999886543      358999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+ +++|.+++..      ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++.....
T Consensus       100 e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880         100 PFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             ecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence            998 6799888863      24889999999999999999999998  99999999999999999999999999986644


Q ss_pred             CCC-CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccc------cccc
Q 006055          525 SST-PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT------SEVF  596 (663)
Q Consensus       525 ~~~-~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~  596 (663)
                      ... ..++..|+|||.+.+ ..++.++|+||||+++|++++|+.||.....      ......+......      ..+.
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07880         171 EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH------LDQLMEIMKVTGTPSKEFVQKLQ  244 (343)
T ss_pred             CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHhcCCCCHHHHHhhc
Confidence            322 335667999999876 4578899999999999999999999964321      1111111110000      0000


Q ss_pred             ch---h----hhcc--c----ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHHhhCC
Q 006055          597 DL---E----LLRY--Q----NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK--RIEELHP  643 (663)
Q Consensus       597 d~---~----~~~~--~----~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~--~L~~~~~  643 (663)
                      ..   .    ....  .    .......++.+++.+|+..||++|||+.++++  .++...+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence            00   0    0000  0    00122345788999999999999999999995  3444433

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=9.9e-32  Score=275.50  Aligned_cols=249  Identities=25%  Similarity=0.339  Sum_probs=191.8

Q ss_pred             cccccccceEEEEEEec-CCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      +.||+|++|.||+|... +++.||+|.+....   ...+.+..|+.+++.++|+|++++++++.+....++||||++ ++
T Consensus         5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~   83 (282)
T cd07829           5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MD   83 (282)
T ss_pred             hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cC
Confidence            57999999999999954 59999999987642   224667889999999999999999999999999999999998 59


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC----
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST----  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~----  527 (663)
                      |.+++....    ..+++..+..++.+++.||.|||+.+  |+||||+|+||++++++.++|+|||.++.......    
T Consensus        84 l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (282)
T cd07829          84 LKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH  157 (282)
T ss_pred             HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence            999997542    35899999999999999999999998  99999999999999999999999999977644321    


Q ss_pred             CCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh---cccc------cc--
Q 006055          528 PNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD---EWTS------EV--  595 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~------~~--  595 (663)
                      ...+..|+|||.+.+. .++.++||||||++++||++|+.||.....      ...+..+...   ....      ..  
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE------IDQLFKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHHHhCCCcHHHHHhhccccc
Confidence            2234569999998766 788999999999999999999999865321      1111111110   0000      00  


Q ss_pred             cchhhhcc------cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          596 FDLELLRY------QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       596 ~d~~~~~~------~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .+......      .........+.+++.+|+..+|++||++++++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            00000000      0001124578899999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.98  E-value=4.5e-32  Score=277.63  Aligned_cols=238  Identities=24%  Similarity=0.359  Sum_probs=192.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCC-CCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||++.. .+|+.||+|.+....    ...+.+.+|++++.+++ |+||+++++++...+..++||||++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (280)
T cd05581           6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP   85 (280)
T ss_pred             eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence            35799999999999995 479999999987532    22456888999999998 9999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-  527 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  527 (663)
                      +++|.+++....     .+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++++|||++........ 
T Consensus        86 ~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          86 NGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            999999997542     5899999999999999999999998  99999999999999999999999999876543221 


Q ss_pred             -----------------------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHH
Q 006055          528 -----------------------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQ  584 (663)
Q Consensus       528 -----------------------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~  584 (663)
                                             ..++..|+|||...+..++.++||||||++++++++|+.||.....      .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~  232 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------YLTFQ  232 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------HHHHH
Confidence                                   1234569999999888889999999999999999999999975321      11111


Q ss_pred             HHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHH
Q 006055          585 SIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSM----SEVIKR  637 (663)
Q Consensus       585 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~----~ev~~~  637 (663)
                      ......            ...+......+.+++.+|+..+|++||++    ++++++
T Consensus       233 ~~~~~~------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         233 KILKLE------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HHHhcC------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            211111            01111224467889999999999999999    777653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.98  E-value=2.1e-31  Score=281.48  Aligned_cols=248  Identities=21%  Similarity=0.305  Sum_probs=185.0

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEec------CccEEEEE
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSM------DEKLLVYD  445 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e  445 (663)
                      +.||+|+||.||++. ..+|+.||+|+++....   ..+.+.+|++++.+++|+||+++++++...      ...+++++
T Consensus        23 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~  102 (345)
T cd07877          23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH  102 (345)
T ss_pred             EEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEeh
Confidence            579999999999998 46799999999875422   245677899999999999999999988643      23577777


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      ++ +++|.+++...      .+++..+..++.|+++||.|||+.+  |+||||||+||++++++.+||+|||+++.....
T Consensus       103 ~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~  173 (345)
T cd07877         103 LM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE  173 (345)
T ss_pred             hc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEeccccccccccc
Confidence            76 77998888642      3899999999999999999999998  999999999999999999999999999765443


Q ss_pred             C-CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc--ccc----ccc
Q 006055          526 S-TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW--TSE----VFD  597 (663)
Q Consensus       526 ~-~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~----~~d  597 (663)
                      . ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....      ......+.....  ...    +.+
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         174 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH------IDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCCHHHHhhccc
Confidence            2 2345667999999866 4678899999999999999999999964221      111111110000  000    000


Q ss_pred             h-------hhhcc--cCh----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          598 L-------ELLRY--QNV----EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       598 ~-------~~~~~--~~~----~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      .       .+...  ...    .....++.+++.+|+..||++||++.+++.+=
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  301 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  301 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence            0       00000  000    01234678899999999999999999999863

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=1.3e-31  Score=282.69  Aligned_cols=248  Identities=23%  Similarity=0.308  Sum_probs=182.7

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEec--------------C
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSM--------------D  438 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------------~  438 (663)
                      .+.||+|+||.||+|.. .+|+.||+|.+.... ...+.+.+|+++++.++||||+++++++...              .
T Consensus        10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~   89 (342)
T cd07854          10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN   89 (342)
T ss_pred             EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence            36799999999999994 568999999986553 3346788999999999999999999876543              3


Q ss_pred             ccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc-CCCceEEeccc
Q 006055          439 EKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT-KSYEARVSDFG  517 (663)
Q Consensus       439 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~-~~~~~kl~Dfg  517 (663)
                      ..++||||++ ++|.+++...      .+++.....++.||+.||.|||+.+  |+||||||+||+++ +++.+|++|||
T Consensus        90 ~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          90 SVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             eEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEECCcc
Confidence            4689999997 5898888532      4789999999999999999999998  99999999999997 45578999999


Q ss_pred             cccccCCCC-------CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh
Q 006055          518 LAHLVGPSS-------TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD  589 (663)
Q Consensus       518 ~a~~~~~~~-------~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  589 (663)
                      .++......       ...++..|+|||.+.. ..++.++|||||||++|||++|+.||......      .........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~------~~~~~~~~~  234 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL------EQMQLILES  234 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHh
Confidence            997653321       1224556999998654 56788999999999999999999999653211      111111100


Q ss_pred             ccc--------------ccccchhhhcccC----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          590 EWT--------------SEVFDLELLRYQN----VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       590 ~~~--------------~~~~d~~~~~~~~----~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...              .............    ......++.+++.+|+..||++|||++|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            000              0000000000000    01123467789999999999999999999963

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.98  E-value=7.7e-32  Score=269.26  Aligned_cols=219  Identities=21%  Similarity=0.189  Sum_probs=174.0

Q ss_pred             ccceEEEEEE-ecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhHhhccC
Q 006055          381 GTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGN  459 (663)
Q Consensus       381 G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~  459 (663)
                      |.||.||++. ..+++.||+|.+....    .+..|...+....|||++++++++.+.+..++||||+++|+|.+++...
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence            8999999999 4678999999987642    2334445555567999999999999999999999999999999998753


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-CCCCCccccCcc
Q 006055          460 KGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-TPNRVAGYRAPE  538 (663)
Q Consensus       460 ~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~y~aPE  538 (663)
                      .     .+++.....++.|++.||.|||+.+  |+||||||+||+++.++.++++|||.+....... ....+..|+|||
T Consensus        80 ~-----~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE  152 (237)
T cd05576          80 L-----NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPE  152 (237)
T ss_pred             c-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCc
Confidence            2     4899999999999999999999998  9999999999999999999999999886655432 233455699999


Q ss_pred             ccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHH
Q 006055          539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAI  618 (663)
Q Consensus       539 ~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~  618 (663)
                      ...+..++.++||||+|+++|||++|+.|+.......            ..     .....     .+......+.+++.
T Consensus       153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~-----~~~~~-----~~~~~~~~~~~li~  210 (237)
T cd05576         153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT-----HTTLN-----IPEWVSEEARSLLQ  210 (237)
T ss_pred             ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc-----ccccC-----CcccCCHHHHHHHH
Confidence            9988888999999999999999999998875321100            00     00000     01112346778888


Q ss_pred             HccCCCCCCCCCHH
Q 006055          619 DCSAQYPDNRPSMS  632 (663)
Q Consensus       619 ~C~~~dP~~RPt~~  632 (663)
                      +|++.||++||++.
T Consensus       211 ~~l~~dp~~R~~~~  224 (237)
T cd05576         211 QLLQFNPTERLGAG  224 (237)
T ss_pred             HHccCCHHHhcCCC
Confidence            99999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=1.5e-31  Score=281.23  Aligned_cols=255  Identities=22%  Similarity=0.282  Sum_probs=183.0

Q ss_pred             hcccccccceEEEEEEec-C--CcEEEEEEecCcc---cCHHHHHHHHHHhhcC-CCCCcccceEEEEec----CccEEE
Q 006055          375 AEVLGKGTFGTAYKAVLE-M--GTIVAVKRLKDVT---ISEREFKDKIEGVGAV-NHENLVPLRAYYYSM----DEKLLV  443 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~--g~~vavK~l~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~~~lv  443 (663)
                      .+.||+|+||.||++... .  +..||+|++....   ...+.+.+|++++.++ +||||+++++++...    ...+++
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~   84 (332)
T cd07857           5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY   84 (332)
T ss_pred             EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence            367999999999999954 4  7899999987532   2245678899999998 599999999875432    346788


Q ss_pred             EEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccC
Q 006055          444 YDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG  523 (663)
Q Consensus       444 ~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~  523 (663)
                      +||+. ++|.+++...     ..+++..+..++.||+.||.|||+.+  |+||||||+||++++++.+||+|||+++...
T Consensus        85 ~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          85 EELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             Eeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            88886 5899988643     35899999999999999999999998  9999999999999999999999999997654


Q ss_pred             CCC--------CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCC---------CCChHHHHHH
Q 006055          524 PSS--------TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEE---------GVDLPRWVQS  585 (663)
Q Consensus       524 ~~~--------~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~  585 (663)
                      ...        ...++..|+|||++.+ ..++.++||||+||++|+|++|+.||......+         +.....+...
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            321        1235667999998765 467899999999999999999999986532100         0000000000


Q ss_pred             HHhhcccccccchhhhcccCh----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          586 IVKDEWTSEVFDLELLRYQNV----EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       586 ~~~~~~~~~~~d~~~~~~~~~----~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      +....................    ......+.+++.+|++.+|++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000000000000000000    0123468889999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=8.7e-32  Score=284.20  Aligned_cols=248  Identities=22%  Similarity=0.317  Sum_probs=187.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCc------cEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDE------KLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~lv~  444 (663)
                      ...||+|++|.||+|.. .+++.||||++.....   ....+.+|+.+++.++|+|++++++++...+.      .++|+
T Consensus        20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~   99 (343)
T cd07851          20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT   99 (343)
T ss_pred             EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence            36799999999999995 4689999999865322   23557789999999999999999998766554      79999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+ +++|.+++..      ..+++..+..++.|+++||.|||+.+  |+||||||+||++++++.++|+|||++.....
T Consensus       100 e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851         100 HLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             ecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEccccccccccc
Confidence            998 5699998874      24899999999999999999999998  99999999999999999999999999987654


Q ss_pred             CC-CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc--ccc----cc
Q 006055          525 SS-TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW--TSE----VF  596 (663)
Q Consensus       525 ~~-~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~----~~  596 (663)
                      .. ...++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....      ...+..+.....  ...    +.
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~  244 (343)
T cd07851         171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH------IDQLKRIMNLVGTPDEELLQKIS  244 (343)
T ss_pred             cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHhcCCCCHHHHhhcc
Confidence            32 2335566999999865 3678899999999999999999999964321      111221111000  000    00


Q ss_pred             ch---------hhhcccC----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          597 DL---------ELLRYQN----VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       597 d~---------~~~~~~~----~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ..         .......    ......++.+++.+|+..+|++|||+.||+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            00         0000000    01124578899999999999999999999874

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-32  Score=301.75  Aligned_cols=242  Identities=24%  Similarity=0.306  Sum_probs=193.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .++||+|+||.|..++. .++++||.|++.+..    .....|..|.++|..-+.+-|+.++-.|.+..+.|+|||||+|
T Consensus        80 lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pG  159 (1317)
T KOG0612|consen   80 LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPG  159 (1317)
T ss_pred             HHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccC
Confidence            57899999999999995 568999999998752    3346799999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----  525 (663)
                      |+|-.++....     ++++.++..++..|..||+-||+.|  +|||||||+|||||..|++||+|||.+-.+...    
T Consensus       160 GDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~  232 (1317)
T KOG0612|consen  160 GDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVR  232 (1317)
T ss_pred             chHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHHhcCCCCcEE
Confidence            99999998643     5899999999999999999999999  999999999999999999999999998777643    


Q ss_pred             -CCCCCCccccCccccCC-----CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          526 -STPNRVAGYRAPEVTDP-----CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       526 -~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                       ....||+.|++||++..     +.|+..+|.||+||++|||+.|..||+..      .++.-...++.....   +..+
T Consensus       233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~KIm~hk~~---l~FP  303 (1317)
T KOG0612|consen  233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGKIMNHKES---LSFP  303 (1317)
T ss_pred             eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHHHhchhhh---cCCC
Confidence             34568999999999842     56889999999999999999999999863      234444444433211   1111


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHH
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPS---MSEVIKRI  638 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt---~~ev~~~L  638 (663)
                        .....+++..+|   |..-+ -+|+.|..   ++++..|-
T Consensus       304 --~~~~VSeeakdL---I~~ll-~~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  304 --DETDVSEEAKDL---IEALL-CDREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             --cccccCHHHHHH---HHHHh-cChhhhcccccHHHHHhCc
Confidence              111233444444   43322 45778877   99888875

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=288.03  Aligned_cols=243  Identities=24%  Similarity=0.367  Sum_probs=201.1

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccCHHHHHHHHHHhhcC-CCCCcccceEEEEe-----cCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAYYYS-----MDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----~~~~~lv~ey~  447 (663)
                      .++||.|.+|.||+++ .++|+.+|||++......+.+++.|.++++.. .|||++.++|+|..     ++++|||||||
T Consensus        24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC  103 (953)
T KOG0587|consen   24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFC  103 (953)
T ss_pred             EEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeecc
Confidence            4789999999999999 67899999999988777788899999999887 69999999999863     56789999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC---
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP---  524 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~---  524 (663)
                      .+|+..|+++...   ...+.|..+..|+..+++|+.|||...  ++|||||-.|||++.++.+|++|||.+..+..   
T Consensus       104 ~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g  178 (953)
T KOG0587|consen  104 GGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG  178 (953)
T ss_pred             CCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeeeeeeeeecccc
Confidence            9999999998765   356999999999999999999999987  99999999999999999999999999876533   


Q ss_pred             -CCCCCCCccccCccccCCC-----CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          525 -SSTPNRVAGYRAPEVTDPC-----KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       525 -~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                       ..+..+|+.|||||++...     .|+.++|+||+|++..||.-|.+|+.++....         ..+.   +..-.-+
T Consensus       179 rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---------aLF~---IpRNPPP  246 (953)
T KOG0587|consen  179 RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---------ALFL---IPRNPPP  246 (953)
T ss_pred             cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---------hhcc---CCCCCCc
Confidence             3556788999999998643     46778999999999999999999986543211         1100   0000001


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                         ....+.....++.++|..|+.+|.++||++.++++|
T Consensus       247 ---kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  247 ---KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ---cccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence               112245567789999999999999999999998864

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=2.5e-31  Score=302.47  Aligned_cols=139  Identities=24%  Similarity=0.403  Sum_probs=124.2

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccC----HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .++||+|+||.||+|... +++.||||+++.....    ...+..|+.++..++|+||+++++++......++||||+.+
T Consensus         9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g   88 (669)
T cd05610           9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG   88 (669)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence            367999999999999954 6899999998754221    35688899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                      ++|.++++...     .+++...+.++.||+.||.|||..+  |+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          89 GDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999997532     4788999999999999999999998  9999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=5e-31  Score=233.67  Aligned_cols=250  Identities=26%  Similarity=0.363  Sum_probs=187.2

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .++||+|.||+||+|+ ..+++.||+|++.-...+   .....+|+-+++.++|+|||++++....++...+|+||+.. 
T Consensus         7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-   85 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-   85 (292)
T ss_pred             HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence            4789999999999999 667899999998754322   46788999999999999999999999999999999999976 


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----  526 (663)
                      +|..+.....+    .++.......+.|+.+||.++|++.  +.|||+||.|.||+.+|+.|++|||+++..+-..    
T Consensus        86 dlkkyfdslng----~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvrcys  159 (292)
T KOG0662|consen   86 DLKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS  159 (292)
T ss_pred             HHHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence            88887765443    4788899999999999999999998  9999999999999999999999999998776542    


Q ss_pred             CCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHh-------hccccc--c
Q 006055          527 TPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVK-------DEWTSE--V  595 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~--~  595 (663)
                      ....|..|.+|.++-+. -|++..|+||-||++.|+.. |++.|.+      .+..+.+.++++       +.|+.-  .
T Consensus       160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg------~dvddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG------NDVDDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC------CcHHHHHHHHHHHhCCCccccCCccccC
Confidence            23346669999998765 58889999999999999998 5554533      344444444432       122111  1


Q ss_pred             cchhhh-ccc---ChHHHH----HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          596 FDLELL-RYQ---NVEEEM----VQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       596 ~d~~~~-~~~---~~~~~~----~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .|.... .++   .....+    ..=.++.++.+.-+|.+|.++++.+++
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            111100 000   011111    111244445555679999999998874

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.5e-32  Score=259.77  Aligned_cols=190  Identities=25%  Similarity=0.357  Sum_probs=166.3

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCccc-CH---HHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI-SE---REFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~-~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .++||+|.||.|-+++ ..+|+.+|+|++++... .+   ..-..|-+++...+||.+..+.-.|...+..++||||+.+
T Consensus       173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanG  252 (516)
T KOG0690|consen  173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANG  252 (516)
T ss_pred             HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccC
Confidence            4789999999999988 66899999999987632 22   3345678889999999999999889999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----  525 (663)
                      |.|.-+|...+     .+++......-..|..||.|||+++  |++||||-+|.|+|.+|++||.|||+++.--..    
T Consensus       253 GeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~  325 (516)
T KOG0690|consen  253 GELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTT  325 (516)
T ss_pred             ceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchhccccccee
Confidence            99998887643     5788888888999999999999998  999999999999999999999999999764322    


Q ss_pred             CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccc
Q 006055          526 STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHAL  571 (663)
Q Consensus       526 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~  571 (663)
                      .+..+|+.|+|||++....|+..+|.|.+|||+|||++|+.||...
T Consensus       326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~  371 (516)
T KOG0690|consen  326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK  371 (516)
T ss_pred             ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence            2345788899999999999999999999999999999999999753

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=278.60  Aligned_cols=233  Identities=27%  Similarity=0.264  Sum_probs=185.1

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      ...+|.|+|+.|-++. ..+++..+||++.+.   ..+-.+|+.++... +|||++++.+.+.+..+.++|||++.++-+
T Consensus       327 ~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~el  403 (612)
T KOG0603|consen  327 REELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGEL  403 (612)
T ss_pred             ccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHH
Confidence            3469999999998888 567899999999765   22344566555544 799999999999999999999999999988


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEE-cCCCceEEeccccccccCCCC-CCCC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEARVSDFGLAHLVGPSS-TPNR  530 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~-~~~~  530 (663)
                      .+.+...+      .....+..|+.+|+.|+.|||.+|  ++||||||+|||+ +..++++|+|||.++...+.. +...
T Consensus       404 l~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~  475 (612)
T KOG0603|consen  404 LRRIRSKP------EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPAL  475 (612)
T ss_pred             HHHHHhcc------hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchhhcccch
Confidence            88776543      222677789999999999999998  9999999999999 689999999999999887763 2345


Q ss_pred             CccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHH
Q 006055          531 VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM  610 (663)
Q Consensus       531 ~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  610 (663)
                      |..|.|||+.....|++.+|+||||++||+|++|+.||......     ...... ++...             .....+
T Consensus       476 t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~~~-i~~~~-------------~s~~vS  536 (612)
T KOG0603|consen  476 TLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIHTR-IQMPK-------------FSECVS  536 (612)
T ss_pred             hhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHHHh-hcCCc-------------cccccC
Confidence            67799999999999999999999999999999999999753322     111111 11110             012223


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          611 VQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       611 ~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....+++.+|++.||.+||+|.++..+
T Consensus       537 ~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  537 DEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             HHHHHHHHHhccCChhhCcChhhhccC
Confidence            455667779999999999999999873

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=5.4e-32  Score=274.82  Aligned_cols=240  Identities=24%  Similarity=0.377  Sum_probs=189.3

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .++||.|.||+||-|+ .++|+.||||.+.+.+   ..+..+..|+.++..+.||.||.+..-|+..+..++|||.+.+.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            6799999999999999 5679999999987653   33577999999999999999999999999999999999998764


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC---ceEEeccccccccCCC--
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY---EARVSDFGLAHLVGPS--  525 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~---~~kl~Dfg~a~~~~~~--  525 (663)
                      =|+-+|...++    .+++.....+..||+.||.|||.++  |+|+||||+|||+....   .+||||||+|++.++.  
T Consensus       649 MLEMILSsEkg----RL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF  722 (888)
T KOG4236|consen  649 MLEMILSSEKG----RLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF  722 (888)
T ss_pred             HHHHHHHhhcc----cchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence            44555554432    4888888999999999999999998  99999999999996543   5999999999998875  


Q ss_pred             -CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          526 -STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       526 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                       .+..+|+.|+|||++..+.|...-|+||.||++|.-++|..||...     .++.+.+++.    .    +-.   ...
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-----EdIndQIQNA----a----FMy---Pp~  786 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-----EDINDQIQNA----A----FMY---PPN  786 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-----cchhHHhhcc----c----ccc---CCC
Confidence             3466899999999999999999999999999999999999999753     2333322211    0    000   011


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      .-.+...+.+++|...++..=.+|.+.++.+.
T Consensus       787 PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             chhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            12233344556666777777777888776554

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-32  Score=266.66  Aligned_cols=253  Identities=26%  Similarity=0.324  Sum_probs=195.8

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCC--C----CcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNH--E----NLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h--~----niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      ...+|+|.||.|-... .+.+..||||+++....-.+..+-|++++.++.+  |    .+|.+.++|.-.++.++|+|.+
T Consensus        94 ~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell  173 (415)
T KOG0671|consen   94 VDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL  173 (415)
T ss_pred             hhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc
Confidence            4579999999999988 4457999999998776556677889999999832  2    3677888898899999999976


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC--------------------
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK--------------------  507 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~--------------------  507 (663)
                       +-|+.+++..+.   ..+++...++.|+.|++++++|||+.+  ++|-||||+|||+.+                    
T Consensus       174 -G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~k  247 (415)
T KOG0671|consen  174 -GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLK  247 (415)
T ss_pred             -ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCccceeccCC
Confidence             449999998654   567899999999999999999999998  999999999999942                    


Q ss_pred             CCceEEeccccccccCCCCCC-CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHH
Q 006055          508 SYEARVSDFGLAHLVGPSSTP-NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSI  586 (663)
Q Consensus       508 ~~~~kl~Dfg~a~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  586 (663)
                      +..++|+|||.|++.....+. ..|.-|.|||++.+-.++.++||||+||||+|+.||...|+.-.+.+..   ..++.+
T Consensus       248 s~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL---aMMerI  324 (415)
T KOG0671|consen  248 STAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL---AMMERI  324 (415)
T ss_pred             CcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH---HHHHHh
Confidence            335899999999987766543 4566799999999999999999999999999999999998764332211   222222


Q ss_pred             Hhhcccccc--------------cc------------------hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 006055          587 VKDEWTSEV--------------FD------------------LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEV  634 (663)
Q Consensus       587 ~~~~~~~~~--------------~d------------------~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev  634 (663)
                      +. ..+..+              +|                  +.........++..+|++|+.+++..||.+|+|+.|+
T Consensus       325 lG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EA  403 (415)
T KOG0671|consen  325 LG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREA  403 (415)
T ss_pred             hC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHH
Confidence            21 011000              11                  0000011224556789999999999999999999999


Q ss_pred             HHH
Q 006055          635 IKR  637 (663)
Q Consensus       635 ~~~  637 (663)
                      +.|
T Consensus       404 L~H  406 (415)
T KOG0671|consen  404 LSH  406 (415)
T ss_pred             hcC
Confidence            875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=3.8e-31  Score=239.77  Aligned_cols=204  Identities=23%  Similarity=0.370  Sum_probs=163.9

Q ss_pred             cCHHHHHHHhhcccccccceEEEEEE-ecCCcEEEEEEecCccc--CHHHHHHHHHHh-hcCCCCCcccceEEEEecCcc
Q 006055          365 FDLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI--SEREFKDKIEGV-GAVNHENLVPLRAYYYSMDEK  440 (663)
Q Consensus       365 ~~~~~l~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~  440 (663)
                      |++.+-.....+.||+|+||.|-+.+ ..+|+..|||++...-.  ..+...+|+.+. +...+|.+|.++|.+......
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            44443333456789999999998877 56799999999976532  345667777764 455899999999999999999


Q ss_pred             EEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          441 LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       441 ~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                      ++.||.|.. ||+.+.+.--. ....+++...-+||..|.+||.|||++- .+||||+||+|||++.+|.+|+||||.+.
T Consensus       121 wIcME~M~t-Sldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccCCcEEEcccccce
Confidence            999999976 88776543221 1345889999999999999999999883 59999999999999999999999999998


Q ss_pred             ccCCCCCC---CCCccccCccccCC----CCCCCcchhhhHHHHHHHHHhCCCCCccc
Q 006055          521 LVGPSSTP---NRVAGYRAPEVTDP----CKVSQKADVYSFGVLLLELLTGKAPTHAL  571 (663)
Q Consensus       521 ~~~~~~~~---~~~~~y~aPE~~~~----~~~~~~~Dv~slGvvl~elltg~~p~~~~  571 (663)
                      .+.++-..   .+-..|||||.+..    ..|+.|+||||+|+.+.||.+++.||+.+
T Consensus       198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            77654221   22234999999854    46899999999999999999999999754

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.4e-32  Score=254.36  Aligned_cols=256  Identities=23%  Similarity=0.308  Sum_probs=186.4

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCc---ccCHHHHHHHHHHhhcCCCCCcccceEEEEec--------CccEEE
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV---TISEREFKDKIEGVGAVNHENLVPLRAYYYSM--------DEKLLV  443 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~~~~lv  443 (663)
                      .+||+|.||+||+|+ .++|++||+|+.--.   .--.....+|++++..++|+|++.+++.|...        ...++|
T Consensus        23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV  102 (376)
T KOG0669|consen   23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV  102 (376)
T ss_pred             HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence            589999999999999 456888999875321   11234567899999999999999999887532        236899


Q ss_pred             EEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccC
Q 006055          444 YDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG  523 (663)
Q Consensus       444 ~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~  523 (663)
                      |++++. +|.-+|....    ..++..++.+++.++..||.|+|...  |+|||+|+.|+||+.++.+||+|||+++...
T Consensus       103 f~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGlar~fs  175 (376)
T KOG0669|consen  103 FDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGLARAFS  175 (376)
T ss_pred             HHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeecccccccee
Confidence            999988 8998886532    45888999999999999999999997  9999999999999999999999999997654


Q ss_pred             CCCCC--C------CCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          524 PSSTP--N------RVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       524 ~~~~~--~------~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                      .....  .      .|..|.+||.+.+ +.|+.+.|||.-||++.||.||.+-+.+..+.....+...+-..+..+.+.+
T Consensus       176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~  255 (376)
T KOG0669|consen  176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN  255 (376)
T ss_pred             cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence            43221  1      2455999999877 4689999999999999999999988876543221111111100001111111


Q ss_pred             ccchhhhc-----------ccChHHHHH------HHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          595 VFDLELLR-----------YQNVEEEMV------QLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       595 ~~d~~~~~-----------~~~~~~~~~------~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      +...++..           .....+..+      +..+++.+++..||.+|+++.+++.+-
T Consensus       256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            11111110           001122222      456778899999999999999998764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=6.1e-30  Score=255.22  Aligned_cols=234  Identities=29%  Similarity=0.376  Sum_probs=190.0

Q ss_pred             cceEEEEEEec-CCcEEEEEEecCcccC--HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhHhhcc
Q 006055          382 TFGTAYKAVLE-MGTIVAVKRLKDVTIS--EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHG  458 (663)
Q Consensus       382 ~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~  458 (663)
                      +||.||+|... +|+.+|+|++......  .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999965 5899999998765332  57899999999999999999999999999999999999999999999875


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC---CCCCCCcccc
Q 006055          459 NKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS---STPNRVAGYR  535 (663)
Q Consensus       459 ~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~y~  535 (663)
                      ..     .+++..+..++.++++++.|||+.+  ++|+||+|+||++++++.++++|||.+......   ....++..|+
T Consensus        81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  153 (244)
T smart00220       81 RG-----RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM  153 (244)
T ss_pred             cc-----CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence            43     2789999999999999999999998  999999999999999999999999999877654   2234566799


Q ss_pred             CccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHH
Q 006055          536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQ  615 (663)
Q Consensus       536 aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~  615 (663)
                      +||...+..++.++||||||+++++|++|..||....     +............. ..        .........++.+
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-----~~~~~~~~~~~~~~-~~--------~~~~~~~~~~~~~  219 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-----QLLELFKKIGKPKP-PF--------PPPEWKISPEAKD  219 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHHHhccCC-CC--------ccccccCCHHHHH
Confidence            9999988888999999999999999999999986531     11112211111110 00        0000003457888


Q ss_pred             HHHHccCCCCCCCCCHHHHHH
Q 006055          616 LAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       616 l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      ++.+|+..+|++||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999987

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.7e-31  Score=262.41  Aligned_cols=245  Identities=23%  Similarity=0.308  Sum_probs=189.1

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccC--------HHHHHHHHHHhhcCCCCCcccceEEEEec-CccEEEE
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS--------EREFKDKIEGVGAVNHENLVPLRAYYYSM-DEKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~--------~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~  444 (663)
                      .++||+|+|++||+|. +...+.||||+-.....+        .+...+|.++-+.+.||.||++++|+.-+ +..+-|+
T Consensus       468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL  547 (775)
T KOG1151|consen  468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL  547 (775)
T ss_pred             HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence            3579999999999998 667899999985433222        24567899999999999999999999755 4568899


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc---CCCceEEeccccccc
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT---KSYEARVSDFGLAHL  521 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~---~~~~~kl~Dfg~a~~  521 (663)
                      ||+++-+|+-+|...+     .+++..+..|+.||+.||.||.+..|||||-||||.|||+-   ..|.+||.|||+++.
T Consensus       548 EYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  548 EYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             eecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            9999999999998644     58899999999999999999999999999999999999994   457899999999999


Q ss_pred             cCCCCCC-----------CCCccccCccccCC----CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHH
Q 006055          522 VGPSSTP-----------NRVAGYRAPEVTDP----CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSI  586 (663)
Q Consensus       522 ~~~~~~~-----------~~~~~y~aPE~~~~----~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  586 (663)
                      +......           .+|..|++||.+.-    ..++.|+||||.||++|..+.|+.||.....         -+.+
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs---------QQdI  693 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS---------QQDI  693 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh---------HHHH
Confidence            8664321           25666999998742    3578899999999999999999999975322         1223


Q ss_pred             HhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          587 VKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      ++.+-+...-...   ++.-+....+...+|++|+.+.-++|....++..
T Consensus       694 LqeNTIlkAtEVq---FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  694 LQENTILKATEVQ---FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             Hhhhchhcceecc---CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            3332222111111   1111122335566778999999999998888765

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-31  Score=259.57  Aligned_cols=230  Identities=23%  Similarity=0.310  Sum_probs=181.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc---CH-HHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SE-REFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~-~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      ..+||+|+||.|-+|.. .+.+.+|||++++...   ++ +--+.|-++++.. +-|.++.++.+|...+.+|+||||+.
T Consensus       354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn  433 (683)
T KOG0696|consen  354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN  433 (683)
T ss_pred             EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence            46899999999999984 4578899999987521   11 1233455566555 57899999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--  526 (663)
                      +|+|--.++...     .+.+..+..+|.+||-||-+||++|  ||+||||.+||++|.+|++||+|||+++.--...  
T Consensus       434 GGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~T  506 (683)
T KOG0696|consen  434 GGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVT  506 (683)
T ss_pred             CchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeecccccccccCCcc
Confidence            999988887543     3677788889999999999999999  9999999999999999999999999998653332  


Q ss_pred             --CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          527 --TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                        +..+|+.|+|||++....|+..+|.|||||+||||+.|++||++..+      .+..+.+.....            .
T Consensus       507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE------~elF~aI~ehnv------------s  568 (683)
T KOG0696|consen  507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------DELFQAIMEHNV------------S  568 (683)
T ss_pred             eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHHccC------------c
Confidence              23477889999999999999999999999999999999999976432      333444433321            1


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCC
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRP  629 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RP  629 (663)
                      .+...+.+...+...-+.+.|.+|.
T Consensus       569 yPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  569 YPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             CcccccHHHHHHHHHHhhcCCcccc
Confidence            2223344556666677888888884

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=7.1e-30  Score=283.45  Aligned_cols=252  Identities=19%  Similarity=0.224  Sum_probs=161.2

Q ss_pred             hcccccccceEEEEEEec-C----CcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEE------EEecCccEEE
Q 006055          375 AEVLGKGTFGTAYKAVLE-M----GTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAY------YYSMDEKLLV  443 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~----g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~~~~~~~lv  443 (663)
                      .++||+|+||.||+|... +    +..||||++......+.. ..+  .+....+.++..+...      +....+.++|
T Consensus       137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~-~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV  213 (566)
T PLN03225        137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIW-MNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLV  213 (566)
T ss_pred             eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHH-HHH--HHHhhchhhHHHHHHhhhcccccccCCceEEE
Confidence            478999999999999954 4    689999987643221111 111  1122222233222211      2345678999


Q ss_pred             EEccCCCChhHhhccCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC-
Q 006055          444 YDYLTMGSLSALLHGNKGA---------------GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK-  507 (663)
Q Consensus       444 ~ey~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~-  507 (663)
                      |||+.+++|.++++.....               .........+..++.|++.||.|||+.+  |+||||||+|||+++ 
T Consensus       214 ~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLKP~NILl~~~  291 (566)
T PLN03225        214 WRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEG  291 (566)
T ss_pred             EEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCCHHHEEEeCC
Confidence            9999999999998753210               0001123445679999999999999998  999999999999986 


Q ss_pred             CCceEEeccccccccCCC-----CCCCCCccccCccccCCC----------------------CCCCcchhhhHHHHHHH
Q 006055          508 SYEARVSDFGLAHLVGPS-----STPNRVAGYRAPEVTDPC----------------------KVSQKADVYSFGVLLLE  560 (663)
Q Consensus       508 ~~~~kl~Dfg~a~~~~~~-----~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dv~slGvvl~e  560 (663)
                      ++.+||+|||+++.....     ....++++|+|||.+...                      .++.++|||||||++||
T Consensus       292 ~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~e  371 (566)
T PLN03225        292 SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ  371 (566)
T ss_pred             CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHH
Confidence            578999999999865432     223456789999965321                      23456799999999999


Q ss_pred             HHhCCCCCcccc-------CCCCCChHHHHHHHHhhcccccccchhhhc-ccChHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006055          561 LLTGKAPTHALL-------NEEGVDLPRWVQSIVKDEWTSEVFDLELLR-YQNVEEEMVQLLQLAIDCSAQYPDNRPSMS  632 (663)
Q Consensus       561 lltg~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~  632 (663)
                      |+++..|++...       ...+.+...|.......      ..++... ............+++.+|+..||++|||++
T Consensus       372 l~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~  445 (566)
T PLN03225        372 MAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAK  445 (566)
T ss_pred             HHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHH
Confidence            999877654310       01111222221111100      0000000 000011122345789999999999999999


Q ss_pred             HHHHH
Q 006055          633 EVIKR  637 (663)
Q Consensus       633 ev~~~  637 (663)
                      |+++|
T Consensus       446 e~L~H  450 (566)
T PLN03225        446 AALAH  450 (566)
T ss_pred             HHhCC
Confidence            99995

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=1.7e-29  Score=273.40  Aligned_cols=250  Identities=20%  Similarity=0.273  Sum_probs=172.7

Q ss_pred             hcccccccceEEEEEEe-----------------cCCcEEEEEEecCcccC-HH--------------HHHHHHHHhhcC
Q 006055          375 AEVLGKGTFGTAYKAVL-----------------EMGTIVAVKRLKDVTIS-ER--------------EFKDKIEGVGAV  422 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-----------------~~g~~vavK~l~~~~~~-~~--------------~~~~e~~~l~~l  422 (663)
                      .++||+|+||+||+|..                 ..++.||||++...... .+              ....|+.++.++
T Consensus       150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l  229 (507)
T PLN03224        150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI  229 (507)
T ss_pred             eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence            47899999999999963                 24568999998643221 12              233467777777


Q ss_pred             CCCCc-----ccceEEEEe--------cCccEEEEEccCCCChhHhhccCCCC-------------------CCCCCCHH
Q 006055          423 NHENL-----VPLRAYYYS--------MDEKLLVYDYLTMGSLSALLHGNKGA-------------------GRTPLNWE  470 (663)
Q Consensus       423 ~h~ni-----v~l~~~~~~--------~~~~~lv~ey~~~gsL~~~l~~~~~~-------------------~~~~l~~~  470 (663)
                      +|.++     ++++++|..        ....++||||+++|+|.++++...+.                   ....++|.
T Consensus       230 ~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~  309 (507)
T PLN03224        230 KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN  309 (507)
T ss_pred             hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHH
Confidence            77654     677787753        34679999999999999999753210                   11235788


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCC-----CCCccccCccccCCCC-
Q 006055          471 MRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP-----NRVAGYRAPEVTDPCK-  544 (663)
Q Consensus       471 ~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~y~aPE~~~~~~-  544 (663)
                      .+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++........     ..++.|+|||.+.... 
T Consensus       310 ~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~  387 (507)
T PLN03224        310 VIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQS  387 (507)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCC
Confidence            89999999999999999998  999999999999999999999999999765433211     2356799999875322 


Q ss_pred             ---------------------CCCcchhhhHHHHHHHHHhCCC-CCccccCC------CCCChHHHHHHHHhhccccccc
Q 006055          545 ---------------------VSQKADVYSFGVLLLELLTGKA-PTHALLNE------EGVDLPRWVQSIVKDEWTSEVF  596 (663)
Q Consensus       545 ---------------------~~~~~Dv~slGvvl~elltg~~-p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~  596 (663)
                                           ...+.||||+||++++|++|.. |+......      ...++..|.. .     ....+
T Consensus       388 ~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~-----~~~~~  461 (507)
T PLN03224        388 CPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-Y-----KGQKY  461 (507)
T ss_pred             CCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-h-----cccCC
Confidence                                 1234799999999999999875 66432110      0111111111 0     00111


Q ss_pred             chhhhcccChHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHH
Q 006055          597 DLELLRYQNVEEEMVQLLQLAIDCSAQYP---DNRPSMSEVIKR  637 (663)
Q Consensus       597 d~~~~~~~~~~~~~~~l~~l~~~C~~~dP---~~RPt~~ev~~~  637 (663)
                      +..     ..........+++.+++..+|   .+|+|++|+++|
T Consensus       462 ~~~-----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        462 DFS-----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             Ccc-----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            111     111223456677778888765   689999999984

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=264.04  Aligned_cols=240  Identities=20%  Similarity=0.271  Sum_probs=195.7

Q ss_pred             cccccccceEEEEEEecCCc-EEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          376 EVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~-~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      ..||-|+||.|-++...+.. .+|+|.+++...    ..+.+..|-.+|...+.|.||++|..|.+.+..|++||-|-+|
T Consensus       426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG  505 (732)
T KOG0614|consen  426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG  505 (732)
T ss_pred             hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence            46999999999998866443 489999886532    2356778999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCC--
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP--  528 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--  528 (663)
                      .+...|+...     .++..+...++..+.+|++|||.++  ||+|||||+|.++|.+|.+||.|||+|+..+.+..+  
T Consensus       506 ElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwT  578 (732)
T KOG0614|consen  506 ELWTILRDRG-----SFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWT  578 (732)
T ss_pred             hhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhccCCceee
Confidence            9999998643     4788888889999999999999998  999999999999999999999999999998876543  


Q ss_pred             -CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          529 -NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       529 -~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                       .+|+.|.|||++..+..+..+|.||+|+++|||++|.+||.+.      +.......+++.-.          ....+.
T Consensus       579 FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~------dpmktYn~ILkGid----------~i~~Pr  642 (732)
T KOG0614|consen  579 FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV------DPMKTYNLILKGID----------KIEFPR  642 (732)
T ss_pred             ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC------chHHHHHHHHhhhh----------hhhccc
Confidence             4788899999999999999999999999999999999999753      22223333332211          111223


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPS-----MSEVIKRI  638 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt-----~~ev~~~L  638 (663)
                      ...+...+++++....+|.+|.-     +.++.+|-
T Consensus       643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~  678 (732)
T KOG0614|consen  643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR  678 (732)
T ss_pred             ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence            34455677888888899999875     66776654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-30  Score=277.45  Aligned_cols=239  Identities=24%  Similarity=0.351  Sum_probs=181.9

Q ss_pred             hcccccccceE-EEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGT-AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+++|.|+.|+ ||+|..+ |+.||||++-...  .....+|+..++.- +|||||++++.-.++...|+..|.|.. +|
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL  589 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SL  589 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hH
Confidence            35699999985 5999987 8999999975422  34567899988776 799999999888888889999999876 99


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC---C--CceEEeccccccccCCCC-
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK---S--YEARVSDFGLAHLVGPSS-  526 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~---~--~~~kl~Dfg~a~~~~~~~-  526 (663)
                      .+++... +.......-...+.+..|++.||+|||+.+  |+||||||.||||+.   +  ..++|+|||+++.+.... 
T Consensus       590 ~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s  666 (903)
T KOG1027|consen  590 QDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS  666 (903)
T ss_pred             HHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence            9999763 111111111334567889999999999987  999999999999976   3  469999999999876543 


Q ss_pred             ------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhC-CCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          527 ------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTG-KAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       527 ------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                            ...||.||+|||++....-+..+||||+||++|+.++| .+||......+        .+++...+....+.  
T Consensus       667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L~~L~--  736 (903)
T KOG1027|consen  667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTLVHLE--  736 (903)
T ss_pred             hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCccceeeec--
Confidence                  23477889999999888878899999999999999995 99997644332        12333322211111  


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                           ...++  +..++|.+|+..+|..||++.+|+.|
T Consensus       737 -----~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  737 -----PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             -----cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence                 11112  56778889999999999999999764

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.5e-31  Score=246.89  Aligned_cols=255  Identities=22%  Similarity=0.333  Sum_probs=188.0

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEec-----CccEEEEEc
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSM-----DEKLLVYDY  446 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~ey  446 (663)
                      +.||-|+||.||.+. -++|+.||+|++....   .+.+.+.+|++++...+|.|+...++...-.     ++.|+++|.
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL  138 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL  138 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence            579999999999988 5689999999987653   3467889999999999999999988775432     356788888


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      |.. +|..++-.     .++++-....-..+||++||.|||+.+  |.||||||.|.|++.+...||||||+|+......
T Consensus       139 mQS-DLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  139 MQS-DLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHh-hhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchhh
Confidence            765 77777653     456888888889999999999999998  9999999999999999999999999999887665


Q ss_pred             CCC-----CCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHH---------HHHHHHhhcc
Q 006055          527 TPN-----RVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPR---------WVQSIVKDEW  591 (663)
Q Consensus       527 ~~~-----~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~---------~~~~~~~~~~  591 (663)
                      ...     .|..|.|||++++. .|+...||||.||++.|++.++..|......+..++..         -++...+...
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk  290 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK  290 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence            433     34569999999885 58899999999999999999999887643221111100         0000000000


Q ss_pred             ccccc-------chh-hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          592 TSEVF-------DLE-LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       592 ~~~~~-------d~~-~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                       ..++       +.. +.........-.+-..+.++++..||+.|.+.++.+.++-
T Consensus       291 -~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  291 -NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             -HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence             0000       000 0000111122234456667889999999999999988763

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.1e-29  Score=259.75  Aligned_cols=193  Identities=25%  Similarity=0.377  Sum_probs=164.4

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      +.||-|+||+|+++. ..+...||.|.+.+...    ....++.|.++|.....+-||+|+-.|.+.+.+|+||||+++|
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG  714 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG  714 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence            469999999999998 55678899999876532    2356788999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccC-------
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-------  523 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~-------  523 (663)
                      ++-.+|-...     .+++..+..++.++..|+++.|..|  +|||||||+|||||.+|++||.|||+++-..       
T Consensus       715 DmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  715 DMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             cHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            9988876433     4788888888899999999999999  9999999999999999999999999985321       


Q ss_pred             --CC-----C--------------------------------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhC
Q 006055          524 --PS-----S--------------------------------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTG  564 (663)
Q Consensus       524 --~~-----~--------------------------------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg  564 (663)
                        ..     +                                ...+|..|+|||++....++..+|.||.|||||||+.|
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g  867 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG  867 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence              00     0                                01145569999999999999999999999999999999


Q ss_pred             CCCCccccCCC
Q 006055          565 KAPTHALLNEE  575 (663)
Q Consensus       565 ~~p~~~~~~~~  575 (663)
                      +.||......+
T Consensus       868 ~~pf~~~tp~~  878 (1034)
T KOG0608|consen  868 QPPFLADTPGE  878 (1034)
T ss_pred             CCCccCCCCCc
Confidence            99998765433

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=2.1e-29  Score=231.67  Aligned_cols=249  Identities=16%  Similarity=0.268  Sum_probs=187.1

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccCHHHHHHHHHHhhcCC-CCCcccceEEEEecC--ccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-HENLVPLRAYYYSMD--EKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~ey~~~g  450 (663)
                      .+++|+|.|++||.|. ..+.++++||.++...  .+.+.+|+.++..++ ||||+++++...++.  ...||+||+.+.
T Consensus        43 vrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~  120 (338)
T KOG0668|consen   43 VRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNT  120 (338)
T ss_pred             HHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccc
Confidence            5689999999999998 6778999999998643  578999999999997 999999999987764  467999999998


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC-CceEEeccccccccCCCCCCC
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS-YEARVSDFGLAHLVGPSSTPN  529 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~  529 (663)
                      +...+..        .++...+.....+++.||.|+|++|  |+|||+||.|++||.. ...+|+|+|+|.++.+....+
T Consensus       121 Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn  190 (338)
T KOG0668|consen  121 DFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN  190 (338)
T ss_pred             cHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCCCceee
Confidence            8877664        2666677888999999999999999  9999999999999965 469999999999998876544


Q ss_pred             ---CCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc-------cccccch
Q 006055          530 ---RVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW-------TSEVFDL  598 (663)
Q Consensus       530 ---~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~d~  598 (663)
                         .+..|.-||.+.. ..|+..-|+|||||++..|+..+.||-...+.. ..++..+ .++....       ..-.+|+
T Consensus       191 VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkIa-kVLGt~el~~Yl~KY~i~Ldp  268 (338)
T KOG0668|consen  191 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKIA-KVLGTDELYAYLNKYQIDLDP  268 (338)
T ss_pred             eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHHH-HHhChHHHHHHHHHHccCCCh
Confidence               3344889999865 457778899999999999999999985422111 0122211 1111000       0011222


Q ss_pred             hhhc---------------ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          599 ELLR---------------YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       599 ~~~~---------------~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ++..               .....-...+.++++.+.+..|-++|||++|.+.|
T Consensus       269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            2211               00001112456777779999999999999999875

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-28  Score=238.34  Aligned_cols=237  Identities=18%  Similarity=0.309  Sum_probs=182.7

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccCH----HHHHHHHHHhhc-CCCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE----REFKDKIEGVGA-VNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~----~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      ..+||+|+|+.|-.+. .++.+.+|+|++++....+    .-.+.|-.+... -+||.+|.+..+|......++|.||++
T Consensus       255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~  334 (593)
T KOG0695|consen  255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN  334 (593)
T ss_pred             eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence            3689999999999998 5678999999988653221    224445544444 479999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccccc-CCCCC
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSST  527 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~-~~~~~  527 (663)
                      +|+|--+++.++     .++++.+..+...|+.||.|||+.|  ||+||||..|||+|..|++|+.|+|+++.- .+.++
T Consensus       335 ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmcke~l~~gd~  407 (593)
T KOG0695|consen  335 GGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT  407 (593)
T ss_pred             Ccceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence            999977776543     4888889899999999999999999  999999999999999999999999999764 33333


Q ss_pred             ---CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccC-CCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          528 ---PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLN-EEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       528 ---~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                         ..+|+.|+|||++.+..|+..+|.|++||+++||+.|+.||+...- ....+...++-+++.+..+..         
T Consensus       408 tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri---------  478 (593)
T KOG0695|consen  408 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI---------  478 (593)
T ss_pred             cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc---------
Confidence               3478889999999999999999999999999999999999985421 122333444444433322111         


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCC
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRP  629 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RP  629 (663)
                        +.........+.+.-+.+||.+|.
T Consensus       479 --prslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  479 --PRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             --cceeehhhHHHHHHhhcCCcHHhc
Confidence              111222344555677788888874

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=3.1e-27  Score=229.91  Aligned_cols=206  Identities=35%  Similarity=0.509  Sum_probs=181.1

Q ss_pred             cccccceEEEEEEec-CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          378 LGKGTFGTAYKAVLE-MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       378 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      ||+|++|.||++... +++.+++|++.....  ....+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999965 489999999886644  25779999999999999999999999998889999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC-CCceEEeccccccccCCCC----CCC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK-SYEARVSDFGLAHLVGPSS----TPN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~----~~~  529 (663)
                      ++....    ..+++..+..++.++++++.|||+.+  ++|+||+|.||+++. ++.++|+|||.+.......    ...
T Consensus        81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (215)
T cd00180          81 LLKENE----GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV  154 (215)
T ss_pred             HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence            987532    35889999999999999999999998  999999999999999 8999999999998765542    233


Q ss_pred             CCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      ....|++||..... ..+.++|+|++|+++++|                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            55669999999877 788899999999999998                                               


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                        ..+.+++..|+..+|++||++.++++++
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence              2577888899999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=4.4e-28  Score=249.57  Aligned_cols=188  Identities=24%  Similarity=0.334  Sum_probs=163.7

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCH---------HHHHHHHHHhhcCC---CCCcccceEEEEecCccE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISE---------REFKDKIEGVGAVN---HENLVPLRAYYYSMDEKL  441 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---------~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~  441 (663)
                      .+.+|+|+||.|+.|.+ ++...|+||.+++.+.-.         ..+-.||.+|+.++   |+||++++++|++++..|
T Consensus       566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy  645 (772)
T KOG1152|consen  566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY  645 (772)
T ss_pred             eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence            57899999999999994 457889999987653221         13557999999997   999999999999999999


Q ss_pred             EEEEcc-CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          442 LVYDYL-TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       442 lv~ey~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                      |+||-. ++.+|.+++...+     .+++.....|+.||+-|+++||+++  |+|||||-+||.++.+|-+||+|||.|.
T Consensus       646 l~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klidfgsaa  718 (772)
T KOG1152|consen  646 LETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLIDFGSAA  718 (772)
T ss_pred             EEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEeeccchh
Confidence            999965 5669999997644     4899999999999999999999999  9999999999999999999999999997


Q ss_pred             ccC--CCCCCCCCccccCccccCCCCC-CCcchhhhHHHHHHHHHhCCCCCc
Q 006055          521 LVG--PSSTPNRVAGYRAPEVTDPCKV-SQKADVYSFGVLLLELLTGKAPTH  569 (663)
Q Consensus       521 ~~~--~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvvl~elltg~~p~~  569 (663)
                      ...  +-+...+|.+|.|||++.+..| +..-|||++|+++|-++....||+
T Consensus       719 ~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  719 YTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            654  4456779999999999999877 456799999999999999999985

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-26  Score=235.08  Aligned_cols=127  Identities=24%  Similarity=0.293  Sum_probs=108.2

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccCHHHHHHHHHHhhcCC-----C---CCcccceEEEEe----cCccE
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-----H---ENLVPLRAYYYS----MDEKL  441 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~----~~~~~  441 (663)
                      ..+||.|-|++||++. ..+.+.||+|+.+....-.+....||+++++++     |   ..||+|+++|..    +.+.+
T Consensus        83 ~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVC  162 (590)
T KOG1290|consen   83 QRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVC  162 (590)
T ss_pred             EEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEE
Confidence            4689999999999999 566889999999988776777889999998873     3   469999999864    46789


Q ss_pred             EEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc
Q 006055          442 LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT  506 (663)
Q Consensus       442 lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~  506 (663)
                      +|+|++.. +|..++....   -+.++...+..|++||+.||.|||..+ .|||-||||+|||+.
T Consensus       163 MVfEvLGd-nLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  163 MVFEVLGD-NLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLLC  222 (590)
T ss_pred             EEehhhhh-HHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeeee
Confidence            99998854 8888887543   345899999999999999999999986 699999999999995

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=4.3e-28  Score=253.65  Aligned_cols=241  Identities=24%  Similarity=0.356  Sum_probs=191.9

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      ..+|.|+||.|||++ .+.++..|||.++-.. ..-+-.++|+-+++..+|+||+.++|.|...+..+++|||+.+|+|.
T Consensus        21 qrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQ  100 (829)
T KOG0576|consen   21 QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQ  100 (829)
T ss_pred             eeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCccc
Confidence            679999999999999 6779999999998653 33466788999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC----CCCCC
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP----SSTPN  529 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~----~~~~~  529 (663)
                      +..+...     ++++.+...+++...+|++|||+++  -+|||||-.|||+++.|++|++|||.+..+..    .....
T Consensus       101 diy~~Tg-----plselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitati~Krksfi  173 (829)
T KOG0576|consen  101 DIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFI  173 (829)
T ss_pred             ceeeecc-----cchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhhhhhhhccc
Confidence            9988644     6888899999999999999999998  89999999999999999999999999865543    35567


Q ss_pred             CCccccCcccc---CCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          530 RVAGYRAPEVT---DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       530 ~~~~y~aPE~~---~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ||+.|||||+.   ..+.|.+++|||+.|+...|+-.-+.|.-......       +-..+.    ..-+++.-+++  .
T Consensus       174 GtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~l~LmT----kS~~qpp~lkD--k  240 (829)
T KOG0576|consen  174 GTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------ALFLMT----KSGFQPPTLKD--K  240 (829)
T ss_pred             CCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------HHHHhh----ccCCCCCcccC--C
Confidence            99999999986   45678999999999999999988877743221110       000010    11112111111  1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      ......+-++++.|+.++|++||+++.+++
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            122334667778999999999999998765

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=1.3e-27  Score=243.03  Aligned_cols=257  Identities=24%  Similarity=0.289  Sum_probs=194.1

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCCC------CCcccceEEEEecCccEEEEEccC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNH------ENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      ...|+|-|++|.+|.. .-|..||||++...+.-.+.=..|+++|.+|..      -|+++++..|...+++|||||-+.
T Consensus       438 ~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls  517 (752)
T KOG0670|consen  438 GYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS  517 (752)
T ss_pred             eccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhh
Confidence            3578999999999983 448899999998876666667789999999852      478999999999999999999776


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC-ceEEeccccccccCCCCC
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY-EARVSDFGLAHLVGPSST  527 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~  527 (663)
                      . +|.++|.....  ...+....+..++.|+..||..|...+  |+|.||||.|||+++.. .+||||||.|........
T Consensus       518 l-NLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei  592 (752)
T KOG0670|consen  518 L-NLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDFGSASFASENEI  592 (752)
T ss_pred             c-hHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccCccccccccccc
Confidence            5 99999986542  345788889999999999999999998  99999999999999765 579999999988776554


Q ss_pred             CCC--CccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHH-----HHHH-hhcccccccch-
Q 006055          528 PNR--VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWV-----QSIV-KDEWTSEVFDL-  598 (663)
Q Consensus       528 ~~~--~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~-----~~~~-~~~~~~~~~d~-  598 (663)
                      +..  +.-|.|||++.|..|+...|+||.||+||||.||+..|.+..+..-..+.--+     ...+ +..+....||. 
T Consensus       593 tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d  672 (752)
T KOG0670|consen  593 TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQD  672 (752)
T ss_pred             cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccc
Confidence            332  33499999999999999999999999999999999998764332100000000     0000 11111111111 


Q ss_pred             -------------------------------hhhccc----ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          599 -------------------------------ELLRYQ----NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       599 -------------------------------~~~~~~----~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                                                     .+...+    .......+|.+|+..|+..||++|.|..++++|
T Consensus       673 ~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  673 LNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             cceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence                                           111111    112335667888899999999999999999875

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=2.3e-27  Score=229.05  Aligned_cols=246  Identities=22%  Similarity=0.313  Sum_probs=181.7

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCc---ccCHHHHHHHHHHhhcCCCCCcccceEEEEec------CccEEEEE
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV---TISEREFKDKIEGVGAVNHENLVPLRAYYYSM------DEKLLVYD  445 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e  445 (663)
                      ..+|.|.- .|..|. .-.+++||+|++...   ....+...+|...+..++|+|+++++.+|+-.      .+.|+|||
T Consensus        23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e  101 (369)
T KOG0665|consen   23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME  101 (369)
T ss_pred             cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence            45777777 555554 335899999987644   23356778899999999999999999998643      35689999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      ||.. +|...++.       .++-.....|..|++.|+.|||+.+  |+||||||+||++..++.+||.|||+|+.....
T Consensus       102 ~m~~-nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~  171 (369)
T KOG0665|consen  102 LMDA-NLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD  171 (369)
T ss_pred             hhhh-HHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhcccCcc
Confidence            9976 99888873       2666788899999999999999999  999999999999999999999999999876654


Q ss_pred             ---CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHH------------------
Q 006055          526 ---STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQ------------------  584 (663)
Q Consensus       526 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~------------------  584 (663)
                         .....+..|.|||++.+..+.+.+||||.||++.||++|+.-|.+..     .+.+|.+                  
T Consensus       172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCCHHHHHHhhH
Confidence               12234556999999999889999999999999999999999886421     1222221                  


Q ss_pred             ---HHHhhcccc-------cccchhhhcc-cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          585 ---SIVKDEWTS-------EVFDLELLRY-QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       585 ---~~~~~~~~~-------~~~d~~~~~~-~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                         ...+.....       .+.|...... +...-......+++.+|+..+|++|.++++++.|
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence               111100000       0000000000 0011223456678889999999999999999985

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=1.2e-25  Score=221.84  Aligned_cols=190  Identities=33%  Similarity=0.466  Sum_probs=166.5

Q ss_pred             hcccccccceEEEEEEecC-CcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|++|.||++.... ++.+|+|.+.....  ..+.+.+|++.++.++|+|++++++++......++++||+++++
T Consensus         4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   83 (225)
T smart00221        4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD   83 (225)
T ss_pred             eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence            3579999999999999654 89999999876543  36788999999999999999999999998899999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-----
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----  526 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-----  526 (663)
                      |.+++.....    .+++.....++.+++.++.|||+.+  ++|+||+|+||+++.++.++|+|||.+.......     
T Consensus        84 L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       84 LFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence            9999975431    1789999999999999999999998  9999999999999999999999999998776542     


Q ss_pred             CCCCCccccCcccc-CCCCCCCcchhhhHHHHHHHHHhCCCCCcc
Q 006055          527 TPNRVAGYRAPEVT-DPCKVSQKADVYSFGVLLLELLTGKAPTHA  570 (663)
Q Consensus       527 ~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGvvl~elltg~~p~~~  570 (663)
                      ...+...|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            23345569999998 666778899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-25  Score=211.82  Aligned_cols=255  Identities=21%  Similarity=0.324  Sum_probs=183.3

Q ss_pred             cCHHHHHHHhhcccccccceEEEEEEec-CCcEEEEEEecCcccCHHHHHHHHHHhhcC-CCCCcccceEE-EEecCccE
Q 006055          365 FDLEDLLRASAEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAY-YYSMDEKL  441 (663)
Q Consensus       365 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~  441 (663)
                      ++++|. ..+.+.+|+|.||.+-+++++ +.+.+++|.+.......++|.+|..---.| .|.||+.-++. |...+..+
T Consensus        20 v~l~d~-y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   20 VDLEDV-YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             cchhhh-hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            444443 233567999999999999954 578999999988877888999998753334 68899987765 56667788


Q ss_pred             EEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc-CC-CceEEeccccc
Q 006055          442 LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT-KS-YEARVSDFGLA  519 (663)
Q Consensus       442 lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~-~~-~~~kl~Dfg~a  519 (663)
                      +++||++-|+|.+-+...      .+-+....+++.|++.|+.|+|++.  ++|||||.+||||- .| ..+||||||..
T Consensus        99 F~qE~aP~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t  170 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLT  170 (378)
T ss_pred             EeeccCccchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccc
Confidence            999999999999988653      3777888999999999999999998  99999999999993 33 37999999999


Q ss_pred             cccCCCCC-CCCCccccCccccCCC-----CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccc
Q 006055          520 HLVGPSST-PNRVAGYRAPEVTDPC-----KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTS  593 (663)
Q Consensus       520 ~~~~~~~~-~~~~~~y~aPE~~~~~-----~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (663)
                      +..+.... ...+..|.+||.....     .....+|||.||++++.++||+.||+..... ......|.+-.  .+...
T Consensus       171 ~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~~w~--~rk~~  247 (378)
T KOG1345|consen  171 RKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWEQWL--KRKNP  247 (378)
T ss_pred             cccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHHHHh--cccCc
Confidence            87654322 2234559999986432     2456789999999999999999999854322 22333443221  11111


Q ss_pred             cccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       594 ~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      ..  |     .........+.++.++-+..+|++|=...++.++.
T Consensus       248 ~~--P-----~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  248 AL--P-----KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             cC--c-----hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            10  0     01112233455666688889999995555555544

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=3.6e-25  Score=258.27  Aligned_cols=191  Identities=18%  Similarity=0.203  Sum_probs=137.2

Q ss_pred             cCCC-CCcccceEEE-------EecCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCc
Q 006055          421 AVNH-ENLVPLRAYY-------YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN  492 (663)
Q Consensus       421 ~l~h-~niv~l~~~~-------~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~  492 (663)
                      .++| +||++++++|       ...+..+.++||+ .++|.++++..    ...+++..++.++.||++||.|||+++  
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g--  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQG--  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence            4456 5788888877       2234567788887 45999999743    235899999999999999999999998  


Q ss_pred             ceecCCCCCCEEEcC-------------------CCceEEeccccccccCCCC--------------------CCCCCcc
Q 006055          493 VSHGNIKSSNILLTK-------------------SYEARVSDFGLAHLVGPSS--------------------TPNRVAG  533 (663)
Q Consensus       493 iiHrdlk~~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~--------------------~~~~~~~  533 (663)
                      |+||||||+||||+.                   ++.+|++|||+++......                    ...+|..
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999954                   4456677777765421100                    0124556


Q ss_pred             ccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHH
Q 006055          534 YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQL  613 (663)
Q Consensus       534 y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l  613 (663)
                      |||||++.+..++.++|||||||++|||++|..|+....        ..+......     ...+.      ......+.
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~~~~-----~~~~~------~~~~~~~~  241 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSLRHR-----VLPPQ------ILLNWPKE  241 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHHHHh-----hcChh------hhhcCHHH
Confidence            999999999999999999999999999999988864311        011111100     01110      01112245


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHH
Q 006055          614 LQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       614 ~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ..++.+|+..+|.+||++.|++++
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhhc
Confidence            577889999999999999999875

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.92  E-value=6.9e-25  Score=262.79  Aligned_cols=205  Identities=31%  Similarity=0.527  Sum_probs=135.8

Q ss_pred             HHHHHHHHHHHHHHhhcccCCChHHHHHHHHHHHhcCC---CCcCCcCCCCCCCccceeEecC-CcEEEEEcCCCCcccc
Q 006055            9 SQNIFLLLLLIISTFSFSFSDLSSDRAALLALRSSVGG---RTLLWNVYEASPCKWAGVECEQ-NRVTMLRLPGVALSGQ   84 (663)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~d~~all~~~~~~~~---~~~~w~~~~~~~c~w~gv~c~~-~~v~~L~L~~~~l~g~   84 (663)
                      ..+.|+++++++.....+.. .+.|++||++||+++..   ...+|+. ..+||.|.||+|+. ++|+.|+|++|+++|.
T Consensus         7 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~w~~-~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~   84 (968)
T PLN00113          7 QHCPYLIFMLFFLFLNFSML-HAEELELLLSFKSSINDPLKYLSNWNS-SADVCLWQGITCNNSSRVVSIDLSGKNISGK   84 (968)
T ss_pred             CCCChHHHHHHHHHHHccCC-CHHHHHHHHHHHHhCCCCcccCCCCCC-CCCCCcCcceecCCCCcEEEEEecCCCcccc
Confidence            33334333333333333333 56899999999999963   2347874 45799999999974 6899999999999888


Q ss_pred             cCccccCCCCCCCEEEccCCCCCCCCCcccc-CCCCCceEEcccccccC----------------------chhhhhcCC
Q 006055           85 IPLGILGNLTSLRTLSLRFNSLTSQLPSDLA-SCSNLRNLYLQGNHFSG----------------------EVPLFLVGL  141 (663)
Q Consensus        85 ~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~----------------------~~p~~~~~l  141 (663)
                      +|. .|..+++|+.|+|++|++++.+|..+. ++++|++|+|++|+++|                      .+|..++++
T Consensus        85 ~~~-~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l  163 (968)
T PLN00113         85 ISS-AIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSF  163 (968)
T ss_pred             CCh-HHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcC
Confidence            875 568888888888888888877776654 66666666666666554                      445555555


Q ss_pred             ccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCC
Q 006055          142 HHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSN  216 (663)
Q Consensus       142 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~  216 (663)
                      ++|+.|+|++|.+.+.+|..++++++|++|+|++|++++.+|..++.+++|+.|+|++|++++.+|..+.+++.+
T Consensus       164 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L  238 (968)
T PLN00113        164 SSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSL  238 (968)
T ss_pred             CCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCC
Confidence            666666666666655556666666666666666666665566666666666666666666666666555544443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=3.1e-24  Score=203.83  Aligned_cols=168  Identities=26%  Similarity=0.311  Sum_probs=127.7

Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN  529 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  529 (663)
                      |+|.++++...    ..++|..++.|+.|++.||.|||+.+        ||+||+++.++.+|+  ||+++...... ..
T Consensus         1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~~-~~   65 (176)
T smart00750        1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPEQ-SR   65 (176)
T ss_pred             CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeecccc-CC
Confidence            68999997532    35899999999999999999999875        999999999999999  99998765533 35


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE  609 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  609 (663)
                      ++..|+|||++.+..++.++|||||||++|||++|+.||.....     ....+.............+     .......
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~~~  135 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-----LSAILEILLNGMPADDPRD-----RSNLESV  135 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-----hcHHHHHHHHHhccCCccc-----cccHHHH
Confidence            67889999999999999999999999999999999999964321     1122222221111100000     0111222


Q ss_pred             H--HHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          610 M--VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       610 ~--~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                      .  .++.+++.+|+..+|++||++.|+++++..+.
T Consensus       136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            2  26889999999999999999999999997764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=1.5e-24  Score=217.51  Aligned_cols=252  Identities=23%  Similarity=0.368  Sum_probs=186.2

Q ss_pred             hcccccccceEEEEEEec----CCcEEEEEEecCcccCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE----MGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .++||+|.|++||++...    .++.||+|.+... .....+..|++++..+ .+.||+++.+++...+...+|+||++.
T Consensus        41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H  119 (418)
T KOG1167|consen   41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEH  119 (418)
T ss_pred             hccccccchhhhhhhhHhhhccccceEeeeecccc-cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCc
Confidence            578999999999999843    4788999988653 3356689999999988 589999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC-CCceEEecccccccc------
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK-SYEARVSDFGLAHLV------  522 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~-~~~~kl~Dfg~a~~~------  522 (663)
                      ....+++..        ++...+...+..+..||.|+|+.|  ||||||||+|+|.+. .+.-.|.|||+|..+      
T Consensus       120 ~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~  189 (418)
T KOG1167|consen  120 DRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQT  189 (418)
T ss_pred             cCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHHHhhhhh
Confidence            999999874        677888899999999999999999  999999999999975 456899999999611      


Q ss_pred             -----------CC-----------------C--------------CCCCCCccccCccccCCC-CCCCcchhhhHHHHHH
Q 006055          523 -----------GP-----------------S--------------STPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLL  559 (663)
Q Consensus       523 -----------~~-----------------~--------------~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~  559 (663)
                                 .+                 .              ....||+||.|||++... ..+.++||||.||+++
T Consensus       190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L  269 (418)
T KOG1167|consen  190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL  269 (418)
T ss_pred             hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence                       00                 0              001267789999998654 5688999999999999


Q ss_pred             HHHhCCCCCccccCCCCCChHHHH--------HHH--Hhhc--ccc-----c---------ccc-hhh--------hccc
Q 006055          560 ELLTGKAPTHALLNEEGVDLPRWV--------QSI--VKDE--WTS-----E---------VFD-LEL--------LRYQ  604 (663)
Q Consensus       560 elltg~~p~~~~~~~~~~~~~~~~--------~~~--~~~~--~~~-----~---------~~d-~~~--------~~~~  604 (663)
                      -+++++.||-...++-+. +...+        ++.  ..+.  ...     .         -++ ...        ....
T Consensus       270 slls~~~PFf~a~dd~~a-l~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~  348 (418)
T KOG1167|consen  270 SLLSRRYPFFKAKDDADA-LAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI  348 (418)
T ss_pred             hhhccccccccCccccch-HHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence            999999998654332211 11110        000  0000  000     0         000 000        0001


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      ..+.....++++..+|++.||.+|.|++|.++|-
T Consensus       349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp  382 (418)
T KOG1167|consen  349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKHP  382 (418)
T ss_pred             ccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence            1112233678889999999999999999999864

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=6.1e-25  Score=207.11  Aligned_cols=246  Identities=21%  Similarity=0.355  Sum_probs=191.1

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      ..+|.+...|+.|+|+++ |..+++|++...+.+   .++|..|.-.++-+.||||.+++|.|..+.+..++..||+.|+
T Consensus       195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            357889999999999998 566677887654322   3679999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCCCCC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV  531 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  531 (663)
                      |+.++|+..   ....+-.+..+.+.+||+|++|||+..|-|..--|.+..+++|++.+++|+ .+-+++..........
T Consensus       274 lynvlhe~t---~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsfqe~gr~y~  349 (448)
T KOG0195|consen  274 LYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEVGRAYS  349 (448)
T ss_pred             HHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeeeeccccccC
Confidence            999999765   345677889999999999999999998555555789999999999998874 2223333333344556


Q ss_pred             ccccCccccCCCCC---CCcchhhhHHHHHHHHHhCCCCCccccCCC-CCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          532 AGYRAPEVTDPCKV---SQKADVYSFGVLLLELLTGKAPTHALLNEE-GVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       532 ~~y~aPE~~~~~~~---~~~~Dv~slGvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      +.||+||.++...-   -..+|+|||.+++||+.|...||......+ +.++       ..++          ++...++
T Consensus       350 pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-------aleg----------lrv~ipp  412 (448)
T KOG0195|consen  350 PAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-------ALEG----------LRVHIPP  412 (448)
T ss_pred             cccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-------hhcc----------ccccCCC
Confidence            77999999976542   346899999999999999999998765533 1111       0011          1122223


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                      .....+.+++.-|..+||.+||.+..++-.|+.+.
T Consensus       413 gis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            34446677888999999999999999999998864

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.2e-21  Score=203.76  Aligned_cols=152  Identities=23%  Similarity=0.257  Sum_probs=118.4

Q ss_pred             hcccccccceEEEEEEec--CCcEEEEEEecCcc------cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE--MGTIVAVKRLKDVT------ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||+||+|...  +++.||||++....      .....+.+|++++..++|+|+++.+..   ....++||||
T Consensus        23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~   99 (365)
T PRK09188         23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGW   99 (365)
T ss_pred             ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEc
Confidence            467999999999999854  58889999875321      124568999999999999999863322   2468999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCC-CCCCEEEcCCCceEEeccccccccCCC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNI-KSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdl-k~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      +++++|... .. .       .   ...++.++++||.|||+.+  |+|||| ||+|||++.++.+||+|||+|+.....
T Consensus       100 ~~G~~L~~~-~~-~-------~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~  165 (365)
T PRK09188        100 TEGVPLHLA-RP-H-------G---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR  165 (365)
T ss_pred             cCCCCHHHh-Cc-c-------c---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence            999999732 11 0       0   1356788999999999998  999999 999999999999999999999876543


Q ss_pred             CC------------CCCCccccCccccCCC
Q 006055          526 ST------------PNRVAGYRAPEVTDPC  543 (663)
Q Consensus       526 ~~------------~~~~~~y~aPE~~~~~  543 (663)
                      ..            ..++..|+|||++...
T Consensus       166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        166 GALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            21            1234559999998654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=6.3e-21  Score=185.25  Aligned_cols=254  Identities=19%  Similarity=0.196  Sum_probs=189.8

Q ss_pred             hhcccccccceEEEEEE-ecCCcEEEEEEecCcccCHHHHHHHHHHhhcCC-CCCcccceEEEEecCccEEEEEccCCCC
Q 006055          374 SAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       374 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+++||+|+||+.+.|+ +-+++.||||.= .......++..|.+..+.|. .+.|...+-|-.++.+..||+|.+ +-+
T Consensus        32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfE-PrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPS  109 (449)
T KOG1165|consen   32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFE-PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPS  109 (449)
T ss_pred             eccccccCcceeeecccccccCceEEEEec-cccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcC
Confidence            36899999999999999 678999999963 33334457788888888874 588888887777788889999966 559


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC-----CceEEeccccccccCCCC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS-----YEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~-----~~~kl~Dfg~a~~~~~~~  526 (663)
                      |+|+..-+.    ..++..++..||.|++.-++|+|++.  +|.|||||+|+||..-     ..+.|+|||+|+.+.+..
T Consensus       110 LEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~  183 (449)
T KOG1165|consen  110 LEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK  183 (449)
T ss_pred             HHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence            988876443    35899999999999999999999998  9999999999999743     358999999999876543


Q ss_pred             C-----------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccc
Q 006055          527 T-----------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV  595 (663)
Q Consensus       527 ~-----------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  595 (663)
                      +           ..+|..||+--...+++-+.+-|+-|+|-++++.+-|..||.+......   ..-.+.+ .+..-...
T Consensus       184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn---K~kYeKI-Ge~Kr~T~  259 (449)
T KOG1165|consen  184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN---KEKYEKI-GETKRSTP  259 (449)
T ss_pred             ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch---HHHHHHh-ccccccCC
Confidence            3           3477889999999999999999999999999999999999998654321   1111111 11110000


Q ss_pred             cchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       596 ~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                      +  +    .-.+..+.++...+...-..+-++-|+.+-+..-+..+.+..
T Consensus       260 i--~----~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~  303 (449)
T KOG1165|consen  260 I--E----VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL  303 (449)
T ss_pred             H--H----HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence            0  0    011223445555555666777888899888777776664443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=7.3e-20  Score=190.89  Aligned_cols=259  Identities=20%  Similarity=0.185  Sum_probs=186.8

Q ss_pred             hcccccccceEEEEEEecCC--cEEEEEEecCcc-cCHHHHHHHHHHhhcCCC----CCcccceEEE-EecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLEMG--TIVAVKRLKDVT-ISEREFKDKIEGVGAVNH----ENLVPLRAYY-YSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g--~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~lv~ey  446 (663)
                      ..+||+|+||.||.+.....  ..+|+|.-.... .....+..|+.++..+..    +++..+++.. ......++||+.
T Consensus        23 ~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l  102 (322)
T KOG1164|consen   23 GKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSL  102 (322)
T ss_pred             eeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEec
Confidence            46899999999999995543  578888765542 212267788888888763    5788888888 466778999995


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC-----CceEEecccccc-
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS-----YEARVSDFGLAH-  520 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~-----~~~kl~Dfg~a~-  520 (663)
                      + +.+|.++.....   ...++..+..+|+.|++.+|.+||+.|  ++||||||.|+.+...     ..+.|.|||+++ 
T Consensus       103 ~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen  103 L-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             c-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            5 669999886544   346899999999999999999999999  9999999999999865     459999999998 


Q ss_pred             -ccC-CC--------C---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHH
Q 006055          521 -LVG-PS--------S---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIV  587 (663)
Q Consensus       521 -~~~-~~--------~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  587 (663)
                       .+. ..        .   ...+|..|.++....+...+.+.|+||++.++.|+..|..||........   ..-+....
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~~~~  253 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFEKDP  253 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHHHHh
Confidence             321 11        1   12267789999999999999999999999999999999999965432211   11111111


Q ss_pred             hhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCCCC
Q 006055          588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGL  652 (663)
Q Consensus       588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~  652 (663)
                      .......          .....+.++.++...+-..+...+|....+...+++...........+
T Consensus       254 ~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~  308 (322)
T KOG1164|consen  254 RKLLTDR----------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSP  308 (322)
T ss_pred             hhhcccc----------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCC
Confidence            1111000          001122345555556666899999999999999987755543333333

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=2e-19  Score=187.39  Aligned_cols=251  Identities=31%  Similarity=0.398  Sum_probs=189.0

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCC-CcccceEEEEecCccEEEEEccCCC
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHE-NLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      +.||.|+||.||++...  ..+++|.+.....    ....+.+|+..+..+.|+ +++++.+++......+++++|+.++
T Consensus         6 ~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~   83 (384)
T COG0515           6 RKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGG   83 (384)
T ss_pred             EeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCC
Confidence            57899999999999976  8899999876532    256799999999999988 7999999997777789999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC-ceEEeccccccccCCC----
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY-EARVSDFGLAHLVGPS----  525 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~-~~kl~Dfg~a~~~~~~----  525 (663)
                      ++.+++......  ..+.......+..+++.++.|+|+.+  ++|||+||+||+++..+ .++++|||.++.....    
T Consensus        84 ~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~  159 (384)
T COG0515          84 SLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS  159 (384)
T ss_pred             cHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence            999777643211  25888999999999999999999998  99999999999999998 7999999999755433    


Q ss_pred             ------CCCCCCccccCccccCC---CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccccccc
Q 006055          526 ------STPNRVAGYRAPEVTDP---CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF  596 (663)
Q Consensus       526 ------~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  596 (663)
                            ....++..|+|||.+.+   ..+....|+||+|++++++++|..||......   .........+...... ..
T Consensus       160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~-~~  235 (384)
T COG0515         160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP-SL  235 (384)
T ss_pred             cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-cc
Confidence                  22346677999999987   57788999999999999999999997543321   0111111111111111 00


Q ss_pred             chhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          597 DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       597 d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .... ...........+.+++..|+..+|..|.++.+....
T Consensus       236 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         236 ASPL-SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccc-CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            0000 000001223467788889999999999999988775

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2.7e-21  Score=214.20  Aligned_cols=245  Identities=18%  Similarity=0.236  Sum_probs=178.3

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEec----CcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLK----DVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~----~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+++|.|++|.|+... ....+..+.|.+.    .....   ...+..|+.+-..++|+|++..+..+.+.....-+|||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~  402 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY  402 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence            5689999999888776 3334445555433    11111   12256677778889999998877777666666666999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      ++. +|..++....     .+....+.-++.|+..|+.|+|+.|  |.|||+|++|++++.+|.+||+|||.+....-..
T Consensus       403 ~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  403 CPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             ccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            999 9999997542     3677788889999999999999999  9999999999999999999999999986543321


Q ss_pred             C--------CCCCccccCccccCCCCCCCc-chhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          527 T--------PNRVAGYRAPEVTDPCKVSQK-ADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       527 ~--------~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                      .        ..+...|+|||.+.+..|... .||||.|++++.|++|+.||......+...        ........ +.
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~~-~~  545 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSDQ-RN  545 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhccccc-cc
Confidence            1        224555999999999888665 799999999999999999998765443211        00000000 10


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      .......-....+.+-..++.++++.+|.+|.|+++|++
T Consensus       546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            000011112334556678888999999999999999986

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=3.3e-20  Score=177.51  Aligned_cols=138  Identities=13%  Similarity=0.142  Sum_probs=107.9

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCcccC---------------------------HHHHHHHHHHhhcCCCCCcc
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---------------------------EREFKDKIEGVGAVNHENLV  428 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---------------------------~~~~~~e~~~l~~l~h~niv  428 (663)
                      ..||+|+||.||+|...+|+.||||+++.....                           ......|++.+.++.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            579999999999999878999999998654211                           01223488999999888775


Q ss_pred             cceEEEEecCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCcceecCCCCCCEEEcC
Q 006055          429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL-HAQGPNVSHGNIKSSNILLTK  507 (663)
Q Consensus       429 ~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~L-H~~~~~iiHrdlk~~Nill~~  507 (663)
                      ....+.  ....++||||++++++......     ...+++.....++.|++.+|.|+ |+.+  |+||||||+||+++ 
T Consensus        83 ~p~~~~--~~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-  152 (190)
T cd05147          83 CPEPIL--LKSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCcEEE--ecCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-
Confidence            443332  2334899999999877654322     12478899999999999999999 6777  99999999999998 


Q ss_pred             CCceEEeccccccccC
Q 006055          508 SYEARVSDFGLAHLVG  523 (663)
Q Consensus       508 ~~~~kl~Dfg~a~~~~  523 (663)
                      ++.++|+|||+|....
T Consensus       153 ~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCcEEEEEccccccCC
Confidence            4789999999997553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=5.7e-20  Score=171.11  Aligned_cols=191  Identities=23%  Similarity=0.287  Sum_probs=155.8

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCC-CCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNH-ENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .++||.|+||.+|.|. ..+|+.||+|.=.. .....++..|..+.+.++| ..|..+..|..+.....+|||.. +-+|
T Consensus        20 vrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsL   97 (341)
T KOG1163|consen   20 VRKIGSGSFGDIYLGISITSGEEVAIKLESS-KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSL   97 (341)
T ss_pred             EEeecCCchhheeeeeeccCCceEEEEeecc-cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccH
Confidence            3689999999999999 78899999997433 3334467778888888876 56777788888888999999966 5699


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC---ceEEeccccccccCCCC---
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY---EARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~---~~kl~Dfg~a~~~~~~~---  526 (663)
                      +++..-+.    ..++..+.+-++-|++.-++|+|.++  .|||||||+|+|..-+.   .+.++|||+|+.+.+..   
T Consensus        98 EdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~  171 (341)
T KOG1163|consen   98 EDLFNFCS----RRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQ  171 (341)
T ss_pred             HHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhhccccccc
Confidence            99987654    35889999999999999999999998  99999999999997543   58999999998764432   


Q ss_pred             --------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccC
Q 006055          527 --------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLN  573 (663)
Q Consensus       527 --------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~  573 (663)
                              ...+|..|.+--...+.+-+.+.|+-|+|.+++++--|..||++...
T Consensus       172 HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  172 HIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             cCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence                    23366678776666666667788999999999999999999987643

>PLN03150 hypothetical protein; Provisional

Probab=99.82  E-value=7.1e-20  Score=205.99  Aligned_cols=132  Identities=34%  Similarity=0.564  Sum_probs=87.0

Q ss_pred             cCCChHHHHHHHHHHHhcCCCC-cCCcCCCCCCC-----ccceeEecCC------cEEEEEcCCCCcccccCccccCCCC
Q 006055           27 FSDLSSDRAALLALRSSVGGRT-LLWNVYEASPC-----KWAGVECEQN------RVTMLRLPGVALSGQIPLGILGNLT   94 (663)
Q Consensus        27 ~~~~~~d~~all~~~~~~~~~~-~~w~~~~~~~c-----~w~gv~c~~~------~v~~L~L~~~~l~g~~p~~~~~~l~   94 (663)
                      .+..+.|.+||+++|++++... .+|+.   +||     .|.||.|...      .|+.|+|++|+++|.+|.. ++.|+
T Consensus       367 ~~t~~~~~~aL~~~k~~~~~~~~~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~-i~~L~  442 (623)
T PLN03150        367 SKTLLEEVSALQTLKSSLGLPLRFGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPND-ISKLR  442 (623)
T ss_pred             cccCchHHHHHHHHHHhcCCcccCCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHH-HhCCC
Confidence            3456789999999999997443 36852   456     6999999521      3666777777776666653 46666


Q ss_pred             CCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCCCC
Q 006055           95 SLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGF  162 (663)
Q Consensus        95 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~  162 (663)
                      +|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+++|.+|..+
T Consensus       443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l  510 (623)
T PLN03150        443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL  510 (623)
T ss_pred             CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHH
Confidence            66666666666666666666666666666666666666666666666666666655555555555544

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=1.1e-19  Score=192.07  Aligned_cols=215  Identities=25%  Similarity=0.418  Sum_probs=163.9

Q ss_pred             hhcCCCCCcccceEEEEecCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCC
Q 006055          419 VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNI  498 (663)
Q Consensus       419 l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdl  498 (663)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+...    ...++|.....+..+|+.||.|||... -..|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeee
Confidence            35688999999999999999999999999999999999763    356999999999999999999999874 2399999


Q ss_pred             CCCCEEEcCCCceEEeccccccccCCCCCC------CCCccccCccccCCC-------CCCCcchhhhHHHHHHHHHhCC
Q 006055          499 KSSNILLTKSYEARVSDFGLAHLVGPSSTP------NRVAGYRAPEVTDPC-------KVSQKADVYSFGVLLLELLTGK  565 (663)
Q Consensus       499 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~------~~~~~y~aPE~~~~~-------~~~~~~Dv~slGvvl~elltg~  565 (663)
                      +++|.++|..+.+||+|||+..........      ....-|.|||.+...       ..+.++||||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999998877531111      011229999998763       1467799999999999999999


Q ss_pred             CCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          566 APTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       566 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                      .||+........  .+.+..+..  .....+.+......   +...++..++.+||..+|++||++++|-..++.+....
T Consensus       156 ~~~~~~~~~~~~--~eii~~~~~--~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  156 GPFDLRNLVEDP--DEIILRVKK--GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             CccccccccCCh--HHHHHHHHh--cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            999864433221  222222222  11111222221111   23336889999999999999999999999998886654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=2.7e-19  Score=171.85  Aligned_cols=138  Identities=19%  Similarity=0.205  Sum_probs=110.1

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCcccC---------------------------HHHHHHHHHHhhcCCCCCcc
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---------------------------EREFKDKIEGVGAVNHENLV  428 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---------------------------~~~~~~e~~~l~~l~h~niv  428 (663)
                      ..||+|+||.||+|...+|+.||||++......                           ...+..|.+.+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (190)
T cd05145           3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP   82 (190)
T ss_pred             ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            579999999999999778999999998754210                           11235788899999999886


Q ss_pred             cceEEEEecCccEEEEEccCCCChhHh-hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCcceecCCCCCCEEEc
Q 006055          429 PLRAYYYSMDEKLLVYDYLTMGSLSAL-LHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA-QGPNVSHGNIKSSNILLT  506 (663)
Q Consensus       429 ~l~~~~~~~~~~~lv~ey~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~iiHrdlk~~Nill~  506 (663)
                      ....+...  ..++||||++++++... +..      ..++......++.+++.++.++|+ .+  |+||||||+||+++
T Consensus        83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~  152 (190)
T cd05145          83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH  152 (190)
T ss_pred             CceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE
Confidence            55544332  35899999998865433 332      236778889999999999999999 88  99999999999999


Q ss_pred             CCCceEEeccccccccCC
Q 006055          507 KSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       507 ~~~~~kl~Dfg~a~~~~~  524 (663)
                       ++.++|+|||+++....
T Consensus       153 -~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 -DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCCEEEEEcccceecCC
Confidence             88999999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=4.1e-19  Score=167.91  Aligned_cols=180  Identities=18%  Similarity=0.115  Sum_probs=135.2

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHH-----HHHHHHHHhhcCC-CCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISER-----EFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~-----~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      ...|++|+||+||.+.- .+.+++.+.+.......+     .+.+|+++++++. |+++.+++++    ...+++|||+.
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            35799999999997766 588888888876543222     5889999999995 4788888886    45799999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCC-CCCCEEEcCCCceEEeccccccccCCCCC
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNI-KSSNILLTKSYEARVSDFGLAHLVGPSST  527 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdl-k~~Nill~~~~~~kl~Dfg~a~~~~~~~~  527 (663)
                      +.+|...+..            ....++.+++++|.++|+.|  |+|||| ||+|||++.++.++|+|||+|....+...
T Consensus        82 G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         82 GAAMYQRPPR------------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             CccHHhhhhh------------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            9998754321            01346778999999999999  999999 79999999999999999999986554331


Q ss_pred             C-----------------CCCccccCccccCCC-CCC-CcchhhhHHHHHHHHHhCCCCCccccC
Q 006055          528 P-----------------NRVAGYRAPEVTDPC-KVS-QKADVYSFGVLLLELLTGKAPTHALLN  573 (663)
Q Consensus       528 ~-----------------~~~~~y~aPE~~~~~-~~~-~~~Dv~slGvvl~elltg~~p~~~~~~  573 (663)
                      .                 ..++.|++|+...-- ..+ ...+.++-|.-+|.++|+..+.....+
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            1                 023345555543211 112 345888999999999999998765443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=9.3e-20  Score=176.24  Aligned_cols=163  Identities=15%  Similarity=0.166  Sum_probs=126.1

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCH-HH---------HHHHHHHhhcCCCCCcccceEEEEec-------
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISE-RE---------FKDKIEGVGAVNHENLVPLRAYYYSM-------  437 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-~~---------~~~e~~~l~~l~h~niv~l~~~~~~~-------  437 (663)
                      .+++|.|+||.||.+.. ++..+|||.+....... +.         +.+|+..+.+++|++|..+..++...       
T Consensus        36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~  114 (232)
T PRK10359         36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRY  114 (232)
T ss_pred             EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccc
Confidence            57899999999999766 57789999997543222 22         68899999999999999999886643       


Q ss_pred             -CccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecc
Q 006055          438 -DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDF  516 (663)
Q Consensus       438 -~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Df  516 (663)
                       ...++||||+++.+|.++..         ++.    ....+++.++..+|+.+  ++|||+||+||++++++ ++++||
T Consensus       115 ~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i~liDf  178 (232)
T PRK10359        115 AHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-LRIIDL  178 (232)
T ss_pred             cCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-EEEEEC
Confidence             24789999999999988732         222    23558899999999998  99999999999999988 999999


Q ss_pred             ccccccCCCCCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHH
Q 006055          517 GLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELL  562 (663)
Q Consensus       517 g~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ell  562 (663)
                      |...........        ..+.....+..++|+|+||+.+....
T Consensus       179 g~~~~~~e~~a~--------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        179 SGKRCTAQRKAK--------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCcccccchhhH--------HHHHHHhHhcccccccceeEeehHHH
Confidence            988655322111        11333344567899999999876554

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.80  E-value=2.1e-19  Score=178.36  Aligned_cols=191  Identities=22%  Similarity=0.237  Sum_probs=134.3

Q ss_pred             CCCCcccceEEEEe---------------------------cCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHH
Q 006055          423 NHENLVPLRAYYYS---------------------------MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI  475 (663)
Q Consensus       423 ~h~niv~l~~~~~~---------------------------~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i  475 (663)
                      +|||||++.++|.+                           +...|+||.-++. +|..++..+.      .+...+.-|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~------~s~r~~~~~  346 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH------RSYRTGRVI  346 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC------CchHHHHHH
Confidence            69999999888743                           1235789987766 8999997543      566777778


Q ss_pred             HHHHHHHHHHHhhcCCcceecCCCCCCEEE--cCCCc--eEEeccccccccCCC------C----CCCCCccccCccccC
Q 006055          476 ALGAARGIEYLHAQGPNVSHGNIKSSNILL--TKSYE--ARVSDFGLAHLVGPS------S----TPNRVAGYRAPEVTD  541 (663)
Q Consensus       476 ~~~ia~al~~LH~~~~~iiHrdlk~~Nill--~~~~~--~kl~Dfg~a~~~~~~------~----~~~~~~~y~aPE~~~  541 (663)
                      +.|+++|+.|||++|  |.|||+|++|||+  |+|+.  ..|+|||.+--....      .    ...+....||||+..
T Consensus       347 laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  347 LAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            899999999999999  9999999999998  44443  688999987322211      1    112334489999986


Q ss_pred             CCC------CCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHH
Q 006055          542 PCK------VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQ  615 (663)
Q Consensus       542 ~~~------~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~  615 (663)
                      ...      .-.|+|.|+.|-+.||+++...||+...+.. .+...    +.+.+         +  ..-++..+..+.+
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~----Yqe~q---------L--Palp~~vpp~~rq  488 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRT----YQESQ---------L--PALPSRVPPVARQ  488 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhh----hhhhh---------C--CCCcccCChHHHH
Confidence            532      2358999999999999999999998632210 11111    10010         0  1112233446778


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHH
Q 006055          616 LAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       616 l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      ++...++.||.+|++..-....|
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHH
Confidence            88899999999999987665554

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.80  E-value=5.1e-20  Score=203.16  Aligned_cols=239  Identities=26%  Similarity=0.319  Sum_probs=173.2

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCc--ccCHHHHHHHHHH--hhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDV--TISEREFKDKIEG--VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||.+.|=.|.+|+.+.|. |+||++-+.  ..+-+.|.++++-  ...++|||.+++.-.-......|||=+|..+ 
T Consensus        28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-  105 (1431)
T KOG1240|consen   28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-  105 (1431)
T ss_pred             ecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-
Confidence            467999999999999998888 889988543  3344444444433  4556999999987776666777888888877 


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccccc-CCCC---
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSS---  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~-~~~~---  526 (663)
                      +|+|.+...+     -+...+...|+.|++.||.-+|..|  |+|||||.+||||+.-.-+.|+||..-+.. -+.+   
T Consensus       106 nLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  106 NLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             hhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            9999987533     4677888899999999999999999  999999999999999999999999765421 1111   


Q ss_pred             -------CCCCCccccCccccCCCC-----------CCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHH
Q 006055          527 -------TPNRVAGYRAPEVTDPCK-----------VSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV  587 (663)
Q Consensus       527 -------~~~~~~~y~aPE~~~~~~-----------~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  587 (663)
                             +..+..+|+|||.+....           .+.+-||||+||++.||++ |++||.-.             +.+
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-------------QL~  245 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-------------QLL  245 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-------------HHH
Confidence                   122334599999875421           4567899999999999998 78888531             111


Q ss_pred             hhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       588 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                      ...... ..+++..-. .+++  ..+.+++..|++.||++|.++++.++.-.
T Consensus       246 aYr~~~-~~~~e~~Le-~Ied--~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  246 AYRSGN-ADDPEQLLE-KIED--VSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             hHhccC-ccCHHHHHH-hCcC--ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence            111100 122211100 0000  15778899999999999999999998743

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.79  E-value=2.7e-20  Score=196.30  Aligned_cols=224  Identities=27%  Similarity=0.342  Sum_probs=174.4

Q ss_pred             ccccccceEEEEEE----ecCCcEEEEEEecCccc--C-HHHHHHHHHHhhcCC-CCCcccceEEEEecCccEEEEEccC
Q 006055          377 VLGKGTFGTAYKAV----LEMGTIVAVKRLKDVTI--S-EREFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       377 ~lg~G~~g~Vy~~~----~~~g~~vavK~l~~~~~--~-~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      ++|+|+||.|+.+.    ...|..+|.|.+++...  . ......|..++...+ ||.++++.-.+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            47999999999765    34578899998875421  1 124556777788886 9999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCC
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP  528 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  528 (663)
                      +|+|...+....     .+++.........++-|++++|+.+  |+|||+|++||+++.+|++++.|||+.+..-.....
T Consensus        81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            999998886433     4666667777778999999999998  999999999999999999999999999887666555


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .++..|||||++.  .....+|.||||++++||+||..||..          +.+..+++..            ...+.+
T Consensus       154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~~------------~~~p~~  209 (612)
T KOG0603|consen  154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKAE------------LEMPRE  209 (612)
T ss_pred             ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhhc------------cCCchh
Confidence            6788899999998  457789999999999999999999965          2233333321            122333


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSM  631 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~  631 (663)
                      ......+++..+...+|..|--.
T Consensus       210 l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  210 LSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hhHHHHHHHHHHHhhCHHHHhcc
Confidence            34445555666777777777544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.76  E-value=9.7e-19  Score=174.24  Aligned_cols=228  Identities=19%  Similarity=0.284  Sum_probs=145.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCC----------CCcccceEEEE----
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNH----------ENLVPLRAYYY----  435 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~----  435 (663)
                      .+.||.|+++.||.+.. .+|+.+|||.+....    ..-+++++|.-....+.+          -.++--++...    
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            46899999999999995 569999999875332    123566666655555332          12222222221    


Q ss_pred             -----ecC--------ccEEEEEccCCCChhHhhcc---CCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCC
Q 006055          436 -----SMD--------EKLLVYDYLTMGSLSALLHG---NKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIK  499 (663)
Q Consensus       436 -----~~~--------~~~lv~ey~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk  499 (663)
                           ...        ..+++|+-+. ++|.+++..   .... ...+....+..+..|+.+.+++||+.|  ++|+|||
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHgdi~  172 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHSYG--LVHGDIK  172 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHHTT--EEEST-S
T ss_pred             CcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhhcc--eEecccc
Confidence                 111        2356788664 488877542   1111 223556777888899999999999999  9999999


Q ss_pred             CCCEEEcCCCceEEeccccccccCCCCC-CCCCccccCccccCC--------CCCCCcchhhhHHHHHHHHHhCCCCCcc
Q 006055          500 SSNILLTKSYEARVSDFGLAHLVGPSST-PNRVAGYRAPEVTDP--------CKVSQKADVYSFGVLLLELLTGKAPTHA  570 (663)
Q Consensus       500 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGvvl~elltg~~p~~~  570 (663)
                      |+|++++.+|.++|+||+.....+.... ...+.+|.+||....        -.++.+.|.|++|+++|.|.++..||+.
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~  252 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL  252 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence            9999999999999999998876665433 334466899997633        2467889999999999999999999976


Q ss_pred             ccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCC
Q 006055          571 LLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNR  628 (663)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~R  628 (663)
                      .........                      .+....+.+..+..++...++.+|++|
T Consensus       253 ~~~~~~~~~----------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  253 SSPEADPEW----------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             CGGGSTSGG----------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCccccccc----------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            433221100                      111222556677888889999999987

>PRK10345 hypothetical protein; Provisional

Probab=99.75  E-value=9.1e-18  Score=162.07  Aligned_cols=133  Identities=13%  Similarity=0.093  Sum_probs=102.5

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCc-ccCHHHHHHHHHHhhcC-----CCCCcccceEEEEecC---ccE-EEE
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDV-TISEREFKDKIEGVGAV-----NHENLVPLRAYYYSMD---EKL-LVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~-lv~  444 (663)
                      .++||+|+||.||. ...++.. +||++... ....+.+.+|+.++..+     .||||++++|++.++.   ..+ +|+
T Consensus         7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             cceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            36899999999996 3334444 78987654 23456799999999999     5799999999998864   223 789


Q ss_pred             Ec--cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCcceecCCCCCCEEEcC----CCceEEeccc
Q 006055          445 DY--LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI-EYLHAQGPNVSHGNIKSSNILLTK----SYEARVSDFG  517 (663)
Q Consensus       445 ey--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al-~~LH~~~~~iiHrdlk~~Nill~~----~~~~kl~Dfg  517 (663)
                      ||  +.+|+|.+++...      .+++.  ..++.+++.++ +|||+++  |+||||||+|||++.    ++.++|+||+
T Consensus        85 e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         85 DFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             cCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            99  5589999999642      14444  34567777777 9999998  999999999999974    3379999954


Q ss_pred             cc
Q 006055          518 LA  519 (663)
Q Consensus       518 ~a  519 (663)
                      .+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            44

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=1.9e-17  Score=187.05  Aligned_cols=184  Identities=22%  Similarity=0.290  Sum_probs=146.4

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCC---CCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN---HENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      ...||+|+||+||+|...+|+.||+|.=+....++  |.--.+++.+|+   -+-|+.+...+.-.+.-+||+||.+.|+
T Consensus       703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gt  780 (974)
T KOG1166|consen  703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGT  780 (974)
T ss_pred             EeeeccccceEEEEeecCCCcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccccc
Confidence            45799999999999998779999999866544332  222233444444   2345555555666788899999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc-------CCCceEEeccccccccCC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT-------KSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~-------~~~~~kl~Dfg~a~~~~~  524 (663)
                      |.+++...     ..++|.....+..++++.+++||..+  |||+||||+|++|.       +...++|+|||.+..+..
T Consensus       781 lld~~N~~-----~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l  853 (974)
T KOG1166|consen  781 LLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL  853 (974)
T ss_pred             HHHhhccC-----CCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence            99999843     35899999999999999999999998  99999999999995       233589999999976643


Q ss_pred             CC---C---CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCC
Q 006055          525 SS---T---PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP  567 (663)
Q Consensus       525 ~~---~---~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p  567 (663)
                      ..   .   ...|-++-.+|...|+.++..+|.|.+.-+++.|+.|+.-
T Consensus       854 fp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  854 FPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             cCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            21   1   1245568899999999999999999999999999999764

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.71  E-value=1.1e-16  Score=156.71  Aligned_cols=133  Identities=18%  Similarity=0.324  Sum_probs=113.7

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCccc---------CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI---------SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      +.||+|++|.||+|.. +|..|+||.......         ....+.+|++++..++|+++.....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4699999999999987 578899998654321         123577899999999999998888888888889999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccc
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL  521 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~  521 (663)
                      +++++|.+++....        + .+..++.+++.+|.++|+.+  ++|||++|.||+++ ++.++|+|||.++.
T Consensus        81 ~~G~~L~~~~~~~~--------~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG--------M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc--------H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999986421        2 78889999999999999998  99999999999999 78999999999865

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=1.2e-16  Score=158.17  Aligned_cols=141  Identities=16%  Similarity=0.165  Sum_probs=107.0

Q ss_pred             hcccccccceEEEEEE--ecCCcEEEEEEecCccc--------------------C-----HHHHHHHHHHhhcCCCCCc
Q 006055          375 AEVLGKGTFGTAYKAV--LEMGTIVAVKRLKDVTI--------------------S-----EREFKDKIEGVGAVNHENL  427 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~--~~~g~~vavK~l~~~~~--------------------~-----~~~~~~e~~~l~~l~h~ni  427 (663)
                      .+.||+|+||.||+|.  ..+|+.||+|.++....                    .     ...+..|++.+.++.+.. 
T Consensus        33 ~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~-  111 (237)
T smart00090       33 GGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG-  111 (237)
T ss_pred             CCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC-
Confidence            5689999999999998  57899999999864321                    0     123567999999987533 


Q ss_pred             ccceEEEEecCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC
Q 006055          428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK  507 (663)
Q Consensus       428 v~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~  507 (663)
                      +.+...+.. ...++||||+++++|.......     ..........++.+++.++.+||+.+ .|+||||||+||+++ 
T Consensus       112 i~~p~~~~~-~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli~-  183 (237)
T smart00090      112 VPVPKPIAW-RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILVH-  183 (237)
T ss_pred             CCCCeeeEe-cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEEE-
Confidence            222222222 3468999999998887654321     12455566789999999999999986 599999999999999 


Q ss_pred             CCceEEeccccccccCC
Q 006055          508 SYEARVSDFGLAHLVGP  524 (663)
Q Consensus       508 ~~~~kl~Dfg~a~~~~~  524 (663)
                      ++.++|+|||.+.....
T Consensus       184 ~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      184 DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             CCCEEEEEChhhhccCC
Confidence            88999999999876543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.68  E-value=2.6e-16  Score=152.55  Aligned_cols=130  Identities=18%  Similarity=0.301  Sum_probs=108.0

Q ss_pred             ccccccceEEEEEEecCCcEEEEEEecCcc--cC-------HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          377 VLGKGTFGTAYKAVLEMGTIVAVKRLKDVT--IS-------EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       377 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .||+|+||.||+|.+ +|..|++|......  ..       ...+.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 47889999865321  11       245678999999999988777666677777889999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccccc
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV  522 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~  522 (663)
                      ++++|.+++....      .      .++.+++.+|.+||+.+  ++|||++|.||+++ ++.+++.|||.++..
T Consensus        80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcH------H------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999999875321      0      78899999999999998  99999999999999 789999999998653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.68  E-value=1.3e-18  Score=153.98  Aligned_cols=156  Identities=29%  Similarity=0.415  Sum_probs=140.2

Q ss_pred             CCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccc
Q 006055           68 QNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        68 ~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  147 (663)
                      .++++.|.|++|+++ .+|+++ ..|.+|+.|++++|+|+. +|.+++.+++|+.|+++-|++. ..|..|+.++.|+.|
T Consensus        32 ~s~ITrLtLSHNKl~-~vppni-a~l~nlevln~~nnqie~-lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl  107 (264)
T KOG0617|consen   32 MSNITRLTLSHNKLT-VVPPNI-AELKNLEVLNLSNNQIEE-LPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL  107 (264)
T ss_pred             hhhhhhhhcccCcee-ecCCcH-HHhhhhhhhhcccchhhh-cChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence            468999999999999 888864 899999999999999986 8999999999999999999998 899999999999999


Q ss_pred             ccccccccc-cCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCC---CCCccCCcC
Q 006055          148 NLATNNFSG-EIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFG---SNSFLGNSL  223 (663)
Q Consensus       148 ~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~---~~~~~~~~l  223 (663)
                      ||.+|+++. .+|..|..++.|+.|+|++|.+. .+|..++.+++|+.|.+..|.+- .+|..++.+.   .+...+|.+
T Consensus       108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl  185 (264)
T KOG0617|consen  108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL  185 (264)
T ss_pred             hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence            999999974 68999999999999999999999 88888999999999999999998 7898877654   455677877


Q ss_pred             CCCCCC
Q 006055          224 CGKPLQ  229 (663)
Q Consensus       224 ~~~p~~  229 (663)
                      .-.|..
T Consensus       186 ~vlppe  191 (264)
T KOG0617|consen  186 TVLPPE  191 (264)
T ss_pred             eecChh
Confidence            665543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.68  E-value=2.9e-16  Score=152.01  Aligned_cols=132  Identities=17%  Similarity=0.141  Sum_probs=104.4

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCccc-----------------------CHHHHHHHHHHhhcCCCCC--ccc
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI-----------------------SEREFKDKIEGVGAVNHEN--LVP  429 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~-----------------------~~~~~~~e~~~l~~l~h~n--iv~  429 (663)
                      .+.||+|+||.||++..++|+.||||++.....                       ....+..|+..+..+.|++  +..
T Consensus        20 ~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~   99 (198)
T cd05144          20 GNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPK   99 (198)
T ss_pred             CCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCc
Confidence            478999999999999988899999998654221                       1123567888888887774  334


Q ss_pred             ceEEEEecCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC
Q 006055          430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY  509 (663)
Q Consensus       430 l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~  509 (663)
                      .++    ....++||||+++++|......           .....++.+++.++.++|+.+  |+||||||+||++++++
T Consensus       100 ~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~~  162 (198)
T cd05144         100 PID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDDE  162 (198)
T ss_pred             eee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCCC
Confidence            433    2456899999999999775431           224568889999999999998  99999999999999999


Q ss_pred             ceEEeccccccccC
Q 006055          510 EARVSDFGLAHLVG  523 (663)
Q Consensus       510 ~~kl~Dfg~a~~~~  523 (663)
                      .++|+|||.+....
T Consensus       163 ~~~liDfg~~~~~~  176 (198)
T cd05144         163 KIYIIDWPQMVSTD  176 (198)
T ss_pred             cEEEEECCccccCC
Confidence            99999999996544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.67  E-value=3.4e-16  Score=174.43  Aligned_cols=131  Identities=18%  Similarity=0.277  Sum_probs=108.3

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEE-ecCc-c-------cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKR-LKDV-T-------ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~-l~~~-~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  445 (663)
                      .+.||+|+||+||++.+.... +++|+ +... .       .....+.+|++++..++|++++....++......++|||
T Consensus       338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E  416 (535)
T PRK09605        338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME  416 (535)
T ss_pred             cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence            478999999999999876443 44443 2221 1       112457899999999999999988888888788899999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccccc
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV  522 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~  522 (663)
                      |+++++|.+++.             ....++.+++++|.|||+.+  ++||||||+||++ +++.++|+|||+++..
T Consensus       417 ~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        417 YIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             ecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            999999999885             34678899999999999998  9999999999999 6789999999999764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.60  E-value=2.5e-15  Score=144.07  Aligned_cols=135  Identities=19%  Similarity=0.192  Sum_probs=96.5

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCcccCHH---H----------------------HHHHHHHhhcCCCCC--cc
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISER---E----------------------FKDKIEGVGAVNHEN--LV  428 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~---~----------------------~~~e~~~l~~l~h~n--iv  428 (663)
                      +.||+|+||+||+|...+|+.||||.+........   .                      ...|.+.+..+.+..  +.
T Consensus         3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~   82 (187)
T cd05119           3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP   82 (187)
T ss_pred             cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence            57999999999999987899999998865422111   1                      124445555553332  33


Q ss_pred             cceEEEEecCccEEEEEccCCCChhH-hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCcceecCCCCCCEEEc
Q 006055          429 PLRAYYYSMDEKLLVYDYLTMGSLSA-LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA-QGPNVSHGNIKSSNILLT  506 (663)
Q Consensus       429 ~l~~~~~~~~~~~lv~ey~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~iiHrdlk~~Nill~  506 (663)
                      +.+++    ...++||||++++.+.. .+....      .. .....++.+++.++.++|. .+  |+||||||+||+++
T Consensus        83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~  149 (187)
T cd05119          83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD  149 (187)
T ss_pred             ceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE
Confidence            33332    35689999999965432 121110      11 5567889999999999999 77  99999999999999


Q ss_pred             CCCceEEeccccccccCC
Q 006055          507 KSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       507 ~~~~~kl~Dfg~a~~~~~  524 (663)
                       ++.++++|||.+.....
T Consensus       150 -~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             -CCcEEEEECcccccccC
Confidence             89999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.59  E-value=7.3e-16  Score=160.04  Aligned_cols=118  Identities=24%  Similarity=0.357  Sum_probs=102.1

Q ss_pred             ccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccc
Q 006055          439 EKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGL  518 (663)
Q Consensus       439 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~  518 (663)
                      ..++.|+++...+|.+|+...+.  ....++...+.++.|++.|++|   ++  .+|||+||.||+...+..+||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhh
Confidence            46899999999999999975432  3446888899999999999999   65  89999999999999999999999999


Q ss_pred             ccccCCCC----------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh
Q 006055          519 AHLVGPSS----------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT  563 (663)
Q Consensus       519 a~~~~~~~----------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt  563 (663)
                      ........          ...+|..||+||.+.+..|+.|+||||||++++|++.
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            97765443          1235666999999999999999999999999999997

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.59  E-value=4.3e-15  Score=136.66  Aligned_cols=133  Identities=16%  Similarity=0.089  Sum_probs=111.6

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCC--CCcccceEEEEecCccEEEEEccCCCChh
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNH--ENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      +.||+|.++.||++...+ ..+++|....... ...+..|+..+..++|  .++.+++.+....+..+++|||++++.+.
T Consensus         4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~   81 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD   81 (155)
T ss_pred             eecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence            569999999999999764 7899999866543 5678999999999977  48888888887777899999999887665


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-CcceecCCCCCCEEEcCCCceEEecccccccc
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG-PNVSHGNIKSSNILLTKSYEARVSDFGLAHLV  522 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~  522 (663)
                      .+            +......++.++++++.++|... ..++|+|++|.||++++.+.+++.|||.++..
T Consensus        82 ~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          82 EV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             cC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            43            44566778899999999999853 34999999999999999899999999998643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.59  E-value=7e-16  Score=170.91  Aligned_cols=197  Identities=25%  Similarity=0.394  Sum_probs=131.7

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .+.|..|+||.||.+.++ +.+.+|.|+ .+...          ++     +||..+.+      ..+.|      |+-.
T Consensus        88 IklisngAygavylvrh~~trqrfa~ki-Nkq~l----------il-----Rnilt~a~------npfvv------gDc~  139 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----------IL-----RNILTFAG------NPFVV------GDCA  139 (1205)
T ss_pred             eEeeccCCCCceeeeeccccccchhhcc-cccch----------hh-----hccccccC------Cccee------chhh
Confidence            478999999999999854 467888843 22110          11     11222221      22222      4444


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC--------
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--------  525 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~--------  525 (663)
                      ..+..-.     +++..+        +.+++|||+.+  |+|||+||+|.+|+.-|++|+.|||+.+.-...        
T Consensus       140 tllk~~g-----~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg  204 (1205)
T KOG0606|consen  140 TLLKNIG-----PLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEG  204 (1205)
T ss_pred             hhcccCC-----CCcchh--------hHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhc
Confidence            4444211     233333        67899999998  999999999999999999999999998642111        


Q ss_pred             -----------CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhc--cc
Q 006055          526 -----------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE--WT  592 (663)
Q Consensus       526 -----------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~  592 (663)
                                 ....+|+.|+|||++....|+..+|+|++|+++||.+.|+.||.+...++      .+...+.+.  |.
T Consensus       205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------lfg~visd~i~wp  278 (1205)
T KOG0606|consen  205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVISDDIEWP  278 (1205)
T ss_pred             chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------HHhhhhhhhcccc
Confidence                       11236778999999999999999999999999999999999997653322      222222221  11


Q ss_pred             ccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCH
Q 006055          593 SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSM  631 (663)
Q Consensus       593 ~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~  631 (663)
                      ++           .+....+..+++.+.++.+|..|--.
T Consensus       279 E~-----------dea~p~Ea~dli~~LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  279 EE-----------DEALPPEAQDLIEQLLRQNPLCRLGT  306 (1205)
T ss_pred             cc-----------CcCCCHHHHHHHHHHHHhChHhhccc
Confidence            11           12223456667778889999998533

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.58  E-value=2.5e-16  Score=163.58  Aligned_cols=153  Identities=25%  Similarity=0.277  Sum_probs=128.3

Q ss_pred             eeEecCCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCc
Q 006055           63 GVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLH  142 (663)
Q Consensus        63 gv~c~~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  142 (663)
                      |+.-....++.|+|+.|+++ .+..+.+-+|+.|+.|+||+|.|+..-++.+..+++|++|+|++|+|+...+..|..|.
T Consensus       263 G~Fy~l~kme~l~L~~N~l~-~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~  341 (873)
T KOG4194|consen  263 GAFYGLEKMEHLNLETNRLQ-AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLS  341 (873)
T ss_pred             cceeeecccceeecccchhh-hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHH
Confidence            44433467999999999999 78888889999999999999999999999999999999999999999988888899999


Q ss_pred             cccccccccccccccCCCCCcccccccccccccccccCcCCC---CCCCCCCCCEEEeecCcCCCCCCcccccCCCC
Q 006055          143 HLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPG---FDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSN  216 (663)
Q Consensus       143 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~---~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~  216 (663)
                      .|+.|+|++|+++..--..|..+++|+.|||++|.|++.+.+   .|..|++|+.|+|.+|+|....-.+|..+..+
T Consensus       342 ~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~L  418 (873)
T KOG4194|consen  342 QLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEAL  418 (873)
T ss_pred             HhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCccc
Confidence            999999999999866666788889999999999999887765   47778888888888888884333556555544

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.58  E-value=2.2e-14  Score=142.28  Aligned_cols=138  Identities=20%  Similarity=0.187  Sum_probs=107.1

Q ss_pred             Hhhcccc-cccceEEEEEEecCCcEEEEEEecCcc--------------cCHHHHHHHHHHhhcCCCCCc--ccceEEEE
Q 006055          373 ASAEVLG-KGTFGTAYKAVLEMGTIVAVKRLKDVT--------------ISEREFKDKIEGVGAVNHENL--VPLRAYYY  435 (663)
Q Consensus       373 ~~~~~lg-~G~~g~Vy~~~~~~g~~vavK~l~~~~--------------~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~  435 (663)
                      .....|| .|+.|+||.+... +..++||++....              .....+.+|++++..++|+++  ++.+++..
T Consensus        34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~  112 (239)
T PRK01723         34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV  112 (239)
T ss_pred             hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence            3456898 8999999999876 7789999875311              123467889999999998875  56676644


Q ss_pred             ecCc----cEEEEEccCC-CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc
Q 006055          436 SMDE----KLLVYDYLTM-GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE  510 (663)
Q Consensus       436 ~~~~----~~lv~ey~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~  510 (663)
                      ....    .++||||+++ .+|.+++...      .++..    .+.+++.++.+||+.|  |+||||||.|||++.++.
T Consensus       113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~  180 (239)
T PRK01723        113 VRHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPDGK  180 (239)
T ss_pred             eecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCC
Confidence            3322    2599999997 6899888642      23433    3567899999999999  999999999999999999


Q ss_pred             eEEeccccccccC
Q 006055          511 ARVSDFGLAHLVG  523 (663)
Q Consensus       511 ~kl~Dfg~a~~~~  523 (663)
                      ++|+|||.++...
T Consensus       181 v~LIDfg~~~~~~  193 (239)
T PRK01723        181 FWLIDFDRGELRT  193 (239)
T ss_pred             EEEEECCCcccCC
Confidence            9999999987643

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.56  E-value=7.6e-17  Score=142.84  Aligned_cols=141  Identities=27%  Similarity=0.424  Sum_probs=130.0

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEccccccc-CchhhhhcCCcccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS-GEVPLFLVGLHHLVRL  147 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L  147 (663)
                      .+++.|++.+|++. .+|.+ ++.++.|+.|+++-|++. .+|..|+.++.|+.|||+.|+++ ..+|..|..++.|+.|
T Consensus        56 ~nlevln~~nnqie-~lp~~-issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlral  132 (264)
T KOG0617|consen   56 KNLEVLNLSNNQIE-ELPTS-ISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRAL  132 (264)
T ss_pred             hhhhhhhcccchhh-hcChh-hhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHH
Confidence            47889999999999 89985 699999999999999997 48999999999999999999987 4589999999999999


Q ss_pred             ccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCC
Q 006055          148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGS  215 (663)
Q Consensus       148 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~  215 (663)
                      +|+.|.+. .+|+.+++|++|+.|.+.+|.+- .+|..++.+..|+.|.+.+|+++ .+|+.++++..
T Consensus       133 yl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l  197 (264)
T KOG0617|consen  133 YLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDL  197 (264)
T ss_pred             HhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhh
Confidence            99999998 89999999999999999999998 89999999999999999999999 77877776543

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.56  E-value=1.1e-15  Score=152.33  Aligned_cols=147  Identities=29%  Similarity=0.397  Sum_probs=125.7

Q ss_pred             cEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEccc-ccccCchh-------------
Q 006055           70 RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQG-NHFSGEVP-------------  135 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p-------------  135 (663)
                      ..+.|+|..|+|+ .||+++|+.+++|+.||||+|+|+.+-|..|.+|.+|..|-+.+ |+|+. +|             
T Consensus        68 ~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~-l~k~~F~gL~slqrL  145 (498)
T KOG4237|consen   68 ETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD-LPKGAFGGLSSLQRL  145 (498)
T ss_pred             cceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh-hhhhHhhhHHHHHHH
Confidence            5788999999999 99999999999999999999999999999999998887776666 76652 21             


Q ss_pred             --------------------------------------------------------------------------------
Q 006055          136 --------------------------------------------------------------------------------  135 (663)
Q Consensus       136 --------------------------------------------------------------------------------  135 (663)
                                                                                                      
T Consensus       146 llNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc  225 (498)
T KOG4237|consen  146 LLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARC  225 (498)
T ss_pred             hcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhccccee
Confidence                                                                                            


Q ss_pred             ------------------------------------------hhhcCCccccccccccccccccCCCCCccccccccccc
Q 006055          136 ------------------------------------------LFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFL  173 (663)
Q Consensus       136 ------------------------------------------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l  173 (663)
                                                                ..|..|++|+.|+|++|+|++.-+.+|..+..|++|.|
T Consensus       226 ~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L  305 (498)
T KOG4237|consen  226 VSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYL  305 (498)
T ss_pred             cchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhc
Confidence                                                      12557888999999999999888889999999999999


Q ss_pred             ccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc
Q 006055          174 ENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF  218 (663)
Q Consensus       174 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~  218 (663)
                      ..|+|...-...|.++..|++|+|.+|+|+...|.+|..+..++-
T Consensus       306 ~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~  350 (498)
T KOG4237|consen  306 TRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLST  350 (498)
T ss_pred             CcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeee
Confidence            999998666678889999999999999999888988877665543

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.51  E-value=1.6e-15  Score=158.50  Aligned_cols=159  Identities=25%  Similarity=0.341  Sum_probs=94.6

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      ..++.|||++|+|+ ..|.+ +.+-.++-.|+||+|+|..+..+-|-+|+.|-.||||+|++. .+|+.+..|.+|++|+
T Consensus       103 ~dLt~lDLShNqL~-EvP~~-LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~  179 (1255)
T KOG0444|consen  103 KDLTILDLSHNQLR-EVPTN-LEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLK  179 (1255)
T ss_pred             ccceeeecchhhhh-hcchh-hhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhh
Confidence            35666777777766 66653 456666666666666665532234456666666666666666 4555556666666666


Q ss_pred             ccccccc-------------------------ccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCC
Q 006055          149 LATNNFS-------------------------GEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       149 l~~N~l~-------------------------~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  203 (663)
                      |++|.+.                         ..+|.++..|.+|..+|||.|.|. .+|+.+..+++|+.|+||+|+|+
T Consensus       180 Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it  258 (1255)
T KOG0444|consen  180 LSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT  258 (1255)
T ss_pred             cCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee
Confidence            6666542                         235666667777777777777776 66776667777777777777666


Q ss_pred             CCC--CcccccCCCCCccCCcCCCCCCCCC
Q 006055          204 GSI--PKRFQTFGSNSFLGNSLCGKPLQDC  231 (663)
Q Consensus       204 g~~--p~~~~~~~~~~~~~~~l~~~p~~~c  231 (663)
                      ..-  -..+.++..+..+.|.|...|...|
T Consensus       259 eL~~~~~~W~~lEtLNlSrNQLt~LP~avc  288 (1255)
T KOG0444|consen  259 ELNMTEGEWENLETLNLSRNQLTVLPDAVC  288 (1255)
T ss_pred             eeeccHHHHhhhhhhccccchhccchHHHh
Confidence            211  1223444455555555554444333

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.49  E-value=2.2e-15  Score=157.40  Aligned_cols=144  Identities=29%  Similarity=0.395  Sum_probs=91.6

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEccccccc-----------------
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS-----------------  131 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-----------------  131 (663)
                      .+...|+|++|+|. +||...|-+|+.|-.||||+|++.. +|+.+.+|.+|++|+|++|-+.                 
T Consensus       126 Kn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~-LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLh  203 (1255)
T KOG0444|consen  126 KNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEM-LPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLH  203 (1255)
T ss_pred             cCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhh-cCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhh
Confidence            46778999999998 8998888899999999999998875 6777777777777777777542                 


Q ss_pred             --------CchhhhhcCCccccccccccccccccCCCCCcccccccccccccccccC----------------------c
Q 006055          132 --------GEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSG----------------------S  181 (663)
Q Consensus       132 --------~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~----------------------~  181 (663)
                              ..+|.++..|.+|..+|||.|++. .+|..+-++++|+.|+||+|+|+.                      .
T Consensus       204 ms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~  282 (1255)
T KOG0444|consen  204 MSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTV  282 (1255)
T ss_pred             cccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhcc
Confidence                    113445555555666666666655 555555555555555555555441                      4


Q ss_pred             CCCCCCCCCCCCEEEeecCcCCC-CCCcccccCCC
Q 006055          182 IPGFDDVLPNLQQLNVSNNLLNG-SIPKRFQTFGS  215 (663)
Q Consensus       182 ~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~~~~  215 (663)
                      +|+.+..|++|+.|++.+|+|+- -||+.++.+..
T Consensus       283 LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~  317 (1255)
T KOG0444|consen  283 LPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQ  317 (1255)
T ss_pred             chHHHhhhHHHHHHHhccCcccccCCccchhhhhh
Confidence            45555555555555555555432 24544444433

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.45  E-value=7.3e-14  Score=145.45  Aligned_cols=147  Identities=27%  Similarity=0.279  Sum_probs=127.4

Q ss_pred             cEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccccc
Q 006055           70 RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL  149 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  149 (663)
                      .+..|+|++|.|+ .+....|.++++|+.++|.+|.|+. +|.......+|+.|+|.+|.|+..-.+.+.-++.|+.|||
T Consensus        79 ~t~~LdlsnNkl~-~id~~~f~nl~nLq~v~l~~N~Lt~-IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDL  156 (873)
T KOG4194|consen   79 QTQTLDLSNNKLS-HIDFEFFYNLPNLQEVNLNKNELTR-IPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDL  156 (873)
T ss_pred             ceeeeeccccccc-cCcHHHHhcCCcceeeeeccchhhh-cccccccccceeEEeeeccccccccHHHHHhHhhhhhhhh
Confidence            4677999999999 5555578999999999999999986 8876667778999999999999877888999999999999


Q ss_pred             ccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc
Q 006055          150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF  218 (663)
Q Consensus       150 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~  218 (663)
                      |.|.|+..--++|..-.++++|+|++|.|+..-.+.|.++.+|..|.|+.|+++...+..|.+++.+.+
T Consensus       157 SrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~  225 (873)
T KOG4194|consen  157 SRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLES  225 (873)
T ss_pred             hhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhh
Confidence            999999555567877789999999999999888889999999999999999999666677877776655

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.45  E-value=1.4e-14  Score=160.92  Aligned_cols=242  Identities=26%  Similarity=0.293  Sum_probs=176.7

Q ss_pred             cccccccceEEEEEEec--CCcEEEEEEecCccc---CHHHHHHHHHHhhcCC-CCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVLE--MGTIVAVKRLKDVTI---SEREFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      +.||+|+|+.|-.....  ....+|+|.+.....   .......|..+-..+. |+|++++++...+.+..+++.+|..+
T Consensus        26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g  105 (601)
T KOG0590|consen   26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG  105 (601)
T ss_pred             ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence            45999999999887743  345677776654432   2334455777767776 99999999999999999999999999


Q ss_pred             CChhHhh-ccCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCcceecCCCCCCEEEcCCC-ceEEeccccccccCC-C
Q 006055          450 GSLSALL-HGNKGAGRTPLNWEMRSLIALGAARGIEYLH-AQGPNVSHGNIKSSNILLTKSY-EARVSDFGLAHLVGP-S  525 (663)
Q Consensus       450 gsL~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH-~~~~~iiHrdlk~~Nill~~~~-~~kl~Dfg~a~~~~~-~  525 (663)
                      +++.+-+ +...    ...+.........|+..++.|+| ..+  +.|||+||+|.+++..+ ..+++|||+|..+.. .
T Consensus       106 ~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~  179 (601)
T KOG0590|consen  106 GSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN  179 (601)
T ss_pred             cccccccccCCc----cCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence            9999888 4321    13455566778899999999999 777  99999999999999999 999999999987765 2


Q ss_pred             CC------CCC-CccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          526 ST------PNR-VAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       526 ~~------~~~-~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                      ..      ..+ +..|+|||...+. ......|+||.|+++.-+++|..|++...... .....|.....         .
T Consensus       180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~~---------~  249 (601)
T KOG0590|consen  180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNKG---------R  249 (601)
T ss_pred             CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeeccccc---------c
Confidence            21      235 6679999999884 44667899999999999999999997654433 11122211110         0


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      .....+   ........++..+++..+|..|.+.+++..
T Consensus       250 ~~~~~~---~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  250 FTQLPW---NSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cccCcc---ccCChhhhhcccccccCCchhccccccccc
Confidence            000011   122234556666888899999999998865

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.42  E-value=1e-12  Score=141.68  Aligned_cols=140  Identities=21%  Similarity=0.274  Sum_probs=98.7

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCccc---------------------------C--------------HHHHHH
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI---------------------------S--------------EREFKD  414 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~---------------------------~--------------~~~~~~  414 (663)
                      +.||.|++|.||+|++++|+.||||+.+....                           .              +-+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            57999999999999999999999999754210                           0              002344


Q ss_pred             HHHHhhcC----CCCCcccceEEEE-ecCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHH-HHHHHhh
Q 006055          415 KIEGVGAV----NHENLVPLRAYYY-SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR-GIEYLHA  488 (663)
Q Consensus       415 e~~~l~~l----~h~niv~l~~~~~-~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-al~~LH~  488 (663)
                      |...+.++    +|.+-+.+-..+. .....++||||+++++|.++......    ..   .+..++..++. .+..+|.
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHHh
Confidence            54444443    2333333322332 23467999999999999887653210    12   23456666665 4778898


Q ss_pred             cCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       489 ~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      .|  ++|+|+||.||++++++.++++|||++....+
T Consensus       276 ~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 DG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CC--ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            88  99999999999999999999999999977654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.40  E-value=4.6e-15  Score=148.01  Aligned_cols=152  Identities=24%  Similarity=0.344  Sum_probs=113.4

Q ss_pred             cEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccccc
Q 006055           70 RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL  149 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  149 (663)
                      .+..|+..+|+++ ++|++ ++++..|..|++.+|.+... |+..-+++.|+.||..+|-++ .+|..++.+.+|..|+|
T Consensus       138 ~l~dl~~~~N~i~-slp~~-~~~~~~l~~l~~~~n~l~~l-~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL  213 (565)
T KOG0472|consen  138 DLEDLDATNNQIS-SLPED-MVNLSKLSKLDLEGNKLKAL-PENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYL  213 (565)
T ss_pred             hhhhhhccccccc-cCchH-HHHHHHHHHhhccccchhhC-CHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHh
Confidence            4666777888888 78874 57888888888888888764 444445888888888888887 77778888888888888


Q ss_pred             ccccccccCCCCCcccccccccccccccccCcCCCC-CCCCCCCCEEEeecCcCCCCCCcccccCC---CCCccCCcCCC
Q 006055          150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGF-DDVLPNLQQLNVSNNLLNGSIPKRFQTFG---SNSFLGNSLCG  225 (663)
Q Consensus       150 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~~~---~~~~~~~~l~~  225 (663)
                      ..|+|. .+| +|+++..|.+|+++.|+|. .+|.. ...+++|..|||..|+++ ..|..+.-++   .+...||.+++
T Consensus       214 ~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~  289 (565)
T KOG0472|consen  214 RRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS  289 (565)
T ss_pred             hhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc
Confidence            888887 666 7888888888888888887 55554 447788888888888887 6776654444   44446777777


Q ss_pred             CCCC
Q 006055          226 KPLQ  229 (663)
Q Consensus       226 ~p~~  229 (663)
                      .|..
T Consensus       290 Lp~s  293 (565)
T KOG0472|consen  290 LPYS  293 (565)
T ss_pred             CCcc
Confidence            6654

>PLN03150 hypothetical protein; Provisional

Probab=99.39  E-value=2.2e-13  Score=153.69  Aligned_cols=108  Identities=34%  Similarity=0.524  Sum_probs=92.2

Q ss_pred             CceEEcccccccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeec
Q 006055          120 LRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSN  199 (663)
Q Consensus       120 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~  199 (663)
                      ++.|+|++|.++|.+|..+..|++|+.|+|++|+|+|.+|..++++++|+.|+|++|+|+|.+|..++.+++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            78899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCCCCCcccccCC----CCCccCC-cCCCCC
Q 006055          200 NLLNGSIPKRFQTFG----SNSFLGN-SLCGKP  227 (663)
Q Consensus       200 N~l~g~~p~~~~~~~----~~~~~~~-~l~~~p  227 (663)
                      |+|+|.+|..+..+.    .+.+.+| .+|+.|
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccCCC
Confidence            999999998776532    2334444 466654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.39  E-value=4.1e-13  Score=131.15  Aligned_cols=199  Identities=20%  Similarity=0.343  Sum_probs=138.8

Q ss_pred             HhhcCCCCCcccceEEEEecC-----ccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCc
Q 006055          418 GVGAVNHENLVPLRAYYYSMD-----EKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN  492 (663)
Q Consensus       418 ~l~~l~h~niv~l~~~~~~~~-----~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~  492 (663)
                      -+-.+.|.||++++.|+.+..     ...++.|||..|++..+|++.+. ....+......+++.||..||.|||+..|+
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            344567999999999987643     36789999999999999986542 234467777788999999999999999999


Q ss_pred             ceecCCCCCCEEEcCCCceEEeccccccccCCC---------CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh
Q 006055          493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS---------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT  563 (663)
Q Consensus       493 iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt  563 (663)
                      |+|+++..+-|++..++-+|++--.... ..+.         ....+-+||.+||+-.....+..+|||+||....||..
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            9999999999999999988885321111 1111         01123567999999877777888999999999999988


Q ss_pred             CCCCCc-cccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          564 GKAPTH-ALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       564 g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                      +...-. ....-+   ...-..+.        ++..+.          ..-...+.+|+.-.|..||+|++++.|.-
T Consensus       278 lEiq~tnseS~~~---~ee~ia~~--------i~~len----------~lqr~~i~kcl~~eP~~rp~ar~llfHpl  333 (458)
T KOG1266|consen  278 LEIQSTNSESKVE---VEENIANV--------IIGLEN----------GLQRGSITKCLEGEPNGRPDARLLLFHPL  333 (458)
T ss_pred             heeccCCCcceee---hhhhhhhh--------eeeccC----------ccccCcCcccccCCCCCCcchhhhhcCce
Confidence            765421 110000   00000000        000000          00124566899999999999999987754

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.36  E-value=1.8e-13  Score=136.83  Aligned_cols=130  Identities=33%  Similarity=0.436  Sum_probs=92.0

Q ss_pred             cEEEEEcCCCCcccccCcc-----------------------ccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcc
Q 006055           70 RVTMLRLPGVALSGQIPLG-----------------------ILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQ  126 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~-----------------------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  126 (663)
                      -|+.++++.|++. ++|..                       .+..+++|+.|+|++|-+.. +|.+++.+..|+.|||+
T Consensus       389 ~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln~-LP~e~~~lv~Lq~LnlS  466 (565)
T KOG0472|consen  389 IVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLND-LPEEMGSLVRLQTLNLS  466 (565)
T ss_pred             ceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhhh-cchhhhhhhhhheeccc
Confidence            3888888888776 55532                       35667777777777777754 67777777777777777


Q ss_pred             cccccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCC
Q 006055          127 GNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       127 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  203 (663)
                      +|+|. .+|..+..+..|+.+-.++|++....|+.+.+|.+|..|||.+|.|. .+|..++++.+|++|+|++|+|.
T Consensus       467 ~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  467 FNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            77776 67777766666766666667776444455777777777777777777 66777777777777777777776

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.32  E-value=7.7e-12  Score=117.73  Aligned_cols=129  Identities=15%  Similarity=0.137  Sum_probs=96.9

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCccc-ceEEEEecCccEEEEEccCCCChhH
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVP-LRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      +.|+.|.++.||++... +..|++|...........+..|++++..+.+.++++ ++.+  .....++||||+++.++.+
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLT   80 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcccc
Confidence            56899999999999876 788999987654323345678888888886666554 4433  3345689999999987754


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---CcceecCCCCCCEEEcCCCceEEeccccccc
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG---PNVSHGNIKSSNILLTKSYEARVSDFGLAHL  521 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~---~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~  521 (663)
                      .-          .   ....++.+++++|..||..+   ..++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 ~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          81 ED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            30          0   11234678999999999886   1259999999999999 66899999998853

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.25  E-value=2.2e-13  Score=141.82  Aligned_cols=152  Identities=28%  Similarity=0.390  Sum_probs=121.4

Q ss_pred             EEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccc
Q 006055           71 VTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLA  150 (663)
Q Consensus        71 v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~  150 (663)
                      |..|.|..|.+. .||. .+.+|..|++|||+.|+++. +|..+..|+ |+.|-+++|+++ .+|+.++.+..|..||.+
T Consensus       100 Le~liLy~n~~r-~ip~-~i~~L~~lt~l~ls~NqlS~-lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s  174 (722)
T KOG0532|consen  100 LESLILYHNCIR-TIPE-AICNLEALTFLDLSSNQLSH-LPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVS  174 (722)
T ss_pred             HHHHHHHhccce-ecch-hhhhhhHHHHhhhccchhhc-CChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhh
Confidence            344555566666 6776 35888889999999999875 777777776 888899999988 788888888899999999


Q ss_pred             cccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc---cCCcCCCCC
Q 006055          151 TNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF---LGNSLCGKP  227 (663)
Q Consensus       151 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~---~~~~l~~~p  227 (663)
                      .|.+. .+|+.++.|.+|+.|.+..|++. .+|..+..| .|..||+|.|+++ .||-.|.+++.|..   .+|+|...|
T Consensus       175 ~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPP  250 (722)
T KOG0532|consen  175 KNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPP  250 (722)
T ss_pred             hhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCCh
Confidence            99988 78888999999999999999998 666666655 4888999999998 88988888877765   577777776


Q ss_pred             CCCC
Q 006055          228 LQDC  231 (663)
Q Consensus       228 ~~~c  231 (663)
                      .+.|
T Consensus       251 AqIC  254 (722)
T KOG0532|consen  251 AQIC  254 (722)
T ss_pred             HHHH
Confidence            6655

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.23  E-value=1e-11  Score=135.41  Aligned_cols=139  Identities=16%  Similarity=0.223  Sum_probs=89.4

Q ss_pred             cccccccceEEEEEEecC-CcEEEEEEecCcc---------------------------cC--------H------HHHH
Q 006055          376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVT---------------------------IS--------E------REFK  413 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~---------------------------~~--------~------~~~~  413 (663)
                      +.||+|++|.||+|.+++ |+.||||+.+...                           ..        .      -+|.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            579999999999999877 9999999986321                           00        0      1233


Q ss_pred             HHHHHhhcC----CCCCcccceEEEEe-cCccEEEEEccCCCChhHhh--ccCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 006055          414 DKIEGVGAV----NHENLVPLRAYYYS-MDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL  486 (663)
Q Consensus       414 ~e~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~ey~~~gsL~~~l--~~~~~~~~~~l~~~~~~~i~~~ia~al~~L  486 (663)
                      +|...+.++    .+.+.+.+-..+.+ ....+|||||++|+.+.++-  ... +.....+.......++.       -+
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~-g~d~~~la~~~v~~~~~-------Qi  276 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA-GTDMKLLAERGVEVFFT-------QV  276 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc-CCCHHHHHHHHHHHHHH-------HH
Confidence            344333333    24444443333332 35678999999999998752  211 11011122222222222       23


Q ss_pred             hhcCCcceecCCCCCCEEEcCCC----ceEEeccccccccCC
Q 006055          487 HAQGPNVSHGNIKSSNILLTKSY----EARVSDFGLAHLVGP  524 (663)
Q Consensus       487 H~~~~~iiHrdlk~~Nill~~~~----~~kl~Dfg~a~~~~~  524 (663)
                      +..|  ++|+|+||.||+++.++    .+++.|||++....+
T Consensus       277 f~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 FRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            4566  99999999999999988    999999999977654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.21  E-value=4e-10  Score=120.98  Aligned_cols=163  Identities=20%  Similarity=0.256  Sum_probs=124.9

Q ss_pred             ecCCcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhHhhccCCCCCCCCCCH
Q 006055          391 LEMGTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNW  469 (663)
Q Consensus       391 ~~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~  469 (663)
                      ..++.+|.|...+.... ......+.++.++.+|||||++++..+......|+|+|-+.  -|..++..        +..
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l~~  103 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------LGK  103 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------hHH
Confidence            55688888888765533 13456777888999999999999999999999999999764  46666653        234


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC----CCCCccccCccccCCCCC
Q 006055          470 EMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST----PNRVAGYRAPEVTDPCKV  545 (663)
Q Consensus       470 ~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~y~aPE~~~~~~~  545 (663)
                      ......+.||+.||.|||+.+ .++|++|.-..|+++..|+.||++|.++........    ..--..|..|+.+.... 
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc-
Confidence            556667889999999999776 699999999999999999999999988754432221    11122377777765443 


Q ss_pred             CCcchhhhHHHHHHHHHhCCC
Q 006055          546 SQKADVYSFGVLLLELLTGKA  566 (663)
Q Consensus       546 ~~~~Dv~slGvvl~elltg~~  566 (663)
                       -..|.|-|||+++|++.|..
T Consensus       182 -~s~D~~~Lg~li~el~ng~~  201 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNGSL  201 (690)
T ss_pred             -cchhhhhHHHHHHHHhCccc
Confidence             24699999999999999933

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.20  E-value=1.5e-11  Score=139.59  Aligned_cols=123  Identities=32%  Similarity=0.512  Sum_probs=75.1

Q ss_pred             EecCCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccc
Q 006055           65 ECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL  144 (663)
Q Consensus        65 ~c~~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  144 (663)
                      .|-..+.+.|+|++++++ .+|..+   .++|+.|+|++|+|+. +|..+.  ++|+.|+|++|+|+ .+|..+.  .+|
T Consensus       174 ~Cl~~~~~~L~L~~~~Lt-sLP~~I---p~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L  243 (754)
T PRK15370        174 DCLKNNKTELRLKILGLT-TIPACI---PEQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTI  243 (754)
T ss_pred             hhcccCceEEEeCCCCcC-cCCccc---ccCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccc
Confidence            455556677777777777 566532   2467777777777764 555443  46777777777776 4555443  356


Q ss_pred             cccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCC
Q 006055          145 VRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       145 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  203 (663)
                      +.|+|++|++. .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+
T Consensus       244 ~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt  296 (754)
T PRK15370        244 QEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR  296 (754)
T ss_pred             cEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc
Confidence            66666666666 5555543  35666666666666 4454432  35666666666666

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.20  E-value=1.3e-11  Score=139.17  Aligned_cols=105  Identities=30%  Similarity=0.449  Sum_probs=54.9

Q ss_pred             CCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCCCCccccccccccc
Q 006055           94 TSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFL  173 (663)
Q Consensus        94 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l  173 (663)
                      .+|+.|+|++|+|++ +|..   ..+|+.|++++|+|+ .+|..   ..+|+.|+|++|+|+ .+|...   ++|+.|+|
T Consensus       342 ~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdL  409 (788)
T PRK15387        342 SGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLT-SLPVLP---SELKELMV  409 (788)
T ss_pred             cccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCccc---ccccceEEecCCccc-CCCCcc---cCCCEEEc
Confidence            367777777777775 4432   234555566666665 24432   234556666666665 344322   34555555


Q ss_pred             ccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCC
Q 006055          174 ENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGS  215 (663)
Q Consensus       174 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~  215 (663)
                      ++|+|+ .+|..   ..+|+.|+|++|+|+ .+|..+.++..
T Consensus       410 S~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~  446 (788)
T PRK15387        410 SGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSS  446 (788)
T ss_pred             cCCcCC-CCCcc---hhhhhhhhhccCccc-ccChHHhhccC
Confidence            555555 24432   234555555555555 45554444433

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.19  E-value=2.8e-11  Score=137.39  Aligned_cols=143  Identities=26%  Similarity=0.380  Sum_probs=115.4

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      ..++.|+|++|+|+ .+|...+   ++|+.|+|++|+|++ +|..+.  .+|+.|+|++|++. .+|..+.  .+|+.|+
T Consensus       199 ~~L~~L~Ls~N~Lt-sLP~~l~---~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~  268 (754)
T PRK15370        199 EQITTLILDNNELK-SLPENLQ---GNIKTLYANSNQLTS-IPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLD  268 (754)
T ss_pred             cCCcEEEecCCCCC-cCChhhc---cCCCEEECCCCcccc-CChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEE
Confidence            47899999999999 8897543   689999999999986 676654  58999999999999 6787764  5899999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCc-ccccCCCCCccCCcCCCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPK-RFQTFGSNSFLGNSLCGKP  227 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~~~~~~~~~~~l~~~p  227 (663)
                      |++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+. +|. ...++..+.+.+|.+.+.|
T Consensus       269 Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~~sL~~L~Ls~N~Lt~LP  341 (754)
T PRK15370        269 LFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA-LPETLPPGLKTLEAGENALTSLP  341 (754)
T ss_pred             CcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc-CCccccccceeccccCCccccCC
Confidence            9999999 6787765  58999999999999 4565442  579999999999995 454 3445666667777777655


Q ss_pred             C
Q 006055          228 L  228 (663)
Q Consensus       228 ~  228 (663)
                      .
T Consensus       342 ~  342 (754)
T PRK15370        342 A  342 (754)
T ss_pred             h
Confidence            3

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.19  E-value=2.6e-11  Score=129.00  Aligned_cols=238  Identities=18%  Similarity=0.212  Sum_probs=169.1

Q ss_pred             hhccccc--ccceEEEEEEe---cCCcEEEEEEecCcc---cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEE
Q 006055          374 SAEVLGK--GTFGTAYKAVL---EMGTIVAVKRLKDVT---ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVY  444 (663)
Q Consensus       374 ~~~~lg~--G~~g~Vy~~~~---~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  444 (663)
                      ....+|.  |.+|.||.+..   .++..+|+|+-+...   .....-.+|+...+.+ .|+|.++....+.+.+..++-+
T Consensus       118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqt  197 (524)
T KOG0601|consen  118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQT  197 (524)
T ss_pred             cccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeee
Confidence            3567899  99999999875   568899999843321   2223334555555555 5999999888899999999999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCcceecCCCCCCEEEcCC-CceEEeccccc
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR----GIEYLHAQGPNVSHGNIKSSNILLTKS-YEARVSDFGLA  519 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----al~~LH~~~~~iiHrdlk~~Nill~~~-~~~kl~Dfg~a  519 (663)
                      |++. .+|..+.+....    .++....+.+..+..+    |+.++|...  ++|-|+||.||++..+ ...++.|||+.
T Consensus       198 E~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  198 ELCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             cccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCccee
Confidence            9776 588888775432    2455556666666666    999999997  9999999999999999 88999999999


Q ss_pred             cccCCCCCC---------CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhc
Q 006055          520 HLVGPSSTP---------NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE  590 (663)
Q Consensus       520 ~~~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  590 (663)
                      ...++....         .+.+-|++||..++ .++...|+|++|.++.+..++..+........      |.+  ++..
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~~--~r~~  341 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS------WSQ--LRQG  341 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC------ccc--cccc
Confidence            877665311         23445999999876 45778999999999999999888764432211      110  0000


Q ss_pred             ccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       591 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      +     .    .....+.-..++..++.++++.+|-.|++.+.+..
T Consensus       342 ~-----i----p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  342 Y-----I----PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             c-----C----chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            0     0    11111122234555788999999999999887654

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.18  E-value=3.1e-12  Score=140.42  Aligned_cols=131  Identities=31%  Similarity=0.355  Sum_probs=103.9

Q ss_pred             cEEEEEcCCCCcccccCccccC-------------------------CCCCCCEEEccCCCCCCCCCccccCCCCCceEE
Q 006055           70 RVTMLRLPGVALSGQIPLGILG-------------------------NLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLY  124 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~-------------------------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  124 (663)
                      .+..|+|..|+|. .+|+..|.                         .++.|+.|+|.+|.|+...-+.|.+..+|+.|+
T Consensus       311 sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLh  389 (1081)
T KOG0618|consen  311 SLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLH  389 (1081)
T ss_pred             eeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeee
Confidence            4888888888886 66653321                         234577788888888877666788888888999


Q ss_pred             cccccccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCC
Q 006055          125 LQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNG  204 (663)
Q Consensus       125 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g  204 (663)
                      |++|+|.......+.+|..|+.|+||+|+++ .+|..+.++..|++|...+|+|. .+| .+..++.|+.+|||.|+|+-
T Consensus       390 LsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~  466 (1081)
T KOG0618|consen  390 LSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSE  466 (1081)
T ss_pred             ecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhh
Confidence            9999888545556788888888899999888 78888888888888888888888 777 67888888888988888874

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.17  E-value=8.9e-12  Score=115.84  Aligned_cols=109  Identities=33%  Similarity=0.476  Sum_probs=31.0

Q ss_pred             CCCCCCCEEEccCCCCCCCCCcccc-CCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCCCC-cccccc
Q 006055           91 GNLTSLRTLSLRFNSLTSQLPSDLA-SCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGF-KNLTKL  168 (663)
Q Consensus        91 ~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L  168 (663)
                      .+...++.|+|++|.|+. + +.++ .+.+|+.|+|++|.++ .++ .+..+++|+.|+|++|+|+ .++..+ ..+++|
T Consensus        16 ~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L   90 (175)
T PF14580_consen   16 NNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNL   90 (175)
T ss_dssp             ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT-
T ss_pred             cccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcC
Confidence            455566666666666654 2 2344 4566666666666666 333 3556666666666666666 333333 246666


Q ss_pred             cccccccccccCcCC-CCCCCCCCCCEEEeecCcCCC
Q 006055          169 KTLFLENNRLSGSIP-GFDDVLPNLQQLNVSNNLLNG  204 (663)
Q Consensus       169 ~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~g  204 (663)
                      +.|+|++|+|...-. ..+..+++|+.|+|.+|+++.
T Consensus        91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~  127 (175)
T PF14580_consen   91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE  127 (175)
T ss_dssp             -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred             CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence            667777776653111 234566777777777777763

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.14  E-value=7.6e-11  Score=133.18  Aligned_cols=113  Identities=29%  Similarity=0.403  Sum_probs=71.5

Q ss_pred             cEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccccc
Q 006055           70 RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL  149 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  149 (663)
                      +++.|+|.+|+|+ .+|.    .+++|++|+|++|+|+. +|..   .++|+.|+|++|.|+ .+|..+   .+|+.|+|
T Consensus       223 ~L~~L~L~~N~Lt-~LP~----lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~L  289 (788)
T PRK15387        223 HITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWI  289 (788)
T ss_pred             CCCEEEccCCcCC-CCCC----CCCCCcEEEecCCccCc-ccCc---ccccceeeccCCchh-hhhhch---hhcCEEEC
Confidence            5677777777777 5664    24677777777777775 4532   356777777777776 455432   45777788


Q ss_pred             ccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCC
Q 006055          150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       150 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  203 (663)
                      ++|+|+ .+|..   +++|+.|+|++|+|++ +|...   .+|+.|++++|+|+
T Consensus       290 s~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~  335 (788)
T PRK15387        290 FGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLT  335 (788)
T ss_pred             cCCccc-ccccc---ccccceeECCCCcccc-CCCCc---ccccccccccCccc
Confidence            888887 45543   3678888888888884 44322   23444444444444

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.14  E-value=4.2e-12  Score=122.48  Aligned_cols=130  Identities=30%  Similarity=0.357  Sum_probs=108.2

Q ss_pred             cEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccccc
Q 006055           70 RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL  149 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  149 (663)
                      -+++|||++|.++ .|.. ...-++.++.|+||+|+|...  ..+..|++|+.||||+|.++ .+..+-..|-+.+.|.|
T Consensus       285 ~LtelDLS~N~I~-~iDE-SvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L  359 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDE-SVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL  359 (490)
T ss_pred             hhhhccccccchh-hhhh-hhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence            4788999999998 7776 457789999999999999753  34888999999999999998 66667778889999999


Q ss_pred             ccccccccCCCCCcccccccccccccccccCcC-CCCCCCCCCCCEEEeecCcCCCCC
Q 006055          150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSI-PGFDDVLPNLQQLNVSNNLLNGSI  206 (663)
Q Consensus       150 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~g~~  206 (663)
                      +.|.|...  +.++.|-+|.+||+++|+|.... -..++++|.|++|.|.+|+|.+.+
T Consensus       360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            99998733  45788889999999999997422 246889999999999999998654

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.13  E-value=4e-12  Score=139.55  Aligned_cols=129  Identities=30%  Similarity=0.391  Sum_probs=111.6

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      ..++.|.|.+|.|+...=+ .|.++.+|+.|+|++|+|.......+.++..|++|+||+|.|+ .+|..+..+..|++|.
T Consensus       359 ~~Lq~LylanN~Ltd~c~p-~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~  436 (1081)
T KOG0618|consen  359 AALQELYLANNHLTDSCFP-VLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLR  436 (1081)
T ss_pred             HHHHHHHHhcCcccccchh-hhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHh
Confidence            3688899999999865443 5789999999999999998744557899999999999999999 8999999999999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccC-cCCCCCCCCCCCCEEEeecCcC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSG-SIPGFDDVLPNLQQLNVSNNLL  202 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l  202 (663)
                      ..+|+|. ..| .+.++++|+.+||+.|+|+- .+|..... ++|++|||++|.-
T Consensus       437 ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  437 AHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTR  488 (1081)
T ss_pred             hcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcc
Confidence            9999998 777 89999999999999999974 34444332 8999999999984

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.12  E-value=1.5e-11  Score=114.35  Aligned_cols=120  Identities=32%  Similarity=0.380  Sum_probs=50.0

Q ss_pred             cEEEEEcCCCCcccccCccccC-CCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhh-cCCcccccc
Q 006055           70 RVTMLRLPGVALSGQIPLGILG-NLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFL-VGLHHLVRL  147 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L  147 (663)
                      +++.|+|.+|+|+ .|..  ++ .+.+|+.|+|++|.|+. ++ .+..+++|++|+|++|+++. ++..+ ..+++|+.|
T Consensus        20 ~~~~L~L~~n~I~-~Ie~--L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L   93 (175)
T PF14580_consen   20 KLRELNLRGNQIS-TIEN--LGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQEL   93 (175)
T ss_dssp             -----------------S----TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EE
T ss_pred             ccccccccccccc-cccc--hhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEE
Confidence            5788999999998 6653  55 68899999999999987 33 58889999999999999994 54444 468999999


Q ss_pred             ccccccccccC-CCCCcccccccccccccccccCcCCC----CCCCCCCCCEEE
Q 006055          148 NLATNNFSGEI-PSGFKNLTKLKTLFLENNRLSGSIPG----FDDVLPNLQQLN  196 (663)
Q Consensus       148 ~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~  196 (663)
                      +|++|+|...- -..+..+++|+.|+|.+|.++. .+.    .+..+|+|+.||
T Consensus        94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~-~~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen   94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE-KKNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG-STTHHHHHHHH-TT-SEET
T ss_pred             ECcCCcCCChHHhHHHHcCCCcceeeccCCcccc-hhhHHHHHHHHcChhheeC
Confidence            99999997421 2346778999999999999983 343    356678888876

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.09  E-value=7.7e-10  Score=108.89  Aligned_cols=140  Identities=20%  Similarity=0.218  Sum_probs=107.4

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCC--CcccceEEEEecC---ccEEEEEccC
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHE--NLVPLRAYYYSMD---EKLLVYDYLT  448 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~ey~~  448 (663)
                      +.|+.|.++.||++...+|+.+++|.......  ....+..|.+++..+++.  ++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            46899999999999987678999998765432  355788999999998764  4566777665432   5689999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG--------------------------------------  490 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~--------------------------------------  490 (663)
                      +.++.+.+..      ..++...+..++.+++++|.+||+..                                      
T Consensus        84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            9888776531      13566777778888888888888421                                      


Q ss_pred             ----------------CcceecCCCCCCEEEcC--CCceEEeccccccc
Q 006055          491 ----------------PNVSHGNIKSSNILLTK--SYEARVSDFGLAHL  521 (663)
Q Consensus       491 ----------------~~iiHrdlk~~Nill~~--~~~~kl~Dfg~a~~  521 (663)
                                      ..++|+|+.+.||+++.  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                            23689999999999998  66789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.09  E-value=1.6e-09  Score=102.81  Aligned_cols=135  Identities=13%  Similarity=0.118  Sum_probs=96.7

Q ss_pred             cccccccceEEEEEEecC-------CcEEEEEEecCcc----------------------cC-HHHHH----HHHHHhhc
Q 006055          376 EVLGKGTFGTAYKAVLEM-------GTIVAVKRLKDVT----------------------IS-EREFK----DKIEGVGA  421 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~l~~~~----------------------~~-~~~~~----~e~~~l~~  421 (663)
                      ..||.|--+.||.|...+       +..+|||+.+...                      .+ .+.+.    +|.+.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998543       5799999874210                      01 12233    78888888


Q ss_pred             CCC--CCcccceEEEEecCccEEEEEccCCCChhH-hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCcceecC
Q 006055          422 VNH--ENLVPLRAYYYSMDEKLLVYDYLTMGSLSA-LLHGNKGAGRTPLNWEMRSLIALGAARGIEYL-HAQGPNVSHGN  497 (663)
Q Consensus       422 l~h--~niv~l~~~~~~~~~~~lv~ey~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~L-H~~~~~iiHrd  497 (663)
                      +..  -++...+++    ...++||||+.++.+.. .+..      ..++......+..+++.+|.+| |+.+  |+|+|
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGD  150 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHAD  150 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCC
Confidence            753  345555554    57889999998754422 2321      1244455667788999999999 7777  99999


Q ss_pred             CCCCCEEEcCCCceEEeccccccccC
Q 006055          498 IKSSNILLTKSYEARVSDFGLAHLVG  523 (663)
Q Consensus       498 lk~~Nill~~~~~~kl~Dfg~a~~~~  523 (663)
                      |++.||+++ ++.+.++|||.+....
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeCC
Confidence            999999997 4689999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PLN03210 Resistant to P

Probab=98.98  E-value=1.2e-09  Score=132.24  Aligned_cols=148  Identities=24%  Similarity=0.238  Sum_probs=91.0

Q ss_pred             cEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccccc
Q 006055           70 RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL  149 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  149 (663)
                      .++.|++.++.+. .+|.. | .+.+|+.|+|++|+|.. +|..+..+++|+.|+|++|...+.+|. +..+++|+.|+|
T Consensus       590 ~Lr~L~~~~~~l~-~lP~~-f-~~~~L~~L~L~~s~l~~-L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L  664 (1153)
T PLN03210        590 KLRLLRWDKYPLR-CMPSN-F-RPENLVKLQMQGSKLEK-LWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKL  664 (1153)
T ss_pred             ccEEEEecCCCCC-CCCCc-C-CccCCcEEECcCccccc-cccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEe
Confidence            4666666666665 66653 2 45677777777777654 566666677777777776654445553 566677777777


Q ss_pred             ccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCccCCcC
Q 006055          150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSL  223 (663)
Q Consensus       150 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~l  223 (663)
                      ++|.....+|..++++++|+.|++++|..-+.+|..+ ++++|+.|+|++|...+.+|....++..+.+.+|.+
T Consensus       665 ~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i  737 (1153)
T PLN03210        665 SDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAI  737 (1153)
T ss_pred             cCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCcc
Confidence            7665555667777777777777777654434555544 566677777766655555555444454444444443

syringae 6; Provisional

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.98  E-value=2.9e-10  Score=121.06  Aligned_cols=240  Identities=19%  Similarity=0.194  Sum_probs=168.0

Q ss_pred             cccccccceEEEEEEe--cCCcEEEEEEecCcccC---HHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVL--EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      ..||.|.|+.||....  .++..|++|.+......   +..-..|+.+...+ .|.++++....|......++=-||+++
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~  350 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG  350 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence            5799999999998773  56889999988655222   22234455554444 588999988888888888899999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC-CceEEeccccccccCCCC-C
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS-YEARVSDFGLAHLVGPSS-T  527 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~-~  527 (663)
                      +++.....-     ...++...++++..+++.++.++|+..  ++|+|+||+||++..+ +.-+++|||.++.+.-.. .
T Consensus       351 ~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~  423 (524)
T KOG0601|consen  351 GSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGV  423 (524)
T ss_pred             cchhhhhHH-----HHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccccceeccc
Confidence            988766521     234677788899999999999999998  9999999999999876 788999999987533222 2


Q ss_pred             CCCCcccc--CccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          528 PNRVAGYR--APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       528 ~~~~~~y~--aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      .....++.  +|+......+..++|++|||.-+.|.+++..--....        .|. . +..+...           .
T Consensus       424 ~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~-~-i~~~~~p-----------~  482 (524)
T KOG0601|consen  424 FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSL-T-IRSGDTP-----------N  482 (524)
T ss_pred             ccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cce-e-eeccccc-----------C
Confidence            22233344  4555555677889999999999999999865432110        000 0 0011000           0


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      ......++..+...+...++..||.+.++..+....+.
T Consensus       483 ~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  483 LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence            11111455666667889999999999988877665543

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.96  E-value=6.6e-11  Score=123.53  Aligned_cols=135  Identities=29%  Similarity=0.323  Sum_probs=102.0

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCC---CCEEEccCCCCCC----CCCccccCC-CCCceEEcccccccCc----hhh
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTS---LRTLSLRFNSLTS----QLPSDLASC-SNLRNLYLQGNHFSGE----VPL  136 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~  136 (663)
                      .+++.|+|++|.+.+..+. .+..+..   |+.|+|++|++++    .+...+..+ ++|+.|+|++|.+++.    ++.
T Consensus        81 ~~L~~L~l~~~~~~~~~~~-~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~  159 (319)
T cd00116          81 CGLQELDLSDNALGPDGCG-VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK  159 (319)
T ss_pred             CceeEEEccCCCCChhHHH-HHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence            5899999999998754443 4455554   9999999999873    233445666 8999999999999843    445


Q ss_pred             hhcCCcccccccccccccccc----CCCCCcccccccccccccccccCc----CCCCCCCCCCCCEEEeecCcCCC
Q 006055          137 FLVGLHHLVRLNLATNNFSGE----IPSGFKNLTKLKTLFLENNRLSGS----IPGFDDVLPNLQQLNVSNNLLNG  204 (663)
Q Consensus       137 ~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~g  204 (663)
                      .+..+++|+.|+|++|.+++.    ++..+..+++|++|+|++|.+++.    ++..+..+++|+.|++++|++++
T Consensus       160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~  235 (319)
T cd00116         160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD  235 (319)
T ss_pred             HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence            567778899999999998842    334455667899999999998743    34456778899999999999885

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PLN03210 Resistant to P

Probab=98.96  E-value=1.7e-09  Score=130.99  Aligned_cols=144  Identities=27%  Similarity=0.339  Sum_probs=92.7

Q ss_pred             cceeEecCCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcC
Q 006055           61 WAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVG  140 (663)
Q Consensus        61 w~gv~c~~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  140 (663)
                      |.|+.+ ..+++.|+|+++...+.+|.  ++.+++|+.|+|++|.....+|..+.++++|+.|+|++|..-+.+|..+ +
T Consensus       627 ~~~~~~-l~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~  702 (1153)
T PLN03210        627 WDGVHS-LTGLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-N  702 (1153)
T ss_pred             cccccc-CCCCCEEECCCCCCcCcCCc--cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-C
Confidence            666533 35688888887765557774  6778888888888876556677778888888888887764334555543 4


Q ss_pred             Ccccccccccc---------------------ccccccCCCCC------------------------------ccccccc
Q 006055          141 LHHLVRLNLAT---------------------NNFSGEIPSGF------------------------------KNLTKLK  169 (663)
Q Consensus       141 l~~L~~L~l~~---------------------N~l~~~~p~~~------------------------------~~l~~L~  169 (663)
                      +++|+.|+|++                     |.+. .+|..+                              ...++|+
T Consensus       703 l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~  781 (1153)
T PLN03210        703 LKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLT  781 (1153)
T ss_pred             CCCCCEEeCCCCCCccccccccCCcCeeecCCCccc-cccccccccccccccccccchhhccccccccchhhhhccccch
Confidence            44444444444                     4433 233221                              0123566


Q ss_pred             ccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcc
Q 006055          170 TLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKR  209 (663)
Q Consensus       170 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~  209 (663)
                      .|+|++|...+.+|..++++++|+.|+|++|..-+.+|..
T Consensus       782 ~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~  821 (1153)
T PLN03210        782 RLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTG  821 (1153)
T ss_pred             heeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCC
Confidence            7777777766678888888888888888877544466654

syringae 6; Provisional

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.95  E-value=1.1e-08  Score=93.80  Aligned_cols=132  Identities=20%  Similarity=0.300  Sum_probs=99.8

Q ss_pred             cccccccceEEEEEEecCCcEEEEEE-ecCc-cc-------CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKR-LKDV-TI-------SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~-l~~~-~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      ..+++|+-+.+|.+.+. |..+++|. +++. ..       ....-.+|..++.+++--.|.-.+-+..+.....++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35889999999999875 55566664 3322 11       123456788888887766666666677788889999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG  523 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~  523 (663)
                      +++-.|.+.+...            +..++..+-.-+.-||..+  |+|+||.++||.+..+. +.++|||++.+..
T Consensus        81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             eCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            9999999888642            2345566667778899999  99999999999998765 9999999997543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.94  E-value=1.1e-08  Score=93.27  Aligned_cols=141  Identities=16%  Similarity=0.240  Sum_probs=103.8

Q ss_pred             cccccccceEEEEEEecCCcEEEEEE-ecCc--------ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKR-LKDV--------TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~-l~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      ++|-+|+-+.|+++.+. |+...||. +.+.        ....+.-.+|.+.+.+++--.|.-..-++.+.....++|||
T Consensus        13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            57889999999999987 88877774 3221        12245677889988887665665555567777888999999


Q ss_pred             cCC-CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc---eEEecccccccc
Q 006055          447 LTM-GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLAHLV  522 (663)
Q Consensus       447 ~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~---~kl~Dfg~a~~~  522 (663)
                      .++ -++.+++.....   ...........+..|-+.+.-||..+  |+|+||..+||++..++.   +.++|||++...
T Consensus        92 ~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   92 IDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             ccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhcc
Confidence            976 477777765331   11222222567778888899999998  999999999999976653   589999998544

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.94  E-value=8.7e-11  Score=122.78  Aligned_cols=137  Identities=30%  Similarity=0.401  Sum_probs=121.0

Q ss_pred             cCCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccc
Q 006055           67 EQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVR  146 (663)
Q Consensus        67 ~~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  146 (663)
                      .-..++.|+|+.|+++ .+|..+ ..|+ |+.|-+++|+++. +|..++.+..|..||.+.|++. .+|..++.|.+|+.
T Consensus       119 ~L~~lt~l~ls~NqlS-~lp~~l-C~lp-Lkvli~sNNkl~~-lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~  193 (722)
T KOG0532|consen  119 NLEALTFLDLSSNQLS-HLPDGL-CDLP-LKVLIVSNNKLTS-LPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRD  193 (722)
T ss_pred             hhhHHHHhhhccchhh-cCChhh-hcCc-ceeEEEecCcccc-CCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHH
Confidence            3467889999999999 888864 5554 9999999999975 8999999999999999999998 78999999999999


Q ss_pred             cccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCccccc
Q 006055          147 LNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQT  212 (663)
Q Consensus       147 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~  212 (663)
                      |++..|++. .+|..+..| .|..||+|.|+++ .||-.|..|+.|++|-|.+|.|+ ..|..+..
T Consensus       194 l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~  255 (722)
T KOG0532|consen  194 LNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICE  255 (722)
T ss_pred             HHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHh
Confidence            999999998 778888855 5889999999999 99999999999999999999999 55655443

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.92  E-value=3.4e-08  Score=103.12  Aligned_cols=171  Identities=25%  Similarity=0.295  Sum_probs=130.0

Q ss_pred             cceEEEEEE-ecCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEe----cCccEEEEEccCC-CChhH
Q 006055          382 TFGTAYKAV-LEMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYS----MDEKLLVYDYLTM-GSLSA  454 (663)
Q Consensus       382 ~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ey~~~-gsL~~  454 (663)
                      -..+.|++. ..||..|++|+++..+ ........-+++++++.|+|+|++.+++..    +...++||+|+++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            345779998 6689999999995432 223334556788999999999999998763    4457899999885 46766


Q ss_pred             hhccCC-C---------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          455 LLHGNK-G---------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       455 ~l~~~~-~---------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      .--... .         ......++...|.++.|+..||.++|+.|  +.-+-|.+.+|+++.+.+++|+.+|......+
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            543221 1         12345788999999999999999999999  88899999999999999999999998877765


Q ss_pred             CCCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCC
Q 006055          525 SSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP  567 (663)
Q Consensus       525 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p  567 (663)
                      +...          -+.   --++-|.-.||.++..|.||..-
T Consensus       446 d~~~----------~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPTE----------PLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCc----------chh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            5411          111   12456999999999999999653

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.90  E-value=7.6e-10  Score=84.63  Aligned_cols=59  Identities=32%  Similarity=0.426  Sum_probs=27.5

Q ss_pred             CCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccccccccc
Q 006055           95 SLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNN  153 (663)
Q Consensus        95 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~  153 (663)
                      +|+.|+|++|+|+...+..|.++++|++|+|++|.++...|..|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            34444444444444333444444444444444444444444444444444444444444

...

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.89  E-value=3.4e-08  Score=99.17  Aligned_cols=141  Identities=14%  Similarity=0.139  Sum_probs=101.6

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCccc------------CHHHHHHHHHHhhcCCCCCc--ccceEEEEe----
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI------------SEREFKDKIEGVGAVNHENL--VPLRAYYYS----  436 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~------------~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~----  436 (663)
                      .+.+-+-....|++..+. |+.|.||+......            ....+.+|...+.++...+|  ...+++...    
T Consensus        27 ~e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         27 GEVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             CcEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            345555555567777664 88999997743221            11247788888888754433  345556543    


Q ss_pred             -cCccEEEEEccCCC-ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC-------
Q 006055          437 -MDEKLLVYDYLTMG-SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK-------  507 (663)
Q Consensus       437 -~~~~~lv~ey~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~-------  507 (663)
                       ....++|+|++++. +|.+++....   ..+.+...+..++.+++..+.-||..|  |+|+|++++|||++.       
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~  180 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREE  180 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCC
Confidence             23468999999986 8998885321   123456777889999999999999999  999999999999975       


Q ss_pred             CCceEEeccccccc
Q 006055          508 SYEARVSDFGLAHL  521 (663)
Q Consensus       508 ~~~~kl~Dfg~a~~  521 (663)
                      +..+.++||+.++.
T Consensus       181 ~~~~~LIDl~r~~~  194 (268)
T PRK15123        181 DLKLSVIDLHRAQI  194 (268)
T ss_pred             CceEEEEECCcccc
Confidence            46799999998864

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.88  E-value=3e-10  Score=113.91  Aligned_cols=133  Identities=26%  Similarity=0.333  Sum_probs=113.1

Q ss_pred             CcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccccccc-ccccccC
Q 006055           80 ALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLAT-NNFSGEI  158 (663)
Q Consensus        80 ~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~  158 (663)
                      +|+ .+|.+.   -+.-+.|+|..|+|+.+.|..|+.+++|+.||||+|+|+-+-|.+|.+|.+|..|-+.+ |+|+...
T Consensus        57 GL~-eVP~~L---P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~  132 (498)
T KOG4237|consen   57 GLT-EVPANL---PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLP  132 (498)
T ss_pred             Ccc-cCcccC---CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhh
Confidence            444 566421   24567899999999998889999999999999999999999999999999998887776 9999655


Q ss_pred             CCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCc-ccccCCCCC
Q 006055          159 PSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPK-RFQTFGSNS  217 (663)
Q Consensus       159 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~~~~~~  217 (663)
                      -..|++|.+|+.|.+.-|++.-...+.|..+++|..|.+-+|.+. .++. .|..+...+
T Consensus       133 k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~  191 (498)
T KOG4237|consen  133 KGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIK  191 (498)
T ss_pred             hhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccc
Confidence            667999999999999999999777889999999999999999998 5555 666665544

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.87  E-value=1.1e-09  Score=83.77  Aligned_cols=60  Identities=42%  Similarity=0.552  Sum_probs=34.4

Q ss_pred             cccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcC
Q 006055          143 HLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL  202 (663)
Q Consensus       143 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l  202 (663)
                      +|+.|++++|+|+...+..|.++++|++|++++|+|+...|..|..+++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            455555555555543344555566666666666666555555566666666666666653

...

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.86  E-value=1.2e-10  Score=121.68  Aligned_cols=136  Identities=24%  Similarity=0.200  Sum_probs=97.6

Q ss_pred             CcEEEEEcCCCCccc------ccCccccCCCCCCCEEEccCCCCCCCCCccccCCCC---CceEEcccccccC----chh
Q 006055           69 NRVTMLRLPGVALSG------QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSN---LRNLYLQGNHFSG----EVP  135 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g------~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p  135 (663)
                      ..++.|+++++.+.+      .++. .+..+++|+.|+|++|.+.+..+..+..+.+   |++|+|++|++++    .+.
T Consensus        51 ~~l~~l~l~~~~~~~~~~~~~~~~~-~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~  129 (319)
T cd00116          51 PSLKELCLSLNETGRIPRGLQSLLQ-GLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA  129 (319)
T ss_pred             CCceEEeccccccCCcchHHHHHHH-HHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHH
Confidence            347788888877752      2222 4567888999999998887666666666655   9999999988873    334


Q ss_pred             hhhcCC-cccccccccccccccc----CCCCCcccccccccccccccccCc----CCCCCCCCCCCCEEEeecCcCCCC
Q 006055          136 LFLVGL-HHLVRLNLATNNFSGE----IPSGFKNLTKLKTLFLENNRLSGS----IPGFDDVLPNLQQLNVSNNLLNGS  205 (663)
Q Consensus       136 ~~~~~l-~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~g~  205 (663)
                      ..+..+ ++|+.|+|++|.+++.    ++..+..+++|++|+|++|.+++.    ++..+..+++|+.|+|++|.+++.
T Consensus       130 ~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~  208 (319)
T cd00116         130 KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDE  208 (319)
T ss_pred             HHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChH
Confidence            456666 8889999999988742    334556677888999999888742    333445567899999999888744

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.85  E-value=1.4e-09  Score=117.27  Aligned_cols=130  Identities=35%  Similarity=0.477  Sum_probs=103.9

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCC-CCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLT-SLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  147 (663)
                      ..++.|++.+|.++ .||+. .+.+. +|+.|++++|++.. +|..+..+++|+.|++++|+++ .+|...+.+++|+.|
T Consensus       116 ~~l~~L~l~~n~i~-~i~~~-~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L  191 (394)
T COG4886         116 TNLTSLDLDNNNIT-DIPPL-IGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL  191 (394)
T ss_pred             cceeEEecCCcccc-cCccc-cccchhhcccccccccchhh-hhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhe
Confidence            36889999999998 78763 46664 89999999999976 6677899999999999999998 677777688899999


Q ss_pred             ccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCC
Q 006055          148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNG  204 (663)
Q Consensus       148 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g  204 (663)
                      ++++|+++ .+|.....+..|++|.+++|++. .++..+..+.++..|.+.+|++..
T Consensus       192 ~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~  246 (394)
T COG4886         192 DLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED  246 (394)
T ss_pred             eccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee
Confidence            99999998 77776666677888888888654 455556677777777777777763

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.84  E-value=1.6e-09  Score=116.63  Aligned_cols=153  Identities=27%  Similarity=0.338  Sum_probs=120.6

Q ss_pred             CccceeEecCCcEE---EEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCC-CCceEEcccccccCch
Q 006055           59 CKWAGVECEQNRVT---MLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCS-NLRNLYLQGNHFSGEV  134 (663)
Q Consensus        59 c~w~gv~c~~~~v~---~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~  134 (663)
                      +.+.+..+......   .|++..|.+...+..  +..++.++.|++.+|.++. +|.....+. +|+.|++++|++. .+
T Consensus        80 ~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~--~~~~~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l  155 (394)
T COG4886          80 ISSLDGSENLLNLLPLPSLDLNLNRLRSNISE--LLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SL  155 (394)
T ss_pred             cccccccccccCCCCCceeeccccccccCchh--hhcccceeEEecCCccccc-Cccccccchhhcccccccccchh-hh
Confidence            66666666655555   588888888544443  4677899999999999987 677777775 9999999999998 67


Q ss_pred             hhhhcCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCC
Q 006055          135 PLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFG  214 (663)
Q Consensus       135 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~  214 (663)
                      |..+..+++|+.|++++|+++ .+|...+.+++|+.|++++|+++ .+|........|+.|++++|++. .++..+.++.
T Consensus       156 ~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~  232 (394)
T COG4886         156 PSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLK  232 (394)
T ss_pred             hhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcc
Confidence            778899999999999999998 77777778899999999999999 77776666677999999999644 4555555555


Q ss_pred             CCCc
Q 006055          215 SNSF  218 (663)
Q Consensus       215 ~~~~  218 (663)
                      .+..
T Consensus       233 ~l~~  236 (394)
T COG4886         233 NLSG  236 (394)
T ss_pred             cccc
Confidence            4443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.81  E-value=1.1e-09  Score=122.54  Aligned_cols=235  Identities=22%  Similarity=0.211  Sum_probs=149.4

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      +.+-+|.++.++.+.- ..|...+.|......    ...+....+-.+.-..+||-+++..-.+......+||++|+.++
T Consensus       810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~  889 (1205)
T KOG0606|consen  810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG  889 (1205)
T ss_pred             ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence            4688899999988763 234444444332211    01111222222222234455555444445567789999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC------
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP------  524 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~------  524 (663)
                      +|...+|...     +.+..........+.++++|||...  +.|||++|.|.++..++..++.|||.....+-      
T Consensus       890 ~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~  962 (1205)
T KOG0606|consen  890 DLPSKLHNSG-----CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD  962 (1205)
T ss_pred             CchhhhhcCC-----CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence            9999998654     2333333444556778999999886  89999999999999999999999984321100      


Q ss_pred             ---------------C--------------CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCC
Q 006055          525 ---------------S--------------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEE  575 (663)
Q Consensus       525 ---------------~--------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~  575 (663)
                                     .              ....+++.|.+||...+......+|+|+.|++++|.++|..||.......
T Consensus       963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen  963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred             cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence                           0              00124556999999999999999999999999999999999997643321


Q ss_pred             CCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006055          576 GVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMS  632 (663)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~  632 (663)
                            .++++....         ..-...+.+...+..+++..-+..+|.+|-.+.
T Consensus      1043 ------~f~ni~~~~---------~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 ------IFENILNRD---------IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             ------hhhccccCC---------CCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence                  111221111         000111222233444555566778888887665

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.77  E-value=4.8e-08  Score=92.45  Aligned_cols=125  Identities=22%  Similarity=0.254  Sum_probs=82.4

Q ss_pred             EEEEEEecCCcEEEEEEecCc---------------c--------cC----HHHHHHHHHHhhcCCCC--CcccceEEEE
Q 006055          385 TAYKAVLEMGTIVAVKRLKDV---------------T--------IS----EREFKDKIEGVGAVNHE--NLVPLRAYYY  435 (663)
Q Consensus       385 ~Vy~~~~~~g~~vavK~l~~~---------------~--------~~----~~~~~~e~~~l~~l~h~--niv~l~~~~~  435 (663)
                      .||.|...+|..+|||+.+..               .        ..    .....+|.+.|.++..-  ++.+++.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            489999888999999987421               0        00    13467899999999766  45555544  


Q ss_pred             ecCccEEEEEccC--CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCcceecCCCCCCEEEcCCCceE
Q 006055          436 SMDEKLLVYDYLT--MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY-LHAQGPNVSHGNIKSSNILLTKSYEAR  512 (663)
Q Consensus       436 ~~~~~~lv~ey~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~-LH~~~~~iiHrdlk~~Nill~~~~~~k  512 (663)
                        ....+||||++  +..+..+....       ++......++.++...+.. +|..|  |+|+||.+.||+++++ .+.
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEE
Confidence              36789999999  55554443321       1123345566777775555 46777  9999999999999988 999


Q ss_pred             EeccccccccC
Q 006055          513 VSDFGLAHLVG  523 (663)
Q Consensus       513 l~Dfg~a~~~~  523 (663)
                      ++|||.+....
T Consensus       147 iIDf~qav~~~  157 (188)
T PF01163_consen  147 IIDFGQAVDSS  157 (188)
T ss_dssp             E--GTTEEETT
T ss_pred             EEecCcceecC
Confidence            99999887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.75  E-value=7.9e-10  Score=107.01  Aligned_cols=130  Identities=25%  Similarity=0.284  Sum_probs=98.4

Q ss_pred             CCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCCCCccccccccc
Q 006055           92 NLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTL  171 (663)
Q Consensus        92 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L  171 (663)
                      ....|+.||||+|.|+. +..+..-++.++.|+||+|.+. .+-. +..|++|+.||||+|.++ .+..+-..|-+++.|
T Consensus       282 TWq~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL  357 (490)
T KOG1259|consen  282 TWQELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL  357 (490)
T ss_pred             hHhhhhhccccccchhh-hhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence            34679999999999986 6777888899999999999998 4444 888999999999999998 555666778889999


Q ss_pred             ccccccccCcCCCCCCCCCCCCEEEeecCcCCCCC-CcccccCCC---CCccCCcCCCCC
Q 006055          172 FLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSI-PKRFQTFGS---NSFLGNSLCGKP  227 (663)
Q Consensus       172 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~-p~~~~~~~~---~~~~~~~l~~~p  227 (663)
                      .|+.|.|. .+. -+..+-+|..||+++|++...- -..+++++-   +.+.+|++.+.+
T Consensus       358 ~La~N~iE-~LS-GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  358 KLAQNKIE-TLS-GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             ehhhhhHh-hhh-hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            99999987 222 2567788999999999986211 123344432   334566665544

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.68  E-value=8.4e-10  Score=94.95  Aligned_cols=141  Identities=23%  Similarity=0.235  Sum_probs=104.3

Q ss_pred             CcEEEEEcCCCCcccccCcc--ccCCCCCCCEEEccCCCCCCCCCcccc-CCCCCceEEcccccccCchhhhhcCCcccc
Q 006055           69 NRVTMLRLPGVALSGQIPLG--ILGNLTSLRTLSLRFNSLTSQLPSDLA-SCSNLRNLYLQGNHFSGEVPLFLVGLHHLV  145 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~--~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  145 (663)
                      .....++|+++.|- .++..  .+....+|+..+|++|.|.. .|+.|. .++.++.|+|++|.|+ .+|..+..++.|+
T Consensus        27 kE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr  103 (177)
T KOG4579|consen   27 KELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALR  103 (177)
T ss_pred             HHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhh
Confidence            35667888888775 56542  23456677888999999987 555554 5568999999999998 7888899999999


Q ss_pred             ccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCC
Q 006055          146 RLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFG  214 (663)
Q Consensus       146 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~  214 (663)
                      .|+++.|.|. ..|..+..|.+|-.|+..+|.+. .+|..+-.-.++-..++.+|.+.+.-|..++.+.
T Consensus       104 ~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa~k  170 (177)
T KOG4579|consen  104 SLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQALK  170 (177)
T ss_pred             hcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcccccccC
Confidence            9999999998 77888888999999999999887 5554322223333345577777777666555443

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.68  E-value=1.6e-07  Score=95.67  Aligned_cols=264  Identities=14%  Similarity=0.142  Sum_probs=154.7

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcC-CCCCcccceEE-----E-Eec-CccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAY-----Y-YSM-DEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-----~-~~~-~~~~lv~ey  446 (663)
                      +..||+|+-+.+|-.---  .-.+.|++......  .-.+.+.+|... .||-+-.-+.+     + -+. +...++|..
T Consensus        16 gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa--~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~   91 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPA--AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK   91 (637)
T ss_pred             CccccCCccceeeecchh--hchhheeecCCCch--HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence            457999999999964311  11244666543221  112334444444 56543331111     0 111 124577776


Q ss_pred             cCCCC-hhHhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          447 LTMGS-LSALLHGNKG-AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       447 ~~~gs-L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      +.+.. ...++..... ..-...+|...++.+..+|.+.+.||..|  .+-+|+.++|+|+.+++.+.|.|-..-.....
T Consensus        92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n  169 (637)
T COG4248          92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN  169 (637)
T ss_pred             CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcccceeeccC
Confidence            65542 2233322111 12235799999999999999999999999  77799999999999999999988654443332


Q ss_pred             CCC---CCCCccccCccccC-----CCCCCCcchhhhHHHHHHHHHhC-CCCCccccCCCC--CChH-HHHHHHHh---h
Q 006055          525 SST---PNRVAGYRAPEVTD-----PCKVSQKADVYSFGVLLLELLTG-KAPTHALLNEEG--VDLP-RWVQSIVK---D  589 (663)
Q Consensus       525 ~~~---~~~~~~y~aPE~~~-----~~~~~~~~Dv~slGvvl~elltg-~~p~~~~~~~~~--~~~~-~~~~~~~~---~  589 (663)
                      +..   ..+...|.+||.-.     +...+...|-|.+||++++++.| ++||.+......  .-.. .+....+.   +
T Consensus       170 g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~  249 (637)
T COG4248         170 GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASD  249 (637)
T ss_pred             CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechh
Confidence            221   33556699999754     34456778999999999999986 999987532211  1111 11000000   0


Q ss_pred             cccccccchhhhcccChHHHHHHHHHHHHHccCCC--CCCCCCHHHHHHHHHhhCCCCCC
Q 006055          590 EWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQY--PDNRPSMSEVIKRIEELHPSSTQ  647 (663)
Q Consensus       590 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~d--P~~RPt~~ev~~~L~~~~~~~~~  647 (663)
                      ......-.+   .....+-...++..+..+|+...  +.-|||++-.+..|.++.++...
T Consensus       250 ~~~g~~p~P---~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         250 QRRGLKPPP---RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             ccCCCCCCC---CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence            000000000   01111222334555566888764  56899999999999877666543

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.64  E-value=7.4e-09  Score=105.52  Aligned_cols=134  Identities=29%  Similarity=0.288  Sum_probs=74.5

Q ss_pred             CcEEEEEcCCCCcccccCc-cccCCCCCCCEEEccCCCCCCCCCccc-cCCCCCceEEcccccccC-chhhhhcCCcccc
Q 006055           69 NRVTMLRLPGVALSGQIPL-GILGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNHFSG-EVPLFLVGLHHLV  145 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~-~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~  145 (663)
                      .+|+.|||++|=+..-.|- .+...|++|+.|+|+.|++.-...+.. ..+++|+.|.|+.+.|+- .+-..+..+|+|+
T Consensus       146 ~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~  225 (505)
T KOG3207|consen  146 PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLE  225 (505)
T ss_pred             CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHH
Confidence            4688888888766522111 345678888888888888764332222 245667777777777662 1223344556666


Q ss_pred             ccccccccccccCCCCCcccccccccccccccccCcCC--CCCCCCCCCCEEEeecCcCC
Q 006055          146 RLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIP--GFDDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       146 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~  203 (663)
                      .|+|..|...+.-......+..|+.|||++|++- ..+  ...+.|+.|..|+++.+.++
T Consensus       226 ~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~  284 (505)
T KOG3207|consen  226 VLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIA  284 (505)
T ss_pred             HhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcc
Confidence            6666666432233333444555666666666654 222  23445555555555555554

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.56  E-value=6.4e-07  Score=87.18  Aligned_cols=135  Identities=22%  Similarity=0.218  Sum_probs=95.2

Q ss_pred             HHhhcccccccceEEEEEEecCCcEEEEEEecCc-----------------------ccCHHHHHHHHHHhhcCCCC--C
Q 006055          372 RASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDV-----------------------TISEREFKDKIEGVGAVNHE--N  426 (663)
Q Consensus       372 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~-----------------------~~~~~~~~~e~~~l~~l~h~--n  426 (663)
                      .+.++.||-|--+.||.|..+.|.++|||.=+..                       ..+....++|.+.|.++.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            3457899999999999999999999999952110                       01123467888889888654  6


Q ss_pred             cccceEEEEecCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc
Q 006055          427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT  506 (663)
Q Consensus       427 iv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~  506 (663)
                      +.+.+++    +...+||||+++-.|...--          +-...-.|+..|++-+...-..|  |+|+|+.+-||+++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~----------~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~  236 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLRL----------DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVT  236 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecccC----------cccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEe
Confidence            6666654    57789999999866654431          11122223333444444444566  99999999999999


Q ss_pred             CCCceEEecccccccc
Q 006055          507 KSYEARVSDFGLAHLV  522 (663)
Q Consensus       507 ~~~~~kl~Dfg~a~~~  522 (663)
                      +||.+.++||--+...
T Consensus       237 ~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         237 EDGDIVVIDWPQAVPI  252 (304)
T ss_pred             cCCCEEEEeCcccccC
Confidence            9999999999766443

>PRK09902 hypothetical protein; Provisional

Probab=98.50  E-value=3.2e-06  Score=80.53  Aligned_cols=137  Identities=13%  Similarity=0.130  Sum_probs=102.2

Q ss_pred             cccccceEEEEEEecCCcEEEEEEecCc-------ccCHHHHHHHHHHhhcCCCC--CcccceEEEEec-----CccEEE
Q 006055          378 LGKGTFGTAYKAVLEMGTIVAVKRLKDV-------TISEREFKDKIEGVGAVNHE--NLVPLRAYYYSM-----DEKLLV  443 (663)
Q Consensus       378 lg~G~~g~Vy~~~~~~g~~vavK~l~~~-------~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~-----~~~~lv  443 (663)
                      -|+||-+.|++.... |..+-+|+-...       ......|.+|+..+..+...  .+.+.+ ++...     -.-+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            367899999998776 557999986521       23467899999999888533  244444 33211     135799


Q ss_pred             EEccCC-CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc--eEEecccccc
Q 006055          444 YDYLTM-GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE--ARVSDFGLAH  520 (663)
Q Consensus       444 ~ey~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~--~kl~Dfg~a~  520 (663)
                      +|-+++ -+|.+++....   ..+.+...+..+..+++..+.-||+.|  +.|+|+.+.||+++.++.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997653 48888886432   234677888899999999999999999  999999999999986666  9999998765


Q ss_pred             c
Q 006055          521 L  521 (663)
Q Consensus       521 ~  521 (663)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            4

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.48  E-value=3.6e-08  Score=100.64  Aligned_cols=134  Identities=25%  Similarity=0.268  Sum_probs=86.1

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCC-CCccccCCCCCceEEcccccccCchhhhhcCCcccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQ-LPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  147 (663)
                      .+++.|+|+.|.+.-......-..+++|+.|.|+.+.|+-. +-..+..+++|+.|+|..|..-+.-.....-+..|+.|
T Consensus       172 p~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~L  251 (505)
T KOG3207|consen  172 PSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQEL  251 (505)
T ss_pred             ccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhc
Confidence            57778888888776444433344677788888888877621 11223456778888888875222333334456677888


Q ss_pred             ccccccccccCC--CCCcccccccccccccccccC-cCCCC-----CCCCCCCCEEEeecCcCC
Q 006055          148 NLATNNFSGEIP--SGFKNLTKLKTLFLENNRLSG-SIPGF-----DDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       148 ~l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~-~~p~~-----~~~l~~L~~L~l~~N~l~  203 (663)
                      ||++|++. ..+  ...+.++.|+.|+++.+.+.. .+|+.     ...+++|++|+++.|++.
T Consensus       252 dLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~  314 (505)
T KOG3207|consen  252 DLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR  314 (505)
T ss_pred             cccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence            88888776 333  456777788888888887763 23333     356778888888888775

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.48  E-value=4.2e-08  Score=106.15  Aligned_cols=144  Identities=18%  Similarity=0.256  Sum_probs=97.4

Q ss_pred             HHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCC-------------CCCccccCccccCCCC
Q 006055          478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP-------------NRVAGYRAPEVTDPCK  544 (663)
Q Consensus       478 ~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-------------~~~~~y~aPE~~~~~~  544 (663)
                      +++.|+.|+|..- ++||++|.|++|.++..+..||+.|+++.........             .....|.|||++.+..
T Consensus       107 ~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             cccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            4558999999873 6999999999999999999999999988655442111             1223499999999988


Q ss_pred             CCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCC
Q 006055          545 VSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQ  623 (663)
Q Consensus       545 ~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~  623 (663)
                      .+.++|+||+||++|.+.. |+.-+.......   .......         ..+.  .......+.+.++.+=+.+.+..
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~---~~~~~~~---------~~~~--~~~~~s~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLL---SYSFSRN---------LLNA--GAFGYSNNLPSELRESLKKLLNG  251 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcc---hhhhhhc---------cccc--ccccccccCcHHHHHHHHHHhcC
Confidence            8999999999999999984 554443321110   0000000         0000  01111233345666667788999


Q ss_pred             CCCCCCCHHHHHH
Q 006055          624 YPDNRPSMSEVIK  636 (663)
Q Consensus       624 dP~~RPt~~ev~~  636 (663)
                      ++.-||++.++..
T Consensus       252 ~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  252 DSAVRPTLDLLLS  264 (700)
T ss_pred             CcccCcchhhhhc
Confidence            9999998776654

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.46  E-value=1.8e-07  Score=65.55  Aligned_cols=37  Identities=41%  Similarity=0.909  Sum_probs=26.9

Q ss_pred             hHHHHHHHHHHHhcCC-C---CcCCcCCC-CCCCccceeEec
Q 006055           31 SSDRAALLALRSSVGG-R---TLLWNVYE-ASPCKWAGVECE   67 (663)
Q Consensus        31 ~~d~~all~~~~~~~~-~---~~~w~~~~-~~~c~w~gv~c~   67 (663)
                      +.|++||++||+++.. .   +.+|+... .+||.|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence            5799999999999984 2   45798763 789999999995

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.44  E-value=2.3e-08  Score=86.28  Aligned_cols=113  Identities=22%  Similarity=0.246  Sum_probs=95.1

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.++|++|.+. .+|+.+-..++.++.|+|++|.|+. +|.++..++.|+.|+++.|.|. ..|..+..|.+|-.|+
T Consensus        53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisd-vPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld  129 (177)
T KOG4579|consen   53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISD-VPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD  129 (177)
T ss_pred             ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhh-chHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence            47899999999999 8998777788899999999999987 8999999999999999999999 7888888899999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGF  185 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~  185 (663)
                      ..+|.+. .+|-.+---+++-..++.++.+.+.-|.-
T Consensus       130 s~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~k  165 (177)
T KOG4579|consen  130 SPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKK  165 (177)
T ss_pred             CCCCccc-cCcHHHhccccHHHHHhcCCcccccCccc
Confidence            9999987 66655433344455667888888766643

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.44  E-value=7.7e-07  Score=96.85  Aligned_cols=141  Identities=18%  Similarity=0.278  Sum_probs=90.9

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCcc---------------------------cCH--------------HHHHH
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVT---------------------------ISE--------------REFKD  414 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~---------------------------~~~--------------~~~~~  414 (663)
                      +.|+.++-|.||+|++++|+.||||+....-                           ...              -++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6788999999999999999999999864210                           110              11333


Q ss_pred             HHHHhhcC----C-CCCcccceEEEEecCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHH-HHHHhh
Q 006055          415 KIEGVGAV----N-HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG-IEYLHA  488 (663)
Q Consensus       415 e~~~l~~l----~-h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~a-l~~LH~  488 (663)
                      |...+.++    + .+++.--.=|+.-.....|+|||++|..+.+...-..    ...+   +..++..++++ +..+=.
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d---~k~ia~~~~~~f~~q~~~  283 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGID---RKELAELLVRAFLRQLLR  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCC---HHHHHHHHHHHHHHHHHh
Confidence            44433333    2 2332222222233467899999999999988742211    1234   23334433333 222323


Q ss_pred             cCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       489 ~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      .|  +.|.|..|.||+++.++.+.+.|||+.....+.
T Consensus       284 dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         284 DG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             cC--ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            45  999999999999999999999999998776553

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.41  E-value=4.1e-09  Score=113.18  Aligned_cols=127  Identities=31%  Similarity=0.393  Sum_probs=79.5

Q ss_pred             CCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCC-CCccccccccccc
Q 006055           95 SLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPS-GFKNLTKLKTLFL  173 (663)
Q Consensus        95 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l  173 (663)
                      .|.+.+.++|.|.- ...++.-++.|+.|||++|+++. +. .+..|++|++|||+.|.+. .+|. ....+. |+.|.|
T Consensus       165 ~L~~a~fsyN~L~~-mD~SLqll~ale~LnLshNk~~~-v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l  239 (1096)
T KOG1859|consen  165 KLATASFSYNRLVL-MDESLQLLPALESLNLSHNKFTK-VD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL  239 (1096)
T ss_pred             hHhhhhcchhhHHh-HHHHHHHHHHhhhhccchhhhhh-hH-HHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence            46666777777754 45566777777777777777773 32 5677777777777777776 4443 223343 777777


Q ss_pred             ccccccCcCCCCCCCCCCCCEEEeecCcCCCCC---C-cccccCCCCCccCCcCCCCCC
Q 006055          174 ENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSI---P-KRFQTFGSNSFLGNSLCGKPL  228 (663)
Q Consensus       174 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~---p-~~~~~~~~~~~~~~~l~~~p~  228 (663)
                      +||.++.. -+ +.+|.+|+.|||++|-|.+--   | ..+..+..+.+.||++|..|+
T Consensus       240 rnN~l~tL-~g-ie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~  296 (1096)
T KOG1859|consen  240 RNNALTTL-RG-IENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW  296 (1096)
T ss_pred             cccHHHhh-hh-HHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence            77777632 22 457777777777777776422   1 122333444456677776665

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.41  E-value=3.2e-06  Score=82.09  Aligned_cols=108  Identities=21%  Similarity=0.211  Sum_probs=83.7

Q ss_pred             HHHHHHHHHHhhcCCCC--CcccceEEEEecC----ccEEEEEccCCC-ChhHhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 006055          409 EREFKDKIEGVGAVNHE--NLVPLRAYYYSMD----EKLLVYDYLTMG-SLSALLHGNKGAGRTPLNWEMRSLIALGAAR  481 (663)
Q Consensus       409 ~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~ey~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~  481 (663)
                      .....+|...+..+...  ...+.+++.....    ..++|+|++++. +|.+++....     ..+...+..++.+++.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~  129 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR  129 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence            44577888877777443  3445666665432    347999999874 7999887532     1455677889999999


Q ss_pred             HHHHHhhcCCcceecCCCCCCEEEcCCC---ceEEeccccccccC
Q 006055          482 GIEYLHAQGPNVSHGNIKSSNILLTKSY---EARVSDFGLAHLVG  523 (663)
Q Consensus       482 al~~LH~~~~~iiHrdlk~~Nill~~~~---~~kl~Dfg~a~~~~  523 (663)
                      .+.-||..|  |+|+|+++.|||++.+.   .+.++||+-++...
T Consensus       130 ~i~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  130 LIAKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            999999999  99999999999999887   89999999887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.37  E-value=3.3e-09  Score=113.85  Aligned_cols=126  Identities=29%  Similarity=0.264  Sum_probs=91.4

Q ss_pred             cEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhh-hcCCccccccc
Q 006055           70 RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLF-LVGLHHLVRLN  148 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~  148 (663)
                      .+...+.+.|.|. .+.. .+.-++.|+.|||++|+++..-  .+..|++|++|||+.|+|. .+|.. -..+ +|+.|.
T Consensus       165 ~L~~a~fsyN~L~-~mD~-SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~  238 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDE-SLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLN  238 (1096)
T ss_pred             hHhhhhcchhhHH-hHHH-HHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hheeee
Confidence            3445556667776 4443 5677888899999999988643  6888889999999999988 55532 2233 488889


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCC-CCCCCCCCCCEEEeecCcCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~  203 (663)
                      |++|.++..  ..+.+|++|+.|||++|-|++.-. ..+..|..|+.|+|.+|++.
T Consensus       239 lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  239 LRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            999988743  357788888999999998875322 22556778888888888886

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.34  E-value=7.1e-06  Score=80.76  Aligned_cols=137  Identities=14%  Similarity=0.143  Sum_probs=85.4

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCc--ccceEEEEecCccEEEEEccCCCC-h
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENL--VPLRAYYYSMDEKLLVYDYLTMGS-L  452 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~~~~~lv~ey~~~gs-L  452 (663)
                      ..||+|..+.||+.   .|..+++|..... .......+|.+++..+..-.+  .+.+++....+...+|||+++|.+ +
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            57999999999983   2556788887643 345567889999988864433  566777766777789999999863 2


Q ss_pred             hHh---------------------hccCCCCCCCCCCHHHHHH-HHH----------HHH-HHHHHHhhc--CCcceecC
Q 006055          453 SAL---------------------LHGNKGAGRTPLNWEMRSL-IAL----------GAA-RGIEYLHAQ--GPNVSHGN  497 (663)
Q Consensus       453 ~~~---------------------l~~~~~~~~~~l~~~~~~~-i~~----------~ia-~al~~LH~~--~~~iiHrd  497 (663)
                      ...                     +|.-.. ..  .....+.. +..          .+. ....+|...  .+.++|+|
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            111                     222110 01  11111000 000          011 112333222  24578999


Q ss_pred             CCCCCEEEcCCCceEEecccccc
Q 006055          498 IKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       498 lk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                      +.|.||++++++ +.++||+.+.
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcC
Confidence            999999999888 9999999874

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.24  E-value=1.9e-05  Score=76.30  Aligned_cols=135  Identities=20%  Similarity=0.227  Sum_probs=90.4

Q ss_pred             ccccccceEEEEEEecCCcEEEEEEecCcccC--------------------HH-----HHHHHHHHhhcCC--CCCccc
Q 006055          377 VLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS--------------------ER-----EFKDKIEGVGAVN--HENLVP  429 (663)
Q Consensus       377 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--------------------~~-----~~~~e~~~l~~l~--h~niv~  429 (663)
                      .|.+|.-+.||+|...++..+|||+++.....                    .+     -..+|..-|.++.  +-.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            68889999999999888999999998643111                    01     1234444455442  233334


Q ss_pred             ceEEEEecCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCcceecCCCCCCEEEcCC
Q 006055          430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA-QGPNVSHGNIKSSNILLTKS  508 (663)
Q Consensus       430 l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~iiHrdlk~~Nill~~~  508 (663)
                      -+++.    +..|||||+.....     ..+.....++.......+..++++.+.-|-. .+  ++|+||..-|||+. +
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~-----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~  202 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGL-----PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-D  202 (268)
T ss_pred             ceeec----CCeEEEEeccCCCC-----CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-C
Confidence            44443    56799999875411     1111122233333566677778888888776 45  99999999999999 8


Q ss_pred             CceEEeccccccccC
Q 006055          509 YEARVSDFGLAHLVG  523 (663)
Q Consensus       509 ~~~kl~Dfg~a~~~~  523 (663)
                      +.+.|+|||-|....
T Consensus       203 ~~p~iID~~QaV~~~  217 (268)
T COG1718         203 GEPYIIDVSQAVTID  217 (268)
T ss_pred             CeEEEEECccccccC
Confidence            899999999887654

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.23  E-value=2e-07  Score=100.77  Aligned_cols=125  Identities=30%  Similarity=0.289  Sum_probs=74.8

Q ss_pred             EEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccc
Q 006055           71 VTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLA  150 (663)
Q Consensus        71 v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~  150 (663)
                      +..++|..|.+. .+- +.++.+++|..|+|..|+|.+ +...+..+++|++|+|++|.|+...+  +..++.|+.|+++
T Consensus        74 l~~l~l~~n~i~-~~~-~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~  148 (414)
T KOG0531|consen   74 LKELNLRQNLIA-KIL-NHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLS  148 (414)
T ss_pred             HHhhccchhhhh-hhh-cccccccceeeeeccccchhh-cccchhhhhcchheeccccccccccc--hhhccchhhheec
Confidence            444555556555 211 124666777777777777765 23236666777777777777764333  4455667777777


Q ss_pred             cccccccCCCCCcccccccccccccccccCcCCCC-CCCCCCCCEEEeecCcCC
Q 006055          151 TNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGF-DDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       151 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~  203 (663)
                      +|.|+..  ..+..+++|+.+++++|+++..-+ . ...+.+|+.+++.+|.+.
T Consensus       149 ~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~  199 (414)
T KOG0531|consen  149 GNLISDI--SGLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIR  199 (414)
T ss_pred             cCcchhc--cCCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchh
Confidence            7777622  345556777777777777763333 1 356666777777777665

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.10  E-value=1.8e-06  Score=100.13  Aligned_cols=128  Identities=33%  Similarity=0.326  Sum_probs=84.4

Q ss_pred             cEEEEEcCCCCcccccCccccCCCCCCCEEEccCCC--CCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccc
Q 006055           70 RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNS--LTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~--l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  147 (663)
                      .+....+-+|.+. .++..  ...++|++|-+..|.  +....+..|..++.|+.|||++|.=-+.+|..+++|-+|++|
T Consensus       524 ~~rr~s~~~~~~~-~~~~~--~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL  600 (889)
T KOG4658|consen  524 SVRRMSLMNNKIE-HIAGS--SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL  600 (889)
T ss_pred             heeEEEEeccchh-hccCC--CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence            4455555556554 44432  234467777777775  443333446667777777777766555777777777777777


Q ss_pred             ccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCc
Q 006055          148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNL  201 (663)
Q Consensus       148 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~  201 (663)
                      +|+...++ .+|..+++|+.|.+|++..+.-...+|.....+.+|++|.+-.-.
T Consensus       601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence            77777777 677777777777777777776554556666667777777765443

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.05  E-value=9.3e-07  Score=95.65  Aligned_cols=126  Identities=27%  Similarity=0.331  Sum_probs=94.2

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      ..++.|+|.+|+|. .+.. .+..+++|++|+|++|.|+...+  +..++.|+.|++++|.++ .++ .+..+.+|+.++
T Consensus        95 ~~l~~l~l~~n~i~-~i~~-~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~-~~~-~~~~l~~L~~l~  168 (414)
T KOG0531|consen   95 KSLEALDLYDNKIE-KIEN-LLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLIS-DIS-GLESLKSLKLLD  168 (414)
T ss_pred             cceeeeeccccchh-hccc-chhhhhcchheeccccccccccc--hhhccchhhheeccCcch-hcc-CCccchhhhccc
Confidence            57899999999999 4543 26789999999999999987543  778888999999999998 333 356689999999


Q ss_pred             cccccccccCCCC-CcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCC
Q 006055          149 LATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       149 l~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  203 (663)
                      +++|++...-+ . ...+.+|+.+++.+|.+.-...  +..+..+..+++..|.++
T Consensus       169 l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~~i~~--~~~~~~l~~~~l~~n~i~  221 (414)
T KOG0531|consen  169 LSYNRIVDIEN-DELSELISLEELDLGGNSIREIEG--LDLLKKLVLLSLLDNKIS  221 (414)
T ss_pred             CCcchhhhhhh-hhhhhccchHHHhccCCchhcccc--hHHHHHHHHhhcccccce
Confidence            99999984433 2 5788899999999998872221  223333444455555554

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	663
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-45
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-44
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-27
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-27
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-27
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-26
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-26
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		9e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-22
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		8e-20
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		7e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-18
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-17
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-15
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		8e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		9e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-12
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		9e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		9e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		9e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		9e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		9e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		9e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		9e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		9e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-09
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-09
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		8e-04
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-09
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-09
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		2e-09
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-04
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-09
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-09
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-08
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-08
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		7e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		7e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		8e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		8e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		9e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		9e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-07
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-07
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-07
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-07
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-07
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-07
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		6e-07
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		6e-07
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		6e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-07
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-07
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-07
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		7e-07
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		7e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-07
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		7e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-07
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		7e-07
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		8e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-07
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-07
2oza_A	356	Structure Of P38alpha Complex Length = 356		8e-07
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		9e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-06
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-06
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-06
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-06
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-06
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-06
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-06
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-06
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-06
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-06
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-06
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		5e-06
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		6e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-05
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-05
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-05
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-05
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-05
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-05
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-05
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-05
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-05
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-05
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-05
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-05
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-05
3soa_A	444	Full-Length Human Camkii Length = 444		6e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-05
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-05
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-05
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-05
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-05
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		9e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-04
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-04
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-04
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-04
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-04
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-04
3gni_B	389	Structure Of Strad And Mo25 Length = 389		4e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-04
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-04
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-04
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-04
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-04
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-04
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-04
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-04
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-04
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-04
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-04
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-04
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-04
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		9e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		9e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		9e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  178 bits (452), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 115/300 (38%), Positives = 173/300 (57%), Gaps = 20/300 (6%)
Query: 356 VFFGNAARVFDLEDLLRAS-----AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS-- 408
           V  G   R F L +L  AS       +LG+G FG  YK  L  GT+VAVKRLK+      
Sbjct: 20  VHLGQLKR-FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGG 78
Query: 409 EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLN 468
           E +F+ ++E +    H NL+ LR +  +  E+LLVY Y+  GS+++ L   +   + PL+
Sbjct: 79  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR-ERPESQPPLD 137
Query: 469 WEMRSLIALGAARGIEYLHAQ-GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST 527
           W  R  IALG+ARG+ YLH    P + H ++K++NILL + +EA V DFGLA L+     
Sbjct: 138 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX 197
Query: 528 PNRVA-----GYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTH--ALLNEEGVDLP 580
               A     G+ APE     K S+K DV+ +GV+LLEL+TG+       L N++ V L 
Sbjct: 198 HVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 257
Query: 581 RWVQSIVKDEWTSEVFDLELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE 639
            WV+ ++K++    + D++L   Y++  EE+ QL+Q+A+ C+   P  RP MSEV++ +E
Sbjct: 258 DWVKGLLKEKKLEALVDVDLQGNYKD--EEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  176 bits (447), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 172/300 (57%), Gaps = 20/300 (6%)
Query: 356 VFFGNAARVFDLEDLLRAS-----AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS-- 408
           V  G   R F L +L  AS       +LG+G FG  YK  L  G +VAVKRLK+      
Sbjct: 12  VHLGQLKR-FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGG 70
Query: 409 EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLN 468
           E +F+ ++E +    H NL+ LR +  +  E+LLVY Y+  GS+++ L   +   + PL+
Sbjct: 71  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR-ERPESQPPLD 129
Query: 469 WEMRSLIALGAARGIEYLHAQ-GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST 527
           W  R  IALG+ARG+ YLH    P + H ++K++NILL + +EA V DFGLA L+     
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX 189
Query: 528 PNRVA-----GYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTH--ALLNEEGVDLP 580
               A     G+ APE     K S+K DV+ +GV+LLEL+TG+       L N++ V L 
Sbjct: 190 HVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 581 RWVQSIVKDEWTSEVFDLELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE 639
            WV+ ++K++    + D++L   Y++  EE+ QL+Q+A+ C+   P  RP MSEV++ +E
Sbjct: 250 DWVKGLLKEKKLEALVDVDLQGNYKD--EEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/198 (40%), Positives = 114/198 (57%), Gaps = 17/198 (8%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLK---DVTISE--REFKDKIEGVGAVNHENLVPLRA 432
           +G+G FG  YK  +   T VAVK+L    D+T  E  ++F  +I+ +    HENLV L  
Sbjct: 39  MGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
           +    D+  LVY Y+  GSL   L    G    PL+W MR  IA GAA GI +LH    +
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGT--PPLSWHMRCKIAQGAANGINFLHEN--H 153
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHL---VGPSSTPNRVAG---YRAPEVTDPCKVS 546
             H +IKS+NILL +++ A++SDFGLA        +   +R+ G   Y APE     +++
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRG-EIT 212
Query: 547 QKADVYSFGVLLLELLTG 564
            K+D+YSFGV+LLE++TG
Sbjct: 213 PKSDIYSFGVVLLEIITG 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  120 bits (301), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 80/198 (40%), Positives = 113/198 (57%), Gaps = 17/198 (8%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLK---DVTISE--REFKDKIEGVGAVNHENLVPLRA 432
           +G+G FG  YK  +   T VAVK+L    D+T  E  ++F  +I+ +    HENLV L  
Sbjct: 39  MGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
           +    D+  LVY Y+  GSL   L    G    PL+W MR  IA GAA GI +LH    +
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGT--PPLSWHMRCKIAQGAANGINFLHEN--H 153
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHL---VGPSSTPNRVAG---YRAPEVTDPCKVS 546
             H +IKS+NILL +++ A++SDFGLA        +    R+ G   Y APE     +++
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRG-EIT 212
Query: 547 QKADVYSFGVLLLELLTG 564
            K+D+YSFGV+LLE++TG
Sbjct: 213 PKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  119 bits (299), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 80/198 (40%), Positives = 112/198 (56%), Gaps = 17/198 (8%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLK---DVTISE--REFKDKIEGVGAVNHENLVPLRA 432
           +G+G FG  YK  +   T VAVK+L    D+T  E  ++F  +I+ +    HENLV L  
Sbjct: 33  MGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
           +    D+  LVY Y+  GSL   L    G    PL+W MR  IA GAA GI +LH    +
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGT--PPLSWHMRCKIAQGAANGINFLHEN--H 147
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHL---VGPSSTPNRVAG---YRAPEVTDPCKVS 546
             H +IKS+NILL +++ A++SDFGLA             R+ G   Y APE     +++
Sbjct: 148 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRG-EIT 206
Query: 547 QKADVYSFGVLLLELLTG 564
            K+D+YSFGV+LLE++TG
Sbjct: 207 PKSDIYSFGVVLLEIITG 224

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  116 bits (291), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 144/270 (53%), Gaps = 11/270 (4%)
Query: 377 VLGKGTFGTAYKAVLEMGTIVAVKR-LKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           ++G G FG  YK VL  G  VA+KR   + +    EF+ +IE +    H +LV L  +  
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105
Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
             +E +L+Y Y+  G+L   L+G+     + ++WE R  I +GAARG+ YLH +   + H
Sbjct: 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMS-MSWEQRLEICIGAARGLHYLHTRA--IIH 162
Query: 496 GNIKSSNILLTKSYEARVSDFGLAHL---VGPSSTPNRVAG---YRAPEVTDPCKVSQKA 549
            ++KS NILL +++  +++DFG++     +G +     V G   Y  PE     ++++K+
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKS 222
Query: 550 DVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           DVYSFGV+L E+L  ++     L  E V+L  W      +    ++ D  L   +   E 
Sbjct: 223 DVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD-KIRPES 281
Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIE 639
           + +    A+ C A   ++RPSM +V+ ++E
Sbjct: 282 LRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  115 bits (289), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 85/273 (31%), Positives = 142/273 (52%), Gaps = 17/273 (6%)
Query: 377 VLGKGTFGTAYKAVLEMGTIVAVKR-LKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           ++G G FG  YK VL  G  VA+KR   + +    EF+ +IE +    H +LV L  +  
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105
Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
             +E +L+Y Y+  G+L   L+G+     + ++WE R  I +GAARG+ YLH +   + H
Sbjct: 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMS-MSWEQRLEICIGAARGLHYLHTRA--IIH 162
Query: 496 GNIKSSNILLTKSYEARVSDFGLA---------HLVGPSSTPNRVAGYRAPEVTDPCKVS 546
            ++KS NILL +++  +++DFG++         HL           GY  PE     +++
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHL---XXVVKGTLGYIDPEYFIKGRLT 219
Query: 547 QKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV 606
           +K+DVYSFGV+L E+L  ++     L  E V+L  W      +    ++ D  L   +  
Sbjct: 220 EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD-KIR 278
Query: 607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE 639
            E + +    A+ C A   ++RPSM +V+ ++E
Sbjct: 279 PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 79/197 (40%), Positives = 109/197 (55%), Gaps = 17/197 (8%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRLK---DVTISE--REFKDKIEGVGAVNHENLVPLRAY 433
           G+G FG  YK  +   T VAVK+L    D+T  E  ++F  +I+      HENLV L  +
Sbjct: 31  GEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGF 89
Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
               D+  LVY Y   GSL   L    G    PL+W  R  IA GAA GI +LH    + 
Sbjct: 90  SSDGDDLCLVYVYXPNGSLLDRLSCLDGT--PPLSWHXRCKIAQGAANGINFLHEN--HH 145
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHL---VGPSSTPNRVAG---YRAPEVTDPCKVSQ 547
            H +IKS+NILL +++ A++SDFGLA            +R+ G   Y APE     +++ 
Sbjct: 146 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRG-EITP 204
Query: 548 KADVYSFGVLLLELLTG 564
           K+D+YSFGV+LLE++TG
Sbjct: 205 KSDIYSFGVVLLEIITG 221

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (262), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 80/242 (33%), Positives = 124/242 (51%), Gaps = 24/242 (9%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI-SER--EFKDKIEGVGAVNHENLVPLRA 432
           E +G G+FGT ++A    G+ VAVK L +    +ER  EF  ++  +  + H N+V    
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
                    +V +YL+ GSL  LLH  K   R  L+   R  +A   A+G+ YLH + P 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG----YRAPEVTDPCKVSQK 548
           + H N+KS N+L+ K Y  +V DFGL+ L   +   ++ A     + APEV      ++K
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 549 ADVYSFGVLLLELLTGKAPTHAL----------LNEEGVDLPR----WVQSIVKDEWTSE 594
           +DVYSFGV+L EL T + P   L             + +++PR     V +I++  WT+E
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNE 279
Query: 595 VF 596
            +
Sbjct: 280 PW 281

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/242 (32%), Positives = 123/242 (50%), Gaps = 24/242 (9%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI-SER--EFKDKIEGVGAVNHENLVPLRA 432
           E +G G+FGT ++A    G+ VAVK L +    +ER  EF  ++  +  + H N+V    
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
                    +V +YL+ GSL  LLH  K   R  L+   R  +A   A+G+ YLH + P 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG----YRAPEVTDPCKVSQK 548
           + H ++KS N+L+ K Y  +V DFGL+ L       ++ A     + APEV      ++K
Sbjct: 160 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEK 219
Query: 549 ADVYSFGVLLLELLTGKAPTHAL----------LNEEGVDLPR----WVQSIVKDEWTSE 594
           +DVYSFGV+L EL T + P   L             + +++PR     V +I++  WT+E
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNE 279
Query: 595 VF 596
            +
Sbjct: 280 PW 281

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 140/288 (48%), Gaps = 34/288 (11%)
Query: 375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            E LG G FG  +       T VAVK LK  ++S   F  +   +  + H+ LV L A  
Sbjct: 26  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPN 492
            + +   ++ +Y+  GSL   L    G   T     +  L+ + A  A G+ ++  +  N
Sbjct: 86  -TQEPIYIITEYMENGSLVDFLKTPSGIKLT-----INKLLDMAAQIAEGMAFIEER--N 137
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQ 547
             H +++++NIL++ +   +++DFGLA L+  +    R        + APE  +    + 
Sbjct: 138 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 197
Query: 548 KADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV 606
           K+DV+SFG+LL E++T G+ P   + N      P  +Q++ +           ++R  N 
Sbjct: 198 KSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDNC 243
Query: 607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQP 654
            EE+ QL++L   C  + P++RP+   +   +E+   ++T+G +  QP
Sbjct: 244 PEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFF-TATEGQYQPQP 287

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 140/288 (48%), Gaps = 34/288 (11%)
Query: 375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            E LG G FG  +       T VAVK LK  ++S   F  +   +  + H+ LV L A  
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPN 492
            + +   ++ +Y+  GSL   L    G   T     +  L+ + A  A G+ ++  +  N
Sbjct: 84  -TQEPIYIITEYMENGSLVDFLKTPSGIKLT-----INKLLDMAAQIAEGMAFIEER--N 135
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQ 547
             H +++++NIL++ +   +++DFGLA L+  +    R        + APE  +    + 
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 195
Query: 548 KADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV 606
           K+DV+SFG+LL E++T G+ P   + N      P  +Q++ +           ++R  N 
Sbjct: 196 KSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDNC 241
Query: 607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQP 654
            EE+ QL++L   C  + P++RP+   +   +E+   ++T+G +  QP
Sbjct: 242 PEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFF-TATEGQYQPQP 285

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 140/288 (48%), Gaps = 34/288 (11%)
Query: 375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            E LG G FG  +       T VAVK LK  ++S   F  +   +  + H+ LV L A  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPN 492
            + +   ++ +Y+  GSL   L    G   T     +  L+ + A  A G+ ++  +  N
Sbjct: 78  -TQEPIYIITEYMENGSLVDFLKTPSGIKLT-----INKLLDMAAQIAEGMAFIEER--N 129
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQ 547
             H +++++NIL++ +   +++DFGLA L+  +    R        + APE  +    + 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 548 KADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV 606
           K+DV+SFG+LL E++T G+ P   + N      P  +Q++ +           ++R  N 
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDNC 235
Query: 607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQP 654
            EE+ QL++L   C  + P++RP+   +   +E+   ++T+G +  QP
Sbjct: 236 PEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFF-TATEGQYQPQP 279

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 140/288 (48%), Gaps = 34/288 (11%)
Query: 375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            E LG G FG  +       T VAVK LK  ++S   F  +   +  + H+ LV L A  
Sbjct: 28  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 87
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPN 492
            + +   ++ +Y+  GSL   L    G   T     +  L+ + A  A G+ ++  +  N
Sbjct: 88  -TQEPIYIITEYMENGSLVDFLKTPSGIKLT-----INKLLDMAAQIAEGMAFIEER--N 139
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQ 547
             H +++++NIL++ +   +++DFGLA L+  +    R        + APE  +    + 
Sbjct: 140 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 199
Query: 548 KADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV 606
           K+DV+SFG+LL E++T G+ P   + N      P  +Q++ +           ++R  N 
Sbjct: 200 KSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDNC 245
Query: 607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQP 654
            EE+ QL++L   C  + P++RP+   +   +E+   ++T+G +  QP
Sbjct: 246 PEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFF-TATEGQYQPQP 289

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 139/288 (48%), Gaps = 34/288 (11%)
Query: 375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            E LG G FG  +       T VAVK LK  ++S   F  +   +  + H+ LV L A  
Sbjct: 27  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPN 492
            + +   ++ +Y+  GSL   L    G   T     +  L+ + A  A G+ ++  +  N
Sbjct: 87  -TQEPIYIITEYMENGSLVDFLKTPSGIKLT-----INKLLDMAAQIAEGMAFIEER--N 138
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQ 547
             H +++++NIL++ +   +++DFGLA L+  +    R        + APE  +    + 
Sbjct: 139 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 198
Query: 548 KADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV 606
           K+DV+SFG+LL E++T G+ P   + N      P  +Q++ +           ++R  N 
Sbjct: 199 KSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDNC 244
Query: 607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQP 654
            EE+ QL++L   C  + P++RP+   +   +E+   ++T+G    QP
Sbjct: 245 PEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFF-TATEGQFQPQP 288

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYA-VVSE 84
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y++ GSL   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 85  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA------YVERMNYVHR 138
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y++ GSL   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 85  EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA------YVERMNYVHR 138
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   S 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 74
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y++ GSL   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 75  EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA------YVERMNYVHR 128
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 188
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 189 WSFGILLTELTTKGRVPYPGMVNREVLD 216

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 250
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y++ GSL   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA------YVERMNYVHR 304
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVLD 392

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 250
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y++ GSL   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA------YVERMNYVHR 304
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVLD 392

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y++ GSL   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 85  EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA------YVERMNYVHR 138
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   S 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 77
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y++ GSL   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 78  EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA------YVERMNYVHR 131
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 191
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 192 WSFGILLTELTTKGRVPYPGMVNREVLD 219

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 139/287 (48%), Gaps = 34/287 (11%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           E LG G  G  +       T VAVK LK  ++S   F  +   +  + H+ LV L A   
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPNV 493
           + +   ++ +Y+  GSL   L    G   T     +  L+ + A  A G+ ++  +  N 
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLT-----INKLLDMAAQIAEGMAFIEER--NY 130
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQK 548
            H +++++NIL++ +   +++DFGLA L+  +    R        + APE  +    + K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 549 ADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE 607
           +DV+SFG+LL E++T G+ P   + N      P  +Q++ +           ++R  N  
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDNCP 236
Query: 608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQP 654
           EE+ QL++L   C  + P++RP+   +   +E+   ++T+G +  QP
Sbjct: 237 EELYQLMRL---CWKERPEDRPTFDYLRSVLEDFF-TATEGQYQPQP 279

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y++ GSL   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 85  EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA------YVERMNYVHR 138
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y++ GSL   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 85  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA------YVERMNYVHR 138
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   S 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 73
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y++ GSL   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 74  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA------YVERMNYVHR 127
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 188 WSFGILLTELTTKGRVPYPGMVNREVLD 215

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 106/208 (50%), Gaps = 14/208 (6%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   S 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 81
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y+  GSL   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 82  EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMA------YVERMNYVHR 135
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 196 WSFGILLTELTTKGRVPYPGMVNREVLD 223

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   S 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 75
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y++ GSL   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 76  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA------YVERMNYVHR 129
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 190 WSFGILLTELTTKGRVPYPGMVNREVLD 217

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 106/208 (50%), Gaps = 14/208 (6%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   S 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 81
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y+  GSL   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 82  EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMA------YVERMNYVHR 135
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 196 WSFGILLTELTTKGRVPYPGMVNREVLD 223

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 134/279 (48%), Gaps = 33/279 (11%)
Query: 375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            E LG G FG  +       T VAVK LK  ++S   F  +   +  + H+ LV L A  
Sbjct: 14  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPN 492
            + +   ++ +Y+  GSL   L    G   T     +  L+ + A  A G+ ++  +  N
Sbjct: 74  -TQEPIYIITEYMENGSLVDFLKTPSGIKLT-----INKLLDMAAQIAEGMAFIEER--N 125
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQ 547
             H N++++NIL++ +   +++DFGLA L+  +    R        + APE  +    + 
Sbjct: 126 YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 185
Query: 548 KADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV 606
           K+DV+SFG+LL E++T G+ P   + N      P  +Q++ +           ++R  N 
Sbjct: 186 KSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDNC 231
Query: 607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
            EE+ QL++L   C  + P++RP+   +   +E+   ++
Sbjct: 232 PEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTAT 267

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 250
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y++ GSL   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 251 EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA------YVERMNYVHR 304
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVLD 392

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   S 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 333
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y++ GSL   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA------YVERMNYVHR 387
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 448 WSFGILLTELTTKGRVPYPGMVNREVLD 475

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 14/208 (6%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y++ G L   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 85  EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMA------YVERMNYVHR 138
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 106/208 (50%), Gaps = 14/208 (6%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y++ GSL   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 85  EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA------YVERMNYVHR 138
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           ++ ++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 14/208 (6%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y++ G L   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 85  EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMA------YVERMNYVHR 138
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+DV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 134/279 (48%), Gaps = 33/279 (11%)
Query: 375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            E LG G FG  +       T VAVK LK  ++S   F  +   +  + H+ LV L A  
Sbjct: 19  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPN 492
            + +   ++ +Y+  GSL   L    G   T     +  L+ + A  A G+ ++  +  N
Sbjct: 79  -TQEPIYIITEYMENGSLVDFLKTPSGIKLT-----INKLLDMAAQIAEGMAFIEER--N 130
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQ 547
             H +++++NIL++ +   +++DFGLA L+  +    R        + APE  +    + 
Sbjct: 131 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 190
Query: 548 KADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV 606
           K+DV+SFG+LL E++T G+ P   + N      P  +Q++ +           ++R  N 
Sbjct: 191 KSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDNC 236
Query: 607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
            EE+ QL++L   C  + P++RP+   +   +E+   ++
Sbjct: 237 PEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTAT 272

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 134/279 (48%), Gaps = 33/279 (11%)
Query: 375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            E LG G FG  +       T VAVK LK  ++S   F  +   +  + H+ LV L A  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPN 492
            + +   ++ +Y+  GSL   L    G   T     +  L+ + A  A G+ ++  +  N
Sbjct: 78  -TQEPIYIITEYMENGSLVDFLKTPSGIKLT-----INKLLDMAAQIAEGMAFIEER--N 129
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQ 547
             H +++++NIL++ +   +++DFGLA L+  +    R        + APE  +    + 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 548 KADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV 606
           K+DV+SFG+LL E++T G+ P   + N      P  +Q++ +           ++R  N 
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDNC 235
Query: 607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
            EE+ QL++L   C  + P++RP+   +   +E+   ++
Sbjct: 236 PEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTAT 271

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 134/279 (48%), Gaps = 33/279 (11%)
Query: 375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            E LG G FG  +       T VAVK LK  ++S   F  +   +  + H+ LV L A  
Sbjct: 20  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPN 492
            + +   ++ +Y+  GSL   L    G   T     +  L+ + A  A G+ ++  +  N
Sbjct: 80  -TQEPIYIITEYMENGSLVDFLKTPSGIKLT-----INKLLDMAAQIAEGMAFIEER--N 131
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQ 547
             H +++++NIL++ +   +++DFGLA L+  +    R        + APE  +    + 
Sbjct: 132 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 191
Query: 548 KADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV 606
           K+DV+SFG+LL E++T G+ P   + N      P  +Q++ +           ++R  N 
Sbjct: 192 KSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDNC 237
Query: 607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
            EE+ QL++L   C  + P++RP+   +   +E+   ++
Sbjct: 238 PEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTAT 273

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 134/279 (48%), Gaps = 33/279 (11%)
Query: 375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            E LG G FG  +       T VAVK LK  ++S   F  +   +  + H+ LV L A  
Sbjct: 23  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPN 492
            + +   ++ +Y+  GSL   L    G   T     +  L+ + A  A G+ ++  +  N
Sbjct: 83  -TQEPIYIITEYMENGSLVDFLKTPSGIKLT-----INKLLDMAAQIAEGMAFIEER--N 134
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQ 547
             H +++++NIL++ +   +++DFGLA L+  +    R        + APE  +    + 
Sbjct: 135 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 194
Query: 548 KADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV 606
           K+DV+SFG+LL E++T G+ P   + N      P  +Q++ +           ++R  N 
Sbjct: 195 KSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDNC 240
Query: 607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
            EE+ QL++L   C  + P++RP+   +   +E+   ++
Sbjct: 241 PEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTAT 276

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 134/279 (48%), Gaps = 33/279 (11%)
Query: 375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            E LG G FG  +       T VAVK LK  ++S   F  +   +  + H+ LV L A  
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPN 492
            + +   ++ +Y+  GSL   L    G   T     +  L+ + A  A G+ ++  +  N
Sbjct: 84  -TQEPIYIITEYMENGSLVDFLKTPSGIKLT-----INKLLDMAAQIAEGMAFIEER--N 135
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQ 547
             H +++++NIL++ +   +++DFGLA L+  +    R        + APE  +    + 
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 195
Query: 548 KADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV 606
           K+DV+SFG+LL E++T G+ P   + N      P  +Q++ +           ++R  N 
Sbjct: 196 KSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDNC 241
Query: 607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
            EE+ QL++L   C  + P++RP+   +   +E+   ++
Sbjct: 242 PEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTAT 277

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 134/279 (48%), Gaps = 33/279 (11%)
Query: 375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            E LG G FG  +       T VAVK LK  ++S   F  +   +  + H+ LV L A  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPN 492
            + +   ++ +Y+  GSL   L    G   T     +  L+ + A  A G+ ++  +  N
Sbjct: 78  -TQEPIYIITEYMENGSLVDFLKTPSGIKLT-----INKLLDMAAQIAEGMAFIEER--N 129
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQ 547
             H +++++NIL++ +   +++DFGLA L+  +    R        + APE  +    + 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 548 KADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV 606
           K+DV+SFG+LL E++T G+ P   + N      P  +Q++ +           ++R  N 
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDNC 235
Query: 607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
            EE+ QL++L   C  + P++RP+   +   +E+   ++
Sbjct: 236 PEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTAT 271

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 137/285 (48%), Gaps = 33/285 (11%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG  +       T VAVK LK  T+S + F ++   +  + H+ LV L A     
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTRE 80
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPNVSH 495
           +   ++ +Y+  GSL   L  ++G G+  L      LI   A  A G+ Y+  +  N  H
Sbjct: 81  EPIYIITEYMAKGSLLDFLKSDEG-GKVLLP----KLIDFSAQIAEGMAYIERK--NYIH 133
Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKAD 550
            +++++N+L+++S   +++DFGLA ++  +    R        + APE  +    + K+D
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSD 193
Query: 551 VYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           V+SFG+LL E++T GK P     N               D  T+      + R +N  +E
Sbjct: 194 VWSFGILLYEIVTYGKIPYPGRTN--------------ADVMTALSQGYRMPRVENCPDE 239
Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQP 654
           +  ++++   C  +  + RP+   +   +++ + ++T+G +  QP
Sbjct: 240 LYDIMKM---CWKEKAEERPTFDYLQSVLDDFY-TATEGQYQQQP 280

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 132/275 (48%), Gaps = 33/275 (12%)
Query: 375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            E LG G FG  +       T VAVK LK  ++S   F  +   +  + H+ LV L A  
Sbjct: 13  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPN 492
            + +   ++ +Y+  GSL   L    G   T     +  L+ + A  A G+ ++  +  N
Sbjct: 73  -TQEPIYIITEYMENGSLVDFLKTPSGIKLT-----INKLLDMAAQIAEGMAFIEER--N 124
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQ 547
             H +++++NIL++ +   +++DFGLA L+  +    R        + APE  +    + 
Sbjct: 125 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 184
Query: 548 KADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV 606
           K+DV+SFG+LL E++T G+ P   + N      P  +Q++ +           ++R  N 
Sbjct: 185 KSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDNC 230
Query: 607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            EE+ QL++L   C  + P++RP+   +   +E+ 
Sbjct: 231 PEELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 262

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 130/279 (46%), Gaps = 44/279 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE-FKDKIEGVGAVNHENLVPLRAYY 434
           EV+G+G FG   KA       VA+K+++  + SER+ F  ++  +  VNH N+V L  Y 
Sbjct: 15  EVVGRGAFGVVCKAKWR-AKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKL--YG 69
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKG----AGRTPLNWEMRSLIALGAARGIEYLHAQG 490
             ++   LV +Y   GSL  +LHG +          ++W       L  ++G+ YLH+  
Sbjct: 70  ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQ 123
Query: 491 PN-VSHGNIKSSNILLTKSYEA-RVSDFGLAHLVGPSSTPNR-VAGYRAPEVTDPCKVSQ 547
           P  + H ++K  N+LL       ++ DFG A  +    T N+  A + APEV +    S+
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSE 183
Query: 548 KADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE 607
           K DV+S+G++L E++T + P                     DE     F +    +    
Sbjct: 184 KCDVFSWGIILWEVITRRKPF--------------------DEIGGPAFRIMWAVHNGTR 223
Query: 608 EEMVQLLQLAID-----CSAQYPDNRPSMSEVIKRIEEL 641
             +++ L   I+     C ++ P  RPSM E++K +  L
Sbjct: 224 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 262

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 135/279 (48%), Gaps = 33/279 (11%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISE-REFKDKIEGVGAVNHENLVPLRAYYYS 436
           +G G+FGT YK        V + ++ D T  + + F++++  +    H N++ L   Y +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNIL-LFMGYMT 102
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYLHAQGPNVS 494
            D   +V  +    SL   LH  +        ++M  LI +    A+G++YLHA+  N+ 
Sbjct: 103 KDNLAIVTQWCEGSSLYKHLHVQE------TKFQMFQLIDIARQTAQGMDYLHAK--NII 154
Query: 495 HGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------YRAPEVT---DPCKV 545
           H ++KS+NI L +    ++ DFGLA +    S   +V        + APEV    D    
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF 214
Query: 546 SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN 605
           S ++DVYS+G++L EL+TG+ P   + N + +        +V   + S   DL  L Y+N
Sbjct: 215 SFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF------MVGRGYASP--DLSKL-YKN 265
Query: 606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS 644
             + M +L+    DC  +  + RP   +++  IE L  S
Sbjct: 266 CPKAMKRLVA---DCVKKVKEERPLFPQILSSIELLQHS 301

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 14/208 (6%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG+G FG  +       T VA+K LK   +S   F  + + +  + HE LV L A   S 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 251
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAG-RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
           +   +V +Y++ GSL   L G  G   R P   +M + IA G A      + +  N  H 
Sbjct: 252 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA------YVERMNYVHR 305
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADV 551
           +++++NIL+ ++   +V+DFGL  L+  +    R        + APE     + + K+DV
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 365
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVD 578
           +SFG+LL EL T G+ P   ++N E +D
Sbjct: 366 WSFGILLTELTTKGRVPYPGMVNREVLD 393

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 128/279 (45%), Gaps = 39/279 (13%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLK-----DVTISEREFKDKIEGVGAVNHENLVPL 430
           E++G G FG  Y+A   +G  VAVK  +     D++ +    + + +    + H N++ L
Sbjct: 13  EIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
           R          LV ++   G L+ +L G +      +NW      A+  ARG+ YLH + 
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARGMNYLHDEA 125
Query: 491 -PNVSHGNIKSSNILLTKSYE--------ARVSDFGLAHLVGPSSTPNRVAGY--RAPEV 539
              + H ++KSSNIL+ +  E         +++DFGLA     ++  +    Y   APEV
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEV 185
Query: 540 TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE 599
                 S+ +DV+S+GVLL ELLTG+ P        G+D       +  ++       L 
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVPFR------GIDGLAVAYGVAMNK-------LA 232
Query: 600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
           L       E   +L++   DC    P +RPS + ++ ++
Sbjct: 233 LPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQL 268

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 130/279 (46%), Gaps = 44/279 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE-FKDKIEGVGAVNHENLVPLRAYY 434
           EV+G+G FG   KA       VA+K+++  + SER+ F  ++  +  VNH N+V L  Y 
Sbjct: 14  EVVGRGAFGVVCKAKWR-AKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKL--YG 68
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKG----AGRTPLNWEMRSLIALGAARGIEYLHAQG 490
             ++   LV +Y   GSL  +LHG +          ++W       L  ++G+ YLH+  
Sbjct: 69  ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQ 122
Query: 491 PN-VSHGNIKSSNILLTKSYEA-RVSDFGLAHLVGPSSTPNR-VAGYRAPEVTDPCKVSQ 547
           P  + H ++K  N+LL       ++ DFG A  +    T N+  A + APEV +    S+
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 548 KADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE 607
           K DV+S+G++L E++T + P                     DE     F +    +    
Sbjct: 183 KCDVFSWGIILWEVITRRKPF--------------------DEIGGPAFRIMWAVHNGTR 222
Query: 608 EEMVQLLQLAID-----CSAQYPDNRPSMSEVIKRIEEL 641
             +++ L   I+     C ++ P  RPSM E++K +  L
Sbjct: 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 138/278 (49%), Gaps = 37/278 (13%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLRAYY 434
           +G G+FGT YK   +    VAVK L     + ++   FK+++  +    H N++ L   Y
Sbjct: 20  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 76
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYLHAQGPN 492
            +  +  +V  +    SL   LH ++        +EM+ LI +    ARG++YLHA+  +
Sbjct: 77  STKPQLAIVTQWCEGSSLYHHLHASE------TKFEMKKLIDIARQTARGMDYLHAK--S 128
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------YRAPEVT---DPC 543
           + H ++KS+NI L +    ++ DFGLA +    S  ++         + APEV    D  
Sbjct: 129 IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 188
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY 603
             S ++DVY+FG++L EL+TG+ P   + N + +     ++ + +   +    DL  +R 
Sbjct: 189 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----IEMVGRGSLSP---DLSKVR- 239
Query: 604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            N  + M +L+    +C  +  D RPS   ++  IEEL
Sbjct: 240 SNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIEEL 274

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 145/296 (48%), Gaps = 37/296 (12%)
Query: 360 NAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE---FKDKI 416
           +AA  +++ D      + +G G+FGT YK   +    VAVK L     + ++   FK+++
Sbjct: 14  DAADDWEIPDGQITVGQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEV 71
Query: 417 EGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIA 476
             +    H N++ L   Y +  +  +V  +    SL   LH ++        +EM+ LI 
Sbjct: 72  GVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHASE------TKFEMKKLID 124
Query: 477 LG--AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG- 533
           +    ARG++YLHA+  ++ H ++KS+NI L +    ++ DFGLA      S  ++    
Sbjct: 125 IARQTARGMDYLHAK--SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL 182
Query: 534 -----YRAPEVT---DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQS 585
                + APEV    D    S ++DVY+FG++L EL+TG+ P   + N + +     ++ 
Sbjct: 183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----IEM 237
Query: 586 IVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           + +   +    DL  +R  N  + M +L+    +C  +  D RPS   ++  IEEL
Sbjct: 238 VGRGSLSP---DLSKVR-SNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIEEL 286

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 139/285 (48%), Gaps = 33/285 (11%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG  +       T VAVK LK  T+S + F ++   +  + H+ LV L A     
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 79
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPNVSH 495
           +   ++ +++  GSL   L  ++G G+  L      LI   A  A G+ Y+  +  N  H
Sbjct: 80  EPIYIITEFMAKGSLLDFLKSDEG-GKVLLP----KLIDFSAQIAEGMAYIERK--NYIH 132
Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKAD 550
            +++++N+L+++S   +++DFGLA ++  +    R        + APE  +    + K++
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSN 192
Query: 551 VYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           V+SFG+LL E++T GK P     N +       V S +   +        + R +N  +E
Sbjct: 193 VWSFGILLYEIVTYGKIPYPGRTNAD-------VMSALSQGY-------RMPRMENCPDE 238
Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQP 654
           +  ++++   C  +  + RP+   +   +++ + ++T+G +  QP
Sbjct: 239 LYDIMKM---CWKEKAEERPTFDYLQSVLDDFY-TATEGQYQQQP 279

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 139/278 (50%), Gaps = 37/278 (13%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLRAYY 434
           +G G+FGT YK   +    VAVK L     + ++   FK+++  +    H N++ L   Y
Sbjct: 32  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 88
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYLHAQGPN 492
            +  +  +V  +    SL   LH ++        +EM+ LI +    ARG++YLHA+  +
Sbjct: 89  STKPQLAIVTQWCEGSSLYHHLHASE------TKFEMKKLIDIARQTARGMDYLHAK--S 140
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLA---HLVGPSSTPNRVAG---YRAPEVT---DPC 543
           + H ++KS+NI L +    ++ DFGLA        S    +++G   + APEV    D  
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY 603
             S ++DVY+FG++L EL+TG+ P   + N + +     ++ + +   +    DL  +R 
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----IEMVGRGSLSP---DLSKVR- 251
Query: 604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            N  + M +L+    +C  +  D RPS   ++  IEEL
Sbjct: 252 SNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIEEL 286

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 326
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  +N  +   +A   +  +EYL  +  N  H 
Sbjct: 327 EPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK--NFIHR 381
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           N+ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 382 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 441
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 442 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 487
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
            +L++    C    P +RPS +E+ +  E +   S+
Sbjct: 488 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQESS 520

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 135/276 (48%), Gaps = 33/276 (11%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG  + A     T VAVK +K  ++S   F  +   +  + H+ LV L A   + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVTK 254
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPNVSH 495
           +   ++ +++  GSL   L  ++G+ + PL      LI   A  A G+ ++  +  N  H
Sbjct: 255 EPIYIITEFMAKGSLLDFLKSDEGS-KQPLP----KLIDFSAQIAEGMAFIEQR--NYIH 307
Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKAD 550
            +++++NIL++ S   +++DFGLA ++  +    R        + APE  +    + K+D
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 551 VYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           V+SFG+LL+E++T G+ P   + N      P  ++++ +           + R +N  EE
Sbjct: 368 VWSFGILLMEIVTYGRIPYPGMSN------PEVIRALER--------GYRMPRPENCPEE 413
Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
           +  ++   + C    P+ RP+   +   +++ + ++
Sbjct: 414 LYNIM---MRCWKNRPEERPTFEYIQSVLDDFYTAT 446

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 140/280 (50%), Gaps = 34/280 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG  + A     T VAVK +K  ++S   F  +   +  + H+ LV L A   + 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVTK 248
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPNVSH 495
           +   ++ +++  GSL   L  ++G+ + PL      LI   A  A G+ ++  +  N  H
Sbjct: 249 EPIYIITEFMAKGSLLDFLKSDEGS-KQPLP----KLIDFSAQIAEGMAFIEQR--NYIH 301
Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFG 555
            +++++NIL++ S   +++DFGLA  VG +  P +   + APE  +    + K+DV+SFG
Sbjct: 302 RDLRAANILVSASLVCKIADFGLAR-VG-AKFPIK---WTAPEAINFGSFTIKSDVWSFG 356
Query: 556 VLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLL 614
           +LL+E++T G+ P   + N      P  ++++ +           + R +N  EE+  ++
Sbjct: 357 ILLMEIVTYGRIPYPGMSN------PEVIRALER--------GYRMPRPENCPEELYNIM 402
Query: 615 QLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQP 654
              + C    P+ RP+   +   +++ + ++T+     QP
Sbjct: 403 ---MRCWKNRPEERPTFEYIQSVLDDFY-TATESQXQQQP 438

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 140/295 (47%), Gaps = 35/295 (11%)
Query: 366 DLEDLLRASAEV---LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAV 422
           D+ ++ R S ++   LG G FG  +       T VA+K LK  T+S   F ++ + +  +
Sbjct: 2   DVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKL 61
Query: 423 NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKG-AGRTPLNWEMRSLIALGAAR 481
            H+ LV L A   S +   +V +Y+  GSL   L   +G A + P   +M + +A G A 
Sbjct: 62  KHDKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA- 119
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRA 536
                + +  N  H +++S+NIL+      +++DFGLA L+  +    R        + A
Sbjct: 120 -----YIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTA 174
Query: 537 PEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV 595
           PE     + + K+DV+SFG+LL EL+T G+ P   + N E       V   V+  +    
Sbjct: 175 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-------VLEQVERGY---- 223
Query: 596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHH 650
                 R    ++  + L +L I C  + P+ RP+  E ++   E + ++T+  +
Sbjct: 224 ------RMPCPQDCPISLHELMIHCWKKDPEERPTF-EYLQSFLEDYFTATEPQY 271

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 128/275 (46%), Gaps = 33/275 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           +G G FG  +         VA+K +K+ ++SE +F ++ E +  ++H  LV L       
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQ 94
Query: 438 DEKLLVYDYLTMGSLSALLHGNKG--AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
               LV++++  G LS  L   +G  A  T L       + L    G+ YL  +   V H
Sbjct: 95  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYL--EEACVIH 146
Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLV----GPSSTPNRV-AGYRAPEVTDPCKVSQKAD 550
            ++ + N L+ ++   +VSDFG+   V      SST  +    + +PEV    + S K+D
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 551 VYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           V+SFGVL+ E+ + GK P     N E          +V+D   S  F L   R  +    
Sbjct: 207 VWSFGVLMWEVFSEGKIPYENRSNSE----------VVED--ISTGFRLYKPRLAS---- 250
Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS 644
              + Q+   C  + P++RP+ S +++++ E+  S
Sbjct: 251 -THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 284

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 129/265 (48%), Gaps = 33/265 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG  + A     T VAVK +K  ++S   F  +   +  + H+ LV L A   + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVTK 81
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA--ARGIEYLHAQGPNVSH 495
           +   ++ +++  GSL   L  ++G+ + PL      LI   A  A G+ ++  +  N  H
Sbjct: 82  EPIYIITEFMAKGSLLDFLKSDEGS-KQPLP----KLIDFSAQIAEGMAFIEQR--NYIH 134
Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKAD 550
            +++++NIL++ S   +++DFGLA ++  +    R        + APE  +    + K+D
Sbjct: 135 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 194
Query: 551 VYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           V+SFG+LL+E++T G+ P   + N      P  ++++ +           + R +N  EE
Sbjct: 195 VWSFGILLMEIVTYGRIPYPGMSN------PEVIRALER--------GYRMPRPENCPEE 240
Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEV 634
           +  ++   + C    P+ RP+   +
Sbjct: 241 LYNIM---MRCWKNRPEERPTFEYI 262

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 127/275 (46%), Gaps = 33/275 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           +G G FG  +         VA+K +++  +SE +F ++ E +  ++H  LV L       
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77
Query: 438 DEKLLVYDYLTMGSLSALLHGNKG--AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
               LV++++  G LS  L   +G  A  T L       + L    G+ YL  +   V H
Sbjct: 78  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYL--EEACVIH 129
Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLV----GPSSTPNRV-AGYRAPEVTDPCKVSQKAD 550
            ++ + N L+ ++   +VSDFG+   V      SST  +    + +PEV    + S K+D
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 189
Query: 551 VYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           V+SFGVL+ E+ + GK P     N E          +V+D   S  F L   R  +    
Sbjct: 190 VWSFGVLMWEVFSEGKIPYENRSNSE----------VVED--ISTGFRLYKPRLAS---- 233
Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS 644
              + Q+   C  + P++RP+ S +++++ E+  S
Sbjct: 234 -THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 127/275 (46%), Gaps = 33/275 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           +G G FG  +         VA+K +++  +SE +F ++ E +  ++H  LV L       
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 438 DEKLLVYDYLTMGSLSALLHGNKG--AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
               LV++++  G LS  L   +G  A  T L       + L    G+ YL  +   V H
Sbjct: 75  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYL--EEACVIH 126
Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLV----GPSSTPNRV-AGYRAPEVTDPCKVSQKAD 550
            ++ + N L+ ++   +VSDFG+   V      SST  +    + +PEV    + S K+D
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 551 VYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           V+SFGVL+ E+ + GK P     N E          +V+D   S  F L   R  +    
Sbjct: 187 VWSFGVLMWEVFSEGKIPYENRSNSE----------VVED--ISTGFRLYKPRLAS---- 230
Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS 644
              + Q+   C  + P++RP+ S +++++ E+  S
Sbjct: 231 -THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 264

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 127/275 (46%), Gaps = 33/275 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           +G G FG  +         VA+K +++  +SE +F ++ E +  ++H  LV L       
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 438 DEKLLVYDYLTMGSLSALLHGNKG--AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
               LV++++  G LS  L   +G  A  T L       + L    G+ YL  +   V H
Sbjct: 73  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYL--EEACVIH 124
Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLV----GPSSTPNRV-AGYRAPEVTDPCKVSQKAD 550
            ++ + N L+ ++   +VSDFG+   V      SST  +    + +PEV    + S K+D
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 551 VYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           V+SFGVL+ E+ + GK P     N E          +V+D   S  F L   R  +    
Sbjct: 185 VWSFGVLMWEVFSEGKIPYENRSNSE----------VVED--ISTGFRLYKPRLAS---- 228
Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS 644
              + Q+   C  + P++RP+ S +++++ E+  S
Sbjct: 229 -THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  ++  +   +A   +  +EYL  +  N  H 
Sbjct: 288 EPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHR 342
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           N+ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 403 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 448
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
            +L++    C    P +RPS +E+ +  E +   S+
Sbjct: 449 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQESS 481

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  +N  +   +A   +  +EYL  +  N  H 
Sbjct: 82  EPPFYIIIEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK--NFIHR 136
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 137 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 197 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 242
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
            +L++    C    P +RPS +E+ +  E +   S+
Sbjct: 243 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQESS 275

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  +N  +   +A   +  +EYL  +  N  H 
Sbjct: 86  EPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK--NFIHR 140
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 201 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 246
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
            +L++    C    P +RPS +E+ +  E +   S+
Sbjct: 247 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQESS 279

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  +N  +   +A   +  +EYL  +  N  H 
Sbjct: 83  EPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK--NFIHR 137
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 198 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 243
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
            +L++    C    P +RPS +E+ +  E +   S+
Sbjct: 244 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQESS 276

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  +N  +   +A   +  +EYL  +  N  H 
Sbjct: 83  EPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK--NFIHR 137
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 198 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 243
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
            +L++    C    P +RPS +E+ +  E +   S+
Sbjct: 244 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQESS 276

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 93
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  +N  +   +A   +  +EYL  +  N  H 
Sbjct: 94  EPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK--NFIHR 148
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 149 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 208
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 209 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 254
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
            +L++    C    P +RPS +E+ +  E +   S+
Sbjct: 255 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQESS 287

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 134/275 (48%), Gaps = 29/275 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  +N  +   +A   +  +EYL  +  N  H 
Sbjct: 86  EPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK--NFIHR 140
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 201 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 246
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
            +L++    C    P +RPS +E+ +  E +   S
Sbjct: 247 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQES 278

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 127/275 (46%), Gaps = 33/275 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           +G G FG  +         VA+K +++  +SE +F ++ E +  ++H  LV L       
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 438 DEKLLVYDYLTMGSLSALLHGNKG--AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
               LV++++  G LS  L   +G  A  T L       + L    G+ YL  +  +V H
Sbjct: 75  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYL--EEASVIH 126
Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLV----GPSSTPNRV-AGYRAPEVTDPCKVSQKAD 550
            ++ + N L+ ++   +VSDFG+   V      SST  +    + +PEV    + S K+D
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 551 VYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           V+SFGVL+ E+ + GK P     N E          +V+D   S  F L   R  +    
Sbjct: 187 VWSFGVLMWEVFSEGKIPYENRSNSE----------VVED--ISTGFRLYKPRLAS---- 230
Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS 644
              + Q+   C  + P++RP+ S +++++  +  S
Sbjct: 231 -THVYQIMNHCWKERPEDRPAFSRLLRQLAAIAAS 264

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 134/275 (48%), Gaps = 29/275 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  +N  +   +A   +  +EYL  +  N  H 
Sbjct: 85  EPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK--NFIHR 139
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 140 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 199
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 200 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 245
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
            +L++    C    P +RPS +E+ +  E +   S
Sbjct: 246 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQES 277

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 134/275 (48%), Gaps = 29/275 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  +N  +   +A   +  +EYL  +  N  H 
Sbjct: 81  EPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK--NFIHR 135
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 196 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 241
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
            +L++    C    P +RPS +E+ +  E +   S
Sbjct: 242 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 133/271 (49%), Gaps = 29/271 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  +N  +   +A   +  +EYL  +  N  H 
Sbjct: 86  EPPFYIIIEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK--NFIHR 140
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 201 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 246
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            +L++    C    P +RPS +E+ +  E +
Sbjct: 247 YELMRA---CWQWNPSDRPSFAEIHQAFETM 274

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 133/271 (49%), Gaps = 29/271 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  +N  +   +A   +  +EYL  +  N  H 
Sbjct: 86  EPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK--NFIHR 140
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 201 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 246
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            +L++    C    P +RPS +E+ +  E +
Sbjct: 247 YELMRA---CWQWNPSDRPSFAEIHQAFETM 274

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 126/275 (45%), Gaps = 33/275 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           +G G FG  +         VA+K +++  +SE +F ++ E +  ++H  LV L       
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 438 DEKLLVYDYLTMGSLSALLHGNKG--AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
               LV +++  G LS  L   +G  A  T L       + L    G+ YL  +   V H
Sbjct: 76  APICLVTEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYL--EEACVIH 127
Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLV----GPSSTPNRV-AGYRAPEVTDPCKVSQKAD 550
            ++ + N L+ ++   +VSDFG+   V      SST  +    + +PEV    + S K+D
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 551 VYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           V+SFGVL+ E+ + GK P     N E          +V+D   S  F L   R  +    
Sbjct: 188 VWSFGVLMWEVFSEGKIPYENRSNSE----------VVED--ISTGFRLYKPRLAS---- 231
Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS 644
              + Q+   C  + P++RP+ S +++++ E+  S
Sbjct: 232 -THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 134/276 (48%), Gaps = 29/276 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  +N  +   +A   +  +EYL  +  N  H 
Sbjct: 83  EPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK--NFIHR 137
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T    A +     APE     K S K+DV
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 198 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 243
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
            +L++    C    P +RPS +E+ +  E +   S+
Sbjct: 244 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQESS 276

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 134/276 (48%), Gaps = 29/276 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  +N  +   +A   +  +EYL  +  N  H 
Sbjct: 82  EPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK--NFIHR 136
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T    A +     APE     K S K+DV
Sbjct: 137 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 197 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 242
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
            +L++    C    P +RPS +E+ +  E +   S+
Sbjct: 243 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQESS 275

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 133/271 (49%), Gaps = 29/271 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  +N  +   +A   +  +EYL  +  N  H 
Sbjct: 81  EPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK--NFIHR 135
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 196 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 241
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            +L++    C    P +RPS +E+ +  E +
Sbjct: 242 YELMRA---CWQWNPSDRPSFAEIHQAFETM 269

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G FG  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  ++  +   +A   +  +EYL  +  N  H 
Sbjct: 79  EPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHR 133
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+D P  V  +++        D  + R +   E++
Sbjct: 194 WAFGVLLWEIATYGMSPY------PGID-PSQVYELLEK-------DYRMERPEGCPEKV 239
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
            +L++    C    P +RPS +E+ +  E +   S+
Sbjct: 240 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQESS 272

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  ++  +   +A   +  +EYL  +  N  H 
Sbjct: 81  EPPFYIIIEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHR 135
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 196 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 241
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
            +L++    C    P +RPS +E+ +  E +   S+
Sbjct: 242 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQESS 274

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  ++  +   +A   +  +EYL  +  N  H 
Sbjct: 81  EPPFYIIIEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHR 135
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 196 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 241
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
            +L++    C    P +RPS +E+ +  E +   S+
Sbjct: 242 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQESS 274

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  ++  +   +A   +  +EYL  +  N  H 
Sbjct: 81  EPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHR 135
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 196 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 241
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
            +L++    C    P +RPS +E+ +  E +   S+
Sbjct: 242 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQESS 274

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  ++  +   +A   +  +EYL  +  N  H 
Sbjct: 86  EPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHR 140
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 201 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 246
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
            +L++    C    P +RPS +E+ +  E +   S+
Sbjct: 247 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQESS 279

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  ++  +   +A   +  +EYL  +  N  H 
Sbjct: 81  EPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHR 135
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+DL +  + + K        D  + R +   E++
Sbjct: 196 WAFGVLLWEIATYGMSPY------PGIDLSQVYELLEK--------DYRMERPEGCPEKV 241
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
            +L++    C    P +RPS +E+ +  E +   S+
Sbjct: 242 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQESS 274

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 136/281 (48%), Gaps = 29/281 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  ++  +   +A   +  +EYL  +  N  H 
Sbjct: 79  EPPFYIIIEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHR 133
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+D P  V  +++        D  + R +   E++
Sbjct: 194 WAFGVLLWEIATYGMSPY------PGID-PSQVYELLEK-------DYRMERPEGCPEKV 239
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHG 651
            +L++    C    P +RPS +E+ +  E +   S+    G
Sbjct: 240 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQESSISDEG 277

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG G +G  Y+ V +  ++ VAVK LK+ T+   EF  +   +  + H NLV L      
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +++T G+L   L   +   R  ++  +   +A   +  +EYL  +  N  H 
Sbjct: 79  EPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHR 133
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADV 551
           ++ + N L+ +++  +V+DFGL+ L+ G + T +  A +     APE     K S K+DV
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FGVLL E+ T G +P        G+D P  V  +++        D  + R +   E++
Sbjct: 194 WAFGVLLWEIATYGMSPY------PGID-PSQVYELLEK-------DYRMERPEGCPEKV 239
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
            +L++    C    P +RPS +E+ +  E +   S+
Sbjct: 240 YELMRA---CWQWNPSDRPSFAEIHQAFETMFQESS 272

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 134/286 (46%), Gaps = 47/286 (16%)
Query: 378 LGKGTFGTAYKA-VLEMGTIVAVKRL--------KDVTISEREFKDKIEGVGAVNHENLV 428
           +GKG FG  +K  +++  ++VA+K L         ++    +EF+ ++  +  +NH N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L  Y    +   +V +++  G L   L         P+ W ++  + L  A GIEY+  
Sbjct: 87  KL--YGLMHNPPRMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQN 140
Query: 489 QGPNVSHGNIKSSNILLTKSYE-----ARVSDFGLAHLVGPSSTPNRVAG------YRAP 537
           Q P + H +++S NI L    E     A+V+DFGL+       + + V+G      + AP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 538 EV--TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV 595
           E    +    ++KAD YSF ++L  +LTG+ P     +E      +++  I ++     +
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDEYSYGKIKFINMIREEGLRPTI 251
Query: 596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            +    R +NV    ++L      C +  P  RP  S ++K + EL
Sbjct: 252 PEDCPPRLRNV----IEL------CWSGDPKKRPHFSYIVKELSEL 287

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 30/221 (13%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRL-KDVTISEREFKDKIEGVG 420
           R+F   DL+    EVLGKG FG A K    E G ++ +K L +    ++R F  +++ + 
Sbjct: 5   RIFRPSDLI--HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMR 62
Query: 421 AVNHENLVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA 479
            + H N++      Y  D++L  + +Y+  G+L  ++            W  R   A   
Sbjct: 63  CLEHPNVLKFIGVLYK-DKRLNFITEYIKGGTLRGIIKSMDSQ----YPWSQRVSFAKDI 117
Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST----------PN 529
           A G+ YLH+   N+ H ++ S N L+ ++    V+DFGLA L+    T          P+
Sbjct: 118 ASGMAYLHSM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 530 RVAGYR--------APEVTDPCKVSQKADVYSFGVLLLELL 562
           R   Y         APE+ +     +K DV+SFG++L E++
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 133/286 (46%), Gaps = 47/286 (16%)
Query: 378 LGKGTFGTAYKA-VLEMGTIVAVKRL--------KDVTISEREFKDKIEGVGAVNHENLV 428
           +GKG FG  +K  +++  ++VA+K L         ++    +EF+ ++  +  +NH N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L  Y    +   +V +++  G L   L         P+ W ++  + L  A GIEY+  
Sbjct: 87  KL--YGLMHNPPRMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQN 140
Query: 489 QGPNVSHGNIKSSNILLTKSYE-----ARVSDFGLAHLVGPSSTPNRVAG------YRAP 537
           Q P + H +++S NI L    E     A+V+DFG +       + + V+G      + AP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 538 EV--TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV 595
           E    +    ++KAD YSF ++L  +LTG+ P     +E      +++  I ++     +
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDEYSYGKIKFINMIREEGLRPTI 251
Query: 596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            +    R +NV    ++L      C +  P  RP  S ++K + EL
Sbjct: 252 PEDCPPRLRNV----IEL------CWSGDPKKRPHFSYIVKELSEL 287

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 136/286 (47%), Gaps = 37/286 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLRAYY 434
           +G G+FGT YK   +    VAVK L     + ++   FK+++  +    H N++ L   Y
Sbjct: 21  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 77
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYLHAQGPN 492
            +  +  +V  +    SL   LH           +EM  LI +    A+G++YLHA+  +
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK--S 129
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------YRAPEVT---DPC 543
           + H ++KS+NI L +    ++ DFGLA +    S  ++         + APEV    D  
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY 603
             S ++DVY+FG++L EL+TG+ P   + N + +        +V   + S   DL  +R 
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRGYLSP--DLSKVR- 240
Query: 604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGH 649
            N  + M +L+    +C  +  D RP   +++  IE L  S  + H
Sbjct: 241 SNCPKAMKRLMA---ECLKKKRDERPLFPQILASIELLARSLPKIH 283

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 136/286 (47%), Gaps = 37/286 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLRAYY 434
           +G G+FGT YK   +    VAVK L     + ++   FK+++  +    H N++ L   Y
Sbjct: 18  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 74
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYLHAQGPN 492
            +  +  +V  +    SL   LH           +EM  LI +    A+G++YLHA+  +
Sbjct: 75  STKPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK--S 126
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------YRAPEVT---DPC 543
           + H ++KS+NI L +    ++ DFGLA +    S  ++         + APEV    D  
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY 603
             S ++DVY+FG++L EL+TG+ P   + N + +        +V   + S   DL  +R 
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRGYLSP--DLSKVR- 237
Query: 604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGH 649
            N  + M +L+    +C  +  D RP   +++  IE L  S  + H
Sbjct: 238 SNCPKAMKRLMA---ECLKKKRDERPLFPQILASIELLARSLPKIH 280

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 136/286 (47%), Gaps = 37/286 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLRAYY 434
           +G G+FGT YK   +    VAVK L     + ++   FK+++  +    H N++ L   Y
Sbjct: 44  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 100
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYLHAQGPN 492
            +  +  +V  +    SL   LH           +EM  LI +    A+G++YLHA+  +
Sbjct: 101 STKPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK--S 152
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------YRAPEVT---DPC 543
           + H ++KS+NI L +    ++ DFGLA +    S  ++         + APEV    D  
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY 603
             S ++DVY+FG++L EL+TG+ P   + N + +        +V   + S   DL  +R 
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRGYLSP--DLSKVR- 263
Query: 604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGH 649
            N  + M +L+    +C  +  D RP   +++  IE L  S  + H
Sbjct: 264 SNCPKAMKRLMA---ECLKKKRDERPLFPQILASIELLARSLPKIH 306

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 136/286 (47%), Gaps = 37/286 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLRAYY 434
           +G G+FGT YK   +    VAVK L     + ++   FK+++  +    H N++ L   Y
Sbjct: 43  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 99
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYLHAQGPN 492
            +  +  +V  +    SL   LH           +EM  LI +    A+G++YLHA+  +
Sbjct: 100 STKPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK--S 151
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------YRAPEVT---DPC 543
           + H ++KS+NI L +    ++ DFGLA +    S  ++         + APEV    D  
Sbjct: 152 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 211
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY 603
             S ++DVY+FG++L EL+TG+ P   + N + +        +V   + S   DL  +R 
Sbjct: 212 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRGYLSP--DLSKVR- 262
Query: 604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGH 649
            N  + M +L+    +C  +  D RP   +++  IE L  S  + H
Sbjct: 263 SNCPKAMKRLMA---ECLKKKRDERPLFPQILASIELLARSLPKIH 305

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 111/237 (46%), Gaps = 35/237 (14%)
Query: 376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLK-DVTISEREFKDKIEGVG--------AVNHE 425
           ++LGKG+FG  + A  +      A+K LK DV + +    D +E           A  H 
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD----DDVECTMVEKRVLSLAWEHP 79
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
            L  +   + + +    V +YL  G L   ++  +   +  L+    +  A     G+++
Sbjct: 80  FLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLS--RATFYAAEIILGLQF 134
Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--HLVGPSSTPNRVAG---YRAPEVT 540
           LH++G  + + ++K  NILL K    +++DFG+   +++G + T N   G   Y APE+ 
Sbjct: 135 LHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NEFCGTPDYIAPEIL 191
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVD--------LPRWVQSIVKD 589
              K +   D +SFGVLL E+L G++P H    EE            PRW++   KD
Sbjct: 192 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 248

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 133/278 (47%), Gaps = 37/278 (13%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLRAYY 434
           +G G+FGT YK   +    VAVK L     + ++   FK+++  +    H N++ L   Y
Sbjct: 21  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 77
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYLHAQGPN 492
            +  +  +V  +    SL   LH           +EM  LI +    A+G++YLHA+  +
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK--S 129
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------YRAPEVT---DPC 543
           + H ++KS+NI L +    ++ DFGLA +    S  ++         + APEV    D  
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY 603
             S ++DVY+FG++L EL+TG+ P   + N + +        +V   + S   DL  +R 
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRGYLSP--DLSKVR- 240
Query: 604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            N  + M +L+    +C  +  D RP   +++  IE L
Sbjct: 241 SNCPKAMKRLMA---ECLKKKRDERPLFPQILASIELL 275

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 133/278 (47%), Gaps = 37/278 (13%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLRAYY 434
           +G G+FGT YK   +    VAVK L     + ++   FK+++  +    H N++ L   Y
Sbjct: 16  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 72
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYLHAQGPN 492
            +  +  +V  +    SL   LH           +EM  LI +    A+G++YLHA+  +
Sbjct: 73  STAPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK--S 124
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------YRAPEVT---DPC 543
           + H ++KS+NI L +    ++ DFGLA +    S  ++         + APEV    D  
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY 603
             S ++DVY+FG++L EL+TG+ P   + N + +        +V   + S   DL  +R 
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRGYLSP--DLSKVR- 235
Query: 604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            N  + M +L+    +C  +  D RP   +++  IE L
Sbjct: 236 SNCPKAMKRLMA---ECLKKKRDERPLFPQILASIELL 270

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 133/286 (46%), Gaps = 47/286 (16%)
Query: 378 LGKGTFGTAYKA-VLEMGTIVAVKRL--------KDVTISEREFKDKIEGVGAVNHENLV 428
           +GKG FG  +K  +++  ++VA+K L         ++    +EF+ ++  +  +NH N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L  Y    +   +V +++  G L   L         P+ W ++  + L  A GIEY+  
Sbjct: 87  KL--YGLMHNPPRMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQN 140
Query: 489 QGPNVSHGNIKSSNILLTKSYE-----ARVSDFGLAHLVGPSSTPNRVAG------YRAP 537
           Q P + H +++S NI L    E     A+V+DF L+       + + V+G      + AP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 538 EV--TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV 595
           E    +    ++KAD YSF ++L  +LTG+ P     +E      +++  I ++     +
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDEYSYGKIKFINMIREEGLRPTI 251
Query: 596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            +    R +NV    ++L      C +  P  RP  S ++K + EL
Sbjct: 252 PEDCPPRLRNV----IEL------CWSGDPKKRPHFSYIVKELSEL 287

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
           E LG+G++G+ YKA+  E G IVA+K++  V    +E   +I  +   +  ++V     Y
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
           +   +  +V +Y   GS+S ++          L  +  + I     +G+EYLH       
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDIIRLRNKT----LTEDEIATILQSTLKGLEYLHFM--RKI 147
Query: 495 HGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPCKVSQKAD 550
           H +IK+ NILL     A+++DFG+A  L    +  N V G   + APEV      +  AD
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVAD 207
Query: 551 VYSFGVLLLELLTGKAP 567
           ++S G+  +E+  GK P
Sbjct: 208 IWSLGITAIEMAEGKPP 224

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 133/278 (47%), Gaps = 37/278 (13%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLRAYY 434
           +G G+FGT YK   +    VAVK L     + ++   FK+++  +    H N++ L   Y
Sbjct: 16  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 72
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYLHAQGPN 492
            +  +  +V  +    SL   LH           +EM  LI +    A+G++YLHA+  +
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK--S 124
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------YRAPEVT---DPC 543
           + H ++KS+NI L +    ++ DFGLA +    S  ++         + APEV    D  
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY 603
             S ++DVY+FG++L EL+TG+ P   + N + +        +V   + S   DL  +R 
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRGYLSP--DLSKVR- 235
Query: 604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            N  + M +L+    +C  +  D RP   +++  IE L
Sbjct: 236 SNCPKAMKRLMA---ECLKKKRDERPLFPQILASIELL 270

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 111/237 (46%), Gaps = 35/237 (14%)
Query: 376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLK-DVTISEREFKDKIEGVG--------AVNHE 425
           ++LGKG+FG  + A  +      A+K LK DV + +    D +E           A  H 
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD----DDVECTMVEKRVLSLAWEHP 78
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
            L  +   + + +    V +YL  G L   ++  +   +  L+    +  A     G+++
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLS--RATFYAAEIILGLQF 133
Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--HLVGPSSTPNRVAG---YRAPEVT 540
           LH++G  + + ++K  NILL K    +++DFG+   +++G + T N   G   Y APE+ 
Sbjct: 134 LHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NXFCGTPDYIAPEIL 190
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVD--------LPRWVQSIVKD 589
              K +   D +SFGVLL E+L G++P H    EE            PRW++   KD
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 247

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 127/283 (44%), Gaps = 42/283 (14%)
Query: 376 EVLGKGTFGTAYKAVLEMGT-----IVAVKRLK-DVTISER-EFKDKIEGVGAVNHENLV 428
           +V+G G FG  YK +L+  +      VA+K LK   T  +R +F  +   +G  +H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYL 486
            L          +++ +Y+  G+L   L    G       + +  L+ +  G A G++YL
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDG------EFSVLQLVGMLRGIAAGMKYL 163
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEV 539
                N  H ++ + NIL+  +   +VSDFGL+ ++   P +T     G     + APE 
Sbjct: 164 ANM--NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
               K +  +DV+SFG+++ E++T G+ P   L N E       V   + D         
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDG-------- 266
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
              R     +    + QL + C  Q    RP  ++++  +++L
Sbjct: 267 --FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 16/197 (8%)
Query: 378 LGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFK-DKIEGVGAVNHENLVPLRAYYY 435
           +G+G+ G    A  +  G  VAVK++       RE   +++  +   +H+N+V + + Y 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
             DE  +V ++L  G+L+ ++        T +N E  + + L   R + YLH QG  V H
Sbjct: 113 VGDELWVVMEFLEGGALTDIV------THTRMNEEQIATVCLSVLRALSYLHNQG--VIH 164
Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR-----VAGYRAPEVTDPCKVSQKAD 550
            +IKS +ILLT     ++SDFG    V     P R        + APEV        + D
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFCAQVS-KEVPKRKXLVGTPYWMAPEVISRLPYGTEVD 223
Query: 551 VYSFGVLLLELLTGKAP 567
           ++S G++++E++ G+ P
Sbjct: 224 IWSLGIMVIEMIDGEPP 240

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 137/286 (47%), Gaps = 37/286 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLRAYY 434
           +G G+FGT YK   +    VAVK L     + ++   FK+++  +    H N++ L   Y
Sbjct: 44  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 100
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYLHAQGPN 492
            +  +  +V  +    SL   LH           +EM  LI +    A+G++YLHA+  +
Sbjct: 101 STKPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK--S 152
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLA---HLVGPSSTPNRVAG---YRAPEVT---DPC 543
           + H ++KS+NI L +    ++ DFGLA        S    +++G   + APEV    D  
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY 603
             S ++DVY+FG++L EL+TG+ P   + N + +        +V   + S   DL  +R 
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRGYLSP--DLSKVR- 263
Query: 604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGH 649
            N  + M +L+    +C  +  D RP   +++  IE L  S  + H
Sbjct: 264 SNCPKAMKRLMA---ECLKKKRDERPLFPQILASIELLARSLPKIH 306

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 378 LGKGTFGTA----YKAVLE-MGTIVAVKRLKDVTISE-REFKDKIEGVGAVNHENLVPLR 431
           LGKG FG+     Y  + +  G +VAVK+L+  T    R+F+ +IE + ++ H+N+V  +
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 432 AYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              YS   +   L+ +YL  GSL   L  +K         +  S I     +G+EYL  +
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEYLGTK 134
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEVTDP 542
                H N+ + NIL+      ++ DFGL  ++       +V         + APE    
Sbjct: 135 --RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 192
Query: 543 CKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVD 578
            K S  +DV+SFGV+L EL T     K+P    +   G D
Sbjct: 193 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 232

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 16/197 (8%)
Query: 378 LGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISEREFK-DKIEGVGAVNHENLVPLRAYYY 435
           +G+G+ G    A V   G +VAVK++       RE   +++  +    HEN+V +   Y 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
             DE  +V ++L  G+L+ ++        T +N E  + + L   + +  LHAQG  V H
Sbjct: 219 VGDELWVVMEFLEGGALTDIV------THTRMNEEQIAAVCLAVLQALSVLHAQG--VIH 270
Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR-----VAGYRAPEVTDPCKVSQKAD 550
            +IKS +ILLT     ++SDFG    V     P R        + APE+        + D
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVD 329
Query: 551 VYSFGVLLLELLTGKAP 567
           ++S G++++E++ G+ P
Sbjct: 330 IWSLGIMVIEMVDGEPP 346

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 16/197 (8%)
Query: 378 LGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISEREFK-DKIEGVGAVNHENLVPLRAYYY 435
           +G+G+ G    A V   G +VAVK++       RE   +++  +    HEN+V +   Y 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
             DE  +V ++L  G+L+ ++        T +N E  + + L   + +  LHAQG  V H
Sbjct: 97  VGDELWVVMEFLEGGALTDIV------THTRMNEEQIAAVCLAVLQALSVLHAQG--VIH 148
Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR-----VAGYRAPEVTDPCKVSQKAD 550
            +IKS +ILLT     ++SDFG    V     P R        + APE+        + D
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVD 207
Query: 551 VYSFGVLLLELLTGKAP 567
           ++S G++++E++ G+ P
Sbjct: 208 IWSLGIMVIEMVDGEPP 224

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 137/292 (46%), Gaps = 49/292 (16%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLRAYY 434
           +G G+FGT YK   +    VAVK L     + ++   FK+++  +    H N++ L   Y
Sbjct: 36  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 92
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYLHAQGPN 492
            +  +  +V  +    SL   LH           +EM  LI +    A+G++YLHA+  +
Sbjct: 93  STKPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK--S 144
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------------YRAPEVT 540
           + H ++KS+NI L +    ++ DFGLA      +  +R +G            + APEV 
Sbjct: 145 IIHRDLKSNNIFLHEDLTVKIGDFGLA------TEKSRWSGSHQFEQLSGSILWMAPEVI 198
Query: 541 ---DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD 597
              D    S ++DVY+FG++L EL+TG+ P   + N + +        +V   + S   D
Sbjct: 199 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRGYLSP--D 250
Query: 598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGH 649
           L  +R  N  + M +L+    +C  +  D RP   +++  IE L  S  + H
Sbjct: 251 LSKVR-SNCPKAMKRLMA---ECLKKKRDERPLFPQILASIELLARSLPKIH 298

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 16/197 (8%)
Query: 378 LGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISEREFK-DKIEGVGAVNHENLVPLRAYYY 435
           +G+G+ G    A V   G +VAVK++       RE   +++  +    HEN+V +   Y 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
             DE  +V ++L  G+L+ ++        T +N E  + + L   + +  LHAQG  V H
Sbjct: 142 VGDELWVVMEFLEGGALTDIV------THTRMNEEQIAAVCLAVLQALSVLHAQG--VIH 193
Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR-----VAGYRAPEVTDPCKVSQKAD 550
            +IKS +ILLT     ++SDFG    V     P R        + APE+        + D
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVD 252
Query: 551 VYSFGVLLLELLTGKAP 567
           ++S G++++E++ G+ P
Sbjct: 253 IWSLGIMVIEMVDGEPP 269

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 16/197 (8%)
Query: 378 LGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISEREFK-DKIEGVGAVNHENLVPLRAYYY 435
           +G+G+ G    A V   G +VAVK++       RE   +++  +    HEN+V +   Y 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
             DE  +V ++L  G+L+ ++        T +N E  + + L   + +  LHAQG  V H
Sbjct: 99  VGDELWVVMEFLEGGALTDIV------THTRMNEEQIAAVCLAVLQALSVLHAQG--VIH 150
Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR-----VAGYRAPEVTDPCKVSQKAD 550
            +IKS +ILLT     ++SDFG    V     P R        + APE+        + D
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVD 209
Query: 551 VYSFGVLLLELLTGKAP 567
           ++S G++++E++ G+ P
Sbjct: 210 IWSLGIMVIEMVDGEPP 226

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 16/197 (8%)
Query: 378 LGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISEREFK-DKIEGVGAVNHENLVPLRAYYY 435
           +G+G+ G    A V   G +VAVK++       RE   +++  +    HEN+V +   Y 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
             DE  +V ++L  G+L+ ++        T +N E  + + L   + +  LHAQG  V H
Sbjct: 92  VGDELWVVMEFLEGGALTDIV------THTRMNEEQIAAVCLAVLQALSVLHAQG--VIH 143
Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR-----VAGYRAPEVTDPCKVSQKAD 550
            +IKS +ILLT     ++SDFG    V     P R        + APE+        + D
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVD 202
Query: 551 VYSFGVLLLELLTGKAP 567
           ++S G++++E++ G+ P
Sbjct: 203 IWSLGIMVIEMVDGEPP 219

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 16/197 (8%)
Query: 378 LGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISEREFK-DKIEGVGAVNHENLVPLRAYYY 435
           +G+G+ G    A V   G +VAVK++       RE   +++  +    HEN+V +   Y 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
             DE  +V ++L  G+L+ ++        T +N E  + + L   + +  LHAQG  V H
Sbjct: 88  VGDELWVVMEFLEGGALTDIV------THTRMNEEQIAAVCLAVLQALSVLHAQG--VIH 139
Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR-----VAGYRAPEVTDPCKVSQKAD 550
            +IKS +ILLT     ++SDFG    V     P R        + APE+        + D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVD 198
Query: 551 VYSFGVLLLELLTGKAP 567
           ++S G++++E++ G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 134/284 (47%), Gaps = 49/284 (17%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLRAYY 434
           +G G+FGT YK   +    VAVK L     + ++   FK+++  +    H N++ L   Y
Sbjct: 16  IGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 72
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYLHAQGPN 492
            +  +  +V  +    SL   LH           +EM  LI +    A+G++YLHA+  +
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK--S 124
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------------YRAPEVT 540
           + H ++KS+NI L +    ++ DFGLA      +  +R +G            + APEV 
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLA------TEKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 541 ---DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD 597
              D    S ++DVY+FG++L EL+TG+ P   + N + +        +V   + S   D
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF------MVGRGYLSP--D 230
Query: 598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           L  +R  N  + M +L+    +C  +  D RP   +++  IE L
Sbjct: 231 LSKVR-SNCPKAMKRLMA---ECLKKKRDERPLFPQILASIELL 270

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 113/253 (44%), Gaps = 31/253 (12%)
Query: 351 ATKKLVFFGNAARVFDLEDLLRASA------EVLGKGTFGTA----YKAVLE-MGTIVAV 399
            T+ L F G     F+  D  +         + LGKG FG+     Y  + +  G +VAV
Sbjct: 16  TTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAV 75
Query: 400 KRLKDVTISE-REFKDKIEGVGAVNHENLVPLRAYYYSMDEK--LLVYDYLTMGSLSALL 456
           K+L+  T    R+F+ +IE + ++ H+N+V  +   YS   +   L+ +YL  GSL   L
Sbjct: 76  KKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 135
Query: 457 HGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDF 516
             +K         +  S I     +G+EYL  +     H ++ + NIL+      ++ DF
Sbjct: 136 QKHKERIDHIKLLQYTSQIC----KGMEYLGTK--RYIHRDLATRNILVENENRVKIGDF 189
Query: 517 GLAHLVGPSSTPNRVAG-------YRAPEVTDPCKVSQKADVYSFGVLLLELLT----GK 565
           GL  ++       +V         + APE     K S  +DV+SFGV+L EL T     K
Sbjct: 190 GLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249
Query: 566 APTHALLNEEGVD 578
           +P    +   G D
Sbjct: 250 SPPAEFMRMIGND 262

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 378 LGKGTFGTA----YKAVLE-MGTIVAVKRLKDVTISE-REFKDKIEGVGAVNHENLVPLR 431
           LGKG FG+     Y  + +  G +VAVK+L+  T    R+F+ +IE + ++ H+N+V  +
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 432 AYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              YS   +   L+ +YL  GSL   L  +K         +  S I     +G+EYL  +
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEYLGTK 140
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEVTDP 542
                H ++ + NIL+      ++ DFGL  ++       +V         + APE    
Sbjct: 141 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 543 CKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVD 578
            K S  +DV+SFGV+L EL T     K+P    +   G D
Sbjct: 199 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 238

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 378 LGKGTFGTA----YKAVLE-MGTIVAVKRLKDVTISE-REFKDKIEGVGAVNHENLVPLR 431
           LGKG FG+     Y  + +  G +VAVK+L+  T    R+F+ +IE + ++ H+N+V  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 432 AYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              YS   +   L+ +YL  GSL   L  +K         +  S I     +G+EYL  +
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEYLGTK 136
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEVTDP 542
                H ++ + NIL+      ++ DFGL  ++       +V         + APE    
Sbjct: 137 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 543 CKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVD 578
            K S  +DV+SFGV+L EL T     K+P    +   G D
Sbjct: 195 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 234

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 378 LGKGTFGTA----YKAVLE-MGTIVAVKRLKDVTISE-REFKDKIEGVGAVNHENLVPLR 431
           LGKG FG+     Y  + +  G +VAVK+L+  T    R+F+ +IE + ++ H+N+V  +
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 432 AYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              YS   +   L+ +YL  GSL   L  +K         +  S I     +G+EYL  +
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEYLGTK 138
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEVTDP 542
                H ++ + NIL+      ++ DFGL  ++       +V         + APE    
Sbjct: 139 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 543 CKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVD 578
            K S  +DV+SFGV+L EL T     K+P    +   G D
Sbjct: 197 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 236

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 378 LGKGTFGTA----YKAVLE-MGTIVAVKRLKDVTISE-REFKDKIEGVGAVNHENLVPLR 431
           LGKG FG+     Y  + +  G +VAVK+L+  T    R+F+ +IE + ++ H+N+V  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 432 AYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              YS   +   L+ +YL  GSL   L  +K         +  S I     +G+EYL  +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEYLGTK 133
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEVTDP 542
                H ++ + NIL+      ++ DFGL  ++       +V         + APE    
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 543 CKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVD 578
            K S  +DV+SFGV+L EL T     K+P    +   G D
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 378 LGKGTFGTA----YKAVLE-MGTIVAVKRLKDVTISE-REFKDKIEGVGAVNHENLVPLR 431
           LGKG FG+     Y  + +  G +VAVK+L+  T    R+F+ +IE + ++ H+N+V  +
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 432 AYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              YS   +   L+ +YL  GSL   L  +K         +  S I     +G+EYL  +
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEYLGTK 137
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEVTDP 542
                H ++ + NIL+      ++ DFGL  ++       +V         + APE    
Sbjct: 138 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 195
Query: 543 CKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVD 578
            K S  +DV+SFGV+L EL T     K+P    +   G D
Sbjct: 196 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 235

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 378 LGKGTFGTA----YKAVLE-MGTIVAVKRLKDVTISE-REFKDKIEGVGAVNHENLVPLR 431
           LGKG FG+     Y  + +  G +VAVK+L+  T    R+F+ +IE + ++ H+N+V  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 432 AYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              YS   +   L+ +YL  GSL   L  +K         +  S I     +G+EYL  +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEYLGTK 133
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEVTDP 542
                H ++ + NIL+      ++ DFGL  ++       +V         + APE    
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 543 CKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVD 578
            K S  +DV+SFGV+L EL T     K+P    +   G D
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 378 LGKGTFGTA----YKAVLE-MGTIVAVKRLKDVTISE-REFKDKIEGVGAVNHENLVPLR 431
           LGKG FG+     Y  + +  G +VAVK+L+  T    R+F+ +IE + ++ H+N+V  +
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 432 AYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              YS   +   L+ +YL  GSL   L  +K         +  S I     +G+EYL  +
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEYLGTK 131
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEVTDP 542
                H ++ + NIL+      ++ DFGL  ++       +V         + APE    
Sbjct: 132 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 189
Query: 543 CKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVD 578
            K S  +DV+SFGV+L EL T     K+P    +   G D
Sbjct: 190 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 229

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 378 LGKGTFGTA----YKAVLE-MGTIVAVKRLKDVTISE-REFKDKIEGVGAVNHENLVPLR 431
           LGKG FG+     Y  + +  G +VAVK+L+  T    R+F+ +IE + ++ H+N+V  +
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 432 AYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              YS   +   L+ +YL  GSL   L  +K         +  S I     +G+EYL  +
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEYLGTK 139
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEVTDP 542
                H ++ + NIL+      ++ DFGL  ++       +V         + APE    
Sbjct: 140 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 197
Query: 543 CKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVD 578
            K S  +DV+SFGV+L EL T     K+P    +   G D
Sbjct: 198 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 237

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 378 LGKGTFGTA----YKAVLE-MGTIVAVKRLKDVTISE-REFKDKIEGVGAVNHENLVPLR 431
           LGKG FG+     Y  + +  G +VAVK+L+  T    R+F+ +IE + ++ H+N+V  +
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 432 AYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              YS   +   L+ +YL  GSL   L  +K         +  S I     +G+EYL  +
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEYLGTK 132
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEVTDP 542
                H ++ + NIL+      ++ DFGL  ++       +V         + APE    
Sbjct: 133 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 543 CKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVD 578
            K S  +DV+SFGV+L EL T     K+P    +   G D
Sbjct: 191 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 378 LGKGTFGTA----YKAVLE-MGTIVAVKRLKDVTISE-REFKDKIEGVGAVNHENLVPLR 431
           LGKG FG+     Y  + +  G +VAVK+L+  T    R+F+ +IE + ++ H+N+V  +
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 432 AYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              YS   +   L+ +YL  GSL   L  +K         +  S I     +G+EYL  +
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEYLGTK 151
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEVTDP 542
                H ++ + NIL+      ++ DFGL  ++       +V         + APE    
Sbjct: 152 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 543 CKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVD 578
            K S  +DV+SFGV+L EL T     K+P    +   G D
Sbjct: 210 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 249

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 378 LGKGTFGTA----YKAVLE-MGTIVAVKRLKDVTISE-REFKDKIEGVGAVNHENLVPLR 431
           LGKG FG+     Y  + +  G +VAVK+L+  T    R+F+ +IE + ++ H+N+V  +
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 432 AYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              YS   +   L+ +YL  GSL   L  +K         +  S I     +G+EYL  +
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEYLGTK 151
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEVTDP 542
                H ++ + NIL+      ++ DFGL  ++       +V         + APE    
Sbjct: 152 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 543 CKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVD 578
            K S  +DV+SFGV+L EL T     K+P    +   G D
Sbjct: 210 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 249

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 143/317 (45%), Gaps = 35/317 (11%)
Query: 338 GNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTI- 396
           G+     +S V+  T+ L F   +   +++E         LG G +G  Y  V +  ++ 
Sbjct: 2   GHHHHHHSSGVDLGTENLYF--QSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLT 59
Query: 397 VAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALL 456
           VAVK LK+ T+   EF  +   +  + H NLV L           +V +Y+  G+L   L
Sbjct: 60  VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL 119
Query: 457 HGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDF 516
              +   R  +   +   +A   +  +EYL  +  N  H ++ + N L+ +++  +V+DF
Sbjct: 120 ---RECNREEVTAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLVGENHVVKVADF 174
Query: 517 GLAHLV-GPSSTPNRVAGY----RAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHA 570
           GL+ L+ G + T +  A +     APE       S K+DV++FGVLL E+ T G +P   
Sbjct: 175 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY-- 232
Query: 571 LLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMV--QLLQLAIDCSAQYPDNR 628
                G+DL             S+V+DL    Y+  + E    ++ +L   C    P +R
Sbjct: 233 ----PGIDL-------------SQVYDLLEKGYRMEQPEGCPPKVYELMRACWKWSPADR 275
Query: 629 PSMSEVIKRIEELHPSS 645
           PS +E  +  E +   S
Sbjct: 276 PSFAETHQAFETMFHDS 292

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 15/198 (7%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLK-DVTISEREFKDKIEGV---GAVNHENLVPLRA 432
           +G G+FG  Y A  +    +VA+K++      S  +++D I+ V     + H N +  R 
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
            Y       LV +Y  +GS S LL  +K     PL     + +  GA +G+ YLH+   N
Sbjct: 122 CYLREHTAWLVMEY-CLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH--N 174
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVT---DPCKVSQKA 549
           + H ++K+ NILL++    ++ DFG A ++ P++       + APEV    D  +   K 
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKV 234
Query: 550 DVYSFGVLLLELLTGKAP 567
           DV+S G+  +EL   K P
Sbjct: 235 DVWSLGITCIELAERKPP 252

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 15/198 (7%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLK-DVTISEREFKDKIEGV---GAVNHENLVPLRA 432
           +G G+FG  Y A  +    +VA+K++      S  +++D I+ V     + H N +  R 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
            Y       LV +Y  +GS S LL  +K     PL     + +  GA +G+ YLH+   N
Sbjct: 83  CYLREHTAWLVMEY-CLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH--N 135
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVT---DPCKVSQKA 549
           + H ++K+ NILL++    ++ DFG A ++ P++       + APEV    D  +   K 
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKV 195
Query: 550 DVYSFGVLLLELLTGKAP 567
           DV+S G+  +EL   K P
Sbjct: 196 DVWSLGITCIELAERKPP 213

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 127/280 (45%), Gaps = 32/280 (11%)
Query: 376 EVLGKGTFGTAYKAVLE-MGTIVAVKR--LKDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           EV+G G       A        VA+KR  L+    S  E   +I+ +   +H N+V    
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTP---LNWEMRSLIALGAARGIEYLHAQ 489
            +   DE  LV   L+ GS+  ++      G      L+    + I      G+EYLH  
Sbjct: 81  SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-------YRAPEVT 540
           G    H ++K+ NILL +    +++DFG++  +  G   T N+V         + APEV 
Sbjct: 141 GQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 541 DPCK-VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSE--VFD 597
           +  +    KAD++SFG+  +EL TG AP H     + + L     ++  D  + E  V D
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-----TLQNDPPSLETGVQD 253
Query: 598 LELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK 636
            E+L +Y     +M+ L      C  + P+ RP+ +E+++
Sbjct: 254 KEMLKKYGKSFRKMISL------CLQKDPEKRPTAAELLR 287

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 378 LGKGTFGTA----YKAVLE-MGTIVAVKRLKDVTISE-REFKDKIEGVGAVNHENLVPLR 431
           LGKG FG+     Y  + +  G +VAVK+L+  T    R+F+ +IE + ++ H+N+V  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 432 AYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              YS   +   L+ +YL  GSL   L  +K         +  S I     +G+EYL  +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC----KGMEYLGTK 133
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEVTDP 542
                H ++ + NIL+      ++ DFGL  ++       +V         + APE    
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 543 CKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVD 578
            K S  +DV+SFGV+L EL T     K+P    +   G D
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 378 LGKGTFGTA----YKAVLE-MGTIVAVKRLKDVTISE-REFKDKIEGVGAVNHENLVPLR 431
           LGKG FG+     Y  + +  G +VAVK+L+  T    R+F+ +IE + ++ H+N+V  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 432 AYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              YS   +   L+ ++L  GSL   L  +K         +  S I     +G+EYL  +
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQIC----KGMEYLGTK 136
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEVTDP 542
                H ++ + NIL+      ++ DFGL  ++       +V         + APE    
Sbjct: 137 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 543 CKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVD 578
            K S  +DV+SFGV+L EL T     K+P    +   G D
Sbjct: 195 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 234

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 127/280 (45%), Gaps = 32/280 (11%)
Query: 376 EVLGKGTFGTAYKAVLE-MGTIVAVKR--LKDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           EV+G G       A        VA+KR  L+    S  E   +I+ +   +H N+V    
Sbjct: 16  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 75
Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTP---LNWEMRSLIALGAARGIEYLHAQ 489
            +   DE  LV   L+ GS+  ++      G      L+    + I      G+EYLH  
Sbjct: 76  SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 135
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRV-------AGYRAPEVT 540
           G    H ++K+ NILL +    +++DFG++  +  G   T N+V         + APEV 
Sbjct: 136 GQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 193
Query: 541 DPCK-VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSE--VFD 597
           +  +    KAD++SFG+  +EL TG AP H     + + L     ++  D  + E  V D
Sbjct: 194 EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-----TLQNDPPSLETGVQD 248
Query: 598 LELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK 636
            E+L +Y     +M+ L      C  + P+ RP+ +E+++
Sbjct: 249 KEMLKKYGKSFRKMISL------CLQKDPEKRPTAAELLR 282

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 128/284 (45%), Gaps = 43/284 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLKD--VTISEREFKDKIEGVGAVNHENLVP 429
           +V+G G FG      L++       VA+K LK        R+F  +   +G  +H N++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYLH 487
           L          +++ +++  GSL + L  N G       + +  L+ +  G A G++YL 
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDG------QFTVIQLVGMLRGIAAGMKYLA 152
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAG--------YRAPE 538
               N  H ++ + NIL+  +   +VSDFGL+  +   +S P   +         + APE
Sbjct: 153 DM--NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 210
Query: 539 VTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD 597
                K +  +DV+S+G+++ E+++ G+ P   + N++ ++      +I +D       D
Sbjct: 211 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN------AIEQDYRLPPPMD 264
Query: 598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
                          L QL +DC  +  ++RP   +++  ++++
Sbjct: 265 CP-----------SALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 297

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 117/237 (49%), Gaps = 33/237 (13%)
Query: 362 ARVFDLEDLLRASAEVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKD 414
           AR+F   +L +   +VLG G FGT +K V       +   V +K ++D +   S +   D
Sbjct: 7   ARIFKETELRKL--KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD 64
Query: 415 KIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGA--GRTPLNWEMR 472
            +  +G+++H ++V L         +L V  YL +GSL   +  ++GA   +  LNW ++
Sbjct: 65  HMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP-------- 524
                  A+G+ YL   G  + H N+ + N+LL    + +V+DFG+A L+ P        
Sbjct: 124 ------IAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 175
Query: 525 -SSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDL 579
            + TP +   + A E     K + ++DV+S+GV + EL+T G  P   L   E  DL
Sbjct: 176 EAKTPIK---WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL 229

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 116/237 (48%), Gaps = 33/237 (13%)
Query: 362 ARVFDLEDLLRASAEVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKD 414
           AR+F   +L +   +VLG G FGT +K V       +   V +K ++D +   S +   D
Sbjct: 25  ARIFKETELRKL--KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD 82
Query: 415 KIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGA--GRTPLNWEMR 472
            +  +G+++H ++V L         +L V  YL +GSL   +  ++GA   +  LNW   
Sbjct: 83  HMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNW--- 138
Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP-------- 524
               +  A+G+ YL   G  + H N+ + N+LL    + +V+DFG+A L+ P        
Sbjct: 139 ---GVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 193
Query: 525 -SSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDL 579
            + TP +   + A E     K + ++DV+S+GV + EL+T G  P   L   E  DL
Sbjct: 194 EAKTPIK---WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL 247

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 129/289 (44%), Gaps = 45/289 (15%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKDVTISERE-FKDKIEGVGAVNHENLVPL 430
           LG+G FG  + A        +   +VAVK LK+ + S R+ F+ + E +  + H+++V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 431 RAYYYSMDEKLLVYDYLTMGSL----------SALLHGNKGAGRTPLNWEMRSLIALGAA 480
                     L+V++Y+  G L          + LL G +     PL       +A   A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------- 533
            G+ YL   G +  H ++ + N L+ +    ++ DFG++  +  S+   RV G       
Sbjct: 169 AGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-STDYYRVGGRTMLPIR 225
Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWT 592
           +  PE     K + ++DV+SFGV+L E+ T GK P + L N E +D       I +    
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID------CITQGR-- 277
Query: 593 SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
                 EL R +    E+  +++    C  + P  R S+ +V  R++ L
Sbjct: 278 ------ELERPRACPPEVYAIMR---GCWQREPQQRHSIKDVHARLQAL 317

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 25/220 (11%)
Query: 378 LGKGTFGTA----YKAVLE-MGTIVAVKRLKDVTISE-REFKDKIEGVGAVNHENLVPLR 431
           LGKG FG+     Y  + +  G +VAVK+L+  T    R+F+ +IE + ++ H+N+V  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 432 AYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              YS   +   L+ +YL  GSL   L  +          +  S I     +G+EYL  +
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQIC----KGMEYLGTK 136
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEVTDP 542
                H ++ + NIL+      ++ DFGL  ++       +V         + APE    
Sbjct: 137 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 543 CKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVD 578
            K S  +DV+SFGV+L EL T     K+P    +   G D
Sbjct: 195 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 234

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 129/289 (44%), Gaps = 45/289 (15%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKDVTISERE-FKDKIEGVGAVNHENLVPL 430
           LG+G FG  + A        +   +VAVK LK+ + S R+ F+ + E +  + H+++V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 431 RAYYYSMDEKLLVYDYLTMGSL----------SALLHGNKGAGRTPLNWEMRSLIALGAA 480
                     L+V++Y+  G L          + LL G +     PL       +A   A
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------- 533
            G+ YL   G +  H ++ + N L+ +    ++ DFG++  +  S+   RV G       
Sbjct: 140 AGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-STDYYRVGGRTMLPIR 196
Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWT 592
           +  PE     K + ++DV+SFGV+L E+ T GK P + L N E +D       I +    
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID------CITQGR-- 248
Query: 593 SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
                 EL R +    E+  +++    C  + P  R S+ +V  R++ L
Sbjct: 249 ------ELERPRACPPEVYAIMR---GCWQREPQQRHSIKDVHARLQAL 288

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 116/247 (46%), Gaps = 31/247 (12%)
Query: 345 NSNVNGATKKLVF-----FGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAV 399
           +S V+  T+ L F     + +  R  + ED      E LG G FG  YKA  +  +++A 
Sbjct: 8   SSGVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGE-LGDGAFGKVYKAQNKETSVLAA 66
Query: 400 KRLKDVTISEREFKD---KIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALL 456
            ++ D T SE E +D   +I+ + + +H N+V L   +Y  +   ++ ++   G++ A++
Sbjct: 67  AKVID-TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM 125
Query: 457 HGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDF 516
                    PL      ++       + YLH     + H ++K+ NIL T   + +++DF
Sbjct: 126 L----ELERPLTESQIQVVCKQTLDALNYLHDN--KIIHRDLKAGNILFTLDGDIKLADF 179
Query: 517 GLAHLVGPSSTPNR------VAGYRAPEVTDPCKVSQ------KADVYSFGVLLLELLTG 564
           G++     + T  R         + APEV   C+ S+      KADV+S G+ L+E+   
Sbjct: 180 GVS--AKNTRTIQRRDSFIGTPYWMAPEVV-MCETSKDRPYDYKADVWSLGITLIEMAEI 236
Query: 565 KAPTHAL 571
           + P H L
Sbjct: 237 EPPHHEL 243

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 129/289 (44%), Gaps = 45/289 (15%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKDVTISERE-FKDKIEGVGAVNHENLVPL 430
           LG+G FG  + A        +   +VAVK LK+ + S R+ F+ + E +  + H+++V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 431 RAYYYSMDEKLLVYDYLTMGSL----------SALLHGNKGAGRTPLNWEMRSLIALGAA 480
                     L+V++Y+  G L          + LL G +     PL       +A   A
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------- 533
            G+ YL   G +  H ++ + N L+ +    ++ DFG++  +  S+   RV G       
Sbjct: 146 AGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-STDYYRVGGRTMLPIR 202
Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWT 592
           +  PE     K + ++DV+SFGV+L E+ T GK P + L N E +D       I +    
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID------CITQGR-- 254
Query: 593 SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
                 EL R +    E+  +++    C  + P  R S+ +V  R++ L
Sbjct: 255 ------ELERPRACPPEVYAIMR---GCWQREPQQRHSIKDVHARLQAL 294

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 108/234 (46%), Gaps = 36/234 (15%)
Query: 362 ARVFDLEDL--LRASA------EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREF 412
           AR  D  DL  LR  A      E++G GT+G  YK   ++ G + A+K +      E E 
Sbjct: 8   ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI 67
Query: 413 KDKIEGVGAVNHENLVPLRAYYYS---------MDEKL-LVYDYLTMGSLSALLHGNKGA 462
           K +I  +   +H   +   A YY          MD++L LV ++   GS++ L+   KG 
Sbjct: 68  KQEINMLKKYSHHRNI---ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG- 123
Query: 463 GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFG----L 518
               L  E  + I     RG+ +LH     V H +IK  N+LLT++ E ++ DFG    L
Sbjct: 124 --NTLKEEWIAYICREILRGLSHLHQH--KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179
Query: 519 AHLVGPSSTPNRVAGYRAPEVT----DP-CKVSQKADVYSFGVLLLELLTGKAP 567
              VG  +T      + APEV     +P      K+D++S G+  +E+  G  P
Sbjct: 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 29  RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 86
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 87  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 141
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS  + + G   Y
Sbjct: 142 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDY 198
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 115/245 (46%), Gaps = 27/245 (11%)
Query: 345 NSNVNGATKKLVF-----FGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAV 399
           +S V+  T+ L F     + +  R  + ED      E LG G FG  YKA  +  +++A 
Sbjct: 8   SSGVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGE-LGDGAFGKVYKAQNKETSVLAA 66
Query: 400 KRLKDVTISEREFKD---KIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALL 456
            ++ D T SE E +D   +I+ + + +H N+V L   +Y  +   ++ ++   G++ A++
Sbjct: 67  AKVID-TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM 125
Query: 457 HGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDF 516
                    PL      ++       + YLH     + H ++K+ NIL T   + +++DF
Sbjct: 126 L----ELERPLTESQIQVVCKQTLDALNYLHDN--KIIHRDLKAGNILFTLDGDIKLADF 179
Query: 517 GLA----HLVGPSSTPNRVAGYRAPEVTDPCKVSQ------KADVYSFGVLLLELLTGKA 566
           G++      +    +      + APEV   C+ S+      KADV+S G+ L+E+   + 
Sbjct: 180 GVSAKNTRXIQRRDSFIGTPYWMAPEVV-MCETSKDRPYDYKADVWSLGITLIEMAEIEP 238
Query: 567 PTHAL 571
           P H L
Sbjct: 239 PHHEL 243

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 3   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 115
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y
Sbjct: 116 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTELCGTLDY 172
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 93/216 (43%), Gaps = 39/216 (18%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLR 431
           E+  +G FG  +KA L M   VAVK      K    SERE    I     + HENL+   
Sbjct: 21  EIKARGRFGCVWKAQL-MNDFVAVKIFPLQDKQSWQSERE----IFSTPGMKHENLLQFI 75
Query: 432 AYYYSMD----EKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           A          E  L+  +   GSL+  L GN       + W     +A   +RG+ YLH
Sbjct: 76  AAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI------ITWNELCHVAETMSRGLSYLH 129
Query: 488 ---------AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG----- 533
                       P+++H + KS N+LL     A ++DFGLA    P   P    G     
Sbjct: 130 EDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTR 189
Query: 534 -YRAPEVTDPCKVSQ-----KADVYSFGVLLLELLT 563
            Y APEV +     Q     + D+Y+ G++L EL++
Sbjct: 190 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 127/284 (44%), Gaps = 43/284 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLKD--VTISEREFKDKIEGVGAVNHENLVP 429
           +V+G G FG      L++       VA+K LK        R+F  +   +G  +H N++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYLH 487
           L          +++ +++  GSL + L  N G       + +  L+ +  G A G++YL 
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDG------QFTVIQLVGMLRGIAAGMKYLA 126
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAG--------YRAPE 538
               N  H  + + NIL+  +   +VSDFGL+  +   +S P   +         + APE
Sbjct: 127 DM--NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 539 VTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD 597
                K +  +DV+S+G+++ E+++ G+ P   + N++ ++      +I +D       D
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN------AIEQDYRLPPPMD 238
Query: 598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
                          L QL +DC  +  ++RP   +++  ++++
Sbjct: 239 CP-----------SALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 271

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 20  RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 77
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 78  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 132
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y
Sbjct: 133 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDY 189
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 190 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 225

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 18/217 (8%)
Query: 362 ARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKI 416
           +R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++
Sbjct: 5   SRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 417 EGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIA 476
           E    + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +   
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYI 117
Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--- 533
              A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS  + + G   
Sbjct: 118 TELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLD 174
Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           Y  PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 4   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 116
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS  + + G   Y
Sbjct: 117 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDTLCGTLDY 173
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 29  RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 86
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 87  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 141
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y
Sbjct: 142 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDY 198
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 130/282 (46%), Gaps = 43/282 (15%)
Query: 377 VLGKGTFGTAYKAVLEMG----TIVAVKRLKDVTISE---REFKDKIEGVGAVNHENLVP 429
           V+G G FG      L++       VA+K LK V  +E   R+F  +   +G  +H N++ 
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNIIH 87
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYLH 487
           L          ++V +Y+  GSL   L  N G       + +  L+ +  G + G++YL 
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSLDTFLKKNDG------QFTVIQLVGMLRGISAGMKYLS 141
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEVT 540
             G    H ++ + NIL+  +   +VSDFGL+ ++   P +      G     + APE  
Sbjct: 142 DMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 199
Query: 541 DPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE 599
              K +  +DV+S+G+++ E+++ G+ P   + N+   D+ + V+              E
Sbjct: 200 AFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQ---DVIKAVE--------------E 242
Query: 600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
             R  +  +    L QL +DC  +  ++RP   E++  +++L
Sbjct: 243 GYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKL 284

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 130/283 (45%), Gaps = 43/283 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMGTI----VAVKRLKDVTISE---REFKDKIEGVGAVNHENLV 428
           +V+G G FG      L++ +     VA+K LK V  +E   R+F  +   +G  +H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYL 486
            L          ++V +Y+  GSL + L  +         + +  L+ +  G A G++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA------QFTVIQLVGMLRGIASGMKYL 163
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEV 539
              G    H ++ + NIL+  +   +VSDFGLA ++   P +      G     + +PE 
Sbjct: 164 SDMG--YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
               K +  +DV+S+G++L E+++ G+ P   + N          Q ++K        D 
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----------QDVIK------AVD- 264
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           E  R     +    L QL +DC  +  +NRP   +++  +++L
Sbjct: 265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 27/206 (13%)
Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRAY 433
           +V+G G+FG  Y+A L + G +VA+K++    + ++ FK++ ++ +  ++H N+V LR +
Sbjct: 34  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYF 89
Query: 434 YYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           +YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+H
Sbjct: 90  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYIH 147
Query: 488 AQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPEV---- 539
           + G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE+    
Sbjct: 148 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 205
Query: 540 TDPCKVSQKADVYSFGVLLLELLTGK 565
           TD    +   DV+S G +L ELL G+
Sbjct: 206 TD---YTSSIDVWSAGCVLAELLLGQ 228

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRAY 433
           +V+G G+FG  Y+A L + G +VA+K++    + ++ FK++ ++ +  ++H N+V LR +
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 434 YYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           +YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+H
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYIH 173
Query: 488 AQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPE-VTDP 542
           + G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE +   
Sbjct: 174 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 231
Query: 543 CKVSQKADVYSFGVLLLELLTGK 565
              +   DV+S G +L ELL G+
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 3   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 115
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y
Sbjct: 116 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDY 172
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 27/206 (13%)
Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRAY 433
           +V+G G+FG  Y+A L + G +VA+K++    + ++ FK++ ++ +  ++H N+V LR +
Sbjct: 45  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYF 100
Query: 434 YYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           +YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+H
Sbjct: 101 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYIH 158
Query: 488 AQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPEV---- 539
           + G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE+    
Sbjct: 159 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 216
Query: 540 TDPCKVSQKADVYSFGVLLLELLTGK 565
           TD    +   DV+S G +L ELL G+
Sbjct: 217 TD---YTSSIDVWSAGCVLAELLLGQ 239

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 8   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 120
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y
Sbjct: 121 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDY 177
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 27/207 (13%)
Query: 375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRA 432
            +V+G G+FG  Y+A L + G +VA+K++    + ++ FK++ ++ +  ++H N+V LR 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 433 YYYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           ++YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYI 138
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPEV--- 539
           H+ G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE+   
Sbjct: 139 HSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 540 -TDPCKVSQKADVYSFGVLLLELLTGK 565
            TD    +   DV+S G +L ELL G+
Sbjct: 197 ATD---YTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 27/207 (13%)
Query: 375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRA 432
            +V+G G+FG  Y+A L + G +VA+K++    + ++ FK++ ++ +  ++H N+V LR 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 433 YYYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           ++YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYI 138
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPEV--- 539
           H+ G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE+   
Sbjct: 139 HSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 540 -TDPCKVSQKADVYSFGVLLLELLTGK 565
            TD    +   DV+S G +L ELL G+
Sbjct: 197 ATD---YTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 27/207 (13%)
Query: 375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRA 432
            +V+G G+FG  Y+A L + G +VA+K++    + ++ FK++ ++ +  ++H N+V LR 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 433 YYYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           ++YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+
Sbjct: 81  FFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYI 138
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPEV--- 539
           H+ G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE+   
Sbjct: 139 HSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 540 -TDPCKVSQKADVYSFGVLLLELLTGK 565
            TD    +   DV+S G +L ELL G+
Sbjct: 197 ATD---YTSSIDVWSAGCVLAELLLGQ 220

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 18/218 (8%)
Query: 361 AARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDK 415
           A R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + +
Sbjct: 1   AKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 416 IEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI 475
           +E    + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +  
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATY 113
Query: 476 ALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-- 533
               A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G  
Sbjct: 114 ITELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTL 170
Query: 534 -YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
            Y  PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 114/245 (46%), Gaps = 27/245 (11%)
Query: 345 NSNVNGATKKLVF-----FGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAV 399
           +S V+  T+ L F     + +  R  + ED      E LG G FG  YKA  +  +++A 
Sbjct: 8   SSGVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGE-LGDGAFGKVYKAQNKETSVLAA 66
Query: 400 KRLKDVTISEREFKD---KIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALL 456
            ++ D T SE E +D   +I+ + + +H N+V L   +Y  +   ++ ++   G++ A++
Sbjct: 67  AKVID-TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM 125
Query: 457 HGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDF 516
                    PL      ++       + YLH     + H ++K+ NIL T   + +++DF
Sbjct: 126 L----ELERPLTESQIQVVCKQTLDALNYLHDN--KIIHRDLKAGNILFTLDGDIKLADF 179
Query: 517 GLA----HLVGPSSTPNRVAGYRAPEVTDPCKVSQ------KADVYSFGVLLLELLTGKA 566
           G++      +           + APEV   C+ S+      KADV+S G+ L+E+   + 
Sbjct: 180 GVSAKNTRXIQRRDXFIGTPYWMAPEVV-MCETSKDRPYDYKADVWSLGITLIEMAEIEP 238
Query: 567 PTHAL 571
           P H L
Sbjct: 239 PHHEL 243

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 3   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 115
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y
Sbjct: 116 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDY 172
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRAY 433
           +V+G G+FG  Y+A L + G +VA+K++    + ++ FK++ ++ +  ++H N+V LR +
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYF 93
Query: 434 YYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           +YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+H
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYIH 151
Query: 488 AQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPE-VTDP 542
           + G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE +   
Sbjct: 152 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 209
Query: 543 CKVSQKADVYSFGVLLLELLTGK 565
              +   DV+S G +L ELL G+
Sbjct: 210 TDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 6   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 118
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y
Sbjct: 119 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDY 175
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 27/207 (13%)
Query: 375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRA 432
            +V+G G+FG  Y+A L + G +VA+K++    + ++ FK++ ++ +  ++H N+V LR 
Sbjct: 26  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 81
Query: 433 YYYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           ++YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+
Sbjct: 82  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYI 139
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPEV--- 539
           H+ G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE+   
Sbjct: 140 HSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 197
Query: 540 -TDPCKVSQKADVYSFGVLLLELLTGK 565
            TD    +   DV+S G +L ELL G+
Sbjct: 198 ATD---YTSSIDVWSAGCVLAELLLGQ 221

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 27/206 (13%)
Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRAY 433
           +V+G G+FG  Y+A L + G +VA+K++    + ++ FK++ ++ +  ++H N+V LR +
Sbjct: 54  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYF 109
Query: 434 YYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           +YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+H
Sbjct: 110 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYIH 167
Query: 488 AQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPEV---- 539
           + G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE+    
Sbjct: 168 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 225
Query: 540 TDPCKVSQKADVYSFGVLLLELLTGK 565
           TD    +   DV+S G +L ELL G+
Sbjct: 226 TD---YTSSIDVWSAGCVLAELLLGQ 248

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 108/224 (48%), Gaps = 26/224 (11%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKDVTISER-EFKDKIEGVGAVNHENLVPL 430
           LG+G FG  + A        +   +VAVK LKD + + R +F  + E +  + HE++V  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALL--HG------NKGAGRTPLNWEMRSLIALGAARG 482
                  D  ++V++Y+  G L+  L  HG       +G   T L       IA   A G
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YR 535
           + YL +Q  +  H ++ + N L+ ++   ++ DFG++  V  S+   RV G       + 
Sbjct: 141 MVYLASQ--HFVHRDLATRNCLVGENLLVKIGDFGMSRDVY-STDYYRVGGHTMLPIRWM 197
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVD 578
            PE     K + ++DV+S GV+L E+ T GK P + L N E ++
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 241

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 5   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 63  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 117
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y
Sbjct: 118 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDY 174
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 210

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRAY 433
           +V+G G+FG  Y+A L + G +VA+K++    + ++ FK++ ++ +  ++H N+V LR +
Sbjct: 31  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYF 86
Query: 434 YYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           +YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+H
Sbjct: 87  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYIH 144
Query: 488 AQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPE-VTDP 542
           + G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE +   
Sbjct: 145 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 202
Query: 543 CKVSQKADVYSFGVLLLELLTGK 565
              +   DV+S G +L ELL G+
Sbjct: 203 TDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRAY 433
           +V+G G+FG  Y+A L + G +VA+K++    + ++ FK++ ++ +  ++H N+V LR +
Sbjct: 30  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYF 85
Query: 434 YYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           +YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+H
Sbjct: 86  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYIH 143
Query: 488 AQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPE-VTDP 542
           + G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE +   
Sbjct: 144 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 201
Query: 543 CKVSQKADVYSFGVLLLELLTGK 565
              +   DV+S G +L ELL G+
Sbjct: 202 TDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 27/206 (13%)
Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRAY 433
           +V+G G+FG  Y+A L + G +VA+K++    + ++ FK++ ++ +  ++H N+V LR +
Sbjct: 39  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYF 94
Query: 434 YYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           +YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+H
Sbjct: 95  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYIH 152
Query: 488 AQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPEV---- 539
           + G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE+    
Sbjct: 153 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 210
Query: 540 TDPCKVSQKADVYSFGVLLLELLTGK 565
           TD    +   DV+S G +L ELL G+
Sbjct: 211 TD---YTSSIDVWSAGCVLAELLLGQ 233

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 24/216 (11%)
Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRAY 433
           +V+G G+FG  Y+A L + G +VA+K++    + ++ FK++ ++ +  ++H N+V LR +
Sbjct: 64  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYF 119
Query: 434 YYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           +YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+H
Sbjct: 120 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYIH 177
Query: 488 AQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPE-VTDP 542
           + G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE +   
Sbjct: 178 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 235
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVD 578
              +   DV+S G +L ELL G+        + GVD
Sbjct: 236 TDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVD 268

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 24/216 (11%)
Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRAY 433
           +V+G G+FG  Y+A L + G +VA+K++    + ++ FK++ ++ +  ++H N+V LR +
Sbjct: 62  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYF 117
Query: 434 YYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           +YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+H
Sbjct: 118 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYIH 175
Query: 488 AQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPE-VTDP 542
           + G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE +   
Sbjct: 176 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 233
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVD 578
              +   DV+S G +L ELL G+        + GVD
Sbjct: 234 TDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVD 266

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 27/206 (13%)
Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRAY 433
           +V+G G+FG  Y+A L + G +VA+K++    + ++ FK++ ++ +  ++H N+V LR +
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 434 YYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           +YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+H
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYIH 173
Query: 488 AQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPEV---- 539
           + G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE+    
Sbjct: 174 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 231
Query: 540 TDPCKVSQKADVYSFGVLLLELLTGK 565
           TD    +   DV+S G +L ELL G+
Sbjct: 232 TD---YTSSIDVWSAGCVLAELLLGQ 254

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 24/216 (11%)
Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRAY 433
           +V+G G+FG  Y+A L + G +VA+K++    + ++ FK++ ++ +  ++H N+V LR +
Sbjct: 105 KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYF 160
Query: 434 YYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           +YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+H
Sbjct: 161 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYIH 218
Query: 488 AQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPE-VTDP 542
           + G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE +   
Sbjct: 219 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 276
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVD 578
              +   DV+S G +L ELL G+        + GVD
Sbjct: 277 TDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVD 309

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRAY 433
           +V+G G+FG  Y+A L + G +VA+K++    + ++ FK++ ++ +  ++H N+V LR +
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYF 93
Query: 434 YYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           +YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+H
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYIH 151
Query: 488 AQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPE-VTDP 542
           + G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE +   
Sbjct: 152 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 209
Query: 543 CKVSQKADVYSFGVLLLELLTGK 565
              +   DV+S G +L ELL G+
Sbjct: 210 TDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 27/207 (13%)
Query: 375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRA 432
            +V+G G+FG  Y+A L + G +VA+K++    + ++ FK++ ++ +  ++H N+V LR 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 433 YYYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           ++YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYI 138
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPEV--- 539
           H+ G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE+   
Sbjct: 139 HSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 540 -TDPCKVSQKADVYSFGVLLLELLTGK 565
            TD    +   DV+S G +L ELL G+
Sbjct: 197 ATD---YTSSIDVWSAGCVLAELLLGQ 220

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 8   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 120
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y
Sbjct: 121 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDY 177
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 106/227 (46%), Gaps = 29/227 (12%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKDVTISER-EFKDKIEGVGAVNHENLVPL 430
           LG+G FG  + A        +   +VAVK LKD T++ R +F+ + E +  + HE++V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLH-----------GNKGAGRTPLNWEMRSLIALGA 479
                  D  ++V++Y+  G L+  L            G     +  L       IA   
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------ 533
           A G+ YL +Q  +  H ++ + N L+  +   ++ DFG++  V  S+   RV G      
Sbjct: 143 ASGMVYLASQ--HFVHRDLATRNCLVGANLLVKIGDFGMSRDVY-STDYYRVGGHTMLPI 199
Query: 534 -YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVD 578
            +  PE     K + ++DV+SFGV+L E+ T GK P   L N E ++
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 246

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 4   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 116
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y
Sbjct: 117 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDY 173
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 3   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 115
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y
Sbjct: 116 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTXLCGTLDY 172
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 8   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 120
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y
Sbjct: 121 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDY 177
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE  +     +K D++S GVL  E L GK P  A
Sbjct: 178 LPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 18/218 (8%)
Query: 361 AARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDK 415
           + R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + +
Sbjct: 5   SKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 62
Query: 416 IEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI 475
           +E    + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +  
Sbjct: 63  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATY 117
Query: 476 ALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-- 533
               A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G  
Sbjct: 118 ITELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTL 174
Query: 534 -YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
            Y  PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 212

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 113/234 (48%), Gaps = 21/234 (8%)
Query: 345 NSNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKD 404
           +S V+  T+ L F     +  D E+L     E +GKG+FG  +K +      V   ++ D
Sbjct: 8   SSGVDLGTENLYF-----QSMDPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID 61
Query: 405 VTISEREFKDKIEGVGAVNHENLVPLRAYY--YSMDEKL-LVYDYLTMGSLSALLHGNKG 461
           +  +E E +D  + +  ++  +   +  YY  Y  D KL ++ +YL  GS   LL     
Sbjct: 62  LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-- 119
Query: 462 AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-H 520
               PL+    + I     +G++YLH++     H +IK++N+LL++  E +++DFG+A  
Sbjct: 120 ----PLDETQIATILREILKGLDYLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQ 173
Query: 521 LVGPSSTPNRVAG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHAL 571
           L       N   G   + APEV        KAD++S G+  +EL  G+ P   L
Sbjct: 174 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 227

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 18/217 (8%)
Query: 362 ARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKI 416
           +R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++
Sbjct: 5   SRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 417 EGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIA 476
           E    + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +   
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYI 117
Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--- 533
              A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   
Sbjct: 118 TELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLD 174
Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           Y  PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 118/273 (43%), Gaps = 43/273 (15%)
Query: 378 LGKGTFGTAYKAVLE-----MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           LG+G+F    K V +         +  KR++  T  E       EG     H N+V L  
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG-----HPNIVKLHE 73
Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
            ++      LV + L  G L   +   K    T  ++ MR L++      + ++H  G  
Sbjct: 74  VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS-----AVSHMHDVG-- 126
Query: 493 VSHGNIKSSNILLTK---SYEARVSDFGLAHLVGPSS----TPNRVAGYRAPEVTDPCKV 545
           V H ++K  N+L T    + E ++ DFG A L  P +    TP     Y APE+ +    
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGY 186
Query: 546 SQKADVYSFGVLLLELLTGKAP----THALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL 601
            +  D++S GV+L  +L+G+ P      +L     V++   ++ I K +     F  E  
Sbjct: 187 DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI---MKKIKKGD-----FSFEGE 238
Query: 602 RYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMS 632
            ++NV +E   L+Q  L +D     P+ R  MS
Sbjct: 239 AWKNVSQEAKDLIQGLLTVD-----PNKRLKMS 266

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 3   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 115
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y
Sbjct: 116 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDY 172
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 130/286 (45%), Gaps = 37/286 (12%)
Query: 378 LGKGTFGTAYKAVLE-----MGTIVAVKRLKDV-TISEREFKDKIEGVGAVNHENLVPLR 431
           LGKG FG+      +      G +VAVK+L+      +R+F+ +I+ + A++ + +V  R
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 432 AYYYS--MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              Y     E  LV +YL  G L   L  +    R  L+     L +    +G+EYL ++
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGSR 130
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG----------PSSTPNRVAGYRAPEV 539
                H ++ + NIL+      +++DFGLA L+           P  +P     + APE 
Sbjct: 131 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSP---IFWYAPES 185
Query: 540 TDPCKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV 595
                 S+++DV+SFGV+L EL T      +P+   L   G +  R V ++ +       
Sbjct: 186 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE--RDVPALCRLL-ELLE 242
Query: 596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
               L        E+ +L++L   C A  P +RPS S +  +++ L
Sbjct: 243 EGQRLPAPPACPAEVHELMKL---CWAPSPQDRPSFSALGPQLDML 285

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 4   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 116
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG +    PSS    ++G   Y
Sbjct: 117 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-CHAPSSRRTTLSGTLDY 173
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 2   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 59
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 60  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 114
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y
Sbjct: 115 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDY 171
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 172 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 207

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 6   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 118
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y
Sbjct: 119 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDY 175
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           + +GKG FG         G  VAVK +K+   + + F  +   +  + H NLV L     
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVI- 83
Query: 436 SMDEK---LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
            ++EK    +V +Y+  GSL   L   +  GR+ L  +     +L     +EYL  +G N
Sbjct: 84  -VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNN 137
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-AGYRAPEVTDPCKVSQKADV 551
             H ++ + N+L+++   A+VSDFGL      +    ++   + APE     K S K+DV
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 197
Query: 552 YSFGVLLLELLT-GKAP 567
           +SFG+LL E+ + G+ P
Sbjct: 198 WSFGILLWEIYSFGRVP 214

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 119/265 (44%), Gaps = 38/265 (14%)
Query: 341 KTQVNSNVNGATKKLVFFGNAARV--FDLEDLLRASAEVLGKGTFGTAYKAVLEMGTI-V 397
           + Q   ++     K V   N  R   FD+E         +G+G+F T YK +    T+ V
Sbjct: 4   RNQQQDDIEELETKAVGXSNDGRFLKFDIE---------IGRGSFKTVYKGLDTETTVEV 54
Query: 398 AVKRLKD--VTISERE-FKDKIEGVGAVNHENLVPLRAYYYSMDEKL-------LVYDYL 447
           A   L+D  +T SER+ FK++ E +  + H N+V    +Y S +  +       LV +  
Sbjct: 55  AWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIV---RFYDSWESTVKGKKCIVLVTELX 111
Query: 448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT- 506
           T G+L   L   K      L    R ++     +G+++LH + P + H ++K  NI +T 
Sbjct: 112 TSGTLKTYLKRFKVXKIKVLRSWCRQIL-----KGLQFLHTRTPPIIHRDLKCDNIFITG 166
Query: 507 KSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVSQKADVYSFGVLLLELLT 563
            +   ++ D GLA L   +S    V G   + APE  +  K  +  DVY+FG   LE  T
Sbjct: 167 PTGSVKIGDLGLATL-KRASFAKAVIGTPEFXAPEXYEE-KYDESVDVYAFGXCXLEXAT 224
Query: 564 GKAPTHALLNEEGVDLPRWVQSIVK 588
            + P     N     + R V S VK
Sbjct: 225 SEYPYSECQN--AAQIYRRVTSGVK 247

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 130/283 (45%), Gaps = 43/283 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISE---REFKDKIEGVGAVNHENLV 428
           +V+G G FG      L++ +     VA+K LK V  +E   R+F  +   +G  +H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYL 486
            L          ++V +Y+  GSL + L  +         + +  L+ +  G A G++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA------QFTVIQLVGMLRGIASGMKYL 163
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEV 539
              G    H ++ + NIL+  +   +VSDFGL+ ++   P +      G     + +PE 
Sbjct: 164 SDMG--FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
               K +  +DV+S+G++L E+++ G+ P   + N          Q ++K        D 
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----------QDVIK------AVD- 264
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           E  R     +    L QL +DC  +  +NRP   +++  +++L
Sbjct: 265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 6   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 118
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y
Sbjct: 119 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDY 175
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L+M  L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 69  LDVIHTENKLYLVFEFLSM-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 123
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 124 -RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 183 STAVDIWSLGCIFAEMVTRRA 203

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           + +GKG FG         G  VAVK +K+   + + F  +   +  + H NLV L     
Sbjct: 12  QTIGKGEFGDVMLGDYR-GNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVI- 68
Query: 436 SMDEK---LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
            ++EK    +V +Y+  GSL   L   +  GR+ L  +     +L     +EYL  +G N
Sbjct: 69  -VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNN 122
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-AGYRAPEVTDPCKVSQKADV 551
             H ++ + N+L+++   A+VSDFGL      +    ++   + APE     K S K+DV
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 552 YSFGVLLLELLT-GKAP 567
           +SFG+LL E+ + G+ P
Sbjct: 183 WSFGILLWEIYSFGRVP 199

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 3   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 115
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y
Sbjct: 116 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDY 172
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L+M  L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 71  LDVIHTENKLYLVFEFLSM-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 125
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 126 -RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 185 STAVDIWSLGCIFAEMVTRRA 205

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 12/207 (5%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG            VA+K +K+ ++SE EF ++ + +  ++HE LV L       
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 75
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGN 497
               ++ +Y+  G L   L   +   +T    EM           +EYL ++     H +
Sbjct: 76  RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM----CKDVCEAMEYLESK--QFLHRD 129
Query: 498 IKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADVY 552
           + + N L+      +VSDFGL+  V      + V       +  PEV    K S K+D++
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 189
Query: 553 SFGVLLLELLT-GKAPTHALLNEEGVD 578
           +FGVL+ E+ + GK P     N E  +
Sbjct: 190 AFGVLMWEIYSLGKMPYERFTNSETAE 216

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L+M  L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 70  LDVIHTENKLYLVFEFLSM-DLKDFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 124
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 125 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 184 STAVDIWSLGCIFAEMVTRRA 204

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 130/283 (45%), Gaps = 43/283 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMGTI----VAVKRLKDVTISE---REFKDKIEGVGAVNHENLV 428
           +V+G G FG      L++ +     VA+K LK V  +E   R+F  +   +G  +H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYL 486
            L          ++V +Y+  GSL + L  +         + +  L+ +  G A G++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA------QFTVIQLVGMLRGIASGMKYL 163
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEV 539
              G    H ++ + NIL+  +   +VSDFGL+ ++   P +      G     + +PE 
Sbjct: 164 SDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
               K +  +DV+S+G++L E+++ G+ P   + N          Q ++K        D 
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----------QDVIK------AVD- 264
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           E  R     +    L QL +DC  +  +NRP   +++  +++L
Sbjct: 265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L+M  L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 71  LDVIHTENKLYLVFEFLSM-DLKDFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 125
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 126 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 185 STAVDIWSLGCIFAEMVTRRA 205

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 12/207 (5%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG            VA+K +K+ ++SE EF ++ + +  ++HE LV L       
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGN 497
               ++ +Y+  G L   L   +   +T    EM           +EYL ++     H +
Sbjct: 77  RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM----CKDVCEAMEYLESK--QFLHRD 130
Query: 498 IKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADVY 552
           + + N L+      +VSDFGL+  V      + V       +  PEV    K S K+D++
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 553 SFGVLLLELLT-GKAPTHALLNEEGVD 578
           +FGVL+ E+ + GK P     N E  +
Sbjct: 191 AFGVLMWEIYSLGKMPYERFTNSETAE 217

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 12/207 (5%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG            VA+K +K+ ++SE EF ++ + +  ++HE LV L       
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGN 497
               ++ +Y+  G L   L   +   +T    EM           +EYL ++     H +
Sbjct: 92  RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM----CKDVCEAMEYLESK--QFLHRD 145
Query: 498 IKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADVY 552
           + + N L+      +VSDFGL+  V      + V       +  PEV    K S K+D++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 553 SFGVLLLELLT-GKAPTHALLNEEGVD 578
           +FGVL+ E+ + GK P     N E  +
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSETAE 232

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 18/218 (8%)
Query: 361 AARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDK 415
           A R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + +
Sbjct: 1   AKRQWALEDF--EIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 416 IEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI 475
           +E    + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +  
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATY 113
Query: 476 ALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-- 533
               A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G  
Sbjct: 114 ITELANALSYCHSK--KVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTL 170
Query: 534 -YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
            Y  PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 130/283 (45%), Gaps = 43/283 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISE---REFKDKIEGVGAVNHENLV 428
           +V+G G FG      L++ +     VA+K LK V  +E   R+F  +   +G  +H N++
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYL 486
            L          ++V +Y+  GSL + L  +         + +  L+ +  G A G++YL
Sbjct: 98  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA------QFTVIQLVGMLRGIASGMKYL 151
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEV 539
              G    H ++ + NIL+  +   +VSDFGL+ ++   P +      G     + +PE 
Sbjct: 152 SDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 209
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
               K +  +DV+S+G++L E+++ G+ P   + N          Q ++K        D 
Sbjct: 210 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----------QDVIK------AVD- 252
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           E  R     +    L QL +DC  +  +NRP   +++  +++L
Sbjct: 253 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 295

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 112/271 (41%), Gaps = 31/271 (11%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG       +    VAVK +K+ ++SE EF  + + +  ++H  LV         
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNW-EMRSLIALGAARGIEYLHAQGPNVSHG 496
               +V +Y++ G L   L  + G G  P    EM          G+ +L +      H 
Sbjct: 76  YPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEM----CYDVCEGMAFLESH--QFIHR 128
Query: 497 NIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-----AGYRAPEVTDPCKVSQKADV 551
           ++ + N L+ +    +VSDFG+   V      + V       + APEV    K S K+DV
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 552 YSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           ++FG+L+ E+ + GK P     N E V        + +    S+                
Sbjct: 189 WAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDT--------------- 233
Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
             + Q+   C  + P+ RP+  +++  IE L
Sbjct: 234 --IYQIMYSCWHELPEKRPTFQQLLSSIEPL 262

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 130/283 (45%), Gaps = 43/283 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISE---REFKDKIEGVGAVNHENLV 428
           +V+G G FG      L++ +     VA+K LK V  +E   R+F  +   +G  +H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYL 486
            L          ++V +Y+  GSL + L  +         + +  L+ +  G A G++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA------QFTVIQLVGMLRGIASGMKYL 163
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEV 539
              G    H ++ + NIL+  +   +VSDFGL+ ++   P +      G     + +PE 
Sbjct: 164 SDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
               K +  +DV+S+G++L E+++ G+ P   + N          Q ++K        D 
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----------QDVIK------AVD- 264
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           E  R     +    L QL +DC  +  +NRP   +++  +++L
Sbjct: 265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 130/283 (45%), Gaps = 43/283 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISE---REFKDKIEGVGAVNHENLV 428
           +V+G G FG      L++ +     VA+K LK V  +E   R+F  +   +G  +H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYL 486
            L          ++V +Y+  GSL + L  +         + +  L+ +  G A G++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA------QFTVIQLVGMLRGIASGMKYL 163
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEV 539
              G    H ++ + NIL+  +   +VSDFGL+ ++   P +      G     + +PE 
Sbjct: 164 SDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
               K +  +DV+S+G++L E+++ G+ P   + N          Q ++K        D 
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----------QDVIK------AVD- 264
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           E  R     +    L QL +DC  +  +NRP   +++  +++L
Sbjct: 265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 12/207 (5%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG            VA+K +K+ ++SE EF ++ + +  ++HE LV L       
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGN 497
               ++ +Y+  G L   L   +   +T    EM           +EYL ++     H +
Sbjct: 72  RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM----CKDVCEAMEYLESK--QFLHRD 125
Query: 498 IKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADVY 552
           + + N L+      +VSDFGL+  V      + V       +  PEV    K S K+D++
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 553 SFGVLLLELLT-GKAPTHALLNEEGVD 578
           +FGVL+ E+ + GK P     N E  +
Sbjct: 186 AFGVLMWEIYSLGKMPYERFTNSETAE 212

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 130/283 (45%), Gaps = 43/283 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISE---REFKDKIEGVGAVNHENLV 428
           +V+G G FG      L++ +     VA+K LK V  +E   R+F  +   +G  +H N++
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYL 486
            L          ++V +Y+  GSL + L  +         + +  L+ +  G A G++YL
Sbjct: 81  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA------QFTVIQLVGMLRGIASGMKYL 134
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEV 539
              G    H ++ + NIL+  +   +VSDFGL+ ++   P +      G     + +PE 
Sbjct: 135 SDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 192
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
               K +  +DV+S+G++L E+++ G+ P   + N          Q ++K        D 
Sbjct: 193 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----------QDVIK------AVD- 235
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           E  R     +    L QL +DC  +  +NRP   +++  +++L
Sbjct: 236 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 90/202 (44%), Gaps = 24/202 (11%)
Query: 378 LGKGTFGTAYKAVLE-----MGTIVAVKRLKDVTISERE--FKDKIEGVGAVNHENLVPL 430
           LG+G FG       +      G +VAVK LK+    +    ++ +IE +  + HE++V  
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 431 RAYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
           +       EK   LV +Y+ +GSL   L       R  +      L A     G+ YLHA
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL------PRHCVGLAQLLLFAQQICEGMAYLHA 129
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-------AGYRAPEVTD 541
           Q  +  H  + + N+LL      ++ DFGLA  V       RV         + APE   
Sbjct: 130 Q--HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 187
Query: 542 PCKVSQKADVYSFGVLLLELLT 563
            CK    +DV+SFGV L ELLT
Sbjct: 188 ECKFYYASDVWSFGVTLYELLT 209

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           + +GKG FG         G  VAVK +K+   ++  F  +   +  + H NLV L     
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ-AFLAEASVMTQLRHSNLVQLLGVI- 255
Query: 436 SMDEK---LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
            ++EK    +V +Y+  GSL   L   +  GR+ L  +     +L     +EYL  +G N
Sbjct: 256 -VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNN 309
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-AGYRAPEVTDPCKVSQKADV 551
             H ++ + N+L+++   A+VSDFGL      +    ++   + APE     K S K+DV
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 552 YSFGVLLLELLT-GKAP 567
           +SFG+LL E+ + G+ P
Sbjct: 370 WSFGILLWEIYSFGRVP 386

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 12/207 (5%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG            VA+K +K+ ++SE EF ++ + +  ++HE LV L       
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 82
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGN 497
               ++ +Y+  G L   L   +   +T    EM           +EYL ++     H +
Sbjct: 83  RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM----CKDVCEAMEYLESK--QFLHRD 136
Query: 498 IKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADVY 552
           + + N L+      +VSDFGL+  V      + V       +  PEV    K S K+D++
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 196
Query: 553 SFGVLLLELLT-GKAPTHALLNEEGVD 578
           +FGVL+ E+ + GK P     N E  +
Sbjct: 197 AFGVLMWEIYSLGKMPYERFTNSETAE 223

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 129/283 (45%), Gaps = 43/283 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISE---REFKDKIEGVGAVNHENLV 428
           +V+G G FG      L++ +     VA+K LK V  +E   R+F  +   +G  +H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYL 486
            L          ++V +Y+  GSL + L  +         + +  L+ +  G A G++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA------QFTVIQLVGMLRGIASGMKYL 163
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEV 539
              G    H ++ + NIL+  +   +VSDFGL  ++   P +      G     + +PE 
Sbjct: 164 SDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
               K +  +DV+S+G++L E+++ G+ P   + N          Q ++K        D 
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----------QDVIK------AVD- 264
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           E  R     +    L QL +DC  +  +NRP   +++  +++L
Sbjct: 265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 90/202 (44%), Gaps = 24/202 (11%)
Query: 378 LGKGTFGTAYKAVLE-----MGTIVAVKRLKDVTISERE--FKDKIEGVGAVNHENLVPL 430
           LG+G FG       +      G +VAVK LK+    +    ++ +IE +  + HE++V  
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 431 RAYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
           +       EK   LV +Y+ +GSL   L       R  +      L A     G+ YLHA
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL------PRHCVGLAQLLLFAQQICEGMAYLHA 130
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-------AGYRAPEVTD 541
           Q  +  H  + + N+LL      ++ DFGLA  V       RV         + APE   
Sbjct: 131 Q--HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 188
Query: 542 PCKVSQKADVYSFGVLLLELLT 563
            CK    +DV+SFGV L ELLT
Sbjct: 189 ECKFYYASDVWSFGVTLYELLT 210

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 130/286 (45%), Gaps = 37/286 (12%)
Query: 378 LGKGTFGTAYKAVLE-----MGTIVAVKRLKDV-TISEREFKDKIEGVGAVNHENLVPLR 431
           LGKG FG+      +      G +VAVK+L+      +R+F+ +I+ + A++ + +V  R
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 432 AYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              Y    +   LV +YL  G L   L  +    R  L+     L +    +G+EYL ++
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGSR 134
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG----------PSSTPNRVAGYRAPEV 539
                H ++ + NIL+      +++DFGLA L+           P  +P     + APE 
Sbjct: 135 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP---IFWYAPES 189
Query: 540 TDPCKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV 595
                 S+++DV+SFGV+L EL T      +P+   L   G +  R V ++ +       
Sbjct: 190 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE--RDVPALCRLL-ELLE 246
Query: 596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
               L        E+ +L++L   C A  P +RPS S +  +++ L
Sbjct: 247 EGQRLPAPPACPAEVHELMKL---CWAPSPQDRPSFSALGPQLDML 289

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 130/283 (45%), Gaps = 43/283 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMGTI----VAVKRLKDVTISE---REFKDKIEGVGAVNHENLV 428
           +V+G G FG      L++ +     VA+K LK V  +E   R+F  +   +G  +H N++
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYL 486
            L          ++V +Y+  GSL + L  +         + +  L+ +  G A G++YL
Sbjct: 108 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA------QFTVIQLVGMLRGIASGMKYL 161
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEV 539
              G    H ++ + NIL+  +   +VSDFGL+ ++   P +      G     + +PE 
Sbjct: 162 SDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 219
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
               K +  +DV+S+G++L E+++ G+ P   + N          Q ++K        D 
Sbjct: 220 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----------QDVIK------AVD- 262
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           E  R     +    L QL +DC  +  +NRP   +++  +++L
Sbjct: 263 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 305

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 130/283 (45%), Gaps = 43/283 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISE---REFKDKIEGVGAVNHENLV 428
           +V+G G FG      L++ +     VA+K LK V  +E   R+F  +   +G  +H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYL 486
            L          ++V +Y+  GSL + L  +         + +  L+ +  G A G++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA------QFTVIQLVGMLRGIASGMKYL 163
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEV 539
              G    H ++ + NIL+  +   +VSDFGL+ ++   P +      G     + +PE 
Sbjct: 164 SDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
               K +  +DV+S+G++L E+++ G+ P   + N          Q ++K        D 
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----------QDVIK------AVD- 264
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           E  R     +    L QL +DC  +  +NRP   +++  +++L
Sbjct: 265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPLRA 432
           LGKG FG  Y A   +   I+A+K L    +     E + + ++E    + H N++ L  
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
           Y++      L+ +Y  +G++   L        +  + +  +      A  + Y H++   
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSK--R 125
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVSQKA 549
           V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y  PE+ +     +K 
Sbjct: 126 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 184
Query: 550 DVYSFGVLLLELLTGKAPTHA 570
           D++S GVL  E L GK P  A
Sbjct: 185 DLWSLGVLCYEFLVGKPPFEA 205

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 8   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y   G +   L        +  + +  +    
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK-----LSKFDEQRTATYIT 120
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y
Sbjct: 121 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDY 177
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 12/207 (5%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG            VA+K +K+ ++SE EF ++ + +  ++HE LV L       
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGN 497
               ++ +Y+  G L   L   +   +T    EM           +EYL ++     H +
Sbjct: 92  RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM----CKDVCEAMEYLESK--QFLHRD 145
Query: 498 IKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKADVY 552
           + + N L+      +VSDFGL+  V      + V       +  PEV    K S K+D++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 553 SFGVLLLELLT-GKAPTHALLNEEGVD 578
           +FGVL+ E+ + GK P     N E  +
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSETAE 232

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 16/214 (7%)
Query: 365 FDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNH 424
            D E+L     E +GKG+FG  +K +      V   ++ D+  +E E +D  + +  ++ 
Sbjct: 3   LDPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 61
Query: 425 ENLVPLRAYY--YSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR 481
            +   +  YY  Y  D KL ++ +YL  GS   LL         PL+    + I     +
Sbjct: 62  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILK 115
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAP 537
           G++YLH++     H +IK++N+LL++  E +++DFG+A  L       N   G   + AP
Sbjct: 116 GLDYLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAP 173
Query: 538 EVTDPCKVSQKADVYSFGVLLLELLTGKAPTHAL 571
           EV        KAD++S G+  +EL  G+ P   L
Sbjct: 174 EVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 16/213 (7%)
Query: 366 DLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHE 425
           D E+L     E +GKG+FG  +K +      V   ++ D+  +E E +D  + +  ++  
Sbjct: 19  DPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 426 NLVPLRAYY--YSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
           +   +  YY  Y  D KL ++ +YL  GS   LL         PL+    + I     +G
Sbjct: 78  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKG 131
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPE 538
           ++YLH++     H +IK++N+LL++  E +++DFG+A  L       N   G   + APE
Sbjct: 132 LDYLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE 189
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHAL 571
           V        KAD++S G+  +EL  G+ P   L
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 127/282 (45%), Gaps = 41/282 (14%)
Query: 376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLKD--VTISEREFKDKIEGVGAVNHENLVP 429
           +V+G G FG      L++       VA+K LK        R+F  +   +G  +H N++ 
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 94
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYLH 487
           L          +++ +Y+  GSL A L  N G       + +  L+ +  G   G++YL 
Sbjct: 95  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDG------RFTVIQLVGMLRGIGSGMKYLS 148
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEVT 540
               +  H ++ + NIL+  +   +VSDFG++ ++   P +      G     + APE  
Sbjct: 149 DM--SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 206
Query: 541 DPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE 599
              K +  +DV+S+G+++ E+++ G+ P   + N+   D+ + ++              E
Sbjct: 207 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVIKAIE--------------E 249
Query: 600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
             R     +  + L QL +DC  +   +RP   +++  +++L
Sbjct: 250 GYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKL 291

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 90/202 (44%), Gaps = 24/202 (11%)
Query: 378 LGKGTFGTAYKAVLE-----MGTIVAVKRLK-DVTISERE-FKDKIEGVGAVNHENLVPL 430
           LG+G FG       +      G +VAVK LK D     R  +K +I+ +  + HE+++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 431 RAYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
           +       EK   LV +Y+ +GSL   L       R  +      L A     G+ YLHA
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL------PRHSIGLAQLLLFAQQICEGMAYLHA 135
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-------AGYRAPEVTD 541
           Q  +  H N+ + N+LL      ++ DFGLA  V       RV         + APE   
Sbjct: 136 Q--HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 542 PCKVSQKADVYSFGVLLLELLT 563
             K    +DV+SFGV L ELLT
Sbjct: 194 EYKFYYASDVWSFGVTLYELLT 215

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 16/214 (7%)
Query: 365 FDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNH 424
            D E+L     E +GKG+FG  +K +      V   ++ D+  +E E +D  + +  ++ 
Sbjct: 3   LDPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 61
Query: 425 ENLVPLRAYY--YSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR 481
            +   +  YY  Y  D KL ++ +YL  GS   LL         PL+    + I     +
Sbjct: 62  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILK 115
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAP 537
           G++YLH++     H +IK++N+LL++  E +++DFG+A  L       N   G   + AP
Sbjct: 116 GLDYLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 173
Query: 538 EVTDPCKVSQKADVYSFGVLLLELLTGKAPTHAL 571
           EV        KAD++S G+  +EL  G+ P   L
Sbjct: 174 EVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 5   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 63  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 117
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E ++++FG + +  PSS    + G   Y
Sbjct: 118 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDY 174
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 210

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRAY 433
           +V+G G+FG  Y+A L + G +VA+K++    +  + FK++ ++ +  ++H N+V LR +
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 434 YYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           +YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+H
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYIH 139
Query: 488 AQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPE-VTDP 542
           + G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE +   
Sbjct: 140 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 543 CKVSQKADVYSFGVLLLELLTGK 565
              +   DV+S G +L ELL G+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 8   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y   G +   L        +  + +  +    
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK-----LSKFDEQRTATYIT 120
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G   Y
Sbjct: 121 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLXGTLDY 177
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 127/282 (45%), Gaps = 41/282 (14%)
Query: 376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLKD--VTISEREFKDKIEGVGAVNHENLVP 429
           +V+G G FG      L++       VA+K LK        R+F  +   +G  +H N++ 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYLH 487
           L          +++ +Y+  GSL A L  N G       + +  L+ +  G   G++YL 
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDG------RFTVIQLVGMLRGIGSGMKYLS 127
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEVT 540
               +  H ++ + NIL+  +   +VSDFG++ ++   P +      G     + APE  
Sbjct: 128 DM--SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 185
Query: 541 DPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE 599
              K +  +DV+S+G+++ E+++ G+ P   + N+   D+ + ++              E
Sbjct: 186 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVIKAIE--------------E 228
Query: 600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
             R     +  + L QL +DC  +   +RP   +++  +++L
Sbjct: 229 GYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKL 270

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 376 EVLGKGTFGTAY--KAVL--EMGTIVAVKRLKDVTISERE-FKDKIEG--VGAVNHENLV 428
           +VLG+G+FG  +  + V   + G + A+K LK  T+  R+  + K+E   +  VNH  +V
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L   + +  +  L+ D+L  G L   L          + + +  L     A G+++LH+
Sbjct: 94  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL-----ALGLDHLHS 148
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPCK 544
            G  + + ++K  NILL +    +++DFGL+   +          G   Y APEV +   
Sbjct: 149 LG--IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQG 206
Query: 545 VSQKADVYSFGVLLLELLTGKAP 567
            S  AD +S+GVL+ E+LTG  P
Sbjct: 207 HSHSADWWSYGVLMFEMLTGSLP 229

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           + +GKG FG         G  VAVK +K+   + + F  +   +  + H NLV L     
Sbjct: 18  QTIGKGEFGDVMLGDYR-GNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVI- 74
Query: 436 SMDEK---LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
            ++EK    +V +Y+  GSL   L   +  GR+ L  +     +L     +EYL  +G N
Sbjct: 75  -VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNN 128
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-AGYRAPEVTDPCKVSQKADV 551
             H ++ + N+L+++   A+VSDFGL      +    ++   + APE       S K+DV
Sbjct: 129 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREAAFSTKSDV 188
Query: 552 YSFGVLLLELLT-GKAP 567
           +SFG+LL E+ + G+ P
Sbjct: 189 WSFGILLWEIYSFGRVP 205

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 127/282 (45%), Gaps = 41/282 (14%)
Query: 376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLKD--VTISEREFKDKIEGVGAVNHENLVP 429
           +V+G G FG      L++       VA+K LK        R+F  +   +G  +H N++ 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYLH 487
           L          +++ +Y+  GSL A L  N G       + +  L+ +  G   G++YL 
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDG------RFTVIQLVGMLRGIGSGMKYLS 133
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEVT 540
               +  H ++ + NIL+  +   +VSDFG++ ++   P +      G     + APE  
Sbjct: 134 DM--SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 191
Query: 541 DPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE 599
              K +  +DV+S+G+++ E+++ G+ P   + N+   D+ + ++              E
Sbjct: 192 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVIKAIE--------------E 234
Query: 600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
             R     +  + L QL +DC  +   +RP   +++  +++L
Sbjct: 235 GYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKL 276

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 12/207 (5%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM 437
           LG G FG            VA+K +K+ ++SE EF ++ + +  ++HE LV L       
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGN 497
               ++ +Y+  G L   L   +   +T    EM           +EYL ++     H +
Sbjct: 77  RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM----CKDVCEAMEYLESK--QFLHRD 130
Query: 498 IKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAGY----RAPEVTDPCKVSQKADVY 552
           + + N L+      +VSDFGL+ +++    T +R + +      PEV    K S K+D++
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 553 SFGVLLLELLT-GKAPTHALLNEEGVD 578
           +FGVL+ E+ + GK P     N E  +
Sbjct: 191 AFGVLMWEIYSLGKMPYERFTNSETAE 217

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R + LED        LGKG FG  Y A  +    I+A+K L    +     E + + ++E
Sbjct: 6   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +    
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYIT 118
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---Y 534
             A  + Y H++   V H +IK  N+LL  + E ++++FG + +  PSS    + G   Y
Sbjct: 119 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDY 175
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
             PE+ +     +K D++S GVL  E L GK P  A
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRAY 433
           +V+G G+FG  Y+A L + G +VA+K++    +  + FK++ ++ +  ++H N+V LR +
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 434 YYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           +YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+H
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYIH 139
Query: 488 AQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPE-VTDP 542
           + G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE +   
Sbjct: 140 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 543 CKVSQKADVYSFGVLLLELLTGK 565
              +   DV+S G +L ELL G+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLRAY 433
           +V+G G+FG  Y+A L + G +VA+K++    +  + FK++ ++ +  ++H N+V LR +
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 434 YYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           +YS  EK       LV DY+         H ++     P+ +    +  L   R + Y+H
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYIH 139
Query: 488 AQGPNVSHGNIKSSNILLTKSYEA-RVSDFGLA-HLVGPSSTPNRVAG--YRAPE-VTDP 542
           + G  + H +IK  N+LL       ++ DFG A  LV      + +    YRAPE +   
Sbjct: 140 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 543 CKVSQKADVYSFGVLLLELLTGK 565
              +   DV+S G +L ELL G+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 130/286 (45%), Gaps = 37/286 (12%)
Query: 378 LGKGTFGTAYKAVLE-----MGTIVAVKRLKDV-TISEREFKDKIEGVGAVNHENLVPLR 431
           LGKG FG+      +      G +VAVK+L+      +R+F+ +I+ + A++ + +V  R
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 432 AYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              Y    +   LV +YL  G L   L  +    R  L+     L +    +G+EYL ++
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGSR 146
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG----------PSSTPNRVAGYRAPEV 539
                H ++ + NIL+      +++DFGLA L+           P  +P     + APE 
Sbjct: 147 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP---IFWYAPES 201
Query: 540 TDPCKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV 595
                 S+++DV+SFGV+L EL T      +P+   L   G +  R V ++ +       
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE--RDVPALSRLL-ELLE 258
Query: 596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
               L        E+ +L++L   C A  P +RPS S +  +++ L
Sbjct: 259 EGQRLPAPPACPAEVHELMKL---CWAPSPQDRPSFSALGPQLDML 301

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 115/248 (46%), Gaps = 39/248 (15%)
Query: 377 VLGKGTFGTAYKAVLEM----GTIVAVKRLKDVTISEREFKD---KIEGVGAVNHENLVP 429
           V+G G FG      L++       VA+K LK V  +E++ +D   +   +G  +H N+V 
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLK-VGYTEKQRRDFLCEASIMGQFDHPNVVH 108
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYLH 487
           L          ++V +++  G+L A L  + G       + +  L+ +  G A G+ YL 
Sbjct: 109 LEGVVTRGKPVMIVIEFMENGALDAFLRKHDG------QFTVIQLVGMLRGIAAGMRYLA 162
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEVT 540
             G    H ++ + NIL+  +   +VSDFGL+ ++   P +      G     + APE  
Sbjct: 163 DMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAI 220
Query: 541 DPCKVSQKADVYSFGVLLLELLT-GKAPTHALLN-------EEG------VDLPRWVQSI 586
              K +  +DV+S+G+++ E+++ G+ P   + N       EEG      +D P  +  +
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDCPAGLHQL 280
Query: 587 VKDEWTSE 594
           + D W  E
Sbjct: 281 MLDCWQKE 288

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 90/202 (44%), Gaps = 24/202 (11%)
Query: 378 LGKGTFGTAYKAVLE-----MGTIVAVKRLK-DVTISERE-FKDKIEGVGAVNHENLVPL 430
           LG+G FG       +      G +VAVK LK D     R  +K +I+ +  + HE+++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 431 RAYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
           +       EK   LV +Y+ +GSL   L       R  +      L A     G+ YLH+
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL------PRHSIGLAQLLLFAQQICEGMAYLHS 135
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-------AGYRAPEVTD 541
           Q  +  H N+ + N+LL      ++ DFGLA  V       RV         + APE   
Sbjct: 136 Q--HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 542 PCKVSQKADVYSFGVLLLELLT 563
             K    +DV+SFGV L ELLT
Sbjct: 194 EYKFYYASDVWSFGVTLYELLT 215

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 18/223 (8%)
Query: 361 AARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDK 415
           + R + LED        LGKG FG  Y A       I+A+K L    +     E + + +
Sbjct: 5   SKRQWTLEDF--DIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRRE 62
Query: 416 IEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI 475
           +E    + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +  
Sbjct: 63  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSRFDEQRTATY 117
Query: 476 ALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-- 533
               A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS  + + G  
Sbjct: 118 ITELANALSYCHSK--RVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRDTLCGTL 174
Query: 534 -YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEE 575
            Y  PE+ +     +K D++S GVL  E L G  P  A   +E
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQE 217

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 132/292 (45%), Gaps = 45/292 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLKD--VTISEREFKDKIEGVGAVNHENLVP 429
           EV+G G FG   +  L+      + VA+K LK        REF  +   +G   H N++ 
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 81
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYLH 487
           L     +    +++ +++  G+L + L  N G       + +  L+ +  G A G+ YL 
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRLNDG------QFTVIQLVGMLRGIASGMRYLA 135
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP-SSTPNRVAG--------YRAPE 538
               +  H ++ + NIL+  +   +VSDFGL+  +   SS P   +         + APE
Sbjct: 136 EM--SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPE 193
Query: 539 VTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD 597
                K +  +D +S+G+++ E+++ G+ P   + N++ ++      +I +D        
Sbjct: 194 AIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVIN------AIEQD-------- 239
Query: 598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL--HPSSTQ 647
               R     +    L QL +DC  +  + RP   +V+  ++++  +P+S +
Sbjct: 240 ---YRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLK 288

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLK----DVTISEREFKDKIEGVGAVNHENLVPLR 431
           E +G+GT+G  YKA    G IVA+KR++    D  I     ++ I  +  ++H N+V L 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIRE-ISLLKELHHPNIVSLI 85
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
              +S     LV++++       L     G   + +   +  L+     RG+ + H    
Sbjct: 86  DVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLL-----RGVAHCHQH-- 138
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVG---PSSTPNRVA-GYRAPEV-TDPCKVS 546
            + H ++K  N+L+      +++DFGLA   G    S T   V   YRAP+V     K S
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198
Query: 547 QKADVYSFGVLLLELLTGK 565
              D++S G +  E++TGK
Sbjct: 199 TSVDIWSIGCIFAEMITGK 217

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 17/210 (8%)
Query: 366 DLEDLLRASAEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---A 421
           D+E+  +   E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     
Sbjct: 5   DMENFQKV--EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 422 VNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR 481
           +NH N+V L    ++ ++  LV+++L    L   +  +   G  PL      L  L   +
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQ 118
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAP 537
           G+ + H+    V H ++K  N+L+      +++DFGLA   G P  T         YRAP
Sbjct: 119 GLAFCHSH--RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 176
Query: 538 EVTDPCK-VSQKADVYSFGVLLLELLTGKA 566
           E+   CK  S   D++S G +  E++T +A
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 206

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLK----DVTISEREFKDKIEGVGAVNHENLVPLR 431
           E +G+GT+G  YKA    G IVA+KR++    D  I     ++ I  +  ++H N+V L 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIRE-ISLLKELHHPNIVSLI 85
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
              +S     LV++++       L     G   + +   +  L+     RG+ + H    
Sbjct: 86  DVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLL-----RGVAHCHQH-- 138
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVG---PSSTPNRVA-GYRAPEV-TDPCKVS 546
            + H ++K  N+L+      +++DFGLA   G    S T   V   YRAP+V     K S
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198
Query: 547 QKADVYSFGVLLLELLTGK 565
              D++S G +  E++TGK
Sbjct: 199 TSVDIWSIGCIFAEMITGK 217

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 130/286 (45%), Gaps = 37/286 (12%)
Query: 378 LGKGTFGTAYKAVLE-----MGTIVAVKRLKDV-TISEREFKDKIEGVGAVNHENLVPLR 431
           LGKG FG+      +      G +VAVK+L+      +R+F+ +I+ + A++ + +V  R
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 432 AYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
              Y    +   LV +YL  G L   L  +    R  L+     L +    +G+EYL ++
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGSR 133
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG----------PSSTPNRVAGYRAPEV 539
                H ++ + NIL+      +++DFGLA L+           P  +P     + APE 
Sbjct: 134 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP---IFWYAPES 188
Query: 540 TDPCKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV 595
                 S+++DV+SFGV+L EL T      +P+   L   G +  R V ++ +       
Sbjct: 189 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSE--RDVPALSRLL-ELLE 245
Query: 596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
               L        E+ +L++L   C A  P +RPS S +  +++ L
Sbjct: 246 EGQRLPAPPACPAEVHELMKL---CWAPSPQDRPSFSALGPQLDML 288

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLSFCHSH- 122
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 123 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 182 STAVDIWSLGCIFAEMVTRRA 202

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 110/236 (46%), Gaps = 25/236 (10%)
Query: 360 NAARVFDLEDLLRASAEVLGKGTFGTAYKAVL--EMGTI---VAVKRLKDVT--ISEREF 412
           N A++  L++      +VLG G FGT YK +   E  T+   VA+K L + T   +  EF
Sbjct: 28  NQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEF 87
Query: 413 KDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKG--AGRTPLNWE 470
            D+   + +++H +LV L     S   + LV   +  G L   +H +K     +  LNW 
Sbjct: 88  MDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNW- 145
Query: 471 MRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR 530
                 +  A+G+ YL  +   + H ++ + N+L+      +++DFGLA L+        
Sbjct: 146 -----CVQIAKGMMYLEER--RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 198
Query: 531 VAGYRAP------EVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDL 579
             G + P      E     K + ++DV+S+GV + EL+T G  P   +   E  DL
Sbjct: 199 ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL 254

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 18/223 (8%)
Query: 361 AARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDK 415
           + R + LED        LGKG FG  Y A       I+A+K L    +     E + + +
Sbjct: 5   SKRQWTLEDF--DIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRRE 62
Query: 416 IEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI 475
           +E    + H N++ L  Y++      L+ +Y  +G++   L        +  + +  +  
Sbjct: 63  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSRFDEQRTATY 117
Query: 476 ALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-- 533
               A  + Y H++   V H +IK  N+LL  + E +++DFG + +  PSS    + G  
Sbjct: 118 ITELANALSYCHSK--RVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRTTLCGTL 174
Query: 534 -YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEE 575
            Y  PE+ +     +K D++S GVL  E L G  P  A   +E
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQE 217

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 110/236 (46%), Gaps = 25/236 (10%)
Query: 360 NAARVFDLEDLLRASAEVLGKGTFGTAYKAVL--EMGTI---VAVKRLKDVT--ISEREF 412
           N A++  L++      +VLG G FGT YK +   E  T+   VA+K L + T   +  EF
Sbjct: 5   NQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEF 64
Query: 413 KDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKG--AGRTPLNWE 470
            D+   + +++H +LV L     S   + LV   +  G L   +H +K     +  LNW 
Sbjct: 65  MDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNW- 122
Query: 471 MRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR 530
                 +  A+G+ YL  +   + H ++ + N+L+      +++DFGLA L+        
Sbjct: 123 -----CVQIAKGMMYLEER--RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 175
Query: 531 VAGYRAP------EVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDL 579
             G + P      E     K + ++DV+S+GV + EL+T G  P   +   E  DL
Sbjct: 176 ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL 231

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 122
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 123 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 182 STAVDIWSLGCIFAEMVTRRA 202

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 67  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 121
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 122 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 181 STAVDIWSLGCIFAEMVTRRA 201

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 132/292 (45%), Gaps = 45/292 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLKD--VTISEREFKDKIEGVGAVNHENLVP 429
           EV+G G FG   +  L+      + VA+K LK        REF  +   +G   H N++ 
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYLH 487
           L     +    +++ +++  G+L + L  N G       + +  L+ +  G A G+ YL 
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRLNDG------QFTVIQLVGMLRGIASGMRYLA 133
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP-SSTPNRVAG--------YRAPE 538
               +  H ++ + NIL+  +   +VSDFGL+  +   SS P   +         + APE
Sbjct: 134 EM--SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPE 191
Query: 539 VTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD 597
                K +  +D +S+G+++ E+++ G+ P   + N++ ++      +I +D        
Sbjct: 192 AIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVIN------AIEQD-------- 237
Query: 598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL--HPSSTQ 647
               R     +    L QL +DC  +  + RP   +V+  ++++  +P+S +
Sbjct: 238 ---YRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLK 286

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 75  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 129
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 130 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 188
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 189 STAVDIWSLGCIFAEMVTRRA 209

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 67  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 121
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 122 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 181 STAVDIWSLGCIFAEMVTRRA 201

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 129/283 (45%), Gaps = 43/283 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISE---REFKDKIEGVGAVNHENLV 428
           +V+G G FG      L++ +     VA+K LK V  +E   R+F  +   +G  +H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYL 486
            L          ++V + +  GSL + L  +         + +  L+ +  G A G++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA------QFTVIQLVGMLRGIASGMKYL 163
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEV 539
              G    H ++ + NIL+  +   +VSDFGL+ ++   P +      G     + +PE 
Sbjct: 164 SDMG--AVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
               K +  +DV+S+G++L E+++ G+ P   + N          Q ++K        D 
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----------QDVIK------AVD- 264
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           E  R     +    L QL +DC  +  +NRP   +++  +++L
Sbjct: 265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 122
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 123 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 182 STAVDIWSLGCIFAEMVTRRA 202

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 69  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 123
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 124 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 182
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 183 STAVDIWSLGCIFAEMVTRRA 203

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISERE-FKDKIEG--VGAVNHENLV 428
           +VLG+G+FG  +      G+    + A+K LK  T+  R+  + K+E   +  VNH  +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L   + +  +  L+ D+L  G L   L          + + +  L     A  +++LH+
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL-----ALALDHLHS 144
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLA-----HLVGPSSTPNRVAGYRAPEVTDPC 543
            G  + + ++K  NILL +    +++DFGL+     H     S    V  Y APEV +  
Sbjct: 145 LG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE-YMAPEVVNRR 201
Query: 544 KVSQKADVYSFGVLLLELLTGKAP 567
             +Q AD +SFGVL+ E+LTG  P
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISERE-FKDKIEG--VGAVNHENLV 428
           +VLG+G+FG  +      G+    + A+K LK  T+  R+  + K+E   +  VNH  +V
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L   + +  +  L+ D+L  G L   L          + + +  L     A  +++LH+
Sbjct: 91  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL-----ALALDHLHS 145
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLA-----HLVGPSSTPNRVAGYRAPEVTDPC 543
            G  + + ++K  NILL +    +++DFGL+     H     S    V  Y APEV +  
Sbjct: 146 LG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE-YMAPEVVNRR 202
Query: 544 KVSQKADVYSFGVLLLELLTGKAP 567
             +Q AD +SFGVL+ E+LTG  P
Sbjct: 203 GHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 122
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 123 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 182 STAVDIWSLGCIFAEMVTRRA 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 71  LDVIHTENKLYLVFEFLHQ-DLKTFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 125
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 126 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 185 STAVDIWSLGCIFAEMVTRRA 205

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISERE-FKDKIEG--VGAVNHENLV 428
           +VLG+G+FG  +      G+    + A+K LK  T+  R+  + K+E   +  VNH  +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L   + +  +  L+ D+L  G L   L          + + +  L     A  +++LH+
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL-----ALALDHLHS 144
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLA-----HLVGPSSTPNRVAGYRAPEVTDPC 543
            G  + + ++K  NILL +    +++DFGL+     H     S    V  Y APEV +  
Sbjct: 145 LG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE-YMAPEVVNRR 201
Query: 544 KVSQKADVYSFGVLLLELLTGKAP 567
             +Q AD +SFGVL+ E+LTG  P
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 122
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 123 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 182 STAVDIWSLGCIFAEMVTRRA 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 67  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 121
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 122 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 181 STAVDIWSLGCIFAEMVTRRA 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 70  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 124
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 125 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 184 STAVDIWSLGCIFAEMVTRRA 204

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 122
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 123 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 182 STAVDIWSLGCIFAEMVTRRA 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 12  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 71
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 72  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 126
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 127 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 185
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 186 STAVDIWSLGCIFAEMVTRRA 206

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 69  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 123
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 124 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 183 STAVDIWSLGCIFAEMVTRRA 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 69  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 123
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 124 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 183 STAVDIWSLGCIFAEMVTRRA 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 71  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 125
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 126 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 185 STAVDIWSLGCIFAEMVTRRA 205

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 70  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 124
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 125 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 184 STAVDIWSLGCIFAEMVTRRA 204

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 67  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 121
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 122 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 181 STAVDIWSLGCIFAEMVTRRA 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 71  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 125
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 126 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 185 STAVDIWSLGCIFAEMVTRRA 205

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 122
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 123 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 182 STAVDIWSLGCIFAEMVTRRA 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 70  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 124
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 125 -RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 184 STAVDIWSLGCIFAEMVTRRA 204

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 69  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 123
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 124 -RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 183 STAVDIWSLGCIFAEMVTRRA 203

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 378 LGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           +G+G +G+  K V +  G I+AVKR++  T+ E+E K  +  +  V   +  P    +Y 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRS-TVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 437 M---DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
               +    +   L   S               +  E+   I L   + + +L  +   +
Sbjct: 89  ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK-ENLKI 147
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVSQ--- 547
            H +IK SNILL +S   ++ DFG++  +  S    R AG   Y APE  DP    Q   
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYD 207
Query: 548 -KADVYSFGVLLLELLTGKAP 567
            ++DV+S G+ L EL TG+ P
Sbjct: 208 VRSDVWSLGITLYELATGRFP 228

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 129/283 (45%), Gaps = 43/283 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISE---REFKDKIEGVGAVNHENLV 428
           +V+G G FG      L++ +     VA+K LK V  +E   R+F  +   +G  +H N++
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYL 486
            L          ++V + +  GSL + L  +         + +  L+ +  G A G++YL
Sbjct: 81  RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA------QFTVIQLVGMLRGIASGMKYL 134
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEV 539
              G    H ++ + NIL+  +   +VSDFGL+ ++   P +      G     + +PE 
Sbjct: 135 SDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 192
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
               K +  +DV+S+G++L E+++ G+ P   + N          Q ++K        D 
Sbjct: 193 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----------QDVIK------AVD- 235
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           E  R     +    L QL +DC  +  +NRP   +++  +++L
Sbjct: 236 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 129/283 (45%), Gaps = 43/283 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISE---REFKDKIEGVGAVNHENLV 428
           +V+G G FG      L++ +     VA+K LK V  +E   R+F  +   +G  +H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYL 486
            L          ++V + +  GSL + L  +         + +  L+ +  G A G++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA------QFTVIQLVGMLRGIASGMKYL 163
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG-----YRAPEV 539
              G    H ++ + NIL+  +   +VSDFGL+ ++   P +      G     + +PE 
Sbjct: 164 SDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
               K +  +DV+S+G++L E+++ G+ P   + N          Q ++K        D 
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----------QDVIK------AVD- 264
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           E  R     +    L QL +DC  +  +NRP   +++  +++L
Sbjct: 265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV--GAVNHENLVP 429
           EV+G+G FG  Y   L          AVK L  +T      +   EG+     +H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 430 LRAYYY-SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYL 486
           L      S    L+V  Y+  G L   +           N  ++ LI  G   A+G++YL
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKYL 148
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--------HLVGPSSTPNRVAGYRAPE 538
            ++     H ++ + N +L + +  +V+DFGLA        + V   +       + A E
Sbjct: 149 ASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 206
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                K + K+DV+SFGVLL EL+T  AP +  +N   +                 V+ L
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------TVYLL 250
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHH 650
           +  R    E     L ++ + C     + RPS SE++ RI  +  +    H+
Sbjct: 251 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 302

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 119/283 (42%), Gaps = 41/283 (14%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV--GAVNHENLVP 429
           EV+G+G FG  Y   L          AVK L  +T      +   EG+     +H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 430 LRAYYY-SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYL 486
           L      S    L+V  Y+  G L   +           N  ++ LI  G   A+G++YL
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKYL 148
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS---STPNRVAG-----YRAPE 538
            ++     H ++ + N +L + +  +V+DFGLA  +      S  N+        + A E
Sbjct: 149 ASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALE 206
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                K + K+DV+SFGVLL EL+T  AP +  +N   +                 V+ L
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------TVYLL 250
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           +  R    E     L ++ + C     + RPS SE++ RI  +
Sbjct: 251 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKDFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 122
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 123 -RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 182 STAVDIWSLGCIFAEMVTRRA 202

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFK-DKIEGVGAVNHENLVPLRAY 433
           E +G+G  GT Y A+ +  G  VA++++      ++E   ++I  +    + N+V     
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
           Y   DE  +V +YL  GSL+ ++        T ++    + +     + +E+LH+    V
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHSN--QV 138
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----STPNRVAGYRAPEVTDPCKVSQKA 549
            H NIKS NILL      +++DFG    + P     ST      + APEV        K 
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 198
Query: 550 DVYSFGVLLLELLTGKAP 567
           D++S G++ +E++ G+ P
Sbjct: 199 DIWSLGIMAIEMIEGEPP 216

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 118/283 (41%), Gaps = 41/283 (14%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV--GAVNHENLVP 429
           EV+G+G FG  Y   L          AVK L  +T      +   EG+     +H N++ 
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 430 LRAYYY-SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYL 486
           L      S    L+V  Y+  G L   +           N  ++ LI  G   A+G++YL
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKYL 167
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--------HLVGPSSTPNRVAGYRAPE 538
            ++     H ++ + N +L + +  +V+DFGLA        + V   +       + A E
Sbjct: 168 ASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 225
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                K + K+DV+SFGVLL EL+T  AP +  +N   +                 V+ L
Sbjct: 226 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------TVYLL 269
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           +  R    E     L ++ + C     + RPS SE++ RI  +
Sbjct: 270 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 122/292 (41%), Gaps = 42/292 (14%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV--GAVNHENLVP 429
           EV+G+G FG  Y   L          AVK L  +T      +   EG+     +H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 430 LRAYYY-SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYL 486
           L      S    L+V  Y+  G L   +           N  ++ LI  G   A+G++YL
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKYL 147
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--------HLVGPSSTPNRVAGYRAPE 538
            ++     H ++ + N +L + +  +V+DFGLA        + V   +       + A E
Sbjct: 148 ASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 205
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                K + K+DV+SFGVLL EL+T  AP +  +N   +                 V+ L
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------TVYLL 249
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHH 650
           +  R    E     L ++ + C     + RPS SE++ RI  +  S+  G H
Sbjct: 250 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF-STFIGEH 300

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 131/285 (45%), Gaps = 27/285 (9%)
Query: 373 ASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDK-IEGVGAVNHENLVPLR 431
            + +V+G G+FG  ++A L     VA+K++    + ++ FK++ ++ +  V H N+V L+
Sbjct: 43  TNCKVIGNGSFGVVFQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLK 98
Query: 432 AYYYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           A++YS  +K       LV +Y+      A  H  K     P+   +  L      R + Y
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPM--LLIKLYMYQLLRSLAY 156
Query: 486 LHAQGPNVSHGNIKSSNILL-TKSYEARVSDFGLAHLV---GPSSTPNRVAGYRAPE-VT 540
           +H+ G  + H +IK  N+LL   S   ++ DFG A ++    P+ +      YRAPE + 
Sbjct: 157 IHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIF 214
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL 600
                +   D++S G ++ EL+ G+        E G+D    +  I+K   T     ++ 
Sbjct: 215 GATNYTTNIDIWSTGCVMAELMQGQP---LFPGESGID---QLVEIIKVLGTPSREQIKT 268
Query: 601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
           +    +E +  Q+         + P   P   ++I R+ E  PS+
Sbjct: 269 MNPNYMEHKFPQIRPHPFSKVFR-PRTPPDAIDLISRLLEYTPSA 312

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV--GAVNHENLVP 429
           EV+G+G FG  Y   L          AVK L  +T      +   EG+     +H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 430 LRAYYY-SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYL 486
           L      S    L+V  Y+  G L   +           N  ++ LI  G   A+G++YL
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKYL 149
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--------HLVGPSSTPNRVAGYRAPE 538
            ++     H ++ + N +L + +  +V+DFGLA        + V   +       + A E
Sbjct: 150 ASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                K + K+DV+SFGVLL EL+T  AP +  +N   +                 V+ L
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------TVYLL 251
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHH 650
           +  R    E     L ++ + C     + RPS SE++ RI  +  +    H+
Sbjct: 252 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 303

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 118/283 (41%), Gaps = 41/283 (14%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV--GAVNHENLVP 429
           EV+G+G FG  Y   L          AVK L  +T      +   EG+     +H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 430 LRAYYY-SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYL 486
           L      S    L+V  Y+  G L   +           N  ++ LI  G   A+G++YL
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKYL 149
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--------HLVGPSSTPNRVAGYRAPE 538
            ++     H ++ + N +L + +  +V+DFGLA        + V   +       + A E
Sbjct: 150 ASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                K + K+DV+SFGVLL EL+T  AP +  +N   +                 V+ L
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------TVYLL 251
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           +  R    E     L ++ + C     + RPS SE++ RI  +
Sbjct: 252 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 42/221 (19%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDV----TISEREFKDKIEGVGAVNHENLVPLRA 432
           LGKG +G  +K++    G +VAVK++ D     T ++R F++ +       HEN+V L  
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 433 YYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
              + +++   LV+DY+    L A++  N       L    +  +     + I+YLH+ G
Sbjct: 77  VLRADNDRDVYLVFDYMET-DLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAH-LVGPSSTPNRVA----------------- 532
             + H ++K SNILL      +V+DFGL+   V      N +                  
Sbjct: 130 --LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 533 -------GYRAPEV-TDPCKVSQKADVYSFGVLLLELLTGK 565
                   YRAPE+     K ++  D++S G +L E+L GK
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV--GAVNHENLVP 429
           EV+G+G FG  Y   L          AVK L  +T      +   EG+     +H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 430 LRAYYY-SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYL 486
           L      S    L+V  Y+  G L   +           N  ++ LI  G   A+G++YL
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKYL 144
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--------HLVGPSSTPNRVAGYRAPE 538
            ++     H ++ + N +L + +  +V+DFGLA        + V   +       + A E
Sbjct: 145 ASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                K + K+DV+SFGVLL EL+T  AP +  +N   +                 V+ L
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------TVYLL 246
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHH 650
           +  R    E     L ++ + C     + RPS SE++ RI  +  +    H+
Sbjct: 247 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 298

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 118/283 (41%), Gaps = 41/283 (14%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV--GAVNHENLVP 429
           EV+G+G FG  Y   L          AVK L  +T      +   EG+     +H N++ 
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 430 LRAYYY-SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYL 486
           L      S    L+V  Y+  G L   +           N  ++ LI  G   A+G++YL
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKYL 168
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--------HLVGPSSTPNRVAGYRAPE 538
            ++     H ++ + N +L + +  +V+DFGLA        + V   +       + A E
Sbjct: 169 ASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 226
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                K + K+DV+SFGVLL EL+T  AP +  +N   +                 V+ L
Sbjct: 227 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------TVYLL 270
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           +  R    E     L ++ + C     + RPS SE++ RI  +
Sbjct: 271 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 34/211 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVK--RLKDVTISEREFKDKIEGVGAVNHENLVPL--- 430
           EV  +G FG  +KA L +   VAVK   ++D    + E++  +  +  + HEN++     
Sbjct: 30  EVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYE--VYSLPGMKHENILQFIGA 86
Query: 431 RAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH-- 487
                S+D  L L+  +   GSLS  L  N       ++W     IA   ARG+ YLH  
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHED 140
Query: 488 ------AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------YR 535
                    P +SH +IKS N+LL  +  A ++DFGLA       +     G      Y 
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200
Query: 536 APEVTDPCKVSQ-----KADVYSFGVLLLEL 561
           APEV +     Q     + D+Y+ G++L EL
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 118/283 (41%), Gaps = 41/283 (14%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV--GAVNHENLVP 429
           EV+G+G FG  Y   L          AVK L  +T      +   EG+     +H N++ 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 430 LRAYYY-SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYL 486
           L      S    L+V  Y+  G L   +           N  ++ LI  G   A+G++YL
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKYL 141
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--------HLVGPSSTPNRVAGYRAPE 538
            ++     H ++ + N +L + +  +V+DFGLA        + V   +       + A E
Sbjct: 142 ASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 199
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                K + K+DV+SFGVLL EL+T  AP +  +N   +                 V+ L
Sbjct: 200 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------TVYLL 243
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           +  R    E     L ++ + C     + RPS SE++ RI  +
Sbjct: 244 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 118/283 (41%), Gaps = 41/283 (14%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV--GAVNHENLVP 429
           EV+G+G FG  Y   L          AVK L  +T      +   EG+     +H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 430 LRAYYY-SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYL 486
           L      S    L+V  Y+  G L   +           N  ++ LI  G   A+G++YL
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKYL 146
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--------HLVGPSSTPNRVAGYRAPE 538
            ++     H ++ + N +L + +  +V+DFGLA        + V   +       + A E
Sbjct: 147 ASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 204
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                K + K+DV+SFGVLL EL+T  AP +  +N   +                 V+ L
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------TVYLL 248
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           +  R    E     L ++ + C     + RPS SE++ RI  +
Sbjct: 249 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV++++    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 67  LDVIHTENKLYLVFEHVHQ-DLKTFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 121
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 122 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 181 STAVDIWSLGCIFAEMVTRRA 201

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 134/301 (44%), Gaps = 55/301 (18%)
Query: 376 EVLGKGTFGTAYKAVL-----EMG-TIVAVKRLKD-VTISE-REFKDKIEGVGAVNHENL 427
           + LG+G FG   KA         G T VAVK LK+  + SE R+   +   +  VNH ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPL------------NWEMRSL- 474
           + L          LL+ +Y   GSL   L  ++  G   L            + + R+L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 475 ------IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP 528
                  A   ++G++YL     ++ H ++ + NIL+ +  + ++SDFGL+  V    + 
Sbjct: 149 MGDLISFAWQISQGMQYLAEM--SLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 529 NRVAGYRAP-------EVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLP 580
            + +  R P        + D    +Q +DV+SFGVLL E++T G  P   +  E   +L 
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL 265
Query: 581 RWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE 640
           +          T    +    R  N  EEM +L+   + C  Q PD RP  +++ K +E+
Sbjct: 266 K----------TGHRME----RPDNCSEEMYRLM---LQCWKQEPDKRPVFADISKDLEK 308
Query: 641 L 641
           +
Sbjct: 309 M 309

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 133/301 (44%), Gaps = 55/301 (18%)
Query: 376 EVLGKGTFGTAYKAVL-----EMG-TIVAVKRLKD-VTISE-REFKDKIEGVGAVNHENL 427
           + LG+G FG   KA         G T VAVK LK+  + SE R+   +   +  VNH ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPL------------NWEMRSL- 474
           + L          LL+ +Y   GSL   L  ++  G   L            + + R+L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 475 ------IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP 528
                  A   ++G++YL      + H ++ + NIL+ +  + ++SDFGL+  V    + 
Sbjct: 149 MGDLISFAWQISQGMQYLAEM--KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 529 NRVAGYRAP-------EVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLP 580
            + +  R P        + D    +Q +DV+SFGVLL E++T G  P   +  E   +L 
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL 265
Query: 581 RWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE 640
           +          T    +    R  N  EEM +L+   + C  Q PD RP  +++ K +E+
Sbjct: 266 K----------TGHRME----RPDNCSEEMYRLM---LQCWKQEPDKRPVFADISKDLEK 308
Query: 641 L 641
           +
Sbjct: 309 M 309

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 41/292 (14%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV--GAVNHENLVP 429
           EV+G+G FG  Y   L          AVK L  +T      +   EG+     +H N++ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 430 LRAYYY-SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYL 486
           L      S    L+V  Y+  G L   +           N  ++ LI  G   A+G+++L
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKFL 150
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS---STPNRVAG-----YRAPE 538
            ++     H ++ + N +L + +  +V+DFGLA  +      S  N+        + A E
Sbjct: 151 ASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 208
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                K + K+DV+SFGVLL EL+T  AP +  +N   +                 V+ L
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------TVYLL 252
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHH 650
           +  R    E     L ++ + C     + RPS SE++ RI  +  +    H+
Sbjct: 253 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 304

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 112/242 (46%), Gaps = 28/242 (11%)
Query: 345 NSNVNGATKKLVF---------FGNAAR-VFDLED--LLRASAEVLGKGTFGTAYKAVLE 392
           +S V+  T+ L F         F  A R V D  D  LL  S   +G+G+ G    A  +
Sbjct: 8   SSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK 67
Query: 393 M-GTIVAVKRLKDVTISEREFK-DKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG 450
             G  VAVK +       RE   +++  +    H N+V +   Y   +E  ++ ++L  G
Sbjct: 68  HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGG 127
Query: 451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE 510
           +L+ ++       +  LN E  + +     + + YLHAQG  V H +IKS +ILLT    
Sbjct: 128 ALTDIV------SQVRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGR 179
Query: 511 ARVSDFGLAHLVGPSSTPNR-----VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGK 565
            ++SDFG    +     P R        + APEV      + + D++S G++++E++ G+
Sbjct: 180 VKLSDFGFCAQIS-KDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
Query: 566 AP 567
            P
Sbjct: 239 PP 240

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 41/292 (14%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV--GAVNHENLVP 429
           EV+G+G FG  Y   L          AVK L  +T      +   EG+     +H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 430 LRAYYY-SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYL 486
           L      S    L+V  Y+  G L   +           N  ++ LI  G   A+G+++L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKFL 208
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS---STPNRVAG-----YRAPE 538
            ++     H ++ + N +L + +  +V+DFGLA  +      S  N+        + A E
Sbjct: 209 ASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                K + K+DV+SFGVLL EL+T  AP +  +N   +                 V+ L
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------TVYLL 310
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHH 650
           +  R    E     L ++ + C     + RPS SE++ RI  +  +    H+
Sbjct: 311 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 362

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 41/292 (14%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV--GAVNHENLVP 429
           EV+G+G FG  Y   L          AVK L  +T      +   EG+     +H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 430 LRAYYY-SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYL 486
           L      S    L+V  Y+  G L   +           N  ++ LI  G   A+G+++L
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKFL 149
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS---STPNRVAG-----YRAPE 538
            ++     H ++ + N +L + +  +V+DFGLA  +      S  N+        + A E
Sbjct: 150 ASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                K + K+DV+SFGVLL EL+T  AP +  +N   +                 V+ L
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------TVYLL 251
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHH 650
           +  R    E     L ++ + C     + RPS SE++ RI  +  +    H+
Sbjct: 252 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 303

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 41/292 (14%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV--GAVNHENLVP 429
           EV+G+G FG  Y   L          AVK L  +T      +   EG+     +H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 430 LRAYYY-SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYL 486
           L      S    L+V  Y+  G L   +           N  ++ LI  G   A+G+++L
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKFL 149
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS---STPNRVAG-----YRAPE 538
            ++     H ++ + N +L + +  +V+DFGLA  +      S  N+        + A E
Sbjct: 150 ASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                K + K+DV+SFGVLL EL+T  AP +  +N   +                 V+ L
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------TVYLL 251
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHH 650
           +  R    E     L ++ + C     + RPS SE++ RI  +  +    H+
Sbjct: 252 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 303

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/275 (22%), Positives = 125/275 (45%), Gaps = 28/275 (10%)
Query: 378 LGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFK----DKIEGVGAVNHENLVPLRA 432
           +G+G F   Y+A   + G  VA+K+++   + + + +     +I+ +  +NH N++   A
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 433 YYYSMDEKLLVYDYLTMGSLSALL-HGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +   +E  +V +    G LS ++ H  K     P     +  + L +A  +E++H++  
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA--LEHMHSR-- 155
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR----VAGYRAPEVTDPCKVSQ 547
            V H +IK +N+ +T +   ++ D GL       +T          Y +PE       + 
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 215
Query: 548 KADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE 607
           K+D++S G LL E+   ++P +     + ++L    + I       E  D   L   +  
Sbjct: 216 KSDIWSLGCLLYEMAALQSPFYG----DKMNLYSLCKKI-------EQCDYPPLPSDHYS 264
Query: 608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH 642
           EE+ QL+ + I+     P+ RP ++ V    + +H
Sbjct: 265 EELRQLVNMCINPD---PEKRPDVTYVYDVAKRMH 296

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 129/280 (46%), Gaps = 52/280 (18%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKD---KIEGVGAVNHENLVPLRAY 433
           LG G FG  YKA   E G + A K ++  T SE E +D   +IE +   +H  +V L   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 434 YYSMDEKLLVYDYLTMGSLSA-LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
           YY   +  ++ ++   G++ A +L  ++G     +    R ++       + +LH++   
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML-----EALNFLHSK--R 137
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGL-AHLVGPSSTPNRVAG---YRAPEVTDPCKVSQ- 547
           + H ++K+ N+L+T   + R++DFG+ A  +      +   G   + APEV   C+  + 
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV-MCETMKD 196
Query: 548 -----KADVYSFGVLLLELLTGKAPTH------ALLNEEGVDLPRWVQSIVKDEWTSEVF 596
                KAD++S G+ L+E+   + P H       LL     D P     +   +W+ E  
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP---TLLTPSKWSVEFR 253
Query: 597 DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK 636
           D                L++A+D   + P+ RPS +++++
Sbjct: 254 D---------------FLKIALD---KNPETRPSAAQLLE 275

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 130/274 (47%), Gaps = 40/274 (14%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKD---KIEGVGAVNHENLVPLRAY 433
           LG G FG  YKA   E G + A K ++  T SE E +D   +IE +   +H  +V L   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDHPYIVKLLGA 76
Query: 434 YYSMDEKLLVYDYLTMGSLSA-LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
           YY   +  ++ ++   G++ A +L  ++G     +    R ++       + +LH++   
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML-----EALNFLHSK--R 129
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGL-AHLVGPSSTPNRVAG---YRAPEVTDPCKVSQ- 547
           + H ++K+ N+L+T   + R++DFG+ A  +      +   G   + APEV   C+  + 
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV-MCETMKD 188
Query: 548 -----KADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR 602
                KAD++S G+ L+E+   + P H L      +  R +  I K +  +      LL 
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPPHHEL------NPMRVLLKIAKSDPPT------LLT 236
Query: 603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK 636
                 E    L++A+D   + P+ RPS +++++
Sbjct: 237 PSKWSVEFRDFLKIALD---KNPETRPSAAQLLE 267

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 41/292 (14%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV--GAVNHENLVP 429
           EV+G+G FG  Y   L          AVK L  +T      +   EG+     +H N++ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 430 LRAYYY-SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYL 486
           L      S    L+V  Y+  G L   +           N  ++ LI  G   A+G+++L
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKFL 150
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH--LVGPSSTPNRVAGYRAP------E 538
            ++     H ++ + N +L + +  +V+DFGLA   L     + +   G + P      E
Sbjct: 151 ASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALE 208
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                K + K+DV+SFGVLL EL+T  AP +  +N   +                 V+ L
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------TVYLL 252
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHH 650
           +  R    E     L ++ + C     + RPS SE++ RI  +  +    H+
Sbjct: 253 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 304

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 41/292 (14%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV--GAVNHENLVP 429
           EV+G+G FG  Y   L          AVK L  +T      +   EG+     +H N++ 
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 430 LRAYYY-SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYL 486
           L      S    L+V  Y+  G L   +           N  ++ LI  G   A+G+++L
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKFL 154
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS---STPNRVAG-----YRAPE 538
            ++     H ++ + N +L + +  +V+DFGLA  +      S  N+        + A E
Sbjct: 155 ASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 212
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                K + K+DV+SFGVLL EL+T  AP +  +N   +                 V+ L
Sbjct: 213 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------TVYLL 256
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHH 650
           +  R    E     L ++ + C     + RPS SE++ RI  +  +    H+
Sbjct: 257 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 308

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV++++    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 71  LDVIHTENKLYLVFEHVDQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 125
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 126 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 185 STAVDIWSLGCIFAEMVTRRA 205

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+ +++  T +E      I  +     +NH N+V L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 122
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 123 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 182 STAVDIWSLGCIFAEMVTRRA 202

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+ +++  T +E      I  +     +NH N+V L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 67  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 121
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+   CK  
Sbjct: 122 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 181 STAVDIWSLGCIFAEMVTRRA 201

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 41/292 (14%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV--GAVNHENLVP 429
           EV+G+G FG  Y   L          AVK L  +T      +   EG+     +H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 430 LRAYYY-SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG--AARGIEYL 486
           L      S    L+V  Y+  G L   +           N  ++ LI  G   A+G+++L
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKFL 147
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS---STPNRVAG-----YRAPE 538
            ++     H ++ + N +L + +  +V+DFGLA  +      S  N+        + A E
Sbjct: 148 ASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 205
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                K + K+DV+SFGVLL EL+T  AP +  +N   +                 V+ L
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------TVYLL 249
Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHH 650
           +  R    E     L ++ + C     + RPS SE++ RI  +  +    H+
Sbjct: 250 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 301

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 133/301 (44%), Gaps = 55/301 (18%)
Query: 376 EVLGKGTFGTAYKAVL-----EMG-TIVAVKRLKD-VTISE-REFKDKIEGVGAVNHENL 427
           + LG+G FG   KA         G T VAVK LK+  + SE R+   +   +  VNH ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPL------------NWEMRSL- 474
           + L          LL+ +Y   GSL   L  ++  G   L            + + R+L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 475 ------IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP 528
                  A   ++G++YL      + H ++ + NIL+ +  + ++SDFGL+  V    + 
Sbjct: 149 MGDLISFAWQISQGMQYLAEM--KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 529 NRVAGYRAP-------EVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLP 580
            + +  R P        + D    +Q +DV+SFGVLL E++T G  P   +  E   +L 
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL 265
Query: 581 RWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE 640
           +          T    +    R  N  EEM +L+   + C  Q PD RP  +++ K +E+
Sbjct: 266 K----------TGHRME----RPDNCSEEMYRLM---LQCWKQEPDKRPVFADISKDLEK 308
Query: 641 L 641
           +
Sbjct: 309 M 309

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 14/198 (7%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFK-DKIEGVGAVNHENLVPLRAY 433
           E +G+G  GT Y A+ +  G  VA++++      ++E   ++I  +    + N+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
           Y   DE  +V +YL  GSL+ ++        T ++    + +     + +E+LH+    V
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHSN--QV 137
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGP-SSTPNRVAG---YRAPEVTDPCKVSQKA 549
            H +IKS NILL      +++DFG    + P  S  + + G   + APEV        K 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKV 197
Query: 550 DVYSFGVLLLELLTGKAP 567
           D++S G++ +E++ G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFK-DKIEGVGAVNHENLVPLRAY 433
           E +G+G  GT Y A+ +  G  VA++++      ++E   ++I  +    + N+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
           Y   DE  +V +YL  GSL+ ++        T ++    + +     + +E+LH+    V
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHSN--QV 137
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----STPNRVAGYRAPEVTDPCKVSQKA 549
            H +IKS NILL      +++DFG    + P     ST      + APEV        K 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 550 DVYSFGVLLLELLTGKAP 567
           D++S G++ +E++ G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 378 LGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKD---KIEGVGAVNHENLVPL 430
           +G+G+FG   KA+L    E G    +K +    +S +E ++   ++  +  + H N+V  
Sbjct: 32  IGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGA---GRTPLNWEMRSLIALGAARGIEYLH 487
           R  +       +V DY   G L   ++  KG        L+W ++  +AL         H
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK--------H 140
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA----GYRAPEVTDPC 543
                + H +IKS NI LTK    ++ DFG+A ++  +    R       Y +PE+ +  
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHA 570
             + K+D+++ G +L EL T K    A
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEA 227

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 107/231 (46%), Gaps = 31/231 (13%)
Query: 378 LGKGTFGTAYKA-VLEMGTIVAVKRLK-DVTISEREFK---DKIEGVGAVNHENLVPLRA 432
           LG G+FG  +       G   A+K LK ++ +  ++ +   D+   +  V H  ++ +  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
            +    +  ++ DY+  G L +LL   + + R P    +    A      +EYLH++  +
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLL---RKSQRFPN--PVAKFYAAEVCLALEYLHSK--D 126
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----TPNRVAGYRAPEVTDPCKVSQ 547
           + + ++K  NILL K+   +++DFG A  V   +     TP+    Y APEV      ++
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPD----YIAPEVVSTKPYNK 182
Query: 548 KADVYSFGVLLLELLTGKAPTH---------ALLNEEGVDLPRWVQSIVKD 589
             D +SFG+L+ E+L G  P +          +LN E +  P +    VKD
Sbjct: 183 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKD 232

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 16/221 (7%)
Query: 358 FGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIE 417
           F N     D E+L     + +GKG+FG  YK +      V   ++ D+  +E E +D  +
Sbjct: 8   FANQHSRVDPEELF-TKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQ 66
Query: 418 GVGAVNHENLVPLRAYY--YSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL 474
            +  ++  +   +  Y+  Y    KL ++ +YL  GS   LL         PL     + 
Sbjct: 67  EITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPG------PLEETYIAT 120
Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG 533
           I     +G++YLH++     H +IK++N+LL++  + +++DFG+A  L       N   G
Sbjct: 121 ILREILKGLDYLHSE--RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVG 178
Query: 534 ---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHAL 571
              + APEV        KAD++S G+  +EL  G+ P   L
Sbjct: 179 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 219

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 14/198 (7%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFK-DKIEGVGAVNHENLVPLRAY 433
           E +G+G  GT Y A+ +  G  VA++++      ++E   ++I  +    + N+V     
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
           Y   DE  +V +YL  GSL+ ++        T ++    + +     + +E+LH+    V
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHSN--QV 138
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGP-SSTPNRVAG---YRAPEVTDPCKVSQKA 549
            H +IKS NILL      +++DFG    + P  S  + + G   + APEV        K 
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKV 198
Query: 550 DVYSFGVLLLELLTGKAP 567
           D++S G++ +E++ G+ P
Sbjct: 199 DIWSLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 14/198 (7%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFK-DKIEGVGAVNHENLVPLRAY 433
           E +G+G  GT Y A+ +  G  VA++++      ++E   ++I  +    + N+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
           Y   DE  +V +YL  GSL+ ++        T ++    + +     + +E+LH+    V
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHSN--QV 137
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGP-SSTPNRVAG---YRAPEVTDPCKVSQKA 549
            H +IKS NILL      +++DFG    + P  S  + + G   + APEV        K 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKV 197
Query: 550 DVYSFGVLLLELLTGKAP 567
           D++S G++ +E++ G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/321 (23%), Positives = 129/321 (40%), Gaps = 42/321 (13%)
Query: 342 TQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEV---LGKGTFGTAYKAVLE------ 392
           T  N    G+     F G  + + DL+++ R +  +   LG G FG  Y+  +       
Sbjct: 14  TTENLYFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP 73
Query: 393 MGTIVAVKRLKDVTISEREFKDKIEG--VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG 450
               VAVK L +V   + E    +E   +  +NH+N+V           + ++ + +  G
Sbjct: 74  SPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGG 133
Query: 451 SLSALLHGNKGAGRTPLNWEMRSL--IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS 508
            L + L   +     P +  M  L  +A   A G +YL     +  H +I + N LLT  
Sbjct: 134 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCP 191
Query: 509 YEARVS---DFGLAHLVGPSSTPNR------VAGYRAPEVTDPCKVSQKADVYSFGVLLL 559
              RV+   DFG+A  +  +S   +         +  PE       + K D +SFGVLL 
Sbjct: 192 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW 251
Query: 560 ELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAI 618
           E+ + G  P  +  N+E ++                 F     R    +     + ++  
Sbjct: 252 EIFSLGYMPYPSKSNQEVLE-----------------FVTSGGRMDPPKNCPGPVYRIMT 294
Query: 619 DCSAQYPDNRPSMSEVIKRIE 639
            C    P++RP+ + +++RIE
Sbjct: 295 QCWQHQPEDRPNFAIILERIE 315

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 102/198 (51%), Gaps = 24/198 (12%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY A+LE    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV-LMKVVNHKNIIGLLNVF 92
Query: 435 Y---SMDEKLLVYDYLTM--GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
               S++E   VY  + +   +LS ++       +  L+ E  S +      GI++LH+ 
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVI-------QMELDHERMSYLLYQMLVGIKHLHSA 145
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVS 546
           G  + H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       
Sbjct: 146 G--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 547 QKADVYSFGVLLLELLTG 564
           +  D++S GV++ E++ G
Sbjct: 204 ENVDIWSVGVIMGEMIKG 221

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 377 VLGKGTFGTAYKAV-LEMGTIVAVKRL--KDVTISEREFKDKIEGVGAVNHENLVPLRAY 433
           VLGKGT+G  Y    L     +A+K +  +D   S+    ++I     + H+N+V    Y
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIV---QY 84
Query: 434 YYSMDEKLLVYDYLTM---GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
             S  E   +  ++     GSLSALL    G  +   N +           G++YLH   
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKD--NEQTIGFYTKQILEGLKYLHDN- 141
Query: 491 PNVSHGNIKSSNILL-TKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTD--PC 543
             + H +IK  N+L+ T S   ++SDFG +  L G +       G   Y APE+ D  P 
Sbjct: 142 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHAL 571
              + AD++S G  ++E+ TGK P + L
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYEL 228

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 127/293 (43%), Gaps = 46/293 (15%)
Query: 368 EDLLRASAEVLGKGTFGTAYKAVL-EMG-------TIVAVKRLKDVTISERE-FKDKIEG 418
           EDL+    E LG+GTF   +K V  E+G       T V +K L     +  E F +    
Sbjct: 8   EDLI--FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASM 65
Query: 419 VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG 478
           +  ++H++LV      +  DE +LV +++  GSL   L  NK      + W++   +A  
Sbjct: 66  MSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNC--INILWKLE--VAKQ 121
Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYE--------ARVSDFGLAHLVGPSSTPNR 530
            A  + +L      + HGN+ + NILL +  +         ++SD G++  V P      
Sbjct: 122 LAWAMHFLEEN--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE 179
Query: 531 VAGYRAPE-VTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVK 588
              +  PE + +P  ++   D +SFG  L E+ + G  P  AL      D  R +Q   +
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL------DSQRKLQ-FYE 232
Query: 589 DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           D            R+Q    +  +L  L  +C    PD+RPS   +I+ +  L
Sbjct: 233 D------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 16/216 (7%)
Query: 359 GNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEG 418
           G    + D E+L     E +GKG+FG  +K +      V   ++ D+  +E E +D  + 
Sbjct: 13  GMQNNIADPEELF-TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQE 71
Query: 419 VGAVNHENLVPLRAYY--YSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI 475
           +  ++  +   +  YY  Y    KL ++ +YL  GS   LL         P +    + +
Sbjct: 72  ITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAG------PFDEFQIATM 125
Query: 476 ALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG- 533
                +G++YLH++     H +IK++N+LL++  + +++DFG+A  L       N   G 
Sbjct: 126 LKEILKGLDYLHSE--KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGT 183
Query: 534 --YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
             + APEV        KAD++S G+  +EL  G+ P
Sbjct: 184 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 377 VLGKGTFGTAYKAV-LEMGTIVAVKRL--KDVTISEREFKDKIEGVGAVNHENLVPLRAY 433
           VLGKGT+G  Y    L     +A+K +  +D   S+    ++I     + H+N+V    Y
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIV---QY 70
Query: 434 YYSMDEKLLVYDYLTM---GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
             S  E   +  ++     GSLSALL    G  +   N +           G++YLH   
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKD--NEQTIGFYTKQILEGLKYLHDN- 127
Query: 491 PNVSHGNIKSSNILL-TKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTD--PC 543
             + H +IK  N+L+ T S   ++SDFG +  L G +       G   Y APE+ D  P 
Sbjct: 128 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 186
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHAL 571
              + AD++S G  ++E+ TGK P + L
Sbjct: 187 GYGKAADIWSLGCTIIEMATGKPPFYEL 214

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 74/321 (23%), Positives = 128/321 (39%), Gaps = 42/321 (13%)
Query: 342 TQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEV---LGKGTFGTAYKAVLE------ 392
           T  N    G+     F G  + + DL+++ R +  +   LG G FG  Y+  +       
Sbjct: 14  TTENLYFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP 73
Query: 393 MGTIVAVKRLKDVTISEREFKDKIEG--VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG 450
               VAVK L +V   + E    +E   +   NH+N+V           + ++ + +  G
Sbjct: 74  SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGG 133
Query: 451 SLSALLHGNKGAGRTPLNWEMRSL--IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS 508
            L + L   +     P +  M  L  +A   A G +YL     +  H +I + N LLT  
Sbjct: 134 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCP 191
Query: 509 YEARVS---DFGLAHLVGPSSTPNR------VAGYRAPEVTDPCKVSQKADVYSFGVLLL 559
              RV+   DFG+A  +  +S   +         +  PE       + K D +SFGVLL 
Sbjct: 192 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW 251
Query: 560 ELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAI 618
           E+ + G  P  +  N+E ++                 F     R    +     + ++  
Sbjct: 252 EIFSLGYMPYPSKSNQEVLE-----------------FVTSGGRMDPPKNCPGPVYRIMT 294
Query: 619 DCSAQYPDNRPSMSEVIKRIE 639
            C    P++RP+ + +++RIE
Sbjct: 295 QCWQHQPEDRPNFAIILERIE 315

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 102/198 (51%), Gaps = 24/198 (12%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY A+LE    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 36  AQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV-LMKVVNHKNIIGLLNVF 92
Query: 435 Y---SMDEKLLVYDYLTM--GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
               S++E   VY  + +   +LS ++       +  L+ E  S +      GI++LH+ 
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVI-------QMELDHERMSYLLYQMLVGIKHLHSA 145
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVS 546
           G  + H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       
Sbjct: 146 G--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 547 QKADVYSFGVLLLELLTG 564
           +  D++S GV++ E++ G
Sbjct: 204 ENVDIWSVGVIMGEMIKG 221

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 127/294 (43%), Gaps = 55/294 (18%)
Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTIS--EREFKDKIEGVGAVNHENL 427
           E LG+  FG  YK  L      E    VA+K LKD        EF+ +      + H N+
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 428 VPLRAYYYSMDEKL-LVYDYLTMGSLSALL-----HGNKGA---GRTPLN-WEMRSLIAL 477
           V L     + D+ L +++ Y + G L   L     H + G+    RT  +  E    + L
Sbjct: 92  VCLLGVV-TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 150
Query: 478 GA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH---------LVGPSS 526
            A  A G+EYL +   +V H ++ + N+L+      ++SD GL           L+G S 
Sbjct: 151 VAQIAAGMEYLSSH--HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 208
Query: 527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQS 585
            P R   + APE     K S  +D++S+GV+L E+ + G  P     N++ V++ R  Q 
Sbjct: 209 LPIR---WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV 265
Query: 586 I-VKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
           +   D+  + V+                   L I+C  ++P  RP   ++  R+
Sbjct: 266 LPCPDDCPAWVY------------------ALMIECWNEFPSRRPRFKDIHSRL 301

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 362 ARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKI 416
            R F ++D        LGKG FG  Y A  +    IVA+K L    I     E + + +I
Sbjct: 17  TRHFTIDDF--EIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREI 74
Query: 417 EGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIA 476
           E    ++H N++ L  Y+Y      L+ +Y   G L   L  +        + +  + I 
Sbjct: 75  EIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKS-----CTFDEQRTATIM 129
Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--- 533
              A  + Y H  G  V H +IK  N+LL    E +++DFG + +  PS     + G   
Sbjct: 130 EELADALMYCH--GKKVIHRDIKPENLLLGLKGELKIADFGWS-VHAPSLRRKTMCGTLD 186
Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           Y  PE+ +    ++K D++  GVL  ELL G  P
Sbjct: 187 YLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 127/294 (43%), Gaps = 55/294 (18%)
Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTIS--EREFKDKIEGVGAVNHENL 427
           E LG+  FG  YK  L      E    VA+K LKD        EF+ +      + H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 428 VPLRAYYYSMDEKL-LVYDYLTMGSLSALL-----HGNKGA---GRTPLN-WEMRSLIAL 477
           V L     + D+ L +++ Y + G L   L     H + G+    RT  +  E    + L
Sbjct: 75  VCLLGVV-TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 478 GA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH---------LVGPSS 526
            A  A G+EYL +   +V H ++ + N+L+      ++SD GL           L+G S 
Sbjct: 134 VAQIAAGMEYLSSH--HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQS 585
            P R   + APE     K S  +D++S+GV+L E+ + G  P     N++ V++ R  Q 
Sbjct: 192 LPIR---WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV 248
Query: 586 I-VKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
           +   D+  + V+                   L I+C  ++P  RP   ++  R+
Sbjct: 249 LPCPDDCPAWVY------------------ALMIECWNEFPSRRPRFKDIHSRL 284

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 76/322 (23%), Positives = 129/322 (40%), Gaps = 44/322 (13%)
Query: 342 TQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEV---LGKGTFGTAYKAVLE------ 392
           T  N    G+     F G  + + DL+++ R +  +   LG G FG  Y+  +       
Sbjct: 14  TTENLYFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDP 73
Query: 393 MGTIVAVKRLKDVTISEREFKDKIEG--VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG 450
               VAVK L +V   + E    +E   +   NH+N+V           + ++ + +  G
Sbjct: 74  SPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 133
Query: 451 SLSALLHGNKGAGRTPLNWEMRSL--IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS 508
            L + L   +     P +  M  L  +A   A G +YL     +  H +I + N LLT  
Sbjct: 134 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCP 191
Query: 509 YEARVS---DFGLAHLVGPSSTPNRVAG-------YRAPEVTDPCKVSQKADVYSFGVLL 558
              RV+   DFG+A  +  +S   R  G       +  PE       + K D +SFGVLL
Sbjct: 192 GPGRVAKIGDFGMARDIYRASY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 250
Query: 559 LELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLA 617
            E+ + G  P  +  N+E ++                 F     R    +     + ++ 
Sbjct: 251 WEIFSLGYMPYPSKSNQEVLE-----------------FVTSGGRMDPPKNCPGPVYRIM 293
Query: 618 IDCSAQYPDNRPSMSEVIKRIE 639
             C    P++RP+ + +++RIE
Sbjct: 294 TQCWQHQPEDRPNFAIILERIE 315

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 88/202 (43%), Gaps = 24/202 (11%)
Query: 378 LGKGTFGTAYKAVLE-----MGTIVAVKRLK-DVTISERE-FKDKIEGVGAVNHENLVPL 430
           LG+G FG       +      G +VAVK LK D     R  +K +I+ +  + HE+++  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 431 RAYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
           +            LV +Y+ +GSL   L       R  +      L A     G+ YLHA
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL------PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-------AGYRAPEVTD 541
           Q  +  H ++ + N+LL      ++ DFGLA  V       RV         + APE   
Sbjct: 153 Q--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLK 210
Query: 542 PCKVSQKADVYSFGVLLLELLT 563
             K    +DV+SFGV L ELLT
Sbjct: 211 EYKFYYASDVWSFGVTLYELLT 232

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 33/223 (14%)
Query: 368 EDLLRASAEVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV--GA 421
           E ++  S  V+GKG FG  Y        +     A+K L  +T  ++      EG+    
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 422 VNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGN-----KGAGRTPLNWEMRSLIA 476
           +NH N++ L          +L  + L    L  + HG+     +   R P    ++ LI+
Sbjct: 79  LNHPNVLALIGI-------MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP---TVKDLIS 128
Query: 477 LG--AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA--------HLVGPSS 526
            G   ARG+EYL  Q     H ++ + N +L +S+  +V+DFGLA        + V    
Sbjct: 129 FGLQVARGMEYLAEQ--KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186
Query: 527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTH 569
                  + A E     + + K+DV+SFGVLL ELLT  AP +
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 15/218 (6%)
Query: 357 FFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFK 413
           F     +V +L+D        LG G  G  +K   +   +V  ++L  + I      +  
Sbjct: 20  FLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII 79
Query: 414 DKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRS 473
            +++ +   N   +V     +YS  E  +  +++  GSL  +L   K AGR P   ++  
Sbjct: 80  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIP--EQILG 134
Query: 474 LIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVA 532
            +++   +G+ YL  +   + H ++K SNIL+    E ++ DFG++  L+   S  N   
Sbjct: 135 KVSIAVIKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV 191
Query: 533 G---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           G   Y +PE       S ++D++S G+ L+E+  G+ P
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 75  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 129
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+    K  
Sbjct: 130 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 188
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 189 STAVDIWSLGCIFAEMVTRRA 209

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 20/196 (10%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY A+LE    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVF 92
Query: 435 Y---SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
               S++E   VY  + M  + A L       +  L+ E  S +      GI++LH+ G 
Sbjct: 93  TPQKSLEEFQDVY--IVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG- 146
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQK 548
            + H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       + 
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGYKEN 205
Query: 549 ADVYSFGVLLLELLTG 564
            D++S G ++ E++ G
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPL 430
            E +G+GT+G  YKA  ++ G +VA+K+++  T +E      I  +     +NH N+V L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++ ++  LV+++L    L   +  +   G  PL      L  L   +G+ + H+  
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCHSH- 122
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDPCK-V 545
             V H ++K  N+L+      +++DFGLA   G P  T         YRAPE+    K  
Sbjct: 123 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 181
Query: 546 SQKADVYSFGVLLLELLTGKA 566
           S   D++S G +  E++T +A
Sbjct: 182 STAVDIWSLGCIFAEMVTRRA 202

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 126/281 (44%), Gaps = 29/281 (10%)
Query: 377 VLGKGTFGTAYKAV-LEMGTIVAVKRL---KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           ++G+G++G   K    + G IVA+K+     D  + ++    +I+ +  + HENLV L  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
                    LV++++    L  L     G     L++++          GI + H+   N
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPNG-----LDYQVVQKYLFQIINGIGFCHSH--N 144
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAH-LVGPSST-PNRVAG--YRAPE-VTDPCKVSQ 547
           + H +IK  NIL+++S   ++ DFG A  L  P     + VA   YRAPE +    K  +
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGK 204
Query: 548 KADVYSFGVLLLELLTGKA---------PTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
             DV++ G L+ E+  G+            + ++   G  +PR  +   K+   + V   
Sbjct: 205 AVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLP 264
Query: 599 ELLRYQNVEEEMVQLLQLAID----CSAQYPDNRPSMSEVI 635
           E+   + +E    +L ++ ID    C    PD RP  +E++
Sbjct: 265 EIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 126/293 (43%), Gaps = 46/293 (15%)
Query: 368 EDLLRASAEVLGKGTFGTAYKAVL-EMG-------TIVAVKRLKDVTISERE-FKDKIEG 418
           EDL+    E LG+GTF   +K V  E+G       T V +K L     +  E F +    
Sbjct: 8   EDLI--FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASM 65
Query: 419 VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG 478
           +  ++H++LV         DE +LV +++  GSL   L  NK      + W++     L 
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC--INILWKLEVAKQLA 123
Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYE--------ARVSDFGLAHLVGPSSTPNR 530
           AA  + +L      + HGN+ + NILL +  +         ++SD G++  V P      
Sbjct: 124 AA--MHFLEEN--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE 179
Query: 531 VAGYRAPE-VTDPCKVSQKADVYSFGVLLLELLTG-KAPTHALLNEEGVDLPRWVQSIVK 588
              +  PE + +P  ++   D +SFG  L E+ +G   P  AL      D  R +Q   +
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL------DSQRKLQ-FYE 232
Query: 589 DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           D            R+Q    +  +L  L  +C    PD+RPS   +I+ +  L
Sbjct: 233 D------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 35/232 (15%)
Query: 377 VLGKGTFGTAYKA-VLEMGTIVAVKRLK-DVTISEREFKDKIEGVG--------AVNHEN 426
           VLGKG+FG    A V E G + AVK LK DV + +    D +E           A NH  
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD----DDVECTMTEKRILSLARNHPF 85
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           L  L   + + D    V +++  G L   +  ++        +    +I+      + +L
Sbjct: 86  LTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS-----ALMFL 140
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTDP 542
           H +G  + + ++K  N+LL      +++DFG+    +    T     G   Y APE+   
Sbjct: 141 HDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE 198
Query: 543 CKVSQKADVYSFGVLLLELLTGKAP---------THALLNEEGVDLPRWVQS 585
                  D ++ GVLL E+L G AP           A+LN+E V  P W+  
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV-YPTWLHE 249

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 24/198 (12%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY A+LE    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVF 92
Query: 435 Y---SMDEKLLVYDYLTM--GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
               S++E   VY  + +   +LS ++       +  L+ E  S +      GI++LH+ 
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVI-------QMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVS 546
           G  + H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       
Sbjct: 146 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 547 QKADVYSFGVLLLELLTG 564
           +  D++S G ++ E++ G
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 15/218 (6%)
Query: 357 FFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFK 413
           F    A+V +L+D        LG G  G   K       ++  ++L  + I      +  
Sbjct: 3   FLTQKAKVGELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQII 62
Query: 414 DKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRS 473
            +++ +   N   +V     +YS  E  +  +++  GSL  +L   K A R P   E+  
Sbjct: 63  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIP--EEILG 117
Query: 474 LIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVA 532
            +++   RG+ YL  +   + H ++K SNIL+    E ++ DFG++  L+   S  N   
Sbjct: 118 KVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV 174
Query: 533 G---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           G   Y APE       S ++D++S G+ L+EL  G+ P
Sbjct: 175 GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLK------DVTISEREFKDKIEGVGAVNHENLV 428
           E LG GT+ T YK + +  G  VA+K +K        + + RE    I  +  + HEN+V
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKHENIV 66
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMR--SLIALGAARGIEYL 486
            L    ++ ++  LV++++    L   +  ++  G TP   E+           +G+ + 
Sbjct: 67  RLYDVIHTENKLTLVFEFMD-NDLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNR---VAGYRAPEVTDP 542
           H     + H ++K  N+L+ K  + ++ DFGLA   G P +T +       YRAP+V   
Sbjct: 125 HEN--KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG 182
Query: 543 CKV-SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDL 579
            +  S   D++S G +L E++TGK       +EE + L
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL 220

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 16/196 (8%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL---KDVTISEREFKDKIEGVGAVNHENLVPLRAY 433
           +G+G++G  +K    + G IVA+K+    +D  + ++    +I  +  + H NLV L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
           +       LV++Y     L  L    +G         +   I     + + + H    N 
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRGVPE-----HLVKSITWQTLQAVNFCHKH--NC 123
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSS-TPNRVA--GYRAPE-VTDPCKVSQK 548
            H ++K  NIL+TK    ++ DFG A L+ GPS    + VA   YR+PE +    +    
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPP 183
Query: 549 ADVYSFGVLLLELLTG 564
            DV++ G +  ELL+G
Sbjct: 184 VDVWAIGCVFAELLSG 199

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 15/218 (6%)
Query: 357 FFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFK 413
           F     +V +L+D        LG G  G  +K   +   +V  ++L  + I      +  
Sbjct: 12  FLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII 71
Query: 414 DKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRS 473
            +++ +   N   +V     +YS  E  +  +++  GSL  +L   K AGR P   ++  
Sbjct: 72  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIP--EQILG 126
Query: 474 LIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVA 532
            +++   +G+ YL  +   + H ++K SNIL+    E ++ DFG++  L+   S  N   
Sbjct: 127 KVSIAVIKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV 183
Query: 533 G---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           G   Y +PE       S ++D++S G+ L+E+  G+ P
Sbjct: 184 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 24/198 (12%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY A+LE    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVF 92
Query: 435 Y---SMDEKLLVYDYLTM--GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
               S++E   VY  + +   +LS ++       +  L+ E  S +      GI++LH+ 
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVI-------QMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVS 546
           G  + H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       
Sbjct: 146 G--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 547 QKADVYSFGVLLLELLTG 564
           +  D++S G ++ E++ G
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 24/198 (12%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY A+LE    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV-LMKVVNHKNIIGLLNVF 92
Query: 435 Y---SMDEKLLVYDYLTM--GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
               S++E   VY  + +   +LS ++       +  L+ E  S +      GI++LH+ 
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVI-------QMELDHERMSYLLYQMLVGIKHLHSA 145
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVS 546
           G  + H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       
Sbjct: 146 G--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 547 QKADVYSFGVLLLELLTG 564
           +  D++S G ++ E++ G
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 124
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 15/218 (6%)
Query: 357 FFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFK 413
           F     +V +L+D        LG G  G  +K   +   +V  ++L  + I      +  
Sbjct: 55  FLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII 114
Query: 414 DKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRS 473
            +++ +   N   +V     +YS  E  +  +++  GSL  +L   K AGR P   ++  
Sbjct: 115 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIP--EQILG 169
Query: 474 LIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVA 532
            +++   +G+ YL  +   + H ++K SNIL+    E ++ DFG++  L+   S  N   
Sbjct: 170 KVSIAVIKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV 226
Query: 533 G---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           G   Y +PE       S ++D++S G+ L+E+  G+ P
Sbjct: 227 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 24/198 (12%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY A+LE    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV-LMKVVNHKNIIGLLNVF 92
Query: 435 Y---SMDEKLLVYDYLTM--GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
               S++E   VY  + +   +LS ++       +  L+ E  S +      GI++LH+ 
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVI-------QMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVS 546
           G  + H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       
Sbjct: 146 G--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 547 QKADVYSFGVLLLELLTG 564
           +  D++S G ++ E++ G
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 20/196 (10%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY A+LE    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVF 92
Query: 435 Y---SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
               S++E   VY  + M  + A L       +  L+ E  S +      GI++LH+ G 
Sbjct: 93  TPQKSLEEFQDVY--IVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG- 146
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQK 548
            + H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       + 
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 549 ADVYSFGVLLLELLTG 564
            D++S G ++ E++ G
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 127/294 (43%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG    A          +    VAVK LKD   +E++  D +  +  +     H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHK 101
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG--------RTPL-NWEMRSLIA 476
           N++ L           ++ +Y + G+L   L   +  G        R P      + L++
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 477 LGA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-----PSSTPN 529
                ARG+EYL +Q     H ++ + N+L+T++   R++DFGLA  +        +T  
Sbjct: 162 CTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVL+ E+ T G +P   +  EE   L +    + 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 279
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 280 KP--------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY AVL+    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVF 92
Query: 435 YSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
                     D YL M  + A L       +  L+ E  S +      GI++LH+ G  +
Sbjct: 93  TPQKTLEEFQDVYLVMELMDANL---XQVIQMELDHERMSYLLYQMLXGIKHLHSAG--I 147
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQKAD 550
            H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       +  D
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 551 VYSFGVLLLELLTGK 565
           ++S G ++ E++  K
Sbjct: 208 IWSVGCIMGEMVRHK 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY AVL+    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 29  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVF 85
Query: 435 YSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
                     D YL M  + A L       +  L+ E  S +      GI++LH+ G  +
Sbjct: 86  TPQKTLEEFQDVYLVMELMDANL---XQVIQMELDHERMSYLLYQMLXGIKHLHSAG--I 140
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQKAD 550
            H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       +  D
Sbjct: 141 IHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 200
Query: 551 VYSFGVLLLELLTGK 565
           ++S G ++ E++  K
Sbjct: 201 IWSVGCIMGEMVRHK 215

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 20/196 (10%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY A+LE    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 37  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVF 93
Query: 435 Y---SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
               S++E   VY  + M  + A L       +  L+ E  S +      GI++LH+ G 
Sbjct: 94  TPQKSLEEFQDVY--IVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG- 147
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQK 548
            + H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       + 
Sbjct: 148 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 206
Query: 549 ADVYSFGVLLLELLTG 564
            D++S G ++ E++ G
Sbjct: 207 VDIWSVGCIMGEMIKG 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 20/196 (10%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY A+LE    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVF 92
Query: 435 Y---SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
               S++E   VY  + M  + A L       +  L+ E  S +      GI++LH+ G 
Sbjct: 93  TPQKSLEEFQDVY--IVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG- 146
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQK 548
            + H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       + 
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 549 ADVYSFGVLLLELLTG 564
            D++S G ++ E++ G
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFY 71
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 125
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 31/205 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLK----DVTISEREFKDKIEGVGAVNHENLVPLR 431
           E +G+GT+G  YKA    G   A+K+++    D  I     ++ I  +  + H N+V L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIRE-ISILKELKHSNIVKLY 66
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIA----LGAARGIEYLH 487
              ++    +LV+++L    L  LL   +G         + S+ A    L    GI Y H
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG--------LESVTAKSFLLQLLNGIAYCH 117
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR-------VAGYRAPEV- 539
            +   V H ++K  N+L+ +  E +++DFGLA   G    P R          YRAP+V 
Sbjct: 118 DR--RVLHRDLKPQNLLINREGELKIADFGLARAFG---IPVRKYTHEIVTLWYRAPDVL 172
Query: 540 TDPCKVSQKADVYSFGVLLLELLTG 564
               K S   D++S G +  E++ G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 31/205 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLK----DVTISEREFKDKIEGVGAVNHENLVPLR 431
           E +G+GT+G  YKA    G   A+K+++    D  I     ++ I  +  + H N+V L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIRE-ISILKELKHSNIVKLY 66
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIA----LGAARGIEYLH 487
              ++    +LV+++L    L  LL   +G         + S+ A    L    GI Y H
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG--------LESVTAKSFLLQLLNGIAYCH 117
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR-------VAGYRAPEV- 539
            +   V H ++K  N+L+ +  E +++DFGLA   G    P R          YRAP+V 
Sbjct: 118 DR--RVLHRDLKPQNLLINREGELKIADFGLARAFG---IPVRKYTHEVVTLWYRAPDVL 172
Query: 540 TDPCKVSQKADVYSFGVLLLELLTG 564
               K S   D++S G +  E++ G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 32/208 (15%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLK----DVTISEREFKDKIEGVGAVNHENLVPLR 431
           E +G+GT+G  YKA    G   A+K+++    D  I     ++ I  +  + H N+V L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIRE-ISILKELKHSNIVKLY 66
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIA----LGAARGIEYLH 487
              ++    +LV+++L    L  LL   +G         + S+ A    L    GI Y H
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG--------LESVTAKSFLLQLLNGIAYCH 117
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR-------VAGYRAPEV- 539
            +   V H ++K  N+L+ +  E +++DFGLA   G    P R          YRAP+V 
Sbjct: 118 DR--RVLHRDLKPQNLLINREGELKIADFGLARAFG---IPVRKYTHEVVTLWYRAPDVL 172
Query: 540 TDPCKVSQKADVYSFGVLLLELLTGKAP 567
               K S   D++S G +  E++ G AP
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG-AP 199

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 124
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 397 VAVKRLKD--VTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA 454
           VA+K LK        R+F  +   +G  +H N++ L          ++V +Y+  GSL  
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 455 LLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEAR 512
            L  + G       + +  L+ +  G   G+ YL   G    H ++ + N+L+  +   +
Sbjct: 140 FLRTHDG------QFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCK 191
Query: 513 VSDFGLAHLV--GPSSTPNRVAG-----YRAPEVTDPCKVSQKADVYSFGVLLLELLT-G 564
           VSDFGL+ ++   P +      G     + APE       S  +DV+SFGV++ E+L  G
Sbjct: 192 VSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYG 251
Query: 565 KAPTHALLN-------EEGVDLP 580
           + P   + N       EEG  LP
Sbjct: 252 ERPYWNMTNRDVISSVEEGYRLP 274

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY AVL+    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV-LMKXVNHKNIISLLNVF 92
Query: 435 YSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
                     D YL M  + A L       +  L+ E  S +      GI++LH+ G  +
Sbjct: 93  TPQKTLEEFQDVYLVMELMDANL---XQVIQMELDHERMSYLLYQMLXGIKHLHSAG--I 147
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQKAD 550
            H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       +  D
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 551 VYSFGVLLLELLTGK 565
           ++S G ++ E++  K
Sbjct: 208 IWSVGCIMGEMVRHK 222

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 71
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 125
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 108/235 (45%), Gaps = 18/235 (7%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYY 434
           LG G  G  +K   +   +V  ++L  + I      +   +++ +   N   +V     +
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
           YS  E  +  +++  GSL  +L   K AGR P   ++   +++   +G+ YL  +   + 
Sbjct: 77  YSDGEISICMEHMDGGSLDQVL---KKAGRIP--EQILGKVSIAVIKGLTYLREKH-KIM 130
Query: 495 HGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPCKVSQKAD 550
           H ++K SNIL+    E ++ DFG++  L+      N   G   Y +PE       S ++D
Sbjct: 131 HRDVKPSNILVNSRGEIKLCDFGVSGQLI--DEMANEFVGTRSYMSPERLQGTHYSVQSD 188
Query: 551 VYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN 605
           ++S G+ L+E+  G+ P   +   E +D   ++ +    +  S VF LE   + N
Sbjct: 189 IWSMGLSLVEMAVGRYPRPPMAIFELLD---YIVNEPPPKLPSAVFSLEFQDFVN 240

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 125
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 10  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 70  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 123
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELP 205

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 124
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 58/116 (50%), Gaps = 1/116 (0%)
Query: 68  QNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQG 127
           +N +  L L     +G+IP   L N + L +L L FN L+  +PS L S S LR+L L  
Sbjct: 393 KNTLQELYLQNNGFTGKIP-PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWL 451
Query: 128 NHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGXXXXXXXXXXXXXXXRLSGSIP 183
           N   GE+P  L+ +  L  L L  N+ +GEIPSG               RL+G IP
Sbjct: 452 NMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 52/138 (37%), Gaps = 23/138 (16%)
Query: 95  SLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNF 154
           S+  L + +N L+  +P ++ S   L  L L  N  SG +P  +  L  L  L+L++N  
Sbjct: 633 SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL 692
Query: 155 SGEIPSGXXXXXXXXXXXXXXXRLSGSIPGFDDXXXXXXXXXXXXXXXXGSIPKRFQTFG 214
            G IP                  LSG IP                         +F+TF 
Sbjct: 693 DGRIPQAMSALTMLTEIDLSNNNLSGPIPEM----------------------GQFETFP 730
Query: 215 SNSFLGN-SLCGKPLQDC 231
              FL N  LCG PL  C
Sbjct: 731 PAKFLNNPGLCGYPLPRC 748

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 124
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 125
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 110/246 (44%), Gaps = 35/246 (14%)
Query: 375 AEVLGKGTFGTAYKAV------LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLV 428
           AE LG+G FG  ++ V        M   V VK    V +     K +I  +    H N++
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV-----KKEISILNIARHRNIL 64
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYL 486
            L   + SM+E ++++++++   L      N  A         R +++        +++L
Sbjct: 65  HLHESFESMEELVMIFEFIS--GLDIFERINTSA----FELNEREIVSYVHQVCEALQFL 118
Query: 487 HAQGPNVSHGNIKSSNILLT--KSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTD 541
           H+   N+ H +I+  NI+    +S   ++ +FG A  + P      +     Y APEV  
Sbjct: 119 HSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 542 PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL 601
              VS   D++S G L+  LL+G  P  A  N++       +++I+  E+T   FD E  
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEYT---FDEEAF 227
Query: 602 RYQNVE 607
           +  ++E
Sbjct: 228 KEISIE 233

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/116 (37%), Positives = 58/116 (50%), Gaps = 1/116 (0%)
Query: 68  QNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQG 127
           +N +  L L     +G+IP   L N + L +L L FN L+  +PS L S S LR+L L  
Sbjct: 390 KNTLQELYLQNNGFTGKIP-PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWL 448
Query: 128 NHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGXXXXXXXXXXXXXXXRLSGSIP 183
           N   GE+P  L+ +  L  L L  N+ +GEIPSG               RL+G IP
Sbjct: 449 NMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 504

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 60/165 (36%), Gaps = 33/165 (20%)
Query: 95  SLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNF 154
           S+  L + +N L+  +P ++ S   L  L L  N  SG +P  +  L  L  L+L++N  
Sbjct: 630 SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL 689
Query: 155 SGEIPSGXXXXXXXXXXXXXXXRLSGSIPGFDDXXXXXXXXXXXXXXXXGSIPKRFQTFG 214
            G IP                  LSG IP                         +F+TF 
Sbjct: 690 DGRIPQAMSALTMLTEIDLSNNNLSGPIPEM----------------------GQFETFP 727
Query: 215 SNSFLGN-SLCGKPLQDCGTKASLVVPSTPSGTDEISHGEKEKKK 258
              FL N  LCG PL  C           PS  D  +H ++   +
Sbjct: 728 PAKFLNNPGLCGYPLPRC----------DPSNADGYAHHQRSHGR 762

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 125
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 125
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 124
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 125
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 125
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 125/278 (44%), Gaps = 32/278 (11%)
Query: 373 ASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE-FKDKIEGVGAVNHENLVPL 430
           +  E+LG G FG  +K      G  +A K +K   + ++E  K++I  +  ++H NL+ L
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
              + S ++ +LV +Y+  G L   +  ++    T L+     L       GI ++H   
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRI-IDESYNLTELD---TILFMKQICEGIRHMHQM- 206
Query: 491 PNVSHGNIKSSNILLTK--SYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKV 545
             + H ++K  NIL     + + ++ DFGLA    P        G   + APEV +   V
Sbjct: 207 -YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV 265
Query: 546 SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN 605
           S   D++S GV+   LL+G +P    L +   +    + +I+   W     DLE   +Q+
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSP---FLGDNDAET---LNNILACRW-----DLEDEEFQD 314
Query: 606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP 643
           + EE  + +   +     +   R S SE +K     HP
Sbjct: 315 ISEEAKEFISKLLIKEKSW---RISASEALK-----HP 344

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 124
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 124
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 130/319 (40%), Gaps = 64/319 (20%)
Query: 357 FFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRL-------KDVTIS 408
           F G    + +L   +R    VL +G F   Y+A  +  G   A+KRL           I 
Sbjct: 18  FVGQTVELGELRLRVR---RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ 74
Query: 409 EREFKDKIEGVGAVNHENLVPL-RAYYYSMDE------KLLVYDYLTMGSLSALLHGNKG 461
           E  F  K+ G     H N+V    A     +E      + L+   L  G L   L   K 
Sbjct: 75  EVCFMKKLSG-----HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL--KKM 127
Query: 462 AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFG---- 517
             R PL+ +    I     R ++++H Q P + H ++K  N+LL+     ++ DFG    
Sbjct: 128 ESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187
Query: 518 LAH------------LVGPSSTPNRVAGYRAPEVTD---PCKVSQKADVYSFGVLLLELL 562
           ++H            LV    T N    YR PE+ D      + +K D+++ G +L  L 
Sbjct: 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247
Query: 563 TGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSA 622
             + P      E+G  L      IV  +++    D +   + ++   M+Q+         
Sbjct: 248 FRQHPF-----EDGAKL-----RIVNGKYSIPPHDTQYTVFHSLIRAMLQV--------- 288
Query: 623 QYPDNRPSMSEVIKRIEEL 641
             P+ R S++EV+ +++E+
Sbjct: 289 -NPEERLSIAEVVHQLQEI 306

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 124
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 14/201 (6%)
Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDV-TISEREFKDKIEGVGAVNHENLVPLRAY 433
           EVLG G F   +     + G + A+K +K      +   +++I  +  + HEN+V L   
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
           Y S     LV   ++ G L      ++   R     +  SL+       ++YLH  G  +
Sbjct: 75  YESTTHYYLVMQLVSGGEL-----FDRILERGVYTEKDASLVIQQVLSAVKYLHENG--I 127
Query: 494 SHGNIKSSNILLTKSYE---ARVSDFGLAHLV--GPSSTPNRVAGYRAPEVTDPCKVSQK 548
            H ++K  N+L     E     ++DFGL+ +   G  ST     GY APEV      S+ 
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKA 187
Query: 549 ADVYSFGVLLLELLTGKAPTH 569
            D +S GV+   LL G  P +
Sbjct: 188 VDCWSIGVITYILLCGYPPFY 208

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 125/306 (40%), Gaps = 42/306 (13%)
Query: 357 FFGNAARVFDLEDLLRASAEV---LGKGTFGTAYKAVLE------MGTIVAVKRLKDVTI 407
           F G  + + DL+++ R +  +   LG G FG  Y+  +           VAVK L +V  
Sbjct: 15  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 74
Query: 408 SEREFKDKIEG--VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRT 465
            + E    +E   +  +NH+N+V           + ++ + +  G L + L   +     
Sbjct: 75  EQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 134
Query: 466 PLNWEMRSL--IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVS---DFGLAH 520
           P +  M  L  +A   A G +YL     +  H +I + N LLT     RV+   DFG+A 
Sbjct: 135 PSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192
Query: 521 LVGPSSTPNR------VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLN 573
            +  +S   +         +  PE       + K D +SFGVLL E+ + G  P  +  N
Sbjct: 193 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 252
Query: 574 EEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSE 633
           +E ++                 F     R    +     + ++   C    P++RP+ + 
Sbjct: 253 QEVLE-----------------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAI 295
Query: 634 VIKRIE 639
           +++RIE
Sbjct: 296 ILERIE 301

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 397 VAVKRLKD--VTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA 454
           VA+K LK        R+F  +   +G  +H N++ L          ++V +Y+  GSL  
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 455 LLHGNKGAGRTPLNWEMRSLIAL--GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEAR 512
            L  + G       + +  L+ +  G   G+ YL   G    H ++ + N+L+  +   +
Sbjct: 140 FLRTHDG------QFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCK 191
Query: 513 VSDFGLAHLV--GPSSTPNRVAG-----YRAPEVTDPCKVSQKADVYSFGVLLLELLT-G 564
           VSDFGL+ ++   P +      G     + APE       S  +DV+SFGV++ E+L  G
Sbjct: 192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYG 251
Query: 565 KAPTHALLN-------EEGVDLP 580
           + P   + N       EEG  LP
Sbjct: 252 ERPYWNMTNRDVISSVEEGYRLP 274

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY AVL+    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV-LMKXVNHKNIISLLNVF 92
Query: 435 YSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
                     D YL M  + A L       +  L+ E  S +      GI++LH+ G  +
Sbjct: 93  TPQKTLEEFQDVYLVMELMDANL---XQVIQMELDHERMSYLLYQMLCGIKHLHSAG--I 147
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQKAD 550
            H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       +  D
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 551 VYSFGVLLLELLTGK 565
           ++S G ++ E++  K
Sbjct: 208 IWSVGCIMGEMVRHK 222

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 124/306 (40%), Gaps = 42/306 (13%)
Query: 357 FFGNAARVFDLEDLLRASAEV---LGKGTFGTAYKAVLE------MGTIVAVKRLKDVTI 407
           F G  + + DL+++ R +  +   LG G FG  Y+  +           VAVK L +V  
Sbjct: 15  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 74
Query: 408 SEREFKDKIEG--VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRT 465
            + E    +E   +   NH+N+V           + ++ + +  G L + L   +     
Sbjct: 75  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 134
Query: 466 PLNWEMRSL--IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVS---DFGLAH 520
           P +  M  L  +A   A G +YL     +  H +I + N LLT     RV+   DFG+A 
Sbjct: 135 PSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192
Query: 521 LVGPSSTPNR------VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLN 573
            +  +S   +         +  PE       + K D +SFGVLL E+ + G  P  +  N
Sbjct: 193 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 252
Query: 574 EEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSE 633
           +E ++                 F     R    +     + ++   C    P++RP+ + 
Sbjct: 253 QEVLE-----------------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAI 295
Query: 634 VIKRIE 639
           +++RIE
Sbjct: 296 ILERIE 301

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 127/294 (43%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG    A          +    VAVK LKD   +E++  D +  +  +     H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHK 101
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG--------RTPL-NWEMRSLIA 476
           N++ L           ++ +Y + G+L   L   +  G        R P      + L++
Sbjct: 102 NIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 477 LGA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-----PSSTPN 529
                ARG+EYL +Q     H ++ + N+L+T++   +++DFGLA  +        +T  
Sbjct: 162 CTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVL+ E+ T G +P   +  EE   L +    + 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 279
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 280 KP--------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 127/294 (43%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG    A          +    VAVK LKD   +E++  D +  +  +     H+
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHK 90
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG--------RTPL-NWEMRSLIA 476
           N++ L           ++ +Y + G+L   L   +  G        R P      + L++
Sbjct: 91  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 150
Query: 477 LGA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-----PSSTPN 529
                ARG+EYL +Q     H ++ + N+L+T++   +++DFGLA  +        +T  
Sbjct: 151 CTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVL+ E+ T G +P   +  EE   L +    + 
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 268
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 269 KP--------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 305

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 377 VLGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISE----REFKDKIEGVGAVNHENLVPLR 431
           +LGKG+F   Y+A  +  G  VA+K +    + +    +  +++++    + H +++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGN-KGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
            Y+   +   LV +    G ++  L    K          M  +I      G+ YLH+ G
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT-----GMLYLHSHG 132
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPCKVS 546
             + H ++  SN+LLT++   +++DFGLA  L  P      + G   Y +PE+       
Sbjct: 133 --ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHG 190
Query: 547 QKADVYSFGVLLLELLTGKAP 567
            ++DV+S G +   LL G+ P
Sbjct: 191 LESDVWSLGCMFYTLLIGRPP 211

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 128/294 (43%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG    A          +    VAVK LKD   +E++  D +  +  +     H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHK 101
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG--------RTPL-NWEMRSLIA 476
           N++ L           ++ +Y + G+L   L   +  G        R P      + L++
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 477 LGA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-----PSSTPN 529
                ARG+EYL +Q     H ++ + N+L+T++   +++DFGLA  +       ++T  
Sbjct: 162 CTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVL+ E+ T G +P   +  EE   L +    + 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 279
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 280 KP--------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY AVL+    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 74  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVF 130
Query: 435 YSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
                     D YL M  + A L       +  L+ E  S +      GI++LH+ G  +
Sbjct: 131 TPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG--I 185
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQKAD 550
            H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       +  D
Sbjct: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 245
Query: 551 VYSFGVLLLELLTGK 565
           ++S G ++ E++  K
Sbjct: 246 IWSVGCIMGEMVRHK 260

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 125/308 (40%), Gaps = 44/308 (14%)
Query: 356 VFFGNAARVFDLEDLLRASAEV---LGKGTFGTAYKAVLE------MGTIVAVKRLKDVT 406
            F G  + + DL+++ R +  +   LG G FG  Y+  +           VAVK L +V 
Sbjct: 5   CFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 64
Query: 407 ISEREFKDKIEG--VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGR 464
             + E    +E   +   NH+N+V           + ++ + +  G L + L   +    
Sbjct: 65  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS 124
Query: 465 TPLNWEMRSL--IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVS---DFGLA 519
            P +  M  L  +A   A G +YL     +  H +I + N LLT     RV+   DFG+A
Sbjct: 125 QPSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 182
Query: 520 HLVGPSSTPNRVAG-------YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHAL 571
             +  +S   R  G       +  PE       + K D +SFGVLL E+ + G  P  + 
Sbjct: 183 RDIYRASY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 241
Query: 572 LNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSM 631
            N+E ++                 F     R    +     + ++   C    P++RP+ 
Sbjct: 242 SNQEVLE-----------------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 284
Query: 632 SEVIKRIE 639
           + +++RIE
Sbjct: 285 AIILERIE 292

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 127/294 (43%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG    A          +    VAVK LKD   +E++  D +  +  +     H+
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHK 88
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG--------RTPL-NWEMRSLIA 476
           N++ L           ++ +Y + G+L   L   +  G        R P      + L++
Sbjct: 89  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 148
Query: 477 LGA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-----PSSTPN 529
                ARG+EYL +Q     H ++ + N+L+T++   +++DFGLA  +        +T  
Sbjct: 149 CTYQLARGMEYLASQ--KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVL+ E+ T G +P   +  EE   L +    + 
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 266
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 267 KP--------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 303

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 124
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/307 (23%), Positives = 124/307 (40%), Gaps = 42/307 (13%)
Query: 356 VFFGNAARVFDLEDLLRASAEV---LGKGTFGTAYKAVLE------MGTIVAVKRLKDVT 406
            F G  + + DL+++ R +  +   LG G FG  Y+  +           VAVK L +V 
Sbjct: 13  CFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 72
Query: 407 ISEREFKDKIEG--VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGR 464
             + E    +E   +   NH+N+V           + ++ + +  G L + L   +    
Sbjct: 73  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPS 132
Query: 465 TPLNWEMRSL--IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVS---DFGLA 519
            P +  M  L  +A   A G +YL     +  H +I + N LLT     RV+   DFG+A
Sbjct: 133 QPSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
Query: 520 HLVGPSSTPNR------VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALL 572
             +  +S   +         +  PE       + K D +SFGVLL E+ + G  P  +  
Sbjct: 191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250
Query: 573 NEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMS 632
           N+E ++                 F     R    +     + ++   C    P++RP+ +
Sbjct: 251 NQEVLE-----------------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 293
Query: 633 EVIKRIE 639
            +++RIE
Sbjct: 294 IILERIE 300

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 125/308 (40%), Gaps = 44/308 (14%)
Query: 356 VFFGNAARVFDLEDLLRASAEV---LGKGTFGTAYKAVLE------MGTIVAVKRLKDVT 406
            F G  + + DL+++ R +  +   LG G FG  Y+  +           VAVK L +V 
Sbjct: 13  CFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 72
Query: 407 ISEREFKDKIEG--VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGR 464
             + E    +E   +   NH+N+V           + ++ + +  G L + L   +    
Sbjct: 73  SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS 132
Query: 465 TPLNWEMRSL--IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVS---DFGLA 519
            P +  M  L  +A   A G +YL     +  H +I + N LLT     RV+   DFG+A
Sbjct: 133 QPSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
Query: 520 HLVGPSSTPNRVAG-------YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHAL 571
             +  +S   R  G       +  PE       + K D +SFGVLL E+ + G  P  + 
Sbjct: 191 RDIYRASY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
Query: 572 LNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSM 631
            N+E ++                 F     R    +     + ++   C    P++RP+ 
Sbjct: 250 SNQEVLE-----------------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 292
Query: 632 SEVIKRIE 639
           + +++RIE
Sbjct: 293 AIILERIE 300

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 123/291 (42%), Gaps = 46/291 (15%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKD-VTISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+         E  T VAVK + +  ++ ER EF ++   +      ++V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALL-----HGNKGAGRTPLNWEMRSLIALGAARGIE 484
           L          L+V + +  G L + L           GR P   +    +A   A G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAGYR 535
           YL+A+     H N+ + N ++   +  ++ DFG+   +         G    P R   + 
Sbjct: 146 YLNAK--KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---WM 200
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           APE       +  +D++SFGV+L E+ +  + P   L NE+       V   V D    +
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLKFVMDGGYLD 253
Query: 595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHPS 644
             D       N  E +  L+++   C    P+ RP+  E++  + ++LHPS
Sbjct: 254 QPD-------NCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLKDDLHPS 294

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 72/322 (22%), Positives = 129/322 (40%), Gaps = 42/322 (13%)
Query: 341 KTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEV---LGKGTFGTAYKAVLE----- 392
           K + ++ +        F G  + + DL+++ R +  +   LG G FG  Y+  +      
Sbjct: 15  KLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND 74
Query: 393 -MGTIVAVKRLKDVTISEREFKDKIEG--VGAVNHENLVPLRAYYYSMDEKLLVYDYLTM 449
                VAVK L +V   + E    +E   +   NH+N+V           + ++ + +  
Sbjct: 75  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 134
Query: 450 GSLSALLHGNKGAGRTPLNWEMRSL--IALGAARGIEYLHAQGPNVSHGNIKSSNILLTK 507
           G L + L   +     P +  M  L  +A   A G +YL     +  H +I + N LLT 
Sbjct: 135 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTC 192
Query: 508 SYEARVS---DFGLAHLVGPSSTPNR------VAGYRAPEVTDPCKVSQKADVYSFGVLL 558
               RV+   DFG+A  +  +S   +         +  PE       + K D +SFGVLL
Sbjct: 193 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 252
Query: 559 LELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLA 617
            E+ + G  P  +  N+E ++                 F     R    +     + ++ 
Sbjct: 253 WEIFSLGYMPYPSKSNQEVLE-----------------FVTSGGRMDPPKNCPGPVYRIM 295
Query: 618 IDCSAQYPDNRPSMSEVIKRIE 639
             C    P++RP+ + +++RIE
Sbjct: 296 TQCWQHQPEDRPNFAIILERIE 317

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 124
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY AVL+    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 35  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVF 91
Query: 435 YSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
                     D YL M  + A L       +  L+ E  S +      GI++LH+ G  +
Sbjct: 92  TPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG--I 146
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQKAD 550
            H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       +  D
Sbjct: 147 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 206
Query: 551 VYSFGVLLLELLTGK 565
           ++S G ++ E++  K
Sbjct: 207 IWSVGCIMGEMVRHK 221

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYY 434
           LG G  G  +K   +   +V  ++L  + I      +   +++ +   N   +V     +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
           YS  E  +  +++  GSL  +L   K AGR P   ++   +++   +G+ YL  +   + 
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL---KKAGRIP--EQILGKVSIAVIKGLTYLREKH-KIM 127
Query: 495 HGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPCKVSQKAD 550
           H ++K SNIL+    E ++ DFG++  L+   S  N   G   Y +PE       S ++D
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 551 VYSFGVLLLELLTGKAPT 568
           ++S G+ L+E+  G+ P 
Sbjct: 186 IWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYY 434
           LG G  G  +K   +   +V  ++L  + I      +   +++ +   N   +V     +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
           YS  E  +  +++  GSL  +L   K AGR P   ++   +++   +G+ YL  +   + 
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL---KKAGRIP--EQILGKVSIAVIKGLTYLREKH-KIM 127
Query: 495 HGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPCKVSQKAD 550
           H ++K SNIL+    E ++ DFG++  L+   S  N   G   Y +PE       S ++D
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 551 VYSFGVLLLELLTGKAPT 568
           ++S G+ L+E+  G+ P 
Sbjct: 186 IWSMGLSLVEMAVGRYPI 203

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY AVL+    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVF 92
Query: 435 YSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
                     D YL M  + A L       +  L+ E  S +      GI++LH+ G  +
Sbjct: 93  TPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG--I 147
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQKAD 550
            H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       +  D
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 551 VYSFGVLLLELLTGK 565
           ++S G ++ E++  K
Sbjct: 208 IWSVGCIMGEMVRHK 222

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 127/294 (43%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG    A          +    VAVK LKD   +E++  D +  +  +     H+
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHK 93
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG--------RTPL-NWEMRSLIA 476
           N++ L           ++ +Y + G+L   L   +  G        R P      + L++
Sbjct: 94  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 153
Query: 477 LGA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-----PSSTPN 529
                ARG+EYL +Q     H ++ + N+L+T++   +++DFGLA  +        +T  
Sbjct: 154 CTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVL+ E+ T G +P   +  EE   L +    + 
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 271
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 272 KP--------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 308

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G +G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 124
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 127/294 (43%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG    A          +    VAVK LKD   +E++  D +  +  +     H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHK 101
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG--------RTPL-NWEMRSLIA 476
           N++ L           ++ +Y + G+L   L   +  G        R P      + L++
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVS 161
Query: 477 LGA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-----PSSTPN 529
                ARG+EYL +Q     H ++ + N+L+T++   +++DFGLA  +        +T  
Sbjct: 162 CTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVL+ E+ T G +P   +  EE   L +    + 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 279
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 280 KP--------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY AVL+    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 29  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVF 85
Query: 435 YSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
                     D YL M  + A L       +  L+ E  S +      GI++LH+ G  +
Sbjct: 86  TPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG--I 140
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQKAD 550
            H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       +  D
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 200
Query: 551 VYSFGVLLLELLTGK 565
           ++S G ++ E++  K
Sbjct: 201 IWSVGCIMGEMVRHK 215

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY AVL+    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 37  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVF 93
Query: 435 YSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
                     D YL M  + A L       +  L+ E  S +      GI++LH+ G  +
Sbjct: 94  TPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG--I 148
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQKAD 550
            H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       +  D
Sbjct: 149 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 208
Query: 551 VYSFGVLLLELLTGK 565
           ++S G ++ E++  K
Sbjct: 209 IWSVGCIMGEMVRHK 223

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY AVL+    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 30  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVF 86
Query: 435 YSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
                     D YL M  + A L       +  L+ E  S +      GI++LH+ G  +
Sbjct: 87  TPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG--I 141
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQKAD 550
            H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       +  D
Sbjct: 142 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 201
Query: 551 VYSFGVLLLELLTGK 565
           ++S G ++ E++  K
Sbjct: 202 IWSVGCIMGEMVRHK 216

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 123/291 (42%), Gaps = 46/291 (15%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKD-VTISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+         E  T VAVK + +  ++ ER EF ++   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALL-----HGNKGAGRTPLNWEMRSLIALGAARGIE 484
           L          L+V + +  G L + L           GR P   +    +A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAGYR 535
           YL+A+     H N+ + N ++   +  ++ DFG+   +         G    P R   + 
Sbjct: 145 YLNAK--KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---WM 199
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           APE       +  +D++SFGV+L E+ +  + P   L NE+       V   V D    +
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLKFVMDGGYLD 252
Query: 595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHPS 644
             D       N  E +  L+++   C    P+ RP+  E++  + ++LHPS
Sbjct: 253 QPD-------NCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLKDDLHPS 293

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 127/294 (43%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG    A          +    VAVK LKD   +E++  D +  +  +     H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHK 101
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG--------RTPL-NWEMRSLIA 476
           N++ L           ++ +Y + G+L   L   +  G        R P      + L++
Sbjct: 102 NIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 477 LGA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-----PSSTPN 529
                ARG+EYL +Q     H ++ + N+L+T++   +++DFGLA  +        +T  
Sbjct: 162 CTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVL+ E+ T G +P   +  EE   L +    + 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 279
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 280 KP--------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 364 VFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVT--ISEREFKDKIEGVGA 421
           V+D  D+L    E LG G FG  ++ V +    V V +  +    + +   K++I  +  
Sbjct: 49  VYDYYDIL----EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQ 104
Query: 422 VNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGN--KGAGRTPLNWEMRSLIALGA 479
           ++H  L+ L   +    E +L+ ++L+ G L   +     K +    +N+ MR      A
Sbjct: 105 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY-MRQ-----A 158
Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILL--TKSYEARVSDFGLAHLVGPS---STPNRVAGY 534
             G++++H    ++ H +IK  NI+    K+   ++ DFGLA  + P          A +
Sbjct: 159 CEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF 216
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
            APE+ D   V    D+++ GVL   LL+G +P
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 124/306 (40%), Gaps = 42/306 (13%)
Query: 357 FFGNAARVFDLEDLLRASAEV---LGKGTFGTAYKAVLE------MGTIVAVKRLKDVTI 407
           F G  + + DL+++ R +  +   LG G FG  Y+  +           VAVK L +V  
Sbjct: 15  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 74
Query: 408 SEREFKDKIEG--VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRT 465
            + E    +E   +   NH+N+V           + ++ + +  G L + L   +     
Sbjct: 75  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 134
Query: 466 PLNWEMRSL--IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVS---DFGLAH 520
           P +  M  L  +A   A G +YL     +  H +I + N LLT     RV+   DFG+A 
Sbjct: 135 PSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192
Query: 521 LVGPSSTPNR------VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLN 573
            +  +S   +         +  PE       + K D +SFGVLL E+ + G  P  +  N
Sbjct: 193 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 252
Query: 574 EEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSE 633
           +E ++                 F     R    +     + ++   C    P++RP+ + 
Sbjct: 253 QEVLE-----------------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAI 295
Query: 634 VIKRIE 639
           +++RIE
Sbjct: 296 ILERIE 301

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY AVL+    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVF 92
Query: 435 YSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
                     D YL M  + A L       +  L+ E  S +      GI++LH+ G  +
Sbjct: 93  TPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG--I 147
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQKAD 550
            H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       +  D
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 551 VYSFGVLLLELLTGK 565
           ++S G ++ E++  K
Sbjct: 208 IWSVGCIMGEMVRHK 222

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY AVL+    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 74  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVF 130
Query: 435 YSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
                     D YL M  + A L       +  L+ E  S +      GI++LH+ G  +
Sbjct: 131 TPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG--I 185
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQKAD 550
            H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       +  D
Sbjct: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 245
Query: 551 VYSFGVLLLELLTGK 565
           ++S G ++ E++  K
Sbjct: 246 IWSVGCIMGEMVRHK 260

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY AVL+    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 37  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVF 93
Query: 435 YSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
                     D YL M  + A L       +  L+ E  S +      GI++LH+ G  +
Sbjct: 94  TPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG--I 148
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQKAD 550
            H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       +  D
Sbjct: 149 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 208
Query: 551 VYSFGVLLLELLTGK 565
           ++S G ++ E++  K
Sbjct: 209 IWSVGCIMGEMVRHK 223

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY AVL+    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 30  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVF 86
Query: 435 YSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
                     D YL M  + A L       +  L+ E  S +      GI++LH+ G  +
Sbjct: 87  TPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG--I 141
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQKAD 550
            H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       +  D
Sbjct: 142 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 201
Query: 551 VYSFGVLLLELLTGK 565
           ++S G ++ E++  K
Sbjct: 202 IWSVGCIMGEMVRHK 216

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 127/294 (43%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG    A          +    VAVK LKD   +E++  D +  +  +     H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHK 101
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG--------RTPL-NWEMRSLIA 476
           N++ L           ++ +Y + G+L   L   +  G        R P      + L++
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 477 LGA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-----PSSTPN 529
                ARG+EYL +Q     H ++ + N+L+T++   +++DFGLA  +        +T  
Sbjct: 162 CTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVL+ E+ T G +P   +  EE   L +    + 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 279
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 280 KP--------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYY 434
           LG G  G  +K   +   +V  ++L  + I      +   +++ +   N   +V     +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
           YS  E  +  +++  GSL  +L   K AGR P   ++   +++   +G+ YL  +   + 
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL---KKAGRIP--EQILGKVSIAVIKGLTYLREKH-KIM 127
Query: 495 HGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPCKVSQKAD 550
           H ++K SNIL+    E ++ DFG++  L+   S  N   G   Y +PE       S ++D
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 551 VYSFGVLLLELLTGKAP 567
           ++S G+ L+E+  G+ P
Sbjct: 186 IWSMGLSLVEMAVGRYP 202

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYY 434
           LG G  G  +K   +   +V  ++L  + I      +   +++ +   N   +V     +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
           YS  E  +  +++  GSL  +L   K AGR P   ++   +++   +G+ YL  +   + 
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL---KKAGRIP--EQILGKVSIAVIKGLTYLREKH-KIM 127
Query: 495 HGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPCKVSQKAD 550
           H ++K SNIL+    E ++ DFG++  L+   S  N   G   Y +PE       S ++D
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 551 VYSFGVLLLELLTGKAP 567
           ++S G+ L+E+  G+ P
Sbjct: 186 IWSMGLSLVEMAVGRYP 202

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY AVL+    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV-LMKXVNHKNIISLLNVF 92
Query: 435 YSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
                     D YL M  + A L       +  L+ E  S +      GI++LH+ G  +
Sbjct: 93  TPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG--I 147
Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQKAD 550
            H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       +  D
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 551 VYSFGVLLLELLTGK 565
           ++S G ++ E++  K
Sbjct: 208 IWSVGCIMGEMVRHK 222

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 136/300 (45%), Gaps = 56/300 (18%)
Query: 364 VFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTI---VAVKRLKDVTISE--REFKDKIEG 418
           V D  D+     +V+G+G FG   KA ++   +    A+KR+K+    +  R+F  ++E 
Sbjct: 18  VLDWNDI--KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 75
Query: 419 VGAV-NHENLVPL------RAYYYSMDEKLLVYDYLTMGSLSALLHGNKG---------A 462
           +  + +H N++ L      R Y Y      L  +Y   G+L   L  ++          A
Sbjct: 76  LCKLGHHPNIINLLGACEHRGYLY------LAIEYAPHGNLLDFLRKSRVLETDPAFAIA 129
Query: 463 GRTPLNWEMRSLIALGA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA- 519
             T      + L+   A  ARG++YL  +     H N+ + NIL+ ++Y A+++DFGL+ 
Sbjct: 130 NSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRNLAARNILVGENYVAKIADFGLSR 187
Query: 520 -HLVGPSSTPNRV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEG 576
              V    T  R+   + A E  +    +  +DV+S+GVLL E+++ G  P   +   E 
Sbjct: 188 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 247
Query: 577 VD-LPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVI 635
            + LP+                  L +  N ++E+  L++    C  + P  RPS ++++
Sbjct: 248 YEKLPQ---------------GYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQIL 289

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYY 434
           LG G  G  +K   +   +V  ++L  + I      +   +++ +   N   +V     +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
           YS  E  +  +++  GSL  +L   K AGR P   ++   +++   +G+ YL  +   + 
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL---KKAGRIP--EQILGKVSIAVIKGLTYLREKH-KIM 127
Query: 495 HGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPCKVSQKAD 550
           H ++K SNIL+    E ++ DFG++  L+   S  N   G   Y +PE       S ++D
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 551 VYSFGVLLLELLTGKAP 567
           ++S G+ L+E+  G+ P
Sbjct: 186 IWSMGLSLVEMAVGRYP 202

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 124/306 (40%), Gaps = 42/306 (13%)
Query: 357 FFGNAARVFDLEDLLRASAEV---LGKGTFGTAYKAVLE------MGTIVAVKRLKDVTI 407
           F G  + + DL+++ R +  +   LG G FG  Y+  +           VAVK L +V  
Sbjct: 21  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 80
Query: 408 SEREFKDKIEG--VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRT 465
            + E    +E   +   NH+N+V           + ++ + +  G L + L   +     
Sbjct: 81  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 140
Query: 466 PLNWEMRSL--IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVS---DFGLAH 520
           P +  M  L  +A   A G +YL     +  H +I + N LLT     RV+   DFG+A 
Sbjct: 141 PSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198
Query: 521 LVGPSSTPNR------VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLN 573
            +  +S   +         +  PE       + K D +SFGVLL E+ + G  P  +  N
Sbjct: 199 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 258
Query: 574 EEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSE 633
           +E ++                 F     R    +     + ++   C    P++RP+ + 
Sbjct: 259 QEVLE-----------------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAI 301
Query: 634 VIKRIE 639
           +++RIE
Sbjct: 302 ILERIE 307

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 127/294 (43%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG    A          +    VAVK LKD   +E++  D +  +  +     H+
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHK 147
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG--------RTPL-NWEMRSLIA 476
           N++ L           ++ +Y + G+L   L   +  G        R P      + L++
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 477 LGA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-----PSSTPN 529
                ARG+EYL +Q     H ++ + N+L+T++   +++DFGLA  +        +T  
Sbjct: 208 CTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVL+ E+ T G +P   +  EE   L +    + 
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 325
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 326 KP--------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 362

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/325 (22%), Positives = 130/325 (40%), Gaps = 48/325 (14%)
Query: 341 KTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEV---LGKGTFGTAYKAVLE----- 392
           K + ++ +        F G  + + DL+++ R +  +   LG G FG  Y+  +      
Sbjct: 16  KLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND 75
Query: 393 -MGTIVAVKRLKDVTISEREFKDKIEG--VGAVNHENLVPLRAYYYSMDEKLLVYDYLTM 449
                VAVK L +V   + E    +E   +   NH+N+V           + ++ + +  
Sbjct: 76  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 135
Query: 450 GSLSALLHGNKGAGRTPLNWEMRSL--IALGAARGIEYLHAQGPNVSHGNIKSSNILLTK 507
           G L + L   +     P +  M  L  +A   A G +YL     +  H +I + N LLT 
Sbjct: 136 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTC 193
Query: 508 SYEARVS---DFGLAHLV---------GPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFG 555
               RV+   DFG+A  +         G +  P +   +  PE       + K D +SFG
Sbjct: 194 PGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK---WMPPEAFMEGIFTSKTDTWSFG 250
Query: 556 VLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLL 614
           VLL E+ + G  P  +  N+E ++                 F     R    +     + 
Sbjct: 251 VLLWEIFSLGYMPYPSKSNQEVLE-----------------FVTSGGRMDPPKNCPGPVY 293
Query: 615 QLAIDCSAQYPDNRPSMSEVIKRIE 639
           ++   C    P++RP+ + +++RIE
Sbjct: 294 RIMTQCWQHQPEDRPNFAIILERIE 318

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 20/197 (10%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY A+LE    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 30  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVF 86
Query: 435 Y---SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
               S++E   VY  + M  + A L       +  L+ E  S +      GI++LH+ G 
Sbjct: 87  TPQKSLEEFQDVY--IVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG- 140
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQK 548
            + H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       + 
Sbjct: 141 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 199
Query: 549 ADVYSFGVLLLELLTGK 565
            D++S G ++ E++  K
Sbjct: 200 VDLWSVGCIMGEMVCHK 216

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 23/179 (12%)
Query: 399 VKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHG 458
           V+ L++ T+ E +   K+ G     H N++ L+  Y +     LV+D +  G L   L  
Sbjct: 50  VQELREATLKEVDILRKVSG-----HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE 104
Query: 459 NKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGL 518
                       MR+L+ +  A     LH    N+ H ++K  NILL      +++DFG 
Sbjct: 105 KVTLSEKETRKIMRALLEVICA-----LHKL--NIVHRDLKPENILLDDDMNIKLTDFGF 157
Query: 519 AHLVGPSSTPNRVAG---YRAPEVTDPCKVS-------QKADVYSFGVLLLELLTGKAP 567
           +  + P      V G   Y APE+ + C ++       ++ D++S GV++  LL G  P
Sbjct: 158 SCQLDPGEKLREVCGTPSYLAPEIIE-CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVPL 430
           E LGKG F    + V +  G   A K +    +S R+F+ K+E    +     H N+V L
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRL 93
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                      LV+D +T G L   +   +       +  ++ ++       I Y H+ G
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL-----ESIAYCHSNG 148
Query: 491 PNVSHGNIKSSNILLT---KSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCK 544
             + H N+K  N+LL    K    +++DFGLA  V  S   +  AG   Y +PEV     
Sbjct: 149 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 206
Query: 545 VSQKADVYSFGVLLLELLTGKAP 567
            S+  D+++ GV+L  LL G  P
Sbjct: 207 YSKPVDIWACGVILYILLVGYPP 229

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R F ++D        LGKG FG  Y A  +    I+A+K L    +     E + + +IE
Sbjct: 9   RKFTIDDF--DIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIE 66
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLI 475
               + H N++ +  Y++      L+ ++   G L   L  HG     R+    E     
Sbjct: 67  IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME----- 121
Query: 476 ALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-- 533
               A  + Y H +   V H +IK  N+L+    E +++DFG + +  PS     + G  
Sbjct: 122 --ELADALHYCHER--KVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTL 176
Query: 534 -YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
            Y  PE+ +     +K D++  GVL  E L G  P
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 20/196 (10%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY A+LE    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 38  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVF 94
Query: 435 Y---SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
               S++E   VY  + M  + A L       +  L+ E  S +      GI++LH+ G 
Sbjct: 95  TPQKSLEEFQDVY--IVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG- 148
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQK 548
            + H ++K SNI++      ++ DFGLA   G S    P  V   YRAPEV       + 
Sbjct: 149 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGYKEN 207
Query: 549 ADVYSFGVLLLELLTG 564
            D++S G ++ E++ G
Sbjct: 208 VDIWSVGCIMGEMIKG 223

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTIS----EREFKDKIE 417
           R F ++D        LGKG FG  Y A  +    I+A+K L    +     E + + +IE
Sbjct: 10  RKFTIDDF--DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIE 67
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLI 475
               + H N++ +  Y++      L+ ++   G L   L  HG     R+    E     
Sbjct: 68  IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME----- 122
Query: 476 ALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-- 533
               A  + Y H +   V H +IK  N+L+    E +++DFG + +  PS     + G  
Sbjct: 123 --ELADALHYCHER--KVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTL 177
Query: 534 -YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
            Y  PE+ +     +K D++  GVL  E L G  P
Sbjct: 178 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 212

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 74/328 (22%), Positives = 128/328 (39%), Gaps = 54/328 (16%)
Query: 341 KTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASAEV---LGKGTFGTAYKAVLE----- 392
           K + ++ +        F G  + + DL+++ R +  +   LG G FG  Y+  +      
Sbjct: 39  KLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND 98
Query: 393 -MGTIVAVKRLKDVTISEREFKDKIEG--VGAVNHENLVPLRAYYYSMDEKLLVYDYLTM 449
                VAVK L +V   + E    +E   +   NH+N+V           + ++ + +  
Sbjct: 99  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 158
Query: 450 GSLSALLHGNKGAGRTPLNWEMRSL--IALGAARGIEYLHAQGPNVSHGNIKSSNILLTK 507
           G L + L   +     P +  M  L  +A   A G +YL     +  H +I + N LLT 
Sbjct: 159 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTC 216
Query: 508 SYEARVS---DFGLAHLVGPSSTPNRVAGYR------------APEVTDPCKVSQKADVY 552
               RV+   DFG+A  +       R   YR             PE       + K D +
Sbjct: 217 PGPGRVAKIGDFGMARDI------YRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 270
Query: 553 SFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMV 611
           SFGVLL E+ + G  P  +  N+E ++                 F     R    +    
Sbjct: 271 SFGVLLWEIFSLGYMPYPSKSNQEVLE-----------------FVTSGGRMDPPKNCPG 313
Query: 612 QLLQLAIDCSAQYPDNRPSMSEVIKRIE 639
            + ++   C    P++RP+ + +++RIE
Sbjct: 314 PVYRIMTQCWQHQPEDRPNFAIILERIE 341

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 37/210 (17%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVK-RLKDVTISERE-------FKDKIEGVGAVNHENLVP 429
           LG G   T Y   L   TI+ +K  +K + I  RE       F+ ++     ++H+N+V 
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           +       D   LV +Y+   +LS  +  HG      T +N+  + L       GI+  H
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVD-TAINFTNQIL------DGIK--H 126
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--TPNRVAG---YRAP----- 537
           A    + H +IK  NIL+  +   ++ DFG+A  +  +S    N V G   Y +P     
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 538 EVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           E TD C      D+YS G++L E+L G+ P
Sbjct: 187 EATDEC-----TDIYSIGIVLYEMLVGEPP 211

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 124/306 (40%), Gaps = 42/306 (13%)
Query: 357 FFGNAARVFDLEDLLRASAEV---LGKGTFGTAYKAVLE------MGTIVAVKRLKDVTI 407
           F G  + + DL+++ R +  +   LG G FG  Y+  +           VAVK L +V  
Sbjct: 41  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 100
Query: 408 SEREFKDKIEG--VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRT 465
            + E    +E   +   NH+N+V           + ++ + +  G L + L   +     
Sbjct: 101 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 160
Query: 466 PLNWEMRSL--IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVS---DFGLAH 520
           P +  M  L  +A   A G +YL     +  H +I + N LLT     RV+   DFG+A 
Sbjct: 161 PSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218
Query: 521 LVGPSSTPNR------VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLN 573
            +  +S   +         +  PE       + K D +SFGVLL E+ + G  P  +  N
Sbjct: 219 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 278
Query: 574 EEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSE 633
           +E ++                 F     R    +     + ++   C    P++RP+ + 
Sbjct: 279 QEVLE-----------------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAI 321
Query: 634 VIKRIE 639
           +++RIE
Sbjct: 322 ILERIE 327

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 25/202 (12%)
Query: 376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISE------REFKDKIEGVGAVNHENLV 428
           + LG+G F T YKA  +    IVA+K++K    SE      R    +I+ +  ++H N++
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L   +       LV+D++    L  ++  N     TP + +   L+ L   +G+EYLH 
Sbjct: 76  GLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV-LTPSHIKAYMLMTL---QGLEYLHQ 130
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRAPEVTD 541
               + H ++K +N+LL ++   +++DFGLA   G   +PNR          YRAPE+  
Sbjct: 131 HW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFG---SPNRAYXHQVVTRWYRAPELLF 185
Query: 542 PCKV-SQKADVYSFGVLLLELL 562
             ++     D+++ G +L ELL
Sbjct: 186 GARMYGVGVDMWAVGCILAELL 207

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 20/197 (10%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY A+LE    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 41  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVF 97
Query: 435 Y---SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
               S++E   VY  + M  + A L       +  L+ E  S +      GI++LH+ G 
Sbjct: 98  TPQKSLEEFQDVY--IVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG- 151
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQK 548
            + H ++K SNI++      ++ DFGLA   G S   TP  V   YRAPEV       + 
Sbjct: 152 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 210
Query: 549 ADVYSFGVLLLELLTGK 565
            D++S G ++ E++  K
Sbjct: 211 VDLWSVGCIMGEMVCHK 227

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 23/179 (12%)
Query: 399 VKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHG 458
           V+ L++ T+ E +   K+ G     H N++ L+  Y +     LV+D +  G L   L  
Sbjct: 63  VQELREATLKEVDILRKVSG-----HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE 117
Query: 459 NKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGL 518
                       MR+L+ +  A     LH    N+ H ++K  NILL      +++DFG 
Sbjct: 118 KVTLSEKETRKIMRALLEVICA-----LHKL--NIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 519 AHLVGPSSTPNRVAG---YRAPEVTDPCKVS-------QKADVYSFGVLLLELLTGKAP 567
           +  + P      V G   Y APE+ + C ++       ++ D++S GV++  LL G  P
Sbjct: 171 SCQLDPGEKLREVCGTPSYLAPEIIE-CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVPL 430
           E LGKG F    + V +  G   A K +    +S R+F+ K+E    +     H N+V L
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRL 70
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                      LV+D +T G L   +   +       +  ++ ++       I Y H+ G
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL-----ESIAYCHSNG 125
Query: 491 PNVSHGNIKSSNILLT---KSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCK 544
             + H N+K  N+LL    K    +++DFGLA  V  S   +  AG   Y +PEV     
Sbjct: 126 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 545 VSQKADVYSFGVLLLELLTGKAP 567
            S+  D+++ GV+L  LL G  P
Sbjct: 184 YSKPVDIWACGVILYILLVGYPP 206

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 126/294 (42%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG    A          +    VAVK LKD   +E +  D +  +  +     H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEEDLSDLVSEMEMMKMIGKHK 101
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG--------RTPL-NWEMRSLIA 476
           N++ L           ++ +Y + G+L   L   +  G        R P      + L++
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 477 LGA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-----PSSTPN 529
                ARG+EYL +Q     H ++ + N+L+T++   +++DFGLA  +        +T  
Sbjct: 162 CTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVL+ E+ T G +P   +  EE   L +    + 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 279
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 280 KP--------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVPL 430
           E LGKG F    + V +  G   A K +    +S R+F+ K+E    +     H N+V L
Sbjct: 11  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRL 69
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                      LV+D +T G L   +   +       +  ++ ++       I Y H+ G
Sbjct: 70  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL-----ESIAYCHSNG 124
Query: 491 PNVSHGNIKSSNILLT---KSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCK 544
             + H N+K  N+LL    K    +++DFGLA  V  S   +  AG   Y +PEV     
Sbjct: 125 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 182
Query: 545 VSQKADVYSFGVLLLELLTGKAP 567
            S+  D+++ GV+L  LL G  P
Sbjct: 183 YSKPVDIWACGVILYILLVGYPP 205

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 122/288 (42%), Gaps = 40/288 (13%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKD-VTISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+         E  T VAVK + +  ++ ER EF ++   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALL-----HGNKGAGRTPLNWEMRSLIALGAARGIE 484
           L          L+V + +  G L + L           GR P   +    +A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYRAPE 538
           YL+A+     H ++ + N ++   +  ++ DFG+   +  +    +         + APE
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE 202
Query: 539 VTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD 597
                  +  +D++SFGV+L E+ +  + P   L NE+       V   V D    +  D
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLKFVMDGGYLDQPD 255
Query: 598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHPS 644
                  N  E +  L+++   C    P+ RP+  E++  + ++LHPS
Sbjct: 256 -------NCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLKDDLHPS 293

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 33/215 (15%)
Query: 376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAVN----------- 423
           +V+G+G      + V    G   AVK + +VT +ER   +++E V               
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVK-IMEVT-AERLSPEQLEEVREATRRETHILRQVA 157
Query: 424 -HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
            H +++ L   Y S     LV+D +  G L   L              MRSL+       
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL-----EA 212
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA---GYRAPEV 539
           + +LHA   N+ H ++K  NILL  + + R+SDFG +  + P      +    GY APE+
Sbjct: 213 VSFLHAN--NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270
Query: 540 TDPCKVSQ-------KADVYSFGVLLLELLTGKAP 567
              C + +       + D+++ GV+L  LL G  P
Sbjct: 271 LK-CSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVPL 430
           E LGKG F    + V +  G   A K +    +S R+F+ K+E    +     H N+V L
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRL 70
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                      LV+D +T G L   +   +       +  ++ ++       I Y H+ G
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL-----ESIAYCHSNG 125
Query: 491 PNVSHGNIKSSNILLT---KSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCK 544
             + H N+K  N+LL    K    +++DFGLA  V  S   +  AG   Y +PEV     
Sbjct: 126 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 545 VSQKADVYSFGVLLLELLTGKAP 567
            S+  D+++ GV+L  LL G  P
Sbjct: 184 YSKPVDIWACGVILYILLVGYPP 206

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 23/179 (12%)
Query: 399 VKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHG 458
           V+ L++ T+ E +   K+ G     H N++ L+  Y +     LV+D +  G L   L  
Sbjct: 63  VQELREATLKEVDILRKVSG-----HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE 117
Query: 459 NKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGL 518
                       MR+L+ +  A     LH    N+ H ++K  NILL      +++DFG 
Sbjct: 118 KVTLSEKETRKIMRALLEVICA-----LHKL--NIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 519 AHLVGPSSTPNRVAG---YRAPEVTDPCKVS-------QKADVYSFGVLLLELLTGKAP 567
           +  + P      V G   Y APE+ + C ++       ++ D++S GV++  LL G  P
Sbjct: 171 SCQLDPGEKLRSVCGTPSYLAPEIIE-CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 20/197 (10%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY A+LE    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVF 92
Query: 435 Y---SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
               S++E   VY  + M  + A L       +  L+ E  S +      GI++LH+ G 
Sbjct: 93  TPQKSLEEFQDVY--IVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG- 146
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQK 548
            + H ++K SNI++      ++ DFGLA   G S    P  V   YRAPEV       + 
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKEN 205
Query: 549 ADVYSFGVLLLELLTGK 565
            D++S G ++ E++  K
Sbjct: 206 VDIWSVGCIMGEMVCHK 222

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 126/294 (42%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG    A          +    VAVK LKD   +E++  D +  +  +     H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHK 101
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG--------RTPL-NWEMRSLIA 476
           N++ L           ++  Y + G+L   L   +  G        R P      + L++
Sbjct: 102 NIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 477 LGA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-----PSSTPN 529
                ARG+EYL +Q     H ++ + N+L+T++   +++DFGLA  +        +T  
Sbjct: 162 CTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVL+ E+ T G +P   +  EE   L +    + 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 279
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 280 KP--------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 375 AEVLGKGTFGT---AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
            + LG+G  G    A   V E    V +  +K         K +I     +NHEN+V   
Sbjct: 11  VQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +    + + L  +Y + G L   +  + G            L+A     G+ YLH  G 
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGIG- 124
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV 545
            ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    + 
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 546 -SQKADVYSFGVLLLELLTGKAP 567
            ++  DV+S G++L  +L G+ P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 14/196 (7%)
Query: 378 LGKGTFGTAYKAVLEM-GTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A+ +  G  VA+K+L    +    ++R +++ +  +  + HEN++ L  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL-LLKHMQHENVIGLLD 108
Query: 433 YYYSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +         YD YL M  +   L    G      + E    +     +G++Y+H+ G 
Sbjct: 109 VFTPASSLRNFYDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAG- 164
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA-GYRAPEVT-DPCKVSQKA 549
            V H ++K  N+ + +  E ++ DFGLA       T   V   YRAPEV       +Q  
Sbjct: 165 -VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTV 223
Query: 550 DVYSFGVLLLELLTGK 565
           D++S G ++ E+LTGK
Sbjct: 224 DIWSVGCIMAEMLTGK 239

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 38/212 (17%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGA-----------VN 423
           E +G+GT+GT +KA   E   IVA+KR++          D  EGV +           + 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVR--------LDDDDEGVPSSALREICLLKELK 59
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
           H+N+V L    +S  +  LV+++     L        G     L+ E+         +G+
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD----LDPEIVKSFLFQLLKGL 114
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRA 536
            + H++  NV H ++K  N+L+ ++ E +++DFGLA   G    P R          YR 
Sbjct: 115 GFCHSR--NVLHRDLKPQNLLINRNGELKLADFGLARAFG---IPVRCYSAEVVTLWYRP 169
Query: 537 PEVTDPCKV-SQKADVYSFGVLLLELLTGKAP 567
           P+V    K+ S   D++S G +  EL     P
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 126/294 (42%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG    A          +    VAVK LKD   +E++  D +  +  +     H+
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHK 101
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG--------RTPL-NWEMRSLIA 476
           N++ L           ++  Y + G+L   L   +  G        R P      + L++
Sbjct: 102 NIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 477 LGA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-----PSSTPN 529
                ARG+EYL +Q     H ++ + N+L+T++   +++DFGLA  +        +T  
Sbjct: 162 CTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVL+ E+ T G +P   +  EE   L +    + 
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 279
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 280 KP--------------ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 24/226 (10%)
Query: 356 VFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISERE--- 411
           VF  N    FD  ++LRA    +GKG+FG        +   + A+K +      ER    
Sbjct: 5   VFDENEDVNFDHFEILRA----IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVR 60
Query: 412 --FKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNW 469
             FK+ ++ +  + H  LV L   +   ++  +V D L  G L   L  N          
Sbjct: 61  NVFKE-LQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN-----VHFKE 114
Query: 470 EMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN 529
           E   L        ++YL  Q   + H ++K  NILL +     ++DF +A ++   +   
Sbjct: 115 ETVKLFICELVMALDYL--QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT 172
Query: 530 RVAG---YRAPEVTDPCK---VSQKADVYSFGVLLLELLTGKAPTH 569
            +AG   Y APE+    K    S   D +S GV   ELL G+ P H
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISERE-FKDKIEGVGAVNHENLVPLRAY 433
           E LG G FG  ++      G   A K +     S++E  + +I+ +  + H  LV L   
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 434 YYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
           +   +E +++Y++++ G L   +    NK +    + + MR +      +G+ ++H    
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-MRQV-----CKGLCHMHEN-- 274
Query: 492 NVSHGNIKSSNILLT--KSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVS 546
           N  H ++K  NI+ T  +S E ++ DFGL   + P  +     G   + APEV +   V 
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 547 QKADVYSFGVLLLELLTGKAP 567
              D++S GVL   LL+G +P
Sbjct: 335 YYTDMWSVGVLSYILLSGLSP 355

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 19/200 (9%)
Query: 378 LGKGTFGT---AYKAVLEMGTIVAVKRLK---DVTISEREFKDKIEGVGAVNHENLVPLR 431
           +G G +G+   AY A L     VAVK+L       I  R    ++  +  + HEN++ L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHG--NKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
             +        + D+  +  ++ L+    N       L+ E    +     RG++Y+H+ 
Sbjct: 94  DVFTPATS---IEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCKVS 546
           G  + H ++K SN+ + +  E R+ DFGLA       T   VA   YRAPE+  +    +
Sbjct: 151 G--IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT-GYVATRWYRAPEIMLNWMHYN 207
Query: 547 QKADVYSFGVLLLELLTGKA 566
           Q  D++S G ++ ELL GKA
Sbjct: 208 QTVDIWSVGCIMAELLQGKA 227

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISERE-FKDKIEGVGAVNHENLVPLRAY 433
           E LG G FG  ++      G   A K +     S++E  + +I+ +  + H  LV L   
Sbjct: 57  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 116
Query: 434 YYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
           +   +E +++Y++++ G L   +    NK +    + + MR +      +G+ ++H    
Sbjct: 117 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-MRQV-----CKGLCHMHEN-- 168
Query: 492 NVSHGNIKSSNILLT--KSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVS 546
           N  H ++K  NI+ T  +S E ++ DFGL   + P  +     G   + APEV +   V 
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 228
Query: 547 QKADVYSFGVLLLELLTGKAP 567
              D++S GVL   LL+G +P
Sbjct: 229 YYTDMWSVGVLSYILLSGLSP 249

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 132/292 (45%), Gaps = 51/292 (17%)
Query: 376 EVLGKGTFG-----TAYKAVLEMGTI-VAVKRLKDVTISERE--FKDKIEGVGAV-NHEN 426
           + LG G FG     TA+    E   + VAVK LK    ++ +     +++ +  +  HEN
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHG------NKGAGRTPLNWEMRSLIALGA- 479
           +V L          L++ +Y   G L   L        +K  GR PL  E+R L+   + 
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGR-PL--ELRDLLHFSSQ 160
Query: 480 -ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPN 529
            A+G+ +L ++  N  H ++ + N+LLT  + A++ DFGLA  +         G +  P 
Sbjct: 161 VAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 218
Query: 530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVK 588
           +   + APE    C  + ++DV+S+G+LL E+ + G  P   +L             +VK
Sbjct: 219 K---WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------FYKLVK 269
Query: 589 DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE 640
           D +       ++ +     + +  ++Q    C A  P +RP+  ++   ++E
Sbjct: 270 DGY-------QMAQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFLQE 311

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 379 GKGTFGTAYKAVLE-MGTIVAVKR-LKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           G+GTFGT      +  G  VA+K+ ++D     RE +  ++ +  ++H N+V L++Y+Y+
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQSYFYT 90
Query: 437 MDE--KLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMR---------SLIALGAARGIEY 485
           + E  +  +Y  + M  +   LH      R   N+  R          +      R I  
Sbjct: 91  LGERDRRDIYLNVVMEYVPDTLH------RCCRNYYRRQVAPPPILIKVFLFQLIRSIGC 144
Query: 486 LHAQGPNVSHGNIKSSNILLTKSY-EARVSDFGLAHLVGPSSTPNRV----AGYRAPE-V 539
           LH    NV H +IK  N+L+ ++    ++ DFG A  + PS  PN        YRAPE +
Sbjct: 145 LHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELI 203
Query: 540 TDPCKVSQKADVYSFGVLLLELLTGK 565
                 +   D++S G +  E++ G+
Sbjct: 204 FGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 14/196 (7%)
Query: 378 LGKGTFGTAYKAVLEM-GTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A+ +  G  VA+K+L    +    ++R +++ +  +  + HEN++ L  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL-LLKHMQHENVIGLLD 90
Query: 433 YYYSMDEKLLVYD-YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            +         YD YL M  +   L    G      + E    +     +G++Y+H+ G 
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEKIQYLVYQMLKGLKYIHSAG- 146
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA-GYRAPEVT-DPCKVSQKA 549
            V H ++K  N+ + +  E ++ DFGLA       T   V   YRAPEV       +Q  
Sbjct: 147 -VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTV 205
Query: 550 DVYSFGVLLLELLTGK 565
           D++S G ++ E+LTGK
Sbjct: 206 DIWSVGCIMAEMLTGK 221

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 38  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 84  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVS 143
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 144 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 201
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+      S+ +D+++ G ++ +L+ G  P  A
Sbjct: 202 SPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 121/288 (42%), Gaps = 40/288 (13%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKD-VTISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+         E  T VAVK + +  ++ ER EF ++   +      ++V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALL-----HGNKGAGRTPLNWEMRSLIALGAARGIE 484
           L          L+V + +  G L + L           GR P   +    +A   A G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYRAPE 538
           YL+A+     H ++ + N ++   +  ++ DFG+   +  +    +         + APE
Sbjct: 142 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE 199
Query: 539 VTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD 597
                  +  +D++SFGV+L E+ +  + P   L NE+       V   V D    +  D
Sbjct: 200 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLKFVMDGGYLDQPD 252
Query: 598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHPS 644
                  N  E +  L+++   C    P  RP+  E++  + ++LHPS
Sbjct: 253 -------NCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDLHPS 290

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 121/288 (42%), Gaps = 40/288 (13%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKD-VTISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+         E  T VAVK + +  ++ ER EF ++   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALL-----HGNKGAGRTPLNWEMRSLIALGAARGIE 484
           L          L+V + +  G L + L           GR P   +    +A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYRAPE 538
           YL+A+     H ++ + N ++   +  ++ DFG+   +  +    +         + APE
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE 202
Query: 539 VTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD 597
                  +  +D++SFGV+L E+ +  + P   L NE+       V   V D    +  D
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLKFVMDGGYLDQPD 255
Query: 598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHPS 644
                  N  E +  L+++   C    P  RP+  E++  + ++LHPS
Sbjct: 256 -------NCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDLHPS 293

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 50/103 (48%), Gaps = 10/103 (9%)
Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY----EARVSDFGLAHLV----GP 524
           S +     + +EYLHAQG  V H ++K SNIL           R+ DFG A  +    G 
Sbjct: 119 SAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 525 SSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
             TP   A + APEV +        D++S GVLL  +LTG  P
Sbjct: 177 LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 90/188 (47%), Gaps = 25/188 (13%)
Query: 461 GAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH 520
           G  + P+  E     +   ARG+E+L ++     H ++ + NILL+++   ++ DFGLA 
Sbjct: 190 GFYKEPITMEDLISYSFQVARGMEFLSSR--KCIHRDLAARNILLSENNVVKICDFGLAR 247
Query: 521 LVGPSSTPNRVAGYR------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLN 573
            +  +    R    R      APE       S K+DV+S+GVLL E+ + G +P   +  
Sbjct: 248 DIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQM 307
Query: 574 EEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSE 633
           +E              ++ S +   E +R +  E    ++ Q+ +DC  + P  RP  +E
Sbjct: 308 DE--------------DFCSRL--REGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAE 351
Query: 634 VIKRIEEL 641
           +++++ +L
Sbjct: 352 LVEKLGDL 359

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 20/197 (10%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    AY A+LE    VA+K+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVF 92
Query: 435 Y---SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
               S++E   VY  + M  + A L       +  L+ E  S +      GI++LH+ G 
Sbjct: 93  TPQKSLEEFQDVY--IVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAG- 146
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVSQK 548
            + H ++K SNI++      ++ DFGLA   G S    P  V   YRAPEV       + 
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKEN 205
Query: 549 ADVYSFGVLLLELLTGK 565
            D++S G ++ E++  K
Sbjct: 206 VDLWSVGCIMGEMVCHK 222

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 19/200 (9%)
Query: 378 LGKGTFGT---AYKAVLEMGTIVAVKRLK---DVTISEREFKDKIEGVGAVNHENLVPLR 431
           +G G +G+   AY A L     VAVK+L       I  R    ++  +  + HEN++ L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHG--NKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
             +        + D+  +  ++ L+    N       L+ E    +     RG++Y+H+ 
Sbjct: 94  DVFTPATS---IEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCKVS 546
           G  + H ++K SN+ + +  E R+ DFGLA       T   VA   YRAPE+  +    +
Sbjct: 151 G--IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT-GYVATRWYRAPEIMLNWMHYN 207
Query: 547 QKADVYSFGVLLLELLTGKA 566
           Q  D++S G ++ ELL GKA
Sbjct: 208 QTVDIWSVGCIMAELLQGKA 227

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 132/292 (45%), Gaps = 51/292 (17%)
Query: 376 EVLGKGTFG-----TAYKAVLEMGTI-VAVKRLKDVTISERE--FKDKIEGVGAV-NHEN 426
           + LG G FG     TA+    E   + VAVK LK    ++ +     +++ +  +  HEN
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHG------NKGAGRTPLNWEMRSLIALGA- 479
           +V L          L++ +Y   G L   L        +K  GR PL  E+R L+   + 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGR-PL--ELRDLLHFSSQ 168
Query: 480 -ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPN 529
            A+G+ +L ++  N  H ++ + N+LLT  + A++ DFGLA  +         G +  P 
Sbjct: 169 VAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 226
Query: 530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVK 588
           +   + APE    C  + ++DV+S+G+LL E+ + G  P   +L             +VK
Sbjct: 227 K---WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------FYKLVK 277
Query: 589 DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE 640
           D +       ++ +     + +  ++Q    C A  P +RP+  ++   ++E
Sbjct: 278 DGY-------QMAQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFLQE 319

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 19/200 (9%)
Query: 378 LGKGTFGT---AYKAVLEMGTIVAVKRLK---DVTISEREFKDKIEGVGAVNHENLVPLR 431
           +G G +G+   AY A L     VAVK+L       I  R    ++  +  + HEN++ L 
Sbjct: 28  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHG--NKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
             +        + D+  +  ++ L+    N       L+ E    +     RG++Y+H+ 
Sbjct: 86  DVFTPATS---IEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA 142
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCKVS 546
           G  + H ++K SN+ + +  E R+ DFGLA       T   VA   YRAPE+  +    +
Sbjct: 143 G--IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMT-GYVATRWYRAPEIMLNWMHYN 199
Query: 547 QKADVYSFGVLLLELLTGKA 566
           Q  D++S G ++ ELL GKA
Sbjct: 200 QTVDIWSVGCIMAELLQGKA 219

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 122/291 (41%), Gaps = 46/291 (15%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKD-VTISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+         E  T VAVK + +  ++ ER EF ++   +      ++V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLH-----GNKGAGRTPLNWEMRSLIALGAARGIE 484
           L          L+V + +  G L + L           GR P   +    +A   A G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAGYR 535
           YL+A+     H ++ + N ++   +  ++ DFG+   +         G    P R   + 
Sbjct: 144 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---WM 198
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           APE       +  +D++SFGV+L E+ +  + P   L NE+       V   V D    +
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLKFVMDGGYLD 251
Query: 595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHPS 644
             D       N  E +  L+++   C    P  RP+  E++  + ++LHPS
Sbjct: 252 QPD-------NCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDLHPS 292

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 136/300 (45%), Gaps = 56/300 (18%)
Query: 364 VFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTI---VAVKRLKDVTISE--REFKDKIEG 418
           V D  D+     +V+G+G FG   KA ++   +    A+KR+K+    +  R+F  ++E 
Sbjct: 21  VLDWNDI--KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 78
Query: 419 VGAV-NHENLVPL------RAYYYSMDEKLLVYDYLTMGSLSALLHGNKG---------A 462
           +  + +H N++ L      R Y Y      L  +Y   G+L   L  ++          A
Sbjct: 79  LCKLGHHPNIINLLGACEHRGYLY------LAIEYAPHGNLLDFLRKSRVLETDPAFAIA 132
Query: 463 GRTPLNWEMRSLIALGA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA- 519
             T      + L+   A  ARG++YL  +     H ++ + NIL+ ++Y A+++DFGL+ 
Sbjct: 133 NSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLSR 190
Query: 520 -HLVGPSSTPNRV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEG 576
              V    T  R+   + A E  +    +  +DV+S+GVLL E+++ G  P   +   E 
Sbjct: 191 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250
Query: 577 VD-LPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVI 635
            + LP+                  L +  N ++E+  L++    C  + P  RPS ++++
Sbjct: 251 YEKLPQ---------------GYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQIL 292

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 122/291 (41%), Gaps = 46/291 (15%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKD-VTISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+         E  T VAVK + +  ++ ER EF ++   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALL-----HGNKGAGRTPLNWEMRSLIALGAARGIE 484
           L          L+V + +  G L + L           GR P   +    +A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAGYR 535
           YL+A+     H ++ + N ++   +  ++ DFG+   +         G    P R   + 
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---WM 199
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           APE       +  +D++SFGV+L E+ +  + P   L NE+       V   V D    +
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLKFVMDGGYLD 252
Query: 595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHPS 644
             D       N  E +  L+++   C    P  RP+  E++  + ++LHPS
Sbjct: 253 QPD-------NCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDLHPS 293

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 136/300 (45%), Gaps = 56/300 (18%)
Query: 364 VFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTI---VAVKRLKDVTISE--REFKDKIEG 418
           V D  D+     +V+G+G FG   KA ++   +    A+KR+K+    +  R+F  ++E 
Sbjct: 11  VLDWNDI--KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 68
Query: 419 VGAV-NHENLVPL------RAYYYSMDEKLLVYDYLTMGSLSALLHGNKG---------A 462
           +  + +H N++ L      R Y Y      L  +Y   G+L   L  ++          A
Sbjct: 69  LCKLGHHPNIINLLGACEHRGYLY------LAIEYAPHGNLLDFLRKSRVLETDPAFAIA 122
Query: 463 GRTPLNWEMRSLIALGA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA- 519
             T      + L+   A  ARG++YL  +     H ++ + NIL+ ++Y A+++DFGL+ 
Sbjct: 123 NSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLSR 180
Query: 520 -HLVGPSSTPNRV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEG 576
              V    T  R+   + A E  +    +  +DV+S+GVLL E+++ G  P   +   E 
Sbjct: 181 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 240
Query: 577 VD-LPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVI 635
            + LP+                  L +  N ++E+  L++    C  + P  RPS ++++
Sbjct: 241 YEKLPQ---------------GYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQIL 282

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 16  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 61
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 62  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 121
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 122 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 214

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 122/291 (41%), Gaps = 46/291 (15%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKD-VTISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+         E  T VAVK + +  ++ ER EF ++   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALL-----HGNKGAGRTPLNWEMRSLIALGAARGIE 484
           L          L+V + +  G L + L           GR P   +    +A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAGYR 535
           YL+A+     H ++ + N ++   +  ++ DFG+   +         G    P R   + 
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR---WM 199
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           APE       +  +D++SFGV+L E+ +  + P   L NE+       V   V D    +
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLKFVMDGGYLD 252
Query: 595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHPS 644
             D       N  E +  L+++   C    P  RP+  E++  + ++LHPS
Sbjct: 253 QPD-------NCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDLHPS 293

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 22/202 (10%)
Query: 378 LGKGTFGTAYKAVLE-----MGTIVAVKRLKDVTISER--EFKDKIEGVGAVNHENLVPL 430
           LG+G FG       +      G  VAVK LK  +      + K +IE +  + HEN+V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 431 RAYYYSM--DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
           +        +   L+ ++L  GSL   L  NK      +N + +   A+   +G++YL +
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQICKGMDYLGS 144
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR-------APEVTD 541
           +     H ++ + N+L+   ++ ++ DFGL   +        V   R       APE   
Sbjct: 145 R--QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 542 PCKVSQKADVYSFGVLLLELLT 563
             K    +DV+SFGV L ELLT
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 117/284 (41%), Gaps = 32/284 (11%)
Query: 378 LGKGTFGTAYKAVLE-----MGTIVAVKRLKDVTISER--EFKDKIEGVGAVNHENLVPL 430
           LG+G FG       +      G  VAVK LK  +      + K +IE +  + HEN+V  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 431 RAYYYSM--DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
           +        +   L+ ++L  GSL   L  NK      +N + +   A+   +G++YL +
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQICKGMDYLGS 132
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR-------APEVTD 541
           +     H ++ + N+L+   ++ ++ DFGL   +        V   R       APE   
Sbjct: 133 R--QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 542 PCKVSQKADVYSFGVLLLELLT----GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD 597
             K    +DV+SFGV L ELLT      +P    L   G   P   Q  V     +    
Sbjct: 191 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG---PTHGQMTVTRLVNTLKEG 247
Query: 598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
             L    N  +E+ QL++    C    P NR S   +I+  E L
Sbjct: 248 KRLPCPPNCPDEVYQLMR---KCWEFQPSNRTSFQNLIEGFEAL 288

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 14  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 59
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 60  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 119
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 120 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 15  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 60
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 61  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 120
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 121 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 213

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 13  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 58
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 59  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 118
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 119 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 211

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 121/250 (48%), Gaps = 43/250 (17%)
Query: 345 NSNVNGATKKLVFFGNAAR---VFDLEDLLRASAEV---------LGKGTFGTAYKAV-L 391
           +S V+  T+ L F  NA++    F  ++L +   EV         +G G +G+   A   
Sbjct: 8   SSGVDLGTENLYFQSNASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDT 67
Query: 392 EMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYYY---SMDEKLLVY 444
           + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L   +    S++E   VY
Sbjct: 68  KTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 126
Query: 445 --DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSN 502
              +L    L+ ++   K      L  +    +     RG++Y+H+   ++ H ++K SN
Sbjct: 127 LVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIHSA--DIIHRDLKPSN 178
Query: 503 ILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------YRAPEVT-DPCKVSQKADVYSFG 555
           + + +  E ++ DFGLA       T + + G      YRAPE+  +    +Q  D++S G
Sbjct: 179 LAVNEDCELKILDFGLAR-----HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 233
Query: 556 VLLLELLTGK 565
            ++ ELLTG+
Sbjct: 234 CIMAELLTGR 243

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 35  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 80
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 81  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 140
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 141 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 233

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 20  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 65
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 66  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 125
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 126 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 218

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L++   +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 83  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 135
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 136 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 35  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 80
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 81  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 140
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 141 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 39  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 84
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 85  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 144
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 145 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 202
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 237

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 36  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 82  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 141
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 142 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 36  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 82  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 141
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 142 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 106/233 (45%), Gaps = 29/233 (12%)
Query: 351 ATKKLVFFG-----NAARVFDLEDLLRASAEVLGKGTFGTAYKAVL-----EMGTIVAVK 400
            T+ L F G     N A +  L++      +VLG G FGT YK +      ++   VA+K
Sbjct: 16  TTENLYFQGSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK 75
Query: 401 RLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALL-- 456
            L++ T   + +E  D+   + +V++ ++  L     +   +L+    +  G L   +  
Sbjct: 76  ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE 134
Query: 457 HGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDF 516
           H +    +  LNW       +  A+G+ YL  +   + H ++ + N+L+      +++DF
Sbjct: 135 HKDNIGSQYLLNW------CVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDF 186
Query: 517 GLAHLVGPSSTPNRVAGYRAP------EVTDPCKVSQKADVYSFGVLLLELLT 563
           GLA L+G         G + P      E       + ++DV+S+GV + EL+T
Sbjct: 187 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 38  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 84  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 143
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 144 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 39  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 84
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 85  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 144
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 145 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 202
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 237

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L++   +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 84  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 136
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 137 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 29/223 (13%)
Query: 367 LEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE--FKDKIEGVGAVN 423
            ED+ + ++E+LG+G +     AV L+ G   AVK ++      R   F++         
Sbjct: 10  FEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQG 69
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
           ++N++ L  ++       LV++ L  GS+ A +   K       N    S +    A  +
Sbjct: 70  NKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH-----FNEREASRVVRDVAAAL 124
Query: 484 EYLHAQGPNVSHGNIKSSNILL---TKSYEARVSDFGLAH----------LVGPS-STPN 529
           ++LH +G  ++H ++K  NIL     K    ++ DF L            +  P  +TP 
Sbjct: 125 DFLHTKG--IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC 182
Query: 530 RVAGYRAPEV----TDPCKV-SQKADVYSFGVLLLELLTGKAP 567
             A Y APEV    TD      ++ D++S GV+L  +L+G  P
Sbjct: 183 GSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 38  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 84  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 143
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 144 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L++   +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 81  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 134 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 38  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 84  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 143
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 144 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L++   +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 82  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 134
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 135 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 193 LHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 36  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 82  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 141
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 142 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYV 199
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L++   +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 85  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 137
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 138 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 196 LHRIYTHQSDVWSYGVTVWELMT 218

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 25/202 (12%)
Query: 378 LGKGTFGTAYKAVL-EMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G    AV    G  VA+K+L    +    ++R +++ +  +  + HEN++ L  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE-LRLLKHMRHENVIGLLD 91
Query: 433 YYYSMDEKLLVYD--YLTMGSLSALL-----HGNKGAGRTPLNWEMRSLIALGAARGIEY 485
            + + DE L  +   YL M  +   L     H   G  R          +     +G+ Y
Sbjct: 92  VF-TPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI-------QFLVYQMLKGLRY 143
Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA-GYRAPEVT-DPC 543
           +HA G  + H ++K  N+ + +  E ++ DFGLA           V   YRAPEV  +  
Sbjct: 144 IHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTRWYRAPEVILNWM 201
Query: 544 KVSQKADVYSFGVLLLELLTGK 565
           + +Q  D++S G ++ E++TGK
Sbjct: 202 RYTQTVDIWSVGCIMAEMITGK 223

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 38  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 84  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 143
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 144 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 76/175 (43%), Gaps = 19/175 (10%)
Query: 405 VTISEREFKDKIEGVGAV----NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNK 460
           V I ++  +D  E +  +     H N++ L+  Y   D+   VY    +     LL  +K
Sbjct: 52  VKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY---DDGKYVYVVTELXKGGELL--DK 106
Query: 461 GAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY----EARVSDF 516
              +   +    S +     + +EYLHAQG  V H ++K SNIL           R+ DF
Sbjct: 107 ILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDF 164
Query: 517 GLAHLV----GPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           G A  +    G   TP   A + APEV +        D++S GVLL   LTG  P
Sbjct: 165 GFAKQLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 41  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 86
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 87  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 146
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 147 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 204
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 205 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 239

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 108/232 (46%), Gaps = 39/232 (16%)
Query: 377 VLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDK---------IEGVGAVNHEN 426
           VLGKG+FG       ++ G   AVK      IS+R+ K K         ++ +  ++H N
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVK-----VISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           ++ L  ++       LV +  T G L   +   K          +R +++     GI Y+
Sbjct: 88  IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS-----GITYM 142
Query: 487 HAQGPNVSHGNIKSSNILL-TKSYEA--RVSDFGLA-HLVGPSSTPNRV--AGYRAPEVT 540
           H     + H ++K  N+LL +KS +A  R+ DFGL+ H        +++  A Y APEV 
Sbjct: 143 HKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 200
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAP-----THALLN--EEG---VDLPRW 582
                 +K DV+S GV+L  LL+G  P      + +L   E+G    +LP+W
Sbjct: 201 HGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 251

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L+    +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 83  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 135
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 136 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 38  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 84  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 143
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 144 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 202 SPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L+    +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 84  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 136
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 137 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/286 (20%), Positives = 127/286 (44%), Gaps = 60/286 (20%)
Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLK-DVTISEREFKDKIEGVGAVNHENLVPLRAY 433
           E++G G FG  +KA   + G    +KR+K +   +ERE    ++ +  ++H N+V     
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGC 72
Query: 434 YYSMDEK----------------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
           +   D                   +  ++   G+L   +   +G        ++  ++AL
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-------KLDKVLAL 125
Query: 478 ----GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG 533
                  +G++Y+H++   + + ++K SNI L  + + ++ DFGL   +       R  G
Sbjct: 126 ELFEQITKGVDYIHSK--KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKG 183
Query: 534 ---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE 590
              Y +PE        ++ D+Y+ G++L ELL         + +   +  ++   + +D 
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLH--------VCDTAFETSKFFTDL-RDG 234
Query: 591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK 636
             S++FD +       E+ ++Q L       ++ P++RP+ SE+++
Sbjct: 235 IISDIFDKK-------EKTLLQKLL------SKKPEDRPNTSEILR 267

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T         T++A    +++  S RE+  KI     +  EN VP     R
Sbjct: 36  KILGEGSFST---------TVLA----RELATS-REYAIKILEKRHIIKENKVPYVTRER 81
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y T      L  G   A    L   +R + +               
Sbjct: 82  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 141
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 142 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L++   +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 82  RLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 134
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 135 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 193 LHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L+    +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 134 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L+    +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 134 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L+    +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 84  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 136
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 137 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L+    +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 84  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 136
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 137 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 51/220 (23%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE----FKD-KIEGVGAVNHENLVPL 430
           E +GKG FG  ++     G  VAVK       S RE    F++ +I     + HEN++  
Sbjct: 12  ESIGKGRFGEVWRGKWR-GEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILG- 64
Query: 431 RAYYYSMDEK--------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
              + + D K         LV DY   GSL   L+      R  +  E    +AL  A G
Sbjct: 65  ---FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASG 115
Query: 483 IEYLH-----AQG-PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST------PNR 530
           + +LH      QG P ++H ++KS NIL+ K+    ++D GLA +   S+T      PN 
Sbjct: 116 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNH 174
Query: 531 VAG---YRAPEVTDPC------KVSQKADVYSFGVLLLEL 561
             G   Y APEV D        +  ++AD+Y+ G++  E+
Sbjct: 175 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 51/220 (23%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE----FKD-KIEGVGAVNHENLVPL 430
           E +GKG FG  ++     G  VAVK       S RE    F++ +I     + HEN++  
Sbjct: 35  ESIGKGRFGEVWRGKWR-GEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILG- 87
Query: 431 RAYYYSMDEK--------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
              + + D K         LV DY   GSL   L+      R  +  E    +AL  A G
Sbjct: 88  ---FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASG 138
Query: 483 IEYLH-----AQG-PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST------PNR 530
           + +LH      QG P ++H ++KS NIL+ K+    ++D GLA +   S+T      PN 
Sbjct: 139 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNH 197
Query: 531 VAG---YRAPEVTDPC------KVSQKADVYSFGVLLLEL 561
             G   Y APEV D        +  ++AD+Y+ G++  E+
Sbjct: 198 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 39/214 (18%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVK----RLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
           E +GKG +G  ++   + G  VAVK    R +     E E  + +     + HEN++   
Sbjct: 43  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTV----MLRHENILGFI 97
Query: 432 AY----YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           A      +S  +  L+  Y  MGSL   L        T L+      I L  A G+ +LH
Sbjct: 98  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLH 151
Query: 488 -----AQG-PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------- 533
                 QG P ++H ++KS NIL+ K+ +  ++D GLA +   S+    V          
Sbjct: 152 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 211
Query: 534 YRAPEVTDP-----CKVSQK-ADVYSFGVLLLEL 561
           Y APEV D      C  S K  D+++FG++L E+
Sbjct: 212 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 51/220 (23%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE----FKD-KIEGVGAVNHENLVPL 430
           E +GKG FG  ++     G  VAVK       S RE    F++ +I     + HEN++  
Sbjct: 9   ESIGKGRFGEVWRGKWR-GEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILG- 61
Query: 431 RAYYYSMDEK--------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
              + + D K         LV DY   GSL   L+      R  +  E    +AL  A G
Sbjct: 62  ---FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASG 112
Query: 483 IEYLH-----AQG-PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST------PNR 530
           + +LH      QG P ++H ++KS NIL+ K+    ++D GLA +   S+T      PN 
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNH 171
Query: 531 VAG---YRAPEVTDPC------KVSQKADVYSFGVLLLEL 561
             G   Y APEV D        +  ++AD+Y+ G++  E+
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L+    +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 87  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 139
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 140 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 197
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 198 LHRIYTHQSDVWSYGVTVWELMT 220

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L+    +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 91  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 143
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 144 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 201
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 202 LHRIYTHQSDVWSYGVTVWELMT 224

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 51/220 (23%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE----FKD-KIEGVGAVNHENLVPL 430
           E +GKG FG  ++     G  VAVK       S RE    F++ +I     + HEN++  
Sbjct: 10  ESIGKGRFGEVWRGKWR-GEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILG- 62
Query: 431 RAYYYSMDEK--------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
              + + D K         LV DY   GSL   L+      R  +  E    +AL  A G
Sbjct: 63  ---FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASG 113
Query: 483 IEYLH-----AQG-PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST------PNR 530
           + +LH      QG P ++H ++KS NIL+ K+    ++D GLA +   S+T      PN 
Sbjct: 114 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNH 172
Query: 531 VAG---YRAPEVTDPC------KVSQKADVYSFGVLLLEL 561
             G   Y APEV D        +  ++AD+Y+ G++  E+
Sbjct: 173 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 51/220 (23%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE----FKD-KIEGVGAVNHENLVPL 430
           E +GKG FG  ++     G  VAVK       S RE    F++ +I     + HEN++  
Sbjct: 15  ESIGKGRFGEVWRGKWR-GEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILG- 67
Query: 431 RAYYYSMDEK--------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
              + + D K         LV DY   GSL   L+      R  +  E    +AL  A G
Sbjct: 68  ---FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASG 118
Query: 483 IEYLH-----AQG-PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST------PNR 530
           + +LH      QG P ++H ++KS NIL+ K+    ++D GLA +   S+T      PN 
Sbjct: 119 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNH 177
Query: 531 VAG---YRAPEVTDPC------KVSQKADVYSFGVLLLEL 561
             G   Y APEV D        +  ++AD+Y+ G++  E+
Sbjct: 178 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L+    +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 88  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 140
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 141 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 375 AEVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENL 427
            +VLG G FGT YK +       +   VA+K L++ T   + +E  D+   +  V    +
Sbjct: 22  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 81
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKG--AGRTPLNWEMRSLIALGAARGIEY 485
             L     +   +L V   +  G L   +  N+G    +  LNW M+       A+G+ Y
Sbjct: 82  SRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAKGMSY 134
Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EV 539
           L  +   + H ++ + N+L+      +++DFGLA L+    T     G + P      E 
Sbjct: 135 L--EDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 192
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDL 579
               + + ++DV+S+GV + EL+T G  P   +   E  DL
Sbjct: 193 ILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL 233

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 108/232 (46%), Gaps = 39/232 (16%)
Query: 377 VLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDK---------IEGVGAVNHEN 426
           VLGKG+FG       ++ G   AVK      IS+R+ K K         ++ +  ++H N
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVK-----VISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           ++ L  ++       LV +  T G L   +   K          +R +++     GI Y+
Sbjct: 111 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS-----GITYM 165
Query: 487 HAQGPNVSHGNIKSSNILL-TKSYEA--RVSDFGLA-HLVGPSSTPNRV--AGYRAPEVT 540
           H     + H ++K  N+LL +KS +A  R+ DFGL+ H        +++  A Y APEV 
Sbjct: 166 HKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 223
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAP-----THALLN--EEG---VDLPRW 582
                 +K DV+S GV+L  LL+G  P      + +L   E+G    +LP+W
Sbjct: 224 HGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 274

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 22/229 (9%)
Query: 354 KLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREF 412
           +++F G   + + + D  + S +VLG G  G   +      G   A+K L D   + +E 
Sbjct: 13  EVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEV 72
Query: 413 KDKIEGVGAVNHENLVPLRAYYYSMDEK----LLVYDYLTMGSLSALLH--GNKGAGRTP 466
               +  G     ++V +   Y +M       L++ + +  G L + +   G++      
Sbjct: 73  DHHWQASGG---PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE 129
Query: 467 LNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT---KSYEARVSDFGLAHLVG 523
               MR +   G A  I++LH+   N++H ++K  N+L T   K    +++DFG A    
Sbjct: 130 AAEIMRDI---GTA--IQFLHSH--NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182
Query: 524 PSS--TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
            ++  TP     Y APEV  P K  +  D++S GV++  LL G  P ++
Sbjct: 183 QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS 231

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 108/232 (46%), Gaps = 39/232 (16%)
Query: 377 VLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDK---------IEGVGAVNHEN 426
           VLGKG+FG       ++ G   AVK      IS+R+ K K         ++ +  ++H N
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVK-----VISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           ++ L  ++       LV +  T G L   +   K          +R +++     GI Y+
Sbjct: 112 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS-----GITYM 166
Query: 487 HAQGPNVSHGNIKSSNILL-TKSYEA--RVSDFGLA-HLVGPSSTPNRV--AGYRAPEVT 540
           H     + H ++K  N+LL +KS +A  R+ DFGL+ H        +++  A Y APEV 
Sbjct: 167 HKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 224
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAP-----THALLN--EEG---VDLPRW 582
                 +K DV+S GV+L  LL+G  P      + +L   E+G    +LP+W
Sbjct: 225 HGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 275

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 24/198 (12%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    A+  VL  G  VAVK+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 34  AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELV-LLKCVNHKNIISLLNVF 90
Query: 435 Y---SMDEKLLVYDYLTM--GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
               +++E   VY  + +   +L  ++H         L+ E  S +      GI++LH+ 
Sbjct: 91  TPQKTLEEFQDVYLVMELMDANLCQVIHME-------LDHERMSYLLYQMLCGIKHLHSA 143
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVS 546
           G  + H ++K SNI++      ++ DFGLA     +   TP  V   YRAPEV       
Sbjct: 144 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGYK 201
Query: 547 QKADVYSFGVLLLELLTG 564
           +  D++S G ++ EL+ G
Sbjct: 202 ENVDIWSVGCIMGELVKG 219

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 103/205 (50%), Gaps = 31/205 (15%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------YRAPEVT- 540
           +   ++ H ++K SN+ + +  E ++ DFGLA       T + +AG      YRAPE+  
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMAGFVATRWYRAPEIML 195
Query: 541 DPCKVSQKADVYSFGVLLLELLTGK 565
           +    +Q  D++S G ++ ELLTG+
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L+    +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 134 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 103/205 (50%), Gaps = 31/205 (15%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------YRAPEVT- 540
           +   ++ H ++K SN+ + +  E ++ DFGLA       T + +AG      YRAPE+  
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMAGFVATRWYRAPEIML 195
Query: 541 DPCKVSQKADVYSFGVLLLELLTGK 565
           +    +Q  D++S G ++ ELLTG+
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 39/214 (18%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVK----RLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
           E +GKG +G  ++   + G  VAVK    R +     E E  + +     + HEN++   
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTV----MLRHENILGFI 68
Query: 432 AY----YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           A      +S  +  L+  Y  MGSL   L        + L       I L  A G+ +LH
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR------IVLSIASGLAHLH 122
Query: 488 -----AQG-PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------- 533
                 QG P ++H ++KS NIL+ K+ +  ++D GLA +   S+    V          
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 534 YRAPEVTDP-----CKVSQK-ADVYSFGVLLLEL 561
           Y APEV D      C  S K  D+++FG++L E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L+    +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 75  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 127
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 128 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 541 DPCKVSQKADVYSFGVLLLELLT-GKAP 567
                + ++DV+S+GV + EL+T G  P
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKP 213

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 39/214 (18%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVK----RLKDVTISEREFKDKIEGVGAVNHENLVPLR 431
           E +GKG +G  ++   + G  VAVK    R +     E E  + +     + HEN++   
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTV----MLRHENILGFI 68
Query: 432 AY----YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           A      +S  +  L+  Y  MGSL   L        + L       I L  A G+ +LH
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR------IVLSIASGLAHLH 122
Query: 488 -----AQG-PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------- 533
                 QG P ++H ++KS NIL+ K+ +  ++D GLA +   S+    V          
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 534 YRAPEVTDP-----CKVSQK-ADVYSFGVLLLEL 561
           Y APEV D      C  S K  D+++FG++L E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 125/291 (42%), Gaps = 48/291 (16%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKDV-TISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+ V       E  T VA+K + +  ++ ER EF ++   +   N  ++V 
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGR-----TPLNWEMRSLIALGAARGIE 484
           L          L++ + +T G L + L   + A        P +      +A   A G+ 
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAGYR 535
           YL+A      H ++ + N ++ + +  ++ DFG+   +         G    P R   + 
Sbjct: 143 YLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---WM 197
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           +PE       +  +DV+SFGV+L E+ T  + P   L NE+ +                 
Sbjct: 198 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------------- 242
Query: 595 VFDLELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHP 643
           V +  LL +  N  + + +L+++   C    P  RPS  E+I  I EE+ P
Sbjct: 243 VMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKEEMEP 290

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 51/220 (23%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE----FKD-KIEGVGAVNHENLVPL 430
           E +GKG FG  ++     G  VAVK       S RE    F++ +I     + HEN++  
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILG- 100
Query: 431 RAYYYSMDEK--------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
              + + D K         LV DY   GSL   L+      R  +  E    +AL  A G
Sbjct: 101 ---FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASG 151
Query: 483 IEYLH-----AQG-PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST------PNR 530
           + +LH      QG P ++H ++KS NIL+ K+    ++D GLA +   S+T      PN 
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNH 210
Query: 531 VAG---YRAPEVTDPC------KVSQKADVYSFGVLLLEL 561
             G   Y APEV D        +  ++AD+Y+ G++  E+
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 108/232 (46%), Gaps = 39/232 (16%)
Query: 377 VLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDK---------IEGVGAVNHEN 426
           VLGKG+FG       ++ G   AVK      IS+R+ K K         ++ +  ++H N
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVK-----VISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           ++ L  ++       LV +  T G L   +   K          +R +++     GI Y+
Sbjct: 94  IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS-----GITYM 148
Query: 487 HAQGPNVSHGNIKSSNILL-TKSYEA--RVSDFGLA-HLVGPSSTPNRV--AGYRAPEVT 540
           H     + H ++K  N+LL +KS +A  R+ DFGL+ H        +++  A Y APEV 
Sbjct: 149 HKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 206
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAP-----THALLN--EEG---VDLPRW 582
                 +K DV+S GV+L  LL+G  P      + +L   E+G    +LP+W
Sbjct: 207 HGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 257

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRL-KDVTISEREFKDKI---EGVGAVNHENL 427
           ++LGKGTFG   K +L      G   A+K L K+V I++ E    +     +    H  L
Sbjct: 11  KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
             L+  + + D    V +Y   G L    H ++    T    E            +EYLH
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTE---ERARFYGAEIVSALEYLH 122
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTDPC 543
           ++  +V + +IK  N++L K    +++DFGL    +   +T     G   Y APEV +  
Sbjct: 123 SR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDN 180
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTH 569
              +  D +  GV++ E++ G+ P +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 38/212 (17%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGA-----------VN 423
           E +G+GT+GT +KA   E   IVA+KR++          D  EGV +           + 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVR--------LDDDDEGVPSSALREICLLKELK 59
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
           H+N+V L    +S  +  LV+++     L        G     L+ E+         +G+
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD----LDPEIVKSFLFQLLKGL 114
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-------YRA 536
            + H++  NV H ++K  N+L+ ++ E ++++FGLA   G    P R          YR 
Sbjct: 115 GFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAFG---IPVRCYSAEVVTLWYRP 169
Query: 537 PEVTDPCKV-SQKADVYSFGVLLLELLTGKAP 567
           P+V    K+ S   D++S G +  EL     P
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 103/205 (50%), Gaps = 31/205 (15%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 84
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 138
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------YRAPEVT- 540
           +   ++ H ++K SN+ + +  E ++ DFGLA       T + +AG      YRAPE+  
Sbjct: 139 SA--DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMAGFVATRWYRAPEIML 191
Query: 541 DPCKVSQKADVYSFGVLLLELLTGK 565
           +    +Q  D++S G ++ ELLTG+
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 74/308 (24%), Positives = 129/308 (41%), Gaps = 58/308 (18%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISERE----FKDKIEGVGAVNHENL 427
           E LG G+FG   +   +  +     VAVK LK   +S+ E    F  ++  + +++H NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           + L     +   K+ V +   +GSL   L  ++G           S  A+  A G+ YL 
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGYLE 132
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--------GYRAPEV 539
           ++     H ++ + N+LL      ++ DFGL   + P +  + V          + APE 
Sbjct: 133 SK--RFIHRDLAARNLLLATRDLVKIGDFGLMRAL-PQNDDHYVMQEHRKVPFAWCAPES 189
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHAL--------LNEEGVDLPRWVQSIVKDE 590
                 S  +D + FGV L E+ T G+ P   L        +++EG  LPR       ++
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR------PED 243
Query: 591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHH 650
              +++++           MVQ       C A  P++RP+   +   + E  P+  +   
Sbjct: 244 CPQDIYNV-----------MVQ-------CWAHKPEDRPTFVALRDFLLEAQPTDMRALQ 285
Query: 651 GL-QPDDL 657
              +PD L
Sbjct: 286 DFEEPDKL 293

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 124/294 (42%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAY--------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG           K      T VAVK LK    +E++  D I  +  +     H+
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMIGKHK 94
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG-----------RTPLNWEMRSL 474
           N++ L           ++ +Y + G+L   L   +  G              L+ +    
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVS 154
Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA----HLVGPSSTPN- 529
            A   ARG+EYL ++     H ++ + N+L+T+    +++DFGLA    H+     T N 
Sbjct: 155 CAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVLL E+ T G +P   +  EE   L +    + 
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 272
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 273 KP--------------SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 125/291 (42%), Gaps = 48/291 (16%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKDV-TISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+ V       E  T VA+K + +  ++ ER EF ++   +   N  ++V 
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGR-----TPLNWEMRSLIALGAARGIE 484
           L          L++ + +T G L + L   +          P +      +A   A G+ 
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAGYR 535
           YL+A      H ++ + N ++ + +  ++ DFG+   +         G    P R   + 
Sbjct: 138 YLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR---WM 192
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           +PE       +  +DV+SFGV+L E+ T  + P   L NE+ +                 
Sbjct: 193 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------------- 237
Query: 595 VFDLELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHP 643
           V +  LL +  N  + +++L+++   C    P  RPS  E+I  I EE+ P
Sbjct: 238 VMEGGLLDKPDNCPDMLLELMRM---CWQYNPKMRPSFLEIISSIKEEMEP 285

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/301 (22%), Positives = 131/301 (43%), Gaps = 59/301 (19%)
Query: 378 LGKGTFGTAYKA------VLEMGTIVAVKRLKDVTISERE--FKDKIEGVGAVNHENLVP 429
           +G+G FG  ++A        E  T+VAVK LK+   ++ +  F+ +   +   ++ N+V 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALL------------HGN-------KGAGRTPLNWE 470
           L           L+++Y+  G L+  L            H +          G  PL+  
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 471 MRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-------- 522
            +  IA   A G+ YL  +     H ++ + N L+ ++   +++DFGL+  +        
Sbjct: 175 EQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 232
Query: 523 -GPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLP 580
            G  + P R   +  PE     + + ++DV+++GV+L E+ + G  P + + +EE     
Sbjct: 233 DGNDAIPIR---WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE----- 284
Query: 581 RWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE 640
             V   V+D          L   +N   E+  L++L   C ++ P +RPS   + + ++ 
Sbjct: 285 --VIYYVRDGNI-------LACPENCPLELYNLMRL---CWSKLPADRPSFCSIHRILQR 332
Query: 641 L 641
           +
Sbjct: 333 M 333

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRL-KDVTISEREFKDKI---EGVGAVNHENL 427
           ++LGKGTFG   K +L      G   A+K L K+V I++ E    +     +    H  L
Sbjct: 16  KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 72
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
             L+  + + D    V +Y   G L    H ++    T    E            +EYLH
Sbjct: 73  TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTE---ERARFYGAEIVSALEYLH 127
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTDPC 543
           ++  +V + +IK  N++L K    +++DFGL    +   +T     G   Y APEV +  
Sbjct: 128 SR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDN 185
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTH 569
              +  D +  GV++ E++ G+ P +
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPFY 211

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 125/291 (42%), Gaps = 48/291 (16%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKDV-TISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+ V       E  T VA+K + +  ++ ER EF ++   +   N  ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGR-----TPLNWEMRSLIALGAARGIE 484
           L          L++ + +T G L + L   + A        P +      +A   A G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAGYR 535
           YL+A      H ++ + N ++ + +  ++ DFG+   +         G    P R   + 
Sbjct: 153 YLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---WM 207
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           +PE       +  +DV+SFGV+L E+ T  + P   L NE+ +                 
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------------- 252
Query: 595 VFDLELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHP 643
           V +  LL +  N  + + +L+++   C    P  RPS  E+I  I EE+ P
Sbjct: 253 VMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKEEMEP 300

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 31/209 (14%)
Query: 376 EVLGKGTFG---TAYKAVLEMGTIVAVKRLKDV---TISEREFKDKIEGVGAVNHENLVP 429
           + +G+G +G   +AY  V +  T VA+K++      T  +R  ++ I+ +    HEN++ 
Sbjct: 49  QYIGEGAYGMVSSAYDHVRK--TRVAIKKISPFEHQTYCQRTLRE-IQILLRFRHENVIG 105
Query: 430 LR-----AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
           +R     +   +M +  +V D L    L  LL   +      L+ +          RG++
Sbjct: 106 IRDILRASTLEAMRDVYIVQD-LMETDLYKLLKSQQ------LSNDHICYFLYQILRGLK 158
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PNRVAG--YRAP 537
           Y+H+   NV H ++K SN+L+  + + ++ DFGLA +  P           VA   YRAP
Sbjct: 159 YIHSA--NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAP 216
Query: 538 EVTDPCK-VSQKADVYSFGVLLLELLTGK 565
           E+    K  ++  D++S G +L E+L+ +
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 128/288 (44%), Gaps = 43/288 (14%)
Query: 376 EVLGKGTFGTAYKAVL--EMGT--IVAVKRLKDVTISEREFKDKIEGVGAV---NHENLV 428
           ++LG+G FG+  +  L  E GT   VAVK +K    S+RE ++ +     +   +H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 429 PLRAYYYSMDEK-----LLVYDYLTMGSLSALLHGNK---GAGRTPLNWEMRSLIALGAA 480
            L      M  +     +++  ++  G L   L  ++   G    PL   ++ ++ +  A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI--A 157
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--GPSSTPNRVAG----Y 534
            G+EYL  +  N  H ++ + N +L       V+DFGL+  +  G      R+A     +
Sbjct: 158 LGMEYLSNR--NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTS 593
            A E       + K+DV++FGV + E+ T G  P   + N E  D               
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD--------------- 260
Query: 594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
             + L   R +  E+ + +L ++   C    P +RP+ S +  ++E+L
Sbjct: 261 --YLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRL-KDVTISEREFKDKI---EGVGAVNHENL 427
           ++LGKGTFG   K +L      G   A+K L K+V I++ E    +     +    H  L
Sbjct: 11  KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
             L+  + + D    V +Y   G L    H ++    T    E            +EYLH
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTE---ERARFYGAEIVSALEYLH 122
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTDPC 543
           ++  +V + +IK  N++L K    +++DFGL    +   +T     G   Y APEV +  
Sbjct: 123 SR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDN 180
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTH 569
              +  D +  GV++ E++ G+ P +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNAMH 199
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 104/224 (46%), Gaps = 22/224 (9%)
Query: 364 VFDLEDLLRASAEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISE--REFKDKIEGVG 420
           V + EDL+    E +G+G FG  +   L    T+VAVK  ++    +   +F  +   + 
Sbjct: 110 VLNHEDLV--LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK 167
Query: 421 AVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--G 478
             +H N+V L           +V + +  G     L       R      +++L+ +   
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLR------VKTLLQMVGD 221
Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH-----LVGPSSTPNRV-A 532
           AA G+EYL ++     H ++ + N L+T+    ++SDFG++      +   S    +V  
Sbjct: 222 AAAGMEYLESK--CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPV 279
Query: 533 GYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
            + APE  +  + S ++DV+SFG+LL E  + G +P   L N++
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 100/200 (50%), Gaps = 21/200 (10%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 95
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 149
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAGYRAPEVT-DPCKV 545
           +   ++ H ++K SN+ + +  E ++ DFGLA H     +       YRAPE+  +    
Sbjct: 150 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 546 SQKADVYSFGVLLLELLTGK 565
           +Q  D++S G ++ ELLTG+
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 100/200 (50%), Gaps = 21/200 (10%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 95
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 149
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAGYRAPEVT-DPCKV 545
           +   ++ H ++K SN+ + +  E ++ DFGLA H     +       YRAPE+  +    
Sbjct: 150 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 546 SQKADVYSFGVLLLELLTGK 565
           +Q  D++S G ++ ELLTG+
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 29/223 (13%)
Query: 367 LEDLLRASAEVLGKGTFG---TAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
            ED+ +   +VLG+G      T    +      V +   +   I  R F++         
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQG 69
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
           H N++ L  ++   D   LV++ +  GS+ + +H      R   N    S++    A  +
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK-----RRHFNELEASVVVQDVASAL 124
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEA---RVSDFGLAHLV------GPSSTPNRV--- 531
           ++LH +G  ++H ++K  NIL     +    ++ DFGL   +       P STP  +   
Sbjct: 125 DFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPC 182
Query: 532 --AGYRAPEVTDPCK-----VSQKADVYSFGVLLLELLTGKAP 567
             A Y APEV +          ++ D++S GV+L  LL+G  P
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 130/297 (43%), Gaps = 45/297 (15%)
Query: 378 LGKGTFGTAYKA----VLEMGTI--VAVKRLKD-VTISE-REFKDKIEGVGAVNHE-NLV 428
           LG+G FG   +A    + +  T   VAVK LK+  T SE R    +++ +  + H  N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 429 PLRAYYYSMDEKLLVY-DYLTMGSLSALLHGNKG---AGRTP-------LNWEMRSLIAL 477
            L          L+V  ++   G+LS  L   +      +TP       L  E     + 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR-- 535
             A+G+E+L ++     H ++ + NILL++    ++ DFGLA  +       R    R  
Sbjct: 156 QVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 536 ----APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDE 590
               APE       + ++DV+SFGVLL E+ + G +P        GV         + +E
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVK--------IDEE 259
Query: 591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ 647
           +   +   E  R +  +    ++ Q  +DC    P  RP+ SE+++ +  L  ++ Q
Sbjct: 260 FCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRL-KDVTISEREFKDKI---EGVGAVNHENL 427
           ++LGKGTFG   K +L      G   A+K L K+V I++ E    +     +    H  L
Sbjct: 11  KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
             L+  + + D    V +Y   G L    H ++    T    E            +EYLH
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTE---ERARFYGAEIVSALEYLH 122
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTDPC 543
           ++  +V + +IK  N++L K    +++DFGL    +   +T     G   Y APEV +  
Sbjct: 123 SR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDN 180
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTH 569
              +  D +  GV++ E++ G+ P +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 104/224 (46%), Gaps = 22/224 (9%)
Query: 364 VFDLEDLLRASAEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISE--REFKDKIEGVG 420
           V + EDL+    E +G+G FG  +   L    T+VAVK  ++    +   +F  +   + 
Sbjct: 110 VLNHEDLV--LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK 167
Query: 421 AVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL--G 478
             +H N+V L           +V + +  G     L       R      +++L+ +   
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLR------VKTLLQMVGD 221
Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH-----LVGPSSTPNRV-A 532
           AA G+EYL ++     H ++ + N L+T+    ++SDFG++      +   S    +V  
Sbjct: 222 AAAGMEYLESK--CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV 279
Query: 533 GYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
            + APE  +  + S ++DV+SFG+LL E  + G +P   L N++
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 100/200 (50%), Gaps = 21/200 (10%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 95
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 149
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAGYRAPEVT-DPCKV 545
           +   ++ H ++K SN+ + +  E ++ DFGLA H     +       YRAPE+  +    
Sbjct: 150 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 546 SQKADVYSFGVLLLELLTGK 565
           +Q  D++S G ++ ELLTG+
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 124/291 (42%), Gaps = 48/291 (16%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKDV-TISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+ V       E  T VA+K + +  ++ ER EF ++   +   N  ++V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGR-----TPLNWEMRSLIALGAARGIE 484
           L          L++ + +T G L + L   +          P +      +A   A G+ 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAGYR 535
           YL+A      H ++ + N ++ + +  ++ DFG+   +         G    P R   + 
Sbjct: 147 YLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR---WM 201
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           +PE       +  +DV+SFGV+L E+ T  + P   L NE+ +                 
Sbjct: 202 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------------- 246
Query: 595 VFDLELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHP 643
           V +  LL +  N  + + +L+++   C    P  RPS  E+I  I EE+ P
Sbjct: 247 VMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKEEMEP 294

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 376 EVLGKGTFGTAYKAV-----LEMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENL 427
           E LG G F    K       LE       KR    +   +S  E + ++  +  V H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           + L   Y +  + +L+ + ++ G L   L     A +  L+ E  +        G+ YLH
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 488 AQGPNVSHGNIKSSNILLTKSY----EARVSDFGLAHLVGPSSTPNRVAG---YRAPEVT 540
            +   ++H ++K  NI+L          ++ DFGLAH +        + G   + APE+ 
Sbjct: 133 TK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAP 567
           +   +  +AD++S GV+   LL+G +P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 93
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 147
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 148 SA--DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 204
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 205 YNQTVDIWSVGCIMAELLTGR 225

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 24/198 (12%)
Query: 379 GKGTFGTAYKAVLEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            +G    A+  VL  G  VAVK+L    ++ T ++R +++ +  +  VNH+N++ L   +
Sbjct: 36  AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELV-LLKCVNHKNIISLLNVF 92
Query: 435 Y---SMDEKLLVYDYLTM--GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
               +++E   VY  + +   +L  ++H         L+ E  S +      GI++LH+ 
Sbjct: 93  TPQKTLEEFQDVYLVMELMDANLCQVIHME-------LDHERMSYLLYQMLCGIKHLHSA 145
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STPNRVAG-YRAPEVTDPCKVS 546
           G  + H ++K SNI++      ++ DFGLA     +   TP  V   YRAPEV      +
Sbjct: 146 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYA 203
Query: 547 QKADVYSFGVLLLELLTG 564
              D++S G ++ EL+ G
Sbjct: 204 ANVDIWSVGCIMGELVKG 221

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 376 EVLGKGTFGTAYKAV-----LEMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENL 427
           E LG G F    K       LE       KR    +   +S  E + ++  +  V H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           + L   Y +  + +L+ + ++ G L   L     A +  L+ E  +        G+ YLH
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 488 AQGPNVSHGNIKSSNILLTKSY----EARVSDFGLAHLVGPSSTPNRVAG---YRAPEVT 540
            +   ++H ++K  NI+L          ++ DFGLAH +        + G   + APE+ 
Sbjct: 133 TK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAP 567
           +   +  +AD++S GV+   LL+G +P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L+    +  G L   +  H +    +  LNW       +  A G+ YL
Sbjct: 78  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAEGMNYL 130
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 131 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 188
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 189 LHRIYTHQSDVWSYGVTVWELMT 211

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRL-KDVTISEREFKDKI---EGVGAVNHENL 427
           ++LGKGTFG   K +L      G   A+K L K+V I++ E    +     +    H  L
Sbjct: 11  KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
             L+  + + D    V +Y   G L    H ++    T    E            +EYLH
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTE---ERARFYGAEIVSALEYLH 122
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTDPC 543
           ++  +V + +IK  N++L K    +++DFGL    +   +T     G   Y APEV +  
Sbjct: 123 SR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTH 569
              +  D +  GV++ E++ G+ P +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRL-KDVTISEREFKDKI---EGVGAVNHENL 427
           ++LGKGTFG   K +L      G   A+K L K+V I++ E    +     +    H  L
Sbjct: 11  KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
             L+  + + D    V +Y   G L    H ++    T    E            +EYLH
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTE---ERARFYGAEIVSALEYLH 122
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTDPC 543
           ++  +V + +IK  N++L K    +++DFGL    +   +T     G   Y APEV +  
Sbjct: 123 SR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTH 569
              +  D +  GV++ E++ G+ P +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRL-KDVTISEREFKDKI---EGVGAVNHENL 427
           ++LGKGTFG   K +L      G   A+K L K+V I++ E    +     +    H  L
Sbjct: 14  KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 70
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
             L+  + + D    V +Y   G L    H ++    T    E            +EYLH
Sbjct: 71  TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTE---ERARFYGAEIVSALEYLH 125
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTDPC 543
           ++  +V + +IK  N++L K    +++DFGL    +   +T     G   Y APEV +  
Sbjct: 126 SR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 183
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTH 569
              +  D +  GV++ E++ G+ P +
Sbjct: 184 DYGRAVDWWGLGVVMYEMMCGRLPFY 209

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAYY 434
           E +G G++    + V +   +    ++ D   S+R+  ++IE +     H N++ L+  Y
Sbjct: 33  ETIGVGSYSECKRCVHKATNMEYAVKVIDK--SKRDPSEEIEILLRYGQHPNIITLKDVY 90
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
                  LV + +  G L   +   K       ++ + ++      + +EYLH+QG  V 
Sbjct: 91  DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTI-----GKTVEYLHSQG--VV 143
Query: 495 HGNIKSSNILLTKSYE----ARVSDFGLAHLV----GPSSTPNRVAGYRAPEVTDPCKVS 546
           H ++K SNIL           R+ DFG A  +    G   TP   A + APEV       
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYD 203
Query: 547 QKADVYSFGVLLLELLTGKAP 567
           +  D++S G+LL  +L G  P
Sbjct: 204 EGCDIWSLGILLYTMLAGYTP 224

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 37/229 (16%)
Query: 377 VLGKGTFGTAYKAVL--EMGT--IVAVKRLK-DVTISEREFKDKIEGVGAVNHENLVP-- 429
           VLGKG+FG   K +L    GT  + AVK LK DV I +    D +E          +P  
Sbjct: 27  VLGKGSFG---KVMLSERKGTDELYAVKILKKDVVIQD----DDVECTMVEKRVLALPGK 79
Query: 430 ------LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
                 L + + +MD    V +Y+  G L   ++  +  GR           A   A G+
Sbjct: 80  PPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGR--FKEPHAVFYAAEIAIGL 134
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEV 539
            +L ++G  + + ++K  N++L      +++DFG+    +    T     G   Y APE+
Sbjct: 135 FFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEI 192
Query: 540 TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK 588
                  +  D ++FGVLL E+L G+AP       EG D     QSI++
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQAPF------EGEDEDELFQSIME 235

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 376 EVLGKGTFGTAYKA---VLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           + LG+G FG  ++A   V +    +   RL +  ++  +   +++ +  + H  +V    
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 433 YYYSMD--EKLL-----VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL---IALGAARG 482
            +   +  EKL      VY Y+ M         +   GR  +    RS+   I L  A  
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH----------LVGPSSTPNRVA 532
           +E+LH++G  + H ++K SNI  T     +V DFGL            ++ P     R  
Sbjct: 131 VEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 533 G------YRAPEVTDPCKVSQKADVYSFGVLLLELL 562
           G      Y +PE       S K D++S G++L ELL
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 114/271 (42%), Gaps = 59/271 (21%)
Query: 362 ARVFDLEDLLRASAEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVG 420
           A + DLE+L       +G GT G  +K    + G ++AVK+++     E           
Sbjct: 22  AEINDLENLGE-----MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE---------- 66
Query: 421 AVNHENLVPLRAYYYSMDEKLLVYDYLT-------------MGSLSALLHGNKGAGRTPL 467
             N   L+ L     S D   +V  + T             MG+ +  L   K   + P+
Sbjct: 67  --NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKL---KKRMQGPI 121
Query: 468 NWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST 527
              +   + +   + + YL  +   V H ++K SNILL +  + ++ DFG++  +     
Sbjct: 122 PERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180
Query: 528 PNRVAG---YRAPEVTDPCKVSQ-----KADVYSFGVLLLELLTGKAPTH---------- 569
            +R AG   Y APE  DP   ++     +ADV+S G+ L+EL TG+ P            
Sbjct: 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT 240
Query: 570 ALLNEEGVDLPRWV------QSIVKDEWTSE 594
            +L EE   LP  +      QS VKD  T +
Sbjct: 241 KVLQEEPPLLPGHMGFSGDFQSFVKDCLTKD 271

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISERE----FKDKIEGVGAVNHENLVPL 430
           + LG GTFG       E+ G  VAVK L    I   +     + +I+ +    H +++ L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                +  +  +V +Y++ G L   +  N   GR     E R L       G++Y H   
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKN---GRLD-EKESRRLFQ-QILSGVDYCHRHM 136
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEV-TDPCKVS 546
             V H ++K  N+LL     A+++DFGL++++          G   Y APEV +      
Sbjct: 137 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAG 194
Query: 547 QKADVYSFGVLLLELLTGKAP 567
            + D++S GV+L  LL G  P
Sbjct: 195 PEVDIWSSGVILYALLCGTLP 215

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 37/229 (16%)
Query: 377 VLGKGTFGTAYKAVL--EMGT--IVAVKRLK-DVTISEREFKDKIEGVGAVNHENLVP-- 429
           VLGKG+FG   K +L    GT  + AVK LK DV I +    D +E          +P  
Sbjct: 348 VLGKGSFG---KVMLSERKGTDELYAVKILKKDVVIQD----DDVECTMVEKRVLALPGK 400
Query: 430 ------LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
                 L + + +MD    V +Y+  G L   ++  +  GR           A   A G+
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGR--FKEPHAVFYAAEIAIGL 455
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEV 539
            +L ++G  + + ++K  N++L      +++DFG+    +    T     G   Y APE+
Sbjct: 456 FFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEI 513
Query: 540 TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK 588
                  +  D ++FGVLL E+L G+AP       EG D     QSI++
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQAPF------EGEDEDELFQSIME 556

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 71/298 (23%), Positives = 125/298 (41%), Gaps = 57/298 (19%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISERE----FKDKIEGVGAVNHENL 427
           E LG G+FG   +   +  +     VAVK LK   +S+ E    F  ++  + +++H NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           + L     +   K+ V +   +GSL   L  ++G           S  A+  A G+ YL 
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGYLE 138
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--------GYRAPEV 539
           ++     H ++ + N+LL      ++ DFGL   + P +  + V          + APE 
Sbjct: 139 SK--RFIHRDLAARNLLLATRDLVKIGDFGLMRAL-PQNDDHXVMQEHRKVPFAWCAPES 195
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHAL--------LNEEGVDLPRWVQSIVKDE 590
                 S  +D + FGV L E+ T G+ P   L        +++EG  LPR       ++
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR------PED 249
Query: 591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQG 648
              +++++           MVQ       C A  P++RP+   +   + E  P+  + 
Sbjct: 250 CPQDIYNV-----------MVQ-------CWAHKPEDRPTFVALRDFLLEAQPTDMRA 289

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 376 EVLGKGTFGTAYKAV-----LEMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENL 427
           E LG G F    K       LE       KR    +   +S  E + ++  +  V H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           + L   Y +  + +L+ + ++ G L   L     A +  L+ E  +        G+ YLH
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 488 AQGPNVSHGNIKSSNILLTKSY----EARVSDFGLAHLVGPSSTPNRVAG---YRAPEVT 540
            +   ++H ++K  NI+L          ++ DFGLAH +        + G   + APE+ 
Sbjct: 133 TK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAP 567
           +   +  +AD++S GV+   LL+G +P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 87/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----R 431
           ++LG+G+F T          +V  + L     + RE+  KI     +  EN VP     R
Sbjct: 43  KILGEGSFST----------VVLARELA----TSREYAIKILEKRHIIKENKVPYVTRER 88
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA----------AR 481
                +D    V  Y        L  G   A    L   +R + +               
Sbjct: 89  DVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 148
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYR 535
            +EYLH +G  + H ++K  NILL +    +++DFG A ++ P S   R       A Y 
Sbjct: 149 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 206
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           +PE+       + +D+++ G ++ +L+ G  P  A
Sbjct: 207 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 241

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 132/302 (43%), Gaps = 58/302 (19%)
Query: 376 EVLGKGTFG-----TAYKAVLEMGTI-VAVKRLKDVTISERE--FKDKIEGVGAV-NHEN 426
           + LG G FG     TA+    E   + VAVK LK    ++ +     +++ +  +  HEN
Sbjct: 37  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 96
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSL--------SALLHGNKGAGRTPLNW--------E 470
           +V L          L++ +Y   G L         A+L  +   G+ P           E
Sbjct: 97  IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLE 156
Query: 471 MRSLIALGA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV------ 522
           +R L+   +  A+G+ +L ++  N  H ++ + N+LLT  + A++ DFGLA  +      
Sbjct: 157 LRDLLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 214
Query: 523 ---GPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVD 578
              G +  P +   + APE    C  + ++DV+S+G+LL E+ + G  P   +L      
Sbjct: 215 IVKGNARLPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-- 269
Query: 579 LPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
                  +VKD +       ++ +     + +  ++Q    C A  P +RP+  ++   +
Sbjct: 270 ----FYKLVKDGY-------QMAQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFL 315
Query: 639 EE 640
           +E
Sbjct: 316 QE 317

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 376 EVLGKGTFGTAYKAV-----LEMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENL 427
           E LG G F    K       LE       KR    +   +S  E + ++  +  V H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           + L   Y +  + +L+ + ++ G L   L     A +  L+ E  +        G+ YLH
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 488 AQGPNVSHGNIKSSNILLTKSY----EARVSDFGLAHLVGPSSTPNRVAG---YRAPEVT 540
            +   ++H ++K  NI+L          ++ DFGLAH +        + G   + APE+ 
Sbjct: 133 TK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAP 567
           +   +  +AD++S GV+   LL+G +P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 376 EVLGKGTFGTAYKAV-----LEMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENL 427
           E LG G F    K       LE       KR    +   +S  E + ++  +  V H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           + L   Y +  + +L+ + ++ G L   L     A +  L+ E  +        G+ YLH
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 488 AQGPNVSHGNIKSSNILLTKSY----EARVSDFGLAHLVGPSSTPNRVAG---YRAPEVT 540
            +   ++H ++K  NI+L          ++ DFGLAH +        + G   + APE+ 
Sbjct: 133 TK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAP 567
           +   +  +AD++S GV+   LL+G +P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 99
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 153
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 154 SA--DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 210
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 211 YNQTVDIWSVGCIMAELLTGR 231

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAYY 434
           E +G G++    + V +   +    ++ D   S+R+  ++IE +     H N++ L+  Y
Sbjct: 33  ETIGVGSYSECKRCVHKATNMEYAVKVIDK--SKRDPSEEIEILLRYGQHPNIITLKDVY 90
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
                  LV + +  G L   +   K       ++ + ++      + +EYLH+QG  V 
Sbjct: 91  DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTI-----GKTVEYLHSQG--VV 143
Query: 495 HGNIKSSNILLTKSYE----ARVSDFGLAHLV----GPSSTPNRVAGYRAPEVTDPCKVS 546
           H ++K SNIL           R+ DFG A  +    G   TP   A + APEV       
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYD 203
Query: 547 QKADVYSFGVLLLELLTGKAP 567
           +  D++S G+LL  +L G  P
Sbjct: 204 EGCDIWSLGILLYTMLAGYTP 224

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 199
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 199
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 377 VLGKGTFGTAYKA-VLEMGTIVAVKRL----------KDVTISEREFKDKIEGVGAVNHE 425
           VLGKG FG      V   G + A K+L          + + ++E++  +K      VN  
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK------VNSR 244
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI-ALGAARGIE 484
            +V L   Y + D   LV   +  G L   ++    AG      E R++  A     G+E
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP----EARAVFYAAEICCGLE 300
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRV--AGYRAPEVTD 541
            LH +   + + ++K  NILL      R+SD GLA H+    +   RV   GY APEV  
Sbjct: 301 DLHRE--RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 358
Query: 542 PCKVSQKADVYSFGVLLLELLTGKAP 567
             + +   D ++ G LL E++ G++P
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 24/202 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG+G+FG  ++    + G   AVK+++       E    +     +    +VPL      
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEE----LMACAGLTSPRIVPLYGAVRE 137
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA-RGIEYLHAQGPNVSH 495
                +  + L  GSL  L+   K  G  P   E R+L  LG A  G+EYLH++   + H
Sbjct: 138 GPWVNIFMELLEGGSLGQLV---KEQGCLP---EDRALYYLGQALEGLEYLHSR--RILH 189
Query: 496 GNIKSSNILLTKS-YEARVSDFGLAHLVGPSS------TPNRVAG---YRAPEVTDPCKV 545
           G++K+ N+LL+     A + DFG A  + P        T + + G   + APEV      
Sbjct: 190 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSC 249
Query: 546 SQKADVYSFGVLLLELLTGKAP 567
             K DV+S   ++L +L G  P
Sbjct: 250 DAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 199
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 93
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 147
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 148 SA--DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 204
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 205 YNQTVDIWSVGCIMAELLTGR 225

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 38/228 (16%)
Query: 370 LLRASAEVLGKGTFGTAYKAVLEMGTIVAVKR------------LKDVTISEREFKDKIE 417
           LL    + LG G FGT  K   +M  +V                LKD  ++E     +++
Sbjct: 11  LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 70
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               V    +    ++       +LV +   +G L+  L  N+           +++I L
Sbjct: 71  NPYIVRMIGICEAESW-------MLVMEMAELGPLNKYLQQNRHVKD-------KNIIEL 116
Query: 478 --GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV---- 531
               + G++YL  +  N  H ++ + N+LL   + A++SDFGL+  +       +     
Sbjct: 117 VHQVSMGMKYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHG 174
Query: 532 ---AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
                + APE  +  K S K+DV+SFGVL+ E  + G+ P   +   E
Sbjct: 175 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 222

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 91/188 (48%), Gaps = 14/188 (7%)
Query: 396 IVAVKRLKDV-TISEREFKDKIEGVGAVNHENLVPLRAYYYS--MDEKLLVYDYLTMGSL 452
           +V V +++D  T   R+F ++   +   +H N++P+     S       L+  ++  GSL
Sbjct: 37  VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSL 96
Query: 453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEAR 512
             +LH  +G     ++       AL  ARG+ +LH   P +    + S ++++ +   AR
Sbjct: 97  YNVLH--EGTNFV-VDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTAR 153
Query: 513 VSDFGLAHLVGPSSTPNRV--AGYRAPEV--TDPCKVSQK-ADVYSFGVLLLELLTGKAP 567
           +S   +A +     +P R+    + APE     P   +++ AD++SF VLL EL+T + P
Sbjct: 154 IS---MADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210
Query: 568 THALLNEE 575
              L N E
Sbjct: 211 FADLSNME 218

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 71/298 (23%), Positives = 125/298 (41%), Gaps = 57/298 (19%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISERE----FKDKIEGVGAVNHENL 427
           E LG G+FG   +   +  +     VAVK LK   +S+ E    F  ++  + +++H NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           + L     +   K+ V +   +GSL   L  ++G           S  A+  A G+ YL 
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGYLE 138
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--------GYRAPEV 539
           ++     H ++ + N+LL      ++ DFGL   + P +  + V          + APE 
Sbjct: 139 SK--RFIHRDLAARNLLLATRDLVKIGDFGLMRAL-PQNDDHYVMQEHRKVPFAWCAPES 195
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHAL--------LNEEGVDLPRWVQSIVKDE 590
                 S  +D + FGV L E+ T G+ P   L        +++EG  LPR       ++
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR------PED 249
Query: 591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQG 648
              +++++           MVQ       C A  P++RP+   +   + E  P+  + 
Sbjct: 250 CPQDIYNV-----------MVQ-------CWAHKPEDRPTFVALRDFLLEAQPTDMRA 289

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 24/202 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG+G+FG  ++    + G   AVK+++       E    +     +    +VPL      
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEE----LMACAGLTSPRIVPLYGAVRE 156
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA-RGIEYLHAQGPNVSH 495
                +  + L  GSL  L+   K  G  P   E R+L  LG A  G+EYLH++   + H
Sbjct: 157 GPWVNIFMELLEGGSLGQLV---KEQGCLP---EDRALYYLGQALEGLEYLHSR--RILH 208
Query: 496 GNIKSSNILLTKS-YEARVSDFGLAHLVGPSS------TPNRVAG---YRAPEVTDPCKV 545
           G++K+ N+LL+     A + DFG A  + P        T + + G   + APEV      
Sbjct: 209 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSC 268
Query: 546 SQKADVYSFGVLLLELLTGKAP 567
             K DV+S   ++L +L G  P
Sbjct: 269 DAKVDVWSSCCMMLHMLNGCHP 290

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 28/204 (13%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           LG+G+FG  ++    + G   AVK+++       E    +     ++   +VPL      
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE----LVACAGLSSPRIVPLYGAVRE 135
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA-RGIEYLHAQGPNVSH 495
                +  + L  GSL  L+   K  G  P   E R+L  LG A  G+EYLH +   + H
Sbjct: 136 GPWVNIFMELLEGGSLGQLI---KQMGCLP---EDRALYYLGQALEGLEYLHTR--RILH 187
Query: 496 GNIKSSNILLTKS-YEARVSDFGLAHLVGPSS------TPNRVAG---YRAPEVT--DPC 543
           G++K+ N+LL+     A + DFG A  + P        T + + G   + APEV    PC
Sbjct: 188 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 247
Query: 544 KVSQKADVYSFGVLLLELLTGKAP 567
               K D++S   ++L +L G  P
Sbjct: 248 DA--KVDIWSSCCMMLHMLNGCHP 269

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 124/294 (42%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAY--------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG           K      T VAVK LK    +E++  D I  +  +     H+
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMIGKHK 135
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG----RTPLNWEMRSL------- 474
           N++ L           ++ +Y + G+L   L   +  G      P +     L       
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA----HLVGPSSTPN- 529
            A   ARG+EYL ++     H ++ + N+L+T+    +++DFGLA    H+     T N 
Sbjct: 196 CAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVLL E+ T G +P   +  EE   L +    + 
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 313
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 314 KP--------------SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 350

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 100/200 (50%), Gaps = 21/200 (10%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAGYRAPEVT-DPCKV 545
           +   ++ H ++K SN+ + +  E ++ DFGLA H     +       YRAPE+  +    
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATRWYRAPEIMLNWMHY 200
Query: 546 SQKADVYSFGVLLLELLTGK 565
           +Q  D++S G ++ ELLTG+
Sbjct: 201 NQTVDIWSVGCIMAELLTGR 220

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 124/291 (42%), Gaps = 48/291 (16%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKDV-TISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+ V       E  T VA+K + +  ++ ER EF ++   +   N  ++V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGR-----TPLNWEMRSLIALGAARGIE 484
           L          L++ + +T G L + L   +          P +      +A   A G+ 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAGYR 535
           YL+A      H ++ + N ++ + +  ++ DFG+   +         G    P R   + 
Sbjct: 140 YLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---WM 194
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           +PE       +  +DV+SFGV+L E+ T  + P   L NE+ +                 
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------------- 239
Query: 595 VFDLELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHP 643
           V +  LL +  N  + + +L+++   C    P  RPS  E+I  I EE+ P
Sbjct: 240 VMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKEEMEP 287

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 100
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 154
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 155 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 211
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 212 YNQTVDIWSVGCIMAELLTGR 232

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 199
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 100
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 154
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 155 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 211
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 212 YNQTVDIWSVGCIMAELLTGR 232

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 124/291 (42%), Gaps = 48/291 (16%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKDV-TISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+ V       E  T VA+K + +  ++ ER EF ++   +   N  ++V 
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGR-----TPLNWEMRSLIALGAARGIE 484
           L          L++ + +T G L + L   +          P +      +A   A G+ 
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAGYR 535
           YL+A      H ++ + N ++ + +  ++ DFG+   +         G    P R   + 
Sbjct: 144 YLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---WM 198
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           +PE       +  +DV+SFGV+L E+ T  + P   L NE+ +                 
Sbjct: 199 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------------- 243
Query: 595 VFDLELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHP 643
           V +  LL +  N  + + +L+++   C    P  RPS  E+I  I EE+ P
Sbjct: 244 VMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKEEMEP 291

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 124/294 (42%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAY--------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG           K      T VAVK LK    +E++  D I  +  +     H+
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMIGKHK 79
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG-----------RTPLNWEMRSL 474
           N++ L           ++ +Y + G+L   L   +  G              L+ +    
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 139
Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA----HLVGPSSTPN- 529
            A   ARG+EYL ++     H ++ + N+L+T+    +++DFGLA    H+     T N 
Sbjct: 140 CAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVLL E+ T G +P   +  EE   L +    + 
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 257
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 258 KP--------------SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 294

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 100
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 154
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 155 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 211
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 212 YNQTVDIWSVGCIMAELLTGR 232

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 90
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 144
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 145 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 201
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 202 YNQTVDIWSVGCIMAELLTGR 222

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 124/291 (42%), Gaps = 48/291 (16%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKDV-TISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+ V       E  T VA+K + +  ++ ER EF ++   +   N  ++V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGR-----TPLNWEMRSLIALGAARGIE 484
           L          L++ + +T G L + L   +          P +      +A   A G+ 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAGYR 535
           YL+A      H ++ + N ++ + +  ++ DFG+   +         G    P R   + 
Sbjct: 147 YLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---WM 201
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           +PE       +  +DV+SFGV+L E+ T  + P   L NE+ +                 
Sbjct: 202 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------------- 246
Query: 595 VFDLELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHP 643
           V +  LL +  N  + + +L+++   C    P  RPS  E+I  I EE+ P
Sbjct: 247 VMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKEEMEP 294

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 93
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 147
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 148 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 204
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 205 YNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 87
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 141
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 142 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 198
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 199 YNQTVDIWSVGCIMAELLTGR 219

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 377 VLGKGTFGTAYKA-VLEMGTIVAVKRL----------KDVTISEREFKDKIEGVGAVNHE 425
           VLGKG FG      V   G + A K+L          + + ++E++  +K      VN  
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK------VNSR 244
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI-ALGAARGIE 484
            +V L   Y + D   LV   +  G L   ++    AG      E R++  A     G+E
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP----EARAVFYAAEICCGLE 300
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRV--AGYRAPEVTD 541
            LH +   + + ++K  NILL      R+SD GLA H+    +   RV   GY APEV  
Sbjct: 301 DLHRE--RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 358
Query: 542 PCKVSQKADVYSFGVLLLELLTGKAP 567
             + +   D ++ G LL E++ G++P
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 95
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 149
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 150 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 206
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 207 YNQTVDIWSVGCIMAELLTGR 227

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 90
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 144
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 145 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 201
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 202 YNQTVDIWSVGCIMAELLTGR 222

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 99
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 153
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 154 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 210
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 211 YNQTVDIWSVGCIMAELLTGR 231

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 199
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 199
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 199
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 23/202 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 111
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 165
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 166 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 222
Query: 545 VSQKADVYSFGVLLLELLTGKA 566
            +Q  D++S G ++ ELLTG+ 
Sbjct: 223 YNQTVDIWSVGCIMAELLTGRT 244

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 90
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 144
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 145 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 201
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 202 YNQTVDIWSVGCIMAELLTGR 222

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 90
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 144
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 145 SA--DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 201
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 202 YNQTVDIWSVGCIMAELLTGR 222

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 108
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 162
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 163 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 219
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 220 YNQTVDIWSVGCIMAELLTGR 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 107
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 161
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 162 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 218
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 219 YNQTVDIWSVGCIMAELLTGR 239

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 107
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 161
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 162 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 218
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 219 YNQTVDIWSVGCIMAELLTGR 239

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 38/228 (16%)
Query: 370 LLRASAEVLGKGTFGTAYKAVLEMGTIVAVKR------------LKDVTISEREFKDKIE 417
           LL    + LG G FGT  K   +M  +V                LKD  ++E     +++
Sbjct: 5   LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 64
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               V    +    ++       +LV +   +G L+  L  N+           +++I L
Sbjct: 65  NPYIVRMIGICEAESW-------MLVMEMAELGPLNKYLQQNRHVKD-------KNIIEL 110
Query: 478 --GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV---- 531
               + G++YL  +  N  H ++ + N+LL   + A++SDFGL+  +       +     
Sbjct: 111 VHQVSMGMKYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 168
Query: 532 ---AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
                + APE  +  K S K+DV+SFGVL+ E  + G+ P   +   E
Sbjct: 169 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 216

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 35/214 (16%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK-----DVTISEREFKDKIEGVGAVNHENLVP 429
           E+LG G     + A  L +   VAVK L+     D +   R F+ + +   A+NH  +V 
Sbjct: 18  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIV- 75
Query: 430 LRAYYYSMDEK-------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
             A Y + + +        +V +Y+   +L  ++H        P+  +    +   A + 
Sbjct: 76  --AVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQA 128
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV---------AG 533
           + + H  G  + H ++K +NI+++ +   +V DFG+A  +  S   N V         A 
Sbjct: 129 LNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSG--NSVTQTAAVIGTAQ 184
Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           Y +PE      V  ++DVYS G +L E+LTG+ P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 23/202 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 108
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 162
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 163 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 219
Query: 545 VSQKADVYSFGVLLLELLTGKA 566
            +Q  D++S G ++ ELLTG+ 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRT 241

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 86/218 (39%), Gaps = 38/218 (17%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL----- 430
           E++G+G +G  YK  L+    VAVK            +  I  V  + H+N+        
Sbjct: 19  ELIGRGRYGAVYKGSLDERP-VAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDE 77
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ- 489
           R       E LLV +Y   GSL   L  +        +W     +A    RG+ YLH + 
Sbjct: 78  RVTADGRMEYLLVMEYYPNGSLXKYLSLHTS------DWVSSCRLAHSVTRGLAYLHTEL 131
Query: 490 ------GPNVSHGNIKSSNILLTKSYEARVSDFGLA------HLVGPSSTPNRVAG---- 533
                  P +SH ++ S N+L+       +SDFGL+       LV P    N        
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 534 --YRAPEV-------TDPCKVSQKADVYSFGVLLLELL 562
             Y APEV        D     ++ D+Y+ G++  E+ 
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 94
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 148
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 149 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 205
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 206 YNQTVDIWSVGCIMAELLTGR 226

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 94
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 148
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 149 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 205
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 206 YNQTVDIWSVGCIMAELLTGR 226

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 38/228 (16%)
Query: 370 LLRASAEVLGKGTFGTAYKAVLEMGTIVAVKR------------LKDVTISEREFKDKIE 417
           LL    + LG G FGT  K   +M  +V                LKD  ++E     +++
Sbjct: 27  LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 86
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               V    +    ++       +LV +   +G L+  L  N+           +++I L
Sbjct: 87  NPYIVRMIGICEAESW-------MLVMEMAELGPLNKYLQQNRHVKD-------KNIIEL 132
Query: 478 --GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV---- 531
               + G++YL  +  N  H ++ + N+LL   + A++SDFGL+  +       +     
Sbjct: 133 VHQVSMGMKYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 190
Query: 532 ---AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
                + APE  +  K S K+DV+SFGVL+ E  + G+ P   +   E
Sbjct: 191 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 238

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 38/228 (16%)
Query: 370 LLRASAEVLGKGTFGTAYKAVLEMGTIVAVKR------------LKDVTISEREFKDKIE 417
           LL    + LG G FGT  K   +M  +V                LKD  ++E     +++
Sbjct: 27  LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 86
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               V    +    ++       +LV +   +G L+  L  N+           +++I L
Sbjct: 87  NPYIVRMIGICEAESW-------MLVMEMAELGPLNKYLQQNRHVKD-------KNIIEL 132
Query: 478 --GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV---- 531
               + G++YL  +  N  H ++ + N+LL   + A++SDFGL+  +       +     
Sbjct: 133 VHQVSMGMKYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 190
Query: 532 ---AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
                + APE  +  K S K+DV+SFGVL+ E  + G+ P   +   E
Sbjct: 191 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 238

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 124/294 (42%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAY--------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG           K      T VAVK LK    +E++  D I  +  +     H+
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMIGKHK 83
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG----RTPLNWEMRSL------- 474
           N++ L           ++ +Y + G+L   L   +  G      P +     L       
Sbjct: 84  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 143
Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA----HLVGPSSTPN- 529
            A   ARG+EYL ++     H ++ + N+L+T+    +++DFGLA    H+     T N 
Sbjct: 144 CAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVLL E+ T G +P   +  EE   L +    + 
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 261
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 262 KP--------------SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 298

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L++   +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 83  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 135
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFG A L+G         G + P      E  
Sbjct: 136 EDR--RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 94
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 148
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 149 SA--DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 205
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 206 YNQTVDIWSVGCIMAELLTGR 226

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 93
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 147
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 148 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 204
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 205 YNQTVDIWSVGCIMAELLTGR 225

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 199
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 199
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 102/205 (49%), Gaps = 31/205 (15%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 94
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 148
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------YRAPEVT- 540
           +   ++ H ++K SN+ + +  E ++ DFGLA       T + + G      YRAPE+  
Sbjct: 149 SA--DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRAPEIML 201
Query: 541 DPCKVSQKADVYSFGVLLLELLTGK 565
           +    +Q  D++S G ++ ELLTG+
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 38/228 (16%)
Query: 370 LLRASAEVLGKGTFGTAYKAVLEMGTIVAVKR------------LKDVTISEREFKDKIE 417
           LL    + LG G FGT  K   +M  +V                LKD  ++E     +++
Sbjct: 7   LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 66
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               V    +    ++       +LV +   +G L+  L  N+           +++I L
Sbjct: 67  NPYIVRMIGICEAESW-------MLVMEMAELGPLNKYLQQNRHVKD-------KNIIEL 112
Query: 478 --GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV---- 531
               + G++YL  +  N  H ++ + N+LL   + A++SDFGL+  +       +     
Sbjct: 113 VHQVSMGMKYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 532 ---AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
                + APE  +  K S K+DV+SFGVL+ E  + G+ P   +   E
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VL  G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L++   +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 88  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 140
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 141 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 38/228 (16%)
Query: 370 LLRASAEVLGKGTFGTAYKAVLEMGTIVAVKR------------LKDVTISEREFKDKIE 417
           LL    + LG G FGT  K   +M  +V                LKD  ++E     +++
Sbjct: 11  LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 70
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               V    +    ++       +LV +   +G L+  L  N+           +++I L
Sbjct: 71  NPYIVRMIGICEAESW-------MLVMEMAELGPLNKYLQQNRHVKD-------KNIIEL 116
Query: 478 --GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV---- 531
               + G++YL  +  N  H ++ + N+LL   + A++SDFGL+  +       +     
Sbjct: 117 VHQVSMGMKYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 174
Query: 532 ---AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
                + APE  +  K S K+DV+SFGVL+ E  + G+ P   +   E
Sbjct: 175 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 222

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 102/205 (49%), Gaps = 31/205 (15%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 108
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 162
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------YRAPEVT- 540
           +   ++ H ++K SN+ + +  E ++ DFGLA       T + + G      YRAPE+  
Sbjct: 163 SA--DIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMXGXVATRWYRAPEIML 215
Query: 541 DPCKVSQKADVYSFGVLLLELLTGK 565
           +    +Q  D++S G ++ ELLTG+
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 199
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 124/294 (42%), Gaps = 57/294 (19%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISERE----FKDKIEGVGAVNHENL 427
           E LG G+FG   +   +  +     VAVK LK   +S+ E    F  ++  + +++H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           + L     +   K+ V +   +GSL   L  ++G           S  A+  A G+ YL 
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGYLE 128
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--------GYRAPEV 539
           ++     H ++ + N+LL      ++ DFGL   + P +  + V          + APE 
Sbjct: 129 SK--RFIHRDLAARNLLLATRDLVKIGDFGLMRAL-PQNDDHXVMQEHRKVPFAWCAPES 185
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHAL--------LNEEGVDLPRWVQSIVKDE 590
                 S  +D + FGV L E+ T G+ P   L        +++EG  LPR       ++
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR------PED 239
Query: 591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS 644
              +++++           MVQ       C A  P++RP+   +   + E  P+
Sbjct: 240 CPQDIYNV-----------MVQ-------CWAHKPEDRPTFVALRDFLLEAQPT 275

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 98
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 152
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 153 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 209
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 210 YNQTVDIWSVGCIMAELLTGR 230

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 38/228 (16%)
Query: 370 LLRASAEVLGKGTFGTAYKAVLEMGTIVAVKR------------LKDVTISEREFKDKIE 417
           LL    + LG G FGT  K   +M  +V                LKD  ++E     +++
Sbjct: 25  LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 84
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               V    +    ++       +LV +   +G L+  L  N+           +++I L
Sbjct: 85  NPYIVRMIGICEAESW-------MLVMEMAELGPLNKYLQQNRHVKD-------KNIIEL 130
Query: 478 --GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV---- 531
               + G++YL  +  N  H ++ + N+LL   + A++SDFGL+  +       +     
Sbjct: 131 VHQVSMGMKYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 188
Query: 532 ---AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
                + APE  +  K S K+DV+SFGVL+ E  + G+ P   +   E
Sbjct: 189 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 236

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 124/291 (42%), Gaps = 48/291 (16%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKDV-TISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+ V       E  T VA+K + +  ++ ER EF ++   +   N  ++V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGR-----TPLNWEMRSLIALGAARGIE 484
           L          L++ + +T G L + L   +          P +      +A   A G+ 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAGYR 535
           YL+A      H ++ + N ++ + +  ++ DFG+   +         G    P R   + 
Sbjct: 146 YLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---WM 200
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           +PE       +  +DV+SFGV+L E+ T  + P   L NE+ +                 
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------------- 245
Query: 595 VFDLELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHP 643
           V +  LL +  N  + + +L+++   C    P  RPS  E+I  I EE+ P
Sbjct: 246 VMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKEEMEP 293

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 124/291 (42%), Gaps = 48/291 (16%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKDV-TISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+ V       E  T VA+K + +  ++ ER EF ++   +   N  ++V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGR-----TPLNWEMRSLIALGAARGIE 484
           L          L++ + +T G L + L   +          P +      +A   A G+ 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAGYR 535
           YL+A      H ++ + N ++ + +  ++ DFG+   +         G    P R   + 
Sbjct: 146 YLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---WM 200
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           +PE       +  +DV+SFGV+L E+ T  + P   L NE+ +                 
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------------- 245
Query: 595 VFDLELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHP 643
           V +  LL +  N  + + +L+++   C    P  RPS  E+I  I EE+ P
Sbjct: 246 VMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKEEMEP 293

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 86
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 140
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 141 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 197
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 198 YNQTVDIWSVGCIMAELLTGR 218

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 106/232 (45%), Gaps = 39/232 (16%)
Query: 377 VLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDK---------IEGVGAVNHEN 426
           VLGKG+FG       ++ G   AVK      IS+R+ K K         ++ +  ++H N
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVK-----VISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           +  L  ++       LV +  T G L   +   K          +R +++     GI Y 
Sbjct: 88  IXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS-----GITYX 142
Query: 487 HAQGPNVSHGNIKSSNILL-TKSYEA--RVSDFGLA-HLVGPSSTPNRV--AGYRAPEVT 540
           H     + H ++K  N+LL +KS +A  R+ DFGL+ H        +++  A Y APEV 
Sbjct: 143 HKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVL 200
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAP-----THALLN--EEG---VDLPRW 582
                 +K DV+S GV+L  LL+G  P      + +L   E+G    +LP+W
Sbjct: 201 HGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 251

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L++   +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 83  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 135
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFG A L+G         G + P      E  
Sbjct: 136 EDR--RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 124/294 (42%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAY--------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG           K      T VAVK LK    +E++  D I  +  +     H+
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMIGKHK 86
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG-----------RTPLNWEMRSL 474
           N++ L           ++ +Y + G+L   L   +  G              L+ +    
Sbjct: 87  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 146
Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA----HLVGPSSTPN- 529
            A   ARG+EYL ++     H ++ + N+L+T+    +++DFGLA    H+     T N 
Sbjct: 147 CAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVLL E+ T G +P   +  EE   L +    + 
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 264
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 265 KP--------------SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 301

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 85
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 139
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 140 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 196
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 197 YNQTVDIWSVGCIMAELLTGR 217

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L++   +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 85  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 137
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFG A L+G         G + P      E  
Sbjct: 138 EDR--RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 196 LHRIYTHQSDVWSYGVTVWELMT 218

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 85
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 139
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 140 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 196
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 197 YNQTVDIWSVGCIMAELLTGR 217

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 124/294 (42%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAY--------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG           K      T VAVK LK    +E++  D I  +  +     H+
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMIGKHK 94
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG-----------RTPLNWEMRSL 474
           N++ L           ++ +Y + G+L   L   +  G              L+ +    
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA----HLVGPSSTPN- 529
            A   ARG+EYL ++     H ++ + N+L+T+    +++DFGLA    H+     T N 
Sbjct: 155 CAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVLL E+ T G +P   +  EE   L +    + 
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 272
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 273 KP--------------SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 84
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 138
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 139 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 195
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 196 YNQTVDIWSVGCIMAELLTGR 216

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 124/291 (42%), Gaps = 48/291 (16%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKDV-TISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+ V       E  T VA+K + +  ++ ER EF ++   +   N  ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGR-----TPLNWEMRSLIALGAARGIE 484
           L          L++ + +T G L + L   +          P +      +A   A G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAGYR 535
           YL+A      H ++ + N ++ + +  ++ DFG+   +         G    P R   + 
Sbjct: 153 YLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---WM 207
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           +PE       +  +DV+SFGV+L E+ T  + P   L NE+ +                 
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------------- 252
Query: 595 VFDLELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHP 643
           V +  LL +  N  + + +L+++   C    P  RPS  E+I  I EE+ P
Sbjct: 253 VMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKEEMEP 300

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 108/236 (45%), Gaps = 30/236 (12%)
Query: 367 LEDLLRASAE-----VLGKGTFGTAYKAVL--EMGTIV--AVKRLK-DVTISE--REFKD 414
           LED+L    +     +LGKG FG+  +A L  E G+ V  AVK LK D+  S    EF  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 415 KIEGVGAVNHENLVPLRAYYYSMDEK------LLVYDYLTMGSLSALLHGNKGAGRTPLN 468
           +   +   +H ++  L         K      +++  ++  G L A L  ++  G  P N
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR-IGENPFN 133
Query: 469 WEMRSLI--ALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS 526
             +++L+   +  A G+EYL ++  N  H ++ + N +L +     V+DFGL+  +    
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSR--NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 527 TPNRVAGYRAP------EVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
              +    + P      E       +  +DV++FGV + E++T G+ P   + N E
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDV---TISEREFKDKIEGVGAVNHENLV----P 429
           +G+G +G    A   +  + VA+K++      T  +R  ++ I+ + A  HEN++     
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLRE-IKILLAFRHENIIGINDI 91
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           +RA      + + +   L    L  LL          L+ +          RG++Y+H+ 
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIHSA 145
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PNRVAG--YRAPEVTDP 542
             NV H ++K SN+LL  + + ++ DFGLA +  P           VA   YRAPE+   
Sbjct: 146 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 543 CK-VSQKADVYSFGVLLLELLTGK 565
            K  ++  D++S G +L E+L+ +
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 124/294 (42%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAY--------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG           K      T VAVK LK    +E++  D I  +  +     H+
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMIGKHK 87
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG----RTPLNWEMRSL------- 474
           N++ L           ++ +Y + G+L   L   +  G      P +     L       
Sbjct: 88  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 147
Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA----HLVGPSSTPN- 529
            A   ARG+EYL ++     H ++ + N+L+T+    +++DFGLA    H+     T N 
Sbjct: 148 CAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVLL E+ T G +P   +  EE   L +    + 
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 265
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 266 KP--------------SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 302

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 38/228 (16%)
Query: 370 LLRASAEVLGKGTFGTAYKAVLEMGTIVAVKR------------LKDVTISEREFKDKIE 417
           LL    + LG G FGT  K   +M  +V                LKD  ++E     +++
Sbjct: 17  LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 76
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               V    +    ++       +LV +   +G L+  L  N+           +++I L
Sbjct: 77  NPYIVRMIGICEAESW-------MLVMEMAELGPLNKYLQQNRHVKD-------KNIIEL 122
Query: 478 --GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV---- 531
               + G++YL  +  N  H ++ + N+LL   + A++SDFGL+  +       +     
Sbjct: 123 VHQVSMGMKYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 180
Query: 532 ---AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
                + APE  +  K S K+DV+SFGVL+ E  + G+ P   +   E
Sbjct: 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 124/294 (42%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAY--------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG           K      T VAVK LK    +E++  D I  +  +     H+
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMIGKHK 94
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG-----------RTPLNWEMRSL 474
           N++ L           ++ +Y + G+L   L   +  G              L+ +    
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 154
Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA----HLVGPSSTPN- 529
            A   ARG+EYL ++     H ++ + N+L+T+    +++DFGLA    H+     T N 
Sbjct: 155 CAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVLL E+ T G +P   +  EE   L +    + 
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 272
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 273 KP--------------SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 84
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 138
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 139 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 195
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 196 YNQTVDIWSVGCIMAELLTGR 216

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 369 DLLRASAEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAV----- 422
           DLLR    V+G+G++       L+    I A+K +K   +++ E  D ++    V     
Sbjct: 23  DLLR----VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 78
Query: 423 NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
           NH  LV L + + +      V +Y+  G L  + H  +   +  L  E     +   +  
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR---QRKLPEEHARFYSAEISLA 133
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPE 538
           + YLH +G  + + ++K  N+LL      +++D+G+    + P  T +   G   Y APE
Sbjct: 134 LNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 191
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           +          D ++ GVL+ E++ G++P
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGRSP 220

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 35/214 (16%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK-----DVTISEREFKDKIEGVGAVNHENLVP 429
           E+LG G     + A  L +   VAVK L+     D +   R F+ + +   A+NH  +V 
Sbjct: 18  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIV- 75
Query: 430 LRAYYYSMDEK-------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
             A Y + + +        +V +Y+   +L  ++H        P+  +    +   A + 
Sbjct: 76  --AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQA 128
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV---------AG 533
           + + H  G  + H ++K +NI+++ +   +V DFG+A  +  S   N V         A 
Sbjct: 129 LNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSG--NSVTQTAAVIGTAQ 184
Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           Y +PE      V  ++DVYS G +L E+LTG+ P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VL  G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L+    +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 134 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VL  G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L+    +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 88  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 140
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 141 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 369 DLLRASAEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAV----- 422
           DLLR    V+G+G++       L+    I A+K +K   +++ E  D ++    V     
Sbjct: 8   DLLR----VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 63
Query: 423 NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
           NH  LV L + + +      V +Y+  G L  + H  +   +  L  E     +   +  
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR---QRKLPEEHARFYSAEISLA 118
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPE 538
           + YLH +G  + + ++K  N+LL      +++D+G+    + P  T +   G   Y APE
Sbjct: 119 LNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 176
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           +          D ++ GVL+ E++ G++P
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGRSP 205

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 124/295 (42%), Gaps = 57/295 (19%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISERE----FKDKIEGVGAVNHENL 427
           E LG G+FG   +   +  +     VAVK LK   +S+ E    F  ++  + +++H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           + L     +   K+ V +   +GSL   L  ++G           S  A+  A G+ YL 
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGYLE 128
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--------GYRAPEV 539
           ++     H ++ + N+LL      ++ DFGL   + P +  + V          + APE 
Sbjct: 129 SK--RFIHRDLAARNLLLATRDLVKIGDFGLMRAL-PQNDDHYVMQEHRKVPFAWCAPES 185
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHAL--------LNEEGVDLPRWVQSIVKDE 590
                 S  +D + FGV L E+ T G+ P   L        +++EG  LPR       ++
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR------PED 239
Query: 591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
              +++++           MVQ       C A  P++RP+   +   + E  P+ 
Sbjct: 240 CPQDIYNV-----------MVQ-------CWAHKPEDRPTFVALRDFLLEAQPTD 276

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+  L++ T   + +E  D+   + +V++ ++ 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L+    +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 115 RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 167
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFGLA L+G         G + P      E  
Sbjct: 168 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 225
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 226 LHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 38/233 (16%)
Query: 378 LGKGTFGTAYKAVLEMGT--IVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVPLR 431
           LGKG F   Y+ + +M T  + A K +    + +   K+K+    A+    ++ ++V   
Sbjct: 34  LGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 92
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            ++   D   +V +     SL  L    K        + MR  I     +G++YLH    
Sbjct: 93  GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN-- 145
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLV--------GPSSTPNRVAGYRAPEVTDPC 543
            V H ++K  N+ L    + ++ DFGLA  +            TPN    Y APEV   C
Sbjct: 146 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPN----YIAPEVL--C 199
Query: 544 KV--SQKADVYSFGVLLLELLTGKAP--------THALLNEEGVDLPRWVQSI 586
           K   S + D++S G +L  LL GK P        T+  + +    +PR +  +
Sbjct: 200 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPV 252

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDV---TISEREFKDKIEGVGAVNHENLV----P 429
           +G+G +G    A   +  + VA+K++      T  +R  ++ I+ + A  HEN++     
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLRE-IKILLAFRHENIIGINDI 91
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           +RA      + + +   L    L  LL          L+ +          RG++Y+H+ 
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIHSA 145
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PNRVAG--YRAPEVTDP 542
             NV H ++K SN+LL  + + ++ DFGLA +  P           VA   YRAPE+   
Sbjct: 146 --NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 543 CK-VSQKADVYSFGVLLLELLTGK 565
            K  ++  D++S G +L E+L+ +
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L+    +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 83  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 135
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFG A L+G         G + P      E  
Sbjct: 136 EDR--RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 37/215 (17%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK-----DVTISEREFKDKIEGVGAVNHENLVP 429
           E+LG G     + A  L +   VAVK L+     D +   R F+ + +   A+NH  +V 
Sbjct: 35  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVA 93
Query: 430 LRAYYYSMDEK--------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR 481
           +    Y   E          +V +Y+   +L  ++H        P+  +    +   A +
Sbjct: 94  V----YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQ 144
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV---------A 532
            + + H  G  + H ++K +NI+++ +   +V DFG+A  +  S   N V         A
Sbjct: 145 ALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSG--NSVTQTAAVIGTA 200
Query: 533 GYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
            Y +PE      V  ++DVYS G +L E+LTG+ P
Sbjct: 201 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L+    +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFG A L+G         G + P      E  
Sbjct: 134 EDR--RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 124/291 (42%), Gaps = 48/291 (16%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKDV-TISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+ V       E  T VA+K + +  ++ ER EF ++   +   N  ++V 
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGR-----TPLNWEMRSLIALGAARGIE 484
           L          L++ + +T G L + L   +          P +      +A   A G+ 
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAGYR 535
           YL+A      H ++ + N ++ + +  ++ DFG+   +         G    P R   + 
Sbjct: 175 YLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---WM 229
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           +PE       +  +DV+SFGV+L E+ T  + P   L NE+ +                 
Sbjct: 230 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------------- 274
Query: 595 VFDLELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHP 643
           V +  LL +  N  + + +L+++   C    P  RPS  E+I  I EE+ P
Sbjct: 275 VMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKEEMEP 322

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 23/222 (10%)
Query: 368 EDLLRASAEVLGKGTFGTAYKAVLEMGTI---VAVKRLKDVTISEREFKDKIEGVGAVNH 424
           ++LL A  E LG G FG+  + V  M      VA+K LK  T  E+   +++     + H
Sbjct: 335 DNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMH 391
Query: 425 E--NLVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR 481
           +  N   +R       E L LV +    G L   L G +         E+   +++G   
Sbjct: 392 QLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG--- 448
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP--SSTPNRVAG-----Y 534
            ++YL  +  N  H N+ + N+LL   + A++SDFGL+  +G   S    R AG     +
Sbjct: 449 -MKYLEEK--NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 505
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
            APE  +  K S ++DV+S+GV + E L+ G+ P   +   E
Sbjct: 506 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 369 DLLRASAEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAV----- 422
           DLLR    V+G+G++       L+    I A+K +K   +++ E  D ++    V     
Sbjct: 12  DLLR----VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 423 NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
           NH  LV L + + +      V +Y+  G L  + H  +   +  L  E     +   +  
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR---QRKLPEEHARFYSAEISLA 122
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPE 538
           + YLH +G  + + ++K  N+LL      +++D+G+    + P  T +   G   Y APE
Sbjct: 123 LNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 180
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           +          D ++ GVL+ E++ G++P
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 66/151 (43%), Gaps = 11/151 (7%)
Query: 421 AVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA 480
           ++ H+++V    ++   D   +V +     SL  L    K        + +R ++     
Sbjct: 71  SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL---- 126
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV----AGYRA 536
            G +YLH     V H ++K  N+ L +  E ++ DFGLA  V       +V      Y A
Sbjct: 127 -GCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183
Query: 537 PEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           PEV      S + DV+S G ++  LL GK P
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 366 DLEDLLRASAEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT-------ISEREFKDKIE 417
           D+ED      E LG G F    K   +  G   A K +K          +S  E + ++ 
Sbjct: 9   DVEDHYEMGEE-LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 67
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
            +  + H N++ L   + +  + +L+ + ++ G L   L     A +  L  +  +    
Sbjct: 68  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-----AEKESLTEDEATQFLK 122
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHLVGPSSTPNRVAG 533
               G+ YLH++   ++H ++K  NI+L      +   ++ DFG+AH +   +    + G
Sbjct: 123 QILDGVHYLHSK--RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG 180
Query: 534 ---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
              + APE+ +   +  +AD++S GV+   LL+G +P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 92/226 (40%), Gaps = 26/226 (11%)
Query: 376 EVLGKGTFGTAYKAVLE-MGTIVAVKRL--KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           E LG G F     A  +  G + AVK +  K +   E   +++I  +  + HEN+V L  
Sbjct: 28  ETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALED 87
Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
            Y S +   LV   ++ G L   +           +  +R ++       + YLH  G  
Sbjct: 88  IYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVL-----DAVYYLHRMG-- 140
Query: 493 VSHGNIKSSNILLTKSYEAR---VSDFGLAHLVGPS---STPNRVAGYRAPEVTDPCKVS 546
           + H ++K  N+L     E     +SDFGL+ + G     ST     GY APEV      S
Sbjct: 141 IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYS 200
Query: 547 QKADVYSFGVLLLELLTGKAPTH----------ALLNEEGVDLPRW 582
           +  D +S GV+   LL G  P +           L  E   D P W
Sbjct: 201 KAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYW 246

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 374 SAEVLGKGTFGTAYK------AVLEMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHE 425
           + E LG G F    K       +      +  +R K     +S  + + ++  +  + H 
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           N++ L   Y +  + +L+ + +  G L   L     A +  L  E  +        G+ Y
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATEFLKQILNGVYY 129
Query: 486 LHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPE 538
           LH+    ++H ++K  NI+L          ++ DFGLAH +   +    + G   + APE
Sbjct: 130 LHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           + +   +  +AD++S GV+   LL+G +P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 124/291 (42%), Gaps = 48/291 (16%)
Query: 378 LGKGTFGTAYKAVL------EMGTIVAVKRLKDV-TISER-EFKDKIEGVGAVNHENLVP 429
           LG+G+FG  Y+ V       E  T VA+K + +  ++ ER EF ++   +   N  ++V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGR-----TPLNWEMRSLIALGAARGIE 484
           L          L++ + +T G L + L   +          P +      +A   A G+ 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTPNRVAGYR 535
           YL+A      H ++ + N  + + +  ++ DFG+   +         G    P R   + 
Sbjct: 140 YLNAN--KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---WM 194
Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           +PE       +  +DV+SFGV+L E+ T  + P   L NE+ +                 
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------------- 239
Query: 595 VFDLELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI-EELHP 643
           V +  LL +  N  + +++L+++   C    P  RPS  E+I  I EE+ P
Sbjct: 240 VMEGGLLDKPDNCPDMLLELMRM---CWQYNPKMRPSFLEIISSIKEEMEP 287

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 374 SAEVLGKGTFGTAYKA------VLEMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHE 425
           + E LG G F    K       +      +  +R K     +S  + + ++  +  + H 
Sbjct: 15  TGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           N++ L   Y +  + +L+ + +  G L   L     A +  L  E  +        G+ Y
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATEFLKQILNGVYY 129
Query: 486 LHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPE 538
           LH+    ++H ++K  NI+L          ++ DFGLAH +   +    + G   + APE
Sbjct: 130 LHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           + +   +  +AD++S GV+   LL+G +P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
            L     +   +L+    +  G L   +  H +    +  LNW       +  A+G+ YL
Sbjct: 88  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 140
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAP------EVT 540
             +   + H ++ + N+L+      +++DFG A L+G         G + P      E  
Sbjct: 141 EDR--RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 541 DPCKVSQKADVYSFGVLLLELLT 563
                + ++DV+S+GV + EL+T
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 23/202 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKSQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGL        T   VA   YRAPE+  +   
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMT-GYVATRWYRAPEIMLNWMH 199
Query: 545 VSQKADVYSFGVLLLELLTGKA 566
            +Q  D++S G ++ ELLTG+ 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRT 221

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 124/294 (42%), Gaps = 50/294 (17%)
Query: 378 LGKGTFGTAY--------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN----HE 425
           LG+G FG           K      T VAVK LK    +E++  D I  +  +     H+
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMIGKHK 94
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG-----------RTPLNWEMRSL 474
           N++ L           ++ +Y + G+L   L   +  G              L+ +    
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA----HLVGPSSTPN- 529
            A   ARG+EYL ++     H ++ + N+L+T+    +++DFGLA    H+     T N 
Sbjct: 155 CAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 530 RV-AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
           R+   + APE       + ++DV+SFGVLL E+ T G +P   +  EE   L +    + 
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 272
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K                N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 273 KP--------------SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/299 (20%), Positives = 127/299 (42%), Gaps = 73/299 (24%)
Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLK-DVTISEREFKDKIEGVGAVNHENLVPLRAY 433
           E++G G FG  +KA   + G    ++R+K +   +ERE    ++ +  ++H N+V     
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIVHYNGC 73
Query: 434 YYSMDEK-----------------------------LLVYDYLTMGSLSALLHGNKGAGR 464
           +   D                                +  ++   G+L   +   +G   
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-- 131
Query: 465 TPLNWEMRSLIAL----GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH 520
                ++  ++AL       +G++Y+H++   + H ++K SNI L  + + ++ DFGL  
Sbjct: 132 -----KLDKVLALELFEQITKGVDYIHSK--KLIHRDLKPSNIFLVDTKQVKIGDFGLVT 184
Query: 521 LVGPSSTPNRVAG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGV 577
            +       R  G   Y +PE        ++ D+Y+ G++L ELL      H    +   
Sbjct: 185 SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL------HVC--DTAF 236
Query: 578 DLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK 636
           +  ++   + +D   S++FD +       E+ ++Q L       ++ P++RP+ SE+++
Sbjct: 237 ETSKFFTDL-RDGIISDIFDKK-------EKTLLQKLL------SKKPEDRPNTSEILR 281

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 66/151 (43%), Gaps = 11/151 (7%)
Query: 421 AVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA 480
           ++ H+++V    ++   D   +V +     SL  L    K        + +R ++     
Sbjct: 95  SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL---- 150
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV----AGYRA 536
            G +YLH     V H ++K  N+ L +  E ++ DFGLA  V       +V      Y A
Sbjct: 151 -GCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 207
Query: 537 PEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           PEV      S + DV+S G ++  LL GK P
Sbjct: 208 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 238

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 374 SAEVLGKGTFGTAYKA------VLEMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHE 425
           + E LG G F    K       +      +  +R K     +S  + + ++  +  + H 
Sbjct: 14  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           N++ L   Y +  + +L+ + +  G L   L     A +  L  E  +        G+ Y
Sbjct: 74  NVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATEFLKQILNGVYY 128
Query: 486 LHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPE 538
           LH+    ++H ++K  NI+L          ++ DFGLAH +   +    + G   + APE
Sbjct: 129 LHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           + +   +  +AD++S GV+   LL+G +P
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 28/204 (13%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           +G+G+FG  ++    + G   AVK+++       E    +     ++   +VPL      
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE----LVACAGLSSPRIVPLYGAVRE 121
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA-RGIEYLHAQGPNVSH 495
                +  + L  GSL  L+   K  G  P   E R+L  LG A  G+EYLH +   + H
Sbjct: 122 GPWVNIFMELLEGGSLGQLI---KQMGCLP---EDRALYYLGQALEGLEYLHTR--RILH 173
Query: 496 GNIKSSNILLTKS-YEARVSDFGLAHLVGPSS------TPNRVAG---YRAPEVT--DPC 543
           G++K+ N+LL+     A + DFG A  + P        T + + G   + APEV    PC
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 544 KVSQKADVYSFGVLLLELLTGKAP 567
               K D++S   ++L +L G  P
Sbjct: 234 DA--KVDIWSSCCMMLHMLNGCHP 255

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 38/233 (16%)
Query: 378 LGKGTFGTAYKAVLEMGT--IVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVPLR 431
           LGKG F   Y+ + +M T  + A K +    + +   K+K+    A+    ++ ++V   
Sbjct: 50  LGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            ++   D   +V +     SL  L    K        + MR  I     +G++YLH    
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN-- 161
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLV--------GPSSTPNRVAGYRAPEVTDPC 543
            V H ++K  N+ L    + ++ DFGLA  +            TPN    Y APEV   C
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPN----YIAPEVL--C 215
Query: 544 KV--SQKADVYSFGVLLLELLTGKAP--------THALLNEEGVDLPRWVQSI 586
           K   S + D++S G +L  LL GK P        T+  + +    +PR +  +
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPV 268

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 38/228 (16%)
Query: 370 LLRASAEVLGKGTFGTAYKAVLEMGTIVAVKR------------LKDVTISEREFKDKIE 417
           LL    + LG G FGT  K   +M  +V                LKD  ++E     +++
Sbjct: 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 428
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               V    +    ++       +LV +   +G L+  L  N+         + +++I L
Sbjct: 429 NPYIVRMIGICEAESW-------MLVMEMAELGPLNKYLQQNRHV-------KDKNIIEL 474
Query: 478 --GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV---- 531
               + G++YL     N  H ++ + N+LL   + A++SDFGL+  +       +     
Sbjct: 475 VHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 532
Query: 532 ---AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
                + APE  +  K S K+DV+SFGVL+ E  + G+ P   +   E
Sbjct: 533 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 580

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 66/151 (43%), Gaps = 11/151 (7%)
Query: 421 AVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA 480
           ++ H+++V    ++   D   +V +     SL  L    K        + +R ++     
Sbjct: 97  SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL---- 152
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV----AGYRA 536
            G +YLH     V H ++K  N+ L +  E ++ DFGLA  V       +V      Y A
Sbjct: 153 -GCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209
Query: 537 PEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           PEV      S + DV+S G ++  LL GK P
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 73/303 (24%), Positives = 130/303 (42%), Gaps = 53/303 (17%)
Query: 376 EVLGKGTFG-----TAYKAVL-EMGTIVAVKRLK-DVTISERE-FKDKIEGVGAV-NHEN 426
           + LG G FG     TAY  +  +    VAVK LK    ++ERE    +++ +  + NH N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGA----GRTPLNWEMRSL-------- 474
           +V L          L++ +Y   G L   L   + +      +P   E   L        
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 475 -IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GP 524
             +   A+G+ +L ++  N  H ++ + NILLT     ++ DFGLA  +         G 
Sbjct: 149 SFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 525 SSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWV 583
           +  P +   + APE    C  + ++DV+S+G+ L EL + G +P        G+ +    
Sbjct: 207 ARLPVK---WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY------PGMPVDSKF 257
Query: 584 QSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP 643
             ++K+          +L  ++   EM  +++   D     P  RP+  ++++ IE+   
Sbjct: 258 YKMIKE-------GFRMLSPEHAPAEMYDIMKTCWDAD---PLKRPTFKQIVQLIEKQIS 307
Query: 644 SST 646
            ST
Sbjct: 308 EST 310

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 374 SAEVLGKGTFGTAYKA------VLEMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHE 425
           + E LG G F    K       +      +  +R K     +S  + + ++  +  + H 
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           N++ L   Y +  + +L+ + +  G L   L     A +  L  E  +        G+ Y
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATEFLKQILNGVYY 129
Query: 486 LHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPE 538
           LH+    ++H ++K  NI+L          ++ DFGLAH +   +    + G   + APE
Sbjct: 130 LHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           + +   +  +AD++S GV+   LL+G +P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 38/228 (16%)
Query: 370 LLRASAEVLGKGTFGTAYKAVLEMGTIVAVKR------------LKDVTISEREFKDKIE 417
           LL    + LG G FGT  K   +M  +V                LKD  ++E     +++
Sbjct: 370 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 429
Query: 418 GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
               V    +    ++       +LV +   +G L+  L  N+         + +++I L
Sbjct: 430 NPYIVRMIGICEAESW-------MLVMEMAELGPLNKYLQQNRHV-------KDKNIIEL 475
Query: 478 --GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV---- 531
               + G++YL     N  H ++ + N+LL   + A++SDFGL+  +       +     
Sbjct: 476 VHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 533
Query: 532 ---AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
                + APE  +  K S K+DV+SFGVL+ E  + G+ P   +   E
Sbjct: 534 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 581

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 19/214 (8%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIV-AVKRLKDVTISEREFKDKIEG-----VGAVNHENLVP 429
           +V+GKG+FG    A  +   +  AVK L+   I +++ +  I       +  V H  LV 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRS-LIALGAARGIEYLHA 488
           L   + + D+   V DY+  G L   L       R     E R+   A   A  + YLH+
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQ------RERCFLEPRARFYAAEIASALGYLHS 157
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTDPCK 544
              N+ + ++K  NILL       ++DFGL    +  +ST +   G   Y APEV     
Sbjct: 158 L--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP 215
Query: 545 VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVD 578
             +  D +  G +L E+L G  P ++    E  D
Sbjct: 216 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 84
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCAK------LTDDHVQFLIYQILRGLKYIH 138
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 139 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 195
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 196 YNQTVDIWSVGCIMAELLTGR 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 374 SAEVLGKGTFGTAYKA------VLEMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHE 425
           + E LG G F    K       +      +  +R K     +S  + + ++  +  + H 
Sbjct: 14  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           N++ L   Y +  + +L+ + +  G L   L     A +  L  E  +        G+ Y
Sbjct: 74  NVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATEFLKQILNGVYY 128
Query: 486 LHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPE 538
           LH+    ++H ++K  NI+L          ++ DFGLAH +   +    + G   + APE
Sbjct: 129 LHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           + +   +  +AD++S GV+   LL+G +P
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 376 EVLGKGTFGTAYKAV-----LEMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENL 427
           E LG G F    K       LE       KR    +   +   E + ++  +  V H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           + L   Y +  + +L+ + ++ G L   L     A +  L+ E  +        G+ YLH
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 488 AQGPNVSHGNIKSSNILLTKSY----EARVSDFGLAHLVGPSSTPNRVAG---YRAPEVT 540
            +   ++H ++K  NI+L          ++ DFGLAH +        + G   + APE+ 
Sbjct: 133 TK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAP 567
           +   +  +AD++S GV+   LL+G +P
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 374 SAEVLGKGTFGTAYKA------VLEMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHE 425
           + E LG G F    K       +      +  +R K     +S  + + ++  +  + H 
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           N++ L   Y +  + +L+ + +  G L   L     A +  L  E  +        G+ Y
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATEFLKQILNGVYY 129
Query: 486 LHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPE 538
           LH+    ++H ++K  NI+L          ++ DFGLAH +   +    + G   + APE
Sbjct: 130 LHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           + +   +  +AD++S GV+   LL+G +P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 38/233 (16%)
Query: 378 LGKGTFGTAYKAVLEMGT--IVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVPLR 431
           LGKG F   Y+ + +M T  + A K +    + +   K+K+    A+    ++ ++V   
Sbjct: 50  LGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            ++   D   +V +     SL  L    K        + MR  I     +G++YLH    
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN-- 161
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLV--------GPSSTPNRVAGYRAPEVTDPC 543
            V H ++K  N+ L    + ++ DFGLA  +            TPN    Y APEV   C
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPN----YIAPEVL--C 215
Query: 544 KV--SQKADVYSFGVLLLELLTGKAP--------THALLNEEGVDLPRWVQSI 586
           K   S + D++S G +L  LL GK P        T+  + +    +PR +  +
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPV 268

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 38/233 (16%)
Query: 378 LGKGTFGTAYKAVLEMGT--IVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVPLR 431
           LGKG F   Y+ + +M T  + A K +    + +   K+K+    A+    ++ ++V   
Sbjct: 50  LGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            ++   D   +V +     SL  L    K        + MR  I     +G++YLH    
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN-- 161
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLV--------GPSSTPNRVAGYRAPEVTDPC 543
            V H ++K  N+ L    + ++ DFGLA  +            TPN    Y APEV   C
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPN----YIAPEVL--C 215
Query: 544 KV--SQKADVYSFGVLLLELLTGKAP--------THALLNEEGVDLPRWVQSI 586
           K   S + D++S G +L  LL GK P        T+  + +    +PR +  +
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPV 268

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 374 SAEVLGKGTFGTAYKA------VLEMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHE 425
           + E LG G F    K       +      +  +R K     +S  + + ++  +  + H 
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           N++ L   Y +  + +L+ + +  G L   L     A +  L  E  +        G+ Y
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATEFLKQILNGVYY 129
Query: 486 LHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPE 538
           LH+    ++H ++K  NI+L          ++ DFGLAH +   +    + G   + APE
Sbjct: 130 LHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           + +   +  +AD++S GV+   LL+G +P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 374 SAEVLGKGTFGTAYKA------VLEMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHE 425
           + E LG G F    K       +      +  +R K     +S  + + ++  +  + H 
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           N++ L   Y +  + +L+ + +  G L   L     A +  L  E  +        G+ Y
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATEFLKQILNGVYY 129
Query: 486 LHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPE 538
           LH+    ++H ++K  NI+L          ++ DFGLAH +   +    + G   + APE
Sbjct: 130 LHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           + +   +  +AD++S GV+   LL+G +P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 72/298 (24%), Positives = 128/298 (42%), Gaps = 48/298 (16%)
Query: 378 LGKGTFGTAYKAVLE---MGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAY 433
           LG+G F  +Y  ++E    G   A+KR+      +RE   +   +  + NH N++ L AY
Sbjct: 37  LGEGGF--SYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 434 YY----SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
                 +  E  L+  +   G+L   +   K  G   L  +    + LG  RG+E +HA+
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGICRGLEAIHAK 153
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFG-----LAHLVGPS--------STPNRVAGYRA 536
           G   +H ++K +NILL    +  + D G       H+ G          +       YRA
Sbjct: 154 G--YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 537 PE---VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTS 593
           PE   V   C + ++ DV+S G +L  ++ G+ P + ++ ++G  +   VQ+        
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP-YDMVFQKGDSVALAVQN-------- 262
Query: 594 EVFDLELLRYQNVEEEMVQLL--QLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGH 649
               L + +       + QLL   + +D     P  RP +  ++ ++E L P +   H
Sbjct: 263 ---QLSIPQSPRHSSALWQLLNSMMTVD-----PHQRPHIPLLLSQLEALQPPAPGQH 312

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 374 SAEVLGKGTFGTAYKA------VLEMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHE 425
           + E LG G F    K       +      +  +R K     +S  + + ++  +  + H 
Sbjct: 15  TGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           N++ L   Y +  + +L+ + +  G L   L     A +  L  E  +        G+ Y
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATEFLKQILNGVYY 129
Query: 486 LHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPE 538
           LH+    ++H ++K  NI+L          ++ DFGLAH +   +    + G   + APE
Sbjct: 130 LHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           + +   +  +AD++S GV+   LL+G +P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 92/209 (44%), Gaps = 22/209 (10%)
Query: 374 SAEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT-------ISEREFKDKIEGVGAVNHE 425
           + E LG G F    K   +  G   A K +K          +S  + + ++  +  + H 
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           N++ L   Y +  + +L+ + +  G L   L     A +  L  E  +        G+ Y
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATEFLKQILNGVYY 129
Query: 486 LHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPE 538
           LH+    ++H ++K  NI+L          ++ DFGLAH +   +    + G   + APE
Sbjct: 130 LHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           + +   +  +AD++S GV+   LL+G +P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ D+GLA       T   VA   YRAPE+  +   
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 199
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 28/204 (13%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           +G+G+FG  ++    + G   AVK+++       E    +     ++   +VPL      
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE----LVACAGLSSPRIVPLYGAVRE 137
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA-RGIEYLHAQGPNVSH 495
                +  + L  GSL  L+   K  G  P   E R+L  LG A  G+EYLH +   + H
Sbjct: 138 GPWVNIFMELLEGGSLGQLI---KQMGCLP---EDRALYYLGQALEGLEYLHTR--RILH 189
Query: 496 GNIKSSNILLTKS-YEARVSDFGLAHLVGPSS------TPNRVAG---YRAPEVT--DPC 543
           G++K+ N+LL+     A + DFG A  + P        T + + G   + APEV    PC
Sbjct: 190 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 249
Query: 544 KVSQKADVYSFGVLLLELLTGKAP 567
               K D++S   ++L +L G  P
Sbjct: 250 DA--KVDIWSSCCMMLHMLNGCHP 271

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 73/303 (24%), Positives = 130/303 (42%), Gaps = 53/303 (17%)
Query: 376 EVLGKGTFG-----TAYKAVL-EMGTIVAVKRLK-DVTISERE-FKDKIEGVGAV-NHEN 426
           + LG G FG     TAY  +  +    VAVK LK    ++ERE    +++ +  + NH N
Sbjct: 52  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 111
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGA----GRTPLNWEMRSL-------- 474
           +V L          L++ +Y   G L   L   + +      +P   E   L        
Sbjct: 112 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 475 -IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GP 524
             +   A+G+ +L ++  N  H ++ + NILLT     ++ DFGLA  +         G 
Sbjct: 172 SFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGN 229
Query: 525 SSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWV 583
           +  P +   + APE    C  + ++DV+S+G+ L EL + G +P        G+ +    
Sbjct: 230 ARLPVK---WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY------PGMPVDSKF 280
Query: 584 QSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP 643
             ++K+          +L  ++   EM  +++   D     P  RP+  ++++ IE+   
Sbjct: 281 YKMIKE-------GFRMLSPEHAPAEMYDIMKTCWDAD---PLKRPTFKQIVQLIEKQIS 330
Query: 644 SST 646
            ST
Sbjct: 331 EST 333

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 374 SAEVLGKGTFGTAYKA------VLEMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHE 425
           + E LG G F    K       +      +  +R K     +S  + + ++  +  + H 
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           N++ L   Y +  + +L+ + +  G L   L     A +  L  E  +        G+ Y
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATEFLKQILNGVYY 129
Query: 486 LHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPE 538
           LH+    ++H ++K  NI+L          ++ DFGLAH +   +    + G   + APE
Sbjct: 130 LHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPE 187
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           + +   +  +AD++S GV+   LL+G +P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 374 SAEVLGKGTFGTAYKA------VLEMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHE 425
           + E LG G F    K       +      +  +R K     +S  + + ++  +  + H 
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           N++ L   Y +  + +L+ + +  G L   L     A +  L  E  +        G+ Y
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATEFLKQILNGVYY 129
Query: 486 LHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPE 538
           LH+    ++H ++K  NI+L          ++ DFGLAH +   +    + G   + APE
Sbjct: 130 LHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           + +   +  +AD++S GV+   LL+G +P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 366 DLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNH 424
           DLE ++      LG+G +G   K   +  G I+AVKR++  T++ +E K  +  +     
Sbjct: 52  DLEPIME-----LGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMR 105
Query: 425 ENLVPLRAYYYSM---DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR 481
               P    +Y     +  + +   L   SL          G+T +  ++   IA+   +
Sbjct: 106 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQT-IPEDILGKIAVSIVK 164
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPE 538
            +E+LH++  +V H ++K SN+L+    + ++ DFG++  +  S      AG   Y APE
Sbjct: 165 ALEHLHSKL-SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPE 223
Query: 539 VTDP----CKVSQKADVYSFGVLLLELLTGKAP 567
             +P       S K+D++S G+ ++EL   + P
Sbjct: 224 RINPELNQKGYSVKSDIWSLGITMIELAILRFP 256

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 30/208 (14%)
Query: 377 VLGKGTFGTAYKAVLE-MGTIVAVKRLK--DVTISEREFKDKIEGVGAVNHENLVPL--- 430
           +LG+G +G    A  +  G IVA+K+++  D  +       +I+ +    HEN++ +   
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 431 -RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
            R   +    ++ +   L    L  ++          L+ +          R ++ LH  
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVISTQM------LSDDHIQYFIYQTLRAVKVLH-- 129
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR--------------VAGYR 535
           G NV H ++K SN+L+  + + +V DFGLA ++  S+  N                  YR
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYR 189
Query: 536 APEVT-DPCKVSQKADVYSFGVLLLELL 562
           APEV     K S+  DV+S G +L EL 
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 73/303 (24%), Positives = 130/303 (42%), Gaps = 53/303 (17%)
Query: 376 EVLGKGTFG-----TAYKAVL-EMGTIVAVKRLK-DVTISERE-FKDKIEGVGAV-NHEN 426
           + LG G FG     TAY  +  +    VAVK LK    ++ERE    +++ +  + NH N
Sbjct: 45  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 104
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGA----GRTPLNWEMRSL-------- 474
           +V L          L++ +Y   G L   L   + +      +P   E   L        
Sbjct: 105 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 164
Query: 475 -IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GP 524
             +   A+G+ +L ++  N  H ++ + NILLT     ++ DFGLA  +         G 
Sbjct: 165 SFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 222
Query: 525 SSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWV 583
           +  P +   + APE    C  + ++DV+S+G+ L EL + G +P        G+ +    
Sbjct: 223 ARLPVK---WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY------PGMPVDSKF 273
Query: 584 QSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP 643
             ++K+          +L  ++   EM  +++   D     P  RP+  ++++ IE+   
Sbjct: 274 YKMIKE-------GFRMLSPEHAPAEMYDIMKTCWDAD---PLKRPTFKQIVQLIEKQIS 323
Query: 644 SST 646
            ST
Sbjct: 324 EST 326

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 30/208 (14%)
Query: 377 VLGKGTFGTAYKAVLE-MGTIVAVKRLK--DVTISEREFKDKIEGVGAVNHENLVPL--- 430
           +LG+G +G    A  +  G IVA+K+++  D  +       +I+ +    HEN++ +   
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 431 -RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
            R   +    ++ +   L    L  ++          L+ +          R ++ LH  
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVISTQM------LSDDHIQYFIYQTLRAVKVLH-- 129
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR--------------VAGYR 535
           G NV H ++K SN+L+  + + +V DFGLA ++  S+  N                  YR
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189
Query: 536 APEVT-DPCKVSQKADVYSFGVLLLELL 562
           APEV     K S+  DV+S G +L EL 
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 93/204 (45%), Gaps = 25/204 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDV---TISEREFKDKIEGVGAVNHENLV----P 429
           +G+G +G    A   +  + VA+K++      T  +R  ++ I+ +    HEN++     
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLRE-IKILLRFRHENIIGINDI 109
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           +RA      + + +  +L    L  LL          L+ +          RG++Y+H+ 
Sbjct: 110 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQH------LSNDHICYFLYQILRGLKYIHSA 163
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN-------RVAGYRAPEVTDP 542
             NV H ++K SN+LL  + + ++ DFGLA +  P                YRAPE+   
Sbjct: 164 --NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 543 CK-VSQKADVYSFGVLLLELLTGK 565
            K  ++  D++S G +L E+L+ +
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 30/208 (14%)
Query: 377 VLGKGTFGTAYKAVLE-MGTIVAVKRLK--DVTISEREFKDKIEGVGAVNHENLVPL--- 430
           +LG+G +G    A  +  G IVA+K+++  D  +       +I+ +    HEN++ +   
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 431 -RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
            R   +    ++ +   L    L  ++          L+ +          R ++ LH  
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVISTQM------LSDDHIQYFIYQTLRAVKVLH-- 129
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR--------------VAGYR 535
           G NV H ++K SN+L+  + + +V DFGLA ++  S+  N                  YR
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYR 189
Query: 536 APEVT-DPCKVSQKADVYSFGVLLLELL 562
           APEV     K S+  DV+S G +L EL 
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 29/223 (13%)
Query: 367 LEDLLRASAEVLGKGTFG---TAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
            ED+ +   +VLG+G      T    +      V +   +   I  R F++         
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQG 69
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
           H N++ L  ++   D   LV++ +  GS+ + +H      R   N    S++    A  +
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK-----RRHFNELEASVVVQDVASAL 124
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEA---RVSDFGLAHLV------GPSSTPNRV--- 531
           ++LH +G  ++H ++K  NIL     +    ++ DF L   +       P STP  +   
Sbjct: 125 DFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 532 --AGYRAPEVTDPCK-----VSQKADVYSFGVLLLELLTGKAP 567
             A Y APEV +          ++ D++S GV+L  LL+G  P
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 73/303 (24%), Positives = 130/303 (42%), Gaps = 53/303 (17%)
Query: 376 EVLGKGTFG-----TAYKAVL-EMGTIVAVKRLK-DVTISERE-FKDKIEGVGAV-NHEN 426
           + LG G FG     TAY  +  +    VAVK LK    ++ERE    +++ +  + NH N
Sbjct: 47  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 106
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGA----GRTPLNWEMRSL-------- 474
           +V L          L++ +Y   G L   L   + +      +P   E   L        
Sbjct: 107 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 166
Query: 475 -IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GP 524
             +   A+G+ +L ++  N  H ++ + NILLT     ++ DFGLA  +         G 
Sbjct: 167 SFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 224
Query: 525 SSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWV 583
           +  P +   + APE    C  + ++DV+S+G+ L EL + G +P        G+ +    
Sbjct: 225 ARLPVK---WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY------PGMPVDSKF 275
Query: 584 QSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP 643
             ++K+          +L  ++   EM  +++   D     P  RP+  ++++ IE+   
Sbjct: 276 YKMIKE-------GFRMLSPEHAPAEMYDIMKTCWDAD---PLKRPTFKQIVQLIEKQIS 325
Query: 644 SST 646
            ST
Sbjct: 326 EST 328

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 119/281 (42%), Gaps = 57/281 (20%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISERE----FKDKIEGVGAVNHENL 427
           E LG G+FG   +   +  +     VAVK LK   +S+ E    F  ++  + +++H NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           + L     +   K+ V +   +GSL   L  ++G           S  A+  A G+ YL 
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGYLE 132
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--------GYRAPEV 539
           ++     H ++ + N+LL      ++ DFGL   + P +  + V          + APE 
Sbjct: 133 SK--RFIHRDLAARNLLLATRDLVKIGDFGLMRAL-PQNDDHYVMQEHRKVPFAWCAPES 189
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHAL--------LNEEGVDLPRWVQSIVKDE 590
                 S  +D + FGV L E+ T G+ P   L        +++EG  LPR       ++
Sbjct: 190 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR------PED 243
Query: 591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSM 631
              +++++           MVQ       C A  P++RP+ 
Sbjct: 244 CPQDIYNV-----------MVQ-------CWAHKPEDRPTF 266

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 369 DLLRASAEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAV----- 422
           DLLR    V+G+G++       L+    I A++ +K   +++ E  D ++    V     
Sbjct: 55  DLLR----VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110
Query: 423 NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
           NH  LV L + + +      V +Y+  G L  + H  +   +  L  E     +   +  
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR---QRKLPEEHARFYSAEISLA 165
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPE 538
           + YLH +G  + + ++K  N+LL      +++D+G+    + P  T +   G   Y APE
Sbjct: 166 LNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 223
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           +          D ++ GVL+ E++ G++P
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 23/222 (10%)
Query: 368 EDLLRASAEVLGKGTFGTAYKAVLEMGTI---VAVKRLKDVTISEREFKDKIEGVGAVNH 424
           ++LL A  E LG G FG+  + V  M      VA+K LK  T  E+   +++     + H
Sbjct: 9   DNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMH 65
Query: 425 E--NLVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR 481
           +  N   +R       E L LV +    G L   L G +         E+   +++G   
Sbjct: 66  QLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG--- 122
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP--SSTPNRVAG-----Y 534
            ++YL  +  N  H ++ + N+LL   + A++SDFGL+  +G   S    R AG     +
Sbjct: 123 -MKYLEEK--NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
            APE  +  K S ++DV+S+GV + E L+ G+ P   +   E
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 73/303 (24%), Positives = 130/303 (42%), Gaps = 53/303 (17%)
Query: 376 EVLGKGTFG-----TAYKAVL-EMGTIVAVKRLK-DVTISERE-FKDKIEGVGAV-NHEN 426
           + LG G FG     TAY  +  +    VAVK LK    ++ERE    +++ +  + NH N
Sbjct: 52  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 111
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGA----GRTPLNWEMRSL-------- 474
           +V L          L++ +Y   G L   L   + +      +P   E   L        
Sbjct: 112 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 475 -IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GP 524
             +   A+G+ +L ++  N  H ++ + NILLT     ++ DFGLA  +         G 
Sbjct: 172 SFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 229
Query: 525 SSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWV 583
           +  P +   + APE    C  + ++DV+S+G+ L EL + G +P        G+ +    
Sbjct: 230 ARLPVK---WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY------PGMPVDSKF 280
Query: 584 QSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP 643
             ++K+          +L  ++   EM  +++   D     P  RP+  ++++ IE+   
Sbjct: 281 YKMIKE-------GFRMLSPEHAPAEMYDIMKTCWDAD---PLKRPTFKQIVQLIEKQIS 330
Query: 644 SST 646
            ST
Sbjct: 331 EST 333

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDV---TISEREFKDKIEGVGAVNHENLV----P 429
           +G+G +G    A   +  + VA+K++      T  +R  ++ I+ +    HEN++     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE-IKILLRFRHENIIGINDI 93
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           +RA      + + +   L    L  LL          L+ +          RG++Y+H+ 
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIHSA 147
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PNRVAG--YRAPEVTDP 542
             NV H ++K SN+LL  + + ++ DFGLA +  P           VA   YRAPE+   
Sbjct: 148 --NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 543 CK-VSQKADVYSFGVLLLELLTGK 565
            K  ++  D++S G +L E+L+ +
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 19/155 (12%)
Query: 421 AVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA 480
           ++ H+++V    ++   D   +V +     SL  L    K        + +R ++     
Sbjct: 73  SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL---- 128
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--------GPSSTPNRVA 532
            G +YLH     V H ++K  N+ L +  E ++ DFGLA  V            TPN   
Sbjct: 129 -GCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPN--- 182
Query: 533 GYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
            Y APEV      S + DV+S G ++  LL GK P
Sbjct: 183 -YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 374 SAEVLGKGTFGTAYKA------VLEMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHE 425
           + E LG G F    K       +      +  +R K     +S  + + ++  +  + H 
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           N++ L   Y +  + +L+ + +  G L   L     A +  L  E  +        G+ Y
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATEFLKQILNGVYY 129
Query: 486 LHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPE 538
           LH+    ++H ++K  NI+L          ++ DFGLAH +   +    + G   + APE
Sbjct: 130 LHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           + +   +  +AD++S GV+   LL+G +P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT-------ISEREFKDKIEGVGAVNHENL 427
           E LG G F    K   +  G   A K +K          +S  E + ++  +  + H N+
Sbjct: 32  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNI 91
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           + L   + +  + +L+ + ++ G L   L     A +  L  +  +        G+ YLH
Sbjct: 92  ITLHDIFENKTDVVLILELVSGGELFDFL-----AEKESLTEDEATQFLKQILDGVHYLH 146
Query: 488 AQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVT 540
           ++   ++H ++K  NI+L      +   ++ DFG+AH +   +    + G   + APE+ 
Sbjct: 147 SK--RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 204
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAP 567
           +   +  +AD++S GV+   LL+G +P
Sbjct: 205 NYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDV---TISEREFKDKIEGVGAVNHENLV----P 429
           +G+G +G    A   +  + VA+K++      T  +R  ++ I+ +    HEN++     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE-IKILLRFRHENIIGINDI 93
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           +RA      + + +   L    L  LL          L+ +          RG++Y+H+ 
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIHSA 147
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN-------RVAGYRAPEVTDP 542
             NV H ++K SN+LL  + + ++ DFGLA +  P                YRAPE+   
Sbjct: 148 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 205
Query: 543 CK-VSQKADVYSFGVLLLELLTGK 565
            K  ++  D++S G +L E+L+ +
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDV---TISEREFKDKIEGVGAVNHENLV----P 429
           +G+G +G    A   +  + VA+K++      T  +R  ++ I+ +    HEN++     
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE-IKILLRFRHENIIGINDI 94
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           +RA      + + +   L    L  LL          L+ +          RG++Y+H+ 
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIHSA 148
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN-------RVAGYRAPEVTDP 542
             NV H ++K SN+LL  + + ++ DFGLA +  P                YRAPE+   
Sbjct: 149 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 206
Query: 543 CK-VSQKADVYSFGVLLLELLTGK 565
            K  ++  D++S G +L E+L+ +
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK-----DVTISEREFKDKIEGVGAVNHENLVP 429
           E+LG G     + A  L     VAVK L+     D +   R F+ + +   A+NH  +V 
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIV- 75
Query: 430 LRAYYYSMDEK-------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
             A Y + + +        +V +Y+   +L  ++H        P+  +    +   A + 
Sbjct: 76  --AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQA 128
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV---------AG 533
           + + H  G  + H ++K +NIL++ +   +V DFG+A  +  S   N V         A 
Sbjct: 129 LNFSHQNG--IIHRDVKPANILISATNAVKVVDFGIARAIADSG--NSVXQTAAVIGTAQ 184
Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           Y +PE      V  ++DVYS G +L E+LTG+ P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PNRVAG-- 533
           RG++Y+H+   NV H ++K SN+LL  + + ++ DFGLA +  P           VA   
Sbjct: 135 RGLKYIHSA--NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 534 YRAPEVTDPCK-VSQKADVYSFGVLLLELLTGK 565
           YRAPE+    K  ++  D++S G +L E+L+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PNRVAG-- 533
           RG++Y+H+   NV H ++K SN+LL  + + ++ DFGLA +  P           VA   
Sbjct: 135 RGLKYIHSA--NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 534 YRAPEVTDPCK-VSQKADVYSFGVLLLELLTGK 565
           YRAPE+    K  ++  D++S G +L E+L+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 27/219 (12%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-------H 424
           ++LGKGTFG   K +L      G   A+K LK   I     KD++      N       H
Sbjct: 154 KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNSRH 207
Query: 425 ENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
             L  L+  + + D    V +Y   G L   L   +        +    +++      ++
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-----ALD 262
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVT 540
           YLH++  NV + ++K  N++L K    +++DFGL    +   +T     G   Y APEV 
Sbjct: 263 YLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDL 579
           +     +  D +  GV++ E++ G+ P +   +E+  +L
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 360

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDV---TISEREFKDKIEGVGAVNHENLV----P 429
           +G+G +G    A   +  + VA+K++      T  +R  ++ I+ +    HEN++     
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE-IKILLRFRHENIIGINDI 94
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           +RA      + + +   L    L  LL          L+ +          RG++Y+H+ 
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIHSA 148
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN-------RVAGYRAPEVTDP 542
             NV H ++K SN+LL  + + ++ DFGLA +  P                YRAPE+   
Sbjct: 149 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 206
Query: 543 CK-VSQKADVYSFGVLLLELLTGK 565
            K  ++  D++S G +L E+L+ +
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDV---TISEREFKDKIEGVGAVNHENLV----P 429
           +G+G +G    A   +  + VA+K++      T  +R  ++ I+ +    HEN++     
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE-IKILLRFRHENIIGINDI 95
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           +RA      + + +   L    L  LL          L+ +          RG++Y+H+ 
Sbjct: 96  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIHSA 149
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN-------RVAGYRAPEVTDP 542
             NV H ++K SN+LL  + + ++ DFGLA +  P                YRAPE+   
Sbjct: 150 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 207
Query: 543 CK-VSQKADVYSFGVLLLELLTGK 565
            K  ++  D++S G +L E+L+ +
Sbjct: 208 SKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDV---TISEREFKDKIEGVGAVNHENLV----P 429
           +G+G +G    A   +  + VA+K++      T  +R  ++ I+ +    HEN++     
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE-IKILLRFRHENIIGINDI 86
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           +RA      + + +   L    L  LL          L+ +          RG++Y+H+ 
Sbjct: 87  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIHSA 140
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN-------RVAGYRAPEVTDP 542
             NV H ++K SN+LL  + + ++ DFGLA +  P                YRAPE+   
Sbjct: 141 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 198
Query: 543 CK-VSQKADVYSFGVLLLELLTGK 565
            K  ++  D++S G +L E+L+ +
Sbjct: 199 SKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDV---TISEREFKDKIEGVGAVNHENLV----P 429
           +G+G +G    A   +  + VA+K++      T  +R  ++ I+ +    HEN++     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE-IKILLRFRHENIIGINDI 93
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           +RA      + + +   L    L  LL          L+ +          RG++Y+H+ 
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIHSA 147
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN-------RVAGYRAPEVTDP 542
             NV H ++K SN+LL  + + ++ DFGLA +  P                YRAPE+   
Sbjct: 148 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 543 CK-VSQKADVYSFGVLLLELLTGK 565
            K  ++  D++S G +L E+L+ +
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 27/219 (12%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-------H 424
           ++LGKGTFG   K +L      G   A+K LK   I     KD++      N       H
Sbjct: 15  KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNSRH 68
Query: 425 ENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
             L  L+  + + D    V +Y   G L   L   +        +    +++      ++
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-----ALD 123
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVT 540
           YLH++  NV + ++K  N++L K    +++DFGL    +   +T     G   Y APEV 
Sbjct: 124 YLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 182
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDL 579
           +     +  D +  GV++ E++ G+ P +   +E+  +L
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 221

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PNRVAG-- 533
           RG++Y+H+   NV H ++K SN+LL  + + ++ DFGLA +  P           VA   
Sbjct: 135 RGLKYIHSA--NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 534 YRAPEVTDPCK-VSQKADVYSFGVLLLELLTGK 565
           YRAPE+    K  ++  D++S G +L E+L+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDV---TISEREFKDKIEGVGAVNHENLV----P 429
           +G+G +G    A   +  + VA+K++      T  +R  ++ I+ +    HEN++     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE-IKILLRFRHENIIGINDI 93
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           +RA      + + +   L    L  LL          L+ +          RG++Y+H+ 
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKCQH------LSNDHICYFLYQILRGLKYIHSA 147
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN-------RVAGYRAPEVTDP 542
             NV H ++K SN+LL  + + ++ DFGLA +  P                YRAPE+   
Sbjct: 148 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 543 CK-VSQKADVYSFGVLLLELLTGK 565
            K  ++  D++S G +L E+L+ +
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 27/219 (12%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-------H 424
           ++LGKGTFG   K +L      G   A+K LK   I     KD++      N       H
Sbjct: 157 KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNSRH 210
Query: 425 ENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
             L  L+  + + D    V +Y   G L   L   +        +    +++      ++
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-----ALD 265
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVT 540
           YLH++  NV + ++K  N++L K    +++DFGL    +   +T     G   Y APEV 
Sbjct: 266 YLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 324
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDL 579
           +     +  D +  GV++ E++ G+ P +   +E+  +L
Sbjct: 325 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 363

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT-------ISEREFKDKIEGVGAVNHENL 427
           E LG G F    K   +  G   A K +K          +S  E + ++  +  + H N+
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           + L   + +  + +L+ + ++ G L   L     A +  L  +  +        G+ YLH
Sbjct: 71  ITLHDIFENKTDVVLILELVSGGELFDFL-----AEKESLTEDEATQFLKQILDGVHYLH 125
Query: 488 AQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVT 540
           ++   ++H ++K  NI+L      +   ++ DFG+AH +   +    + G   + APE+ 
Sbjct: 126 SK--RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAP 567
           +   +  +AD++S GV+   LL+G +P
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PNRVAG-- 533
           RG++Y+H+   NV H ++K SN+LL  + + ++ DFGLA +  P           VA   
Sbjct: 139 RGLKYIHSA--NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 534 YRAPEVTDPCK-VSQKADVYSFGVLLLELLTGK 565
           YRAPE+    K  ++  D++S G +L E+L+ +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 27/219 (12%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-------H 424
           ++LGKGTFG   K +L      G   A+K LK   I     KD++      N       H
Sbjct: 14  KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNSRH 67
Query: 425 ENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
             L  L+  + + D    V +Y   G L   L   +        +    +++      ++
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-----ALD 122
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVT 540
           YLH++  NV + ++K  N++L K    +++DFGL    +   +T     G   Y APEV 
Sbjct: 123 YLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 181
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDL 579
           +     +  D +  GV++ E++ G+ P +   +E+  +L
Sbjct: 182 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 220

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDV---TISEREFKDKIEGVGAVNHENLV----P 429
           +G+G +G    A   +  + VA+K++      T  +R  ++ I+ +    HEN++     
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE-IKILLRFRHENIIGINDI 87
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           +RA      + + +   L    L  LL          L+ +          RG++Y+H+ 
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIHSA 141
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PNRVAG--YRAPEVTDP 542
             NV H ++K SN+LL  + + ++ DFGLA +  P           VA   YRAPE+   
Sbjct: 142 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 543 CK-VSQKADVYSFGVLLLELLTGK 565
            K  ++  D++S G +L E+L+ +
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 19/155 (12%)
Query: 421 AVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA 480
           ++ H+++V    ++   D   +V +     SL  L    K        + +R ++     
Sbjct: 73  SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL---- 128
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--------GPSSTPNRVA 532
            G +YLH     V H ++K  N+ L +  E ++ DFGLA  V            TPN   
Sbjct: 129 -GCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPN--- 182
Query: 533 GYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
            Y APEV      S + DV+S G ++  LL GK P
Sbjct: 183 -YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 119/281 (42%), Gaps = 57/281 (20%)
Query: 376 EVLGKGTFGTAYKAVLEMGT----IVAVKRLKDVTISERE----FKDKIEGVGAVNHENL 427
           E LG G+FG   +   +  +     VAVK LK   +S+ E    F  ++  + +++H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           + L     +   K+ V +   +GSL   L  ++G           S  A+  A G+ YL 
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGYLE 128
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--------GYRAPEV 539
           ++     H ++ + N+LL      ++ DFGL   + P +  + V          + APE 
Sbjct: 129 SK--RFIHRDLAARNLLLATRDLVKIGDFGLMRAL-PQNDDHYVMQEHRKVPFAWCAPES 185
Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHAL--------LNEEGVDLPRWVQSIVKDE 590
                 S  +D + FGV L E+ T G+ P   L        +++EG  LPR       ++
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR------PED 239
Query: 591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSM 631
              +++++           MVQ       C A  P++RP+ 
Sbjct: 240 CPQDIYNV-----------MVQ-------CWAHKPEDRPTF 262

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTI-VAVKRLKDV---TISEREFKDKIEGVGAVNHENLV----P 429
           +G+G +G    A   +  + VA+K++      T  +R  ++ I+ +    HEN++     
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE-IKILLRFRHENIIGINDI 87
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           +RA      + + +   L    L  LL          L+ +          RG++Y+H+ 
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIHSA 141
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PNRVAG--YRAPEVTDP 542
             NV H ++K SN+LL  + + ++ DFGLA +  P           VA   YRAPE+   
Sbjct: 142 --NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 543 CK-VSQKADVYSFGVLLLELLTGK 565
            K  ++  D++S G +L E+L+ +
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 7/94 (7%)
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLT---KSYEARVSDFGLAHLVGPSS--TPNRVAGYRA 536
            I++LH+   N++H ++K  N+L T   K    +++DFG A     ++  TP     Y A
Sbjct: 121 AIQFLHSH--NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVA 178
Query: 537 PEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           PEV  P K  +  D++S GV++  LL G  P ++
Sbjct: 179 PEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS 212

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 129/296 (43%), Gaps = 44/296 (14%)
Query: 378 LGKGTFGTAYKA----VLEMGT--IVAVKRLKD-VTISE-REFKDKIEGVGAVNHE-NLV 428
           LG+G FG   +A    + +  T   VAVK LK+  T SE R    +++ +  + H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 429 PLRAYYYSMDEKLLVY-DYLTMGSLSALLHG--NKGAGRTP-------LNWEMRSLIALG 478
            L          L+V  ++   G+LS  L    N+     P       L  E     +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR--- 535
            A+G+E+L ++     H ++ + NILL++    ++ DFGLA  +       R    R   
Sbjct: 157 VAKGMEFLASR--KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 536 ---APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEW 591
              APE       + ++DV+SFGVLL E+ + G +P        GV         + +E+
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVK--------IDEEF 260
Query: 592 TSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ 647
              +   E  R +  +    ++ Q  +DC    P  RP+ SE+++ +  L  ++ Q
Sbjct: 261 CRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 27/219 (12%)
Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-------H 424
           ++LGKGTFG   K +L      G   A+K LK   I     KD++      N       H
Sbjct: 16  KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNSRH 69
Query: 425 ENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
             L  L+  + + D    V +Y   G L   L   +        +    +++      ++
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-----ALD 124
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVT 540
           YLH++  NV + ++K  N++L K    +++DFGL    +   +T     G   Y APEV 
Sbjct: 125 YLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVL 183
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDL 579
           +     +  D +  GV++ E++ G+ P +   +E+  +L
Sbjct: 184 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 222

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 128/298 (42%), Gaps = 46/298 (15%)
Query: 378 LGKGTFGTAYKA----VLEMGTI--VAVKRLKD-VTISE-REFKDKIEGVGAVNHE-NLV 428
           LG+G FG   +A    + +  T   VAVK LK+  T SE R    +++ +  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 429 PLRAYYYSMDEKLLVY-DYLTMGSLSALLHGNKGAG-----------RTPLNWEMRSLIA 476
            L          L+V  ++   G+LS  L   +              +  L  E     +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR- 535
              A+G+E+L ++     H ++ + NILL++    ++ DFGLA  +       R    R 
Sbjct: 146 FQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 536 -----APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKD 589
                APE       + ++DV+SFGVLL E+ + G +P        GV         + +
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVK--------IDE 249
Query: 590 EWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ 647
           E+   +   E  R +  +    ++ Q  +DC    P  RP+ SE+++ +  L  ++ Q
Sbjct: 250 EFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 305

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 128/298 (42%), Gaps = 46/298 (15%)
Query: 378 LGKGTFGTAYKA----VLEMGTI--VAVKRLKD-VTISE-REFKDKIEGVGAVNHE-NLV 428
           LG+G FG   +A    + +  T   VAVK LK+  T SE R    +++ +  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 429 PLRAYYYSMDEKLLVY-DYLTMGSLSALLHGNKGAG-----------RTPLNWEMRSLIA 476
            L          L+V  ++   G+LS  L   +              +  L  E     +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR- 535
              A+G+E+L ++     H ++ + NILL++    ++ DFGLA  +       R    R 
Sbjct: 146 FQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 536 -----APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKD 589
                APE       + ++DV+SFGVLL E+ + G +P        GV         + +
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVK--------IDE 249
Query: 590 EWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ 647
           E+   +   E  R +  +    ++ Q  +DC    P  RP+ SE+++ +  L  ++ Q
Sbjct: 250 EFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 305

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 45/222 (20%)
Query: 377 VLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           VLG+G FG   KA   + +   A+K+++           ++  + ++NH+ +V    YY 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVV---RYYA 69
Query: 436 SMDEK----------------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA 479
           +  E+                 +  +Y   G+L  L+H      +    W +   I    
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL--- 126
Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-------------PSS 526
              + Y+H+QG  + H ++K  NI + +S   ++ DFGLA  V              P S
Sbjct: 127 -EALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 527 TPNR-----VAGYRAPEVTDPC-KVSQKADVYSFGVLLLELL 562
           + N       A Y A EV D     ++K D+YS G++  E++
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK-----DVTISEREFKDKIEGVGAVNHENLVP 429
           E+LG G     + A  L     VAVK L+     D +   R F+ + +   A+NH  +V 
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIV- 75
Query: 430 LRAYYYSMDEK-------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
             A Y + + +        +V +Y+   +L  ++H        P+  +    +   A + 
Sbjct: 76  --AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQA 128
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV---------AG 533
           + + H  G  + H ++K +NI+++ +   +V DFG+A  +  S   N V         A 
Sbjct: 129 LNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSG--NSVTQTAAVIGTAQ 184
Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           Y +PE      V  ++DVYS G +L E+LTG+ P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 19/155 (12%)
Query: 421 AVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA 480
           ++ H+++V    ++   D   +V +     SL  L    K        + +R ++     
Sbjct: 77  SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL---- 132
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--------GPSSTPNRVA 532
            G +YLH     V H ++K  N+ L +  E ++ DFGLA  V            TPN   
Sbjct: 133 -GCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPN--- 186
Query: 533 GYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
            Y APEV      S + DV+S G ++  LL GK P
Sbjct: 187 -YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 220

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PNRVAG-- 533
           RG++Y+H+   NV H ++K SN+LL  + + ++ DFGLA +  P           VA   
Sbjct: 135 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 534 YRAPEVTDPCK-VSQKADVYSFGVLLLELLTGK 565
           YRAPE+    K  ++  D++S G +L E+L+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PNRVAG-- 533
           RG++Y+H+   NV H ++K SN+LL  + + ++ DFGLA +  P           VA   
Sbjct: 137 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 534 YRAPEVTDPCK-VSQKADVYSFGVLLLELLTGK 565
           YRAPE+    K  ++  D++S G +L E+L+ +
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 128/298 (42%), Gaps = 46/298 (15%)
Query: 378 LGKGTFGTAYKA----VLEMGTI--VAVKRLKD-VTISE-REFKDKIEGVGAVNHE-NLV 428
           LG+G FG   +A    + +  T   VAVK LK+  T SE R    +++ +  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 429 PLRAYYYSMDEKLLVY-DYLTMGSLSALLHGNKGAG-----------RTPLNWEMRSLIA 476
            L          L+V  ++   G+LS  L   +              +  L  E     +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR- 535
              A+G+E+L ++     H ++ + NILL++    ++ DFGLA  +       R    R 
Sbjct: 155 FQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 536 -----APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKD 589
                APE       + ++DV+SFGVLL E+ + G +P        GV         + +
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVK--------IDE 258
Query: 590 EWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ 647
           E+   +   E  R +  +    ++ Q  +DC    P  RP+ SE+++ +  L  ++ Q
Sbjct: 259 EFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 10/93 (10%)
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN-------RVAG 533
           RG++Y+H+   NV H ++K SN+LL  + + ++ DFGLA +  P                
Sbjct: 143 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 200
Query: 534 YRAPEVTDPCK-VSQKADVYSFGVLLLELLTGK 565
           YRAPE+    K  ++  D++S G +L E+L+ +
Sbjct: 201 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 10/93 (10%)
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN-------RVAG 533
           RG++Y+H+   NV H ++K SN+LL  + + ++ DFGLA +  P                
Sbjct: 135 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 534 YRAPEVTDPCK-VSQKADVYSFGVLLLELLTGK 565
           YRAPE+    K  ++  D++S G +L E+L+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PNRVAG-- 533
           RG++Y+H+   NV H ++K SN+LL  + + ++ DFGLA +  P           VA   
Sbjct: 139 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 534 YRAPEVTDPCK-VSQKADVYSFGVLLLELLTGK 565
           YRAPE+    K  ++  D++S G +L E+L+ +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 80/172 (46%), Gaps = 28/172 (16%)
Query: 412 FKDKIEGVGAVNHENLVPLRAYYYSMDEK-------LLVYDYLTMGSLSALLHGNKGAGR 464
           F+ + +   A+NH  +V   A Y + + +        +V +Y+   +L  ++H       
Sbjct: 59  FRREAQNAAALNHPAIV---AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---- 111
Query: 465 TPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP 524
            P+  +    +   A + + + H  G  + H ++K +NI+++ +   +V DFG+A  +  
Sbjct: 112 -PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIAD 168
Query: 525 SSTPNRV---------AGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           S   N V         A Y +PE      V  ++DVYS G +L E+LTG+ P
Sbjct: 169 SG--NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 374 SAEVLGKGTFGTAYKA------VLEMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHE 425
           + E LG G F    K       +      +  +R K     +S  + + ++  +  + H 
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           N++ L   Y +  + +L+ + +  G L   L     A +  L  E  +        G+ Y
Sbjct: 75  NVITLHEVYENKTDVILIGELVAGGELFDFL-----AEKESLTEEEATEFLKQILNGVYY 129
Query: 486 LHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPE 538
           LH+    ++H ++K  NI+L          ++ DFGLAH +   +    + G   + APE
Sbjct: 130 LHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           + +   +  +AD++S GV+   LL+G +P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 127/293 (43%), Gaps = 49/293 (16%)
Query: 376 EVLGKGTFG-----TAYKAVLEMGTI-VAVKRLKDVTISERE--FKDKIEGVGAV-NHEN 426
           + LG G FG     TA+    E   + VAVK LK    ++ +     +++ +  +  HEN
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSL-------SALLHGNKGAGRTPLNWEMRSLIALGA 479
           +V L          L++ +Y   G L       S +L  +            R L+   +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSS 171
Query: 480 --ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTP 528
             A+G+ +L ++  N  H ++ + N+LLT  + A++ DFGLA  +         G +  P
Sbjct: 172 QVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
            +   + APE    C  + ++DV+S+G+LL E+ + G  P   +L             +V
Sbjct: 230 VK---WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------FYKLV 280
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE 640
           KD +       ++ +     + +  ++Q    C A  P +RP+  ++   ++E
Sbjct: 281 KDGY-------QMAQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFLQE 323

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 10/93 (10%)
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN-------RVAG 533
           RG++Y+H+   NV H ++K SN+LL  + + ++ DFGLA +  P                
Sbjct: 155 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 534 YRAPEVTDPCK-VSQKADVYSFGVLLLELLTGK 565
           YRAPE+    K  ++  D++S G +L E+L+ +
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 13/210 (6%)
Query: 369 DLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENL 427
           D  + +++VLG G  G   +          A+K L+D   + RE +         +   +
Sbjct: 31  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRI 90
Query: 428 VPLRAYYYSMDEKLL-VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           V +    Y+  + LL V + L  G L + +      G         S I       I+YL
Sbjct: 91  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYL 147
Query: 487 HAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLAHLVGPS---STPNRVAGYRAPEVT 540
           H+   N++H ++K  N+L T        +++DFG A         +TP     Y APEV 
Sbjct: 148 HSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 205
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
            P K  +  D++S GV++  LL G  P ++
Sbjct: 206 GPEKYDKSCDMWSLGVIMYILLCGYPPFYS 235

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 373 ASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           A  E +GKG +G  ++  L  G  VAVK            + +I     + H+N++   A
Sbjct: 11  ALVECVGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIA 69
Query: 433 YYY----SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
                  S  +  L+  Y   GSL   L       R  L   +   +A+ AA G+ +LH 
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFLQ------RQTLEPHLALRLAVSAACGLAHLHV 123
Query: 489 Q------GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--------Y 534
           +       P ++H + KS N+L+  + +  ++D GLA +    S    +          Y
Sbjct: 124 EIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRY 183
Query: 535 RAPEVTDP-----CKVSQK-ADVYSFGVLLLEL 561
            APEV D      C  S K  D+++FG++L E+
Sbjct: 184 MAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 13/210 (6%)
Query: 369 DLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENL 427
           D  + +++VLG G  G   +          A+K L+D   + RE +         +   +
Sbjct: 23  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRI 82
Query: 428 VPLRAYYYSMDEKLL-VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           V +    Y+  + LL V + L  G L + +      G         S I       I+YL
Sbjct: 83  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYL 139
Query: 487 HAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLAHLVGPS---STPNRVAGYRAPEVT 540
           H+   N++H ++K  N+L T        +++DFG A         +TP     Y APEV 
Sbjct: 140 HSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 197
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
            P K  +  D++S GV++  LL G  P ++
Sbjct: 198 GPEKYDKSCDMWSLGVIMYILLCGYPPFYS 227

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 13/210 (6%)
Query: 369 DLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENL 427
           D  + +++VLG G  G   +          A+K L+D   + RE +         +   +
Sbjct: 22  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRI 81
Query: 428 VPLRAYYYSMDEKLL-VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           V +    Y+  + LL V + L  G L + +      G         S I       I+YL
Sbjct: 82  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYL 138
Query: 487 HAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLAHLVGPS---STPNRVAGYRAPEVT 540
           H+   N++H ++K  N+L T        +++DFG A         +TP     Y APEV 
Sbjct: 139 HSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 196
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
            P K  +  D++S GV++  LL G  P ++
Sbjct: 197 GPEKYDKSCDMWSLGVIMYILLCGYPPFYS 226

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 27/209 (12%)
Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLK---DVTISEREFKDKIEGVGAVNHENLVPLR 431
           E +G G +G    A   + G  VA+K++    DV  + +    +++ +    H+N++ ++
Sbjct: 61  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK 120
Query: 432 ------AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
                   Y       +V D L    L  ++H ++     PL  E          RG++Y
Sbjct: 121 DILRPTVPYGEFKSVYVVLD-LMESDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKY 174
Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR--------VAGYRAP 537
           +H+    V H ++K SN+L+ ++ E ++ DFG+A  +  S   ++           YRAP
Sbjct: 175 MHSA--QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 232
Query: 538 EVTDPC-KVSQKADVYSFGVLLLELLTGK 565
           E+     + +Q  D++S G +  E+L  +
Sbjct: 233 ELMLSLHEYTQAIDLWSVGCIFGEMLARR 261

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 16/202 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISERE----FKDKIEGVGAVNHENLVP 429
            + LG GTFG       ++ G  VAVK L    I   +     K +I+ +    H +++ 
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           L     +  +  +V +Y++ G L   +  +   GR     E R L        ++Y H  
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKH---GRVE-EMEARRLFQ-QILSAVDYCHRH 130
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEV-TDPCKV 545
              V H ++K  N+LL     A+++DFGL++++          G   Y APEV +     
Sbjct: 131 --MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYA 188
Query: 546 SQKADVYSFGVLLLELLTGKAP 567
             + D++S GV+L  LL G  P
Sbjct: 189 GPEVDIWSCGVILYALLCGTLP 210

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 16/202 (7%)
Query: 375 AEVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISERE----FKDKIEGVGAVNHENLVP 429
            + LG GTFG       ++ G  VAVK L    I   +     K +I+ +    H +++ 
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           L     +  +  +V +Y++ G L   +  +   GR     E R L        ++Y H  
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKH---GRVE-EMEARRLFQ-QILSAVDYCHRH 130
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEV-TDPCKV 545
              V H ++K  N+LL     A+++DFGL++++          G   Y APEV +     
Sbjct: 131 --MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 546 SQKADVYSFGVLLLELLTGKAP 567
             + D++S GV+L  LL G  P
Sbjct: 189 GPEVDIWSCGVILYALLCGTLP 210

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 13/210 (6%)
Query: 369 DLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENL 427
           D  + +++VLG G  G   +          A+K L+D   + RE +         +   +
Sbjct: 21  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRI 80
Query: 428 VPLRAYYYSMDEKLL-VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           V +    Y+  + LL V + L  G L + +      G         S I       I+YL
Sbjct: 81  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYL 137
Query: 487 HAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLAHLVGPS---STPNRVAGYRAPEVT 540
           H+   N++H ++K  N+L T        +++DFG A         +TP     Y APEV 
Sbjct: 138 HSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 195
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
            P K  +  D++S GV++  LL G  P ++
Sbjct: 196 GPEKYDKSCDMWSLGVIMYILLCGYPPFYS 225

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 58/129 (44%), Gaps = 6/129 (4%)
Query: 61  WAGVECEQN----RVTMLRLPGVALSGQIPL-GILGNLTSLRTLSLR-FNSLTSQLPSDL 114
           W GV C+ +    RV  L L G+ L    P+   L NL  L  L +   N+L   +P  +
Sbjct: 38  WLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAI 97
Query: 115 ASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGXXXXXXXXXXXXX 174
           A  + L  LY+   + SG +P FL  +  LV L+ + N  SG +P               
Sbjct: 98  AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157
Query: 175 XXRLSGSIP 183
             R+SG+IP
Sbjct: 158 GNRISGAIP 166

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 128/298 (42%), Gaps = 46/298 (15%)
Query: 378 LGKGTFGTAYKA----VLEMGTI--VAVKRLKD-VTISE-REFKDKIEGVGAVNHE-NLV 428
           LG+G FG   +A    + +  T   VAVK LK+  T SE R    +++ +  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 429 PLRAYYYSMDEKLLVY-DYLTMGSLSALLHGNKGAG-----------RTPLNWEMRSLIA 476
            L          L+V  ++   G+LS  L   +              +  L  E     +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR- 535
              A+G+E+L ++     H ++ + NILL++    ++ DFGLA  +       R    R 
Sbjct: 155 FQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARL 212
Query: 536 -----APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKD 589
                APE       + ++DV+SFGVLL E+ + G +P        GV         + +
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVK--------IDE 258
Query: 590 EWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ 647
           E+   +   E  R +  +    ++ Q  +DC    P  RP+ SE+++ +  L  ++ Q
Sbjct: 259 EFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 8/104 (7%)
Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLAHLVGPS---S 526
           S I       I+YLH+   N++H ++K  N+L T        +++DFG A         +
Sbjct: 120 SEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 177
Query: 527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           TP     Y APEV  P K  +  D++S GV++  LL G  P ++
Sbjct: 178 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 221

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 42/288 (14%)
Query: 378 LGKGTFGTAYKA----VLEMGT--IVAVKRLKD-VTISE-REFKDKIEGVGAVNHE-NLV 428
           LG+G FG   +A    + +  T   VAVK LK+  T SE R    +++ +  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 429 PLRAYYYSMDEKLLVY-DYLTMGSLSALLHGN-------KGAGRTPLNWEMRSLIALGAA 480
            L          L+V  ++   G+LS  L          K   +  L  E     +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR----- 535
           +G+E+L ++     H ++ + NILL++    ++ DFGLA  +       R    R     
Sbjct: 155 KGMEFLASR--KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 536 -APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTS 593
            APE       + ++DV+SFGVLL E+ + G +P        GV         + +E+  
Sbjct: 213 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVK--------IDEEFCR 258
Query: 594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            +   E  R +  +    ++ Q  +DC    P  RP+ SE+++ +  L
Sbjct: 259 RL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 127/293 (43%), Gaps = 49/293 (16%)
Query: 376 EVLGKGTFG-----TAYKAVLEMGTI-VAVKRLKDVTISERE--FKDKIEGVGAV-NHEN 426
           + LG G FG     TA+    E   + VAVK LK    ++ +     +++ +  +  HEN
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSL-------SALLHGNKGAGRTPLNWEMRSLIALGA 479
           +V L          L++ +Y   G L       S +L  +            R L+   +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 480 --ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSSTP 528
             A+G+ +L ++  N  H ++ + N+LLT  + A++ DFGLA  +         G +  P
Sbjct: 172 QVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
            +   + APE    C  + ++DV+S+G+LL E+ + G  P   +L             +V
Sbjct: 230 VK---WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------FYKLV 280
Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE 640
           KD +       ++ +     + +  ++Q    C A  P +RP+  ++   ++E
Sbjct: 281 KDGY-------QMAQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFLQE 323

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 8/104 (7%)
Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLAHLVGPS---S 526
           S I       I+YLH+   N++H ++K  N+L T        +++DFG A         +
Sbjct: 119 SEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 176
Query: 527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           TP     Y APEV  P K  +  D++S GV++  LL G  P ++
Sbjct: 177 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 220

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 8/104 (7%)
Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLAHLVGPS---S 526
           S I       I+YLH+   N++H ++K  N+L T        +++DFG A         +
Sbjct: 118 SEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 175
Query: 527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           TP     Y APEV  P K  +  D++S GV++  LL G  P ++
Sbjct: 176 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 219

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 85/193 (44%), Gaps = 26/193 (13%)
Query: 414 DKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRS 473
           D++  +  ++H N++ L  ++       LV +    G L   +   +          M+ 
Sbjct: 53  DEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQ 112
Query: 474 LIALGAARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEA--RVSDFGL-AHLVGPSSTPN 529
           +++     G  YLH    N+ H ++K  N+LL +KS +A  ++ DFGL AH         
Sbjct: 113 VLS-----GTTYLHKH--NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKE 165
Query: 530 RV--AGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEE----------GV 577
           R+  A Y APEV    K  +K DV+S GV+L  LL G  P     ++E            
Sbjct: 166 RLGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSF 224
Query: 578 DLPRWVQSIVKDE 590
           D P W Q  V DE
Sbjct: 225 DPPDWTQ--VSDE 235

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 8/104 (7%)
Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLAHLVGPS---S 526
           S I       I+YLH+   N++H ++K  N+L T        +++DFG A         +
Sbjct: 164 SEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221
Query: 527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           TP     Y APEV  P K  +  D++S GV++  LL G  P ++
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 16/228 (7%)
Query: 352 TKKLVFFGNAARVFDLE-DLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE 409
           T + ++F  A   F+++ D L    E LG+G +G   K   +  G I AVKR++  T++ 
Sbjct: 16  TTENLYFQGAXENFEVKADDLEPIXE-LGRGAYGVVEKXRHVPSGQIXAVKRIR-ATVNS 73
Query: 410 REFKDKIEGVGAVNHENLVPLRAYYYSM---DEKLLVYDYLTMGSLSALLHGNKGAGRTP 466
           +E K  +  +         P    +Y     +  + +   L   SL          G+T 
Sbjct: 74  QEQKRLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQT- 132
Query: 467 LNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS 526
           +  ++   IA+   + +E+LH++  +V H ++K SN+L+    + +  DFG++  +    
Sbjct: 133 IPEDILGKIAVSIVKALEHLHSKL-SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDV 191
Query: 527 TPNRVAG---YRAPEVTDP----CKVSQKADVYSFGVLLLELLTGKAP 567
             +  AG   Y APE  +P       S K+D++S G+  +EL   + P
Sbjct: 192 AKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFP 239

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 366 DLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNH 424
           DLE ++      LG+G +G   K   +  G I+AVKR++  T++ +E K  +  +     
Sbjct: 8   DLEPIME-----LGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMR 61
Query: 425 ENLVPLRAYYYSM---DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR 481
               P    +Y     +  + +   L   SL          G+T +  ++   IA+   +
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQT-IPEDILGKIAVSIVK 120
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPE 538
            +E+LH++  +V H ++K SN+L+    + ++ DFG++  +      +  AG   Y APE
Sbjct: 121 ALEHLHSKL-SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE 179
Query: 539 VTDP----CKVSQKADVYSFGVLLLELLTGKAP 567
             +P       S K+D++S G+ ++EL   + P
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 8/104 (7%)
Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLAHLVGPS---S 526
           S I       I+YLH+   N++H ++K  N+L T        +++DFG A         +
Sbjct: 120 SEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 177
Query: 527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           TP     Y APEV  P K  +  D++S GV++  LL G  P ++
Sbjct: 178 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 221

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 8/104 (7%)
Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLAHLVGPS---S 526
           S I       I+YLH+   N++H ++K  N+L T        +++DFG A         +
Sbjct: 170 SEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 227
Query: 527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           TP     Y APEV  P K  +  D++S GV++  LL G  P ++
Sbjct: 228 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 271

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 27/209 (12%)
Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLK---DVTISEREFKDKIEGVGAVNHENLVPLR 431
           E +G G +G    A   + G  VA+K++    DV  + +    +++ +    H+N++ ++
Sbjct: 60  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK 119
Query: 432 ------AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
                   Y       +V D L    L  ++H ++     PL  E          RG++Y
Sbjct: 120 DILRPTVPYGEFKSVYVVLD-LMESDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKY 173
Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR--------VAGYRAP 537
           +H+    V H ++K SN+L+ ++ E ++ DFG+A  +  S   ++           YRAP
Sbjct: 174 MHSA--QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 231
Query: 538 EVTDPC-KVSQKADVYSFGVLLLELLTGK 565
           E+     + +Q  D++S G +  E+L  +
Sbjct: 232 ELMLSLHEYTQAIDLWSVGCIFGEMLARR 260

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 29/205 (14%)
Query: 398 AVKRLKDVTISEREFKDKIEGVGAV---NHENLVPLRAYYYSMDEKLLVYDYLTMGSL-S 453
           A+K ++  ++S       +E V  +   +H N++ L  ++       LV +    G L  
Sbjct: 66  AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125
Query: 454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEA- 511
            ++H      R   N    ++I      G+ YLH    N+ H ++K  N+LL +K  +A 
Sbjct: 126 EIIH------RMKFNEVDAAVIIKQVLSGVTYLHKH--NIVHRDLKPENLLLESKEKDAL 177
Query: 512 -RVSDFGLAHLV-GPSSTPNRV--AGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
            ++ DFGL+ +         R+  A Y APEV    K  +K DV+S GV+L  LL G  P
Sbjct: 178 IKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPP 236
Query: 568 THALLNEE----------GVDLPRW 582
                ++E            D P W
Sbjct: 237 FGGQTDQEILRKVEKGKYTFDSPEW 261

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 128/298 (42%), Gaps = 46/298 (15%)
Query: 378 LGKGTFGTAYKA----VLEMGTI--VAVKRLKD-VTISE-REFKDKIEGVGAVNHE-NLV 428
           LG+G FG   +A    + +  T   VAVK LK+  T SE R    +++ +  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 429 PLRAYYYSMDEKLLVY-DYLTMGSLSALLHGNKGAG-----------RTPLNWEMRSLIA 476
            L          L+V  ++   G+LS  L   +              +  L  E     +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR- 535
              A+G+E+L ++     H ++ + NILL++    ++ DFGLA  +       R    R 
Sbjct: 146 FQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 536 -----APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKD 589
                APE       + ++DV+SFGVLL E+ + G +P        GV         + +
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVK--------IDE 249
Query: 590 EWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ 647
           E+   +   E  R +  +    ++ Q  +DC    P  RP+ SE+++ +  L  ++ Q
Sbjct: 250 EFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 305

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 21/214 (9%)
Query: 369 DLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENL 427
           D  + +++VLG G  G   +          A+K L+D   + RE +         +   +
Sbjct: 15  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRI 74
Query: 428 VPLRAYYYSMDEKLL-VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           V +    Y+  + LL V + L  G L + +      G         S I       I+YL
Sbjct: 75  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYL 131
Query: 487 HAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLAH-------LVGPSSTPNRVAGYRA 536
           H+   N++H ++K  N+L T        +++DFG A        L  P  TP     Y A
Sbjct: 132 HSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPY----YVA 185
Query: 537 PEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           PEV  P K  +  D++S GV++  LL G  P ++
Sbjct: 186 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 219

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 122/285 (42%), Gaps = 42/285 (14%)
Query: 378 LGKGTFGTAYKA----VLEMGT--IVAVKRLKD-VTISE-REFKDKIEGVGAVNHE-NLV 428
           LG+G FG   +A    + +  T   VAVK LK+  T SE R    +++ +  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 429 PLRAYYYSMDEKLLVY-DYLTMGSLSALLHGN-------KGAGRTPLNWEMRSLIALGAA 480
            L          L+V  ++   G+LS  L          K   +  L  E     +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR----- 535
           +G+E+L ++     H ++ + NILL++    ++ DFGLA  +       R    R     
Sbjct: 155 KGMEFLASR--KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 536 -APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTS 593
            APE       + ++DV+SFGVLL E+ + G +P        GV +       +K     
Sbjct: 213 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVKIDEEFXRRLK----- 261
Query: 594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
                E  R +  +    ++ Q  +DC    P  RP+ SE+++ +
Sbjct: 262 -----EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 128/298 (42%), Gaps = 46/298 (15%)
Query: 378 LGKGTFGTAYKA----VLEMGTI--VAVKRLKD-VTISE-REFKDKIEGVGAVNHE-NLV 428
           LG+G FG   +A    + +  T   VAVK LK+  T SE R    +++ +  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 429 PLRAYYYSMDEKLLVY-DYLTMGSLSALLHGNKGAG-----------RTPLNWEMRSLIA 476
            L          L+V  ++   G+LS  L   +              +  L  E     +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR- 535
              A+G+E+L ++     H ++ + NILL++    ++ DFGLA  +       R    R 
Sbjct: 146 FQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 536 -----APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKD 589
                APE       + ++DV+SFGVLL E+ + G +P        GV         + +
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVK--------IDE 249
Query: 590 EWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ 647
           E+   +   E  R +  +    ++ Q  +DC    P  RP+ SE+++ +  L  ++ Q
Sbjct: 250 EFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 305

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 128/298 (42%), Gaps = 46/298 (15%)
Query: 378 LGKGTFGTAYKA----VLEMGTI--VAVKRLKD-VTISE-REFKDKIEGVGAVNHE-NLV 428
           LG+G FG   +A    + +  T   VAVK LK+  T SE R    +++ +  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 429 PLRAYYYSMDEKLLVY-DYLTMGSLSALLHGNKGAG-----------RTPLNWEMRSLIA 476
            L          L+V  ++   G+LS  L   +              +  L  E     +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR- 535
              A+G+E+L ++     H ++ + NILL++    ++ DFGLA  +       R    R 
Sbjct: 155 FQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 536 -----APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKD 589
                APE       + ++DV+SFGVLL E+ + G +P        GV         + +
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVK--------IDE 258
Query: 590 EWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ 647
           E+   +   E  R +  +    ++ Q  +DC    P  RP+ SE+++ +  L  ++ Q
Sbjct: 259 EFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 100/201 (49%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++  FGLA       T   VA   YRAPE+  +   
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 199
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 128/298 (42%), Gaps = 46/298 (15%)
Query: 378 LGKGTFGTAYKA----VLEMGTI--VAVKRLKD-VTISE-REFKDKIEGVGAVNHE-NLV 428
           LG+G FG   +A    + +  T   VAVK LK+  T SE R    +++ +  + H  N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 429 PLRAYYYSMDEKLLVY-DYLTMGSLSALLHGNKGAG-----------RTPLNWEMRSLIA 476
            L          L+V  ++   G+LS  L   +              +  L  E     +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR- 535
              A+G+E+L ++     H ++ + NILL++    ++ DFGLA  +       R    R 
Sbjct: 192 FQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 249
Query: 536 -----APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKD 589
                APE       + ++DV+SFGVLL E+ + G +P        GV         + +
Sbjct: 250 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVK--------IDE 295
Query: 590 EWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ 647
           E+   +   E  R +  +    ++ Q  +DC    P  RP+ SE+++ +  L  ++ Q
Sbjct: 296 EFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 351

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 128/298 (42%), Gaps = 46/298 (15%)
Query: 378 LGKGTFGTAYKA----VLEMGTI--VAVKRLKD-VTISE-REFKDKIEGVGAVNHE-NLV 428
           LG+G FG   +A    + +  T   VAVK LK+  T SE R    +++ +  + H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 429 PLRAYYYSMDEKLLVY-DYLTMGSLSALLHGNKGAG-----------RTPLNWEMRSLIA 476
            L          L+V  ++   G+LS  L   +              +  L  E     +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR- 535
              A+G+E+L ++     H ++ + NILL++    ++ DFGLA  +       R    R 
Sbjct: 157 FQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 214
Query: 536 -----APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKD 589
                APE       + ++DV+SFGVLL E+ + G +P        GV         + +
Sbjct: 215 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVK--------IDE 260
Query: 590 EWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ 647
           E+   +   E  R +  +    ++ Q  +DC    P  RP+ SE+++ +  L  ++ Q
Sbjct: 261 EFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 316

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 100/231 (43%), Gaps = 38/231 (16%)
Query: 377 VLGKGTFGTAYKA---VLEMGTIVAV-----KRLKDVTISEREFKDKIEGVGAVNHENLV 428
           +LGKG+FG   K    + +    V V      + KD +   RE    +E +  ++H N++
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE----VELLKKLDHPNIM 84
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L           +V +  T G L      ++   R   +    + I      GI Y+H 
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGEL-----FDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 489 QGPNVSHGNIKSSNILLT---KSYEARVSDFGLAHLVGPSST-PNRV--AGYRAPEVTDP 542
              N+ H ++K  NILL    K  + ++ DFGL+     ++   +R+  A Y APEV   
Sbjct: 140 H--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG 197
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGV-----------DLPRW 582
               +K DV+S GV+L  LL+G  P +   NE  +           DLP+W
Sbjct: 198 T-YDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQW 246

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 100/201 (49%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DF LA       T   VA   YRAPE+  +   
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMT-GYVATRWYRAPEIMLNWMH 199
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEG----VGAVNHENLVP 429
            + LG+G+FG    A     G  VA+K +    +++ + + +IE     +  + H +++ 
Sbjct: 19  VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 78
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           L     S DE ++V +Y        ++  +K + +    +  + + A      +EY H  
Sbjct: 79  LYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISA------VEYCHRH 132
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEV-TDPCKV 545
              + H ++K  N+LL +    +++DFGL++++   +      G   Y APEV +     
Sbjct: 133 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 190
Query: 546 SQKADVYSFGVLLLELLTGKAP 567
             + DV+S GV+L  +L  + P
Sbjct: 191 GPEVDVWSCGVILYVMLCRRLP 212

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 100/201 (49%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ D GLA       T   VA   YRAPE+  +   
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 199
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEG----VGAVNHENLVP 429
            + LG+G+FG    A     G  VA+K +    +++ + + +IE     +  + H +++ 
Sbjct: 13  VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 72
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           L     S DE ++V +Y        ++  +K + +    +  + + A      +EY H  
Sbjct: 73  LYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISA------VEYCHRH 126
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEV-TDPCKV 545
              + H ++K  N+LL +    +++DFGL++++   +      G   Y APEV +     
Sbjct: 127 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 184
Query: 546 SQKADVYSFGVLLLELLTGKAP 567
             + DV+S GV+L  +L  + P
Sbjct: 185 GPEVDVWSCGVILYVMLCRRLP 206

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEG----VGAVNHENLVP 429
            + LG+G+FG    A     G  VA+K +    +++ + + +IE     +  + H +++ 
Sbjct: 18  VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 77
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           L     S DE ++V +Y        ++  +K + +    +  + + A      +EY H  
Sbjct: 78  LYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISA------VEYCHRH 131
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEV-TDPCKV 545
              + H ++K  N+LL +    +++DFGL++++   +      G   Y APEV +     
Sbjct: 132 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 189
Query: 546 SQKADVYSFGVLLLELLTGKAP 567
             + DV+S GV+L  +L  + P
Sbjct: 190 GPEVDVWSCGVILYVMLCRRLP 211

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 376 EVLGKGTFG-----TAYKAVLEMGTI-VAVKRLKDVTISERE--FKDKIEGVGAV-NHEN 426
           + LG G FG     TA+    E   + VAVK LK    ++ +     +++ +  +  HEN
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG---------RTPLNWEMRSLIAL 477
           +V L          L++ +Y   G L   L   +  G                 R L+  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHF 171
Query: 478 GA--ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---------GPSS 526
            +  A+G+ +L ++  N  H ++ + N+LLT  + A++ DFGLA  +         G + 
Sbjct: 172 SSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 229
Query: 527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQS 585
            P +   + APE    C  + ++DV+S+G+LL E+ + G  P   +L             
Sbjct: 230 LPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------FYK 280
Query: 586 IVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE 640
           +VKD +       ++ +     + +  ++Q    C A  P +RP+  ++   ++E
Sbjct: 281 LVKDGY-------QMAQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFLQE 325

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 85/193 (44%), Gaps = 26/193 (13%)
Query: 414 DKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRS 473
           D++  +  ++H N++ L  ++       LV +    G L   +   +          M+ 
Sbjct: 70  DEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQ 129
Query: 474 LIALGAARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEA--RVSDFGL-AHLVGPSSTPN 529
           +++     G  YLH    N+ H ++K  N+LL +KS +A  ++ DFGL AH         
Sbjct: 130 VLS-----GTTYLHKH--NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKE 182
Query: 530 RV--AGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEE----------GV 577
           R+  A Y APEV    K  +K DV+S GV+L  LL G  P     ++E            
Sbjct: 183 RLGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSF 241
Query: 578 DLPRWVQSIVKDE 590
           D P W Q  V DE
Sbjct: 242 DPPDWTQ--VSDE 252

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 101/202 (50%), Gaps = 23/202 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   +  ++ G  +AVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 117
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 171
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRAPE+  +   
Sbjct: 172 SA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 228
Query: 545 VSQKADVYSFGVLLLELLTGKA 566
            +   D++S G ++ ELLTG+ 
Sbjct: 229 YNMTVDIWSVGCIMAELLTGRT 250

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 100/201 (49%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YY---YSMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ D GLA       T   VA   YRAPE+  +   
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 199
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEG----VGAVNHENLVP 429
            + LG+G+FG    A     G  VA+K +    +++ + + +IE     +  + H +++ 
Sbjct: 9   VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 68
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           L     S DE ++V +Y        ++  +K + +    +  + +I+      +EY H  
Sbjct: 69  LYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF-FQQIIS-----AVEYCHRH 122
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTD-PCKV 545
              + H ++K  N+LL +    +++DFGL++++   +      G   Y APEV       
Sbjct: 123 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 180
Query: 546 SQKADVYSFGVLLLELLTGKAP 567
             + DV+S GV+L  +L  + P
Sbjct: 181 GPEVDVWSCGVILYVMLCRRLP 202

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 26/208 (12%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE--FKDKIEGVGAVNHENLVPLRA 432
           +VLG G F     A       +VA+K +    +  +E   +++I  +  + H N+V L  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 433 YYYSMDEKLLVYDYLTMGSLSALL-----HGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            Y S     L+   ++ G L   +     +  + A R          +       ++YLH
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR----------LIFQVLDAVKYLH 133
Query: 488 AQGPNVSHGNIKSSNIL---LTKSYEARVSDFGLAHLVGPSS---TPNRVAGYRAPEVTD 541
             G  + H ++K  N+L   L +  +  +SDFGL+ +  P S   T     GY APEV  
Sbjct: 134 DLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 191
Query: 542 PCKVSQKADVYSFGVLLLELLTGKAPTH 569
               S+  D +S GV+   LL G  P +
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYPPFY 219

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 27/224 (12%)
Query: 377 VLGKGTFGTAY----KAVLEMGTIVAVKRLKDVTISEREFKDKI--EGVGAVNHEN--LV 428
           VLGKG+FG       K   E+  I  +K  KDV I + + +  +  + V A+  +   L 
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILK--KDVVIQDDDVECTMVEKRVLALLDKPPFLT 83
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L + + ++D    V +Y+  G L   +    G  + P         A   + G+ +LH 
Sbjct: 84  QLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-QVGKFKEP----QAVFYAAEISIGLFFLHK 138
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLA--HLVGPSSTPNRVA--GYRAPEVTDPCK 544
           +G  + + ++K  N++L      +++DFG+   H++   +T        Y APE+     
Sbjct: 139 RG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQP 196
Query: 545 VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK 588
             +  D +++GVLL E+L G+ P       +G D     QSI++
Sbjct: 197 YGKSVDWWAYGVLLYEMLAGQPPF------DGEDEDELFQSIME 234

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 23/224 (10%)
Query: 367 LEDLLRASAEVLGKGTFGTAY---KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
           +EDL       +G+GT+G  Y   +   +     A+K+++   IS    ++ I  +  + 
Sbjct: 18  VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE-IALLRELK 76
Query: 424 HENLVPLRAYYYSMDEK--LLVYDYLTMGSLSAL-LHGNKGAGRTPLNWE--MRSLIALG 478
           H N++ L+  + S  ++   L++DY        +  H    A + P+     M   +   
Sbjct: 77  HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLT----KSYEARVSDFGLAHLVGPSSTPNR---- 530
              GI YLHA    V H ++K +NIL+     +    +++D G A L      P      
Sbjct: 137 ILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 531 ---VAGYRAPEVTDPCKVSQKA-DVYSFGVLLLELLTGKAPTHA 570
                 YRAPE+    +   KA D+++ G +  ELLT +   H 
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 26/208 (12%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE--FKDKIEGVGAVNHENLVPLRA 432
           +VLG G F     A       +VA+K +    +  +E   +++I  +  + H N+V L  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 433 YYYSMDEKLLVYDYLTMGSLSALL-----HGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            Y S     L+   ++ G L   +     +  + A R          +       ++YLH
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR----------LIFQVLDAVKYLH 133
Query: 488 AQGPNVSHGNIKSSNIL---LTKSYEARVSDFGLAHLVGPSS---TPNRVAGYRAPEVTD 541
             G  + H ++K  N+L   L +  +  +SDFGL+ +  P S   T     GY APEV  
Sbjct: 134 DLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 191
Query: 542 PCKVSQKADVYSFGVLLLELLTGKAPTH 569
               S+  D +S GV+   LL G  P +
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYPPFY 219

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 378 LGKGTFGTAYKAVLEM-GTIVAVK--RLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
           LG+GT+ T YK   ++   +VA+K  RL+    +      ++  +  + H N+V L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
           ++     LV++YL       L       G   +N     L      RG+ Y H Q   V 
Sbjct: 70  HTEKSLTLVFEYLDKDLKQYL----DDCGNI-INMHNVKLFLFQLLRGLAYCHRQ--KVL 122
Query: 495 HGNIKSSNILLTKSYEARVSDFGLAHLVG-PSST-PNRVAG--YRAPEV-TDPCKVSQKA 549
           H ++K  N+L+ +  E +++DFGLA     P+ T  N V    YR P++       S + 
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQI 182
Query: 550 DVYSFGVLLLELLTGK 565
           D++  G +  E+ TG+
Sbjct: 183 DMWGVGCIFYEMATGR 198

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 26/208 (12%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE--FKDKIEGVGAVNHENLVPLRA 432
           +VLG G F     A       +VA+K +    +  +E   +++I  +  + H N+V L  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 433 YYYSMDEKLLVYDYLTMGSLSALL-----HGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            Y S     L+   ++ G L   +     +  + A R          +       ++YLH
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR----------LIFQVLDAVKYLH 133
Query: 488 AQGPNVSHGNIKSSNIL---LTKSYEARVSDFGLAHLVGPSS---TPNRVAGYRAPEVTD 541
             G  + H ++K  N+L   L +  +  +SDFGL+ +  P S   T     GY APEV  
Sbjct: 134 DLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 191
Query: 542 PCKVSQKADVYSFGVLLLELLTGKAPTH 569
               S+  D +S GV+   LL G  P +
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYPPFY 219

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 26/208 (12%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE--FKDKIEGVGAVNHENLVPLRA 432
           +VLG G F     A       +VA+K +    +  +E   +++I  +  + H N+V L  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 433 YYYSMDEKLLVYDYLTMGSLSALL-----HGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            Y S     L+   ++ G L   +     +  + A R          +       ++YLH
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR----------LIFQVLDAVKYLH 133
Query: 488 AQGPNVSHGNIKSSNIL---LTKSYEARVSDFGLAHLVGPSS---TPNRVAGYRAPEVTD 541
             G  + H ++K  N+L   L +  +  +SDFGL+ +  P S   T     GY APEV  
Sbjct: 134 DLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 191
Query: 542 PCKVSQKADVYSFGVLLLELLTGKAPTH 569
               S+  D +S GV+   LL G  P +
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCGYPPFY 219

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 45/222 (20%)
Query: 377 VLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           VLG+G FG   KA   + +   A+K+++           ++  + ++NH+ +V    YY 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVV---RYYA 69
Query: 436 SMDEK----------------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA 479
           +  E+                 +  +Y    +L  L+H      +    W +   I    
Sbjct: 70  AWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL--- 126
Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-------------PSS 526
              + Y+H+QG  + H N+K  NI + +S   ++ DFGLA  V              P S
Sbjct: 127 -EALSYIHSQG--IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 527 TPNR-----VAGYRAPEVTDPC-KVSQKADVYSFGVLLLELL 562
           + N       A Y A EV D     ++K D YS G++  E +
Sbjct: 184 SDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 100/201 (49%), Gaps = 23/201 (11%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL----KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           +G G +G+   A   + G  VAVK+L    + +  ++R +++ +  +  + HEN++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 433 YYY---SMDEKLLVY--DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +    S++E   VY   +L    L+ ++   K      L  +    +     RG++Y+H
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRAPEVT-DPCK 544
           +   ++ H ++K SN+ + +  E ++ D GLA       T   VA   YRAPE+  +   
Sbjct: 143 SA--DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMT-GYVATRWYRAPEIMLNWMH 199
Query: 545 VSQKADVYSFGVLLLELLTGK 565
            +Q  D++S G ++ ELLTG+
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 100/231 (43%), Gaps = 38/231 (16%)
Query: 377 VLGKGTFGTAYKA---VLEMGTIVAV-----KRLKDVTISEREFKDKIEGVGAVNHENLV 428
           +LGKG+FG   K    + +    V V      + KD +   RE    +E +  ++H N++
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE----VELLKKLDHPNIM 84
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L           +V +  T G L      ++   R   +    + I      GI Y+H 
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELF-----DEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 489 QGPNVSHGNIKSSNILLT---KSYEARVSDFGLAHLVGPSST-PNRV--AGYRAPEVTDP 542
              N+ H ++K  NILL    K  + ++ DFGL+     ++   +R+  A Y APEV   
Sbjct: 140 H--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG 197
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGV-----------DLPRW 582
               +K DV+S GV+L  LL+G  P +   NE  +           DLP+W
Sbjct: 198 T-YDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQW 246

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 100/231 (43%), Gaps = 38/231 (16%)
Query: 377 VLGKGTFGTAYKA---VLEMGTIVAV-----KRLKDVTISEREFKDKIEGVGAVNHENLV 428
           +LGKG+FG   K    + +    V V      + KD +   RE    +E +  ++H N++
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE----VELLKKLDHPNIM 84
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L           +V +  T G L      ++   R   +    + I      GI Y+H 
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELF-----DEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 489 QGPNVSHGNIKSSNILLT---KSYEARVSDFGLAHLVGPSS-TPNRV--AGYRAPEVTDP 542
              N+ H ++K  NILL    K  + ++ DFGL+     ++   +R+  A Y APEV   
Sbjct: 140 H--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG 197
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGV-----------DLPRW 582
               +K DV+S GV+L  LL+G  P +   NE  +           DLP+W
Sbjct: 198 T-YDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQW 246

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA---GYRAP 537
           RG+++LH+    V H ++K  NIL+T S + +++DFGLA +         V     YRAP
Sbjct: 131 RGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 538 EVTDPCKVSQKADVYSFGVLLLELLTGK 565
           EV      +   D++S G +  E+   K
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 378 LGKGTFGTAYKA--VLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNH------ENLVP 429
           +G+G +G  +KA  +   G  VA+KR++  T  E      I  V  + H       N+V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 430 L----RAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
           L           + KL LV++++    L+  L      G   +  E    +     RG++
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG---VPTETIKDMMFQLLRGLD 134
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA---GYRAPEVTD 541
           +LH+    V H ++K  NIL+T S + +++DFGLA +         V     YRAPEV  
Sbjct: 135 FLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 542 PCKVSQKADVYSFGVLLLELLTGK 565
               +   D++S G +  E+   K
Sbjct: 193 QSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA---GYRAP 537
           RG+++LH+    V H ++K  NIL+T S + +++DFGLA +         V     YRAP
Sbjct: 131 RGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 538 EVTDPCKVSQKADVYSFGVLLLELLTGK 565
           EV      +   D++S G +  E+   K
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 13/210 (6%)
Query: 369 DLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENL 427
           D  + +++VLG G  G   +          A+K L+D   + RE +         +   +
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQDCPKARREVELHWRASQCPHIVRI 120
Query: 428 VPLRAYYYSMDEKLL-VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           V +    Y+  + LL V + L  G L + +      G         S I       I+YL
Sbjct: 121 VDVYENLYAGRKCLLIVXECLDGGELFSRIQDR---GDQAFTEREASEIXKSIGEAIQYL 177
Query: 487 HAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLAHLVGPS---STPNRVAGYRAPEVT 540
           H+   N++H ++K  N+L T        +++DFG A         +TP     Y APEV 
Sbjct: 178 HSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 235
Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
            P K  +  D +S GV+   LL G  P ++
Sbjct: 236 GPEKYDKSCDXWSLGVIXYILLCGYPPFYS 265

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 125/296 (42%), Gaps = 37/296 (12%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY-- 435
           +GKG +G  +      G  VAVK       +    + +I     + HEN++   A     
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKG 103
Query: 436 --SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ---- 489
             S  +  L+ DY   GSL   L       ++ L       +A  +  G+ +LH +    
Sbjct: 104 TGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLK------LAYSSVSGLCHLHTEIFST 157
Query: 490 --GPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSST----PNRVAG---YRAPEV 539
              P ++H ++KS NIL+ K+    ++D GLA   +  ++     PN   G   Y  PEV
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 540 TDPC------KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTS 593
            D        +    AD+YSFG++L E +  +  +  ++ E  +     V S    E   
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWE-VARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 594 EVFDLELLR-----YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS 644
           E+  ++ LR       + +E + Q+ +L  +C A  P +R +   V K + ++  S
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 367 LEDLLRASAEVLGKGTFGTAYKAVLEMGT--IVAVKRLKDVTISEREFKDKIEGVGAVNH 424
           L D     +E LG+G     Y+   + GT    A+K LK  T+ ++  + +I  +  ++H
Sbjct: 51  LSDFFEVESE-LGRGATSIVYRCK-QKGTQKPYALKVLKK-TVDKKIVRTEIGVLLRLSH 107
Query: 425 ENLVPLRAYYYSMDEKLLVYDYLTMGSL-SALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
            N++ L+  + +  E  LV + +T G L   ++     + R   +   + L A      +
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEA------V 161
Query: 484 EYLHAQGPNVSHGNIKSSNILL-TKSYEA--RVSDFGLAHLVGPSSTPNRVAG---YRAP 537
            YLH  G  + H ++K  N+L  T + +A  +++DFGL+ +V        V G   Y AP
Sbjct: 162 AYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAP 219
Query: 538 EVTDPCKVSQKADVYSFGVLLLELLTGKAPTH 569
           E+   C    + D++S G++   LL G  P +
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCGFEPFY 251

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 92/222 (41%), Gaps = 45/222 (20%)
Query: 377 VLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           VLG+G FG   KA   + +   A+K+++           ++  + ++NH+ +V    YY 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVV---RYYA 69
Query: 436 SMDEK----------------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA 479
           +  E+                 +  +Y    +L  L+H      +    W +   I    
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL--- 126
Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-------------PSS 526
              + Y+H+QG  + H ++K  NI + +S   ++ DFGLA  V              P S
Sbjct: 127 -EALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 527 TPNR-----VAGYRAPEVTDPC-KVSQKADVYSFGVLLLELL 562
           + N       A Y A EV D     ++K D+YS G++  E++
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 82/179 (45%), Gaps = 25/179 (13%)
Query: 476 ALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR 535
           +   A+G+E+L ++     H ++ + NILL++    ++ DFGLA  +       R    R
Sbjct: 199 SFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 536 ------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVK 588
                 APE       + ++DV+SFGVLL E+ + G +P        GV         + 
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVK--------ID 302
Query: 589 DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ 647
           +E+   +   E  R +  +    ++ Q  +DC    P  RP+ SE+++ +  L  ++ Q
Sbjct: 303 EEFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 359

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT-------ISEREFKDKIEGVGAVNHEN 426
            EV+GKG F    + +  E G   AVK + DV        +S  + K +      + H +
Sbjct: 29  CEVIGKGAFSVVRRCINRETGQQFAVK-IVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG----RTPLNWEMRSLIALGAARG 482
           +V L   Y S     +V++++    L   +     AG        +  MR ++       
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL-----EA 142
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTK---SYEARVSDFGLAHLVGPSSTPNRVAG------ 533
           + Y H    N+ H ++K  N+LL     S   ++ DFG+A  +G S     VAG      
Sbjct: 143 LRYCHDN--NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGL---VAGGRVGTP 197
Query: 534 -YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTH 569
            + APEV       +  DV+  GV+L  LL+G  P +
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK-DVTISERE-FKDKIEGVGAVNHENLVPLRA 432
           E LG G FG   + +  + G  VA+K+ + +++   RE +  +I+ +  +NH N+V  R 
Sbjct: 21  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 80
Query: 433 YYYSM------DEKLLVYDYLTMGSLSALLHGNK---GAGRTPLNWEMRSLIALGAARGI 483
               +      D  LL  +Y   G L   L+  +   G    P+    R+L++   +  +
Sbjct: 81  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI----RTLLS-DISSAL 135
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEA---RVSDFGLAHLVGPSSTPNRVAG---YRAP 537
            YLH     + H ++K  NI+L    +    ++ D G A  +          G   Y AP
Sbjct: 136 RYLHEN--RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 193
Query: 538 EVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           E+ +  K +   D +SFG L  E +TG  P
Sbjct: 194 ELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 82/179 (45%), Gaps = 25/179 (13%)
Query: 476 ALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR 535
           +   A+G+E+L ++     H ++ + NILL++    ++ DFGLA  +       R    R
Sbjct: 204 SFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 261
Query: 536 ------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVK 588
                 APE       + ++DV+SFGVLL E+ + G +P        GV         + 
Sbjct: 262 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVK--------ID 307
Query: 589 DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ 647
           +E+   +   E  R +  +    ++ Q  +DC    P  RP+ SE+++ +  L  ++ Q
Sbjct: 308 EEFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 364

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK-DVTISERE-FKDKIEGVGAVNHENLVPLRA 432
           E LG G FG   + +  + G  VA+K+ + +++   RE +  +I+ +  +NH N+V  R 
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 433 YYYSM------DEKLLVYDYLTMGSLSALLHGNK---GAGRTPLNWEMRSLIALGAARGI 483
               +      D  LL  +Y   G L   L+  +   G    P+    R+L++   +  +
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI----RTLLS-DISSAL 134
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEA---RVSDFGLAHLVGPSSTPNRVAG---YRAP 537
            YLH     + H ++K  NI+L    +    ++ D G A  +          G   Y AP
Sbjct: 135 RYLHEN--RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 538 EVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           E+ +  K +   D +SFG L  E +TG  P
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 14/188 (7%)
Query: 396 IVAVKRLKDV-TISEREFKDKIEGVGAVNHENLVPLRAYYYS--MDEKLLVYDYLTMGSL 452
           +V V +++D  T   R+F ++   +   +H N++P+     S       L+  +   GSL
Sbjct: 37  VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSL 96
Query: 453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEAR 512
             +LH  +G     ++       AL  ARG  +LH   P +    + S ++ + +   AR
Sbjct: 97  YNVLH--EGTNFV-VDQSQAVKFALDXARGXAFLHTLEPLIPRHALNSRSVXIDEDXTAR 153
Query: 513 VSDFGLAHLVGPSSTPNR--VAGYRAPEV--TDPCKVSQK-ADVYSFGVLLLELLTGKAP 567
           +S    A +     +P R     + APE     P   +++ AD +SF VLL EL+T + P
Sbjct: 154 IS---XADVKFSFQSPGRXYAPAWVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVP 210
Query: 568 THALLNEE 575
              L N E
Sbjct: 211 FADLSNXE 218

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 82/179 (45%), Gaps = 25/179 (13%)
Query: 476 ALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR 535
           +   A+G+E+L ++     H ++ + NILL++    ++ DFGLA  +       R    R
Sbjct: 206 SFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 263
Query: 536 ------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVK 588
                 APE       + ++DV+SFGVLL E+ + G +P        GV         + 
Sbjct: 264 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVK--------ID 309
Query: 589 DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ 647
           +E+   +   E  R +  +    ++ Q  +DC    P  RP+ SE+++ +  L  ++ Q
Sbjct: 310 EEFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 366

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/93 (29%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSY---EARVSDFGLAHLVGPSSTPNRVAG---Y 534
            G+ YLH    N+ H ++K  NILL+  Y   + ++ DFG++  +G +     + G   Y
Sbjct: 142 EGVYYLHQN--NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEY 199
Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
            APE+ +   ++   D+++ G++   LLT  +P
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 98/234 (41%), Gaps = 39/234 (16%)
Query: 369 DLLRASAEV---LGKGTFGTAYKAVLEM--GTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
           D+L A  E+   LG+G FG   + +     G  VAVK +K+V       + +I+ +  +N
Sbjct: 10  DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLN 69
Query: 424 HEN------LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
             +       V +  ++       +V++ L + +   +    K  G  P   +    +A 
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFI----KENGFLPFRLDHIRKMAY 125
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILL-----TKSY--------------EARVSDFGL 518
              + + +LH+    ++H ++K  NIL      T++Y              + +V DFG 
Sbjct: 126 QICKSVNFLHSN--KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 519 AHLVGPS-STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKA--PTH 569
           A       ST      YRAPEV      SQ  DV+S G +L+E   G    PTH
Sbjct: 184 ATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 98/234 (41%), Gaps = 39/234 (16%)
Query: 369 DLLRASAEV---LGKGTFGTAYKAVLEM--GTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
           D+L A  E+   LG+G FG   + +     G  VAVK +K+V       + +I+ +  +N
Sbjct: 10  DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLN 69
Query: 424 HEN------LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL 477
             +       V +  ++       +V++ L + +   +    K  G  P   +    +A 
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFI----KENGFLPFRLDHIRKMAY 125
Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILL-----TKSY--------------EARVSDFGL 518
              + + +LH+    ++H ++K  NIL      T++Y              + +V DFG 
Sbjct: 126 QICKSVNFLHSN--KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 519 AHLVGPS-STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKA--PTH 569
           A       ST      YRAPEV      SQ  DV+S G +L+E   G    PTH
Sbjct: 184 ATYDDEHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 476 ALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR 535
           +   A+G+E+L ++     H ++ + NILL++    ++ DFGLA  +       R    R
Sbjct: 197 SFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 254
Query: 536 ------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVK 588
                 APE       + ++DV+SFGVLL E+ + G +P        GV         + 
Sbjct: 255 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------PGVK--------ID 300
Query: 589 DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
           +E+   +   E  R +  +    ++ Q  +DC    P  RP+ SE+++ +
Sbjct: 301 EEFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 76/171 (44%), Gaps = 14/171 (8%)
Query: 403 KDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGA 462
           K++     E  ++I  + +++H N++ L   +       LV ++   G L   +      
Sbjct: 84  KNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF 143
Query: 463 GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS---YEARVSDFGLA 519
                   M+ +++     GI YLH    N+ H +IK  NILL         ++ DFGL+
Sbjct: 144 DECDAANIMKQILS-----GICYLHKH--NIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 520 HLVGPS-STPNRV--AGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
                     +R+  A Y APEV    K ++K DV+S GV++  LL G  P
Sbjct: 197 SFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 10/159 (6%)
Query: 415 KIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL 474
           +IE + +++H N++ +   +       +V +    G L   +   +  G+      +  L
Sbjct: 70  EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL 129
Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLAHLVGPSSTPNRV 531
           +       + Y H+Q  +V H ++K  NIL   +      ++ DFGLA L          
Sbjct: 130 MK-QMMNALAYFHSQ--HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA 186
Query: 532 AG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           AG   Y APEV     V+ K D++S GV++  LLTG  P
Sbjct: 187 AGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 377 VLGKGTFGTAYKAVLE----MGTIVAVKRLK-DVTISERE-FKDKIEGVGAVNHENLVPL 430
           +LG+G FG  Y+ V          VAVK  K D T+  +E F  +   +  ++H ++V L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                  +   ++ +    G L   L  NK + +         L +L   + + YL  + 
Sbjct: 75  IGII-EEEPTWIIMELYPYGELGHYLERNKNSLKV----LTLVLYSLQICKAMAYL--ES 127
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-----PSSTPNRVAGYRAPEVTDPCKV 545
            N  H +I   NIL+      ++ DFGL+  +       +S       + +PE  +  + 
Sbjct: 128 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 187
Query: 546 SQKADVYSFGVLLLELLT-GKAPTHALLNEEGV 577
           +  +DV+ F V + E+L+ GK P   L N++ +
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 220

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 377 VLGKGTFGTAYKAVLE----MGTIVAVKRLK-DVTISERE-FKDKIEGVGAVNHENLVPL 430
           +LG+G FG  Y+ V          VAVK  K D T+  +E F  +   +  ++H ++V L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                  +   ++ +    G L   L  NK +    L      L +L   + + YL  + 
Sbjct: 91  IGII-EEEPTWIIMELYPYGELGHYLERNKNS----LKVLTLVLYSLQICKAMAYL--ES 143
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-----PSSTPNRVAGYRAPEVTDPCKV 545
            N  H +I   NIL+      ++ DFGL+  +       +S       + +PE  +  + 
Sbjct: 144 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 203
Query: 546 SQKADVYSFGVLLLELLT-GKAPTHALLNEEGV 577
           +  +DV+ F V + E+L+ GK P   L N++ +
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 236

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 377 VLGKGTFGTAYKAVLE----MGTIVAVKRLK-DVTISERE-FKDKIEGVGAVNHENLVPL 430
           +LG+G FG  Y+ V          VAVK  K D T+  +E F  +   +  ++H ++V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                  +   ++ +    G L   L  NK +    L      L +L   + + YL  + 
Sbjct: 79  IGII-EEEPTWIIMELYPYGELGHYLERNKNS----LKVLTLVLYSLQICKAMAYL--ES 131
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-----PSSTPNRVAGYRAPEVTDPCKV 545
            N  H +I   NIL+      ++ DFGL+  +       +S       + +PE  +  + 
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 546 SQKADVYSFGVLLLELLT-GKAPTHALLNEEGV 577
           +  +DV+ F V + E+L+ GK P   L N++ +
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 224

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPL 430
           + +GKG F     A  +  G  VAVK +    ++    ++ F++ +  +  +NH N+V L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFRE-VRIMKVLNHPNIVKL 78
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                +     LV +Y + G +   L  +          + R +++      ++Y H + 
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQYCHQKF 133
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVS- 546
             + H ++K+ N+LL      +++DFG ++     +  +   G   Y APE+    K   
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 547 QKADVYSFGVLLLELLTGKAP 567
            + DV+S GV+L  L++G  P
Sbjct: 192 PEVDVWSLGVILYTLVSGSLP 212

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPL 430
           + +GKG F     A  +  G  VAVK +    ++    ++ F++ +  +  +NH N+V L
Sbjct: 13  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFRE-VRIMKVLNHPNIVKL 71
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                +     LV +Y + G +   L  +          + R +++      ++Y H + 
Sbjct: 72  FEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVS-----AVQYCHQKF 126
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVS- 546
             + H ++K+ N+LL      +++DFG ++     +  +   G   Y APE+    K   
Sbjct: 127 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 184
Query: 547 QKADVYSFGVLLLELLTGKAP 567
            + DV+S GV+L  L++G  P
Sbjct: 185 PEVDVWSLGVILYTLVSGSLP 205

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 28/214 (13%)
Query: 369 DLLRASAEVLGKGTFGTAYKAV----LEMGTIVAVKRLKDVTISEREFKDKIEG------ 418
           +LLR    VLGKG +G  ++         G I A+K LK   I  R  KD          
Sbjct: 20  ELLR----VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV-RNAKDTAHTKAERNI 74
Query: 419 VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG 478
           +  V H  +V L   + +  +  L+ +YL+ G L   L       R  +  E  +   L 
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE------REGIFMEDTACFYLA 128
Query: 479 A-ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA----HLVGPSSTPNRVAG 533
             +  + +LH +G  + + ++K  NI+L      +++DFGL     H    + T      
Sbjct: 129 EISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186
Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           Y APE+      ++  D +S G L+ ++LTG  P
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 28/214 (13%)
Query: 369 DLLRASAEVLGKGTFGTAYKAV----LEMGTIVAVKRLKDVTISEREFKDKIEG------ 418
           +LLR    VLGKG +G  ++         G I A+K LK   I  R  KD          
Sbjct: 20  ELLR----VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV-RNAKDTAHTKAERNI 74
Query: 419 VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG 478
           +  V H  +V L   + +  +  L+ +YL+ G L   L       R  +  E  +   L 
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE------REGIFMEDTACFYLA 128
Query: 479 A-ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG--- 533
             +  + +LH +G  + + ++K  NI+L      +++DFGL    +   +  +   G   
Sbjct: 129 EISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIE 186
Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           Y APE+      ++  D +S G L+ ++LTG  P
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPL 430
           + +GKG F     A  +  G  VAVK +    ++    ++ F++ +  +  +NH N+V L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFRE-VRIMKVLNHPNIVKL 78
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                +     LV +Y + G +   L  +          + R +++      ++Y H + 
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQYCHQKF 133
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVS- 546
             + H ++K+ N+LL      +++DFG ++     +  +   G   Y APE+    K   
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 547 QKADVYSFGVLLLELLTGKAP 567
            + DV+S GV+L  L++G  P
Sbjct: 192 PEVDVWSLGVILYTLVSGSLP 212

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPL 430
           + +GKG F     A  +  G  VAVK +    ++    ++ F++ +  +  +NH N+V L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFRE-VRIMKVLNHPNIVKL 78
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                +     LV +Y + G +   L  +          + R +++      ++Y H + 
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQYCHQKF 133
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVS- 546
             + H ++K+ N+LL      +++DFG ++     +  +   G   Y APE+    K   
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 547 QKADVYSFGVLLLELLTGKAP 567
            + DV+S GV+L  L++G  P
Sbjct: 192 PEVDVWSLGVILYTLVSGSLP 212

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 375 AEVLGKGTFGTAYKAVLEMGTIV--AVKRLKDVTIS-----EREFKDKIEGVGAVNHENL 427
            ++LG+G++G   K VL+  T+   AVK LK   +      E   K +I+ +  + H+N+
Sbjct: 10  GDLLGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 428 VPLRAYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           + L    Y+ +++   +V +Y   G    L   +    R P+         L    G+EY
Sbjct: 69  IQLVDVLYNEEKQKMYMVMEYCVCGMQEML--DSVPEKRFPVCQAHGYFCQL--IDGLEY 124
Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS------TPNRVAGYRAPEV 539
           LH+QG  + H +IK  N+LLT     ++S  G+A  + P +      T      ++ PE+
Sbjct: 125 LHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 540 TDPCKVSQ--KADVYSFGVLLLELLTGKAP 567
            +        K D++S GV L  + TG  P
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 92/232 (39%), Gaps = 37/232 (15%)
Query: 364 VFDLEDLLRASAEV---LGKGTFGTAYKAVLEM--GTIVAVKRLKDVTISEREFKDKIEG 418
           ++ + D L+   E+   LG+GTFG   + V     G  VA+K +K+V   +   + +I  
Sbjct: 24  IYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINV 83
Query: 419 VGAVNHEN------LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMR 472
           +  +N ++       V +  ++       + ++ L + +   L    K     P      
Sbjct: 84  LEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFL----KDNNYLPYPIHQV 139
Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT-------------------KSYEARV 513
             +A    + +++LH     ++H ++K  NIL                     KS   RV
Sbjct: 140 RHMAFQLCQAVKFLHDN--KLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRV 197
Query: 514 SDFGLAHLVGPS-STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTG 564
            DFG A       ST      YRAPEV      SQ  DV+S G ++ E   G
Sbjct: 198 VDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVG 249

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 376 EVLGKGTFGTAYKA--VLEMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVP 429
           + +GKG F     A  VL  G  VAVK +    ++    ++ F++ +  +  +NH N+V 
Sbjct: 21  KTIGKGNFAKVKLARHVL-TGREVAVKIIDKTQLNPTSLQKLFRE-VRIMKILNHPNIVK 78
Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           L     +     LV +Y + G +   L  +          + R +++      ++Y H +
Sbjct: 79  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQYCHQK 133
Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVS 546
              + H ++K+ N+LL      +++DFG ++     +  +   G   Y APE+    K  
Sbjct: 134 --YIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYD 191
Query: 547 -QKADVYSFGVLLLELLTGKAP 567
             + DV+S GV+L  L++G  P
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLP 213

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/201 (22%), Positives = 90/201 (44%), Gaps = 17/201 (8%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPL 430
           + +GKG F     A  +  G  VA+K +    ++    ++ F++ +  +  +NH N+V L
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFRE-VRIMKILNHPNIVKL 79
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                +     L+ +Y + G +   L  +          + R +++      ++Y H + 
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-----AVQYCHQK- 133
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVS- 546
             + H ++K+ N+LL      +++DFG ++        +   G   Y APE+    K   
Sbjct: 134 -RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 547 QKADVYSFGVLLLELLTGKAP 567
            + DV+S GV+L  L++G  P
Sbjct: 193 PEVDVWSLGVILYTLVSGSLP 213

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPL 430
           + +GKG F     A  +  G  VAV+ +    ++    ++ F++ +  +  +NH N+V L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFRE-VRIMKVLNHPNIVKL 78
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                +     LV +Y + G +   L  +          + R +++      ++Y H + 
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQYCHQKF 133
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVS- 546
             + H ++K+ N+LL      +++DFG ++     +  +   G   Y APE+    K   
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDG 191
Query: 547 QKADVYSFGVLLLELLTGKAP 567
            + DV+S GV+L  L++G  P
Sbjct: 192 PEVDVWSLGVILYTLVSGSLP 212

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/201 (22%), Positives = 90/201 (44%), Gaps = 17/201 (8%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPL 430
           + +GKG F     A  +  G  VA+K +    ++    ++ F++ +  +  +NH N+V L
Sbjct: 18  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFRE-VRIMKILNHPNIVKL 76
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                +     L+ +Y + G +   L  +          + R +++      ++Y H + 
Sbjct: 77  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-----AVQYCHQK- 130
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVS- 546
             + H ++K+ N+LL      +++DFG ++        +   G   Y APE+    K   
Sbjct: 131 -RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDG 189
Query: 547 QKADVYSFGVLLLELLTGKAP 567
            + DV+S GV+L  L++G  P
Sbjct: 190 PEVDVWSLGVILYTLVSGSLP 210

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 109/240 (45%), Gaps = 30/240 (12%)
Query: 345 NSNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTIV--AVKRL 402
           N    G+TK     G+  + + LE+        +G+G++G   K  ++ GT +  A K++
Sbjct: 13  NLYFQGSTK-----GDINQYYTLEN-------TIGRGSWGEV-KIAVQKGTRIRRAAKKI 59
Query: 403 KDVTISERE-FKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKG 461
               + + + FK +IE + +++H N++ L   +    +  LV +  T G L   +   + 
Sbjct: 60  PKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV 119
Query: 462 AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNIL-LTKSYEA--RVSDFGL 518
              +     M+ +++      + Y H    NV+H ++K  N L LT S ++  ++ DFGL
Sbjct: 120 FRESDAARIMKDVLS-----AVAYCHKL--NVAHRDLKPENFLFLTDSPDSPLKLIDFGL 172
Query: 519 AHLVGPSSTPNRVAG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEE 575
           A    P        G   Y +P+V +      + D +S GV++  LL G  P  A  + E
Sbjct: 173 AARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDXE 231

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 377 VLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTI-SERE-FKDKIEGVGAVNHENLVPL 430
            +G+G FG  ++ +          VA+K  K+ T  S RE F  +   +   +H ++V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                + +   ++ +  T+G L + L   K       + ++ SLI           + + 
Sbjct: 77  IGVI-TENPVWIIMELCTLGELRSFLQVRK------FSLDLASLILYAYQLSTALAYLES 129
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKV 545
               H +I + N+L++ +   ++ DFGL+  +  S+      G     + APE  +  + 
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 546 SQKADVYSFGVLLLELLT-GKAPTHALLNEEGV 577
           +  +DV+ FGV + E+L  G  P   + N + +
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 466 PLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEARVSDFGLAHLVGP 524
           PL  E   L      RG++Y+H+   NV H ++K +N+ + T+    ++ DFGLA ++ P
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173
Query: 525 SSTPN-------RVAGYRAPEVT-DPCKVSQKADVYSFGVLLLELLTGKA 566
             +             YR+P +   P   ++  D+++ G +  E+LTGK 
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/242 (21%), Positives = 105/242 (43%), Gaps = 22/242 (9%)
Query: 351 ATKKLVF---FGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVL----EMGTIVAVKRLK 403
            T+ L F    G++ R ++++         +G+G FG  ++ +          VA+K  K
Sbjct: 16  TTENLYFQGAMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK 75
Query: 404 DVTI-SERE-FKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKG 461
           + T  S RE F  +   +   +H ++V L     + +   ++ +  T+G L + L   K 
Sbjct: 76  NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK- 133
Query: 462 AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL 521
                 + ++ SLI           + +     H +I + N+L++ +   ++ DFGL+  
Sbjct: 134 -----YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 188
Query: 522 VGPSSTPNRVAG-----YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
           +  S+      G     + APE  +  + +  +DV+ FGV + E+L  G  P   + N +
Sbjct: 189 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 248
Query: 576 GV 577
            +
Sbjct: 249 VI 250

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 86/200 (43%), Gaps = 15/200 (7%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGV---GAVNHENLVPLR 431
           + +GKG F     A  +  G  VAVK +    ++    +     V     +NH N+V L 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLF 79
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
               +     LV +Y + G +   L  +          + R +++      ++Y H +  
Sbjct: 80  EVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVS-----AVQYCHQKF- 133
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVS-Q 547
            + H ++K+ N+LL      +++DFG ++     +  +   G   Y APE+    K    
Sbjct: 134 -IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGP 192
Query: 548 KADVYSFGVLLLELLTGKAP 567
           + DV+S GV+L  L++G  P
Sbjct: 193 EVDVWSLGVILYTLVSGSLP 212

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 5/88 (5%)
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG--PSSTPNRVA-GYRAP 537
           RG+++LHA    + H ++K  NIL+T     +++DFGLA +     + TP  V   YRAP
Sbjct: 131 RGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAP 188
Query: 538 EVTDPCKVSQKADVYSFGVLLLELLTGK 565
           EV      +   D++S G +  E+   K
Sbjct: 189 EVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 27/206 (13%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKR---------LKDVTISEREFKDKIEGVGAVNHENL 427
           +G G +GT YKA     G  VA+K          L   T+ E     ++E   A  H N+
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE---AFEHPNV 68
Query: 428 VPLRAYYYS--MDEKL---LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
           V L     +   D ++   LV++++    L   L      G   L  E    +     RG
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG---LPAETIKDLMRQFLRG 124
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA---GYRAPEV 539
           +++LHA    + H ++K  NIL+T     +++DFGLA +       + V     YRAPEV
Sbjct: 125 LDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEV 182
Query: 540 TDPCKVSQKADVYSFGVLLLELLTGK 565
                 +   D++S G +  E+   K
Sbjct: 183 LLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPL 430
           + +GKG F     A  +  G  VAV+ +    ++    ++ F++ +  +  +NH N+V L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFRE-VRIMKVLNHPNIVKL 78
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                +     LV +Y + G +   L  +          + R +++      ++Y H + 
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQYCHQKF 133
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVS- 546
             + H ++K+ N+LL      +++DFG ++     +  +   G   Y APE+    K   
Sbjct: 134 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 547 QKADVYSFGVLLLELLTGKAP 567
            + DV+S GV+L  L++G  P
Sbjct: 192 PEVDVWSLGVILYTLVSGSLP 212

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 18/202 (8%)
Query: 377 VLGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISERE-----FKDKI--EGVGAVNHENLV 428
           ++G+G FG  Y     + G + A+K L    I  ++       ++I    V   +   +V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            +   +++ D+   + D +  G L   L  +       + +    +I      G+E++H 
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL-----GLEHMHN 310
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVTDP-CKV 545
           +   V + ++K +NILL +    R+SD GLA           V   GY APEV       
Sbjct: 311 RF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 546 SQKADVYSFGVLLLELLTGKAP 567
              AD +S G +L +LL G +P
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSP 390

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 18/202 (8%)
Query: 377 VLGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISERE-----FKDKI--EGVGAVNHENLV 428
           ++G+G FG  Y     + G + A+K L    I  ++       ++I    V   +   +V
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 254
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            +   +++ D+   + D +  G L   L  +       + +    +I      G+E++H 
Sbjct: 255 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL-----GLEHMHN 309
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVTDP-CKV 545
           +   V + ++K +NILL +    R+SD GLA           V   GY APEV       
Sbjct: 310 RF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAY 367
Query: 546 SQKADVYSFGVLLLELLTGKAP 567
              AD +S G +L +LL G +P
Sbjct: 368 DSSADWFSLGCMLFKLLRGHSP 389

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/231 (21%), Positives = 101/231 (43%), Gaps = 19/231 (8%)
Query: 359 GNAARVFDLEDLLRASAEVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTI-SERE-F 412
           G++ R ++++         +G+G FG  ++ +          VA+K  K+ T  S RE F
Sbjct: 4   GSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF 63
Query: 413 KDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMR 472
             +   +   +H ++V L     + +   ++ +  T+G L + L   K       + ++ 
Sbjct: 64  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK------YSLDLA 116
Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA 532
           SLI           + +     H +I + N+L++ +   ++ DFGL+  +  S+      
Sbjct: 117 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 176
Query: 533 G-----YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGV 577
           G     + APE  +  + +  +DV+ FGV + E+L  G  P   + N + +
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 227

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAV------NHENLV 428
           +V+GKG+FG   KA   ++   VA+K +++     R+  ++I  +  +      N  N++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            +   +   +   + ++ L+M +L  L+  NK  G    +  +    A    + ++ LH 
Sbjct: 163 HMLENFTFRNHICMTFELLSM-NLYELIKKNKFQG---FSLPLVRKFAHSILQCLDALHK 218
Query: 489 QGPNVSHGNIKSSNILLTKSYEA--RVSDFG---LAHLVGPSSTPNRVAGYRAPEVTDPC 543
               + H ++K  NILL +   +  +V DFG     H    +   +R   YRAPEV    
Sbjct: 219 N--RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF--YRAPEVILGA 274
Query: 544 KVSQKADVYSFGVLLLELLTG 564
           +     D++S G +L ELLTG
Sbjct: 275 RYGMPIDMWSLGCILAELLTG 295

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAV------NHENLV 428
           +V+GKG+FG   KA   ++   VA+K +++     R+  ++I  +  +      N  N++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            +   +   +   + ++ L+M +L  L+  NK  G    +  +    A    + ++ LH 
Sbjct: 163 HMLENFTFRNHICMTFELLSM-NLYELIKKNKFQG---FSLPLVRKFAHSILQCLDALHK 218
Query: 489 QGPNVSHGNIKSSNILLTKSYEA--RVSDFG---LAHLVGPSSTPNRVAGYRAPEVTDPC 543
               + H ++K  NILL +   +  +V DFG     H    +   +R   YRAPEV    
Sbjct: 219 N--RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF--YRAPEVILGA 274
Query: 544 KVSQKADVYSFGVLLLELLTG 564
           +     D++S G +L ELLTG
Sbjct: 275 RYGMPIDMWSLGCILAELLTG 295

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 377 VLGKGTFGTAY---KAVLEMGTIVAVKRLKDVTISERE-----FKDKI--EGVGAVNHEN 426
           ++G+G FG  Y   KA  + G + A+K L    I  ++       ++I    V   +   
Sbjct: 196 IIGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           +V +   +++ D+   + D +  G L   L  +       + +    +I      G+E++
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL-----GLEHM 308
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVTDP-C 543
           H +   V + ++K +NILL +    R+SD GLA           V   GY APEV     
Sbjct: 309 HNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGV 366
Query: 544 KVSQKADVYSFGVLLLELLTGKAP 567
                AD +S G +L +LL G +P
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 377 VLGKGTFGTAY---KAVLEMGTIVAVKRLKDVTISERE-----FKDKI--EGVGAVNHEN 426
           ++G+G FG  Y   KA  + G + A+K L    I  ++       ++I    V   +   
Sbjct: 196 IIGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           +V +   +++ D+   + D +  G L   L  +       + +    +I      G+E++
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL-----GLEHM 308
Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVTDP-C 543
           H +   V + ++K +NILL +    R+SD GLA           V   GY APEV     
Sbjct: 309 HNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGV 366
Query: 544 KVSQKADVYSFGVLLLELLTGKAP 567
                AD +S G +L +LL G +P
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 83/197 (42%), Gaps = 14/197 (7%)
Query: 378 LGKGTFGTA-YKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           +G G FG A      +   +VAVK ++     +   K +I    ++ H N+V  +    +
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                +V +Y + G L   +            +  + LI+     G+ Y HA    V+H 
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYAHAM--QVAHR 139
Query: 497 NIKSSNILLTKSYEAR--VSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVSQK-AD 550
           ++K  N LL  S   R  ++DFG +      S P    G   Y APEV    +   K AD
Sbjct: 140 DLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVAD 199
Query: 551 VYSFGVLLLELLTGKAP 567
           V+S GV L  +L G  P
Sbjct: 200 VWSCGVTLYVMLVGAYP 216

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 378 LGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPLRAY 433
           +G G++G   K   +  G I+  K L   +++E E +  +  V     + H N+V  R Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV--RYY 71
Query: 434 YYSMDEK----LLVYDYLTMGSLSALL-HGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
              +D       +V +Y   G L++++  G K        + +R +  L  A  ++  H 
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA--LKECHR 129
Query: 489 Q---GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNRVAG---YRAPEVTD 541
           +   G  V H ++K +N+ L      ++ DFGLA ++   +S      G   Y +PE  +
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMN 189
Query: 542 PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEE 575
               ++K+D++S G LL EL     P  A   +E
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 378 LGKGTFGTAYKAVLEMGTIV--AVKRLKDVTISERE-FKDKIEGVGAVNHENLVPLRAYY 434
           +G+G++G   K  ++ GT +  A K++    + + + FK +IE + +++H N++ L   +
Sbjct: 17  IGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
               +  LV +  T G L   +   +    +     M+ +++      + Y H    NV+
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS-----AVAYCHKL--NVA 128
Query: 495 HGNIKSSNIL-LTKSYEA--RVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVSQK 548
           H ++K  N L LT S ++  ++ DFGLA    P        G   Y +P+V +      +
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPE 187
Query: 549 ADVYSFGVLLLELLTGKAPTHALLNEE 575
            D +S GV++  LL G  P  A  + E
Sbjct: 188 CDEWSAGVMMYVLLCGYPPFSAPTDXE 214

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 378 LGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPLRAY 433
           +G G++G   K   +  G I+  K L   +++E E +  +  V     + H N+V  R Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV--RYY 71
Query: 434 YYSMDEK----LLVYDYLTMGSLSALL-HGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
              +D       +V +Y   G L++++  G K        + +R +  L  A  ++  H 
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA--LKECHR 129
Query: 489 Q---GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR----VAGYRAPEVTD 541
           +   G  V H ++K +N+ L      ++ DFGLA ++   ++  +       Y +PE  +
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN 189
Query: 542 PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEE 575
               ++K+D++S G LL EL     P  A   +E
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 377 VLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTI-SERE-FKDKIEGVGAVNHENLVPL 430
            +G+G FG  ++ +          VA+K  K+ T  S RE F  +   +   +H ++V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                + +   ++ +  T+G L + L   K       + ++ SLI           + + 
Sbjct: 77  IGVI-TENPVWIIMELCTLGELRSFLQVRK------FSLDLASLILYAYQLSTALAYLES 129
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKV 545
               H +I + N+L++ +   ++ DFGL+  +  S+      G     + APE  +  + 
Sbjct: 130 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 546 SQKADVYSFGVLLLELLT-GKAPTHALLNEEGV 577
           +  +DV+ FGV + E+L  G  P   + N + +
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/231 (21%), Positives = 100/231 (43%), Gaps = 19/231 (8%)
Query: 359 GNAARVFDLEDLLRASAEVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTI-SERE-F 412
           G + R ++++         +G+G FG  ++ +          VA+K  K+ T  S RE F
Sbjct: 1   GASTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF 60
Query: 413 KDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMR 472
             +   +   +H ++V L     + +   ++ +  T+G L + L   K       + ++ 
Sbjct: 61  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK------YSLDLA 113
Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA 532
           SLI           + +     H +I + N+L++ +   ++ DFGL+  +  S+      
Sbjct: 114 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 173
Query: 533 G-----YRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGV 577
           G     + APE  +  + +  +DV+ FGV + E+L  G  P   + N + +
Sbjct: 174 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 224

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 376 EVLGKGTFG-----TAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL 430
           E LG+G+FG     T YK   ++      ++L   +      + +I  +  + H +++ L
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                +  + ++V +Y   G L   +   K           + +I       IEY H   
Sbjct: 75  YDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC-----AIEYCHRH- 127
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTD-PCKVS 546
             + H ++K  N+LL  +   +++DFGL++++   +      G   Y APEV +      
Sbjct: 128 -KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAG 186
Query: 547 QKADVYSFGVLLLELLTGKAP 567
            + DV+S G++L  +L G+ P
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLP 207

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 39/223 (17%)
Query: 376 EVLGKGTFG-----TAYKAVLEMGTI-VAVKRLKD-VTISERE-FKDKIEGVGAV-NHEN 426
           +VLG G FG     TAY       +I VAVK LK+    SERE    +++ +  + +HEN
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTP------------------LN 468
           +V L           L+++Y   G L   L   +                        L 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 469 WEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP 528
           +E     A   A+G+E+L  +  +  H ++ + N+L+T     ++ DFGLA  +   S  
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHGKVVKICDFGLARDI--MSDS 226
Query: 529 NRV--------AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT 563
           N V          + APE       + K+DV+S+G+LL E+ +
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVPL 430
           E +GKG F    + V L  G   A K +    +S R+ + K+E    +     H N+V L
Sbjct: 10  EDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQ-KLEREARICRLLKHSNIVRL 68
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                      LV+D +T G L   +   +       +  ++ ++          LH   
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE-------AVLHCHQ 121
Query: 491 PNVSHGNIKSSNILLT---KSYEARVSDFGLAHLV--------GPSSTPNRVAGYRAPEV 539
             V H ++K  N+LL    K    +++DFGLA  V        G + TP    GY +PEV
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTP----GYLSPEV 177
Query: 540 TDPCKVSQKADVYSFGVLLLELLTGKAP 567
                  +  D+++ GV+L  LL G  P
Sbjct: 178 LRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 378 LGKGTFGTAYKAVL----EMGTIVAVKRLKDVTI-SERE-FKDKIEGVGAVNHENLVPLR 431
           +G+G FG  ++ +          VA+K  K+ T  S RE F  +   +   +H ++V L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
               + +   ++ +  T+G L + L   K       + ++ SLI           + +  
Sbjct: 458 GVI-TENPVWIIMELCTLGELRSFLQVRK------FSLDLASLILYAYQLSTALAYLESK 510
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVS 546
              H +I + N+L++ +   ++ DFGL+  +  S+      G     + APE  +  + +
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 547 QKADVYSFGVLLLELLT-GKAPTHALLNEEGV 577
             +DV+ FGV + E+L  G  P   + N + +
Sbjct: 571 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 602

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 27/206 (13%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKR---------LKDVTISEREFKDKIEGVGAVNHENL 427
           +G G +GT YKA     G  VA+K          L   T+ E     ++E   A  H N+
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE---AFEHPNV 68
Query: 428 VPLRAYYYS--MDEKL---LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
           V L     +   D ++   LV++++    L   L      G   L  E    +     RG
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG---LPAETIKDLMRQFLRG 124
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA---GYRAPEV 539
           +++LHA    + H ++K  NIL+T     +++DFGLA +         V     YRAPEV
Sbjct: 125 LDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEV 182
Query: 540 TDPCKVSQKADVYSFGVLLLELLTGK 565
                 +   D++S G +  E+   K
Sbjct: 183 LLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 45/104 (43%), Gaps = 18/104 (17%)
Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG- 533
           I +  A  +E+LH++G  + H ++K SNI  T     +V DFGL   +        V   
Sbjct: 169 IFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 534 ---------------YRAPEVTDPCKVSQKADVYSFGVLLLELL 562
                          Y +PE       S K D++S G++L ELL
Sbjct: 227 MPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 81/197 (41%), Gaps = 14/197 (7%)
Query: 378 LGKGTFGTA-YKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           +G G FG A      +   +VAVK ++     +   K +I    ++ H N+V  +    +
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                +V +Y + G L   +            +  + LI+     G+ Y HA    V H 
Sbjct: 86  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYCHAM--QVCHR 138
Query: 497 NIKSSNILLTKSYEAR--VSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVSQK-AD 550
           ++K  N LL  S   R  + DFG +      S P    G   Y APEV    +   K AD
Sbjct: 139 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVAD 198
Query: 551 VYSFGVLLLELLTGKAP 567
           V+S GV L  +L G  P
Sbjct: 199 VWSCGVTLYVMLVGAYP 215

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVPL 430
           E LGKG F    + V  + G   A K +    +S R+ + K+E    +     H N+V L
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQ-KLEREARICRLLKHPNIVRL 86
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                      L++D +T G L   +   +       +  ++ ++          LH   
Sbjct: 87  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE-------AVLHCHQ 139
Query: 491 PNVSHGNIKSSNILLT---KSYEARVSDFGLAHLV--------GPSSTPNRVAGYRAPEV 539
             V H ++K  N+LL    K    +++DFGLA  V        G + TP    GY +PEV
Sbjct: 140 MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP----GYLSPEV 195
Query: 540 TDPCKVSQKADVYSFGVLLLELLTGKAP 567
                  +  D+++ GV+L  LL G  P
Sbjct: 196 LRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 378 LGKGTFGTAYKAVL----EMGTIVAVKRLKDVTI-SERE-FKDKIEGVGAVNHENLVPLR 431
           +G+G FG  ++ +          VA+K  K+ T  S RE F  +   +   +H ++V L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
               + +   ++ +  T+G L + L   K       + ++ SLI           + +  
Sbjct: 458 GVI-TENPVWIIMELCTLGELRSFLQVRK------FSLDLASLILYAYQLSTALAYLESK 510
Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVS 546
              H +I + N+L++ +   ++ DFGL+  +  S+      G     + APE  +  + +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 547 QKADVYSFGVLLLELLT-GKAPTHALLNEEGV 577
             +DV+ FGV + E+L  G  P   + N + +
Sbjct: 571 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 602

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 85/211 (40%), Gaps = 34/211 (16%)
Query: 376 EVLGKGTFGTAYKAVLEMG------TIVAVKRL--KDVTISEREFKDKIEGVGAVNHENL 427
           E LGKG F    + V  +        I+  K+L  +D    ERE +        + H N+
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI----CRLLKHPNI 72
Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           V L           L++D +T G L   +   +       +  ++ ++          LH
Sbjct: 73  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE-------AVLH 125
Query: 488 AQGPNVSHGNIKSSNILLT---KSYEARVSDFGLAHLV--------GPSSTPNRVAGYRA 536
                V H N+K  N+LL    K    +++DFGLA  V        G + TP    GY +
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP----GYLS 181
Query: 537 PEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           PEV       +  D+++ GV+L  LL G  P
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 27/206 (13%)
Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKR---------LKDVTISEREFKDKIEGVGAVNHENL 427
           +G G +GT YKA     G  VA+K          L   T+ E     ++E   A  H N+
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE---AFEHPNV 68
Query: 428 VPLRAYYYS--MDEKL---LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
           V L     +   D ++   LV++++    L   L      G   L  E    +     RG
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG---LPAETIKDLMRQFLRG 124
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA---GYRAPEV 539
           +++LHA    + H ++K  NIL+T     +++DFGLA +         V     YRAPEV
Sbjct: 125 LDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEV 182
Query: 540 TDPCKVSQKADVYSFGVLLLELLTGK 565
                 +   D++S G +  E+   K
Sbjct: 183 LLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 377 VLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTI-SERE-FKDKIEGVGAVNHENLVPL 430
            +G+G FG  ++ +          VA+K  K+ T  S RE F  +   +   +H ++V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                + +   ++ +  T+G L + L   K       + ++ SLI           + + 
Sbjct: 77  IGVI-TENPVWIIMELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLES 129
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKV 545
               H +I + N+L++ +   ++ DFGL+  +  S+      G     + APE  +  + 
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 546 SQKADVYSFGVLLLELLT-GKAPTHALLNEEGV 577
           +  +DV+ FGV + E+L  G  P   + N + +
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAV------NHENLV 428
           +V+GKG FG   KA   ++   VA+K +++     R+  ++I  +  +      N  N++
Sbjct: 103 KVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            +   +   +   + ++ L+M +L  L+  NK  G    +  +    A    + ++ LH 
Sbjct: 163 HMLENFTFRNHICMTFELLSM-NLYELIKKNKFQG---FSLPLVRKFAHSILQCLDALHK 218
Query: 489 QGPNVSHGNIKSSNILLTKSYEA--RVSDFG---LAHLVGPSSTPNRVAGYRAPEVTDPC 543
               + H ++K  NILL +   +  +V DFG     H        +R   YRAPEV    
Sbjct: 219 N--RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQSRF--YRAPEVILGA 274
Query: 544 KVSQKADVYSFGVLLLELLTG 564
           +     D++S G +L ELLTG
Sbjct: 275 RYGMPIDMWSLGCILAELLTG 295

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 99/241 (41%), Gaps = 34/241 (14%)
Query: 345 NSNVNGATKKLVF--FGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMGTI-VAVKR 401
           +S V+  T+ L F       R  D   L     E LGKG F    + V +  T   A K 
Sbjct: 8   SSGVDLGTENLYFQXMATCTRFTDDYQLF----EELGKGAFSVVRRCVKKTPTQEYAAKI 63
Query: 402 LKDVTISEREFKDKIEGVGAV----NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLH 457
           +    +S R+ + K+E    +     H N+V L           LV+D +T G L   + 
Sbjct: 64  INTKKLSARDHQ-KLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV 122
Query: 458 GNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT---KSYEARVS 514
             +       +  +  ++       + ++H    ++ H ++K  N+LL    K    +++
Sbjct: 123 AREYYSEADASHCIHQIL-----ESVNHIHQH--DIVHRDLKPENLLLASKCKGAAVKLA 175
Query: 515 DFGLAHLV--------GPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKA 566
           DFGLA  V        G + TP    GY +PEV       +  D+++ GV+L  LL G  
Sbjct: 176 DFGLAIEVQGEQQAWFGFAGTP----GYLSPEVLRKDPYGKPVDIWACGVILYILLVGYP 231
Query: 567 P 567
           P
Sbjct: 232 P 232

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 378 LGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPLRAY 433
           +G G++G   K   +  G I+  K L   +++E E +  +  V     + H N+V  R Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV--RYY 71
Query: 434 YYSMDEK----LLVYDYLTMGSLSALL-HGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
              +D       +V +Y   G L++++  G K        + +R +  L  A  ++  H 
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA--LKECHR 129
Query: 489 Q---GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR----VAGYRAPEVTD 541
           +   G  V H ++K +N+ L      ++ DFGLA ++       +       Y +PE  +
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMN 189
Query: 542 PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEE 575
               ++K+D++S G LL EL     P  A   +E
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR----VAGYRAP 537
           G+E+LH +  N+ + ++K  N+LL      R+SD GLA  +    T  +      G+ AP
Sbjct: 301 GLEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358
Query: 538 EVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           E+    +     D ++ GV L E++  + P  A
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR----VAGYRAP 537
           G+E+LH +  N+ + ++K  N+LL      R+SD GLA  +    T  +      G+ AP
Sbjct: 301 GLEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358
Query: 538 EVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           E+    +     D ++ GV L E++  + P  A
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR----VAGYRAP 537
           G+E+LH +  N+ + ++K  N+LL      R+SD GLA  +    T  +      G+ AP
Sbjct: 301 GLEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358
Query: 538 EVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           E+    +     D ++ GV L E++  + P  A
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR----VAGYRAP 537
           G+E+LH +  N+ + ++K  N+LL      R+SD GLA  +    T  +      G+ AP
Sbjct: 301 GLEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358
Query: 538 EVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
           E+    +     D ++ GV L E++  + P  A
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 377 VLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTI-SERE-FKDKIEGVGAVNHENLVPL 430
            +G+G FG  ++ +          VA+K  K+ T  S RE F  +   +   +H ++V L
Sbjct: 20  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 79
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                + +   ++ +  T+G L + L   K       + ++ SLI           + + 
Sbjct: 80  IGVI-TENPVWIIMELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLES 132
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKV 545
               H +I + N+L++ +   ++ DFGL+  +  S+      G     + APE  +  + 
Sbjct: 133 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 192
Query: 546 SQKADVYSFGVLLLELLT-GKAPTHALLNEEGV 577
           +  +DV+ FGV + E+L  G  P   + N + +
Sbjct: 193 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 225

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 377 VLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTI-SERE-FKDKIEGVGAVNHENLVPL 430
            +G+G FG  ++ +          VA+K  K+ T  S RE F  +   +   +H ++V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                + +   ++ +  T+G L + L   K       + ++ SLI           + + 
Sbjct: 77  IGVI-TENPVWIIMELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLES 129
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKV 545
               H +I + N+L++ +   ++ DFGL+  +  S+      G     + APE  +  + 
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 546 SQKADVYSFGVLLLELLT-GKAPTHALLNEEGV 577
           +  +DV+ FGV + E+L  G  P   + N + +
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 377 VLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTI-SERE-FKDKIEGVGAVNHENLVPL 430
            +G+G FG  ++ +          VA+K  K+ T  S RE F  +   +   +H ++V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                + +   ++ +  T+G L + L   K       + ++ SLI           + + 
Sbjct: 74  IGVI-TENPVWIIMELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLES 126
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKV 545
               H +I + N+L++ +   ++ DFGL+  +  S+      G     + APE  +  + 
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 546 SQKADVYSFGVLLLELLT-GKAPTHALLNEEGV 577
           +  +DV+ FGV + E+L  G  P   + N + +
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 28/220 (12%)
Query: 371 LRASAE------VLGKGTFGTA----YKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVG 420
           LR  AE      V+G+G FG      +K+  ++  +  + + + +  S+  F  +   + 
Sbjct: 64  LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 123
Query: 421 AVNHENLVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA 479
           A  +   V    Y +  D  L +V +Y+  G L  L+       +    +    ++AL A
Sbjct: 124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA 183
Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-----STPNRVAGY 534
                 +H+ G    H ++K  N+LL KS   +++DFG    +         T      Y
Sbjct: 184 ------IHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 235
Query: 535 RAPEVTDPC----KVSQKADVYSFGVLLLELLTGKAPTHA 570
            +PEV           ++ D +S GV L E+L G  P +A
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 28/220 (12%)
Query: 371 LRASAE------VLGKGTFGTA----YKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVG 420
           LR  AE      V+G+G FG      +K+  ++  +  + + + +  S+  F  +   + 
Sbjct: 69  LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 128
Query: 421 AVNHENLVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA 479
           A  +   V    Y +  D  L +V +Y+  G L  L+       +    +    ++AL A
Sbjct: 129 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA 188
Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-----STPNRVAGY 534
                 +H+ G    H ++K  N+LL KS   +++DFG    +         T      Y
Sbjct: 189 ------IHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 240
Query: 535 RAPEVTDPC----KVSQKADVYSFGVLLLELLTGKAPTHA 570
            +PEV           ++ D +S GV L E+L G  P +A
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 280

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 28/208 (13%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVPL 430
           E LGKG F    + + +  G   A K +    +S R+ + K+E    +     H N+V L
Sbjct: 10  EELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ-KLEREARICRLLKHPNIVRL 68
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                      LV+D +T G L   +   +       +  ++ ++       + + H  G
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQIL-----ESVNHCHLNG 123
Query: 491 PNVSHGNIKSSNILL---TKSYEARVSDFGLAHLV--------GPSSTPNRVAGYRAPEV 539
             + H ++K  N+LL   +K    +++DFGLA  V        G + TP    GY +PEV
Sbjct: 124 --IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTP----GYLSPEV 177
Query: 540 TDPCKVSQKADVYSFGVLLLELLTGKAP 567
                  +  D+++ GV+L  LL G  P
Sbjct: 178 LRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 28/220 (12%)
Query: 371 LRASAE------VLGKGTFGTA----YKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVG 420
           LR  AE      V+G+G FG      +K+  ++  +  + + + +  S+  F  +   + 
Sbjct: 69  LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 128
Query: 421 AVNHENLVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA 479
           A  +   V    Y +  D  L +V +Y+  G L  L+       +    +    ++AL A
Sbjct: 129 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA 188
Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-----STPNRVAGY 534
                 +H+ G    H ++K  N+LL KS   +++DFG    +         T      Y
Sbjct: 189 ------IHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 240
Query: 535 RAPEVTDPC----KVSQKADVYSFGVLLLELLTGKAPTHA 570
            +PEV           ++ D +S GV L E+L G  P +A
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 280

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 67/138 (48%), Gaps = 8/138 (5%)
Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVPL 430
           E +G G FG+ +K V  + G I A+KR K       + ++ +  V A      H ++V  
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 74
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
            + +   D  L+  +Y   GSL+  +  N          E++ L+ L   RG+ Y+H+  
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL-LQVGRGLRYIHSM- 132
Query: 491 PNVSHGNIKSSNILLTKS 508
            ++ H +IK SNI ++++
Sbjct: 133 -SLVHMDIKPSNIFISRT 149

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 28/208 (13%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVPL 430
           E LGKG F    + + +  G   A K +    +S R+ + K+E    +     H N+V L
Sbjct: 10  EELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ-KLEREARICRLLKHPNIVRL 68
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
                      LV+D +T G L   +   +       +  ++ ++       + + H  G
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQIL-----ESVNHCHLNG 123
Query: 491 PNVSHGNIKSSNILL---TKSYEARVSDFGLAHLV--------GPSSTPNRVAGYRAPEV 539
             + H ++K  N+LL   +K    +++DFGLA  V        G + TP    GY +PEV
Sbjct: 124 --IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTP----GYLSPEV 177
Query: 540 TDPCKVSQKADVYSFGVLLLELLTGKAP 567
                  +  D+++ GV+L  LL G  P
Sbjct: 178 LRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 90/208 (43%), Gaps = 27/208 (12%)
Query: 376 EVLGKGTFGTAY------------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
           + LG G+FG                 +L+   +V +K+++  T++E+        + AVN
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-TLNEKRI------LQAVN 120
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
              LV L   +       +V +Y+  G + + L   +  GR   +       A       
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGR--FSEPHARFYAAQIVLTF 175
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDP 542
           EYLH+   ++ + ++K  N+L+ +    +V+DFG A  V G + T      Y APE+   
Sbjct: 176 EYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPEYLAPEIILS 233
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHA 570
              ++  D ++ GVL+ E+  G  P  A
Sbjct: 234 KGYNKAVDWWALGVLIYEMAAGYPPFFA 261

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 67/138 (48%), Gaps = 8/138 (5%)
Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVPL 430
           E +G G FG+ +K V  + G I A+KR K       + ++ +  V A      H ++V  
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 74
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
            + +   D  L+  +Y   GSL+  +  N          E++ L+ L   RG+ Y+H+  
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL-LQVGRGLRYIHSM- 132
Query: 491 PNVSHGNIKSSNILLTKS 508
            ++ H +IK SNI ++++
Sbjct: 133 -SLVHMDIKPSNIFISRT 149

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 67/138 (48%), Gaps = 8/138 (5%)
Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVPL 430
           E +G G FG+ +K V  + G I A+KR K       + ++ +  V A      H ++V  
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
            + +   D  L+  +Y   GSL+  +  N          E++ L+ L   RG+ Y+H+  
Sbjct: 77  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL-LQVGRGLRYIHSM- 134
Query: 491 PNVSHGNIKSSNILLTKS 508
            ++ H +IK SNI ++++
Sbjct: 135 -SLVHMDIKPSNIFISRT 151

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 59/132 (44%), Gaps = 26/132 (19%)
Query: 456 LHGNKGAGRTPLNWEMRSLIALGAARGI----EYLHAQGPNVSHGNIKSSNILLT--KSY 509
           ++G+    R  L++  R  +     R I     YLH QG  + H +IK  N L +  KS+
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSF 207
Query: 510 EARVSDFGLAH------------LVGPSSTPNRVAGYRAPEVTDPCKVSQ--KADVYSFG 555
           E ++ DFGL+             +   + TP  VA    PEV +    S   K D +S G
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA----PEVLNTTNESYGPKCDAWSAG 263
Query: 556 VLLLELLTGKAP 567
           VLL  LL G  P
Sbjct: 264 VLLHLLLMGAVP 275

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 67/138 (48%), Gaps = 8/138 (5%)
Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVPL 430
           E +G G FG+ +K V  + G I A+KR K       + ++ +  V A      H ++V  
Sbjct: 13  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 72
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
            + +   D  L+  +Y   GSL+  +  N          E++ L+ L   RG+ Y+H+  
Sbjct: 73  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL-LQVGRGLRYIHSM- 130
Query: 491 PNVSHGNIKSSNILLTKS 508
            ++ H +IK SNI ++++
Sbjct: 131 -SLVHMDIKPSNIFISRT 147

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 16/222 (7%)
Query: 378 LGKGTFGTAYKAVLEMGT-IVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           +G G FG A     ++   +VAVK ++     +   + +I    ++ H N+V  +    +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                ++ +Y + G L   +            +  + L++     G+ Y H+    + H 
Sbjct: 88  PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS-----GVSYCHSM--QICHR 140
Query: 497 NIKSSNILLTKSYEAR--VSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVSQK-AD 550
           ++K  N LL  S   R  + DFG +      S P    G   Y APEV    +   K AD
Sbjct: 141 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIAD 200
Query: 551 VYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT 592
           V+S GV L  +L G  P      EE  D  + +Q I+  +++
Sbjct: 201 VWSCGVTLYVMLVGAYPFED--PEEPRDYRKTIQRILSVKYS 240

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 25/212 (11%)
Query: 376 EVLGKGTFGTAYKAVLEM---GTIVAVKRLKDVTISERE----FKDKIEGVGAVNHENLV 428
           +V+G+G FG    AV+++     + A+K L    + +R     F+++ + +   + + + 
Sbjct: 80  KVIGRGAFGEV--AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L   +   +   LV DY   G L  LL  +K   R P   EM           I+ +H 
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPE--EMARFYLAEMVIAIDSVHQ 193
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFG-LAHLVGPSSTPNRVA----GYRAPEVTDPC 543
              +  H +IK  NIL+  +   R++DFG    L+   +  + VA     Y +PE+    
Sbjct: 194 L--HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251
Query: 544 -----KVSQKADVYSFGVLLLELLTGKAPTHA 570
                +   + D +S GV + E+L G+ P +A
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 93/215 (43%), Gaps = 32/215 (14%)
Query: 375 AEVLGKGTFGTA----YKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPL 430
            +V+G+G FG      +KA  ++  +  + + + +  S+  F  +   + A  +   V +
Sbjct: 80  VKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-V 138
Query: 431 RAYYYSMDEKLL--VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
           + +    D+K L  V +Y+  G L  L+       +    +    ++AL A      +H+
Sbjct: 139 QLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDA------IHS 192
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDF---------GLAHLVGPSSTPNRVAGYRAPEV 539
            G  + H ++K  N+LL K    +++DF         G+ H      TP+    Y +PEV
Sbjct: 193 MG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPD----YISPEV 246
Query: 540 TDP----CKVSQKADVYSFGVLLLELLTGKAPTHA 570
                      ++ D +S GV L E+L G  P +A
Sbjct: 247 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 281

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 30/213 (14%)
Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRL---KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           E++GKG FG  Y         VA++ +   +D     + FK ++       HEN+V    
Sbjct: 39  ELIGKGRFGQVYHG--RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
              S     ++       +L +++   K      L+      IA    +G+ YLHA+G  
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAKG-- 150
Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR---------APEVT--- 540
           + H ++KS N+      +  ++DFGL  + G      R    R         APE+    
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 541 ------DPCKVSQKADVYSFGVLLLELLTGKAP 567
                 D    S+ +DV++ G +  EL   + P
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 376 EVLGKGTFGTAY---------------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVG 420
           +VLG G +G  +                 VL+  TIV   +  + T +ER+  + I    
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--- 116
Query: 421 AVNHENLVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA 479
                 LV L  Y +  + KL L+ DY+  G L   L   +      +   +  ++    
Sbjct: 117 --QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL--- 170
Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR-----VAGY 534
              +E+LH  G  + + +IK  NILL  +    ++DFGL+       T           Y
Sbjct: 171 --ALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 535 RAPEVTD--PCKVSQKADVYSFGVLLLELLTGKAP 567
            AP++         +  D +S GVL+ ELLTG +P
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVK--------RLKDV--TISEREFKDKIEGVGAVNH 424
           + LG G+FG       +E G   A+K        +LK +  T++E+        + AVN 
Sbjct: 33  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI------LQAVNF 86
Query: 425 ENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
             LV L   +       +V +Y+  G + + L   +  GR   +       A       E
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGR--FSEPHARFYAAQIVLTFE 141
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDPC 543
           YLH+   ++ + ++K  N+L+ +    +V+DFG A  V G + T      Y APE+    
Sbjct: 142 YLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSK 199
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHA 570
             ++  D ++ GVL+ E+  G  P  A
Sbjct: 200 GYNKAVDWWALGVLIYEMAAGYPPFFA 226

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVK--------RLKDV--TISEREFKDKIEGVGAVNH 424
           + LG G+FG       +E G   A+K        +LK +  T++E+        + AVN 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI------LQAVNF 101
Query: 425 ENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
             LV L   +       +V +Y+  G + + L   +  GR   +       A       E
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGR--FSEPHARFYAAQIVLTFE 156
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDPC 543
           YLH+   ++ + ++K  N+L+ +    +V+DFG A  V G + T      Y APE+    
Sbjct: 157 YLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSK 214
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHA 570
             ++  D ++ GVL+ E+  G  P  A
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 28/210 (13%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKR-------------LKDVTISEREFKDKIEGVGAVNH 424
           +  G++G     V   G  VA+KR             L D  + +R  ++ I  +   +H
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE-IRLLNHFHH 88
Query: 425 ENLVPLRAYYYSMDE----KLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA 480
            N++ LR  +   +E    KL +   L    L+ ++H      R  ++ +          
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQ----RIVISPQHIQYFMYHIL 144
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAP 537
            G+  LH  G  V H ++   NILL  + +  + DF LA      +          YRAP
Sbjct: 145 LGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAP 202
Query: 538 EVTDPCK-VSQKADVYSFGVLLLELLTGKA 566
           E+    K  ++  D++S G ++ E+   KA
Sbjct: 203 ELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 28/210 (13%)
Query: 378 LGKGTFGTAYKAVLEMGTIVAVKR-------------LKDVTISEREFKDKIEGVGAVNH 424
           +  G++G     V   G  VA+KR             L D  + +R  ++ I  +   +H
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE-IRLLNHFHH 88
Query: 425 ENLVPLRAYYYSMDE----KLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA 480
            N++ LR  +   +E    KL +   L    L+ ++H      R  ++ +          
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQ----RIVISPQHIQYFMYHIL 144
Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAP 537
            G+  LH  G  V H ++   NILL  + +  + DF LA      +          YRAP
Sbjct: 145 LGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAP 202
Query: 538 EVTDPCK-VSQKADVYSFGVLLLELLTGKA 566
           E+    K  ++  D++S G ++ E+   KA
Sbjct: 203 ELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 25/212 (11%)
Query: 376 EVLGKGTFGTAYKAVLEMGT---IVAVKRLKDVTISERE----FKDKIEGVGAVNHENLV 428
           +V+G+G FG    AV++M     I A+K L    + +R     F+++ + +   + + + 
Sbjct: 96  KVIGRGAFGEV--AVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWIT 153
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L   +   +   LV DY   G L  LL  +K   + P +  M           I+ +H 
Sbjct: 154 ALHYAFQDENHLYLVMDYYVGGDLLTLL--SKFEDKLPED--MARFYIGEMVLAIDSIHQ 209
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDP------ 542
              +  H +IK  N+LL  +   R++DFG    +    T         P+   P      
Sbjct: 210 L--HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAM 267
Query: 543 ----CKVSQKADVYSFGVLLLELLTGKAPTHA 570
                K   + D +S GV + E+L G+ P +A
Sbjct: 268 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 299

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 466 PLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH-LVGP 524
           PL+ +          +GIEYLH Q   + H +IK SN+L+ +    +++DFG+++   G 
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQ--KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 525 SSTPNRVAG---YRAPEVTDPCK--VSQKA-DVYSFGVLLLELLTGKAPTHALLNEEGVD 578
            +  +   G   + APE     +   S KA DV++ GV L   + G+ P    ++E  + 
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP---FMDERIMC 247
Query: 579 LPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
           L   ++S            LE     ++ E++  L+   +D   + P++R  + E+    
Sbjct: 248 LHSKIKSQA----------LEFPDQPDIAEDLKDLITRMLD---KNPESRIVVPEI---- 290
Query: 639 EELHPSSTQ 647
            +LHP  T+
Sbjct: 291 -KLHPWVTR 298

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 22/160 (13%)
Query: 423 NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
           NH N+VP RA + + +E  +V  ++  GS   L+  +   G   +N    + I  G  + 
Sbjct: 68  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG---MNELAIAYILQGVLKA 124
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------------ 530
           ++Y+H  G    H ++K+S+IL+  S + +V   GL   +   S   R            
Sbjct: 125 LDYIHHMG--YVHRSVKASHILI--SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 180
Query: 531 -VAGYRAPEV--TDPCKVSQKADVYSFGVLLLELLTGKAP 567
            V  + +PEV   +      K+D+YS G+   EL  G  P
Sbjct: 181 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 220

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 25/212 (11%)
Query: 376 EVLGKGTFGTAYKAVLEMGT---IVAVKRLKDVTISERE----FKDKIEGVGAVNHENLV 428
           +V+G+G FG    AV++M     I A+K L    + +R     F+++ + +   + + + 
Sbjct: 80  KVIGRGAFGEV--AVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWIT 137
Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L   +   +   LV DY   G L  LL  +K   + P +  M           I+ +H 
Sbjct: 138 ALHYAFQDENHLYLVMDYYVGGDLLTLL--SKFEDKLPED--MARFYIGEMVLAIDSIHQ 193
Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDP------ 542
              +  H +IK  N+LL  +   R++DFG    +    T         P+   P      
Sbjct: 194 L--HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAM 251
Query: 543 ----CKVSQKADVYSFGVLLLELLTGKAPTHA 570
                K   + D +S GV + E+L G+ P +A
Sbjct: 252 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 283

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 33/217 (15%)
Query: 375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT-------ISEREFKDKIEGVGAVNHEN 426
            EV+GKG F    + +  E G   AVK + DV        +S  + K +      + H +
Sbjct: 31  CEVIGKGPFSVVRRCINRETGQQFAVK-IVDVAKFTSSPGLSTEDLKREASICHMLKHPH 89
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG----RTPLNWEMRSLIALGAARG 482
           +V L   Y S     +V++++    L   +     AG        +  MR ++       
Sbjct: 90  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL-----EA 144
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTK---SYEARVSDFGLAHLVGPSSTPNRVAG------ 533
           + Y H    N+ H ++K   +LL     S   ++  FG+A  +G S     VAG      
Sbjct: 145 LRYCHDN--NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL---VAGGRVGTP 199
Query: 534 -YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTH 569
            + APEV       +  DV+  GV+L  LL+G  P +
Sbjct: 200 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 236

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 22/160 (13%)
Query: 423 NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
           NH N+VP RA + + +E  +V  ++  GS   L+  +   G   +N    + I  G  + 
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG---MNELAIAYILQGVLKA 140
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------------ 530
           ++Y+H  G    H ++K+S+IL+  S + +V   GL   +   S   R            
Sbjct: 141 LDYIHHMG--YVHRSVKASHILI--SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 531 -VAGYRAPEV--TDPCKVSQKADVYSFGVLLLELLTGKAP 567
            V  + +PEV   +      K+D+YS G+   EL  G  P
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 33/217 (15%)
Query: 375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT-------ISEREFKDKIEGVGAVNHEN 426
            EV+GKG F    + +  E G   AVK + DV        +S  + K +      + H +
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVK-IVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG----RTPLNWEMRSLIALGAARG 482
           +V L   Y S     +V++++    L   +     AG        +  MR ++       
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL-----EA 142
Query: 483 IEYLHAQGPNVSHGNIKSSNILLTK---SYEARVSDFGLAHLVGPSSTPNRVAG------ 533
           + Y H    N+ H ++K   +LL     S   ++  FG+A  +G S     VAG      
Sbjct: 143 LRYCHDN--NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL---VAGGRVGTP 197
Query: 534 -YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTH 569
            + APEV       +  DV+  GV+L  LL+G  P +
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 80/197 (40%), Gaps = 14/197 (7%)
Query: 378 LGKGTFGTA-YKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           +G G FG A      +   +VAVK ++     +   K +I    ++ H N+V  +    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                +V +Y + G L   +            +  + LI+     G+ Y HA    V H 
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYCHAM--QVCHR 139
Query: 497 NIKSSNILLTKSYEAR--VSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVSQK-AD 550
           ++K  N LL  S   R  +  FG +      S P    G   Y APEV    +   K AD
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVAD 199
Query: 551 VYSFGVLLLELLTGKAP 567
           V+S GV L  +L G  P
Sbjct: 200 VWSCGVTLYVMLVGAYP 216

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 80/197 (40%), Gaps = 14/197 (7%)
Query: 378 LGKGTFGTA-YKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS 436
           +G G FG A      +   +VAVK ++     +   K +I    ++ H N+V  +    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHG 496
                +V +Y + G L   +            +  + LI+     G+ Y HA    V H 
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYCHAM--QVCHR 139
Query: 497 NIKSSNILLTKSYEAR--VSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVSQK-AD 550
           ++K  N LL  S   R  +  FG +      S P    G   Y APEV    +   K AD
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVAD 199
Query: 551 VYSFGVLLLELLTGKAP 567
           V+S GV L  +L G  P
Sbjct: 200 VWSCGVTLYVMLVGAYP 216

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 376 EVLGKGTFGTAY------------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
           + LG G+FG                 +L+   +V +K+++  T++E+        + AVN
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-TLNEKRI------LQAVN 99
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
              LV L   +       +V +Y+  G + + L   +  GR   +       A       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGR--FSEPHARFYAAQIVLTF 154
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDP 542
           EYLH+   ++ + ++K  N+L+ +    +V+DFG A  V G +        Y APE+   
Sbjct: 155 EYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGTPEYLAPEIILS 212
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHA 570
              ++  D ++ GVL+ E+  G  P  A
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRL---KDVTISEREFK-DKIEGVGAVNHENLVPL 430
           + LG G+FG       +E G   A+K L   K V + E E   ++   + AVN   LV L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKL 106
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
              +       +V +Y   G + + L   +  GR   +       A       EYLH+  
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGR--FSEPHARFYAAQIVLTFEYLHSL- 160
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDPCKVSQKA 549
            ++ + ++K  N+++ +    +V+DFGLA  V G +        Y APE+      ++  
Sbjct: 161 -DLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 550 DVYSFGVLLLELLTGKAPTHA 570
           D ++ GVL+ E+  G  P  A
Sbjct: 220 DWWALGVLIYEMAAGYPPFFA 240

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 376 EVLGKGTFGTAY------------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
           + LG G+FG                 +L+   +V +K+++  T++E+        + AVN
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-TLNEKRI------LQAVN 99
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
              LV L   +       +V +Y+  G + + L   +  GR   +       A       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGR--FSEPHARFYAAQIVLTF 154
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDP 542
           EYLH+   ++ + ++K  N+L+ +    +V+DFG A  V G +        Y APE+   
Sbjct: 155 EYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPEYLAPEIILS 212
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHA 570
              ++  D ++ GVL+ E+  G  P  A
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 82/182 (45%), Gaps = 15/182 (8%)
Query: 390 VLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM 449
           +L+   +V +K+++  T++E+        + AVN   LV L   +       +V +Y+  
Sbjct: 73  ILDKQKVVKLKQIEH-TLNEKRI------LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPG 125
Query: 450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY 509
           G + + L   +  GR   +       A       EYLH+   ++ + ++K  N+L+ +  
Sbjct: 126 GDMFSHL---RRIGR--FSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQG 178
Query: 510 EARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPT 568
             +V+DFG A  V G +        Y APE+      ++  D ++ GVL+ E+  G  P 
Sbjct: 179 YIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238
Query: 569 HA 570
            A
Sbjct: 239 FA 240

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 82/182 (45%), Gaps = 15/182 (8%)
Query: 390 VLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM 449
           +L+   +V +K+++  T++E+        + AVN   LV L   +       +V +Y+  
Sbjct: 73  ILDKQKVVKLKQIEH-TLNEKRI------LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPG 125
Query: 450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY 509
           G + + L   +  GR   +       A       EYLH+   ++ + ++K  N+L+ +  
Sbjct: 126 GDMFSHL---RRIGR--FSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQG 178
Query: 510 EARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPT 568
             +V+DFG A  V G +        Y APE+      ++  D ++ GVL+ E+  G  P 
Sbjct: 179 YIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238
Query: 569 HA 570
            A
Sbjct: 239 FA 240

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 376 EVLGKGTFGTAY------------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
           + LG G+FG                 +L+   +V +K+++  T++E+        + AVN
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-TLNEKRI------LQAVN 99
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
              LV L   +       +V +Y+  G + + L   +  GR   +       A       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGR--FSEPHARFYAAQIVLTF 154
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDP 542
           EYLH+   ++ + ++K  N+L+ +    +V+DFG A  V G +        Y APE+   
Sbjct: 155 EYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILS 212
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHA 570
              ++  D ++ GVL+ E+  G  P  A
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 376 EVLGKGTFGTAY------------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
           + LG G+FG                 +L+   +V +K+++  T++E+        + AVN
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-TLNEKRI------LQAVN 100
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
              LV L   +       +V +Y+  G + + L   +  GR   +       A       
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGR--FSEPHARFYAAQIVLTF 155
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDP 542
           EYLH+   ++ + ++K  N+L+ +    +V+DFG A  V G +        Y APE+   
Sbjct: 156 EYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILS 213
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHA 570
              ++  D ++ GVL+ E+  G  P  A
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 376 EVLGKGTFGTAY------------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
           + LG G+FG                 +L+   +V +K+++  T++E+        + AVN
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-TLNEKRI------LQAVN 99
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
              LV L   +       +V +Y+  G + + L   +  GR   +       A       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGR--FSEPHARFYAAQIVLTF 154
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDP 542
           EYLH+   ++ + ++K  N+L+ +    +V+DFG A  V G +        Y APE+   
Sbjct: 155 EYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILS 212
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHA 570
              ++  D ++ GVL+ E+  G  P  A
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 376 EVLGKGTFGTAY------------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
           + LG G+FG                 +L+   +V +K+++  T++E+        + AVN
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-TLNEKRI------LQAVN 99
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
              LV L   +       +V +Y+  G + + L   +  GR   +       A       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGR--FSEPHARFYAAQIVLTF 154
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDP 542
           EYLH+   ++ + ++K  N+L+ +    +V+DFG A  V G +        Y APE+   
Sbjct: 155 EYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILS 212
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHA 570
              ++  D ++ GVL+ E+  G  P  A
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 25/207 (12%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVK--------RLKDV--TISEREFKDKIEGVGAVNH 424
           + LG G+FG       +E G   A+K        +LK +  T++E+        + AVN 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI------LQAVNF 100
Query: 425 ENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
             LV L   +       +V +Y+  G + + L   +  GR   +       A       E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGR--FSEPHARFYAAQIVLTFE 155
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDPC 543
           YLH+   ++ + ++K  N+L+ +    +V+DFG A  V G +        Y APE+    
Sbjct: 156 YLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK 213
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHA 570
             ++  D ++ GVL+ E+  G  P  A
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 376 EVLGKGTFGTAY------------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
           + LG G+FG                 +L+   +V +K+++  T++E+        + AVN
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-TLNEKRI------LQAVN 99
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
              LV L   +       +V +Y+  G + + L   +  GR   +       A       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGR--FSEPHARFYAAQIVLTF 154
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDP 542
           EYLH+   ++ + ++K  N+L+ +    +V+DFG A  V G +        Y APE+   
Sbjct: 155 EYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILS 212
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHA 570
              ++  D ++ GVL+ E+  G  P  A
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 376 EVLGKGTFGTAY------------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
           + LG G+FG                 +L+   +V +K+++  T++E+        + AVN
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-TLNEKRI------LQAVN 86
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
              LV L   +       +V +Y+  G + + L   +  GR   +       A       
Sbjct: 87  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGR--FSEPHARFYAAQIVLTF 141
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDP 542
           EYLH+   ++ + ++K  N+L+ +    +V+DFG A  V G +        Y APE+   
Sbjct: 142 EYLHSL--DLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILS 199
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHA 570
              ++  D ++ GVL+ E+  G  P  A
Sbjct: 200 KGYNKAVDWWALGVLIYEMAAGYPPFFA 227

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 376 EVLGKGTFGTAY------------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
           + LG G+FG                 +L+   +V +K+++  T++E+        + AVN
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-TLNEKRI------LQAVN 99
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
              LV L   +       +V +Y+  G + + L   +  GR   +       A       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGR--FSEPHARFYAAQIVLTF 154
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDP 542
           EYLH+   ++ + ++K  N+L+ +    +V+DFG A  V G +        Y APE+   
Sbjct: 155 EYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILS 212
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHA 570
              ++  D ++ GVL+ E+  G  P  A
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRL---KDVTISEREFK-DKIEGVGAVNHENLVPL 430
           + LG G+FG       +E G   A+K L   K V + E E   ++   + AVN   LV L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKL 106
Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
              +       +V +Y   G + + L   +  GR   +       A       EYLH+  
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGR--FSEPHARFYAAQIVLTFEYLHSL- 160
Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDPCKVSQKA 549
            ++ + ++K  N+++ +    +V+DFGLA  V G +        Y APE+      ++  
Sbjct: 161 -DLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 550 DVYSFGVLLLELLTGKAPTHA 570
           D ++ GVL+ E+  G  P  A
Sbjct: 220 DWWALGVLIYEMAAGYPPFFA 240

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 376 EVLGKGTFGTAY------------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
           + LG G+FG                 +L+   +V +K+++  T++E+        + AVN
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEH-TLNEKRI------LQAVN 92
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
              LV L   +       +V +Y+  G + + L   +  GR   +       A       
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGR--FSEPHARFYAAQIVLTF 147
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDP 542
           EYLH+   ++ + ++K  N+L+ +    +V+DFG A  V G +        Y APE+   
Sbjct: 148 EYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILS 205
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHA 570
              ++  D ++ GVL+ E+  G  P  A
Sbjct: 206 KGYNKAVDWWALGVLIYEMAAGYPPFFA 233

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 25/207 (12%)
Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVK--------RLKDV--TISEREFKDKIEGVGAVNH 424
           + LG G+FG       +E G   A+K        +LK +  T++E+        + AVN 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI------LQAVNF 101
Query: 425 ENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
             LV L   +       +V +Y+  G + + L   +  GR   +       A       E
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGR--FSEPHARFYAAQIVLTFE 156
Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDPC 543
           YLH+   ++ + ++K  N+L+ +    +V+DFG A  V G +        Y APE+    
Sbjct: 157 YLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK 214
Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHA 570
             ++  D ++ GVL+ E+  G  P  A
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPFFA 241

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 376 EVLGKGTFGTAY------------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
           + LG G+FG                 +L+   +V +K+++  T++E+        + AVN
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEH-TLNEKRI------LQAVN 99
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
              LV L   +       +V +Y+  G + + L   +  GR   +       A       
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL---RRIGR--FSEPHARFYAAQIVLTF 154
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDP 542
           EYLH+   ++ + ++K  N+L+ +    +V+DFG A  V G +        Y APE+   
Sbjct: 155 EYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILS 212
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHA 570
              ++  D ++ GVL+ E+  G  P  A
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 376 EVLGKGTFGTAY------------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
           + LG G+FG                 +L+   +V +K+++  T++E+        + AVN
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEH-TLNEKRI------LQAVN 99
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
              LV L   +       +V +Y+  G + + L   +  GR   +       A       
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL---RRIGR--FSEPHARFYAAQIVLTF 154
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDP 542
           EYLH+   ++ + ++K  N+L+ +    +V+DFG A  V G +        Y APE+   
Sbjct: 155 EYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILS 212
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHA 570
              ++  D ++ GVL+ E+  G  P  A
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 27/208 (12%)
Query: 376 EVLGKGTFGTAY------------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
           + LG G+FG                 +L+   +V +K+++  T++E+        + AVN
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-TLNEKRI------LQAVN 99
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
              LV L   +       +V +Y+  G + + L    G    P         A       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFXEP----HARFYAAQIVLTF 154
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDP 542
           EYLH+   ++ + ++K  N+L+ +    +V+DFG A  V G +        Y APE+   
Sbjct: 155 EYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILS 212
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHA 570
              ++  D ++ GVL+ E+  G  P  A
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFA 240

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 85/202 (42%), Gaps = 28/202 (13%)
Query: 378 LGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVG---AVNHENLVPLRAY 433
           LG+GT+G  YKA+  +    VA+KR++     E      I  V     + H N++ L++ 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
            +      L+++Y     L   +  N       +   +  LI      G+ + H++    
Sbjct: 102 IHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIKSFLYQLI-----NGVNFCHSR--RC 153
Query: 494 SHGNIKSSNILLTKSYEA-----RVSDFGLAHLVGPSSTPNR-------VAGYRAPEVTD 541
            H ++K  N+LL+ S  +     ++ DFGLA   G    P R          YR PE+  
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG---IPIRQFTHEIITLWYRPPEILL 210
Query: 542 PCK-VSQKADVYSFGVLLLELL 562
             +  S   D++S   +  E+L
Sbjct: 211 GSRHYSTSVDIWSIACIWAEML 232

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 27/208 (12%)
Query: 376 EVLGKGTFGTAY------------KAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN 423
           + LG G+FG                 +L+   +V +K+++  T++E+        + AVN
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-TLNEKRI------LQAVN 94
Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
              LV L   +       +V +Y+  G + + L    G    P         A       
Sbjct: 95  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFXEP----HARFYAAQIVLTF 149
Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDP 542
           EYLH+   ++ + ++K  N+L+ +    +V+DFG A  V G +        Y APE+   
Sbjct: 150 EYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILS 207
Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHA 570
              ++  D ++ GVL+ E+  G  P  A
Sbjct: 208 KGYNKAVDWWALGVLIYEMAAGYPPFFA 235

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 82/182 (45%), Gaps = 15/182 (8%)
Query: 390 VLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM 449
           +L+   +V +K+++  T++E+        + AVN   LV L   +       +V +Y+  
Sbjct: 73  ILDKQKVVKLKQIEH-TLNEKRI------LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY 509
           G + + L   +  GR   +       A       EYLH+   ++ + ++K  N+L+ +  
Sbjct: 126 GEMFSHL---RRIGR--FSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQG 178
Query: 510 EARVSDFGLAHLV-GPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPT 568
             +V+DFG A  V G +        Y APE+      ++  D ++ GVL+ E+  G  P 
Sbjct: 179 YIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238
Query: 569 HA 570
            A
Sbjct: 239 FA 240

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	663
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-86
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-77
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-73
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-60
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-51
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-51
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-51
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-49
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-48
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-48
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-46
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-45
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-41
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-45
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-44
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-44
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-43
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-43
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-41
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-41
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-41
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-38
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-36
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-36
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-35
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-35
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-34
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-34
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-33
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-33
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-32
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-30
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-26
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-25
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-23
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-22
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-22
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-18
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-14
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-29
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	9e-27
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-26
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-26
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-25
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-25
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-23
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-22
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-12
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-26
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-26
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-26
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-26
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-26
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-26
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-26
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-26
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-25
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-25
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-25
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-25
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-24
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-23
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-23
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-23
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-21
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-21
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-10
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-25
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-24
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-24
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-23
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-22
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-22
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-12
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-12
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-24
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-24
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-24
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-24
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-24
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-24
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-24
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-24
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-24
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-24
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-23
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-22
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-22
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-22
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-22
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-21
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-21
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-21
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-16
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-23
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-23
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-23
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-23
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-23
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-23
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-23
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-23
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-22
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-22
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-22
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-22
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-22
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-22
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-22
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-22
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-22
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-22
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-22
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-22
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-20
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-20
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-20
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-19
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-19
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-10
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-21
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-21
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-21
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-21
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-21
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-21
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-21
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-21
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-20
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-19
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-12
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-21
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-20
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-20
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-20
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-20
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-20
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-04
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-20
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-20
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-20
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-18
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-16
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-13
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-09
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-20
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-20
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-20
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-20
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-19
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-18
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-16
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-20
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-20
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-19
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-19
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-16
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-07
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-20
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-16
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-20
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-18
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-17
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-17
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-15
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-08
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-20
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	9e-20
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-20
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-20
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-19
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-19
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-18
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-17
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-09
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-14
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-19
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-19
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-19
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-19
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-18
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-19
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-19
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-19
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-18
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-18
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-18
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-16
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-14
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-12
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-08
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-18
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-17
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-15
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-14
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-11
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-11
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-18
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-18
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-06
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-18
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-18
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-18
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-17
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-08
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-06
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-18
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-17
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-17
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-16
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-15
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-15
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-18
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	8e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-18
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-18
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-18
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-17
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-17
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-14
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-14
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-12
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-17
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-17
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-16
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-14
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	8e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-09
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-18
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-18
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-18
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-18
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-18
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-18
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-18
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-18
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-18
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-16
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-11
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-08
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-18
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-13
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-17
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-17
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-17
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-17
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-17
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-16
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-04
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-17
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-16
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-16
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-15
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-12
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-16
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-16
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-16
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-16
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-16
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-16
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-16
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-16
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	9e-16
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-15
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-14
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-14
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-13
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-16
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-16
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-16
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-16
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-13
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-12
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-12
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-15
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-15
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-15
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-15
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-15
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	9e-06
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-15
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-15
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-13
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-15
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-15
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-15
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-14
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-04
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-15
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-15
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-14
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-12
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-07
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-14
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-12
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-08
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-04
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-15
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-14
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-14
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-14
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-14
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-14
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-12
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-12
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-12
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-08
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-14
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-14
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-12
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-12
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-12
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-06
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-09
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-08
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-06
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-14
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-14
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-14
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	8e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-08
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-14
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-09
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	9e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-06
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-12
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-12
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-12
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-07
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-13
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-13
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-13
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-11
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-12
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-12
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-07
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-12
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-12
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-12
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-10
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-09
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-12
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-12
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-11
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-11
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-09
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-07
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-12
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-12
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-11
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-05
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	8e-06
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-11
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-11
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-11
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-11
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-11
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-05
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-08
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-11
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-11
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	7e-11
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-05
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-11
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	8e-11
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-10
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-08
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	9e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-08
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-10
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	9e-10
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-07
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-05
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	8e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	8e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	9e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	8e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	3e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	9e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	1e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	2e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	4e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	5e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	3e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	7e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	5e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-04
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-04
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  272 bits (698), Expect = 3e-86
 Identities = 112/296 (37%), Positives = 169/296 (57%), Gaps = 18/296 (6%)

Query: 356 VFFGNAARVFDLEDLLRA-----SAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI--S 408
           V  G   + F L +L  A     +  +LG+G FG  YK  L  GT+VAVKRLK+      
Sbjct: 12  VHLGQL-KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG 70

Query: 409 EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLN 468
           E +F+ ++E +    H NL+ LR +  +  E+LLVY Y+  GS+++ L   +   + PL+
Sbjct: 71  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLD 129

Query: 469 WEMRSLIALGAARGIEYLHAQ-GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST 527
           W  R  IALG+ARG+ YLH    P + H ++K++NILL + +EA V DFGLA L+    T
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 189

Query: 528 --PNRVAG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA--LLNEEGVDLP 580
                V G   + APE     K S+K DV+ +GV+LLEL+TG+       L N++ V L 
Sbjct: 190 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249

Query: 581 RWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK 636
            WV+ ++K++    + D   L+    +EE+ QL+Q+A+ C+   P  RP MSEV++
Sbjct: 250 DWVKGLLKEKKLEALVD-VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  247 bits (634), Expect = 6e-77
 Identities = 94/318 (29%), Positives = 154/318 (48%), Gaps = 22/318 (6%)

Query: 338 GNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRA-----SAEVLGKGTFGTAYKAVLE 392
           G+  ++  +++N A          +    L DL  A        ++G G FG  YK VL 
Sbjct: 2   GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61

Query: 393 MGTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS 451
            G  VA+KR    +     EF+ +IE +    H +LV L  +    +E +L+Y Y+  G+
Sbjct: 62  DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121

Query: 452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEA 511
           L   L+G        ++WE R  I +GAARG+ YLH     + H ++KS NILL +++  
Sbjct: 122 LKRHLYG-SDLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVP 178

Query: 512 RVSDFGLAHLVGPS------STPNRVAG---YRAPEVTDPCKVSQKADVYSFGVLLLELL 562
           +++DFG++   G        ST   V G   Y  PE     ++++K+DVYSFGV+L E+L
Sbjct: 179 KITDFGISKK-GTELDQTHLST--VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

Query: 563 TGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSA 622
             ++     L  E V+L  W      +    ++ D   L  +   E + +    A+ C A
Sbjct: 236 CARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD-PNLADKIRPESLRKFGDTAVKCLA 294

Query: 623 QYPDNRPSMSEVIKRIEE 640
              ++RPSM +V+ ++E 
Sbjct: 295 LSSEDRPSMGDVLWKLEY 312

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  236 bits (605), Expect = 6e-73
 Identities = 92/313 (29%), Positives = 148/313 (47%), Gaps = 41/313 (13%)

Query: 359 GNAARVFDLEDLLRA-----------SAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI 407
                 F   +L                  +G+G FG  YK  +   T VAVK+L  +  
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVD 67

Query: 408 S-----EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGA 462
                 +++F  +I+ +    HENLV L  +    D+  LVY Y+  GSL   L      
Sbjct: 68  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-- 125

Query: 463 GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV 522
           G  PL+W MR  IA GAA GI +LH +  ++ H +IKS+NILL +++ A++SDFGLA   
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLH-ENHHI-HRDIKSANILLDEAFTAKISDFGLARA- 182

Query: 523 GPS------STPNRVAG---YRAPE-VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALL 572
                    ++  R+ G   Y APE +    +++ K+D+YSFGV+LLE++TG        
Sbjct: 183 SEKFAQTVMTS--RIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDE-- 236

Query: 573 NEEGVDLPRWVQSIVKDEWT-SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSM 631
           + E   L    + I  +E T  +  D ++         +  +  +A  C  +  + RP +
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD--STSVEAMYSVASQCLHEKKNKRPDI 294

Query: 632 SEVIKRIEELHPS 644
            +V + ++E+  S
Sbjct: 295 KKVQQLLQEMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  204 bits (521), Expect = 1e-60
 Identities = 74/310 (23%), Positives = 117/310 (37%), Gaps = 40/310 (12%)

Query: 365 FDLEDLLRAS-----AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGV 419
              E+L   S      EV  +G FG  +KA L     VAVK          + + ++  +
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSL 72

Query: 420 GAVNHENLVPLRAY----YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI 475
             + HEN++              +  L+  +   GSLS  L  N       ++W     I
Sbjct: 73  PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHI 126

Query: 476 ALGAARGIEYLH--------AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST 527
           A   ARG+ YLH           P +SH +IKS N+LL  +  A ++DFGLA       +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 528 P---NRVAG---YRAPEVTD-----PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEG 576
               +   G   Y APEV +           + D+Y+ G++L EL +        ++E  
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 577 VDLPRWVQSIVKDEWTSEVFDLELLRYQ-----NVEEEMVQLLQLAIDCSAQYPDNRPSM 631
           +     +      E   EV   +  R            M  L +   +C     + R S 
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

Query: 632 SEVIKRIEEL 641
             V +RI ++
Sbjct: 307 GCVGERITQM 316

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  179 bits (457), Expect = 1e-51
 Identities = 80/278 (28%), Positives = 131/278 (47%), Gaps = 26/278 (9%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISE---REFKDKIEGVGAVNHENLVPLRA 432
           E +G G+FGT ++A    G+ VAVK L +         EF  ++  +  + H N+V    
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
                    +V +YL+ GSL  LLH +    R  L+   R  +A   A+G+ YLH + P 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRNPP 159

Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-TPNRVAG---YRAPEVTDPCKVSQK 548
           + H N+KS N+L+ K Y  +V DFGL+ L   +  +    AG   + APEV      ++K
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219

Query: 549 ADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE 608
           +DVYSFGV+L EL T + P         ++  + V ++             L   +N+  
Sbjct: 220 SDVYSFGVILWELATLQQPW------GNLNPAQVVAAVGFK-------CKRLEIPRNLNP 266

Query: 609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
           ++  +++    C    P  RPS + ++  +  L  S+ 
Sbjct: 267 QVAAIIE---GCWTNEPWKRPSFATIMDLLRPLIKSAV 301

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  178 bits (453), Expect = 3e-51
 Identities = 70/285 (24%), Positives = 126/285 (44%), Gaps = 41/285 (14%)

Query: 376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISE--------REFKDKIEGVGAVNHEN 426
           + +GKG FG  +K  L    ++VA+K L               +EF+ ++  +  +NH N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           +V L       +   +V +++  G L   L         P+ W ++  + L  A GIEY+
Sbjct: 85  IVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYM 138

Query: 487 HAQGPNVSHGNIKSSNILLTKSYE-----ARVSDFGLAHLVGPSSTPNRVAG---YRAPE 538
             Q P + H +++S NI L    E     A+V+DFGL+     S +   + G   + APE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS--GLLGNFQWMAPE 196

Query: 539 V--TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF 596
               +    ++KAD YSF ++L  +LTG+ P       +     +++  I ++       
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREE------- 245

Query: 597 DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            L     ++    +  +++    C +  P  RP  S ++K + EL
Sbjct: 246 GLRPTIPEDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSEL 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  177 bits (452), Expect = 7e-51
 Identities = 74/282 (26%), Positives = 131/282 (46%), Gaps = 32/282 (11%)

Query: 366 DLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHE 425
           D +++     EV+G+G FG   KA       VA+K+++  +   + F  ++  +  VNH 
Sbjct: 6   DYKEIEVE--EVVGRGAFGVVCKAKW-RAKDVAIKQIESESE-RKAFIVELRQLSRVNHP 61

Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           N+V L      ++   LV +Y   GSL  +LHG +                L  ++G+ Y
Sbjct: 62  NIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAY 117

Query: 486 LHAQGPN-VSHGNIKSSNILLTKSYE-ARVSDFGLAHLVGPSSTPNR-VAGYRAPEVTDP 542
           LH+  P  + H ++K  N+LL       ++ DFG A  +    T N+  A + APEV + 
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEG 177

Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD---LE 599
              S+K DV+S+G++L E++T + P          ++      I+       V +     
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFD--------EIGGPAFRIMW-----AVHNGTRPP 224

Query: 600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           L+  +N+ + +  L+     C ++ P  RPSM E++K +  L
Sbjct: 225 LI--KNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHL 261

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  175 bits (444), Expect = 2e-49
 Identities = 71/324 (21%), Positives = 114/324 (35%), Gaps = 58/324 (17%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKD--KIEGVGAVNHENLVPL--- 430
           E++G+G +G  YK  L     VAVK       + + F +   I  V  + H+N+      
Sbjct: 19  ELIGRGRYGAVYKGSL-DERPVAVKVFS--FANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 431 --RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
             R       E LLV +Y   GSL   L           +W     +A    RG+ YLH 
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLS------LHTSDWVSSCRLAHSVTRGLAYLHT 129

Query: 489 QG-------PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---------TPNRVA 532
           +        P +SH ++ S N+L+       +SDFGL+  +  +                
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189

Query: 533 G---YRAPEV-------TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLP-- 580
           G   Y APEV        D     ++ D+Y+ G++  E+           +     +   
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249

Query: 581 RWVQSIVKDEWTSEVFDLELLR------YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEV 634
             V +    E    +   E  R      ++     +  L +   DC  Q  + R +    
Sbjct: 250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309

Query: 635 IKRIEELH--------PSSTQGHH 650
            +R+ EL          S T  HH
Sbjct: 310 EERMAELMMIWERNKSVSPTAHHH 333

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  168 bits (428), Expect = 6e-48
 Identities = 61/290 (21%), Positives = 110/290 (37%), Gaps = 43/290 (14%)

Query: 366 DLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISE---REFKDKIEGVGAV 422
           D + L       L +   G  +K   + G  + VK LK    S    R+F ++   +   
Sbjct: 8   DFKQLNFL--TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64

Query: 423 NHENLVPLRAYYYS-MDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA 480
           +H N++P+     S       L+  ++  GSL  +LH         ++       AL  A
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMA 121

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV---GPSSTPNRVAGYRAP 537
           RG+ +LH   P +    + S ++++ +   AR+S   +       G    P     + AP
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAP----AWVAP 177

Query: 538 EV---TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
           E           + AD++SF VLL EL+T + P         +        +        
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPF------ADLSNMEIGMKVA------- 224

Query: 595 VFDLELLRY---QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
              LE LR      +   + +L++    C  + P  RP    ++  +E++
Sbjct: 225 ---LEGLRPTIPPGISPHVSKLMK---ICMNEDPAKRPKFDMIVPILEKM 268

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  168 bits (427), Expect = 8e-48
 Identities = 76/292 (26%), Positives = 129/292 (44%), Gaps = 41/292 (14%)

Query: 366 DLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLK-----DVTISEREFKDKIEGVG 420
           D  +L     E++G G FG  Y+A    G  VAVK  +     D++ +    + + +   
Sbjct: 5   DFAELTLE--EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61

Query: 421 AVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA 480
            + H N++ LR          LV ++   G L+ +L G +      +  ++    A+  A
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIA 115

Query: 481 RGIEYLHAQGPN-VSHGNIKSSNILLTKSYEAR--------VSDFGLAHLVGPSSTPNRV 531
           RG+ YLH +    + H ++KSSNIL+ +  E          ++DFGLA     ++  +  
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175

Query: 532 AGYR--APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD 589
             Y   APEV      S+ +DV+S+GVLL ELLTG+ P        G+D       +  +
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF------RGIDGLAVAYGVAMN 229

Query: 590 EWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
                   L L       E   +L++   DC    P +RPS + ++ ++  +
Sbjct: 230 -------KLALPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  165 bits (419), Expect = 7e-46
 Identities = 68/301 (22%), Positives = 116/301 (38%), Gaps = 49/301 (16%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           + +GKG +G  +      G  VAVK       +    + +I     + HEN++     + 
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENIL----GFI 97

Query: 436 SMDEK--------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           + D K         L+ DY   GSL   L        T L+ +    +A  +  G+ +LH
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLH 151

Query: 488 AQG------PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----TPNRVAG--- 533
            +       P ++H ++KS NIL+ K+    ++D GLA      +      PN   G   
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211

Query: 534 YRAPEV------TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLP----RWV 583
           Y  PEV       +  +    AD+YSFG++L E+         +   E   LP       
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV---EEYQLPYHDLVPS 268

Query: 584 QSIVKDEWTSEVFD---LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE 640
               +D                  + +E + Q+ +L  +C A  P +R +   V K + +
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328

Query: 641 L 641
           +
Sbjct: 329 M 329

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  162 bits (413), Expect = 3e-45
 Identities = 58/188 (30%), Positives = 85/188 (45%), Gaps = 12/188 (6%)

Query: 31  SSDRAALLALRSSVGGRTLL--WNVY-EASPCKWAGVEC----EQNRVTMLRLPGVALSG 83
             D+ ALL ++  +G  T L  W    +     W GV C    +  RV  L L G+ L  
Sbjct: 5   PQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64

Query: 84  Q--IPLGILGNLTSLRTLSLR-FNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVG 140
              IP  +  NL  L  L +   N+L   +P  +A  + L  LY+   + SG +P FL  
Sbjct: 65  PYPIPSSL-ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123

Query: 141 LHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQ-LNVSN 199
           +  LV L+ + N  SG +P    +L  L  +  + NR+SG+IP        L   + +S 
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183

Query: 200 NLLNGSIP 207
           N L G IP
Sbjct: 184 NRLTGKIP 191

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  150 bits (381), Expect = 8e-41
 Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 7/164 (4%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRT-LSLRFNSLTSQLPSDLASCSNLRNLYLQGNHF 130
             +   G  +SG IP    G+ + L T +++  N LT ++P   A+  NL  + L  N  
Sbjct: 152 VGITFDGNRISGAIPDSY-GSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNML 209

Query: 131 SGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLP 190
            G+  +      +  +++LA N+ + ++         L  L L NNR+ G++P     L 
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLK 268

Query: 191 NLQQLNVSNNLLNGSIPK--RFQTFGSNSFLGNS-LCGKPLQDC 231
            L  LNVS N L G IP+    Q F  +++  N  LCG PL  C
Sbjct: 269 FLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  161 bits (410), Expect = 4e-45
 Identities = 76/279 (27%), Positives = 132/279 (47%), Gaps = 35/279 (12%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISER---EFKDKIEGVGAVNHENLVPLRA 432
           + +G G+FGT YK     G  VAVK L     + +    FK+++  +    H N++    
Sbjct: 30  QRIGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 433 YYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
           Y  S   +L +V  +    SL   LH ++         +    IA   ARG++YLHA+  
Sbjct: 88  Y--STAPQLAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLHAK-- 139

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------YRAPEV---TDP 542
           ++ H ++KS+NI L +    ++ DFGLA      S  ++         + APEV    D 
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199

Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR 602
              S ++DVY+FG++L EL+TG+ P   + N + +     ++ + +   + ++  +    
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----IEMVGRGSLSPDLSKV---- 250

Query: 603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
             N  + M +L+    +C  +  D RPS   ++  IEEL
Sbjct: 251 RSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIEEL 286

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  161 bits (408), Expect = 2e-44
 Identities = 66/298 (22%), Positives = 113/298 (37%), Gaps = 43/298 (14%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           E +GKG FG  ++     G  VAVK            + +I     + HEN++   A   
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106

Query: 436 SMDEK----LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG- 490
             +       LV DY   GSL   L+      R  +  E    +AL  A G+ +LH +  
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 491 -----PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PNRVAG---YRAP 537
                P ++H ++KS NIL+ K+    ++D GLA     ++      PN   G   Y AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 538 EV------TDPCKVSQKADVYSFGVLLLELLT-----GKAPTHALLNEEGVDLPRWVQSI 586
           EV          +  ++AD+Y+ G++  E+       G    + L   + V         
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV----PSDPS 276

Query: 587 VKDEWTSEVFD---LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           V++             +       E +  + ++  +C       R +   + K + +L
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  159 bits (403), Expect = 4e-44
 Identities = 66/297 (22%), Positives = 114/297 (38%), Gaps = 41/297 (13%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           E +GKG +G  ++   + G  VAVK            + ++     + HEN++   A   
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72

Query: 436 SMDEK----LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG- 490
           +         L+  Y  MGSL   L        T L+      I L  A G+ +LH +  
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 491 -----PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PNRVAG---YRAP 537
                P ++H ++KS NIL+ K+ +  ++D GLA +   S+       N   G   Y AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 538 EV------TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLP----RWVQSIV 587
           EV       D     ++ D+++FG++L E+         +   E    P           
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV---EDYKPPFYDVVPNDPSF 243

Query: 588 KDEWTSEVFD---LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           +D       D     +      +  +  L +L  +C  Q P  R +   + K + ++
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  152 bits (386), Expect = 1e-41
 Identities = 75/313 (23%), Positives = 121/313 (38%), Gaps = 44/313 (14%)

Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV-TISEREFKDKIEGVG 420
           R+F   DL+    EVLGKG FG A K    E G ++ +K L      ++R F  +++ + 
Sbjct: 5   RIFRPSDLIHG--EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMR 62

Query: 421 AVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA 480
            + H N++      Y       + +Y+  G+L  ++            W  R   A   A
Sbjct: 63  CLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIA 118

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV--------GPSSTPNRVA 532
            G+ YLH+   N+ H ++ S N L+ ++    V+DFGLA L+        G  S      
Sbjct: 119 SGMAYLHSM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176

Query: 533 GYR----------APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRW 582
             R          APE+ +     +K DV+SFG++L E++                LPR 
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY-------LPRT 229

Query: 583 VQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH 642
           +   +             L              + + C    P+ RPS  ++   +E L 
Sbjct: 230 MDFGLNVR--------GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281

Query: 643 PSSTQGHHGLQPD 655
                GH  L P 
Sbjct: 282 -MHLAGHLPLGPQ 293

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  151 bits (383), Expect = 4e-41
 Identities = 63/310 (20%), Positives = 114/310 (36%), Gaps = 52/310 (16%)

Query: 366 DLEDLLRASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISE---REFKDKIEGVGAV 422
             E L     E++GKG FG  Y      G  VA++ +     +E   + FK ++      
Sbjct: 31  PFEQLEIG--ELIGKGRFGQVYHGRWH-GE-VAIRLIDIERDNEDQLKAFKREVMAYRQT 86

Query: 423 NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
            HEN+V       S     ++       +L +++   K      L+      IA    +G
Sbjct: 87  RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKG 142

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--------- 533
           + YLHA+   + H ++KS N+      +  ++DFGL  + G      R            
Sbjct: 143 MGYLHAK--GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199

Query: 534 YRAPEV---------TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQ 584
           + APE+          D    S+ +DV++ G +  EL   + P       +       + 
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF------KTQPAEAIIW 253

Query: 585 SIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL--- 641
            +              L    + +E+  +L     C A   + RP+ ++++  +E+L   
Sbjct: 254 QMGTGM-------KPNLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDMLEKLPKR 303

Query: 642 -HPSSTQGHH 650
               S  GH 
Sbjct: 304 NRRLSHPGHF 313

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  158 bits (402), Expect = 7e-41
 Identities = 50/198 (25%), Positives = 84/198 (42%), Gaps = 15/198 (7%)

Query: 22  TFSFSFSD-LSSDRAALLALRSSVGGRTLL--WNVYEASPCKWAGVECEQNRVTMLRLPG 78
           +F  S S  L  +   L++ +  +  + LL  W+    +PC + GV C  ++VT + L  
Sbjct: 1   SFQASPSQSLYREIHQLISFKDVLPDKNLLPDWSS-NKNPCTFDGVTCRDDKVTSIDLSS 59

Query: 79  VALS---GQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP 135
             L+     +    L +LT L +L L  + +   +       ++L +L L  N  SG V 
Sbjct: 60  KPLNVGFSAVSSS-LLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVT 117

Query: 136 --LFLVGLHHLVRLNLATNNFSGEIP-SGFKNLTKLKTLFLENNRLSGSIP---GFDDVL 189
               L     L  LN+++N        SG   L  L+ L L  N +SG+        D  
Sbjct: 118 TLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGC 177

Query: 190 PNLQQLNVSNNLLNGSIP 207
             L+ L +S N ++G + 
Sbjct: 178 GELKHLAISGNKISGDVD 195

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  150 bits (382), Expect = 3e-38
 Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 4/159 (2%)

Query: 81  LSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVG 140
             G     +   L++    ++              +  ++  L +  N  SG +P  +  
Sbjct: 596 FQGIRSEQL-NRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS 654

Query: 141 LHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
           + +L  LNL  N+ SG IP    +L  L  L L +N+L G IP     L  L ++++SNN
Sbjct: 655 MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714

Query: 201 LLNGSIPKR--FQTFGSNSFLGNS-LCGKPLQDCGTKAS 236
            L+G IP+   F+TF    FL N  LCG PL  C    +
Sbjct: 715 NLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNA 753

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  143 bits (363), Expect = 7e-36
 Identities = 59/148 (39%), Positives = 79/148 (53%), Gaps = 4/148 (2%)

Query: 81  LSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVG 140
            +G+IP  +  N + L +L L FN L+  +PS L S S LR+L L  N   GE+P  L+ 
Sbjct: 406 FTGKIPPTL-SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464

Query: 141 LHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
           +  L  L L  N+ +GEIPSG  N T L  + L NNRL+G IP +   L NL  L +SNN
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN 524

Query: 201 LLNGSIPKRFQTFGSNSFL---GNSLCG 225
             +G+IP       S  +L    N   G
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNG 552

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  143 bits (363), Expect = 7e-36
 Identities = 54/172 (31%), Positives = 73/172 (42%), Gaps = 6/172 (3%)

Query: 81  LSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVG 140
           LSG IP   LG+L+ LR L L  N L  ++P +L     L  L L  N  +GE+P  L  
Sbjct: 430 LSGTIPSS-LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488

Query: 141 LHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
             +L  ++L+ N  +GEIP     L  L  L L NN  SG+IP       +L  L+++ N
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548

Query: 201 LLNGSIPKRFQTFGSNSFL--GNSLCGKPLQDCGTKASLVVPSTPSGTDEIS 250
           L NG+IP         S     N + GK                     E  
Sbjct: 549 LFNGTIPA---AMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ 597

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  140 bits (356), Expect = 5e-35
 Identities = 54/164 (32%), Positives = 76/164 (46%), Gaps = 12/164 (7%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCS-NLRNLYLQGNHF 130
             L L     SG++P+  L  +  L+ L L FN  + +LP  L + S +L  L L  N+F
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNF 380

Query: 131 SGEVP--LFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDV 188
           SG +   L     + L  L L  N F+G+IP    N ++L +L L  N LSG+IP     
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGS 440

Query: 189 LPNLQQLNVSNNLLNGSIPKRFQTFGSNSFL------GNSLCGK 226
           L  L+ L +  N+L G IP   Q       L       N L G+
Sbjct: 441 LSKLRDLKLWLNMLEGEIP---QELMYVKTLETLILDFNDLTGE 481

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  140 bits (355), Expect = 7e-35
 Identities = 49/131 (37%), Positives = 68/131 (51%), Gaps = 4/131 (3%)

Query: 81  LSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPL-FLV 139
            +G+IP  + G   +L  L L  N     +P    SCS L +L L  N+FSGE+P+  L+
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340

Query: 140 GLHHLVRLNLATNNFSGEIPSGFKNLT-KLKTLFLENNRLSGSIPG--FDDVLPNLQQLN 196
            +  L  L+L+ N FSGE+P    NL+  L TL L +N  SG I      +    LQ+L 
Sbjct: 341 KMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY 400

Query: 197 VSNNLLNGSIP 207
           + NN   G IP
Sbjct: 401 LQNNGFTGKIP 411

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  139 bits (353), Expect = 1e-34
 Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 7/140 (5%)

Query: 70  RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNH 129
            +  L + G  +SG +    +    +L  L +  N+ ++ +P  L  CS L++L + GN 
Sbjct: 179 ELKHLAISGNKISGDVD---VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNK 234

Query: 130 FSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPG-FDDV 188
            SG+    +     L  LN+++N F G IP     L  L+ L L  N+ +G IP      
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGA 292

Query: 189 LPNLQQLNVSNNLLNGSIPK 208
              L  L++S N   G++P 
Sbjct: 293 CDTLTGLDLSGNHFYGAVPP 312

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  137 bits (347), Expect = 7e-34
 Identities = 54/150 (36%), Positives = 74/150 (49%), Gaps = 9/150 (6%)

Query: 81  LSGQIPLGILGN-LTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLV 139
            SG I   +  N   +L+ L L+ N  T ++P  L++CS L +L+L  N+ SG +P  L 
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439

Query: 140 GLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSN 199
            L  L  L L  N   GEIP     +  L+TL L+ N L+G IP       NL  +++SN
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499

Query: 200 NLLNGSIPKRFQT--------FGSNSFLGN 221
           N L G IPK              +NSF GN
Sbjct: 500 NRLTGEIPKWIGRLENLAILKLSNNSFSGN 529

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  135 bits (343), Expect = 2e-33
 Identities = 41/138 (29%), Positives = 64/138 (46%), Gaps = 5/138 (3%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS 131
             L +     S  IP   LG+ ++L+ L +  N L+      +++C+ L+ L +  N F 
Sbjct: 203 EFLDVSSNNFSTGIPF--LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFV 260

Query: 132 GEVPLFLVGLHHLVRLNLATNNFSGEIPSGFK-NLTKLKTLFLENNRLSGSIPGFDDVLP 190
           G +P     L  L  L+LA N F+GEIP         L  L L  N   G++P F     
Sbjct: 261 GPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS 318

Query: 191 NLQQLNVSNNLLNGSIPK 208
            L+ L +S+N  +G +P 
Sbjct: 319 LLESLALSSNNFSGELPM 336

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  135 bits (341), Expect = 3e-33
 Identities = 39/137 (28%), Positives = 61/137 (44%), Gaps = 6/137 (4%)

Query: 74  LRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLA---SCSNLRNLYLQGNHF 130
           L +    L     +     L SL  L L  NS++            C  L++L + GN  
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI 190

Query: 131 SGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLP 190
           SG+V +      +L  L++++NNFS  IP    + + L+ L +  N+LSG          
Sbjct: 191 SGDVDVSR--CVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCT 247

Query: 191 NLQQLNVSNNLLNGSIP 207
            L+ LN+S+N   G IP
Sbjct: 248 ELKLLNISSNQFVGPIP 264

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  124 bits (314), Expect = 6e-32
 Identities = 67/280 (23%), Positives = 122/280 (43%), Gaps = 39/280 (13%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLR 431
             +G+G+F T YK +  E    VA   L+D  +++ E   FK++ E +  + H N+V   
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 432 AYYYSMDEK----LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
             + S  +     +LV + +T G+L   L   K      +  ++         +G+++LH
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 146

Query: 488 AQGPNVSHGNIKSSNILLT-KSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPC 543
            + P + H ++K  NI +T  +   ++ D GLA L   +S    V G   + APE+ +  
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE- 204

Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY 603
           K  +  DVY+FG+ +LE+ T + P     N         +   V        FD      
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKPASFD------ 252

Query: 604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP 643
           +    E+ ++++    C  Q  D R S+ +++      H 
Sbjct: 253 KVAIPEVKEIIEG---CIRQNKDERYSIKDLLN-----HA 284

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  125 bits (317), Expect = 2e-30
 Identities = 32/144 (22%), Positives = 52/144 (36%), Gaps = 1/144 (0%)

Query: 74  LRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGE 133
           L      L       +  +L +L  L +                S+L  L + GN F   
Sbjct: 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460

Query: 134 V-PLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNL 192
             P     L +L  L+L+        P+ F +L+ L+ L + +N            L +L
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 520

Query: 193 QQLNVSNNLLNGSIPKRFQTFGSN 216
           Q L+ S N +  S  +  Q F S+
Sbjct: 521 QVLDYSLNHIMTSKKQELQHFPSS 544

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  112 bits (281), Expect = 6e-26
 Identities = 32/133 (24%), Positives = 47/133 (35%), Gaps = 4/133 (3%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
           +IP  +     S + L L FN L         S   L+ L L               L H
Sbjct: 21  KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
           L  L L  N         F  L+ L+ L      L+         L  L++LNV++NL+ 
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137

Query: 204 G-SIPKRFQTFGS 215
              +P+ F    +
Sbjct: 138 SFKLPEYFSNLTN 150

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  110 bits (278), Expect = 1e-25
 Identities = 35/136 (25%), Positives = 57/136 (41%), Gaps = 6/136 (4%)

Query: 81  LSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVG 140
           +      G   +L+ L TL L  N + S      +  S+L+ L     + +      +  
Sbjct: 64  IQTIED-GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122

Query: 141 LHHLVRLNLATNNF-SGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQ----QL 195
           L  L  LN+A N   S ++P  F NLT L+ L L +N++         VL  +      L
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182

Query: 196 NVSNNLLNGSIPKRFQ 211
           ++S N +N   P  F+
Sbjct: 183 DLSLNPMNFIQPGAFK 198

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  103 bits (260), Expect = 2e-23
 Identities = 29/143 (20%), Positives = 53/143 (37%), Gaps = 3/143 (2%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS 131
            +L++ G +        I   L +L  L L    L    P+   S S+L+ L +  N+F 
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 507

Query: 132 GEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNL-TKLKTLFLENNRLSGSIP--GFDDV 188
                    L+ L  L+ + N+         ++  + L  L L  N  + +     F   
Sbjct: 508 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQW 567

Query: 189 LPNLQQLNVSNNLLNGSIPKRFQ 211
           + + +QL V    +  + P   Q
Sbjct: 568 IKDQRQLLVEVERMECATPSDKQ 590

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  101 bits (254), Expect = 1e-22
 Identities = 32/147 (21%), Positives = 58/147 (39%), Gaps = 9/147 (6%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHF-SGEVPLFLVGLH 142
            + LG    L+SL+ L     +L S     +     L+ L +  N   S ++P +   L 
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 143 HLVRLNLATNNFSGEIPSGFKNLTKLK----TLFLENNRLSGSIPG-FDDVLPNLQQLNV 197
           +L  L+L++N       +  + L ++     +L L  N ++   PG F      L +L +
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK--EIRLHKLTL 207

Query: 198 SNNLLNGSIPKR-FQTFGSNSFLGNSL 223
            NN  + ++ K   Q           L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVL 234

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 99.3 bits (248), Expect = 7e-22
 Identities = 34/156 (21%), Positives = 59/156 (37%), Gaps = 8/156 (5%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTS-QLPSDLASCSNLRNLYLQGNHF 130
             L      L+       +G+L +L+ L++  N + S +LP   ++ +NL +L L  N  
Sbjct: 103 QKLVAVETNLASLEN-FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161

Query: 131 SGEVPLFLVGLHHL----VRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIP-GF 185
                  L  LH +    + L+L+ N  +   P  FK + +L  L L NN  S ++    
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTC 220

Query: 186 DDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGN 221
              L  L+   +                 +   L N
Sbjct: 221 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 88.9 bits (221), Expect = 1e-18
 Identities = 35/167 (20%), Positives = 54/167 (32%), Gaps = 26/167 (15%)

Query: 74  LRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGE 133
            RL  +       + +   LT++ + SL   ++      D +     ++L L    F   
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQF 319

Query: 134 VPLFL-------------------VGLHHLVRLNLATN--NFSGEIPSGFKNLTKLKTLF 172
             L L                   V L  L  L+L+ N  +F G         T LK L 
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379

Query: 173 LENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFL 219
           L  N +      F   L  L+ L+  ++ L       F  F S   L
Sbjct: 380 LSFNGVITMSSNFLG-LEQLEHLDFQHSNLKQMSE--FSVFLSLRNL 423

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 74.7 bits (184), Expect = 4e-14
 Identities = 21/147 (14%), Positives = 45/147 (30%), Gaps = 14/147 (9%)

Query: 70  RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQ---LPSDLASCSNLRNLYLQ 126
           R+  L L     S  +    +  L  L    L      ++      D ++   L NL ++
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260

Query: 127 GNHFS------GEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSG 180
               +       ++      L ++   +L +          F      + L L N +   
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQ 318

Query: 181 SIPGFDDVLPNLQQLNVSNNLLNGSIP 207
                   L +L++L  ++N    +  
Sbjct: 319 FPTLK---LKSLKRLTFTSNKGGNAFS 342

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  118 bits (297), Expect = 6e-29
 Identities = 61/278 (21%), Positives = 112/278 (40%), Gaps = 35/278 (12%)

Query: 376 EVLGKGTFGTAYKAVLEMGTI-VAVKRLKDVTISE--REFKDKIEGVGAVNHENLVPLRA 432
           E +G+G FG  +   L      VAVK  ++    +   +F  +   +   +H N+V L  
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
                    +V + +  G     L          L  +    +   AA G+EYL ++   
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESK--C 233

Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR-------APEVTDPCKV 545
             H ++ + N L+T+    ++SDFG++             G R       APE  +  + 
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWTAPEALNYGRY 292

Query: 546 SQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ 604
           S ++DV+SFG+LL E  + G +P   L N++        + + K           L   +
Sbjct: 293 SSESDVWSFGILLWETFSLGASPYPNLSNQQ-T-----REFVEKGGR--------LPCPE 338

Query: 605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH 642
              + + +L++    C A  P  RPS S + + ++ + 
Sbjct: 339 LCPDAVFRLME---QCWAYEPGQRPSFSTIYQELQSIR 373

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  110 bits (276), Expect = 9e-27
 Identities = 60/284 (21%), Positives = 94/284 (33%), Gaps = 56/284 (19%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGA----VNHENLVPL 430
             LG G++G  +K    E G + AVKR        ++   K+  VG+      H   V  
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV-- 120

Query: 431 RAYYYS--MDEKLLVYDYLTM----GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
                +      L    YL       SL         A    L               + 
Sbjct: 121 -RLEQAWEEGGIL----YLQTELCGPSLQQHCE----AWGASLPEAQVWGYLRDTLLALA 171

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTD 541
           +LH+Q   + H ++K +NI L      ++ DFGL   +G +       G   Y APE+  
Sbjct: 172 HLHSQ--GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL- 228

Query: 542 PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL 601
                  ADV+S G+ +LE+       H      G    +  Q  +  E+T         
Sbjct: 229 QGSYGTAADVFSLGLTILEVACNMELPH-----GGEGWQQLRQGYLPPEFT--------- 274

Query: 602 RYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
               +  E+  +L   L  D     P  R +   ++       P
Sbjct: 275 --AGLSSELRSVLVMMLEPD-----PKLRATAEALLA-----LP 306

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  114 bits (287), Expect = 1e-26
 Identities = 44/152 (28%), Positives = 60/152 (39%), Gaps = 9/152 (5%)

Query: 74  LRLPGVALSG-QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS- 131
           L L  VAL            L +L  L L  N++ +     L     L  L LQ N+ + 
Sbjct: 459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR 518

Query: 132 -------GEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPG 184
                  G    FL GL HL  LNL +N F       FK+L +LK + L  N L+     
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578

Query: 185 FDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSN 216
             +   +L+ LN+  NL+     K F     N
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  113 bits (285), Expect = 2e-26
 Identities = 38/147 (25%), Positives = 60/147 (40%), Gaps = 1/147 (0%)

Query: 71  VTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHF 130
           +T+L L    L            + L +L + FN+++   P        L+ L LQ N  
Sbjct: 27  ITVLNLTHNQLRRLPA-ANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85

Query: 131 SGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLP 190
           S           +L  L+L +N+      + F     L TL L +N LS +  G    L 
Sbjct: 86  SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 145

Query: 191 NLQQLNVSNNLLNGSIPKRFQTFGSNS 217
           NLQ+L +SNN +     +    F ++S
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSS 172

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  111 bits (279), Expect = 1e-25
 Identities = 32/138 (23%), Positives = 51/138 (36%), Gaps = 2/138 (1%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
           Q+        T+L  L L  NS+     +      NL  L L  N  S       V L +
Sbjct: 87  QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146

Query: 144 LVRLNLATNNFSGEIPSGFK--NLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNL 201
           L  L L+ N               + LK L L +N++    PG    +  L  L ++N  
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206

Query: 202 LNGSIPKRFQTFGSNSFL 219
           L  S+ ++     +N+ +
Sbjct: 207 LGPSLTEKLCLELANTSI 224

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  110 bits (278), Expect = 2e-25
 Identities = 32/128 (25%), Positives = 48/128 (37%), Gaps = 3/128 (2%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
           Q+P  +    T++  L+L  N L     ++    S L +L +  N  S   P     L  
Sbjct: 18  QVPDDLP---TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPM 74

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
           L  LNL  N  S      F   T L  L L +N +            NL  L++S+N L+
Sbjct: 75  LKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS 134

Query: 204 GSIPKRFQ 211
            +      
Sbjct: 135 STKLGTQV 142

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  107 bits (269), Expect = 2e-24
 Identities = 29/141 (20%), Positives = 55/141 (39%), Gaps = 10/141 (7%)

Query: 81  LSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSG--EVPLFL 138
           +  ++       L ++  + L +N       +  A   +L+ L L+          P   
Sbjct: 417 IGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476

Query: 139 VGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLS--------GSIPGFDDVLP 190
             L +L  L+L+ NN +       + L KL+ L L++N L+        G    F   L 
Sbjct: 477 QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLS 536

Query: 191 NLQQLNVSNNLLNGSIPKRFQ 211
           +L  LN+ +N  +    + F+
Sbjct: 537 HLHILNLESNGFDEIPVEVFK 557

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  104 bits (261), Expect = 2e-23
 Identities = 37/155 (23%), Positives = 56/155 (36%), Gaps = 7/155 (4%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLA---SCSNLRNLYLQGN 128
             L L    +    P G    +  L  L L    L   L   L    + +++RNL L  +
Sbjct: 174 KKLELSSNQIKEFSP-GCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNS 232

Query: 129 HFSGEVPLFLVGLH--HLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFD 186
             S       +GL   +L  L+L+ NN +      F  L +L+  FLE N +        
Sbjct: 233 QLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292

Query: 187 DVLPNLQQLNVSNNLLNGSIPK-RFQTFGSNSFLG 220
             L N++ LN+  +    SI           SF  
Sbjct: 293 HGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQW 327

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  100 bits (250), Expect = 5e-22
 Identities = 32/138 (23%), Positives = 47/138 (34%), Gaps = 7/138 (5%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEV--PLFLVGL 141
           +I       L  L  L++  N +     +      NL+ L L  +  S         V L
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL 378

Query: 142 HH--LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNV 197
            H  L  LNL  N  S      F  L  L+ L L  N +   + G  +   L N+ ++ +
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG-LENIFEIYL 437

Query: 198 SNNLLNGSIPKRFQTFGS 215
           S N         F    S
Sbjct: 438 SYNKYLQLTRNSFALVPS 455

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 98.1 bits (245), Expect = 2e-21
 Identities = 29/126 (23%), Positives = 42/126 (33%), Gaps = 6/126 (4%)

Query: 94  TSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNN 153
            S          LT  +P DL   +N+  L L  N               L  L++  N 
Sbjct: 4   VSHEVADCSHLKLTQ-VPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 154 FSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTF 213
            S   P   + L  LK L L++N LS           NL +L++ +N +          F
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN---NPF 117

Query: 214 GSNSFL 219
                L
Sbjct: 118 VKQKNL 123

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 97.4 bits (243), Expect = 3e-21
 Identities = 43/183 (23%), Positives = 69/183 (37%), Gaps = 18/183 (9%)

Query: 57  SPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILG-NLTSLRTLSLRFNSLTSQLPSDLA 115
           S  +   +E     +  L L    LS       LG   T+L  L L +N+L        A
Sbjct: 210 SLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFA 269

Query: 116 SCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATN---------NFSGEIPSGFKNLT 166
               L   +L+ N+        L GL ++  LNL  +         +        F+ L 
Sbjct: 270 WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329

Query: 167 KLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGK 226
            L+ L +E+N + G        L NL+ L++SN+  +       +T  + +F   SL   
Sbjct: 330 CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS------LRTLTNETF--VSLAHS 381

Query: 227 PLQ 229
           PL 
Sbjct: 382 PLH 384

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 67.7 bits (166), Expect = 6e-12
 Identities = 21/99 (21%), Positives = 39/99 (39%), Gaps = 1/99 (1%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP-LFLVGLHH 143
           IP+ +  +L  L+ + L  N+L +   S   +  +L++L LQ N  +     +F     +
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSI 182
           L  L++  N F     S    +  +         LS   
Sbjct: 611 LTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  108 bits (273), Expect = 2e-26
 Identities = 73/310 (23%), Positives = 131/310 (42%), Gaps = 35/310 (11%)

Query: 359 GNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEM-----GTIVAVKRLKDVTISE-REF 412
           G+    F+   L     + LGKG FG+      +      G +VAVK+L+  T    R+F
Sbjct: 1   GSDPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 58

Query: 413 KDKIEGVGAVNHENLVPLRAYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWE 470
           + +IE + ++ H+N+V  +   YS   +   L+ +YL  GSL   L  +K      ++  
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHI 114

Query: 471 MRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR 530
                     +G+EYL  +     H ++ + NIL+      ++ DFGL  ++       +
Sbjct: 115 KLLQYTSQICKGMEYLGTK--RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK 172

Query: 531 VAGYR-------APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWV 583
           V           APE     K S  +DV+SFGV+L EL T    + +   E    +    
Sbjct: 173 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232

Query: 584 QSIVKDEWTSEVFD-LE----LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
           Q  +       + + L+    L R     +E+  ++    +C     + RPS  ++  R+
Sbjct: 233 QGQMIVF---HLIELLKNNGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRV 286

Query: 639 EELHPSSTQG 648
           +++   +  G
Sbjct: 287 DQIR-DNMAG 295

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  108 bits (273), Expect = 2e-26
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 19/211 (9%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE-REFKDKIEGVGAVNHENLVPLRAY 433
            VLGKGT+G  Y    L     +A+K + +      +   ++I     + H+N+V    Y
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV---QY 84

Query: 434 Y--YSMDEKLLVY-DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
              +S +  + ++ + +  GSLSALL    G      N +           G++YLH   
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPL--KDNEQTIGFYTKQILEGLKYLHDNQ 142

Query: 491 PNVSHGNIKSSNILL-TKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPCKV 545
             + H +IK  N+L+ T S   ++SDFG +  L G +       G   Y APE+ D    
Sbjct: 143 --IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200

Query: 546 --SQKADVYSFGVLLLELLTGKAPTHALLNE 574
              + AD++S G  ++E+ TGK P + L   
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEP 231

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  109 bits (275), Expect = 2e-26
 Identities = 70/293 (23%), Positives = 124/293 (42%), Gaps = 33/293 (11%)

Query: 376 EVLGKGTFGTAYKAVLEM-----GTIVAVKRLKDVTISE-REFKDKIEGVGAVNHENLVP 429
           + LGKG FG+      +      G +VAVK+L+  T    R+F+ +IE + ++ H+N+V 
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 430 LRAYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            +   YS   +   L+ +YL  GSL   L  +K      ++            +G+EYL 
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 162

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR-------APEVT 540
            +     H ++ + NIL+      ++ DFGL  ++       +V           APE  
Sbjct: 163 TK--RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL-- 598
              K S  +DV+SFGV+L EL T    + +   E    +    Q  +       + +L  
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF---HLIELLK 277

Query: 599 ---ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQG 648
               L R     +E+  ++    +C     + RPS  ++  R++++      G
Sbjct: 278 NNGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIR-DQMAG 326

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  111 bits (279), Expect = 3e-26
 Identities = 74/276 (26%), Positives = 124/276 (44%), Gaps = 29/276 (10%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
             LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 248

Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
           S +   +V +Y++ GSL   L G  G     L       +A   A G+ Y+     N  H
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVH 303

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKAD 550
            +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363

Query: 551 VYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           V+SFG+LL EL T G+ P   ++N E V     +  + +           +       E 
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNRE-V-----LDQVERGYR--------MPCPPECPES 409

Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
           +  L+     C  + P+ RP+   +   +E+   S+
Sbjct: 410 LHDLM---CQCWRKEPEERPTFEYLQAFLEDYFTST 442

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  109 bits (274), Expect = 4e-26
 Identities = 49/385 (12%), Positives = 99/385 (25%), Gaps = 77/385 (20%)

Query: 297 VDITSLKQQEVEIVDDKAVGEMDNGYSVAAAAAAAMVGIGNGNGKTQVNSNVNGATKKLV 356
             +  L ++E E++        +     AA   A    +   N +T V+S ++   +KL 
Sbjct: 9   SFMRDLLKREEELIG---YCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLK 65

Query: 357 FFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDK 415
                              E L  G     +    +E     A+K       + R   ++
Sbjct: 66  L-----------------VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELER 108

Query: 416 ----IEGVGAVNHENLVPLRAYY--------------------------YSMDEKLLVYD 445
                     +  E+    R                             Y++   LL+  
Sbjct: 109 LHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP 168

Query: 446 YLTMGSLSALLH--GNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNI 503
             +   L  L          R         ++     R    L ++G  + HG+    N+
Sbjct: 169 AAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNL 225

Query: 504 LLTKSYEARVSDFGLAHLVGPSSTPNRV-AGYRAPEVTDP--CKVSQKADVYSFGVLLLE 560
            +       + D      VG     + V   Y   E  +      +   + +  G+ +  
Sbjct: 226 FIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285

Query: 561 LLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQ--LAI 618
           +     P   +         R    +   +       L       + + +  L+   L  
Sbjct: 286 VWCLFLPFGLVTPGIKGSWKRPSLRVPGTD------SLAFGSCTPLPDFVKTLIGRFLNF 339

Query: 619 DCSAQYPDNRPSMSEVIKRIEELHP 643
           D        R    E ++      P
Sbjct: 340 D-----RRRRLLPLEAME-----TP 354

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  110 bits (278), Expect = 4e-26
 Identities = 65/276 (23%), Positives = 131/276 (47%), Gaps = 29/276 (10%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           + LG G FG  + A     T VAVK +K  ++S   F  +   +  + H+ LV L A   
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VV 252

Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
           + +   ++ +++  GSL   L  ++G   +          +   A G+ ++  +  N  H
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQR--NYIH 307

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKAD 550
            +++++NIL++ S   +++DFGLA ++  +    R        + APE  +    + K+D
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367

Query: 551 VYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           V+SFG+LL+E++T G+ P   + N E V     ++++ +           + R +N  EE
Sbjct: 368 VWSFGILLMEIVTYGRIPYPGMSNPE-V-----IRALERGYR--------MPRPENCPEE 413

Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
              L  + + C    P+ RP+   +   +++ + ++
Sbjct: 414 ---LYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  109 bits (273), Expect = 5e-26
 Identities = 40/326 (12%), Positives = 91/326 (27%), Gaps = 58/326 (17%)

Query: 319 DNGYSVAAAAAAAMVGIGNGNGKTQVNSNVNGATKKLVFFGNAARVFDLEDLLRASA--- 375
             G  V       +           + S  +      ++        + E   R      
Sbjct: 18  GPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVR 77

Query: 376 -EVLGKGTFGTAYKAV-LEMGTIVAVK--------------RLKDVTISEREFKD----- 414
             VLG+       +A   E G    V               ++K+  +  R  +      
Sbjct: 78  GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 137

Query: 415 ----------KIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHG---NKG 461
                       + V     + ++ +R     M      + Y  M S          +  
Sbjct: 138 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 197

Query: 462 AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL 521
           +    L    R  + L   R +  LH  G  + H  ++  +I+L +     ++ F     
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 522 VGPSSTPNRVAGYRAPEVTDP-----------CKVSQKADVYSFGVLLLELLTGKAP--- 567
            G     +   G+  PE+                ++   D ++ G+++  +     P   
Sbjct: 256 DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315

Query: 568 -----THALLNEEGVDLPRWVQSIVK 588
                    +     ++P+ V+++++
Sbjct: 316 DAALGGSEWIFRSCKNIPQPVRALLE 341

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  108 bits (271), Expect = 5e-26
 Identities = 59/286 (20%), Positives = 126/286 (44%), Gaps = 44/286 (15%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEG----VGAVNHENLVPL 430
           + +G+G F   Y+A  L  G  VA+K+++   + + + +         +  +NH N++  
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI-- 95

Query: 431 RAYYYS-MDEKLL--VYDYLTMGSLSALLHGNKGAGRT---PLNWEMRSLIALGAARGIE 484
             YY S +++  L  V +    G LS ++   K   R       W+    +       +E
Sbjct: 96  -KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA----LE 150

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVT 540
           ++H++   V H +IK +N+ +T +   ++ D GL       ++  + + G   Y +PE  
Sbjct: 151 HMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT---SEVFD 597
                + K+D++S G LL E+   ++P +     + ++L    + I + ++    S+ + 
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLYSLCKKIEQCDYPPLPSDHYS 264

Query: 598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP 643
            EL        ++V +  +  D     P+ RP ++ V    + +H 
Sbjct: 265 EEL-------RQLVNMC-INPD-----PEKRPDVTYVYDVAKRMHA 297

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  108 bits (271), Expect = 7e-26
 Identities = 72/291 (24%), Positives = 123/291 (42%), Gaps = 35/291 (12%)

Query: 376 EVLGKGTFGTAYKAVLEM-----GTIVAVKRLK-DVTISEREFKDKIEGVGAVNHENLVP 429
             LGKG FG+      +      G +VAVK+L+      +R+F+ +I+ + A++ + +V 
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 430 LRAYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            R   Y    +   LV +YL  G L   L  ++      L+     L +    +G+EYL 
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICKGMEYLG 144

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR-------APEVT 540
           ++     H ++ + NIL+      +++DFGLA L+        V           APE  
Sbjct: 145 SR--RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202

Query: 541 DPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD-L 598
                S+++DV+SFGV+L EL T              +         +     S + + L
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL-----SRLLELL 257

Query: 599 E----LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
           E    L        E+ +L++    C A  P +RPS S +  +++ L   S
Sbjct: 258 EEGQRLPAPPACPAEVHELMK---LCWAPSPQDRPSFSALGPQLDMLWSGS 305

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  110 bits (277), Expect = 9e-26
 Identities = 74/276 (26%), Positives = 124/276 (44%), Gaps = 29/276 (10%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
             LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 331

Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
           S +   +V +Y++ GSL   L G  G     L       +A   A G+ Y+     N  H
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVH 386

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKAD 550
            +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+D
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446

Query: 551 VYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           V+SFG+LL EL T G+ P   ++N E V     +  + +           +       E 
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNRE-V-----LDQVERGYR--------MPCPPECPES 492

Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
           +  L+     C  + P+ RP+   +   +E+   S+
Sbjct: 493 LHDLM---CQCWRKEPEERPTFEYLQAFLEDYFTST 525

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  108 bits (271), Expect = 1e-25
 Identities = 31/216 (14%), Positives = 67/216 (31%), Gaps = 26/216 (12%)

Query: 376 EVLGKGTFGTAYKAV------LEMGTIVAVKRLKDVTISEREFKDKIEGV-GAVNHENLV 428
            +LG+G F   Y+A        +      +K  K     E     ++            +
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
              + +   +  +LV +  + G+L   ++  K      +   +    A+     IE +H 
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190

Query: 489 QGPNVSHGNIKSSNILLTKSYEA-----------RVSDFGLA---HLVGPSSTPNRVAG- 533
               + HG+IK  N +L   +              + D G +    L    +        
Sbjct: 191 CE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCET 248

Query: 534 --YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
             ++  E+      + + D +     +  +L G   
Sbjct: 249 SGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  106 bits (267), Expect = 1e-25
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 23/203 (11%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKD---KIEGVGAVNHENLVPLR 431
           E +GKG+FG  +K +      +VA+K + D+  +E E +D   +I  +   +   +    
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVT--- 83

Query: 432 AYY--YSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            YY  Y  D KL ++ +YL  GS   LL         PL+    + I     +G++YLH+
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHS 137

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGL-AHLVGPSSTPNRVAG---YRAPEVTDPCK 544
           +     H +IK++N+LL++  E +++DFG+   L       N   G   + APEV     
Sbjct: 138 EK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 195

Query: 545 VSQKADVYSFGVLLLELLTGKAP 567
              KAD++S G+  +EL  G+ P
Sbjct: 196 YDSKADIWSLGITAIELARGEPP 218

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  104 bits (262), Expect = 3e-25
 Identities = 66/281 (23%), Positives = 117/281 (41%), Gaps = 45/281 (16%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           + +G G FG  +         VA+K +++  +SE +F ++ E +  ++H  LV L     
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73

Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
                 LV +++  G LS  L   +G         M     L    G+ YL      V H
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM----CLDVCEGMAYLEEA--CVIH 127

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR------APEVTDPCKVSQKA 549
            ++ + N L+ ++   +VSDFG+   V          G +      +PEV    + S K+
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186

Query: 550 DVYSFGVLLLELLT-GKAPTHALLNEEGVD-------LPRWVQSIVKDEWTSEVFDLELL 601
           DV+SFGVL+ E+ + GK P     N E V+       L +          ++ V+ +   
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK------PRLASTHVYQI--- 237

Query: 602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH 642
                   M         C  + P++RP+ S +++++ E+ 
Sbjct: 238 --------MNH-------CWRERPEDRPAFSRLLRQLAEIA 263

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  108 bits (272), Expect = 4e-25
 Identities = 72/281 (25%), Positives = 128/281 (45%), Gaps = 35/281 (12%)

Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
             LG G +G  Y+ V  +    VAVK LK+ T+   EF  +   +  + H NLV L    
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285

Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
                  ++ +++T G+L   L   +   R  ++  +   +A   +  +EYL  +  N  
Sbjct: 286 TREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK--NFI 340

Query: 495 HGNIKSSNILLTKSYEARVSDFGLAHLV--------GPSSTPNRVAGYRAPEVTDPCKVS 546
           H N+ + N L+ +++  +V+DFGL+ L+          +  P +   + APE     K S
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK---WTAPESLAYNKFS 397

Query: 547 QKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN 605
            K+DV++FGVLL E+ T G +P   +   + V      + + KD          + R + 
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-V-----YELLEKDYR--------MERPEG 443

Query: 606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
             E++ +L+     C    P +RPS +E+ +  E +   S+
Sbjct: 444 CPEKVYELM---RACWQWNPSDRPSFAEIHQAFETMFQESS 481

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  105 bits (264), Expect = 4e-25
 Identities = 70/303 (23%), Positives = 121/303 (39%), Gaps = 54/303 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRL-----KDVTISEREFKDKIEGVGAVNHENLVP 429
           + LG+G F        L  G   A+KR+     +D   ++RE     +     NH N++ 
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE----ADMHRLFNHPNILR 90

Query: 430 LRAYYY----SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL-IALGAARGIE 484
           L AY      +  E  L+  +   G+L   +   K  G   L  E + L + LG  RG+E
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG-NFLT-EDQILWLLLGICRGLE 148

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG----------- 533
            +HA     +H ++K +NILL    +  + D G  +        +R A            
Sbjct: 149 AIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 534 --YRAPEVTDP---CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK 588
             YRAPE+      C + ++ DV+S G +L  ++ G+ P   +  +        V   V+
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-----VALAVQ 261

Query: 589 DEWTSEVFDLELLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
           ++ +                 + QLL   + +D     P  RP +  ++ ++E L P + 
Sbjct: 262 NQLSIPQSP-------RHSSALWQLLNSMMTVD-----PHQRPHIPLLLSQLEALQPPAP 309

Query: 647 QGH 649
             H
Sbjct: 310 GQH 312

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  107 bits (267), Expect = 5e-25
 Identities = 31/265 (11%), Positives = 73/265 (27%), Gaps = 55/265 (20%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIE----------------- 417
            VLG+       +A   E G    V               +++                 
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 418 ---------GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM----GSLSALLH--GNKGA 462
                        V       +        +  ++  +        +L        +  +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 463 GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV 522
               L    R  + L   R +  LH  G  + H  ++  +I+L +     ++ F      
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 523 GPSSTPNRVAGYRAPEVTDP----------CKVSQKADVYSFGVLLLELLTGKAP----- 567
           G S+      G+  PE T              ++   D ++ G+ +  +     P     
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321

Query: 568 ----THALLNEEGVDLPRWVQSIVK 588
               +  +      ++P+ V+++++
Sbjct: 322 ALGGSEWIFRSC-KNIPQPVRALLE 345

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  105 bits (265), Expect = 5e-25
 Identities = 66/282 (23%), Positives = 121/282 (42%), Gaps = 54/282 (19%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGV---GAVNHENLVPLR 431
           + +G+G+FG A      E G    +K +    +S +E ++    V     + H N+V   
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIV--- 86

Query: 432 AYYYSMDEKLLVY---DYLTMGSLSALLHGNKGAG---RTPLNWEMRSLIALGAARGIEY 485
            Y  S +E   +Y   DY   G L   ++  KG        L+W ++  +AL      ++
Sbjct: 87  QYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL------KH 140

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--------TPNRVAGYRAP 537
           +H +   + H +IKS NI LTK    ++ DFG+A ++  +         TP     Y +P
Sbjct: 141 VHDR--KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY----YLSP 194

Query: 538 EVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT--SEV 595
           E+ +    + K+D+++ G +L EL T K    A        +   V  I+   +   S  
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHAFEAG------SMKNLVLKIISGSFPPVSLH 248

Query: 596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR 637
           +  +L         +V  L    +     P +RPS++ ++++
Sbjct: 249 YSYDL-------RSLVSQL-FKRN-----PRDRPSVNSILEK 277

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  109 bits (274), Expect = 5e-25
 Identities = 22/136 (16%), Positives = 46/136 (33%), Gaps = 11/136 (8%)

Query: 81  LSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHF--------SG 132
                 L    NL  L  + +      ++LP+ L +   ++ + +  N            
Sbjct: 237 QYKTEDLKW-DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDW 295

Query: 133 EVPLFLVGLHHLVRLNLATNNF-SGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPN 191
           +          +  + +  NN  +  + +  + + KL  L    N+L G +P F      
Sbjct: 296 QALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGS-EIK 354

Query: 192 LQQLNVSNNLLNGSIP 207
           L  LN++ N +     
Sbjct: 355 LASLNLAYNQITEIPA 370

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  105 bits (264), Expect = 7e-24
 Identities = 26/147 (17%), Positives = 52/147 (35%), Gaps = 13/147 (8%)

Query: 81  LSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP--LFL 138
           L G++P    G+   L +L+L +N +T    +       + NL    N     +P     
Sbjct: 342 LEGKLPA--FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDA 398

Query: 139 VGLHHLVRLNLATNNFSG-------EIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPN 191
             +  +  ++ + N            +         + ++ L NN++S            
Sbjct: 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458

Query: 192 LQQLNVSNNLLNGSIPKRFQTFGSNSF 218
           L  +N+  N+L   IPK      + +F
Sbjct: 459 LSSINLMGNMLTE-IPKNSLKDENENF 484

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  102 bits (257), Expect = 5e-23
 Identities = 28/151 (18%), Positives = 54/151 (35%), Gaps = 6/151 (3%)

Query: 76  LPGVALSGQIPLGILGNLTSLRTLSLRFNSLTS-QLPSDLASCSNLRNLYLQGNHFSGEV 134
              +    Q           ++ + + +N+L +  + + L     L  L    N   G++
Sbjct: 288 GEQLKDDWQALAD-APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL 346

Query: 135 PLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDV--LPNL 192
           P F      L  LNLA N  +    +      +++ L   +N+L   IP   D   +  +
Sbjct: 347 PAF-GSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVM 404

Query: 193 QQLNVSNNLLNGSIPKRFQTFGSNSFLGNSL 223
             ++ S N +     K F       F G ++
Sbjct: 405 SAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  102 bits (256), Expect = 7e-23
 Identities = 34/215 (15%), Positives = 67/215 (31%), Gaps = 22/215 (10%)

Query: 28  SDLSSDRAALLALRSSVGGRTLLWNV----------YEASPCKWA---GVECEQN-RVTM 73
           ++   D  AL  +  ++ G+                +      W    GV    N RVT 
Sbjct: 26  AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTG 85

Query: 74  LRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLT----SQLPSDLASCSNLRNLYLQGNH 129
           L L G   SG++P  I G LT L  L+L  +          P  +++  +         H
Sbjct: 86  LSLEGFGASGRVPDAI-GQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMH 144

Query: 130 FSGEVP--LFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDD 187
           +               L++  + ++     I    +   K   +   +N ++  +     
Sbjct: 145 YQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVM 203

Query: 188 VLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNS 222
            L  L+Q  + N+              ++ +    
Sbjct: 204 RLTKLRQFYMGNSPFVAENICEAWENENSEYAQQY 238

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  102 bits (255), Expect = 9e-23
 Identities = 28/138 (20%), Positives = 45/138 (32%), Gaps = 13/138 (9%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLA--SCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL 147
             N   L ++ LRFN LT  L  D    +   L  + L  N FS   P   +    L   
Sbjct: 484 FKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGF 541

Query: 148 ------NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNL 201
                 +   N    E P G      L  L + +N +   +   + + PN+  L++ +N 
Sbjct: 542 GIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVN--EKITPNISVLDIKDNP 598

Query: 202 LNGSIPKRFQTFGSNSFL 219
                      +      
Sbjct: 599 NISIDLSYVCPYIEAGMY 616

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 98.6 bits (246), Expect = 1e-21
 Identities = 20/169 (11%), Positives = 44/169 (26%), Gaps = 30/169 (17%)

Query: 70  RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNH 129
            +    +        I             +    N++T  +   +   + LR  Y+  + 
Sbjct: 160 DLIKDCINSDPQQKSIKKSS-RITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSP 217

Query: 130 FSGEVPLFLV-------------------GLHHLVRLNLATNNFSGEIPSGFKNLTKLKT 170
           F  E                          L  L  + +       ++P+  K L +++ 
Sbjct: 218 FVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL 277

Query: 171 LFLENNRL--------SGSIPGFDDVLPNLQQLNVS-NNLLNGSIPKRF 210
           + +  NR                  V   +Q + +  NNL    +    
Sbjct: 278 INVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSL 326

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 97.4 bits (243), Expect = 3e-21
 Identities = 25/134 (18%), Positives = 46/134 (34%), Gaps = 16/134 (11%)

Query: 90  LGNLTSLRTLSLRFNSLTS-------QLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLH 142
             +++ +  +   +N + S        L        N+ ++ L  N  S           
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457

Query: 143 HLVRLNLATNNFSG-------EIPSGFKNLTKLKTLFLENNRLSGSIPGFDDV-LPNLQQ 194
            L  +NL  N  +        +    FKN   L ++ L  N+L+     F    LP L  
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVG 517

Query: 195 LNVSNNLLNGSIPK 208
           +++S N  +   P 
Sbjct: 518 IDLSYNSFSK-FPT 530

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 61.6 bits (150), Expect = 4e-10
 Identities = 14/93 (15%), Positives = 28/93 (30%), Gaps = 4/93 (4%)

Query: 141 LHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSG----SIPGFDDVLPNLQQLN 196
              +  L+L     SG +P     LT+L+ L L ++          P       + +Q  
Sbjct: 80  NGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQ 139

Query: 197 VSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPLQ 229
                   +          +  + + +   P Q
Sbjct: 140 KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQ 172

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  105 bits (264), Expect = 8e-25
 Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 22/210 (10%)

Query: 366 DLEDLLRASAEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKD---KIEGVGA 421
           D E +       LG G  G  +K      G ++A K +  + I          +++ +  
Sbjct: 34  DFEKI-----SELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHE 87

Query: 422 VNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR 481
            N   +V     +YS  E  +  +++  GSL  +L   K AGR P   ++   +++   +
Sbjct: 88  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPE--QILGKVSIAVIK 142

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAP 537
           G+ YL  +   + H ++K SNIL+    E ++ DFG++  L+   S  N   G   Y +P
Sbjct: 143 GLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSP 199

Query: 538 EVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           E       S ++D++S G+ L+E+  G+ P
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  103 bits (259), Expect = 1e-24
 Identities = 55/281 (19%), Positives = 111/281 (39%), Gaps = 50/281 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
           E++G G FG  +KA     G    +KR   V  +  + + +++ +  ++H N+V     +
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNNEKAEREVKALAKLDHVNIVHYNGCW 73

Query: 435 YSMDEKLLVYD-----------YLTM-----GSLSALLHGNKGAGRTPLNWEMRSLIALG 478
              D                  ++ M     G+L   +   +G     L+  +   +   
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQ 130

Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YR 535
             +G++Y+H++   + + ++K SNI L  + + ++ DFGL   +       R  G   Y 
Sbjct: 131 ITKGVDYIHSK--KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188

Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV 595
           +PE        ++ D+Y+ G++L ELL           E           I+ D +  + 
Sbjct: 189 SPEQISSQDYGKEVDLYALGLILAELLHVCDTAF----ETSKFFTDLRDGIISDIFDKKE 244

Query: 596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK 636
             L           + +LL          P++RP+ SE+++
Sbjct: 245 KTL-----------LQKLLSKK-------PEDRPNTSEILR 267

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  103 bits (260), Expect = 1e-24
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 26/216 (12%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKD---KIEGVGAVNHENLVPLR 431
           EV+G G       A        VA+KR+ ++   +    +   +I+ +   +H N+V   
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIV--- 76

Query: 432 AYY--YSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIAL---GAARGIEY 485
           +YY  + + ++L LV   L+ GS+  ++      G         S IA        G+EY
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFG----LAHLVGPSSTPNR--VAG---YRA 536
           LH  G    H ++K+ NILL +    +++DFG    LA     +    R    G   + A
Sbjct: 137 LHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194

Query: 537 PEVTDPCKV-SQKADVYSFGVLLLELLTGKAPTHAL 571
           PEV +  +    KAD++SFG+  +EL TG AP H  
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  107 bits (270), Expect = 1e-24
 Identities = 28/147 (19%), Positives = 48/147 (32%), Gaps = 4/147 (2%)

Query: 81  LSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP-LFLV 139
           L          +L  L  L + + +            ++L  L + GN F          
Sbjct: 411 LKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470

Query: 140 GLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSN 199
              +L  L+L+           F  L +L+ L + +N L        + L +L  L+ S 
Sbjct: 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSF 530

Query: 200 NLLNGSIPKRFQTFGSNSFL---GNSL 223
           N +  S         S +F     NS+
Sbjct: 531 NRIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  102 bits (257), Expect = 4e-23
 Identities = 34/130 (26%), Positives = 48/130 (36%), Gaps = 2/130 (1%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLP-SDLASCSNLRNLYLQGNHFSGEVPLFLVGLH 142
            I       L  L+ L  + ++L      S   S   L  L +   +   +     +GL 
Sbjct: 389 IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT 448

Query: 143 HLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNL 201
            L  L +A N+F     S  F N T L  L L   +L     G  D L  LQ LN+S+N 
Sbjct: 449 SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNN 508

Query: 202 LNGSIPKRFQ 211
           L       + 
Sbjct: 509 LLFLDSSHYN 518

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  101 bits (253), Expect = 1e-22
 Identities = 33/141 (23%), Positives = 51/141 (36%), Gaps = 5/141 (3%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
            I       L  L  L L  N + S  P   +  ++L NL       +      +  L  
Sbjct: 70  TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLIT 129

Query: 144 LVRLNLATNNFSG-EIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL 202
           L +LN+A N     ++P+ F NLT L  + L  N +          L    Q+N+S ++ 
Sbjct: 130 LKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189

Query: 203 NGSIPKRFQTFGSNSFLGNSL 223
              I          +F G  L
Sbjct: 190 LNPI----DFIQDQAFQGIKL 206

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  100 bits (252), Expect = 2e-22
 Identities = 34/133 (25%), Positives = 53/133 (39%), Gaps = 4/133 (3%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
           ++P  I    +S + + L FN L        ++ S L+ L L              GLHH
Sbjct: 25  KVPDDIP---SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHH 81

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
           L  L L  N      P  F  LT L+ L     +L+         L  L++LNV++N ++
Sbjct: 82  LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH 141

Query: 204 G-SIPKRFQTFGS 215
              +P  F    +
Sbjct: 142 SCKLPAYFSNLTN 154

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 87.8 bits (218), Expect = 3e-18
 Identities = 23/131 (17%), Positives = 39/131 (29%), Gaps = 4/131 (3%)

Query: 74  LRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGE 133
           L++ G +        +  N T+L  L L    L         +   L+ L +  N+    
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512

Query: 134 VPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQ 193
                  L+ L  L+ + N               L    L NN ++  I    +    LQ
Sbjct: 513 DSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-CIC---EHQKFLQ 568

Query: 194 QLNVSNNLLNG 204
            +      L  
Sbjct: 569 WVKEQKQFLVN 579

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 87.4 bits (217), Expect = 4e-18
 Identities = 27/143 (18%), Positives = 51/143 (35%), Gaps = 7/143 (4%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTS-QLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
           +    +G L +L+ L++  N + S +LP+  ++ +NL ++ L  N+        L  L  
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178

Query: 144 L----VRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVS 198
                + L+++ N         F+ + KL  L L  N  S +I       L  L    + 
Sbjct: 179 NPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237

Query: 199 NNLLNGSIPKRFQTFGSNSFLGN 221
                               L +
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCD 260

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 86.6 bits (215), Expect = 7e-18
 Identities = 26/124 (20%), Positives = 47/124 (37%), Gaps = 6/124 (4%)

Query: 91  GNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS--GEVPLFLVGLHHLVRLN 148
            +L  L++L+L  N  +  +     +  +L  L L  N  S  G      +G + L  L+
Sbjct: 325 LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382

Query: 149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVSNNLLNGSIP 207
           L+ N     + + F  L +L+ L  +++ L           L  L  L++S         
Sbjct: 383 LSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441

Query: 208 KRFQ 211
             F 
Sbjct: 442 GIFL 445

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 78.9 bits (195), Expect = 2e-15
 Identities = 27/134 (20%), Positives = 44/134 (32%), Gaps = 10/134 (7%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
              +     L ++  +SL   S+      D+      ++L +             + L  
Sbjct: 275 SDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ---FPTLDLPF 329

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPG-FDDV-LPNLQQLNVSNNL 201
           L  L L  N  S  I      L  L  L L  N LS S    + D+   +L+ L++S N 
Sbjct: 330 LKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNG 387

Query: 202 LNGSIPKRFQTFGS 215
               +   F     
Sbjct: 388 AI-IMSANFMGLEE 400

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 69.7 bits (171), Expect = 1e-12
 Identities = 23/130 (17%), Positives = 37/130 (28%), Gaps = 12/130 (9%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSD-LASCSNLRNLYLQGNHFSGEVPL------ 136
            I       +  L  L+LR N  +S +    L + + L    L    F  E  L      
Sbjct: 195 FIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPS 253

Query: 137 FLVGLHHLVR--LNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQ 194
            + GL  +      L   N   +    F  L  +  + L    +              Q 
Sbjct: 254 IMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPK--HFKWQS 311

Query: 195 LNVSNNLLNG 204
           L++    L  
Sbjct: 312 LSIIRCQLKQ 321

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 68.5 bits (168), Expect = 3e-12
 Identities = 29/168 (17%), Positives = 51/168 (30%), Gaps = 17/168 (10%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRN----LYLQG 127
             L +    +          NLT+L  + L +N + +   +DL            L +  
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190

Query: 128 NHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTL------FLENNRLSG 180
           N           G+  L  L L  N  S  I     +NL  L         F +   L  
Sbjct: 191 NPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249

Query: 181 SIPGFDDVLPNLQ--QLNVSNNLLNGSIPKRFQTFGSNSFL---GNSL 223
             P   + L ++   +  ++          +F    + S +   G S+
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  104 bits (261), Expect = 1e-24
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 22/215 (10%)

Query: 366 DLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIE----GVG 420
           DL+DL       +G+G +G+  K V    G I+AVKR+   T+ E+E K  +      + 
Sbjct: 23  DLKDL-----GEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMR 76

Query: 421 AVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA 480
           + +   +V      +   +  +  + ++  S               +  E+   I L   
Sbjct: 77  SSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATV 135

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGL-AHLVGPSSTPNRVAG---YRA 536
           + + +L      + H +IK SNILL +S   ++ DFG+   LV  S    R AG   Y A
Sbjct: 136 KALNHLKENL-KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD-SIAKTRDAGCRPYMA 193

Query: 537 PEVTDPCKVSQ----KADVYSFGVLLLELLTGKAP 567
           PE  DP    Q    ++DV+S G+ L EL TG+ P
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  103 bits (258), Expect = 1e-24
 Identities = 76/285 (26%), Positives = 137/285 (48%), Gaps = 30/285 (10%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           E LG G FG  +       T VAVK LK  ++S   F  +   +  + H+ LV L A   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 77

Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
           + +   ++ +Y+  GSL   L    G     L       +A   A G+ ++  +  N  H
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEER--NYIH 132

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YR--APEVTDPCKVSQKAD 550
            +++++NIL++ +   +++DFGLA L+  +    R       +  APE  +    + K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192

Query: 551 VYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           V+SFG+LL E++T G+ P   + N E V     +Q++ +           ++R  N  EE
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPE-V-----IQNLERGYR--------MVRPDNCPEE 238

Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQP 654
           + QL++    C  + P++RP+   +   +E+   ++T+G +  QP
Sbjct: 239 LYQLMR---LCWKERPEDRPTFDYLRSVLEDFF-TATEGQYQPQP 279

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  102 bits (257), Expect = 2e-24
 Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 32/233 (13%)

Query: 377 VLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPLR 431
            LGKG FG  Y A   +   I+A+K L    +     E + + ++E    + H N++ L 
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            Y++      L+ +Y  +G++   L   +   +        + I    A  + Y H++  
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYREL---QKLSKFD-EQRTATYITE-LANALSYCHSKR- 129

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-------TPNRVAGYRAPEVTDPCK 544
            V H +IK  N+LL  + E +++DFG +    PSS       T +    Y  PE+ +   
Sbjct: 130 -VIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTDLCGTLD----YLPPEMIEGRM 183

Query: 545 VSQKADVYSFGVLLLELLTGKAP--------THALLNEEGVDLPRWVQSIVKD 589
             +K D++S GVL  E L GK P        T+  ++      P +V    +D
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  103 bits (258), Expect = 2e-24
 Identities = 70/289 (24%), Positives = 116/289 (40%), Gaps = 38/289 (13%)

Query: 376 EVLGKGTFGTAYKAVLEM-----GTIVAVKRLKDVTISE--REFKDKIEGVGAVNHENLV 428
             LG+G FG       +      G  VAVK LK  +      + K +IE +  + HEN+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 429 PLRAYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
             +            L+ ++L  GSL   L  NK      +N + +   A+   +G++YL
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDYL 142

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR-------APEV 539
            ++     H ++ + N+L+   ++ ++ DFGL   +        V   R       APE 
Sbjct: 143 GSR--QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200

Query: 540 TDPCKVSQKADVYSFGVLLLELLT--GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD 597
               K    +DV+SFGV L ELLT      +   L  + +       +       + + +
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT------VTRLVN 254

Query: 598 L-----ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
                  L    N  +E+ QL++    C    P NR S   +I+  E L
Sbjct: 255 TLKEGKRLPCPPNCPDEVYQLMR---KCWEFQPSNRTSFQNLIEGFEAL 300

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  104 bits (262), Expect = 3e-24
 Identities = 58/288 (20%), Positives = 109/288 (37%), Gaps = 52/288 (18%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRL--KDVTISEREFKDKIEGVGAVNHENLVPLRAY 433
           +VLG G  GT     +     VAVKR+  +  + ++RE +   E   +  H N++     
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRE---SDEHPNVIRYFCT 86

Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
                 + +  +     +L   +   K      L  E  +L+      G+ +LH+    +
Sbjct: 87  EKDRQFQYIAIELCA-ATLQEYVE-QKDFAHLGL--EPITLL-QQTTSGLAHLHSLN--I 139

Query: 494 SHGNIKSSNILLTKSYE-----ARVSDFGLA-HLVGPSSTPNRVA------GYRAPEV-- 539
            H ++K  NIL++         A +SDFGL   L     + +R +      G+ APE+  
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199

Query: 540 -TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                  +   D++S G +   +++  +             P       +         L
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSH------------PFGKSLQRQANILLGACSL 247

Query: 599 ELLRY-QNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
           + L   ++ +    +L++  +A+D     P  RPS   V+K     HP
Sbjct: 248 DCLHPEKHEDVIARELIEKMIAMD-----PQKRPSAKHVLK-----HP 285

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  101 bits (253), Expect = 5e-24
 Identities = 65/281 (23%), Positives = 109/281 (38%), Gaps = 45/281 (16%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           + LG G FG       +    VAVK +K+ ++SE EF  + + +  ++H  LV       
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
                 +V +Y++ G L   L  +          EM          G+ +L +      H
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM----CYDVCEGMAFLESH--QFIH 127

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR------APEVTDPCKVSQKA 549
            ++ + N L+ +    +VSDFG+   V          G +      APEV    K S K+
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186

Query: 550 DVYSFGVLLLELLT-GKAPTHALLNEEGVD-------LPRWVQSIVKDEWTSEVFDLELL 601
           DV++FG+L+ E+ + GK P     N E V        L R          +  ++ +   
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR------PHLASDTIYQI--- 237

Query: 602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH 642
                   M         C  + P+ RP+  +++  IE L 
Sbjct: 238 --------MYS-------CWHELPEKRPTFQQLLSSIEPLR 263

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  101 bits (254), Expect = 5e-24
 Identities = 56/286 (19%), Positives = 106/286 (37%), Gaps = 53/286 (18%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGV---GAVNHENLVPLR 431
             +G G++G   K      G I+  K L   +++E E +  +  V     + H N+V   
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 432 AYYYSMDEKLL--VYDYLTMGSLSALLHGNKGAGR-----TPLNWEMRSLIALGAARGIE 484
                     L  V +Y   G L++++       +       L    +  +AL      +
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL------K 125

Query: 485 YLHAQGP---NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--------TPNRVAG 533
             H +      V H ++K +N+ L      ++ DFGLA ++   +        TP     
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY---- 181

Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT- 592
           Y +PE  +    ++K+D++S G LL EL     P                  I + ++  
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF------TAFSQKELAGKIREGKFRR 235

Query: 593 -SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR 637
               +  EL        E++  + L +        +RPS+ E+++ 
Sbjct: 236 IPYRYSDEL-------NEIITRM-LNLK-----DYHRPSVEEILEN 268

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  103 bits (259), Expect = 5e-24
 Identities = 49/215 (22%), Positives = 84/215 (39%), Gaps = 32/215 (14%)

Query: 376 EVLGKG--TFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEG----VGAVNHENLV 428
            V+GKG     T   A     G  V V+R+ ++     E    ++G        NH N+V
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRI-NLEACSNEMVTFLQGELHVSKLFNHPNIV 89

Query: 429 PLRAYY--YSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
           P   Y   +  D +L +V  ++  GS   L+          +N    + I  G  + ++Y
Sbjct: 90  P---YRATFIADNELWVVTSFMAYGSAKDLI---CTHFMDGMNELAIAYILQGVLKALDY 143

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH-LVGPSSTPNRVAGYR--------- 535
           +H  G    H ++K+S+IL++   +  +S       ++        V  +          
Sbjct: 144 IHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 536 -APEVTDPCKV--SQKADVYSFGVLLLELLTGKAP 567
            +PEV          K+D+YS G+   EL  G  P
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  101 bits (253), Expect = 6e-24
 Identities = 62/280 (22%), Positives = 109/280 (38%), Gaps = 45/280 (16%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           + LG G FG            VA+K +K+ ++SE EF ++ + +  ++HE LV L     
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89

Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
                 ++ +Y+  G L   L   +         +    +       +EYL ++     H
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESK--QFLH 143

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR------APEVTDPCKVSQKA 549
            ++ + N L+      +VSDFGL+  V          G +       PEV    K S K+
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202

Query: 550 DVYSFGVLLLELLT-GKAPTHALLNEEGVD-------LPRWVQSIVKDEWTSEVFDLELL 601
           D+++FGVL+ E+ + GK P     N E  +       L R          + +V+ +   
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR------PHLASEKVYTI--- 253

Query: 602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
                   M         C  +  D RP+   ++  I ++
Sbjct: 254 --------M-------YSCWHEKADERPTFKILLSNILDV 278

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  101 bits (254), Expect = 6e-24
 Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 25/222 (11%)

Query: 366 DLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKD-----KIEGV 419
           DLE +       LG+G +G   K   +  G I+AVKR+   T++ +E K       I  +
Sbjct: 8   DLEPI-----MELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDI-SM 60

Query: 420 GAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA 479
             V+    V      +   +  +  + +                  P +      IA+  
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDI--LGKIAVSI 118

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGL-AHLVGPSSTPNRVAG---YR 535
            + +E+LH++  +V H ++K SN+L+    + ++ DFG+  +LV      +  AG   Y 
Sbjct: 119 VKALEHLHSKL-SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD-DVAKDIDAGCKPYM 176

Query: 536 APEVTDPCKV----SQKADVYSFGVLLLELLTGKAPTHALLN 573
           APE  +P       S K+D++S G+ ++EL   + P  +   
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  102 bits (255), Expect = 7e-24
 Identities = 70/293 (23%), Positives = 115/293 (39%), Gaps = 40/293 (13%)

Query: 376 EVLGKGTFGTAYKAVLEM-----GTIVAVKRLKD--VTISEREFKDKIEGVGAVNHENLV 428
             LG+G FG       +      G +VAVK LK          +K +I+ +  + HE+++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 429 PLRAYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
             +            LV +Y+ +GSL   L  +       +      L A     G+ YL
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAYL 150

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR-------APEV 539
           HAQ  +  H ++ + N+LL      ++ DFGLA  V       RV           APE 
Sbjct: 151 HAQ--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208

Query: 540 TDPCKVSQKADVYSFGVLLLELLT--GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD 597
               K    +DV+SFGV L ELLT    + +      E + + +   ++        + +
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV------LRLTE 262

Query: 598 -LE----LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
            LE    L R      E+  L++   +C       RP+   +I  ++ +H   
Sbjct: 263 LLERGERLPRPDKCPAEVYHLMK---NCWETEASFRPTFENLIPILKTVHEKY 312

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  101 bits (254), Expect = 8e-24
 Identities = 56/298 (18%), Positives = 115/298 (38%), Gaps = 67/298 (22%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLRA 432
           + +G G     ++ + E   I A+K +       +    ++++I  +  +   +   +R 
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 433 YYYSMDEKLLVYDYLTM----GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
           Y Y + ++ +   Y+ M      L++ L   K      ++   R          +  +H 
Sbjct: 94  YDYEITDQYI---YMVMECGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ 145

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----------TPNRVAGYRAPE 538
            G  + H ++K +N L+      ++ DFG+A+ + P +          T N    Y  PE
Sbjct: 146 HG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN----YMPPE 198

Query: 539 V-----------TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIV 587
                           K+S K+DV+S G +L  +  GK P   ++N+    + + + +I+
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----ISK-LHAII 253

Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
                 E            E+++  +L+  L  D     P  R S+ E++      HP
Sbjct: 254 DPNHEIEF-------PDIPEKDLQDVLKCCLKRD-----PKQRISIPELLA-----HP 294

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  104 bits (262), Expect = 1e-23
 Identities = 24/132 (18%), Positives = 37/132 (28%), Gaps = 3/132 (2%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
           +IP  +     S   L   FN L +   +  +   NL  L L                H 
Sbjct: 26  EIPGTLP---NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHR 82

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
           L  L L  N       +       LK LF     +S            L+ L + +N ++
Sbjct: 83  LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142

Query: 204 GSIPKRFQTFGS 215
                +      
Sbjct: 143 SIKLPKGFPTEK 154

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  101 bits (253), Expect = 1e-22
 Identities = 37/158 (23%), Positives = 59/158 (37%), Gaps = 7/158 (4%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS 131
            +L L    L  +       NL  L+ L+L  + L             L++L LQGNHF 
Sbjct: 403 ELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP 462

Query: 132 GEVPL---FLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDV 188
                    L  L  L  L L+  + S      F +L  +  + L +NRL+ S       
Sbjct: 463 KGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522

Query: 189 LPNLQQLNVSNNLLNGSIPKRFQTFGSNSFL---GNSL 223
           L  +  LN+++N ++  +P           +    N L
Sbjct: 523 LKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  100 bits (252), Expect = 2e-22
 Identities = 38/149 (25%), Positives = 60/149 (40%), Gaps = 3/149 (2%)

Query: 74  LRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSD--LASCSNLRNLYLQGNHFS 131
           L + G     ++  G L NL +LR L L  + + +    +  L + S+L++L L  N   
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389

Query: 132 GEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPGFDDVLP 190
                       L  L+LA      +     F+NL  LK L L ++ L  S     D LP
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449

Query: 191 NLQQLNVSNNLLNGSIPKRFQTFGSNSFL 219
            LQ LN+  N       ++  +  +   L
Sbjct: 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRL 478

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  100 bits (250), Expect = 4e-22
 Identities = 34/151 (22%), Positives = 50/151 (33%), Gaps = 4/151 (2%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
            I      +   L TL L  N L     + L+    L++L+      S    + L     
Sbjct: 71  WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQ--LNVSNNL 201
           L  L L +N+ S           KLK L  +NN +          L       LN++ N 
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190

Query: 202 LNGSIPKRFQ--TFGSNSFLGNSLCGKPLQD 230
           + G  P  F    F S +F G        + 
Sbjct: 191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKG 221

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  100 bits (250), Expect = 4e-22
 Identities = 26/135 (19%), Positives = 40/135 (29%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
           I       L +L  L L    +         S   L  L L  N         L G   L
Sbjct: 48  IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKAL 107

Query: 145 VRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNG 204
             L       S        N   L++L+L +N +S            L+ L+  NN ++ 
Sbjct: 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167

Query: 205 SIPKRFQTFGSNSFL 219
              +   +    + L
Sbjct: 168 LSKEDMSSLQQATNL 182

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 98.5 bits (246), Expect = 1e-21
 Identities = 39/132 (29%), Positives = 56/132 (42%), Gaps = 4/132 (3%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSD-LASCSNLRNLYLQGNH--FSGEVPLFLVG 140
            +      N  SL  LS++ N+   +L +  L +  NLR L L  +    S    L L  
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374

Query: 141 LHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVSN 199
           L HL  LNL+ N         FK   +L+ L L   RL           L  L+ LN+S+
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSH 434

Query: 200 NLLNGSIPKRFQ 211
           +LL+ S  + F 
Sbjct: 435 SLLDISSEQLFD 446

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 98.5 bits (246), Expect = 1e-21
 Identities = 30/136 (22%), Positives = 45/136 (33%), Gaps = 4/136 (2%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSG-EVPLFLVGLH 142
                 L NL+ L++L+L +N   S        C  L  L L        +       LH
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425

Query: 143 HLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDV---LPNLQQLNVSN 199
            L  LNL+ +         F  L  L+ L L+ N          +    L  L+ L +S 
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485

Query: 200 NLLNGSIPKRFQTFGS 215
             L+      F +   
Sbjct: 486 CDLSSIDQHAFTSLKM 501

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 96.6 bits (241), Expect = 5e-21
 Identities = 24/124 (19%), Positives = 47/124 (37%), Gaps = 4/124 (3%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTS---QLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGL 141
               +   L +L+ L+L+ N       Q  + L +   L  L L     S         L
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499

Query: 142 HHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNL 201
             +  ++L+ N  +        +L  +  L L +N +S  +P    +L   + +N+  N 
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNP 558

Query: 202 LNGS 205
           L+ +
Sbjct: 559 LDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 91.2 bits (227), Expect = 2e-19
 Identities = 28/144 (19%), Positives = 48/144 (33%), Gaps = 4/144 (2%)

Query: 70  RVTMLRLPGVALSGQIPLGILGN-LTSLRTLSLRFNSLTSQLPSDLASCS--NLRNLYLQ 126
               L   G      I  G+  + + SL   +          P+        ++ ++ LQ
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ 262

Query: 127 GNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFD 186
            ++F             L  L+L   + S E+PSG   L+ LK L L  N+         
Sbjct: 263 KHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISA 321

Query: 187 DVLPNLQQLNVSNNLLNGSIPKRF 210
              P+L  L++  N     +    
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGC 345

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 80.8 bits (200), Expect = 4e-16
 Identities = 25/137 (18%), Positives = 43/137 (31%), Gaps = 5/137 (3%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
           I    L N  +L +L L  N ++S           L+ L  Q N         +  L   
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA 179

Query: 145 --VRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNN 200
             + LNL  N+ +  I  G  +    ++L     +    I     +  + +L      + 
Sbjct: 180 TNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238

Query: 201 LLNGSIPKRFQTFGSNS 217
                 P  F+     S
Sbjct: 239 DDEDISPAVFEGLCEMS 255

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 80.8 bits (200), Expect = 4e-16
 Identities = 25/137 (18%), Positives = 43/137 (31%), Gaps = 6/137 (4%)

Query: 83  GQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCS--NLRNLYLQGNHFSGEVPLFLVG 140
             I  G   +    ++L+         +   L + +  +L     +        P    G
Sbjct: 192 AGIEPGAF-DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250

Query: 141 LH--HLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVS 198
           L    +  +NL  + F     + F   + L+ L L    LS    G    L  L++L +S
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVG-LSTLKKLVLS 309

Query: 199 NNLLNGSIPKRFQTFGS 215
            N            F S
Sbjct: 310 ANKFENLCQISASNFPS 326

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  101 bits (253), Expect = 1e-23
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 30/207 (14%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
             +G+G+FG  ++    + G   AVK+++       E    +     ++   +VP    Y
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE----LVACAGLSSPRIVP---LY 116

Query: 435 --YSMDEKLLVY-DYLTMGSLSALLHGNKGAGRTPLNWEMR-SLIALGAARGIEYLHAQG 490
                   + ++ + L  GSL  L+   K  G  P   E R       A  G+EYLH + 
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLI---KQMGCLP---EDRALYYLGQALEGLEYLHTRR 170

Query: 491 PNVSHGNIKSSNILLTKS-YEARVSDFGLA------HLVGPSSTPNRVAG---YRAPEVT 540
             + HG++K+ N+LL+     A + DFG A       L     T + + G   + APEV 
Sbjct: 171 --ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAP 567
                  K D++S   ++L +L G  P
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  100 bits (251), Expect = 1e-23
 Identities = 57/233 (24%), Positives = 95/233 (40%), Gaps = 32/233 (13%)

Query: 377 VLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPLR 431
            LGKG FG  Y A   +   I+A+K L    +     E + + +IE    + H N++ + 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
            Y++      L+ ++   G L   L   +  GR        + +    A  + Y H +  
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFD-EQRSATFMEE-LADALHYCHER-- 133

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-------TPNRVAGYRAPEVTDPCK 544
            V H +IK  N+L+    E +++DFG +    PS        T +    Y  PE+ +   
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHA-PSLRRRTMCGTLD----YLPPEMIEGKT 188

Query: 545 VSQKADVYSFGVLLLELLTGKAP--------THALLNEEGVDLPRWVQSIVKD 589
             +K D++  GVL  E L G  P        TH  +    +  P ++    KD
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKD 241

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  102 bits (257), Expect = 2e-23
 Identities = 65/270 (24%), Positives = 115/270 (42%), Gaps = 29/270 (10%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           + +GKG FG         G  VAVK +K+   + + F  +   +  + H NLV L     
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIV 256

Query: 436 SMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
                L +V +Y+  GSL   L      GR+ L  +     +L     +EYL     N  
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGN--NFV 311

Query: 495 HGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR--APEVTDPCKVSQKADVY 552
           H ++ + N+L+++   A+VSDFGL      +    ++   +  APE     K S K+DV+
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-VKWTAPEALREKKFSTKSDVW 370

Query: 553 SFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMV 611
           SFG+LL E+ + G+ P   +  ++ V     V  + K           +         + 
Sbjct: 371 SFGILLWEIYSFGRVPYPRIPLKD-V-----VPRVEKGYK--------MDAPDGCPPAVY 416

Query: 612 QLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            ++    +C       RP+  ++ +++E +
Sbjct: 417 DVM---KNCWHLDAATRPTFLQLREQLEHI 443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  100 bits (250), Expect = 3e-23
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 18/200 (9%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
           E LG+G++G+ YKA+  E G IVA+K++  V    +E   +I  +   +  ++V    YY
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQCDSPHVV---KYY 90

Query: 435 --YSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
             Y  +  L +V +Y   GS+S ++          L  +  + I     +G+EYLH    
Sbjct: 91  GSYFKNTDLWIVMEYCGAGSVSDIIRLRNK----TLTEDEIATILQSTLKGLEYLHFMR- 145

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGL-AHLVGPSSTPNRVAG---YRAPEVTDPCKVSQ 547
              H +IK+ NILL     A+++DFG+   L    +  N V G   + APEV      + 
Sbjct: 146 -KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNC 204

Query: 548 KADVYSFGVLLLELLTGKAP 567
            AD++S G+  +E+  GK P
Sbjct: 205 VADIWSLGITAIEMAEGKPP 224

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 99.7 bits (249), Expect = 3e-23
 Identities = 71/312 (22%), Positives = 117/312 (37%), Gaps = 75/312 (24%)

Query: 376 EVLGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISERE-FKDKIEGVGAVNHEN 426
           E LG+GTF   +K V            T V +K L     +  E F +    +  ++H++
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73

Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           LV         DE +LV +++  GSL   L  NK      + W++   +A   A  + +L
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN--CINILWKLE--VAKQLAAAMHFL 129

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEAR--------VSDFGLAHLVGPSSTPNRVAGYR--- 535
                 + HGN+ + NILL +  + +        +SD G++  V P          +   
Sbjct: 130 EEN--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERI 181

Query: 536 ---APEVTDPCKV-SQKADVYSFGVLLLELLT-GKAPTHALLNEE-------GVDLPRWV 583
               PE  +  K  +   D +SFG  L E+ + G  P  AL ++           LP   
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA-- 239

Query: 584 QSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL-- 641
                 +   E+ +L           +         C    PD+RPS   +I+ +  L  
Sbjct: 240 -----PKAA-ELANL-----------INN-------CMDYEPDHRPSFRAIIRDLNSLFT 275

Query: 642 ---HPSSTQGHH 650
               P  +  HH
Sbjct: 276 PDLVPRGSHHHH 287

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 99.7 bits (249), Expect = 3e-23
 Identities = 53/236 (22%), Positives = 101/236 (42%), Gaps = 24/236 (10%)

Query: 346 SNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKD 404
           S  +G     +  G      ++ DL       +G GT G  +K    + G ++AVK++  
Sbjct: 3   SGSSGKQTGYLTIGGQRYQAEINDLENL--GEMGSGTCGQVWKMRFRKTGHVIAVKQM-R 59

Query: 405 VTISEREFKDKIE----GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNK 460
            + ++ E K  +      + + +   +V     + +  +  +  + +   +         
Sbjct: 60  RSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG 119

Query: 461 GAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGL-A 519
                P+   +   + +   + + YL  +   V H ++K SNILL +  + ++ DFG+  
Sbjct: 120 -----PIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGQIKLCDFGISG 173

Query: 520 HLVGPSSTPNRVAG---YRAPEVTDPCKVSQ-----KADVYSFGVLLLELLTGKAP 567
            LV      +R AG   Y APE  DP   ++     +ADV+S G+ L+EL TG+ P
Sbjct: 174 RLVD-DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 99.2 bits (248), Expect = 4e-23
 Identities = 66/297 (22%), Positives = 120/297 (40%), Gaps = 57/297 (19%)

Query: 376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLKDVTISE----REFKDKIEGVGAVNHENL 427
           E LG G+FG   +   +        VAVK LK   +S+     +F  ++  + +++H NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 428 VPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           + L  Y   +   + +V +   +GSL   L  ++G              A+  A G+ YL
Sbjct: 84  IRL--YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY----AVQVAEGMGYL 137

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR-------APEV 539
            ++     H ++ + N+LL      ++ DFGL   +  +     +  +R       APE 
Sbjct: 138 ESK--RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195

Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVD--------LPRWVQSIVKDE 590
                 S  +D + FGV L E+ T G+ P   L   + +         LPR       ++
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR------PED 249

Query: 591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ 647
              +++++           MVQ       C A  P++RP+   +   + E  P+  +
Sbjct: 250 CPQDIYNV-----------MVQ-------CWAHKPEDRPTFVALRDFLLEAQPTDMR 288

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 99.6 bits (249), Expect = 4e-23
 Identities = 62/288 (21%), Positives = 116/288 (40%), Gaps = 54/288 (18%)

Query: 376 EVLGKGTFGTAYKAVLEMG-----TIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +           VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 429 PLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            L      +   + L+   +  G L   +  +K    +           +  A+G+ YL 
Sbjct: 81  RL--LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW----CVQIAKGMNYLE 134

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR------APEVTD 541
            +   + H ++ + N+L+      +++DFGLA L+G         G +      A E   
Sbjct: 135 DR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 542 PCKVSQKADVYSFGVLLLELLT-GKAPTHALLN-------EEGVDLPRWVQSIVKDEWTS 593
               + ++DV+S+GV + EL+T G  P   +         E+G  LP+          T 
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ------PPICTI 246

Query: 594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           +V+ +           M +       C     D+RP   E+I    ++
Sbjct: 247 DVYMI-----------MRK-------CWMIDADSRPKFRELIIEFSKM 276

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 98.9 bits (247), Expect = 5e-23
 Identities = 52/202 (25%), Positives = 101/202 (50%), Gaps = 22/202 (10%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE--FKDKIEGVGAVNHENLVPLRA 432
           E +G+G  GT Y A+ +  G  VA++++ ++    ++    ++I  +    + N+V    
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIV---N 81

Query: 433 YY--YSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           Y   Y + ++L +V +YL  GSL+ ++        T ++    + +     + +E+LH+ 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGL-AHLVGPSSTPNRVAG---YRAPEVTDPCKV 545
              V H +IKS NILL      +++DFG  A +    S  + + G   + APEV      
Sbjct: 136 Q--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193

Query: 546 SQKADVYSFGVLLLELLTGKAP 567
             K D++S G++ +E++ G+ P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 98.5 bits (246), Expect = 6e-23
 Identities = 68/285 (23%), Positives = 122/285 (42%), Gaps = 43/285 (15%)

Query: 376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
             LG G +G  Y+ V +     VAVK LK+ T+   EF  +   +  + H NLV L    
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78

Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
                  ++ +++T G+L   L   +   R  ++  +   +A   +  +EYL  +  N  
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK--NFI 133

Query: 495 HGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCKVSQKA 549
           H ++ + N L+ +++  +V+DFGL+ L+   +            + APE     K S K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193

Query: 550 DVYSFGVLLLELLT-GKAPTHALLNEEGVD-------LPRWVQSIVKDEWTSEVFDLELL 601
           DV++FGVLL E+ T G +P   +   +  +       + R       +    +V++L   
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER------PEGCPEKVYEL--- 244

Query: 602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
                   M         C    P +RPS +E+ +  E +   S+
Sbjct: 245 --------MRA-------CWQWNPSDRPSFAEIHQAFETMFQESS 274

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 98.2 bits (245), Expect = 7e-23
 Identities = 47/225 (20%), Positives = 87/225 (38%), Gaps = 44/225 (19%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVPL 430
           E +G G FG+ +K V    G I A+KR K       + ++ +  V A      H ++V  
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV-- 74

Query: 431 RAYY--YSMDEKLLVY-DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
             Y+  ++ D+ +L+  +Y   GSL+  +  N               + L   RG+ Y+H
Sbjct: 75  -RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS-YFKEAELKDLLLQVGRGLRYIH 132

Query: 488 AQGPNVSHGNIKSSNILLTKS-------------------YEARVSDFGLAHLVGPSSTP 528
           +    + H +IK SNI ++++                      ++ D G        S+P
Sbjct: 133 SMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSP 187

Query: 529 NRVAG---YRAPEV---TDPCKVSQKADVYSFGVLLLELLTGKAP 567
               G   + A EV           KAD+++  + ++     +  
Sbjct: 188 QVEEGDSRFLANEVLQENYTH--LPKADIFALALTVVCAAGAEPL 230

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 23/206 (11%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE-FKDKIEGVGAVNHENLVPLRAY 433
             LG G FG  YKA   E G + A K ++  +  E E +  +IE +   +H  +V     
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIV---KL 81

Query: 434 Y--YSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
              Y  D KL ++ ++   G++ A++          L      ++       + +LH++ 
Sbjct: 82  LGAYYHDGKLWIMIEFCPGGAVDAIMLELDR----GLTEPQIQVVCRQMLEALNFLHSKR 137

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGL-AHLVGPSSTPNRVAG---YRAPEVTDPCKVS 546
             + H ++K+ N+L+T   + R++DFG+ A  +      +   G   + APEV     + 
Sbjct: 138 --IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195

Query: 547 Q-----KADVYSFGVLLLELLTGKAP 567
                 KAD++S G+ L+E+   + P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPP 221

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 28/212 (13%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVP- 429
           E++G GT+G  YK   ++ G + A+K +    ++  E ++  + +  +    +H N+   
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATY 86

Query: 430 ----LRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
               ++     MD++L LV ++   GS++ L+   KG     L  E  + I     RG+ 
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN---TLKEEWIAYICREILRGLS 143

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGL-AHLVGPSSTPNRVAG---YRAPEVT 540
           +LH     V H +IK  N+LLT++ E ++ DFG+ A L       N   G   + APEV 
Sbjct: 144 HLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201

Query: 541 DPCKVSQ-----KADVYSFGVLLLELLTGKAP 567
              +        K+D++S G+  +E+  G  P
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 56/298 (18%), Positives = 117/298 (39%), Gaps = 67/298 (22%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLRA 432
           + +G G     ++ + E   I A+K +       +    ++++I  +  +   +   +R 
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 433 YYYSMDEKLLVYDYLTM----GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
           Y Y + ++ +   Y+ M      L++ L   K      ++   R          +  +H 
Sbjct: 75  YDYEITDQYI---YMVMECGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ 126

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----------TPNRVAGYRAPE 538
            G  + H ++K +N L+      ++ DFG+A+ + P +          T N    Y  PE
Sbjct: 127 HG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN----YMPPE 179

Query: 539 V-----------TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIV 587
                           K+S K+DV+S G +L  +  GK P   ++N+    + + + +I+
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----ISK-LHAII 234

Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
                    + E+      E+++  +L+  L  D     P  R S+ E++      HP
Sbjct: 235 DP-------NHEIEFPDIPEKDLQDVLKCCLKRD-----PKQRISIPELLA-----HP 275

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 22/202 (10%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE--FKDKIEGVGAVNHENLVPLRA 432
             +G+G+ G    A     G  VAVK + D+   +R     +++  +    H N+V    
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHFNVV---E 106

Query: 433 YY--YSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
            Y  Y + E+L ++ ++L  G+L+ ++       +  LN E  + +     + + YLHAQ
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVS------QVRLNEEQIATVCEAVLQALAYLHAQ 160

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGL-AHLVGPSSTPNRVAG---YRAPEVTDPCKV 545
           G  V H +IKS +ILLT     ++SDFG  A +         + G   + APEV      
Sbjct: 161 G--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218

Query: 546 SQKADVYSFGVLLLELLTGKAP 567
           + + D++S G++++E++ G+ P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPP 240

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 67/277 (24%), Positives = 115/277 (41%), Gaps = 43/277 (15%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           + +GKG FG         G  VAVK +K+   + + F  +   +  + H NLV L     
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIV 84

Query: 436 SMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
                L +V +Y+  GSL   L      GR+ L  +     +L     +EYL     N  
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGN--NFV 139

Query: 495 HGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR--APEVTDPCKVSQKADVY 552
           H ++ + N+L+++   A+VSDFGL      +    ++   +  APE     K S K+DV+
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-VKWTAPEALREKKFSTKSDVW 198

Query: 553 SFGVLLLELLT-GKAPTHALLNEEGVD-------LPRWVQSIVKDEWTSEVFDLELLRYQ 604
           SFG+LL E+ + G+ P   +  ++ V        +         D     V+++      
Sbjct: 199 SFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA------PDGCPPAVYEV------ 246

Query: 605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
                M        +C       RPS  ++ +++E +
Sbjct: 247 -----M-------KNCWHLDAAMRPSFLQLREQLEHI 271

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 62/300 (20%), Positives = 108/300 (36%), Gaps = 68/300 (22%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVK--RLKDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           + LG+G FG  ++A         A+K  RL +  ++  +   +++ +  + H  +V    
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV---R 67

Query: 433 YYYSMDEKLLVYD----------YLTM-----GSLSALLHGNKGAGRTPLNWEMRSLIAL 477
           Y+ +  EK               Y+ M      +L   ++G         +  +   I L
Sbjct: 68  YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH--IFL 125

Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----------- 526
             A  +E+LH++G  + H ++K SNI  T     +V DFGL   +               
Sbjct: 126 QIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 527 ---------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGV 577
                    T      Y +PE       S K D++S G++L ELL     T         
Sbjct: 184 YARHTGQVGTKL----YMSPEQIHGNSYSHKVDIFSLGLILFELLY-PFSTQMERVR--- 235

Query: 578 DLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR 637
                  + V++     +F     +    E  MVQ + L+       P  RP    +I+ 
Sbjct: 236 -----TLTDVRNLKFPPLFT----QKYPCEYVMVQDM-LSPS-----PMERPEAINIIEN 280

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 78/314 (24%), Positives = 130/314 (41%), Gaps = 62/314 (19%)

Query: 350 GATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAVLEMG-----TIVAVKRLKD 404
           GA K L      AR+F   +L +   +VLG G FGT +K V           V +K ++D
Sbjct: 1   GAMKVL------ARIFKETELRKL--KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIED 52

Query: 405 VT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKG 461
            +   S +   D +  +G+++H ++V L          L LV  YL +GSL   +  ++G
Sbjct: 53  KSGRQSFQAVTDHMLAIGSLDHAHIVRL--LGLCPGSSLQLVTQYLPLGSLLDHVRQHRG 110

Query: 462 AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL 521
           A    L         +  A+G+ YL      + H N+ + N+LL    + +V+DFG+A L
Sbjct: 111 ALGPQLLLNW----GVQIAKGMYYLEEH--GMVHRNLAARNVLLKSPSQVQVADFGVADL 164

Query: 522 VGPSSTPNRVAGYR------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLN- 573
           + P       +  +      A E     K + ++DV+S+GV + EL+T G  P   L   
Sbjct: 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA 224

Query: 574 ------EEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDN 627
                 E+G  L +          T +V+ +           MV+       C     + 
Sbjct: 225 EVPDLLEKGERLAQ------PQICTIDVYMV-----------MVK-------CWMIDENI 260

Query: 628 RPSMSEVIKRIEEL 641
           RP+  E+      +
Sbjct: 261 RPTFKELANEFTRM 274

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 96.6 bits (241), Expect = 3e-22
 Identities = 50/216 (23%), Positives = 81/216 (37%), Gaps = 45/216 (20%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK-----DVTISEREFKDKIEGVGAVNHENLVP 429
            ++G+G  G  Y+A       IVA+K +      D     R  + +    G +   ++VP
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR-MQREARTAGRLQEPHVVP 98

Query: 430 LRAYYYSMDEKLLVYD--------YLTM-----GSLSALLHGNKGAGRTPLNWEMRSLIA 476
                        ++D        Y+ M       L+A+L       + PL       I 
Sbjct: 99  -------------IHDFGEIDGQLYVDMRLINGVDLAAMLRR-----QGPLAPPRAVAIV 140

Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--TPNRVAG- 533
                 ++  HA G   +H ++K  NIL++    A + DFG+A               G 
Sbjct: 141 RQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGT 198

Query: 534 --YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
             Y APE       + +AD+Y+   +L E LTG  P
Sbjct: 199 LYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 95.7 bits (239), Expect = 4e-22
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 33/208 (15%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDK----IEGVGAVNHENLVPLRA 432
           LGKG+F   Y+A  +  G  VA+K +    + +     +    ++    + H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLN-WE----MRSLIALGAARGIEYLH 487
           Y+   +   LV +    G ++  L         P +  E    M  +I      G+ YLH
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVK----PFSENEARHFMHQIIT-----GMLYLH 129

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSS-------TPNRVAGYRAPEV 539
           + G  + H ++  SN+LLT++   +++DFGLA  L  P         TPN    Y +PE+
Sbjct: 130 SHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN----YISPEI 183

Query: 540 TDPCKVSQKADVYSFGVLLLELLTGKAP 567
                   ++DV+S G +   LL G+ P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 97.1 bits (242), Expect = 5e-22
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 33/209 (15%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGV-------GAVNHENL 427
             +G G+FG  Y A  +    +VA+K++     S ++  +K + +         + H N 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMS---YSGKQSNEKWQDIIKEVRFLQKLRHPNT 116

Query: 428 VPLRAYY--YSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
           +    Y   Y  +    LV +Y   GS S LL  +K     PL     + +  GA +G+ 
Sbjct: 117 I---QYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK----PLQEVEIAAVTHGALQGLA 168

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTD 541
           YLH+    + H ++K+ NILL++    ++ DFG A ++ P+++     G   + APEV  
Sbjct: 169 YLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS---FVGTPYWMAPEVIL 223

Query: 542 PCKVSQ---KADVYSFGVLLLELLTGKAP 567
                Q   K DV+S G+  +EL   K P
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPP 252

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 97.9 bits (244), Expect = 7e-22
 Identities = 58/303 (19%), Positives = 117/303 (38%), Gaps = 61/303 (20%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRL--KDVTISEREFKDKIEGVGAVNHENLVPLRAY 433
           ++LG G+ GT        G  VAVKR+      I+  E K   E   + +H N++     
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTE---SDDHPNVIRYYCS 77

Query: 434 YYSMDEKLLVYDYLTMGSLSALL--HGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
             +     +  +     +L  L+                    +    A G+ +LH+   
Sbjct: 78  ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK- 135

Query: 492 NVSHGNIKSSNILLT-------------KSYEARVSDFGLAHLVGPSSTPNRV------- 531
            + H ++K  NIL++             ++    +SDFGL   +    +  R        
Sbjct: 136 -IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194

Query: 532 -AGYRAPEV-------TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRW 582
            +G+RAPE+           ++++  D++S G +   +L+ GK P     + E       
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------- 247

Query: 583 VQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEE 640
             +I++  ++ +  +++ L  +++  E   L+   +  D     P  RP+  +V++    
Sbjct: 248 -SNIIRGIFSLD--EMKCLHDRSLIAEATDLISQMIDHD-----PLKRPTAMKVLR---- 295

Query: 641 LHP 643
            HP
Sbjct: 296 -HP 297

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 97.2 bits (242), Expect = 7e-22
 Identities = 55/298 (18%), Positives = 114/298 (38%), Gaps = 67/298 (22%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLRA 432
           + +G G     ++ + E   I A+K +       +    ++++I  +  +   +   +R 
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 433 YYYSMDEKLLVYDYLTM----GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
           Y Y + ++ +   Y+ M      L++ L   K      ++   R          +  +H 
Sbjct: 122 YDYEITDQYI---YMVMECGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ 173

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----------TPNRVAGYRAPE 538
            G  + H ++K +N L+      ++ DFG+A+ + P +            N    Y  PE
Sbjct: 174 HG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVN----YMPPE 226

Query: 539 V-----------TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIV 587
                           K+S K+DV+S G +L  +  GK P   ++N+    + + + +I+
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----ISK-LHAII 281

Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
                 E            E+++  +L+  L  D     P  R S+ E++      HP
Sbjct: 282 DPNHEIEF-------PDIPEKDLQDVLKCCLKRD-----PKQRISIPELLA-----HP 322

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 99.6 bits (248), Expect = 8e-22
 Identities = 33/157 (21%), Positives = 57/157 (36%), Gaps = 19/157 (12%)

Query: 88  GILGNLTSLRTLSLRFNSLTSQLPSDLASC--SNLRNLYLQGNHFSGEVPLFLVGLHHLV 145
           G   N   L T+ LRFN LTS L  D  +     L N+ +  N FS   P   +    L 
Sbjct: 722 GNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLK 779

Query: 146 RLNL------ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSN 199
              +        N    + P+G      L  L + +N +   +   + + P L  L++++
Sbjct: 780 AFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVD--EKLTPQLYILDIAD 836

Query: 200 N-LLNGSIPK--RFQTFGSNSFLGNS---LCGKPLQD 230
           N  ++  +     +   G    L +    + G     
Sbjct: 837 NPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALG 873

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 98.8 bits (246), Expect = 1e-21
 Identities = 31/150 (20%), Positives = 55/150 (36%), Gaps = 14/150 (9%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTS---------QLPSDLASCSNLRN 122
           T + L       Q+P  +  +L  L++L++  N   S         +L  D  +   ++ 
Sbjct: 494 TDVELYNCPNMTQLPDFL-YDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI 552

Query: 123 LYLQGNHFSG-EVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGS 181
            Y+  N+         L  +  L  L+   N     + + F    KL  L L+ N++   
Sbjct: 553 FYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEEI 610

Query: 182 IPGFDDVLPNLQQLNVSNNLLNGSIPKRFQ 211
              F      ++ L  S+N L   IP  F 
Sbjct: 611 PEDFCAFTDQVEGLGFSHNKLK-YIPNIFN 639

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 95.7 bits (238), Expect = 1e-20
 Identities = 23/137 (16%), Positives = 44/137 (32%), Gaps = 11/137 (8%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNHFSGEVP--LFLVGLHHLVR 146
            G    L  L L +N +   +P D  A    +  L    N     +P       ++ +  
Sbjct: 591 FGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGS 648

Query: 147 LNLATNNFSGEIPSGFK-----NLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNL 201
           ++ + N    E  +              T+ L  N +             +  + +SNNL
Sbjct: 649 VDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNL 708

Query: 202 LNGSIPKRFQTFGSNSF 218
           +  SIP+        ++
Sbjct: 709 M-TSIPENSLKPKDGNY 724

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 95.7 bits (238), Expect = 2e-20
 Identities = 20/127 (15%), Positives = 38/127 (29%), Gaps = 15/127 (11%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           +  LT L+ +    +  T           +  +             L    L  L  + L
Sbjct: 444 IQRLTKLQIIYFANSPFTY-----DNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL 498

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSG---------SIPGFDDVLPNLQQLNVSNN 200
                  ++P    +L +L++L +  NR             +   +D  P +Q   +  N
Sbjct: 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYN 558

Query: 201 LLNGSIP 207
            L    P
Sbjct: 559 NLE-EFP 564

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 93.4 bits (232), Expect = 7e-20
 Identities = 22/142 (15%), Positives = 43/142 (30%), Gaps = 16/142 (11%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSD--LASCSNLRNLYLQGNHFSGE-----VPL 136
           +IP         +  L    N L   +P+     S   + ++    N    E       +
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667

Query: 137 FLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLS-------GSIPGFDDVL 189
                 +   + L+ N         F   + + T+ L NN ++           G     
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNT 727

Query: 190 PNLQQLNVSNNLLNGSIPKRFQ 211
             L  +++  N L  S+   F+
Sbjct: 728 YLLTTIDLRFNKLT-SLSDDFR 748

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 91.9 bits (228), Expect = 2e-19
 Identities = 24/157 (15%), Positives = 47/157 (29%), Gaps = 12/157 (7%)

Query: 68  QNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPS--DLASCSNLRNLYL 125
            NR           + ++          ++   + +N+L    P+   L     L  L  
Sbjct: 524 CNRGISAAQLKADWT-RLA-DDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDC 580

Query: 126 QGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG 184
             N     +  F      L  L L  N    EIP        +++ L   +N+L   IP 
Sbjct: 581 VHNKVR-HLEAF-GTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN 636

Query: 185 FDDV--LPNLQQLNVSNNLLNGSIPKRFQTFGSNSFL 219
             +   +  +  ++ S N +         +      +
Sbjct: 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGI 673

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 91.5 bits (227), Expect = 3e-19
 Identities = 40/245 (16%), Positives = 64/245 (26%), Gaps = 68/245 (27%)

Query: 32  SDRAALLALRSSVGGRTL--------------LWNVYEASPCKWAGVEC----EQNRVTM 73
            D  AL A+  ++ G+                 WN        W            RVT 
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNF-NKELDMWGDQPGVDLDNNGRVTG 327

Query: 74  LRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGE 133
           L L G    G++P   +G LT L+ LS   +S T                  + +     
Sbjct: 328 LSLAGFGAKGRVP-DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMH 386

Query: 134 VP-LFLVGLHHLVRLNLATN----------------------------NFSGEIPSGFKN 164
              +FL     L   +L  +                            N    I    + 
Sbjct: 387 YKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQR 446

Query: 165 LTKLKTLFLENNRLSGSIPGFDDV-------------------LPNLQQLNVSNNLLNGS 205
           LTKL+ ++  N+  +      D                     L +L  + + N      
Sbjct: 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQ 506

Query: 206 IPKRF 210
           +P   
Sbjct: 507 LPDFL 511

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 86.5 bits (214), Expect = 1e-17
 Identities = 22/139 (15%), Positives = 41/139 (29%), Gaps = 7/139 (5%)

Query: 83  GQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLH 142
             I      +L   + +    N +T  +   +   + L+ +Y   + F+ +         
Sbjct: 415 KPIKKDSRISLKDTQ-IGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVD---- 468

Query: 143 HLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL 202
                N             + NL  L  + L N      +P F   LP LQ LN++ N  
Sbjct: 469 -WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527

Query: 203 NGSIPKRFQTFGSNSFLGN 221
             +   +            
Sbjct: 528 ISAAQLKADWTRLADDEDT 546

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 62.2 bits (151), Expect = 4e-10
 Identities = 19/104 (18%), Positives = 35/104 (33%), Gaps = 4/104 (3%)

Query: 128 NHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDD 187
           + +  +  + L     +  L+LA     G +P     LT+LK L    +  + S   F D
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 188 VLPNLQQLNVSNNLLNGSIPKRF----QTFGSNSFLGNSLCGKP 227
                       + +     K F    Q    +  L +++   P
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP 412

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 45/216 (20%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK-----DVTISEREFKDKIEGVGAVNHENLVP 429
           + LG G   T Y A    +   VA+K +           +R F+ ++     ++H+N+V 
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSSQLSHQNIVS 75

Query: 430 LRAYYYSMDEKLLVYD--------YLTM-----GSLSALLHGNKGAGRTPLNWEMRSLIA 476
                        + D        YL M      +LS  +  +      PL+ +      
Sbjct: 76  -------------MIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFT 117

Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--TPNRVAG- 533
                GI++ H     + H +IK  NIL+  +   ++ DFG+A  +  +S    N V G 
Sbjct: 118 NQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGT 175

Query: 534 --YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
             Y +PE        +  D+YS G++L E+L G+ P
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 36/211 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDK----IEGVGAVNHENLVPL 430
             LGKG F   ++    +   + A K +    + +   ++K    I    ++ H+++V  
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWE------MRSLIALGAARGIE 484
             ++   D   +V +     SL  L    K         E      +R ++      G +
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALT---EPEARYYLRQIVL-----GCQ 129

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--------TPNRVAGYRA 536
           YLH     V H ++K  N+ L +  E ++ DFGLA  V            TPN    Y A
Sbjct: 130 YLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN----YIA 183

Query: 537 PEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           PEV      S + DV+S G ++  LL GK P
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 95.2 bits (237), Expect = 2e-21
 Identities = 68/302 (22%), Positives = 119/302 (39%), Gaps = 65/302 (21%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRL-----KDVTISEREFKDKIEGVGAV-NHENLV 428
            VL +G F   Y+A  +  G   A+KRL     +      +E    +  +  +  H N+V
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQE----VCFMKKLSGHPNIV 89

Query: 429 PLRAYYYSMDEK-------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL-IALGAA 480
              +      E+        L+   L  G L   L   K   R PL      L I     
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL--KKMESRGPL-SCDTVLKIFYQTC 146

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA----HLVGPSSTPNRVAG--- 533
           R ++++H Q P + H ++K  N+LL+     ++ DFG A    H    S +  R A    
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 534 ---------YRAPEVTDP---CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPR 581
                    YR PE+ D      + +K D+++ G +L  L   + P      E+G  L  
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF-----EDGAKL-- 259

Query: 582 WVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIE 639
               IV  +++       +  +         L++  L ++     P+ R S++EV+ +++
Sbjct: 260 ---RIVNGKYS-------IPPHDTQYTVFHSLIRAMLQVN-----PEERLSIAEVVHQLQ 304

Query: 640 EL 641
           E+
Sbjct: 305 EI 306

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 36/211 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDK----IEGVGAVNHENLVPL 430
             LGKG F   ++    +   + A K +    + +   ++K    I    ++ H+++V  
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWE------MRSLIALGAARGIE 484
             ++   D   +V +     SL  L    K         E      +R ++      G +
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALT---EPEARYYLRQIVL-----GCQ 155

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--------TPNRVAGYRA 536
           YLH     V H ++K  N+ L +  E ++ DFGLA  V            TPN    Y A
Sbjct: 156 YLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN----YIA 209

Query: 537 PEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           PEV      S + DV+S G ++  LL GK P
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 66/311 (21%), Positives = 124/311 (39%), Gaps = 54/311 (17%)

Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKI-EGV--GAVNHENLV 428
            +LGKG FG+  +A L         VAVK LK   I+  + ++ + E       +H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 429 PL------RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI--ALGAA 480
            L            +   +++  ++  G L A L  ++  G  P N  +++L+   +  A
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR-IGENPFNLPLQTLVRFMVDIA 147

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR----- 535
            G+EYL ++  N  H ++ + N +L +     V+DFGL+  +           YR     
Sbjct: 148 CGMEYLSSR--NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY------YRQGCAS 199

Query: 536 -------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIV 587
                  A E       +  +DV++FGV + E++T G+ P   + N E       + + +
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-------IYNYL 252

Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ 647
                       L +     EE+  L+     C +  P  RPS + +   +E +    + 
Sbjct: 253 IGGNR-------LKQPPECMEEVYDLMY---QCWSADPKQRPSFTCLRMELENILGHLSV 302

Query: 648 GHHGLQPDDLD 658
                 P  ++
Sbjct: 303 LSTSQDPLYIN 313

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 93.7 bits (233), Expect = 4e-21
 Identities = 45/227 (19%), Positives = 83/227 (36%), Gaps = 54/227 (23%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVG-------AVNHENL 427
           ++LG+G     ++    + G + A+K       +   F   ++           +NH+N+
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIK-----VFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 428 VPLRAYYYSMDEKL--LVYDYLTMGSLSALLHGNKGAGRTPLNWE------MRSLIALGA 479
           V L A       +   L+ ++   GSL  +L     A   P   E      +R ++    
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP---ESEFLIVLRDVVG--- 123

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEAR----VSDFGLAHLVGPSS-------TP 528
             G+ +L   G  + H NIK  NI+     + +    ++DFG A  +           T 
Sbjct: 124 --GMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179

Query: 529 NRVAGYRAPEVTDPCKVSQ--------KADVYSFGVLLLELLTGKAP 567
                Y  P++ +   + +          D++S GV      TG  P
Sbjct: 180 E----YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 93.9 bits (234), Expect = 5e-21
 Identities = 63/288 (21%), Positives = 117/288 (40%), Gaps = 54/288 (18%)

Query: 376 EVLGKGTFGTAYKAVLEMG-----TIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +           VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 429 PLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            L      +   + L+   +  G L   +  +K    +           +  A+G+ YL 
Sbjct: 81  RL--LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW----CVQIAKGMNYLE 134

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR------APEVTD 541
            +   + H ++ + N+L+      +++DFGLA L+G         G +      A E   
Sbjct: 135 DR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 542 PCKVSQKADVYSFGVLLLELLT-GKAPTHALLN-------EEGVDLPRWVQSIVKDEWTS 593
               + ++DV+S+GV + EL+T G  P   +         E+G  LP+          T 
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ------PPICTI 246

Query: 594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           +V+ +           MV+       C     D+RP   E+I    ++
Sbjct: 247 DVYMI-----------MVK-------CWMIDADSRPKFRELIIEFSKM 276

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 95.9 bits (239), Expect = 5e-21
 Identities = 63/318 (19%), Positives = 117/318 (36%), Gaps = 66/318 (20%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK--------------DVTISEREFKDKIEGVG 420
             LG G +G           +  A+K +K              ++     E  ++I  + 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 421 AVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL--SALLHGN---KGAGRTPLNWEMRSLI 475
           +++H N++ L   +       LV ++   G L    +         A        M+ ++
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI-----MKQIL 156

Query: 476 ALGAARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEA--RVSDFGLAHLVGPSSTPNRVA 532
                 GI YLH     + H +IK  NILL  K+     ++ DFGL+             
Sbjct: 157 -----SGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL 209

Query: 533 G---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD 589
           G   Y APEV    K ++K DV+S GV++  LL G  P     N++ +     ++ + K 
Sbjct: 210 GTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDI-----IKKVEKG 262

Query: 590 EWTSEVFDLELLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP---- 643
           +     +  +   ++N+ +E  +L++  L  D      + R +  E +            
Sbjct: 263 K-----YYFDFNDWKNISDEAKELIKLMLTYD-----YNKRCTAEEALN-----SRWIKK 307

Query: 644 SSTQGHHGLQPDDLDNIS 661
            +   +   Q      +S
Sbjct: 308 YANNINKSDQKTLCGALS 325

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 92.8 bits (231), Expect = 7e-21
 Identities = 31/147 (21%), Positives = 54/147 (36%), Gaps = 7/147 (4%)

Query: 74  LRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSD-LASCSNLRNLYLQGNHFSG 132
           L      L       +  +L +L  L +          +      S+L  L + GN F  
Sbjct: 106 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQE 164

Query: 133 EV-PLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPGFDDVLP 190
              P     L +L  L+L+      ++    F +L+ L+ L + +N            L 
Sbjct: 165 NFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 223

Query: 191 NLQQLNVSNNLLNGSIPKR-FQTFGSN 216
           +LQ L+ S N +  +  K+  Q F S+
Sbjct: 224 SLQVLDYSLNHIM-TSKKQELQHFPSS 249

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 87.0 bits (216), Expect = 6e-19
 Identities = 32/128 (25%), Positives = 47/128 (36%), Gaps = 10/128 (7%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNH--FSGEVPLFLVGL 141
            +P GI    +S   L L  N L S         + L  L L  N   F G       G 
Sbjct: 21  SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77

Query: 142 HHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFD--DVLPNLQQLNVSN 199
             L  L+L+ N     + S F  L +L+ L  +++ L   +  F     L NL  L++S+
Sbjct: 78  TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISH 135

Query: 200 NLLNGSIP 207
                   
Sbjct: 136 THTR-VAF 142

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 25/132 (18%), Positives = 41/132 (31%), Gaps = 29/132 (21%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS 131
            +L++ G +        I   L +L  L L    L   L                     
Sbjct: 153 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTA----------------- 194

Query: 132 GEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDV 188
                    L  L  LN++ NNF   + +  +K L  L+ L    N +  +         
Sbjct: 195 ------FNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHF 246

Query: 189 LPNLQQLNVSNN 200
             +L  LN++ N
Sbjct: 247 PSSLAFLNLTQN 258

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 93.1 bits (232), Expect = 7e-21
 Identities = 65/289 (22%), Positives = 111/289 (38%), Gaps = 55/289 (19%)

Query: 376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLKDVTISE--REFKDKIEGVGAVNHENLVP 429
           +++G G  G      L +       VA+K LK        R+F  +   +G  +H N++ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI--ALGAARGIEYLH 487
           L          ++V +Y+  GSL   L  + G       + +  L+    G   G+ YL 
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG------QFTIMQLVGMLRGVGAGMRYLS 168

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA-GYR------APEVT 540
                  H ++ + N+L+  +   +VSDFGL+ ++           G +      APE  
Sbjct: 169 DL--GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226

Query: 541 DPCKVSQKADVYSFGVLLLELLT-GKAPTHALLN-------EEGVDLPRWVQSIVKDEWT 592
                S  +DV+SFGV++ E+L  G+ P   + N       EEG  LP            
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA------PMGCP 280

Query: 593 SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
             +  L           M       +DC  +    RP  S+++  ++ L
Sbjct: 281 HALHQL-----------M-------LDCWHKDRAQRPRFSQIVSVLDAL 311

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 95.5 bits (237), Expect = 1e-20
 Identities = 56/296 (18%), Positives = 106/296 (35%), Gaps = 53/296 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRL-KDVTISERE-FKDKIEGVGAVNHENLVPLRA 432
           E LG G FG   + +  + G  VA+K+  ++++   RE +  +I+ +  +NH N+V  R 
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79

Query: 433 YYYSM------DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWE------MRSLIALGAA 480
               +      D  LL  +Y   G L   L+  +         E      +  + +    
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK---EGPIRTLLSDISS---- 132

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEAR---VSDFGLAHLVGPSS-------TPNR 530
             + YLH     + H ++K  NI+L    +     + D G A  +           T   
Sbjct: 133 -ALRYLHEN--RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQ- 188

Query: 531 VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA----------LLNEEGVDLP 580
              Y APE+ +  K +   D +SFG L  E +TG  P             +  +    + 
Sbjct: 189 ---YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245

Query: 581 RWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK 636
            +       +++S +          +  ++ + LQ  +         R +  +   
Sbjct: 246 VYDDLTGAVKFSSVLPT-PNHLSGILAGKLERWLQCMLMWH---QRQRGTDPQNPN 297

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 52/226 (23%), Positives = 91/226 (40%), Gaps = 47/226 (20%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
            VLG+G FG   KA         A+K+++           ++  + ++NH+ +V    YY
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVV---RYY 68

Query: 435 YSMDEKL----------------LVYDYLTMGSLSALLHGNKGAGRTPLNWE-MRSLIAL 477
            +  E+                 +  +Y   G+L  L+H      +    W   R ++  
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL-- 126

Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA---------------HLV 522
                + Y+H+QG  + H ++K  NI + +S   ++ DFGLA               +L 
Sbjct: 127 ---EALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 523 GPSSTPNRVAG---YRAPEVTDPCKV-SQKADVYSFGVLLLELLTG 564
           G S       G   Y A EV D     ++K D+YS G++  E++  
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 51/222 (22%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK-----DVTISEREFKDKIEGVGAVNHENLVP 429
           E+LG G     + A  L     VAVK L+     D +   R F+ + +   A+NH  +V 
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVA 76

Query: 430 LRAYYYSMDEKLLVYD------------YLTM-----GSLSALLHGNKGAGRTPLNWEMR 472
                        VYD            Y+ M      +L  ++H        P+  +  
Sbjct: 77  -------------VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRA 118

Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---- 528
             +   A + + + H  G  + H ++K +NI+++ +   +V DFG+A  +  S       
Sbjct: 119 IEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176

Query: 529 NRVAG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
             V G   Y +PE      V  ++DVYS G +L E+LTG+ P
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 71/313 (22%), Positives = 118/313 (37%), Gaps = 66/313 (21%)

Query: 369 DLLRASAEVLGKGTFGTAYKAVLEMG---TIVAVKRLKDVTIS---EREFKDKIEGVGAV 422
            LL    + LG G FGT  K   +M      VAVK LK+       + E   +   +  +
Sbjct: 16  KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 75

Query: 423 NHENLVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR 481
           ++  +V +        E   LV +   +G L+  L  N+      +  +    +    + 
Sbjct: 76  DNPYIVRM--IGICEAESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSM 128

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR------ 535
           G++YL     N  H ++ + N+LL   + A++SDFGL+  +           Y+      
Sbjct: 129 GMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-----YYKAQTHGK 181

Query: 536 ------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLN-------EEGVDLPR 581
                 APE  +  K S K+DV+SFGVL+ E  + G+ P   +         E+G  +  
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 241

Query: 582 WVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
                       E++DL           M         C     +NRP  + V  R+   
Sbjct: 242 ------PAGCPREMYDL-----------MNL-------CWTYDVENRPGFAAVELRLRNY 277

Query: 642 HPS-STQGHHGLQ 653
           +     +GHH   
Sbjct: 278 YYDVVNEGHHHHH 290

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 94.0 bits (234), Expect = 2e-20
 Identities = 71/286 (24%), Positives = 118/286 (41%), Gaps = 52/286 (18%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDK----IEGVGAVNHENLVPL 430
            VLGKG+FG          G   AVK +    + ++  K+     ++ +  ++H N++ L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 431 RAYYYSMDEKLLVYDYLTMGSL--SALLHGN---KGAGRTPLNWEMRSLIALGAARGIEY 485
             ++       LV +  T G L    +         A R      +R ++      GI Y
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-----IRQVL-----SGITY 141

Query: 486 LHAQGPNVSHGNIKSSNILL-TKSYEA--RVSDFGLAHLVGPSSTPNRVAG---YRAPEV 539
           +H     + H ++K  N+LL +KS +A  R+ DFGL+     S       G   Y APEV
Sbjct: 142 MHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 199

Query: 540 TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE 599
                  +K DV+S GV+L  LL+G  P +   NE  +     ++ + K +     +  E
Sbjct: 200 LHG-TYDEKCDVWSTGVILYILLSGCPPFNG-ANEYDI-----LKKVEKGK-----YTFE 247

Query: 600 LLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
           L +++ V E    L++  L        P  R S  + +      H 
Sbjct: 248 LPQWKKVSESAKDLIRKMLTYV-----PSMRISARDALD-----HE 283

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 40/221 (18%), Positives = 75/221 (33%), Gaps = 37/221 (16%)

Query: 377 VLGKGTFGTAYKAVLEMGTIVAVK-----RLKDVTISEREFKDKIEGVGA---------- 421
            L +G F        +     A+K      L+      +   DKI               
Sbjct: 38  TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 422 ---VNHENLVPLRAYYYSMDEKLLVYDYLTMGSL----SALLHGNKGAGRTPLNWEMRSL 474
              + +E  +       + DE  ++Y+Y+   S+          +K          ++ +
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS------TP 528
           I         Y+H +  N+ H ++K SNIL+ K+   ++SDFG +  +          T 
Sbjct: 157 IK-SVLNSFSYIHNE-KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTY 214

Query: 529 NRVAGYRAPEV--TDPCKVSQKADVYSFGVLLLELLTGKAP 567
                +  PE    +      K D++S G+ L  +     P
Sbjct: 215 E----FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 40/120 (33%), Positives = 60/120 (50%), Gaps = 8/120 (6%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSD-LASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
           +  G+   L +L+ L L+ N+L + LP D      NL +L+L GN  S        GLH 
Sbjct: 120 LGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS 178

Query: 144 LVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNN 200
           L RL L  N  +  +    F++L +L TL+L  N LS ++P       L  LQ L +++N
Sbjct: 179 LDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAP-LRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 35/145 (24%), Positives = 57/145 (39%), Gaps = 10/145 (6%)

Query: 66  CEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYL 125
           C          P   L   +P+GI     + + + L  N ++    +   +C NL  L+L
Sbjct: 8   CYNEPKVTTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWL 63

Query: 126 QGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG 184
             N  +        GL  L +L+L+ N     +    F  L +L TL L+   L   +  
Sbjct: 64  HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGP 122

Query: 185 --FDDVLPNLQQLNVSNNLLNGSIP 207
             F   L  LQ L + +N L  ++P
Sbjct: 123 GLFRG-LAALQYLYLQDNALQ-ALP 145

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 40/153 (26%), Positives = 55/153 (35%), Gaps = 13/153 (8%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSD-LASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
           +       L  L TL L    L   L        + L+ LYLQ N            L +
Sbjct: 96  VDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGN 154

Query: 144 LVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNN 200
           L  L L  N  S  +P   F+ L  L  L L  NR++  +    F D L  L  L +  N
Sbjct: 155 LTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD-LGRLMTLYLFAN 211

Query: 201 LLNGSIPKR-FQTFGSNSFLGNSLCGKPLQ-DC 231
            L+ ++P        +  +L   L   P   DC
Sbjct: 212 NLS-ALPTEALAPLRALQYL--RLNDNPWVCDC 241

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 86.2 bits (214), Expect = 8e-19
 Identities = 39/141 (27%), Positives = 58/141 (41%), Gaps = 11/141 (7%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS 131
             + L G  +S  +P        +L  L L  N L     +     + L  L L  N   
Sbjct: 35  QRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 132 GEVP--LFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FD 186
             V    F  GL  L  L+L       E+  G F+ L  L+ L+L++N L  ++P   F 
Sbjct: 94  RSVDPATF-HGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150

Query: 187 DVLPNLQQLNVSNNLLNGSIP 207
           D L NL  L +  N ++ S+P
Sbjct: 151 D-LGNLTHLFLHGNRIS-SVP 169

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 88.5 bits (220), Expect = 2e-20
 Identities = 24/115 (20%), Positives = 51/115 (44%), Gaps = 3/115 (2%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           +  L++L  L +    +TS    +L+  ++L  L +  +     +   +  L  +  ++L
Sbjct: 84  ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNG 204
           + N    +I    K L +LK+L ++ + +     G +D  P L QL   +  + G
Sbjct: 144 SYNGAITDI-MPLKTLPELKSLNIQFDGVH-DYRGIED-FPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 84.2 bits (209), Expect = 7e-19
 Identities = 23/111 (20%), Positives = 47/111 (42%), Gaps = 3/111 (2%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           +    +++ L++     T+   + ++  SNL  L + G   + +    L GL  L  L++
Sbjct: 62  IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
           + +     I +    L K+ ++ L  N     I      LP L+ LN+  +
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKT-LPELKSLNIQFD 169

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 24/116 (20%), Positives = 50/116 (43%), Gaps = 4/116 (3%)

Query: 91  GNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLA 150
             + SL  ++L   ++T    + +    N+++L +   H +   P+   GL +L RL + 
Sbjct: 41  AQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHATNYNPIS--GLSNLERLRIM 96

Query: 151 TNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSI 206
             + + +       LT L  L + ++    SI    + LP +  +++S N     I
Sbjct: 97  GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 15/120 (12%), Positives = 44/120 (36%), Gaps = 7/120 (5%)

Query: 92  NLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLAT 151
              +     L  +S  +   + +   ++L  + L   + +    +     H++  L +  
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVTDLTGI--EYAHNIKDLTINN 75

Query: 152 NNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQ 211
            + +    +    L+ L+ L +    ++         L +L  L++S++  + SI  +  
Sbjct: 76  IHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 40.3 bits (95), Expect = 7e-04
 Identities = 9/44 (20%), Positives = 18/44 (40%), Gaps = 2/44 (4%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGE 133
           L  L  L++L+++F+ +       +     L  LY       G+
Sbjct: 155 LKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGGK 196

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 19/205 (9%)

Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKR-LKDVTISEREFKDKIEGVGAVNHENLVPLRAY 433
            + G+GTFGT         G  VA+K+ ++D     RE +  ++ +  ++H N+V L++Y
Sbjct: 29  RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNIVQLQSY 87

Query: 434 YYSMDEK-------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           +Y++ E+        +V +Y+   +L           +      +  +      R I  L
Sbjct: 88  FYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR-QVAPPPILIKVFLFQLIRSIGCL 145

Query: 487 HAQGPNVSHGNIKSSNILL-TKSYEARVSDFGLAHLVGPSSTPNR--VAG--YRAPEVTD 541
           H    NV H +IK  N+L+       ++ DFG A  + P S PN   +    YRAPE+  
Sbjct: 146 HLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP-SEPNVAYICSRYYRAPELIF 204

Query: 542 PCKV-SQKADVYSFGVLLLELLTGK 565
             +  +   D++S G +  E++ G+
Sbjct: 205 GNQHYTTAVDIWSVGCIFAEMMLGE 229

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 93.6 bits (233), Expect = 3e-20
 Identities = 60/285 (21%), Positives = 111/285 (38%), Gaps = 51/285 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRL---KDVTISEREFKDKIEGVGAVNHENLVPLR 431
           + LG G +G              A+K +      T S  +  +++  +  ++H N++ L 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102

Query: 432 AYYYSMDEKLLVYDYLTMGSL--SALLHGN---KGAGRTPLNWEMRSLIALGAARGIEYL 486
            ++       LV +    G L    +         A        ++ ++      G+ YL
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI-----IKQVL-----SGVTYL 152

Query: 487 HAQGPNVSHGNIKSSNILL-TKSYEA--RVSDFGLAHLVGPSSTPNRVAG---YRAPEVT 540
           H     + H ++K  N+LL +K  +A  ++ DFGL+ +           G   Y APEV 
Sbjct: 153 HKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL 210

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL 600
              K  +K DV+S GV+L  LL G  P      ++ +     ++ + K +     +  + 
Sbjct: 211 RK-KYDEKCDVWSIGVILFILLAGYPPFGG-QTDQEI-----LRKVEKGK-----YTFDS 258

Query: 601 LRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
             ++NV E    L++  L  D        R S  + ++     HP
Sbjct: 259 PEWKNVSEGAKDLIKQMLQFD-----SQRRISAQQALE-----HP 293

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 63/301 (20%), Positives = 124/301 (41%), Gaps = 63/301 (20%)

Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKD---KIEGVGAVNHENLV 428
           ++LG+G FG+  +  L         VAVK +K    S+RE ++   +   +   +H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 429 PL-----RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI--ALGAAR 481
            L           + + +++  ++  G L   L  ++     P +  +++L+   +  A 
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET-GPKHIPLQTLLKFMVDIAL 158

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR------ 535
           G+EYL  +  N  H ++ + N +L       V+DFGL+  +           YR      
Sbjct: 159 GMEYLSNR--NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY------YRQGRIAK 210

Query: 536 ------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVK 588
                 A E       + K+DV++FGV + E+ T G  P   + N               
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-------------- 256

Query: 589 DEWTSEVFDLELLRY-----QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP 643
                E++D  L  +     ++  +E+ +++     C    P +RP+ S +  ++E+L  
Sbjct: 257 -----EMYDYLLHGHRLKQPEDCLDELYEIMY---SCWRTDPLDRPTFSVLRLQLEKLLE 308

Query: 644 S 644
           S
Sbjct: 309 S 309

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 34/144 (23%), Positives = 53/144 (36%), Gaps = 3/144 (2%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS 131
             LRL    +   +P  I  NL +L++L +R + L++ L   +     L  L L+G    
Sbjct: 186 QSLRLEWTGIR-SLPASI-ANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTAL 242

Query: 132 GEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPN 191
              P    G   L RL L   +    +P     LT+L+ L L        +P     LP 
Sbjct: 243 RNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302

Query: 192 LQQLNVSNNLLNGSIPKRFQTFGS 215
              + V  +L       R     +
Sbjct: 303 NCIILVPPHLQAQLDQHRPVARPA 326

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 29/123 (23%), Positives = 56/123 (45%), Gaps = 4/123 (3%)

Query: 87  LGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVR 146
            G    L +L++L L +  + S LP+ +A+  NL++L ++ +  S  +   +  L  L  
Sbjct: 176 SGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEE 233

Query: 147 LNLATNNFSGEIPSGFKNLTKLKTLFLEN-NRLSGSIPGFDDVLPNLQQLNVSNNLLNGS 205
           L+L         P  F     LK L L++ + L  ++P     L  L++L++   +    
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSR 292

Query: 206 IPK 208
           +P 
Sbjct: 293 LPS 295

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 34/128 (26%), Positives = 56/128 (43%), Gaps = 12/128 (9%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP---------LFLVG 140
           +     L TL+L  N L + LP+ +AS + LR L ++      E+P             G
Sbjct: 123 MQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181

Query: 141 LHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
           L +L  L L        +P+   NL  LK+L + N+ LS ++      LP L++L++   
Sbjct: 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGC 239

Query: 201 LLNGSIPK 208
               + P 
Sbjct: 240 TALRNYPP 247

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 22/130 (16%), Positives = 44/130 (33%), Gaps = 6/130 (4%)

Query: 81  LSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCS--NLRNLYLQGNHFSGEVPLFL 138
            +         N  + +  +    +L +     L   +      L L+      + P   
Sbjct: 43  RNRWHSAWRQANSNNPQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQA 100

Query: 139 VGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVS 198
             L HL  + +       E+P   +    L+TL L  N L  ++P     L  L++L++ 
Sbjct: 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR 158

Query: 199 NNLLNGSIPK 208
                  +P+
Sbjct: 159 ACPELTELPE 168

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 58.0 bits (141), Expect = 3e-09
 Identities = 17/140 (12%), Positives = 38/140 (27%), Gaps = 24/140 (17%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP----LFLVGLHH-- 143
             + +    L  + ++        L+      N      H +          +       
Sbjct: 8   HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRA 67

Query: 144 ---------------LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDV 188
                           V L L +     + P     L+ L+ + ++   L   +P     
Sbjct: 68  LKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQ 125

Query: 189 LPNLQQLNVSNNLLNGSIPK 208
              L+ L ++ N L  ++P 
Sbjct: 126 FAGLETLTLARNPLR-ALPA 144

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 92.2 bits (229), Expect = 3e-20
 Identities = 45/227 (19%), Positives = 83/227 (36%), Gaps = 54/227 (23%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGA-------VNHENL 427
           ++LG+G     ++    + G + A+K       +   F   ++           +NH+N+
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIK-----VFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 428 VPLRAYYYSMDEKL--LVYDYLTMGSLSALLHGNKGAGRTPLNWE------MRSLIALGA 479
           V L A       +   L+ ++   GSL  +L     A   P   E      +R ++    
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP---ESEFLIVLRDVVG--- 123

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEAR----VSDFGLAHLVGPSS-------TP 528
             G+ +L   G  + H NIK  NI+     + +    ++DFG A  +           T 
Sbjct: 124 --GMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179

Query: 529 NRVAGYRAPEVTDPCKVSQ--------KADVYSFGVLLLELLTGKAP 567
                Y  P++ +   + +          D++S GV      TG  P
Sbjct: 180 E----YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 90.4 bits (225), Expect = 4e-20
 Identities = 69/302 (22%), Positives = 117/302 (38%), Gaps = 66/302 (21%)

Query: 378 LGKGTFGTAYKAVLEMG---TIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRA 432
           LG G FG+  + V  M      VA+K LK  T      E   + + +  +++  +V L  
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 433 YYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
                 E L LV +    G L   L G +      +     + +    + G++YL  +  
Sbjct: 78  V--CQAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEEK-- 129

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR------------APEV 539
           N  H ++ + N+LL   + A++SDFGL+  +G        + Y             APE 
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLKWYAPEC 184

Query: 540 TDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLN-------EEGVDLPRWVQSIVKDEW 591
            +  K S ++DV+S+GV + E L+ G+ P   +         E+G  +          E 
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC------PPEC 238

Query: 592 TSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH---PSSTQG 648
             E++ L           M         C     ++RP    V +R+   +    S  +G
Sbjct: 239 PPELYAL-----------MSD-------CWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280

Query: 649 HH 650
           HH
Sbjct: 281 HH 282

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 90.4 bits (225), Expect = 5e-20
 Identities = 71/306 (23%), Positives = 126/306 (41%), Gaps = 66/306 (21%)

Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTISER-EFKDKIEGVGAVNHENLV 428
             LG+G FG  + A        +   +VAVK LKD T++ R +F+ + E +  + HE++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL-----------IAL 477
                    D  ++V++Y+  G L+  L  +       ++ + R             IA 
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR-- 535
             A G+ YL +Q  +  H ++ + N L+  +   ++ DFG++  V  +        YR  
Sbjct: 141 QIASGMVYLASQ--HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY------YRVG 192

Query: 536 ----------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQ 584
                      PE     K + ++DV+SFGV+L E+ T GK P   L N           
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---------- 242

Query: 585 SIVKDEWTSEVFDL-----ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE 639
                    EV +       L R +   +E+  ++     C  + P  R ++ E+ K + 
Sbjct: 243 ---------EVIECITQGRVLERPRVCPKEVYDVML---GCWQREPQQRLNIKEIYKILH 290

Query: 640 ELHPSS 645
            L  ++
Sbjct: 291 ALGKAT 296

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 90.8 bits (226), Expect = 5e-20
 Identities = 67/288 (23%), Positives = 120/288 (41%), Gaps = 52/288 (18%)

Query: 376 EVLGKGTFGTAYKAVLEMGTI-----VAVKRLKDVTISE--REFKDKIEGVGAVNHENLV 428
           +V+G G FG  YK +L+  +      VA+K LK     +   +F  +   +G  +H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L          +++ +Y+  G+L   L    G      +      +  G A G++YL  
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLAN 165

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA-GYR------APEVTD 541
              N  H ++ + NIL+  +   +VSDFGL+ ++           G +      APE   
Sbjct: 166 M--NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223

Query: 542 PCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE-------GVDLPRWVQSIVKDEWTS 593
             K +  +DV+SFG+++ E++T G+ P   L N E       G  LP         +  S
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT------PMDCPS 277

Query: 594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            ++ L           M       + C  Q    RP  ++++  +++L
Sbjct: 278 AIYQL-----------M-------MQCWQQERARRPKFADIVSILDKL 307

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 32/157 (20%), Positives = 60/157 (38%), Gaps = 14/157 (8%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTS-QLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLH 142
            +     G  + ++ L L+ N + +       AS   L +L LQ N    +V    V   
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG-QVVFA 191

Query: 143 HLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL 202
            L  L+L++N  +  +   F++   +  + L NN+L   I        NL+  ++  N  
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249

Query: 203 NGSIPK-------RFQTFGSNSFLGNSLCGKPLQDCG 232
           +    +       R QT    +     L G+  ++C 
Sbjct: 250 HCGTLRDFFSKNQRVQTVAKQTV--KKLTGQNEEECT 284

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 31/119 (26%), Positives = 52/119 (43%), Gaps = 8/119 (6%)

Query: 89  ILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN 148
           I  N    +   +  +SL   L S   S  N++ L L GN  S      L     L  LN
Sbjct: 5   IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64

Query: 149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
           L++N    E     ++L+ L+TL L NN +   +       P+++ L+ +NN ++  + 
Sbjct: 65  LSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELLV----GPSIETLHAANNNIS-RVS 115

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 83.9 bits (208), Expect = 8e-18
 Identities = 29/147 (19%), Positives = 52/147 (35%), Gaps = 11/147 (7%)

Query: 69  NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGN 128
           NR  + ++   +L  Q    +  +  +++ L L  N L+    +DLA  + L  L L  N
Sbjct: 10  NRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 129 HFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDV 188
               E       L  L  L+L  N    E+         ++TL   NN +S  +      
Sbjct: 69  VLY-ETLDL-ESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNIS-RVS--CSR 118

Query: 189 LPNLQQLNVSNNLLNGSIPKRFQTFGS 215
               + + ++NN +             
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSR 145

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 31/120 (25%), Positives = 48/120 (40%), Gaps = 10/120 (8%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
           QI    L   T L  L+L  N L      DL S S LR L L  N+        L+    
Sbjct: 48  QISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPS 100

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
           +  L+ A NN S  +          K ++L NN+++      +     +Q L++  N ++
Sbjct: 101 IETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 9/54 (16%), Positives = 22/54 (40%)

Query: 158 IPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQ 211
           I    +N  + K   + ++ L  ++        N+++L++S N L+        
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLA 55

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 92.9 bits (231), Expect = 6e-20
 Identities = 36/141 (25%), Positives = 57/141 (40%), Gaps = 5/141 (3%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
            I  G   +L+ L TL L  N + S      +  S+L+ L     + +      +  L  
Sbjct: 66  TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125

Query: 144 LVRLNLATNNF-SGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL 202
           L  LN+A N   S ++P  F NLT L+ L L +N++         VL  +  LN+S +L 
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185

Query: 203 NGSIPKRFQTFGSNSFLGNSL 223
              +          +F    L
Sbjct: 186 LNPM----NFIQPGAFKEIRL 202

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 92.9 bits (231), Expect = 6e-20
 Identities = 26/129 (20%), Positives = 49/129 (37%), Gaps = 6/129 (4%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPL-FLVGLHH 143
                    TSL+ L L FN + + + S+      L +L  Q ++          + L +
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNNL 201
           L+ L+++  +        F  L+ L+ L +  N    +     F + L NL  L++S   
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE-LRNLTFLDLSQCQ 481

Query: 202 LNGSIPKRF 210
           L   +    
Sbjct: 482 LE-QLSPTA 489

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 91.7 bits (228), Expect = 1e-19
 Identities = 32/133 (24%), Positives = 47/133 (35%), Gaps = 4/133 (3%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
           +IP  +     S + L L FN L         S   L+ L L               L H
Sbjct: 21  KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
           L  L L  N         F  L+ L+ L      L+         L  L++LNV++NL+ 
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137

Query: 204 -GSIPKRFQTFGS 215
              +P+ F    +
Sbjct: 138 SFKLPEYFSNLTN 150

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 89.8 bits (223), Expect = 6e-19
 Identities = 29/123 (23%), Positives = 50/123 (40%), Gaps = 1/123 (0%)

Query: 86  PLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEV-PLFLVGLHHL 144
              +  +L +L  L +                S+L  L + GN F     P     L +L
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472

Query: 145 VRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNG 204
             L+L+        P+ F +L+ L+ L + +N+L     G  D L +LQ++ +  N  + 
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 532

Query: 205 SIP 207
           S P
Sbjct: 533 SCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 84.8 bits (210), Expect = 2e-17
 Identities = 25/122 (20%), Positives = 45/122 (36%), Gaps = 4/122 (3%)

Query: 92  NLTSLRTLSLRFNSLTSQ--LPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           +L SL  L L  N L+ +          ++L+ L L  N     +    +GL  L  L+ 
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 403

Query: 150 ATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPK 208
             +N         F +L  L  L + +     +  G  + L +L+ L ++ N    +   
Sbjct: 404 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463

Query: 209 RF 210
             
Sbjct: 464 DI 465

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 80.5 bits (199), Expect = 5e-16
 Identities = 28/100 (28%), Positives = 35/100 (35%), Gaps = 1/100 (1%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSD-LASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
              GI   L+SL  L +  NS       D      NL  L L         P     L  
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIP 183
           L  LN+A+N         F  LT L+ ++L  N    S P
Sbjct: 496 LQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 32/147 (21%), Positives = 55/147 (37%), Gaps = 10/147 (6%)

Query: 71  VTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHF 130
           +   RL  +       + +   LT++ + SL   ++      D +     ++L L    F
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKF 316

Query: 131 SGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLS--GSIPGFDDV 188
                   + L  L RL   T+N  G   S   +L  L+ L L  N LS  G     D  
Sbjct: 317 GQ---FPTLKLKSLKRLTF-TSNKGGNAFS-EVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371

Query: 189 LPNLQQLNVSNNLLNGSIPKRFQTFGS 215
             +L+ L++S N +  ++   F     
Sbjct: 372 TTSLKYLDLSFNGVI-TMSSNFLGLEQ 397

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 27/150 (18%), Positives = 46/150 (30%), Gaps = 13/150 (8%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSD-LASCSNLRNLYLQGNHFSGEVPL------ 136
            I  G    +  L  L+LR N  +  +    +   + L    L    F  E  L      
Sbjct: 191 FIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249

Query: 137 FLVGLHHLVRLNLATN---NFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQ 193
            L GL +L            +  +I   F  LT + +  L +  +   +  F       Q
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFS-YNFGWQ 307

Query: 194 QLNVSNNLLNGSIPKRFQTFGSNSFLGNSL 223
            L + N         + ++    +F  N  
Sbjct: 308 HLELVNCKFGQFPTLKLKSLKRLTFTSNKG 337

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 55.1 bits (133), Expect = 5e-08
 Identities = 25/158 (15%), Positives = 41/158 (25%), Gaps = 16/158 (10%)

Query: 85  IPLGILGNLTSLR----TLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP-LFLV 139
           I    L  L  +     +L L  N +   +         L  L L+ N  S  V    + 
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222

Query: 140 GLHHLVRLNLA------TNNFSGEIPSGFKNLTKLKTLFLENNRLSGS---IPGFDDVLP 190
           GL  L    L         N      S  + L  L         L      I    + L 
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282

Query: 191 NLQQLNVSNNLLNGSIPKRFQTFGSN-SFLGNSLCGKP 227
           N+   ++ +  +       +     +   +       P
Sbjct: 283 NVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFP 320

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 31/182 (17%), Positives = 55/182 (30%), Gaps = 38/182 (20%)

Query: 70  RVTMLRLPGVALSGQIPLGILGNLTSLRTLSL------RFNSLTSQLPSDLASCSNLRNL 123
           R+  L L     S  +    +  L  L    L         +L     S L    NL   
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260

Query: 124 YLQGNH---FSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG------------------- 161
             +  +   +  ++      L ++   +L +      +                      
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQF 319

Query: 162 -FKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLG 220
               L  LK L   +N+   +     D LP+L+ L++S N L+      F+   S S  G
Sbjct: 320 PTLKLKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLS------FKGCCSQSDFG 371

Query: 221 NS 222
            +
Sbjct: 372 TT 373

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 91.7 bits (228), Expect = 7e-20
 Identities = 44/153 (28%), Positives = 65/153 (42%), Gaps = 14/153 (9%)

Query: 85  IPLGILGNLTSLRTLSL-RFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
           IP      + SL  L L     L            NL+ L L   +   ++P     L  
Sbjct: 162 IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNL-TPLVG 219

Query: 144 LVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNN 200
           L  L ++ N+F  EI  G F  L+ LK L++ N+++S  I    FD  L +L +LN+++N
Sbjct: 220 LEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDG-LASLVELNLAHN 276

Query: 201 LLNGSIPKR-FQTFGSNSFLGNSLCGKPLQ-DC 231
            L+ S+P   F        L   L   P   DC
Sbjct: 277 NLS-SLPHDLFTPLRYLVEL--HLHHNPWNCDC 306

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 90.6 bits (225), Expect = 2e-19
 Identities = 40/138 (28%), Positives = 52/138 (37%), Gaps = 11/138 (7%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
           QI +G    L SL TL L  N LT          S LR L+L+ N            +  
Sbjct: 113 QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPS 172

Query: 144 LVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL 202
           L+RL+L        I  G F+ L  LK L L    +   +P     L  L++L +S N  
Sbjct: 173 LMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTP-LVGLEELEMSGN-- 228

Query: 203 NGSIPKRFQTFGSNSFLG 220
                  F      SF G
Sbjct: 229 ------HFPEIRPGSFHG 240

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 82.1 bits (203), Expect = 1e-16
 Identities = 33/128 (25%), Positives = 45/128 (35%), Gaps = 8/128 (6%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
            I      +L  L  L L  NS+           ++L  L L  N  +         L  
Sbjct: 89  MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSK 148

Query: 144 LVRLNLATNNFSGEIPSG-FKNLTKLKTLFL-ENNRLSGSIPG--FDDVLPNLQQLNVSN 199
           L  L L  N     IPS  F  +  L  L L E  +L   I    F+  L NL+ LN+  
Sbjct: 149 LRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEG-LFNLKYLNLGM 205

Query: 200 NLLNGSIP 207
             +   +P
Sbjct: 206 CNIK-DMP 212

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 90.3 bits (225), Expect = 8e-20
 Identities = 28/113 (24%), Positives = 44/113 (38%), Gaps = 6/113 (5%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L NL+ L  L +  N ++    + +   + L+ L +  N  S    L    L  L  L L
Sbjct: 239 LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDISVL--NNLSQLNSLFL 294

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL 202
             N    E       LT L TLFL  N ++  I      L  +   + +N ++
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHIT-DIRPLAS-LSKMDSADFANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 89.1 bits (222), Expect = 2e-19
 Identities = 35/122 (28%), Positives = 57/122 (46%), Gaps = 8/122 (6%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L +LTSL   +   N +T    + +A+ + L +L +  N  +   PL    L  L  L +
Sbjct: 195 LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSPL--ANLSQLTWLEI 250

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKR 209
            TN  S    +  K+LTKLK L + +N++S  I   ++ L  L  L ++NN L     + 
Sbjct: 251 GTNQISD--INAVKDLTKLKMLNVGSNQIS-DISVLNN-LSQLNSLFLNNNQLGNEDMEV 306

Query: 210 FQ 211
             
Sbjct: 307 IG 308

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 88.8 bits (221), Expect = 3e-19
 Identities = 29/118 (24%), Positives = 47/118 (39%), Gaps = 7/118 (5%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L NLT + +L+L  N   S   S L++ + L  L +  +      P+    L  L  L+L
Sbjct: 128 LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTPI--ANLTDLYSLSL 184

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
             N      P    +LT L       N+++  I    + +  L  L + NN +    P
Sbjct: 185 NYNQIEDISP--LASLTSLHYFTAYVNQIT-DITPVAN-MTRLNSLKIGNNKITDLSP 238

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 88.0 bits (219), Expect = 5e-19
 Identities = 36/136 (26%), Positives = 58/136 (42%), Gaps = 10/136 (7%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS 131
             L L G  ++   PL    NL  L  L +  N +T    S L + +NLR LYL  ++ S
Sbjct: 69  EYLNLNGNQITDISPLS---NLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNIS 123

Query: 132 GEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPN 191
                 L  L  +  LNL  N+      S   N+T L  L +  +++   +    + L +
Sbjct: 124 D--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVK-DVTPIAN-LTD 178

Query: 192 LQQLNVSNNLLNGSIP 207
           L  L+++ N +    P
Sbjct: 179 LYSLSLNYNQIEDISP 194

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 84.5 bits (210), Expect = 8e-18
 Identities = 30/118 (25%), Positives = 47/118 (39%), Gaps = 8/118 (6%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
              L S+  L +    + S     +   +NL  L L GN  +   PL    L  L  L +
Sbjct: 40  QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYI 95

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
            TN  +    S  +NLT L+ L+L  + +S  I    + L  +  LN+  N     + 
Sbjct: 96  GTNKIT--DISALQNLTNLRELYLNEDNIS-DISPLAN-LTKMYSLNLGANHNLSDLS 149

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 84.1 bits (209), Expect = 1e-17
 Identities = 37/118 (31%), Positives = 53/118 (44%), Gaps = 6/118 (5%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           + N+T L +L +  N +T    S LA+ S L  L +  N  S    +    L  L  LN+
Sbjct: 217 VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISDINAV--KDLTKLKMLNV 272

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
            +N  S    S   NL++L +LFL NN+L          L NL  L +S N +    P
Sbjct: 273 GSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 81.4 bits (202), Expect = 7e-17
 Identities = 33/118 (27%), Positives = 51/118 (43%), Gaps = 7/118 (5%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           +  LT+L  L+L  N +T    S L++   L NLY+  N  +      L  L +L  L L
Sbjct: 62  IEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYL 117

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
             +N S    S   NLTK+ +L L  N     +    + +  L  L V+ + +    P
Sbjct: 118 NEDNISD--ISPLANLTKMYSLNLGANHNLSDLSPLSN-MTGLNYLTVTESKVKDVTP 172

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 76.8 bits (190), Expect = 3e-15
 Identities = 25/118 (21%), Positives = 49/118 (41%), Gaps = 8/118 (6%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
             +L       L+  S+T           ++  L + G   +  +   +  L +L  LNL
Sbjct: 18  DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNL 73

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
             N  +   P    NL KL  L++  N+++  I    + L NL++L ++ + ++   P
Sbjct: 74  NGNQITDISP--LSNLVKLTNLYIGTNKIT-DISALQN-LTNLRELYLNEDNISDISP 127

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 65.6 bits (161), Expect = 1e-11
 Identities = 22/108 (20%), Positives = 38/108 (35%), Gaps = 8/108 (7%)

Query: 96  LRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFS 155
             TL+     +    P   A  +      LQ    +  V      L  + +L +A    +
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQ--EELESITKLVVAGEKVA 57

Query: 156 GEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
                G + LT L+ L L  N+++  I    + L  L  L +  N + 
Sbjct: 58  S--IQGIEYLTNLEYLNLNGNQIT-DISPLSN-LVKLTNLYIGTNKIT 101

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 55.6 bits (135), Expect = 2e-08
 Identities = 17/93 (18%), Positives = 32/93 (34%), Gaps = 26/93 (27%)

Query: 87  LGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVR 146
           + +L NL+ L +L L  N L ++    +   +NL  L+L  NH +               
Sbjct: 280 ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI------------- 326

Query: 147 LNLATNNFSGEIPSGFKNLTKLKTLFLENNRLS 179
                            +L+K+ +    N  + 
Sbjct: 327 -------------RPLASLSKMDSADFANQVIK 346

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 90.9 bits (226), Expect = 8e-20
 Identities = 65/292 (22%), Positives = 125/292 (42%), Gaps = 55/292 (18%)

Query: 376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLKDVTISE--REFKDKIEGVGAVNHENLVP 429
           +V+G G FG      L++       VA+K LK     +  R+F  +   +G  +H N++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI--ALGAARGIEYLH 487
           L          ++V +Y+  GSL + L  +         + +  L+    G A G++YL 
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA------QFTVIQLVGMLRGIASGMKYLS 164

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG--PSSTPNRVAG-----YRAPEVT 540
                  H ++ + NIL+  +   +VSDFGL  ++   P +      G     + +PE  
Sbjct: 165 DM--GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222

Query: 541 DPCKVSQKADVYSFGVLLLELLT-GKAPTHALLN-------EEGVDLPRWVQSIVKDEWT 592
              K +  +DV+S+G++L E+++ G+ P   + N       +EG  LP         +  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP------PMDCP 276

Query: 593 SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS 644
           + ++ L           M       +DC  +  +NRP   +++  +++L  +
Sbjct: 277 AALYQL-----------M-------LDCWQKDRNNRPKFEQIVSILDKLIRN 310

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 89.2 bits (222), Expect = 9e-20
 Identities = 68/294 (23%), Positives = 117/294 (39%), Gaps = 45/294 (15%)

Query: 376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLKDVTISE--REFKDKIEGVGAVNHENLVP 429
           EV+G+G FG  Y   L          AVK L  +T      +F  +   +   +H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 430 LRAYYYSMDEKLL-VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI--ALGAARGIEYL 486
           L       +   L V  Y+  G L   +           N  ++ LI   L  A+G++YL
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKYL 144

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR---------AP 537
            ++     H ++ + N +L + +  +V+DFGLA  +        V             A 
Sbjct: 145 ASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWMAL 201

Query: 538 EVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF 596
           E     K + K+DV+SFGVLL EL+T G  P   +   +       +   +         
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQ------- 247

Query: 597 DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHH 650
              LL+ +   + + +++     C     + RPS SE++ RI  +  +    H+
Sbjct: 248 GRRLLQPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 298

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 92.1 bits (229), Expect = 9e-20
 Identities = 61/285 (21%), Positives = 116/285 (40%), Gaps = 51/285 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKD---KIEGVGAVNHENLVPLR 431
            +LGKG+FG   K          AVK +   +   ++      ++E +  ++H N++ L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 432 AYYYSMDEKLLVYDYLTMGSL--SALLHGN---KGAGRTPLNWEMRSLIALGAARGIEYL 486
                     +V +  T G L    +         A R      ++ +       GI Y+
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVF-----SGITYM 137

Query: 487 HAQGPNVSHGNIKSSNILL-TKSYEA--RVSDFGLAHLVGPSSTPNRVAG---YRAPEVT 540
           H     + H ++K  NILL +K  +   ++ DFGL+     ++      G   Y APEV 
Sbjct: 138 HKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL 600
                 +K DV+S GV+L  LL+G  P +   NE  +     ++ +   +     +  +L
Sbjct: 196 RG-TYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDI-----LKRVETGK-----YAFDL 243

Query: 601 LRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
            +++ + ++   L++  L        P  R + ++ ++     HP
Sbjct: 244 PQWRTISDDAKDLIRKMLTFH-----PSLRITATQCLE-----HP 278

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 92.6 bits (230), Expect = 9e-20
 Identities = 41/208 (19%), Positives = 71/208 (34%), Gaps = 34/208 (16%)

Query: 376 EVLGKGTFGTAYKA---VLEMGTIVAVKRLKDVT--------ISEREFKDKIEGVGAVNH 424
             +  G  G  Y A    +  G  V +K L            ++ER+F      +  V H
Sbjct: 86  GCIAHGGLGWIYLALDRNVN-GRPVVLKGLVHSGDAEAQAMAMAERQF------LAEVVH 138

Query: 425 ENLVPLRAYYYSMDEKLLVYDYLTM-----GSLSALLHGNKGAGRTPLNWEMRSLIALGA 479
            ++V +  +    D       Y+ M      SL              L         L  
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEI 191

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEV 539
              + YLH+ G  + + ++K  NI+LT+  + ++ D G    +          G++APE+
Sbjct: 192 LPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLYGTPGFQAPEI 248

Query: 540 TDPCKVSQKADVYSFGVLLLELLTGKAP 567
                 +   D+Y+ G  L  L      
Sbjct: 249 VR-TGPTVATDIYTVGRTLAALTLDLPT 275

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 60/293 (20%), Positives = 112/293 (38%), Gaps = 58/293 (19%)

Query: 376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVP 429
            +LG+G FG  Y+ V          VAVK  K      ++ +F  +   +  ++H ++V 
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 430 LRAYYY---SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           L          +   ++ +    G L   L  NK + +           +L   + + YL
Sbjct: 78  L----IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY----SLQICKAMAYL 129

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR------APEVT 540
            +   N  H +I   NIL+      ++ DFGL+  +       + +  R      +PE  
Sbjct: 130 ESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESI 186

Query: 541 DPCKVSQKADVYSFGVLLLELLT-GKAPTHALLN-------EEGVDLPRWVQSIVKDEWT 592
           +  + +  +DV+ F V + E+L+ GK P   L N       E+G  LP+       D   
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK------PDLCP 240

Query: 593 SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
             ++ L           M +       C    P +RP  +E++  + +++   
Sbjct: 241 PVLYTL-----------MTR-------CWDYDPSDRPRFTELVCSLSDVYQME 275

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 67/301 (22%), Positives = 111/301 (36%), Gaps = 61/301 (20%)

Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTISE--REFKDKIEGVGAVNHENL 427
             LG G FG  Y+  +           VAVK L +V   +   +F  +   +   NH+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI--ALGAARGIEY 485
           V           + ++ + +  G L + L   +     P +  M  L+  A   A G +Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARV---SDFGLAHLVGPSSTPNRVAGYR------- 535
           L     +  H +I + N LLT     RV    DFG+A  +  +S       YR       
Sbjct: 156 LEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY------YRKGGCAML 207

Query: 536 -----APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKD 589
                 PE       + K D +SFGVLL E+ + G  P  +  N+E              
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------------- 253

Query: 590 EWTSEVFDLELLRY-----QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS 644
                V +           +N    + +++     C    P++RP+ + +++RIE     
Sbjct: 254 -----VLEFVTSGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQD 305

Query: 645 S 645
            
Sbjct: 306 P 306

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 89.8 bits (223), Expect = 2e-19
 Identities = 66/297 (22%), Positives = 110/297 (37%), Gaps = 61/297 (20%)

Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTISE--REFKDKIEGVGAVNHENL 427
             LG G FG  Y+  +           VAVK L +V   +   +F  +   +   NH+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI--ALGAARGIEY 485
           V           + ++ + +  G L + L   +     P +  M  L+  A   A G +Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARV---SDFGLAHLVGPSSTPNRVAGYR------- 535
           L     +  H +I + N LLT     RV    DFG+A  +  +        YR       
Sbjct: 197 LEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY------YRKGGCAML 248

Query: 536 -----APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKD 589
                 PE       + K D +SFGVLL E+ + G  P  +  N+               
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------------- 293

Query: 590 EWTSEVFDLELLRY-----QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
               EV +           +N    + +++     C    P++RP+ + +++RIE  
Sbjct: 294 ----EVLEFVTSGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYC 343

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 89.3 bits (222), Expect = 3e-19
 Identities = 23/119 (19%), Positives = 46/119 (38%), Gaps = 5/119 (4%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
                L N   L  + L +N L   +         L  LY+  N     + L+   +  L
Sbjct: 239 TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTL 297

Query: 145 VRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
             L+L+ N+    +        +L+ L+L++N +  ++         L+ L +S+N  +
Sbjct: 298 KVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 86.6 bits (215), Expect = 2e-18
 Identities = 34/137 (24%), Positives = 54/137 (39%), Gaps = 7/137 (5%)

Query: 69  NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGN 128
           N   ++      +  ++P  +L +   +  L+L    +        A    ++ LY+  N
Sbjct: 45  NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 103

Query: 129 HFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--F 185
                 P     +  L  L L  N+ S  +P G F N  KL TL + NN L   I    F
Sbjct: 104 AIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTF 161

Query: 186 DDVLPNLQQLNVSNNLL 202
                +LQ L +S+N L
Sbjct: 162 QA-TTSLQNLQLSSNRL 177

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 82.8 bits (205), Expect = 4e-17
 Identities = 32/131 (24%), Positives = 54/131 (41%), Gaps = 9/131 (6%)

Query: 92  NLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLAT 151
            L + + ++ + +++     + L S   +  L L                H + +L +  
Sbjct: 43  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 102

Query: 152 NNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNNLLNGSIPK 208
           N     +P   F+N+  L  L LE N LS S+P   F +  P L  L++SNN L   I  
Sbjct: 103 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN-TPKLTTLSMSNNNLE-RIED 158

Query: 209 RFQTFGSNSFL 219
              TF + + L
Sbjct: 159 --DTFQATTSL 167

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 36/146 (24%), Positives = 51/146 (34%), Gaps = 26/146 (17%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLT----SQLPS------------DLASCSNLRNLYLQG 127
           +I        TSL+ L L  N LT    S +PS             LA    +  L    
Sbjct: 155 RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASH 214

Query: 128 NHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPG--F 185
           N  +  V   +     L  L L  NN + +      N   L  + L  N L   I    F
Sbjct: 215 NSIN-VVRGPV--NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPF 268

Query: 186 DDVLPNLQQLNVSNNLLNGSIPKRFQ 211
              +  L++L +SNN L  ++    Q
Sbjct: 269 VK-MQRLERLYISNNRLV-ALNLYGQ 292

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 70.5 bits (173), Expect = 5e-13
 Identities = 22/133 (16%), Positives = 47/133 (35%), Gaps = 9/133 (6%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L        + +   +       +  + +N + +  + +         L     +  LNL
Sbjct: 17  LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNL 76

Query: 150 ATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNNLLNGSI 206
                  EI +  F     ++ L++  N +   +P   F + +P L  L +  N L+ S+
Sbjct: 77  NDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQN-VPLLTVLVLERNDLS-SL 132

Query: 207 PKRFQTFGSNSFL 219
           P+    F +   L
Sbjct: 133 PRG--IFHNTPKL 143

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 57.0 bits (138), Expect = 8e-09
 Identities = 11/96 (11%), Positives = 36/96 (37%), Gaps = 6/96 (6%)

Query: 110 LPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKL 168
           + S+L       ++++             + L++   +    +    ++P+    +  ++
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 169 KTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNNLL 202
           + L L + ++   I    F      +Q+L +  N +
Sbjct: 72  ELLNLNDLQIE-EIDTYAFAY-AHTIQKLYMGFNAI 105

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 91.2 bits (226), Expect = 3e-19
 Identities = 67/302 (22%), Positives = 116/302 (38%), Gaps = 61/302 (20%)

Query: 368 EDLLRASAEVLGKGTFGTAYKAVLEMG---TIVAVKRLKDVTI--SEREFKDKIEGVGAV 422
            D L  +   LG G FG+  + V  M      VA+K LK  T      E   + + +  +
Sbjct: 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 393

Query: 423 NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARG 482
           ++  +V L       +  +LV +    G L   L G +      +     + +    + G
Sbjct: 394 DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMG 448

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR------- 535
           ++YL  +  N  H N+ + N+LL   + A++SDFGL+  +G        + Y        
Sbjct: 449 MKYLEEK--NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKW 501

Query: 536 -----APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLN-------EEGVDLPRW 582
                APE  +  K S ++DV+S+GV + E L+ G+ P   +         E+G  +   
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC- 560

Query: 583 VQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH 642
                  E   E++ L           M         C     ++RP    V +R+   +
Sbjct: 561 -----PPECPPELYAL-----------MSD-------CWIYKWEDRPDFLTVEQRMRACY 597

Query: 643 PS 644
            S
Sbjct: 598 YS 599

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 89.8 bits (223), Expect = 3e-19
 Identities = 38/139 (27%), Positives = 54/139 (38%), Gaps = 13/139 (9%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFL-VGLH 142
            I +G    L +L TL L  N LT+         S L+ L+L+ N     +P +    + 
Sbjct: 102 TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIP 160

Query: 143 HLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNL 201
            L RL+L        I  G F+ L+ L+ L L    L   IP     L  L +L++S N 
Sbjct: 161 SLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTP-LIKLDELDLSGN- 217

Query: 202 LNGSIPKRFQTFGSNSFLG 220
                          SF G
Sbjct: 218 -------HLSAIRPGSFQG 229

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 89.4 bits (222), Expect = 5e-19
 Identities = 39/151 (25%), Positives = 64/151 (42%), Gaps = 13/151 (8%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
           I  G    L++LR L+L   +L   +P +L     L  L L GNH S   P    GL HL
Sbjct: 176 ISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHL 233

Query: 145 VRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNNL 201
            +L +  +     I    F NL  L  + L +N L+  +P   F   L +L+++++ +N 
Sbjct: 234 QKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTP-LHHLERIHLHHNP 290

Query: 202 LN-----GSIPKRFQTFGSNSFLGNSLCGKP 227
            N       +    +    ++    + C  P
Sbjct: 291 WNCNCDILWLSWWIKDMAPSNTACCARCNTP 321

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 40/142 (28%), Positives = 54/142 (38%), Gaps = 9/142 (6%)

Query: 70  RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNH 129
              +L L    +   I +    +L  L  L L  N + +         +NL  L L  N 
Sbjct: 65  NTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123

Query: 130 FSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFL-ENNRLSGSIPG--F 185
            +       V L  L  L L  N     IPS  F  +  L+ L L E  RLS  I    F
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAF 181

Query: 186 DDVLPNLQQLNVSNNLLNGSIP 207
           +  L NL+ LN++   L   IP
Sbjct: 182 EG-LSNLRYLNLAMCNLR-EIP 201

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 74.4 bits (183), Expect = 3e-14
 Identities = 35/116 (30%), Positives = 50/116 (43%), Gaps = 10/116 (8%)

Query: 95  SLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNF 154
               +     +L   +P  +++  N R L L  N            L HL  L L+ N+ 
Sbjct: 44  QFSKVICVRKNLRE-VPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100

Query: 155 SGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNNLLNGSIP 207
              I  G F  L  L TL L +NRL+ +IP   F   L  L++L + NN +  SIP
Sbjct: 101 R-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVY-LSKLKELWLRNNPIE-SIP 152

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 67/303 (22%), Positives = 118/303 (38%), Gaps = 61/303 (20%)

Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLKD-VTISER-EFKDKIEGVGAVNHENL 427
             LG+G+FG  Y+ V       E  T VA+K + +  ++ ER EF ++   +   N  ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL-----IALGAARG 482
           V L          L++ + +T G L + L   + A          SL     +A   A G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR------- 535
           + YL+A      H ++ + N ++ + +  ++ DFG+   +  +        YR       
Sbjct: 151 MAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY------YRKGGKGLL 202

Query: 536 -----APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKD 589
                +PE       +  +DV+SFGV+L E+ T  + P   L NE+              
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------------- 248

Query: 590 EWTSEVFDLELLRY-----QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS 644
                V    +         N  + + +L++    C    P  RPS  E+I  I+E    
Sbjct: 249 -----VLRFVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIKEEMEP 300

Query: 645 STQ 647
             +
Sbjct: 301 GFR 303

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 89.0 bits (221), Expect = 3e-19
 Identities = 49/209 (23%), Positives = 79/209 (37%), Gaps = 33/209 (15%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVK-----RLKDVTISEREFKDKIEGVGAVNHENLVP 429
           E LG G FG  ++ V    G +   K        D    + E    I  +  ++H  L+ 
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNE----ISIMNQLHHPKLIN 112

Query: 430 LRAYYYSMDEKLLVYDYLTMGSL------SALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
           L   +    E +L+ ++L+ G L                        MR         G+
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY-----MRQACE-----GL 162

Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARV--SDFGLAHLVGPSSTPNRVAG---YRAPE 538
           +++H     + H +IK  NI+      + V   DFGLA  + P            + APE
Sbjct: 163 KHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE 220

Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           + D   V    D+++ GVL   LL+G +P
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 90.2 bits (224), Expect = 3e-19
 Identities = 40/163 (24%), Positives = 64/163 (39%), Gaps = 12/163 (7%)

Query: 74  LRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGE 133
           LRL  + ++  I       L  L+ L +        +  +     NL +L +   + +  
Sbjct: 181 LRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAV 239

Query: 134 VPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLP 190
             L +  L +L  LNL+ N  S  I       L +L+ + L   +L+  +    F   L 
Sbjct: 240 PYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRG-LN 296

Query: 191 NLQQLNVSNNLLNGSIPKRFQTFGSNSFLGN-SLCGKPLQ-DC 231
            L+ LNVS N L  ++ +    F S   L    L   PL  DC
Sbjct: 297 YLRVLNVSGNQLT-TLEES--VFHSVGNLETLILDSNPLACDC 336

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 89.4 bits (222), Expect = 6e-19
 Identities = 36/124 (29%), Positives = 50/124 (40%), Gaps = 8/124 (6%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSD-LASCSNLRNLYLQGNHFSGEVPLFLVGLH 142
            +  G   NL +LRTL LR N L   +P       SNL  L +  N     +      L+
Sbjct: 70  AVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLY 128

Query: 143 HLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSN 199
           +L  L +  N+    I    F  L  L+ L LE   L+ SIP       L  L  L + +
Sbjct: 129 NLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSH-LHGLIVLRLRH 185

Query: 200 NLLN 203
             +N
Sbjct: 186 LNIN 189

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 87.1 bits (216), Expect = 3e-18
 Identities = 26/121 (21%), Positives = 46/121 (38%), Gaps = 4/121 (3%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
            I       L SL  L+L   +LTS     L+    L  L L+  + +         L+ 
Sbjct: 142 YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYR 201

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIP--GFDDVLPNLQQLNVSNNL 201
           L  L ++   +   +         L +L + +  L+ ++P       L  L+ LN+S N 
Sbjct: 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRH-LVYLRFLNLSYNP 259

Query: 202 L 202
           +
Sbjct: 260 I 260

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 82.1 bits (203), Expect = 1e-16
 Identities = 38/122 (31%), Positives = 52/122 (42%), Gaps = 9/122 (7%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
            +P GI    T  R L L  N + +    + AS  +L  L L  N  S   P     L +
Sbjct: 25  AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFN 81

Query: 144 LVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNN 200
           L  L L +N     IP G F  L+ L  L +  N++   +    F D L NL+ L V +N
Sbjct: 82  LRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQD-LYNLKSLEVGDN 138

Query: 201 LL 202
            L
Sbjct: 139 DL 140

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 67/301 (22%), Positives = 118/301 (39%), Gaps = 65/301 (21%)

Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTISER-EFKDKIEGVGAVNHENLV 428
             LG+G FG  + A        +   +VAVK LK+ + S R +F+ + E +  + H+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALL----------HGNKGAGRTPLNWEMRSLIALG 478
                       L+V++Y+  G L+  L           G +     PL       +A  
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR--- 535
            A G+ YL     +  H ++ + N L+ +    ++ DFG++  +  +        YR   
Sbjct: 167 VAAGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY------YRVGG 218

Query: 536 ---------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQS 585
                     PE     K + ++DV+SFGV+L E+ T GK P + L N            
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT----------- 267

Query: 586 IVKDEWTSEVFDLELLRY-----QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE 640
                   E  D           +    E+  +++    C  + P  R S+ +V  R++ 
Sbjct: 268 --------EAIDCITQGRELERPRACPPEVYAIMR---GCWQREPQQRHSIKDVHARLQA 316

Query: 641 L 641
           L
Sbjct: 317 L 317

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 88.3 bits (219), Expect = 6e-19
 Identities = 66/292 (22%), Positives = 116/292 (39%), Gaps = 43/292 (14%)

Query: 376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLKDVTISE--REFKDKIEGVGAVNHENLVP 429
           EV+G+G FG  Y   L          AVK L  +T      +F  +   +   +H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 430 LRAYYYSMDEKLL-VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI--ALGAARGIEYL 486
           L       +   L V  Y+  G L   +           N  ++ LI   L  A+G+++L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGMKFL 208

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR--------APE 538
            ++     H ++ + N +L + +  +V+DFGLA  +      +              A E
Sbjct: 209 ASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266

Query: 539 VTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD 597
                K + K+DV+SFGVLL EL+T G  P   +   +       +   +          
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQ-------G 312

Query: 598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGH 649
             LL+ +   + + +++     C     + RPS SE++ RI  +  +    H
Sbjct: 313 RRLLQPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 89.9 bits (223), Expect = 6e-19
 Identities = 50/209 (23%), Positives = 83/209 (39%), Gaps = 33/209 (15%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVK-----RLKDVTISEREFKDKIEGVGAVNHENLVP 429
           E LG G FG  ++      G   A K        D     +E    I+ +  + H  LV 
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKE----IQTMSVLRHPTLVN 218

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKG------AGRTPLNWEMRSLIALGAARGI 483
           L   +   +E +++Y++++ G L   +           A        MR +      +G+
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-----MRQVC-----KGL 268

Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARV--SDFGLAHLVGPSSTPNRVAG---YRAPE 538
            ++H       H ++K  NI+ T      +   DFGL   + P  +     G   + APE
Sbjct: 269 CHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 326

Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           V +   V    D++S GVL   LL+G +P
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 86.1 bits (214), Expect = 9e-19
 Identities = 66/293 (22%), Positives = 109/293 (37%), Gaps = 65/293 (22%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGV-------GAVNHENL 427
             LG G FG  +       G    +K     TI++   +  +E +        +++H N+
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIK-----TINKDRSQVPMEQIEAEIEVLKSLDHPNI 82

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSL------SALLHGN---KGAGRTPLNWEMRSLIALG 478
           + +   +       +V +    G L      +                    M+ ++   
Sbjct: 83  IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL-----MKQMMN-- 135

Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEA--RVSDFGLAHLVGPSSTPNRVAG-- 533
               + Y H+Q   V H ++K  NIL    S  +  ++ DFGLA L          AG  
Sbjct: 136 ---ALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTA 190

Query: 534 -YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT 592
            Y APEV     V+ K D++S GV++  LLTG  P     + E V      Q     E  
Sbjct: 191 LYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTG-TSLEEV-----QQKATYKEPN 243

Query: 593 SEVFDLELLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
              + +E    + +  + V LL+  L  D     P+ RPS ++V+      H 
Sbjct: 244 ---YAVE---CRPLTPQAVDLLKQMLTKD-----PERRPSAAQVLH-----HE 280

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 87.2 bits (216), Expect = 1e-18
 Identities = 48/246 (19%), Positives = 81/246 (32%), Gaps = 56/246 (22%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVK-----RLKDVTISERE-FKDKIEGVGAVNHENLV 428
             +G+G++G    A+  +   I A+K     +++ +   + E  K ++  +  ++H N+ 
Sbjct: 32  GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG---------- 478
            L   Y       LV +    G L   L+            ++                 
Sbjct: 92  RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151

Query: 479 ------------------AAR-------GIEYLHAQGPNVSHGNIKSSNILLTKSYEARV 513
                              +         + YLH QG  + H +IK  N L + +    +
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEI 209

Query: 514 --SDFGLAHLVGPSSTPNRV--------AGYRAPEV--TDPCKVSQKADVYSFGVLLLEL 561
              DFGL+      +               + APEV  T       K D +S GVLL  L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269

Query: 562 LTGKAP 567
           L G  P
Sbjct: 270 LMGAVP 275

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 89.2 bits (221), Expect = 1e-18
 Identities = 27/147 (18%), Positives = 52/147 (35%), Gaps = 7/147 (4%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
                L N   L  + L +N L   +         L  LY+  N     + L+   +  L
Sbjct: 245 TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTL 303

Query: 145 VRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN-LLN 203
             L+L+ N+    +        +L+ L+L++N +  ++         L+ L +S+N    
Sbjct: 304 KVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWDC 359

Query: 204 GSIPKRFQTFGSNSFLGNSL-CGKPLQ 229
            S+   F+     +       C    Q
Sbjct: 360 NSLRALFRNVARPAVDDADQHCKIDYQ 386

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 86.9 bits (215), Expect = 5e-18
 Identities = 34/137 (24%), Positives = 54/137 (39%), Gaps = 7/137 (5%)

Query: 69  NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGN 128
           N   ++      +  ++P  +L +   +  L+L    +        A    ++ LY+  N
Sbjct: 51  NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 109

Query: 129 HFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--F 185
                 P     +  L  L L  N+ S  +P G F N  KL TL + NN L   I    F
Sbjct: 110 AIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTF 167

Query: 186 DDVLPNLQQLNVSNNLL 202
                +LQ L +S+N L
Sbjct: 168 QA-TTSLQNLQLSSNRL 183

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 82.3 bits (203), Expect = 2e-16
 Identities = 32/131 (24%), Positives = 54/131 (41%), Gaps = 9/131 (6%)

Query: 92  NLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLAT 151
            L + + ++ + +++     + L S   +  L L                H + +L +  
Sbjct: 49  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 108

Query: 152 NNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNNLLNGSIPK 208
           N     +P   F+N+  L  L LE N LS S+P   F +  P L  L++SNN L   I  
Sbjct: 109 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN-TPKLTTLSMSNNNLE-RIED 164

Query: 209 RFQTFGSNSFL 219
              TF + + L
Sbjct: 165 D--TFQATTSL 173

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 73.8 bits (181), Expect = 7e-14
 Identities = 26/147 (17%), Positives = 43/147 (29%), Gaps = 7/147 (4%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
           +I       +  L  L +  N L + L         L+ L L  NH    V         
Sbjct: 268 KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 325

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
           L  L L  N+    +         LK L L +N    +      +  N+ +  V +   +
Sbjct: 326 LENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQH 380

Query: 204 GSIPKRFQTFGSNSFLGNSLCGKPLQD 230
             I  + +              + LQ 
Sbjct: 381 CKIDYQLEHGLCCKESDKPYLDRLLQY 407

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 71.9 bits (176), Expect = 3e-13
 Identities = 29/136 (21%), Positives = 50/136 (36%), Gaps = 16/136 (11%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
           +I        TSL+ L L  N LT    S +    +L +  +  N  S      L     
Sbjct: 161 RIEDDTFQATTSLQNLQLSSNRLTHVDLSLI---PSLFHANVSYNLLS-----TLAIPIA 212

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
           +  L+ + N+ +  +        +L  L L++N L+       +  P L ++++S N L 
Sbjct: 213 VEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNELE 267

Query: 204 GSIPKRFQTFGSNSFL 219
             I      F     L
Sbjct: 268 -KIMYH--PFVKMQRL 280

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 69.6 bits (170), Expect = 2e-12
 Identities = 22/133 (16%), Positives = 47/133 (35%), Gaps = 9/133 (6%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L        + +   +       +  + +N + +  + +         L     +  LNL
Sbjct: 23  LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNL 82

Query: 150 ATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNNLLNGSI 206
                  EI +  F     ++ L++  N +   +P   F + +P L  L +  N L+ S+
Sbjct: 83  NDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQN-VPLLTVLVLERNDLS-SL 138

Query: 207 PKRFQTFGSNSFL 219
           P+    F +   L
Sbjct: 139 PRG--IFHNTPKL 149

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 14/110 (12%), Positives = 40/110 (36%), Gaps = 11/110 (10%)

Query: 101 LRFNSLTSQ-----LPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFS 155
            R+N    Q     + S+L       ++++             + L++   +    +   
Sbjct: 5   QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64

Query: 156 GEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNNLL 202
            ++P+    +  +++ L L + ++   I    F      +Q+L +  N +
Sbjct: 65  -KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAY-AHTIQKLYMGFNAI 111

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 88.3 bits (219), Expect = 1e-18
 Identities = 35/165 (21%), Positives = 59/165 (35%), Gaps = 5/165 (3%)

Query: 71  VTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNH 129
           V  + L   +++ ++       L  L+ L +   +    + ++     S+L  L L  N 
Sbjct: 32  VNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 130 FSGEVPLFLVGLHHLVRLNLATNNF-SGEIPSG-FKNLTKLKTLFLENNRLSGSIP-GFD 186
           F         GL +L  L L   N     +    FK LT L+ L L +N +    P  F 
Sbjct: 91  FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150

Query: 187 DVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPLQDC 231
             +     L+++ N +     +    F    F    L    LQD 
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDM 195

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 84.8 bits (210), Expect = 2e-17
 Identities = 39/179 (21%), Positives = 70/179 (39%), Gaps = 11/179 (6%)

Query: 27  FSDLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIP 86
           F  ++  +   L L +S    +   +     P  +     E + V    L    +   + 
Sbjct: 233 FDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALL 291

Query: 87  LGILGNLTSLRTLSLRFNSLTSQLPSD-LASCSNLRNLYLQGNHFSGEVP--LFLVGLHH 143
             +  + T L  L+L  N +   +  +     ++L  L L  N     +   +F   L  
Sbjct: 292 KSVFSHFTDLEQLTLAQNEINK-IDDNAFWGLTHLLKLNLSQNFLG-SIDSRMF-ENLDK 348

Query: 144 LVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVSNN 200
           L  L+L+ N+    +    F  L  LK L L+ N+L  S+P G  D L +LQ++ +  N
Sbjct: 349 LEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 78.6 bits (194), Expect = 1e-15
 Identities = 35/118 (29%), Positives = 58/118 (49%), Gaps = 9/118 (7%)

Query: 94  TSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATN 152
           + ++T  L  + + + L   + +  ++L  L L  N  +        GL HL++LNL+ N
Sbjct: 275 SGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQN 333

Query: 153 NFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNNLLNGSIP 207
                I S  F+NL KL+ L L  N +  ++    F   LPNL++L +  N L  S+P
Sbjct: 334 FLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLG-LPNLKELALDTNQLK-SVP 387

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 75.6 bits (186), Expect = 2e-14
 Identities = 26/115 (22%), Positives = 47/115 (40%), Gaps = 9/115 (7%)

Query: 94  TSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP--LFLVGLHHLVRLNLAT 151
             +  + L  NS+     +  +   +L+ L ++       +    F  GL  L+ L L  
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTF-RGLSSLIILKLDY 88

Query: 152 NNFSGEIPSG-FKNLTKLKTLFLENNRL-SGSIPG--FDDVLPNLQQLNVSNNLL 202
           N F  ++ +G F  L  L+ L L    L    + G  F   L +L+ L + +N +
Sbjct: 89  NQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP-LTSLEMLVLRDNNI 141

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 35/156 (22%), Positives = 58/156 (37%), Gaps = 23/156 (14%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPS---DLASCSNLRNLYLQGN 128
           T+  +    L      G     TS+ TL L  N     +     D  + + +++L L  +
Sbjct: 191 TLQDMNEYWLG-WEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS 249

Query: 129 H----------FSGEVPLFLVGLH--HLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLEN 175
           +          F         GL    +   +L+ +     +    F + T L+ L L  
Sbjct: 250 YNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQ 308

Query: 176 NRLSGSIPG--FDDVLPNLQQLNVSNNLLNGSIPKR 209
           N ++  I    F   L +L +LN+S N L GSI  R
Sbjct: 309 NEIN-KIDDNAFWG-LTHLLKLNLSQNFL-GSIDSR 341

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 63.6 bits (155), Expect = 8e-11
 Identities = 31/155 (20%), Positives = 49/155 (31%), Gaps = 16/155 (10%)

Query: 82  SGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNHFSGEVPLFLVG 140
              +       LTSL  L LR N++    P+    +      L L  N         L+ 
Sbjct: 117 GAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLN 176

Query: 141 LH--HLVRLNLATNN--------FSGEIPSGFKNLTKLKTLFLENNRLSGSIPG-FDDVL 189
               H   L L++             E        T + TL L  N    S+   F D +
Sbjct: 177 FQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAI 236

Query: 190 PNLQ----QLNVSNNLLNGSIPKRFQTFGSNSFLG 220
              +     L+ S N+ +      F+   + +F G
Sbjct: 237 AGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 64/318 (20%), Positives = 112/318 (35%), Gaps = 81/318 (25%)

Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTISEREFKD---------KIEGVG 420
           + LG G FG   +A        +    VAVK LK       E +           +    
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLG--- 84

Query: 421 AVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL------ 474
             NH N+V L          L++ +Y   G L   L   + +                  
Sbjct: 85  --NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 475 -------IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST 527
                   +   A+G+ +L ++  N  H ++ + NILLT     ++ DFGLA  +   S 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 528 PNRVAGYR------------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNE 574
                 Y             APE    C  + ++DV+S+G+ L EL + G +P   +  +
Sbjct: 201 ------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254

Query: 575 EGVDLPRWVQSIVKDEWTSEVFDL-----ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRP 629
                              + + +      +L  ++   EM  +++    C    P  RP
Sbjct: 255 S------------------KFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRP 293

Query: 630 SMSEVIKRIEELHPSSTQ 647
           +  ++++ IE+    ST 
Sbjct: 294 TFKQIVQLIEKQISESTN 311

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 43/297 (14%)

Query: 376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLKDVTISE--REFKDKIEGVGAVNHENLVP 429
            V+GKG FG  Y              A+K L  +T  +    F  +   +  +NH N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 430 LRAYYYSMDE-KLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI--ALGAARGIEYL 486
           L       +    ++  Y+  G L   +   +       N  ++ LI   L  ARG+EYL
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR------NPTVKDLISFGLQVARGMEYL 140

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--TPNRVAGYR------APE 538
             Q     H ++ + N +L +S+  +V+DFGLA  +      +  +    R      A E
Sbjct: 141 AEQ--KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

Query: 539 VTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD 597
                + + K+DV+SFGVLL ELLT G  P   +   +       +   +          
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-------LTHFLAQ-------G 244

Query: 598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQP 654
             L + +   + + Q++Q    C    P  RP+   ++  +E++  +    H+   P
Sbjct: 245 RRLPQPEYCPDSLYQVMQ---QCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQLP 298

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 87.0 bits (216), Expect = 2e-18
 Identities = 66/307 (21%), Positives = 119/307 (38%), Gaps = 72/307 (23%)

Query: 376 EVLGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISEREFKD---------KIEG 418
           + LG+G FG    A             T VAVK LK    +E++  D          I  
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIG- 132

Query: 419 VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL-----------SALLHGNKGAGRTPL 467
                H+N++ L           ++ +Y + G+L               +         L
Sbjct: 133 ----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 468 NWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST 527
           + +     A   ARG+EYL ++     H ++ + N+L+T+    +++DFGLA  +     
Sbjct: 189 SSKDLVSCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246

Query: 528 PNRVAGYR------------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNE 574
                 Y+            APE       + ++DV+SFGVLL E+ T G +P   +  E
Sbjct: 247 ------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300

Query: 575 EGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEV 634
           E   L       +K+          + +  N   E+  +++   DC    P  RP+  ++
Sbjct: 301 ELFKL-------LKE-------GHRMDKPSNCTNELYMMMR---DCWHAVPSQRPTFKQL 343

Query: 635 IKRIEEL 641
           ++ ++ +
Sbjct: 344 VEDLDRI 350

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 36/157 (22%), Positives = 61/157 (38%), Gaps = 19/157 (12%)

Query: 59  CKWAGVECEQNR-----------VTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLT 107
           C+   V+C   +              LRL     +     GI   L  LR ++   N +T
Sbjct: 11  CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70

Query: 108 SQLPSDLASCSNLRNLYLQGNHFSGEVP--LFLVGLHHLVRLNLATNNFSGEIPSG-FKN 164
                     S +  + L  N     V   +F  GL  L  L L +N  +  + +  F  
Sbjct: 71  DIEEGAFEGASGVNEILLTSNRLE-NVQHKMF-KGLESLKTLMLRSNRIT-CVGNDSFIG 127

Query: 165 LTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVSNN 200
           L+ ++ L L +N+++ ++  G  D L +L  LN+  N
Sbjct: 128 LSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 15/66 (22%), Positives = 33/66 (50%), Gaps = 4/66 (6%)

Query: 146 RLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG-FDDVLPNLQQLNVSNNLLN 203
            L L  N F+    +G FK L +L+ +   NN+++    G F+     + ++ +++N L 
Sbjct: 36  ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEG-ASGVNEILLTSNRLE 94

Query: 204 GSIPKR 209
            ++  +
Sbjct: 95  -NVQHK 99

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 49/221 (22%), Positives = 86/221 (38%), Gaps = 50/221 (22%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGV-------GAVNHENL 427
           E LG G F    K      G   A K +K             E +         V H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77

Query: 428 VPLRAYYYSMDEKLLVYDYLT----------MGSLS----ALLHGNKGAGRTPLNWEMRS 473
           + L   Y +  + +L+ + ++            SLS                     ++ 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--------------IKQ 123

Query: 474 LIALGAARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEA---RVSDFGLAHLVGPSSTPN 529
           ++      G+ YLH +   ++H ++K  NI+L  K+      ++ DFGLAH +       
Sbjct: 124 IL-----DGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176

Query: 530 RVAG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
            + G   + APE+ +   +  +AD++S GV+   LL+G +P
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 46/221 (20%), Positives = 90/221 (40%), Gaps = 50/221 (22%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGV-------GAVNHENL 427
           E LG G F    K      G   A K +K   +S        E +         + H N+
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70

Query: 428 VPLRAYYYSMDEKLLVYDYLT----------MGSLS----ALLHGNKGAGRTPLNWEMRS 473
           + L   + +  + +L+ + ++            SL+                     ++ 
Sbjct: 71  ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF--------------LKQ 116

Query: 474 LIALGAARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEA---RVSDFGLAHLVGPSSTPN 529
           ++      G+ YLH++   ++H ++K  NI+L  K+      ++ DFG+AH +   +   
Sbjct: 117 IL-----DGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK 169

Query: 530 RVAG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
            + G   + APE+ +   +  +AD++S GV+   LL+G +P
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 87.6 bits (217), Expect = 2e-18
 Identities = 27/134 (20%), Positives = 52/134 (38%), Gaps = 5/134 (3%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTS-QLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLH 142
            +     G  + ++ L L+ N + +       AS   L +L LQ N    +V    V   
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG-QVVFA 191

Query: 143 HLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL 202
            L  L+L++N  +  +   F++   +  + L NN+L   I        NL+  ++  N  
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249

Query: 203 NGSIPKRFQTFGSN 216
           +    + F +    
Sbjct: 250 HCGTLRDFFSKNQR 263

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 87.2 bits (216), Expect = 3e-18
 Identities = 33/123 (26%), Positives = 53/123 (43%), Gaps = 7/123 (5%)

Query: 89  ILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN 148
           I  N    +   +  +SL   L S   S  N++ L L GN  S      L     L  LN
Sbjct: 5   IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64

Query: 149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPK 208
           L++N    E     ++L+ L+TL L NN +   +       P+++ L+ +NN ++     
Sbjct: 65  LSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELLV----GPSIETLHAANNNISRVSCS 117

Query: 209 RFQ 211
           R Q
Sbjct: 118 RGQ 120

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 84.1 bits (208), Expect = 3e-17
 Identities = 29/143 (20%), Positives = 53/143 (37%), Gaps = 11/143 (7%)

Query: 69  NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGN 128
           NR  + ++   +L  Q    +  +  +++ L L  N L+    +DLA  + L  L L  N
Sbjct: 10  NRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 129 HFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDV 188
                + L    L  L  L+L  N    E+         ++TL   NN +S  +      
Sbjct: 69  VLYETLDLE--SLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNIS-RVS--CSR 118

Query: 189 LPNLQQLNVSNNLLNGSIPKRFQ 211
               + + ++NN +         
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEG 141

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 71.0 bits (174), Expect = 4e-13
 Identities = 16/94 (17%), Positives = 36/94 (38%), Gaps = 2/94 (2%)

Query: 110 LPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLK 169
           +     + +  +   +  +     +        ++  L+L+ N  S    +     TKL+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 170 TLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
            L L +N L       +  L  L+ L+++NN + 
Sbjct: 62  LLNLSSNVLY-ETLDLES-LSTLRTLDLNNNYVQ 93

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 11/139 (7%), Positives = 31/139 (22%), Gaps = 6/139 (4%)

Query: 81  LSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVG 140
                          ++T++    ++      +   C+     +            F   
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306

Query: 141 LHHLVRLNLAT----NNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLN 196
           L  L R   A      + +  +    +N  + + +     +    I            L 
Sbjct: 307 LIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLE 366

Query: 197 VSNNLLNGSIPKRFQTFGS 215
                L+  +    +    
Sbjct: 367 QKKKALDEQVSNGRRAHAE 385

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 21/188 (11%), Positives = 48/188 (25%), Gaps = 8/188 (4%)

Query: 29  DLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLG 88
           DL  +      LR        +  V + +  K  G   E+  V  L   G      +P  
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAP 302

Query: 89  ILGNLTSLRTLSLRFNSLT----SQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
               L +L+       S       +L  +  + +  R +      +   +    +     
Sbjct: 303 FADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAK 362

Query: 145 VRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNG 204
           + L         ++ +G +   +L     +                    L +   ++  
Sbjct: 363 ITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI----ELQHATEEQSPLQLLRAIVKR 418

Query: 205 SIPKRFQT 212
                 + 
Sbjct: 419 YEEMYVEQ 426

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 36/141 (25%), Positives = 63/141 (44%), Gaps = 6/141 (4%)

Query: 82  SGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGL 141
           S  I  G    +  L  + +   ++T+ +P  L    +L  L+L GN  +      L GL
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGL 215

Query: 142 HHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
           ++L +L L+ N+ S  + +G   N   L+ L L NN+L   +PG       +Q + + NN
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 273

Query: 201 LLNGSIPKRFQTFGSNSFLGN 221
            ++      F   G N+   +
Sbjct: 274 NISAIGSNDFCPPGYNTKKAS 294

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 81.6 bits (202), Expect = 5e-17
 Identities = 33/153 (21%), Positives = 56/153 (36%), Gaps = 19/153 (12%)

Query: 68  QNRVTMLRLPGVALSGQIPLGIL------------GNLTSLRTLSLRFNSLTSQLPSDLA 115
            N +    +   A  G   L  +            G   SL  L L  N +T    + L 
Sbjct: 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLK 213

Query: 116 SCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLEN 175
             +NL  L L  N  S      L    HL  L+L  N    ++P G  +   ++ ++L N
Sbjct: 214 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 272

Query: 176 NRLSG------SIPGFDDVLPNLQQLNVSNNLL 202
           N +S         PG++    +   +++ +N +
Sbjct: 273 NNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 305

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 81.2 bits (201), Expect = 7e-17
 Identities = 29/126 (23%), Positives = 47/126 (37%), Gaps = 13/126 (10%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
           +    L  L +L  L L FNS+++     LA+  +LR L+L  N    +VP  L    ++
Sbjct: 207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 265

Query: 145 VRLNLATNNFSGEIPSG-------FKNLTKLKTLFLENNRLS-GSIPG--FDDVLPNLQQ 194
             + L  NN S  I S                 + L +N +    I    F   +     
Sbjct: 266 QVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC-VYVRAA 323

Query: 195 LNVSNN 200
           + + N 
Sbjct: 324 VQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 32/128 (25%), Positives = 52/128 (40%), Gaps = 10/128 (7%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
           I  G   NL +L TL L  N ++   P   A    L  LYL  N    E+P  +     L
Sbjct: 67  IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTL 123

Query: 145 VRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRL-SGSIPG--FDDVLPNLQQLNVSNN 200
             L +  N  + ++    F  L ++  + L  N L S  I    F   +  L  + +++ 
Sbjct: 124 QELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG-MKKLSYIRIADT 181

Query: 201 LLNGSIPK 208
            +  +IP+
Sbjct: 182 NIT-TIPQ 188

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 33/115 (28%), Positives = 48/115 (41%), Gaps = 9/115 (7%)

Query: 95  SLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNF 154
            LR +      L   +P DL    +   L LQ N  +         L +L  L L  N  
Sbjct: 32  HLRVVQCSDLGLEK-VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 155 SGEIPSG-FKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPK 208
           S +I  G F  L KL+ L+L  N+L   +P  + +   LQ+L V  N +   + K
Sbjct: 89  S-KISPGAFAPLVKLERLYLSKNQLK-ELP--EKMPKTLQELRVHENEIT-KVRK 138

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 75.8 bits (187), Expect = 5e-15
 Identities = 24/101 (23%), Positives = 38/101 (37%), Gaps = 9/101 (8%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSG------EVPLFL 138
           +  G L N   LR L L  N L   +P  LA    ++ +YL  N+ S         P + 
Sbjct: 231 VDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYN 289

Query: 139 VGLHHLVRLNLATNNFS-GEIPSG-FKNLTKLKTLFLENNR 177
                   ++L +N     EI    F+ +     + L N +
Sbjct: 290 TKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 29/122 (23%), Positives = 46/122 (37%), Gaps = 12/122 (9%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
           +P  +         L L+ N +T     D  +  NL  L L  N  S   P     L  L
Sbjct: 46  VPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102

Query: 145 VRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNNL 201
            RL L+ N    E+P    K L +L+   +  N ++  +    F+  L  +  + +  N 
Sbjct: 103 ERLYLSKNQLK-ELPEKMPKTLQELR---VHENEIT-KVRKSVFNG-LNQMIVVELGTNP 156

Query: 202 LN 203
           L 
Sbjct: 157 LK 158

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 86.4 bits (214), Expect = 2e-18
 Identities = 46/168 (27%), Positives = 66/168 (39%), Gaps = 10/168 (5%)

Query: 71  VTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSD-LASCSNLRNLYLQGNH 129
             +L L    LS          LT+L +L L  N L   + S+      NLR L L  NH
Sbjct: 41  TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNH 99

Query: 130 FSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FD 186
                      L  L  L L  N+    +    F+++ +L+ L+L  N++S   P     
Sbjct: 100 LHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK 157

Query: 187 DV--LPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPLQ-DC 231
           D   LP L  L++S+N L        Q   +    G  L   PL+ DC
Sbjct: 158 DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDC 205

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 78.3 bits (193), Expect = 8e-16
 Identities = 33/140 (23%), Positives = 61/140 (43%), Gaps = 15/140 (10%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASC--SNLRNLYLQGNHFSGEVPLFLVGLH 142
           +P  +    +    L L  N+L+  L ++      +NL +L L  NH +       V + 
Sbjct: 33  VPQSLP---SYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP 88

Query: 143 HLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSN 199
           +L  L+L++N+    +    F +L  L+ L L NN +   +    F+D +  LQ+L +S 
Sbjct: 89  NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFED-MAQLQKLYLSQ 145

Query: 200 NLLNGSIPKRFQTFGSNSFL 219
           N ++   P         + L
Sbjct: 146 NQIS-RFPVE--LIKDGNKL 162

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 87.3 bits (217), Expect = 2e-18
 Identities = 43/118 (36%), Positives = 51/118 (43%), Gaps = 8/118 (6%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           LG LT+L  LSL  N L       LAS +NL +L L  N  S   PL   GL  L  L L
Sbjct: 217 LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKL 272

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
             N  S   P     LT L  L L  N+L   I    + L NL  L +  N ++   P
Sbjct: 273 GANQISNISP--LAGLTALTNLELNENQLE-DISPISN-LKNLTYLTLYFNNISDISP 326

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 86.2 bits (214), Expect = 6e-18
 Identities = 37/121 (30%), Positives = 52/121 (42%), Gaps = 8/121 (6%)

Query: 87  LGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVR 146
           + +L  LT+L +L    N ++    + L   +NL  L L GN       L    L +L  
Sbjct: 192 ISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKDIGTLA--SLTNLTD 247

Query: 147 LNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSI 206
           L+LA N  S   P     LTKL  L L  N++S +I      L  L  L ++ N L    
Sbjct: 248 LDLANNQISNLAP--LSGLTKLTELKLGANQIS-NISPLAG-LTALTNLELNENQLEDIS 303

Query: 207 P 207
           P
Sbjct: 304 P 304

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 86.2 bits (214), Expect = 6e-18
 Identities = 35/118 (29%), Positives = 52/118 (44%), Gaps = 8/118 (6%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L NLT+L  L +  N ++    S LA  +NL +L    N  S   PL    L +L  L+L
Sbjct: 173 LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSL 228

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
             N           +LT L  L L NN++S ++      L  L +L +  N ++   P
Sbjct: 229 NGNQLKD--IGTLASLTNLTDLDLANNQIS-NLAPLSG-LTKLTELKLGANQISNISP 282

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 85.4 bits (212), Expect = 1e-17
 Identities = 33/132 (25%), Positives = 52/132 (39%), Gaps = 8/132 (6%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L  LT+L  L L  N L     S +++  NL  L L  N+ S   P+    L  L RL  
Sbjct: 283 LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFF 338

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKR 209
             N  S    S   NLT +  L   +N++S  +    + L  + QL +++     +    
Sbjct: 339 YNNKVSD--VSSLANLTNINWLSAGHNQIS-DLTPLAN-LTRITQLGLNDQAWTNAPVNY 394

Query: 210 FQTFGSNSFLGN 221
                  + + N
Sbjct: 395 KANVSIPNTVKN 406

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 82.7 bits (205), Expect = 7e-17
 Identities = 37/118 (31%), Positives = 50/118 (42%), Gaps = 8/118 (6%)

Query: 87  LGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVR 146
           +G L +LT+L  L L  N +++   + L+  + L  L L  N  S   PL   GL  L  
Sbjct: 236 IGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPLA--GLTALTN 291

Query: 147 LNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNG 204
           L L  N       S   NL  L  L L  N +S  I      L  LQ+L   NN ++ 
Sbjct: 292 LELNENQLED--ISPISNLKNLTYLTLYFNNIS-DISPVSS-LTKLQRLFFYNNKVSD 345

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 81.9 bits (203), Expect = 1e-16
 Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 9/115 (7%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L NLT+L  L L  N+++    S L+  ++L+ L   GN  +   PL    L  L RL++
Sbjct: 130 LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKPLA--NLTTLERLDI 184

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNG 204
           ++N  S    S    LT L++L   NN++S  I      L NL +L+++ N L  
Sbjct: 185 SSNKVSD--ISVLAKLTNLESLIATNNQIS-DITPLGI-LTNLDELSLNGNQLKD 235

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 81.9 bits (203), Expect = 1e-16
 Identities = 38/118 (32%), Positives = 55/118 (46%), Gaps = 9/118 (7%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L NLT+L  L+L  N +T      L + +NL  L L  N  S    L   GL  L +L+ 
Sbjct: 108 LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISDISALS--GLTSLQQLSF 163

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
             N  +   P    NLT L+ L + +N++S  I      L NL+ L  +NN ++   P
Sbjct: 164 G-NQVTDLKP--LANLTTLERLDISSNKVS-DISVLAK-LTNLESLIATNNQISDITP 216

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 81.5 bits (202), Expect = 2e-16
 Identities = 29/115 (25%), Positives = 48/115 (41%), Gaps = 8/115 (6%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
             +L  + TL      + S     +   +NL  +    N  +   PL    L  LV + +
Sbjct: 42  QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITPLK--NLTKLVDILM 97

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNG 204
             N  +   P    NLT L  L L NN+++  I    + L NL +L +S+N ++ 
Sbjct: 98  NNNQIADITP--LANLTNLTGLTLFNNQIT-DIDPLKN-LTNLNRLELSSNTISD 148

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 75.4 bits (186), Expect = 1e-14
 Identities = 25/118 (21%), Positives = 44/118 (37%), Gaps = 8/118 (6%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
              L       L   ++T  +         +  L              +  L++L ++N 
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINF 75

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
           + N  +   P   KNLTKL  + + NN+++  I    + L NL  L + NN +    P
Sbjct: 76  SNNQLTDITP--LKNLTKLVDILMNNNQIA-DITPLAN-LTNLTGLTLFNNQITDIDP 129

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 73.5 bits (181), Expect = 6e-14
 Identities = 28/118 (23%), Positives = 50/118 (42%), Gaps = 9/118 (7%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           + NL +L  L+L FN+++   P  ++S + L+ L+   N  S      L  L ++  L+ 
Sbjct: 305 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSA 360

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
             N  S   P    NLT++  L L +   + +   +     N+   N   N+    I 
Sbjct: 361 GHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNY---KANVSIPNTVKNVTGALIA 413

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 66.9 bits (164), Expect = 9e-12
 Identities = 19/113 (16%), Positives = 41/113 (36%), Gaps = 7/113 (6%)

Query: 95  SLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNF 154
            L + ++  ++  +Q+ +D  + +      L   + +  V      L  +  L       
Sbjct: 2   PLGSATITQDTPINQIFTD-TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI 58

Query: 155 SGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
                 G + L  L  +   NN+L+  I    + L  L  + ++NN +    P
Sbjct: 59  K--SIDGVEYLNNLTQINFSNNQLT-DITPLKN-LTKLVDILMNNNQIADITP 107

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 85.9 bits (213), Expect = 3e-18
 Identities = 53/240 (22%), Positives = 99/240 (41%), Gaps = 32/240 (13%)

Query: 345 NSNVNGATKKLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLK 403
           + + + +  +++F G   + + + D  + S +VLG G  G   +      G   A+K L 
Sbjct: 4   HHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY 63

Query: 404 DVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEK----LLVYDYLTMGSL----SAL 455
           D   + +E         A    ++V +   Y +M       L++ + +  G L       
Sbjct: 64  DSPKARQEVD--HH-WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER 120

Query: 456 LHGN---KGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEA 511
                  + A        MR +        I++LH+    ++H ++K  N+L  +K  +A
Sbjct: 121 GDQAFTEREAAEI-----MRDI-----GTAIQFLHSHN--IAHRDVKPENLLYTSKEKDA 168

Query: 512 --RVSDFGLAHLVGPSSTPNRV--AGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
             +++DFG A     ++         Y APEV  P K  +  D++S GV++  LL G  P
Sbjct: 169 VLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 42/217 (19%), Positives = 82/217 (37%), Gaps = 50/217 (23%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVK----RLKDVTISEREFKDKIEGVGAVNHENLVPL 430
           E LG+G FG  ++ V          K    +  D  + ++E    I  +    H N++ L
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKE----ISILNIARHRNILHL 66

Query: 431 RAYYYSMDEKLLVYDYLTMGSL---------------SALLHGNKGAGRTPLNWEMRSLI 475
              + SM+E ++++++++   +                                 +  + 
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY--------------VHQVC 112

Query: 476 ALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARV--SDFGLAHLVGPSSTPNRVAG 533
                  +++LH+    + H +I+  NI+      + +   +FG A  + P      +  
Sbjct: 113 -----EALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT 165

Query: 534 ---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
              Y APEV     VS   D++S G L+  LL+G  P
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 86.3 bits (214), Expect = 3e-18
 Identities = 68/322 (21%), Positives = 124/322 (38%), Gaps = 90/322 (27%)

Query: 376 EVLGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISEREFKD---------KIEG 418
           + LG+G FG    A          +    VAVK LKD   +E++  D          I  
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIG- 144

Query: 419 VGAVNHENLVPLRAYYY---SMDEKL-LVYDYLTMGSLSALL-----------HGNKGAG 463
                H+N++ L        + D  L ++ +Y + G+L   L           +      
Sbjct: 145 ----KHKNIINL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 464 RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG 523
              + ++         ARG+EYL +Q     H ++ + N+L+T++   +++DFGLA  + 
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDIN 254

Query: 524 PSSTPNRVAGYR------------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHA 570
                     Y+            APE       + ++DV+SFGVL+ E+ T G +P   
Sbjct: 255 NIDY------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308

Query: 571 LLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY-----QNVEEEMVQLLQLAIDCSAQYP 625
           +  EE                   +F L    +      N   E+  +++   DC    P
Sbjct: 309 IPVEE-------------------LFKLLKEGHRMDKPANCTNELYMMMR---DCWHAVP 346

Query: 626 DNRPSMSEVIKRIEELHPSSTQ 647
             RP+  ++++ ++ +   +T 
Sbjct: 347 SQRPTFKQLVEDLDRILTLTTN 368

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 88.3 bits (219), Expect = 3e-18
 Identities = 32/157 (20%), Positives = 53/157 (33%), Gaps = 6/157 (3%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS 131
            +L L        I      NL +LR L L  + +    P       +L  L L     S
Sbjct: 51  QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110

Query: 132 GEV--PLFLVGLHHLVRLNLATNNFSG-EIPSGFKNLTKLKTLFLENNRLSGSIPG-FDD 187
             V    +   L  L RL+L+ N      +   F  L  LK++   +N++        + 
Sbjct: 111 DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170

Query: 188 V-LPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSL 223
           +    L   +++ N L   +   +     N F    L
Sbjct: 171 LQGKTLSFFSLAANSLYSRVSVDWGKCM-NPFRNMVL 206

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 87.9 bits (218), Expect = 4e-18
 Identities = 30/135 (22%), Positives = 53/135 (39%), Gaps = 7/135 (5%)

Query: 89  ILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEV-PLFLVGLHHLVRL 147
           +   L +   L L FN + +   S       L+ L L   +    +       L +L  L
Sbjct: 19  VPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRIL 78

Query: 148 NLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSI--PGFDDVLPNLQQLNVSNNLLNG 204
           +L ++     +    F+ L  L  L L    LS ++   G+   L  L +L++S N +  
Sbjct: 79  DLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR- 136

Query: 205 SIPKRFQTFGSNSFL 219
           S+     +FG  + L
Sbjct: 137 SLYLH-PSFGKLNSL 150

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 86.0 bits (213), Expect = 2e-17
 Identities = 31/150 (20%), Positives = 50/150 (33%), Gaps = 4/150 (2%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSD-LASCSNLRNLYLQGNHFSGEVPLFLVGLH 142
            +       L  L+ L L        +  +   +  NLR L L  +      P    GL 
Sbjct: 38  TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLF 97

Query: 143 HLVRLNLATNNFSGEI--PSGFKNLTKLKTLFLENNRLSG-SIPGFDDVLPNLQQLNVSN 199
           HL  L L     S  +     F+NL  L  L L  N++    +      L +L+ ++ S+
Sbjct: 98  HLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSS 157

Query: 200 NLLNGSIPKRFQTFGSNSFLGNSLCGKPLQ 229
           N +        +     +    SL    L 
Sbjct: 158 NQIFLVCEHELEPLQGKTLSFFSLAANSLY 187

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 84.5 bits (209), Expect = 5e-17
 Identities = 42/159 (26%), Positives = 62/159 (38%), Gaps = 10/159 (6%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLAS-CSNLRNLYLQGNHF 130
            ++ L    L     L  L  +  L+ L L  N  +S       S   +L  L+L  N  
Sbjct: 404 NLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENML 463

Query: 131 SGEV-----PLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG 184
                         GL HL  L L  N  +  +P G F +LT L+ L L +NRL+  +  
Sbjct: 464 QLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLT-VLS- 520

Query: 185 FDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSL 223
            +D+  NL+ L++S N L    P  F +        N  
Sbjct: 521 HNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKF 559

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 82.9 bits (205), Expect = 1e-16
 Identities = 33/194 (17%), Positives = 60/194 (30%), Gaps = 15/194 (7%)

Query: 13  FLLLLLIISTFSFSFSDLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVT 72
           +   +           D+S +   +    +     +              G     + + 
Sbjct: 194 WGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253

Query: 73  MLRLPGVALSGQIPLGILGNL--TSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHF 130
                               L  +S+R L L    + S       +  +L+ L L  N  
Sbjct: 254 -----------DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKI 302

Query: 131 SGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPGFDDVL 189
           +        GL +L  LNL+ N    E+ S  F  L K+  + L+ N ++         L
Sbjct: 303 NKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFL 361

Query: 190 PNLQQLNVSNNLLN 203
             LQ L++ +N L 
Sbjct: 362 EKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 76.8 bits (189), Expect = 1e-14
 Identities = 26/135 (19%), Positives = 45/135 (33%), Gaps = 4/135 (2%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLAS--CSNLRNLYLQGNHFSGEVPLFLVGL 141
           +     L     +      F+++     +  A    S++R+L L               L
Sbjct: 230 KSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETL 289

Query: 142 HHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
             L  LNLA N  + +I    F  L  L+ L L  N L          LP +  +++  N
Sbjct: 290 KDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348

Query: 201 LLNGSIPKRFQTFGS 215
            +     + F+    
Sbjct: 349 HIAIIQDQTFKFLEK 363

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 71.4 bits (175), Expect = 5e-13
 Identities = 30/128 (23%), Positives = 50/128 (39%), Gaps = 11/128 (8%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
           I       L  L+TL LR N+LT      +    ++ +++L GN       + L      
Sbjct: 353 IQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANL-- 405

Query: 145 VRLNLATNNFSG-EIPSGFKNLTKLKTLFLENNRLSG-SIPGFDDVLPNLQQLNVSNNLL 202
             ++L+ N     +I      +  L+ L L  NR S  S        P+L+QL +  N+L
Sbjct: 406 --IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENML 463

Query: 203 NGSIPKRF 210
             +     
Sbjct: 464 QLAWETEL 471

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 64.4 bits (157), Expect = 8e-11
 Identities = 28/175 (16%), Positives = 54/175 (30%), Gaps = 27/175 (15%)

Query: 67  EQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLR-----------------FNSLTSQ 109
           +   ++   L   +L  ++ +     +   R + L                   N+++  
Sbjct: 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231

Query: 110 LPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH--LVRLNLATNNFSGEIPSGFKNLTK 167
               L    ++       ++          GL    +  L+L+           F+ L  
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKD 291

Query: 168 LKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNS 222
           LK L L  N+++         L NLQ LN+S N              S++F G  
Sbjct: 292 LKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN--------LLGELYSSNFYGLP 338

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 23/156 (14%), Positives = 47/156 (30%), Gaps = 25/156 (16%)

Query: 86  PLGILGNLTSLRTLSLRFNSLTSQLPSDLASCS--NLRNLYLQGNHFSGEVPLFLVGLH- 142
                G L SL+++    N +      +L       L    L  N     V +       
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199

Query: 143 -----HLVRLNLATNNFSGEIPSGFKN------------LTKLKTLFLENNRLSGSIPGF 185
                 L  L+++ N ++ +I   F N               +       + +       
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNT 259

Query: 186 DDVLP--NLQQLNVSNNLLNGSIPKRFQTFGSNSFL 219
              L   +++ L++S+  +  S+  R   F +   L
Sbjct: 260 FAGLARSSVRHLDLSHGFVF-SLNSR--VFETLKDL 292

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 86.7 bits (215), Expect = 3e-18
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 27/206 (13%)

Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKR-LKDVTISEREFKDKIEGVGAVNHENLVPLRAY 433
           +V+G G+FG  Y+A L + G +VA+K+ L+D     RE    ++ +  ++H N+V LR +
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYF 115

Query: 434 YYSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI--ALGAARGIEY 485
           +YS  EK       LV DY+   ++  +      A +T     ++  +       R + Y
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF---RSLAY 171

Query: 486 LHAQGPNVSHGNIKSSNILL-TKSYEARVSDFGLAHLVGPSSTPNR--VAG--YRAPEVT 540
           +H+ G  + H +IK  N+LL   +   ++ DFG A  +     PN   +    YRAPE+ 
Sbjct: 172 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRYYRAPELI 228

Query: 541 DPCKV-SQKADVYSFGVLLLELLTGK 565
                 +   DV+S G +L ELL G+
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQ 254

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 85.0 bits (211), Expect = 4e-18
 Identities = 66/318 (20%), Positives = 121/318 (38%), Gaps = 82/318 (25%)

Query: 376 EVLGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISEREFKD---------KIEG 418
           + LG+G FG    A          +    VAVK LKD   +E++  D          I  
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIG- 98

Query: 419 VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALL-----------HGNKGAGRTPL 467
                H+N++ L           ++ +Y + G+L   L           +         +
Sbjct: 99  ----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 468 NWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST 527
            ++         ARG+EYL +Q     H ++ + N+L+T++   +++DFGLA  +     
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212

Query: 528 PNRVAGYR------------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNE 574
                 Y+            APE       + ++DV+SFGVL+ E+ T G +P   +  E
Sbjct: 213 ------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266

Query: 575 EGVDLPRWVQSIVKDEWTSEVFDLELLRY-----QNVEEEMVQLLQLAIDCSAQYPDNRP 629
           E                   +F L    +      N   E+  +++   DC    P  RP
Sbjct: 267 E-------------------LFKLLKEGHRMDKPANCTNELYMMMR---DCWHAVPSQRP 304

Query: 630 SMSEVIKRIEELHPSSTQ 647
           +  ++++ ++ +   +T 
Sbjct: 305 TFKQLVEDLDRILTLTTN 322

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 83.8 bits (208), Expect = 4e-18
 Identities = 55/288 (19%), Positives = 109/288 (37%), Gaps = 50/288 (17%)

Query: 376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLKDVTISE--REFKDKIEGVGAVNHENLVP 429
             +G+G FG  ++ +          VA+K  K+ T      +F  +   +   +H ++V 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           L     + +   ++ +  T+G L + L   K +             A   +  + YL ++
Sbjct: 81  LIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY----AYQLSTALAYLESK 135

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCK 544
                H +I + N+L++ +   ++ DFGL+  +  S+      G     + APE  +  +
Sbjct: 136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 193

Query: 545 VSQKADVYSFGVLLLELLT-GKAPTHALLNEE-------GVDLPRWVQSIVKDEWTSEVF 596
            +  +DV+ FGV + E+L  G  P   + N +       G  LP              ++
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------PPNCPPTLY 247

Query: 597 DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS 644
            L           M +       C A  P  RP  +E+  ++  +   
Sbjct: 248 SL-----------MTK-------CWAYDPSRRPRFTELKAQLSTILEE 277

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 84.0 bits (208), Expect = 5e-18
 Identities = 40/140 (28%), Positives = 62/140 (44%), Gaps = 11/140 (7%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS 131
           T+L L    L     L  L   T L  L+L    LT  L  D  +   L  L L  N   
Sbjct: 34  TILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ 90

Query: 132 GEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDV 188
             +PL    L  L  L+++ N  +  +P G  + L +L+ L+L+ N L  ++P       
Sbjct: 91  -SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTP- 146

Query: 189 LPNLQQLNVSNNLLNGSIPK 208
            P L++L+++NN L   +P 
Sbjct: 147 TPKLEKLSLANNNLT-ELPA 165

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 49/149 (32%), Positives = 62/149 (41%), Gaps = 13/149 (8%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS 131
           T L L    L+    L + G L  L TL L  N L S LP    +   L  L +  N  +
Sbjct: 58  TQLNLDRAELTK---LQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT 113

Query: 132 GEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDV 188
                 L GL  L  L L  N     +P G      KL+ L L NN L+  +P    +  
Sbjct: 114 SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNG- 170

Query: 189 LPNLQQLNVSNNLLNGSIPKRFQTFGSNS 217
           L NL  L +  N L  +IPK F  FGS+ 
Sbjct: 171 LENLDTLLLQENSLY-TIPKGF--FGSHL 196

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 39/113 (34%), Positives = 51/113 (45%), Gaps = 9/113 (7%)

Query: 92  NLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLA 150
            L +L  L + FN LTS LP         L+ LYL+GN      P  L     L +L+LA
Sbjct: 98  TLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156

Query: 151 TNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNN 200
            NN + E+P+G    L  L TL L+ N L  +IP   F      L    +  N
Sbjct: 157 NNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG--SHLLPFAFLHGN 205

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 85.1 bits (211), Expect = 5e-18
 Identities = 49/221 (22%), Positives = 86/221 (38%), Gaps = 50/221 (22%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGV-------GAVNHENL 427
           E LG G F    K      G   A K +K             E +         V H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77

Query: 428 VPLRAYYYSMDEKLLVYDYLT----------MGSLS----ALLHGNKGAGRTPLNWEMRS 473
           + L   Y +  + +L+ + ++            SLS                     ++ 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--------------IKQ 123

Query: 474 LIALGAARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEA---RVSDFGLAHLVGPSSTPN 529
           ++      G+ YLH +   ++H ++K  NI+L  K+      ++ DFGLAH +       
Sbjct: 124 IL-----DGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176

Query: 530 RVAG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
            + G   + APE+ +   +  +AD++S GV+   LL+G +P
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 85.1 bits (211), Expect = 5e-18
 Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 33/209 (15%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVK-----RLKDVTISEREFKDKIEGVGAVNHENLVP 429
           E+LG G FG  +K      G  +A K      +KD    + E    I  +  ++H NL+ 
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNE----ISVMNQLDHANLIQ 150

Query: 430 LRAYYYSMDEKLLVYDYLTMGSL------SALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
           L   + S ++ +LV +Y+  G L       +                M+ +       GI
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF-----MKQICE-----GI 200

Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARV--SDFGLAHLVGPSSTPNRVAG---YRAPE 538
            ++H     + H ++K  NIL       ++   DFGLA    P        G   + APE
Sbjct: 201 RHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPE 258

Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           V +   VS   D++S GV+   LL+G +P
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 84.6 bits (210), Expect = 6e-18
 Identities = 46/221 (20%), Positives = 86/221 (38%), Gaps = 50/221 (22%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGV-------GAVNHENL 427
           E LG G F    K      G   A K +K             E +         + H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76

Query: 428 VPLRAYYYSMDEKLLVYDYLT----------MGSLS----ALLHGNKGAGRTPLNWEMRS 473
           + L   Y +  + +L+ + +             SL+                     ++ 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--------------LKQ 122

Query: 474 LIALGAARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEA---RVSDFGLAHLVGPSSTPN 529
           ++      G+ YLH+    ++H ++K  NI+L  ++      ++ DFGLAH +   +   
Sbjct: 123 IL-----NGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175

Query: 530 RVAG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
            + G   + APE+ +   +  +AD++S GV+   LL+G +P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 84.6 bits (210), Expect = 6e-18
 Identities = 63/314 (20%), Positives = 114/314 (36%), Gaps = 77/314 (24%)

Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTISEREFKD---------KIEGVG 420
           + LG G FG   +A        +    VAVK LK       E +           +    
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLG--- 107

Query: 421 AVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL------ 474
              HEN+V L          L++ +Y   G L   L        T   + + +       
Sbjct: 108 --QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 475 ---IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV 531
               +   A+G+ +L ++  N  H ++ + N+LLT  + A++ DFGLA  +   S     
Sbjct: 166 LLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN---- 219

Query: 532 AGYR------------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVD 578
             Y             APE    C  + ++DV+S+G+LL E+ + G  P   +L      
Sbjct: 220 --YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--- 274

Query: 579 LPRWVQSIVKDEWTSEVFDL-----ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSE 633
                          + + L     ++ +     + +  ++Q    C A  P +RP+  +
Sbjct: 275 ---------------KFYKLVKDGYQMAQPAFAPKNIYSIMQ---ACWALEPTHRPTFQQ 316

Query: 634 VIKRIEELHPSSTQ 647
           +   ++E      +
Sbjct: 317 ICSFLQEQAQEDRR 330

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 86.7 bits (215), Expect = 6e-18
 Identities = 38/137 (27%), Positives = 58/137 (42%), Gaps = 6/137 (4%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
            IP G+     ++++L L FN +T     DL +C+NL+ L L+ +  +         L  
Sbjct: 19  SIPSGLT---AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS 75

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSG-SIPGFDDVLPNLQQLNVSNNLL 202
           L  L+L+ N+ S    S F  L+ LK L L  N      +      L NLQ L + N   
Sbjct: 76  LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135

Query: 203 NGSIPKRFQTFGSNSFL 219
              I +    F   + L
Sbjct: 136 FSEIRR--IDFAGLTSL 150

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 81.3 bits (201), Expect = 3e-16
 Identities = 35/138 (25%), Positives = 54/138 (39%), Gaps = 2/138 (1%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
            I  G L    +L+ L L+ + + +       S  +L +L L  NH S     +   L  
Sbjct: 40  YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSS 99

Query: 144 LVRLNLATNNFSG-EIPSGFKNLTKLKTLFLENNRLSGSIPGFD-DVLPNLQQLNVSNNL 201
           L  LNL  N +    + S F NLT L+TL + N      I   D   L +L +L +    
Sbjct: 100 LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS 159

Query: 202 LNGSIPKRFQTFGSNSFL 219
           L     +  ++      L
Sbjct: 160 LRNYQSQSLKSIRDIHHL 177

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 79.4 bits (196), Expect = 1e-15
 Identities = 34/155 (21%), Positives = 57/155 (36%), Gaps = 26/155 (16%)

Query: 86  PLGILGNLTSLRTLSLRFNSLTS--QLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
                G   SL+TL L  N L S  +    L +  NL +L +  N F   +P        
Sbjct: 353 NSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEK 411

Query: 144 LVRLNLATNNFSGEIPSG------------------FKNLTKLKTLFLENNRLSGSIPGF 185
           +  LNL++      + +                      L +L+ L++  N+L  ++P  
Sbjct: 412 MRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPD- 468

Query: 186 DDVLPNLQQLNVSNNLLNGSIPKR-FQTFGSNSFL 219
             + P L  + +S N L  S+P   F    S   +
Sbjct: 469 ASLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKI 502

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 32/210 (15%), Positives = 60/210 (28%), Gaps = 16/210 (7%)

Query: 9   SQNIFLLLLLIISTFSFSFSDLSSDRAALLALRS------SVGGRTLLWNVYEASPCKWA 62
           S  +  L          SF++L      +L L        ++ G             +  
Sbjct: 222 SSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG 281

Query: 63  GVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRN 122
            VE    R   L +P   L       +   L  ++ +++  + +     S      +L  
Sbjct: 282 KVETVTIRR--LHIPQFYLF-YDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEF 338

Query: 123 LYLQGNHFSGEV---PLFLVGLHHLVRLNLATNNFS--GEIPSGFKNLTKLKTLFLENNR 177
           L L  N    E             L  L L+ N+     +       L  L +L +  N 
Sbjct: 339 LDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNT 398

Query: 178 LSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
                         ++ LN+S+  +   + 
Sbjct: 399 FHPMPDSCQW-PEKMRFLNLSSTGIR-VVK 426

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 73.2 bits (180), Expect = 1e-13
 Identities = 25/161 (15%), Positives = 48/161 (29%), Gaps = 1/161 (0%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSL-RFNSLTSQLPSDLASCSNLRNLYLQGNHF 130
             L L G          +  NLT+L+TL +    + +     D A  ++L  L ++    
Sbjct: 101 KYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160

Query: 131 SGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLP 190
                  L  +  +  L L  +  +  +      L+ ++ L L +  L+        V  
Sbjct: 161 RNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDE 220

Query: 191 NLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPLQDC 231
               +       +    + F            L      DC
Sbjct: 221 VSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDC 261

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 72.8 bits (179), Expect = 1e-13
 Identities = 26/131 (19%), Positives = 44/131 (33%), Gaps = 22/131 (16%)

Query: 88  GILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP---------LFL 138
            IL  L +L +L +  N+    +P        +R L L        V          L +
Sbjct: 381 EILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDV 438

Query: 139 ---------VGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVL 189
                    + L  L  L ++ N     +P        L  + +  N+L     G  D L
Sbjct: 439 SNNNLDSFSLFLPRLQELYISRNKLK-TLPDAS-LFPVLLVMKISRNQLKSVPDGIFDRL 496

Query: 190 PNLQQLNVSNN 200
            +LQ++ +  N
Sbjct: 497 TSLQKIWLHTN 507

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 21/134 (15%), Positives = 43/134 (32%), Gaps = 6/134 (4%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
             + T         +               +R L++   +   ++      L  + R+ +
Sbjct: 258 FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITV 317

Query: 150 ATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSI---PGFDDVLPNLQQLNVSNNLLNGS 205
             +     +P    ++L  L+ L L  N +              P+LQ L +S N L  S
Sbjct: 318 ENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-S 375

Query: 206 IPKRFQTFGSNSFL 219
           + K  +   +   L
Sbjct: 376 MQKTGEILLTLKNL 389

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 66.3 bits (162), Expect = 2e-11
 Identities = 28/159 (17%), Positives = 49/159 (30%), Gaps = 10/159 (6%)

Query: 74  LRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGE 133
           LR+  V    +I       LTSL  L ++  SL +     L S  ++ +L L  +  +  
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187

Query: 134 VPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLS-------GSIPGFD 186
           + +F   L  +  L L   N +    S          +     R S         +    
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247

Query: 187 DVLPNLQQLNVSNNLLNG---SIPKRFQTFGSNSFLGNS 222
             +  L ++   +  LNG     P           +   
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETV 286

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 28/149 (18%), Positives = 56/149 (37%), Gaps = 15/149 (10%)

Query: 86  PLGILGNLTSLRTLSLRFNSLTS----QLPSDLASCSNLRNLYLQGNHFSGEVPLFL--- 138
           PL +    + ++ L+ R + LT     +L   L     L  +       +G         
Sbjct: 215 PLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSES 274

Query: 139 --------VGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLP 190
                   V    + RL++       ++ + +  L K+K + +EN+++      F   L 
Sbjct: 275 DVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLK 334

Query: 191 NLQQLNVSNNLLNGSIPKRFQTFGSNSFL 219
           +L+ L++S NL+     K     G+   L
Sbjct: 335 SLEFLDLSENLMVEEYLKNSACKGAWPSL 363

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 19/88 (21%), Positives = 32/88 (36%), Gaps = 6/88 (6%)

Query: 91  GNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLA 150
               +L  L +  N+L S     L     L+ LY+  N     +P        L+ + ++
Sbjct: 428 CIPQTLEVLDVSNNNLDS-FSLFL---PRLQELYISRNKLK-TLPDA-SLFPVLLVMKIS 481

Query: 151 TNNFSGEIPSGFKNLTKLKTLFLENNRL 178
            N         F  LT L+ ++L  N  
Sbjct: 482 RNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 83.4 bits (207), Expect = 7e-18
 Identities = 50/209 (23%), Positives = 87/209 (41%), Gaps = 34/209 (16%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVK-----RLKDVTISEREFKDKIEGVGAVNHENLVP 429
             +G+G++G    AV        A K      ++DV   ++E    IE + +++H N++ 
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQE----IEIMKSLDHPNIIR 70

Query: 430 LRAYYYSMDEKLLVYDYLTMGSL--SALLHGN---KGAGRTPLNWEMRSLIALGAARGIE 484
           L   +    +  LV +  T G L    +         A R      M+ +++      + 
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKDVLS-----AVA 120

Query: 485 YLHAQGPNVSHGNIKSSNILL-TKSYEA--RVSDFGLAHLVGPSSTPNRVAG---YRAPE 538
           Y H     V+H ++K  N L  T S ++  ++ DFGLA    P        G   Y +P+
Sbjct: 121 YCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178

Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           V +      + D +S GV++  LL G  P
Sbjct: 179 VLEG-LYGPECDEWSAGVMMYVLLCGYPP 206

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 52/207 (25%), Positives = 85/207 (41%), Gaps = 28/207 (13%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRL--KDVTISERE-FKDKIEGVGAVNHENLVPLR 431
            +LGKG+FG   K          AVK +        +      ++E +  ++H N++ L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 432 AYYYSMDEKLLVYDYLTMGSL--SALLHGN---KGAGRTPLNWEMRSLIALGAARGIEYL 486
                     +V +  T G L    +         A R      ++ + +     GI Y+
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFS-----GITYM 137

Query: 487 HAQGPNVSHGNIKSSNILL-TKSYEA--RVSDFGLAHLVGPSSTPNRVAG---YRAPEVT 540
           H     + H ++K  NILL +K  +   ++ DFGL+     ++      G   Y APEV 
Sbjct: 138 HKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAP 567
                 +K DV+S GV+L  LL+G  P
Sbjct: 196 R-GTYDEKCDVWSAGVILYILLSGTPP 221

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 48/142 (33%), Positives = 63/142 (44%), Gaps = 14/142 (9%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNHF 130
            +L L    L   +P GI   L +L TL +  N L + LP  +     NL  L L  N  
Sbjct: 64  RLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQL 121

Query: 131 SGEVP--LFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--F 185
              +P  +F   L  L  L+L  N     +P G F  LT LK L L NN+L   +P   F
Sbjct: 122 K-SLPPRVF-DSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAF 177

Query: 186 DDVLPNLQQLNVSNNLLNGSIP 207
           D  L  L+ L + NN L   +P
Sbjct: 178 DK-LTELKTLKLDNNQLK-RVP 197

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 47/142 (33%), Positives = 64/142 (45%), Gaps = 14/142 (9%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNHF 130
             L L    LS  +P      LT LR L L  N L + LP+ +     NL  L++  N  
Sbjct: 40  KKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKL 97

Query: 131 SGEVP--LFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--F 185
              +P  +F   L +L  L L  N     +P   F +LTKL  L L  N L  S+P   F
Sbjct: 98  Q-ALPIGVF-DQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153

Query: 186 DDVLPNLQQLNVSNNLLNGSIP 207
           D  L +L++L + NN L   +P
Sbjct: 154 DK-LTSLKELRLYNNQLK-RVP 173

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 42/120 (35%), Positives = 56/120 (46%), Gaps = 8/120 (6%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNHFSGEVP--LFLVGL 141
           +P+G+   L +L  L L  N L S LP  +  S + L  L L  N     +P  +F   L
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF-DKL 156

Query: 142 HHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
             L  L L  N     +P G F  LT+LKTL L+NN+L     G  D L  L+ L +  N
Sbjct: 157 TSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 40/128 (31%), Positives = 55/128 (42%), Gaps = 14/128 (10%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP--LFLVGLH 142
           IP  I       + L L+ N L+S         + LR LYL  N     +P  +F   L 
Sbjct: 31  IPSNIP---ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIF-KELK 85

Query: 143 HLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSN 199
           +L  L +  N     +P G F  L  L  L L+ N+L  S+P   FD  L  L  L++  
Sbjct: 86  NLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDS-LTKLTYLSLGY 142

Query: 200 NLLNGSIP 207
           N L  S+P
Sbjct: 143 NELQ-SLP 149

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 85.3 bits (211), Expect = 2e-17
 Identities = 57/289 (19%), Positives = 111/289 (38%), Gaps = 50/289 (17%)

Query: 376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLKDVTISE--REFKDKIEGVGAVNHENLVP 429
             +G+G FG  ++ +          VA+K  K+ T      +F  +   +   +H ++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           L     + +   ++ +  T+G L + L   K      L+     L A   +  + YL ++
Sbjct: 456 LIGVI-TENPVWIIMELCTLGELRSFLQVRKF----SLDLASLILYAYQLSTALAYLESK 510

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCK 544
                H +I + N+L++ +   ++ DFGL+  +  S+      G     + APE  +  +
Sbjct: 511 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568

Query: 545 VSQKADVYSFGVLLLELLT-GKAPTHALLNEE-------GVDLPRWVQSIVKDEWTSEVF 596
            +  +DV+ FGV + E+L  G  P   + N +       G  LP              ++
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------PPNCPPTLY 622

Query: 597 DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
            L           M +       C A  P  RP  +E+  ++  +    
Sbjct: 623 SL-----------MTK-------CWAYDPSRRPRFTELKAQLSTILEEE 653

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 63/304 (20%), Positives = 109/304 (35%), Gaps = 67/304 (22%)

Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLK-DVTISER-EFKDKIEGVGAVNHENL 427
           E LG+  FG  YK  L      E    VA+K LK       R EF+ +      + H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL-----------IA 476
           V L           +++ Y + G L   L             + R++           + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR- 535
              A G+EYL +   +V H ++ + N+L+      ++SD GL   V  +        Y+ 
Sbjct: 135 AQIAAGMEYLSSH--HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY------YKL 186

Query: 536 -----------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWV 583
                      APE     K S  +D++S+GV+L E+ + G  P     N+         
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--------- 237

Query: 584 QSIVKDEWTSEVFDLELLRY-----QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI 638
                     +V ++   R       +    +  L+    +C  ++P  RP   ++  R+
Sbjct: 238 ----------DVVEMIRNRQVLPCPDDCPAWVYALMI---ECWNEFPSRRPRFKDIHSRL 284

Query: 639 EELH 642
               
Sbjct: 285 RAWG 288

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 67/317 (21%), Positives = 111/317 (35%), Gaps = 80/317 (25%)

Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTISEREFKD---------KIEGVG 420
           + LG+G FG   +A             VAVK LK+   +  E +           I    
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIG--- 88

Query: 421 AVNHENLVPLRAYYYSMDEKLLV-YDYLTMGSLSALLHGNKGAGRTPLNWEMRSL----- 474
             +H N+V L          L+V  ++   G+LS  L   +                   
Sbjct: 89  --HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 475 ------IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP 528
                  +   A+G+E+L ++     H ++ + NILL++    ++ DFGLA  +      
Sbjct: 147 LEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD- 203

Query: 529 NRVAGYR------------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
                Y             APE       + ++DV+SFGVLL E+ + G +P   +  +E
Sbjct: 204 -----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258

Query: 576 GVDLPRWVQSIVKDEWTSEVFDLELLRY-----QNVEEEMVQLLQLAIDCSAQYPDNRPS 630
                             E                   EM Q +    DC    P  RP+
Sbjct: 259 ------------------EFCRRLKEGTRMRAPDYTTPEMYQTML---DCWHGEPSQRPT 297

Query: 631 MSEVIKRIEELHPSSTQ 647
            SE+++ +  L  ++ Q
Sbjct: 298 FSELVEHLGNLLQANAQ 314

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 82.2 bits (204), Expect = 2e-17
 Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 42/213 (19%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRL-KDVTISEREFKDKIEGVGAVNHENLVPLRAY 433
           EVLG G F   +       G + A+K + K     +   +++I  +  + HEN+V L   
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74

Query: 434 YYSMDEKLLVYDYLTMGSL--------------SALLHGNKGAGRTPLNWEMRSLIALGA 479
           Y S     LV   ++ G L              ++L+              ++ +     
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV--------------IQQV----- 115

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEARV--SDFGLAHLVGPSSTPNRV--AGY 534
              ++YLH  G  + H ++K  N+L  T    +++  +DFGL+ +             GY
Sbjct: 116 LSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGY 173

Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
            APEV      S+  D +S GV+   LL G  P
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 83.7 bits (207), Expect = 4e-17
 Identities = 52/212 (24%), Positives = 88/212 (41%), Gaps = 39/212 (18%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGA---------VNHE 425
           + +G G  G    A    +   VA+K+L         F+++     A         VNH+
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHK 121

Query: 426 NLVPLR------AYYYSMDEKLLVYDYLTMGS-LSALLHGNKGAGRTPLNWEMRSLIALG 478
           N++ L              +  LV +   M + L  ++       +  L+ E  S +   
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMEL--MDANLCQVI-------QMELDHERMSYLLYQ 172

Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--TPNRVAG--Y 534
              GI++LH+    + H ++K SNI++      ++ DFGLA   G S   TP  V    Y
Sbjct: 173 MLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRYY 229

Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKA 566
           RAPEV       +  D++S G ++ E++  K 
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 79.7 bits (197), Expect = 4e-17
 Identities = 34/132 (25%), Positives = 54/132 (40%), Gaps = 5/132 (3%)

Query: 71  VTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNH 129
           +T +RL    +   IP G       LR + L  N ++  L  D      +L +L L GN 
Sbjct: 34  ITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNK 91

Query: 130 FSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPGFDDV 188
            +        GL  L  L L  N  +  +    F++L  L  L L +N+L     G    
Sbjct: 92  ITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150

Query: 189 LPNLQQLNVSNN 200
           L  +Q ++++ N
Sbjct: 151 LRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 77.8 bits (192), Expect = 2e-16
 Identities = 36/129 (27%), Positives = 57/129 (44%), Gaps = 14/129 (10%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP--LFLVGLH 142
           IP  +     ++  + L  N++    P   +    LR + L  N  S E+    F  GL 
Sbjct: 26  IPTNLP---ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQ-GLR 80

Query: 143 HLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSN 199
            L  L L  N  + E+P   F+ L  L+ L L  N+++  +    F D L NL  L++ +
Sbjct: 81  SLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQD-LHNLNLLSLYD 137

Query: 200 NLLNGSIPK 208
           N L  +I K
Sbjct: 138 NKLQ-TIAK 145

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 10/46 (21%), Positives = 20/46 (43%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHF 130
           + +    +L +L  LSL  N L +      +    ++ ++L  N F
Sbjct: 119 LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 82.8 bits (205), Expect = 5e-17
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 28/207 (13%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKR-LKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
           +V+G G+FG  ++A L     VA+K+ L+D     RE    ++ +  V H N+V L+A++
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRE----LQIMRIVKHPNVVDLKAFF 101

Query: 435 YSMDEKL------LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI--ALGAARGIEYL 486
           YS  +K       LV +Y+   ++           +T     ++  +   L   R + Y+
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL---RSLAYI 157

Query: 487 HAQGPNVSHGNIKSSNILL-TKSYEARVSDFGLA-HLVGPSSTPNR--VAG--YRAPEVT 540
           H+ G  + H +IK  N+LL   S   ++ DFG A  L+  +  PN   +    YRAPE+ 
Sbjct: 158 HSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI--AGEPNVSYICSRYYRAPELI 213

Query: 541 DPCKV-SQKADVYSFGVLLLELLTGKA 566
                 +   D++S G ++ EL+ G+ 
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQP 240

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 81.6 bits (202), Expect = 6e-17
 Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 34/214 (15%)

Query: 371 LRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAV----NHE 425
           L    + LG+G+F    K V  +     AVK      IS+R   +  + + A+     H 
Sbjct: 12  LDLKDKPLGEGSFSICRKCVHKKSNQAFAVK-----IISKRMEANTQKEITALKLCEGHP 66

Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSL--SALLHGN---KGAGRTPLNWEMRSLIALGAA 480
           N+V L   ++      LV + L  G L        +     A        MR L      
Sbjct: 67  NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRKL-----V 116

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILL-TKSYEA--RVSDFGLAHLVGPS----STPNRVAG 533
             + ++H  G  V H ++K  N+L   ++     ++ DFG A L  P      TP     
Sbjct: 117 SAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH 174

Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           Y APE+ +     +  D++S GV+L  +L+G+ P
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 81.1 bits (201), Expect = 7e-17
 Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 32/213 (15%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKI-----------EGVGAVN 423
             +G G +GT YKA     G  VA+K ++    +       +             + A  
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVALLRRLEAFE 72

Query: 424 HENLVPLR----AYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWE--MRSLIA 476
           H N+V L           + K+ LV++++    L   L      G      +  MR  + 
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL- 130

Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNRVAG-- 533
               RG+++LHA    + H ++K  NIL+T     +++DFGLA +     +    V    
Sbjct: 131 ----RGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLW 184

Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKA 566
           YRAPEV      +   D++S G +  E+   K 
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 81.3 bits (201), Expect = 8e-17
 Identities = 31/157 (19%), Positives = 52/157 (33%), Gaps = 14/157 (8%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
           I       LT L  L +  + L S  P  L S  N+ +L L        + +F+     +
Sbjct: 165 IQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSV 224

Query: 145 VRLNLATNNFSG----EIPSG----FKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLN 196
             L L   +       E+ +G           + + + +  L   +    + +  L +L 
Sbjct: 225 ECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELE 283

Query: 197 VSNNLLNGSIPKRFQTFGSNSFLGN-SLCGKPLQ-DC 231
            S N L  S+P     F   + L    L   P    C
Sbjct: 284 FSRNQLK-SVPDG--IFDRLTSLQKIWLHTNPWDCSC 317

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 37/128 (28%), Positives = 53/128 (41%), Gaps = 8/128 (6%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
           IP G+     ++++L L  N +T    SDL  C NL+ L L  N  +         L  L
Sbjct: 46  IPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102

Query: 145 VRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIP--GFDDVLPNLQQLNVSNNL 201
             L+L+ N  S  + S  FK L+ L  L L  N    ++        L  LQ L V N  
Sbjct: 103 EHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160

Query: 202 LNGSIPKR 209
               I ++
Sbjct: 161 TFTKIQRK 168

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 79.0 bits (195), Expect = 5e-16
 Identities = 29/126 (23%), Positives = 46/126 (36%), Gaps = 5/126 (3%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNHFSGEVPL-FLVGLH 142
           I      +L SL  L L +N L++ L S      S+L  L L GN +           L 
Sbjct: 91  IEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLT 149

Query: 143 HLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNL 201
            L  L +   +   +I    F  LT L+ L ++ + L    P     + N+  L +    
Sbjct: 150 KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ 209

Query: 202 LNGSIP 207
               + 
Sbjct: 210 HI-LLL 214

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 24/141 (17%), Positives = 51/141 (36%), Gaps = 6/141 (4%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNHFSGEVPL-FLVGL 141
            +       L+SL  L+L  N   +   + L +  + L+ L +       ++      GL
Sbjct: 114 NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173

Query: 142 HHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVSN 199
             L  L +  ++          K++  +  L L   +    +   F DV  +++ L + +
Sbjct: 174 TFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRD 231

Query: 200 NLLNGSIPKRFQTFGSNSFLG 220
             L+        T  +NS + 
Sbjct: 232 TDLDTFHFSELSTGETNSLIK 252

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 36/141 (25%), Positives = 57/141 (40%), Gaps = 8/141 (5%)

Query: 71  VTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNH 129
           V  L L    ++  I    L    +L+ L L  N + + +  D  +S  +L +L L  N+
Sbjct: 54  VKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYNY 111

Query: 130 FSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FD 186
            S     +   L  L  LNL  N +     +  F +LTKL+ L + N      I    F 
Sbjct: 112 LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171

Query: 187 DVLPNLQQLNVSNNLLNGSIP 207
             L  L++L +  + L  S  
Sbjct: 172 G-LTFLEELEIDASDLQ-SYE 190

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 80.4 bits (199), Expect = 9e-17
 Identities = 50/218 (22%), Positives = 84/218 (38%), Gaps = 38/218 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRL---KDVTISEREFKDKIEGVG---AV-----N 423
           E+LG+G      + +        AVK +      + S  E ++  E       +      
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSL--SALLHGN---KGAGRTPLNWEMRSLIALG 478
           H N++ L+  Y +     LV+D +  G L            K   +      MR+L+   
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-----MRALL--- 134

Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YR 535
               I  LH     + H ++K  NILL      +++DFG +  + P      V G   Y 
Sbjct: 135 --EVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 190

Query: 536 APEVTDPCKV------SQKADVYSFGVLLLELLTGKAP 567
           APE+ +           ++ D++S GV++  LL G  P
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 38/211 (18%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGA---------VNHE 425
             +G G +G+   A+    G  VA+K+L         F+ +I    A         + HE
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRP------FQSEIFAKRAYRELLLLKHMQHE 83

Query: 426 NLVPLR------AYYYSMDEKLLVYDYLTMGS-LSALLHGNKGAGRTPLNWEMRSLIALG 478
           N++ L       +   +  +  LV  +  M + L  ++           + E    +   
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPF--MQTDLQKIM-------GLKFSEEKIQYLVYQ 134

Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRA 536
             +G++Y+H+    V H ++K  N+ + +  E ++ DFGLA       T   V    YRA
Sbjct: 135 MLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY-VVTRWYRA 191

Query: 537 PEV-TDPCKVSQKADVYSFGVLLLELLTGKA 566
           PEV       +Q  D++S G ++ E+LTGK 
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 62/326 (19%), Positives = 108/326 (33%), Gaps = 86/326 (26%)

Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTISEREFKD---------KIEGVG 420
           +VLG G FG    A         +   VAVK LK+      E +          ++    
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLG--- 106

Query: 421 AVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL------ 474
             +HEN+V L           L+++Y   G L   L   +                    
Sbjct: 107 --SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 475 ------------IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV 522
                        A   A+G+E+L  +  +  H ++ + N+L+T     ++ DFGLA  +
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHGKVVKICDFGLARDI 222

Query: 523 GPSSTPNRVAGYR------------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTH 569
              S       Y             APE       + K+DV+S+G+LL E+ + G  P  
Sbjct: 223 MSDSN------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276

Query: 570 ALLNEEGVDLPRWVQSIVKDEWTSEVFDL-----ELLRYQNVEEEMVQLLQLAIDCSAQY 624
            +  +                     + L     ++ +     EE+  ++Q    C A  
Sbjct: 277 GIPVDA------------------NFYKLIQNGFKMDQPFYATEEIYIIMQ---SCWAFD 315

Query: 625 PDNRPSMSEVIKRIEELHPSSTQGHH 650
              RPS   +   +      + +  +
Sbjct: 316 SRKRPSFPNLTSFLGCQLADAEEAMY 341

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 30/209 (14%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGV-----------GAVN 423
           E LG GT+ T YK +    G  VA+K +K     + E     EG              + 
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVK----LDSE-----EGTPSTAIREISLMKELK 61

Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALL-HGNKGAGRTPLNWEMRSLIALGAARG 482
           HEN+V L    ++ ++  LV++++    L   +     G     L   +         +G
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP--NRVAG--YRAPE 538
           + + H     + H ++K  N+L+ K  + ++ DFGLA   G       + V    YRAP+
Sbjct: 121 LAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178

Query: 539 VTDPCKV-SQKADVYSFGVLLLELLTGKA 566
           V    +  S   D++S G +L E++TGK 
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKP 207

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 39/212 (18%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGA---------VNHE 425
           + +G G  G    A    +   VA+K+L         F+++     A         VNH+
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHK 84

Query: 426 NLVPLR------AYYYSMDEKLLVYDYLTMGS-LSALLHGNKGAGRTPLNWEMRSLIALG 478
           N++ L              +  +V +   M + L  ++       +  L+ E  S +   
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMEL--MDANLCQVI-------QMELDHERMSYLLYQ 135

Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--TPNRVAG--Y 534
              GI++LH+    + H ++K SNI++      ++ DFGLA   G S   TP  V    Y
Sbjct: 136 MLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRYY 192

Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKA 566
           RAPEV       +  D++S G ++ E++ G  
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 67/314 (21%), Positives = 123/314 (39%), Gaps = 94/314 (29%)

Query: 376 EVLGKGTFGTAYKAVL---EMGTIVAVKRLKDVTISEREFKD---------KIEGVGAVN 423
           +V+G+G FG   KA +    +    A+KR+K+   S+ + +D         K+      +
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLG-----H 84

Query: 424 HENLVPL------RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL--- 474
           H N++ L      R Y Y      L  +Y   G+L   L  ++     P      S    
Sbjct: 85  HPNIINLLGACEHRGYLY------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138

Query: 475 --------IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS 526
                    A   ARG++YL  +     H ++ + NIL+ ++Y A+++DFGL+       
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLS------- 189

Query: 527 TPNRVAG-YR------------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALL 572
              R    Y             A E  +    +  +DV+S+GVLL E+++ G  P   + 
Sbjct: 190 ---RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246

Query: 573 NEEGVDLPRWVQSIVKDEWTSEVFDLELLRY-----QNVEEEMVQLLQLAIDCSAQYPDN 627
                                E+++     Y      N ++E+  L++    C  + P  
Sbjct: 247 CA-------------------ELYEKLPQGYRLEKPLNCDDEVYDLMR---QCWREKPYE 284

Query: 628 RPSMSEVIKRIEEL 641
           RPS ++++  +  +
Sbjct: 285 RPSFAQILVSLNRM 298

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 51/217 (23%), Positives = 90/217 (41%), Gaps = 31/217 (14%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRL---KDVTISEREFKDKIEGVGAVNHENLVPLR 431
             LG+G     Y+          A+K L    D  I   E    I  +  ++H N++ L+
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTE----IGVLLRLSHPNIIKLK 114

Query: 432 AYYYSMDEKLLVYDYLTMGSL--SALLHGN---KGAGRTPLNWEMRSLIALGAARGIEYL 486
             + +  E  LV + +T G L    +  G    + A        ++ +        + YL
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-----VKQI-----LEAVAYL 164

Query: 487 HAQGPNVSHGNIKSSNILL-TKSYEARV--SDFGLAHLVGPSSTPNRVAG---YRAPEVT 540
           H  G  + H ++K  N+L  T + +A +  +DFGL+ +V        V G   Y APE+ 
Sbjct: 165 HENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEIL 222

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGV 577
             C    + D++S G++   LL G  P +    ++ +
Sbjct: 223 RGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 44/223 (19%), Positives = 77/223 (34%), Gaps = 42/223 (18%)

Query: 433 YYYSMDEKLLVY---DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
                  K+ +Y         +L   ++             +   I +  A  +E+LH++
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQI--AEAVEFLHSK 183

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---------------- 533
           G  + H ++K SNI  T     +V DFGL   +        V                  
Sbjct: 184 G--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241

Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTS 593
           Y +PE       S K D++S G++L ELL   +     +          +  +   +   
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI--------ITDVRNLK--- 290

Query: 594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK 636
             F L   +    E  MVQ + L+       P  RP  +++I+
Sbjct: 291 --FPLLFTQKYPQEHMMVQDM-LSPS-----PTERPEATDIIE 325

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 81.3 bits (201), Expect = 2e-16
 Identities = 59/289 (20%), Positives = 112/289 (38%), Gaps = 49/289 (16%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRL--KDVTISEREFKDKIEGV-------GAVNHE 425
           + LG G  G    A   +    VA++ +  +   I      D    V         +NH 
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200

Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
            ++ ++ ++ + D   +V + +  G L      +K  G   L      L        ++Y
Sbjct: 201 CIIKIKNFFDAED-YYIVLELMEGGELF-----DKVVGNKRLKEATCKLYFYQMLLAVQY 254

Query: 486 LHAQGPNVSHGNIKSSNILL-TKSYEARV--SDFGLAHLVGPSSTPNRVAG---YRAPEV 539
           LH  G  + H ++K  N+LL ++  +  +  +DFG + ++G +S    + G   Y APEV
Sbjct: 255 LHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312

Query: 540 ---TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF 596
                    ++  D +S GV+L   L+G  P      +  +        I   +     +
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----KDQITSGK-----Y 362

Query: 597 DLELLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
           +     +  V E+ + L++  L +D     P  R +  E ++     HP
Sbjct: 363 NFIPEVWAEVSEKALDLVKKLLVVD-----PKARFTTEEALR-----HP 401

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 75/312 (24%), Positives = 121/312 (38%), Gaps = 77/312 (24%)

Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTISEREFKD---KIEGVGAVNHEN 426
           + LG+G FG   KA           T VAVK LK+   S  E +D   +   +  VNH +
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPH 87

Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL------------ 474
           ++ L          LL+ +Y   GSL   L  ++  G   L                   
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 475 -------IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST 527
                   A   ++G++YL      + H ++ + NIL+ +  + ++SDFGL+  V    +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM--KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

Query: 528 PNRVAGYR------------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNE 574
                 Y             A E       + ++DV+SFGVLL E++T G  P   +  E
Sbjct: 206 ------YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259

Query: 575 EGVDLPRWVQSIVKDEWTSEVFDLELLRY-----QNVEEEMVQLLQLAIDCSAQYPDNRP 629
                               +F+L    +      N  EEM +L+     C  Q PD RP
Sbjct: 260 R-------------------LFNLLKTGHRMERPDNCSEEMYRLML---QCWKQEPDKRP 297

Query: 630 SMSEVIKRIEEL 641
             +++ K +E++
Sbjct: 298 VFADISKDLEKM 309

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 79.5 bits (197), Expect = 2e-16
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 37/210 (17%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLK--------DVTISEREFKDKIEGVGAVNHENL 427
           E +G+GT+G  YKA    G IVA+KR++          T + RE     E    ++H N+
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPST-AIREISLLKE----LHHPNI 81

Query: 428 VPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWE-----MRSLIALGAAR 481
           V L    +S +  L LV++++    L  +L  N    +T L        +  L+     R
Sbjct: 82  VSLIDVIHS-ERCLTLVFEFMEK-DLKKVLDEN----KTGLQDSQIKIYLYQLL-----R 130

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP--NRVAG--YRAP 537
           G+ + H     + H ++K  N+L+      +++DFGLA   G       + V    YRAP
Sbjct: 131 GVAHCHQH--RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188

Query: 538 EVTDPCKV-SQKADVYSFGVLLLELLTGKA 566
           +V    K  S   D++S G +  E++TGK 
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 42/217 (19%)

Query: 376 EVLGKGTFGTAYKA--VLEMGTIVAVKRLKDVTISEREFKDKIEGV-------------- 419
             +G+G +G  +KA  +   G  VA+KR++    +  E      G+              
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEE------GMPLSTIREVAVLRHL 68

Query: 420 GAVNHENLVPLR----AYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWE--MR 472
               H N+V L           + KL LV++++    L+  L      G      +  M 
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMF 127

Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP-NRV 531
            L+     RG+++LH+    V H ++K  NIL+T S + +++DFGLA +        + V
Sbjct: 128 QLL-----RGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180

Query: 532 AG--YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKA 566
               YRAPEV      +   D++S G +  E+   K 
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 33/140 (23%), Positives = 55/140 (39%), Gaps = 13/140 (9%)

Query: 70  RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNH 129
           ++  LR+    L+  IP  +     +L  L L  N + +    DL   S L  L L  N 
Sbjct: 173 KLNYLRISEAKLT-GIPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQ 228

Query: 130 FSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIP------ 183
                   L  L  L  L+L  N  S  +P+G  +L  L+ ++L  N ++  +       
Sbjct: 229 IRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCP 286

Query: 184 -GFDDVLPNLQQLNVSNNLL 202
            GF         +++ NN +
Sbjct: 287 VGFGVKRAYYNGISLFNNPV 306

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 78.1 bits (193), Expect = 9e-16
 Identities = 28/126 (22%), Positives = 42/126 (33%), Gaps = 13/126 (10%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
           I L  L   + L  L L  N +       L+    LR L+L  N  S  VP  L  L  L
Sbjct: 208 IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLL 266

Query: 145 VRLNLATNNFSGEIPSG-------FKNLTKLKTLFLENNRLS-GSIPG--FDDVLPNLQQ 194
             + L TNN + ++                   + L NN +    +    F   + +   
Sbjct: 267 QVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC-VTDRLA 324

Query: 195 LNVSNN 200
           +   N 
Sbjct: 325 IQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 28/132 (21%), Positives = 49/132 (37%), Gaps = 11/132 (8%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQ-LPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
           +P G+   L ++  + +  N L +            L  L +     +  +P  L     
Sbjct: 138 VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PET 194

Query: 144 LVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNN 200
           L  L+L  N     I        +KL  L L +N++   I        LP L++L++ NN
Sbjct: 195 LNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSF-LPTLRELHLDNN 251

Query: 201 LLNGSIPKRFQT 212
            L+  +P     
Sbjct: 252 KLS-RVPAGLPD 262

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 34/142 (23%), Positives = 55/142 (38%), Gaps = 18/142 (12%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
           +P  I  + T    L L+ N ++     D     +L  L L  N  S         L  L
Sbjct: 48  VPKEISPDTT---LLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104

Query: 145 VRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNNL 201
            +L ++ N+   EIP     +L +L+   + +NR+   +P   F   L N+  + +  N 
Sbjct: 105 QKLYISKNHLV-EIPPNLPSSLVELR---IHDNRIR-KVPKGVFSG-LRNMNCIEMGGNP 158

Query: 202 LNGSIPKRFQTFGSNSFLGNSL 223
           L  S       F   +F G  L
Sbjct: 159 LENS------GFEPGAFDGLKL 174

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 32/128 (25%), Positives = 48/128 (37%), Gaps = 11/128 (8%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
           +       L  L  L L  N ++       +    L+ LY+  NH   E+P  L     L
Sbjct: 69  LRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSL 125

Query: 145 VRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRL-SGSIPG--FDDVLPNLQQLNVSNN 200
           V L +  N    ++P G F  L  +  + +  N L +       FD +   L  L +S  
Sbjct: 126 VELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL--KLNYLRISEA 182

Query: 201 LLNGSIPK 208
            L   IPK
Sbjct: 183 KLT-GIPK 189

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 25/102 (24%), Positives = 42/102 (41%), Gaps = 11/102 (10%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP-------LF 137
           I  G L  L +LR L L  N L+  +P+ L     L+ +YL  N+ + +V         F
Sbjct: 232 IENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGF 289

Query: 138 LVGLHHLVRLNLATNNFS-GEIPSG-FKNLTKLKTLFLENNR 177
            V   +   ++L  N     E+    F+ +T    +   N +
Sbjct: 290 GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 27/207 (13%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKD---KIEGVGAVNHENLVPLR 431
           E LGKG F    + V    G   A K +    +S R+F+    +      + H N+V L 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 432 AYYYSMDEKLLVYDYLTMGSL--SALLHGN---KGAGRTPLNWEMRSLIALGAARGIEYL 486
                     LV+D +T G L    +         A        ++ ++       I Y 
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQIL-----ESIAYC 121

Query: 487 HAQGPNVSHGNIKSSNILL-TKSYEARV--SDFGLAHLVGPSSTPNRVAG---YRAPEVT 540
           H+ G  + H N+K  N+LL +K+  A V  +DFGLA  V  S   +  AG   Y +PEV 
Sbjct: 122 HSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAP 567
                S+  D+++ GV+L  LL G  P
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPP 206

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 80.5 bits (199), Expect = 3e-16
 Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 33/210 (15%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
           +VLG G  G   +          A+K L+D   + RE   ++    A    ++V +   Y
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE--VELH-WRASQCPHIVRIVDVY 124

Query: 435 ---YSMDEKL-LVYDYLTMGSL----SALLHGN---KGAGRTPLNWEMRSLIALGAARGI 483
              Y+  + L +V + L  G L              + A        M+S+        I
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-----MKSI-----GEAI 174

Query: 484 EYLHAQGPNVSHGNIKSSNILL-TKSYEA--RVSDFGLAHLVGPS---STPNRVAGYRAP 537
           +YLH+    ++H ++K  N+L  +K   A  +++DFG A         +TP     Y AP
Sbjct: 175 QYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232

Query: 538 EVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           EV  P K  +  D++S GV++  LL G  P
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 30/214 (14%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVG-AVNHENLVPLRAY 433
           E +G G++    + +        AVK +     S+R+  ++IE +     H N++ L+  
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKIIDK---SKRDPTEEIEILLRYGQHPNIITLKDV 84

Query: 434 YYSMDEKLLVYDYLTMGSL--SALLHGN---KGAGRTPLNWEMRSLIALGAARGIEYLHA 488
           Y       +V + +  G L    L       + A        + ++      + +EYLHA
Sbjct: 85  YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV-----LFTI-----TKTVEYLHA 134

Query: 489 QGPNVSHGNIKSSNILL-TKSYEA---RVSDFGLAHLVGPS----STPNRVAGYRAPEVT 540
           QG  V H ++K SNIL   +S      R+ DFG A  +        TP   A + APEV 
Sbjct: 135 QG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 192

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNE 574
           +        D++S GVLL  +LTG  P     ++
Sbjct: 193 ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD 226

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 37/211 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGA---------VNHE 425
           + +G G +G    AV    G  VA+K+L         F+ ++    A         + HE
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP------FQSELFAKRAYRELRLLKHMRHE 84

Query: 426 NLVPLR------AYYYSMDEKLLVYDYLTMGS-LSALLHGNKGAGRTPLNWEMRSLIALG 478
           N++ L              +  LV  +  MG+ L  L+          L  +    +   
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPF--MGTDLGKLMKHE------KLGEDRIQFLVYQ 136

Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRA 536
             +G+ Y+HA    + H ++K  N+ + +  E ++ DFGLA       T   V    YRA
Sbjct: 137 MLKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY-VVTRWYRA 193

Query: 537 PEVTDPCKV-SQKADVYSFGVLLLELLTGKA 566
           PEV       +Q  D++S G ++ E++TGK 
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 78.3 bits (194), Expect = 4e-16
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 25/204 (12%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLK--------DVTISEREFKDKIEGVGAVNHENL 427
           E +G+GT+G  YKA    G   A+K+++          T + RE     E    + H N+
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPST-TIREISILKE----LKHSNI 62

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           V L    ++    +LV+++L    L  LL   +G     L         L    GI Y H
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCH 117

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP--NRVAG--YRAPEVTDPC 543
            +   V H ++K  N+L+ +  E +++DFGLA   G       + +    YRAP+V    
Sbjct: 118 DR--RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 544 KV-SQKADVYSFGVLLLELLTGKA 566
           K  S   D++S G +  E++ G  
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTP 199

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 78.8 bits (195), Expect = 4e-16
 Identities = 44/220 (20%), Positives = 87/220 (39%), Gaps = 30/220 (13%)

Query: 366 DLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRL---KDVTISEREFKDKIEGVGA 421
           +  +    +++ LG+G F    + +    G   A K L   +       E   +I  +  
Sbjct: 25  NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84

Query: 422 VNH-ENLVPLRAYYYSMDEKLLVYDYLTMGSL----SALLHGN---KGAGRTPLNWEMRS 473
                 ++ L   Y +  E +L+ +Y   G +       L          R      ++ 
Sbjct: 85  AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-----IKQ 139

Query: 474 LIALGAARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEARV--SDFGLAHLVGPSSTPNR 530
           ++      G+ YLH    N+ H ++K  NILL +      +   DFG++  +G +     
Sbjct: 140 IL-----EGVYYLHQN--NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE 192

Query: 531 VAG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP 567
           + G   Y APE+ +   ++   D+++ G++   LLT  +P
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 79.0 bits (195), Expect = 5e-16
 Identities = 52/217 (23%), Positives = 85/217 (39%), Gaps = 37/217 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVK--RLKDVTISEREFKDKIEGVGA--------VNH 424
           +V+G+G      + V    G   AVK   +    +S  + ++  E              H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 425 ENLVPLRAYYYSMDEKLLVYDYLTMGSL--SALLHGN---KGAGRTPLNWEMRSLIALGA 479
            +++ L   Y S     LV+D +  G L            K          MRSL+    
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI-----MRSLL---- 210

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRA 536
              + +LHA    + H ++K  NILL  + + R+SDFG +  + P      + G   Y A
Sbjct: 211 -EAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLA 267

Query: 537 PEVTDPCKV------SQKADVYSFGVLLLELLTGKAP 567
           PE+             ++ D+++ GV+L  LL G  P
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 78.2 bits (193), Expect = 5e-16
 Identities = 32/113 (28%), Positives = 49/113 (43%), Gaps = 8/113 (7%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L NLT +  L L  N L +   S +A   +++ L L     +   PL   GL +L  L L
Sbjct: 81  LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTPL--AGLSNLQVLYL 136

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL 202
             N  +  I S    LT L+ L + N ++S  +    + L  L  L   +N +
Sbjct: 137 DLNQIT-NI-SPLAGLTNLQYLSIGNAQVS-DLTPLAN-LSKLTTLKADDNKI 185

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 32/132 (24%), Positives = 54/132 (40%), Gaps = 8/132 (6%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L  L++L+ L L  N +T+   S LA  +NL+ L +     S   PL    L  L  L  
Sbjct: 125 LAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDLTPL--ANLSKLTTLKA 180

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKR 209
             N  S +I S   +L  L  + L+NN++S  +    +   NL  + ++N  +       
Sbjct: 181 DDNKIS-DI-SPLASLPNLIEVHLKNNQIS-DVSPLAN-TSNLFIVTLTNQTITNQPVFY 236

Query: 210 FQTFGSNSFLGN 221
                  + +  
Sbjct: 237 NNNLVVPNVVKG 248

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 21/114 (18%), Positives = 49/114 (42%), Gaps = 8/114 (7%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
              L +   ++   +++T       A    +  L   G   +  +   +  L++L+ L L
Sbjct: 15  DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLEL 70

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
             N  + ++ +  KNLTK+  L L  N L  ++      L +++ L++++  + 
Sbjct: 71  KDNQIT-DL-APLKNLTKITELELSGNPLK-NVSAIAG-LQSIKTLDLTSTQIT 120

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 32/118 (27%), Positives = 48/118 (40%), Gaps = 9/118 (7%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L  LT+L+ LS+    ++    + LA+ S L  L    N  S   PL    L +L+ ++L
Sbjct: 147 LAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKADDNKISDISPL--ASLPNLIEVHL 202

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
             N  S    S   N + L  + L N  ++ + P F     NL   NV        I 
Sbjct: 203 KNNQISDV--SPLANTSNLFIVTLTNQTIT-NQPVF--YNNNLVVPNVVKGPSGAPIA 255

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 80.7 bits (199), Expect = 6e-16
 Identities = 57/240 (23%), Positives = 92/240 (38%), Gaps = 39/240 (16%)

Query: 369 DLLRASAEVLGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISER--------EFKDKIEGV 419
            + R    ++G+G FG  Y     + G + A+K L    I  +        E +  +  V
Sbjct: 192 SVHR----IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLV 246

Query: 420 GAVNHENLVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL---- 474
              +   +V + +Y +   +KL  + D +  G L   L      G      E        
Sbjct: 247 STGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFS---EADMRFYAA 299

Query: 475 -IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-- 531
            I L    G+E++H +   V + ++K +NILL +    R+SD GLA           V  
Sbjct: 300 EIIL----GLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 353

Query: 532 AGYRAPEV-TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE 590
            GY APEV          AD +S G +L +LL G +P       +  D     +  +   
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ---HKTKDKHEIDRMTLTMA 410

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 78.5 bits (194), Expect = 8e-16
 Identities = 48/213 (22%), Positives = 82/213 (38%), Gaps = 30/213 (14%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISERE---FKDKIEGVGAV---------N 423
             +  G++G     V   G  VA+KR+ +     R      D       +         +
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87

Query: 424 HENLVPLR-----AYYYSMDEKLLVYDYLTMGS-LSALLHGNKGAGRTPLNWEMRSLIAL 477
           H N++ LR         +M +  LV +   M + L+ ++H      R  ++ +       
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTEL--MRTDLAQVIH----DQRIVISPQHIQYFMY 141

Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-PNRVAG--Y 534
               G+  LH     V H ++   NILL  + +  + DF LA      +   + V    Y
Sbjct: 142 HILLGLHVLHEA--GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWY 199

Query: 535 RAPEVTDPCKVSQKA-DVYSFGVLLLELLTGKA 566
           RAPE+    K   K  D++S G ++ E+   KA
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 69/306 (22%), Positives = 113/306 (36%), Gaps = 81/306 (26%)

Query: 369 DLLRASAEVLGKGTFGTAYKAVL----EMGTIVAVK--------RLKDV--TISEREFKD 414
           ++LR     +GKG+FG   K  +    +   + A+K           +V     E +   
Sbjct: 18  EILR----AIGKGSFG---KVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQI-- 68

Query: 415 KIEGVGAVNHENLVPLRAYYYSM--DEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEM 471
               +  + H  LV L    YS   +E + +V D L  G L   L   +         E 
Sbjct: 69  ----MQGLEHPFLVNLW---YSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFK---EE 115

Query: 472 RSL-----IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS 526
                   + +     ++YL  Q   + H ++K  NILL +     ++DF +A ++   +
Sbjct: 116 TVKLFICELVMA----LDYLQNQ--RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169

Query: 527 TPNRVAG---YRAPEVTDPCKV---SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLP 580
               +AG   Y APE+    K    S   D +S GV   ELL G+ P H   +    ++ 
Sbjct: 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI- 228

Query: 581 RWVQSIVKDEWTSEVFDLELLRY-QNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKR 637
             V +               + Y     +EMV LL+  L  +     PD R S    ++ 
Sbjct: 229 --VHTFETTV----------VTYPSAWSQEMVSLLKKLLEPN-----PDQRFSQLSDVQN 271

Query: 638 IEELHP 643
                P
Sbjct: 272 ----FP 273

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 79.4 bits (196), Expect = 1e-15
 Identities = 54/239 (22%), Positives = 93/239 (38%), Gaps = 34/239 (14%)

Query: 369 DLLRASAEVLGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISEREFKDKIEGV-------G 420
              R    VLG+G FG  +   +   G + A K+L    + +R      +G         
Sbjct: 188 LDFR----VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR---KGYQGAMVEKKILA 240

Query: 421 AVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL-----I 475
            V+   +V L   + +  +  LV   +  G +    H        P   E R++     I
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYTAQI 298

Query: 476 ALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG- 533
             G    +E+LH +   + + ++K  N+LL      R+SD GLA  L    +     AG 
Sbjct: 299 VSG----LEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGT 352

Query: 534 --YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE 590
             + APE+    +     D ++ GV L E++  + P  A    E V+     Q +++  
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA--RGEKVENKELKQRVLEQA 409

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 37/211 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGA---------VNHE 425
             +G G +G+   A   + G  VAVK+L         F+  I              + HE
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP------FQSIIHAKRTYRELRLLKHMKHE 88

Query: 426 NLVPLR------AYYYSMDEKLLVYDYLTMGS-LSALLHGNKGAGRTPLNWEMRSLIALG 478
           N++ L             ++  LV     MG+ L+ ++          L  +    +   
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHL--MGADLNNIVKCQ------KLTDDHVQFLIYQ 140

Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--YRA 536
             RG++Y+H+   ++ H ++K SN+ + +  E ++ DFGLA       T   VA   YRA
Sbjct: 141 ILRGLKYIHSA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY-VATRWYRA 197

Query: 537 PEV-TDPCKVSQKADVYSFGVLLLELLTGKA 566
           PE+  +    +Q  D++S G ++ ELLTG+ 
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 35/211 (16%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGV-----------GAVN 423
           + LG+G F T YKA       IVA+K++K       E KD   G+             ++
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIK--LGHRSEAKD---GINRTALREIKLLQELS 70

Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLN---WEMRSLIALGAA 480
           H N++ L   +       LV+D++    L  ++  +     TP +   + M   +     
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIK-DNSLVLTPSHIKAY-MLMTL----- 122

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP--NRVAG--YRA 536
           +G+EYLH     + H ++K +N+LL ++   +++DFGLA   G  +    ++V    YRA
Sbjct: 123 QGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRA 180

Query: 537 PEVTDPCKV-SQKADVYSFGVLLLELLTGKA 566
           PE+    ++     D+++ G +L ELL    
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVP 211

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 61/314 (19%), Positives = 110/314 (35%), Gaps = 88/314 (28%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVK-----RLKDVTISEREFKDKIEGVGA---------- 421
           +GKG++G    A      T  A+K     +L       R    +                
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 422 ------------VNHENLVPLR-AYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPL 467
                       ++H N+V L        ++ L +V++ +  G +  +          PL
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPL 134

Query: 468 NWEM-----RSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV 522
           + +      + LI      GIEYLH Q   + H +IK SN+L+ +    +++DFG+++  
Sbjct: 135 SEDQARFYFQDLIK-----GIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

Query: 523 GPSS--------TPNRVAGYRAPEVTDPCKVS---QKADVYSFGVLLLELLTGKAPTHAL 571
             S         TP     + APE     +     +  DV++ GV L   + G+ P    
Sbjct: 188 KGSDALLSNTVGTPA----FMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF--- 240

Query: 572 LNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRP 629
                  +      I           LE     ++ E++  L+   L  +     P++R 
Sbjct: 241 ---MDERIMCLHSKIKSQA-------LEFPDQPDIAEDLKDLITRMLDKN-----PESRI 285

Query: 630 SMSEVIKRIEELHP 643
            + E+       HP
Sbjct: 286 VVPEIKL-----HP 294

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 76.4 bits (189), Expect = 2e-15
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 32/209 (15%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK--------DVTISEREFKDKIEGVGAVNHEN 426
           E +G+GT+GT +KA   E   IVA+KR++          + + RE     E    + H+N
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS-ALREICLLKE----LKHKN 62

Query: 427 LVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWE--MRSLIALGAARGI 483
           +V L    +S D+KL LV+++     L      +      P   +  +  L+     +G+
Sbjct: 63  IVRLHDVLHS-DKKLTLVFEFCDQ-DLKKYFD-SCNGDLDPEIVKSFLFQLL-----KGL 114

Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP--NRVAG--YRAPEV 539
            + H++  NV H ++K  N+L+ ++ E ++++FGLA   G         V    YR P+V
Sbjct: 115 GFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172

Query: 540 TDPCKV-SQKADVYSFGVLLLELLTGKAP 567
               K+ S   D++S G +  EL     P
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 27/207 (13%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKD---KIEGVGAVNHENLVPLR 431
           E LGKG F    + V    G   A K +    +S R+F+    +      + H N+V L 
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94

Query: 432 AYYYSMDEKLLVYDYLTMGSL--SALLHGN---KGAGRTPLNWEMRSLIALGAARGIEYL 486
                     LV+D +T G L    +         A        ++ ++       I Y 
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQIL-----ESIAYC 144

Query: 487 HAQGPNVSHGNIKSSNILL-TKSYEARV--SDFGLAHLVGPSSTPNRVAG---YRAPEVT 540
           H+ G  + H N+K  N+LL +K+  A V  +DFGLA  V  S   +  AG   Y +PEV 
Sbjct: 145 HSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 202

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAP 567
                S+  D+++ GV+L  LL G  P
Sbjct: 203 KKDPYSKPVDIWACGVILYILLVGYPP 229

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 36/210 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE-------REFKDKIEGVGAVNHENL 427
            ++G+G++G   K    + G IVA+K+  +    +       RE K   +    + HENL
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ----LRHENL 86

Query: 428 VPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWE-----MRSLIALGAAR 481
           V L        ++  LV++++   ++   L          L+++     +  +I      
Sbjct: 87  VNLLEVCKK-KKRWYLVFEFVDH-TILDDLELFPN----GLDYQVVQKYLFQII-----N 135

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP--NRVAG--YRAP 537
           GI + H+   N+ H +IK  NIL+++S   ++ DFG A  +        + VA   YRAP
Sbjct: 136 GIGFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193

Query: 538 EVTDPCKV-SQKADVYSFGVLLLELLTGKA 566
           E+        +  DV++ G L+ E+  G+ 
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEP 223

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 48/216 (22%), Positives = 80/216 (37%), Gaps = 31/216 (14%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDK------IEGVGAVNHENLV 428
           EV+GKG F    + +  E G   AVK +     +                   + H ++V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSL-SALLHGNKGAGRTPLNWE------MRSLIALGAAR 481
            L   Y S     +V++++    L   ++   +       + E      MR ++      
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVK--RADAGFVYS-EAVASHYMRQIL-----E 141

Query: 482 GIEYLHAQGPNVSHGNIKSSNILL-TKSYEARV--SDFGLA-HLVGPSSTPNRVAG---Y 534
            + Y H     + H ++K   +LL +K   A V    FG+A  L           G   +
Sbjct: 142 ALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199

Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
            APEV       +  DV+  GV+L  LL+G  P + 
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 30/129 (23%), Positives = 51/129 (39%), Gaps = 10/129 (7%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNHFSGEVPLFLVGLH 142
            +      +   L+ L L    + + +      S S+L  L L GN           GL 
Sbjct: 42  HLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLS 100

Query: 143 HLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG---FDDVLPNLQQLNVS 198
            L +L     N +  + +    +L  LK L + +N +  S      F + L NL+ L++S
Sbjct: 101 SLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSN-LTNLEHLDLS 157

Query: 199 NNLLNGSIP 207
           +N +  SI 
Sbjct: 158 SNKIQ-SIY 165

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 74.6 bits (184), Expect = 6e-15
 Identities = 37/124 (29%), Positives = 64/124 (51%), Gaps = 12/124 (9%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTS-QLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
           +    +G+L +L+ L++  N + S +LP   ++ +NL +L L  N         L  LH 
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174

Query: 144 L----VRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLN 196
           +    + L+L+ N  +  I  G FK + +LK L L+ N+L  S+P   FD  L +LQ++ 
Sbjct: 175 MPLLNLSLDLSLNPMN-FIQPGAFKEI-RLKELALDTNQLK-SVPDGIFDR-LTSLQKIW 230

Query: 197 VSNN 200
           +  N
Sbjct: 231 LHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 28/126 (22%), Positives = 40/126 (31%), Gaps = 34/126 (26%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
           IP  +     S + L L FN L         S   L+ L L                   
Sbjct: 22  IPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ------------- 65

Query: 145 VRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNNL 201
                        I  G +++L+ L TL L  N +  S+    F   L +LQ+L      
Sbjct: 66  ------------TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSG-LSSLQKLVAVETN 111

Query: 202 LNGSIP 207
           L  S+ 
Sbjct: 112 LA-SLE 116

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 26/133 (19%), Positives = 44/133 (33%), Gaps = 14/133 (10%)

Query: 93  LTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP--LFLVGLHHLVRLNLA 150
             S +TL L    L +      ++  N+  +Y+  +    ++    F   L  +  + + 
Sbjct: 30  PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSF-YNLSKVTHIEIR 88

Query: 151 TNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNNLLNGSIP 207
                  I     K L  LK L + N  L    P             L +++N    SIP
Sbjct: 89  NTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147

Query: 208 KRFQTFGSNSFLG 220
                   N+F G
Sbjct: 148 -------VNAFQG 153

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 29/129 (22%), Positives = 46/129 (35%), Gaps = 9/129 (6%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSD--LASCSNLRNLYLQGNHFSGEVP--LFLVG 140
           I    L  L  L+ L +    L    P    + S      L +  N +   +P   F   
Sbjct: 96  IDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGL 154

Query: 141 LHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVS 198
            +  + L L  N F+  +     N TKL  ++L  N+    I    F  V      L+VS
Sbjct: 155 CNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVS 213

Query: 199 NNLLNGSIP 207
              +  ++P
Sbjct: 214 QTSVT-ALP 221

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 46.5 bits (111), Expect = 9e-06
 Identities = 20/92 (21%), Positives = 39/92 (42%), Gaps = 8/92 (8%)

Query: 85  IPLGILGNLTS-LRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP--LFLVGL 141
           IP+     L +   TL L  N  TS +     + + L  +YL  N +   +    F  G+
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAF-GGV 203

Query: 142 HH-LVRLNLATNNFSGEIPSG-FKNLTKLKTL 171
           +     L+++  + +  +PS   ++L +L   
Sbjct: 204 YSGPSLLDVSQTSVT-ALPSKGLEHLKELIAR 234

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 76.4 bits (189), Expect = 2e-15
 Identities = 50/204 (24%), Positives = 84/204 (41%), Gaps = 24/204 (11%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE-------REFKDKIEGVGAVNHENL 427
             +G+G++G  +K    + G IVA+K+  +            RE +   +    + H NL
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQ----LKHPNL 64

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           V L   +       LV++Y     L  L    +G     +       +     + + + H
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTL-----QAVNFCH 119

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP--NRVAG--YRAPEVTDPC 543
               N  H ++K  NIL+TK    ++ DFG A L+   S    + VA   YR+PE+    
Sbjct: 120 KH--NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD 177

Query: 544 KV-SQKADVYSFGVLLLELLTGKA 566
                  DV++ G +  ELL+G  
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVP 201

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 28/160 (17%), Positives = 52/160 (32%), Gaps = 25/160 (15%)

Query: 64  VECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNL 123
             C++++VT           +IP  +  N      L      L        +   +L  +
Sbjct: 14  FLCQESKVT-----------EIPSDLPRNAI---ELRFVLTKLRVIQKGAFSGFGDLEKI 59

Query: 124 YLQGNHFSGEVPLF-LVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGS 181
            +  N     +       L  L  + +   N    I    F+NL  L+ L + N  +   
Sbjct: 60  EISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-H 118

Query: 182 IPGFD-DVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLG 220
           +P            L++ +N+   +I         NSF+G
Sbjct: 119 LPDVHKIHSLQKVLLDIQDNINIHTIE-------RNSFVG 151

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 28/129 (21%), Positives = 43/129 (33%), Gaps = 11/129 (8%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP--LFLVGLH 142
           I      NL +L+ L +    +                L +Q N     +    F VGL 
Sbjct: 95  INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF-VGLS 153

Query: 143 H-LVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVS 198
              V L L  N    EI +  F      +    +NN L   +P   F         L++S
Sbjct: 154 FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHG-ASGPVILDIS 210

Query: 199 NNLLNGSIP 207
              ++ S+P
Sbjct: 211 RTRIH-SLP 218

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 22/197 (11%), Positives = 54/197 (27%), Gaps = 37/197 (18%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIE----GVGAVNHENLVPL 430
              G       ++A+   +   VA+  +    +   +   +       +  ++   +  +
Sbjct: 37  IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
               ++    L+V +++  GSL  +         T  +           A   +  H  G
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVA-------DTSPSPVGAIRAMQSLAAAADAAHRAG 149

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKAD 550
             V+      S + ++   +  ++         P                         D
Sbjct: 150 --VALSIDHPSRVRVSIDGDVVLAYPATMPDANPQD-----------------------D 184

Query: 551 VYSFGVLLLELLTGKAP 567
           +   G  L  LL  + P
Sbjct: 185 IRGIGASLYALLVNRWP 201

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 76.5 bits (189), Expect = 4e-15
 Identities = 53/222 (23%), Positives = 95/222 (42%), Gaps = 48/222 (21%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK--------DVTISEREFKDKIEGVGAVNHEN 426
             +G+GTFG  +KA   + G  VA+K++          +T + RE    I+ +  + HEN
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT-ALRE----IKILQLLKHEN 77

Query: 427 LVPLR-------AYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWE-----MRS 473
           +V L        + Y      + LV+D+     L+ LL                   M+ 
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS----NVLVKFTLSEIKRVMQM 132

Query: 474 LIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTP---- 528
           L+      G+ Y+H     + H ++K++N+L+T+    +++DFGLA       ++     
Sbjct: 133 LL-----NGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185

Query: 529 -NRVAG--YRAPEVTDPCKV-SQKADVYSFGVLLLELLTGKA 566
            NRV    YR PE+    +      D++  G ++ E+ T   
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 76.8 bits (189), Expect = 4e-15
 Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 44/233 (18%)

Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAV---LEMGTIVAVKRLKDVTISE---REFKDKI 416
           RV DL +        +G+GT+G  YKA     +     A+K+++   IS    RE    I
Sbjct: 17  RVEDLFEYEG---CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----I 69

Query: 417 EGVGAVNHENLVPLR-AYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWE---- 470
             +  + H N++ L+  +    D K+ L++DY     L  ++  ++ +       +    
Sbjct: 70  ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRG 128

Query: 471 -----MRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEAR----VSDFGLAHL 521
                +  ++      GI YLHA    V H ++K +NIL+      R    ++D G A L
Sbjct: 129 MVKSLLYQIL-----DGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181

Query: 522 VGP-----SSTPNRVAG--YRAPEVTDPCKVSQKA-DVYSFGVLLLELLTGKA 566
                   +     V    YRAPE+    +   KA D+++ G +  ELLT + 
Sbjct: 182 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 234

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 77.6 bits (191), Expect = 4e-15
 Identities = 27/115 (23%), Positives = 51/115 (44%), Gaps = 6/115 (5%)

Query: 88  GILGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVR 146
            +   + SL+ L +  NS++        +   +L +L +  N  +  +  F      +  
Sbjct: 368 EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI--FRCLPPRIKV 425

Query: 147 LNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVSNN 200
           L+L +N     IP     L  L+ L + +N+L  S+P G  D L +LQ++ +  N
Sbjct: 426 LDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 35/127 (27%), Positives = 56/127 (44%), Gaps = 7/127 (5%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTS--QLPSDLASCSNLRNLYLQGNHF-SGEVPLFLVGL 141
                 G+LT L TL L+ N L    ++        +L+ L +  N     E        
Sbjct: 339 TVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWT 398

Query: 142 HHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNL 201
             L+ LN+++N  +  I        ++K L L +N++  SIP     L  LQ+LNV++N 
Sbjct: 399 KSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQ 455

Query: 202 LNGSIPK 208
           L  S+P 
Sbjct: 456 LK-SVPD 461

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 70.3 bits (172), Expect = 9e-13
 Identities = 27/130 (20%), Positives = 43/130 (33%), Gaps = 9/130 (6%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
            +P  +         L++  N ++    SD+ S S LR L +  N               
Sbjct: 14  HVPKDLS---QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQE 70

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIP--GFDDVLPNLQQLNVSNNL 201
           L  L+L+ N    +I         LK L L  N    ++P       +  L+ L +S   
Sbjct: 71  LEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTH 126

Query: 202 LNGSIPKRFQ 211
           L  S      
Sbjct: 127 LEKSSVLPIA 136

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 69.5 bits (170), Expect = 1e-12
 Identities = 30/198 (15%), Positives = 67/198 (33%), Gaps = 5/198 (2%)

Query: 14  LLLLLIISTFSFSFSDLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQNRVTM 73
           +  +L  +  S+  S L+  +        ++      WN +                ++ 
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN 256

Query: 74  LRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGE 133
           ++L G             +L +L    +  +             SN+       +     
Sbjct: 257 VKLQGQLDFRDFDY-SGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315

Query: 134 VPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIP---GFDDVLP 190
             L    +   + L+ + N  +  +     +LT+L+TL L+ N+L   +         + 
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMK 374

Query: 191 NLQQLNVSNNLLNGSIPK 208
           +LQQL++S N ++    K
Sbjct: 375 SLQQLDISQNSVSYDEKK 392

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 68.4 bits (167), Expect = 3e-12
 Identities = 31/162 (19%), Positives = 54/162 (33%), Gaps = 9/162 (5%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSD-LASCSNLRNLYLQGNHFSGEVPLFLVGLH 142
           ++    + +L+ LR L +  N +   L          L  L L  N       +      
Sbjct: 35  ELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLSHNKLVK---ISCHPTV 90

Query: 143 HLVRLNLATNNFSGEIPSG--FKNLTKLKTLFLENNRL-SGSIPGFDDVLPNLQQLNVSN 199
           +L  L+L+ N F   +P    F N+++LK L L    L   S+     +  +   L +  
Sbjct: 91  NLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGE 149

Query: 200 NLLNGSIPKRFQTFGSNSFLGNSLCGKPLQDCGTKASLVVPS 241
                  P+  Q F + S        K        +   V +
Sbjct: 150 TYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN 191

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 68.0 bits (166), Expect = 4e-12
 Identities = 23/128 (17%), Positives = 42/128 (32%), Gaps = 3/128 (2%)

Query: 86  PLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLV 145
              I    +++   +   +          +  S   +L    N  +  V      L  L 
Sbjct: 292 QSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELE 351

Query: 146 RLNLATNNFS--GEIPSGFKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVSNNLL 202
            L L  N      +I      +  L+ L +  N +S     G      +L  LN+S+N+L
Sbjct: 352 TLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411

Query: 203 NGSIPKRF 210
             +I +  
Sbjct: 412 TDTIFRCL 419

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 26/217 (11%), Positives = 59/217 (27%), Gaps = 20/217 (9%)

Query: 10  QNIFLLLLLIISTFSFSFSDLSSDRAALLALRSSVGGRTLLWNVYEASPCKWAGVECEQN 69
           Q+     L I+   +  F  +       +A       + +L +   +             
Sbjct: 161 QDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNP 220

Query: 70  RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNH 129
           +++ L L  +  +    + IL  +                         ++ N+ LQG  
Sbjct: 221 KLSNLTLNNIETTWNSFIRILQLVWHTTVWYF-----------------SISNVKLQGQL 263

Query: 130 FSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVL 189
              +       L  L    + ++ F       ++  + +       +            +
Sbjct: 264 DFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKI 323

Query: 190 PNLQQLNVSNNLLNGSIPKRFQTFGSNSFL---GNSL 223
                L+ SNNLL  ++ +          L    N L
Sbjct: 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 54.5 bits (131), Expect = 7e-08
 Identities = 25/138 (18%), Positives = 43/138 (31%), Gaps = 4/138 (2%)

Query: 91  GNLTSLRTLSLRFNSLTS-QLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL-VRLN 148
               +L+ L L FN+  +  +  +  + S L+ L L   H      L +  L+   V L 
Sbjct: 87  HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146

Query: 149 LATNNFSGEIPSGFKNL--TKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSI 206
           L       E P G ++     L  +F  N      +      + NL+  N+   L +   
Sbjct: 147 LGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC 206

Query: 207 PKRFQTFGSNSFLGNSLC 224
                             
Sbjct: 207 SYFLSILAKLQTNPKLSN 224

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 42.2 bits (99), Expect = 5e-04
 Identities = 15/72 (20%), Positives = 26/72 (36%), Gaps = 2/72 (2%)

Query: 84  QIPLGILGNLTS-LRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLH 142
            +   I   L   ++ L L  N + S +P  +     L+ L +  N            L 
Sbjct: 410 ILTDTIFRCLPPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRLT 468

Query: 143 HLVRLNLATNNF 154
            L ++ L TN +
Sbjct: 469 SLQKIWLHTNPW 480

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 77.9 bits (192), Expect = 4e-15
 Identities = 59/207 (28%), Positives = 84/207 (40%), Gaps = 29/207 (14%)

Query: 377 VLGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISEREFKDKIEGV-------GAVNHENLV 428
           VLGKG FG      V   G + A K+L+   I +R                  VN   +V
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGEAMALNEKQILEKVNSRFVV 247

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL-----IALGAARGI 483
            L   Y + D   LV   +  G L    H     G+     E R++     I  G    +
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDL--KFHIYH-MGQAGFP-EARAVFYAAEICCG----L 299

Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVT 540
           E LH +   + + ++K  NILL      R+SD GLA  V    T     G   Y APEV 
Sbjct: 300 EDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 357

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAP 567
              + +   D ++ G LL E++ G++P
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSP 384

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 77.5 bits (190), Expect = 5e-15
 Identities = 34/113 (30%), Positives = 52/113 (46%), Gaps = 8/113 (7%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
              L S+  +    + + S     +    N+  L+L GN  +   PL    L +L  L L
Sbjct: 39  QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKPLT--NLKNLGWLFL 94

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL 202
             N    ++ S  K+L KLK+L LE+N +S  I G    LP L+ L + NN +
Sbjct: 95  DENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DINGLVH-LPQLESLYLGNNKI 143

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 76.3 bits (187), Expect = 1e-14
 Identities = 32/111 (28%), Positives = 51/111 (45%), Gaps = 8/111 (7%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           +  L ++  L L  N LT      L +  NL  L+L  N       L    L  L  L+L
Sbjct: 61  IQYLPNVTKLFLNGNKLTDI--KPLTNLKNLGWLFLDENKIKDLSSL--KDLKKLKSLSL 116

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
             N  S +I +G  +L +L++L+L NN+++  I      L  L  L++ +N
Sbjct: 117 EHNGIS-DI-NGLVHLPQLESLYLGNNKIT-DITVLSR-LTKLDTLSLEDN 163

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 72.8 bits (178), Expect = 1e-13
 Identities = 33/121 (27%), Positives = 49/121 (40%), Gaps = 8/121 (6%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L +L  L++LSL  N ++    + L     L +LYL  N  +      L  L  L  L+L
Sbjct: 105 LKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSL 160

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKR 209
             N  S +I      LTKL+ L+L  N +S  +      L NL  L + +          
Sbjct: 161 EDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DLRALAG-LKNLDVLELFSQECLNKPINH 216

Query: 210 F 210
            
Sbjct: 217 Q 217

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 71.3 bits (174), Expect = 5e-13
 Identities = 21/114 (18%), Positives = 43/114 (37%), Gaps = 14/114 (12%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGN---HFSGEVPLFLVGLHHLVR 146
                     +L+  S+T          +++  +    +      G     +  L ++ +
Sbjct: 17  DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG-----IQYLPNVTK 69

Query: 147 LNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
           L L  N  + +I     NL  L  LFL+ N++   +    D L  L+ L++ +N
Sbjct: 70  LFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSSLKD-LKKLKSLSLEHN 119

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 68.2 bits (166), Expect = 4e-12
 Identities = 29/114 (25%), Positives = 44/114 (38%), Gaps = 6/114 (5%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L +L  L +L L  N +T    + L+  + L  L L+ N  S  VPL   GL  L  L L
Sbjct: 127 LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPL--AGLTKLQNLYL 182

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
           + N+ S ++      L  L  L L +             L     +  ++  L 
Sbjct: 183 SKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 51.6 bits (123), Expect = 7e-07
 Identities = 13/84 (15%), Positives = 28/84 (33%), Gaps = 6/84 (7%)

Query: 120 LRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLS 179
           +              P         ++ NL   + +  +      L  +  +   N+ + 
Sbjct: 1   MGETITVSTPIKQIFPD--DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56

Query: 180 GSIPGFDDVLPNLQQLNVSNNLLN 203
            S+ G    LPN+ +L ++ N L 
Sbjct: 57  -SVQGIQY-LPNVTKLFLNGNKLT 78

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 75.8 bits (187), Expect = 5e-15
 Identities = 59/311 (18%), Positives = 120/311 (38%), Gaps = 75/311 (24%)

Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLK-DVTISER-EFKDKIEGVGAVNHENL 427
             +G+G FG  ++A        E  T+VAVK LK + +   + +F+ +   +   ++ N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL------------- 474
           V L           L+++Y+  G L+  L          L+    S              
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 475 ------IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP 528
                 IA   A G+ YL  +     H ++ + N L+ ++   +++DFGL+  +  +   
Sbjct: 173 CAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY- 229

Query: 529 NRVAGYR------------APEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEE 575
                Y+             PE     + + ++DV+++GV+L E+ + G  P + + +EE
Sbjct: 230 -----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284

Query: 576 GVDLPRWVQSIVKDEWTSEVFDLELLRY-----QNVEEEMVQLLQLAIDCSAQYPDNRPS 630
                              V             +N   E+  L++    C ++ P +RPS
Sbjct: 285 -------------------VIYYVRDGNILACPENCPLELYNLMR---LCWSKLPADRPS 322

Query: 631 MSEVIKRIEEL 641
              + + ++ +
Sbjct: 323 FCSIHRILQRM 333

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 77.2 bits (190), Expect = 5e-15
 Identities = 36/139 (25%), Positives = 60/139 (43%), Gaps = 15/139 (10%)

Query: 64  VECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASC-SNLRN 122
           +  ++N +       VA        +  N++SL TL +  NSL S       +   ++  
Sbjct: 382 LILQRNGLKNF--FKVA-------LMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432

Query: 123 LYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSI 182
           L L  N  +G V   L     +  L+L  N     IP    +L  L+ L + +N+L  S+
Sbjct: 433 LNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SV 488

Query: 183 P-GFDDVLPNLQQLNVSNN 200
           P G  D L +LQ + + +N
Sbjct: 489 PDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 74.1 bits (182), Expect = 5e-14
 Identities = 39/138 (28%), Positives = 57/138 (41%), Gaps = 12/138 (8%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHF----SGEVPLFLV 139
                    L  L+TL L+ N L +          N+ +L           S        
Sbjct: 367 DSVFQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCA 425

Query: 140 GLHHLVRLNLATNNFSGEIPSGFKNLT-KLKTLFLENNRLSGSIPGFDDVLPNLQQLNVS 198
               ++ LNL++N  +G +   F+ L  K+K L L NNR+  SIP     L  LQ+LNV+
Sbjct: 426 WAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVA 481

Query: 199 NNLLNGSIPK-RFQTFGS 215
           +N L  S+P   F    S
Sbjct: 482 SNQLK-SVPDGVFDRLTS 498

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 67.2 bits (164), Expect = 9e-12
 Identities = 31/151 (20%), Positives = 52/151 (34%), Gaps = 14/151 (9%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSG-EVPLFLVGLH 142
            +P  +       + LSL  NS++     D++  S LR L L  N     +  +FL    
Sbjct: 45  HVPKDLP---PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFL-FNQ 100

Query: 143 HLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPG---FDDVLPNLQQLNVSN 199
            L  L+++ N     I      +  L+ L L  N     +P    F + L  L  L +S 
Sbjct: 101 DLEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGN-LTKLTFLGLSA 155

Query: 200 NLLNGSIPKRFQTFGSNSFLGNSLCGKPLQD 230
                 +          S +   L    ++ 
Sbjct: 156 AKFR-QLDLLPVAHLHLSCILLDLVSYHIKG 185

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 54.1 bits (130), Expect = 9e-08
 Identities = 16/127 (12%), Positives = 37/127 (29%), Gaps = 5/127 (3%)

Query: 92  NLTSLRTLSLRFNSLTSQLPSDLASCS--NLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
            +  L   +L       +     +  +  +L   +++   F             +    L
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336

Query: 150 ATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPK 208
           + ++ +  I      + +    L    N  + S+      L  LQ L +  N L  +  K
Sbjct: 337 SISD-TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFK 394

Query: 209 RFQTFGS 215
                 +
Sbjct: 395 VALMTKN 401

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 16/121 (13%), Positives = 32/121 (26%)

Query: 93  LTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATN 152
           L  + T       L            N+ NL +       E       L  L+  ++   
Sbjct: 256 LQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQ 315

Query: 153 NFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQT 212
            F     + +    ++    L  +              +   LN + N+   S+ +   T
Sbjct: 316 VFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCST 375

Query: 213 F 213
            
Sbjct: 376 L 376

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 34/136 (25%), Positives = 50/136 (36%), Gaps = 5/136 (3%)

Query: 91  GNLTSLRTLSLRFNSLTSQLP--SDLASCSNLRNLYLQGNHFSGEVPLFLVGLH-HLVRL 147
             + SLR L L FN     LP   +  + + L  L L    F     L +  LH   + L
Sbjct: 118 CPMASLRHLDLSFNDFDV-LPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILL 176

Query: 148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
           +L + +  G      +       L L  +  S      +  +  L  L +SN  LN    
Sbjct: 177 DLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENC 235

Query: 208 KRFQTFGSNSFLGNSL 223
           +R  TF S    G +L
Sbjct: 236 QRLMTFLSELTRGPTL 251

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 42.2 bits (99), Expect = 5e-04
 Identities = 11/47 (23%), Positives = 23/47 (48%), Gaps = 1/47 (2%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHF 130
            IP  +  +L +L+ L++  N L S         ++L+ ++L  N +
Sbjct: 464 SIPKDVT-HLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 48/210 (22%), Positives = 85/210 (40%), Gaps = 32/210 (15%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK--------DVTISEREFKDKIEGVGAVNHEN 426
             LG+GT+G  YKA+       VA+KR++          T + RE     E    + H N
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGT-AIREVSLLKE----LQHRN 94

Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           ++ L++  +      L+++Y     L   +  N       +   +  LI      G+ + 
Sbjct: 95  IIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLI-----NGVNFC 148

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEAR-----VSDFGLAHLVGPSSTP--NRVAG--YRAP 537
           H++     H ++K  N+LL+ S  +      + DFGLA   G       + +    YR P
Sbjct: 149 HSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPP 206

Query: 538 EVTDPCKV-SQKADVYSFGVLLLELLTGKA 566
           E+    +  S   D++S   +  E+L    
Sbjct: 207 EILLGSRHYSTSVDIWSIACIWAEMLMKTP 236

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 75.8 bits (187), Expect = 1e-14
 Identities = 52/211 (24%), Positives = 84/211 (39%), Gaps = 28/211 (13%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRL--KDVTISERE-FKDKIEGVGAVNHENLVPLR 431
           E LGKG F    + V +  G   A   +  K ++  + +  + +      + H N+V L 
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76

Query: 432 AYYYSMDEKLLVYDYLTMGSL--SALLHGN---KGAGRTPLNWEMRSLIALGAARGIEYL 486
                     L++D +T G L    +         A        ++ ++       + + 
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQIL-----EAVLHC 126

Query: 487 HAQGPNVSHGNIKSSNILL-TKSYEARV--SDFGLA-HLVGPSSTPNRVAG---YRAPEV 539
           H  G  V H N+K  N+LL +K   A V  +DFGLA  + G        AG   Y +PEV
Sbjct: 127 HQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184

Query: 540 TDPCKVSQKADVYSFGVLLLELLTGKAPTHA 570
                  +  D+++ GV+L  LL G  P   
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVGYPPFWD 215

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 37/210 (17%)

Query: 376 EVLGKGTFGTAYKA-VLEMGTIVAVKRLKDVTISEREFKDKIEGV-----------GAVN 423
           + LG+GT+ T YK        +VA+K ++     E E     EG              + 
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIR----LEHE-----EGAPCTAIREVSLLKDLK 58

Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWE--MRSLIALGAAR 481
           H N+V L    ++     LV++YL    L   L  + G      N +  +  L+     R
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLD-DCGNIINMHNVKLFLFQLL-----R 111

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP--NRVAG--YRAP 537
           G+ Y H Q   V H ++K  N+L+ +  E +++DFGLA      +    N V    YR P
Sbjct: 112 GLAYCHRQ--KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPP 169

Query: 538 EVTDPCKV-SQKADVYSFGVLLLELLTGKA 566
           ++       S + D++  G +  E+ TG+ 
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGRP 199

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 52/268 (19%), Positives = 95/268 (35%), Gaps = 61/268 (22%)

Query: 366 DLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAV-- 422
             ED+ +   +VLG+G        + L      AVK      I     K        V  
Sbjct: 9   RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVK-----IIE----KQPGHIRSRVFR 59

Query: 423 ---------NHENLVPLRAYYYSMDEKLLVYDYLTMGSL-SALL-HGN---KGAGRTPLN 468
                     H N++ L  ++   D   LV++ +  GS+ S +    +     A      
Sbjct: 60  EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV--- 116

Query: 469 WEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEA--RVSDFGLAHLVGPS 525
             ++ +     A  +++LH +G  ++H ++K  NIL    +  +  ++ DF L   +  +
Sbjct: 117 --VQDV-----ASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167

Query: 526 STPNRV-----------AGYRAPEVTDPCKVSQK-----ADVYSFGVLLLELLTGKAPTH 569
              + +           A Y APEV +             D++S GV+L  LL+G  P  
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227

Query: 570 ALLNEEGVDLPRWVQSIVKDEWTSEVFD 597
                       W +        + +F+
Sbjct: 228 G----RCGSDCGWDRGEACPACQNMLFE 251

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 50/234 (21%), Positives = 92/234 (39%), Gaps = 51/234 (21%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKR-LKDVTISEREFKDKIEGVGAVNHENLVPLRAY 433
           + LG G+FG   +   +E G   A+K+ L+D     RE    ++ +  ++H N++ L  Y
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVNIIKLVDY 68

Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTP----------------------LNWEM 471
           +Y+  ++                  N                             L+  +
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128

Query: 472 RSLIALGAA--------------RGIEYLHAQGPNVSHGNIKSSNILL-TKSYEARVSDF 516
           +S I  G +              R + ++H+    + H +IK  N+L+ +K    ++ DF
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--GICHRDIKPQNLLVNSKDNTLKLCDF 186

Query: 517 GLAHLVGPSSTPNR--VAG--YRAPEVTDPCKV-SQKADVYSFGVLLLELLTGK 565
           G A  + PS  P+   +    YRAPE+       +   D++S G +  EL+ GK
Sbjct: 187 GSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 75.8 bits (187), Expect = 1e-14
 Identities = 32/134 (23%), Positives = 54/134 (40%), Gaps = 13/134 (9%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L N + L+ + +  NSL   LP       +L  +    N    E+P  L  L  L  +  
Sbjct: 149 LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYA 202

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKR 209
             N+   ++P        L+++   NN L   +P   + LP L  +   NNLL  ++P  
Sbjct: 203 DNNSLK-KLPD---LPLSLESIVAGNNILE-ELPELQN-LPFLTTIYADNNLLK-TLPDL 255

Query: 210 FQTFGSNSFLGNSL 223
             +  + +   N L
Sbjct: 256 PPSLEALNVRDNYL 269

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 75.0 bits (185), Expect = 2e-14
 Identities = 26/128 (20%), Positives = 49/128 (38%), Gaps = 25/128 (19%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPS---------------DLASCSNLRNLYLQGNHFSGEV 134
             +L SL   +    +L+   P                +L + S L+ + +  N    ++
Sbjct: 110 PQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KL 168

Query: 135 PLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQ 194
           P        L  +    N    E+P   +NL  L  ++ +NN L   +P   D+  +L+ 
Sbjct: 169 P---DLPPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLP---DLPLSLES 219

Query: 195 LNVSNNLL 202
           +   NN+L
Sbjct: 220 IVAGNNIL 227

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 67.7 bits (166), Expect = 4e-12
 Identities = 34/150 (22%), Positives = 52/150 (34%), Gaps = 37/150 (24%)

Query: 90  LGNLTSLRTLSLRFNSLTS------------------QLPSDLASCSNLRNLYLQGNHFS 131
           L NL  L  +    NSL                    +   +L +   L  +Y   N   
Sbjct: 191 LQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK 250

Query: 132 GEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPG------- 184
             +P        L  LN+  N  + ++P   ++LT L       + LS   P        
Sbjct: 251 -TLPD---LPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 305

Query: 185 ------FDDVLPNLQQLNVSNNLLNGSIPK 208
                   D+ P+L++LNVSNN L   +P 
Sbjct: 306 SNEIRSLCDLPPSLEELNVSNNKLI-ELPA 334

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 66.9 bits (164), Expect = 7e-12
 Identities = 28/137 (20%), Positives = 44/137 (32%), Gaps = 27/137 (19%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLAS-------------CSNLRNLYLQGNHF 130
           ++P+    N+ S       ++      P                        L L     
Sbjct: 25  EMPVEA-ENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGL 83

Query: 131 SGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLP 190
           S  +P       HL  L  + N+ + E+P   ++L  L         LS       D+ P
Sbjct: 84  S-SLP---ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS-------DLPP 131

Query: 191 NLQQLNVSNNLLNGSIP 207
            L+ L VSNN L   +P
Sbjct: 132 LLEYLGVSNNQLE-KLP 147

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 66.9 bits (164), Expect = 8e-12
 Identities = 29/140 (20%), Positives = 51/140 (36%), Gaps = 29/140 (20%)

Query: 89  ILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN 148
           +     SL  L++  N L   LP+       L  L    NH + EVP       +L +L+
Sbjct: 312 LCDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPE---LPQNLKQLH 363

Query: 149 LATNNFSGEIPSGFKNLT----------------KLKTLFLENNRLSGSIPGFDDVLPNL 192
           +  N    E P   +++                  LK L +E N L    P   D+  ++
Sbjct: 364 VEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFP---DIPESV 418

Query: 193 QQLNVSNNLLNGSIPKRFQT 212
           + L +++  +        +T
Sbjct: 419 EDLRMNSERVVDPYEFAHET 438

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 64.6 bits (158), Expect = 4e-11
 Identities = 29/119 (24%), Positives = 46/119 (38%), Gaps = 20/119 (16%)

Query: 89  ILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN 148
           +  +LT L      F+ L+   P       NL  L    N     +         L  LN
Sbjct: 275 LPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SLCDL---PPSLEELN 323

Query: 149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
           ++ N    E+P+      +L+ L    N L+  +P   ++  NL+QL+V  N L    P
Sbjct: 324 VSNNKLI-ELPA---LPPRLERLIASFNHLA-EVP---ELPQNLKQLHVEYNPLR-EFP 373

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 58.9 bits (143), Expect = 3e-09
 Identities = 26/132 (19%), Positives = 47/132 (35%), Gaps = 17/132 (12%)

Query: 92  NLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLAT 151
           + T L+      ++LT  +P +  +  +    Y   + +    P        +    L  
Sbjct: 9   SNTFLQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67

Query: 152 NNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQ 211
                          +   L L N  LS S+P   ++ P+L+ L  S N L   +P+  Q
Sbjct: 68  C-----------LDRQAHELELNNLGLS-SLP---ELPPHLESLVASCNSLT-ELPELPQ 111

Query: 212 TFGSNSFLGNSL 223
           +  S     N+L
Sbjct: 112 SLKSLLVDNNNL 123

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 56.9 bits (138), Expect = 1e-08
 Identities = 22/128 (17%), Positives = 42/128 (32%), Gaps = 27/128 (21%)

Query: 93  LTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATN 152
              L  L   FN L   +P       NL+ L+++ N    E P     +      +L  N
Sbjct: 336 PPRLERLIASFNHLAE-VPELP---QNLKQLHVEYNPLR-EFPDIPESVE-----DLRMN 385

Query: 153 NFSGEIPSGFKNLTKL-----------------KTLFLENNRLSGSIPGFDDVLPNLQQL 195
           +   E+P   +NL +L                 + L + + R+        +    L+  
Sbjct: 386 SHLAEVPELPQNLKQLHVETNPLREFPDIPESVEDLRMNSERVVDPYEFAHETTDKLEDD 445

Query: 196 NVSNNLLN 203
              ++  +
Sbjct: 446 VFEHHHHH 453

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 29/209 (13%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK---DVTISEREFKDKIEGVGAVNHENLVPLR 431
             +G+G +G    A        VA+K++      T  +R  ++ I+ +    HEN++ + 
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE-IKILLRFRHENIIGIN 91

Query: 432 -----AYYYSMDEKLLVYDYLTMGS-LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
                     M +  +V D   M + L  LL          L+ +          RG++Y
Sbjct: 92  DIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQ------HLSNDHICYFLYQILRGLKY 143

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR-----VAG--YRAPE 538
           +H+   NV H ++K SN+LL  + + ++ DFGLA +  P           VA   YRAPE
Sbjct: 144 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201

Query: 539 VTDPCKVSQKA-DVYSFGVLLLELLTGKA 566
           +    K   K+ D++S G +L E+L+ + 
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 76.1 bits (187), Expect = 2e-14
 Identities = 42/174 (24%), Positives = 66/174 (37%), Gaps = 43/174 (24%)

Query: 65  ECEQNRVTMLRLPGVALSGQIPLGILGNLTS-----------------LRTLSLRFNSLT 107
            C  N   +L +    L+  +P  +  ++T+                 LRTL +  N LT
Sbjct: 36  ACLNNGNAVLNVGESGLT-TLPDCLPAHITTLVIPDNNLTSLPALPPELRTLEVSGNQLT 94

Query: 108 SQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLH--------------HLVRLNLATNN 153
           S LP        L        H    +P  L  L                L  L+++ N 
Sbjct: 95  S-LPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQ 152

Query: 154 FSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
            +  +P+    L KL      NN+L+ S+P    +   LQ+L+VS+N L  S+P
Sbjct: 153 LA-SLPALPSELCKLW---AYNNQLT-SLP---MLPSGLQELSVSDNQLA-SLP 197

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 69.2 bits (169), Expect = 2e-12
 Identities = 34/115 (29%), Positives = 52/115 (45%), Gaps = 17/115 (14%)

Query: 93  LTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATN 152
              L+ LS+  N L S LP+     S L  L+   N  +  +P   +    L  L+++ N
Sbjct: 140 PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLT-SLP---MLPSGLQELSVSDN 191

Query: 153 NFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
             +  +P+    L KL      NNRL+ S+P        L++L VS N L  S+P
Sbjct: 192 QLA-SLPTLPSELYKLWAY---NNRLT-SLPAL---PSGLKELIVSGNRLT-SLP 237

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 67.6 bits (165), Expect = 6e-12
 Identities = 27/144 (18%), Positives = 50/144 (34%), Gaps = 16/144 (11%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
              L  L   + R  SL        A  S L+ L + GN  +  +P   V    L  L +
Sbjct: 200 PSELYKLWAYNNRLTSLP-------ALPSGLKELIVSGNRLT-SLP---VLPSELKELMV 248

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKR 209
           + N  +  +P      + L +L +  N+L+  +P     L +   +N+  N L+    + 
Sbjct: 249 SGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA 303

Query: 210 FQTFGSNSFLGNSLCGKPLQDCGT 233
            +   S       +    +     
Sbjct: 304 LREITSAPGYSGPIIRFDMAGASA 327

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 67.6 bits (165), Expect = 7e-12
 Identities = 27/131 (20%), Positives = 48/131 (36%), Gaps = 22/131 (16%)

Query: 93  LTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATN 152
                 L++  + LT+ LP  L   +++  L +  N+ +  +P        L  L ++ N
Sbjct: 39  NNGNAVLNVGESGLTT-LPDCL--PAHITTLVIPDNNLT-SLP---ALPPELRTLEVSGN 91

Query: 153 NFSGEIPSGFKNLTKLKTLFLENNRLSGSIPG-------------FDDVLPNLQQLNVSN 199
             +  +P     L +L         L     G                + P LQ+L+VS+
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSD 150

Query: 200 NLLNGSIPKRF 210
           N L  S+P   
Sbjct: 151 NQLA-SLPALP 160

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 22/112 (19%), Positives = 37/112 (33%), Gaps = 6/112 (5%)

Query: 93  LTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN---L 149
            + L +LS+  N LT  LP  L   S+   + L+GN  S      L  +      +   +
Sbjct: 260 PSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPII 318

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNL 201
             +      P   + L      +L   R     P   D      Q + ++  
Sbjct: 319 RFDMAGASAPRETRALHLAAADWLVPAREGEPAPA--DRWHMFGQEDNADAF 368

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 28/135 (20%), Positives = 44/135 (32%), Gaps = 12/135 (8%)

Query: 82  SGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASC----SNLRNLYLQGNHF---SGEV 134
           S       +    +L TL L  N    +     A C      L+ L L+       SG  
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220

Query: 135 PLFLVGLHHLVRLNLATNNFSGEIP-SGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQ 193
                    L  L+L+ N+             ++L +L L    L   +P    +   L 
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK--GLPAKLS 277

Query: 194 QLNVSNNLLNGSIPK 208
            L++S N L+   P 
Sbjct: 278 VLDLSYNRLD-RNPS 291

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 71.9 bits (176), Expect = 7e-14
 Identities = 30/129 (23%), Positives = 45/129 (34%), Gaps = 12/129 (9%)

Query: 81  LSGQIPLG---ILGNLTSLRTLSLRFNSLTS---QLPSDLASCSNLRNLYLQGNHFSGEV 134
             G+  L          +L+ L+LR   + +      +  A+   L+ L L  N      
Sbjct: 185 ELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244

Query: 135 P-LFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQ 193
                     L  LNL+      ++P G     KL  L L  NRL    P   D LP + 
Sbjct: 245 GAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNP-SPDELPQVG 299

Query: 194 QLNVSNNLL 202
            L++  N  
Sbjct: 300 NLSLKGNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 33/160 (20%), Positives = 54/160 (33%), Gaps = 12/160 (7%)

Query: 69  NRVTMLRLPGVALSGQIPLGIL-GNLTSLRTLSLRFNSLTS--QLPSDLASCS--NLRNL 123
           + +  L L  + ++G  P  +L      L  L+LR  S  +     ++L       L+ L
Sbjct: 95  SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154

Query: 124 YLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIP----SGFKNLTKLKTLFLENNR-- 177
            +   H        +     L  L+L+ N   GE              L+ L L N    
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214

Query: 178 -LSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSN 216
             SG           LQ L++S+N L  +       + S 
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 65.7 bits (160), Expect = 8e-12
 Identities = 32/176 (18%), Positives = 54/176 (30%), Gaps = 18/176 (10%)

Query: 70  RVTMLRLPGVALSGQIPLGILG--NLTSLRTLSLRFNSLTSQLPSDLASCS--NLRNLYL 125
            +  L +    +  +I  G L    ++ L+ L+L    +T   P  L   +  +L  L L
Sbjct: 69  SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128

Query: 126 QGNHFSGEVP----LFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGS 181
           +   ++        L       L  L++A  +         +    L TL L +N   G 
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188

Query: 182 IP----GFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFL------GNSLCGKP 227
                       P LQ L + N  +            +   L       NSL    
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 25/125 (20%), Positives = 40/125 (32%), Gaps = 9/125 (7%)

Query: 92  NLTSLRTLSLRFNSLTSQLPSDLA---SCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN 148
              SL+ L++R   + S++          S L+ L L+    +G  P  L+         
Sbjct: 66  KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125

Query: 149 LATNNFSGEIPSGF------KNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL 202
           L   N S      +           LK L +              V P L  L++S+N  
Sbjct: 126 LNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185

Query: 203 NGSIP 207
            G   
Sbjct: 186 LGERG 190

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 56.4 bits (136), Expect = 9e-09
 Identities = 24/98 (24%), Positives = 35/98 (35%), Gaps = 6/98 (6%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLAS-CSNLRNLYLQGNHFSGEVPLFLVGLHH 143
           +   +      L+ L L  NSL     +      S L +L L       +VP  L     
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAK 275

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGS 181
           L  L+L+ N      PS    L ++  L L+ N    S
Sbjct: 276 LSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 23/139 (16%), Positives = 48/139 (34%), Gaps = 10/139 (7%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLP-SDLASCSNLRNLYLQGNHFSGEVP---LFLVG 140
             + + G   SL  L  R ++       +D+    +L+ L ++       +    L ++G
Sbjct: 34  ADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLG 93

Query: 141 LHHLVRLNLATNNFSGEIPS--GFKNLTKLKTLFLENNRLSGSIPGFDDV----LPNLQQ 194
           +  L  L L     +G  P          L  L L N   +       ++     P L+ 
Sbjct: 94  ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKV 153

Query: 195 LNVSNNLLNGSIPKRFQTF 213
           L+++         ++ + F
Sbjct: 154 LSIAQAHSLNFSCEQVRVF 172

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 18/76 (23%), Positives = 25/76 (32%), Gaps = 5/76 (6%)

Query: 81  LSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVG 140
           L            + L +L+L F  L   +P  L   + L  L L  N      P     
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLP--AKLSVLDLSYNRLD-RNPSPD-E 294

Query: 141 LHHLVRLNLATNNFSG 156
           L  +  L+L  N F  
Sbjct: 295 LPQVGNLSLKGNPFLD 310

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 53/218 (24%), Positives = 98/218 (44%), Gaps = 42/218 (19%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVK-----RLKDVTISEREFKDKIEGVGAVNHENLVP 429
           ++LG+G++G   + +  E     AVK     +L+ +   E   K +I+ +  + H+N++ 
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 430 LRAYYYSMDEKLLVYDYLTM----GSLSALLHGNKGAGRTPLNWEMRS----LIALGAAR 481
           L    Y+ +++ +   Y+ M      +  +L       R P+  +       LI      
Sbjct: 71  LVDVLYNEEKQKM---YMVMEYCVCGMQEMLDSVP-EKRFPV-CQAHGYFCQLID----- 120

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----------TPNRV 531
           G+EYLH+QG  + H +IK  N+LLT     ++S  G+A  + P +          +P   
Sbjct: 121 GLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA-- 176

Query: 532 AGYRAPEVTDPCKV--SQKADVYSFGVLLLELLTGKAP 567
             ++ PE+ +        K D++S GV L  + TG  P
Sbjct: 177 --FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 46/225 (20%), Positives = 85/225 (37%), Gaps = 55/225 (24%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRL--KDVTISEREFKDKIEGV-------GAVNHE 425
           + LG G  G    A   +    VA+K +  +   I      D    V         +NH 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSL--------------SALLHGNKGAGRTPLNWEM 471
            ++ ++ ++ + D   +V + +  G L                L                
Sbjct: 76  CIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLY--------------F 120

Query: 472 RSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEARV--SDFGLAHLVGPSSTP 528
             ++       ++YLH  G  + H ++K  N+LL ++  +  +  +DFG + ++G +S  
Sbjct: 121 YQMLL-----AVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173

Query: 529 NRVAG---YRAPEV---TDPCKVSQKADVYSFGVLLLELLTGKAP 567
             + G   Y APEV         ++  D +S GV+L   L+G  P
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 27/113 (23%), Positives = 43/113 (38%), Gaps = 9/113 (7%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           +   T+L+ L L  N ++    S L   + L  L +  N       +       L RL L
Sbjct: 59  MQFFTNLKELHLSHNQISD--LSPLKDLTKLEELSVNRNRLKNLNGI---PSACLSRLFL 113

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL 202
             N           +L  L+ L + NN+L  SI      L  L+ L++  N +
Sbjct: 114 DNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVMLGF-LSKLEVLDLHGNEI 162

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 27/113 (23%), Positives = 47/113 (41%), Gaps = 9/113 (7%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
              L +    +L   S+T          S ++N     ++      +      +L  L+L
Sbjct: 15  DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSLAGMQ--FFTNLKELHL 70

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL 202
           + N  S ++ S  K+LTKL+ L +  NRL  ++ G       L +L + NN L
Sbjct: 71  SHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNGIP--SACLSRLFLDNNEL 118

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 27/111 (24%), Positives = 47/111 (42%), Gaps = 9/111 (8%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L +LT L  LS+  N L +   + + S   L  L+L  N       L  + L +L  L++
Sbjct: 81  LKDLTKLEELSVNRNRLKN--LNGIPSA-CLSRLFLDNNELRDTDSL--IHLKNLEILSI 135

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
             N     I      L+KL+ L L  N ++ +  G    L  +  ++++  
Sbjct: 136 RNNKLK-SI-VMLGFLSKLEVLDLHGNEIT-NTGGLTR-LKKVNWIDLTGQ 182

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 28/113 (24%), Positives = 51/113 (45%), Gaps = 9/113 (7%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
              L+ ++  +   +++ S   + +   +NL+ L+L  N  S ++   L  L  L  L++
Sbjct: 37  QKELSGVQNFNGDNSNIQS--LAGMQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSV 92

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL 202
             N     + +G  +   L  LFL+NN L          L NL+ L++ NN L
Sbjct: 93  NRNRLK-NL-NGIPSAC-LSRLFLDNNELR-DTDSLIH-LKNLEILSIRNNKL 140

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 23/112 (20%), Positives = 38/112 (33%), Gaps = 12/112 (10%)

Query: 92  NLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLAT 151
               L  L L  N L       L    NL  L ++ N     V L    L  L  L+L  
Sbjct: 104 PSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKSIVML--GFLSKLEVLDLHG 159

Query: 152 NNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
           N  +     G   L K+  + L   +        ++ +    +L ++N + +
Sbjct: 160 NEIT-NT-GGLTRLKKVNWIDLTGQKCV------NEPVKYQPELYITNTVKD 203

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 21/92 (22%), Positives = 36/92 (39%), Gaps = 6/92 (6%)

Query: 112 SDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTL 171
                 +N     L     +  V      L  +   N   +N    + +G +  T LK L
Sbjct: 13  FPDPGLANAVKQNLGKQSVTDLVSQ--KELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKEL 68

Query: 172 FLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
            L +N++S  +    D L  L++L+V+ N L 
Sbjct: 69  HLSHNQIS-DLSPLKD-LTKLEELSVNRNRLK 98

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 25/114 (21%), Positives = 36/114 (31%), Gaps = 6/114 (5%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L +L +L  LS+R N L S     L   S L  L L GN  +    L    L  +  ++L
Sbjct: 124 LIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWIDL 179

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
                  E       L    T+   + R        +    +     V   L  
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISN--GGSYVDGCVLWELPV 231

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 73.1 bits (180), Expect = 4e-14
 Identities = 44/211 (20%), Positives = 85/211 (40%), Gaps = 41/211 (19%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV----TISE----REFKDKIEGVGAVNHEN 426
             LG+G +   ++A+ +     V VK LK V       E       +            N
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRG---------GPN 92

Query: 427 LVPLRAYYYSMDEK--LLVYDYLTMGSLSALLHGNKGAGRTPL-NWEMRSLI--ALGAAR 481
           ++ L         +   LV++++       L           L ++++R  +   L   +
Sbjct: 93  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEIL---K 141

Query: 482 GIEYLHAQGPNVSHGNIKSSNILL-TKSYEARVSDFGLAHLVGPSSTPN-RVAG--YRAP 537
            ++Y H+ G  + H ++K  N+++  +  + R+ D+GLA    P    N RVA   ++ P
Sbjct: 142 ALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 199

Query: 538 EV-TDPCKVSQKADVYSFGVLLLELLTGKAP 567
           E+  D        D++S G +L  ++  K P
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 72.6 bits (179), Expect = 5e-14
 Identities = 55/245 (22%), Positives = 94/245 (38%), Gaps = 52/245 (21%)

Query: 377 VLGKGTFGTAYKAVL-EMGTIVAVK--------RLKDV--TISEREFKDKIEGVGAVNHE 425
           +LG+G+F T   A         A+K        +   V     ER+       +  ++H 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV------MSRLDHP 90

Query: 426 NLVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL-----IALGA 479
             V L  + +  DEKL     Y   G L   +   +  G      E  +      I    
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFD---ETCTRFYTAEIVSA- 142

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV------AG 533
              +EYLH +   + H ++K  NILL +    +++DFG A ++ P S   R       A 
Sbjct: 143 ---LEYLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197

Query: 534 YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA---------LLNEEGVDLPRWVQ 584
           Y +PE+       + +D+++ G ++ +L+ G  P  A         ++  E  D P    
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFF 256

Query: 585 SIVKD 589
              +D
Sbjct: 257 PKARD 261

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 33/111 (29%), Positives = 52/111 (46%), Gaps = 8/111 (7%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           +  L ++  L L  N LT      LA+  NL  L+L  N       L    L  L  L+L
Sbjct: 64  IQYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVKDLSSLK--DLKKLKSLSL 119

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
             N  S +I +G  +L +L++L+L NN+++  I      L  L  L++ +N
Sbjct: 120 EHNGIS-DI-NGLVHLPQLESLYLGNNKIT-DITVLSR-LTKLDTLSLEDN 166

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 20/111 (18%), Positives = 42/111 (37%), Gaps = 8/111 (7%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
                     +L+  S+T          +++  +    +         +  L ++ +L L
Sbjct: 20  DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFL 75

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
             N  + +I     NL  L  LFL+ N++   +    D L  L+ L++ +N
Sbjct: 76  NGNKLT-DI-KPLANLKNLGWLFLDENKVK-DLSSLKD-LKKLKSLSLEHN 122

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 29/113 (25%), Positives = 44/113 (38%), Gaps = 6/113 (5%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L +L  L +L L  N +T    + L+  + L  L L+ N  S  VPL   GL  L  L L
Sbjct: 130 LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPL--AGLTKLQNLYL 185

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL 202
           + N+ S ++      L  L  L L +             L     +  ++  L
Sbjct: 186 SKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 16/89 (17%), Positives = 33/89 (37%), Gaps = 6/89 (6%)

Query: 112 SDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTL 171
               + +      L+    +  V      L+ + ++    ++    +  G + L  +  L
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 73

Query: 172 FLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
           FL  N+L+  I    + L NL  L +  N
Sbjct: 74  FLNGNKLT-DIKPLAN-LKNLGWLFLDEN 100

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 12/66 (18%), Positives = 26/66 (39%), Gaps = 4/66 (6%)

Query: 138 LVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNV 197
                  ++ NL   + +  +      L  +  +   N+ +  S+ G    LPN+ +L +
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGIQY-LPNVTKLFL 75

Query: 198 SNNLLN 203
           + N L 
Sbjct: 76  NGNKLT 81

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 73.2 bits (180), Expect = 7e-14
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 22/208 (10%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI----SEREFK--DKIEGVGAVNHENLV 428
           +V+GKG+FG   KA   ++   VA+K +++       +  E +  + +      N  N++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            +   +   +   + ++ L+M +L  L+  NK  G    +  +    A    + ++ LH 
Sbjct: 163 HMLENFTFRNHICMTFELLSM-NLYELIKKNKFQG---FSLPLVRKFAHSILQCLDALHK 218

Query: 489 QGPNVSHGNIKSSNILLT--KSYEARVSDFGLAHLVGPSSTP---NRVAGYRAPEVTDPC 543
               + H ++K  NILL        +V DFG +            +R   YRAPEV    
Sbjct: 219 N--RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF--YRAPEVILGA 274

Query: 544 KVSQKADVYSFGVLLLELLTGKA--PTH 569
           +     D++S G +L ELLTG    P  
Sbjct: 275 RYGMPIDMWSLGCILAELLTGYPLLPGE 302

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.9 bits (177), Expect = 8e-14
 Identities = 50/218 (22%), Positives = 98/218 (44%), Gaps = 38/218 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRL--KDVTISEREFKDKIEGVGAVNHENLVPLR- 431
           + LG G  G  + AV  +    VA+K++   D    +   + +I+ +  ++H+N+V +  
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFE 75

Query: 432 -------------AYYYSMDEKLLVYDYLTMGS-LSALLHGNKGAGRTPLNWEMRSLIAL 477
                             ++   +V +Y  M + L+ +L         PL  E   L   
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEY--METDLANVLEQG------PLLEEHARLFMY 127

Query: 478 GAARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEARVSDFGLAHLVGPSSTPNR-----V 531
              RG++Y+H+   NV H ++K +N+ + T+    ++ DFGLA ++ P  +        +
Sbjct: 128 QLLRGLKYIHSA--NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185

Query: 532 AG--YRAPEVT-DPCKVSQKADVYSFGVLLLELLTGKA 566
               YR+P +   P   ++  D+++ G +  E+LTGK 
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 51/216 (23%), Positives = 93/216 (43%), Gaps = 36/216 (16%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK---DVTISEREFKDKIEGVGAVNHENLVPLR 431
            +LG+G +G    A     G IVA+K+++       + R  ++ I+ +    HEN++ + 
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE-IKILKHFKHENIITIF 75

Query: 432 -----AYYYSMDEKLLVYDYLTMGS-LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
                  + + +E  ++ +   M + L  ++          L+ +          R ++ 
Sbjct: 76  NIQRPDSFENFNEVYIIQEL--MQTDLHRVISTQ------MLSDDHIQYFIYQTLRAVKV 127

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------------ 533
           LH    NV H ++K SN+L+  + + +V DFGLA ++  S+  N                
Sbjct: 128 LHGS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185

Query: 534 --YRAPEVTDPCKV-SQKADVYSFGVLLLELLTGKA 566
             YRAPEV       S+  DV+S G +L EL   + 
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 48/140 (34%), Positives = 63/140 (45%), Gaps = 8/140 (5%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNHF 130
             L L    L+  +       LT L  L+L +N L + L + +    + L  L L  N  
Sbjct: 38  EKLDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQL 95

Query: 131 SGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIP-GFDDV 188
           +         L  L +L L  N     +PSG F  LTKLK L L  N+L  SIP G  D 
Sbjct: 96  ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK 153

Query: 189 LPNLQQLNVSNNLLNGSIPK 208
           L NLQ L++S N L  S+P 
Sbjct: 154 LTNLQTLSLSTNQLQ-SVPH 172

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 48/135 (35%), Positives = 61/135 (45%), Gaps = 7/135 (5%)

Query: 69  NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQG 127
            ++T L L    L   +  G+  +LT L TL L  N L S LP  +    + L  LYL G
Sbjct: 59  TKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGG 116

Query: 128 NHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIP-GF 185
           N            L  L  L L TN     IP+G F  LT L+TL L  N+L  S+P G 
Sbjct: 117 NQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGA 174

Query: 186 DDVLPNLQQLNVSNN 200
            D L  LQ + +  N
Sbjct: 175 FDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 38/125 (30%), Positives = 55/125 (44%), Gaps = 8/125 (6%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
           +P GI  +   L    L+   L +   +     + L  L L  N            L  L
Sbjct: 29  VPSGIPADTEKLD---LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85

Query: 145 VRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVSNNLL 202
             L LA N  +  +P G F +LT+L  L+L  N+L  S+P G  D L  L++L ++ N L
Sbjct: 86  GTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL 143

Query: 203 NGSIP 207
             SIP
Sbjct: 144 Q-SIP 147

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 55.9 bits (135), Expect = 9e-09
 Identities = 32/91 (35%), Positives = 43/91 (47%), Gaps = 5/91 (5%)

Query: 121 RNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLS 179
             L LQ    +        GL  L  LNL  N     + +G F +LT+L TL L NN+L+
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96

Query: 180 GSIP-GFDDVLPNLQQLNVSNNLLNGSIPKR 209
            S+P G  D L  L +L +  N L  S+P  
Sbjct: 97  -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSG 125

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 72.5 bits (177), Expect = 2e-13
 Identities = 30/109 (27%), Positives = 40/109 (36%), Gaps = 8/109 (7%)

Query: 94  TSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNN 153
             +R L L    LT      L     + +L L  N     +P  L  L  L  L  + N 
Sbjct: 441 ADVRVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNA 497

Query: 154 FSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDV--LPNLQQLNVSNN 200
               +  G  NL +L+ L L NNRL         +   P L  LN+  N
Sbjct: 498 LE-NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 71.7 bits (175), Expect = 3e-13
 Identities = 33/145 (22%), Positives = 52/145 (35%), Gaps = 18/145 (12%)

Query: 59  CKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCS 118
            + + ++ E   V +L L    L+    L  L  L  +  L L  N L + LP  LA+  
Sbjct: 431 LENSVLKMEYADVRVLHLAHKDLTV---LCHLEQLLLVTHLDLSHNRLRA-LPPALAALR 486

Query: 119 NLRNLYLQGN---HFSGEVPLFLVGLHHLVRLNLATNNFSG-EIPSGFKNLTKLKTLFLE 174
            L  L    N   +  G     +  L  L  L L  N            +  +L  L L+
Sbjct: 487 CLEVLQASDNALENVDG-----VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQ 541

Query: 175 NNRLSGSIPGFDD----VLPNLQQL 195
            N L     G  +    +LP++  +
Sbjct: 542 GNSLC-QEEGIQERLAEMLPSVSSI 565

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 64.4 bits (156), Expect = 6e-11
 Identities = 26/123 (21%), Positives = 48/123 (39%), Gaps = 13/123 (10%)

Query: 89  ILGNLTSLRTL--------SLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVG 140
            L   ++L+ +            +    +        +++R L+L     +  V   L  
Sbjct: 404 TLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQ 461

Query: 141 LHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
           L  +  L+L+ N     +P     L  L+ L   +N L  ++ G  + LP LQ+L + NN
Sbjct: 462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVAN-LPRLQELLLCNN 518

Query: 201 LLN 203
            L 
Sbjct: 519 RLQ 521

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 49.8 bits (118), Expect = 2e-06
 Identities = 28/116 (24%), Positives = 48/116 (41%), Gaps = 7/116 (6%)

Query: 89  ILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNH--FSGEVPLFLVGLHHLVR 146
           I+  + +L  L     +L  Q  S L +   +R  YL      F  E  +  +    +  
Sbjct: 388 IILLMRALDPLLYEKETL--QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRV 445

Query: 147 LNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL 202
           L+LA  + +  +    + L  +  L L +NRL  ++P     L  L+ L  S+N L
Sbjct: 446 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL 498

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 42.8 bits (100), Expect = 3e-04
 Identities = 25/140 (17%), Positives = 43/140 (30%), Gaps = 25/140 (17%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
                 L    L     T  L S+L SC  L+ L  +       + L +  L  L+    
Sbjct: 345 SATDEQLFRCELSVEKSTV-LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKE 403

Query: 150 ATNNFSG---------------------EIPSGFKNLTKLKTLFLENNRLSGSIPGFDDV 188
               FS                      E          ++ L L +  L+  +   +  
Sbjct: 404 TLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCHLEQ- 461

Query: 189 LPNLQQLNVSNNLLNGSIPK 208
           L  +  L++S+N L  ++P 
Sbjct: 462 LLLVTHLDLSHNRLR-ALPP 480

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 72.4 bits (178), Expect = 2e-13
 Identities = 28/120 (23%), Positives = 43/120 (35%), Gaps = 12/120 (10%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
           +I    +   T L TL   FN +T     D++    L  L    N+ +    L L     
Sbjct: 160 KITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK---LDLNQNIQ 213

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
           L  L+ ++N  + EI      LT+L       N L+  +      L  L  L+     L 
Sbjct: 214 LTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL 267

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 21/114 (18%), Positives = 40/114 (35%), Gaps = 11/114 (9%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           +     L  L+   N+LT     D++  + L  L    N    ++ +       L  L+ 
Sbjct: 123 VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLDVT--PQTQLTTLDC 177

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
           + N  + E+         L  L  + N ++  +         L  L+ S+N L 
Sbjct: 178 SFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLDLNQ--NIQLTFLDCSSNKLT 225

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 67.8 bits (166), Expect = 4e-12
 Identities = 27/118 (22%), Positives = 42/118 (35%), Gaps = 12/118 (10%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           +  LT L  L    N++T+    DL+  +NL  L    N  +    L +  L  L  LN 
Sbjct: 60  IEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNC 113

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
            TN  + ++         L  L    N L+  I         L +L+   N     + 
Sbjct: 114 DTNKLT-KLD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD 165

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 67.0 bits (164), Expect = 6e-12
 Identities = 26/114 (22%), Positives = 44/114 (38%), Gaps = 11/114 (9%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
              L +L +L    +S+T    + +   + L  L    N+ +    L L    +L  L  
Sbjct: 38  EEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNITT---LDLSQNTNLTYLAC 92

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
            +N  +  +      LTKL  L  + N+L+  +       P L  LN + N L 
Sbjct: 93  DSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVSQ--NPLLTYLNCARNTLT 140

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 63.9 bits (156), Expect = 7e-11
 Identities = 21/113 (18%), Positives = 37/113 (32%), Gaps = 11/113 (9%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           +  LT L       N LT     D+++ S L  L+           + L     L+    
Sbjct: 229 VTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQA 282

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL 202
                  E+     + T+L  L  +   ++  +       P L  L ++N  L
Sbjct: 283 EGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD-LSQ-NPKLVYLYLNNTEL 330

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 22/122 (18%), Positives = 41/122 (33%), Gaps = 10/122 (8%)

Query: 84  QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
           +I    + + T L  L  +   +T     DL+    L  LYL     + E+   +     
Sbjct: 287 KIKELDVTHNTQLYLLDCQAAGITE---LDLSQNPKLVYLYLNNTELT-ELD--VSHNTK 340

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
           L  L+    +   +  S    +  L   F    +        + +  N   + VS +LL+
Sbjct: 341 LKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPK--ETLTNNSLTIAVSPDLLD 396

Query: 204 GS 205
             
Sbjct: 397 QF 398

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 61.6 bits (150), Expect = 4e-10
 Identities = 23/119 (19%), Positives = 38/119 (31%), Gaps = 14/119 (11%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
           + +  L  LT   TL      L      DL   + L     +G     E+ +       L
Sbjct: 248 LDVSTLSKLT---TLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKELDVT--HNTQL 299

Query: 145 VRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
             L+      + E+        KL  L+L N  L+  +         L+ L+  N  + 
Sbjct: 300 YLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD-VSH-NTKLKSLSCVNAHIQ 352

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 57.4 bits (139), Expect = 7e-09
 Identities = 18/107 (16%), Positives = 38/107 (35%), Gaps = 8/107 (7%)

Query: 96  LRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFS 155
             +       + +         + L +L    +  + ++   +  L  L +L   +NN +
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77

Query: 156 GEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL 202
             +       T L  L  ++N+L+ ++      L  L  LN   N L
Sbjct: 78  -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL 118

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 17/114 (14%), Positives = 33/114 (28%), Gaps = 7/114 (6%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L     L  L L    LT  L  D++  + L++L     H   +    +  +  L     
Sbjct: 314 LSQNPKLVYLYLNNTELTE-L--DVSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFE 368

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
           A             N     T+ +  + L       +    +    + + N + 
Sbjct: 369 AEGQTITMPKETLTNN--SLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTIT 420

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 48.1 bits (115), Expect = 6e-06
 Identities = 15/86 (17%), Positives = 30/86 (34%), Gaps = 5/86 (5%)

Query: 118 SNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNR 177
            N  +             +    L  L  L+   ++ + ++  G + LT L  L   +N 
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN 75

Query: 178 LSGSIPGFDDVLPNLQQLNVSNNLLN 203
           ++ ++        NL  L   +N L 
Sbjct: 76  IT-TLDLSQ--NTNLTYLACDSNKLT 98

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 47/221 (21%), Positives = 91/221 (41%), Gaps = 34/221 (15%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT------ISEREFKDKI-----EGVGAVN 423
             LG G F T + A  +   T VA+K ++           E +   ++         ++ 
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 424 HENLVPLRAY-YYSMDEKL---LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGA 479
             +++ L  +  +     +   +V++ L   +L AL+   +  G  PL + ++  I+   
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRG-IPLIY-VKQ-ISKQL 140

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILL------TKSYEARVSDFGLAHLVGPSSTPN---R 530
             G++Y+H +   + H +IK  N+L+          + +++D G A       T +   R
Sbjct: 141 LLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199

Query: 531 VAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKA--PTH 569
              YR+PEV         AD++S   L+ EL+TG       
Sbjct: 200 E--YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 62/341 (18%), Positives = 117/341 (34%), Gaps = 102/341 (29%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVK-----RLKDVTISEREFKDK----IEGVGAVNHE 425
             LG G FG  + AV  E    V VK     ++ +    E     K    I  +  V H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 426 NLVPL------RAYYYSMDEKLL----VYDYLTMGSLSALLHGN---KGAGRTPLNWEMR 472
           N++ +      + ++  + EK      ++ ++         H       A         R
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID-------RHPRLDEPLASYI-----FR 137

Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS------ 526
            L++      + YL  +   + H +IK  NI++ + +  ++ DFG A  +          
Sbjct: 138 QLVS-----AVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC 190

Query: 527 -TPNRVAGYRAPEVTDPCKVSQK------ADVYSFGVLLLELLTGKAPTHAL-------- 571
            T      Y APEV     +          +++S GV L  L+  + P   L        
Sbjct: 191 GTIE----YCAPEV-----LMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAI 241

Query: 572 -----LNEEGVDLPRW-----------VQSIVKDEWTSEVFDL------ELLRYQNVEEE 609
                +++E + L              ++ +V D W ++  +L      E+ R    E  
Sbjct: 242 HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESG 301

Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHH 650
           ++     +++   +      S+S+V +  E         HH
Sbjct: 302 VLS--AASLEMGNR------SLSDVAQAQELCGGEGHHHHH 334

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 47/208 (22%), Positives = 85/208 (40%), Gaps = 20/208 (9%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT------ISEREFKDKIEGVGAVNHENLV 428
            ++GKG+FG   KA        VA+K +K+          E    + +          +V
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L+ ++   +   LV++ L+  +L  LL      G   ++  +    A      + +L  
Sbjct: 120 HLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRG---VSLNLTRKFAQQMCTALLFLAT 175

Query: 489 QGPNVSHGNIKSSNILLT--KSYEARVSDFGLAHLVGPSSTP---NRVAGYRAPEVTDPC 543
              ++ H ++K  NILL   K    ++ DFG +  +G        +R   YR+PEV    
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF--YRSPEVLLGM 233

Query: 544 KVSQKADVYSFGVLLLELLTGKA--PTH 569
                 D++S G +L+E+ TG+      
Sbjct: 234 PYDLAIDMWSLGCILVEMHTGEPLFSGA 261

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 67.4 bits (165), Expect = 4e-13
 Identities = 35/142 (24%), Positives = 60/142 (42%), Gaps = 13/142 (9%)

Query: 66  CEQNRVTMLRLPGVALSGQIP-----LGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNL 120
            E+  V       V L G IP        L  L + + L+L  N++     S L+   NL
Sbjct: 15  EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI--SSLSGMENL 72

Query: 121 RNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSG 180
           R L L  N    ++         L  L ++ N  +  + SG + L  L+ L++ NN+++ 
Sbjct: 73  RILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT- 128

Query: 181 SIPGFDDV--LPNLQQLNVSNN 200
           +    D +  L  L+ L ++ N
Sbjct: 129 NWGEIDKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 62.8 bits (153), Expect = 2e-11
 Identities = 24/108 (22%), Positives = 49/108 (45%), Gaps = 12/108 (11%)

Query: 99  LSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS---GEVPLFLVGLHHLVRLNLATNNFS 155
           L      +  ++ + L++    ++L L  N+           L G+ +L  L+L  N   
Sbjct: 30  LHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRILSLGRNLIK 83

Query: 156 GEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
            +I +       L+ L++  N+++ S+ G +  L NL+ L +SNN + 
Sbjct: 84  -KIENLDAVADTLEELWISYNQIA-SLSGIEK-LVNLRVLYMSNNKIT 128

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 68.4 bits (168), Expect = 7e-13
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 40/213 (18%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDK----IEGVGAVNHENLVPL 430
           + LG GTFG          G  VAVK L    I   +   K    I+ +    H +++ L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLN---WEMRSLIALGAARGIEYLH 487
                +  +  +V +Y++ G L   +  +   GR          + +++      ++Y H
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKH---GRVEEMEARRLFQQILS-----AVDYCH 128

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-------TPNRVAGYRAPEVT 540
                V H ++K  N+LL     A+++DFGL++++           +PN    Y APEV 
Sbjct: 129 RHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN----YAAPEV- 181

Query: 541 DPCKVSQK------ADVYSFGVLLLELLTGKAP 567
               +S +       D++S GV+L  LL G  P
Sbjct: 182 ----ISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 70.1 bits (172), Expect = 7e-13
 Identities = 67/281 (23%), Positives = 115/281 (40%), Gaps = 55/281 (19%)

Query: 341 KTQVNSNVNGATKKLVFFGNAARVFDLED--LLRASAEVLGKGTFGTAYKAVL----EMG 394
           ++   S+ +GA +  V          + +   L+    +LGKGTFG   K +L      G
Sbjct: 121 RSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLK----LLGKGTFG---KVILVKEKATG 173

Query: 395 TIVAVKRL-KDVTISEREFKDKIEGV-------GAVNHENLVPLRAYYYSMDEKLLVYDY 446
              A+K L K+V ++    KD++              H  L  L+  + + D    V +Y
Sbjct: 174 RYYAMKILKKEVIVA----KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229

Query: 447 LTMGSLSALLHGNKGAGRTPLNWEMRSL-----IALGAARGIEYLHAQGPNVSHGNIKSS 501
              G L   L       R  +  E R+      I       ++YLH++  NV + ++K  
Sbjct: 230 ANGGELFFHLS------RERVFSEDRARFYGAEIVS----ALDYLHSE-KNVVYRDLKLE 278

Query: 502 NILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTDPCKVSQKADVYSFGVL 557
           N++L K    +++DFGL    +   +T     G   Y APEV +     +  D +  GV+
Sbjct: 279 NLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 338

Query: 558 LLELLTGKAPTHA---------LLNEEGVDLPRWVQSIVKD 589
           + E++ G+ P +          +L EE +  PR +    K 
Sbjct: 339 MYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLGPEAKS 378

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 70.1 bits (171), Expect = 1e-12
 Identities = 62/262 (23%), Positives = 103/262 (39%), Gaps = 59/262 (22%)

Query: 363 RVFDLED--LLRASAEVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKI 416
               L D   L     VLGKG+FG   K +L        + AVK LK   + +    D +
Sbjct: 336 DRMKLTDFNFLM----VLGKGSFG---KVMLSERKGTDELYAVKILKKDVVIQD---DDV 385

Query: 417 EG--------VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLN 468
           E                 L  L + + +MD    V +Y+  G L   +      GR    
Sbjct: 386 ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ---VGRFK-- 440

Query: 469 WEMRSL-----IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-V 522
            E  ++     IA+G    + +L ++G  + + ++K  N++L      +++DFG+    +
Sbjct: 441 -EPHAVFYAAEIAIG----LFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493

Query: 523 GPSSTPNRVAG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA--------- 570
               T     G   Y APE+       +  D ++FGVLL E+L G+AP            
Sbjct: 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 553

Query: 571 LLNEEGVDLPRWV----QSIVK 588
           ++    V  P+ +     +I K
Sbjct: 554 IMEHN-VAYPKSMSKEAVAICK 574

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 60/257 (23%), Positives = 110/257 (42%), Gaps = 50/257 (19%)

Query: 361 AARVFDLED--LLRASAEVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKD 414
           A     L+D  LLR    V+G+G++    K +L    +   I A+K +K   +++ E  D
Sbjct: 2   AMDPLGLQDFDLLR----VIGRGSYA---KVLLVRLKKTDRIYAMKVVKKELVNDDEDID 54

Query: 415 KIEG-----VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNW 469
            ++        A NH  LV L + + +      V +Y+  G L  + H  +   + P   
Sbjct: 55  WVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR-QRKLP--- 108

Query: 470 EMRSL-----IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VG 523
           E  +      I+L     + YLH +G  + + ++K  N+LL      +++D+G+    + 
Sbjct: 109 EEHARFYSAEISL----ALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162

Query: 524 PSS-------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP---THALLN 573
           P         TPN    Y APE+          D ++ GVL+ E++ G++P     +  N
Sbjct: 163 PGDTTSTFCGTPN----YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218

Query: 574 EEGVDLPRWVQSIVKDE 590
            +        Q I++ +
Sbjct: 219 PDQNTEDYLFQVILEKQ 235

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 60/259 (23%), Positives = 112/259 (43%), Gaps = 50/259 (19%)

Query: 359 GNAARVFDLED--LLRASAEVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREF 412
           G A+    L+D  LLR    V+G+G++    K +L    +   I A++ +K   +++ E 
Sbjct: 43  GKASSSLGLQDFDLLR----VIGRGSYA---KVLLVRLKKTDRIYAMRVVKKELVNDDED 95

Query: 413 KDKIEG-----VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPL 467
            D ++        A NH  LV L + + +      V +Y+  G L  + H  +   + P 
Sbjct: 96  IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR-QRKLP- 151

Query: 468 NWEMRSL-----IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL- 521
             E  +      I+L     + YLH +G  + + ++K  N+LL      +++D+G+    
Sbjct: 152 --EEHARFYSAEISL----ALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203

Query: 522 VGPSS-------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP---THAL 571
           + P         TPN    Y APE+          D ++ GVL+ E++ G++P     + 
Sbjct: 204 LRPGDTTSTFCGTPN----YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 259

Query: 572 LNEEGVDLPRWVQSIVKDE 590
            N +        Q I++ +
Sbjct: 260 DNPDQNTEDYLFQVILEKQ 278

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 68.3 bits (168), Expect = 1e-12
 Identities = 67/283 (23%), Positives = 118/283 (41%), Gaps = 66/283 (23%)

Query: 340 GKTQVNSNVNGATKKLVFFGNAARVFDLED--LLRASAEVLGKGTFGTAY----KAVLEM 393
            +  +  +V    +K           D     LL+    VLG+G+FG  +     +  + 
Sbjct: 6   KEIAITHHVKEGHEKA----------DPSQFELLK----VLGQGSFGKVFLVKKISGSDA 51

Query: 394 GTIVAVKRLKDVTISEREFKDKIEGVG------AVNHENLVPLRAYYYSM--DEKL-LVY 444
             + A+K LK  T+     +D++           VNH  +V L   +Y+   + KL L+ 
Sbjct: 52  RQLYAMKVLKKATLKV---RDRVRTKMERDILVEVNHPFIVKL---HYAFQTEGKLYLIL 105

Query: 445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSL-----IALGAARGIEYLHAQGPNVSHGNIK 499
           D+L  G L      +K         E         +AL     +++LH+ G  + + ++K
Sbjct: 106 DFLRGGDL--FTRLSK-EVMFT---EEDVKFYLAELALA----LDHLHSLG--IIYRDLK 153

Query: 500 SSNILLTKSYEARVSDFGLAHL-VGPSSTPNRVAG---YRAPEVTDPCKVSQKADVYSFG 555
             NILL +    +++DFGL+   +          G   Y APEV +    +Q AD +SFG
Sbjct: 154 PENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFG 213

Query: 556 VLLLELLTGKAP---------THALLNEEGVDLPRWVQSIVKD 589
           VL+ E+LTG  P            +L  + + +P+++    + 
Sbjct: 214 VLMFEMLTGTLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQS 255

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 51/226 (22%), Positives = 90/226 (39%), Gaps = 27/226 (11%)

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI--ALGAARGIEYLHA 488
           R    +  +      ++   SLS +               +  LI  +   A+G+E+L +
Sbjct: 152 RLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 211

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYR------APEVTDP 542
           +     H ++ + NILL++    ++ DFGLA  +       R    R      APE    
Sbjct: 212 R--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269

Query: 543 CKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL 601
              + ++DV+SFGVLL E+ + G +P        GV +       +K+          + 
Sbjct: 270 RVYTIQSDVWSFGVLLWEIFSLGASPY------PGVKIDEEFCRRLKEGTR-------MR 316

Query: 602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ 647
                  EM Q +    DC    P  RP+ SE+++ +  L  ++ Q
Sbjct: 317 APDYTTPEMYQTML---DCWHGEPSQRPTFSELVEHLGNLLQANAQ 359

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 47/209 (22%), Positives = 80/209 (38%), Gaps = 52/209 (24%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFK--DKIEGVGAVNHENLVPLRA 432
           +VLG G  G   +          A+K L+D   + RE +   +          ++V +  
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ-----CPHIVRIVD 78

Query: 433 YY---YSMDEKL-LVYDYLTMGSL----SALLHGN---KGAGRTPLNWEMRSLIALGAAR 481
            Y   Y+  + L +V + L  G L              + A        M+S+       
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-----MKSI-----GE 128

Query: 482 GIEYLHAQGPNVSHGNIKSSNILL-TKSYEA--RVSDFGLAHLVGPSSTPNRVAGYRAPE 538
            I+YLH+    ++H ++K  N+L  +K   A  +++DFG A                  E
Sbjct: 129 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA-----------------KE 169

Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAP 567
            T   K  +  D++S GV++  LL G  P
Sbjct: 170 TTG-EKYDKSCDMWSLGVIMYILLCGYPP 197

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 53/228 (23%)

Query: 369 DLLRASAEVLGKGTFGTAYKAVL----EMGTIVAVKRL-KDVTISERE---FKDKIEGVG 420
           ++L+    V+G+G FG   +  +        + A+K L K   +   E   F+++ + + 
Sbjct: 77  EILK----VIGRGAFG---EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV 129

Query: 421 AVNHENLVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNW------EMRS 473
             + + +  L  Y +  D  L LV DY   G L  LL  +K   R P         EM  
Sbjct: 130 NGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEMARFYLAEM-- 184

Query: 474 LIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS------- 526
           +IA+      + +H       H +IK  NIL+  +   R++DFG    +           
Sbjct: 185 VIAI------DSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236

Query: 527 --TPNRVAGYRAPEVTDPCKVSQK-----ADVYSFGVLLLELLTGKAP 567
             TP+    Y +PE+    +  +       D +S GV + E+L G+ P
Sbjct: 237 VGTPD----YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 59/234 (25%), Positives = 92/234 (39%), Gaps = 62/234 (26%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV---------TISE----REFKDKIEGVGA 421
           + LGKG +G  +K++    G +VAVK++ D          T  E     E          
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG------- 67

Query: 422 VNHENLVPLRAYYY--SMDEKLLVYDYLTMGS-LSALLHGNKGAGRTPLNWEMRSLIALG 478
             HEN+V L       +  +  LV+DY  M + L A++  N       L    +  +   
Sbjct: 68  --HENIVNLLNVLRADNDRDVYLVFDY--METDLHAVIRAN------ILEPVHKQYVVYQ 117

Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG----- 533
             + I+YLH+    + H ++K SNILL      +V+DFGL+                   
Sbjct: 118 LIKVIKYLHSG--GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175

Query: 534 --------------------YRAPEV-TDPCKVSQKADVYSFGVLLLELLTGKA 566
                               YRAPE+     K ++  D++S G +L E+L GK 
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 48/230 (20%), Positives = 82/230 (35%), Gaps = 66/230 (28%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGV-----------GAVN 423
            +LGKG FGT +    L     VA+K +    +                           
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 424 HENLVPLRAYYYSMDEKLLV----------YDYLTMGSLSALLHGN---KGAGRTPLNWE 470
           H  ++ L  ++ + +  +LV          +DY+T         G      +        
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT-------EKGPLGEGPSRCF----- 144

Query: 471 MRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEARVSDFGLAHLVGPSS--- 526
              ++A      I++ H++G  V H +IK  NIL+  +   A++ DFG   L+       
Sbjct: 145 FGQVVA-----AIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD 197

Query: 527 ---TPNRVAGYRAPEVTDPCKVSQK------ADVYSFGVLLLELLTGKAP 567
              T      Y  PE      +S+       A V+S G+LL +++ G  P
Sbjct: 198 FDGTRV----YSPPEW-----ISRHQYHALPATVWSLGILLYDMVCGDIP 238

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 44/125 (35%), Positives = 57/125 (45%), Gaps = 7/125 (5%)

Query: 87  LGILGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNHFSGEVPLFLVGLHHLV 145
           +  L  LT+L  L L  N L S LP+ +    +NL+ L L  N            L +L 
Sbjct: 78  ISALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLT 136

Query: 146 RLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVSNNLLN 203
            LNLA N     +P G F  LT L  L L  N+L  S+P G  D L  L+ L +  N L 
Sbjct: 137 YLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK 194

Query: 204 GSIPK 208
            S+P 
Sbjct: 195 -SVPD 198

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 38/151 (25%), Positives = 56/151 (37%), Gaps = 20/151 (13%)

Query: 58  PCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASC 117
             +      ++  VT                    L S+  +    + + S         
Sbjct: 18  FAETIKANLKKKSVT-----------DAVTQN--ELNSIDQIIANNSDIKSVQGIQ--YL 62

Query: 118 SNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENN 176
            N+R L L GN    ++      L +L  L L  N     +P+G F  LT LK L L  N
Sbjct: 63  PNVRYLALGGNKLH-DISAL-KELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVEN 119

Query: 177 RLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
           +L     G  D L NL  LN+++N L  S+P
Sbjct: 120 QLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLP 149

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 35/121 (28%), Positives = 49/121 (40%), Gaps = 27/121 (22%)

Query: 64  VECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPS---DLASCSNL 120
           +   +N++  L           P G+   LT+L  L+L  N L S LP    D    +NL
Sbjct: 114 LVLVENQLQSL-----------PDGVFDKLTNLTYLNLAHNQLQS-LPKGVFD--KLTNL 159

Query: 121 RNLYLQGNHFSGEVPLFLVG----LHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLEN 175
             L L  N     +P    G    L  L  L L  N     +P G F  LT L+ ++L +
Sbjct: 160 TELDLSYNQLQ-SLP---EGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHD 214

Query: 176 N 176
           N
Sbjct: 215 N 215

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 59/307 (19%), Positives = 103/307 (33%), Gaps = 99/307 (32%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVG-------AVNHE-- 425
            +LG G FG+ Y  + +     VA+K ++   IS+         V         V+    
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 426 NLVPLRAYYYSMDEKLLV----------YDYLTMGSLSALLHGN---KGAGRTPLNWEMR 472
            ++ L  ++   D  +L+          +D++T         G    + A          
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------ERGALQEELARSF-----FW 156

Query: 473 SLIALGAARGIEYLHAQGPNVSHGNIKSSNILL-TKSYEARVSDFGLAHLVGPSS----- 526
            ++       + + H  G  V H +IK  NIL+     E ++ DFG   L+  +      
Sbjct: 157 QVLE-----AVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 209

Query: 527 -TPNRVAGYRAPEVTDPCKVSQK------ADVYSFGVLLLELLTGKAP---THALLNEEG 576
            T      Y  PE      +         A V+S G+LL +++ G  P      ++  + 
Sbjct: 210 GTRV----YSPPEW-----IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ- 259

Query: 577 VDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK 636
           V   + V S  +           L+R           L L        P +RP+  E+  
Sbjct: 260 VFFRQRVSSECQH----------LIR---------WCLALR-------PSDRPTFEEIQN 293

Query: 637 RIEELHP 643
                HP
Sbjct: 294 -----HP 295

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 66.4 bits (163), Expect = 4e-12
 Identities = 67/255 (26%), Positives = 112/255 (43%), Gaps = 65/255 (25%)

Query: 369 DLLRASAEVLGKGTFGTAYKAVL----EMGTIVAVK--------RLKDV--TISEREFKD 414
            +LR     LG G+FG   +  L      G   A+K        RLK V  T  ER    
Sbjct: 9   QILR----TLGTGSFG---RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER---- 57

Query: 415 KIEGVGAVNHENLVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRS 473
            +  +  V H  ++ +    +   +++ ++ DY+  G L +LL   + + R P      +
Sbjct: 58  LM--LSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFP---NPVA 108

Query: 474 L-----IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-- 526
                 + L     +EYLH++  ++ + ++K  NILL K+   +++DFG A  V   +  
Sbjct: 109 KFYAAEVCLA----LEYLHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 162

Query: 527 ---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA---------LLNE 574
              TP+    Y APEV      ++  D +SFG+L+ E+L G  P +          +LN 
Sbjct: 163 LCGTPD----YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 218

Query: 575 EGVDLPRWVQSIVKD 589
           E +  P +    VKD
Sbjct: 219 E-LRFPPFFNEDVKD 232

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 66.1 bits (162), Expect = 5e-12
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 41/212 (19%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVK------RLKDVTISEREFKDKIEGVGAVNHENLVPL 430
           LG+G +G    AV       VAVK       +      ++E    I     +NHEN+V  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRS----LIALGAARGIEYL 486
             +    + + L  +Y + G L   +  +      P   + +     L+A     G+ YL
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMP-EPDAQRFFHQLMA-----GVVYL 121

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----------TPNRVAGYRA 536
           H  G  ++H +IK  N+LL +    ++SDFGLA +   ++          T      Y A
Sbjct: 122 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP----YVA 175

Query: 537 PEVTDPCK-VSQKADVYSFGVLLLELLTGKAP 567
           PE+    +  ++  DV+S G++L  +L G+ P
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 63.2 bits (154), Expect = 5e-12
 Identities = 24/89 (26%), Positives = 41/89 (46%), Gaps = 3/89 (3%)

Query: 116 SCSNLRNLYLQGNHFS-GEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLE 174
           + S+++ L L  +  + G++         L  L+      +  I +    L KLK L L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72

Query: 175 NNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
           +NR+SG +    +  PNL  LN+S N + 
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 57.0 bits (138), Expect = 6e-10
 Identities = 30/114 (26%), Positives = 47/114 (41%), Gaps = 8/114 (7%)

Query: 87  LGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVR 146
            G+      L  LS     LTS   ++L   + L+ L L  N  SG + +      +L  
Sbjct: 35  EGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92

Query: 147 LNLATNNFSG-EIPSGFKNLTKLKTLFLENNRLSGSIPGFDD----VLPNLQQL 195
           LNL+ N           K L  LK+L L N  ++ ++  + +    +LP L  L
Sbjct: 93  LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT-NLNDYRENVFKLLPQLTYL 145

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 55.8 bits (135), Expect = 2e-09
 Identities = 23/118 (19%), Positives = 39/118 (33%), Gaps = 18/118 (15%)

Query: 92  NLTSLRTLSLRFNSLTS-QLPSDLASCSNLRNLYLQGN---HFSGEVPLFLVGLHHLVRL 147
             + ++ L L  +     +L         L  L          +      L  L+ L +L
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIAN-----LPKLNKLKKL 69

Query: 148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDV-----LPNLQQLNVSNN 200
            L+ N  SG +    +    L  L L  N+    I     +     L NL+ L++ N 
Sbjct: 70  ELSDNRVSGGLEVLAEKCPNLTHLNLSGNK----IKDLSTIEPLKKLENLKSLDLFNC 123

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 67.3 bits (164), Expect = 7e-12
 Identities = 34/139 (24%), Positives = 61/139 (43%), Gaps = 20/139 (14%)

Query: 65  ECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLY 124
           EC  N+ + L+L  + LS  +P  +      +  L +  N+L S LP      ++L  L 
Sbjct: 55  ECLINQFSELQLNRLNLS-SLPDNLP---PQITVLEITQNALIS-LPELP---ASLEYLD 106

Query: 125 LQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPG 184
              N  S  +P        L  L++  N  +  +P        L+ +  +NN+L+  +P 
Sbjct: 107 ACDNRLS-TLP---ELPASLKHLDVDNNQLT-MLPEL---PALLEYINADNNQLT-MLP- 156

Query: 185 FDDVLPNLQQLNVSNNLLN 203
             ++  +L+ L+V NN L 
Sbjct: 157 --ELPTSLEVLSVRNNQLT 173

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 67.3 bits (164), Expect = 8e-12
 Identities = 30/125 (24%), Positives = 43/125 (34%), Gaps = 10/125 (8%)

Query: 93  LTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL----VRLN 148
            TSL  LS+R N LT  LP       +L  L +  N     +P   V  HH     +   
Sbjct: 159 PTSLEVLSVRNNQLTF-LPELP---ESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFR 213

Query: 149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPK 208
              N  +  IP    +L    T+ LE+N LS  I             +      + S  +
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272

Query: 209 RFQTF 213
           +    
Sbjct: 273 QNTLH 277

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 66.5 bits (162), Expect = 1e-11
 Identities = 27/119 (22%), Positives = 48/119 (40%), Gaps = 16/119 (13%)

Query: 93  LTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATN 152
           +     L L   +L+S LP +L     +  L +  N     +P        L  L+   N
Sbjct: 58  INQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDN 110

Query: 153 NFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQ 211
             S  +P    +L  L    ++NN+L+  +P   ++   L+ +N  NN L   +P+   
Sbjct: 111 RLS-TLPELPASLKHLD---VDNNQLT-MLP---ELPALLEYINADNNQLT-MLPELPT 160

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 26/135 (19%), Positives = 42/135 (31%), Gaps = 19/135 (14%)

Query: 74  LRLPGVALSGQIP------LGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQG 127
             L   +    I                        N   S L       +    L L  
Sbjct: 11  FSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLNR 68

Query: 128 NHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDD 187
            + S  +P  L     +  L +  N     +P    +L  L      +NRLS ++P   +
Sbjct: 69  LNLS-SLPDNL--PPQITVLEITQNALI-SLPELPASLEYLD---ACDNRLS-TLP---E 117

Query: 188 VLPNLQQLNVSNNLL 202
           +  +L+ L+V NN L
Sbjct: 118 LPASLKHLDVDNNQL 132

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 58.4 bits (141), Expect = 4e-09
 Identities = 23/121 (19%), Positives = 50/121 (41%), Gaps = 10/121 (8%)

Query: 91  GNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP-LFLVGLHHLVRLNL 149
            N  SL + +  +N+++       ++        L G + +  V  L    ++    L L
Sbjct: 8   NNNFSL-SQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQL 66

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKR 209
              N S  +P       ++  L +  N L  S+P   ++  +L+ L+  +N L+ ++P+ 
Sbjct: 67  NRLNLS-SLPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLS-TLPEL 118

Query: 210 F 210
            
Sbjct: 119 P 119

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 19/107 (17%), Positives = 30/107 (28%), Gaps = 6/107 (5%)

Query: 93  LTSLRTLSLRFNSLTSQLPSDLASCSNLRN----LYLQGNHFSGEVPLFLVGLHHLVRLN 148
             SL  L +  N L S LP+      +          + N  +  +P  ++ L     + 
Sbjct: 179 PESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTII 236

Query: 149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQL 195
           L  N  S  I       T            S S    + +   L   
Sbjct: 237 LEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADA 283

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 66.7 bits (163), Expect = 7e-12
 Identities = 49/229 (21%), Positives = 80/229 (34%), Gaps = 65/229 (28%)

Query: 377 VLGKGTFGTAYKAVL-EMGTIVAVKRLK--------DV--TISEREFKDKIEGVGAVNHE 425
           V+G+G F       + + G + A+K +         +V     ER+       +   +  
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV------LVNGDRR 121

Query: 426 NLVPLRAYYYSM--DEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAAR- 481
            +  L   +++   +  L LV +Y   G L  LL  +K   R P             AR 
Sbjct: 122 WITQL---HFAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEM----------ARF 166

Query: 482 -------GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-------- 526
                   I+ +H  G    H +IK  NILL +    R++DFG    +            
Sbjct: 167 YLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV 224

Query: 527 -TPNRVAGYRAPEVTDPCKVSQKADVY-------SFGVLLLELLTGKAP 567
            TP+    Y +PE+            Y       + GV   E+  G+ P
Sbjct: 225 GTPD----YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 66.7 bits (163), Expect = 8e-12
 Identities = 47/239 (19%), Positives = 84/239 (35%), Gaps = 64/239 (26%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAV---------NHE 425
            ++G+G++G  Y A        VA+K++  +      F+D I+    +           +
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM------FEDLIDCKRILREITILNRLKSD 85

Query: 426 NLVPLR-----AYYYSMDEKLLVYDYLTMGS-LSALLHGNKGAGRTPLNWE-MRSLI--A 476
            ++ L            DE  +V +     S L  L           L  E +++++   
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEI--ADSDLKKLFKTPI-----FLTEEHIKTILYNL 138

Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG--- 533
           L    G  ++H     + H ++K +N LL +    +V DFGLA  +      N V     
Sbjct: 139 L---LGENFIHES--GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193

Query: 534 -----------------------YRAPEV-TDPCKVSQKADVYSFGVLLLELLTGKAPT 568
                                  YRAPE+       ++  D++S G +  ELL      
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 65.8 bits (161), Expect = 8e-12
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 39/210 (18%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVK-----RLKDVTIS--EREFKDKIEGVGAVNHENLVP 429
           +GKG F     A  +  G  VA+K     +L   ++    RE    +  +  +NH N+V 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFRE----VRIMKILNHPNIVK 78

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRS----LIALGAARGIEY 485
           L     +     L+ +Y + G +   L  +   GR     E RS    +++      ++Y
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAH---GRMKEK-EARSKFRQIVS-----AVQY 129

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-------TPNRVAGYRAPE 538
            H +   + H ++K+ N+LL      +++DFG ++              P     Y APE
Sbjct: 130 CHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP----YAAPE 183

Query: 539 V-TDPCKVSQKADVYSFGVLLLELLTGKAP 567
           +         + DV+S GV+L  L++G  P
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 38/122 (31%), Positives = 54/122 (44%), Gaps = 14/122 (11%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSD--LASCSNLRNLYLQGNHFSG-EVPLFLVGL 141
           IP  I         L L  N L   + SD       +L  L L+ N  +G E   F  G 
Sbjct: 23  IPRDIP---LHTTELLLNDNELGR-ISSDGLFGRLPHLVKLELKRNQLTGIEPNAFE-GA 77

Query: 142 HHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIP--GFDDVLPNLQQLNVS 198
            H+  L L  N    EI +  F  L +LKTL L +N++S  +    F+  L +L  LN++
Sbjct: 78  SHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEH-LNSLTSLNLA 134

Query: 199 NN 200
           +N
Sbjct: 135 SN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 25/108 (23%), Positives = 42/108 (38%), Gaps = 11/108 (10%)

Query: 105 SLTSQLPSDLASCSNLRNLYLQGNHFSGEVPL-FLVGLHHLVRLNLATNNFSGEIPSG-F 162
            L   +P D+    +   L L  N             L HLV+L L  N  +  I    F
Sbjct: 19  GLKE-IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAF 74

Query: 163 KNLTKLKTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNNLLNGSIPK 208
           +  + ++ L L  N++   I    F   L  L+ LN+ +N ++  +  
Sbjct: 75  EGASHIQELQLGENKIK-EISNKMFLG-LHQLKTLNLYDNQIS-CVMP 119

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 17/65 (26%), Positives = 27/65 (41%), Gaps = 2/65 (3%)

Query: 146 RLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNG 204
            L L  N        G F  L  L  L L+ N+L+G  P   +   ++Q+L +  N +  
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91

Query: 205 SIPKR 209
            I  +
Sbjct: 92  EISNK 96

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 57/214 (26%), Positives = 86/214 (40%), Gaps = 48/214 (22%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRL-KDVTISE---REFKDKIEGVGAVNHENLVPLRA 432
           +G G FG A          +VAVK + +   I E   RE    I    ++ H N+V  + 
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIVRFKE 83

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRS----LIALGAARGIEYLHA 488
              +     ++ +Y + G L   +     AGR   + E R     L++     G+ Y H+
Sbjct: 84  VILTPTHLAIIMEYASGGELYERI---CNAGRFSED-EARFFFQQLLS-----GVSYCHS 134

Query: 489 QGPNVSHGNIKSSNILLTKSYEAR--VSDFGLAHLVGPSS-------TPNRVAGYRAPEV 539
               + H ++K  N LL  S   R  + DFG +      S       TP     Y APEV
Sbjct: 135 MQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA----YIAPEV 188

Query: 540 TDPCKVSQK------ADVYSFGVLLLELLTGKAP 567
                + ++      ADV+S GV L  +L G  P
Sbjct: 189 -----LLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 63.1 bits (154), Expect = 1e-11
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 6/93 (6%)

Query: 118 SNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENN 176
            ++  LYL GN F+  VP  L    HL  ++L+ N  S  + +  F N+T+L TL L  N
Sbjct: 31  RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN 88

Query: 177 RLSGSIP-GFDDVLPNLQQLNVSNNLLNGSIPK 208
           RL   IP    D L +L+ L++  N ++  +P+
Sbjct: 89  RLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPE 119

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 54.2 bits (131), Expect = 1e-08
 Identities = 31/108 (28%), Positives = 47/108 (43%), Gaps = 6/108 (5%)

Query: 71  VTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNH 129
           VT L L G   +  +P   L N   L  + L  N +++ L +   ++ + L  L L  N 
Sbjct: 33  VTELYLDGNQFT-LVP-KELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYNR 89

Query: 130 FSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENN 176
                P    GL  L  L+L  N+ S  +P G F +L+ L  L +  N
Sbjct: 90  LRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 46.1 bits (110), Expect = 8e-06
 Identities = 20/64 (31%), Positives = 26/64 (40%), Gaps = 2/64 (3%)

Query: 146 RLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGS 205
            L L  N F+  +P    N   L  + L NNR+S         +  L  L +S N L   
Sbjct: 35  ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-C 92

Query: 206 IPKR 209
           IP R
Sbjct: 93  IPPR 96

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 65.3 bits (160), Expect = 1e-11
 Identities = 62/250 (24%), Positives = 101/250 (40%), Gaps = 52/250 (20%)

Query: 369 DLLRASAEVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV----- 419
           D L+    +LGKGTFG   K +L      G   A+K L+   I  +   D++        
Sbjct: 8   DYLK----LLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAK---DEVAHTVTESR 57

Query: 420 --GAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL--- 474
                 H  L  L+  + + D    V +Y   G L    H ++         E R+    
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSR-ERVFT---EERARFYG 111

Query: 475 --IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNRV 531
             I       +EYLH++   V + +IK  N++L K    +++DFGL    +   +T    
Sbjct: 112 AEIVS----ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 165

Query: 532 AG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA---------LLNEEGVDL 579
            G   Y APEV +     +  D +  GV++ E++ G+ P +          +L EE +  
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRF 224

Query: 580 PRWVQSIVKD 589
           PR +    K 
Sbjct: 225 PRTLSPEAKS 234

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 64.9 bits (159), Expect = 2e-11
 Identities = 63/251 (25%), Positives = 103/251 (41%), Gaps = 53/251 (21%)

Query: 369 DLLRASAEVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV----- 419
            L +    +LGKG+FG   K  L    +     A+K LK   +      D +E       
Sbjct: 20  ILHK----MLGKGSFG---KVFLAEFKKTNQFFAIKALKKDVVLMD---DDVECTMVEKR 69

Query: 420 ---GAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL-- 474
               A  H  L  +   + + +    V +YL  G L   +       +       R+   
Sbjct: 70  VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFD---LSRATFY 123

Query: 475 ---IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNR 530
              I LG    +++LH++G  + + ++K  NILL K    +++DFG+    +   +  N 
Sbjct: 124 AAEIILG----LQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 177

Query: 531 VAG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA---------LLNEEGVD 578
             G   Y APE+    K +   D +SFGVLL E+L G++P H          +  +    
Sbjct: 178 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PF 236

Query: 579 LPRWVQSIVKD 589
            PRW++   KD
Sbjct: 237 YPRWLEKEAKD 247

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 42/214 (19%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDK----IEGVGAVNHENLVPL 430
           + LG GTFG          G  VAVK L    I   +   K    I+ +    H +++ L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRS----LIALGAARGIEYL 486
                +  +  +V +Y++ G L   +  N   GR     E R     +++     G++Y 
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKN---GRLDEK-ESRRLFQQILS-----GVDYC 132

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-------TPNRVAGYRAPEV 539
           H     V H ++K  N+LL     A+++DFGL++++           +PN    Y APEV
Sbjct: 133 HRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN----YAAPEV 186

Query: 540 TDPCKVSQK------ADVYSFGVLLLELLTGKAP 567
                +S +       D++S GV+L  LL G  P
Sbjct: 187 -----ISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 51/217 (23%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVK-----RLKDVTIS-EREFKDKIEGVGAVNHENLVPL 430
           LG+G +G    AV       VAVK     R  D   + ++E    I     +NHEN+V  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRS----LIALGAARGIEYL 486
             +    + + L  +Y + G L   +  +      P   + +     L+A     G+ YL
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMP-EPDAQRFFHQLMA-----GVVYL 121

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----------TPNRVAGYRA 536
           H  G  ++H +IK  N+LL +    ++SDFGLA +   ++          T      Y A
Sbjct: 122 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP----YVA 175

Query: 537 PEVTDPCKVSQK------ADVYSFGVLLLELLTGKAP 567
           PE+     + ++       DV+S G++L  +L G+ P
Sbjct: 176 PEL-----LKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 64.6 bits (158), Expect = 3e-11
 Identities = 69/262 (26%), Positives = 108/262 (41%), Gaps = 55/262 (20%)

Query: 360 NAARVFDLED--LLRASAEVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFK 413
           N++    +++   +R    VLGKG+FG   K +L    E G + AVK LK   I +    
Sbjct: 15  NSSNRLGIDNFEFIR----VLGKGSFG---KVMLARVKETGDLYAVKVLKKDVILQD--- 64

Query: 414 DKIEGV--------GAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRT 465
           D +E           A NH  L  L   + + D    V +++  G L  + H  K + R 
Sbjct: 65  DDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQK-SRRF 121

Query: 466 PLNWEMRSL-----IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH 520
               E R+      I       + +LH +G  + + ++K  N+LL      +++DFG+  
Sbjct: 122 D---EARARFYAAEIIS----ALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCK 172

Query: 521 L-VGPSSTPNRVAG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP--------- 567
             +    T     G   Y APE+          D ++ GVLL E+L G AP         
Sbjct: 173 EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232

Query: 568 THALLNEEGVDLPRWVQSIVKD 589
             A+LN+E V  P W+      
Sbjct: 233 FEAILNDE-VVYPTWLHEDATG 253

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 64.2 bits (157), Expect = 3e-11
 Identities = 47/219 (21%), Positives = 93/219 (42%), Gaps = 53/219 (24%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIE----GVGAVNHENLVPL 430
           E LG+G+FG    A   +    VA+K +    + + +   ++E     +  + H +++ L
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 431 RAYYYSMDEKLLV--------YDYLTM-GSLSALLHGNKGAGRTPLNWEMRSLIALGAAR 481
                +  + ++V        +DY+     ++          R       + +I      
Sbjct: 75  YDVITTPTDIVMVIEYAGGELFDYIVEKKRMT-----EDEGRRF-----FQQIIC----- 119

Query: 482 GIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-------TPNRVAGY 534
            IEY H     + H ++K  N+LL  +   +++DFGL++++   +       +PN    Y
Sbjct: 120 AIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN----Y 173

Query: 535 RAPEVTDPCKVSQK------ADVYSFGVLLLELLTGKAP 567
            APEV     ++ K       DV+S G++L  +L G+ P
Sbjct: 174 AAPEV-----INGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 64.4 bits (156), Expect = 3e-11
 Identities = 25/121 (20%), Positives = 39/121 (32%), Gaps = 12/121 (9%)

Query: 116 SCSNLRNLY-LQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFL 173
                  L   +           L G  +L  L +        +     + L +L+ L +
Sbjct: 6   CPHGSSGLRCTRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTI 63

Query: 174 ENNRLSGSIPG--FDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPLQ-D 230
             + L   +    F    P L +LN+S N L  S+  +  T    S     L G PL   
Sbjct: 64  VKSGLR-FVAPDAFHF-TPRLSRLNLSFNALE-SLSWK--TVQGLSLQELVLSGNPLHCS 118

Query: 231 C 231
           C
Sbjct: 119 C 119

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.0 bits (142), Expect = 2e-09
 Identities = 24/103 (23%), Positives = 37/103 (35%), Gaps = 5/103 (4%)

Query: 103 FNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLF-LVGLHHLVRLNLATNNFSGEIPSG 161
            +         L    NL  LY++       + L  L GL  L  L +  +     +   
Sbjct: 17  RDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74

Query: 162 -FKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
            F    +L  L L  N L  S+        +LQ+L +S N L+
Sbjct: 75  AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 46.3 bits (109), Expect = 2e-05
 Identities = 20/85 (23%), Positives = 28/85 (32%), Gaps = 1/85 (1%)

Query: 70  RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNH 129
            +T L +        + L  L  L  LR L++  + L    P        L  L L  N 
Sbjct: 32  NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91

Query: 130 FSGEVPLFLVGLHHLVRLNLATNNF 154
                   + GL  L  L L+ N  
Sbjct: 92  LESLSWKTVQGL-SLQELVLSGNPL 115

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 64.1 bits (157), Expect = 4e-11
 Identities = 60/253 (23%), Positives = 100/253 (39%), Gaps = 54/253 (21%)

Query: 369 DLLRASAEVLGKGTFGTAY----KAVLEMGTIVAVKRLKDVTISEREFKDKIEGV----- 419
           +LLR    VLGKG +G  +          G I A+K LK   I                 
Sbjct: 20  ELLR----VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN--AKDTAHTKAERN 73

Query: 420 --GAVNHENLVPLRAYYYSM--DEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL 474
               V H  +V L    Y+     KL L+ +YL+ G L   L      G      E  + 
Sbjct: 74  ILEEVKHPFIVDL---IYAFQTGGKLYLILEYLSGGELFMQLER---EGIFM---EDTAC 124

Query: 475 -----IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTP 528
                I++     + +LH +G  + + ++K  NI+L      +++DFGL    +   +  
Sbjct: 125 FYLAEISMA----LGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT 178

Query: 529 NRVAG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP---------THALLNEEG 576
           +   G   Y APE+      ++  D +S G L+ ++LTG  P            +L  + 
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK- 237

Query: 577 VDLPRWVQSIVKD 589
           ++LP ++    +D
Sbjct: 238 LNLPPYLTQEARD 250

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 62.4 bits (152), Expect = 4e-11
 Identities = 37/134 (27%), Positives = 59/134 (44%), Gaps = 12/134 (8%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNHF 130
            +L L    ++ ++  G+  +L +L+ L L  N L + LP  +  S + L  L L  N  
Sbjct: 43  QILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQL 100

Query: 131 SGEVPLFLVG----LHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFD 186
           +  +P         L HL  L +  N  + E+P G + LT L  L L+ N+L     G  
Sbjct: 101 T-VLP---SAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAF 155

Query: 187 DVLPNLQQLNVSNN 200
           D L +L    +  N
Sbjct: 156 DRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 44/130 (33%), Positives = 59/130 (45%), Gaps = 17/130 (13%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHF----SGEVPLFLVG 140
           +P GI    T+ + L L  N +T   P    S  NL+ LYL  N       G V   L  
Sbjct: 34  VPAGIP---TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG-VFDSLTQ 89

Query: 141 LHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVS 198
           L     L+L TN  +  +PS  F  L  LK LF+  N+L+  +P G +  L +L  L + 
Sbjct: 90  LT---VLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIER-LTHLTHLALD 143

Query: 199 NNLLNGSIPK 208
            N L  SIP 
Sbjct: 144 QNQLK-SIPH 152

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 3/94 (3%)

Query: 118 SNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENN 176
           +N + LYL  N  +   P     L +L  L L +N     +P G F +LT+L  L L  N
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98

Query: 177 RLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRF 210
           +L+       D L +L++L +  N L   +P+  
Sbjct: 99  QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGI 131

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 64.2 bits (157), Expect = 4e-11
 Identities = 61/244 (25%), Positives = 104/244 (42%), Gaps = 55/244 (22%)

Query: 377 VLGKGTFGTAYKAVL-EMGTIVAVK--------RLKDV--TISEREFKDKIEGVGAVNHE 425
            LG G+FG        E G   A+K        +LK +  T++E+    +I  + AVN  
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK----RI--LQAVNFP 101

Query: 426 NLVPLRAYYYSMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL-----IALGA 479
            LV L  + +  +  L +V +Y+  G + + L   +  GR     E  +      I L  
Sbjct: 102 FLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFS---EPHARFYAAQIVLT- 153

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----TPNRVAGY 534
               EYLH+   ++ + ++K  N+L+ +    +V+DFG A  V   +     TP      
Sbjct: 154 ---FEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE----A 204

Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA---------LLNEEGVDLPRWVQS 585
            APE+      ++  D ++ GVL+ E+  G  P  A         +++ + V  P    S
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSS 263

Query: 586 IVKD 589
            +KD
Sbjct: 264 DLKD 267

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 62.0 bits (151), Expect = 4e-11
 Identities = 44/126 (34%), Positives = 56/126 (44%), Gaps = 8/126 (6%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
           +P GI         L L  NSL S         ++L  LYL GN            L  L
Sbjct: 22  VPTGIP---AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78

Query: 145 VRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVSNNLL 202
             LNL+TN     +P+G F  LT+LK L L  N+L  S+P G  D L  L+ L +  N L
Sbjct: 79  TYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136

Query: 203 NGSIPK 208
             S+P 
Sbjct: 137 K-SVPD 141

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 61.2 bits (149), Expect = 7e-11
 Identities = 46/132 (34%), Positives = 61/132 (46%), Gaps = 7/132 (5%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNHF 130
           T L L   +L   +P G+   LTSL  L L  N L S LP+ +    ++L  L L  N  
Sbjct: 31  TYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQL 88

Query: 131 SGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIP-GFDDV 188
                     L  L  L L TN     +P G F  LT+LK L L  N+L  S+P G  D 
Sbjct: 89  QSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDR 146

Query: 189 LPNLQQLNVSNN 200
           L +LQ + + +N
Sbjct: 147 LTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 22/64 (34%), Positives = 30/64 (46%), Gaps = 1/64 (1%)

Query: 146 RLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGS 205
            L+L TN+        F  LT L  L+L  N+L     G  + L +L  LN+S N L  S
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-S 90

Query: 206 IPKR 209
           +P  
Sbjct: 91  LPNG 94

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 63.8 bits (156), Expect = 5e-11
 Identities = 61/254 (24%), Positives = 105/254 (41%), Gaps = 57/254 (22%)

Query: 369 DLLRASAEVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEGV----- 419
           + L     VLGKG+FG   K +L        + AVK LK   + +    D +E       
Sbjct: 23  NFLM----VLGKGSFG---KVMLSERKGTDELYAVKILKKDVVIQD---DDVECTMVEKR 72

Query: 420 ---GAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL-- 474
                     L  L + + +MD    V +Y+  G L  + H  +  GR     E  ++  
Sbjct: 73  VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQ-VGRFK---EPHAVFY 126

Query: 475 ---IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNR 530
              IA+    G+ +L ++G  + + ++K  N++L      +++DFG+    +    T   
Sbjct: 127 AAEIAI----GLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 180

Query: 531 VAG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP---------THALLNEEGVD 578
             G   Y APE+       +  D ++FGVLL E+L G+AP           +++    V 
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VA 239

Query: 579 LPRWV----QSIVK 588
            P+ +     +I K
Sbjct: 240 YPKSMSKEAVAICK 253

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 64.1 bits (156), Expect = 6e-11
 Identities = 49/247 (19%), Positives = 85/247 (34%), Gaps = 63/247 (25%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAV---------NHE 425
            ++G G++G   +A       +VA+K++  V      F+D I+    +         NH+
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRV------FEDLIDCKRILREIAILNRLNHD 112

Query: 426 NLVPLR-----AYYYSMDEKLLVYDYLTMGS-LSALLHGNKGAGRTPLNWEMRSLIALGA 479
           ++V +            DE  +V +     S    L           L       +    
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEI--ADSDFKKLFRTPV-----YLTELHIKTLLYNL 165

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------ 533
             G++Y+H+    + H ++K +N L+ +    +V DFGLA  V      N          
Sbjct: 166 LVGVKYVHSA--GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 534 -------------------------YRAPEVTDPCKVSQKA-DVYSFGVLLLELLTGKAP 567
                                    YRAPE+    +   +A DV+S G +  ELL     
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283

Query: 568 THALLNE 574
             A   +
Sbjct: 284 NVAYHAD 290

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 63.4 bits (154), Expect = 8e-11
 Identities = 60/367 (16%), Positives = 106/367 (28%), Gaps = 119/367 (32%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVK------RLKDVTISEREFKDKIEGVGAVNHENLVPL 430
           LG G F T + +  ++    VA+K         +  + E      +      N  N   +
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRN-SDPNDPNREMV 103

Query: 431 RAYYYSMDEK-------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
                             +V++ L    L   +  +   G   L       I     +G+
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQG---LPLPCVKKIIQQVLQGL 159

Query: 484 EYLHAQGPNVSHGNIKSSNILLT------------------------------------- 506
           +YLH +   + H +IK  NILL+                                     
Sbjct: 160 DYLHTKC-RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 507 ------------KSYEARVSDFGLA-----HLVGPSSTPNRVAGYRAPEVTDPCKVSQKA 549
                       +  + +++D G A     H      T      YR+ EV      +  A
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTR----QYRSLEVLIGSGYNTPA 274

Query: 550 DVYSFGVLLLELLTGKAPTHALLNEEGVD--------------LPR-WVQSIVKDEWTSE 594
           D++S   +  EL TG         EE                 +PR  +      +++ E
Sbjct: 275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV---AGKYSKE 331

Query: 595 VFD----------------LELL--RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK 636
            F                  E+L  +Y+  +EE        +      P+ R + +E ++
Sbjct: 332 FFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391

Query: 637 RIEELHP 643
                HP
Sbjct: 392 -----HP 393

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 60.4 bits (147), Expect = 8e-11
 Identities = 25/90 (27%), Positives = 41/90 (45%), Gaps = 3/90 (3%)

Query: 114 LASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFL 173
             +    R L L+G      +      L     ++  ++N   ++  GF  L +LKTL +
Sbjct: 15  YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDF-SDNEIRKL-DGFPLLRRLKTLLV 71

Query: 174 ENNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
            NNR+     G D  LP+L +L ++NN L 
Sbjct: 72  NNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 60.1 bits (146), Expect = 1e-10
 Identities = 24/119 (20%), Positives = 35/119 (29%), Gaps = 18/119 (15%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVR--- 146
             N    R L LR   +   + +  A+      +    N         L G   L R   
Sbjct: 15  YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-----LDGFPLLRRLKT 68

Query: 147 LNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDV-----LPNLQQLNVSNN 200
           L +  N          + L  L  L L NN     +    D+     L +L  L +  N
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNNS----LVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 52.4 bits (126), Expect = 4e-08
 Identities = 17/115 (14%), Positives = 35/115 (30%), Gaps = 10/115 (8%)

Query: 88  GILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL 147
            +   L     +    N +             L+ L +  N            L  L  L
Sbjct: 36  NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93

Query: 148 NLATNNFS--GEIPSGFKNLTKLKTLFLENNRLSGSIPGFDD----VLPNLQQLN 196
            L  N+    G++     +L  L  L +  N ++ +   +       +P ++ L+
Sbjct: 94  ILTNNSLVELGDL-DPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 146

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 63.0 bits (154), Expect = 9e-11
 Identities = 63/251 (25%), Positives = 100/251 (39%), Gaps = 53/251 (21%)

Query: 369 DLLRASAEVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISEREFKDKIEG-----V 419
             L+    V+GKG+FG   K +L          AVK L+   I +++ +  I       +
Sbjct: 41  HFLK----VIGKGSFG---KVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93

Query: 420 GAVNHENLVPLRAYYYSM--DEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL-- 474
             V H  LV L   ++S    +KL  V DY+  G L    H  +         E R+   
Sbjct: 94  KNVKHPFLVGL---HFSFQTADKLYFVLDYINGGEL--FYHLQR-ERCFL---EPRARFY 144

Query: 475 ---IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL-VGPSSTPNR 530
              IA      + YLH+    + + ++K  NILL       ++DFGL    +  +ST + 
Sbjct: 145 AAEIASA----LGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST 198

Query: 531 VAG---YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP---------THALLNEEGVD 578
             G   Y APEV       +  D +  G +L E+L G  P            +LN+  + 
Sbjct: 199 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQ 257

Query: 579 LPRWVQSIVKD 589
           L   + +  + 
Sbjct: 258 LKPNITNSARH 268

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 64.1 bits (155), Expect = 1e-10
 Identities = 59/402 (14%), Positives = 109/402 (27%), Gaps = 150/402 (37%)

Query: 364 VFDLEDLLRASAEVLGKGTFGTAYKAVLEMGT-IVAVKRLKDVTISERE--FKDKIEGVG 420
             D++D+ +    +L K         ++     +    RL    +S++E   +  +E V 
Sbjct: 35  CKDVQDMPK---SILSK----EEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVL 87

Query: 421 AVNHENLV------------PLRAYYYSMDE---------KLLV-----YDYLTMGSLSA 454
            +N++ L+              R Y    D          K  V     Y  L    L  
Sbjct: 88  RINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQA-LLE 146

Query: 455 L-------LHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV---SHGNIKSSNIL 504
           L       + G  G+G+T +        AL      +        +   +  N  S   +
Sbjct: 147 LRPAKNVLIDGVLGSGKTWV--------ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETV 198

Query: 505 LTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTG 564
           L    +       L + + P+ T                +             L  LL  
Sbjct: 199 LEMLQK-------LLYQIDPNWTSRSDHSSNIKLRIHSIQAE-----------LRRLLKS 240

Query: 565 KAPTHALLNEEGV--DLPRWVQSIVKDEWTSEVFDLE---LL--RYQNV----------- 606
           K   + LL    V  +        V++      F+L    LL  R++ V           
Sbjct: 241 KPYENCLL----VLLN--------VQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTH 288

Query: 607 -----------EEEMVQLLQLAIDCSAQ-----------------------YPD------ 626
                       +E+  LL   +DC  Q                                
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWK 348

Query: 627 --NRPSMSEVIKR-IEELHPSSTQGHH---GLQPDDLDNISS 662
             N   ++ +I+  +  L P+  +       + P    +I +
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA-HIPT 389

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.0 bits (134), Expect = 4e-08
 Identities = 87/624 (13%), Positives = 179/624 (28%), Gaps = 187/624 (29%)

Query: 107 TSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLV-------GLHHLVRLNLATN-NFSGEI 158
              +P  + S   + ++ +  +  SG + LF          +   V   L  N  F   +
Sbjct: 38  VQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKF---L 94

Query: 159 PSGFKNLTKLKTLFLEN-----NRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTF 213
            S  K   +  ++         +RL      F        + NVS          R Q +
Sbjct: 95  MSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA-------KYNVS----------RLQPY 137

Query: 214 GSNSFLGNSLCG-KPLQD--------CGTKASLVVPSTPSGTDEISHGEKEKKKLSGGAI 264
                L  +L   +P ++         G K  + +        ++    K + K+    I
Sbjct: 138 LK---LRQALLELRPAKNVLIDGVLGSG-KTWVAL--------DVCLSYKVQCKMDFK-I 184

Query: 265 AGIVIGSVIGFLLILLILLILCRK-KSNRNTRS-------VDITSLKQQEVEIVDDKAVG 316
             + + +      +L +L  L  +   N  +RS       + I S++ +   ++  K   
Sbjct: 185 FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE 244

Query: 317 E----MDNGYSVAAAAAAAMVGIGNGNGKT-------QVNSNVNGATKKLVFFGNAARVF 365
                + N  +  A A  A     N + K        QV   ++ AT   +   + +   
Sbjct: 245 NCLLVLLNVQN--AKAWNAF----NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTL 298

Query: 366 DLEDLLRASAEVLGKGTFGTAYKAV----LEMGTIVAVKRLKDVTIS--EREFKDKIEGV 419
             +++     + L         + +      +  I    R    T    +    DK+  +
Sbjct: 299 TPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTI 358

Query: 420 GAVNHENLVP--LRAYYYSMDEKLLVYD---YLTMGSLSALLHGNKGAGRTPLNW-EM-- 471
              +   L P   R  +    ++L V+    ++    LS +             W ++  
Sbjct: 359 IESSLNVLEPAEYRKMF----DRLSVFPPSAHIPTILLSLI-------------WFDVIK 401

Query: 472 ------------RSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA 519
                        SL+          +               +I L    + ++ +    
Sbjct: 402 SDVMVVVNKLHKYSLVEKQPKESTISIP--------------SIYL--ELKVKLENEYAL 445

Query: 520 HLVGPSSTPNR-VAGYRAPEVTDPCKVS-QKADVYS-------------------FGVLL 558
           H           V  Y  P+  D   +     D Y                    F ++ 
Sbjct: 446 H--------RSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVF 497

Query: 559 LEL--LTGK--APTHALLNEEGV-----DLPRWVQSIVKDEWTSEVFDLELLRY-QNVEE 608
           L+   L  K    + A      +      L  +   I  ++   E     +L +   +EE
Sbjct: 498 LDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEE 557

Query: 609 EMVQ-----LLQLAIDCSAQYPDN 627
            ++      LL++A+       D 
Sbjct: 558 NLICSKYTDLLRIAL----MAEDE 577

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 54/221 (24%)

Query: 377 VLGKGTFGTAYKAVL----EMGTIVAVKRL-KDVTISERE---FKDKIEGVGAVNHENLV 428
           V+G+G FG   +  L        + A+K L K   I   +   F ++ + +   N   +V
Sbjct: 76  VIGRGAFG---EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132

Query: 429 PLRAYYYSM--DEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNW------EMRSLIALGA 479
            L   +Y+   D  L +V +Y+  G L  L+         P  W      E+  ++AL  
Sbjct: 133 QL---FYAFQDDRYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEV--VLAL-- 181

Query: 480 ARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---------TPNR 530
               + +H+ G    H ++K  N+LL KS   +++DFG    +             TP+ 
Sbjct: 182 ----DAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD- 234

Query: 531 VAGYRAPEV----TDPCKVSQKADVYSFGVLLLELLTGKAP 567
              Y +PEV           ++ D +S GV L E+L G  P
Sbjct: 235 ---YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 66/270 (24%), Positives = 108/270 (40%), Gaps = 60/270 (22%)

Query: 354 KLVFFGNAARVFDLED--LLRASAEVLGKGTFGTAY----KAVLEMGTIVAVKRLK---- 403
           +       A    +E+  LL+    VLG G +G  +     +  + G + A+K LK    
Sbjct: 40  RTANLTGHAEKVGIENFELLK----VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATI 95

Query: 404 -----DV--TISEREFKDKIEGVGAVNHEN-LVPLRAYYYSM--DEKL-LVYDYLTMGSL 452
                    T +ER    ++  +  +     LV L   +Y+   + KL L+ DY+  G L
Sbjct: 96  VQKAKTTEHTRTER----QV--LEHIRQSPFLVTL---HYAFQTETKLHLILDYINGGEL 146

Query: 453 SALLHGNKGAGRTPLNWEMRSL-----IALGAARGIEYLHAQGPNVSHGNIKSSNILLTK 507
               H ++   R     E         I L     +E+LH  G  + + +IK  NILL  
Sbjct: 147 --FTHLSQ-RERFT---EHEVQIYVGEIVL----ALEHLHKLG--IIYRDIKLENILLDS 194

Query: 508 SYEARVSDFGLA--HLVGPSSTPNRVAG---YRAPEV--TDPCKVSQKADVYSFGVLLLE 560
           +    ++DFGL+   +   +       G   Y AP++         +  D +S GVL+ E
Sbjct: 195 NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254

Query: 561 LLTGKAPTHALLNEEGVDLPRWVQSIVKDE 590
           LLTG +P     + E        + I+K E
Sbjct: 255 LLTGASPFTV--DGEKNSQAEISRRILKSE 282

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 60.4 bits (147), Expect = 9e-10
 Identities = 27/133 (20%), Positives = 48/133 (36%), Gaps = 18/133 (13%)

Query: 88  GILGNLTSLRTLSLRFNSLTSQ----LPSDLASCSNLRNLYLQGNHFSGE-VPLFLVGLH 142
           G+L     L  L L + SL++     L S L +  + + L +  N  +   V +   GL 
Sbjct: 136 GLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLK 195

Query: 143 H----LVRLNLATNNFSGE----IPSGFKNLTKLKTLFLENNRLSGS-----IPGFDDVL 189
                L  L L +   + +    +     +   L+ L L +N+L         PG     
Sbjct: 196 DSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPS 255

Query: 190 PNLQQLNVSNNLL 202
             L+ L +    +
Sbjct: 256 SRLRTLWIWECGI 268

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 56.5 bits (137), Expect = 2e-08
 Identities = 30/132 (22%), Positives = 47/132 (35%), Gaps = 18/132 (13%)

Query: 89  ILGNLTSLRTLSLRFNSLTSQ----LPSDLASCSNLRNLYLQGNHFSGE-VPLFLVGLHH 143
           +L  L   + + L    LT      + S L     L  L L+ N      V   L GL  
Sbjct: 23  LLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82

Query: 144 ----LVRLNLATNNFSGE----IPSGFKNLTKLKTLFLENNRLSGS-----IPGFDDVLP 190
               + +L+L     +G     + S  + L  L+ L L +N L  +       G  D   
Sbjct: 83  PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQC 142

Query: 191 NLQQLNVSNNLL 202
            L++L +    L
Sbjct: 143 RLEKLQLEYCSL 154

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 55.0 bits (133), Expect = 5e-08
 Identities = 30/133 (22%), Positives = 50/133 (37%), Gaps = 18/133 (13%)

Query: 88  GILGNLTSLRTLSLRFNSLTSQ----LPSDLASCSNLRNLYLQGNHFSGE-VPLFLVGLH 142
           G+L   + LRTL +    +T++    L   L +  +L+ L L GN    E   L    L 
Sbjct: 250 GLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLL 309

Query: 143 H----LVRLNLATNNFSGE----IPSGFKNLTKLKTLFLENNRLSGS-----IPGFDDVL 189
                L  L + + +F+        S       L  L + NNRL  +       G     
Sbjct: 310 EPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPG 369

Query: 190 PNLQQLNVSNNLL 202
             L+ L +++  +
Sbjct: 370 SVLRVLWLADCDV 382

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 51.1 bits (123), Expect = 6e-07
 Identities = 28/127 (22%), Positives = 47/127 (37%), Gaps = 18/127 (14%)

Query: 94  TSLRTLSLRFNSLTSQ----LPSDLASCSNLRNLYLQGNHFSGE-VPLFLVGLHH----L 144
             ++ LSL+   LT      L S L +   L+ L+L  N      + L   GL      L
Sbjct: 85  CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRL 144

Query: 145 VRLNLATNNFSGE----IPSGFKNLTKLKTLFLENNRLSGS-----IPGFDDVLPNLQQL 195
            +L L   + S      + S  +     K L + NN ++ +       G  D    L+ L
Sbjct: 145 EKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEAL 204

Query: 196 NVSNNLL 202
            + +  +
Sbjct: 205 KLESCGV 211

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 45.0 bits (107), Expect = 7e-05
 Identities = 25/125 (20%), Positives = 43/125 (34%), Gaps = 31/125 (24%)

Query: 88  GILGNLTSLRTLSLRFNSLTSQ----LPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH 143
            +L     L +L ++  S T+       S LA    L  L +  N           G+  
Sbjct: 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA------GVRE 360

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDD------VLPNLQQLNV 197
           L +  L                + L+ L+L +  +S S               +L++L++
Sbjct: 361 LCQG-LGQPG------------SVLRVLWLADCDVSDS--SCSSLAATLLANHSLRELDL 405

Query: 198 SNNLL 202
           SNN L
Sbjct: 406 SNNCL 410

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 41.9 bits (99), Expect = 5e-04
 Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 13/97 (13%)

Query: 88  GILGNLTSLRTLSLRFNSLTSQ----LPSDLASCSNLRNLYLQGNHFSGE-VPLFLVGLH 142
           G+    + LR L L    ++      L + L +  +LR L L  N      +   +  + 
Sbjct: 364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 423

Query: 143 H----LVRLNLATNNFSGE----IPSGFKNLTKLKTL 171
                L +L L    +S E    + +  K+   L+ +
Sbjct: 424 QPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 460

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 56.7 bits (137), Expect = 1e-09
 Identities = 26/89 (29%), Positives = 39/89 (43%), Gaps = 3/89 (3%)

Query: 116 SCSNLRNLYLQGNHFS-GEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLE 174
           + + +R L L     + G++        +L  L+L        + S    L KLK L L 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79

Query: 175 NNRLSGSIPGFDDVLPNLQQLNVSNNLLN 203
            NR+ G +    + LPNL  LN+S N L 
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 56.7 bits (137), Expect = 1e-09
 Identities = 34/133 (25%), Positives = 52/133 (39%), Gaps = 10/133 (7%)

Query: 69  NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGN 128
             V  L L     +     G+     +L  LSL    L S   S+L     L+ L L  N
Sbjct: 24  AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSEN 81

Query: 129 HFSGEVPLFLVGLHHLVRLNLATNNFS--GEIPSGFKNLTKLKTLFLENNRLSGSIPGFD 186
              G + +    L +L  LNL+ N       +    K L  LK+L L N  ++ ++  + 
Sbjct: 82  RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVT-NLNDYR 139

Query: 187 D----VLPNLQQL 195
           +    +LP L  L
Sbjct: 140 ESVFKLLPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 25/115 (21%), Positives = 39/115 (33%), Gaps = 12/115 (10%)

Query: 92  NLTSLRTLSLRFNSLT-SQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLA 150
              ++R L L        ++    A   NL  L L        V   L  L  L +L L+
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELS 79

Query: 151 TNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDV-----LPNLQQLNVSNN 200
            N   G +    + L  L  L L  N+    +     +     L  L+ L++ N 
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNK----LKDISTLEPLKKLECLKSLDLFNC 130

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 56.5 bits (137), Expect = 2e-09
 Identities = 39/122 (31%), Positives = 53/122 (43%), Gaps = 15/122 (12%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVG---- 140
           +P GI    +S   L L  N L S         + L  L L  N     +P    G    
Sbjct: 22  VPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLP---DGVFDK 74

Query: 141 LHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVS 198
           L  L  L L  N     +P+G F  LT+LK L L+ N+L  S+P G  D L +LQ++ + 
Sbjct: 75  LTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLH 132

Query: 199 NN 200
            N
Sbjct: 133 TN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 51.5 bits (124), Expect = 8e-08
 Identities = 31/93 (33%), Positives = 44/93 (47%), Gaps = 5/93 (5%)

Query: 118 SNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENN 176
           S+   L L+ N            L  L +L+L+ N     +P G F  LTKL  L+L  N
Sbjct: 28  SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHEN 86

Query: 177 RLSGSIP-GFDDVLPNLQQLNVSNNLLNGSIPK 208
           +L  S+P G  D L  L++L +  N L  S+P 
Sbjct: 87  KLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPD 117

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 57.3 bits (139), Expect = 6e-09
 Identities = 51/226 (22%), Positives = 79/226 (34%), Gaps = 40/226 (17%)

Query: 376 EVLGKGTFGTAYKAV--LEMGTIVAVKRLKDVT------ISEREFKDKIEGVGAVNHENL 427
             LG+GTFG   + +      + VA+K +++V         E     KI+     N    
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           V +  ++       + ++ L   +    L  N      P        +A      + +LH
Sbjct: 85  VLMSDWFNFHGHMCIAFELLGK-NTFEFLKEN---NFQPYPLPHVRHMAYQLCHALRFLH 140

Query: 488 AQGPNVSHGNIKSSNILLT-------------------KSYEARVSDFGLAHLVGPSSTP 528
                ++H ++K  NIL                     K+   RV+DFG A       T 
Sbjct: 141 EN--QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTT 198

Query: 529 ---NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKA--PTH 569
               R   YR PEV      +Q  DV+S G +L E   G     TH
Sbjct: 199 IVATRH--YRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 53/233 (22%), Positives = 90/233 (38%), Gaps = 54/233 (23%)

Query: 376 EVLGKGTFGTAYKAV--LEMGTIVAVKRLKDVTI----SEREFK--DKIEGVGAVNHENL 427
           + LG+G FG   + +     G  VAVK +K+V      +  E +  + +      +    
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           V +  ++       +V++ L + S    +  N   G  P   +    +A    + + +LH
Sbjct: 80  VQMLEWFEHHGHICIVFELLGL-STYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLH 135

Query: 488 AQGPNVSHGNIKSSNILLT-------------------KSYEARVSDFGLAHLVGPSSTP 528
           +    ++H ++K  NIL                      + + +V DFG       S+T 
Sbjct: 136 SN--KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-------SATY 186

Query: 529 N----------RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKA--PTH 569
           +          R   YRAPEV      SQ  DV+S G +L+E   G    PTH
Sbjct: 187 DDEHHSTLVSTRH--YRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 54.3 bits (131), Expect = 6e-08
 Identities = 50/233 (21%), Positives = 83/233 (35%), Gaps = 50/233 (21%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKD--KIEGVGAV--------NH 424
             +G GTFG       ++     AVK ++++    +++    KIE    +        N+
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIE-ADILKKIQNDDINN 95

Query: 425 ENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE 484
            N+V     +   D   L+++ L   SL  ++  N        + E   L  +   + + 
Sbjct: 96  NNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRN---NYNGFHIEDIKLYCIEILKALN 151

Query: 485 YLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG----------- 533
           YL     +++H ++K  NILL   Y  +          G      R              
Sbjct: 152 YLRKM--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209

Query: 534 ---------------YRAPEVTDPCKVSQKADVYSFGVLLLELLTGKA--PTH 569
                          YRAPEV         +D++SFG +L EL TG     TH
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 51.3 bits (123), Expect = 6e-07
 Identities = 27/135 (20%), Positives = 50/135 (37%), Gaps = 23/135 (17%)

Query: 90  LGNLTSLRTLSLRFNSLTSQ----LPSDLASCSNLRNLYLQGNHFSGE----VPLFLVGL 141
           +    S+   SL+ +++T++    + + L    +++ + L GN    E    +   +   
Sbjct: 1   MARF-SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59

Query: 142 HHLVRLNLA---TNNFSGEIPSGFKNL-------TKLKTLFLENNRLSGS-IPGFDDVL- 189
             L     +   T     EIP   + L        KL T+ L +N    +      D L 
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119

Query: 190 --PNLQQLNVSNNLL 202
               L+ L + NN L
Sbjct: 120 KHTPLEHLYLHNNGL 134

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 24/139 (17%), Positives = 41/139 (29%), Gaps = 26/139 (18%)

Query: 90  LGNLTSLRTLSLRFNSLT----SQLPSDLASCSNLRNLYLQGNHFSGE------------ 133
           L     L T+ L  N+        L   L+  + L +LYL  N    +            
Sbjct: 90  LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 149

Query: 134 -VPLFLVGLHHLVRLNLATNNFSGE----IPSGFKNLTKLKTLFLENNRLS--GSIPGFD 186
            V         L  +    N             F++   L T+ +  N +   G      
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 209

Query: 187 DVL---PNLQQLNVSNNLL 202
           + L     L+ L++ +N  
Sbjct: 210 EGLAYCQELKVLDLQDNTF 228

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 31/140 (22%), Positives = 44/140 (31%), Gaps = 19/140 (13%)

Query: 80  ALSGQIPLGILGNLTSLRTLSLRFNSLTSQ----LPSDLASCSNLRNLYLQGNHFSGE-- 133
           AL          N   LR++    N L +           S   L  + +  N    E  
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204

Query: 134 VPLFLVGLHH---LVRLNLATNNFSGE----IPSGFKNLTKLKTLFLENNRLSGS-IPGF 185
             L L GL +   L  L+L  N F+      +    K+   L+ L L +  LS       
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 264

Query: 186 DDVL-----PNLQQLNVSNN 200
            D         LQ L +  N
Sbjct: 265 VDAFSKLENIGLQTLRLQYN 284

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 30/133 (22%), Positives = 49/133 (36%), Gaps = 20/133 (15%)

Query: 90  LGNLTSLRTLSLRFNSLTSQ-----LPSDLASCSNLRNLYLQGNHFSGE----VPLFLVG 140
             +   L T+ +  N +  +     L   LA C  L+ L LQ N F+      + + L  
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242

Query: 141 LHHLVRLNLATNNFSGE----IPSGFKNL--TKLKTLFLENNRLSGS-----IPGFDDVL 189
             +L  L L     S      +   F  L    L+TL L+ N +            D+ +
Sbjct: 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 302

Query: 190 PNLQQLNVSNNLL 202
           P+L  L ++ N  
Sbjct: 303 PDLLFLELNGNRF 315

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 47.6 bits (112), Expect = 8e-06
 Identities = 22/141 (15%), Positives = 43/141 (30%), Gaps = 18/141 (12%)

Query: 74  LRLPGVALSGQIPLGIL-GNLTSLRTLSLRF---NSLTSQLPSDLA------SCSNLRNL 123
           L +    L   +   IL  +L +L  L L     +       +            NL+ L
Sbjct: 198 LEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWL 257

Query: 124 YLQGNHFSGEVPLFLVG---LHHLVRLNLATNNFSGE----IPSGFKNLTKLKTLFLENN 176
            +        V    +    L  L  ++++    + E    +      +  LK + ++ N
Sbjct: 258 GIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317

Query: 177 RLSGS-IPGFDDVLPNLQQLN 196
            LS          LP    ++
Sbjct: 318 YLSDEMKKELQKSLPMKIDVS 338

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 47.3 bits (111), Expect = 9e-06
 Identities = 24/158 (15%), Positives = 53/158 (33%), Gaps = 19/158 (12%)

Query: 72  TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLAS--CSNLR--NLYLQG 127
            +L    +  +  + +G       L++L +    L   +  D+      NL    LY+  
Sbjct: 172 PLLNNLKIKGTNNLSIGKKPRPN-LKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGV 230

Query: 128 NHFSGEVP-------LFLVGLHHLVRLNLATNNFSGEIPSGF---KNLTKLKTLFLENNR 177
             +  +                +L  L +        +   F     L +L+T+ +    
Sbjct: 231 EDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGV 290

Query: 178 LSGS----IPGFDDVLPNLQQLNVSNNLLNGSIPKRFQ 211
           L+      +    D + +L+ +N+  N L+  + K  Q
Sbjct: 291 LTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQ 328

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 44.6 bits (104), Expect = 6e-05
 Identities = 22/128 (17%), Positives = 46/128 (35%), Gaps = 17/128 (13%)

Query: 89  ILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVG--LHHLVR 146
           +L  +  L  L ++  +    L        NL++L +        V   ++G  L +L +
Sbjct: 167 VLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEK 223

Query: 147 LNL--ATNNFSGEIPSGF-------KNLTKLKTLFLENNRLSGSIPGFD---DVLPNLQQ 194
           L L     ++  +                 LK L + +      +       D+LP L+ 
Sbjct: 224 LVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLET 283

Query: 195 LNVSNNLL 202
           +++S  +L
Sbjct: 284 MDISAGVL 291

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 45.7 bits (109), Expect = 8e-06
 Identities = 31/97 (31%), Positives = 42/97 (43%), Gaps = 13/97 (13%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVG---- 140
           +P GI    T  + L L  N +T   P       NL+ LY   N  +  +P    G    
Sbjct: 27  VPAGIP---TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIP---TGVFDK 79

Query: 141 LHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENN 176
           L  L +L+L  N+    IP G F NL  L  ++L NN
Sbjct: 80  LTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 43.8 bits (104), Expect = 3e-05
 Identities = 24/65 (36%), Positives = 39/65 (60%), Gaps = 5/65 (7%)

Query: 146 RLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVSNNLLN 203
           RL L  N  + ++  G F +L  L+ L+  +N+L+ +IP G  D L  L QL++++N L 
Sbjct: 37  RLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLK 94

Query: 204 GSIPK 208
            SIP+
Sbjct: 95  -SIPR 98

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 47.2 bits (112), Expect = 9e-06
 Identities = 35/146 (23%), Positives = 52/146 (35%), Gaps = 24/146 (16%)

Query: 70  RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNH 129
           RV  + L    +      GIL   + L+ LSL    L+  + + LA  SNL  L L G  
Sbjct: 94  RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 153

Query: 130 FSGEVPLFLV--GLHHLVRLNLA------TNNFSGEIPSGFKNLTKLKTLFLENNRLSGS 181
              E  L  +      L  LNL+        +    +    + +T+L         LSG 
Sbjct: 154 GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQL--------NLSGY 205

Query: 182 IPGFDDV--------LPNLQQLNVSN 199
                           PNL  L++S+
Sbjct: 206 RKNLQKSDLSTLVRRCPNLVHLDLSD 231

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 44.9 bits (107), Expect = 1e-05
 Identities = 25/65 (38%), Positives = 38/65 (58%), Gaps = 5/65 (7%)

Query: 146 RLNLATNNFSGEIPSG-FKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVSNNLLN 203
            L L  N  + ++  G F  LT+L  L L+NN+L+  +P G  D L  L QL++++N L 
Sbjct: 34  VLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLK 91

Query: 204 GSIPK 208
            SIP+
Sbjct: 92  -SIPR 95

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 30/97 (30%), Positives = 41/97 (42%), Gaps = 13/97 (13%)

Query: 85  IPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVG---- 140
           +P GI    T+ + L L  N +T   P      + L  L L  N  +  +P    G    
Sbjct: 24  VPTGIP---TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLP---AGVFDK 76

Query: 141 LHHLVRLNLATNNFSGEIPSG-FKNLTKLKTLFLENN 176
           L  L +L+L  N     IP G F NL  L  ++L NN
Sbjct: 77  LTQLTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 22/125 (17%), Positives = 45/125 (36%), Gaps = 7/125 (5%)

Query: 89  ILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQG------NHFSGEVPLFLVGLH 142
           ++    +L++L L       +L + L     L  L   G            + + L G  
Sbjct: 206 LVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCK 265

Query: 143 HLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSG-SIPGFDDVLPNLQQLNVSNNL 201
            L  L+   +     +P+ +   ++L TL L    +    +       P LQ+L V + +
Sbjct: 266 ELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYI 325

Query: 202 LNGSI 206
            +  +
Sbjct: 326 EDAGL 330

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 24/138 (17%), Positives = 49/138 (35%), Gaps = 9/138 (6%)

Query: 70  RVTMLRLPGVALSGQIPLGILGNLTSLRTLSL-RFNSLTSQLPSDLAS-CSNLRNLYLQG 127
            +  +RL  + ++      I  +  + + L L      ++   + +A+ C NL+ L L+ 
Sbjct: 106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRE 165

Query: 128 NHFSGEVPLFLV----GLHHLVRLNLA--TNNFSGE-IPSGFKNLTKLKTLFLENNRLSG 180
           +        +L         LV LN++   +  S   +         LK+L L       
Sbjct: 166 SDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE 225

Query: 181 SIPGFDDVLPNLQQLNVS 198
            +       P L++L   
Sbjct: 226 KLATLLQRAPQLEELGTG 243

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 21/118 (17%), Positives = 36/118 (30%), Gaps = 7/118 (5%)

Query: 89  ILGNLTSLRTLSLRF------NSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLH 142
           +L     L  L            + S L   L+ C  LR L    +     +P       
Sbjct: 230 LLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCS 289

Query: 143 HLVRLNLATNNFSGE-IPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSN 199
            L  LNL+        +        KL+ L++ +      +        +L++L V  
Sbjct: 290 RLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFP 347

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 32/155 (20%), Positives = 57/155 (36%), Gaps = 27/155 (17%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVK---RLKDVTISEREFKDKIEGVGAVNHENLVPLRAY 433
           +G G FG       L     VA+K             E++   +          +P + Y
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG----IP-QVY 71

Query: 434 YYSMDEKLLVYDYLTM---G-SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           Y+    K   Y+ + +   G SL  L        RT  + +   +IA+     +EY+H++
Sbjct: 72  YFGPCGK---YNAMVLELLGPSLEDLF---DLCDRT-FSLKTVLMIAIQLISRMEYVHSK 124

Query: 490 GPNVSHGNIKSSNILLTKSYEARVS-----DFGLA 519
              + + ++K  N L+ +            DF LA
Sbjct: 125 N--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 45.1 bits (107), Expect = 5e-05
 Identities = 26/104 (25%), Positives = 39/104 (37%), Gaps = 12/104 (11%)

Query: 88  GILGNLTSLRTLSLRFNSLTSQ----LPSDLASCSNLRNLYLQGNHFSGE-VPLFLVGLH 142
            +L +   + TL L  N LT+     L   LA  +++ +L L       E + L    L 
Sbjct: 149 LLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLD 208

Query: 143 ---HLVRLNLATNNFSGE----IPSGFKNLTKLKTLFLENNRLS 179
               L  LN+A N         +    +    L+ L L  N LS
Sbjct: 209 RNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 24/125 (19%), Positives = 46/125 (36%), Gaps = 15/125 (12%)

Query: 93  LTSLRTLSLRFNSLTSQLPSDLA-----SCSNLRNLYLQGNHFSGE-VPLFLVGLHHLVR 146
           L+SLR L+L    +T    + +A         L  + L         +   L       +
Sbjct: 71  LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130

Query: 147 LNLATNNFSGE----IPSGFK-NLTKLKTLFLENNRLSGS-IPGFDDVL---PNLQQLNV 197
           L L  N+   E    +      +  ++ TL L NN L+ + +    + L    ++  L++
Sbjct: 131 LGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSL 190

Query: 198 SNNLL 202
            +  L
Sbjct: 191 LHTGL 195

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 29/172 (16%), Positives = 62/172 (36%), Gaps = 24/172 (13%)

Query: 88  GILGNLTSLRTLSLRFNSLTSQLPSDLASC-----SNLRNLYLQGNHFSGE-VPLFLVGL 141
                  S+ +L+LR N L  +   +L        +N+ +L L+GN+ + +        L
Sbjct: 132 AFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFL 191

Query: 142 ----HHLVRLNLATNNFSGE----IPSGFK-NLTKLKTLFLENNRLSGS----IPGFDDV 188
                 +  L+L+ N    +    +   F      + +L L  N L G     +    D 
Sbjct: 192 ASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDS 251

Query: 189 LPNLQQLNVSNNLLNGSIPKRFQTFGS----NSFLGN-SLCGKPLQDCGTKA 235
           L +LQ + +  +++     ++ +  G+       +      GK +    +  
Sbjct: 252 LKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIP 303

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 32/135 (23%), Positives = 51/135 (37%), Gaps = 20/135 (14%)

Query: 88  GILGNLTSLRTLSLRFNSLTSQLPSDLAS-----CSNLRNLYLQGNHFSGE-VPLFLVGL 141
                  S+ +L+L  NSL  +   +L        +N+ +L L GN  S +     +  L
Sbjct: 45  AFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTL 104

Query: 142 HH----LVRLNLATNNFSGE----IPSGFKNL-TKLKTLFLENNRLSGS-----IPGFDD 187
                 +  L+L  N+FS +        F NL   + +L L  N L        I     
Sbjct: 105 AAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAA 164

Query: 188 VLPNLQQLNVSNNLL 202
           +  N+  LN+  N L
Sbjct: 165 IPANVNSLNLRGNNL 179

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 24/130 (18%), Positives = 47/130 (36%), Gaps = 17/130 (13%)

Query: 94  TSLRTLSLRFNSLTSQLPSDLASC-----SNLRNLYLQGNHFSGE----VPLFLVGLHHL 144
            S+ +L L  N L  +  ++LA       +++ +L L  N   G     + L    L HL
Sbjct: 196 ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHL 255

Query: 145 VRLNLATNNFSG-------EIPSGFKNLTKLKTLFLENNRLSGS-IPGFDDVLPNLQQLN 196
             + L  +            + + F N+ K+  +      +  S      +++  L    
Sbjct: 256 QTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKA 315

Query: 197 VSNNLLNGSI 206
              +LLN  +
Sbjct: 316 DVPSLLNQCL 325

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 41.6 bits (98), Expect = 5e-04
 Identities = 25/134 (18%), Positives = 47/134 (35%), Gaps = 20/134 (14%)

Query: 89  ILGNLTSLRTLSLRFNSLTSQLPSDLASC-----SNLRNLYLQGNHFSGE-----VPLFL 138
                  + +L L  N+L S    +L        +++ +L L GN    +     V +  
Sbjct: 17  FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA 76

Query: 139 VGLHHLVRLNLATNNFSGE----IPSGFKNL-TKLKTLFLENNRLSGS-----IPGFDDV 188
               ++  LNL+ N  S +    +      +   +  L L  N  S          F ++
Sbjct: 77  AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136

Query: 189 LPNLQQLNVSNNLL 202
             ++  LN+  N L
Sbjct: 137 PASITSLNLRGNDL 150

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 32/157 (20%), Positives = 60/157 (38%), Gaps = 27/157 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK---DVTISEREFKDKIEGVGAVNHENLVPLR 431
             +G+G+FG  ++   L     VA+K      D      E++      G       +P  
Sbjct: 16  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG----IP-N 70

Query: 432 AYYYSMDEKLLVYDYLTM---G-SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
            YY+  +     ++ L +   G SL  LL      GR   + +  ++ A      ++ +H
Sbjct: 71  VYYFGQEGL---HNVLVIDLLGPSLEDLL---DLCGRK-FSVKTVAMAAKQMLARVQSIH 123

Query: 488 AQGPNVSHGNIKSSNILLTKSYEAR-----VSDFGLA 519
            +   + + +IK  N L+ +          V DFG+ 
Sbjct: 124 EKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 27/167 (16%), Positives = 55/167 (32%), Gaps = 33/167 (19%)

Query: 378 LGKGTFGTAYKAV---------LEMGTIVAVK--RLKDVTISEREFKDKIEGVGAVNHEN 426
             +   G  Y+A                 ++K         +E+ F  +      VN   
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 427 L--------VPLRAYYYSMDEKLLVYDYLTM----GSLSALLHGNKGAGRTPLNWEMRSL 474
                    +P     + + +    Y +L +     SL + L  +    +  L+      
Sbjct: 110 KLYSTPLLAIP-TCMGFGVHQDK--YRFLVLPSLGRSLQSALDVS---PKHVLSERSVLQ 163

Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARV--SDFGLA 519
           +A      +E+LH       HGN+ + NI +    +++V  + +G A
Sbjct: 164 VACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFA 208

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 22/120 (18%), Positives = 41/120 (34%), Gaps = 7/120 (5%)

Query: 89  ILGNLTSLRTLSLRFNSLTSQLPSDLAS----CSNLRNLYLQGNHFSGEVPLFLVGLHHL 144
           +  + TSL  L+          P DL +    C +L ++ +        V  F     +L
Sbjct: 187 LAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFK-AAANL 245

Query: 145 VRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSG--SIPGFDDVLPNLQQLNVSNNLL 202
                 + N    +P  + NL   + L        G   +P        +++L++   LL
Sbjct: 246 EEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALL 305

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 38/156 (24%), Positives = 59/156 (37%), Gaps = 31/156 (19%)

Query: 378 LGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS---EREFK--DKIEG-VGAVNHENLVPL 430
           +G G+FG  Y    +  G  VA+K     T       E K    ++G VG       +P 
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVG-------IP- 68

Query: 431 RAYYYSMDEKLLVYDYLTM----GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
              +   +     Y+ + M     SL  L        R   + +   L+A      IEY+
Sbjct: 69  TIRWCGAEGD---YNVMVMELLGPSLEDLF---NFCSRK-FSLKTVLLLADQMISRIEYI 121

Query: 487 HAQGPNVSHGNIKSSNILL---TKSYEARVSDFGLA 519
           H++     H ++K  N L+    K     + DFGLA
Sbjct: 122 HSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 35/165 (21%), Positives = 58/165 (35%), Gaps = 29/165 (17%)

Query: 378 LGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---------EREFKDKIEGVGAVNHENL- 427
           +G+G FG  Y A +     V       V +          E +F  +      +      
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 428 -------VPLRAYYYSMDEKLLVYDYLTM---G-SLSALLHGNKGAGRTPLNWEMRSLIA 476
                  VP        D+    Y ++ M   G  L  +   N    +   + +    ++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEAN---AKR-FSRKTVLQLS 158

Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARV--SDFGLA 519
           L     +EY+H       HG+IK+SN+LL      +V   D+GLA
Sbjct: 159 LRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLA 201

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Length = 130

 Score = 39.0 bits (91), Expect = 7e-04
 Identities = 22/77 (28%), Positives = 32/77 (41%), Gaps = 16/77 (20%)

Query: 57  SPCKWAG--VECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSD- 113
           +PC  AG  V+C +  +T   LP    +   P            L L  N+LT+ LP   
Sbjct: 4   APCSCAGTLVDCGRRGLTWASLP----TA-FP-------VDTTELVLTGNNLTA-LPPGL 50

Query: 114 LASCSNLRNLYLQGNHF 130
           L +   LR  +L  N +
Sbjct: 51  LDALPALRTAHLGANPW 67

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	663
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.92
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.92
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.91
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.89
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.87
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.87
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.85
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.85
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.85
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.84
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.83
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.83
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.8
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.8
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.8
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.79
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.79
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.78
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.78
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.78
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.77
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.77
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.77
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.77
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.77
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.76
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.76
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.76
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.76
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.76
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.75
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.75
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.75
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.75
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.74
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.74
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.74
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.74
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.74
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.74
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.73
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.72
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.72
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.72
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.71
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.71
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.71
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.71
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.7
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.7
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.7
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.7
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.7
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.7
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.69
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.69
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.69
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.69
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.69
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.69
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.69
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.68
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.68
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.68
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.67
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.67
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.67
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.67
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.67
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.66
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.66
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.66
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.66
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.66
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.66
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.65
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.65
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.65
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.64
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.64
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.64
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.63
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.63
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.63
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.63
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.62
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.62
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.62
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.61
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.61
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.61
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.61
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.61
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.6
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.6
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.6
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.6
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.6
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.6
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.6
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.6
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.59
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.57
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.57
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.56
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.56
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.56
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.55
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.54
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.54
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.54
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.54
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.53
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.53
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.51
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.51
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.51
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.5
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.5
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.49
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.49
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.48
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.46
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.46
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.45
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.44
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.42
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.42
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.4
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.39
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.38
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.38
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.38
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.36
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.23
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.21
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.16
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.13
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	99.1
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.09
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.06
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.03
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.98
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.81
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.74
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.74
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.71
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	98.59
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.53
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.53
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	98.51
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.44
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.42
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.33
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.33
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.27
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.24
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.23
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.21
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.1
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.01
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.92
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.75
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.62
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	97.56
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.52
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.49
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	97.45
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.38
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	97.35
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	97.27
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	97.27
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.26
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.24
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.21
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	97.15
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.95
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.93
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.9
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.89
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.8
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.77
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.58
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.45
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.37
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.25
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.24
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	95.97
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	94.62
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.52
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.24
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	92.02
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	89.73
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.65
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	82.88
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	82.2

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.2e-52  Score=432.49  Aligned_cols=251  Identities=24%  Similarity=0.370  Sum_probs=202.7

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .++||+|+||+||+|+++      +++.||||+++... ...++|.+|++++++++|||||+++|+|.+.+..++|||||
T Consensus        46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~  125 (329)
T 4aoj_A           46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM  125 (329)
T ss_dssp             EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            468999999999999864      47899999997653 23567999999999999999999999999999999999999


Q ss_pred             CCCChhHhhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccc
Q 006055          448 TMGSLSALLHGNKG----------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFG  517 (663)
Q Consensus       448 ~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg  517 (663)
                      ++|+|.++++....          ....+++|..++.|+.|||.||+|||+++  |+||||||+|||+++++.+||+|||
T Consensus       126 ~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~~~~Ki~DFG  203 (329)
T 4aoj_A          126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFG  203 (329)
T ss_dssp             TTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC
T ss_pred             CCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCCCcEEEcccc
Confidence            99999999976432          12346999999999999999999999998  9999999999999999999999999


Q ss_pred             cccccCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhc
Q 006055          518 LAHLVGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDE  590 (663)
Q Consensus       518 ~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  590 (663)
                      +++......      ...+|+.|||||++.+..++.++|||||||++|||+| |+.||....      ....+..+....
T Consensus       204 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~------~~~~~~~i~~g~  277 (329)
T 4aoj_A          204 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS------NTEAIDCITQGR  277 (329)
T ss_dssp             ----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC------HHHHHHHHHHTC
T ss_pred             cceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC------HHHHHHHHHcCC
Confidence            998764432      2346778999999999999999999999999999999 899996532      223333333222


Q ss_pred             ccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       591 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      ..           ..+..++.++.+++.+||+.||++||||+||+++|+.+.+.
T Consensus       278 ~~-----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          278 EL-----------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             CC-----------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CC-----------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            11           11223345788899999999999999999999999998654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.7e-52  Score=429.02  Aligned_cols=248  Identities=25%  Similarity=0.354  Sum_probs=204.6

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||+||+|.+.      +++.||||+++...  ...++|.+|+.++++++|||||+++|+|.+.+..++||||
T Consensus        31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey  110 (308)
T 4gt4_A           31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY  110 (308)
T ss_dssp             EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEc
Confidence            468999999999999863      57899999997543  3357899999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEec
Q 006055          447 LTMGSLSALLHGNKGA-----------GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSD  515 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~D  515 (663)
                      |++|+|.++|+.....           ....++|..+..|+.|||.||+|||+++  ||||||||+||||++++.+||+|
T Consensus       111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~~~~Ki~D  188 (308)
T 4gt4_A          111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISD  188 (308)
T ss_dssp             CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECC
T ss_pred             CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEECCCCCEEECC
Confidence            9999999999753211           1246899999999999999999999998  99999999999999999999999


Q ss_pred             cccccccCCC------CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHh
Q 006055          516 FGLAHLVGPS------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVK  588 (663)
Q Consensus       516 fg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  588 (663)
                      ||+++.....      ....+|+.|||||++.+..++.++|||||||++|||+| |+.||....      ....+..+..
T Consensus       189 FGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~------~~~~~~~i~~  262 (308)
T 4gt4_A          189 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS------NQDVVEMIRN  262 (308)
T ss_dssp             SCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC------HHHHHHHHHT
T ss_pred             cccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHc
Confidence            9999865332      12346778999999999999999999999999999999 899996532      2233333322


Q ss_pred             hcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          589 DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                      ....           +.+.+++.++.+++.+||+.||++||||+||+++|+.+
T Consensus       263 ~~~~-----------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          263 RQVL-----------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             TCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CCCC-----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            2111           11233455788999999999999999999999999875

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.7e-52  Score=428.71  Aligned_cols=251  Identities=25%  Similarity=0.383  Sum_probs=206.0

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||+|+||+||+|++.      +++.||||+++... ...++|.+|++++++++|||||+++|+|.+.+..++|||||
T Consensus        18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~   97 (299)
T 4asz_A           18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM   97 (299)
T ss_dssp             EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcC
Confidence            468999999999999853      47899999997653 23567999999999999999999999999999999999999


Q ss_pred             CCCChhHhhccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccc
Q 006055          448 TMGSLSALLHGNK--------GAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA  519 (663)
Q Consensus       448 ~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a  519 (663)
                      ++|+|.++++...        +.....++|..+..|+.|||.||+|||+++  |+||||||+|||+++++.+||+|||+|
T Consensus        98 ~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~~~~Ki~DFGla  175 (299)
T 4asz_A           98 KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMS  175 (299)
T ss_dssp             TTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCSCH
T ss_pred             CCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCCCcEEECCcccc
Confidence            9999999997542        123456999999999999999999999998  999999999999999999999999999


Q ss_pred             cccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhccc
Q 006055          520 HLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWT  592 (663)
Q Consensus       520 ~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  592 (663)
                      +.......      ..+|+.|||||++.+..++.++|||||||++|||+| |+.||....      ..+.+..+......
T Consensus       176 ~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~------~~~~~~~i~~~~~~  249 (299)
T 4asz_A          176 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS------NNEVIECITQGRVL  249 (299)
T ss_dssp             HHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC------HHHHHHHHHHTCCC
T ss_pred             eecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHHcCCCC
Confidence            87644321      236778999999999999999999999999999999 899997532      22333333332211


Q ss_pred             ccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          593 SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       593 ~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                                 ..+..++.++.+++.+||+.||++|||++||++.|+++...
T Consensus       250 -----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          250 -----------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                       11223445788999999999999999999999999988544

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.8e-51  Score=417.31  Aligned_cols=250  Identities=30%  Similarity=0.435  Sum_probs=199.4

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .++||+|+||+||+|+++.  .||||.++....+   .+.|.+|++++++++|||||+++++|.+ +..++|||||++|+
T Consensus        41 ~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGs  117 (307)
T 3omv_A           41 STRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSS  117 (307)
T ss_dssp             EEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCB
T ss_pred             eeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCC
Confidence            5789999999999998753  5999998755333   3679999999999999999999998864 57899999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC------
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS------  525 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~------  525 (663)
                      |.++++...    ..++|..+..|+.|||.||+|||+++  ||||||||+|||+++++.+||+|||+|+.....      
T Consensus       118 L~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~  191 (307)
T 3omv_A          118 LYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV  191 (307)
T ss_dssp             HHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred             HHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence            999997543    35999999999999999999999998  999999999999999999999999999876432      


Q ss_pred             CCCCCCccccCccccCC---CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          526 STPNRVAGYRAPEVTDP---CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       526 ~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                      ....+|+.|||||++.+   ..|+.++|||||||++|||+||+.||.....      ...+..........    +..  
T Consensus       192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~------~~~~~~~~~~~~~~----p~~--  259 (307)
T 3omv_A          192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN------RDQIIFMVGRGYAS----PDL--  259 (307)
T ss_dssp             --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHHHHTTCCC----CCS--
T ss_pred             cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh------HHHHHHHHhcCCCC----CCc--
Confidence            12357889999999854   4589999999999999999999999965321      22222333222111    100  


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                      .....+++.++.+++.+||+.||++||||.||+++|+.+....
T Consensus       260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            0111234457888999999999999999999999999886543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2e-51  Score=423.28  Aligned_cols=258  Identities=23%  Similarity=0.300  Sum_probs=200.5

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecC----ccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMD----EKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ey~~~g  450 (663)
                      .++||+|+||+||+|++. |+.||||+++........++.|+..+.+++|||||+++++|.+++    ..++|||||++|
T Consensus         8 ~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~g   86 (303)
T 3hmm_A            8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG   86 (303)
T ss_dssp             EEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred             EEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCC
Confidence            468999999999999985 899999999765433444556777778899999999999998764    468999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc------CCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ------GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~------~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      +|.++++..      .++|..+.+++.|+|.||+|||++      .++|+||||||+|||++.++.+||+|||+|+....
T Consensus        87 sL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  160 (303)
T 3hmm_A           87 SLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  160 (303)
T ss_dssp             BHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             cHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence            999999853      489999999999999999999986      24599999999999999999999999999987644


Q ss_pred             CC--------CCCCCccccCccccCCC------CCCCcchhhhHHHHHHHHHhCCCCCccccCCC---------CCChHH
Q 006055          525 SS--------TPNRVAGYRAPEVTDPC------KVSQKADVYSFGVLLLELLTGKAPTHALLNEE---------GVDLPR  581 (663)
Q Consensus       525 ~~--------~~~~~~~y~aPE~~~~~------~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~---------~~~~~~  581 (663)
                      ..        ...+|+.|||||++.+.      .++.++|||||||++|||+||+.||.......         ......
T Consensus       161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~  240 (303)
T 3hmm_A          161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE  240 (303)
T ss_dssp             TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred             CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence            32        12478889999998764      35778999999999999999988775432211         011222


Q ss_pred             HHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          582 WVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       582 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      ....+...     ..++.+.......+.+..+.+++.+||+.||++||||.||+++|+++.++
T Consensus       241 ~~~~~~~~-----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          241 MRKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHTTS-----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHhcc-----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            22222211     12222222222335667889999999999999999999999999998654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-50  Score=418.68  Aligned_cols=247  Identities=21%  Similarity=0.253  Sum_probs=201.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .++||+|+||+||+|.. .+|+.||||+++....    ..+|+.+++.++|||||++++++.+.+..++||||+++|+|.
T Consensus        63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~  138 (336)
T 4g3f_A           63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG  138 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHH
T ss_pred             CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHH
Confidence            46799999999999995 5699999999976432    246999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC-ceEEeccccccccCCCC------
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY-EARVSDFGLAHLVGPSS------  526 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~------  526 (663)
                      ++++...     .+++..+..++.||+.||+|||+++  |+||||||+|||++.++ .+||+|||+|+......      
T Consensus       139 ~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~  211 (336)
T 4g3f_A          139 QLIKQMG-----CLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL  211 (336)
T ss_dssp             HHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred             HHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence            9997533     5899999999999999999999998  99999999999999988 69999999998765431      


Q ss_pred             ---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          527 ---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       527 ---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                         ...||+.|||||++.+..|+.++|||||||++|||++|+.||......+   +   +..+........         
T Consensus       212 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~---~~~i~~~~~~~~---------  276 (336)
T 4g3f_A          212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---L---CLKIASEPPPIR---------  276 (336)
T ss_dssp             --CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---C---HHHHHHSCCGGG---------
T ss_pred             cCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---H---HHHHHcCCCCch---------
Confidence               1247889999999999999999999999999999999999997543221   1   122222211100         


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ  647 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~  647 (663)
                      ..+.....++.+++.+||..||++|||+.|++++|.........
T Consensus       277 ~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~  320 (336)
T 4g3f_A          277 EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG  320 (336)
T ss_dssp             GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred             hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence            01122344677888899999999999999999999877554433

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.5e-50  Score=407.11  Aligned_cols=241  Identities=25%  Similarity=0.412  Sum_probs=194.7

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEec----CccEEEEEcc
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSM----DEKLLVYDYL  447 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~----~~~~lv~ey~  447 (663)
                      ++||+|+||+||+|.. .++..||||++......   .+.|.+|++++++++|||||+++++|.+.    ...++||||+
T Consensus        32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~  111 (290)
T 3fpq_A           32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM  111 (290)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence            5799999999999995 56899999999765433   35689999999999999999999998752    3479999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC-CCceEEeccccccccCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK-SYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~  526 (663)
                      ++|+|.++++...     .+++..+..++.||+.||+|||+++++|+||||||+|||++. ++.+||+|||+|+......
T Consensus       112 ~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~  186 (290)
T 3fpq_A          112 TSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF  186 (290)
T ss_dssp             CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred             CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc
Confidence            9999999997533     589999999999999999999999878999999999999984 7899999999998654432


Q ss_pred             --CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          527 --TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                        +..||+.|||||++.+ .|+.++|||||||++|||+||+.||....     +.......+..... ...++       
T Consensus       187 ~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-----~~~~~~~~i~~~~~-~~~~~-------  252 (290)
T 3fpq_A          187 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVTSGVK-PASFD-------  252 (290)
T ss_dssp             BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHTTTCC-CGGGG-------
T ss_pred             cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----cHHHHHHHHHcCCC-CCCCC-------
Confidence              2458899999999875 59999999999999999999999996422     22222332222211 11111       


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                        .....++.+++.+||..||++|||++|+++|
T Consensus       253 --~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          253 --KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             --GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              1112357788889999999999999999873

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.5e-50  Score=416.45  Aligned_cols=241  Identities=22%  Similarity=0.335  Sum_probs=198.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||+||+|.. .+|+.||||++......   .+.+.+|++++++++|||||++++++.+.+..|+||||+++|
T Consensus        29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg  108 (350)
T 4b9d_A           29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG  108 (350)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence            46899999999999994 57999999999765433   356899999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----  526 (663)
                      +|.+++....   ...+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+|+......    
T Consensus       109 ~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  183 (350)
T 4b9d_A          109 DLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR  183 (350)
T ss_dssp             BHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHH
T ss_pred             cHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCCccccc
Confidence            9999997543   235789999999999999999999998  9999999999999999999999999998775432    


Q ss_pred             CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      +..||+.|||||++.+..|+.++|||||||++|||++|+.||...      +....+..+........           .
T Consensus       184 ~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~------~~~~~~~~i~~~~~~~~-----------~  246 (350)
T 4b9d_A          184 ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG------SMKNLVLKIISGSFPPV-----------S  246 (350)
T ss_dssp             HHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHTCCCCC-----------C
T ss_pred             ccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------CHHHHHHHHHcCCCCCC-----------C
Confidence            234788999999999999999999999999999999999999642      34445555554432110           1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .....++.+++.+||..||++|||++|++++
T Consensus       247 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1223467888899999999999999999875

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=8.5e-50  Score=413.75  Aligned_cols=239  Identities=24%  Similarity=0.378  Sum_probs=200.5

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      +.||+|+||+||+|.. .+|+.||||++.... ...+.+.+|+++++.++|||||+++++|.+.+..|+||||+++|+|.
T Consensus        80 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~  159 (346)
T 4fih_A           80 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  159 (346)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHH
T ss_pred             EEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHH
Confidence            6799999999999995 579999999996543 33456889999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----CCCC
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----STPN  529 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----~~~~  529 (663)
                      +++...      .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+|+.....    .+..
T Consensus       160 ~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~  231 (346)
T 4fih_A          160 DIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV  231 (346)
T ss_dssp             HHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred             HHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccc
Confidence            999753      3899999999999999999999998  999999999999999999999999999876543    2345


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE  609 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  609 (663)
                      ||+.|||||++.+..|+.++|||||||++|||++|+.||...      +....+..+... .....        ......
T Consensus       232 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~------~~~~~~~~i~~~-~~~~~--------~~~~~~  296 (346)
T 4fih_A          232 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE------PPLKAMKMIRDN-LPPRL--------KNLHKV  296 (346)
T ss_dssp             SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHS-SCCCC--------SCGGGS
T ss_pred             cCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------CHHHHHHHHHcC-CCCCC--------CccccC
Confidence            888999999999999999999999999999999999999642      223333333222 11111        111223


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          610 MVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       610 ~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ..++.+++.+||..||++|||++|+++|
T Consensus       297 s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          297 SPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            3467788889999999999999999884

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.2e-49  Score=416.54  Aligned_cols=252  Identities=24%  Similarity=0.358  Sum_probs=203.5

Q ss_pred             hcccccccceEEEEEEecC------CcEEEEEEecCccc--CHHHHHHHHHHhhcCCC-CCcccceEEEEec-CccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLEM------GTIVAVKRLKDVTI--SEREFKDKIEGVGAVNH-ENLVPLRAYYYSM-DEKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~-~~~~lv~  444 (663)
                      .+.||+|+||+||+|.+..      ++.||||+++....  ..+.|.+|++++.+++| ||||+++|+|.+. ...++||
T Consensus        69 ~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~  148 (353)
T 4ase_A           69 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV  148 (353)
T ss_dssp             EEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred             eeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEE
Confidence            5789999999999998542      36899999976532  24679999999999966 8999999999765 4689999


Q ss_pred             EccCCCChhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEE
Q 006055          445 DYLTMGSLSALLHGNKG-----------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARV  513 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl  513 (663)
                      |||++|+|.++|+....           .....++|..+..++.|||+||+|||+++  ||||||||+|||+++++.+||
T Consensus       149 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~~~vKi  226 (353)
T 4ase_A          149 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKI  226 (353)
T ss_dssp             ECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEE
T ss_pred             EcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCccceeeCCCCCEEE
Confidence            99999999999975431           11345899999999999999999999998  999999999999999999999


Q ss_pred             eccccccccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHH
Q 006055          514 SDFGLAHLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSI  586 (663)
Q Consensus       514 ~Dfg~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  586 (663)
                      +|||+|+.......      ..+|+.|||||++.+..|+.++|||||||++|||+| |+.||.....      ...+...
T Consensus       227 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~------~~~~~~~  300 (353)
T 4ase_A          227 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------DEEFCRR  300 (353)
T ss_dssp             CCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC------SHHHHHH
T ss_pred             CcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH------HHHHHHH
Confidence            99999987654332      235677999999999999999999999999999998 9999975322      1223333


Q ss_pred             HhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          587 VKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      +.++....          .+...+.++.+++.+||+.||++|||+.||+++|+++.+.
T Consensus       301 i~~g~~~~----------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          301 LKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             HHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHcCCCCC----------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            33322111          1122345688899999999999999999999999988543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.5e-49  Score=404.21  Aligned_cols=237  Identities=21%  Similarity=0.307  Sum_probs=200.7

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCc----ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV----TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .++||+|+||+||+|. ..+|+.||||++...    ....+.+.+|+++++.++|||||++++++.+.+..++||||+++
T Consensus        37 ~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~g  116 (311)
T 4aw0_A           37 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN  116 (311)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence            5789999999999999 467999999999753    23356799999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++....     .+++.....++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+|+......   
T Consensus       117 G~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          117 GELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence            99999997533     5899999999999999999999998  9999999999999999999999999998765332   


Q ss_pred             ---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          527 ---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       527 ---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                         +..||+.|||||++.+..|+.++||||+||++|||++|+.||...      +.......+......           
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~------~~~~~~~~i~~~~~~-----------  252 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG------NEGLIFAKIIKLEYD-----------  252 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCC-----------
T ss_pred             cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHcCCCC-----------
Confidence               235888999999999999999999999999999999999999642      334444444443221           


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                       .+.....++.+++.+|+..||++|||++|+..
T Consensus       253 -~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          253 -FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             -CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             -CCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence             01112335778888999999999999999743

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.5e-48  Score=414.33  Aligned_cols=240  Identities=24%  Similarity=0.371  Sum_probs=200.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||+||+|.. .+|+.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+.+..|+|||||++|+|
T Consensus       156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L  235 (423)
T 4fie_A          156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  235 (423)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred             eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcH
Confidence            36799999999999995 579999999997543 3346689999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----CC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----TP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~~  528 (663)
                      .++++..      .+++..+..++.||+.||+|||+++  ||||||||+||||+.++.+||+|||+|+......    +.
T Consensus       236 ~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~  307 (423)
T 4fie_A          236 TDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  307 (423)
T ss_dssp             HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCC
T ss_pred             HHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCCcccccc
Confidence            9999753      3899999999999999999999998  9999999999999999999999999998765432    34


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .||+.|||||++.+..|+.++|||||||++|||++|+.||...      +....+..+... .....        .....
T Consensus       308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~------~~~~~~~~i~~~-~~~~~--------~~~~~  372 (423)
T 4fie_A          308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE------PPLKAMKMIRDN-LPPRL--------KNLHK  372 (423)
T ss_dssp             EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHS-CCCCC--------SCTTS
T ss_pred             ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------CHHHHHHHHHcC-CCCCC--------ccccc
Confidence            5788899999999999999999999999999999999999642      223333333222 11111        11112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...++.+++.+||..||++|||++|+++|
T Consensus       373 ~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          373 VSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            23467788889999999999999999884

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.4e-48  Score=393.22  Aligned_cols=237  Identities=23%  Similarity=0.328  Sum_probs=187.6

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||+|. ..+|+.||||++....    .....+.+|+++++.++|||||++++++.+.+..++||||+ +
T Consensus        18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~   96 (275)
T 3hyh_A           18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-G   96 (275)
T ss_dssp             EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-C
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-C
Confidence            4689999999999999 4579999999997542    22467899999999999999999999999999999999999 6


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++....     .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+|+......   
T Consensus        97 g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~  169 (275)
T 3hyh_A           97 NELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK  169 (275)
T ss_dssp             EEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCCCccC
Confidence            79999987533     5899999999999999999999998  9999999999999999999999999998765432   


Q ss_pred             CCCCCccccCccccCCCCC-CCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 TPNRVAGYRAPEVTDPCKV-SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      +..||+.|||||++.+..+ +.++||||+||++|||++|+.||...      +.....+.+......            .
T Consensus       170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~------~~~~~~~~i~~~~~~------------~  231 (275)
T 3hyh_A          170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE------SIPVLFKNISNGVYT------------L  231 (275)
T ss_dssp             -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCC------------C
T ss_pred             CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHcCCCC------------C
Confidence            3458889999999998876 57999999999999999999999642      333444444332211            0


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      +.....++.+++.+|++.||++|||++|+++|
T Consensus       232 p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          232 PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            11123457788889999999999999999984

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.3e-48  Score=398.97  Aligned_cols=237  Identities=27%  Similarity=0.316  Sum_probs=190.7

Q ss_pred             hcccccccceEEEEEEe----cCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||+|+||+||+|+.    .+++.||||.++...   .....+.+|++++++++|||||++++++.+++..++||||+
T Consensus        29 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~  108 (304)
T 3ubd_A           29 LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFL  108 (304)
T ss_dssp             EEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCC
T ss_pred             EEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcC
Confidence            47899999999999984    247899999997542   12346888999999999999999999999999999999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC--
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--  525 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~--  525 (663)
                      ++|+|.+++....     .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+|+.....  
T Consensus       109 ~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  181 (304)
T 3ubd_A          109 RGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  181 (304)
T ss_dssp             TTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred             CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence            9999999997533     5899999999999999999999998  999999999999999999999999999865432  


Q ss_pred             --CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          526 --STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       526 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                        .+..||+.|||||++.+..|+.++||||+||++|||++|+.||...      +....+..+......           
T Consensus       182 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~------~~~~~~~~i~~~~~~-----------  244 (304)
T 3ubd_A          182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK------DRKETMTMILKAKLG-----------  244 (304)
T ss_dssp             CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC-----------
T ss_pred             cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc------CHHHHHHHHHcCCCC-----------
Confidence              2345888999999999999999999999999999999999999642      333444444433211           


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSM-----SEVIK  636 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~-----~ev~~  636 (663)
                       .+.....++.+++.+||+.||++|||+     +|+++
T Consensus       245 -~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          245 -MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             -CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence             111223467788889999999999984     67765

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.3e-47  Score=387.48  Aligned_cols=240  Identities=21%  Similarity=0.328  Sum_probs=183.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCc------------
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDE------------  439 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------------  439 (663)
                      .+.||+|+||+||+|.. .+|+.||||+++...  ...+.+.+|++++++++|||||+++++|.+.+.            
T Consensus        10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~   89 (299)
T 4g31_A           10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY   89 (299)
T ss_dssp             EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEE
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcE
Confidence            46899999999999995 579999999986542  234678999999999999999999999876543            


Q ss_pred             cEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccc
Q 006055          440 KLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA  519 (663)
Q Consensus       440 ~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a  519 (663)
                      .++||||+++|+|.++++....  ....++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+|
T Consensus        90 l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~DFGla  165 (299)
T 4g31_A           90 LYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLV  165 (299)
T ss_dssp             EEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred             EEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEccCccc
Confidence            5899999999999999985432  234577888999999999999999998  999999999999999999999999999


Q ss_pred             cccCCCC----------------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHH
Q 006055          520 HLVGPSS----------------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWV  583 (663)
Q Consensus       520 ~~~~~~~----------------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~  583 (663)
                      +......                +..||+.|||||++.+..|+.++|||||||++|||++   ||....+     ....+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-----~~~~~  237 (299)
T 4g31_A          166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-----RVRTL  237 (299)
T ss_dssp             --------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----HHHHH
T ss_pred             eecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-----HHHHH
Confidence            8765421                1247888999999999999999999999999999996   7753210     11111


Q ss_pred             HHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          584 QSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       584 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ..+.....           .+...+....+.+++.+|++.||++|||+.|++++
T Consensus       238 ~~~~~~~~-----------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          238 TDVRNLKF-----------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHHTTCC-----------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHhcCCC-----------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11111110           01112233456778999999999999999999883

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=382.18  Aligned_cols=249  Identities=22%  Similarity=0.319  Sum_probs=192.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEec------CccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSM------DEKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~  444 (663)
                      .+.||+|+||+||+|.. .+|+.||||+++.....   .+.+.+|+++|+.++|||||++++++...      +..|+||
T Consensus        59 ~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivm  138 (398)
T 4b99_A           59 IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL  138 (398)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEE
T ss_pred             EEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEE
Confidence            46899999999999995 57999999999765333   35688999999999999999999987643      5679999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||++ |+|.+++...     ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+|+....
T Consensus       139 E~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~  210 (398)
T 4b99_A          139 DLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCT  210 (398)
T ss_dssp             ECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred             eCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence            9996 6899999753     35999999999999999999999998  99999999999999999999999999986533


Q ss_pred             C--------CCCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccc--
Q 006055          525 S--------STPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTS--  593 (663)
Q Consensus       525 ~--------~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  593 (663)
                      .        .+..+|+.|||||++.+. .++.++||||+||++|||++|+.||.+.      +....+..+.......  
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~------~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK------NYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS------SHHHHHHHHHHHHCCCCG
T ss_pred             CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC------CHHHHHHHHHHhcCCCCh
Confidence            2        234578889999998775 5689999999999999999999999653      2223333332211100  


Q ss_pred             cccc----h-------hhhcc--cCh----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          594 EVFD----L-------ELLRY--QNV----EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       594 ~~~d----~-------~~~~~--~~~----~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....    .       .+...  ...    .....++.+++.+|+..||++|||++|+++|
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000    0       00000  000    0113467788999999999999999999984

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.6e-43  Score=372.59  Aligned_cols=185  Identities=24%  Similarity=0.446  Sum_probs=162.5

Q ss_pred             hcccccccceEEEEEEec----CCcEEEEEEecCcccCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE----MGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .++||+|+||+||+|+.+    +++.||||.+.... ....+.+|++++..+ +||||+++++++.+.++.++||||+++
T Consensus        26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g  104 (361)
T 4f9c_A           26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEH  104 (361)
T ss_dssp             EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCC
T ss_pred             EEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCc
Confidence            468999999999999843    47899999986543 456788999999988 699999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC-CceEEeccccccccCCCC--
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS-YEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~--  526 (663)
                      |+|.++++        .+++..+..++.|++.||+|||+++  |+||||||+|||++.+ +.+||+|||+|+......  
T Consensus       105 ~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~  174 (361)
T 4f9c_A          105 ESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE  174 (361)
T ss_dssp             CCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred             ccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence            99999995        2889999999999999999999998  9999999999999877 799999999997553321  


Q ss_pred             ------------------------------CCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCcc
Q 006055          527 ------------------------------TPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHA  570 (663)
Q Consensus       527 ------------------------------~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~  570 (663)
                                                    +..+|+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence                                          12478889999999775 589999999999999999999999964

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.2e-42  Score=362.17  Aligned_cols=265  Identities=31%  Similarity=0.532  Sum_probs=223.3

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .+.||+|+||.||+|..++|+.||||++..... ..+.+.+|+++++.++||||+++++++.+.+..++||||+++|+|.
T Consensus        44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  123 (321)
T 2qkw_B           44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK  123 (321)
T ss_dssp             CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred             cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence            367999999999999988899999999876533 3567999999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC------C
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS------T  527 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~------~  527 (663)
                      +++.... .....++|..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++......      .
T Consensus       124 ~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  200 (321)
T 2qkw_B          124 RHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV  200 (321)
T ss_dssp             GGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCC
T ss_pred             HHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecccccccccccccccccc
Confidence            9997543 22346899999999999999999999998  9999999999999999999999999998654321      1


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..++..|+|||++.+..++.++||||||+++|||++|+.||......+......|.............+++... .....
T Consensus       201 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  279 (321)
T 2qkw_B          201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA-DKIRP  279 (321)
T ss_dssp             CEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT-TCSCH
T ss_pred             cCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc-cccCH
Confidence            23567799999998888999999999999999999999999876666666677766555555444455544332 22345


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      +....+.+++.+|++.||++|||+.|++++|+.+..
T Consensus       280 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          280 ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             HHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            677889999999999999999999999999998754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.2e-43  Score=389.65  Aligned_cols=241  Identities=22%  Similarity=0.267  Sum_probs=194.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHH---HHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKD---KIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .++||+|+||+||+|.. .+|+.||||++++..    .....+.+   ++.+++.++|||||+++++|.+.+..|+||||
T Consensus       194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy  273 (689)
T 3v5w_A          194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL  273 (689)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEec
Confidence            46899999999999994 579999999996532    22333334   45667788999999999999999999999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      +++|+|.+++....     .+++..+..++.||+.||+|||+++  ||||||||+||||+.+|++||+|||+|+......
T Consensus       274 ~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~  346 (689)
T 3v5w_A          274 MNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  346 (689)
T ss_dssp             CCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred             CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence            99999999997533     5899999999999999999999998  9999999999999999999999999998775543


Q ss_pred             --CCCCCccccCccccC-CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          527 --TPNRVAGYRAPEVTD-PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~-~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                        +..||+.|||||++. +..|+.++||||+||++|||++|+.||......   +.......+.....            
T Consensus       347 ~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~---~~~~i~~~i~~~~~------------  411 (689)
T 3v5w_A          347 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---DKHEIDRMTLTMAV------------  411 (689)
T ss_dssp             CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC---CHHHHHHHHHHCCC------------
T ss_pred             CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhhcCCCC------------
Confidence              356899999999996 457999999999999999999999999764322   22222222222211            


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPS-----MSEVIKR  637 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt-----~~ev~~~  637 (663)
                      ..+.....++.+++.+|+..||++|++     ++||.+|
T Consensus       412 ~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          412 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            011122346778888999999999998     6888765

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.5e-43  Score=389.37  Aligned_cols=243  Identities=21%  Similarity=0.341  Sum_probs=201.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||+||+|.. .+|+.||+|++..... ..+.+.+|+.+|+.++|||||+++++|.+....++|||||++|+|
T Consensus       162 ~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L  241 (573)
T 3uto_A          162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL  241 (573)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred             EEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcH
Confidence            46899999999999995 5799999999876533 356788999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC--CceEEeccccccccCCCCC---
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS--YEARVSDFGLAHLVGPSST---  527 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~--~~~kl~Dfg~a~~~~~~~~---  527 (663)
                      .+++....    ..+++..+..++.||+.||.|||+++  |+||||||+|||++.+  +.+||+|||+|+...+...   
T Consensus       242 ~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~  315 (573)
T 3uto_A          242 FEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV  315 (573)
T ss_dssp             HHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEE
T ss_pred             HHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCCCceee
Confidence            99986432    35899999999999999999999998  9999999999999854  8999999999998765532   


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..+|+.|||||++.+..|+.++||||+||++|||++|+.||.+.      +....+..+.......   ...  .+   .
T Consensus       316 ~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~------~~~~~~~~i~~~~~~~---~~~--~~---~  381 (573)
T 3uto_A          316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE------NDDETLRNVKSCDWNM---DDS--AF---S  381 (573)
T ss_dssp             ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHHHHTTCCCC---CSG--GG---T
T ss_pred             eEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------CHHHHHHHHHhCCCCC---Ccc--cc---c
Confidence            34788899999999999999999999999999999999999653      2333344443332211   000  11   1


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....++.+++.+||..||++|||++|+++|
T Consensus       382 ~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          382 GISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            123456788889999999999999999983

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.6e-42  Score=362.09  Aligned_cols=277  Identities=39%  Similarity=0.652  Sum_probs=226.8

Q ss_pred             cccCHHHHHHHh-----hcccccccceEEEEEEecCCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEE
Q 006055          363 RVFDLEDLLRAS-----AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYY  435 (663)
Q Consensus       363 ~~~~~~~l~~~~-----~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~  435 (663)
                      ..|++.++....     .+.||+|+||.||+|...+|+.||||++.....  ....+.+|+++++.++||||+++++++.
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   97 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM   97 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence            346666665544     468999999999999988899999999876432  2346899999999999999999999999


Q ss_pred             ecCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc---CCcceecCCCCCCEEEcCCCceE
Q 006055          436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ---GPNVSHGNIKSSNILLTKSYEAR  512 (663)
Q Consensus       436 ~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~---~~~iiHrdlk~~Nill~~~~~~k  512 (663)
                      +....++||||+++|+|.++++.... ....+++..+..++.|++.||.|||+.   +  |+||||||+||+++.++.+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           98 TPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCCEE
T ss_pred             cCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCCEE
Confidence            99999999999999999999986542 244699999999999999999999998   6  99999999999999999999


Q ss_pred             EeccccccccCCCC-----CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCcccc--CCCCCChHHHHHH
Q 006055          513 VSDFGLAHLVGPSS-----TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALL--NEEGVDLPRWVQS  585 (663)
Q Consensus       513 l~Dfg~a~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~--~~~~~~~~~~~~~  585 (663)
                      |+|||+++......     ...++..|+|||++.+..++.++||||||+++|||++|+.||+...  .........|+..
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            99999998765432     2336788999999988888999999999999999999999997432  2233455666655


Q ss_pred             HHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          586 IVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      ...........+.... .....+....+.+++.+|++.||++|||+.||+++|++...
T Consensus       255 ~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             TTSSCCSTTSSCTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             HhhchhhhhhcChhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            5555544455444332 23456778899999999999999999999999999987533

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.2e-42  Score=360.51  Aligned_cols=255  Identities=27%  Similarity=0.368  Sum_probs=202.3

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCc----cEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDE----KLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----~~lv~ey~~~g  450 (663)
                      .++||+|+||+||+|... ++.||||+++........+..|+.++.+++||||+++++++.....    .++||||+++|
T Consensus        29 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g  107 (322)
T 3soc_A           29 LEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKG  107 (322)
T ss_dssp             EEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred             hheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCC
Confidence            468999999999999876 8999999997665555667779999999999999999999987554    59999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc----------CCcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ----------GPNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~----------~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                      +|.++++..      .+++..+..++.|++.||.|||+.          +  |+||||||+|||++.++.+||+|||+++
T Consensus       108 ~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~~~~kL~DFg~a~  179 (322)
T 3soc_A          108 SLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNNLTACIADFGLAL  179 (322)
T ss_dssp             BHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCCCeEEEccCCccc
Confidence            999999753      389999999999999999999998          6  9999999999999999999999999997


Q ss_pred             ccCCCCC------CCCCccccCccccCCC-----CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCC----------h
Q 006055          521 LVGPSST------PNRVAGYRAPEVTDPC-----KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVD----------L  579 (663)
Q Consensus       521 ~~~~~~~------~~~~~~y~aPE~~~~~-----~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~----------~  579 (663)
                      .......      ..++..|+|||++.+.     .++.++|||||||++|||++|+.||..........          .
T Consensus       180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  259 (322)
T 3soc_A          180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL  259 (322)
T ss_dssp             EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred             ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence            7654322      3467889999999863     45567899999999999999999998654332221          1


Q ss_pred             HHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          580 PRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       580 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      ..+.........     .+.............++.+++.+||+.||++|||++||++.|+++..
T Consensus       260 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          260 EDMQEVVVHKKK-----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             HHHHHHHTTSCC-----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhhhhhhhcccC-----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            111111111111     11111111123455678999999999999999999999999998753

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=351.37  Aligned_cols=249  Identities=25%  Similarity=0.408  Sum_probs=203.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc-ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV-TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .++||+|+||+||+|.. .+++.||+|++... ....+.+.+|+++++.++||||+++++++.+....++||||+++|+|
T Consensus        15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L   94 (310)
T 3s95_A           15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL   94 (310)
T ss_dssp             EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence            47899999999999995 56999999988654 23356799999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC------
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS------  526 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~------  526 (663)
                      .++++...    ..+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||+++......      
T Consensus        95 ~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  168 (310)
T 3s95_A           95 RGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL  168 (310)
T ss_dssp             HHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred             HHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence            99998633    35899999999999999999999998  9999999999999999999999999998764332      


Q ss_pred             ------------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          527 ------------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       527 ------------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                                  ...++..|+|||++.+..++.++||||||+++|||++|..|+........... .........     
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-~~~~~~~~~-----  242 (310)
T 3s95_A          169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-LNVRGFLDR-----  242 (310)
T ss_dssp             -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-BCHHHHHHH-----
T ss_pred             ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-hhhhccccc-----
Confidence                        23467789999999999999999999999999999999999875433221100 000000000     


Q ss_pred             ccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       595 ~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                               ......+..+.+++.+||+.||++|||++|+++.|+++...
T Consensus       243 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          243 ---------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             ---------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                     00112233578899999999999999999999999988654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.8e-41  Score=348.88  Aligned_cols=252  Identities=31%  Similarity=0.434  Sum_probs=198.5

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||+||+|.. +|+.||||++......   .+.+.+|++++++++||||+++++++.+....++||||+++|+
T Consensus        42 ~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~  120 (309)
T 3p86_A           42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS  120 (309)
T ss_dssp             EEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCB
T ss_pred             eeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCc
Confidence            46899999999999987 4899999999765433   3468899999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----CC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----ST  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----~~  527 (663)
                      |.+++.....  ...+++..+..++.|++.||.|||+.+++|+||||||+||+++.++.+||+|||+++.....    ..
T Consensus       121 L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  198 (309)
T 3p86_A          121 LYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS  198 (309)
T ss_dssp             HHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--------------
T ss_pred             HHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccccccc
Confidence            9999975321  12489999999999999999999999877999999999999999999999999999765443    22


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+.......          ..+.
T Consensus       199 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~------~~~~~~~~~~~~~~~----------~~~~  262 (309)
T 3p86_A          199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN------PAQVVAAVGFKCKRL----------EIPR  262 (309)
T ss_dssp             ---CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC------HHHHHHHHHHSCCCC----------CCCT
T ss_pred             CCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhcCCCC----------CCCc
Confidence            346788999999999999999999999999999999999996532      222222221111110          1111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                      ....++.+++.+||..||++|||++|+++.|+.+....
T Consensus       263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            23346788999999999999999999999999986653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3e-41  Score=342.38  Aligned_cols=247  Identities=25%  Similarity=0.398  Sum_probs=207.9

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|+||.||+|...+++.||+|++.......+.+.+|++++++++||||+++++++.+....++||||+++|+|.+
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   94 (269)
T 4hcu_A           15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD   94 (269)
T ss_dssp             EEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHH
T ss_pred             eheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHH
Confidence            36899999999999998889999999998877778899999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC-----CCCC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-----STPN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~-----~~~~  529 (663)
                      +++...    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++.....     ....
T Consensus        95 ~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  168 (269)
T 4hcu_A           95 YLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK  168 (269)
T ss_dssp             HHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred             HHHhcC----cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccccccccccccccccCcc
Confidence            997543    35899999999999999999999998  999999999999999999999999999866442     2233


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      ++..|+|||.+.+..++.++||||+|+++|||++ |+.||....      .......+......           ..+..
T Consensus       169 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~------~~~~~~~~~~~~~~-----------~~~~~  231 (269)
T 4hcu_A          169 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGFRL-----------YKPRL  231 (269)
T ss_dssp             CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTTCCC-----------CCCTT
T ss_pred             cccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC------HHHHHHHHhcCccC-----------CCCCc
Confidence            5567999999988889999999999999999999 999996432      22222222221110           01111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      ...++.+++.+|++.||++|||++|++++|+++.+.
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            234678889999999999999999999999998654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.4e-41  Score=350.25  Aligned_cols=240  Identities=25%  Similarity=0.354  Sum_probs=199.6

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCc-ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV-TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||+||+|. ..+|+.||||++... ....+.+.+|+.+++.++||||+++++++...+..++||||+++|+|
T Consensus        25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (297)
T 3fxz_A           25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL  104 (297)
T ss_dssp             CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCH
Confidence            3679999999999999 467999999998654 34467789999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----CC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----TP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~~  528 (663)
                      .+++...      .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++.......    ..
T Consensus       105 ~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  176 (297)
T 3fxz_A          105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (297)
T ss_dssp             HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred             HHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCc
Confidence            9999753      3899999999999999999999998  9999999999999999999999999998765432    23


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+.......         ......
T Consensus       177 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~~~~~~~~---------~~~~~~  241 (297)
T 3fxz_A          177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN------PLRALYLIATNGTPE---------LQNPEK  241 (297)
T ss_dssp             CSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHHCSCC---------CSCGGG
T ss_pred             cCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCCC---------CCCccc
Confidence            47788999999999899999999999999999999999996432      122222222221110         111222


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....+.+++.+|++.||++|||++|++++
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          242 LSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            34467888999999999999999999884

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.5e-41  Score=340.88  Aligned_cols=248  Identities=24%  Similarity=0.372  Sum_probs=206.9

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|+||.||+|...++..||||+++......+++.+|++++..++||||+++++++.+....++||||+++++|.+
T Consensus        13 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   92 (268)
T 3sxs_A           13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLN   92 (268)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHH
T ss_pred             eeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHH
Confidence            36899999999999999888899999998877778889999999999999999999999999899999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-----CCC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----TPN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-----~~~  529 (663)
                      ++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++.......     ...
T Consensus        93 ~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  166 (268)
T 3sxs_A           93 YLRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK  166 (268)
T ss_dssp             HHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCC
T ss_pred             HHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCC
Confidence            997532    24899999999999999999999998  9999999999999999999999999998765432     123


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      ++..|+|||.+.+..++.++||||||+++|||++ |+.||....      .......+......   .        .+..
T Consensus       167 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~~~~~~~~~~---~--------~~~~  229 (268)
T 3sxs_A          167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT------NSEVVLKVSQGHRL---Y--------RPHL  229 (268)
T ss_dssp             CCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC------HHHHHHHHHTTCCC---C--------CCTT
T ss_pred             cCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC------hHHHHHHHHcCCCC---C--------CCCc
Confidence            4556999999988888999999999999999999 999996432      12222222221110   0        0111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                      ....+.+++.+|++.||++|||++|++++|+.+.+..
T Consensus       230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          230 ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            2346788999999999999999999999999997764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6.1e-41  Score=356.17  Aligned_cols=250  Identities=23%  Similarity=0.379  Sum_probs=202.6

Q ss_pred             hcccccccceEEEEEEe--------cCCcEEEEEEecCccc--CHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEE
Q 006055          375 AEVLGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLV  443 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~--------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  443 (663)
                      .+.||+|+||.||+|..        .++..||||+++....  ..+.+.+|+++++.+ +||||++++++|.+.+..++|
T Consensus        86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  165 (370)
T 2psq_A           86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI  165 (370)
T ss_dssp             EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence            46899999999999985        2456899999976532  235789999999999 899999999999999999999


Q ss_pred             EEccCCCChhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceE
Q 006055          444 YDYLTMGSLSALLHGNKG-----------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEAR  512 (663)
Q Consensus       444 ~ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~k  512 (663)
                      |||+++|+|.+++.....           .....+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+|
T Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~k  243 (370)
T 2psq_A          166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMK  243 (370)
T ss_dssp             EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEE
T ss_pred             EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEEECCCCCEE
Confidence            999999999999976432           11345899999999999999999999998  99999999999999999999


Q ss_pred             EeccccccccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHH
Q 006055          513 VSDFGLAHLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQS  585 (663)
Q Consensus       513 l~Dfg~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  585 (663)
                      |+|||+++.......      ..++..|+|||++.+..++.++|||||||++|||++ |+.||.....      ......
T Consensus       244 l~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~------~~~~~~  317 (370)
T 2psq_A          244 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------EELFKL  317 (370)
T ss_dssp             ECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GGHHHH
T ss_pred             EccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH
Confidence            999999986654321      224567999999998899999999999999999999 9999965322      112222


Q ss_pred             HHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          586 IVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      +... ...          ..+.....++.+++.+||+.||++|||+.|++++|+++..
T Consensus       318 ~~~~-~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          318 LKEG-HRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             HHTT-CCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhcC-CCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            2111 110          1112234468889999999999999999999999998754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.7e-41  Score=366.37  Aligned_cols=249  Identities=23%  Similarity=0.422  Sum_probs=207.5

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|+||+||+|.+.++..||||+++......+.|.+|+.+++.++||||+++++++. .+..++||||+++|+|.+
T Consensus       193 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~  271 (454)
T 1qcf_A          193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLD  271 (454)
T ss_dssp             EEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHH
T ss_pred             EEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHH
Confidence            4689999999999999988999999999877677889999999999999999999999986 667899999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC-----CCCC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-----STPN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~-----~~~~  529 (663)
                      +++...   ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.....     ....
T Consensus       272 ~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~  346 (454)
T 1qcf_A          272 FLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK  346 (454)
T ss_dssp             HHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSS
T ss_pred             HHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCc
Confidence            997532   124789999999999999999999998  999999999999999999999999999876542     2223


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      ++..|+|||++....++.++|||||||++|||++ |+.||....      .......+.....           ...+..
T Consensus       347 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~------~~~~~~~i~~~~~-----------~~~~~~  409 (454)
T 1qcf_A          347 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS------NPEVIRALERGYR-----------MPRPEN  409 (454)
T ss_dssp             SCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHHHHHHTCC-----------CCCCTT
T ss_pred             ccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCC-----------CCCCCC
Confidence            4567999999988889999999999999999999 999996532      2222222222111           111122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST  646 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~  646 (663)
                      .+.++.+++.+||+.||++|||+++|++.|+++.....
T Consensus       410 ~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~  447 (454)
T 1qcf_A          410 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE  447 (454)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence            34578889999999999999999999999999876543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.8e-40  Score=342.51  Aligned_cols=251  Identities=23%  Similarity=0.320  Sum_probs=205.6

Q ss_pred             ccCHHHHHHHhh---------------cccccccceEEEEEEec-CCcEEEEEEecCc-ccCHHHHHHHHHHhhcCCCCC
Q 006055          364 VFDLEDLLRASA---------------EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDV-TISEREFKDKIEGVGAVNHEN  426 (663)
Q Consensus       364 ~~~~~~l~~~~~---------------~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~h~n  426 (663)
                      .++.+++..++.               +.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+++.++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            467777766652               47999999999999965 7999999998755 344677899999999999999


Q ss_pred             cccceEEEEecCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc
Q 006055          427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT  506 (663)
Q Consensus       427 iv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~  506 (663)
                      |+++++++...+..++||||+++|+|.+++...      .+++..+..++.|++.||.|||+.+  |+||||||+||+++
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~  175 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV------RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLT  175 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC
Confidence            999999999999999999999999999998742      4899999999999999999999998  99999999999999


Q ss_pred             CCCceEEeccccccccCCC----CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHH
Q 006055          507 KSYEARVSDFGLAHLVGPS----STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRW  582 (663)
Q Consensus       507 ~~~~~kl~Dfg~a~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~  582 (663)
                      .++.+||+|||+++.....    ....++..|+|||++.+..++.++||||||+++|||++|+.||....      ....
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~------~~~~  249 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS------PVQA  249 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHH
T ss_pred             CCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHH
Confidence            9999999999999876543    22357788999999999899999999999999999999999996432      2222


Q ss_pred             HHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          583 VQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       583 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...+... .....        .........+.+++.+|+..||++|||++|++++
T Consensus       250 ~~~~~~~-~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          250 MKRLRDS-PPPKL--------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HHHHHHS-SCCCC--------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHhcC-CCCCc--------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            2222211 11110        0111223467788889999999999999999985

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.4e-40  Score=340.05  Aligned_cols=246  Identities=23%  Similarity=0.340  Sum_probs=203.8

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|+||+||++...++..||||+++......+++.+|++++..++||||+++++++.+....++||||+++|+|.+
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  108 (283)
T 3gen_A           29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN  108 (283)
T ss_dssp             EEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHH
T ss_pred             HhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHH
Confidence            46899999999999999889999999998877778899999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC-----CCCC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-----STPN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~-----~~~~  529 (663)
                      ++....    ..+++..+..++.|++.||.|||+++  |+||||||+||+++.++.+||+|||+++.....     ....
T Consensus       109 ~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  182 (283)
T 3gen_A          109 YLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK  182 (283)
T ss_dssp             HHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTT
T ss_pred             HHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEccccccccccccccccccCCc
Confidence            997532    24899999999999999999999998  999999999999999999999999999866442     2233


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      ++..|+|||.+.+..++.++||||||+++|||++ |+.||....      .......+......           .....
T Consensus       183 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~------~~~~~~~~~~~~~~-----------~~~~~  245 (283)
T 3gen_A          183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT------NSETAEHIAQGLRL-----------YRPHL  245 (283)
T ss_dssp             SCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC------HHHHHHHHHTTCCC-----------CCCTT
T ss_pred             cCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC------hhHHHHHHhcccCC-----------CCCCc
Confidence            5567999999988889999999999999999998 999996532      12222222221110           00111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      ....+.+++.+||+.||++|||++|++++|+++.+
T Consensus       246 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          246 ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence            23467889999999999999999999999998754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.4e-41  Score=345.57  Aligned_cols=250  Identities=25%  Similarity=0.382  Sum_probs=193.5

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhc--CCCCCcccceEEEEec----CccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGA--VNHENLVPLRAYYYSM----DEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~~lv~ey~~  448 (663)
                      .+.||+|+||+||+|.. +|+.||||++....  ...+..|.+++..  ++||||+++++++...    ...++||||++
T Consensus        13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~   89 (301)
T 3q4u_A           13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE   89 (301)
T ss_dssp             EEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCT
T ss_pred             EEeeccCCCcEEEEEEE-CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhcc
Confidence            46899999999999988 59999999986543  4455556666555  8999999999997653    34789999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH--------AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH--------~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                      +|+|.++++..      .+++..+..++.|++.||.|||        +.+  |+||||||+|||++.++.+||+|||+++
T Consensus        90 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  161 (301)
T 3q4u_A           90 MGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCIADLGLAV  161 (301)
T ss_dssp             TCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEEeeCCCee
Confidence            99999999642      4899999999999999999999        776  9999999999999999999999999997


Q ss_pred             ccCCCC--------CCCCCccccCccccCCC------CCCCcchhhhHHHHHHHHHhC----------CCCCccccCCCC
Q 006055          521 LVGPSS--------TPNRVAGYRAPEVTDPC------KVSQKADVYSFGVLLLELLTG----------KAPTHALLNEEG  576 (663)
Q Consensus       521 ~~~~~~--------~~~~~~~y~aPE~~~~~------~~~~~~Dv~slGvvl~elltg----------~~p~~~~~~~~~  576 (663)
                      ......        ...++..|+|||++.+.      .++.++|||||||++|||++|          +.||....... 
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~-  240 (301)
T 3q4u_A          162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND-  240 (301)
T ss_dssp             EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS-
T ss_pred             ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC-
Confidence            654332        22577889999999876      344689999999999999999          77876543222 


Q ss_pred             CChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          577 VDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                      ..... ..........    .+.............++.+++.+||+.||++|||++||++.|+++
T Consensus       241 ~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          241 PSFED-MRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCHHH-HHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhh-hhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            11212 2222111111    111111112335667899999999999999999999999999986

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=9.6e-41  Score=348.46  Aligned_cols=238  Identities=20%  Similarity=0.303  Sum_probs=198.7

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||.||+|.. .+|+.||||++......   .+.+.+|+++++.++||||+++++++......++||||+++|
T Consensus        20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~   99 (328)
T 3fe3_A           20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG   99 (328)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCC
Confidence            36899999999999995 68999999999765433   356889999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---C
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---T  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---~  527 (663)
                      +|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++......   .
T Consensus       100 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  172 (328)
T 3fe3_A          100 EVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA  172 (328)
T ss_dssp             BHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGT
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccc
Confidence            9999997532     4899999999999999999999998  9999999999999999999999999998765432   3


Q ss_pred             CCCCccccCccccCCCCCC-CcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          528 PNRVAGYRAPEVTDPCKVS-QKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ..++..|+|||++.+..+. .++||||+||++|||++|+.||...      +.......+......            .+
T Consensus       173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~------~~~~~~~~i~~~~~~------------~p  234 (328)
T 3fe3_A          173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ------NLKELRERVLRGKYR------------IP  234 (328)
T ss_dssp             TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC------------CC
T ss_pred             ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCC------------CC
Confidence            4578889999999887764 7899999999999999999999642      333333333332211            01


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .....++.+++.+|+..||++|||++|++++
T Consensus       235 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          235 FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1123457788899999999999999999984

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8e-40  Score=338.53  Aligned_cols=272  Identities=32%  Similarity=0.517  Sum_probs=216.7

Q ss_pred             CcccCHHHHHHHhh-----------cccccccceEEEEEEecCCcEEEEEEecCcc-----cCHHHHHHHHHHhhcCCCC
Q 006055          362 ARVFDLEDLLRASA-----------EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVT-----ISEREFKDKIEGVGAVNHE  425 (663)
Q Consensus       362 ~~~~~~~~l~~~~~-----------~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~h~  425 (663)
                      ...|+..++..++.           +.||+|+||.||+|.. +++.||||++....     ...+.+.+|+.+++.++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            34678888887762           6799999999999987 58999999986532     2246789999999999999


Q ss_pred             CcccceEEEEecCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEE
Q 006055          426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL  505 (663)
Q Consensus       426 niv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill  505 (663)
                      ||+++++++.+.+..++||||+++|+|.+++.....  ..++++..+..++.|++.||.|||+.+  |+||||||+||++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili  166 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILL  166 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEE
Confidence            999999999999999999999999999999974321  345899999999999999999999998  9999999999999


Q ss_pred             cCCCceEEeccccccccCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCCh
Q 006055          506 TKSYEARVSDFGLAHLVGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDL  579 (663)
Q Consensus       506 ~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~  579 (663)
                      +.++.+||+|||+++......      ...++..|+|||.+.+ .++.++||||||+++|+|++|+.||.......  .+
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~  243 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LL  243 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--BT
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--HH
Confidence            999999999999998765422      2346778999999876 47889999999999999999999997654322  22


Q ss_pred             HHHHHHHHhhcc-cccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          580 PRWVQSIVKDEW-TSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       580 ~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      ..+......... ....++...  ..........+.+++.+|++.||++|||++||+++|+++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          244 LDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             THHHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            222222221111 111122111  12345567789999999999999999999999999999864

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=8.5e-41  Score=348.85  Aligned_cols=248  Identities=24%  Similarity=0.373  Sum_probs=201.7

Q ss_pred             hcccccccceEEEEEEec----CCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLE----MGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|...    .+..||||.++...  ...+.+.+|+.+++.++||||+++++++.+....++||||++
T Consensus        54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  133 (325)
T 3kul_A           54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME  133 (325)
T ss_dssp             EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCT
T ss_pred             eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCC
Confidence            468999999999999963    45569999997642  234678999999999999999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-  527 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  527 (663)
                      +|+|.++++...    ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++....... 
T Consensus       134 ~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  207 (325)
T 3kul_A          134 NGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA  207 (325)
T ss_dssp             TCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred             CCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence            999999997543    35899999999999999999999998  99999999999999999999999999987654322 


Q ss_pred             ------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          528 ------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       528 ------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                            ..++..|+|||++.+..++.++||||||+++|||++ |+.||....      .......+.....         
T Consensus       208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~------~~~~~~~~~~~~~---------  272 (325)
T 3kul_A          208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT------NRDVISSVEEGYR---------  272 (325)
T ss_dssp             CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC------HHHHHHHHHTTCC---------
T ss_pred             eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC------HHHHHHHHHcCCC---------
Confidence                  123456999999988889999999999999999999 999996532      1222222222111         


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                        .........++.+++.+||..||++|||+.||++.|+++....
T Consensus       273 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          273 --LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             --CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence              1111223456888999999999999999999999999986543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.5e-40  Score=340.27  Aligned_cols=259  Identities=20%  Similarity=0.292  Sum_probs=205.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|.. .+++.||+|.+.....    ..+.+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g   95 (294)
T 4eqm_A           16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG   95 (294)
T ss_dssp             EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCC
Confidence            36899999999999994 5689999999854322    235788999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++....     ++++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++......   
T Consensus        96 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           96 PTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence            99999997532     5899999999999999999999998  9999999999999999999999999998765432   


Q ss_pred             --CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          527 --TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                        ...++..|+|||.+.+..++.++||||||+++|||++|+.||....      ..............    ...   ..
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~------~~~~~~~~~~~~~~----~~~---~~  235 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET------AVSIAIKHIQDSVP----NVT---TD  235 (294)
T ss_dssp             ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC------HHHHHHHHHSSCCC----CHH---HH
T ss_pred             cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhhccCC----Ccc---hh
Confidence              1236788999999999889999999999999999999999996532      12222222222111    000   00


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHhhCCCCCCCCCCCC
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRP-SMSEVIKRIEELHPSSTQGHHGLQ  653 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RP-t~~ev~~~L~~~~~~~~~~~~~~~  653 (663)
                      .....+..+.+++.+|++.||++|| +++++.+.|+.+............
T Consensus       236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~~~~  285 (294)
T 4eqm_A          236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYE  285 (294)
T ss_dssp             SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCCCCC
T ss_pred             cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcchhh
Confidence            1112345688899999999999998 999999999998766555444443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.2e-40  Score=340.96  Aligned_cols=270  Identities=18%  Similarity=0.261  Sum_probs=208.1

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecC--ccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMD--EKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ey~~~  449 (663)
                      .++||+|+||+||+|... +|+.||||+++...  ...+.+.+|+++++.++||||+++++++....  ..++||||+++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   93 (319)
T 4euu_A           14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC   93 (319)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred             EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence            368999999999999954 58999999997542  34577889999999999999999999998765  67999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEE----cCCCceEEeccccccccCCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill----~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+|.+++.....  ...+++..++.++.|++.||.|||+.+  |+||||||+||++    +.++.+||+|||+++.....
T Consensus        94 ~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~  169 (319)
T 4euu_A           94 GSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD  169 (319)
T ss_dssp             CBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT
T ss_pred             CCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC
Confidence            999999986432  234899999999999999999999998  9999999999999    78888999999999877554


Q ss_pred             C---CCCCCccccCccccC--------CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          526 S---TPNRVAGYRAPEVTD--------PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       526 ~---~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                      .   ...++..|+|||++.        +..++.++|||||||++|||++|+.||.......  .....+..+........
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~p~~~  247 (319)
T 4euu_A          170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKIITGKPSGA  247 (319)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG--GCHHHHHHHHHHCCTTC
T ss_pred             CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc--hhHHHHHHHhcCCCccc
Confidence            3   234678899999875        5678899999999999999999999997543221  22333333333221110


Q ss_pred             c---cc---------hhhh-cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCC
Q 006055          595 V---FD---------LELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHH  650 (663)
Q Consensus       595 ~---~d---------~~~~-~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~~~~  650 (663)
                      +   ..         .... ...........+.+++.+|++.||++|||++|++++..+........+|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~~~~~~  316 (319)
T 4euu_A          248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGNSHHH  316 (319)
T ss_dssp             CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-------
T ss_pred             chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcCCcccc
Confidence            0   00         0000 1122356667888999999999999999999999999987665544443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-40  Score=344.91  Aligned_cols=244  Identities=23%  Similarity=0.346  Sum_probs=202.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .+.||+|+||.||++.. .+++.||+|.++........+.+|+.+++.++||||+++++++.+.+..++||||+++|+|.
T Consensus        10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~   89 (321)
T 1tki_A           10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF   89 (321)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHH
T ss_pred             eeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHH
Confidence            46799999999999995 46899999999866555677899999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC--CCceEEeccccccccCCCCC---C
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK--SYEARVSDFGLAHLVGPSST---P  528 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~---~  528 (663)
                      +++....    ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.  ++.+||+|||+++.......   .
T Consensus        90 ~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  163 (321)
T 1tki_A           90 ERINTSA----FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL  163 (321)
T ss_dssp             HHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred             HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence            9997532    35899999999999999999999998  999999999999987  78999999999988765432   2


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .+++.|+|||++.+..++.++|||||||++|||++|+.||....      ....+..+......   ++...     ...
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~~---~~~~~-----~~~  229 (321)
T 1tki_A          164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET------NQQIIENIMNAEYT---FDEEA-----FKE  229 (321)
T ss_dssp             ESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHTCCC---CCHHH-----HTT
T ss_pred             cCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC------HHHHHHHHHcCCCC---CChhh-----hcc
Confidence            36778999999998888999999999999999999999996532      23333333333211   11110     012


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      ...++.+++.+|+..||++|||+.|++++-
T Consensus       230 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          230 ISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence            234678889999999999999999999854

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2e-40  Score=365.65  Aligned_cols=248  Identities=26%  Similarity=0.402  Sum_probs=206.7

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .+.||+|+||.||+|.+. ++..||||.++......+.|.+|+.++++++||||++++++|......++||||+++|+|.
T Consensus       225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~  304 (495)
T 1opk_A          225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL  304 (495)
T ss_dssp             EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred             eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHH
Confidence            468999999999999965 4899999999877667888999999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-----CC
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----TP  528 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-----~~  528 (663)
                      ++++...   ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++......     ..
T Consensus       305 ~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~  379 (495)
T 1opk_A          305 DYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  379 (495)
T ss_dssp             HHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTC
T ss_pred             HHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCC
Confidence            9997543   245899999999999999999999998  9999999999999999999999999998765432     12


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      .++..|+|||.+.+..++.++|||||||++|||++ |+.||.....      ...... +.....          ...+.
T Consensus       380 ~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~------~~~~~~-~~~~~~----------~~~~~  442 (495)
T 1opk_A          380 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYEL-LEKDYR----------MERPE  442 (495)
T ss_dssp             CCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GGHHHH-HHTTCC----------CCCCT
T ss_pred             cCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH------HHHHHH-HHcCCC----------CCCCC
Confidence            23567999999988889999999999999999999 9999965322      111111 111111          01112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      ....++.+++.+||+.||++|||+.||++.|+.+...
T Consensus       443 ~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          443 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            2345688899999999999999999999999988644

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.3e-40  Score=361.19  Aligned_cols=249  Identities=27%  Similarity=0.408  Sum_probs=203.0

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|+||.||+|.+.++..||||+++......+.|.+|++++++++||||+++++++.+ +..++||||+++|+|.+
T Consensus       189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~  267 (452)
T 1fmk_A          189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD  267 (452)
T ss_dssp             EEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHH
T ss_pred             eeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHH
Confidence            46899999999999999888899999998776677889999999999999999999999866 67899999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-----CCC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----TPN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-----~~~  529 (663)
                      +++...   ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++......     ...
T Consensus       268 ~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  342 (452)
T 1fmk_A          268 FLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK  342 (452)
T ss_dssp             HHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC--------------
T ss_pred             HHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCc
Confidence            997432   134899999999999999999999998  9999999999999999999999999998765432     122


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      ++..|+|||.+.+..++.++|||||||++|||++ |+.||....      .......+.....           ...+..
T Consensus       343 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~------~~~~~~~i~~~~~-----------~~~~~~  405 (452)
T 1fmk_A          343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------NREVLDQVERGYR-----------MPCPPE  405 (452)
T ss_dssp             CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHHHTTCC-----------CCCCTT
T ss_pred             ccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCC-----------CCCCCC
Confidence            4567999999988889999999999999999999 999996532      2222222222111           011123


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST  646 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~  646 (663)
                      .+..+.+++.+||+.||++|||++++++.|+++.....
T Consensus       406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence            34568889999999999999999999999999876543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6.1e-40  Score=332.68  Aligned_cols=248  Identities=22%  Similarity=0.311  Sum_probs=202.3

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEec--CccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSM--DEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|... |+.||||+++.....   .+.+.+|+.+++.++||||+++++++.+.  ...++||||+++
T Consensus        15 ~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   93 (271)
T 3kmu_A           15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY   93 (271)
T ss_dssp             EEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTT
T ss_pred             HHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCC
Confidence            468999999999999986 899999999765433   45789999999999999999999999877  678999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN  529 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  529 (663)
                      |+|.++++...   ...+++..+..++.|++.||.|||+.+++|+||||||+||+++.++.++|+|||++..... ....
T Consensus        94 ~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-~~~~  169 (271)
T 3kmu_A           94 GSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-PGRM  169 (271)
T ss_dssp             CBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-TTCB
T ss_pred             CcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-cCcc
Confidence            99999998643   2358999999999999999999999877799999999999999999999999998765432 3345


Q ss_pred             CCccccCccccCCCCCCC---cchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          530 RVAGYRAPEVTDPCKVSQ---KADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~---~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ++..|+|||.+.+..++.   ++||||||+++|||++|+.||....      ................          .+
T Consensus       170 ~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~~~----------~~  233 (271)
T 3kmu_A          170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS------NMEIGMKVALEGLRPT----------IP  233 (271)
T ss_dssp             SCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC------HHHHHHHHHHSCCCCC----------CC
T ss_pred             CCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC------hHHHHHHHHhcCCCCC----------CC
Confidence            788899999998765444   7999999999999999999996432      2222222222221111          11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      .....++.+++.+||+.||++|||++|+++.|+++.+
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          234 PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            1233468888999999999999999999999999865

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.5e-40  Score=342.72  Aligned_cols=238  Identities=24%  Similarity=0.301  Sum_probs=198.0

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc----ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV----TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||+|.. .+|+.||+|+++..    ......+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~g   89 (337)
T 1o6l_A           10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG   89 (337)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46899999999999995 46999999999753    23456788999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----  525 (663)
                      |+|.+++....     .+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++.....    
T Consensus        90 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~  162 (337)
T 1o6l_A           90 GELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence            99999997532     4899999999999999999999998  999999999999999999999999999864332    


Q ss_pred             CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          526 STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       526 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      ....+++.|+|||++.+..++.++|||||||++|||++|+.||...      +.......+......            .
T Consensus       163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~------~~~~~~~~i~~~~~~------------~  224 (337)
T 1o6l_A          163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHERLFELILMEEIR------------F  224 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC------------C
T ss_pred             cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC------CHHHHHHHHHcCCCC------------C
Confidence            2234678899999999999999999999999999999999999642      222333333322110            0


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                      +.....++.+++.+|+..||++||     +++|+++|
T Consensus       225 p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            112234677888899999999999     89999876

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=8.6e-40  Score=345.44  Aligned_cols=241  Identities=23%  Similarity=0.343  Sum_probs=199.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc-------CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI-------SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|.. .+|+.||+|.++....       ....+.+|+.++..++||||+++++++.+....++||||
T Consensus        17 ~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~   96 (361)
T 2yab_A           17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL   96 (361)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEc
Confidence            46899999999999995 4699999999875422       357899999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC----ceEEecccccccc
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY----EARVSDFGLAHLV  522 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~----~~kl~Dfg~a~~~  522 (663)
                      +++|+|.+++...     ..+++..+..++.||+.||.|||+.+  |+||||||+|||+++++    .+||+|||+++..
T Consensus        97 ~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A           97 VSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             CCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence            9999999999753     25899999999999999999999998  99999999999998877    7999999999877


Q ss_pred             CCCC---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          523 GPSS---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       523 ~~~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                      ....   ...+++.|+|||++.+..++.++|||||||++|+|++|..||...      +.......+......   ++..
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~------~~~~~~~~i~~~~~~---~~~~  240 (361)
T 2yab_A          170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD------TKQETLANITAVSYD---FDEE  240 (361)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHHHHTTCCC---CCHH
T ss_pred             CCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhcCCC---CCch
Confidence            5542   345788899999999989999999999999999999999999653      222333333322111   1111


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      .  +   .....++.+++.+|+..||++|||++|+++
T Consensus       241 ~--~---~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          241 F--F---SQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             H--H---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             h--c---cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1  0   112345778888999999999999999987

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.6e-40  Score=332.39  Aligned_cols=247  Identities=25%  Similarity=0.393  Sum_probs=207.2

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|+||.||+|...+++.||+|.+.......+.+.+|+++++.++||||+++++++.+.+..++||||+++++|.+
T Consensus        13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   92 (267)
T 3t9t_A           13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD   92 (267)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHH
T ss_pred             eeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHH
Confidence            46899999999999998889999999998877777889999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC-----CCCC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-----STPN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~-----~~~~  529 (663)
                      ++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++.....     ....
T Consensus        93 ~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  166 (267)
T 3t9t_A           93 YLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK  166 (267)
T ss_dssp             HHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred             HHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEccccccccccccccccccccc
Confidence            997543    35899999999999999999999998  999999999999999999999999999876432     2233


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      ++..|+|||.+.+..++.++||||||+++|||++ |+.||...      +.......+......           ..+..
T Consensus       167 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------~~~~~~~~i~~~~~~-----------~~~~~  229 (267)
T 3t9t_A          167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR------SNSEVVEDISTGFRL-----------YKPRL  229 (267)
T ss_dssp             CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHTTCCC-----------CCCTT
T ss_pred             ccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC------CHHHHHHHHhcCCcC-----------CCCcc
Confidence            5567999999988889999999999999999999 89998642      222223222222110           00111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      ....+.+++.+|+..||++|||++|++++|+++.+.
T Consensus       230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            234678889999999999999999999999998653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2e-40  Score=352.42  Aligned_cols=247  Identities=24%  Similarity=0.415  Sum_probs=192.9

Q ss_pred             hcccccccceEEEEEEec----CCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLE----MGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|...    ++..||||.++...  ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus        50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  129 (373)
T 2qol_A           50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME  129 (373)
T ss_dssp             CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCC
Confidence            468999999999999854    57789999997542  234679999999999999999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCC
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP  528 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  528 (663)
                      +|+|.++++...    ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++........
T Consensus       130 ~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  203 (373)
T 2qol_A          130 NGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA  203 (373)
T ss_dssp             TCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             CCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence            999999997542    35899999999999999999999998  999999999999999999999999999876543211


Q ss_pred             -------CCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          529 -------NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       529 -------~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                             .++..|+|||++.+..++.++||||||+++|||++ |+.||....      .......+.....         
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~------~~~~~~~i~~~~~---------  268 (373)
T 2qol_A          204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS------NQDVIKAVDEGYR---------  268 (373)
T ss_dssp             ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC------HHHHHHHHHTTEE---------
T ss_pred             ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCC---------
Confidence                   12456999999998889999999999999999998 999996432      1222222221111         


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                        .........++.+++.+||+.||++||+++||++.|+++...
T Consensus       269 --~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          269 --LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             --CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence              111122345788999999999999999999999999987543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=9e-41  Score=356.01  Aligned_cols=246  Identities=24%  Similarity=0.375  Sum_probs=200.9

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||.||+|... +++.||||.++....  ....+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus       119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~  198 (377)
T 3cbl_A          119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD  198 (377)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCC
Confidence            478999999999999965 799999999875422  13468899999999999999999999999899999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-----
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----  526 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-----  526 (663)
                      |.++++...    ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++......     
T Consensus       199 L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~  272 (377)
T 3cbl_A          199 FLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG  272 (377)
T ss_dssp             HHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence            999997532    24899999999999999999999998  9999999999999999999999999998654321     


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                       ....+..|+|||.+.+..++.++|||||||++|||++ |..||.....      .. +...+.....          ..
T Consensus       273 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~------~~-~~~~~~~~~~----------~~  335 (377)
T 3cbl_A          273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN------QQ-TREFVEKGGR----------LP  335 (377)
T ss_dssp             SCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH------HH-HHHHHHTTCC----------CC
T ss_pred             CCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHHcCCC----------CC
Confidence             1123456999999988889999999999999999998 9999965321      11 1112211110          01


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      .+...+.++.+++.+||+.||++|||++++++.|+++..
T Consensus       336 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            112234468889999999999999999999999998753

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-40  Score=344.18  Aligned_cols=254  Identities=26%  Similarity=0.353  Sum_probs=195.4

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhh--cCCCCCcccceEEEEec----CccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVG--AVNHENLVPLRAYYYSM----DEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~----~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|... |+.||||++....  ...+..|.+++.  .++||||+++++++...    ...++||||++
T Consensus        42 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~  118 (337)
T 3mdy_A           42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHE  118 (337)
T ss_dssp             EEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCT
T ss_pred             EeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccC
Confidence            578999999999999986 9999999986543  333444445444  45999999999999887    67899999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc--------CCcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ--------GPNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~--------~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                      +|+|.++++..      .+++..+..++.|++.||.|||+.        +  |+||||||+|||++.++.+||+|||+++
T Consensus       119 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~kl~Dfg~a~  190 (337)
T 3mdy_A          119 NGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKNGTCCIADLGLAV  190 (337)
T ss_dssp             TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCCCCEEEEeCCCce
Confidence            99999999753      489999999999999999999988        6  9999999999999999999999999997


Q ss_pred             ccCCCC--------CCCCCccccCccccCCCCCCCc------chhhhHHHHHHHHHhC----------CCCCccccCCCC
Q 006055          521 LVGPSS--------TPNRVAGYRAPEVTDPCKVSQK------ADVYSFGVLLLELLTG----------KAPTHALLNEEG  576 (663)
Q Consensus       521 ~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~------~Dv~slGvvl~elltg----------~~p~~~~~~~~~  576 (663)
                      ......        ...++..|+|||++.+.....+      +|||||||++|||++|          +.||....... 
T Consensus       191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~-  269 (337)
T 3mdy_A          191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD-  269 (337)
T ss_dssp             ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS-
T ss_pred             eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC-
Confidence            664432        2346788999999988766665      9999999999999999          55554432221 


Q ss_pred             CChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          577 VDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                      ... ............    .+.........+...++.+++.+||+.||++|||+.||+++|+.+.+..
T Consensus       270 ~~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          270 PSY-EDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CCH-HHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             Cch-hhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            111 112222111111    1111111122356778999999999999999999999999999986653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.5e-40  Score=359.55  Aligned_cols=246  Identities=26%  Similarity=0.415  Sum_probs=202.1

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecC-ccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMD-EKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ey~~~gsL~  453 (663)
                      .+.||+|+||.||+|... |+.||||.++... ..+.|.+|+.++++++||||+++++++.+.. ..++||||+++|+|.
T Consensus       198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~  275 (450)
T 1k9a_A          198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV  275 (450)
T ss_dssp             EEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHH
T ss_pred             EeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHH
Confidence            468999999999999986 8899999998654 4567999999999999999999999988765 689999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-CCCCCc
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-TPNRVA  532 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~  532 (663)
                      ++++...   ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++...... ...++.
T Consensus       276 ~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  350 (450)
T 1k9a_A          276 DYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV  350 (450)
T ss_dssp             HHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEECC------CCCT
T ss_pred             HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCCCc
Confidence            9998543   234789999999999999999999998  9999999999999999999999999998654332 234566


Q ss_pred             cccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHH
Q 006055          533 GYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMV  611 (663)
Q Consensus       533 ~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  611 (663)
                      .|+|||.+.+..++.++|||||||++|||++ |+.||......   .   ....+... ..          ...+...+.
T Consensus       351 ~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~---~~~~i~~~-~~----------~~~p~~~~~  413 (450)
T 1k9a_A          351 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---D---VVPRVEKG-YK----------MDAPDGCPP  413 (450)
T ss_dssp             TTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT---T---HHHHHHTT-CC----------CCCCTTCCH
T ss_pred             ceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---H---HHHHHHcC-CC----------CCCCCcCCH
Confidence            7999999999899999999999999999998 99999754322   1   12222211 11          111123345


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          612 QLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       612 ~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      ++.+++.+||+.||++|||+.|+++.|+++...
T Consensus       414 ~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          414 AVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            788899999999999999999999999988644

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.3e-40  Score=334.11  Aligned_cols=244  Identities=27%  Similarity=0.431  Sum_probs=190.0

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcc-----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVT-----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|... |+.||||+++...     ...+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus        12 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   90 (271)
T 3dtc_A           12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG   90 (271)
T ss_dssp             EEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTT
T ss_pred             eeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCC
Confidence            368999999999999976 8999999986542     2246789999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-CcceecCCCCCCEEEcC--------CCceEEecccccc
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG-PNVSHGNIKSSNILLTK--------SYEARVSDFGLAH  520 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-~~iiHrdlk~~Nill~~--------~~~~kl~Dfg~a~  520 (663)
                      ++|.+++...      .+++..+..++.|++.||.|||+.+ .+|+||||||+||+++.        ++.+||+|||+++
T Consensus        91 ~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~  164 (271)
T 3dtc_A           91 GPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR  164 (271)
T ss_dssp             EEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred             CCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence            9999999642      4899999999999999999999997 45899999999999986        6789999999998


Q ss_pred             ccCCCC--CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          521 LVGPSS--TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       521 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                      ......  ...++..|+|||.+.+..++.++||||||+++|||++|+.||....      ...............     
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~-----  233 (271)
T 3dtc_A          165 EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID------GLAVAYGVAMNKLAL-----  233 (271)
T ss_dssp             -----------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC------HHHHHHHHHTSCCCC-----
T ss_pred             ccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHhhhcCCCCC-----
Confidence            765432  2456788999999988889999999999999999999999996532      111122222111111     


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                           .........+.+++.+|++.||++|||+.|++++|+++
T Consensus       234 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          234 -----PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                 11122334688899999999999999999999999864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.2e-40  Score=343.73  Aligned_cols=252  Identities=17%  Similarity=0.171  Sum_probs=202.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||+||+|.. .+|+.||||.+..... ...+.+|+++++.+ +||||+++++++......++||||+ +++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L   91 (330)
T 2izr_A           14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSL   91 (330)
T ss_dssp             EEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCH
Confidence            36899999999999994 6799999999875432 34688999999999 9999999999999999999999999 8999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc-----eEEeccccccccCCCC-
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE-----ARVSDFGLAHLVGPSS-  526 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~-----~kl~Dfg~a~~~~~~~-  526 (663)
                      .+++....    ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.     +||+|||+++...... 
T Consensus        92 ~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~  165 (330)
T 2izr_A           92 EDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET  165 (330)
T ss_dssp             HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred             HHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence            99998542    35899999999999999999999998  999999999999999887     9999999998654322 


Q ss_pred             ----------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccccccc
Q 006055          527 ----------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF  596 (663)
Q Consensus       527 ----------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  596 (663)
                                ...++..|+|||++.+..++.++|||||||++|||++|+.||.....   ......+..+.......   
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~---~~~~~~~~~i~~~~~~~---  239 (330)
T 2izr_A          166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA---DTLKERYQKIGDTKRAT---  239 (330)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---SSHHHHHHHHHHHHHHS---
T ss_pred             CccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc---ccHHHHHHHHHhhhccC---
Confidence                      23467889999999999999999999999999999999999976432   22333333222111100   


Q ss_pred             chhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          597 DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       597 d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                      .....    ....+ ++.+++..|++.||.+||++++|++.|+++....
T Consensus       240 ~~~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          240 PIEVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             CHHHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CHHHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            00000    00122 7888999999999999999999999998875443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.2e-40  Score=340.76  Aligned_cols=254  Identities=26%  Similarity=0.419  Sum_probs=198.0

Q ss_pred             hcccccccceEEEEEEe-----cCCcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEec--CccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSM--DEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ey  446 (663)
                      .+.||+|+||+||+|.+     .+++.||||++..... ..+.+.+|+++++.++||||+++++++...  ...++||||
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   94 (295)
T 3ugc_A           15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY   94 (295)
T ss_dssp             EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEEC
T ss_pred             hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEe
Confidence            46899999999999984     3689999999976532 246789999999999999999999998653  558999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      +++|+|.+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++......
T Consensus        95 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (295)
T 3ugc_A           95 LPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  168 (295)
T ss_dssp             CTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred             CCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence            99999999997643    24899999999999999999999998  9999999999999999999999999998765432


Q ss_pred             C-------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCC-------CCC--ChHHHHHHHHhhc
Q 006055          527 T-------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNE-------EGV--DLPRWVQSIVKDE  590 (663)
Q Consensus       527 ~-------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~-------~~~--~~~~~~~~~~~~~  590 (663)
                      .       ..++..|+|||.+.+..++.++||||||+++|||++|..|+......       ...  .....+.......
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (295)
T 3ugc_A          169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN  248 (295)
T ss_dssp             -------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred             ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc
Confidence            1       22445699999998888999999999999999999999998643210       000  0000111111111


Q ss_pred             ccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       591 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      .          ....+...+.++.+++.+||+.||++|||++|+++.|+++...
T Consensus       249 ~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          249 G----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             C----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C----------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            0          1111223445788899999999999999999999999998654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-40  Score=346.12  Aligned_cols=253  Identities=22%  Similarity=0.370  Sum_probs=203.5

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|...      +++.||||.++....  ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  131 (343)
T 1luf_A           52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY  131 (343)
T ss_dssp             EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEec
Confidence            468999999999999964      358999999976432  246789999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC
Q 006055          447 LTMGSLSALLHGNKGA-------------------GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK  507 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~  507 (663)
                      +++|+|.+++......                   ....+++..++.++.||+.||.|||+++  |+||||||+||+++.
T Consensus       132 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~  209 (343)
T 1luf_A          132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGE  209 (343)
T ss_dssp             CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECG
T ss_pred             CCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEECC
Confidence            9999999999764211                   1256899999999999999999999998  999999999999999


Q ss_pred             CCceEEeccccccccCCC------CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChH
Q 006055          508 SYEARVSDFGLAHLVGPS------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLP  580 (663)
Q Consensus       508 ~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~  580 (663)
                      ++.+||+|||+++.....      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||....      ..
T Consensus       210 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~------~~  283 (343)
T 1luf_A          210 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA------HE  283 (343)
T ss_dssp             GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC------HH
T ss_pred             CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC------hH
Confidence            999999999999765332      22345677999999988889999999999999999999 999996432      22


Q ss_pred             HHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006055          581 RWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST  646 (663)
Q Consensus       581 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~  646 (663)
                      .....+..... ..          .+.....++.+++.+||+.||++|||+.|++++|+++.+...
T Consensus       284 ~~~~~~~~~~~-~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          284 EVIYYVRDGNI-LA----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             HHHHHHHTTCC-CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             HHHHHHhCCCc-CC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            22222222211 10          111233468889999999999999999999999999977643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-40  Score=350.90  Aligned_cols=251  Identities=23%  Similarity=0.327  Sum_probs=201.3

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||+||+|.+.      +++.||||+++...  .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus        76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  155 (367)
T 3l9p_A           76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL  155 (367)
T ss_dssp             EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEe
Confidence            468999999999999843      46789999997542  2345788999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC---ceEEeccccccc
Q 006055          447 LTMGSLSALLHGNKG--AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY---EARVSDFGLAHL  521 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~---~~kl~Dfg~a~~  521 (663)
                      +++|+|.++++....  .....+++..++.++.||+.||.|||+.+  |+||||||+|||++.++   .+||+|||+++.
T Consensus       156 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~  233 (367)
T 3l9p_A          156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD  233 (367)
T ss_dssp             CTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred             CCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEECCCccccc
Confidence            999999999975432  12345899999999999999999999998  99999999999999555   599999999975


Q ss_pred             cCCC------CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          522 VGPS------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       522 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                      ....      ....++..|+|||++.+..++.++|||||||++|||++ |..||....      .......+......  
T Consensus       234 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~------~~~~~~~i~~~~~~--  305 (367)
T 3l9p_A          234 IYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS------NQEVLEFVTSGGRM--  305 (367)
T ss_dssp             HHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHHHHHTTCCC--
T ss_pred             cccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCCC--
Confidence            4221      12235677999999988889999999999999999998 999996532      22223222222111  


Q ss_pred             ccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       595 ~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                               .........+.+++.+||+.||++|||+.||+++|+.+...
T Consensus       306 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          306 ---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence                     01112334678899999999999999999999999887544

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=347.61  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=203.3

Q ss_pred             hcccccccceEEEEEEec--------CCcEEEEEEecCccc--CHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEE
Q 006055          375 AEVLGKGTFGTAYKAVLE--------MGTIVAVKRLKDVTI--SEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLV  443 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  443 (663)
                      .++||+|+||+||+|...        .+..||||+++....  ..+.+.+|+++++.+ +||||+++++++...+..++|
T Consensus        74 ~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  153 (382)
T 3tt0_A           74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI  153 (382)
T ss_dssp             EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEE
Confidence            468999999999999842        346899999976532  236788999999999 999999999999999999999


Q ss_pred             EEccCCCChhHhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceE
Q 006055          444 YDYLTMGSLSALLHGNKGA-----------GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEAR  512 (663)
Q Consensus       444 ~ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~k  512 (663)
                      |||+++|+|.+++......           ....+++..++.++.||+.||.|||+.+  |+||||||+|||++.++.+|
T Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~k  231 (382)
T 3tt0_A          154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMK  231 (382)
T ss_dssp             EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEE
T ss_pred             EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceEEEcCCCcEE
Confidence            9999999999999764321           1245899999999999999999999998  99999999999999999999


Q ss_pred             EeccccccccCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHH
Q 006055          513 VSDFGLAHLVGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQS  585 (663)
Q Consensus       513 l~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  585 (663)
                      |+|||+++......      ...++..|+|||++.+..++.++|||||||++|||++ |..||...      +.......
T Consensus       232 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~------~~~~~~~~  305 (382)
T 3tt0_A          232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------PVEELFKL  305 (382)
T ss_dssp             ECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------CHHHHHHH
T ss_pred             EcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------CHHHHHHH
Confidence            99999998765432      1234567999999999999999999999999999999 99999643      22223322


Q ss_pred             HHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          586 IVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      +...... .          .......++.+++.+||+.||++|||++||+++|+++...
T Consensus       306 ~~~~~~~-~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  353 (382)
T 3tt0_A          306 LKEGHRM-D----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  353 (382)
T ss_dssp             HHTTCCC-C----------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHcCCCC-C----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            2222111 0          1112334688899999999999999999999999987543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.6e-39  Score=332.98  Aligned_cols=247  Identities=28%  Similarity=0.435  Sum_probs=196.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC--H------HHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS--E------REFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~------~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  445 (663)
                      .+.||+|+||+||+|.. .+++.||||++......  .      +.+.+|+++++.++||||+++++++.+.  .++|||
T Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~lv~e  101 (287)
T 4f0f_A           24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVME  101 (287)
T ss_dssp             EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--TEEEEE
T ss_pred             hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--CeEEEE
Confidence            36899999999999995 57999999998654221  1      6789999999999999999999998543  479999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc-----eEEecccccc
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE-----ARVSDFGLAH  520 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~-----~kl~Dfg~a~  520 (663)
                      |+++|+|.+.+....    ..+++..+..++.|++.||.|||+.+++|+||||||+||+++.++.     +||+|||+++
T Consensus       102 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~  177 (287)
T 4f0f_A          102 FVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ  177 (287)
T ss_dssp             CCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCB
T ss_pred             ecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccc
Confidence            999999999886533    3589999999999999999999999766999999999999988776     9999999998


Q ss_pred             ccCCCC-CCCCCccccCccccC--CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          521 LVGPSS-TPNRVAGYRAPEVTD--PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       521 ~~~~~~-~~~~~~~y~aPE~~~--~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                      ...... ...++..|+|||.+.  ...++.++||||||+++|||++|+.||......    ................   
T Consensus       178 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~---  250 (287)
T 4f0f_A          178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG----KIKFINMIREEGLRPT---  250 (287)
T ss_dssp             CCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC----HHHHHHHHHHSCCCCC---
T ss_pred             cccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc----HHHHHHHHhccCCCCC---
Confidence            654432 345778899999984  455788999999999999999999999753321    1222222222211111   


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                             .......++.+++.+||+.||++|||++|+++.|+++
T Consensus       251 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          251 -------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             -------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             -------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                   1122344688899999999999999999999999874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.7e-40  Score=337.94  Aligned_cols=251  Identities=26%  Similarity=0.383  Sum_probs=197.4

Q ss_pred             hcccccccceEEEEEEec-CC-------cEEEEEEecCc-ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLE-MG-------TIVAVKRLKDV-TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g-------~~vavK~l~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  445 (663)
                      .+.||+|+||+||+|... ++       ..||+|.+... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   92 (289)
T 4fvq_A           13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQE   92 (289)
T ss_dssp             EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEE
Confidence            468999999999999844 34       57999998755 3446789999999999999999999999999999999999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc--------eEEeccc
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE--------ARVSDFG  517 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~--------~kl~Dfg  517 (663)
                      |+++|+|.+++....    ..+++..+..++.|++.||.|||+++  |+||||||+||+++.++.        +||+|||
T Consensus        93 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg  166 (289)
T 4fvq_A           93 FVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG  166 (289)
T ss_dssp             CCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred             CCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccceeeeccCc
Confidence            999999999998643    34899999999999999999999998  999999999999998887        9999999


Q ss_pred             cccccCCCCCCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccccccc
Q 006055          518 LAHLVGPSSTPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF  596 (663)
Q Consensus       518 ~a~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  596 (663)
                      ++..........++..|+|||.+.+ ..++.++||||||+++|||++|..|+....     +...............   
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~~~~~~~~~~~~~---  238 (289)
T 4fvq_A          167 ISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-----DSQRKLQFYEDRHQLP---  238 (289)
T ss_dssp             SCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-----CHHHHHHHHHTTCCCC---
T ss_pred             ccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-----chHHHHHHhhccCCCC---
Confidence            9976655444446778999999987 678999999999999999999655543221     1111111111110000   


Q ss_pred             chhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCC
Q 006055          597 DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGH  649 (663)
Q Consensus       597 d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~~~  649 (663)
                                .....++.+++.+||+.||++|||++|++++|+++........
T Consensus       239 ----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~  281 (289)
T 4fvq_A          239 ----------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR  281 (289)
T ss_dssp             ----------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred             ----------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence                      0112357788999999999999999999999999977654433

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=338.93  Aligned_cols=242  Identities=21%  Similarity=0.339  Sum_probs=198.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc-------cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-------ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|.. .+|+.||||.++...       .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   95 (326)
T 2y0a_A           16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL   95 (326)
T ss_dssp             EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEc
Confidence            57899999999999995 468999999986542       1367899999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC----ceEEecccccccc
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY----EARVSDFGLAHLV  522 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~----~~kl~Dfg~a~~~  522 (663)
                      +++|+|.+++...     ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++    .+||+|||+++..
T Consensus        96 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  168 (326)
T 2y0a_A           96 VAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  168 (326)
T ss_dssp             CCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             CCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence            9999999999753     35899999999999999999999998  99999999999999887    7999999999876


Q ss_pred             CCCC---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          523 GPSS---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       523 ~~~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                      ....   ...++..|+|||++.+..++.++|||||||++|||++|+.||....      .......+......   +...
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~~~~~~~~---~~~~  239 (326)
T 2y0a_A          169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT------KQETLANVSAVNYE---FEDE  239 (326)
T ss_dssp             CTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHHHHHHHTCCC---CCHH
T ss_pred             CCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC------HHHHHHHHHhcCCC---cCcc
Confidence            5432   3447788999999998899999999999999999999999996432      22222222221110   0111


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .     .......+.+++.+|+..||++|||++|++++
T Consensus       240 ~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          240 Y-----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             H-----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             c-----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0     01123467788999999999999999999984

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=336.37  Aligned_cols=239  Identities=22%  Similarity=0.326  Sum_probs=189.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---------------------------HHHHHHHHHHhhcCCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---------------------------EREFKDKIEGVGAVNHEN  426 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---------------------------~~~~~~e~~~l~~l~h~n  426 (663)
                      .+.||+|+||.||+|.. .+|+.||||++......                           .+.+.+|+++++.++|||
T Consensus        18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   97 (298)
T 2zv2_A           18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN   97 (298)
T ss_dssp             EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTT
T ss_pred             EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCC
Confidence            46899999999999995 56899999998654211                           245889999999999999


Q ss_pred             cccceEEEEe--cCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEE
Q 006055          427 LVPLRAYYYS--MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNIL  504 (663)
Q Consensus       427 iv~l~~~~~~--~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nil  504 (663)
                      |+++++++.+  ....++||||+++|+|.+++..      ..+++..+..++.|++.||.|||+.+  |+||||||+||+
T Consensus        98 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil  169 (298)
T 2zv2_A           98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLL  169 (298)
T ss_dssp             BCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEE
T ss_pred             CCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEE
Confidence            9999999987  4578999999999999887643      35899999999999999999999998  999999999999


Q ss_pred             EcCCCceEEeccccccccCCCC----CCCCCccccCccccCCCC---CCCcchhhhHHHHHHHHHhCCCCCccccCCCCC
Q 006055          505 LTKSYEARVSDFGLAHLVGPSS----TPNRVAGYRAPEVTDPCK---VSQKADVYSFGVLLLELLTGKAPTHALLNEEGV  577 (663)
Q Consensus       505 l~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~y~aPE~~~~~~---~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~  577 (663)
                      ++.++.+||+|||+++......    ...++..|+|||.+.+..   ++.++|||||||++|||++|+.||...      
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~------  243 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE------  243 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS------
T ss_pred             ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc------
Confidence            9999999999999998765432    345778899999997765   367899999999999999999999642      


Q ss_pred             ChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          578 DLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       578 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      +.......+..... .         .+.......++.+++.+|+..||++|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~-~---------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          244 RIMCLHSKIKSQAL-E---------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SHHHHHHHHHHCCC-C---------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             cHHHHHHHHhcccC-C---------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            22222222222111 0         01111223467888999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.6e-39  Score=337.05  Aligned_cols=253  Identities=25%  Similarity=0.327  Sum_probs=195.4

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||+||+|...+|+.||||++......   ...+.+|+++++.++||||+++++++.+....++||||+++ +
T Consensus        26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~  104 (311)
T 3niz_A           26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-D  104 (311)
T ss_dssp             EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-E
T ss_pred             hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-C
Confidence            3689999999999999888999999998754322   36788999999999999999999999999999999999985 8


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----C
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----T  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~  527 (663)
                      |.+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++......    .
T Consensus       105 l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  178 (311)
T 3niz_A          105 LKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH  178 (311)
T ss_dssp             HHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---C
T ss_pred             HHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCCcccccC
Confidence            888886533    35899999999999999999999998  9999999999999999999999999998765332    2


Q ss_pred             CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccch---hhh--
Q 006055          528 PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL---ELL--  601 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~---~~~--  601 (663)
                      ..++..|+|||++.+ ..++.++|||||||++|||++|+.||......+   ....+...........+...   ...  
T Consensus       179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~  255 (311)
T 3niz_A          179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---QLPKIFSILGTPNPREWPQVQELPLWKQ  255 (311)
T ss_dssp             CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---HHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred             CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHHCCCChHHhhhhhccchhhh
Confidence            346778999999876 568999999999999999999999997643322   22222222211111110000   000  


Q ss_pred             ------cccC----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          602 ------RYQN----VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       602 ------~~~~----~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                            ....    ......++.+++.+|+..||++|||++|++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                  0000    01123467889999999999999999999983

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=8.7e-40  Score=336.62  Aligned_cols=262  Identities=15%  Similarity=0.155  Sum_probs=207.0

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||.||+|.. .+|+.||||++.... ....+.+|+.++..+ +|+|++++++++.+....++||||+ +++|
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L   92 (298)
T 1csn_A           15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL   92 (298)
T ss_dssp             EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCH
Confidence            36799999999999994 679999999986543 234578899999999 7999999999999999999999999 9999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc-----eEEeccccccccCCCC-
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE-----ARVSDFGLAHLVGPSS-  526 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~-----~kl~Dfg~a~~~~~~~-  526 (663)
                      .+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.     +||+|||+++...... 
T Consensus        93 ~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~  166 (298)
T 1csn_A           93 EDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT  166 (298)
T ss_dssp             HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred             HHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence            99998543    34899999999999999999999998  999999999999987776     9999999998764432 


Q ss_pred             ----------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccccccc
Q 006055          527 ----------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF  596 (663)
Q Consensus       527 ----------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  596 (663)
                                ...++..|+|||.+.+..++.++||||||+++|||++|+.||.......   .......+........  
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~--  241 (298)
T 1csn_A          167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT---NKQKYERIGEKKQSTP--  241 (298)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC---HHHHHHHHHHHHHHSC--
T ss_pred             cccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc---cHHHHHHHHhhccCcc--
Confidence                      2346778999999999999999999999999999999999997643221   1222222211110000  


Q ss_pred             chhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCCCCCC
Q 006055          597 DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQP  654 (663)
Q Consensus       597 d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~  654 (663)
                      ....     ....+.++.+++.+||+.||++||++++|++.|+++............+
T Consensus       242 ~~~~-----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~d  294 (298)
T 1csn_A          242 LREL-----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD  294 (298)
T ss_dssp             HHHH-----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCG
T ss_pred             HHHH-----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccc
Confidence            0000     0122457888999999999999999999999999987665544444433

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.1e-40  Score=342.32  Aligned_cols=245  Identities=24%  Similarity=0.361  Sum_probs=181.4

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCC-CCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      +.||+|+||+||+|.. .+|+.||||++...  ....+.+|+.++..++ ||||+++++++.+....++||||+++|+|.
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~   94 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF   94 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence            6799999999999995 46899999998653  3567889999999997 999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC---ceEEeccccccccCCCC----
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY---EARVSDFGLAHLVGPSS----  526 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~---~~kl~Dfg~a~~~~~~~----  526 (663)
                      +++....     .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++   .+||+|||+++......    
T Consensus        95 ~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  167 (325)
T 3kn6_A           95 ERIKKKK-----HFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK  167 (325)
T ss_dssp             HHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccc
Confidence            9998643     5899999999999999999999998  99999999999998766   79999999998765432    


Q ss_pred             CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCC-CChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEG-VDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||........ .........+......   +..     ..
T Consensus       168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~---~~~-----~~  239 (325)
T 3kn6_A          168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS---FEG-----EA  239 (325)
T ss_dssp             ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC---CCS-----HH
T ss_pred             ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC---CCc-----cc
Confidence            23457789999999999999999999999999999999999976433211 2223333333222111   000     00


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ......++.+++.+|+..||++|||++|++++
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            11234567889999999999999999999873

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-39  Score=336.84  Aligned_cols=238  Identities=23%  Similarity=0.315  Sum_probs=199.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|.. .+|+.||+|.++...    .....+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus        11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~g   90 (318)
T 1fot_A           11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG   90 (318)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCC
Confidence            46899999999999995 479999999987542    3356788999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-CC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-TP  528 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~  528 (663)
                      |+|.+++....     .+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++...... ..
T Consensus        91 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~~  163 (318)
T 1fot_A           91 GELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL  163 (318)
T ss_dssp             CBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCC
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCCccccc
Confidence            99999997533     4899999999999999999999998  9999999999999999999999999998765432 34


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .+++.|+|||++.+..++.++|||||||++|||++|+.||...      +.......+......            .+..
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~------~~~~~~~~i~~~~~~------------~p~~  225 (318)
T 1fot_A          164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS------NTMKTYEKILNAELR------------FPPF  225 (318)
T ss_dssp             CSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHCCCC------------CCTT
T ss_pred             cCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCC------------CCCC
Confidence            5788899999999999999999999999999999999999642      223333333332210            0111


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                      ...++.+++.+|+..||++||     +++|+++|
T Consensus       226 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          226 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            234677888899999999999     89999865

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=6.3e-40  Score=342.65  Aligned_cols=245  Identities=23%  Similarity=0.405  Sum_probs=194.5

Q ss_pred             hcccccccceEEEEEEe-cCCc----EEEEEEecCc--ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGT----IVAVKRLKDV--TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~----~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .++||+|+||+||+|.. .+++    +||+|.+...  ....+.+.+|+.++++++||||++++++|.+. ..++|+||+
T Consensus        20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~~   98 (327)
T 3poz_A           20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM   98 (327)
T ss_dssp             EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEECC
T ss_pred             ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEec
Confidence            46899999999999994 3444    3688887643  23467899999999999999999999999865 478999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST  527 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  527 (663)
                      ++|+|.+++....    ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++.......
T Consensus        99 ~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  172 (327)
T 3poz_A           99 PFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             TTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred             CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence            9999999997643    35899999999999999999999998  99999999999999999999999999987654322


Q ss_pred             ------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          528 ------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       528 ------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                            ..++.+|+|||++.+..++.++|||||||++|||++ |+.||......+   +    ...+.....        
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~----~~~~~~~~~--------  237 (327)
T 3poz_A          173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGER--------  237 (327)
T ss_dssp             -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H----HHHHHTTCC--------
T ss_pred             cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---H----HHHHHcCCC--------
Confidence                  223557999999999999999999999999999999 999997543211   1    111111110        


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                        .........++.+++.+||+.||++||++.|++++|+.+..
T Consensus       238 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          238 --LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             --CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             --CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence              01112234468889999999999999999999999988754

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4e-40  Score=348.67  Aligned_cols=251  Identities=24%  Similarity=0.374  Sum_probs=200.2

Q ss_pred             hcccccccceEEEEEEe------cCCcEEEEEEecCccc--CHHHHHHHHHHhhcC-CCCCcccceEEEEecCc-cEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAV-NHENLVPLRAYYYSMDE-KLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~-~~lv~  444 (663)
                      .+.||+|+||.||+|.+      .+++.||||+++....  ..+.+.+|++++.++ +||||+++++++.+... .++||
T Consensus        27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~  106 (359)
T 3vhe_A           27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV  106 (359)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred             ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence            46899999999999973      3468999999976432  235689999999999 78999999999987655 89999


Q ss_pred             EccCCCChhHhhccCCCC-------------------------------------------------------------C
Q 006055          445 DYLTMGSLSALLHGNKGA-------------------------------------------------------------G  463 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~-------------------------------------------------------------~  463 (663)
                      ||+++|+|.++++.....                                                             .
T Consensus       107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (359)
T 3vhe_A          107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY  186 (359)
T ss_dssp             ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred             EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence            999999999999764321                                                             0


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC------CCCCccccCc
Q 006055          464 RTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST------PNRVAGYRAP  537 (663)
Q Consensus       464 ~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~y~aP  537 (663)
                      ...+++..+..++.|++.||.|||+++  |+||||||+|||++.++.+||+|||+++.......      ..++..|+||
T Consensus       187 ~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP  264 (359)
T 3vhe_A          187 KDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  264 (359)
T ss_dssp             TTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCH
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeECh
Confidence            122899999999999999999999998  99999999999999999999999999986643321      2346679999


Q ss_pred             cccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHH
Q 006055          538 EVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQL  616 (663)
Q Consensus       538 E~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l  616 (663)
                      |++.+..++.++|||||||++|||++ |+.||......      ..+...+.......          .+.....++.++
T Consensus       265 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~~~~~~~~~~----------~~~~~~~~l~~l  328 (359)
T 3vhe_A          265 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEGTRMR----------APDYTTPEMYQT  328 (359)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS------HHHHHHHHHTCCCC----------CCTTCCHHHHHH
T ss_pred             hhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh------HHHHHHHHcCCCCC----------CCCCCCHHHHHH
Confidence            99988889999999999999999998 99999653221      12222222211111          111123467888


Q ss_pred             HHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          617 AIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       617 ~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      +.+|++.||++|||++|++++|+++.+
T Consensus       329 i~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          329 MLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            999999999999999999999998754

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=346.75  Aligned_cols=242  Identities=26%  Similarity=0.336  Sum_probs=195.1

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      ++||+|+||.||+|.. .+|+.||+|+++... ...+.+.+|+++++.++||||+++++++.+.+..++||||+++|+|.
T Consensus        95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~  174 (373)
T 2x4f_A           95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF  174 (373)
T ss_dssp             EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred             eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence            5799999999999995 579999999997653 34567999999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEE--cCCCceEEeccccccccCCCC---CC
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL--TKSYEARVSDFGLAHLVGPSS---TP  528 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill--~~~~~~kl~Dfg~a~~~~~~~---~~  528 (663)
                      +++....    ..+++..+..++.||+.||.|||+.+  |+||||||+|||+  ++++.+||+|||+++......   ..
T Consensus       175 ~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~  248 (373)
T 2x4f_A          175 DRIIDES----YNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN  248 (373)
T ss_dssp             HHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCC
T ss_pred             HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccc
Confidence            9886532    35899999999999999999999998  9999999999999  567889999999998776543   23


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .++.+|+|||++.+..++.++|||||||++|||++|+.||...      +....+..+....+...  .      .....
T Consensus       249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~------~~~~~~~~i~~~~~~~~--~------~~~~~  314 (373)
T 2x4f_A          249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD------NDAETLNNILACRWDLE--D------EEFQD  314 (373)
T ss_dssp             CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHTCCCSC--S------GGGTT
T ss_pred             cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhccCCCC--h------hhhcc
Confidence            4778899999999888999999999999999999999999653      22333444443322110  0      00112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...++.+++.+|+..||++|||++|++++
T Consensus       315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          315 ISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            23467888899999999999999999984

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-39  Score=335.02  Aligned_cols=250  Identities=27%  Similarity=0.419  Sum_probs=194.8

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|+||+||+|... ++.||||.+... ...+.+.+|++++++++||||+++++++.  +..++||||+++|+|.+
T Consensus        13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~   88 (307)
T 2eva_A           13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYN   88 (307)
T ss_dssp             EEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHH
T ss_pred             eeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHH
Confidence            468999999999999986 889999998653 33567899999999999999999999875  45899999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCcceecCCCCCCEEEcCCCc-eEEeccccccccCCC-CCCC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA---QGPNVSHGNIKSSNILLTKSYE-ARVSDFGLAHLVGPS-STPN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~---~~~~iiHrdlk~~Nill~~~~~-~kl~Dfg~a~~~~~~-~~~~  529 (663)
                      +++....  ...+++..++.++.|+++||.|||+   ++  |+||||||+||+++.++. +||+|||++...... ....
T Consensus        89 ~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~  164 (307)
T 2eva_A           89 VLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK  164 (307)
T ss_dssp             HHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred             HHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcccccccccccccccCC
Confidence            9985431  2247889999999999999999999   55  999999999999998886 799999999766543 2345


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE  609 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  609 (663)
                      ++..|+|||++.+..++.++||||||+++|||++|+.||.....    .............. .          ......
T Consensus       165 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~~~-~----------~~~~~~  229 (307)
T 2eva_A          165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG----PAFRIMWAVHNGTR-P----------PLIKNL  229 (307)
T ss_dssp             CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS----SHHHHHHHHHTTCC-C----------CCBTTC
T ss_pred             CCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc----cHHHHHHHHhcCCC-C----------Cccccc
Confidence            78889999999999999999999999999999999999975322    11111111111111 0          011122


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 006055          610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ  647 (663)
Q Consensus       610 ~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~  647 (663)
                      ...+.+++.+|++.||++|||++|++++|+.+......
T Consensus       230 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence            34678889999999999999999999999988665543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.8e-39  Score=344.45  Aligned_cols=261  Identities=16%  Similarity=0.183  Sum_probs=197.1

Q ss_pred             hcccccccceEEEEEEecC------CcEEEEEEecCcccC------------HHHHHHHHHHhhcCCCCCcccceEEEEe
Q 006055          375 AEVLGKGTFGTAYKAVLEM------GTIVAVKRLKDVTIS------------EREFKDKIEGVGAVNHENLVPLRAYYYS  436 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~------------~~~~~~e~~~l~~l~h~niv~l~~~~~~  436 (663)
                      .+.||+|+||.||+|....      ++.||||++......            ...+..|+..+..++||||+++++++..
T Consensus        40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~  119 (364)
T 3op5_A           40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLH  119 (364)
T ss_dssp             EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEE
T ss_pred             EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeee
Confidence            4689999999999998654      478999998654211            1223455666778899999999999876


Q ss_pred             c----CccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc--CCCc
Q 006055          437 M----DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT--KSYE  510 (663)
Q Consensus       437 ~----~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~--~~~~  510 (663)
                      .    ...++||||+ +++|.+++....    ..+++..+..++.||+.||.|||+.+  |+||||||+|||++  .++.
T Consensus       120 ~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~~~~~  192 (364)
T 3op5_A          120 DKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQ  192 (364)
T ss_dssp             EETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESSCTTC
T ss_pred             ccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecCCCCe
Confidence            5    3479999999 999999997642    35899999999999999999999998  99999999999999  8899


Q ss_pred             eEEeccccccccCCCC-----------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCCh
Q 006055          511 ARVSDFGLAHLVGPSS-----------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDL  579 (663)
Q Consensus       511 ~kl~Dfg~a~~~~~~~-----------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~  579 (663)
                      +||+|||+++......           ...++..|+|||++.+..++.++|||||||++|||++|+.||.......  ..
T Consensus       193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~--~~  270 (364)
T 3op5_A          193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP--KY  270 (364)
T ss_dssp             EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH--HH
T ss_pred             EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH--HH
Confidence            9999999997654321           1237778999999999999999999999999999999999998533211  11


Q ss_pred             HHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCC
Q 006055          580 PRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGH  649 (663)
Q Consensus       580 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~~~  649 (663)
                      .......... .....++..+.    ....+.++.+++..||..+|++||+++++++.|+++........
T Consensus       271 ~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~  335 (364)
T 3op5_A          271 VRDSKIRYRE-NIASLMDKCFP----AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD  335 (364)
T ss_dssp             HHHHHHHHHH-CHHHHHHHHSC----TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHhhh-hHHHHHHHhcc----cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence            1111111111 11111111110    01224578889999999999999999999999998765544333

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.7e-40  Score=343.65  Aligned_cols=241  Identities=23%  Similarity=0.286  Sum_probs=193.5

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||+||+|... +++.||||++....  ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+
T Consensus        12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~   91 (323)
T 3tki_A           12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE   91 (323)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred             eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCc
Confidence            468999999999999954 79999999986542  224678899999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC------
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS------  525 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~------  525 (663)
                      |.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++.....      
T Consensus        92 L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  164 (323)
T 3tki_A           92 LFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (323)
T ss_dssp             GGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence            999997532     4899999999999999999999998  999999999999999999999999999765322      


Q ss_pred             CCCCCCccccCccccCCCCC-CCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          526 STPNRVAGYRAPEVTDPCKV-SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       526 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                      ....++..|+|||++.+..+ +.++|||||||++|||++|+.||.......     ............   .       .
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~---~-------~  229 (323)
T 3tki_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----QEYSDWKEKKTY---L-------N  229 (323)
T ss_dssp             CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-----HHHHHHHTTCTT---S-------T
T ss_pred             CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-----HHHHHHhccccc---C-------C
Confidence            23457788999999977665 778999999999999999999997543211     111111111100   0       0


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .......++.+++.+|+..||++|||++|++++
T Consensus       230 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          230 PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            111223467788999999999999999999885

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.1e-39  Score=363.14  Aligned_cols=249  Identities=27%  Similarity=0.418  Sum_probs=206.8

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .++||+|+||.||+|.+.++..||||+++......+.|.+|+++++.++|+||+++++++.+ +..++||||+++|+|.+
T Consensus       272 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~  350 (535)
T 2h8h_A          272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD  350 (535)
T ss_dssp             EEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHH
T ss_pred             heecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHH
Confidence            46899999999999999888899999998776677889999999999999999999999866 67899999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC-----CCCC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-----STPN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~-----~~~~  529 (663)
                      +++...   ...+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.....     ....
T Consensus       351 ~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~  425 (535)
T 2h8h_A          351 FLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK  425 (535)
T ss_dssp             HHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTT
T ss_pred             HHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCc
Confidence            997432   134899999999999999999999998  999999999999999999999999999876532     1233


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      ++..|+|||.+.+..++.++|||||||++|||++ |+.||....      ....+..+... ..          ......
T Consensus       426 ~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~------~~~~~~~i~~~-~~----------~~~~~~  488 (535)
T 2h8h_A          426 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------NREVLDQVERG-YR----------MPCPPE  488 (535)
T ss_dssp             SCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC------HHHHHHHHHTT-CC----------CCCCTT
T ss_pred             CcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcC-CC----------CCCCCC
Confidence            4567999999988889999999999999999999 999996532      22222222221 10          011122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST  646 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~  646 (663)
                      ...++.+++.+||+.||++|||+++|++.|+++.....
T Consensus       489 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          489 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence            34568889999999999999999999999999876543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.1e-39  Score=345.22  Aligned_cols=244  Identities=21%  Similarity=0.278  Sum_probs=191.8

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .+.||+|+||+||++... +++.||||++.......+.+.+|+.+++.++||||+++++++.+....++||||+++|+|.
T Consensus        25 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~  104 (361)
T 3uc3_A           25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELY  104 (361)
T ss_dssp             EEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHH
T ss_pred             EEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHH
Confidence            468999999999999954 7999999999876655678899999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc--eEEeccccccccCCC---CCC
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE--ARVSDFGLAHLVGPS---STP  528 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~--~kl~Dfg~a~~~~~~---~~~  528 (663)
                      +++....     .+++..+..++.|++.||.|||+++  |+||||||+||+++.++.  +||+|||+++.....   ...
T Consensus       105 ~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  177 (361)
T 3uc3_A          105 ERICNAG-----RFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST  177 (361)
T ss_dssp             HHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC------------
T ss_pred             HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCC
Confidence            9987532     4899999999999999999999998  999999999999987775  999999999754332   234


Q ss_pred             CCCccccCccccCCCCCCCc-chhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          529 NRVAGYRAPEVTDPCKVSQK-ADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~-~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      .++..|+|||++.+..+..+ +|||||||++|||++|+.||......  ......+..+.......          +...
T Consensus       178 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~~~~~~~~~~----------~~~~  245 (361)
T 3uc3_A          178 VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP--RDYRKTIQRILSVKYSI----------PDDI  245 (361)
T ss_dssp             ---CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C--CCHHHHHHHHHTTCCCC----------CTTS
T ss_pred             cCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhcCCCCC----------CCcC
Confidence            57888999999988777655 89999999999999999999754322  22333333333221100          0000


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....++.+++.+|+..||++|||++|+++|
T Consensus       246 ~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          246 RISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            123467788899999999999999999987

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2e-39  Score=345.96  Aligned_cols=245  Identities=18%  Similarity=0.299  Sum_probs=194.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC----HHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS----EREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .++||+|+||+||+|+. .+++.||||+++.....    ...+..|..++..+ +||||+++++++.+.+..++||||++
T Consensus        57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~  136 (396)
T 4dc2_A           57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN  136 (396)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC
Confidence            46899999999999995 46889999999765322    23477888888776 89999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC---
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS---  525 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~---  525 (663)
                      +|+|.+++....     .+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++.....   
T Consensus       137 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~  209 (396)
T 4dc2_A          137 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  209 (396)
T ss_dssp             TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeecccCCCc
Confidence            999999997533     4899999999999999999999998  999999999999999999999999999863222   


Q ss_pred             -CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCC--CChHHHHHHHHhhcccccccchhhhc
Q 006055          526 -STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEG--VDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       526 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                       ....+|+.|+|||++.+..++.++|||||||++|||++|+.||......+.  ......+...+.....          
T Consensus       210 ~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------  279 (396)
T 4dc2_A          210 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------  279 (396)
T ss_dssp             BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC----------
T ss_pred             cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc----------
Confidence             234578889999999999999999999999999999999999975432211  1112222222221111          


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSM------SEVIKR  637 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~------~ev~~~  637 (663)
                       ..+.....++.+++.+|+..||++||++      +|+++|
T Consensus       280 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          280 -RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             -CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence             0111223467788899999999999995      566663

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.4e-39  Score=341.54  Aligned_cols=242  Identities=25%  Similarity=0.305  Sum_probs=198.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||.||+|.. .+|+.||+|++......   ...+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg  113 (362)
T 2bdw_A           34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG  113 (362)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence            57899999999999995 46899999999765433   356889999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC---ceEEeccccccccCCCCC
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY---EARVSDFGLAHLVGPSST  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~---~~kl~Dfg~a~~~~~~~~  527 (663)
                      +|.+++...     ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.++   .+||+|||++........
T Consensus       114 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~  186 (362)
T 2bdw_A          114 ELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  186 (362)
T ss_dssp             BHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred             CHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence            999998753     25899999999999999999999998  99999999999998654   599999999987764432


Q ss_pred             ---CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          528 ---PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       528 ---~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                         ..+++.|+|||++.+..++.++|||||||++|||++|+.||...      +.......+........     ...  
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~------~~~~~~~~i~~~~~~~~-----~~~--  253 (362)
T 2bdw_A          187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE------DQHRLYAQIKAGAYDYP-----SPE--  253 (362)
T ss_dssp             CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCCCC-----TTG--
T ss_pred             cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhCCCCCC-----ccc--
Confidence               35778899999999989999999999999999999999999642      22233333332221100     000  


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                       ......++.+++.+|+..||++|||+.|++++
T Consensus       254 -~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          254 -WDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             11223467788899999999999999999876

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.3e-39  Score=337.40  Aligned_cols=240  Identities=20%  Similarity=0.328  Sum_probs=191.9

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCc------------
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDE------------  439 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------------  439 (663)
                      .+.||+|+||.||+|... +|+.||||+++...  ...+.+.+|++++++++||||++++++|.+...            
T Consensus        11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~   90 (332)
T 3qd2_B           11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL   90 (332)
T ss_dssp             EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred             eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence            468999999999999965 79999999987542  335779999999999999999999999866542            


Q ss_pred             ---------------------------------------------cEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHH
Q 006055          440 ---------------------------------------------KLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSL  474 (663)
Q Consensus       440 ---------------------------------------------~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~  474 (663)
                                                                   .++||||+++|+|.+++.....  ....++..++.
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~  168 (332)
T 3qd2_B           91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDREHGVCLH  168 (332)
T ss_dssp             -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSCHHHHHH
T ss_pred             ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchhhHHHHH
Confidence                                                         7899999999999999986442  33467888999


Q ss_pred             HHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----------------CCCCCccccCcc
Q 006055          475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----------------TPNRVAGYRAPE  538 (663)
Q Consensus       475 i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----------------~~~~~~~y~aPE  538 (663)
                      ++.||+.||.|||+++  |+||||||+||+++.++.+||+|||+++......                ...++..|+|||
T Consensus       169 i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  246 (332)
T 3qd2_B          169 IFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE  246 (332)
T ss_dssp             HHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHH
T ss_pred             HHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChH
Confidence            9999999999999998  9999999999999999999999999998765431                124677899999


Q ss_pred             ccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHH
Q 006055          539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAI  618 (663)
Q Consensus       539 ~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~  618 (663)
                      ++.+..++.++|||||||++|||++|..|+....        ....... ...    .      .........++.+++.
T Consensus       247 ~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--------~~~~~~~-~~~----~------~~~~~~~~~~~~~li~  307 (332)
T 3qd2_B          247 QIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--------RIITDVR-NLK----F------PLLFTQKYPQEHMMVQ  307 (332)
T ss_dssp             HHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--------HHHHHHH-TTC----C------CHHHHHHCHHHHHHHH
T ss_pred             HhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--------HHHHHhh-ccC----C------CcccccCChhHHHHHH
Confidence            9999899999999999999999999987753210        1111111 110    0      0112233456788999


Q ss_pred             HccCCCCCCCCCHHHHHHH
Q 006055          619 DCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       619 ~C~~~dP~~RPt~~ev~~~  637 (663)
                      +|++.||++|||++|++++
T Consensus       308 ~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          308 DMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHCSSGGGSCCHHHHHHS
T ss_pred             HHccCCCCcCCCHHHHhhc
Confidence            9999999999999999973

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4e-39  Score=349.27  Aligned_cols=242  Identities=24%  Similarity=0.294  Sum_probs=196.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||+||+|.. .+|+.||+|.+......   .+.+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus        16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg   95 (444)
T 3soa_A           16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG   95 (444)
T ss_dssp             EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCC
T ss_pred             EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCC
Confidence            47899999999999984 57999999998765432   356889999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc---CCCceEEeccccccccCCCC-
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT---KSYEARVSDFGLAHLVGPSS-  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~---~~~~~kl~Dfg~a~~~~~~~-  526 (663)
                      +|.+.+....     .+++..+..++.||+.||.|||+++  |+||||||+|||++   +++.+||+|||+++...... 
T Consensus        96 ~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           96 ELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             BHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            9999987543     4899999999999999999999998  99999999999998   46789999999998765432 


Q ss_pred             ---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          527 ---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       527 ---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                         ...++++|+|||++.+..++.++||||+||++|+|++|+.||...      +.......+.......     ....+
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~------~~~~~~~~i~~~~~~~-----~~~~~  237 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE------DQHRLYQQIKAGAYDF-----PSPEW  237 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHTCCCC-----CTTTT
T ss_pred             eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc------cHHHHHHHHHhCCCCC-----Ccccc
Confidence               235788899999999989999999999999999999999999642      2223333333222110     00001


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                         .....++.+++.+|+..||++|||+.|++++
T Consensus       238 ---~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          238 ---DTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             ---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence               1223467788889999999999999999984

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.8e-39  Score=342.42  Aligned_cols=245  Identities=21%  Similarity=0.312  Sum_probs=197.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc------ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV------TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||+|+||+||+|.. .+|+.||||++...      ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        29 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  108 (351)
T 3c0i_A           29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM  108 (351)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCC
Confidence            57899999999999985 57999999998532      224678999999999999999999999999999999999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc---eEEeccccccccCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLAHLVGP  524 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~---~kl~Dfg~a~~~~~  524 (663)
                      ++|+|.+.+..... ....+++..+..++.||+.||.|||+++  |+||||||+|||++.++.   +||+|||+++....
T Consensus       109 ~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~  185 (351)
T 3c0i_A          109 DGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE  185 (351)
T ss_dssp             SSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCT
T ss_pred             CCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcceeEecC
Confidence            99999887754221 1235899999999999999999999998  999999999999987655   99999999987755


Q ss_pred             CC----CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          525 SS----TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       525 ~~----~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                      ..    ...++..|+|||++.+..++.++|||||||++|||++|+.||....       ......+......   ..+..
T Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~i~~~~~~---~~~~~  255 (351)
T 3c0i_A          186 SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-------ERLFEGIIKGKYK---MNPRQ  255 (351)
T ss_dssp             TSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-------HHHHHHHHHTCCC---CCHHH
T ss_pred             CCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-------HHHHHHHHcCCCC---CCccc
Confidence            32    2347888999999999889999999999999999999999996521       1222222222111   11110


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                        .   .....++.+++.+|+..||++|||+.|++++
T Consensus       256 --~---~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          256 --W---SHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             --H---TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --c---ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              0   1123467888999999999999999999874

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-39  Score=344.65  Aligned_cols=255  Identities=25%  Similarity=0.372  Sum_probs=194.2

Q ss_pred             hcccccccceEEEEEEec--CC--cEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEe-cCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVLE--MG--TIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYS-MDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~--~g--~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ey~  447 (663)
                      .++||+|+||+||+|...  ++  ..||||.++....  ..+.+.+|+.++++++||||+++++++.. .+..++||||+
T Consensus        94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~  173 (373)
T 3c1x_A           94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  173 (373)
T ss_dssp             EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred             CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence            368999999999999853  22  4689999875432  34678999999999999999999999765 45789999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-  526 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-  526 (663)
                      ++|+|.++++...    ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++...... 
T Consensus       174 ~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          174 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             CCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccccccc
Confidence            9999999997543    34789999999999999999999998  9999999999999999999999999998654321 


Q ss_pred             -------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          527 -------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       527 -------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                             ...++..|+|||.+.+..++.++|||||||++|||++ |..||......   +...   .+......      
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~---~~~~~~~~------  315 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITV---YLLQGRRL------  315 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHH---HHHTTCCC------
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHH---HHHcCCCC------
Confidence                   1224557999999998889999999999999999999 66777543221   1211   11111110      


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCCCC
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGL  652 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~  652 (663)
                           ..+......+.+++.+||..||++|||++|++++|+++...........
T Consensus       316 -----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~~~  364 (373)
T 3c1x_A          316 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH  364 (373)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBCC
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccceee
Confidence                 0111233468889999999999999999999999999977665544333

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=340.38  Aligned_cols=265  Identities=23%  Similarity=0.310  Sum_probs=193.2

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEec-----CccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM-----DEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|.. +++.||||++............|+..+..++||||+++++++...     ...++||||+++
T Consensus        18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~   96 (336)
T 3g2f_A           18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPN   96 (336)
T ss_dssp             EEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTT
T ss_pred             eeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCC
Confidence            46899999999999987 589999999875433222333444445668999999999876432     245899999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc---------CCcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ---------GPNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~---------~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                      |+|.+++....      .++..+..++.||+.||.|||+.         +  |+||||||+|||++.++.+||+|||+++
T Consensus        97 g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~kL~DFG~a~  168 (336)
T 3g2f_A           97 GSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKNDGTCVISDFGLSM  168 (336)
T ss_dssp             CBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCCCcEEEeecccee
Confidence            99999997543      58999999999999999999998         6  9999999999999999999999999997


Q ss_pred             ccCCCC------------CCCCCccccCccccCC-------CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCC---
Q 006055          521 LVGPSS------------TPNRVAGYRAPEVTDP-------CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVD---  578 (663)
Q Consensus       521 ~~~~~~------------~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~---  578 (663)
                      ......            ...++..|+|||++.+       ..++.++|||||||++|||++|..||..........   
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~  248 (336)
T 3g2f_A          169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF  248 (336)
T ss_dssp             ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTT
T ss_pred             ecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhh
Confidence            654321            2246778999999987       345678999999999999999988765432211110   


Q ss_pred             --------hHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCC
Q 006055          579 --------LPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHH  650 (663)
Q Consensus       579 --------~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~~~~  650 (663)
                              .................+..   ..........++.+++.+||+.||++|||++|+++.|+++...-.+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~  325 (336)
T 3g2f_A          249 QTEVGNHPTFEDMQVLVSREKQRPKFPE---AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKS  325 (336)
T ss_dssp             HHHHCSSCCHHHHHHHHTTSCCCCCCCT---TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC---
T ss_pred             hcccCCCchHHHHHhhhcccccCCCCCc---ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhccc
Confidence                    00111111111110000000   1112234566799999999999999999999999999998655444433


Q ss_pred             C
Q 006055          651 G  651 (663)
Q Consensus       651 ~  651 (663)
                      .
T Consensus       326 ~  326 (336)
T 3g2f_A          326 V  326 (336)
T ss_dssp             -
T ss_pred             C
Confidence            3

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7.8e-40  Score=344.82  Aligned_cols=238  Identities=23%  Similarity=0.308  Sum_probs=194.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc----ccCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV----TISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .++||+|+||+||+|.. .+|+.||||+++..    ......+.+|..++..+ +||||+++++++.+.+..++||||++
T Consensus        28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~  107 (353)
T 3txo_A           28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN  107 (353)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence            46899999999999995 46899999999753    22346678899999988 79999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC---
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS---  525 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~---  525 (663)
                      +|+|.++++...     .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.....   
T Consensus       108 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~  180 (353)
T 3txo_A          108 GGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT  180 (353)
T ss_dssp             SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeecccCCcc
Confidence            999999997533     4899999999999999999999998  999999999999999999999999999864332   


Q ss_pred             -CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          526 -STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       526 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                       ....+|+.|+|||++.+..++.++|||||||++|||++|+.||...      +.......+......            
T Consensus       181 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~------~~~~~~~~i~~~~~~------------  242 (353)
T 3txo_A          181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE------NEDDLFEAILNDEVV------------  242 (353)
T ss_dssp             -----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC------------
T ss_pred             ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC------CHHHHHHHHHcCCCC------------
Confidence             2234788899999998888999999999999999999999999653      223334444332211            


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSM------SEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~------~ev~~~  637 (663)
                      .+.....++.+++.+|+..||++||++      +|+++|
T Consensus       243 ~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          243 YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            011123457788889999999999998      777764

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.2e-39  Score=330.49  Aligned_cols=247  Identities=26%  Similarity=0.420  Sum_probs=203.8

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|+||.||+|...++..||||.++......+.+.+|+++++.++||||+++++++. .+..++||||+++++|.+
T Consensus        18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~   96 (279)
T 1qpc_A           18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVD   96 (279)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHH
T ss_pred             eeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHH
Confidence            4689999999999999888889999999877667888999999999999999999999876 456899999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-----CCC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----TPN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-----~~~  529 (663)
                      ++....   ...+++..+..++.|++.||.|||+.+  |+||||||+||++++++.+||+|||++.......     ...
T Consensus        97 ~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  171 (279)
T 1qpc_A           97 FLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK  171 (279)
T ss_dssp             HTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCC
T ss_pred             HHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCC
Confidence            997432   124899999999999999999999998  9999999999999999999999999998765432     123


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      ++..|+|||.+.+..++.++||||||+++|||++ |+.||....      .......+..... .          .....
T Consensus       172 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~~~~~~~~~~~~~-~----------~~~~~  234 (279)
T 1qpc_A          172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT------NPEVIQNLERGYR-M----------VRPDN  234 (279)
T ss_dssp             CCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHHHTTCC-C----------CCCTT
T ss_pred             CccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC------HHHHHHHHhcccC-C----------CCccc
Confidence            4567999999988888999999999999999999 999986432      2222222222110 0          01112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      ...++.+++.+|+..||++|||++++++.|+++...
T Consensus       235 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence            234688899999999999999999999999988544

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.6e-39  Score=338.81  Aligned_cols=252  Identities=23%  Similarity=0.353  Sum_probs=190.4

Q ss_pred             hcccccccceEEEEEEecC-Cc---EEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecCcc------E
Q 006055          375 AEVLGKGTFGTAYKAVLEM-GT---IVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEK------L  441 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~-g~---~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~------~  441 (663)
                      .+.||+|+||.||+|.... +.   .||||.++...   ...+.+.+|+++++.++||||+++++++......      +
T Consensus        28 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~  107 (323)
T 3qup_A           28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPM  107 (323)
T ss_dssp             EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEE
T ss_pred             eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccE
Confidence            4689999999999999543 32   79999987542   2346789999999999999999999999877655      9


Q ss_pred             EEEEccCCCChhHhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          442 LVYDYLTMGSLSALLHGNKG-AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       442 lv~ey~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                      +||||+++|+|.+++..... .....+++..+..++.|++.||.|||+.+  |+||||||+||++++++.+||+|||+++
T Consensus       108 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~~~~kl~Dfg~a~  185 (323)
T 3qup_A          108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSR  185 (323)
T ss_dssp             EEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             EEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCCCCEEEeeccccc
Confidence            99999999999999864321 12335899999999999999999999998  9999999999999999999999999998


Q ss_pred             ccCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccc
Q 006055          521 LVGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTS  593 (663)
Q Consensus       521 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (663)
                      ......      ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......      .....+...... 
T Consensus       186 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~~~~~~~~~~~~-  258 (323)
T 3qup_A          186 KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA------EIYNYLIGGNRL-  258 (323)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------GHHHHHHTTCCC-
T ss_pred             cccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH------HHHHHHhcCCCC-
Confidence            764432      1234567999999988889999999999999999999 99999753321      222222222111 


Q ss_pred             cccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       594 ~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                                ........++.+++.+|++.||++|||+.|+++.|+++....
T Consensus       259 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          259 ----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             ----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             ----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                      111223346888999999999999999999999999985443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.3e-39  Score=340.92  Aligned_cols=243  Identities=25%  Similarity=0.389  Sum_probs=198.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC----HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||+|.. .+|+.||||++......    .+.+.+|+++++.++||||+++++++.+.+..++||||+. 
T Consensus        59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-  137 (348)
T 1u5q_A           59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-  137 (348)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred             eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-
Confidence            46799999999999994 67999999998754222    2568899999999999999999999999999999999998 


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN  529 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  529 (663)
                      |+|.+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++.........
T Consensus       138 g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~  211 (348)
T 1u5q_A          138 GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV  211 (348)
T ss_dssp             EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCC
T ss_pred             CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCCCCccc
Confidence            68888875422    35899999999999999999999998  9999999999999999999999999998887766677


Q ss_pred             CCccccCccccC---CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          530 RVAGYRAPEVTD---PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       530 ~~~~y~aPE~~~---~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ++..|+|||++.   ...++.++|||||||++|||++|+.||...      +....+..+....... .         ..
T Consensus       212 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~------~~~~~~~~~~~~~~~~-~---------~~  275 (348)
T 1u5q_A          212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQNESPA-L---------QS  275 (348)
T ss_dssp             SCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHSCCCC-C---------CC
T ss_pred             CCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHhcCCCC-C---------CC
Confidence            889999999984   567889999999999999999999999643      2222233332222111 0         01


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE  640 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~  640 (663)
                      ......+.+++.+||+.||++|||++|++++.--
T Consensus       276 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~  309 (348)
T 1u5q_A          276 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  309 (348)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred             CCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence            1123457788889999999999999999986543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.2e-39  Score=339.95  Aligned_cols=238  Identities=21%  Similarity=0.230  Sum_probs=199.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|.. .+|+.||||++....    .....+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus        46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g  125 (350)
T 1rdq_E           46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG  125 (350)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence            46899999999999995 469999999986542    3356788999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-CC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-TP  528 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~  528 (663)
                      |+|.+++....     .+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++...... ..
T Consensus       126 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~  198 (350)
T 1rdq_E          126 GEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL  198 (350)
T ss_dssp             CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCC
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccCCcccc
Confidence            99999997532     4899999999999999999999998  9999999999999999999999999998765443 34


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .+++.|+|||++.+..++.++|||||||++|||++|+.||...      +.......+......            .+..
T Consensus       199 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~------~~~~~~~~i~~~~~~------------~p~~  260 (350)
T 1rdq_E          199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD------QPIQIYEKIVSGKVR------------FPSH  260 (350)
T ss_dssp             EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC------------CCTT
T ss_pred             cCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC------CHHHHHHHHHcCCCC------------CCCC
Confidence            5788899999999999999999999999999999999999642      223333333332110            0112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPS-----MSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt-----~~ev~~~  637 (663)
                      ...++.+++.+|+..||++||+     ++|+++|
T Consensus       261 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence            2346788899999999999998     8888875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.3e-39  Score=337.92  Aligned_cols=251  Identities=27%  Similarity=0.395  Sum_probs=202.4

Q ss_pred             hcccccccceEEEEEEe------cCCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|..      .+++.||||+++....  ..+.+.+|+++++.++||||+++++++.+....++||||
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  107 (314)
T 2ivs_A           28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEY  107 (314)
T ss_dssp             EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEee
Confidence            46899999999999985      3458899999975432  236788999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC
Q 006055          447 LTMGSLSALLHGNKGA-------------------GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK  507 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~  507 (663)
                      +++|+|.+++......                   ....+++..++.++.|++.||.|||+++  |+||||||+||+++.
T Consensus       108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~NIli~~  185 (314)
T 2ivs_A          108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAE  185 (314)
T ss_dssp             CTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEET
T ss_pred             cCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--CcccccchheEEEcC
Confidence            9999999999764321                   1234899999999999999999999998  999999999999999


Q ss_pred             CCceEEeccccccccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChH
Q 006055          508 SYEARVSDFGLAHLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLP  580 (663)
Q Consensus       508 ~~~~kl~Dfg~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~  580 (663)
                      ++.+||+|||+++.......      ..++..|+|||.+.+..++.++||||||+++|||++ |+.||......      
T Consensus       186 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------  259 (314)
T 2ivs_A          186 GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE------  259 (314)
T ss_dssp             TTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG------
T ss_pred             CCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------
Confidence            99999999999987654321      234567999999988888999999999999999999 99999653321      


Q ss_pred             HHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          581 RWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       581 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      ..... +......          ........++.+++.+|++.||++|||+.|++++|+++...
T Consensus       260 ~~~~~-~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          260 RLFNL-LKTGHRM----------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             GHHHH-HHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHH-hhcCCcC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            11111 1111110          01112334688899999999999999999999999987543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-39  Score=341.88  Aligned_cols=255  Identities=23%  Similarity=0.356  Sum_probs=200.4

Q ss_pred             hcccccccceEEEEEEe------cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  445 (663)
                      .+.||+|+||.||+|..      .+++.||||.++...  ...+.+.+|+.++.++ +||||+++++++...+..++|||
T Consensus        50 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e  129 (344)
T 1rjb_A           50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE  129 (344)
T ss_dssp             EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEe
Confidence            57899999999999985      246789999997542  2346789999999999 99999999999999999999999


Q ss_pred             ccCCCChhHhhccCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC
Q 006055          446 YLTMGSLSALLHGNKGA------------------GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK  507 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~  507 (663)
                      |+++|+|.+++......                  ....+++..++.++.||+.||.|||+.+  |+||||||+||+++.
T Consensus       130 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~  207 (344)
T 1rjb_A          130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTH  207 (344)
T ss_dssp             CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEEET
T ss_pred             cCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEEcC
Confidence            99999999999764321                  0134899999999999999999999998  999999999999999


Q ss_pred             CCceEEeccccccccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChH
Q 006055          508 SYEARVSDFGLAHLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLP  580 (663)
Q Consensus       508 ~~~~kl~Dfg~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~  580 (663)
                      ++.+||+|||++........      ..++..|+|||.+.+..++.++||||||+++|||++ |..||......      
T Consensus       208 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------  281 (344)
T 1rjb_A          208 GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD------  281 (344)
T ss_dssp             TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS------
T ss_pred             CCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH------
Confidence            99999999999986644322      124557999999988889999999999999999998 99999654221      


Q ss_pred             HHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 006055          581 RWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ  647 (663)
Q Consensus       581 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~  647 (663)
                      ..+...........          .+.....++.+++.+||..||++|||+.|++++|+.+.....+
T Consensus       282 ~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  338 (344)
T 1rjb_A          282 ANFYKLIQNGFKMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE  338 (344)
T ss_dssp             HHHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             HHHHHHHhcCCCCC----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence            12222222221110          1112234688899999999999999999999999998776543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.4e-39  Score=333.53  Aligned_cols=247  Identities=27%  Similarity=0.392  Sum_probs=204.8

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .+.||+|+||.||+|... ++..||+|.+.......+.+.+|+++++.++||||+++++++.+....++||||+++|+|.
T Consensus        18 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   97 (288)
T 3kfa_A           18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL   97 (288)
T ss_dssp             EEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHH
T ss_pred             EeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHH
Confidence            468999999999999965 5889999999876666788999999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-----C
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----P  528 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~  528 (663)
                      +++....   ...+++..+..++.+++.||.|||+.+  |+||||||+||+++.++.+||+|||++........     .
T Consensus        98 ~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  172 (288)
T 3kfa_A           98 DYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  172 (288)
T ss_dssp             HHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTE
T ss_pred             HHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCC
Confidence            9997643   345899999999999999999999998  99999999999999999999999999987654432     1


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      .++..|+|||.+.+..++.++||||||+++|+|++ |..||.....      ......+.....           ...+.
T Consensus       173 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~------~~~~~~~~~~~~-----------~~~~~  235 (288)
T 3kfa_A          173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEKDYR-----------MERPE  235 (288)
T ss_dssp             EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GGHHHHHHTTCC-----------CCCCT
T ss_pred             ccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhccCC-----------CCCCC
Confidence            23556999999988889999999999999999999 9999865321      111111111110           01112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      ....++.+++.+|+..||++|||++|+++.|+++..
T Consensus       236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence            233468889999999999999999999999987654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.8e-39  Score=341.74  Aligned_cols=240  Identities=24%  Similarity=0.318  Sum_probs=196.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc----ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV----TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||++.. .+++.||+|.+...    ......+.+|+.++..++||||+++++++.+.+..++||||+.+
T Consensus        20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g   99 (384)
T 4fr4_A           20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLG   99 (384)
T ss_dssp             EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence            46899999999999995 46899999998653    23356788999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++...     ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++......   
T Consensus       100 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~  172 (384)
T 4fr4_A          100 GDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT  172 (384)
T ss_dssp             EEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBC
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeeccCCCcee
Confidence            9999999853     25899999999999999999999998  9999999999999999999999999998765432   


Q ss_pred             CCCCCccccCccccCC---CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          527 TPNRVAGYRAPEVTDP---CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~---~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                      ...+|..|+|||++.+   ..++.++|||||||++|||++|+.||......   .....+..+.....            
T Consensus       173 ~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---~~~~~~~~~~~~~~------------  237 (384)
T 4fr4_A          173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST---SSKEIVHTFETTVV------------  237 (384)
T ss_dssp             CCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS---CHHHHHHHHHHCCC------------
T ss_pred             ccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc---cHHHHHHHHhhccc------------
Confidence            3457888999999864   45889999999999999999999999753221   22222222211110            


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPS-MSEVIK  636 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt-~~ev~~  636 (663)
                      ..+.....++.+++.+|+..||++||+ ++++.+
T Consensus       238 ~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            111123346788899999999999998 777765

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.2e-39  Score=329.44  Aligned_cols=250  Identities=23%  Similarity=0.327  Sum_probs=194.2

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||+||+|...+|+.||||++.....   ....+.+|+++++.++||||+++++++.+.+..++||||+++ +
T Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~   85 (288)
T 1ob3_A            7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D   85 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred             hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence            368999999999999988899999999865432   236788999999999999999999999999999999999986 9


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----CC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----ST  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----~~  527 (663)
                      |.+++....    ..+++..+..++.|++.||.|||+++  |+||||||+||+++.++.+||+|||+++.....    ..
T Consensus        86 l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (288)
T 1ob3_A           86 LKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH  159 (288)
T ss_dssp             HHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             HHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence            999887543    34899999999999999999999998  999999999999999999999999999876432    12


Q ss_pred             CCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh---ccccc--------c
Q 006055          528 PNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD---EWTSE--------V  595 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~--------~  595 (663)
                      ..++..|+|||++.+. .++.++|||||||++|||++|+.||.....      ...+..+...   .....        .
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE------ADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHHCCCChhhchhhhcccc
Confidence            3467789999998764 589999999999999999999999965321      1222222211   00000        0


Q ss_pred             cchhhhcc------cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          596 FDLELLRY------QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       596 ~d~~~~~~------~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      +++.....      ........++.+++.+|++.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            01000000      0011223467889999999999999999999873

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.4e-39  Score=330.70  Aligned_cols=245  Identities=22%  Similarity=0.362  Sum_probs=189.6

Q ss_pred             hcccccccceEEEEEEec----CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLE----MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|...    .+..||+|.++....  ..+.+.+|+.+++.++||||+++++++ ..+..++||||++
T Consensus        20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~   98 (281)
T 1mp8_A           20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCT   98 (281)
T ss_dssp             EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEECCT
T ss_pred             EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEecCC
Confidence            468999999999999854    256799999875422  245788999999999999999999997 4567899999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-  527 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  527 (663)
                      +|+|.+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++....... 
T Consensus        99 ~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (281)
T 1mp8_A           99 LGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  172 (281)
T ss_dssp             TEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred             CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECccccccccCccccc
Confidence            999999997543    35899999999999999999999998  99999999999999999999999999987654322 


Q ss_pred             ----CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          528 ----PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       528 ----~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                          ..++..|+|||.+.+..++.++||||||+++|||++ |..||......      .....+......          
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~------~~~~~i~~~~~~----------  236 (281)
T 1mp8_A          173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGERL----------  236 (281)
T ss_dssp             ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------GHHHHHHTTCCC----------
T ss_pred             ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH------HHHHHHHcCCCC----------
Confidence                224567999999988889999999999999999997 99999754321      122222221110          


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                       ........++.+++.+|++.||++|||+.|++++|+++.+
T Consensus       237 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          237 -PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             0111233467889999999999999999999999998754

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-39  Score=330.10  Aligned_cols=253  Identities=25%  Similarity=0.356  Sum_probs=199.8

Q ss_pred             hcccccccceEEEEEEec-CC---cEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCcc-EEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVLE-MG---TIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEK-LLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv~ey~  447 (663)
                      .++||+|+||+||+|... ++   ..||+|.+.....  ..+.+.+|+.+++.++||||+++++++.+.+.. ++||||+
T Consensus        26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~  105 (298)
T 3pls_A           26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM  105 (298)
T ss_dssp             EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred             CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence            468999999999999843 23   3799999876432  246788999999999999999999999876665 9999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC--
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--  525 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~--  525 (663)
                      .+|+|.+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++.....  
T Consensus       106 ~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          106 CHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             cCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            9999999997532    35899999999999999999999998  999999999999999999999999999755332  


Q ss_pred             ------CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          526 ------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       526 ------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                            ....++..|+|||.+.+..++.++||||||+++|||++|..|+.....     .......+......       
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~-------  247 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-----PFDLTHFLAQGRRL-------  247 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-----GGGHHHHHHTTCCC-------
T ss_pred             cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-----HHHHHHHhhcCCCC-------
Confidence                  123356679999999999999999999999999999996666543211     11111111111110       


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCC
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGH  649 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~~~  649 (663)
                          .........+.+++.+|++.||++|||++|+++.|+++.......+
T Consensus       248 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~  293 (298)
T 3pls_A          248 ----PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH  293 (298)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred             ----CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence                1111223468889999999999999999999999999876654433

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.7e-39  Score=340.92  Aligned_cols=237  Identities=24%  Similarity=0.340  Sum_probs=195.2

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc----ccCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV----TISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|.. .+|+.||||+++..    ......+..|..++..+ +||||+++++++.+.+..++||||++
T Consensus        22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~  101 (345)
T 1xjd_A           22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN  101 (345)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence            46899999999999995 46899999999754    23456678888888876 99999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC---
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS---  525 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~---  525 (663)
                      +|+|.+++....     .+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++.....   
T Consensus       102 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  174 (345)
T 1xjd_A          102 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  174 (345)
T ss_dssp             TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCc
Confidence            999999997532     4899999999999999999999998  999999999999999999999999999864322   


Q ss_pred             -CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          526 -STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       526 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                       ....+++.|+|||++.+..++.++|||||||++|||++|+.||...      +.......+......            
T Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~------~~~~~~~~i~~~~~~------------  236 (345)
T 1xjd_A          175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ------DEEELFHSIRMDNPF------------  236 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC------------
T ss_pred             ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC------CHHHHHHHHHhCCCC------------
Confidence             2345788899999999999999999999999999999999999643      222333333222110            


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMS-EVIK  636 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~-ev~~  636 (663)
                      .+.....++.+++.+|+..||++||++. |+.+
T Consensus       237 ~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          237 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence            0111234677888899999999999998 6654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.1e-39  Score=349.81  Aligned_cols=242  Identities=20%  Similarity=0.286  Sum_probs=197.3

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .++||+|+||+||+|..+ +++.||+|+++...    .....+.+|+.++..++||||++++++|.+....++||||+++
T Consensus        74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g  153 (410)
T 3v8s_A           74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG  153 (410)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            368999999999999954 68999999986531    2234588999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.++++..      .+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++......   
T Consensus       154 g~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~  225 (410)
T 3v8s_A          154 GDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR  225 (410)
T ss_dssp             EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred             CcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence            9999999753      3889999999999999999999998  9999999999999999999999999998765432   


Q ss_pred             --CCCCCccccCccccCCCC----CCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          527 --TPNRVAGYRAPEVTDPCK----VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~~----~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                        +..+|+.|+|||++.+..    ++.++|||||||++|||++|+.||...      +.......+.......       
T Consensus       226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~------~~~~~~~~i~~~~~~~-------  292 (410)
T 3v8s_A          226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD------SLVGTYSKIMNHKNSL-------  292 (410)
T ss_dssp             CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHTHHHHC-------
T ss_pred             ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC------ChhhHHHHHHhccccc-------
Confidence              445788999999987654    788999999999999999999999642      2333334443321100       


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDN--RPSMSEVIKRI  638 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~--RPt~~ev~~~L  638 (663)
                       ..+.......++.+++.+|+..+|++  ||+++||++|-
T Consensus       293 -~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          293 -TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             -CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred             -cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence             01111112346778888999999998  99999999863

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.6e-39  Score=338.26  Aligned_cols=238  Identities=21%  Similarity=0.295  Sum_probs=194.7

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc----ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV----TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|.. .+|+.||||++...    ......+.+|+.+++.++||||+++++++.+....++||||+ +
T Consensus        14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~   92 (336)
T 3h4j_B           14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G   92 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-C
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-C
Confidence            46899999999999995 67999999998643    122457899999999999999999999999999999999999 6


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+|||+++++.+||+|||++.......   
T Consensus        93 g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~  165 (336)
T 3h4j_B           93 GELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK  165 (336)
T ss_dssp             EEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTC
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccCCcccc
Confidence            79998886532     4899999999999999999999998  9999999999999999999999999998765542   


Q ss_pred             CCCCCccccCccccCCCCC-CCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 TPNRVAGYRAPEVTDPCKV-SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      ...+++.|+|||.+.+..+ +.++|||||||++|+|++|+.||.........               ..+...   ....
T Consensus       166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~i~~~---~~~~  227 (336)
T 3h4j_B          166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KKVNSC---VYVM  227 (336)
T ss_dssp             CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CCCCSS---CCCC
T ss_pred             cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HHHHcC---CCCC
Confidence            3447788999999988775 68999999999999999999999764322110               000000   0011


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      +.....++.+++.+|+..||++|||++|++++-
T Consensus       228 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          228 PDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence            112234677889999999999999999998853

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-39  Score=343.25  Aligned_cols=243  Identities=22%  Similarity=0.350  Sum_probs=199.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||.||+|.. .+|+.||+|.+.... .....+.+|++++..++||||+++++++.+....++||||+++|+|
T Consensus        56 ~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L  135 (387)
T 1kob_A           56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL  135 (387)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred             EEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcH
Confidence            46899999999999995 468999999987653 2345789999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC--CCceEEeccccccccCCCCC---
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK--SYEARVSDFGLAHLVGPSST---  527 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~---  527 (663)
                      .+++....    ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.  ++.+||+|||+++.......   
T Consensus       136 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~  209 (387)
T 1kob_A          136 FDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV  209 (387)
T ss_dssp             HHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred             HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCCcceee
Confidence            99997532    35899999999999999999999998  999999999999974  46799999999987765432   


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||...      +....+..+....+..   +.     ....
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~------~~~~~~~~i~~~~~~~---~~-----~~~~  275 (387)
T 1kob_A          210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE------DDLETLQNVKRCDWEF---DE-----DAFS  275 (387)
T ss_dssp             ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHHHHHCCCCC---CS-----STTT
T ss_pred             eccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCCC---Cc-----cccc
Confidence            34778899999999989999999999999999999999999653      2223333333222110   00     0111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....++.+++.+|+..||++|||++|++++
T Consensus       276 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          276 SVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            223467888999999999999999999984

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.8e-39  Score=338.01  Aligned_cols=245  Identities=18%  Similarity=0.299  Sum_probs=194.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC----HHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS----EREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|.. .+|+.||+|+++.....    ...+.+|..++..+ +||||+++++++.+....++||||++
T Consensus        14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~   93 (345)
T 3a8x_A           14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN   93 (345)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence            46899999999999995 46899999999765322    34578899999887 89999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC---
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS---  525 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~---  525 (663)
                      +|+|.+++....     .+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++.....   
T Consensus        94 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~  166 (345)
T 3a8x_A           94 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  166 (345)
T ss_dssp             SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence            999999997532     4899999999999999999999998  999999999999999999999999999864322   


Q ss_pred             -CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCC--ChHHHHHHHHhhcccccccchhhhc
Q 006055          526 -STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGV--DLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       526 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                       ....++..|+|||++.+..++.++|||||||++|||++|+.||......+..  .....+...+.....          
T Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------  236 (345)
T 3a8x_A          167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------  236 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----------
T ss_pred             ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----------
Confidence             2345788899999999999999999999999999999999999753221111  111112222111110          


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSM------SEVIKR  637 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~------~ev~~~  637 (663)
                       ..+.....++.+++.+|+..||++||++      +|+++|
T Consensus       237 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          237 -RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             -CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence             0111223467788899999999999995      677654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.6e-39  Score=335.46  Aligned_cols=252  Identities=24%  Similarity=0.404  Sum_probs=203.6

Q ss_pred             hcccccccceEEEEEEe------cCCcEEEEEEecCccc--CHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  445 (663)
                      .+.||+|+||.||+|..      .+++.||||+++....  ..+.+.+|+.++.++ +||||+++++++...+..++|||
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  107 (313)
T 1t46_A           28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE  107 (313)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEe
Confidence            46899999999999984      3578999999975532  246789999999999 99999999999999999999999


Q ss_pred             ccCCCChhHhhccCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceE
Q 006055          446 YLTMGSLSALLHGNKGA-------------GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEAR  512 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~k  512 (663)
                      |+++|+|.+++......             ....+++..++.++.|++.||.|||+.+  |+||||||+||+++.++.+|
T Consensus       108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~k  185 (313)
T 1t46_A          108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITK  185 (313)
T ss_dssp             CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEETTTEEE
T ss_pred             cCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEcCCCCEE
Confidence            99999999999764321             1235899999999999999999999998  99999999999999999999


Q ss_pred             EeccccccccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHH
Q 006055          513 VSDFGLAHLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQS  585 (663)
Q Consensus       513 l~Dfg~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  585 (663)
                      |+|||+++.......      ..++..|+|||.+.+..++.++||||||+++|||++ |+.||......      ..+..
T Consensus       186 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~  259 (313)
T 1t46_A          186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD------SKFYK  259 (313)
T ss_dssp             ECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS------HHHHH
T ss_pred             EccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch------hHHHH
Confidence            999999987655432      123456999999988889999999999999999999 99999653221      11222


Q ss_pred             HHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          586 IVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      ........          ........++.+++.+|+..||++|||++|++++|+++...
T Consensus       260 ~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          260 MIKEGFRM----------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             HHHHTCCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HhccCCCC----------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            22221110          01112334678899999999999999999999999987544

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.6e-39  Score=338.98  Aligned_cols=253  Identities=23%  Similarity=0.389  Sum_probs=202.1

Q ss_pred             hcccccccceEEEEEEe--------cCCcEEEEEEecCccc--CHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEE
Q 006055          375 AEVLGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLV  443 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~--------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  443 (663)
                      .+.||+|+||.||+|..        .++..||||+++....  ..+.+.+|+++++.+ +||||+++++++.+.+..++|
T Consensus        40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  119 (334)
T 2pvf_A           40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI  119 (334)
T ss_dssp             EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEE
T ss_pred             eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEE
Confidence            46899999999999985        3577899999976432  245688999999999 899999999999999999999


Q ss_pred             EEccCCCChhHhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceE
Q 006055          444 YDYLTMGSLSALLHGNKGA-----------GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEAR  512 (663)
Q Consensus       444 ~ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~k  512 (663)
                      |||+++|+|.+++......           ....+++..++.++.||+.||.|||+.+  |+||||||+||+++.++.+|
T Consensus       120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~k  197 (334)
T 2pvf_A          120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMK  197 (334)
T ss_dssp             EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEE
T ss_pred             EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccceEEEcCCCCEE
Confidence            9999999999999864321           1234899999999999999999999998  99999999999999999999


Q ss_pred             EeccccccccCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHH
Q 006055          513 VSDFGLAHLVGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQS  585 (663)
Q Consensus       513 l~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  585 (663)
                      |+|||+++......      ...++..|+|||++.+..++.++||||||+++|||++ |+.||...      ........
T Consensus       198 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~------~~~~~~~~  271 (334)
T 2pvf_A          198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI------PVEELFKL  271 (334)
T ss_dssp             ECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC------CHHHHHHH
T ss_pred             EccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC------CHHHHHHH
Confidence            99999998765432      1234567999999988888999999999999999999 99999643      22222222


Q ss_pred             HHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006055          586 IVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST  646 (663)
Q Consensus       586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~  646 (663)
                      +..... .          ........++.+++.+||..||++|||++|++++|+++.....
T Consensus       272 ~~~~~~-~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          272 LKEGHR-M----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHHTCC-C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HhcCCC-C----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            222111 0          0111233468889999999999999999999999998865433

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.8e-39  Score=363.78  Aligned_cols=244  Identities=25%  Similarity=0.363  Sum_probs=198.8

Q ss_pred             ccccccceEEEEEEec---CCcEEEEEEecCc--ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          377 VLGKGTFGTAYKAVLE---MGTIVAVKRLKDV--TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       377 ~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .||+|+||.||+|.+.   ++..||||+++..  ....+.+.+|+++++.++||||++++++|.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            6999999999999853   5678999999764  2346789999999999999999999999875 66899999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC----
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST----  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~----  527 (663)
                      |.+++....    ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.......    
T Consensus       422 L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  495 (613)
T 2ozo_A          422 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  495 (613)
T ss_dssp             HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred             HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence            999997532    35899999999999999999999998  99999999999999999999999999987654321    


Q ss_pred             ---CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          528 ---PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       528 ---~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                         ..++..|+|||++.+..++.++|||||||++|||++ |+.||.....      ......+.....           .
T Consensus       496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------~~~~~~i~~~~~-----------~  558 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------PEVMAFIEQGKR-----------M  558 (613)
T ss_dssp             ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS------HHHHHHHHTTCC-----------C
T ss_pred             ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH------HHHHHHHHcCCC-----------C
Confidence               123457999999988899999999999999999998 9999975432      222222222111           0


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      ..+.....++.+++.+||..||++||++++|++.|+.+...
T Consensus       559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            11123345788999999999999999999999999987443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.8e-39  Score=328.75  Aligned_cols=251  Identities=23%  Similarity=0.286  Sum_probs=193.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||+||+|.. .+|+.||||++......   ...+.+|+.+++.++||||+++++++.+.+..++||||+++ 
T Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-   85 (292)
T 3o0g_A            7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-   85 (292)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred             eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-
Confidence            36899999999999995 46899999999754322   46788999999999999999999999999999999999986 


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----  526 (663)
                      ++.+.+....    ..+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||+++......    
T Consensus        86 ~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (292)
T 3o0g_A           86 DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred             CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence            5655554322    35899999999999999999999998  9999999999999999999999999998765332    


Q ss_pred             CCCCCccccCccccCCCC-CCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc---cccccchhh--
Q 006055          527 TPNRVAGYRAPEVTDPCK-VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW---TSEVFDLEL--  600 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d~~~--  600 (663)
                      ...++..|+|||++.+.. ++.++|||||||++|||++|..||...     .+....+..+.....   .........  
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~-----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG-----NDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC-----SSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC-----CCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence            234677899999997765 799999999999999999998886432     222233333322100   000000000  


Q ss_pred             ------------hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          601 ------------LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       601 ------------~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                                  ...........++.+++.+|++.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence                        0000011234567788999999999999999999973

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.7e-39  Score=332.63  Aligned_cols=252  Identities=27%  Similarity=0.364  Sum_probs=198.3

Q ss_pred             hcccccccceEEEEEEe-----cCCcEEEEEEecCc--ccCHHHHHHHHHHhhcCCCCCcccceEEEEec--CccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDV--TISEREFKDKIEGVGAVNHENLVPLRAYYYSM--DEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  445 (663)
                      .+.||+|+||.||+|.+     .+++.||||+++..  ......+.+|+++++.++||||+++++++...  ...++|||
T Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e  105 (302)
T 4e5w_A           26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME  105 (302)
T ss_dssp             EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEE
T ss_pred             hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEE
Confidence            46899999999999983     46899999998754  23457899999999999999999999999876  56799999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+++|+|.+++....    ..+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||+++.....
T Consensus       106 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  179 (302)
T 4e5w_A          106 FLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  179 (302)
T ss_dssp             CCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             eCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECcccccccccCC
Confidence            999999999996432    34899999999999999999999998  999999999999999999999999999876543


Q ss_pred             C-------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccC--------CCCCChHHHHHHHHhhc
Q 006055          526 S-------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLN--------EEGVDLPRWVQSIVKDE  590 (663)
Q Consensus       526 ~-------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~--------~~~~~~~~~~~~~~~~~  590 (663)
                      .       ...++..|+|||.+.+..++.++||||||+++|||++|+.|+.....        ..+......+.......
T Consensus       180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (302)
T 4e5w_A          180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG  259 (302)
T ss_dssp             CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred             CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence            2       23355669999999888889999999999999999999998753210        00000111111111111


Q ss_pred             ccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       591 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                      .          ..........++.+++.+|++.||++|||++|+++.|+++.
T Consensus       260 ~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          260 K----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             C----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            0          01111233457889999999999999999999999999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.7e-39  Score=339.34  Aligned_cols=260  Identities=27%  Similarity=0.390  Sum_probs=199.8

Q ss_pred             hcccccccceEEEEEEe-----cCCcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEe--cCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYS--MDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ey  446 (663)
                      .+.||+|+||.||++.+     .+++.||||++..... ..+.+.+|+++++.++||||+++++++..  ....++||||
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~  107 (327)
T 3lxl_A           28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY  107 (327)
T ss_dssp             EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEEC
T ss_pred             hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEee
Confidence            46899999999999983     4689999999976532 34568999999999999999999999874  4557899999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      +++|+|.+++....    ..+++..++.++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++......
T Consensus       108 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~  181 (327)
T 3lxl_A          108 LPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDK  181 (327)
T ss_dssp             CTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCEECCTTC
T ss_pred             cCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEcccccceecccCC
Confidence            99999999997532    24899999999999999999999998  9999999999999999999999999998765432


Q ss_pred             -------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCC--------CCCChHHHHHHHHhhcc
Q 006055          527 -------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNE--------EGVDLPRWVQSIVKDEW  591 (663)
Q Consensus       527 -------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~--------~~~~~~~~~~~~~~~~~  591 (663)
                             ...++..|+|||++.+..++.++||||||+++|+|++|+.||......        ........+........
T Consensus       182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (327)
T 3lxl_A          182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ  261 (327)
T ss_dssp             SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTC
T ss_pred             ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhccc
Confidence                   123556699999998888899999999999999999999998653211        00011111111111111


Q ss_pred             cccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCC
Q 006055          592 TSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHH  650 (663)
Q Consensus       592 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~~~~  650 (663)
                                ..........++.+++.+|++.||++|||++|++++|+.+.........
T Consensus       262 ----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~  310 (327)
T 3lxl_A          262 ----------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET  310 (327)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred             ----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence                      0111223345688899999999999999999999999998776655443

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.3e-39  Score=334.48  Aligned_cols=238  Identities=22%  Similarity=0.282  Sum_probs=189.1

Q ss_pred             hcccccccceEEEEEEe----cCCcEEEEEEecCcc-----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVT-----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  445 (663)
                      .+.||+|+||.||++..    .+|+.||+|+++...     .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus        22 ~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  101 (327)
T 3a62_A           22 LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILE  101 (327)
T ss_dssp             EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEe
Confidence            46899999999999986    479999999997642     123567889999999999999999999999999999999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+++|+|.+++....     .+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++.....
T Consensus       102 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  174 (327)
T 3a62_A          102 YLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD  174 (327)
T ss_dssp             CCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred             CCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence            999999999997532     4889999999999999999999998  999999999999999999999999999764332


Q ss_pred             ----CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhh
Q 006055          526 ----STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL  601 (663)
Q Consensus       526 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  601 (663)
                          ....++..|+|||++.+..++.++|||||||++|||++|+.||...      +....+..+......         
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~------~~~~~~~~i~~~~~~---------  239 (327)
T 3a62_A          175 GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE------NRKKTIDKILKCKLN---------  239 (327)
T ss_dssp             ----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHTCCC---------
T ss_pred             CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhCCCC---------
Confidence                2234778899999999988999999999999999999999999643      222333333332110         


Q ss_pred             cccChHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          602 RYQNVEEEMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       602 ~~~~~~~~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                         .+.....++.+++.+|+..||++||     +++|+++|
T Consensus       240 ---~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          240 ---LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             ---CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             ---CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence               0111234677888999999999999     78888775

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.8e-39  Score=336.44  Aligned_cols=245  Identities=26%  Similarity=0.408  Sum_probs=195.0

Q ss_pred             hcccccccceEEEEEEe-cCCcE----EEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTI----VAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~----vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .++||+|+||+||+|.. .+++.    ||+|.+....  .....+.+|+.+++.++||||+++++++. ....++||||+
T Consensus        18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   96 (325)
T 3kex_A           18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYL   96 (325)
T ss_dssp             EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECC
T ss_pred             eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeC
Confidence            46899999999999995 44554    7888875432  22356778999999999999999999885 56789999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST  527 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  527 (663)
                      ++|+|.+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++.......
T Consensus        97 ~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  170 (325)
T 3kex_A           97 PLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK  170 (325)
T ss_dssp             TTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred             CCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence            9999999997542    25888999999999999999999998  99999999999999999999999999987754322


Q ss_pred             ------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          528 ------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       528 ------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                            ..++.+|+|||++.+..++.++||||||+++|||++ |+.||......      .....+......        
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~--------  236 (325)
T 3kex_A          171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA------EVPDLLEKGERL--------  236 (325)
T ss_dssp             CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT------HHHHHHHTTCBC--------
T ss_pred             cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH------HHHHHHHcCCCC--------
Confidence                  224557999999998889999999999999999999 99999753221      111111111110        


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                         ..+.....++.+++.+||..||++|||++|++++|+++..
T Consensus       237 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          237 ---AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             ---CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             ---CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence               0011122357788899999999999999999999998854

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-39  Score=328.20  Aligned_cols=246  Identities=25%  Similarity=0.354  Sum_probs=200.5

Q ss_pred             cccccccceEEEEEEec---CCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          376 EVLGKGTFGTAYKAVLE---MGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      +.||+|+||.||+|...   ++..||||.++...  ...+.+.+|+++++.++||||+++++++ ..+..++||||++++
T Consensus        16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~   94 (287)
T 1u59_A           16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG   94 (287)
T ss_dssp             EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred             ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence            47999999999999853   68889999997642  2346789999999999999999999999 556789999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC---
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST---  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~---  527 (663)
                      +|.+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++.......   
T Consensus        95 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  168 (287)
T 1u59_A           95 PLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT  168 (287)
T ss_dssp             EHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred             CHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceeeeccCcceee
Confidence            9999997432    35899999999999999999999998  99999999999999999999999999987654321   


Q ss_pred             ----CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          528 ----PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       528 ----~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                          ..++..|+|||.+.+..++.++||||||+++|||++ |+.||.....      ......+......          
T Consensus       169 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~i~~~~~~----------  232 (287)
T 1u59_A          169 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------PEVMAFIEQGKRM----------  232 (287)
T ss_dssp             CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT------HHHHHHHHTTCCC----------
T ss_pred             ccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHhcCCcC----------
Confidence                224567999999988888999999999999999998 9999965322      2222222221110          


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                       ..+.....++.+++.+||..||++||++.|++++|+++..+.
T Consensus       233 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          233 -ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence             111223447888999999999999999999999999885443

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.1e-38  Score=327.88  Aligned_cols=262  Identities=19%  Similarity=0.178  Sum_probs=204.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEE-EecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY-YSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||.||+|.. .+|+.||||++..... ...+.+|+.++..++|++++..+.++ ......++||||+ +++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L   91 (296)
T 3uzp_A           14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL   91 (296)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCH
Confidence            36899999999999995 6799999999865432 34688999999999999888777766 4556679999999 8999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEE---cCCCceEEeccccccccCCCC---
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL---TKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      .+++....    ..+++..+..++.|++.||.|||+++  |+||||||+||++   +.++.+||+|||+++......   
T Consensus        92 ~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (296)
T 3uzp_A           92 EDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  165 (296)
T ss_dssp             HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred             HHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc
Confidence            99997432    35899999999999999999999998  9999999999999   488899999999998765432   


Q ss_pred             --------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          527 --------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       527 --------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                              ...++..|+|||.+.+..++.++|||||||++|||++|+.||..............+.........     .
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~  240 (296)
T 3uzp_A          166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----E  240 (296)
T ss_dssp             BCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----H
T ss_pred             ccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-----H
Confidence                    234677899999999999999999999999999999999999865433322222211111100000     0


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCCCCCC
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQP  654 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~  654 (663)
                      ..     ....+.++.+++.+||+.||++|||++|+++.|+++............+
T Consensus       241 ~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~d  291 (296)
T 3uzp_A          241 VL-----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD  291 (296)
T ss_dssp             HH-----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCG
T ss_pred             HH-----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccc
Confidence            00     0112346888999999999999999999999999987665554444433

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.7e-39  Score=343.89  Aligned_cols=244  Identities=23%  Similarity=0.298  Sum_probs=188.3

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHh-hcCCCCCcccceEEEEe----cCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGV-GAVNHENLVPLRAYYYS----MDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~ey~~~  449 (663)
                      ++||+|+||+||++.. .+|+.||||+++..    ..+.+|++++ +..+||||+++++++..    ....++||||+++
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g  143 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG  143 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence            5799999999999995 46899999998643    4567788876 45589999999999875    5568999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC---CCceEEeccccccccCCCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK---SYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~---~~~~kl~Dfg~a~~~~~~~  526 (663)
                      |+|.+++....   ...+++..+..++.||+.||.|||+.+  |+||||||+|||++.   ++.+||+|||+++......
T Consensus       144 g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~  218 (400)
T 1nxk_A          144 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN  218 (400)
T ss_dssp             EEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred             CcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence            99999998543   245899999999999999999999998  999999999999998   7889999999998765432


Q ss_pred             ---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          527 ---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       527 ---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                         ...++..|+|||++.+..++.++|||||||++|||++|+.||..........  .....+......     ...   
T Consensus       219 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~i~~~~~~-----~~~---  288 (400)
T 1nxk_A          219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKTRIRMGQYE-----FPN---  288 (400)
T ss_dssp             --------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC--SHHHHHHHTCCC-----CCT---
T ss_pred             ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH--HHHHHHHcCccc-----CCC---
Confidence               2346778999999999999999999999999999999999997643322110  111111111110     000   


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      ........++.+++.+||..||++|||++|++++-
T Consensus       289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            00112334678889999999999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.8e-39  Score=338.25  Aligned_cols=241  Identities=21%  Similarity=0.303  Sum_probs=183.5

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .+.||+|+||.||+|... +++.||||+++... ..+.+.+|++++.+++||||+++++++.+....++||||+++|+|.
T Consensus        58 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~  136 (349)
T 2w4o_A           58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELF  136 (349)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             eeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHH
Confidence            468999999999999965 58899999997643 3467889999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC---CCceEEeccccccccCCCC---C
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK---SYEARVSDFGLAHLVGPSS---T  527 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~---~~~~kl~Dfg~a~~~~~~~---~  527 (663)
                      +++....     .+++..+..++.|++.||.|||+.+  |+||||||+||+++.   ++.+||+|||+++......   .
T Consensus       137 ~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  209 (349)
T 2w4o_A          137 DRIVEKG-----YYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT  209 (349)
T ss_dssp             HHHTTCS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred             HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccCccccccc
Confidence            9997532     4899999999999999999999998  999999999999975   8899999999998765432   2


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||.....     .......+.......  ..      ....
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~i~~~~~~~--~~------~~~~  276 (349)
T 2w4o_A          210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG-----DQFMFRRILNCEYYF--IS------PWWD  276 (349)
T ss_dssp             ---CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC-----HHHHHHHHHTTCCCC--CT------TTTT
T ss_pred             ccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc-----cHHHHHHHHhCCCcc--CC------chhh
Confidence            3467889999999998999999999999999999999999964321     111222222221110  00      0111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      ....++.+++.+|+..||++|||+.|+++
T Consensus       277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            23346788899999999999999999998

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.2e-38  Score=341.26  Aligned_cols=260  Identities=22%  Similarity=0.306  Sum_probs=196.4

Q ss_pred             hcccccc--cceEEEEEEec-CCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKG--TFGTAYKAVLE-MGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G--~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .++||+|  +||.||+|... +|+.||||+++.....   .+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        30 ~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  109 (389)
T 3gni_B           30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA  109 (389)
T ss_dssp             EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             EecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccC
Confidence            4689999  99999999954 7999999999765433   3567889999999999999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC----
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP----  524 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~----  524 (663)
                      +|+|.+++....   ...+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||.+.....    
T Consensus       110 ~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~  184 (389)
T 3gni_B          110 YGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR  184 (389)
T ss_dssp             TCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEE
T ss_pred             CCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccceeecccccc
Confidence            999999997643   234899999999999999999999998  99999999999999999999999998854321    


Q ss_pred             -------CCCCCCCccccCccccCC--CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh------
Q 006055          525 -------SSTPNRVAGYRAPEVTDP--CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD------  589 (663)
Q Consensus       525 -------~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------  589 (663)
                             .....++..|+|||++.+  ..++.++|||||||++|||++|+.||.......  .+...+......      
T Consensus       185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~  262 (389)
T 3gni_B          185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDTST  262 (389)
T ss_dssp             CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT--HHHHC-------------
T ss_pred             ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhcCCCCccccccc
Confidence                   112346677999999987  578999999999999999999999997533211  000000000000      


Q ss_pred             ----------------cccccccc--------hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhh
Q 006055          590 ----------------EWTSEVFD--------LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR--IEEL  641 (663)
Q Consensus       590 ----------------~~~~~~~d--------~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~--L~~~  641 (663)
                                      ........        ..............++.+++.+||+.||++|||++|++++  ++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~  340 (389)
T 3gni_B          263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  340 (389)
T ss_dssp             -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred             cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence                            00000000        0000001112234568889999999999999999999976  4444

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=7.5e-39  Score=337.15  Aligned_cols=238  Identities=22%  Similarity=0.284  Sum_probs=196.4

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCc----ccCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDV----TISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .++||+|+||.||+|... +|+.||||+++..    ......+..|..++..+ +||||+++++++.+.+..++||||++
T Consensus        25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~  104 (353)
T 2i0e_A           25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN  104 (353)
T ss_dssp             EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence            468999999999999965 5889999999754    23356788899999887 89999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC---
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS---  525 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~---  525 (663)
                      +|+|.+++....     .+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++.....   
T Consensus       105 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  177 (353)
T 2i0e_A          105 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT  177 (353)
T ss_dssp             SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence            999999997532     4899999999999999999999998  999999999999999999999999999864322   


Q ss_pred             -CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          526 -STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       526 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                       ....+++.|+|||++.+..++.++|||||||++|||++|+.||...      +.......+......            
T Consensus       178 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~------~~~~~~~~i~~~~~~------------  239 (353)
T 2i0e_A          178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE------DEDELFQSIMEHNVA------------  239 (353)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC------------
T ss_pred             cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC------CHHHHHHHHHhCCCC------------
Confidence             2345788899999999999999999999999999999999999642      223334444332210            


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPS-----MSEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt-----~~ev~~~  637 (663)
                      .+.....++.+++.+|+..||++||+     ++|+++|
T Consensus       240 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          240 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            11122346788889999999999995     5777765

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.4e-39  Score=363.46  Aligned_cols=242  Identities=24%  Similarity=0.350  Sum_probs=197.2

Q ss_pred             cccccccceEEEEEEe---cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVL---EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~---~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      +.||+|+||+||+|.+   ..++.||||+++....   ..+++.+|+++++.++||||+++++++. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            4799999999999964   3468899999976532   3578999999999999999999999986 4568899999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC--
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST--  527 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--  527 (663)
                      |+|.++++...     .+++..+..|+.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++.......  
T Consensus       454 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            99999997533     5899999999999999999999998  99999999999999999999999999987654321  


Q ss_pred             -----CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhh
Q 006055          528 -----PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL  601 (663)
Q Consensus       528 -----~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  601 (663)
                           ..++..|+|||++.+..++.++|||||||++|||++ |+.||.....      ......+..... .        
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------~~~~~~i~~~~~-~--------  591 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------SEVTAMLEKGER-M--------  591 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTCC-C--------
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCC-C--------
Confidence                 123466999999998899999999999999999998 9999965322      222222222111 1        


Q ss_pred             cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       602 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                        ..+.....++.+++.+||+.||++||++++|++.|+++.
T Consensus       592 --~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          592 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence              111223457888999999999999999999999998763

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-38  Score=331.82  Aligned_cols=254  Identities=24%  Similarity=0.352  Sum_probs=188.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||+||+|.. .+|+.||||+++...  .....+.+|+++++.++||||+++++++.+.+..++||||++ |+
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~   88 (317)
T 2pmi_A           10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-ND   88 (317)
T ss_dssp             ---------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CB
T ss_pred             eeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CC
Confidence            46799999999999994 568999999987542  234678899999999999999999999999999999999998 59


Q ss_pred             hhHhhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----C
Q 006055          452 LSALLHGNK-GAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----S  526 (663)
Q Consensus       452 L~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----~  526 (663)
                      |.+++.... ......+++..+..++.||+.||.|||+.+  |+||||||+||+++.++.+||+|||+++.....    .
T Consensus        89 L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (317)
T 2pmi_A           89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFS  166 (317)
T ss_dssp             HHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCC
T ss_pred             HHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCC
Confidence            999886432 122345899999999999999999999998  999999999999999999999999999876532    2


Q ss_pred             CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhc-cccc-----c----
Q 006055          527 TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE-WTSE-----V----  595 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~-----~----  595 (663)
                      ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.....      ...+..+.... ....     .    
T Consensus       167 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (317)
T 2pmi_A          167 SEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND------EEQLKLIFDIMGTPNESLWPSVTKLP  240 (317)
T ss_dssp             CCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred             CCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhCCCChhHhhhhhhhh
Confidence            2346788999999876 4689999999999999999999999975322      11222221100 0000     0    


Q ss_pred             -cchh-----------hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          596 -FDLE-----------LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       596 -~d~~-----------~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                       +.+.           ............++.+++.+|+..||++|||++|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence             0000           00000011123468899999999999999999999984

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.3e-38  Score=325.34  Aligned_cols=243  Identities=20%  Similarity=0.378  Sum_probs=197.5

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEe----------------c
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS----------------M  437 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----------------~  437 (663)
                      .+.||+|+||.||+|... +|+.||||+++...   ..+.+|+++++.++||||+++++++..                .
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (284)
T 2a19_B           16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKT   92 (284)
T ss_dssp             EEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEE
T ss_pred             eeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCc
Confidence            468999999999999965 79999999987543   357789999999999999999998864                3


Q ss_pred             CccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccc
Q 006055          438 DEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFG  517 (663)
Q Consensus       438 ~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg  517 (663)
                      ...++||||+++|+|.+++....   ...+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg  167 (284)
T 2a19_B           93 KCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFG  167 (284)
T ss_dssp             EEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCT
T ss_pred             ceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCCEEECcch
Confidence            44789999999999999997532   235899999999999999999999998  9999999999999999999999999


Q ss_pred             cccccCCCC---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          518 LAHLVGPSS---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       518 ~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                      +++......   ...++..|+|||.+.+..++.++||||||+++|||++|..|+....        ...... .......
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~~~~-~~~~~~~  238 (284)
T 2a19_B          168 LVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFFTDL-RDGIISD  238 (284)
T ss_dssp             TCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHHHHH-HTTCCCT
T ss_pred             hheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHHHHh-hcccccc
Confidence            998765432   2346778999999998889999999999999999999999874311        111111 1111111


Q ss_pred             ccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 006055          595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ  647 (663)
Q Consensus       595 ~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~  647 (663)
                                   .....+.+++.+|++.||++|||+.|++++|..+......
T Consensus       239 -------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          239 -------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             -------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             -------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence                         1223567888999999999999999999999999766443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.3e-38  Score=337.29  Aligned_cols=191  Identities=25%  Similarity=0.361  Sum_probs=169.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCC-----CCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-----HENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .++||+|+||+||+|.. .+++.||||+++........+..|++++..++     ||||+++++++...+..++||||+ 
T Consensus        40 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-  118 (360)
T 3llt_A           40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-  118 (360)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-
T ss_pred             EEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-
Confidence            46899999999999995 57899999999865555667888999998886     999999999999999999999999 


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC---------------------
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK---------------------  507 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~---------------------  507 (663)
                      +++|.+++....   ...+++..+..++.||+.||+|||+.+  |+||||||+|||++.                     
T Consensus       119 ~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~  193 (360)
T 3llt_A          119 GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI  193 (360)
T ss_dssp             CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEE
T ss_pred             CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchhcccccccccc
Confidence            889999997643   235899999999999999999999998  999999999999975                     


Q ss_pred             ----CCceEEeccccccccCCC-CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccc
Q 006055          508 ----SYEARVSDFGLAHLVGPS-STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHAL  571 (663)
Q Consensus       508 ----~~~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~  571 (663)
                          ++.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       194 ~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          194 YRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             EEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence                788999999999876543 3345788899999999999999999999999999999999999753

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.2e-38  Score=327.73  Aligned_cols=261  Identities=19%  Similarity=0.187  Sum_probs=202.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEE-EecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY-YSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||+||+|.. .+++.||||++..... ...+.+|++++..++|++++..+.++ ......++||||+ +++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L   91 (296)
T 4hgt_A           14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL   91 (296)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             eeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCH
Confidence            46899999999999994 6799999998755422 23578899999999999888877766 5566779999999 8999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEE---cCCCceEEeccccccccCCCC---
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL---TKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      .+++....    ..+++..+..++.|++.||.|||+++  |+||||||+||++   +.++.+||+|||+++......   
T Consensus        92 ~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~  165 (296)
T 4hgt_A           92 EDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  165 (296)
T ss_dssp             HHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred             HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCc
Confidence            99997432    24899999999999999999999998  9999999999999   789999999999998764432   


Q ss_pred             --------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          527 --------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       527 --------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                              ...++..|+|||.+.+..++.++|||||||++|||++|+.||..............+........      .
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~  239 (296)
T 4hgt_A          166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP------I  239 (296)
T ss_dssp             BCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC------H
T ss_pred             cCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch------h
Confidence                    23467789999999999999999999999999999999999986544332222221111100000      0


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCCCCC
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQ  653 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~  653 (663)
                      ..    .....+.++.+++.+|++.||++|||++|+++.|+++............
T Consensus       240 ~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~  290 (296)
T 4hgt_A          240 EV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF  290 (296)
T ss_dssp             HH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCC
T ss_pred             hh----hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCcc
Confidence            00    0011234788899999999999999999999999998766554444433

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-38  Score=327.29  Aligned_cols=236  Identities=21%  Similarity=0.225  Sum_probs=185.8

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccCH---HHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISE---REFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .++||+|+||+||+|... +|+.||||++.......   ..+..|+..+..+ +||||++++++|.+....++||||+ +
T Consensus        62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~  140 (311)
T 3p1a_A           62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G  140 (311)
T ss_dssp             EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-C
T ss_pred             eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-C
Confidence            468999999999999965 79999999987653332   3344455554444 9999999999999999999999999 6


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      ++|.+++....    ..++|..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.......   
T Consensus       141 ~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  214 (311)
T 3p1a_A          141 PSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE  214 (311)
T ss_dssp             CBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred             CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeecccCCCCc
Confidence            69998887543    35899999999999999999999998  9999999999999999999999999998765432   


Q ss_pred             CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ...++.+|+|||++.+ .++.++|||||||++|||++|..|+....         ....+ ....    ..+..     .
T Consensus       215 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---------~~~~~-~~~~----~~~~~-----~  274 (311)
T 3p1a_A          215 VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQQL-RQGY----LPPEF-----T  274 (311)
T ss_dssp             CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---------HHHHH-TTTC----CCHHH-----H
T ss_pred             ccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HHHHH-hccC----CCccc-----c
Confidence            2347888999999876 68999999999999999999977764321         01111 1111    11111     1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .....++.+++.+|++.||++|||++|++++
T Consensus       275 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          275 AGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            1223568889999999999999999999973

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.5e-39  Score=335.58  Aligned_cols=252  Identities=25%  Similarity=0.382  Sum_probs=199.9

Q ss_pred             hcccccccceEEEEEEe-----cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEec--CccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSM--DEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  445 (663)
                      .+.||+|+||+||++.+     .+|+.||||+++...  .....+.+|+++++.++||||+++++++.+.  ...++|||
T Consensus        36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e  115 (318)
T 3lxp_A           36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME  115 (318)
T ss_dssp             EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEEC
T ss_pred             hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEe
Confidence            46899999999998864     368999999997653  2246789999999999999999999999874  56789999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+++|+|.+++...      .+++..++.++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++.....
T Consensus       116 ~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          116 YVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             CCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             cccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            99999999999753      3899999999999999999999998  999999999999999999999999999877543


Q ss_pred             C-------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCC----CCC----hHHHHHHHHhhc
Q 006055          526 S-------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEE----GVD----LPRWVQSIVKDE  590 (663)
Q Consensus       526 ~-------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~----~~~----~~~~~~~~~~~~  590 (663)
                      .       ...++..|+|||.+.+..++.++||||||+++|||++|+.||.......    ...    ....+.......
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG  267 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence            2       1235566999999988888999999999999999999999986532110    000    000011111111


Q ss_pred             ccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       591 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      .          ..........++.+++.+||+.||++|||++|+++.|+++.+.
T Consensus       268 ~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          268 E----------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             c----------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence            0          0111223345788999999999999999999999999988544

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.8e-38  Score=325.49  Aligned_cols=248  Identities=29%  Similarity=0.426  Sum_probs=189.7

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||+||+|...  ..||||.++.....   .+.+.+|+++++.++||||+++++++ .....++||||+++++
T Consensus        29 ~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~  105 (289)
T 3og7_A           29 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSS  105 (289)
T ss_dssp             EEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEE
T ss_pred             eeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCc
Confidence            468999999999999864  35999998765433   35689999999999999999999965 5567899999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-----
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----  526 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-----  526 (663)
                      |.++++...    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++......     
T Consensus       106 L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  179 (289)
T 3og7_A          106 LYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF  179 (289)
T ss_dssp             HHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred             HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceeccccccccccccc
Confidence            999997533    35899999999999999999999998  9999999999999999999999999997654321     


Q ss_pred             -CCCCCccccCccccC---CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          527 -TPNRVAGYRAPEVTD---PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~---~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                       ...++..|+|||.+.   +..++.++||||||+++|||++|+.||.....     . ..+..............     
T Consensus       180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~-~~~~~~~~~~~~~~~~~-----  248 (289)
T 3og7_A          180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-----R-DQIIEMVGRGSLSPDLS-----  248 (289)
T ss_dssp             ----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-----H-HHHHHHHHHTSCCCCTT-----
T ss_pred             cccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-----H-HHHHHHhcccccCcchh-----
Confidence             234677899999986   56678899999999999999999999965322     1 12222222211111000     


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                       ......+.++.+++.+|++.||++|||++|+++.|+++..
T Consensus       249 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          249 -KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             -SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             -hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence             0112234578899999999999999999999999999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-38  Score=347.56  Aligned_cols=238  Identities=24%  Similarity=0.367  Sum_probs=198.2

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|... +|+.||||++....    .....+.+|+.+++.++||||+++++++......++||||+++
T Consensus        21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g  100 (476)
T 2y94_A           21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG  100 (476)
T ss_dssp             EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSS
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence            468999999999999954 79999999986542    2346789999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++...     ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++......   
T Consensus       101 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~  173 (476)
T 2y94_A          101 GELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR  173 (476)
T ss_dssp             EEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBC
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhcccccccc
Confidence            9999999753     25899999999999999999999998  9999999999999999999999999998775532   


Q ss_pred             CCCCCccccCccccCCCCC-CCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 TPNRVAGYRAPEVTDPCKV-SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      ...+++.|+|||++.+..+ +.++|||||||++|||++|+.||+..      +.......+......            .
T Consensus       174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~------~~~~~~~~i~~~~~~------------~  235 (476)
T 2y94_A          174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD------HVPTLFKKICDGIFY------------T  235 (476)
T ss_dssp             CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS------SSHHHHHHHHTTCCC------------C
T ss_pred             ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC------CHHHHHHHHhcCCcC------------C
Confidence            3457788999999988765 67999999999999999999999643      223333333322110            0


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      +.....++.+++.+|+..||++|||++|++++
T Consensus       236 p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          236 PQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            11122357788899999999999999999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.4e-39  Score=336.96  Aligned_cols=254  Identities=24%  Similarity=0.350  Sum_probs=200.7

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhc--CCCCCcccceEEEEecC----ccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGA--VNHENLVPLRAYYYSMD----EKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|... |+.||||++...  ....+.+|.+++..  ++||||+++++++....    ..++||||++
T Consensus        47 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~  123 (342)
T 1b6c_B           47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE  123 (342)
T ss_dssp             EEEEEEETTEEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCT
T ss_pred             EeeecCCCCcEEEEEEEc-CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecC
Confidence            578999999999999984 999999998653  34667788888876  79999999999998776    7899999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH--------AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH--------~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                      +|+|.+++...      .+++..++.++.|++.||.|||        +.+  |+||||||+||+++.++.+||+|||++.
T Consensus       124 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~  195 (342)
T 1b6c_B          124 HGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIADLGLAV  195 (342)
T ss_dssp             TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEEEEECCCce
Confidence            99999999753      3899999999999999999999        666  9999999999999999999999999997


Q ss_pred             ccCCCC--------CCCCCccccCccccCCCC------CCCcchhhhHHHHHHHHHhC----------CCCCccccCCCC
Q 006055          521 LVGPSS--------TPNRVAGYRAPEVTDPCK------VSQKADVYSFGVLLLELLTG----------KAPTHALLNEEG  576 (663)
Q Consensus       521 ~~~~~~--------~~~~~~~y~aPE~~~~~~------~~~~~Dv~slGvvl~elltg----------~~p~~~~~~~~~  576 (663)
                      ......        ...++..|+|||++.+..      ++.++|||||||++|||++|          ..||......+ 
T Consensus       196 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~-  274 (342)
T 1b6c_B          196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD-  274 (342)
T ss_dssp             EEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS-
T ss_pred             eccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc-
Confidence            664432        234677899999987653      23689999999999999999          67776543221 


Q ss_pred             CChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          577 VDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                      .....+...+........     ........+....+.+++.+||+.||++|||++||+++|+++.++.
T Consensus       275 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          275 PSVEEMRKVVCEQKLRPN-----IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             CCHHHHHHHHTTSCCCCC-----CCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ccHHHHHHHHHHHHhCCC-----CcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence            222333332222211111     1111112356678899999999999999999999999999986653

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7e-39  Score=349.20  Aligned_cols=238  Identities=22%  Similarity=0.288  Sum_probs=189.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc----ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV----TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .++||+|+||.||+|.. .+|+.||||+++..    ......+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus       153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~  232 (446)
T 4ejn_A          153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG  232 (446)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSS
T ss_pred             eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCC
Confidence            46899999999999994 57999999998753    22235678899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCcceecCCCCCCEEEcCCCceEEeccccccccCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA-QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS---  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~---  525 (663)
                      |+|.+++....     .+++..+..++.||+.||+|||+ .+  |+||||||+|||++.++.+||+|||+++.....   
T Consensus       233 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  305 (446)
T 4ejn_A          233 GELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT  305 (446)
T ss_dssp             CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred             CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCceeccCCCcc
Confidence            99999997533     58999999999999999999998 77  999999999999999999999999999864332   


Q ss_pred             -CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          526 -STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       526 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                       ....++.+|+|||++.+..++.++|||||||++|||++|+.||...      +.......+......            
T Consensus       306 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~------~~~~~~~~i~~~~~~------------  367 (446)
T 4ejn_A          306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHEKLFELILMEEIR------------  367 (446)
T ss_dssp             -CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC------------
T ss_pred             cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC------CHHHHHHHHHhCCCC------------
Confidence             2345788899999999999999999999999999999999999642      222333333322110            


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                      .+.....++.+++.+|+..||++||     +++|+++|
T Consensus       368 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          368 FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence            0111234678888999999999999     99999874

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=8.6e-39  Score=331.57  Aligned_cols=249  Identities=23%  Similarity=0.325  Sum_probs=192.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC----HHHHHHHHHHhhcCCCCCcccceEEEEecCcc----EEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPLRAYYYSMDEK----LLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~----~lv~e  445 (663)
                      .+.||+|+||.||+|.. .+++.||||+++.....    ...+.+|+.++..++||||+++++++......    ++|||
T Consensus        17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e   96 (311)
T 3ork_A           17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME   96 (311)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEe
Confidence            46899999999999994 67999999999765322    34688999999999999999999998776554    99999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+++|+|.++++...     .+++..+..++.|++.||.|||+++  |+||||||+||+++.++.+||+|||+++.....
T Consensus        97 ~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           97 YVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADS  169 (311)
T ss_dssp             CCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred             cCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence            999999999997532     5899999999999999999999998  999999999999999999999999999866443


Q ss_pred             C-------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          526 S-------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       526 ~-------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                      .       ...++..|+|||++.+..++.++||||||+++|||++|+.||....      ..............    .+
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~------~~~~~~~~~~~~~~----~~  239 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPI----PP  239 (311)
T ss_dssp             ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCC----CH
T ss_pred             ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhcCCCC----Cc
Confidence            2       1236778999999999899999999999999999999999996532      22222222222111    00


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHH-HHHHHHhhCCC
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSE-VIKRIEELHPS  644 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~e-v~~~L~~~~~~  644 (663)
                      .. .   ......++.+++.+|++.||++||++.+ +.+.+.++...
T Consensus       240 ~~-~---~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          240 SA-R---HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             HH-H---STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             cc-c---cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence            00 0   0112346788899999999999996555 44566665443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.3e-38  Score=324.90  Aligned_cols=239  Identities=25%  Similarity=0.361  Sum_probs=195.2

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|.. .+++.||||.+....    .....+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   93 (279)
T 3fdn_A           14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL   93 (279)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCC
Confidence            46899999999999985 457899999986432    2356789999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--C
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--T  527 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--~  527 (663)
                      |+|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++.......  .
T Consensus        94 ~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  166 (279)
T 3fdn_A           94 GTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD  166 (279)
T ss_dssp             EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred             CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccCCcccccc
Confidence            99999987533     4899999999999999999999998  9999999999999999999999999986654432  3


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|+.||...      +.......+.....            ..+.
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~------------~~~~  228 (279)
T 3fdn_A          167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN------TYQETYKRISRVEF------------TFPD  228 (279)
T ss_dssp             -CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHTCC------------CCCT
T ss_pred             cCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC------cHHHHHHHHHhCCC------------CCCC
Confidence            45678899999999989999999999999999999999999642      22222222221111            1111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      ....++.+++.+|++.||++|||++|++++-
T Consensus       229 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          229 FVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             cCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence            1234677889999999999999999999864

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-38  Score=331.16  Aligned_cols=247  Identities=24%  Similarity=0.407  Sum_probs=195.8

Q ss_pred             hcccccccceEEEEEEecC-----CcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVLEM-----GTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||+|+||.||+|....     +..||||.++....  ....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  128 (333)
T 1mqb_A           49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM  128 (333)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence            4689999999999998542     24699999975432  2456889999999999999999999999989999999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST  527 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  527 (663)
                      ++|+|.+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++.......
T Consensus       129 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  202 (333)
T 1mqb_A          129 ENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  202 (333)
T ss_dssp             TTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence            9999999997542    35899999999999999999999998  99999999999999999999999999987654321


Q ss_pred             -------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          528 -------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       528 -------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                             ..++..|+|||.+.+..++.++||||||+++|||++ |+.||....      .......+......       
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~------~~~~~~~~~~~~~~-------  269 (333)
T 1mqb_A          203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS------NHEVMKAINDGFRL-------  269 (333)
T ss_dssp             --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTTCCC-------
T ss_pred             cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC------HHHHHHHHHCCCcC-------
Confidence                   123556999999988889999999999999999999 999996432      12222222221110       


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                          .........+.+++.+||+.||++||++.|++++|+++...
T Consensus       270 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          270 ----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             ----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                11112334678899999999999999999999999987544

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.5e-39  Score=337.07  Aligned_cols=255  Identities=18%  Similarity=0.229  Sum_probs=191.9

Q ss_pred             hcccccccceEEEEEEec----CCcEEEEEEecCccc------------CHHHHHHHHHHhhcCCCCCcccceEEEEe--
Q 006055          375 AEVLGKGTFGTAYKAVLE----MGTIVAVKRLKDVTI------------SEREFKDKIEGVGAVNHENLVPLRAYYYS--  436 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~------------~~~~~~~e~~~l~~l~h~niv~l~~~~~~--  436 (663)
                      .+.||+|+||.||+|...    ++..||||.+.....            ....+.+|+..+..++||||+++++++..  
T Consensus        42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~  121 (345)
T 2v62_A           42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF  121 (345)
T ss_dssp             EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES
T ss_pred             EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc
Confidence            468999999999999964    578999999875421            12346678888999999999999999987  


Q ss_pred             --cCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC--ceE
Q 006055          437 --MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY--EAR  512 (663)
Q Consensus       437 --~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~--~~k  512 (663)
                        ....++||||+ +++|.+++....     .+++..++.++.||+.||.|||+.+  |+||||||+|||++.++  .+|
T Consensus       122 ~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          122 KGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             SSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSSTTSEE
T ss_pred             CCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCCCcEE
Confidence              67789999999 999999997543     5899999999999999999999998  99999999999999887  999


Q ss_pred             EeccccccccCCC-----------CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHH
Q 006055          513 VSDFGLAHLVGPS-----------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPR  581 (663)
Q Consensus       513 l~Dfg~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~  581 (663)
                      |+|||+++.....           ....++..|+|||++.+..++.++|||||||++|||++|+.||.......  ....
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~  271 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP--VAVQ  271 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH--HHHH
T ss_pred             EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc--HHHH
Confidence            9999999765332           12346778999999999889999999999999999999999996432111  0011


Q ss_pred             HHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          582 WVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       582 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      .........     +.............+.++.+++.+||..||++||++++|++.|+++...
T Consensus       272 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  329 (345)
T 2v62_A          272 TAKTNLLDE-----LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP  329 (345)
T ss_dssp             HHHHHHHHT-----TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred             HHHHhhccc-----ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence            111111110     0000000000112344788899999999999999999999999987553

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.7e-38  Score=329.40  Aligned_cols=242  Identities=23%  Similarity=0.332  Sum_probs=199.0

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc-------CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI-------SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|.. .+|+.||||.++....       ....+.+|+.++..++||||+++++++.+....++||||
T Consensus        17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   96 (321)
T 2a2a_A           17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL   96 (321)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEc
Confidence            57899999999999995 4689999999865421       367899999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC----ceEEecccccccc
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY----EARVSDFGLAHLV  522 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~----~~kl~Dfg~a~~~  522 (663)
                      +++++|.+++...     ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++    .+||+|||+++..
T Consensus        97 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~  169 (321)
T 2a2a_A           97 VSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (321)
T ss_dssp             CCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred             CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence            9999999999753     25899999999999999999999998  99999999999999888    7999999999876


Q ss_pred             CCCC---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          523 GPSS---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       523 ~~~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                      ....   ...++..|+|||.+.+..++.++||||||+++|||++|+.||....      .......+.....   ..+..
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~i~~~~~---~~~~~  240 (321)
T 2a2a_A          170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT------KQETLANITSVSY---DFDEE  240 (321)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHHHHHHTTCC---CCCHH
T ss_pred             CccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhccc---ccChh
Confidence            5542   2346788999999999899999999999999999999999996432      2222222222111   01111


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .     .......+.+++.+|+..||++|||++|++++
T Consensus       241 ~-----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          241 F-----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             H-----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             h-----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1     01123467888999999999999999999983

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.3e-38  Score=330.37  Aligned_cols=252  Identities=23%  Similarity=0.365  Sum_probs=192.1

Q ss_pred             hcccccccceEEEEEEec----CCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCc-----cEE
Q 006055          375 AEVLGKGTFGTAYKAVLE----MGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDE-----KLL  442 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~~l  442 (663)
                      .+.||+|+||.||+|...    +++.||||.++.....   .+.+.+|+.++++++||||+++++++.+...     .++
T Consensus        39 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~  118 (313)
T 3brb_A           39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV  118 (313)
T ss_dssp             EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEE
T ss_pred             ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEE
Confidence            468999999999999853    3558999998755333   3568899999999999999999999987553     499


Q ss_pred             EEEccCCCChhHhhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccc
Q 006055          443 VYDYLTMGSLSALLHGNK-GAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL  521 (663)
Q Consensus       443 v~ey~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~  521 (663)
                      ||||+++|+|.+++.... ......+++..++.++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++.
T Consensus       119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kl~Dfg~~~~  196 (313)
T 3brb_A          119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKK  196 (313)
T ss_dssp             EEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTTSCEEECSCSCC--
T ss_pred             EEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEEeecCccee
Confidence            999999999999985322 122356899999999999999999999998  99999999999999999999999999986


Q ss_pred             cCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          522 VGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       522 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                      .....      ...++..|+|||.+.+..++.++||||||+++|||++ |..||......      ............  
T Consensus       197 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~~~~~--  268 (313)
T 3brb_A          197 IYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH------EMYDYLLHGHRL--  268 (313)
T ss_dssp             --------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG------GHHHHHHTTCCC--
T ss_pred             cccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHHcCCCC--
Confidence            64332      1234567999999998889999999999999999999 88898653221      122222221110  


Q ss_pred             ccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       595 ~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                               ........++.+++.+|+..||++|||+.+++++|+++....
T Consensus       269 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          269 ---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             ---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence                     111223346888999999999999999999999999886543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.9e-39  Score=336.86  Aligned_cols=232  Identities=22%  Similarity=0.300  Sum_probs=193.7

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCccc---------CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEE
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI---------SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  444 (663)
                      .+.||+|+||.||+|. ..+|+.||||+++....         ....+.+|+++++.++||||+++++++.+....++||
T Consensus        29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  108 (335)
T 3dls_A           29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM  108 (335)
T ss_dssp             EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEE
Confidence            4689999999999998 46789999999876532         2235778999999999999999999999999999999


Q ss_pred             EccCCC-ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccC
Q 006055          445 DYLTMG-SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG  523 (663)
Q Consensus       445 ey~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~  523 (663)
                      ||+..| +|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus       109 e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          109 EKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             ECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence            999777 9999997543     4899999999999999999999998  9999999999999999999999999998776


Q ss_pred             CCCC---CCCCccccCccccCCCCC-CCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          524 PSST---PNRVAGYRAPEVTDPCKV-SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       524 ~~~~---~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                      ....   ..++..|+|||++.+..+ +.++|||||||++|||++|+.||.......                 .....  
T Consensus       182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----------------~~~~~--  242 (335)
T 3dls_A          182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-----------------EAAIH--  242 (335)
T ss_dssp             TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----------------TTCCC--
T ss_pred             CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----------------hhccC--
Confidence            5432   246788999999988776 788999999999999999999996532110                 00000  


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                           .+.....++.+++.+|+..||++|||++|++++
T Consensus       243 -----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          243 -----PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 001123367888899999999999999999995

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.5e-39  Score=347.61  Aligned_cols=244  Identities=21%  Similarity=0.269  Sum_probs=196.1

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .++||+|+||+||+|..+ +++.||||+++...    .....+.+|+.++..++||||++++++|.+.+..++||||+++
T Consensus        79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g  158 (437)
T 4aw2_A           79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG  158 (437)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence            468999999999999965 58999999997532    1223488999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.++++...    ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++......   
T Consensus       159 g~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~  232 (437)
T 4aw2_A          159 GDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  232 (437)
T ss_dssp             CBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred             CcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcc
Confidence            99999998532    35899999999999999999999998  9999999999999999999999999997765432   


Q ss_pred             --CCCCCccccCccccC-----CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          527 --TPNRVAGYRAPEVTD-----PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                        ...+|++|+|||++.     ...++.++|||||||++|||++|+.||...      +.......++........    
T Consensus       233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~------~~~~~~~~i~~~~~~~~~----  302 (437)
T 4aw2_A          233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE------SLVETYGKIMNHKERFQF----  302 (437)
T ss_dssp             CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHTHHHHCCC----
T ss_pred             cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC------ChhHHHHhhhhccccccC----
Confidence              235788899999986     556899999999999999999999999643      223333333322110000    


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDN--RPSMSEVIKR  637 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~--RPt~~ev~~~  637 (663)
                         .........++.+++.+|+..+|++  ||+++|+++|
T Consensus       303 ---p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          303 ---PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             ---CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ---CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence               0000112345677888999888888  9999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-38  Score=338.52  Aligned_cols=248  Identities=27%  Similarity=0.371  Sum_probs=183.0

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCC-CCCcccceEEEEecC--ccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVN-HENLVPLRAYYYSMD--EKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~ey~  447 (663)
                      .+.||+|+||.||+|.. .+|+.||||++.....   ....+.+|+.++..+. ||||+++++++...+  ..++||||+
T Consensus        14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~   93 (388)
T 3oz6_A           14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM   93 (388)
T ss_dssp             EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred             EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence            46899999999999984 5799999999865432   2456778999999997 999999999997654  679999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC--
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--  525 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~--  525 (663)
                      + |+|.++++..      .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++.....  
T Consensus        94 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           94 E-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             S-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             C-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence            8 5999999753      4899999999999999999999998  999999999999999999999999999865321  


Q ss_pred             -----------------------CCCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHH
Q 006055          526 -----------------------STPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPR  581 (663)
Q Consensus       526 -----------------------~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~  581 (663)
                                             ....+|..|+|||++.+ ..++.++|||||||++|||++|+.||....      ...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~------~~~  238 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS------TMN  238 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHH
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC------HHH
Confidence                                   11246777999999876 678999999999999999999999996532      222


Q ss_pred             HHHHHHhhccccc--------------------------------ccc---hhhhcccChHHHHHHHHHHHHHccCCCCC
Q 006055          582 WVQSIVKDEWTSE--------------------------------VFD---LELLRYQNVEEEMVQLLQLAIDCSAQYPD  626 (663)
Q Consensus       582 ~~~~~~~~~~~~~--------------------------------~~d---~~~~~~~~~~~~~~~l~~l~~~C~~~dP~  626 (663)
                      .+..+........                                .+.   ..............++.+++.+|+..||+
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            2222221100000                                000   00000000002234678899999999999


Q ss_pred             CCCCHHHHHHH
Q 006055          627 NRPSMSEVIKR  637 (663)
Q Consensus       627 ~RPt~~ev~~~  637 (663)
                      +|||++|+++|
T Consensus       319 ~R~t~~e~l~H  329 (388)
T 3oz6_A          319 KRISANDALKH  329 (388)
T ss_dssp             GSCCHHHHTTS
T ss_pred             cCCCHHHHhCC
Confidence            99999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.2e-38  Score=328.12  Aligned_cols=249  Identities=25%  Similarity=0.374  Sum_probs=195.8

Q ss_pred             hcccccccceEEEEEEecC----CcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEe-cCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVLEM----GTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYS-MDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ey~  447 (663)
                      .++||+|+||+||+|...+    ...||+|.+.....  ..+.+.+|+.++++++||||+++++++.. ....++||||+
T Consensus        30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~  109 (298)
T 3f66_A           30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  109 (298)
T ss_dssp             EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECC
T ss_pred             cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCC
Confidence            4689999999999998532    23689999876432  24678899999999999999999999654 45789999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-  526 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-  526 (663)
                      ++|+|.++++...    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++...... 
T Consensus       110 ~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  183 (298)
T 3f66_A          110 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY  183 (298)
T ss_dssp             TTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred             CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccccccch
Confidence            9999999997533    35799999999999999999999998  9999999999999999999999999998654321 


Q ss_pred             -------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhC-CCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          527 -------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTG-KAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       527 -------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                             ...++..|+|||.+.+..++.++||||||+++|||++| ..||.....   ...   ..........      
T Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~---~~~~~~~~~~------  251 (298)
T 3f66_A          184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDI---TVYLLQGRRL------  251 (298)
T ss_dssp             CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT---TTH---HHHHHTTCCC------
T ss_pred             hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH---HHH---HHHHhcCCCC------
Confidence                   22345679999999888899999999999999999994 555543221   111   1122211110      


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST  646 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~  646 (663)
                           ..+......+.+++.+|++.||++|||++|+++.|+++.....
T Consensus       252 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          252 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             -----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence                 0011123468889999999999999999999999999866543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.2e-38  Score=330.12  Aligned_cols=256  Identities=21%  Similarity=0.326  Sum_probs=195.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|.. .+|+.||||+++...    .....+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus        37 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  116 (310)
T 2wqm_A           37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA  116 (310)
T ss_dssp             EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCS
T ss_pred             EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCC
Confidence            46899999999999995 579999999987532    1245688999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++..... ....+++..++.++.+++.||.|||+.+  |+||||||+||+++.++.+||+|||+++......   
T Consensus       117 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  193 (310)
T 2wqm_A          117 GDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA  193 (310)
T ss_dssp             CBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC-------------
T ss_pred             CCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccc
Confidence            999999864211 1235899999999999999999999998  9999999999999999999999999997665432   


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       ...++..|+|||.+.+..++.++||||||+++|||++|+.||....    .........+....... .         .
T Consensus       194 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~-~---------~  259 (310)
T 2wqm_A          194 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEQCDYPP-L---------P  259 (310)
T ss_dssp             -----CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCHHHHHHHHHTTCSCC-C---------C
T ss_pred             cccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc----hhHHHHHHHhhcccCCC-C---------c
Confidence             2346778999999999899999999999999999999999996432    22223333322221110 0         0


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ  647 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~  647 (663)
                      ......++.+++.+||..||++|||++||+++|+++.+....
T Consensus       260 ~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~  301 (310)
T 2wqm_A          260 SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS  301 (310)
T ss_dssp             TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence            112234678889999999999999999999999998665433

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=333.03  Aligned_cols=246  Identities=23%  Similarity=0.389  Sum_probs=193.0

Q ss_pred             hcccccccceEEEEEEe-cCCcE----EEEEEecCc--ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTI----VAVKRLKDV--TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~----vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .++||+|+||+||+|.. .+++.    ||+|.+...  ....+.+.+|+.+++.++||||+++++++... ..++|+||+
T Consensus        20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~v~~~~   98 (327)
T 3lzb_A           20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM   98 (327)
T ss_dssp             EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEEEECCC
T ss_pred             EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceEEEEec
Confidence            36899999999999994 44554    577777543  33567899999999999999999999999865 488999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST  527 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  527 (663)
                      .+|+|.+++....    ..+++..++.++.|++.||.|||+++  |+||||||+|||++.++.+||+|||+++.......
T Consensus        99 ~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~  172 (327)
T 3lzb_A           99 PFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             SSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred             CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence            9999999997643    34899999999999999999999998  99999999999999999999999999987654322


Q ss_pred             ------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          528 ------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       528 ------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                            ..++..|+|||.+.+..++.++|||||||++|||++ |+.||......+      ....+.....         
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~~~~~~~---------  237 (327)
T 3lzb_A          173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKGER---------  237 (327)
T ss_dssp             -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTTCC---------
T ss_pred             cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCC---------
Confidence                  223557999999998899999999999999999999 999997543221      1111111111         


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                        .........++.+++.+||..||++||+++|+++.|+++...
T Consensus       238 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          238 --LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             --CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             --CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence              011112334678899999999999999999999999987643

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.8e-38  Score=330.18  Aligned_cols=254  Identities=23%  Similarity=0.382  Sum_probs=200.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEE--EEEEecCc--ccCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIV--AVKRLKDV--TISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~v--avK~l~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|.. .+|..+  |||.++..  ....+.+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus        30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~  109 (327)
T 1fvr_A           30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP  109 (327)
T ss_dssp             EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence            46899999999999994 456654  99998753  22345789999999999 99999999999999999999999999


Q ss_pred             CCChhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccc
Q 006055          449 MGSLSALLHGNKG-----------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFG  517 (663)
Q Consensus       449 ~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg  517 (663)
                      +|+|.+++.....           .....+++..++.++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||
T Consensus       110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kL~Dfg  187 (327)
T 1fvr_A          110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFG  187 (327)
T ss_dssp             TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTT
T ss_pred             CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCCCeEEEcccC
Confidence            9999999975430           12346899999999999999999999998  9999999999999999999999999


Q ss_pred             cccccCCC---CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccc
Q 006055          518 LAHLVGPS---STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTS  593 (663)
Q Consensus       518 ~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (663)
                      +++.....   ....++..|+|||++.+..++.++||||||+++|||++ |+.||....      .......+.....  
T Consensus       188 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~------~~~~~~~~~~~~~--  259 (327)
T 1fvr_A          188 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYEKLPQGYR--  259 (327)
T ss_dssp             CEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHGGGTCC--
T ss_pred             cCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc------HHHHHHHhhcCCC--
Confidence            99754322   22234667999999988888999999999999999998 999996432      2222222211110  


Q ss_pred             cccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 006055          594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ  647 (663)
Q Consensus       594 ~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~  647 (663)
                               .........++.+++.+|+..||++|||++|++++|+++......
T Consensus       260 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  304 (327)
T 1fvr_A          260 ---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  304 (327)
T ss_dssp             ---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             ---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence                     011112234678889999999999999999999999988665543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=341.70  Aligned_cols=264  Identities=17%  Similarity=0.251  Sum_probs=207.7

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecC--ccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMD--EKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ey~~~  449 (663)
                      .++||+|+||+||+|... +|+.||||+++...  ...+.+.+|+++++.++||||+++++++....  ..++||||+++
T Consensus        14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~   93 (396)
T 4eut_A           14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC   93 (396)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTT
T ss_pred             EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCC
Confidence            368999999999999954 59999999997542  34577889999999999999999999998765  67999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEE----cCCCceEEeccccccccCCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill----~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+|.+++.....  ...+++..++.++.|++.||+|||+.+  |+||||||+|||+    +.++.+||+|||+++.....
T Consensus        94 g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~  169 (396)
T 4eut_A           94 GSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD  169 (396)
T ss_dssp             EEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG
T ss_pred             CCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC
Confidence            999999975432  234899999999999999999999998  9999999999999    77888999999999876554


Q ss_pred             C---CCCCCccccCccccCC--------CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          526 S---TPNRVAGYRAPEVTDP--------CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       526 ~---~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                      .   ...++..|+|||++.+        ..++.++|||||||++|||++|+.||.......  .....+..+........
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~~p~~~  247 (396)
T 4eut_A          170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKIITGKPSGA  247 (396)
T ss_dssp             GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT--TCHHHHHHHHHSCCTTC
T ss_pred             CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc--chHHHHHHHhcCCCccc
Confidence            2   3346788999999754        456778999999999999999999997543222  22333334433321111


Q ss_pred             ccc------------hhhh-cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          595 VFD------------LELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       595 ~~d------------~~~~-~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      +..            .... ...........+.+++.+|++.||++||+++|+++.++++...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            000            0000 1112356677888999999999999999999999999988654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.8e-39  Score=332.33  Aligned_cols=250  Identities=23%  Similarity=0.279  Sum_probs=191.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc------cCHHHHHHHHHHhhcC---CCCCcccceEEEEecC-----c
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT------ISEREFKDKIEGVGAV---NHENLVPLRAYYYSMD-----E  439 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~------~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~-----~  439 (663)
                      .+.||+|+||+||+|.. .+|+.||||++....      .....+.+|+.+++.+   +||||+++++++....     .
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~   93 (308)
T 3g33_A           14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK   93 (308)
T ss_dssp             EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence            36899999999999994 679999999986432      1235677788777766   4999999999998765     4


Q ss_pred             cEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccc
Q 006055          440 KLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA  519 (663)
Q Consensus       440 ~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a  519 (663)
                      .++||||+. |+|.+++....   ...+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||++
T Consensus        94 ~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  167 (308)
T 3g33_A           94 VTLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLA  167 (308)
T ss_dssp             EEEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred             EEEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEEeeCccc
Confidence            789999998 59999998643   234899999999999999999999998  999999999999999999999999999


Q ss_pred             cccCCCCC---CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhc------
Q 006055          520 HLVGPSST---PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE------  590 (663)
Q Consensus       520 ~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------  590 (663)
                      +.......   ..++..|+|||++.+..++.++|||||||++|||++|+.||.....      ......+....      
T Consensus       168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          168 RIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE------ADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             TTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH------HHHHHHHHHHHCCCCTT
T ss_pred             cccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCChh
Confidence            87654432   2357789999999888899999999999999999999999965321      22222222110      


Q ss_pred             -cccccc--chhhhc--ccC----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          591 -WTSEVF--DLELLR--YQN----VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       591 -~~~~~~--d~~~~~--~~~----~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                       +.....  ......  ...    ..+...++.+++.+|++.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence             000000  000000  000    0122356788899999999999999999998

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.8e-38  Score=325.68  Aligned_cols=251  Identities=20%  Similarity=0.265  Sum_probs=194.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC----HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|.. .+++.||||.+......    .+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus        39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  118 (309)
T 2h34_A           39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLING  118 (309)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCC
T ss_pred             EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCC
Confidence            46899999999999995 47899999998755322    36788999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      ++|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++.......   
T Consensus       119 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  191 (309)
T 2h34_A          119 VDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ  191 (309)
T ss_dssp             EEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence            99999997532     5899999999999999999999998  9999999999999999999999999997665432   


Q ss_pred             --CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          527 --TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                        ...++..|+|||.+.+..++.++||||||+++|||++|+.||....       ...+...+.....    .+.    .
T Consensus       192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~----~~~----~  256 (309)
T 2h34_A          192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ-------LSVMGAHINQAIP----RPS----T  256 (309)
T ss_dssp             -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH-------HHHHHHHHHSCCC----CGG----G
T ss_pred             ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch-------HHHHHHHhccCCC----Ccc----c
Confidence              2346778999999999889999999999999999999999996532       1122222222111    000    0


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHhhCCCCCC
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRP-SMSEVIKRIEELHPSSTQ  647 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RP-t~~ev~~~L~~~~~~~~~  647 (663)
                      .......++.+++.+|+..||++|| +++++++.|+++......
T Consensus       257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~  300 (309)
T 2h34_A          257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ  300 (309)
T ss_dssp             TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred             cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence            0112234678889999999999999 999999999998776544

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-38  Score=323.87  Aligned_cols=244  Identities=23%  Similarity=0.327  Sum_probs=191.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||.||++.. .++..||+|++....  ...+.+.+|+++++.++||||+++++++.+....++||||+++|+
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~  106 (285)
T 3is5_A           27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE  106 (285)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCB
T ss_pred             cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCc
Confidence            47899999999999995 568999999987653  346789999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEE---cCCCceEEeccccccccCCCC--
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL---TKSYEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~--  526 (663)
                      |.+++..... ....+++..+..++.|++.||.|||+.+  |+||||||+||++   +.++.+||+|||+++......  
T Consensus       107 L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~  183 (285)
T 3is5_A          107 LLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS  183 (285)
T ss_dssp             HHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------
T ss_pred             HHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccC
Confidence            9998854211 1235899999999999999999999998  9999999999999   456789999999998765432  


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       ...++..|+|||.+. ..++.++||||||+++|||++|+.||....      ................ ..        
T Consensus       184 ~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~------~~~~~~~~~~~~~~~~-~~--------  247 (285)
T 3is5_A          184 TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS------LEEVQQKATYKEPNYA-VE--------  247 (285)
T ss_dssp             ---CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCCCC-C---------
T ss_pred             cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC------HHHHHhhhccCCcccc-cc--------
Confidence             234677899999986 467899999999999999999999996532      2222222211111000 00        


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ......++.+++.+|++.||++|||++|++++
T Consensus       248 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          248 CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             -CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00123467788999999999999999999873

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.8e-38  Score=320.18  Aligned_cols=241  Identities=22%  Similarity=0.271  Sum_probs=196.5

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCc-ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDV-TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||.||+|... ++..||+|++... ....+.+.+|+++++.++||||+++++++.+....++||||+++++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   93 (277)
T 3f3z_A           14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL   93 (277)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred             eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcH
Confidence            468999999999999954 5789999998765 34467899999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEE---cCCCceEEeccccccccCCCC---
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL---TKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      .+++....     .+++..+..++.|++.||.|||+.+  |+||||||+||++   +.++.+||+|||++.......   
T Consensus        94 ~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~  166 (277)
T 3f3z_A           94 FERVVHKR-----VFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR  166 (277)
T ss_dssp             HHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBC
T ss_pred             HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchh
Confidence            99887532     4899999999999999999999998  9999999999999   788899999999998765443   


Q ss_pred             CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ...++..|+|||.+.+. ++.++||||||+++|||++|+.||....      .......+.......   ....     .
T Consensus       167 ~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~---~~~~-----~  231 (277)
T 3f3z_A          167 TKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT------DSEVMLKIREGTFTF---PEKD-----W  231 (277)
T ss_dssp             CCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCCC---CHHH-----H
T ss_pred             ccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhCCCCC---Cchh-----h
Confidence            34467789999998765 8899999999999999999999996532      122222222221100   0000     0


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .....++.+++.+|++.||++|||+.|++++
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          232 LNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             hcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0123467888999999999999999999874

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.3e-39  Score=332.47  Aligned_cols=256  Identities=23%  Similarity=0.341  Sum_probs=198.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc-ccCHHHHHHHHHHhhcCCCCCcccceEEEEe----cCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV-TISEREFKDKIEGVGAVNHENLVPLRAYYYS----MDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||++.. .+|+.||||++... ....+.+.+|+++++.++||||+++++++..    ....++||||++
T Consensus        34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~  113 (317)
T 2buj_A           34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFK  113 (317)
T ss_dssp             EEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCT
T ss_pred             EEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCC
Confidence            46899999999999995 67999999988654 2335678999999999999999999999873    346789999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-  527 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  527 (663)
                      +|+|.+++..... ....+++..++.++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++....... 
T Consensus       114 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~  190 (317)
T 2buj_A          114 RGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG  190 (317)
T ss_dssp             TCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEES
T ss_pred             CCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecCcchhccccccc
Confidence            9999999875321 1345899999999999999999999998  99999999999999999999999999876542211 


Q ss_pred             ------------CCCCccccCccccCCCC---CCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccc
Q 006055          528 ------------PNRVAGYRAPEVTDPCK---VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT  592 (663)
Q Consensus       528 ------------~~~~~~y~aPE~~~~~~---~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  592 (663)
                                  ..++..|+|||.+.+..   ++.++||||||+++|||++|+.||....... ......    ..... 
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~----~~~~~-  264 (317)
T 2buj_A          191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVALA----VQNQL-  264 (317)
T ss_dssp             HHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHHH----HHCC--
T ss_pred             ccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhHH----hhccC-
Confidence                        12477799999987654   6889999999999999999999996532211 111111    11100 


Q ss_pred             ccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCC
Q 006055          593 SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQG  648 (663)
Q Consensus       593 ~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~~  648 (663)
                               ..........++.+++.+||..||++|||++|++++|+.+.+..+..
T Consensus       265 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~  311 (317)
T 2buj_A          265 ---------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ  311 (317)
T ss_dssp             ----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred             ---------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence                     00111122346888999999999999999999999999997765543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2e-38  Score=325.57  Aligned_cols=246  Identities=24%  Similarity=0.346  Sum_probs=197.8

Q ss_pred             ccccccceEEEEEEe---cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          377 VLGKGTFGTAYKAVL---EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       377 ~lg~G~~g~Vy~~~~---~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .||+|+||.||+|..   .+++.||||+++.....   .+.+.+|+++++.++||||+++++++ ..+..++||||++++
T Consensus        24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~  102 (291)
T 1xbb_A           24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG  102 (291)
T ss_dssp             EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred             ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence            799999999999963   34789999999765322   46789999999999999999999998 667789999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC---
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST---  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~---  527 (663)
                      +|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++.......   
T Consensus       103 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  175 (291)
T 1xbb_A          103 PLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  175 (291)
T ss_dssp             EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCccc
Confidence            9999997643     4899999999999999999999998  99999999999999999999999999987654322   


Q ss_pred             ----CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          528 ----PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       528 ----~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                          ..++..|+|||.+.+..++.++||||||+++|||++ |+.||.....      ......+..... .         
T Consensus       176 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~-~---------  239 (291)
T 1xbb_A          176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------SEVTAMLEKGER-M---------  239 (291)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTCC-C---------
T ss_pred             ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCC-C---------
Confidence                123467999999988888899999999999999999 9999965321      122222211111 0         


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQ  647 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~  647 (663)
                       ..+.....++.+++.+||+.||++||++.|+++.|+++......
T Consensus       240 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  283 (291)
T 1xbb_A          240 -GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  283 (291)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence             01122344688899999999999999999999999988655433

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.5e-38  Score=351.88  Aligned_cols=244  Identities=25%  Similarity=0.288  Sum_probs=200.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc----ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV----TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .++||+|+||.||+|.. .+|+.||||++...    ......+.+|++++..++||||+++++++.+.+..++||||+++
T Consensus       189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g  268 (576)
T 2acx_A          189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG  268 (576)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence            36899999999999995 47999999998653    23456788999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++....   ...+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++......   
T Consensus       269 g~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~  343 (576)
T 2acx_A          269 GDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK  343 (576)
T ss_dssp             CBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEE
T ss_pred             CcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceecccCcccc
Confidence            99999997543   235899999999999999999999998  9999999999999999999999999998775543   


Q ss_pred             CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      ...+|+.|+|||++.+..++.++|||||||++|||++|+.||......  .........+. ....           ...
T Consensus       344 ~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~--~~~~~i~~~i~-~~~~-----------~~p  409 (576)
T 2acx_A          344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK--IKREEVERLVK-EVPE-----------EYS  409 (576)
T ss_dssp             CCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC--CCHHHHHHHHH-HCCC-----------CCC
T ss_pred             ccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc--hhHHHHHHHhh-cccc-----------cCC
Confidence            245788899999999988999999999999999999999999764321  12222222221 1110           001


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                      .....++.+++.+|+..||++||     +++|+++|
T Consensus       410 ~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            12234678888899999999999     78898875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.4e-38  Score=321.07  Aligned_cols=241  Identities=24%  Similarity=0.402  Sum_probs=193.1

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEec----CccEEEEEcc
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSM----DEKLLVYDYL  447 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~----~~~~lv~ey~  447 (663)
                      +.||+|+||.||+|.. .++..||+|.+......   .+.+.+|+.+++.++||||+++++++...    ...++||||+
T Consensus        32 ~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~  111 (290)
T 1t4h_A           32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM  111 (290)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred             eeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEec
Confidence            5799999999999985 56889999998765433   45688999999999999999999998753    4479999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc-CCCceEEeccccccccCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT-KSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      ++|+|.+++....     .+++..+..++.+++.||.|||+.+++|+||||||+||+++ .++.+||+|||++.......
T Consensus       112 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~  186 (290)
T 1t4h_A          112 TSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF  186 (290)
T ss_dssp             CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred             CCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc
Confidence            9999999997532     48999999999999999999999876799999999999998 78999999999997655432


Q ss_pred             --CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          527 --TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                        ...++..|+|||.+.+ .++.++||||||+++|+|++|+.||....     +............. ...+        
T Consensus       187 ~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~-~~~~--------  251 (290)
T 1t4h_A          187 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVTSGVK-PASF--------  251 (290)
T ss_dssp             BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHTTTCC-CGGG--------
T ss_pred             cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC-----cHHHHHHHHhccCC-cccc--------
Confidence              2346788999998875 58999999999999999999999996432     22222222222111 1101        


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                       ......++.+++.+|+..||++|||++|++++
T Consensus       252 -~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          252 -DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence             01112367889999999999999999999874

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=337.23  Aligned_cols=244  Identities=15%  Similarity=0.163  Sum_probs=195.8

Q ss_pred             hcccccccceEEEEEE------ecCCcEEEEEEecCcccCHHHHHHHHHHhhcCC---CCCcccceEEEEecCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAV------LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN---HENLVPLRAYYYSMDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e  445 (663)
                      .++||+|+||+||+|.      ..+++.||||+++..  ...++..|++++..++   |+||+++++++...+..++|||
T Consensus        70 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e  147 (365)
T 3e7e_A           70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE  147 (365)
T ss_dssp             EEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEEC
T ss_pred             EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEe
Confidence            3689999999999993      556899999998754  4567888888888886   9999999999999999999999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC-----------CCceEEe
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK-----------SYEARVS  514 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~-----------~~~~kl~  514 (663)
                      |+++|+|.++++.........+++..+..++.||+.||+|||+.+  |+||||||+|||++.           ++.+||+
T Consensus       148 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~  225 (365)
T 3e7e_A          148 LYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI  225 (365)
T ss_dssp             CCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC------CTTEEEC
T ss_pred             ccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCccccccccCCEEEe
Confidence            999999999997533223456999999999999999999999998  999999999999998           8999999


Q ss_pred             ccccccccCC---C---CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHh
Q 006055          515 DFGLAHLVGP---S---STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK  588 (663)
Q Consensus       515 Dfg~a~~~~~---~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  588 (663)
                      |||+++....   .   ....+|.+|+|||++.+..++.++|||||||++|||++|+.||........            
T Consensus       226 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------------  293 (365)
T 3e7e_A          226 DLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------------  293 (365)
T ss_dssp             CCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------------
T ss_pred             eCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------------
Confidence            9999975431   1   234578889999999999999999999999999999999999965322110            


Q ss_pred             hcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHhhCCC
Q 006055          589 DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNR-PSMSEVIKRIEELHPS  644 (663)
Q Consensus       589 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~R-Pt~~ev~~~L~~~~~~  644 (663)
                        .....    +....    ....+.+++..|+..+|.+| |+++++.+.|+++.+.
T Consensus       294 --~~~~~----~~~~~----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          294 --KPEGL----FRRLP----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             --EECSC----CTTCS----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --eechh----ccccC----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence              00000    00111    12345567779999999998 6888888888876543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.5e-38  Score=337.34  Aligned_cols=236  Identities=24%  Similarity=0.275  Sum_probs=185.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHH-hhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEG-VGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .++||+|+||.||+|.. .+++.||||+++....    ....+..|..+ ++.++||||+++++++.+.+..++||||++
T Consensus        43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~  122 (373)
T 2r5t_A           43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN  122 (373)
T ss_dssp             EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCC
Confidence            46899999999999995 4688999999976532    23456667666 577899999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC---
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS---  525 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~---  525 (663)
                      +|+|.+++....     .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.....   
T Consensus       123 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~  195 (373)
T 2r5t_A          123 GGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST  195 (373)
T ss_dssp             SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCC
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCccccccccCCCc
Confidence            999999997532     4889999999999999999999998  999999999999999999999999999864322   


Q ss_pred             -CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          526 -STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       526 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                       ....+|..|+|||++.+..++.++|||||||++|||++|+.||...      +.......+......            
T Consensus       196 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~------~~~~~~~~i~~~~~~------------  257 (373)
T 2r5t_A          196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR------NTAEMYDNILNKPLQ------------  257 (373)
T ss_dssp             CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS------BHHHHHHHHHHSCCC------------
T ss_pred             cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC------CHHHHHHHHHhcccC------------
Confidence             2234788899999999999999999999999999999999999643      223333343332110            


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVI  635 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~  635 (663)
                      .......++.+++.+|+..||++||++.+.+
T Consensus       258 ~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          258 LKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             CCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence            0011233577888899999999999985433

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.6e-38  Score=329.45  Aligned_cols=251  Identities=23%  Similarity=0.353  Sum_probs=202.0

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|...      +++.||||.+.....  ....+.+|+.+++.++||||+++++++.+....++||||
T Consensus        30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  109 (322)
T 1p4o_A           30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL  109 (322)
T ss_dssp             EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEe
Confidence            468999999999999854      478899999875432  235688999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccc
Q 006055          447 LTMGSLSALLHGNKG-----AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL  521 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~  521 (663)
                      +++|+|.++++....     .....+++..+..++.|++.||.|||+++  |+||||||+||+++.++.+||+|||+++.
T Consensus       110 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~~~kl~Dfg~~~~  187 (322)
T 1p4o_A          110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRD  187 (322)
T ss_dssp             CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCCEEECCTTCCCG
T ss_pred             CCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCCCeEEECcCccccc
Confidence            999999999874220     11235789999999999999999999998  99999999999999999999999999976


Q ss_pred             cCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          522 VGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       522 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                      .....      ...++..|+|||.+.+..++.++||||||+++|||++ |+.||...      +.......+....... 
T Consensus       188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~------~~~~~~~~~~~~~~~~-  260 (322)
T 1p4o_A          188 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------SNEQVLRFVMEGGLLD-  260 (322)
T ss_dssp             GGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------CHHHHHHHHHTTCCCC-
T ss_pred             cccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC------CHHHHHHHHHcCCcCC-
Confidence            54322      1224567999999988889999999999999999999 88998643      2222232222221110 


Q ss_pred             ccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       595 ~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                                ........+.+++.+|+..||++|||+.|++++|+++...
T Consensus       261 ----------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          261 ----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             ----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence                      1112334678899999999999999999999999987553

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.5e-38  Score=321.52  Aligned_cols=242  Identities=25%  Similarity=0.316  Sum_probs=197.2

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||.||+|.. .+|+.||+|++......   ...+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   90 (284)
T 3kk8_A           11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG   90 (284)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCC
Confidence            36899999999999995 46899999999765433   356789999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc---eEEeccccccccCCCCC
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLAHLVGPSST  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~---~kl~Dfg~a~~~~~~~~  527 (663)
                      +|.+.+....     .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.   +||+|||++........
T Consensus        91 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           91 ELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            9998887532     4899999999999999999999998  999999999999987665   99999999987655432


Q ss_pred             ---CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          528 ---PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       528 ---~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                         ..++..|+|||.+.+..++.++||||||+++|+|++|+.||...      +.......+........  .      .
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~------~~~~~~~~~~~~~~~~~--~------~  229 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE------DQHRLYAQIKAGAYDYP--S------P  229 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCCCC--T------T
T ss_pred             ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC------chhHHHHHHHhccccCC--c------h
Confidence               35677899999999999999999999999999999999999642      22222222222211100  0      0


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .......++.+++.+|++.||++|||++|++++
T Consensus       230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          230 EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            011223467788899999999999999999985

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.1e-38  Score=343.96  Aligned_cols=247  Identities=21%  Similarity=0.285  Sum_probs=187.9

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecC------ccEEEE
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMD------EKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  444 (663)
                      .+.||+|+||+||+|. ..+|+.||||++.....   ..+.+.+|+.+++.++||||+++++++....      +.++||
T Consensus        67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~  146 (464)
T 3ttj_A           67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM  146 (464)
T ss_dssp             EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred             EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEE
Confidence            4689999999999998 45699999999976432   2467889999999999999999999996553      459999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+++ +|.+.+..       .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++....
T Consensus       147 E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          147 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             ECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             eCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            99987 56666642       3889999999999999999999998  99999999999999999999999999987765


Q ss_pred             CC---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh------------
Q 006055          525 SS---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD------------  589 (663)
Q Consensus       525 ~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------  589 (663)
                      ..   ...+|..|+|||++.+..++.++||||+||++|||++|+.||.+..      ....+..++..            
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~------~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD------YIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCCCHHHHHHc
Confidence            42   2356788999999999999999999999999999999999996532      12222222111            


Q ss_pred             ----------cccccccch-hhh-----ccc--ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          590 ----------EWTSEVFDL-ELL-----RYQ--NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       590 ----------~~~~~~~d~-~~~-----~~~--~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                                ......... ...     ...  .......++.+++.+|+..||++|||++|+++|
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                      000000000 000     000  011225578899999999999999999999985

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=325.13  Aligned_cols=238  Identities=23%  Similarity=0.388  Sum_probs=177.7

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|.. .+|+.||||.+....    .....+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus        16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   95 (278)
T 3cok_A           16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN   95 (278)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCC
Confidence            36899999999999995 579999999986432    2246789999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      ++|.+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++.......   
T Consensus        96 ~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  169 (278)
T 3cok_A           96 GEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH  169 (278)
T ss_dssp             EEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             CcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence            99999997542    35899999999999999999999998  9999999999999999999999999998765322   


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       ...++..|+|||.+.+..++.++||||||+++|||++|+.||......+      ........    .        ...
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~----~--------~~~  231 (278)
T 3cok_A          170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN------TLNKVVLA----D--------YEM  231 (278)
T ss_dssp             ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCSS----C--------CCC
T ss_pred             eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH------HHHHHhhc----c--------cCC
Confidence             2346778999999998889999999999999999999999997543211      01110000    0        001


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      +.....++.+++.+|+..||++|||++|+++
T Consensus       232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            1112346778899999999999999999988

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.6e-39  Score=326.34  Aligned_cols=245  Identities=26%  Similarity=0.404  Sum_probs=192.8

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEec-CccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSM-DEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ey~~~gsL~  453 (663)
                      .+.||+|+||.||++... |+.||||.++... ..+.+.+|+++++.++||||+++++++.+. ...++||||+++|+|.
T Consensus        26 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~  103 (278)
T 1byg_A           26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV  103 (278)
T ss_dssp             EEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred             EeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHH
Confidence            468999999999999875 8999999987543 456789999999999999999999997654 4689999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-CCCCCc
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-TPNRVA  532 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~  532 (663)
                      +++....   ...+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++....... ...++.
T Consensus       104 ~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  178 (278)
T 1byg_A          104 DYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV  178 (278)
T ss_dssp             HHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC------------CCT
T ss_pred             HHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeeccccccccccccCCCccc
Confidence            9997532   123789999999999999999999998  9999999999999999999999999997665432 234567


Q ss_pred             cccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHH
Q 006055          533 GYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMV  611 (663)
Q Consensus       533 ~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  611 (663)
                      .|+|||.+.+..++.++||||||+++|||++ |+.||.....      ......+... ...          ........
T Consensus       179 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------~~~~~~~~~~-~~~----------~~~~~~~~  241 (278)
T 1byg_A          179 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRVEKG-YKM----------DAPDGCPP  241 (278)
T ss_dssp             TTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG------GGHHHHHTTT-CCC----------CCCTTCCH
T ss_pred             cccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhcC-CCC----------CCcccCCH
Confidence            7999999988889999999999999999998 9999965321      1122222111 100          11122334


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          612 QLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       612 ~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      .+.+++.+|++.||++|||+.|+++.|+++..
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          242 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            68888999999999999999999999998854

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=336.39  Aligned_cols=265  Identities=17%  Similarity=0.150  Sum_probs=203.0

Q ss_pred             hcccccccceEEEEEEec---------CCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCccc---------------c
Q 006055          375 AEVLGKGTFGTAYKAVLE---------MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVP---------------L  430 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~---------~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~---------------l  430 (663)
                      .+.||+|+||.||+|...         +++.||||.+...    ..+.+|++++..++||||++               +
T Consensus        47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~  122 (352)
T 2jii_A           47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTC  122 (352)
T ss_dssp             EEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCC
T ss_pred             EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccCccch
Confidence            468999999999999965         3889999998754    46889999999999999887               6


Q ss_pred             eEEEEe-cCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC
Q 006055          431 RAYYYS-MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY  509 (663)
Q Consensus       431 ~~~~~~-~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~  509 (663)
                      ++++.. ....++||||+ +|+|.+++....   ...+++..+..++.||+.||.|||+++  |+||||||+||+++.++
T Consensus       123 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIl~~~~~  196 (352)
T 2jii_A          123 MGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPED  196 (352)
T ss_dssp             CEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGEEEETTE
T ss_pred             hhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEcCCC
Confidence            777776 67789999999 999999998642   235899999999999999999999998  99999999999999998


Q ss_pred             --ceEEeccccccccCCC-----------CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCC
Q 006055          510 --EARVSDFGLAHLVGPS-----------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEG  576 (663)
Q Consensus       510 --~~kl~Dfg~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~  576 (663)
                        .+||+|||+++.....           ....++..|+|||++.+..++.++|||||||++|||++|+.||....... 
T Consensus       197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  275 (352)
T 2jii_A          197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT-  275 (352)
T ss_dssp             EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-
T ss_pred             CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH-
Confidence              8999999999765432           11246778999999999899999999999999999999999997643111 


Q ss_pred             CChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCCCCCCCCCC
Q 006055          577 VDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQPDD  656 (663)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~  656 (663)
                      ..+........ . ......+... ..   .....++.+++.+|+..||++|||++|+++.|+++............+++
T Consensus       276 ~~~~~~~~~~~-~-~~~~~~~~~~-~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~  349 (352)
T 2jii_A          276 EDIMKQKQKFV-D-KPGPFVGPCG-HW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLP  349 (352)
T ss_dssp             HHHHHHHHHHH-H-SCCCEECTTS-CE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCC
T ss_pred             HHHHHHHHhcc-C-Chhhhhhhcc-cc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCc
Confidence            01111111111 1 1111111000 00   01234678888899999999999999999999999777665555555444

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=333.95  Aligned_cols=240  Identities=20%  Similarity=0.327  Sum_probs=190.0

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCC--CCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNH--ENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||++...+++.||||++......   .+.+.+|+.++..++|  +||+++++++.+....++||| +.+
T Consensus        14 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~   92 (343)
T 3dbq_A           14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN   92 (343)
T ss_dssp             EEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred             EEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCC
Confidence            3689999999999999888999999998755333   3568899999999977  999999999999999999999 567


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+|||++ ++.+||+|||+++......   
T Consensus        93 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  164 (343)
T 3dbq_A           93 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  164 (343)
T ss_dssp             EEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence            89999998643     5899999999999999999999998  99999999999997 6789999999998765432   


Q ss_pred             ---CCCCCccccCccccCC-----------CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccc
Q 006055          527 ---TPNRVAGYRAPEVTDP-----------CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT  592 (663)
Q Consensus       527 ---~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  592 (663)
                         ...++..|+|||++.+           ..++.++|||||||++|||++|+.||....     +....+.........
T Consensus       165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~~~~~~~~~  239 (343)
T 3dbq_A          165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNHE  239 (343)
T ss_dssp             -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHHCTTSC
T ss_pred             cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-----hHHHHHHHHhcCCcc
Confidence               2347888999999854           568889999999999999999999996432     112222222211111


Q ss_pred             ccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          593 SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       593 ~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      ...          +.....++.+++.+||..||++|||+.|++++-
T Consensus       240 ~~~----------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          240 IEF----------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             CCC----------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             cCC----------cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence            110          111123577888999999999999999999874

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.5e-38  Score=328.68  Aligned_cols=247  Identities=23%  Similarity=0.354  Sum_probs=191.3

Q ss_pred             cccccccceEEEEEE-ecCCcEEEEEEecCcc-cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT-ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      ++||+|+||.||+|. ..+++.||||++.... .....+.+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (316)
T 2ac3_A           19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI   98 (316)
T ss_dssp             CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence            579999999999999 4579999999997653 3467889999999884 799999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc---eEEeccccccccCCCC---
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~---~kl~Dfg~a~~~~~~~---  526 (663)
                      .+++....     .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.   +||+|||+++......   
T Consensus        99 ~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  171 (316)
T 2ac3_A           99 LSHIHKRR-----HFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS  171 (316)
T ss_dssp             HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred             HHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence            99997532     4899999999999999999999998  999999999999998776   9999999987653211   


Q ss_pred             --------CCCCCccccCccccCC-----CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCC-C--------hHHHHH
Q 006055          527 --------TPNRVAGYRAPEVTDP-----CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGV-D--------LPRWVQ  584 (663)
Q Consensus       527 --------~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~-~--------~~~~~~  584 (663)
                              ...++..|+|||++.+     ..++.++|||||||++|||++|+.||......+.. .        ......
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  251 (316)
T 2ac3_A          172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE  251 (316)
T ss_dssp             ----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHH
T ss_pred             cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHH
Confidence                    1236778999999864     45788999999999999999999999765332210 0        001111


Q ss_pred             HHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          585 SIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       585 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .+.....  .....   .   ......++.+++.+|+..||++|||++|++++
T Consensus       252 ~i~~~~~--~~~~~---~---~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          252 SIQEGKY--EFPDK---D---WAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHCCC--CCCHH---H---HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhccCc--ccCch---h---cccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            1111110  00000   0   01123467889999999999999999999983

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-38  Score=333.36  Aligned_cols=247  Identities=22%  Similarity=0.258  Sum_probs=193.2

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc------ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV------TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||+|+||+||+|.. .+++.||+|++...      ....+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus        31 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  110 (345)
T 3hko_A           31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC  110 (345)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCC
Confidence            57899999999999995 56889999998643      123467899999999999999999999999999999999999


Q ss_pred             CCCChhHhhccCCCC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCc
Q 006055          448 TMGSLSALLHGNKGA-----------------------------------GRTPLNWEMRSLIALGAARGIEYLHAQGPN  492 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~  492 (663)
                      ++|+|.+++......                                   ....+++..+..++.|++.||.|||+.+  
T Consensus       111 ~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--  188 (345)
T 3hko_A          111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--  188 (345)
T ss_dssp             CSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             CCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence            999999998521100                                   0112457778889999999999999998  


Q ss_pred             ceecCCCCCCEEEcCCC--ceEEeccccccccCCC--------CCCCCCccccCccccCC--CCCCCcchhhhHHHHHHH
Q 006055          493 VSHGNIKSSNILLTKSY--EARVSDFGLAHLVGPS--------STPNRVAGYRAPEVTDP--CKVSQKADVYSFGVLLLE  560 (663)
Q Consensus       493 iiHrdlk~~Nill~~~~--~~kl~Dfg~a~~~~~~--------~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvvl~e  560 (663)
                      |+||||||+||+++.++  .+||+|||+++.....        ....++..|+|||.+.+  ..++.++|||||||++||
T Consensus       189 ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~e  268 (345)
T 3hko_A          189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL  268 (345)
T ss_dssp             EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHH
T ss_pred             ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHH
Confidence            99999999999998776  8999999999865321        22346778999999875  678899999999999999


Q ss_pred             HHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          561 LLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       561 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      |++|+.||....      .......+........  .      ........++.+++.+|+..||++|||+.|++++
T Consensus       269 l~~g~~pf~~~~------~~~~~~~~~~~~~~~~--~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          269 LLMGAVPFPGVN------DADTISQVLNKKLCFE--N------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             HHHSSCSSCCSS------HHHHHHHHHHCCCCTT--S------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred             HHHCCCCCCCCC------hHHHHHHHHhcccccC--C------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            999999996532      2223333332221110  0      1111223467888999999999999999999985

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2e-38  Score=323.71  Aligned_cols=245  Identities=23%  Similarity=0.365  Sum_probs=195.3

Q ss_pred             hcccccccceEEEEEEecC----CcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLEM----GTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|...+    +..||||.++...  ...+.+.+|+.+++.++||||+++++++.+ +..++||||++
T Consensus        17 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   95 (281)
T 3cc6_A           17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYP   95 (281)
T ss_dssp             EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCC
Confidence            4689999999999998542    3469999987642  235678999999999999999999999764 56799999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--  526 (663)
                      +++|.+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++.......  
T Consensus        96 ~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  169 (281)
T 3cc6_A           96 YGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY  169 (281)
T ss_dssp             TCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred             CCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence            999999997532    34899999999999999999999998  9999999999999999999999999998765432  


Q ss_pred             ---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          527 ---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       527 ---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                         ...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+      ....+......          
T Consensus       170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~------~~~~~~~~~~~----------  233 (281)
T 3cc6_A          170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD------VIGVLEKGDRL----------  233 (281)
T ss_dssp             ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG------HHHHHHHTCCC----------
T ss_pred             ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH------HHHHHhcCCCC----------
Confidence               2234567999999988889999999999999999998 999996532211      11111111110          


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                       .........+.+++.+|+..||++|||+.|++++|+++..
T Consensus       234 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          234 -PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence             0111123467888999999999999999999999998743

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-38  Score=332.44  Aligned_cols=253  Identities=23%  Similarity=0.339  Sum_probs=190.0

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecC------ccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMD------EKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  444 (663)
                      .+.||+|+||.||+|.. .+|+.||||++......   .+.+.+|+++++.++||||+++++++....      ..++||
T Consensus        30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~  109 (367)
T 1cm8_A           30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM  109 (367)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEE
Confidence            36799999999999995 57999999998654333   456889999999999999999999997653      459999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+ +++|.+++...      .+++..+..++.||+.||.|||+.+  |+||||||+||+++.++.+||+|||+++....
T Consensus       110 e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          110 PFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             ECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence            999 78999999753      4899999999999999999999998  99999999999999999999999999987654


Q ss_pred             CC-CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc--ccc----cc
Q 006055          525 SS-TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW--TSE----VF  596 (663)
Q Consensus       525 ~~-~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~----~~  596 (663)
                      .. ...++..|+|||++.+ ..++.++||||+||+++||++|+.||....      ....+..+.....  ..+    +.
T Consensus       181 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~l~~i~~~~g~~~~~~~~~~~  254 (367)
T 1cm8_A          181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD------HLDQLKEIMKVTGTPPAEFVQRLQ  254 (367)
T ss_dssp             SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCCCHHHHHHhh
Confidence            33 3456788999999876 678999999999999999999999996532      2222222221100  000    00


Q ss_pred             ch-------hhh-----cc-cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhC
Q 006055          597 DL-------ELL-----RY-QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR--IEELH  642 (663)
Q Consensus       597 d~-------~~~-----~~-~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~--L~~~~  642 (663)
                      ..       .+.     .. ........++.+++.+|+..||++|||++|+++|  ++++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence            00       000     00 0011223467888899999999999999999985  44443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.4e-38  Score=330.33  Aligned_cols=251  Identities=24%  Similarity=0.374  Sum_probs=199.7

Q ss_pred             hcccccccceEEEEEEe------cCCcEEEEEEecCccc--CHHHHHHHHHHhhcC-CCCCcccceEEEEecCc-cEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAV-NHENLVPLRAYYYSMDE-KLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~-~~lv~  444 (663)
                      .+.||+|+||.||+|..      .+++.||||+++....  ..+.+.+|+.++..+ +||||+++++++...+. .++||
T Consensus        32 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~  111 (316)
T 2xir_A           32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV  111 (316)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred             eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEE
Confidence            46899999999999984      3568999999976532  235788999999999 78999999999877554 89999


Q ss_pred             EccCCCChhHhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEE
Q 006055          445 DYLTMGSLSALLHGNKGA-----------GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARV  513 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl  513 (663)
                      ||+++|+|.+++......           ....+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl  189 (316)
T 2xir_A          112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKI  189 (316)
T ss_dssp             ECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEE
T ss_pred             EcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEE
Confidence            999999999999864321           0123789999999999999999999998  999999999999999999999


Q ss_pred             eccccccccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHH
Q 006055          514 SDFGLAHLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSI  586 (663)
Q Consensus       514 ~Dfg~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  586 (663)
                      +|||+++.......      ..++..|+|||++.+..++.++||||||+++|||++ |+.||......      ..+...
T Consensus       190 ~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------~~~~~~  263 (316)
T 2xir_A          190 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRR  263 (316)
T ss_dssp             CCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS------HHHHHH
T ss_pred             CCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh------HHHHHH
Confidence            99999987654322      124567999999988889999999999999999998 99999653221      111122


Q ss_pred             HhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          587 VKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      +.......          .......++.+++.+||+.||++|||+.|++++|+++.+
T Consensus       264 ~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          264 LKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             HHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hccCccCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            22211110          011123467888999999999999999999999998754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.6e-38  Score=325.30  Aligned_cols=253  Identities=22%  Similarity=0.324  Sum_probs=192.5

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||+||+|... +|+.||||++......   .+.+.+|+++++.++||||+++++++.+....++||||++++
T Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (311)
T 4agu_A            8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT   87 (311)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred             eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCc
Confidence            368999999999999964 5999999998765433   456889999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----  526 (663)
                      +|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++......    
T Consensus        88 ~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           88 VLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             HHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             hHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            9999887533     4899999999999999999999998  9999999999999999999999999998765332    


Q ss_pred             CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh------------cccc
Q 006055          527 TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD------------EWTS  593 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~  593 (663)
                      ...++..|+|||++.+ ..++.++||||||+++|||++|+.||......+   ....+......            .+..
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD---QLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhcccccccccccccccccc
Confidence            2346778999999865 567999999999999999999999997532211   11111111100            0000


Q ss_pred             c--ccchhhhc--ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          594 E--VFDLELLR--YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       594 ~--~~d~~~~~--~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .  ..++....  .........++.+++.+|++.||++|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0  00000000  00001234467889999999999999999999985

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.3e-38  Score=347.33  Aligned_cols=244  Identities=19%  Similarity=0.258  Sum_probs=199.1

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      ++||+|+||.||+|.. .+|+.||+|++....    .....+.+|+++++.++||||+++++++.+....++||||+++|
T Consensus       191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg  270 (543)
T 3c4z_A          191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG  270 (543)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred             EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence            5799999999999996 469999999996542    33567889999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC---
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST---  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~---  527 (663)
                      +|.+++..... ....+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++.......   
T Consensus       271 ~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~  347 (543)
T 3c4z_A          271 DIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK  347 (543)
T ss_dssp             BHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBC
T ss_pred             CHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccc
Confidence            99999875431 2346899999999999999999999998  99999999999999999999999999987654422   


Q ss_pred             -CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          528 -PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       528 -~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                       ..+|+.|+|||++.+..++.++|||||||++|||++|+.||.....  ..........+.....            ..+
T Consensus       348 ~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~--~~~~~~~~~~i~~~~~------------~~p  413 (543)
T 3c4z_A          348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE--KVENKELKQRVLEQAV------------TYP  413 (543)
T ss_dssp             CCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC--CCCHHHHHHHHHHCCC------------CCC
T ss_pred             cccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc--chhHHHHHHHHhhccc------------CCC
Confidence             3578889999999999999999999999999999999999976422  1222333333332211            011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSM-----SEVIK  636 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~-----~ev~~  636 (663)
                      ......+.+++.+|+..||++||++     +++++
T Consensus       414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            1223467788889999999999975     66665

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7.1e-40  Score=349.17  Aligned_cols=237  Identities=14%  Similarity=0.165  Sum_probs=183.2

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc----ccCHHHHHHHH---HHhhcCCCCCcccce-------EEEEecCc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV----TISEREFKDKI---EGVGAVNHENLVPLR-------AYYYSMDE  439 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~~~~~~~  439 (663)
                      .+.||+|+||+||+|.. .+|+.||||++...    ....+.+.+|+   +.++.++||||++++       +++.+.+.
T Consensus        78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  157 (377)
T 3byv_A           78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  157 (377)
T ss_dssp             EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred             cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence            46899999999999994 67999999998743    22346788999   456666899999998       66655432


Q ss_pred             -----------------cEEEEEccCCCChhHhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCC
Q 006055          440 -----------------KLLVYDYLTMGSLSALLHGNKGA--GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKS  500 (663)
Q Consensus       440 -----------------~~lv~ey~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~  500 (663)
                                       .++||||+ +|+|.+++......  ....+++..++.|+.||+.||+|||+++  |+||||||
T Consensus       158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp  234 (377)
T 3byv_A          158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRP  234 (377)
T ss_dssp             CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred             ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence                             78999999 57999999753211  1123557888999999999999999998  99999999


Q ss_pred             CCEEEcCCCceEEeccccccccCCCC-CCCCCccccCccccCCC-----------CCCCcchhhhHHHHHHHHHhCCCCC
Q 006055          501 SNILLTKSYEARVSDFGLAHLVGPSS-TPNRVAGYRAPEVTDPC-----------KVSQKADVYSFGVLLLELLTGKAPT  568 (663)
Q Consensus       501 ~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~y~aPE~~~~~-----------~~~~~~Dv~slGvvl~elltg~~p~  568 (663)
                      +|||++.++.+||+|||+++...... ...+ ..|+|||++.+.           .++.++|||||||++|||++|+.||
T Consensus       235 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf  313 (377)
T 3byv_A          235 VDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI  313 (377)
T ss_dssp             GGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             HHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCC
Confidence            99999999999999999998755432 2335 889999999877           7899999999999999999999999


Q ss_pred             ccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          569 HALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ..........               .+..    ..   .....++.+++.+||..||++|||+.|++++
T Consensus       314 ~~~~~~~~~~---------------~~~~----~~---~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          314 TKDAALGGSE---------------WIFR----SC---KNIPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             ------CCSG---------------GGGS----SC---CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             cccccccchh---------------hhhh----hc---cCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            7543221100               0000    00   1123467788899999999999999999873

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.4e-39  Score=335.95  Aligned_cols=248  Identities=23%  Similarity=0.351  Sum_probs=182.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCC-CCCcccceEEEEe--------cCccEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVN-HENLVPLRAYYYS--------MDEKLLV  443 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--------~~~~~lv  443 (663)
                      .++||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.++.++. ||||+++++++..        ....++|
T Consensus        33 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv  112 (337)
T 3ll6_A           33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL  112 (337)
T ss_dssp             EEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEE
T ss_pred             EEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEE
Confidence            46899999999999995 579999999986543 33467889999999996 9999999999853        2336899


Q ss_pred             EEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccC
Q 006055          444 YDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG  523 (663)
Q Consensus       444 ~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~  523 (663)
                      |||+. |+|.+++.....  ...+++..++.++.||+.||.|||+.+++|+||||||+|||++.++.+||+|||+++...
T Consensus       113 ~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  189 (337)
T 3ll6_A          113 TELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS  189 (337)
T ss_dssp             EECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCS
T ss_pred             EEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceecc
Confidence            99996 699998864221  235899999999999999999999987679999999999999999999999999998765


Q ss_pred             CCC----------------CCCCCccccCcccc---CCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHH
Q 006055          524 PSS----------------TPNRVAGYRAPEVT---DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQ  584 (663)
Q Consensus       524 ~~~----------------~~~~~~~y~aPE~~---~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~  584 (663)
                      ...                ...++..|+|||++   .+..++.++|||||||++|||++|+.||.......      .  
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~--  261 (337)
T 3ll6_A          190 HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR------I--  261 (337)
T ss_dssp             SCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred             ccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH------h--
Confidence            432                12366779999998   56678889999999999999999999996532111      0  


Q ss_pred             HHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          585 SIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       585 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                        .......          .........+.+++.+|++.||++|||++|++++|+++....
T Consensus       262 --~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          262 --VNGKYSI----------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             ------CCC----------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             --hcCcccC----------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence              0010000          000111124678889999999999999999999999886544

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.9e-38  Score=338.84  Aligned_cols=257  Identities=22%  Similarity=0.288  Sum_probs=197.6

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccCHHHHHHHHHHhhcCC--------CCCcccceEEEE----ecCccE
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN--------HENLVPLRAYYY----SMDEKL  441 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~----~~~~~~  441 (663)
                      .++||+|+||+||+|. ..+++.||||+++......+.+.+|+++++.++        |+||+++++++.    +....+
T Consensus        42 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~  121 (397)
T 1wak_A           42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC  121 (397)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEE
T ss_pred             EEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEE
Confidence            4689999999999998 456899999999866555677889999998885        788999999987    455789


Q ss_pred             EEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCcceecCCCCCCEEEcCCC-----------
Q 006055          442 LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ-GPNVSHGNIKSSNILLTKSY-----------  509 (663)
Q Consensus       442 lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~iiHrdlk~~Nill~~~~-----------  509 (663)
                      +||||+ +++|.+.+....   ...+++..++.++.||+.||.|||++ +  |+||||||+|||++.++           
T Consensus       122 lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~~~~~~~~~  195 (397)
T 1wak_A          122 MVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEAT  195 (397)
T ss_dssp             EEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred             EEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhhhhhhhhhH
Confidence            999999 556666655432   23589999999999999999999998 7  99999999999999775           


Q ss_pred             --------------------------------------ceEEeccccccccCCCC-CCCCCccccCccccCCCCCCCcch
Q 006055          510 --------------------------------------EARVSDFGLAHLVGPSS-TPNRVAGYRAPEVTDPCKVSQKAD  550 (663)
Q Consensus       510 --------------------------------------~~kl~Dfg~a~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~D  550 (663)
                                                            .+||+|||+++...... ...++..|+|||++.+..++.++|
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  275 (397)
T 1wak_A          196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD  275 (397)
T ss_dssp             ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHHH
T ss_pred             HHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHHH
Confidence                                                  79999999998765442 345788899999999988999999


Q ss_pred             hhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHh---h---------cccccccch------------------hh
Q 006055          551 VYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK---D---------EWTSEVFDL------------------EL  600 (663)
Q Consensus       551 v~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~---------~~~~~~~d~------------------~~  600 (663)
                      ||||||++|||++|+.||......+.......+..+..   .         ......+..                  -.
T Consensus       276 iwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (397)
T 1wak_A          276 IWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLV  355 (397)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHH
T ss_pred             HHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhh
Confidence            99999999999999999986544332211111111111   0         000000000                  00


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .......+....+.+++.+|+..||++|||++|+++|
T Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          356 EKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             HTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             hhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            0112245667789999999999999999999999874

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4e-38  Score=336.81  Aligned_cols=240  Identities=20%  Similarity=0.325  Sum_probs=190.4

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCC--CCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVN--HENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||++...+++.||||++......   ...+.+|+.++..++  ||||+++++++...+..++||| +.+
T Consensus        61 ~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~  139 (390)
T 2zmd_A           61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN  139 (390)
T ss_dssp             EEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCS
T ss_pred             EEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCC
Confidence            4689999999999999888999999998754333   367899999999996  5999999999999999999999 567


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      ++|.+++....     .+++..+..++.||+.||.|||+.+  |+||||||+|||++ ++.+||+|||+++......   
T Consensus       140 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          140 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             EEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence            89999997643     5889999999999999999999998  99999999999995 5799999999998765432   


Q ss_pred             ---CCCCCccccCccccCC-----------CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccc
Q 006055          527 ---TPNRVAGYRAPEVTDP-----------CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT  592 (663)
Q Consensus       527 ---~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  592 (663)
                         ...+++.|+|||++.+           ..++.++|||||||++|||++|+.||....     +....+..+......
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~~~~~~~~~  286 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNHE  286 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CHHHHHHHHHCTTSC
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-----HHHHHHHHHhCcccc
Confidence               2347888999999864           368889999999999999999999996432     112222222222111


Q ss_pred             ccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          593 SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       593 ~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      ...          +.....++.+++.+||..||++|||+.|++++-
T Consensus       287 ~~~----------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          287 IEF----------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             CCC----------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             CCC----------CccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence            100          001123677889999999999999999999764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.1e-38  Score=320.33  Aligned_cols=241  Identities=23%  Similarity=0.288  Sum_probs=195.1

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||.||+|... +++.||||.+....  ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++++
T Consensus        12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   91 (276)
T 2yex_A           12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE   91 (276)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCc
Confidence            468999999999999964 78999999986543  235778999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC------
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS------  525 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~------  525 (663)
                      |.+++...     ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||.+......      
T Consensus        92 L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           92 LFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             GGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             HHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence            99999753     35899999999999999999999998  999999999999999999999999999765322      


Q ss_pred             CCCCCCccccCccccCCCCC-CCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          526 STPNRVAGYRAPEVTDPCKV-SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       526 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                      ....++..|+|||.+.+..+ +.++||||||+++|||++|+.||.......     ............   .       .
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~---~-------~  229 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----QEYSDWKEKKTY---L-------N  229 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-----HHHHHHHTTCTT---S-------T
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-----HHHHHhhhcccc---c-------C
Confidence            23346778999999987664 778999999999999999999997643211     111111111100   0       0


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ........+.+++.+|+..||++|||++|++++
T Consensus       230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          230 PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence            011223467788999999999999999999873

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=341.07  Aligned_cols=243  Identities=19%  Similarity=0.256  Sum_probs=194.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .++||+|+||+||++.. .+|+.||||+++....    ....+.+|..++..++||||+++++++.+.+..++||||+++
T Consensus        66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g  145 (412)
T 2vd5_A           66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG  145 (412)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence            36899999999999996 4799999999975321    123478899999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++....    ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++++||+|||+++......   
T Consensus       146 g~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~  219 (412)
T 2vd5_A          146 GDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR  219 (412)
T ss_dssp             CBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred             CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhheeccCCCccc
Confidence            99999997532    25899999999999999999999998  9999999999999999999999999998765432   


Q ss_pred             --CCCCCccccCccccC-------CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          527 --TPNRVAGYRAPEVTD-------PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                        ...+|+.|+|||++.       ...++.++|||||||++|||++|+.||...      +.......+.........  
T Consensus       220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~------~~~~~~~~i~~~~~~~~~--  291 (412)
T 2vd5_A          220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD------STAETYGKIVHYKEHLSL--  291 (412)
T ss_dssp             CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHTHHHHCCC--
T ss_pred             cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC------CHHHHHHHHHhcccCcCC--
Confidence              235788899999986       456889999999999999999999999653      222333333321100000  


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHH
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNR---PSMSEVIKR  637 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~R---Pt~~ev~~~  637 (663)
                           .........++.+++.+|+. +|++|   |+++|+++|
T Consensus       292 -----p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          292 -----PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             -----C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             -----CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence                 00011223467788889998 99998   699999876

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.1e-39  Score=335.97  Aligned_cols=251  Identities=24%  Similarity=0.383  Sum_probs=199.9

Q ss_pred             hcccccccceEEEEEEec-CC-----cEEEEEEecCccc--CHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLE-MG-----TIVAVKRLKDVTI--SEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g-----~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  445 (663)
                      .+.||+|+||.||+|... ++     ..||+|.+.....  ..+.+.+|+.++..+ +||||+++++++.+....++|||
T Consensus        51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e  130 (333)
T 2i1m_A           51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE  130 (333)
T ss_dssp             EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence            468999999999999953 23     4799999976532  346789999999999 89999999999999999999999


Q ss_pred             ccCCCChhHhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecc
Q 006055          446 YLTMGSLSALLHGNKG---------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDF  516 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Df  516 (663)
                      |+++|+|.+++.....         .....+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+||
T Consensus       131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Df  208 (333)
T 2i1m_A          131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDF  208 (333)
T ss_dssp             CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEEGGGEEEBCCC
T ss_pred             cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEECCCCeEEECcc
Confidence            9999999999864321         01235799999999999999999999998  999999999999999999999999


Q ss_pred             ccccccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhh
Q 006055          517 GLAHLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKD  589 (663)
Q Consensus       517 g~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  589 (663)
                      |+++.......      ..++..|+|||.+.+..++.++||||||+++|||++ |..||......      ..+......
T Consensus       209 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------~~~~~~~~~  282 (333)
T 2i1m_A          209 GLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN------SKFYKLVKD  282 (333)
T ss_dssp             GGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS------HHHHHHHHH
T ss_pred             ccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh------HHHHHHHhc
Confidence            99986543321      224567999999988889999999999999999999 99999653221      122222222


Q ss_pred             cccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          590 EWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       590 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      .....          .+......+.+++.+||+.||++|||++|++++|+++..
T Consensus       283 ~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          283 GYQMA----------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             TCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCC----------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence            21110          011123467889999999999999999999999988743

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.3e-38  Score=330.70  Aligned_cols=238  Identities=24%  Similarity=0.316  Sum_probs=196.5

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||++... +++.||+|.+....    .....+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus        46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  125 (335)
T 2owb_A           46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR  125 (335)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCC
Confidence            468999999999999954 58899999987542    2246688999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      ++|.+++...     ..+++..+..++.|++.||.|||+++  |+||||||+||+++.++.+||+|||+++......   
T Consensus       126 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  198 (335)
T 2owb_A          126 RSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  198 (335)
T ss_dssp             CBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             CCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence            9999998753     24899999999999999999999998  9999999999999999999999999998764322   


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       ...++..|+|||++.+..++.++||||||+++|||++|+.||....      .......+......            .
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~------------~  260 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKETYLRIKKNEYS------------I  260 (335)
T ss_dssp             CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHTCCC------------C
T ss_pred             cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC------HHHHHHHHhcCCCC------------C
Confidence             2346778999999988889999999999999999999999996422      22222222221110            0


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .......+.+++.+|++.||++|||++|++++
T Consensus       261 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          261 PKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11122357788899999999999999999985

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.7e-38  Score=319.62  Aligned_cols=247  Identities=21%  Similarity=0.356  Sum_probs=198.7

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc-------cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT-------ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|... +|+.||||.++...       ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   89 (283)
T 3bhy_A           10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL   89 (283)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEee
Confidence            468999999999999965 69999999986542       1367899999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC----ceEEecccccccc
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY----EARVSDFGLAHLV  522 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~----~~kl~Dfg~a~~~  522 (663)
                      +++++|.+++...     ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++    .+||+|||++...
T Consensus        90 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           90 VSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             CCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            9999999999753     25899999999999999999999998  99999999999998877    7999999999876


Q ss_pred             CCCC---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          523 GPSS---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       523 ~~~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                      ....   ...++..|+|||.+.+..++.++||||||+++|+|++|+.||....      .......+.....   .....
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~---~~~~~  233 (283)
T 3bhy_A          163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET------KQETLTNISAVNY---DFDEE  233 (283)
T ss_dssp             C--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTTCC---CCCHH
T ss_pred             cCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc------hHHHHHHhHhccc---CCcch
Confidence            5432   2346778999999998899999999999999999999999996532      1222222221111   01111


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhC
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR--IEELH  642 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~--L~~~~  642 (663)
                      .     .......+.+++.+|+..||++|||+.|++++  ++++.
T Consensus       234 ~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          234 Y-----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             H-----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             h-----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            1     01123467888999999999999999999984  45553

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6e-38  Score=327.65  Aligned_cols=243  Identities=19%  Similarity=0.279  Sum_probs=195.5

Q ss_pred             cccccccceEEEEEEec-CCcEEEEEEecCcc---cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCCC
Q 006055          376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT---ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      +.||+|+||.||+|... +|+.||||+++...   .....+.+|+.++..+ .||||+++++++.+....++||||+++|
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~  114 (327)
T 3lm5_A           35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG  114 (327)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence            68999999999999954 69999999987642   3367899999999998 5699999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC---CCceEEeccccccccCCCC-
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK---SYEARVSDFGLAHLVGPSS-  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~---~~~~kl~Dfg~a~~~~~~~-  526 (663)
                      +|.+++....   ...+++..+..++.|++.||+|||+.+  |+||||||+||+++.   ++.+||+|||+++...... 
T Consensus       115 ~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~  189 (327)
T 3lm5_A          115 EIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE  189 (327)
T ss_dssp             EGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-----
T ss_pred             cHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc
Confidence            9999986532   245899999999999999999999998  999999999999998   7899999999998775442 


Q ss_pred             --CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          527 --TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                        ...++..|+|||++.+..++.++||||||+++|||++|+.||....      .......+......   ..     ..
T Consensus       190 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~~---~~-----~~  255 (327)
T 3lm5_A          190 LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED------NQETYLNISQVNVD---YS-----EE  255 (327)
T ss_dssp             ----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCC---CC-----TT
T ss_pred             cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHHHhcccc---cC-----ch
Confidence              2347788999999999999999999999999999999999996532      12222222211110   00     01


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ........+.+++.+|+..||++|||++|++++
T Consensus       256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          256 TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            111233467788999999999999999999985

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.7e-38  Score=334.91  Aligned_cols=189  Identities=22%  Similarity=0.363  Sum_probs=166.9

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||+||+|... +|+.||+|++....  ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+
T Consensus        38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  117 (360)
T 3eqc_A           38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS  117 (360)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred             eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCC
Confidence            368999999999999954 78999999987642  224678999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCcceecCCCCCCEEEcCCCceEEeccccccccCC--CCCC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ-GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP--SSTP  528 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~--~~~~  528 (663)
                      |.+++....     .+++..+..++.+++.||.|||+. +  |+||||||+||+++.++.+||+|||++.....  ....
T Consensus       118 L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  190 (360)
T 3eqc_A          118 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  190 (360)
T ss_dssp             HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----
T ss_pred             HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCcccccccccCC
Confidence            999997533     489999999999999999999986 7  99999999999999999999999999875432  2234


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCcc
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHA  570 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~  570 (663)
                      .++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       191 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          191 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             CCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            578889999999999999999999999999999999999975

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-37  Score=318.78  Aligned_cols=240  Identities=20%  Similarity=0.284  Sum_probs=194.2

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc---cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT---ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||+|... +++.||||+++...   .....+.+|+..+..+ +||||+++++++.+.+..++||||+++
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   95 (289)
T 1x8b_A           16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG   95 (289)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence            468999999999999964 79999999987542   2356788899999988 999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC-------------------Cc
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS-------------------YE  510 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~-------------------~~  510 (663)
                      |+|.+++..... ....+++..+..++.||+.||.|||+++  |+||||||+||+++.+                   ..
T Consensus        96 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~  172 (289)
T 1x8b_A           96 GSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM  172 (289)
T ss_dssp             CBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC--------------------CCC
T ss_pred             CcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccccCCceE
Confidence            999999975321 1135899999999999999999999998  9999999999999844                   47


Q ss_pred             eEEeccccccccCCCCCCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh
Q 006055          511 ARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD  589 (663)
Q Consensus       511 ~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  589 (663)
                      +||+|||.+..........++..|+|||.+.+. .++.++|||||||++|||++|..|+....         ....+...
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~~~~~~~~  243 (289)
T 1x8b_A          173 FKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---------QWHEIRQG  243 (289)
T ss_dssp             EEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---------HHHHHHTT
T ss_pred             EEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---------HHHHHHcC
Confidence            999999999988776667788899999999765 56689999999999999999998764311         11111111


Q ss_pred             cccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          590 EWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       590 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                       .....          +.....++.+++.+|++.||++|||+.|++++
T Consensus       244 -~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          244 -RLPRI----------PQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             -CCCCC----------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             -CCCCC----------CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence             11110          11123467888999999999999999999883

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.5e-37  Score=320.84  Aligned_cols=239  Identities=25%  Similarity=0.377  Sum_probs=198.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc--ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV--TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||.||+|.. .+++.||||.+...  ....+.+.+|+.+++.++||||+++++++.+....++||||+++++
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  106 (303)
T 3a7i_A           27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS  106 (303)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCc
Confidence            46899999999999984 57899999998754  2345789999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----C
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----T  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~  527 (663)
                      |.+++...      .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++.......    .
T Consensus       107 L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  178 (303)
T 3a7i_A          107 ALDLLEPG------PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT  178 (303)
T ss_dssp             HHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred             HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence            99999642      4899999999999999999999998  9999999999999999999999999997765432    2


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..++..|+|||++.+..++.++||||||+++|||++|+.||....      .......+... ....          ...
T Consensus       179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~-~~~~----------~~~  241 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH------PMKVLFLIPKN-NPPT----------LEG  241 (303)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHS-CCCC----------CCS
T ss_pred             cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC------HHHHHHHhhcC-CCCC----------Ccc
Confidence            346778999999999889999999999999999999999996432      11222221111 1110          011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      .....+.+++.+|+..||++|||++|++++.
T Consensus       242 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          242 NYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            1234678889999999999999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.4e-38  Score=320.06  Aligned_cols=238  Identities=23%  Similarity=0.286  Sum_probs=197.2

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCc----ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDV----TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|... +++.||||.+...    ......+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus        19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   98 (284)
T 2vgo_A           19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR   98 (284)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCC
Confidence            468999999999999954 6889999998643    22356789999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC--CC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--ST  527 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~--~~  527 (663)
                      |+|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++......  ..
T Consensus        99 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  171 (284)
T 2vgo_A           99 GELYKELQKHG-----RFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT  171 (284)
T ss_dssp             EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBCC
T ss_pred             CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccCccccccc
Confidence            99999997532     4899999999999999999999998  999999999999999999999999998765432  23


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..++..|+|||.+.+..++.++||||||+++|||++|+.||....      .......+.....            ..+.
T Consensus       172 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~------------~~~~  233 (284)
T 2vgo_A          172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS------HTETHRRIVNVDL------------KFPP  233 (284)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTTCC------------CCCT
T ss_pred             ccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC------HhHHHHHHhcccc------------CCCC
Confidence            456788999999999889999999999999999999999996432      1222222222111            0011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....++.+++.+|+..||++|||++|++++
T Consensus       234 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          234 FLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             cCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence            123467788999999999999999999984

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.2e-38  Score=332.53  Aligned_cols=243  Identities=24%  Similarity=0.312  Sum_probs=192.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||.||++.. .+|+.||||+++....   ...+|++++.++ +||||+++++++.+....++||||+++|+|
T Consensus        27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L  103 (342)
T 2qr7_A           27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL  103 (342)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcH
Confidence            46899999999999995 4689999999976532   235677777777 799999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC----CceEEeccccccccCCCC--
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS----YEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~----~~~kl~Dfg~a~~~~~~~--  526 (663)
                      .+++....     .+++..+..++.||+.||.|||+++  |+||||||+|||+.++    +.+||+|||+++......  
T Consensus       104 ~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~  176 (342)
T 2qr7_A          104 LDKILRQK-----FFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL  176 (342)
T ss_dssp             HHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC
T ss_pred             HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc
Confidence            99997533     5899999999999999999999998  9999999999998543    359999999998764432  


Q ss_pred             --CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          527 --TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                        ...++..|+|||++.+..++.++|||||||++|||++|+.||.....   .........+........        ..
T Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~~~~i~~~~~~~~--------~~  245 (342)
T 2qr7_A          177 LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD---DTPEEILARIGSGKFSLS--------GG  245 (342)
T ss_dssp             BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT---SCHHHHHHHHHHCCCCCC--------ST
T ss_pred             eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc---CCHHHHHHHHccCCcccC--------cc
Confidence              23467789999999887788999999999999999999999975321   223333333332221100        00


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      .......++.+++.+|+..||++|||+.|++++-
T Consensus       246 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence            0112234677888899999999999999999853

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.5e-38  Score=339.95  Aligned_cols=191  Identities=26%  Similarity=0.339  Sum_probs=166.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcC------CCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAV------NHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .++||+|+||+||+|.. .+++.||||+++........+.+|++++..+      +|+||+++++++......++||||+
T Consensus       102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~  181 (429)
T 3kvw_A          102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL  181 (429)
T ss_dssp             EEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCC
T ss_pred             EEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEecc
Confidence            46899999999999984 5689999999987654456777888887766      6779999999999999999999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc--eEEeccccccccCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE--ARVSDFGLAHLVGPS  525 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~--~kl~Dfg~a~~~~~~  525 (663)
                      . ++|.+++....   ...+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.  +||+|||++......
T Consensus       182 ~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~  255 (429)
T 3kvw_A          182 S-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR  255 (429)
T ss_dssp             C-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC
T ss_pred             C-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeecccceecCCc
Confidence            7 59999987643   235899999999999999999999998  999999999999999987  999999999776544


Q ss_pred             C-CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccc
Q 006055          526 S-TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHAL  571 (663)
Q Consensus       526 ~-~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~  571 (663)
                      . ...++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       256 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          256 VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            3 345788899999999989999999999999999999999999753

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.3e-38  Score=339.14  Aligned_cols=242  Identities=23%  Similarity=0.350  Sum_probs=185.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc---------CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---------SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  444 (663)
                      .+.||+|+||+||+|.. .+++.||||++.....         ....+.+|+.++++++||||+++++++. .+..++||
T Consensus       140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~  218 (419)
T 3i6u_A          140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVL  218 (419)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEE
T ss_pred             EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEE
Confidence            46899999999999984 5689999999865321         1124789999999999999999999975 45689999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC---ceEEeccccccc
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY---EARVSDFGLAHL  521 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~---~~kl~Dfg~a~~  521 (663)
                      ||+++|+|.+++...     ..+++..+..++.|++.||.|||+++  |+||||||+|||++.++   .+||+|||+++.
T Consensus       219 e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          219 ELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             ECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             EcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            999999999988753     35899999999999999999999998  99999999999997544   599999999987


Q ss_pred             cCCCC---CCCCCccccCccccCC---CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccc
Q 006055          522 VGPSS---TPNRVAGYRAPEVTDP---CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV  595 (663)
Q Consensus       522 ~~~~~---~~~~~~~y~aPE~~~~---~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  595 (663)
                      .....   ...++..|+|||++.+   ..++.++|||||||++|||++|+.||.......  .+...    +......  
T Consensus       292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~----i~~~~~~--  363 (419)
T 3i6u_A          292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ----ITSGKYN--  363 (419)
T ss_dssp             CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH----HHTTCCC--
T ss_pred             cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH----HhcCCCC--
Confidence            76543   2346788999999864   567889999999999999999999997533211  12111    1111100  


Q ss_pred             cchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       596 ~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ..+..     ......++.+++.+|+..||++|||++|++++
T Consensus       364 ~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          364 FIPEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             CCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCchh-----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00100     01123467888999999999999999999984

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8.3e-38  Score=323.01  Aligned_cols=242  Identities=22%  Similarity=0.342  Sum_probs=195.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||.||++.. .+|+.||+|.++... .....+.+|+.+++.++||||+++++++.+....++||||+++|+|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   93 (304)
T 2jam_A           14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL   93 (304)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccH
Confidence            46899999999999995 479999999997653 2356788999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEE---cCCCceEEeccccccccCCCCC--
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL---TKSYEARVSDFGLAHLVGPSST--  527 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~~--  527 (663)
                      .+++....     .+++..+..++.|++.||.|||+.+  |+||||||+||++   ++++.+||+|||+++.......  
T Consensus        94 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  166 (304)
T 2jam_A           94 FDRILERG-----VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST  166 (304)
T ss_dssp             HHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHH
T ss_pred             HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcccc
Confidence            99986532     4899999999999999999999998  9999999999999   7888999999999976543321  


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..++..|+|||.+.+..++.++||||||+++|||++|+.||....      .......+.......   ..     ....
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~i~~~~~~~---~~-----~~~~  232 (304)
T 2jam_A          167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET------ESKLFEKIKEGYYEF---ES-----PFWD  232 (304)
T ss_dssp             HHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHCCCCC---CT-----TTTT
T ss_pred             ccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCCCCC---Cc-----cccc
Confidence            236778999999999899999999999999999999999996432      222222322221100   00     0111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....++.+++.+|+..||++|||++|++++
T Consensus       233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          233 DISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             TSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            233467888999999999999999999985

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-38  Score=329.15  Aligned_cols=253  Identities=26%  Similarity=0.424  Sum_probs=199.1

Q ss_pred             hcccccccceEEEEEEe-----cCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecC--ccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMD--EKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ey  446 (663)
                      .+.||+|+||.||++..     .+|+.||||++.... ...+.+.+|+++++.++||||+++++++...+  ..++||||
T Consensus        46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~  125 (326)
T 2w1i_A           46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY  125 (326)
T ss_dssp             EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECC
T ss_pred             eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEEC
Confidence            46899999999999983     468999999997653 23467999999999999999999999987644  68999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      +++|+|.+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++......
T Consensus       126 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~  199 (326)
T 2w1i_A          126 LPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  199 (326)
T ss_dssp             CTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred             CCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence            99999999997643    35899999999999999999999998  9999999999999999999999999998765432


Q ss_pred             C-------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCC------CCCC---hHHHHHHHHhhc
Q 006055          527 T-------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNE------EGVD---LPRWVQSIVKDE  590 (663)
Q Consensus       527 ~-------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~------~~~~---~~~~~~~~~~~~  590 (663)
                      .       ..++..|+|||.+.+..++.++||||||+++|||++|..|+......      ....   ....+...+...
T Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (326)
T 2w1i_A          200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN  279 (326)
T ss_dssp             SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred             cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence            1       23455699999998888899999999999999999999998642100      0000   000111111111


Q ss_pred             ccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       591 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      .          ..........++.+++.+||..||++|||+.|+++.|+++.+
T Consensus       280 ~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          280 G----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             C----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            0          011112234578889999999999999999999999998854

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.3e-39  Score=341.68  Aligned_cols=246  Identities=12%  Similarity=0.031  Sum_probs=176.0

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc----CHHHHHHHHH---HhhcCCCCCcccce-------EEEEecC-
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI----SEREFKDKIE---GVGAVNHENLVPLR-------AYYYSMD-  438 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~----~~~~~~~e~~---~l~~l~h~niv~l~-------~~~~~~~-  438 (663)
                      .+.||+|+||+||+|.. .+|+.||||++.....    ....+.+|+.   .++. +||||++++       +++.... 
T Consensus        67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~  145 (371)
T 3q60_A           67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQ  145 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTS
T ss_pred             eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCC
Confidence            46899999999999995 4799999999987543    2345677754   5555 799977744       4544332 


Q ss_pred             ----------------ccEEEEEccCCCChhHhhccCCCCCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCcceec
Q 006055          439 ----------------EKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMR------SLIALGAARGIEYLHAQGPNVSHG  496 (663)
Q Consensus       439 ----------------~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~al~~LH~~~~~iiHr  496 (663)
                                      ..++||||++ |+|.+++....    ..+.+..+      ..++.||+.||+|||+++  |+||
T Consensus       146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHr  218 (371)
T 3q60_A          146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHG  218 (371)
T ss_dssp             CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred             CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccC
Confidence                            3799999999 89999997532    12455555      788899999999999998  9999


Q ss_pred             CCCCCCEEEcCCCceEEeccccccccCCCC-CCCCCccccCccccCC--CCCCCcchhhhHHHHHHHHHhCCCCCccccC
Q 006055          497 NIKSSNILLTKSYEARVSDFGLAHLVGPSS-TPNRVAGYRAPEVTDP--CKVSQKADVYSFGVLLLELLTGKAPTHALLN  573 (663)
Q Consensus       497 dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvvl~elltg~~p~~~~~~  573 (663)
                      ||||+|||++.++.+||+|||+++...... ...++..|+|||++.+  ..++.++|||||||++|||++|+.||.....
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~  298 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP  298 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence            999999999999999999999998776544 3456688999999987  6789999999999999999999999986532


Q ss_pred             CCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          574 EEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ......        ............. ...........+.+++.+||+.||++|||+.|++++
T Consensus       299 ~~~~~~--------~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          299 GIKGSW--------KRPSLRVPGTDSL-AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             TCTTCC--------CBCCTTSCCCCSC-CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             ccccch--------hhhhhhhcccccc-chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            211000        0000000000000 011111234567888899999999999999999863

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.6e-38  Score=328.51  Aligned_cols=251  Identities=24%  Similarity=0.329  Sum_probs=197.1

Q ss_pred             hcccccccceEEEEEEe------cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|..      .+++.||||.+....  .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus        35 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  114 (327)
T 2yfx_A           35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMEL  114 (327)
T ss_dssp             EEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEec
Confidence            46899999999999983      357789999996542  2346788999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC---CCceEEeccccccc
Q 006055          447 LTMGSLSALLHGNKGA--GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK---SYEARVSDFGLAHL  521 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~---~~~~kl~Dfg~a~~  521 (663)
                      +++|+|.+++......  ....+++..++.++.|++.||.|||+.+  |+||||||+||+++.   +..+||+|||+++.
T Consensus       115 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~  192 (327)
T 2yfx_A          115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD  192 (327)
T ss_dssp             CTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred             CCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEEECccccccc
Confidence            9999999999864321  2245899999999999999999999998  999999999999984   44699999999975


Q ss_pred             cCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          522 VGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       522 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                      .....      ...++..|+|||.+.+..++.++||||||+++|||++ |+.||....      .......+......  
T Consensus       193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------~~~~~~~~~~~~~~--  264 (327)
T 2yfx_A          193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS------NQEVLEFVTSGGRM--  264 (327)
T ss_dssp             HHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHHHHHTTCCC--
T ss_pred             cccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC------HHHHHHHHhcCCCC--
Confidence            43321      1234667999999988889999999999999999998 999986432      22222222222111  


Q ss_pred             ccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       595 ~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                               .........+.+++.+||..||++||++.|++++|+.+...
T Consensus       265 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          265 ---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence                     01112234678899999999999999999999999887544

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.4e-38  Score=320.96  Aligned_cols=239  Identities=24%  Similarity=0.314  Sum_probs=196.8

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||++... +++.||+|.+....    .....+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus        20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   99 (294)
T 2rku_A           20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR   99 (294)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCC
Confidence            468999999999999954 58899999986542    1245688999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      ++|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++.......   
T Consensus       100 ~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  172 (294)
T 2rku_A          100 RSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  172 (294)
T ss_dssp             CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence            99999887532     5899999999999999999999998  9999999999999999999999999998764322   


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       ...++..|+|||.+.+..++.++||||||+++|||++|+.||....      .......+.....            ..
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~------------~~  234 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKETYLRIKKNEY------------SI  234 (294)
T ss_dssp             CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTTCC------------CC
T ss_pred             ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhhccC------------CC
Confidence             2346778999999998889999999999999999999999996432      2222222222111            00


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      +......+.+++.+|++.||++|||++|++++-
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          235 PKHINPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             ccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            111223677888999999999999999999863

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.6e-37  Score=342.38  Aligned_cols=241  Identities=23%  Similarity=0.292  Sum_probs=197.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc---ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV---TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .++||+|+||+||+|.. .+|+.||||++...   ......+.+|+++++.++||||+++++++.+....++||||+.+|
T Consensus        27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~  106 (486)
T 3mwu_A           27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG  106 (486)
T ss_dssp             EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCC
Confidence            46899999999999995 47999999998643   334678999999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc---CCCceEEeccccccccCCCC-
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT---KSYEARVSDFGLAHLVGPSS-  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~---~~~~~kl~Dfg~a~~~~~~~-  526 (663)
                      +|.+.+....     .+++..+..++.||+.||.|||+.+  |+||||||+|||++   .++.+||+|||+++...... 
T Consensus       107 ~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~  179 (486)
T 3mwu_A          107 ELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (486)
T ss_dssp             BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence            9999886532     4899999999999999999999998  99999999999995   45679999999998765442 


Q ss_pred             --CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          527 --TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                        ...+++.|+|||++.+ .++.++||||+||++|+|++|+.||...      +....+..+.........        +
T Consensus       180 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i~~~~~~~~~--------~  244 (486)
T 3mwu_A          180 MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK------NEYDILKRVETGKYAFDL--------P  244 (486)
T ss_dssp             --CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCCSCS--------G
T ss_pred             cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCCCCC--------c
Confidence              2457888999999976 4899999999999999999999999653      223333333332221110        0


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .......++.+++.+|+..||++|||+.|++++
T Consensus       245 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            111223467788899999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.7e-38  Score=328.38  Aligned_cols=250  Identities=23%  Similarity=0.337  Sum_probs=192.1

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||.||+|... +|+.||||++......   .+.+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus        30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  109 (331)
T 4aaa_A           30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT  109 (331)
T ss_dssp             EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred             eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcc
Confidence            468999999999999954 5899999998655333   356789999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----C
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----S  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----~  526 (663)
                      +|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++.....    .
T Consensus       110 ~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  182 (331)
T 4aaa_A          110 ILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD  182 (331)
T ss_dssp             HHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred             hHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCCccccC
Confidence            9998876432     4899999999999999999999998  999999999999999999999999999765442    2


Q ss_pred             CCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHh--------------hc-
Q 006055          527 TPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK--------------DE-  590 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------------~~-  590 (663)
                      ...++..|+|||++.+. .++.++|||||||++|||++|+.||......      ..+..+..              .. 
T Consensus       183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI------DQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHHHhCCCChhhhhHhhhcc
Confidence            23467789999999775 6889999999999999999999999753221      11111110              00 


Q ss_pred             ccccccchhhhcccCh----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          591 WTSEVFDLELLRYQNV----EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       591 ~~~~~~d~~~~~~~~~----~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .......+........    ......+.+++.+|+..||++|||++|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000000000000000    1234578899999999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.7e-38  Score=323.89  Aligned_cols=243  Identities=24%  Similarity=0.342  Sum_probs=193.3

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .+||+|+||.||+|.. .+++.||||.+.... ...+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            4799999999999994 568999999987653 33567899999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC-CCceEEeccccccccCCC----CCC
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK-SYEARVSDFGLAHLVGPS----STP  528 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~-~~~~kl~Dfg~a~~~~~~----~~~  528 (663)
                      +++....  ....+++..+..++.|++.||.|||+.+  |+||||||+||+++. ++.+||+|||++......    ...
T Consensus       108 ~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  183 (295)
T 2clq_A          108 ALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF  183 (295)
T ss_dssp             HHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCC
T ss_pred             HHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCCccccc
Confidence            9997643  2345678999999999999999999998  999999999999987 899999999999876542    233


Q ss_pred             CCCccccCccccCCC--CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          529 NRVAGYRAPEVTDPC--KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~--~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      .++..|+|||++.+.  .++.++||||||+++|||++|+.||.......    ......... ....          ...
T Consensus       184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~-~~~~----------~~~  248 (295)
T 2clq_A          184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----AAMFKVGMF-KVHP----------EIP  248 (295)
T ss_dssp             CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----HHHHHHHHH-CCCC----------CCC
T ss_pred             CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----HHHHhhccc-cccc----------ccc
Confidence            467789999998654  37889999999999999999999996532110    111111000 0000          111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .....++.+++.+|+..||++||+++|++++
T Consensus       249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          249 ESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1233467888999999999999999999874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=332.37  Aligned_cols=253  Identities=22%  Similarity=0.302  Sum_probs=188.7

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccC--HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTIS--EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||+||+|... +++.||||++......  ...+.+|+++++.++||||+++++++.+....++||||++ |+
T Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~   85 (324)
T 3mtl_A            7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD   85 (324)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EE
T ss_pred             EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cC
Confidence            368999999999999954 7899999998754322  1245579999999999999999999999999999999998 59


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----C
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----T  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~  527 (663)
                      |.+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++......    .
T Consensus        86 l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  159 (324)
T 3mtl_A           86 LKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN  159 (324)
T ss_dssp             HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence            999887543    35899999999999999999999998  9999999999999999999999999998654332    2


Q ss_pred             CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccc---ccccch-hhhc
Q 006055          528 PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT---SEVFDL-ELLR  602 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~d~-~~~~  602 (663)
                      ..++..|+|||++.+ ..++.++|||||||++|||++|+.||......+   ....+.........   ...... ....
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
T 3mtl_A          160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEEFKT  236 (324)
T ss_dssp             ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred             ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcchhhcc
Confidence            345778999999876 568999999999999999999999997532111   11111111111000   000000 0000


Q ss_pred             -------cc----ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          603 -------YQ----NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       603 -------~~----~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                             ..    .......++.+++.+|+..||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                   00    001123467889999999999999999999984

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.6e-37  Score=316.11  Aligned_cols=238  Identities=23%  Similarity=0.336  Sum_probs=190.6

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCc----ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDV----TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|... +|+.||||.+...    ......+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   95 (276)
T 2h6d_A           16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG   95 (276)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCC
Confidence            468999999999999965 7999999998643    22356789999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      ++|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++.......   
T Consensus        96 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  168 (276)
T 2h6d_A           96 GELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR  168 (276)
T ss_dssp             CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred             CcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccccCCCccee
Confidence            99999997532     4899999999999999999999998  9999999999999999999999999998765432   


Q ss_pred             CCCCCccccCccccCCCCC-CCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 TPNRVAGYRAPEVTDPCKV-SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      ...++..|+|||.+.+..+ +.++||||||+++|+|++|+.||...      +.......+......            .
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~------~~~~~~~~~~~~~~~------------~  230 (276)
T 2h6d_A          169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE------HVPTLFKKIRGGVFY------------I  230 (276)
T ss_dssp             --------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC------------C
T ss_pred             cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC------cHHHHHHHhhcCccc------------C
Confidence            2346777999999988765 57899999999999999999999642      222222222211100            0


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      +......+.+++.+|++.||++|||++|++++
T Consensus       231 ~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          231 PEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            11123467788999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.6e-37  Score=324.72  Aligned_cols=246  Identities=19%  Similarity=0.278  Sum_probs=192.1

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccCHHHHHHHHHHhhcCC-CCCcccceEEEEe--cCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-HENLVPLRAYYYS--MDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||+||+|. ..+++.||||+++..  ..+.+.+|+++++.++ ||||+++++++.+  ....++||||++++
T Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~  118 (330)
T 3nsz_A           41 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT  118 (330)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCC
T ss_pred             EEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCch
Confidence            4689999999999998 467999999998743  3578999999999997 9999999999987  56689999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC-ceEEeccccccccCCCCC--
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY-EARVSDFGLAHLVGPSST--  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~--  527 (663)
                      +|.++++.        +++..+..++.|++.||.|||+.+  |+||||||+|||++.++ .+||+|||+++.......  
T Consensus       119 ~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~  188 (330)
T 3nsz_A          119 DFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN  188 (330)
T ss_dssp             CHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC
T ss_pred             hHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccc
Confidence            99999863        788999999999999999999998  99999999999999777 899999999987654432  


Q ss_pred             -CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccccc----------c
Q 006055          528 -PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSE----------V  595 (663)
Q Consensus       528 -~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~  595 (663)
                       ..++..|+|||.+.+ ..++.++|||||||++|||++|+.||......     ...+..+........          .
T Consensus       189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-----~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-----YDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-----HHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-----HHHHHHHHHhcCCchhhhHHHHhccc
Confidence             346777999999877 66899999999999999999999999542211     111111110000000          0


Q ss_pred             cchh---------------hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          596 FDLE---------------LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       596 ~d~~---------------~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .++.               ............++.+++.+|+..||++|||++|+++|
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0000               00001111234578889999999999999999999984

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.5e-38  Score=328.20  Aligned_cols=248  Identities=19%  Similarity=0.253  Sum_probs=186.9

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .++||+|+||+||+|. ..+|+.||||+++.....   ...+.+|+++++.++||||+++++++.+....++||||+++ 
T Consensus        39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-  117 (329)
T 3gbz_A           39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-  117 (329)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred             EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-
Confidence            4689999999999998 457999999999754322   35678999999999999999999999999999999999985 


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc-----CCCceEEeccccccccCCC
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT-----KSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~-----~~~~~kl~Dfg~a~~~~~~  525 (663)
                      +|.+++....     .+++..+..++.||+.||.|||+.+  |+||||||+|||++     .++.+||+|||+++.....
T Consensus       118 ~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~  190 (329)
T 3gbz_A          118 DLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP  190 (329)
T ss_dssp             EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred             CHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence            9999997643     4899999999999999999999998  99999999999994     5556999999999876533


Q ss_pred             C----CCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc-ccc--ccc
Q 006055          526 S----TPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW-TSE--VFD  597 (663)
Q Consensus       526 ~----~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~d  597 (663)
                      .    ...++..|+|||++.+. .++.++|||||||++|||++|+.||.....      ...+..+..... ...  ...
T Consensus       191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~  264 (329)
T 3gbz_A          191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE------IDQLFKIFEVLGLPDDTTWPG  264 (329)
T ss_dssp             ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCCCTTTSTT
T ss_pred             ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH------HHHHHHHHHHhCCCchhhhhh
Confidence            2    23457789999999774 489999999999999999999999965321      222222221100 000  000


Q ss_pred             --------hhhh--cccChH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          598 --------LELL--RYQNVE-----EEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       598 --------~~~~--~~~~~~-----~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                              ....  ......     ....++.+++.+|++.||++|||++|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                    0000  000000     12356788999999999999999999987

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=7.9e-38  Score=341.98  Aligned_cols=251  Identities=20%  Similarity=0.256  Sum_probs=196.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCC-cccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHEN-LVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .++||+|+||.||+|.. .+++.||||++..... ...+..|++++..++|++ +..+..++.+.+..++||||+ +++|
T Consensus        12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL   89 (483)
T 3sv0_A           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL   89 (483)
T ss_dssp             CCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCH
Confidence            46899999999999994 6799999998765432 235788999999998755 445555666777889999999 8999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEE---cCCCceEEeccccccccCCCC---
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL---TKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      .+++....    ..+++..++.|+.||+.||.|||+++  |+||||||+|||+   +.++.+||+|||+++......   
T Consensus        90 ~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (483)
T 3sv0_A           90 EDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ  163 (483)
T ss_dssp             HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred             HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc
Confidence            99997533    35899999999999999999999998  9999999999999   688999999999998765432   


Q ss_pred             --------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          527 --------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       527 --------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                              ...++..|+|||++.+..++.++|||||||++|||++|+.||.......   ....+..+...... ..+. 
T Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~i~~~~~~-~~~~-  238 (483)
T 3sv0_A          164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---KKQKYEKISEKKVA-TSIE-  238 (483)
T ss_dssp             BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS---HHHHHHHHHHHHHH-SCHH-
T ss_pred             ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh---HHHHHHHHhhcccc-ccHH-
Confidence                    3346778999999999999999999999999999999999997643322   22222222211110 0000 


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      .+     ......++.+++..||..+|++||++++|++.|+++..
T Consensus       239 ~l-----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          239 AL-----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             HH-----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HH-----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            00     01223578899999999999999999999999998744

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.9e-38  Score=336.27  Aligned_cols=259  Identities=21%  Similarity=0.294  Sum_probs=180.9

Q ss_pred             hcccccccceEEEEEEec---CCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEe--cCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE---MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS--MDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ey~~~  449 (663)
                      +++||+|+||+||+|...   +++.||||++...... ..+.+|+.+++.++||||+++++++..  ....++||||+.+
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~  104 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH  104 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC
Confidence            568999999999999965   5789999999765433 468899999999999999999999965  5678999999975


Q ss_pred             CChhHhhccCC----CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEE----cCCCceEEeccccccc
Q 006055          450 GSLSALLHGNK----GAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL----TKSYEARVSDFGLAHL  521 (663)
Q Consensus       450 gsL~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill----~~~~~~kl~Dfg~a~~  521 (663)
                       +|.+++....    ......+++..++.++.||+.||.|||+.+  |+||||||+|||+    +.++.+||+|||+++.
T Consensus       105 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  181 (405)
T 3rgf_A          105 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARL  181 (405)
T ss_dssp             -EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-
T ss_pred             -CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEEEEECCCcee
Confidence             8887775221    112235899999999999999999999998  9999999999999    7788999999999987


Q ss_pred             cCCC-------CCCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCC---CChHHHHHHHHhhc
Q 006055          522 VGPS-------STPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEG---VDLPRWVQSIVKDE  590 (663)
Q Consensus       522 ~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~  590 (663)
                      ....       ....++..|+|||++.+. .++.++|||||||++|||++|+.||........   ......+..+....
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~  261 (405)
T 3rgf_A          182 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  261 (405)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHH
T ss_pred             cCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhh
Confidence            6532       123467789999998874 589999999999999999999999975432110   01111222221110


Q ss_pred             -cc--ccccch---------------hhhcccChHH--------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          591 -WT--SEVFDL---------------ELLRYQNVEE--------EMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       591 -~~--~~~~d~---------------~~~~~~~~~~--------~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                       ..  ..+-+.               ..........        ...++.+++.+|+..||++|||++|+++|
T Consensus       262 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             CCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             00  000000               0000000000        03467789999999999999999999985

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-37  Score=339.50  Aligned_cols=182  Identities=24%  Similarity=0.367  Sum_probs=146.7

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEec-----CccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSM-----DEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e  445 (663)
                      .++||+|+||+||+|.. .+|+.||||++......   .+.+.+|+++++.++||||+++++++...     ...++|||
T Consensus        58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  137 (458)
T 3rp9_A           58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE  137 (458)
T ss_dssp             CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEC
T ss_pred             eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEe
Confidence            46899999999999984 47999999998764322   46788999999999999999999998543     46899999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+. |+|.+++...     ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++.....
T Consensus       138 ~~~-~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          138 IAD-SDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             CCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             ccc-cchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            985 6999998753     35899999999999999999999998  999999999999999999999999999876422


Q ss_pred             C-------------------------------CCCCCccccCcccc-CCCCCCCcchhhhHHHHHHHHHhC
Q 006055          526 S-------------------------------TPNRVAGYRAPEVT-DPCKVSQKADVYSFGVLLLELLTG  564 (663)
Q Consensus       526 ~-------------------------------~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGvvl~elltg  564 (663)
                      .                               ...+|..|+|||++ ....++.++|||||||++|||++|
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            1                               12347779999976 566799999999999999999994

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.1e-37  Score=343.56  Aligned_cols=241  Identities=25%  Similarity=0.336  Sum_probs=198.6

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCc----ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDV----TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .++||+|+||.||+|... +|+.||||++...    ......+.+|+.+++.++||||+++++++.+....++||||+.+
T Consensus        31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  110 (484)
T 3nyv_A           31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG  110 (484)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence            468999999999999954 7999999998654    23467899999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEE---cCCCceEEeccccccccCCCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL---TKSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      |+|.+++....     .+++..+..++.||+.||.|||+++  |+||||||+|||+   +.++.+||+|||+++......
T Consensus       111 ~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  183 (484)
T 3nyv_A          111 GELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK  183 (484)
T ss_dssp             CBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence            99999987533     4899999999999999999999998  9999999999999   567899999999998776543


Q ss_pred             C---CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          527 T---PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       527 ~---~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                      .   ..+++.|+|||++.+ .++.++||||+||++|+|++|+.||...      +....+..+.........        
T Consensus       184 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i~~~~~~~~~--------  248 (484)
T 3nyv_A          184 KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA------NEYDILKKVEKGKYTFEL--------  248 (484)
T ss_dssp             SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCCCCS--------
T ss_pred             ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHcCCCCCCC--------
Confidence            2   347888999999876 6899999999999999999999999653      223333333332221110        


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      +.......++.+++.+|+..||++|||++|+++|
T Consensus       249 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          249 PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            0111233467788899999999999999999985

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.7e-37  Score=327.61  Aligned_cols=241  Identities=23%  Similarity=0.374  Sum_probs=194.5

Q ss_pred             cccccccceEEEEEEec-CCcEEEEEEecCccc--C-------HHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEE
Q 006055          376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTI--S-------EREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVY  444 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~-------~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  444 (663)
                      +.||+|+||.||+|... +|+.||||++.....  .       .+.+.+|+.++..+ +||||+++++++......++||
T Consensus       100 ~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~  179 (365)
T 2y7j_A          100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF  179 (365)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEE
T ss_pred             eEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEE
Confidence            78999999999999964 799999999865421  1       34578899999998 8999999999999999999999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+++|+|.+++...     ..+++..+..++.||+.||.|||+.+  |+||||||+||+++.++.+||+|||++.....
T Consensus       180 e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          180 DLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             CCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            999999999999753     25899999999999999999999998  99999999999999999999999999987654


Q ss_pred             CC---CCCCCccccCccccCC------CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccc
Q 006055          525 SS---TPNRVAGYRAPEVTDP------CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV  595 (663)
Q Consensus       525 ~~---~~~~~~~y~aPE~~~~------~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  595 (663)
                      ..   ...++..|+|||++.+      ..++.++|||||||++|||++|+.||....      .......+......   
T Consensus       253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~---  323 (365)
T 2y7j_A          253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR------QILMLRMIMEGQYQ---  323 (365)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCC---
T ss_pred             CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhCCCC---
Confidence            43   2457788999999853      357889999999999999999999996421      12222222222110   


Q ss_pred             cchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       596 ~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....  .+   ......+.+++.+|+..||++|||++|++++
T Consensus       324 ~~~~--~~---~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          324 FSSP--EW---DDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             CCHH--HH---SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCc--cc---ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0000  00   1123467888999999999999999999984

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-38  Score=333.21  Aligned_cols=243  Identities=23%  Similarity=0.295  Sum_probs=194.8

Q ss_pred             hcccccccceEEEEEEe----cCCcEEEEEEecCcc-----cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVT-----ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  444 (663)
                      .+.||+|+||.||++..    .+|+.||||+++...     .....+.+|++++..+ +||||+++++++......++||
T Consensus        59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~  138 (355)
T 1vzo_A           59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL  138 (355)
T ss_dssp             EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEe
Confidence            47899999999999996    478999999987532     2345677899999999 6999999999999999999999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+++|+|.+++....     .+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++....
T Consensus       139 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  211 (355)
T 1vzo_A          139 DYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  211 (355)
T ss_dssp             CCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             ecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence            9999999999997532     4899999999999999999999998  99999999999999999999999999986543


Q ss_pred             CC-----CCCCCccccCccccCC--CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          525 SS-----TPNRVAGYRAPEVTDP--CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       525 ~~-----~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                      ..     ...++..|+|||++.+  ..++.++|||||||++|||++|+.||......  .........+.....      
T Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~------  283 (355)
T 1vzo_A          212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSEP------  283 (355)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC--CCHHHHHHHHHHCCC------
T ss_pred             CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc--chHHHHHHHHhccCC------
Confidence            21     2246788999999986  34788999999999999999999999753322  222333333222111      


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRP-----SMSEVIKRI  638 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~L  638 (663)
                            ..+......+.+++.+|+..||++||     +++|++++.
T Consensus       284 ------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          284 ------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                  11112234677889999999999999     999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.8e-37  Score=341.80  Aligned_cols=241  Identities=23%  Similarity=0.314  Sum_probs=194.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--------------cCHHHHHHHHHHhhcCCCCCcccceEEEEecCc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--------------ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDE  439 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  439 (663)
                      .++||+|+||+||+|.. .+++.||||+++...              ...+.+.+|+.+++.++||||+++++++.+...
T Consensus        41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  120 (504)
T 3q5i_A           41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY  120 (504)
T ss_dssp             EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            46899999999999995 468999999987542              224678999999999999999999999999999


Q ss_pred             cEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC---ceEEecc
Q 006055          440 KLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY---EARVSDF  516 (663)
Q Consensus       440 ~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~---~~kl~Df  516 (663)
                      .++||||+++|+|.+++....     .+++..+..++.||+.||.|||+.+  |+||||||+|||++.++   .+||+||
T Consensus       121 ~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          121 FYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            999999999999999886532     4899999999999999999999998  99999999999998776   6999999


Q ss_pred             ccccccCCCC---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccc
Q 006055          517 GLAHLVGPSS---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTS  593 (663)
Q Consensus       517 g~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (663)
                      |+++......   ...+++.|+|||++.+ .++.++||||+||++|+|++|+.||...      +....+..+...... 
T Consensus       194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i~~~~~~-  265 (504)
T 3q5i_A          194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQ------NDQDIIKKVEKGKYY-  265 (504)
T ss_dssp             TTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC-
T ss_pred             CCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHcCCCC-
Confidence            9998775542   3457888999999874 5899999999999999999999999653      223333333332211 


Q ss_pred             cccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       594 ~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                        ++..  .+   .....++.+++.+|+..||++|||++|++++
T Consensus       266 --~~~~--~~---~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          266 --FDFN--DW---KNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             --CCHH--HH---TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --CCcc--cc---CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence              1111  01   1123467888899999999999999999975

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.3e-37  Score=341.62  Aligned_cols=241  Identities=22%  Similarity=0.309  Sum_probs=192.2

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||+||+|.. .++..||||++....   .....+.+|+.+++.++||||++++++|.+....++||||+++|
T Consensus        42 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  121 (494)
T 3lij_A           42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG  121 (494)
T ss_dssp             EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence            46899999999999995 478999999987542   23567899999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC---CceEEeccccccccCCCC-
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS---YEARVSDFGLAHLVGPSS-  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~-  526 (663)
                      +|.+.+....     .+++..+..++.||+.||.|||+.+  |+||||||+|||++..   +.+||+|||+++...... 
T Consensus       122 ~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~  194 (494)
T 3lij_A          122 ELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK  194 (494)
T ss_dssp             BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence            9999886532     4899999999999999999999998  9999999999999764   459999999998765432 


Q ss_pred             --CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          527 --TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                        ...+++.|+|||++.+ .++.++||||+||++|+|++|+.||....      .......+........   ..  .+ 
T Consensus       195 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~~---~~--~~-  261 (494)
T 3lij_A          195 MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQT------DQEILRKVEKGKYTFD---SP--EW-  261 (494)
T ss_dssp             BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCCCC---SG--GG-
T ss_pred             ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCCCC---ch--hc-
Confidence              3457888999999874 68999999999999999999999996532      2333333333221110   00  01 


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                        .....++.+++.+|+..||++|||++|++++
T Consensus       262 --~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          262 --KNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             --TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             --ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence              1223467788889999999999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.7e-38  Score=320.53  Aligned_cols=246  Identities=20%  Similarity=0.277  Sum_probs=193.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEe--cCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYS--MDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||++.. .+|+.||+|.+......   .+.+.+|+++++.++||||+++++++.+  ....++||||++
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   90 (279)
T 2w5a_A           11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE   90 (279)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCT
T ss_pred             ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCC
Confidence            36899999999999995 47899999999765332   4568899999999999999999998865  456899999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---CcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG---PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~---~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      +|+|.+++..... ....+++..++.++.|++.||.|||+.+   .+|+||||||+||+++.++.+||+|||+++.....
T Consensus        91 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~  169 (279)
T 2w5a_A           91 GGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD  169 (279)
T ss_dssp             TEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---
T ss_pred             CCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccc
Confidence            9999999975321 1345899999999999999999999986   34999999999999999999999999999876543


Q ss_pred             CC----CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhh
Q 006055          526 ST----PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL  601 (663)
Q Consensus       526 ~~----~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  601 (663)
                      ..    ..++..|+|||.+.+..++.++||||||+++|||++|+.||....      .......+.... ...       
T Consensus       170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~i~~~~-~~~-------  235 (279)
T 2w5a_A          170 TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS------QKELAGKIREGK-FRR-------  235 (279)
T ss_dssp             CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTC-CCC-------
T ss_pred             cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC------HHHHHHHHhhcc-ccc-------
Confidence            21    235777999999988889999999999999999999999996532      122222222221 111       


Q ss_pred             cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       602 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                         .......++.+++.+||+.||++|||++|+++++
T Consensus       236 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          236 ---IPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             ---CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence               0112234678889999999999999999999854

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.9e-38  Score=321.73  Aligned_cols=248  Identities=25%  Similarity=0.385  Sum_probs=190.7

Q ss_pred             hcccccccceEEEEEEec--CCc--EEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE--MGT--IVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~--~g~--~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||+||+|.+.  +++  .||||.++...    ...+.+.+|+++++.++||||+++++++.+. ..++||||
T Consensus        23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~  101 (291)
T 1u46_A           23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTEL  101 (291)
T ss_dssp             EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEEC
T ss_pred             eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC-CceeeEec
Confidence            468999999999999853  333  68999987542    2246788999999999999999999998765 48999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      +++|+|.+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++......
T Consensus       102 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  175 (291)
T 1u46_A          102 APLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  175 (291)
T ss_dssp             CTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             ccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEccccccccccccc
Confidence            99999999997532    24899999999999999999999998  9999999999999999999999999998765432


Q ss_pred             C-------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          527 T-------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       527 ~-------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                      .       ..++..|+|||.+.+..++.++||||||+++|||++ |+.||...      +....+..+.......     
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------~~~~~~~~~~~~~~~~-----  244 (291)
T 1u46_A          176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------NGSQILHKIDKEGERL-----  244 (291)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHTSCCCC-----
T ss_pred             cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC------CHHHHHHHHHccCCCC-----
Confidence            1       234557999999988888999999999999999999 99999643      2223333332221110     


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                           ........++.+++.+|+..||++|||+.+++++|+++.+..
T Consensus       245 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          245 -----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             -----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence                 111223456888999999999999999999999999987654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2e-37  Score=328.54  Aligned_cols=248  Identities=21%  Similarity=0.295  Sum_probs=176.0

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEec------CccEEEE
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSM------DEKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~  444 (663)
                      .+.||+|+||.||+|. ..+|+.||||++......   .+.+.+|+++++.++||||+++++++...      ...++|+
T Consensus        34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~  113 (367)
T 2fst_X           34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  113 (367)
T ss_dssp             EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred             eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEe
Confidence            4689999999999998 467999999998754332   46788999999999999999999998654      5579999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+ +++|.+++..      ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++....
T Consensus       114 e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          114 HLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             ECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             ccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            998 6799998864      24899999999999999999999998  99999999999999999999999999987654


Q ss_pred             CC-CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc------ccccc
Q 006055          525 SS-TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW------TSEVF  596 (663)
Q Consensus       525 ~~-~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~  596 (663)
                      .. ...++..|+|||++.+ ..++.++|||||||++|||++|+.||....      ....+..+.....      ...+.
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~l~~i~~~~g~p~~~~~~~~~  258 (367)
T 2fst_X          185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD------HIDQLKLILRLVGTPGAELLKKIS  258 (367)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred             cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhCCCCHHHHHHhh
Confidence            32 3457788999999877 678999999999999999999999996532      2222222221100      00000


Q ss_pred             chh-------hhc--ccCh----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          597 DLE-------LLR--YQNV----EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       597 d~~-------~~~--~~~~----~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...       +..  ....    ......+.+++.+|+..||++|||++|++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            000       000  0000    0123467888999999999999999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.5e-37  Score=332.63  Aligned_cols=187  Identities=23%  Similarity=0.357  Sum_probs=159.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEec-----CccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSM-----DEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e  445 (663)
                      .++||+|+||.||+|.. .+|+.||||+++.....   .+.+.+|+++++.++||||+++++++...     ...++|||
T Consensus        31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  110 (432)
T 3n9x_A           31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE  110 (432)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEE
T ss_pred             EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEe
Confidence            46899999999999994 56899999999764322   46788999999999999999999998766     56899999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+. |+|.+++...     ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++.....
T Consensus       111 ~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          111 IAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             CCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             cCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            987 5999999753     35899999999999999999999998  999999999999999999999999999876432


Q ss_pred             --------------------------CCCCCCccccCcccc-CCCCCCCcchhhhHHHHHHHHHhCCCCCc
Q 006055          526 --------------------------STPNRVAGYRAPEVT-DPCKVSQKADVYSFGVLLLELLTGKAPTH  569 (663)
Q Consensus       526 --------------------------~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGvvl~elltg~~p~~  569 (663)
                                                ....+|..|+|||++ ....++.++||||+||++|||++|..||.
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence                                      223467789999986 56679999999999999999998766654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-37  Score=326.69  Aligned_cols=251  Identities=24%  Similarity=0.306  Sum_probs=192.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC------HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS------EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||+|+||.||+|.. .+|+.||||++......      .+.+.+|+++++.++||||+++++++.+....++||||+
T Consensus        15 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   94 (346)
T 1ua2_A           15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   94 (346)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcC
Confidence            46899999999999995 46899999998753221      246789999999999999999999999999999999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-  526 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-  526 (663)
                      ++ +|.+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++...... 
T Consensus        95 ~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (346)
T 1ua2_A           95 ET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  167 (346)
T ss_dssp             SE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             CC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence            86 8988887532    35788899999999999999999998  9999999999999999999999999998764332 


Q ss_pred             ---CCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc---cccccch-
Q 006055          527 ---TPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW---TSEVFDL-  598 (663)
Q Consensus       527 ---~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d~-  598 (663)
                         ...++..|+|||++.+. .++.++|||||||++|||++|..||....      ....+..+.....   ...+.+. 
T Consensus       168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~------~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS------DLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHHHcCCCChhhhhhhc
Confidence               23467789999998764 57899999999999999999999986532      2222222222110   0000000 


Q ss_pred             ---hhh---ccc--C----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          599 ---ELL---RYQ--N----VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       599 ---~~~---~~~--~----~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                         ...   ...  .    ......++.+++.+|+..||++|||++|++++-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence               000   000  0    012235788899999999999999999999863

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8.3e-38  Score=320.45  Aligned_cols=244  Identities=20%  Similarity=0.323  Sum_probs=180.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||+||+|.. .+|+.||||+++.....   .+.+.++...++.++||||+++++++.+.+..++||||+++ 
T Consensus        12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-   90 (290)
T 3fme_A           12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-   90 (290)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-
T ss_pred             HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-
Confidence            46899999999999995 57999999999764322   23344555568888999999999999999999999999985 


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC--
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ-GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST--  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--  527 (663)
                      +|.+++..... ....+++..+..++.|++.||.|||++ +  |+||||||+||+++.++.+||+|||+++.......  
T Consensus        91 ~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  167 (290)
T 3fme_A           91 SLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD  167 (290)
T ss_dssp             EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC-------------
T ss_pred             chHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCccccccccccc
Confidence            88877753211 123589999999999999999999998 8  99999999999999999999999999987654322  


Q ss_pred             -CCCCccccCcccc----CCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          528 -PNRVAGYRAPEVT----DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       528 -~~~~~~y~aPE~~----~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                       ..++..|+|||++    .+..++.++||||||+++|||++|+.||....     .....+...........        
T Consensus       168 ~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~--------  234 (290)
T 3fme_A          168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG-----TPFQQLKQVVEEPSPQL--------  234 (290)
T ss_dssp             --CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS-----CHHHHHHHHHHSCCCCC--------
T ss_pred             ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC-----chHHHHHHHhccCCCCc--------
Confidence             3467789999996    55678899999999999999999999996421     11222222222211110        


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                        .......++.+++.+|++.||++|||++|++++
T Consensus       235 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          235 --PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             --CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             --ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence              011223467889999999999999999999883

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.7e-37  Score=353.55  Aligned_cols=238  Identities=22%  Similarity=0.283  Sum_probs=196.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc----ccCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV----TISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .++||+|+||.||+|.. .+++.||||+++..    ......+..|..++..+ +||+|+++++++.+.+..++||||++
T Consensus       346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~  425 (674)
T 3pfq_A          346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN  425 (674)
T ss_dssp             EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred             EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence            46899999999999995 46889999999753    22345678889998887 79999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC---
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS---  525 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~---  525 (663)
                      +|+|.++++...     .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.....   
T Consensus       426 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~  498 (674)
T 3pfq_A          426 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT  498 (674)
T ss_dssp             SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCC
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeeccccCCcc
Confidence            999999998533     4899999999999999999999998  999999999999999999999999999864322   


Q ss_pred             -CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          526 -STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       526 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                       ....+|+.|+|||++.+..++.++|||||||++|||++|+.||...      +.......+......            
T Consensus       499 ~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~------~~~~~~~~i~~~~~~------------  560 (674)
T 3pfq_A          499 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE------DEDELFQSIMEHNVA------------  560 (674)
T ss_dssp             BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHSSCCC------------
T ss_pred             cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC------CHHHHHHHHHhCCCC------------
Confidence             2345788899999999999999999999999999999999999653      233344444432210            


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSM-----SEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~-----~ev~~~  637 (663)
                      .+.....++.+++.+|+..||++||++     +||++|
T Consensus       561 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          561 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            111233467888889999999999998     777654

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.4e-38  Score=324.53  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=179.2

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCc--ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV--TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||.||+|. ..+++.||||.+...  ....+.+.+|+.+++.++||||+++++++...+..++||||+++|+
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   99 (303)
T 2vwi_A           20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS   99 (303)
T ss_dssp             EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCB
T ss_pred             hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCc
Confidence            4689999999999998 457899999998654  2334678899999999999999999999999999999999999999


Q ss_pred             hhHhhccC---CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--
Q 006055          452 LSALLHGN---KGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       452 L~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--  526 (663)
                      |.+++...   .......+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++.......  
T Consensus       100 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  177 (303)
T 2vwi_A          100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI  177 (303)
T ss_dssp             HHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCHHHHHCC-----
T ss_pred             hHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCc
Confidence            99998631   1112345899999999999999999999998  9999999999999999999999999997654321  


Q ss_pred             -------CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          527 -------TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       527 -------~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                             ...++..|+|||.+.+ ..++.++||||||+++|||++|+.||......      ........... ..... 
T Consensus       178 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~-~~~~~-  249 (303)
T 2vwi_A          178 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM------KVLMLTLQNDP-PSLET-  249 (303)
T ss_dssp             ----------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG------GHHHHHHTSSC-CCTTC-
T ss_pred             cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh------hHHHHHhccCC-Ccccc-
Confidence                   2246777999999865 46789999999999999999999999753221      11111111111 00000 


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .............++.+++.+|+..||++|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            000000111223467888999999999999999999983

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.4e-37  Score=327.72  Aligned_cols=250  Identities=21%  Similarity=0.292  Sum_probs=186.4

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccC------------HHHHHHHHHHhhcCCCCCcccceEEEEecC----
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS------------EREFKDKIEGVGAVNHENLVPLRAYYYSMD----  438 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~------------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  438 (663)
                      .+.||+|+||.||+|...+|+.||||++......            .+.+.+|+++++.++||||+++++++...+    
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (362)
T 3pg1_A           27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM  106 (362)
T ss_dssp             EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTC
T ss_pred             eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCc
Confidence            4689999999999999888999999998643211            267899999999999999999999986533    


Q ss_pred             -ccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccc
Q 006055          439 -EKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFG  517 (663)
Q Consensus       439 -~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg  517 (663)
                       ..++||||++ |+|.+++....    ..+++..+..++.||+.||.|||+.+  |+||||||+||+++.++.+||+|||
T Consensus       107 ~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg  179 (362)
T 3pg1_A          107 HKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFN  179 (362)
T ss_dssp             CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCTT
T ss_pred             ceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCCCEEEEecC
Confidence             4699999998 58888887432    35899999999999999999999998  9999999999999999999999999


Q ss_pred             cccccCCCC---CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccc
Q 006055          518 LAHLVGPSS---TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTS  593 (663)
Q Consensus       518 ~a~~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (663)
                      +++......   ...++..|+|||++.+ ..++.++|||||||++|+|++|+.||....      ....+..+.......
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~------~~~~~~~i~~~~~~~  253 (362)
T 3pg1_A          180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST------FYNQLNKIVEVVGTP  253 (362)
T ss_dssp             C---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCCC
T ss_pred             cccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHcCCC
Confidence            997654332   2346777999999876 678999999999999999999999996532      122222221110000


Q ss_pred             cccc------hh--------hhc--c----cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          594 EVFD------LE--------LLR--Y----QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       594 ~~~d------~~--------~~~--~----~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ..-+      ..        ...  .    .........+.+++.+|+..||++|||++|++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            0000      00        000  0    0001123467889999999999999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.7e-37  Score=330.13  Aligned_cols=257  Identities=21%  Similarity=0.285  Sum_probs=196.0

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCC-----------CCCcccceEEEEecC----
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-----------HENLVPLRAYYYSMD----  438 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~~~----  438 (663)
                      .+.||+|+||+||+|.. .+++.||||++.........+.+|++++.+++           |+||+++++++....    
T Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  103 (373)
T 1q8y_A           24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV  103 (373)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred             EEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCc
Confidence            46899999999999994 67999999999866555677889999988876           899999999987654    


Q ss_pred             ccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCcceecCCCCCCEEEc------CCCce
Q 006055          439 EKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ-GPNVSHGNIKSSNILLT------KSYEA  511 (663)
Q Consensus       439 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~iiHrdlk~~Nill~------~~~~~  511 (663)
                      ..++||||+ +++|.+++....   ...+++..+..++.||+.||.|||++ +  |+||||||+|||++      ..+.+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~~~~~~~~  177 (373)
T 1q8y_A          104 HVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQI  177 (373)
T ss_dssp             EEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             eEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCCCcCcceE
Confidence            679999999 889999997643   23489999999999999999999998 8  99999999999994      44479


Q ss_pred             EEeccccccccCCC-CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhc
Q 006055          512 RVSDFGLAHLVGPS-STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE  590 (663)
Q Consensus       512 kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  590 (663)
                      ||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||++|+.||..............+..+....
T Consensus       178 kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (373)
T 1q8y_A          178 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL  257 (373)
T ss_dssp             EECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHH
T ss_pred             EEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhc
Confidence            99999999876544 23457888999999999889999999999999999999999998643322221122222211100


Q ss_pred             --cccc----------cc------------------chhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          591 --WTSE----------VF------------------DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       591 --~~~~----------~~------------------d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                        ....          .+                  +..............++.+++.+|+..||++|||++|++++
T Consensus       258 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          258 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             CCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence              0000          00                  00000112335667789999999999999999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.9e-37  Score=318.45  Aligned_cols=242  Identities=22%  Similarity=0.358  Sum_probs=191.9

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCc-ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDV-TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||.||+|... +|+.||+|.+... ......+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l  103 (302)
T 2j7t_A           24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV  103 (302)
T ss_dssp             EEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEH
T ss_pred             cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcH
Confidence            467999999999999964 5899999998754 33457889999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccC----CCCCC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG----PSSTP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~----~~~~~  528 (663)
                      .+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++....    .....
T Consensus       104 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  177 (302)
T 2j7t_A          104 DAIMLELD----RGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF  177 (302)
T ss_dssp             HHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC----
T ss_pred             HHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCccccccccccccc
Confidence            99886532    34899999999999999999999998  9999999999999999999999999875421    12334


Q ss_pred             CCCccccCcccc-----CCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          529 NRVAGYRAPEVT-----DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       529 ~~~~~y~aPE~~-----~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                      .++..|+|||++     .+..++.++||||||+++|||++|+.||....      .............. ...       
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~-~~~-------  243 (302)
T 2j7t_A          178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKIAKSDPP-TLL-------  243 (302)
T ss_dssp             -CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCCC-CCS-------
T ss_pred             cCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC------HHHHHHHHhccCCc-ccC-------
Confidence            577889999998     46678899999999999999999999996432      22222222222111 110       


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                       .......++.+++.+|+..||++|||++|++++
T Consensus       244 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          244 -TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             -SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             -CccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence             111223467889999999999999999999873

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=323.68  Aligned_cols=242  Identities=25%  Similarity=0.392  Sum_probs=190.7

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcC-CCCCcccceEEEEe------cCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAYYYS------MDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|.. .+|+.||||++.........+.+|+.++.++ +||||+++++++..      ....++||||
T Consensus        29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~  108 (326)
T 2x7f_A           29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF  108 (326)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEEC
T ss_pred             EEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEc
Confidence            46899999999999995 5799999999977666667899999999998 89999999999987      4578999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC-
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-  525 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~-  525 (663)
                      +++|+|.+++....   ...+++..+..++.||+.||.|||+.+  |+||||||+||+++.++.+||+|||++...... 
T Consensus       109 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  183 (326)
T 2x7f_A          109 CGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV  183 (326)
T ss_dssp             CTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCTTTC------
T ss_pred             CCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc
Confidence            99999999997543   235899999999999999999999998  999999999999999999999999999866432 


Q ss_pred             ---CCCCCCccccCccccC-----CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          526 ---STPNRVAGYRAPEVTD-----PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       526 ---~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                         ....++..|+|||++.     +..++.++|||||||++|||++|+.||....      .......+..... .... 
T Consensus       184 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~-~~~~-  255 (326)
T 2x7f_A          184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH------PMRALFLIPRNPA-PRLK-  255 (326)
T ss_dssp             -------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCC-CCCS-
T ss_pred             cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHhhcCcc-ccCC-
Confidence               2234677899999987     5568899999999999999999999996432      1111222211111 0000 


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                              .......+.+++.+|+..||++|||++|++++
T Consensus       256 --------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          256 --------SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             --------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             --------ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                    01123467888899999999999999999884

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.3e-38  Score=329.53  Aligned_cols=253  Identities=20%  Similarity=0.261  Sum_probs=190.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEec--------CccEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSM--------DEKLL  442 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~~~~l  442 (663)
                      .+.||+|+||+||+|.. .+|+.||||++....   .....+.+|+++++.++||||+++++++...        ...++
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l  101 (351)
T 3mi9_A           22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL  101 (351)
T ss_dssp             EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEE
T ss_pred             EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEE
Confidence            46899999999999995 679999999986542   2245788999999999999999999999774        45799


Q ss_pred             EEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccccc
Q 006055          443 VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV  522 (663)
Q Consensus       443 v~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~  522 (663)
                      ||||+++ +|.+.+....    ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus       102 v~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  174 (351)
T 3mi9_A          102 VFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAF  174 (351)
T ss_dssp             EEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence            9999986 7777776432    34899999999999999999999998  999999999999999999999999999876


Q ss_pred             CCC--------CCCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccc
Q 006055          523 GPS--------STPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTS  593 (663)
Q Consensus       523 ~~~--------~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (663)
                      ...        ....++..|+|||++.+ ..++.++|||||||++|||++|+.||......   .....+..........
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLCGSITPE  251 (351)
T ss_dssp             CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTT
T ss_pred             cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChh
Confidence            422        12235778999999876 45799999999999999999999999753211   1111111111110000


Q ss_pred             cccc---hhhh--------cccChHHH------HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          594 EVFD---LELL--------RYQNVEEE------MVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       594 ~~~d---~~~~--------~~~~~~~~------~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....   ....        ......+.      ...+.+++.+|+..||++|||++|++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            0000   0000        00011111      2357889999999999999999999984

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.4e-37  Score=317.32  Aligned_cols=241  Identities=25%  Similarity=0.393  Sum_probs=193.0

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .+.||+|+||.||+|... +|+.||||.+.... ....+.+|+.++..++||||+++++++......++||||+++|+|.
T Consensus        34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  112 (314)
T 3com_A           34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS  112 (314)
T ss_dssp             EEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred             heeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHH
Confidence            468999999999999954 59999999987643 3467889999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----CCCC
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----STPN  529 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----~~~~  529 (663)
                      +++....    ..+++..+..++.+++.||.|||+.+  |+||||||+||+++.++.+||+|||++......    ....
T Consensus       113 ~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  186 (314)
T 3com_A          113 DIIRLRN----KTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI  186 (314)
T ss_dssp             HHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCC
T ss_pred             HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccC
Confidence            9986322    35899999999999999999999998  999999999999999999999999999766443    2234


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE  609 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  609 (663)
                      ++..|+|||.+.+..++.++||||||+++|+|++|+.||....      ........... .....        ......
T Consensus       187 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~-~~~~~--------~~~~~~  251 (314)
T 3com_A          187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH------PMRAIFMIPTN-PPPTF--------RKPELW  251 (314)
T ss_dssp             SCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHS-CCCCC--------SSGGGS
T ss_pred             CCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhcC-CCccc--------CCcccC
Confidence            6778999999999889999999999999999999999996432      11111111111 11111        011122


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          610 MVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       610 ~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...+.+++.+|+..||++|||+.|++++
T Consensus       252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          252 SDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            3467889999999999999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=8.1e-37  Score=315.58  Aligned_cols=240  Identities=24%  Similarity=0.354  Sum_probs=190.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc-----cCHHHHHHHHHHhhcCCCCCcccceEEEE--ecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-----ISEREFKDKIEGVGAVNHENLVPLRAYYY--SMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||++.. .+++.||||.++...     .....+.+|+++++.++||||+++++++.  +....++||||
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   89 (305)
T 2wtk_C           10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY   89 (305)
T ss_dssp             CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred             eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehh
Confidence            36899999999999995 568999999987542     23567999999999999999999999984  44578999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      ++++ |.+++....   ...+++..+..++.|++.||.|||+++  |+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~  163 (305)
T 2wtk_C           90 CVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA  163 (305)
T ss_dssp             CSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred             ccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence            9986 777776433   245899999999999999999999998  9999999999999999999999999998765321


Q ss_pred             ------CCCCCccccCccccCCCC--CCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          527 ------TPNRVAGYRAPEVTDPCK--VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       527 ------~~~~~~~y~aPE~~~~~~--~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                            ...++..|+|||++.+..  ++.++||||||+++|||++|+.||...      +.......+.....       
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~i~~~~~-------  230 (305)
T 2wtk_C          164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD------NIYKLFENIGKGSY-------  230 (305)
T ss_dssp             SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHCCC-------
T ss_pred             cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc------hHHHHHHHHhcCCC-------
Confidence                  234677899999987644  377899999999999999999999642      22333333222211       


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                           .........+.+++.+|+..||++|||++|++++-
T Consensus       231 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  265 (305)
T 2wtk_C          231 -----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS  265 (305)
T ss_dssp             -----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred             -----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence                 00112234677889999999999999999999863

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.7e-37  Score=321.87  Aligned_cols=254  Identities=23%  Similarity=0.304  Sum_probs=197.1

Q ss_pred             hcccccccceEEEEEEe--cCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCC------CcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL--EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHE------NLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|..  .+|+.||||+++........+.+|++++..++|+      +++++++++...+..++||||
T Consensus        19 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   98 (339)
T 1z57_A           19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFEL   98 (339)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcC
Confidence            36899999999999985  3689999999986554456788899998888665      499999999999999999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC-------------------
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK-------------------  507 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~-------------------  507 (663)
                      + +++|.+++....   ..++++..+..++.|++.||+|||+++  |+||||||+||+++.                   
T Consensus        99 ~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~  172 (339)
T 1z57_A           99 L-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI  172 (339)
T ss_dssp             C-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred             C-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence            9 889999997643   245899999999999999999999998  999999999999987                   


Q ss_pred             CCceEEeccccccccCCCC-CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHH
Q 006055          508 SYEARVSDFGLAHLVGPSS-TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSI  586 (663)
Q Consensus       508 ~~~~kl~Dfg~a~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  586 (663)
                      ++.+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++|+.||......+   ....+...
T Consensus       173 ~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~  249 (339)
T 1z57_A          173 NPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE---HLAMMERI  249 (339)
T ss_dssp             CCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH---HHHHHHHH
T ss_pred             CCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHH
Confidence            6689999999998765443 3457888999999999899999999999999999999999997532211   11111111


Q ss_pred             Hhhc--------ccccccc---------------------hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          587 VKDE--------WTSEVFD---------------------LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       587 ~~~~--------~~~~~~d---------------------~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....        .....+.                     ..............++.+++.+|+..||++|||++|++++
T Consensus       250 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH  329 (339)
T ss_dssp             HCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             hCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence            1000        0000000                     0000001123446678999999999999999999999875

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=8.8e-37  Score=324.48  Aligned_cols=248  Identities=21%  Similarity=0.283  Sum_probs=186.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecC------ccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMD------EKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  444 (663)
                      .+.||+|+||.||+|.. .+|+.||||++......   .+.+.+|+.+++.++||||+++++++....      ..++||
T Consensus        30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~  109 (371)
T 2xrw_A           30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM  109 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEE
T ss_pred             eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEE
Confidence            46899999999999984 56899999999764322   356889999999999999999999997654      579999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+++ +|.+++..       .+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++....
T Consensus       110 e~~~~-~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          110 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             ECCSE-EHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             EcCCC-CHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence            99985 78888852       3789999999999999999999998  99999999999999999999999999987654


Q ss_pred             CC---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh------------
Q 006055          525 SS---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD------------  589 (663)
Q Consensus       525 ~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------  589 (663)
                      ..   ...++..|+|||++.+..++.++|||||||++|||++|+.||.....      ...+..+...            
T Consensus       180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH------IDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHC-CCCCCHHHHTTS
T ss_pred             ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCCHHHHHHh
Confidence            32   23467789999999998999999999999999999999999975321      1111121111            


Q ss_pred             ----------cccccccchh-----hh-cc--cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          590 ----------EWTSEVFDLE-----LL-RY--QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       590 ----------~~~~~~~d~~-----~~-~~--~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                                ..........     .. ..  ........++.+++.+|+..||++|||++|++++-
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence                      0000000000     00 00  00122356788999999999999999999999864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7.9e-37  Score=324.86  Aligned_cols=247  Identities=22%  Similarity=0.319  Sum_probs=189.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCcc------EEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEK------LLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~------~lv~  444 (663)
                      .+.||+|+||.||+|.. .+|+.||||++......   .+.+.+|+.+++.++||||+++++++......      ++||
T Consensus        47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  126 (371)
T 4exu_A           47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM  126 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEE
T ss_pred             EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEE
Confidence            46899999999999984 57999999999765333   46788999999999999999999999876654      9999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+. ++|.+++..       .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++....
T Consensus       127 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          127 PFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             ECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             cccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence            9998 589888742       3899999999999999999999998  99999999999999999999999999987654


Q ss_pred             CC-CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccc------cccc
Q 006055          525 SS-TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT------SEVF  596 (663)
Q Consensus       525 ~~-~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~  596 (663)
                      .. ...++..|+|||++.+ ..++.++|||||||++|||++|+.||....      ....+..+......      ....
T Consensus       197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~  270 (371)
T 4exu_A          197 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD------YLDQLTQILKVTGVPGTEFVQKLN  270 (371)
T ss_dssp             ---CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred             CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCcHHHHHHhh
Confidence            43 3456888999999877 678999999999999999999999996532      22222222211000      0000


Q ss_pred             ch-------hhhc--ccC----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          597 DL-------ELLR--YQN----VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       597 d~-------~~~~--~~~----~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      +.       ....  ...    ......++.+++.+|+..||++|||++|++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            00       0000  000    01124578889999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.5e-37  Score=325.67  Aligned_cols=252  Identities=17%  Similarity=0.261  Sum_probs=197.1

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccC------------------HHHHHHHHHHhhcCCCCCcccceEEEEe
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS------------------EREFKDKIEGVGAVNHENLVPLRAYYYS  436 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~------------------~~~~~~e~~~l~~l~h~niv~l~~~~~~  436 (663)
                      .+.||+|+||.||+|.. +|+.||||.+......                  ...+.+|+.+++.++||||+++++++.+
T Consensus        36 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~  114 (348)
T 2pml_X           36 IRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN  114 (348)
T ss_dssp             EEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEES
T ss_pred             EEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEee
Confidence            46899999999999999 8999999998654211                  1789999999999999999999999999


Q ss_pred             cCccEEEEEccCCCChhHh------hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCcceecCCCCCCEEEcCCC
Q 006055          437 MDEKLLVYDYLTMGSLSAL------LHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA-QGPNVSHGNIKSSNILLTKSY  509 (663)
Q Consensus       437 ~~~~~lv~ey~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~iiHrdlk~~Nill~~~~  509 (663)
                      .+..++||||+++|+|.++      +....   ...+++..+..++.|++.||.|||+ .+  |+||||||+||+++.++
T Consensus       115 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~~~~~  189 (348)
T 2pml_X          115 YDEVYIIYEYMENDSILKFDEYFFVLDKNY---TCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNG  189 (348)
T ss_dssp             SSEEEEEEECCTTCBSSEESSSEESSCSSS---CCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEECTTS
T ss_pred             CCeEEEEEeccCCCcHHHHHHHhhhhhhcc---ccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEEcCCC
Confidence            9999999999999999998      54321   3468999999999999999999999 87  99999999999999999


Q ss_pred             ceEEeccccccccCCC--CCCCCCccccCccccCCC-CCCC-cchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHH
Q 006055          510 EARVSDFGLAHLVGPS--STPNRVAGYRAPEVTDPC-KVSQ-KADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQS  585 (663)
Q Consensus       510 ~~kl~Dfg~a~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~-~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~  585 (663)
                      .+||+|||.+......  ....++..|+|||.+.+. .++. ++||||||+++|||++|+.||......     ......
T Consensus       190 ~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~  264 (348)
T 2pml_X          190 RVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-----VELFNN  264 (348)
T ss_dssp             CEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-----HHHHHH
T ss_pred             cEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHH
Confidence            9999999999875443  234577889999999877 5655 899999999999999999999753221     222222


Q ss_pred             HHhhcccccc----cchhhhc---ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          586 IVKDEWTSEV----FDLELLR---YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       586 ~~~~~~~~~~----~d~~~~~---~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      +.........    .......   .........++.+++.+|+..||++|||++|++++
T Consensus       265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            2222110000    0000000   00002234578889999999999999999999983

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=324.15  Aligned_cols=249  Identities=21%  Similarity=0.307  Sum_probs=190.3

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||.||+|....  .||+|.++....   ..+.+.+|+.+++.++||||+++++++.+....++||||+++++
T Consensus        38 ~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~  115 (319)
T 2y4i_B           38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT  115 (319)
T ss_dssp             CCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEE
T ss_pred             eeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCc
Confidence            4689999999999998753  599999875422   23567889999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC------
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS------  525 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~------  525 (663)
                      |.+++....    ..+++..+..++.|++.||.|||+.+  |+||||||+||+++ ++.+||+|||+++.....      
T Consensus       116 L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~  188 (319)
T 2y4i_B          116 LYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE  188 (319)
T ss_dssp             HHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC----------C
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCccccccccccccc
Confidence            999997532    35889999999999999999999998  99999999999998 679999999998754321      


Q ss_pred             ---CCCCCCccccCccccCC---------CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccc
Q 006055          526 ---STPNRVAGYRAPEVTDP---------CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTS  593 (663)
Q Consensus       526 ---~~~~~~~~y~aPE~~~~---------~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (663)
                         ....++..|+|||.+.+         ..++.++||||||+++|||++|+.||....      .......+..... .
T Consensus       189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~-~  261 (319)
T 2y4i_B          189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP------AEAIIWQMGTGMK-P  261 (319)
T ss_dssp             CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC------HHHHHHHHHTTCC-C
T ss_pred             cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHhccCCC-C
Confidence               11236677999999864         347889999999999999999999996432      1222222221111 1


Q ss_pred             cccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCC
Q 006055          594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQG  648 (663)
Q Consensus       594 ~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~~  648 (663)
                      ....         .....++.+++.+||..||++|||+.|++++|+++.......
T Consensus       262 ~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~  307 (319)
T 2y4i_B          262 NLSQ---------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL  307 (319)
T ss_dssp             CCCC---------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred             CCCc---------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence            1100         012235778899999999999999999999999997765443

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.3e-37  Score=325.38  Aligned_cols=251  Identities=20%  Similarity=0.298  Sum_probs=191.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEec-----CccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSM-----DEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|.. .+++.||||++.....  ..+.+.+|++++..++||||+++++++...     ...++||||
T Consensus        32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~  111 (364)
T 3qyz_A           32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL  111 (364)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred             EEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcc
Confidence            46899999999999994 4789999999975432  236788999999999999999999999765     357999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC-
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS-  525 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~-  525 (663)
                      +.+ +|.+++...      .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++..... 
T Consensus       112 ~~~-~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          112 MET-DLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             CSE-EHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             cCc-CHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            984 999998753      3899999999999999999999998  999999999999999999999999999876532 


Q ss_pred             ------CCCCCCccccCccccC-CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccc---ccc
Q 006055          526 ------STPNRVAGYRAPEVTD-PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT---SEV  595 (663)
Q Consensus       526 ------~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  595 (663)
                            ....++..|+|||++. +..++.++|||||||++|||++|+.||......+   ....+.........   ...
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHHCSCCHHHHHTC
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHh
Confidence                  2235678899999864 4558999999999999999999999997543211   11111111110000   000


Q ss_pred             cchhh-------hc--ccC----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          596 FDLEL-------LR--YQN----VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       596 ~d~~~-------~~--~~~----~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .+...       ..  ...    ......++.+++.+|+..||++|||++|++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000       00  000    01123467889999999999999999999984

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.5e-37  Score=324.65  Aligned_cols=258  Identities=22%  Similarity=0.312  Sum_probs=182.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCc-------cEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDE-------KLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-------~~lv~ey  446 (663)
                      .+.||+|+||+||+|.. .+|+.||||++.........+.++++.+..++||||+++++++.....       .++||||
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~  107 (360)
T 3e3p_A           28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY  107 (360)
T ss_dssp             C----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEEC
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeec
Confidence            46799999999999995 568999999987654444566778888889999999999999976544       7899999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCcceecCCCCCCEEEcC-CCceEEeccccccccC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH--AQGPNVSHGNIKSSNILLTK-SYEARVSDFGLAHLVG  523 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH--~~~~~iiHrdlk~~Nill~~-~~~~kl~Dfg~a~~~~  523 (663)
                      +++ +|.+.+.... .....+++..+..++.|++.||.|||  +.+  |+||||||+|||++. ++.+||+|||+++...
T Consensus       108 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~  183 (360)
T 3e3p_A          108 VPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS  183 (360)
T ss_dssp             CSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEECCCTTCBCCC
T ss_pred             ccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEEeeCCCceecC
Confidence            987 5544433211 11345889999999999999999999  777  999999999999997 8999999999998775


Q ss_pred             CCC---CCCCCccccCccccCCCC-CCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccc-------
Q 006055          524 PSS---TPNRVAGYRAPEVTDPCK-VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT-------  592 (663)
Q Consensus       524 ~~~---~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------  592 (663)
                      ...   ...++..|+|||++.+.. ++.++|||||||++|||++|+.||.....      ...+..+.+....       
T Consensus       184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~  257 (360)
T 3e3p_A          184 PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS------AGQLHEIVRVLGCPSREVLR  257 (360)
T ss_dssp             TTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCCCHHHHH
T ss_pred             CCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh------HHHHHHHHHHcCCCCHHHHH
Confidence            543   234677899999986654 89999999999999999999999975321      1222222211000       


Q ss_pred             ---ccccchhhh----------cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhC
Q 006055          593 ---SEVFDLELL----------RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR--IEELH  642 (663)
Q Consensus       593 ---~~~~d~~~~----------~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~--L~~~~  642 (663)
                         ....+....          ..........++.+++.+|++.||++|||+.|+++|  ++++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence               000000000          000111235678899999999999999999999985  44443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-37  Score=330.52  Aligned_cols=250  Identities=22%  Similarity=0.313  Sum_probs=186.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecC---------------
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMD---------------  438 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---------------  438 (663)
                      .+.||+|+||+||+|.. .+|+.||||++....   ....+|+++++.++||||+++++++....               
T Consensus        12 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~   88 (383)
T 3eb0_A           12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNK   88 (383)
T ss_dssp             EEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTCCCTTBCCEEEEEEEC----------------
T ss_pred             EEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHcCCCCccchhheeeecCccccccccccccccc
Confidence            46899999999999984 679999999986542   22347999999999999999999985432               


Q ss_pred             -----------------------ccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCccee
Q 006055          439 -----------------------EKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH  495 (663)
Q Consensus       439 -----------------------~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiH  495 (663)
                                             ..++||||+++ +|.+.+..... ....+++..+..++.||+.||.|||+.+  |+|
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g--i~H  164 (383)
T 3eb0_A           89 LGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSLG--ICH  164 (383)
T ss_dssp             ---------------------CCEEEEEECCCSE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT--EEC
T ss_pred             ccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCc--Ccc
Confidence                                   37899999984 88777753211 1235899999999999999999999998  999


Q ss_pred             cCCCCCCEEEc-CCCceEEeccccccccCCCC---CCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCcc
Q 006055          496 GNIKSSNILLT-KSYEARVSDFGLAHLVGPSS---TPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHA  570 (663)
Q Consensus       496 rdlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~---~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~  570 (663)
                      |||||+||+++ .++.+||+|||+++......   ...++..|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus       165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  244 (383)
T 3eb0_A          165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG  244 (383)
T ss_dssp             SCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence            99999999998 68899999999998765433   33467779999998765 489999999999999999999999975


Q ss_pred             ccCCCCCChHHHHHHHHhhcc---ccccc--ch--------hh----hcccChHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 006055          571 LLNEEGVDLPRWVQSIVKDEW---TSEVF--DL--------EL----LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSE  633 (663)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~---~~~~~--d~--------~~----~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~e  633 (663)
                      ...      ...+..++....   ...+.  ++        ..    ...........++.+++.+|+..||++|||+.|
T Consensus       245 ~~~------~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  318 (383)
T 3eb0_A          245 ETS------IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE  318 (383)
T ss_dssp             SSH------HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             CCh------HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            321      222222221100   00000  00        00    000011123446889999999999999999999


Q ss_pred             HHHH
Q 006055          634 VIKR  637 (663)
Q Consensus       634 v~~~  637 (663)
                      +++|
T Consensus       319 ~l~h  322 (383)
T 3eb0_A          319 AMAH  322 (383)
T ss_dssp             HHTS
T ss_pred             HhcC
Confidence            9864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6e-37  Score=315.46  Aligned_cols=241  Identities=21%  Similarity=0.294  Sum_probs=195.0

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----------cCHHHHHHHHHHhhcCC-CCCcccceEEEEecCccEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----------ISEREFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLL  442 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  442 (663)
                      .+.||+|+||.||+|.. .+|+.||||.+....          ...+.+.+|++++.+++ ||||+++++++......++
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  101 (298)
T 1phk_A           22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL  101 (298)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence            36899999999999995 468999999986542          11356788999999995 9999999999999999999


Q ss_pred             EEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccccc
Q 006055          443 VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV  522 (663)
Q Consensus       443 v~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~  522 (663)
                      ||||+++++|.+++...     ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++...
T Consensus       102 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A          102 VFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            99999999999999753     25899999999999999999999998  999999999999999999999999999876


Q ss_pred             CCCC---CCCCCccccCccccC------CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccc
Q 006055          523 GPSS---TPNRVAGYRAPEVTD------PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTS  593 (663)
Q Consensus       523 ~~~~---~~~~~~~y~aPE~~~------~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (663)
                      ....   ...++..|+|||++.      ...++.++||||||+++|||++|+.||....      .......+.......
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~  248 (298)
T 1phk_A          175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK------QMLMLRMIMSGNYQF  248 (298)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCCC
T ss_pred             CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc------HHHHHHHHhcCCccc
Confidence            5433   234677899999874      4567889999999999999999999996432      222223322222110


Q ss_pred             cccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       594 ~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      .        .........++.+++.+|+..||++|||++|+++
T Consensus       249 ~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          249 G--------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             C--------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             C--------cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            0        0111223456888999999999999999999987

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.6e-37  Score=333.83  Aligned_cols=250  Identities=24%  Similarity=0.304  Sum_probs=185.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecC------ccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMD------EKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ey~  447 (663)
                      .++||+|+||.||+|.. .+|+.||||++....   ....+|+++++.++||||++++++|....      ..++||||+
T Consensus        59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~  135 (420)
T 1j1b_A           59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV  135 (420)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECC
T ss_pred             eeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcc
Confidence            46899999999999996 469999999986542   22347999999999999999999986432      257899999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC-CceEEeccccccccCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS-YEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~  526 (663)
                      ++ ++.+.+.... .....+++..++.++.||++||.|||+.+  |+||||||+|||++.+ +.+||+|||+++......
T Consensus       136 ~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~  211 (420)
T 1j1b_A          136 PE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  211 (420)
T ss_dssp             CE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             cc-cHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhhhhcccCC
Confidence            86 6666554211 11245899999999999999999999998  9999999999999965 568999999998764432


Q ss_pred             ---CCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc-----------
Q 006055          527 ---TPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW-----------  591 (663)
Q Consensus       527 ---~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------  591 (663)
                         ...++..|+|||++.+. .++.++|||||||++|||++|+.||.....      ...+..++....           
T Consensus       212 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~------~~~l~~i~~~lg~p~~~~~~~~~  285 (420)
T 1j1b_A          212 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG------VDQLVEIIKVLGTPTREQIREMN  285 (420)
T ss_dssp             CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCSCCHHHHHHHC
T ss_pred             CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCCHHHHHhhC
Confidence               34567789999998764 789999999999999999999999975321      122222221100           


Q ss_pred             --cccccchhhhcc----cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          592 --TSEVFDLELLRY----QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       592 --~~~~~d~~~~~~----~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                        ..+..-+.....    ........++.+++.+|+..||++|||+.|+++|
T Consensus       286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence              000000000000    0001123568889999999999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.7e-37  Score=320.92  Aligned_cols=242  Identities=24%  Similarity=0.359  Sum_probs=188.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc---------CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---------SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  444 (663)
                      .+.||+|+||.||+|.. .+++.||||.+.....         ....+.+|+++++.++||||+++++++... ..++||
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~lv~   93 (322)
T 2ycf_A           15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVL   93 (322)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-ceEEEE
Confidence            46899999999999995 4689999999865321         123588999999999999999999998654 489999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc---eEEeccccccc
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLAHL  521 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~---~kl~Dfg~a~~  521 (663)
                      ||+++|+|.+++...     ..+++..+..++.||+.||.|||+++  |+||||||+||+++.++.   +||+|||+++.
T Consensus        94 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           94 ELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             ECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             ecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence            999999999998753     35899999999999999999999998  999999999999987665   99999999987


Q ss_pred             cCCCC---CCCCCccccCcccc---CCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccc
Q 006055          522 VGPSS---TPNRVAGYRAPEVT---DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV  595 (663)
Q Consensus       522 ~~~~~---~~~~~~~y~aPE~~---~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  595 (663)
                      .....   ...++..|+|||++   ....++.++|||||||++|||++|+.||.......  .+...+    ......  
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~----~~~~~~--  238 (322)
T 2ycf_A          167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI----TSGKYN--  238 (322)
T ss_dssp             CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH----HHTCCC--
T ss_pred             cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH----HhCccc--
Confidence            75432   12367789999996   35678899999999999999999999997543221  121111    111100  


Q ss_pred             cchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       596 ~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ..+..     ......++.+++.+|+..||++|||++|++++
T Consensus       239 ~~~~~-----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          239 FIPEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             CCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCchh-----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            00110     01123467889999999999999999999863

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.3e-37  Score=347.82  Aligned_cols=245  Identities=22%  Similarity=0.346  Sum_probs=197.5

Q ss_pred             hcccccccceEEEEEEec----CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLE----MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||.||+|...    .+..||||.++....  ..+.+.+|+.+++.++||||+++++++. .+..++||||++
T Consensus       395 ~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~  473 (656)
T 2j0j_A          395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT  473 (656)
T ss_dssp             EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCC
Confidence            568999999999999863    256799999875432  2367899999999999999999999984 467899999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-  527 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  527 (663)
                      +|+|.++++...    ..+++..+..++.|++.||.|||+++  |+||||||+|||++.++.+||+|||+++....... 
T Consensus       474 ~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~  547 (656)
T 2j0j_A          474 LGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  547 (656)
T ss_dssp             TCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred             CCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCCeecCCCcce
Confidence            999999997543    35899999999999999999999998  99999999999999999999999999987654322 


Q ss_pred             ----CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          528 ----PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       528 ----~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                          ..++..|+|||++.+..++.++|||||||++|||++ |..||....      .......+......          
T Consensus       548 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~------~~~~~~~i~~~~~~----------  611 (656)
T 2j0j_A          548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK------NNDVIGRIENGERL----------  611 (656)
T ss_dssp             ------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHHTCCC----------
T ss_pred             eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHcCCCC----------
Confidence                224567999999988889999999999999999997 999996532      22222222222111          


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                       ..+......+.+++.+||..||++|||+.|+++.|+++.+
T Consensus       612 -~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          612 -PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence             0111233468889999999999999999999999998743

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.4e-36  Score=324.24  Aligned_cols=193  Identities=24%  Similarity=0.333  Sum_probs=164.0

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCC-CC-----CcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-HE-----NLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .+.||+|+||+||+|.. .+++.||||+++........+..|+.++..++ |+     +++++++++...+..++||||+
T Consensus        59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~  138 (382)
T 2vx3_A           59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML  138 (382)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecC
Confidence            46899999999999995 46899999999865444567778888888774 44     4999999999999999999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc--CCCceEEeccccccccCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT--KSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~--~~~~~kl~Dfg~a~~~~~~  525 (663)
                      . |+|.+++....   ...+++..+..++.|++.||.|||.+...|+||||||+|||++  .++.+||+|||+++.....
T Consensus       139 ~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~  214 (382)
T 2vx3_A          139 S-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR  214 (382)
T ss_dssp             C-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC
T ss_pred             C-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc
Confidence            6 59999997643   2358999999999999999999995322399999999999995  4778999999999877654


Q ss_pred             C-CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccc
Q 006055          526 S-TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHAL  571 (663)
Q Consensus       526 ~-~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~  571 (663)
                      . ...++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       215 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          215 IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            3 345788899999999999999999999999999999999999753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.4e-37  Score=329.27  Aligned_cols=256  Identities=24%  Similarity=0.319  Sum_probs=188.6

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCc------cEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDE------KLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~lv~ey~~  448 (663)
                      .++||+|+||+||+|....+..||+|++.....   ...+|+++++.++||||+++++++.....      .++||||++
T Consensus        45 ~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~  121 (394)
T 4e7w_A           45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP  121 (394)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCS
T ss_pred             eEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccC
Confidence            468999999999999987777799998865422   22468999999999999999999876543      789999998


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc-CCCceEEeccccccccCCCC-
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT-KSYEARVSDFGLAHLVGPSS-  526 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~-  526 (663)
                      ++.+....+...  ....+++..+..++.||+.||.|||+.+  |+||||||+|||++ .++.+||+|||+++...... 
T Consensus       122 ~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~  197 (394)
T 4e7w_A          122 ETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP  197 (394)
T ss_dssp             EEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred             ccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC
Confidence            754443332111  1235899999999999999999999998  99999999999999 79999999999998764432 


Q ss_pred             --CCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccc----------c
Q 006055          527 --TPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT----------S  593 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------~  593 (663)
                        ...++..|+|||++.+. .++.++|||||||++|||++|+.||.....      ...+..+......          .
T Consensus       198 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~------~~~l~~i~~~~g~p~~~~~~~~~~  271 (394)
T 4e7w_A          198 NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG------IDQLVEIIKVLGTPSREQIKTMNP  271 (394)
T ss_dssp             CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred             CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCCHHHHHhhCh
Confidence              34467789999998764 589999999999999999999999975321      1222222111000          0


Q ss_pred             cccchhhh--ccc-----ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhCC
Q 006055          594 EVFDLELL--RYQ-----NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR--IEELHP  643 (663)
Q Consensus       594 ~~~d~~~~--~~~-----~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~--L~~~~~  643 (663)
                      ........  ...     .......++.+++.+|+..||++|||+.|+++|  ++++..
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence            00000000  000     001133578899999999999999999999986  444433

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.5e-37  Score=323.00  Aligned_cols=245  Identities=22%  Similarity=0.294  Sum_probs=168.7

Q ss_pred             cccccccceEEEEEEec-CCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEe----cCccEEEEEccCCC
Q 006055          376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS----MDEKLLVYDYLTMG  450 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ey~~~g  450 (663)
                      ++||+|+||+||+|... +|+.||||++....   ....+....+..++||||+++++++..    ....++||||+++|
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg  111 (336)
T 3fhr_A           35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGG  111 (336)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTE
T ss_pred             eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCC
Confidence            56999999999999955 79999999986542   222333334567799999999999876    34479999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC---CCceEEeccccccccCCCC-
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK---SYEARVSDFGLAHLVGPSS-  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~---~~~~kl~Dfg~a~~~~~~~-  526 (663)
                      +|.+++....   ...+++..++.++.|++.||.|||+.+  |+||||||+||+++.   ++.+||+|||+++...... 
T Consensus       112 ~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~  186 (336)
T 3fhr_A          112 ELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL  186 (336)
T ss_dssp             EHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred             CHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccceecccccc
Confidence            9999998643   246899999999999999999999998  999999999999986   4459999999998765432 


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       ...++..|+|||++.+..++.++||||||+++|+|++|+.||.........  ......+.....     ..   ....
T Consensus       187 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~-----~~---~~~~  256 (336)
T 3fhr_A          187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--PGMKRRIRLGQY-----GF---PNPE  256 (336)
T ss_dssp             -----------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------CC---CTTT
T ss_pred             ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh--hhHHHhhhcccc-----cc---Cchh
Confidence             334677899999998888899999999999999999999999754322110  000000000000     00   0001


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      ......++.+++.+|+..||++|||++|++++-
T Consensus       257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            112344678889999999999999999999843

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.4e-37  Score=334.37  Aligned_cols=245  Identities=21%  Similarity=0.294  Sum_probs=184.0

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .++||+|+||+||.+...+|+.||||++....  ...+.+|+.++..+ +||||+++++++.+....++||||+. |+|.
T Consensus        20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~   96 (434)
T 2rio_A           20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ   96 (434)
T ss_dssp             EEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred             cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence            36799999999987777789999999986532  45678899999876 89999999999999999999999996 6999


Q ss_pred             HhhccCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC-------------CceEEecccc
Q 006055          454 ALLHGNKGAGR--TPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS-------------YEARVSDFGL  518 (663)
Q Consensus       454 ~~l~~~~~~~~--~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~-------------~~~kl~Dfg~  518 (663)
                      +++........  ....+..+..++.||+.||+|||+.+  |+||||||+|||++.+             +.+||+|||+
T Consensus        97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~  174 (434)
T 2rio_A           97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL  174 (434)
T ss_dssp             HHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTT
T ss_pred             HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceEEEEccccc
Confidence            99986432111  11133445789999999999999998  9999999999999754             4899999999


Q ss_pred             ccccCCCC--------CCCCCccccCccccCC-------CCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHH
Q 006055          519 AHLVGPSS--------TPNRVAGYRAPEVTDP-------CKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRW  582 (663)
Q Consensus       519 a~~~~~~~--------~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~  582 (663)
                      ++......        ...++.+|+|||++.+       ..++.++|||||||++|||++ |+.||......+       
T Consensus       175 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-------  247 (434)
T 2rio_A          175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-------  247 (434)
T ss_dssp             CEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-------
T ss_pred             ceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-------
Confidence            98775432        2346788999999865       568899999999999999999 999996432110       


Q ss_pred             HHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          583 VQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       583 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                       ..+.........     ...........++.+++.+|+..||++|||+.||+++
T Consensus       248 -~~i~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 -SNIIRGIFSLDE-----MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             -HHHHHTCCCCCC-----CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -HHHhcCCCCccc-----ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence             112221111100     0111223455678899999999999999999999863

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=316.55  Aligned_cols=248  Identities=21%  Similarity=0.312  Sum_probs=182.9

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEE--------------ecC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYY--------------SMD  438 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~--------------~~~  438 (663)
                      .+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+++++.++||||+++++++.              +..
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~   95 (320)
T 2i6l_A           16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN   95 (320)
T ss_dssp             EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCS
T ss_pred             EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccC
Confidence            368999999999999965 59999999987543 23467889999999999999999999873              335


Q ss_pred             ccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc-CCCceEEeccc
Q 006055          439 EKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT-KSYEARVSDFG  517 (663)
Q Consensus       439 ~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~-~~~~~kl~Dfg  517 (663)
                      ..++||||++ |+|.+++..      ..+++..+..++.|++.||+|||+.+  |+||||||+||+++ +++.+||+|||
T Consensus        96 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~Dfg  166 (320)
T 2i6l_A           96 SVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFG  166 (320)
T ss_dssp             EEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred             ceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEEEccCc
Confidence            6789999998 599999964      24889999999999999999999998  99999999999997 56799999999


Q ss_pred             cccccCCCCC-------CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh
Q 006055          518 LAHLVGPSST-------PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD  589 (663)
Q Consensus       518 ~a~~~~~~~~-------~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  589 (663)
                      +++.......       ..++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....      ......+...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~~~~  240 (320)
T 2i6l_A          167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE------LEQMQLILES  240 (320)
T ss_dssp             TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHH
T ss_pred             cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHh
Confidence            9987643211       124667999998754 6789999999999999999999999975321      2222222221


Q ss_pred             ccccc-------------ccchhhhcc-cC----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          590 EWTSE-------------VFDLELLRY-QN----VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       590 ~~~~~-------------~~d~~~~~~-~~----~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .....             ......... ..    ......++.+++.+|++.||++|||++|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            10000             000000000 00    01224578889999999999999999999884

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=9e-37  Score=314.49  Aligned_cols=240  Identities=22%  Similarity=0.342  Sum_probs=186.2

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEe-------------cCcc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS-------------MDEK  440 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------------~~~~  440 (663)
                      .+.||+|+||.||+|.. .+|+.||||++.......+.+.+|+.+++.++||||+++++++.+             ....
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (303)
T 1zy4_A           11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTL   90 (303)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEE
T ss_pred             hheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCce
Confidence            46899999999999995 579999999997654445778999999999999999999999865             3457


Q ss_pred             EEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          441 LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       441 ~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                      ++||||+++|+|.++++...    ..+++..++.++.|++.||.|||+++  |+||||||+||+++.++.+||+|||+++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~  164 (303)
T 1zy4_A           91 FIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAK  164 (303)
T ss_dssp             EEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred             EEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEeeCcchh
Confidence            89999999999999997532    34788999999999999999999998  9999999999999999999999999997


Q ss_pred             ccCCC------------------CCCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHH
Q 006055          521 LVGPS------------------STPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPR  581 (663)
Q Consensus       521 ~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~  581 (663)
                      .....                  ....++..|+|||.+.+. .++.++|||||||++|||++   ||....     +...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-----~~~~  236 (303)
T 1zy4_A          165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-----ERVN  236 (303)
T ss_dssp             CTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHHH
T ss_pred             hcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-----hHHH
Confidence            65422                  112356779999999764 68999999999999999998   553211     1111


Q ss_pred             HHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          582 WVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       582 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      ....+.....   .+.     ..........+.+++.+|+..||++|||++|+++
T Consensus       237 ~~~~~~~~~~---~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          237 ILKKLRSVSI---EFP-----PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHSTTC---CCC-----TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcccccc---ccC-----ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            1111111100   000     0111223346788899999999999999999998

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.7e-36  Score=317.54  Aligned_cols=247  Identities=23%  Similarity=0.308  Sum_probs=189.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCc------cEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDE------KLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~lv~  444 (663)
                      .+.||+|+||.||+|.. .+|+.||||++......   .+.+.+|+.+++.++||||+++++++.....      .++||
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~  108 (353)
T 3coi_A           29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM  108 (353)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred             eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence            36799999999999995 56999999999765333   3568899999999999999999999987654      49999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+. |+|.+++..       .+++..+..++.||+.||.|||+++  |+||||||+||+++.++.+||+|||+++....
T Consensus       109 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          109 PFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             ECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             cccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence            9998 588887742       3899999999999999999999998  99999999999999999999999999987654


Q ss_pred             CC-CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc------ccccc
Q 006055          525 SS-TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW------TSEVF  596 (663)
Q Consensus       525 ~~-~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~  596 (663)
                      .. ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||....      ....+..+.....      ...+.
T Consensus       179 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~  252 (353)
T 3coi_A          179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD------YLDQLTQILKVTGVPGTEFVQKLN  252 (353)
T ss_dssp             -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC------HHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred             CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhCCCCHHHHHHHh
Confidence            32 2356788999999876 678999999999999999999999997532      1222222221100      00000


Q ss_pred             chh-------hh-----c-ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          597 DLE-------LL-----R-YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       597 d~~-------~~-----~-~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      +..       +.     . .........++.+++.+|+..||++|||++|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000       00     0 00011234578889999999999999999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.1e-36  Score=308.52  Aligned_cols=241  Identities=23%  Similarity=0.286  Sum_probs=194.5

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||.||+|... +++.||||++....   .....+.+|++++++++||||+++++++.+....++||||++++
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  106 (287)
T 2wei_A           27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG  106 (287)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCC
Confidence            468999999999999964 79999999986542   34678999999999999999999999999999999999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC---CceEEeccccccccCCCCC
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS---YEARVSDFGLAHLVGPSST  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~~  527 (663)
                      +|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+||+++.+   +.+||+|||++........
T Consensus       107 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~  179 (287)
T 2wei_A          107 ELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (287)
T ss_dssp             BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred             CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence            9999886432     4899999999999999999999998  9999999999999754   4699999999987655432


Q ss_pred             C---CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          528 P---NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       528 ~---~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                      .   .++..|+|||.+.+. ++.++||||||+++|+|++|+.||....      .......+........     .   .
T Consensus       180 ~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~-----~---~  244 (287)
T 2wei_A          180 MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN------EYDILKRVETGKYAFD-----L---P  244 (287)
T ss_dssp             CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCCCC-----S---G
T ss_pred             cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCCCCCC-----c---h
Confidence            2   245679999998764 8899999999999999999999996532      2223333322211110     0   0


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .......++.+++.+|+..||++|||++|++++
T Consensus       245 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            011223467888999999999999999999984

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.4e-36  Score=318.75  Aligned_cols=253  Identities=24%  Similarity=0.310  Sum_probs=193.9

Q ss_pred             hcccccccceEEEEEEec-CC-cEEEEEEecCcccCHHHHHHHHHHhhcCCCCC------cccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE-MG-TIVAVKRLKDVTISEREFKDKIEGVGAVNHEN------LVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||+||+|... ++ +.||||+++........+.+|+.+++.++|++      ++.+++++......++||||
T Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~  103 (355)
T 2eu9_A           24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFEL  103 (355)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEec
Confidence            468999999999999953 44 78999999865555677888999999887665      88999999999999999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEE-------------------cC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILL-------------------TK  507 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill-------------------~~  507 (663)
                      + ++++.+++....   ...+++..+..++.||+.||.|||+++  |+||||||+|||+                   +.
T Consensus       104 ~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~  177 (355)
T 2eu9_A          104 L-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK  177 (355)
T ss_dssp             C-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred             c-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccccccccccccC
Confidence            9 567777776432   235899999999999999999999998  9999999999999                   66


Q ss_pred             CCceEEeccccccccCCCC-CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHH
Q 006055          508 SYEARVSDFGLAHLVGPSS-TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSI  586 (663)
Q Consensus       508 ~~~~kl~Dfg~a~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  586 (663)
                      ++.+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++|+.||......+   ....+...
T Consensus       178 ~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~  254 (355)
T 2eu9_A          178 NTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE---HLVMMEKI  254 (355)
T ss_dssp             CCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHH
T ss_pred             CCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHH
Confidence            7899999999998765443 3457888999999999999999999999999999999999997532211   11111111


Q ss_pred             Hhhcccccc---------c------------chh---------hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          587 VKDEWTSEV---------F------------DLE---------LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       587 ~~~~~~~~~---------~------------d~~---------~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      ... .....         +            +..         ............++.+++.+|+..||++|||++|+++
T Consensus       255 ~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          255 LGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cCC-CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            100 00000         0            000         0000111234557889999999999999999999987


Q ss_pred             H
Q 006055          637 R  637 (663)
Q Consensus       637 ~  637 (663)
                      +
T Consensus       334 h  334 (355)
T 2eu9_A          334 H  334 (355)
T ss_dssp             S
T ss_pred             C
Confidence            4

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.9e-36  Score=315.96  Aligned_cols=251  Identities=23%  Similarity=0.306  Sum_probs=190.9

Q ss_pred             hcccccccceEEEEEEe--cCCcEEEEEEecCccc---CHHHHHHHHHHhhcC---CCCCcccceEEEE-----ecCccE
Q 006055          375 AEVLGKGTFGTAYKAVL--EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAV---NHENLVPLRAYYY-----SMDEKL  441 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~--~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~-----~~~~~~  441 (663)
                      .+.||+|+||.||+|..  .+|+.||||+++....   ....+.+|+.+++.+   +||||+++++++.     .....+
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~   95 (326)
T 1blx_A           16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   95 (326)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred             eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEE
Confidence            36899999999999996  4689999999864322   123466777776655   8999999999987     455689


Q ss_pred             EEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccc
Q 006055          442 LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL  521 (663)
Q Consensus       442 lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~  521 (663)
                      +||||+. |+|.+++....   ...+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++.
T Consensus        96 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  169 (326)
T 1blx_A           96 LVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI  169 (326)
T ss_dssp             EEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             EEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEecCccccc
Confidence            9999998 69999997643   234899999999999999999999998  99999999999999999999999999987


Q ss_pred             cCCC---CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh-------cc
Q 006055          522 VGPS---STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD-------EW  591 (663)
Q Consensus       522 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~  591 (663)
                      ....   ....++..|+|||++.+..++.++||||||+++|||++|+.||.....      ...+..+...       .+
T Consensus       170 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          170 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD------VDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCGGGS
T ss_pred             ccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHHHcCCCCcccC
Confidence            6532   234567789999999998899999999999999999999999975321      2222222211       00


Q ss_pred             cccccchh--hh------cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          592 TSEVFDLE--LL------RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       592 ~~~~~d~~--~~------~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ......+.  ..      ...........+.+++.+|+..||++|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00000000  00      000011234467788999999999999999999974

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.8e-36  Score=318.30  Aligned_cols=248  Identities=22%  Similarity=0.281  Sum_probs=189.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEec-----CccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSM-----DEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~ey  446 (663)
                      .+.||+|+||.||+|.. .+|+.||||.+.....  ....+.+|+++++.++||||+++++++...     ...++||||
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~   95 (353)
T 2b9h_A           16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL   95 (353)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECC
T ss_pred             eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEec
Confidence            36899999999999995 4699999999965422  245678999999999999999999988654     567999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      +. |+|.+++...      .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||+++......
T Consensus        96 ~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           96 MQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA  166 (353)
T ss_dssp             CS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             cC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence            98 5999998753      4899999999999999999999998  9999999999999999999999999998764321


Q ss_pred             --------------CCCCCccccCccccC-CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHh---
Q 006055          527 --------------TPNRVAGYRAPEVTD-PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK---  588 (663)
Q Consensus       527 --------------~~~~~~~y~aPE~~~-~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---  588 (663)
                                    ...++..|+|||++. +..++.++|||||||++|||++|+.||.....      ...+..+..   
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~  240 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY------RHQLLLIFGIIG  240 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHC
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHHHHhC
Confidence                          123577799999865 46789999999999999999999999975321      111111110   


Q ss_pred             hcc----cccccchh-------hhc--ccC----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          589 DEW----TSEVFDLE-------LLR--YQN----VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       589 ~~~----~~~~~d~~-------~~~--~~~----~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...    ........       +..  ...    ......++.+++.+|+..||++|||++|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000    00000000       000  000    01234567889999999999999999999984

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.2e-37  Score=320.45  Aligned_cols=248  Identities=21%  Similarity=0.332  Sum_probs=172.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc--CHHHHHHHHH-HhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI--SEREFKDKIE-GVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||.||+|.. .+|+.||||+++....  ....+..|+. +++.++||||+++++++...+..++||||+++ 
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-  105 (327)
T 3aln_A           27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-  105 (327)
T ss_dssp             -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred             hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence            36899999999999996 4799999999976432  2344555555 67788999999999999999999999999986 


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC--
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ-GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST--  527 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--  527 (663)
                      +|.+++..........+++..+..++.+++.||.|||+. +  |+||||||+||+++.++.+||+|||+++.......  
T Consensus       106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  183 (327)
T 3aln_A          106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT  183 (327)
T ss_dssp             EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCCSSSCC--------
T ss_pred             ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccCCCceecccccccc
Confidence            888777531111134589999999999999999999998 8  99999999999999999999999999987654322  


Q ss_pred             -CCCCccccCcccc----CCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          528 -PNRVAGYRAPEVT----DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       528 -~~~~~~y~aPE~~----~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                       ..++..|+|||++    .+..++.++||||||+++|||++|+.||.......     ..+....... ...     + .
T Consensus       184 ~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~-~~~-----~-~  251 (327)
T 3aln_A          184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLTQVVKGD-PPQ-----L-S  251 (327)
T ss_dssp             ----------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCCSC-CCC-----C-C
T ss_pred             cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHHHHhcCC-CCC-----C-C
Confidence             2467789999998    45668899999999999999999999997532110     0000000000 000     0 0


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .........++.+++.+||..||++|||+.|++++
T Consensus       252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            00011233468888999999999999999999874

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.4e-36  Score=312.26  Aligned_cols=240  Identities=20%  Similarity=0.327  Sum_probs=188.8

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCC--CCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVN--HENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||++...+++.||||.+......   ...+.+|++++.+++  |+||+++++++.+....++||| +.+
T Consensus        33 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~  111 (313)
T 3cek_A           33 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN  111 (313)
T ss_dssp             EEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred             EEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCC
Confidence            3689999999999999888999999998754332   367889999999997  5999999999999999999999 667


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      ++|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+||++++ +.+||+|||+++......   
T Consensus       112 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~  183 (313)
T 3cek_A          112 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV  183 (313)
T ss_dssp             EEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSSSCC--------
T ss_pred             CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeeccccccccCccccc
Confidence            89999997543     5899999999999999999999998  999999999999964 899999999998765432   


Q ss_pred             ---CCCCCccccCccccCC-----------CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccc
Q 006055          527 ---TPNRVAGYRAPEVTDP-----------CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT  592 (663)
Q Consensus       527 ---~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  592 (663)
                         ...++..|+|||.+.+           ..++.++||||||+++|||++|+.||.....     ....+.........
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~  258 (313)
T 3cek_A          184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNHE  258 (313)
T ss_dssp             ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCTTSC
T ss_pred             cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHHHHhcccc
Confidence               2246778999999875           4678899999999999999999999964321     12222222221111


Q ss_pred             ccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          593 SEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       593 ~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      ...          ......++.+++.+|+..||++||+++|++++-
T Consensus       259 ~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          259 IEF----------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             CCC----------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             cCC----------cccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            000          011124678888999999999999999999864

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.1e-37  Score=318.96  Aligned_cols=232  Identities=22%  Similarity=0.342  Sum_probs=189.6

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCccc-------CHHHHHHHHHHhhcCC--CCCcccceEEEEecCccEEEE
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI-------SEREFKDKIEGVGAVN--HENLVPLRAYYYSMDEKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  444 (663)
                      .+.||+|+||.||+|. ..+|+.||||.++....       ....+.+|+.+++.++  |+||+++++++...+..++||
T Consensus        48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~  127 (320)
T 3a99_A           48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL  127 (320)
T ss_dssp             EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred             EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEE
Confidence            4689999999999998 45789999999875432       1245678899999986  599999999999999999999


Q ss_pred             EccCC-CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc-CCCceEEecccccccc
Q 006055          445 DYLTM-GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT-KSYEARVSDFGLAHLV  522 (663)
Q Consensus       445 ey~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~-~~~~~kl~Dfg~a~~~  522 (663)
                      ||+.. ++|.+++...     ..+++..+..++.|++.||.|||+.+  |+||||||+||+++ +++.+||+|||+++..
T Consensus       128 e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~  200 (320)
T 3a99_A          128 ERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL  200 (320)
T ss_dssp             ECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence            99976 8999998753     25899999999999999999999998  99999999999999 7889999999999876


Q ss_pred             CCCC--CCCCCccccCccccCCCCC-CCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          523 GPSS--TPNRVAGYRAPEVTDPCKV-SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       523 ~~~~--~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                      ....  ...++..|+|||++.+..+ +.++||||||+++|||++|+.||....            ........   .   
T Consensus       201 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~~~~~~---~---  262 (320)
T 3a99_A          201 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQVF---F---  262 (320)
T ss_dssp             CSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCCC---C---
T ss_pred             ccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhhccccc---c---
Confidence            5432  2357788999999876655 678899999999999999999996421            11111100   0   


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                            ......++.+++.+||..||++|||++|++++
T Consensus       263 ------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          263 ------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             ------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  01122367788999999999999999999884

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-36  Score=325.65  Aligned_cols=239  Identities=21%  Similarity=0.257  Sum_probs=179.6

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .++||+|+||+||.....+|+.||||++.....  ..+.+|+++++.+ +||||+++++++.+....++||||+. |+|.
T Consensus        29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~  105 (432)
T 3p23_A           29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ  105 (432)
T ss_dssp             EEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHH
T ss_pred             CCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHH
Confidence            368999999997765566799999999865422  2356789999998 89999999999999999999999997 5999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC-----CCceEEeccccccccCCC---
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK-----SYEARVSDFGLAHLVGPS---  525 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~-----~~~~kl~Dfg~a~~~~~~---  525 (663)
                      +++.....    ...+..+..++.||+.||.|||+.+  |+||||||+|||++.     ...+||+|||+++.....   
T Consensus       106 ~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~  179 (432)
T 3p23_A          106 EYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS  179 (432)
T ss_dssp             HHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred             HHHHhcCC----CccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence            99976432    2344456789999999999999998  999999999999953     335889999999876533   


Q ss_pred             ----CCCCCCccccCccccC---CCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          526 ----STPNRVAGYRAPEVTD---PCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       526 ----~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                          ....++.+|+|||++.   ...++.++|||||||++|||++ |..||.....       ...... ......... 
T Consensus       180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-------~~~~~~-~~~~~~~~~-  250 (432)
T 3p23_A          180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-------RQANIL-LGACSLDCL-  250 (432)
T ss_dssp             ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-------HHHHHH-TTCCCCTTS-
T ss_pred             eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-------HHHHHH-hccCCcccc-
Confidence                1234788899999997   4567789999999999999999 9999854211       111111 111111111 


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                            .........+.+++.+|++.||++|||++||++|
T Consensus       251 ------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          251 ------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             ------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence                  1112233457788999999999999999999953

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.9e-36  Score=310.42  Aligned_cols=242  Identities=21%  Similarity=0.321  Sum_probs=174.1

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~g  450 (663)
                      .+.||+|+||.||+|... +|+.||||.+......   .+.+.++..+++.++||||+++++++.+.+..++||||+ ++
T Consensus        30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~  108 (318)
T 2dyl_A           30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GT  108 (318)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SE
T ss_pred             cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CC
Confidence            468999999999999964 7999999999765322   233445555688889999999999999999999999999 44


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ-GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      .+..+.....    ..+++..+..++.+++.||.|||+. +  |+||||||+||+++.++.+||+|||++.......   
T Consensus       109 ~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  182 (318)
T 2dyl_A          109 CAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD  182 (318)
T ss_dssp             EHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             cHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcccc
Confidence            5555554321    3589999999999999999999985 7  9999999999999999999999999997664432   


Q ss_pred             CCCCCccccCccccC-----CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhh
Q 006055          527 TPNRVAGYRAPEVTD-----PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL  601 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  601 (663)
                      ...++..|+|||++.     ...++.++||||||+++|||++|+.||....     ........+....... .      
T Consensus       183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~-~------  250 (318)
T 2dyl_A          183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK-----TDFEVLTKVLQEEPPL-L------  250 (318)
T ss_dssp             ----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHHHSCCCC-C------
T ss_pred             ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC-----ccHHHHHHHhccCCCC-C------
Confidence            234677899999984     4567889999999999999999999996422     1222333333322110 0      


Q ss_pred             cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       602 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                        ........++.+++.+|+..||++||+++|++++
T Consensus       251 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          251 --PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             --CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             --CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence              0001123467788899999999999999999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-36  Score=314.85  Aligned_cols=232  Identities=24%  Similarity=0.334  Sum_probs=184.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc-------CHHHHHHHHHHhhcC----CCCCcccceEEEEecCccEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI-------SEREFKDKIEGVGAV----NHENLVPLRAYYYSMDEKLL  442 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-------~~~~~~~e~~~l~~l----~h~niv~l~~~~~~~~~~~l  442 (663)
                      .+.||+|+||.||+|.. .+++.||||++.....       ....+.+|+.++.++    +|+||+++++++...+..++
T Consensus        36 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~  115 (312)
T 2iwi_A           36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML  115 (312)
T ss_dssp             EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEE
T ss_pred             eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEE
Confidence            46899999999999984 5789999999975432       123456788888887    89999999999999999999


Q ss_pred             EEEc-cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc-CCCceEEecccccc
Q 006055          443 VYDY-LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT-KSYEARVSDFGLAH  520 (663)
Q Consensus       443 v~ey-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~-~~~~~kl~Dfg~a~  520 (663)
                      |||| +.+++|.+++....     .+++..+..++.|++.||.|||+.+  |+||||||+||+++ .++.+||+|||+++
T Consensus       116 v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~dfg~~~  188 (312)
T 2iwi_A          116 VLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGA  188 (312)
T ss_dssp             EEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred             EEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence            9999 78999999997532     4899999999999999999999998  99999999999999 88999999999998


Q ss_pred             ccCCCC--CCCCCccccCccccCCCCC-CCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          521 LVGPSS--TPNRVAGYRAPEVTDPCKV-SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       521 ~~~~~~--~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                      ......  ...++..|+|||++.+..+ +.++||||||+++|||++|+.||....            .......      
T Consensus       189 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~~~~~~------  250 (312)
T 2iwi_A          189 LLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------EILEAEL------  250 (312)
T ss_dssp             ECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHTCC------
T ss_pred             hcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------HHhhhcc------
Confidence            765432  3346778999999876655 458999999999999999999996421            1111110      


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                            ........++.+++.+|+..||++|||++|++++
T Consensus       251 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          251 ------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  0011223467788999999999999999999984

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.8e-35  Score=301.12  Aligned_cols=228  Identities=12%  Similarity=0.069  Sum_probs=177.6

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccC----HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||.||+|... +|+.||||.+......    .+.+.+|+..+..++||||+++++++.+.+..++||||+++
T Consensus        36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g  115 (286)
T 3uqc_A           36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG  115 (286)
T ss_dssp             EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCE
T ss_pred             EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCC
Confidence            368999999999999964 5899999999765332    26789999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN  529 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  529 (663)
                      ++|.+++...       .......+++.|++.||.|||+++  |+||||||+|||++.++.+||+++|            
T Consensus       116 ~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~------------  174 (286)
T 3uqc_A          116 GSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA------------  174 (286)
T ss_dssp             EEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred             CCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc------------
Confidence            9999999532       344567889999999999999998  9999999999999999999998554            


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE  609 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  609 (663)
                          |++|       ++.++|||||||++|||++|+.||......+.....       ..........+...    ....
T Consensus       175 ----~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-------~~~~~~~~~~~~~~----~~~~  232 (286)
T 3uqc_A          175 ----TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------ERDTAGQPIEPADI----DRDI  232 (286)
T ss_dssp             ----CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-------CBCTTSCBCCHHHH----CTTS
T ss_pred             ----ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-------HHHhccCCCChhhc----ccCC
Confidence                3333       578999999999999999999999864432211000       00000000000000    0122


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006055          610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST  646 (663)
Q Consensus       610 ~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~  646 (663)
                      ..++.+++.+||+.||++| |+.|+++.|+++.....
T Consensus       233 ~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          233 PFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            3467888999999999999 99999999999866543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.5e-35  Score=337.72  Aligned_cols=232  Identities=19%  Similarity=0.225  Sum_probs=188.1

Q ss_pred             hcccccccceEEEEEEec--CCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCc-----cEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLE--MGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDE-----KLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~~lv~e  445 (663)
                      .++||+|+||.||+|...  +|+.||||.+....  .....+.+|++++..++||||+++++++...+.     .++|||
T Consensus        85 ~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E  164 (681)
T 2pzi_A           85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME  164 (681)
T ss_dssp             EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEE
T ss_pred             EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEE
Confidence            368999999999999964  68999999986542  224568899999999999999999999988766     699999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+++++|.+++..       .+++..++.++.||+.||.|||+++  |+||||||+|||++.+ .+||+|||+++.....
T Consensus       165 ~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          165 YVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             CCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred             eCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence            9999999987753       4899999999999999999999998  9999999999999986 8999999999988776


Q ss_pred             CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          526 STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       526 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                      ....+|.+|+|||++.+.. +.++|||||||++|||++|..||........               .         ....
T Consensus       235 ~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------~---------~~~~  289 (681)
T 2pzi_A          235 GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------P---------EDDP  289 (681)
T ss_dssp             SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------C---------TTCH
T ss_pred             CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc---------------c---------cccc
Confidence            6667899999999987654 8899999999999999999988864321110               0         0000


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHhh
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPS-MSEVIKRIEEL  641 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt-~~ev~~~L~~~  641 (663)
                      .......+.+++.+|++.||++||+ ++++.+.|..+
T Consensus       290 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          290 VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            1122346788999999999999995 66666666544

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.9e-35  Score=300.45  Aligned_cols=226  Identities=21%  Similarity=0.271  Sum_probs=174.5

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHh-hcCCCCCcccceEEEEe----cCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGV-GAVNHENLVPLRAYYYS----MDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~ey~~~  449 (663)
                      ++||+|+||.||+|.. .+++.||||+++..    ..+.+|++++ +..+||||+++++++..    ....++||||+++
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~   99 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   99 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence            5799999999999995 57899999998653    4567888887 66699999999999877    6678999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC---CCceEEeccccccccCCCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK---SYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~---~~~~kl~Dfg~a~~~~~~~  526 (663)
                      |+|.+++....   ...+++..+..++.|++.||.|||+.+  |+||||||+||+++.   ++.+||+|||++.....  
T Consensus       100 ~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~--  172 (299)
T 3m2w_A          100 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG--  172 (299)
T ss_dssp             CBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT--
T ss_pred             CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEecccccccccc--
Confidence            99999998643   245899999999999999999999998  999999999999998   78899999999875432  


Q ss_pred             CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          527 TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                                      ..++.++|||||||++|||++|+.||..........       ...............   ...
T Consensus       173 ----------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-------~~~~~~~~~~~~~~~---~~~  226 (299)
T 3m2w_A          173 ----------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------GMKTRIRMGQYEFPN---PEW  226 (299)
T ss_dssp             ----------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-------CSCCSSCTTCCSSCH---HHH
T ss_pred             ----------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-------HHHHHHhhccccCCc---hhc
Confidence                            345778999999999999999999996532211000       000000000000000   000


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRI  638 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L  638 (663)
                      .....++.+++.+|+..||++|||++|++++-
T Consensus       227 ~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence            12345688899999999999999999999853

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.4e-35  Score=331.28  Aligned_cols=261  Identities=20%  Similarity=0.239  Sum_probs=195.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEe------cCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYS------MDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~~lv~e  445 (663)
                      .+.||+|+||.||+|.. .+|+.||||+++...  .....+.+|+++++.++||||+++++++..      ....++|||
T Consensus        19 ~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmE   98 (676)
T 3qa8_A           19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME   98 (676)
T ss_dssp             CCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEE
T ss_pred             EEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEE
Confidence            46899999999999995 569999999987542  224668899999999999999999998755      567799999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc---eEEecccccccc
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE---ARVSDFGLAHLV  522 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~---~kl~Dfg~a~~~  522 (663)
                      |+++|+|.+++.....  ...+++..+..++.+++.||.|||+.+  |+||||||+||+++.++.   +||+|||++...
T Consensus        99 y~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~  174 (676)
T 3qa8_A           99 YCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL  174 (676)
T ss_dssp             CCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBT
T ss_pred             eCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEccccccccc
Confidence            9999999999986432  235888999999999999999999998  999999999999997765   999999999877


Q ss_pred             CCCC---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHh--------hcc
Q 006055          523 GPSS---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK--------DEW  591 (663)
Q Consensus       523 ~~~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~  591 (663)
                      ....   ...++..|+|||.+.+..++.++||||||+++|||++|+.||.....     ...|......        ...
T Consensus       175 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~~~~~~~~  249 (676)
T 3qa8_A          175 DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNEHIVVYDD  249 (676)
T ss_dssp             TSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC------CCSCCC
T ss_pred             ccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccchhhhhhhh
Confidence            5543   23467789999999999999999999999999999999999964211     0011000000        000


Q ss_pred             ccccc--chhhh-cccChHHHHHHHHHHHHHccCCCCCCCCCHHH-----HHHHHHhhCCC
Q 006055          592 TSEVF--DLELL-RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSE-----VIKRIEELHPS  644 (663)
Q Consensus       592 ~~~~~--d~~~~-~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~e-----v~~~L~~~~~~  644 (663)
                      ....+  ..... ...........+.+++.+|+..||++|||++|     ..+.++++...
T Consensus       250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~  310 (676)
T 3qa8_A          250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL  310 (676)
T ss_dssp             CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred             hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence            00000  00000 01112235567889999999999999999988     55666665443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-35  Score=316.72  Aligned_cols=236  Identities=15%  Similarity=0.164  Sum_probs=173.8

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcc----cCHHHHHHHHHHhhcCCC-CCcc---------cceEE------
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT----ISEREFKDKIEGVGAVNH-ENLV---------PLRAY------  433 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h-~niv---------~l~~~------  433 (663)
                      .++||+|+||+||+|. ..+|+.||||++....    ...+.+.+|+.+++.++| +|..         .....      
T Consensus        83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (413)
T 3dzo_A           83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  162 (413)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred             ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence            3689999999999999 5679999999987432    124678999999999987 3211         11111      


Q ss_pred             ------EEe-----cCccEEEEEccCCCChhHhhccCC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCC
Q 006055          434 ------YYS-----MDEKLLVYDYLTMGSLSALLHGNK--GAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKS  500 (663)
Q Consensus       434 ------~~~-----~~~~~lv~ey~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~  500 (663)
                            +..     ....+++|+++ .++|.+++....  ......+++..++.++.||+.||+|||+++  |+||||||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iiHrDiKp  239 (413)
T 3dzo_A          163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRP  239 (413)
T ss_dssp             --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred             CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCccc
Confidence                  111     12346667754 579999884110  011235788999999999999999999998  99999999


Q ss_pred             CCEEEcCCCceEEeccccccccCCCC-CCCCCccccCcccc----------CCCCCCCcchhhhHHHHHHHHHhCCCCCc
Q 006055          501 SNILLTKSYEARVSDFGLAHLVGPSS-TPNRVAGYRAPEVT----------DPCKVSQKADVYSFGVLLLELLTGKAPTH  569 (663)
Q Consensus       501 ~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~y~aPE~~----------~~~~~~~~~Dv~slGvvl~elltg~~p~~  569 (663)
                      +|||++.++.+||+|||+++...... ...+ ..|+|||++          .+..++.++|||||||++|||++|+.||.
T Consensus       240 ~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~  318 (413)
T 3dzo_A          240 VDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT  318 (413)
T ss_dssp             GGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             ceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            99999999999999999998765442 2345 889999999          66668889999999999999999999997


Q ss_pred             cccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          570 ALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      .....+...               .+    +....   ..+.++.+++.+||..||++||++.|+++
T Consensus       319 ~~~~~~~~~---------------~~----~~~~~---~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          319 DDAALGGSE---------------WI----FRSCK---NIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             TTGGGSCSG---------------GG----GSSCC---CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CcchhhhHH---------------HH----Hhhcc---cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            543222110               00    00011   12246788888999999999999776654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.2e-34  Score=303.75  Aligned_cols=235  Identities=13%  Similarity=0.129  Sum_probs=179.8

Q ss_pred             HhhcccccccceEEEEEEecCCcEEEEEEecCcc---------cCHHHHHHHHHHhhcCC---------CCCcccceEEE
Q 006055          373 ASAEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVT---------ISEREFKDKIEGVGAVN---------HENLVPLRAYY  434 (663)
Q Consensus       373 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~---------~~~~~~~~e~~~l~~l~---------h~niv~l~~~~  434 (663)
                      ...+.||+|+||+||+|.. +|+.||||+++...         ...+.+.+|+.+++.++         ||||+++.+.+
T Consensus        23 ~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~  101 (336)
T 2vuw_A           23 QRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH  101 (336)
T ss_dssp             HTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEE
T ss_pred             hheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhccee
Confidence            3468999999999999998 68999999987542         12367888999888775         77777777764


Q ss_pred             E------------------------------ecCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 006055          435 Y------------------------------SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE  484 (663)
Q Consensus       435 ~------------------------------~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~  484 (663)
                      .                              +....++||||+++|++.+.+..      ..+++..++.++.||+.||+
T Consensus       102 ~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A          102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHHHH
T ss_pred             EecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHHHH
Confidence            3                              15778999999999977666643      24799999999999999999


Q ss_pred             HHh-hcCCcceecCCCCCCEEEcCCC--------------------ceEEeccccccccCCCCCCCCCccccCccccCCC
Q 006055          485 YLH-AQGPNVSHGNIKSSNILLTKSY--------------------EARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPC  543 (663)
Q Consensus       485 ~LH-~~~~~iiHrdlk~~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~  543 (663)
                      ||| +.+  |+||||||+|||++.++                    .+||+|||+++..... ...+|..|+|||++.+.
T Consensus       176 ~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~~g~  252 (336)
T 2vuw_A          176 VAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLFTGD  252 (336)
T ss_dssp             HHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGGCCC
T ss_pred             HHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhhcCC
Confidence            999 888  99999999999999887                    8999999999877543 34577889999999877


Q ss_pred             CCCCcchhhhHHHH-HHHHHhCCCCCccccCCCCCChHHHHHH----HHhhcccccccchhhhcccChHHHHHHHHHHHH
Q 006055          544 KVSQKADVYSFGVL-LLELLTGKAPTHALLNEEGVDLPRWVQS----IVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAI  618 (663)
Q Consensus       544 ~~~~~~Dv~slGvv-l~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~  618 (663)
                      . +.++||||++++ .+++++|..||...         .|...    ...........     ..........++.+++.
T Consensus       253 ~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~s~~~~dli~  317 (336)
T 2vuw_A          253 G-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTDKMLKQMTFKTKC-----NTPAMKQIKRKIQEFHR  317 (336)
T ss_dssp             S-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHHHHHHTCCCSSCC-----CSHHHHHHHHHHHHHHH
T ss_pred             C-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHHhhhhhhccCccc-----chhhhhhcCHHHHHHHH
Confidence            6 889999998777 77888899998531         12111    11110100000     01112345678899999


Q ss_pred             HccCCCCCCCCCHHHHH-HH
Q 006055          619 DCSAQYPDNRPSMSEVI-KR  637 (663)
Q Consensus       619 ~C~~~dP~~RPt~~ev~-~~  637 (663)
                      +|+..|     |++|++ +|
T Consensus       318 ~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          318 TMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HGGGSS-----SHHHHHHHC
T ss_pred             HHhccC-----CHHHHHhcC
Confidence            999876     999998 63

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.95  E-value=9.3e-29  Score=256.16  Aligned_cols=196  Identities=31%  Similarity=0.537  Sum_probs=176.0

Q ss_pred             CCChHHHHHHHHHHHhcCCC--CcCCcCCCCCCCc--cceeEecC----CcEEEEEcCCCCccc--ccCccccCCCCCCC
Q 006055           28 SDLSSDRAALLALRSSVGGR--TLLWNVYEASPCK--WAGVECEQ----NRVTMLRLPGVALSG--QIPLGILGNLTSLR   97 (663)
Q Consensus        28 ~~~~~d~~all~~~~~~~~~--~~~w~~~~~~~c~--w~gv~c~~----~~v~~L~L~~~~l~g--~~p~~~~~~l~~L~   97 (663)
                      .|.+.|++||++||+++++.  ..+|+. +.+||.  |.||+|+.    ++|+.|+|++|+++|  .+|. .|+++++|+
T Consensus         2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~-~l~~l~~L~   79 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLGNPTTLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLN   79 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCGGGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCS
T ss_pred             CCCHHHHHHHHHHHHhcCCcccccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccCh-hHhCCCCCC
Confidence            57889999999999999743  236864 457998  99999975    799999999999999  8997 579999999


Q ss_pred             EEEccC-CCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccc
Q 006055           98 TLSLRF-NSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENN  176 (663)
Q Consensus        98 ~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N  176 (663)
                      +|+|++ |.+.+.+|..|.++++|++|+|++|++++.+|..|.++++|++|+|++|++++.+|..|.++++|++|+|++|
T Consensus        80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  159 (313)
T 1ogq_A           80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred             eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence            999995 9999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCcCCCCCCCCC-CCCEEEeecCcCCCCCCcccccCC--CCCccCCcCCC
Q 006055          177 RLSGSIPGFDDVLP-NLQQLNVSNNLLNGSIPKRFQTFG--SNSFLGNSLCG  225 (663)
Q Consensus       177 ~l~~~~p~~~~~l~-~L~~L~l~~N~l~g~~p~~~~~~~--~~~~~~~~l~~  225 (663)
                      +|++.+|..+..++ +|+.|+|++|++++.+|..|..+.  .+.+.+|.+.+
T Consensus       160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~  211 (313)
T 1ogq_A          160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEG  211 (313)
T ss_dssp             CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEE
T ss_pred             cccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcccC
Confidence            99999999999998 999999999999999999888765  22234555543

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=8.7e-29  Score=275.91  Aligned_cols=181  Identities=17%  Similarity=0.032  Sum_probs=127.9

Q ss_pred             ccccccceEEEEEE-ecCCcEEEEEEecCcc-----------cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEE
Q 006055          377 VLGKGTFGTAYKAV-LEMGTIVAVKRLKDVT-----------ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLV  443 (663)
Q Consensus       377 ~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~-----------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  443 (663)
                      ..+.|+.|.+..+. .-.|+.||||.+....           ...++|.+|+++|+++ .|+||+++++++.+..+.|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            46677777776655 4458999999986431           1235699999999999 799999999999999999999


Q ss_pred             EEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccC
Q 006055          444 YDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVG  523 (663)
Q Consensus       444 ~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~  523 (663)
                      |||++|++|.+++....     +++..   +|+.||+.||+|+|++|  ||||||||+|||+++++.+||+|||+|+...
T Consensus       321 MEyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             EECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             EecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            99999999999998543     35543   58899999999999999  9999999999999999999999999998776


Q ss_pred             CCCCC----CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCC
Q 006055          524 PSSTP----NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPT  568 (663)
Q Consensus       524 ~~~~~----~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~  568 (663)
                      .....    .+|++|||||++.+. +..++|+||+|++++++.++..++
T Consensus       391 ~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          391 QDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence            54332    367789999999764 567899999999988887665543

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.92  E-value=8.5e-26  Score=262.42  Aligned_cols=181  Identities=27%  Similarity=0.394  Sum_probs=113.8

Q ss_pred             hcccCCChHHHHHHHHHHHhcCCC--CcCCcCCCCCCCccceeEecCCcEEEEEcCCCCcccc---cCc-----------
Q 006055           24 SFSFSDLSSDRAALLALRSSVGGR--TLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQ---IPL-----------   87 (663)
Q Consensus        24 ~~~~~~~~~d~~all~~~~~~~~~--~~~w~~~~~~~c~w~gv~c~~~~v~~L~L~~~~l~g~---~p~-----------   87 (663)
                      +.+.++.+.|++||++||+++.+.  ..+|+ .+.+||.|.||+|+.++|+.|+|+++++.|.   +|+           
T Consensus         4 ~~~~~~~~~~~~all~~k~~~~~~~~l~~W~-~~~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l   82 (768)
T 3rgz_A            4 ASPSQSLYREIHQLISFKDVLPDKNLLPDWS-SNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL   82 (768)
T ss_dssp             ----CCHHHHHHHHHHHHTTCSCTTSSTTCC-TTSCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred             CccccCCHHHHHHHHHHHhhCCCcccccCCC-CCCCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence            334455678999999999999643  34797 3567999999999989999999999999987   654           


Q ss_pred             -----------cccCCCCCCCEEEccCCCCCCCCCc--cccCCCCCceEEcccccccCchhhhh-cCCcccccccccccc
Q 006055           88 -----------GILGNLTSLRTLSLRFNSLTSQLPS--DLASCSNLRNLYLQGNHFSGEVPLFL-VGLHHLVRLNLATNN  153 (663)
Q Consensus        88 -----------~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~l~~N~  153 (663)
                                 ..|+++++|++|+|++|.++|.+|.  .++++++|++|+|++|.+++.+|..+ .++++|++|+|++|+
T Consensus        83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~  162 (768)
T 3rgz_A           83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS  162 (768)
T ss_dssp             ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred             CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence                       2456677777777777777776666  67777777777777777666666544 555556666666555


Q ss_pred             ccccCCCC---CcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCC
Q 006055          154 FSGEIPSG---FKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP  207 (663)
Q Consensus       154 l~~~~p~~---~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p  207 (663)
                      +++..|..   +.++++|++|+|++|++++.+|.  ..+++|++|+|++|++++.+|
T Consensus       163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~  217 (768)
T 3rgz_A          163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIP  217 (768)
T ss_dssp             CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCC
T ss_pred             cCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCc
Confidence            55444433   33333343333333333333221  333444444444444443333

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.92  E-value=4e-26  Score=264.46  Aligned_cols=193  Identities=24%  Similarity=0.367  Sum_probs=166.1

Q ss_pred             ChHHHHHHHHHHHhcCCCCcCCcCCC----CCC--Ccc------------ceeEec-CCcEEEEEcCCCCcccccCcccc
Q 006055           30 LSSDRAALLALRSSVGGRTLLWNVYE----ASP--CKW------------AGVECE-QNRVTMLRLPGVALSGQIPLGIL   90 (663)
Q Consensus        30 ~~~d~~all~~~~~~~~~~~~w~~~~----~~~--c~w------------~gv~c~-~~~v~~L~L~~~~l~g~~p~~~~   90 (663)
                      ...|++||++||+++++.  +|+..+    .+|  |.|            .||+|+ .++|+.|+|++|+|+|.+|+ .|
T Consensus       267 ~~~d~~ALl~~k~~l~~~--~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~-~l  343 (876)
T 4ecn_A          267 YIKDYKALKAIWEALDGK--NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD-AI  343 (876)
T ss_dssp             HHHHHHHHHHHHHHTTGG--GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECG-GG
T ss_pred             chHHHHHHHHHHHHcCCC--CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCch-HH
Confidence            457999999999999765  787543    456  999            999998 48999999999999999997 57


Q ss_pred             CCCCCCCEEEc-cCCCCCCC------------------------------------------------------------
Q 006055           91 GNLTSLRTLSL-RFNSLTSQ------------------------------------------------------------  109 (663)
Q Consensus        91 ~~l~~L~~L~L-~~N~l~~~------------------------------------------------------------  109 (663)
                      ++|++|+.|+| ++|.++|.                                                            
T Consensus       344 ~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l  423 (876)
T 4ecn_A          344 GQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI  423 (876)
T ss_dssp             GGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCC
T ss_pred             hccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccccccc
Confidence            99999999999 77765444                                                            


Q ss_pred             ----------------CCccccCCCCCceEEcccccccC-----------------chhhhhc--CCccccccccccccc
Q 006055          110 ----------------LPSDLASCSNLRNLYLQGNHFSG-----------------EVPLFLV--GLHHLVRLNLATNNF  154 (663)
Q Consensus       110 ----------------~p~~~~~l~~L~~L~L~~N~l~~-----------------~~p~~~~--~l~~L~~L~l~~N~l  154 (663)
                                      +|..|++|++|++|+|++|+|+|                 .+|..++  ++++|+.|+|++|++
T Consensus       424 ~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l  503 (876)
T 4ecn_A          424 SLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPN  503 (876)
T ss_dssp             CCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTT
T ss_pred             chhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCC
Confidence                            78889999999999999999998                 4899987  999999999999999


Q ss_pred             cccCCCCCccccccccccccccc-ccC-cCCCCCCC-------CCCCCEEEeecCcCCCCCCc--ccccCCCCCc---cC
Q 006055          155 SGEIPSGFKNLTKLKTLFLENNR-LSG-SIPGFDDV-------LPNLQQLNVSNNLLNGSIPK--RFQTFGSNSF---LG  220 (663)
Q Consensus       155 ~~~~p~~~~~l~~L~~L~l~~N~-l~~-~~p~~~~~-------l~~L~~L~l~~N~l~g~~p~--~~~~~~~~~~---~~  220 (663)
                      .+.+|..|++|++|++|+|++|+ |+| .+|..++.       +++|+.|+|++|+++ .+|.  .|..++.+..   .+
T Consensus       504 ~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~  582 (876)
T 4ecn_A          504 MTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVH  582 (876)
T ss_dssp             CCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTT
T ss_pred             CccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCC
Confidence            99999999999999999999998 998 78865544       459999999999999 8898  7877766654   55


Q ss_pred             CcCCCC
Q 006055          221 NSLCGK  226 (663)
Q Consensus       221 ~~l~~~  226 (663)
                      |.+...
T Consensus       583 N~l~~l  588 (876)
T 4ecn_A          583 NKVRHL  588 (876)
T ss_dssp             SCCCBC
T ss_pred             CCcccc
Confidence            555533

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=9e-26  Score=250.19  Aligned_cols=177  Identities=15%  Similarity=0.168  Sum_probs=144.1

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccC---------HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS---------EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  445 (663)
                      .++||+|+||+||++.. .++.+|+|+.......         .+.+.+|++++++++||||+++..++...++.++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            56899999999999954 4788999986443211         2457999999999999999988888888889999999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+++|+|.++++.             +..++.|+++||.|||+++  |+||||||+|||++.  .+||+|||+++.....
T Consensus       420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            9999999999974             4578999999999999998  999999999999999  9999999999987653


Q ss_pred             C-----------CCCCCccccCccccCC--CCCCCcchhhhHHHHHHHHHhCCCCCc
Q 006055          526 S-----------TPNRVAGYRAPEVTDP--CKVSQKADVYSFGVLLLELLTGKAPTH  569 (663)
Q Consensus       526 ~-----------~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvvl~elltg~~p~~  569 (663)
                      .           ...+|+.|||||++..  ..|+...|+|+..+-..+-+.++.+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            2           2236778999999976  567788999999998888888777763

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.91  E-value=1e-25  Score=256.02  Aligned_cols=190  Identities=26%  Similarity=0.387  Sum_probs=165.5

Q ss_pred             hHHHHHHHHHHHhcCCCCc-----------CCcCCCCCCCcc---ceeEecC-CcEEEEEcCCCCcccccCccccCCCCC
Q 006055           31 SSDRAALLALRSSVGGRTL-----------LWNVYEASPCKW---AGVECEQ-NRVTMLRLPGVALSGQIPLGILGNLTS   95 (663)
Q Consensus        31 ~~d~~all~~~~~~~~~~~-----------~w~~~~~~~c~w---~gv~c~~-~~v~~L~L~~~~l~g~~p~~~~~~l~~   95 (663)
                      ..|++||.+|+.++++..+           +|+. +.+||.|   .||+|+. ++|+.|+|++++++|.+|+ .+++|++
T Consensus        29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~-~l~~L~~  106 (636)
T 4eco_A           29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPD-AIGQLTE  106 (636)
T ss_dssp             HHHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECG-GGGGCTT
T ss_pred             HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCCh-HHhcCcc
Confidence            4699999999999974322           4874 4679999   9999965 6999999999999999997 5799999


Q ss_pred             CCEEEccCCC----------------------------------------------------------------------
Q 006055           96 LRTLSLRFNS----------------------------------------------------------------------  105 (663)
Q Consensus        96 L~~L~L~~N~----------------------------------------------------------------------  105 (663)
                      |++|+|++|.                                                                      
T Consensus       107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l  186 (636)
T 4eco_A          107 LEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT  186 (636)
T ss_dssp             CCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTT
T ss_pred             ceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhh
Confidence            9999999883                                                                      


Q ss_pred             --------CCCCCCccccCCCCCceEEcccccccCc-----------------hhhhhc--CCccccccccccccccccC
Q 006055          106 --------LTSQLPSDLASCSNLRNLYLQGNHFSGE-----------------VPLFLV--GLHHLVRLNLATNNFSGEI  158 (663)
Q Consensus       106 --------l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~l~~N~l~~~~  158 (663)
                              |+| +|..|+++++|++|+|++|+|+|.                 +|..++  ++++|++|+|++|++.+.+
T Consensus       187 ~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~  265 (636)
T 4eco_A          187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKL  265 (636)
T ss_dssp             TTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSC
T ss_pred             hhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccC
Confidence                    446 888999999999999999999986                 999998  9999999999999999999


Q ss_pred             CCCCccccccccccccccc-ccC-cCCCCCCCC------CCCCEEEeecCcCCCCCCc--ccccCCCCCc---cCCcCC
Q 006055          159 PSGFKNLTKLKTLFLENNR-LSG-SIPGFDDVL------PNLQQLNVSNNLLNGSIPK--RFQTFGSNSF---LGNSLC  224 (663)
Q Consensus       159 p~~~~~l~~L~~L~l~~N~-l~~-~~p~~~~~l------~~L~~L~l~~N~l~g~~p~--~~~~~~~~~~---~~~~l~  224 (663)
                      |..|+++++|++|+|++|+ ++| .+|..++.+      ++|+.|+|++|+++ .+|.  .+..++.+..   .+|.+.
T Consensus       266 p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~  343 (636)
T 4eco_A          266 PTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLE  343 (636)
T ss_dssp             CTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCE
T ss_pred             hHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCc
Confidence            9999999999999999998 998 888877776      89999999999999 8888  7777766654   455554

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.89  E-value=6.3e-24  Score=221.24  Aligned_cols=193  Identities=20%  Similarity=0.258  Sum_probs=165.9

Q ss_pred             cCCChHHHHHHHHHHHhcCCC----CcCCc---CCCCCCCccceeEecC----------CcEEEEEcCCCCcccccCccc
Q 006055           27 FSDLSSDRAALLALRSSVGGR----TLLWN---VYEASPCKWAGVECEQ----------NRVTMLRLPGVALSGQIPLGI   89 (663)
Q Consensus        27 ~~~~~~d~~all~~~~~~~~~----~~~w~---~~~~~~c~w~gv~c~~----------~~v~~L~L~~~~l~g~~p~~~   89 (663)
                      .++...|++||++||+++...    ..+|.   ....++|.|.|+.|..          .+|+.|+|++|+++ .+|.. 
T Consensus        22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~-   99 (328)
T 4fcg_A           22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQ-   99 (328)
T ss_dssp             -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSC-
T ss_pred             cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChh-
Confidence            445678999999999988422    23573   3456789999999952          68999999999999 89985 


Q ss_pred             cCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCCCCcc-----
Q 006055           90 LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKN-----  164 (663)
Q Consensus        90 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----  164 (663)
                      ++++++|++|+|++|.|+ .+|..|+++++|++|+|++|+++ .+|..+.++++|+.|+|++|++.+.+|..+..     
T Consensus       100 l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~  177 (328)
T 4fcg_A          100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG  177 (328)
T ss_dssp             GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CC
T ss_pred             hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchh
Confidence            577999999999999999 69999999999999999999999 88999999999999999999999999998765     


Q ss_pred             ----cccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc---cCCcCCC
Q 006055          165 ----LTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF---LGNSLCG  225 (663)
Q Consensus       165 ----l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~---~~~~l~~  225 (663)
                          +++|++|+|++|+|+ .+|..+..+++|+.|+|++|++++ +|..+..++.+..   .+|.+.+
T Consensus       178 ~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~  243 (328)
T 4fcg_A          178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALR  243 (328)
T ss_dssp             CEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCC
T ss_pred             hhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchh
Confidence                999999999999999 889899999999999999999995 6767777766654   4444433

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.87  E-value=6.8e-22  Score=197.73  Aligned_cols=148  Identities=28%  Similarity=0.296  Sum_probs=104.3

Q ss_pred             cEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccccc
Q 006055           70 RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL  149 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  149 (663)
                      .++.|+|++|++++ +++..|+++++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus        36 ~l~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  114 (251)
T 3m19_A           36 DTEKLDLQSTGLAT-LSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL  114 (251)
T ss_dssp             TCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEEccCCCcCc-cCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence            46677777777774 33345677777777777777777766666777777777777777777666666777777777777


Q ss_pred             ccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc
Q 006055          150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF  218 (663)
Q Consensus       150 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~  218 (663)
                      ++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|..++.+..
T Consensus       115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  183 (251)
T 3m19_A          115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQT  183 (251)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred             CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCE
Confidence            777777555555677777777777777777666666777777777777777777666666665555443

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.87  E-value=9.8e-23  Score=236.67  Aligned_cols=164  Identities=35%  Similarity=0.573  Sum_probs=133.8

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccc----------------------------------
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDL----------------------------------  114 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~----------------------------------  114 (663)
                      .+++.|+|++|.++|.+|. .++++++|+.|+|++|.++|.+|..+                                  
T Consensus       514 ~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (768)
T 3rgz_A          514 ENLAILKLSNNSFSGNIPA-ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGN  592 (768)
T ss_dssp             TTCCEEECCSSCCEEECCG-GGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEE
T ss_pred             CCCCEEECCCCcccCcCCH-HHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccc
Confidence            4577777777777777775 45777778888887777776666433                                  


Q ss_pred             ------------------------------------cCCCCCceEEcccccccCchhhhhcCCccccccccccccccccC
Q 006055          115 ------------------------------------ASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEI  158 (663)
Q Consensus       115 ------------------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  158 (663)
                                                          .++++|+.|||++|+++|.+|..|+++++|+.|+|++|+++|.+
T Consensus       593 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~i  672 (768)
T 3rgz_A          593 LLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSI  672 (768)
T ss_dssp             EEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCC
T ss_pred             ccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCC
Confidence                                                33567888888888888888988999999999999999999999


Q ss_pred             CCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcc--cccCCCCCccCC-cCCCCCCCCCCC
Q 006055          159 PSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKR--FQTFGSNSFLGN-SLCGKPLQDCGT  233 (663)
Q Consensus       159 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~~~~~~~~~-~l~~~p~~~c~~  233 (663)
                      |..|+++++|+.|||++|+|+|.+|..+..+++|++|+|++|+|+|.+|..  |.+++..+|.+| .+||.|+..|..
T Consensus       673 p~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~  750 (768)
T 3rgz_A          673 PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP  750 (768)
T ss_dssp             CGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCS
T ss_pred             ChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCC
Confidence            999999999999999999999999999999999999999999999999864  677888888666 599998877753

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=2.5e-22  Score=204.17  Aligned_cols=138  Identities=14%  Similarity=0.194  Sum_probs=114.3

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCccc-------------------CHHHHHHHHHHhhcCCCCCcccceEEEEe
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI-------------------SEREFKDKIEGVGAVNHENLVPLRAYYYS  436 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~-------------------~~~~~~~e~~~l~~l~h~niv~l~~~~~~  436 (663)
                      +.||+|+||.||+|...+|+.||||.++....                   ....+.+|+.+++.++  | +++.+++. 
T Consensus        96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~-  171 (282)
T 1zar_A           96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA-  171 (282)
T ss_dssp             EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE-
T ss_pred             CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe-
Confidence            78999999999999997899999999864321                   2356889999999999  5 77777654 


Q ss_pred             cCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecc
Q 006055          437 MDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDF  516 (663)
Q Consensus       437 ~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Df  516 (663)
                      .+..++||||+++|+|.+ +..           .....++.|++.||.|||+.+  |+||||||+|||++ ++.+||+||
T Consensus       172 ~~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~vkl~DF  236 (282)
T 1zar_A          172 WEGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWIIDF  236 (282)
T ss_dssp             EETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEEEECCC
T ss_pred             ccceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcEEEEEC
Confidence            456799999999999998 531           123469999999999999998  99999999999999 999999999


Q ss_pred             ccccccCCCCCCCCCccccCccccC
Q 006055          517 GLAHLVGPSSTPNRVAGYRAPEVTD  541 (663)
Q Consensus       517 g~a~~~~~~~~~~~~~~y~aPE~~~  541 (663)
                      |+++...         .|+|||++.
T Consensus       237 G~a~~~~---------~~~a~e~l~  252 (282)
T 1zar_A          237 PQSVEVG---------EEGWREILE  252 (282)
T ss_dssp             TTCEETT---------STTHHHHHH
T ss_pred             CCCeECC---------CCCHHHHHH
Confidence            9997543         367888874

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.85  E-value=3.2e-21  Score=190.01  Aligned_cols=150  Identities=25%  Similarity=0.338  Sum_probs=94.0

Q ss_pred             CCCCCccceeEecCC-----------cEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceE
Q 006055           55 EASPCKWAGVECEQN-----------RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNL  123 (663)
Q Consensus        55 ~~~~c~w~gv~c~~~-----------~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  123 (663)
                      ....|.|.+|.|...           +++.|+|++|++++..| ..|.++++|+.|+|++|+|++..+..|.++++|++|
T Consensus        15 ~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L   93 (229)
T 3e6j_A           15 SQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEP-GVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVL   93 (229)
T ss_dssp             TTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCH-HHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEE
Confidence            455799999999642           45566666666664333 345666666666666666655444555666666666


Q ss_pred             EcccccccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCC
Q 006055          124 YLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       124 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  203 (663)
                      +|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+.++++|++|+|++|+|++..+..|..+++|+.|+|++|+++
T Consensus        94 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  172 (229)
T 3e6j_A           94 DLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD  172 (229)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred             ECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence            66666666555555566666666666666666 55666666666666666666666555555666666666666666666


Q ss_pred             CCC
Q 006055          204 GSI  206 (663)
Q Consensus       204 g~~  206 (663)
                      +..
T Consensus       173 c~c  175 (229)
T 3e6j_A          173 CEC  175 (229)
T ss_dssp             TTB
T ss_pred             CCc
Confidence            543

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.85  E-value=7.7e-21  Score=192.26  Aligned_cols=146  Identities=28%  Similarity=0.295  Sum_probs=93.5

Q ss_pred             EEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccc
Q 006055           71 VTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLA  150 (663)
Q Consensus        71 v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~  150 (663)
                      ++.|+|++|+++ .+|...|.++++|++|+|++|.|+...+..|.++++|++|+|++|++++..+..|..+++|+.|+|+
T Consensus        39 l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  117 (270)
T 2o6q_A           39 TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD  117 (270)
T ss_dssp             CSEEECCSSCCS-CCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred             CCEEECcCCCCC-eeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence            556666666665 4444456666777777777776665444455666677777777777665555566666677777777


Q ss_pred             cccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCC
Q 006055          151 TNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNS  217 (663)
Q Consensus       151 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~  217 (663)
                      +|++++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|++++..|..|..++.+.
T Consensus       118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  184 (270)
T 2o6q_A          118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELK  184 (270)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred             CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcC
Confidence            7777665555666667777777777777655555566667777777777777655555555444443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.85  E-value=2.3e-21  Score=189.70  Aligned_cols=149  Identities=24%  Similarity=0.342  Sum_probs=119.6

Q ss_pred             CccceeEecC-----------CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEccc
Q 006055           59 CKWAGVECEQ-----------NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQG  127 (663)
Q Consensus        59 c~w~gv~c~~-----------~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  127 (663)
                      |.|..+.|+.           ..++.|+|++|++++..|.+.|..+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus        11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            6788888853           24667888888888655666678888888888888888887777788888888888888


Q ss_pred             ccccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCC
Q 006055          128 NHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP  207 (663)
Q Consensus       128 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p  207 (663)
                      |+|++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            88887777778888888888888888887778888888888888888888887778888888888888888888876654

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.84  E-value=7.6e-21  Score=184.36  Aligned_cols=149  Identities=30%  Similarity=0.343  Sum_probs=132.0

Q ss_pred             CCccceeEecC-----------CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcc
Q 006055           58 PCKWAGVECEQ-----------NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQ  126 (663)
Q Consensus        58 ~c~w~gv~c~~-----------~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  126 (663)
                      .|.|.+|.|..           .+++.|+|++|+++ .+|...|+++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus         6 ~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls   84 (208)
T 2o6s_A            6 SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLS   84 (208)
T ss_dssp             EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccC-cCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECC
Confidence            37899999964           26889999999998 6776778999999999999999998767778999999999999


Q ss_pred             cccccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCC
Q 006055          127 GNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSI  206 (663)
Q Consensus       127 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~  206 (663)
                      +|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..+..+++|+.|+|++|++.+..
T Consensus        85 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  164 (208)
T 2o6s_A           85 TNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC  164 (208)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred             CCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCC
Confidence            99999777777899999999999999999777777899999999999999999777777899999999999999998766


Q ss_pred             C
Q 006055          207 P  207 (663)
Q Consensus       207 p  207 (663)
                      |
T Consensus       165 ~  165 (208)
T 2o6s_A          165 P  165 (208)
T ss_dssp             T
T ss_pred             C
Confidence            5

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.83  E-value=8.3e-21  Score=185.76  Aligned_cols=144  Identities=25%  Similarity=0.334  Sum_probs=81.3

Q ss_pred             CccceeEecCCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhh
Q 006055           59 CKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFL  138 (663)
Q Consensus        59 c~w~gv~c~~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~  138 (663)
                      |.|..|.|.          +++++ .+|..+   .++|+.|+|++|+|++..+..|.++++|+.|+|++|++++..|..|
T Consensus        11 C~~~~v~c~----------~~~l~-~iP~~l---~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~   76 (220)
T 2v9t_B           11 CSNNIVDCR----------GKGLT-EIPTNL---PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAF   76 (220)
T ss_dssp             EETTEEECT----------TSCCS-SCCSSC---CTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTT
T ss_pred             ECCCEEEcC----------CCCcC-cCCCcc---CcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHh
Confidence            566666664          34444 455422   1455666666666655544555566666666666666665555556


Q ss_pred             cCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCC
Q 006055          139 VGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSN  216 (663)
Q Consensus       139 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~  216 (663)
                      .++++|++|+|++|+|+...+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..++.+
T Consensus        77 ~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  154 (220)
T 2v9t_B           77 QGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAI  154 (220)
T ss_dssp             TTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred             hCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCC
Confidence            666666666666666654333345556666666666666665555555566666666666666665555445544443

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.83  E-value=2.2e-21  Score=200.65  Aligned_cols=143  Identities=22%  Similarity=0.381  Sum_probs=91.3

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCC-CCceEEcccccccCchhhhhcCCcccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCS-NLRNLYLQGNHFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  147 (663)
                      .+++.|+|++|.+++.+|. .|+.+++|++|+|++|.|++.+|..+.+++ +|++|+|++|++++.+|..+..++ |+.|
T Consensus       125 ~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L  202 (313)
T 1ogq_A          125 KTLVTLDFSYNALSGTLPP-SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFV  202 (313)
T ss_dssp             TTCCEEECCSSEEESCCCG-GGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEE
T ss_pred             CCCCEEeCCCCccCCcCCh-HHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEE
Confidence            4677788888888777775 467778888888888888777777777776 777777777777766666666655 6666


Q ss_pred             ccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCC
Q 006055          148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFG  214 (663)
Q Consensus       148 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~  214 (663)
                      +|++|++++.+|..|.++++|++|+|++|++++.+|. +..+++|++|+|++|+++|.+|..|..++
T Consensus       203 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~  268 (313)
T 1ogq_A          203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLK  268 (313)
T ss_dssp             ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCT
T ss_pred             ECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCc
Confidence            6666666655555555555555555555555544443 34445555555555555544554444433

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.80  E-value=2.5e-19  Score=181.09  Aligned_cols=158  Identities=28%  Similarity=0.338  Sum_probs=139.8

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|+++ .+|.++|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|..+++|+.|+
T Consensus        61 ~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  139 (270)
T 2o6q_A           61 TKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS  139 (270)
T ss_dssp             TTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence            57999999999998 78888889999999999999999997778889999999999999999988888899999999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCccCCcCCCCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPL  228 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~l~~~p~  228 (663)
                      |++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+..|..++.+...  .+.++|+
T Consensus       140 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L--~l~~N~~  217 (270)
T 2o6q_A          140 LGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKML--QLQENPW  217 (270)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE--ECCSSCB
T ss_pred             CCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEE--EecCCCe
Confidence            99999997666779999999999999999998877889999999999999999997766677777666542  3444554


Q ss_pred             C
Q 006055          229 Q  229 (663)
Q Consensus       229 ~  229 (663)
                      .
T Consensus       218 ~  218 (270)
T 2o6q_A          218 D  218 (270)
T ss_dssp             C
T ss_pred             e
Confidence            3

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.80  E-value=2.2e-19  Score=175.53  Aligned_cols=136  Identities=24%  Similarity=0.330  Sum_probs=127.3

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      ..++.|+|++|+++ .+|+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+
T Consensus        32 ~~l~~L~l~~n~i~-~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~  110 (220)
T 2v9t_B           32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLL  110 (220)
T ss_dssp             TTCCEEECCSSCCC-EECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cCCCEEECCCCcCC-CcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEE
Confidence            57999999999999 66766889999999999999999998899999999999999999999977777789999999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGS  205 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~  205 (663)
                      |++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+++..
T Consensus       111 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  167 (220)
T 2v9t_B          111 LNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD  167 (220)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             CCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence            999999988899999999999999999999988888899999999999999999753

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.80  E-value=2.7e-20  Score=196.44  Aligned_cols=170  Identities=25%  Similarity=0.305  Sum_probs=138.9

Q ss_pred             CccceeEecC-----------CcEEEEEcCCCCcccccCccccC-CCCCCCEEEccCCCCCCCCCccccCCCCCceEEcc
Q 006055           59 CKWAGVECEQ-----------NRVTMLRLPGVALSGQIPLGILG-NLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQ  126 (663)
Q Consensus        59 c~w~gv~c~~-----------~~v~~L~L~~~~l~g~~p~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  126 (663)
                      |.|.-+.|..           ..++.|+|++|+|+ .++...|. ++++|+.|+|++|+|++..|..|.++++|++|+|+
T Consensus        18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~-~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   96 (361)
T 2xot_A           18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS   96 (361)
T ss_dssp             EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCC-EECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCC-ccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence            6788888953           25789999999999 56666777 99999999999999999888889999999999999


Q ss_pred             cccccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCC---CCCCCCCEEEeecCcCC
Q 006055          127 GNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFD---DVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       127 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~---~~l~~L~~L~l~~N~l~  203 (663)
                      +|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|   ..+++|+.|+|++|+|+
T Consensus        97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~  176 (361)
T 2xot_A           97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK  176 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred             CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence            999998778889999999999999999998888999999999999999999996555555   57999999999999999


Q ss_pred             CCCCcccccCCCCCccCCcCCCCCCC
Q 006055          204 GSIPKRFQTFGSNSFLGNSLCGKPLQ  229 (663)
Q Consensus       204 g~~p~~~~~~~~~~~~~~~l~~~p~~  229 (663)
                      +..+..|..++.+......+.++|+.
T Consensus       177 ~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          177 KLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             CCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             ccCHHHhhhccHhhcceEEecCCCcc
Confidence            65556666665432222234455554

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.79  E-value=2.7e-19  Score=175.01  Aligned_cols=153  Identities=24%  Similarity=0.259  Sum_probs=134.6

Q ss_pred             CCccceeEecCCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCC-ccccCCCCCceEEcccccccCchhh
Q 006055           58 PCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLP-SDLASCSNLRNLYLQGNHFSGEVPL  136 (663)
Q Consensus        58 ~c~w~gv~c~~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~  136 (663)
                      .|- .+-.|..   +.+++++|+++ .+|..+   ...++.|+|++|+|++..| ..|.++++|+.|+|++|+|++..|.
T Consensus         4 ~CP-~~C~C~~---~~l~~s~n~l~-~iP~~~---~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~   75 (220)
T 2v70_A            4 ACP-EKCRCEG---TTVDCSNQKLN-KIPEHI---PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEG   75 (220)
T ss_dssp             CCC-TTCEEET---TEEECCSSCCS-SCCSCC---CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTT
T ss_pred             CCC-CCCEECC---CEeEeCCCCcc-cCccCC---CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHH
Confidence            353 3456754   37999999998 789743   3567999999999998755 4589999999999999999988888


Q ss_pred             hhcCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCC
Q 006055          137 FLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSN  216 (663)
Q Consensus       137 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~  216 (663)
                      .|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..++.+
T Consensus        76 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  155 (220)
T 2v70_A           76 AFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSL  155 (220)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTC
T ss_pred             HhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCC
Confidence            99999999999999999998888889999999999999999999999999999999999999999999989998887776


Q ss_pred             Cc
Q 006055          217 SF  218 (663)
Q Consensus       217 ~~  218 (663)
                      ..
T Consensus       156 ~~  157 (220)
T 2v70_A          156 ST  157 (220)
T ss_dssp             CE
T ss_pred             CE
Confidence            54

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.79  E-value=4.9e-19  Score=179.14  Aligned_cols=148  Identities=30%  Similarity=0.292  Sum_probs=131.5

Q ss_pred             CCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccc
Q 006055           68 QNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        68 ~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  147 (663)
                      ..+++.|+|++|.+++ ++  .++.+++|++|+|++|.|++..|..|.++++|++|+|++|++++..|..|..+++|+.|
T Consensus        62 l~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  138 (272)
T 3rfs_A           62 LPNVRYLALGGNKLHD-IS--ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL  138 (272)
T ss_dssp             CTTCCEEECTTSCCCC-CG--GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCCcEEECCCCCCCC-ch--hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEE
Confidence            3679999999999985 54  47899999999999999998877788999999999999999998888889999999999


Q ss_pred             ccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc
Q 006055          148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF  218 (663)
Q Consensus       148 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~  218 (663)
                      +|++|++++..|..|.++++|++|+|++|+|++..+..+..+++|+.|+|++|++++..|..|..++.+..
T Consensus       139 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  209 (272)
T 3rfs_A          139 NLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQY  209 (272)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred             ECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCE
Confidence            99999999777777899999999999999999888888899999999999999999888877777766654

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.78  E-value=1e-18  Score=172.05  Aligned_cols=159  Identities=27%  Similarity=0.346  Sum_probs=136.8

Q ss_pred             cceeEecCCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcC
Q 006055           61 WAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVG  140 (663)
Q Consensus        61 w~gv~c~~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  140 (663)
                      |..-.|+.   +.++.++++++ .+|.++   .++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..
T Consensus        14 ~~~~~Cs~---~~v~c~~~~l~-~ip~~~---~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~   86 (229)
T 3e6j_A           14 PSQCSCSG---TTVDCRSKRHA-SVPAGI---PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDS   86 (229)
T ss_dssp             CTTCEEET---TEEECTTSCCS-SCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             CCCCEEeC---CEeEccCCCcC-ccCCCC---CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhccc
Confidence            55667864   45889999998 899744   499999999999999988999999999999999999999777778899


Q ss_pred             CccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCccC
Q 006055          141 LHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLG  220 (663)
Q Consensus       141 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~  220 (663)
                      +++|+.|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..++.+... 
T Consensus        87 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L-  164 (229)
T 3e6j_A           87 LTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHA-  164 (229)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE-
T ss_pred             CCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEE-
Confidence            999999999999999777777899999999999999999 889889999999999999999997777778777766542 


Q ss_pred             CcCCCCCCC
Q 006055          221 NSLCGKPLQ  229 (663)
Q Consensus       221 ~~l~~~p~~  229 (663)
                       .+.++|+.
T Consensus       165 -~l~~N~~~  172 (229)
T 3e6j_A          165 -YLFGNPWD  172 (229)
T ss_dssp             -ECTTSCBC
T ss_pred             -EeeCCCcc
Confidence             23444443

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.78  E-value=2.3e-19  Score=186.68  Aligned_cols=153  Identities=22%  Similarity=0.255  Sum_probs=135.7

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccC---------CCCCceEEcccccccCchhhhhc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLAS---------CSNLRNLYLQGNHFSGEVPLFLV  139 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~---------l~~L~~L~L~~N~l~~~~p~~~~  139 (663)
                      .+++.|+|++|.++ .+|. .++++++|++|+|++|++.+.+|..+..         +++|++|+|++|+++ .+|..+.
T Consensus       127 ~~L~~L~Ls~n~l~-~lp~-~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~  203 (328)
T 4fcg_A          127 AGLETLTLARNPLR-ALPA-SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA  203 (328)
T ss_dssp             TTCSEEEEESCCCC-CCCG-GGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGG
T ss_pred             CCCCEEECCCCccc-cCcH-HHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhc
Confidence            57999999999999 8887 4799999999999999998989988765         999999999999999 8888999


Q ss_pred             CCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc-
Q 006055          140 GLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF-  218 (663)
Q Consensus       140 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~-  218 (663)
                      ++++|+.|+|++|+++ .+|..++++++|++|+|++|++.+.+|..+..+++|+.|+|++|++.+.+|..+..++.+.. 
T Consensus       204 ~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L  282 (328)
T 4fcg_A          204 NLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL  282 (328)
T ss_dssp             GCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEE
T ss_pred             CCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEE
Confidence            9999999999999999 47778999999999999999999999999999999999999999999999988888777654 


Q ss_pred             --cCCcCCC
Q 006055          219 --LGNSLCG  225 (663)
Q Consensus       219 --~~~~l~~  225 (663)
                        .+|.+.+
T Consensus       283 ~L~~n~~~~  291 (328)
T 4fcg_A          283 DLRGCVNLS  291 (328)
T ss_dssp             ECTTCTTCC
T ss_pred             eCCCCCchh
Confidence              4444444

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.78  E-value=4.9e-19  Score=169.27  Aligned_cols=132  Identities=29%  Similarity=0.330  Sum_probs=120.2

Q ss_pred             EEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCc-cccCCCCCceEEcccccccCchhhhhcCCccccccccc
Q 006055           72 TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPS-DLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLA  150 (663)
Q Consensus        72 ~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~  150 (663)
                      +.|++++|+++ .+|..+.   .+|+.|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|.++++|+.|+|+
T Consensus        11 ~~l~~s~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls   86 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CEEEcCCCCcC-cCccCCC---CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence            35667778886 8997543   4999999999999986664 48999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCC
Q 006055          151 TNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP  207 (663)
Q Consensus       151 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p  207 (663)
                      +|+|++..|..|.++++|++|+|++|+|++.+|..+..+++|++|+|++|++++..+
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A           87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            999998888889999999999999999999999999999999999999999998776

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.78  E-value=6.3e-19  Score=179.59  Aligned_cols=156  Identities=22%  Similarity=0.233  Sum_probs=130.2

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEccccc-ccCchhhhhcCCcccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNH-FSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L  147 (663)
                      .+++.|+|++|+++ .+|.+.|.++++|++|+|++|.|++..|..|.++++|++|+|++|. ++...|..|..+++|++|
T Consensus        32 ~~l~~L~l~~n~i~-~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L  110 (285)
T 1ozn_A           32 AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL  110 (285)
T ss_dssp             TTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred             CCceEEEeeCCcCC-ccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence            36889999999998 5665678899999999999999998878889999999999999997 776668888999999999


Q ss_pred             ccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc---cCCcCC
Q 006055          148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF---LGNSLC  224 (663)
Q Consensus       148 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~---~~~~l~  224 (663)
                      +|++|++++..|..|.++++|++|+|++|++++..+..+..+++|+.|+|++|++++..+..|..++.+..   .+|.+.
T Consensus       111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  190 (285)
T 1ozn_A          111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA  190 (285)
T ss_dssp             ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccc
Confidence            99999999877888899999999999999998777777888999999999999998766666766655543   455554


Q ss_pred             C
Q 006055          225 G  225 (663)
Q Consensus       225 ~  225 (663)
                      +
T Consensus       191 ~  191 (285)
T 1ozn_A          191 H  191 (285)
T ss_dssp             E
T ss_pred             c
Confidence            4

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.77  E-value=4.2e-19  Score=186.82  Aligned_cols=160  Identities=24%  Similarity=0.274  Sum_probs=141.1

Q ss_pred             CCCCccceeEecC-------------CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCce
Q 006055           56 ASPCKWAGVECEQ-------------NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRN  122 (663)
Q Consensus        56 ~~~c~w~gv~c~~-------------~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  122 (663)
                      ..+|.|.|+ |+.             .+++.|+|++|+++ .+|...|.++++|+.|+|++|+|++..|..|.++++|++
T Consensus        27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  104 (353)
T 2z80_A           27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEH  104 (353)
T ss_dssp             CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCc-ccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCE
Confidence            347899988 742             37999999999999 577667899999999999999999988889999999999


Q ss_pred             EEcccccccCchhhhhcCCccccccccccccccccCCC--CCcccccccccccccc-cccCcCCCCCCCCCCCCEEEeec
Q 006055          123 LYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPS--GFKNLTKLKTLFLENN-RLSGSIPGFDDVLPNLQQLNVSN  199 (663)
Q Consensus       123 L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~  199 (663)
                      |+|++|++++..+..|.++++|++|+|++|++++ +|.  .|.++++|++|+|++| .+++..|..+..+++|+.|++++
T Consensus       105 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~  183 (353)
T 2z80_A          105 LDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA  183 (353)
T ss_dssp             EECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEE
T ss_pred             EECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCC
Confidence            9999999997777779999999999999999994 554  7999999999999999 47767778899999999999999


Q ss_pred             CcCCCCCCcccccCCCCCc
Q 006055          200 NLLNGSIPKRFQTFGSNSF  218 (663)
Q Consensus       200 N~l~g~~p~~~~~~~~~~~  218 (663)
                      |++++..|..|..++.+..
T Consensus       184 n~l~~~~~~~l~~l~~L~~  202 (353)
T 2z80_A          184 SDLQSYEPKSLKSIQNVSH  202 (353)
T ss_dssp             TTCCEECTTTTTTCSEEEE
T ss_pred             CCcCccCHHHHhccccCCe
Confidence            9999988988887766544

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.77  E-value=3.1e-19  Score=202.53  Aligned_cols=148  Identities=20%  Similarity=0.202  Sum_probs=135.3

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      ..++.|+|++|+|+ .+|+..|.++++|++|+|++|+|+++.|..|.+|++|++|+|++|+|++..|..|.++++|++|+
T Consensus        52 ~~~~~LdLs~N~i~-~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~  130 (635)
T 4g8a_A           52 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV  130 (635)
T ss_dssp             TTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred             cCCCEEEeeCCCCC-CCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence            36899999999999 77777899999999999999999998888999999999999999999988888999999999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccC-cCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSG-SIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNS  217 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~  217 (663)
                      |++|+|++..+..|+++++|++|+|++|+|++ .+|..+..+++|++|+|++|+|++..|..|..+..+.
T Consensus       131 Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~  200 (635)
T 4g8a_A          131 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP  200 (635)
T ss_dssp             CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCT
T ss_pred             CCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhh
Confidence            99999997777789999999999999999986 4688899999999999999999998888887665544

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.77  E-value=4.7e-19  Score=182.47  Aligned_cols=156  Identities=24%  Similarity=0.330  Sum_probs=105.8

Q ss_pred             CccceeEecC-----------CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCC--CCccccCCCCCceEEc
Q 006055           59 CKWAGVECEQ-----------NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQ--LPSDLASCSNLRNLYL  125 (663)
Q Consensus        59 c~w~gv~c~~-----------~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L  125 (663)
                      |.|.+|.|+.           .+++.|+|++|+++ .+|.++|+++++|+.|+|++|.|+..  .|..+..+++|++|+|
T Consensus         7 C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L   85 (306)
T 2z66_A            7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL   85 (306)
T ss_dssp             EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred             eCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence            7999999964           36899999999998 88888889999999999999999742  2455556667777777


Q ss_pred             ccccccCchhhhhcCCccccccccccccccccCC-CCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCC
Q 006055          126 QGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIP-SGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNG  204 (663)
Q Consensus       126 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g  204 (663)
                      ++|.++ .+|..+..+++|+.|+|++|++++..+ ..+.++++|++|+|++|++++..|..+..+++|+.|+|++|++++
T Consensus        86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  164 (306)
T 2z66_A           86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE  164 (306)
T ss_dssp             CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred             CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence            777666 355556666666666666666654333 355566666666666666655555555556666666666666554


Q ss_pred             -CCCcccccCCCC
Q 006055          205 -SIPKRFQTFGSN  216 (663)
Q Consensus       205 -~~p~~~~~~~~~  216 (663)
                       .+|..+..++.+
T Consensus       165 ~~~~~~~~~l~~L  177 (306)
T 2z66_A          165 NFLPDIFTELRNL  177 (306)
T ss_dssp             GEECSCCTTCTTC
T ss_pred             ccchhHHhhCcCC
Confidence             345544444433

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.77  E-value=3.8e-19  Score=180.34  Aligned_cols=146  Identities=21%  Similarity=0.204  Sum_probs=132.1

Q ss_pred             cEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccccc
Q 006055           70 RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL  149 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  149 (663)
                      .++.|+|++|+++ .++...|.++++|++|+|++|+|++..+..|.++++|++|+|++|.+++..|..|.++++|+.|++
T Consensus        29 ~l~~L~ls~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  107 (276)
T 2z62_A           29 STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (276)
T ss_dssp             TCCEEECTTCCCC-EECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CccEEECCCCccc-ccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence            6999999999999 556557899999999999999999987889999999999999999999888899999999999999


Q ss_pred             ccccccccCCCCCcccccccccccccccccCc-CCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCC
Q 006055          150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGS-IPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSN  216 (663)
Q Consensus       150 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~  216 (663)
                      ++|++++..+..+.++++|++|+|++|++++. +|..+..+++|+.|+|++|++++..+..|..+..+
T Consensus       108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  175 (276)
T 2z62_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM  175 (276)
T ss_dssp             TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTC
T ss_pred             CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhc
Confidence            99999987777899999999999999999873 68999999999999999999998777777655443

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.77  E-value=1.4e-18  Score=177.03  Aligned_cols=158  Identities=26%  Similarity=0.299  Sum_probs=137.3

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCC-CCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNS-LTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  147 (663)
                      .+++.|+|++|.+++..| ..|.++++|++|+|++|. ++...|..|.++++|++|+|++|.+++..|..|.++++|++|
T Consensus        56 ~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  134 (285)
T 1ozn_A           56 RNLTILWLHSNVLARIDA-AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL  134 (285)
T ss_dssp             TTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCCEEECCCCccceeCH-hhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEE
Confidence            579999999999985445 468999999999999997 888778899999999999999999998889999999999999


Q ss_pred             ccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc---cCCcCC
Q 006055          148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF---LGNSLC  224 (663)
Q Consensus       148 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~---~~~~l~  224 (663)
                      +|++|++++..+..|.++++|++|+|++|+|++..+..+..+++|+.|+|++|++++..|..|..++.+..   .+|.+.
T Consensus       135 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  214 (285)
T 1ozn_A          135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS  214 (285)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             ECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCC
Confidence            99999999777777999999999999999999777778999999999999999999888988887766554   556555


Q ss_pred             CCC
Q 006055          225 GKP  227 (663)
Q Consensus       225 ~~p  227 (663)
                      +.+
T Consensus       215 ~~~  217 (285)
T 1ozn_A          215 ALP  217 (285)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            543

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.76  E-value=3.4e-18  Score=170.79  Aligned_cols=167  Identities=23%  Similarity=0.286  Sum_probs=146.1

Q ss_pred             CCCccceeEecCCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhh
Q 006055           57 SPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPL  136 (663)
Q Consensus        57 ~~c~w~gv~c~~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  136 (663)
                      +||.|.|.+|.. ..+.+++++++++ .+|.++   .++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|.
T Consensus         3 ~Cp~~~gC~C~~-~~~~l~~~~~~l~-~~p~~~---~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~   77 (251)
T 3m19_A            3 TCETVTGCTCNE-GKKEVDCQGKSLD-SVPSGI---PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAG   77 (251)
T ss_dssp             -CHHHHSSEEEG-GGTEEECTTCCCS-SCCSCC---CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT
T ss_pred             cCCCCCceEcCC-CCeEEecCCCCcc-ccCCCC---CCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHh
Confidence            478999999953 3557999999999 899754   37999999999999998888999999999999999999998898


Q ss_pred             hhcCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCC
Q 006055          137 FLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSN  216 (663)
Q Consensus       137 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~  216 (663)
                      .|..+++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|..++.+
T Consensus        78 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  157 (251)
T 3m19_A           78 VFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNL  157 (251)
T ss_dssp             TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             HhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCC
Confidence            99999999999999999998778889999999999999999998877888999999999999999997777778776665


Q ss_pred             Cc---cCCcCCCCCC
Q 006055          217 SF---LGNSLCGKPL  228 (663)
Q Consensus       217 ~~---~~~~l~~~p~  228 (663)
                      ..   .+|.+.+.+.
T Consensus       158 ~~L~L~~N~l~~~~~  172 (251)
T 3m19_A          158 QTLSLSTNQLQSVPH  172 (251)
T ss_dssp             CEEECCSSCCSCCCT
T ss_pred             CEEECCCCcCCccCH
Confidence            54   5666665543

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.76  E-value=1.8e-18  Score=175.06  Aligned_cols=138  Identities=30%  Similarity=0.345  Sum_probs=128.8

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|+++ .+|+..|+++++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|..+++|+.|+
T Consensus        85 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  163 (272)
T 3rfs_A           85 TNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD  163 (272)
T ss_dssp             TTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCccC-ccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence            58999999999999 56666789999999999999999998888899999999999999999988888899999999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP  207 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p  207 (663)
                      |++|++++..+..|.++++|++|+|++|+|++..|..+..+++|+.|+|++|++++..|
T Consensus       164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  222 (272)
T 3rfs_A          164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP  222 (272)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence            99999998878788999999999999999999888889999999999999999998876

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.76  E-value=6.2e-19  Score=196.85  Aligned_cols=158  Identities=24%  Similarity=0.251  Sum_probs=140.8

Q ss_pred             CCccceeEecC-------------CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEE
Q 006055           58 PCKWAGVECEQ-------------NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLY  124 (663)
Q Consensus        58 ~c~w~gv~c~~-------------~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  124 (663)
                      .|.|.|+ |+.             .+++.|+|++|++++..| ..|+++++|++|+|++|+|++..|..|.++++|++|+
T Consensus         3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   80 (549)
T 2z81_A            3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGH-GDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLD   80 (549)
T ss_dssp             EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECS-STTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccCh-hhhhcCCcccEEECCCCCcCccChhhccccccCCEEE
Confidence            5999999 863             279999999999995555 4689999999999999999998889999999999999


Q ss_pred             cccccccCchhhhhcCCccccccccccccccc-cCCCCCcccccccccccccccccCcCC-CCCCCCCCCCEEEeecCcC
Q 006055          125 LQGNHFSGEVPLFLVGLHHLVRLNLATNNFSG-EIPSGFKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVSNNLL  202 (663)
Q Consensus       125 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l  202 (663)
                      |++|++++..|..|+++++|++|+|++|++++ .+|..|+++++|++|+|++|++.+.+| ..+..+++|++|++++|++
T Consensus        81 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l  160 (549)
T 2z81_A           81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL  160 (549)
T ss_dssp             CTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred             CCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence            99999999888889999999999999999986 467889999999999999999655655 6899999999999999999


Q ss_pred             CCCCCcccccCCCCC
Q 006055          203 NGSIPKRFQTFGSNS  217 (663)
Q Consensus       203 ~g~~p~~~~~~~~~~  217 (663)
                      ++.+|..+..++.+.
T Consensus       161 ~~~~~~~l~~l~~L~  175 (549)
T 2z81_A          161 RNYQSQSLKSIRDIH  175 (549)
T ss_dssp             CEECTTTTTTCSEEE
T ss_pred             cccChhhhhccccCc
Confidence            999998887665443

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.76  E-value=1.6e-18  Score=173.85  Aligned_cols=133  Identities=16%  Similarity=0.126  Sum_probs=103.9

Q ss_pred             hcccccccceEEEEEEe-cCCcE--EEEEEecCcccC-------------------------HHHHHHHHHHhhcCCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTI--VAVKRLKDVTIS-------------------------EREFKDKIEGVGAVNHEN  426 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~--vavK~l~~~~~~-------------------------~~~~~~e~~~l~~l~h~n  426 (663)
                      .+.||+|+||.||+|.. .+|+.  ||||+++.....                         ...+.+|+..+..+.|++
T Consensus        52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~  131 (258)
T 1zth_A           52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG  131 (258)
T ss_dssp             EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence            36799999999999997 78999  999987543111                         135788999999998886


Q ss_pred             cc--cceEEEEecCccEEEEEccCC-C----ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCcceecCC
Q 006055          427 LV--PLRAYYYSMDEKLLVYDYLTM-G----SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH-AQGPNVSHGNI  498 (663)
Q Consensus       427 iv--~l~~~~~~~~~~~lv~ey~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH-~~~~~iiHrdl  498 (663)
                      +.  .++.+    ...++||||+.+ |    +|.++...        .++.....++.|++.||.||| +.+  |+||||
T Consensus       132 i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDl  197 (258)
T 1zth_A          132 VSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE--LVHADL  197 (258)
T ss_dssp             CCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSC
T ss_pred             CCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCC
Confidence            53  33332    467999999942 4    67666532        123456789999999999999 888  999999


Q ss_pred             CCCCEEEcCCCceEEeccccccccC
Q 006055          499 KSSNILLTKSYEARVSDFGLAHLVG  523 (663)
Q Consensus       499 k~~Nill~~~~~~kl~Dfg~a~~~~  523 (663)
                      ||+|||+++  .++|+|||+|....
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEETT
T ss_pred             CHHHEEEcC--cEEEEECcccccCC
Confidence            999999998  99999999997653

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.76  E-value=2.3e-18  Score=175.74  Aligned_cols=155  Identities=26%  Similarity=0.305  Sum_probs=126.0

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      ..++.|+|++|.+++ +++..|.++++|+.|+|++|.|++. |. ...+++|++|+|++|+|+ .+|..+..+++|+.|+
T Consensus        31 ~~l~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~  106 (290)
T 1p9a_G           31 KDTTILHLSENLLYT-FSLATLMPYTRLTQLNLDRAELTKL-QV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLD  106 (290)
T ss_dssp             TTCCEEECTTSCCSE-EEGGGGTTCTTCCEEECTTSCCCEE-EC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEE
T ss_pred             CCCCEEEcCCCcCCc-cCHHHhhcCCCCCEEECCCCccCcc-cC-CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEE
Confidence            468899999999984 4445789999999999999999874 33 378899999999999998 6788888899999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCC---ccCCcCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNS---FLGNSLCG  225 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~---~~~~~l~~  225 (663)
                      |++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..++.+.   +.+|.+..
T Consensus       107 l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~  186 (290)
T 1p9a_G          107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT  186 (290)
T ss_dssp             CCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCc
Confidence            999999977777899999999999999999977777888899999999999999866555566555544   45666665


Q ss_pred             CC
Q 006055          226 KP  227 (663)
Q Consensus       226 ~p  227 (663)
                      .|
T Consensus       187 ip  188 (290)
T 1p9a_G          187 IP  188 (290)
T ss_dssp             CC
T ss_pred             cC
Confidence            44

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.75  E-value=1.8e-18  Score=162.93  Aligned_cols=135  Identities=27%  Similarity=0.333  Sum_probs=118.9

Q ss_pred             CccceeEecCCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhh
Q 006055           59 CKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFL  138 (663)
Q Consensus        59 c~w~gv~c~~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~  138 (663)
                      |.|.++.|+.          ++++ .+|..   ..++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|
T Consensus         7 C~~~~l~~~~----------~~l~-~~p~~---~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~   72 (177)
T 2o6r_A            7 CSGTEIRCNS----------KGLT-SVPTG---IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVF   72 (177)
T ss_dssp             EETTEEECCS----------SCCS-SCCTT---CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT
T ss_pred             eCCCEEEecC----------CCCc-cCCCC---CCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHc
Confidence            6788777754          4555 67753   34799999999999998777788999999999999999998777888


Q ss_pred             cCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCC
Q 006055          139 VGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP  207 (663)
Q Consensus       139 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p  207 (663)
                      ..+++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..+..+++|+.|+|++|++++..|
T Consensus        73 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           73 DKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             cCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            999999999999999997777778999999999999999997777778999999999999999998776

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.75  E-value=2.8e-18  Score=175.16  Aligned_cols=141  Identities=32%  Similarity=0.322  Sum_probs=83.6

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|+++ .+|.  .+.+++|+.|+|++|+|+. +|..+.++++|++|+|++|+|++..|..|.++++|+.|+
T Consensus        55 ~~L~~L~L~~n~l~-~~~~--~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~  130 (290)
T 1p9a_G           55 TRLTQLNLDRAELT-KLQV--DGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY  130 (290)
T ss_dssp             TTCCEEECTTSCCC-EEEC--CSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCccC-cccC--CCCCCcCCEEECCCCcCCc-CchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEE
Confidence            45666666666665 3333  2556666666666666653 555566666666666666666655555566666666666


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFG  214 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~  214 (663)
                      |++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+.
T Consensus       131 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~  195 (290)
T 1p9a_G          131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSH  195 (290)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTC
T ss_pred             CCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccc
Confidence            6666666554555566666666666666666444445556666666666666666 4555444433

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.75  E-value=8.5e-19  Score=198.24  Aligned_cols=159  Identities=21%  Similarity=0.245  Sum_probs=141.3

Q ss_pred             CCCccc----eeEecC-----------CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCc
Q 006055           57 SPCKWA----GVECEQ-----------NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLR  121 (663)
Q Consensus        57 ~~c~w~----gv~c~~-----------~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  121 (663)
                      +||.|.    .|.|..           .+++.|+|++|++++ +++..|.++++|++|+|++|.|++..|..|.++++|+
T Consensus         5 ~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~   83 (606)
T 3vq2_A            5 NPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKI-LKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS   83 (606)
T ss_dssp             -CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred             CCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCE-eChhhccCCccCcEEeCCCCcccccCHHHhhchhhcC
Confidence            467653    577743           479999999999994 5555789999999999999999998899999999999


Q ss_pred             eEEcccccccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccccccC-cCCCCCCCCCCCCEEEeecC
Q 006055          122 NLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSG-SIPGFDDVLPNLQQLNVSNN  200 (663)
Q Consensus       122 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N  200 (663)
                      +|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++ .+|..++++++|++|+|++|
T Consensus        84 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n  163 (606)
T 3vq2_A           84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN  163 (606)
T ss_dssp             EEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred             EeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence            99999999998889999999999999999999998777889999999999999999986 67999999999999999999


Q ss_pred             cCCCCCCcccccCCCC
Q 006055          201 LLNGSIPKRFQTFGSN  216 (663)
Q Consensus       201 ~l~g~~p~~~~~~~~~  216 (663)
                      ++++..|..|..+..+
T Consensus       164 ~l~~~~~~~~~~l~~L  179 (606)
T 3vq2_A          164 YIQTITVNDLQFLREN  179 (606)
T ss_dssp             CCCEECTTTTHHHHHC
T ss_pred             cceecChhhhhhhhcc
Confidence            9999888877766543

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.75  E-value=1.2e-18  Score=189.80  Aligned_cols=158  Identities=23%  Similarity=0.268  Sum_probs=138.5

Q ss_pred             CCCccce--eEecC----------CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCC-CccccCCCCCceE
Q 006055           57 SPCKWAG--VECEQ----------NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQL-PSDLASCSNLRNL  123 (663)
Q Consensus        57 ~~c~w~g--v~c~~----------~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L  123 (663)
                      +.|.|.+  |.|..          .+++.|+|++|.+++..| ..|+++++|++|+|++|.+.+.+ |..|.++++|++|
T Consensus         6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L   84 (455)
T 3v47_A            6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNE-TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIIL   84 (455)
T ss_dssp             -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECT-TTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEE
T ss_pred             ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCCh-hHhccCccccEEECcCCcccceECcccccccccCCEE
Confidence            3566665  88864          368999999999996555 46899999999999999998666 5679999999999


Q ss_pred             EcccccccCchhhhhcCCccccccccccccccccCCCC--CcccccccccccccccccCcCCCC-CCCCCCCCEEEeecC
Q 006055          124 YLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG--FKNLTKLKTLFLENNRLSGSIPGF-DDVLPNLQQLNVSNN  200 (663)
Q Consensus       124 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~l~~N  200 (663)
                      +|++|++++..|..|.++++|++|+|++|++++.+|..  |.++++|++|+|++|++++..|.. +..+++|++|+|++|
T Consensus        85 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n  164 (455)
T 3v47_A           85 KLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN  164 (455)
T ss_dssp             ECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTC
T ss_pred             eCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCC
Confidence            99999999888999999999999999999999866554  999999999999999999888876 899999999999999


Q ss_pred             cCCCCCCcccccCCC
Q 006055          201 LLNGSIPKRFQTFGS  215 (663)
Q Consensus       201 ~l~g~~p~~~~~~~~  215 (663)
                      ++++..|..+..+..
T Consensus       165 ~l~~~~~~~l~~l~~  179 (455)
T 3v47_A          165 KVKSICEEDLLNFQG  179 (455)
T ss_dssp             CBSCCCTTTSGGGTT
T ss_pred             cccccChhhhhcccc
Confidence            999999988877643

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.74  E-value=1.5e-17  Score=160.93  Aligned_cols=148  Identities=28%  Similarity=0.322  Sum_probs=128.8

Q ss_pred             eEecCCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcc
Q 006055           64 VECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH  143 (663)
Q Consensus        64 v~c~~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  143 (663)
                      -.|..   +.++.++++++ .+|.+   ..++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++
T Consensus         5 C~C~~---~~v~c~~~~l~-~~p~~---~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~   77 (208)
T 2o6s_A            5 CSCSG---TTVECYSQGRT-SVPTG---IPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTS   77 (208)
T ss_dssp             CEEET---TEEECCSSCCS-SCCSC---CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTT
T ss_pred             CEECC---CEEEecCCCcc-CCCCC---CCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCC
Confidence            45643   46788999998 78864   3579999999999999877778899999999999999999877778899999


Q ss_pred             ccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc
Q 006055          144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF  218 (663)
Q Consensus       144 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~  218 (663)
                      |++|+|++|+|++..+..|.++++|++|+|++|+|++..+..+..+++|+.|+|++|++++..+..|..++.+..
T Consensus        78 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  152 (208)
T 2o6s_A           78 LTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQY  152 (208)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred             cCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccE
Confidence            999999999999776777899999999999999999887888999999999999999999777766776666554

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.74  E-value=2.1e-18  Score=194.57  Aligned_cols=155  Identities=20%  Similarity=0.187  Sum_probs=138.5

Q ss_pred             cEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccccc
Q 006055           70 RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL  149 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  149 (663)
                      +++.|++++|.+. .+|+.+|+++++|+.|+|++|.|++..|..|.++++|++|+|++|.+++..|..|+++++|+.|+|
T Consensus        52 ~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  130 (597)
T 3oja_B           52 NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL  130 (597)
T ss_dssp             CCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence            5688999999997 788888999999999999999999988889999999999999999999989999999999999999


Q ss_pred             ccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCccCCcCCC
Q 006055          150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCG  225 (663)
Q Consensus       150 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~l~~  225 (663)
                      ++|+|++..+..|+++++|++|+|++|.|++..|..|..+++|+.|+|++|++++..+..+..+..+.+.+|.+.+
T Consensus       131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~  206 (597)
T 3oja_B          131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLST  206 (597)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSE
T ss_pred             eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCcccc
Confidence            9999996655667999999999999999999999999999999999999999998765666666666556665544

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.74  E-value=6.9e-19  Score=168.21  Aligned_cols=153  Identities=25%  Similarity=0.361  Sum_probs=126.0

Q ss_pred             CccceeEecC-----------CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEccc
Q 006055           59 CKWAGVECEQ-----------NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQG  127 (663)
Q Consensus        59 c~w~gv~c~~-----------~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  127 (663)
                      |.|..+.|..           ..++.|+|++|++++..+.+.|+.+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus         8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A            8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            7899999964           27899999999999555545689999999999999999998899999999999999999


Q ss_pred             ccccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCC-CCCCEEEeecCcCCCCC
Q 006055          128 NHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVL-PNLQQLNVSNNLLNGSI  206 (663)
Q Consensus       128 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l-~~L~~L~l~~N~l~g~~  206 (663)
                      |+|++..|..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|.+++..+-.  .+ ..|+...+..+......
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~--~~~~~l~~~~~~~~~~~C~~  165 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA--WFAEWLRKKSLNGGAARCGA  165 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH--HHHHHHHHHCCSGGGCBBCS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcch--HHHHHHHHcCCCCCCCCCCC
Confidence            9999988888999999999999999999999999999999999999999999766521  11 11222233445555555


Q ss_pred             CcccccC
Q 006055          207 PKRFQTF  213 (663)
Q Consensus       207 p~~~~~~  213 (663)
                      |..+...
T Consensus       166 P~~l~~~  172 (192)
T 1w8a_A          166 PSKVRDV  172 (192)
T ss_dssp             STTTTTS
T ss_pred             ChHHcCC
Confidence            6555444

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.74  E-value=3.1e-18  Score=187.80  Aligned_cols=165  Identities=19%  Similarity=0.193  Sum_probs=144.4

Q ss_pred             ccceeEecC-----------CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccc
Q 006055           60 KWAGVECEQ-----------NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGN  128 (663)
Q Consensus        60 ~w~gv~c~~-----------~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  128 (663)
                      .|..|.|..           ..++.|+|++|++++ +++..|.++++|++|+|++|.|++..|..|.++++|++|+|++|
T Consensus        12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKT-LNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccce-ECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            478899953           368899999999995 54457899999999999999999988999999999999999999


Q ss_pred             cccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCc
Q 006055          129 HFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPK  208 (663)
Q Consensus       129 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~  208 (663)
                      ++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|+.|+|++|++++..+.
T Consensus        91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  170 (477)
T 2id5_A           91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE  170 (477)
T ss_dssp             CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred             cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence            99977777889999999999999999988899999999999999999999988899999999999999999999976666


Q ss_pred             ccccCCCCCc---cCCcCCC
Q 006055          209 RFQTFGSNSF---LGNSLCG  225 (663)
Q Consensus       209 ~~~~~~~~~~---~~~~l~~  225 (663)
                      .|..++.+..   .+|.+.+
T Consensus       171 ~l~~l~~L~~L~l~~n~i~~  190 (477)
T 2id5_A          171 ALSHLHGLIVLRLRHLNINA  190 (477)
T ss_dssp             HHTTCTTCCEEEEESCCCCE
T ss_pred             HhcccCCCcEEeCCCCcCcE
Confidence            6766665543   4555443

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.74  E-value=3.1e-18  Score=176.35  Aligned_cols=157  Identities=23%  Similarity=0.214  Sum_probs=130.3

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCC-ccccCCCCCceEEcccccccCchhhhhcCCcccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLP-SDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  147 (663)
                      .+++.|+|++|.++ .+|.. +..+++|++|+|++|++++..+ ..+.++++|++|+|++|.+++..|..+..+++|+.|
T Consensus        78 ~~L~~L~Ls~n~i~-~l~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  155 (306)
T 2z66_A           78 TSLKYLDLSFNGVI-TMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL  155 (306)
T ss_dssp             SCCCEEECCSCSEE-EEEEE-EETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEE
T ss_pred             cccCEEECCCCccc-cChhh-cCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEE
Confidence            57889999999998 67764 6889999999999999987554 578889999999999999988888888899999999


Q ss_pred             ccccccccc-cCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCC---ccCCcC
Q 006055          148 NLATNNFSG-EIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNS---FLGNSL  223 (663)
Q Consensus       148 ~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~---~~~~~l  223 (663)
                      +|++|++++ .+|..+..+++|++|+|++|+|++..|..+..+++|+.|+|++|++++..+..|..++.+.   +.+|.+
T Consensus       156 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  235 (306)
T 2z66_A          156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI  235 (306)
T ss_dssp             ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCC
T ss_pred             ECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCC
Confidence            999999986 5788899999999999999999988888888999999999999999877666666655554   356666


Q ss_pred             CCCC
Q 006055          224 CGKP  227 (663)
Q Consensus       224 ~~~p  227 (663)
                      .+.+
T Consensus       236 ~~~~  239 (306)
T 2z66_A          236 MTSK  239 (306)
T ss_dssp             CBCS
T ss_pred             cccC
Confidence            5543

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.74  E-value=6.8e-19  Score=202.02  Aligned_cols=194  Identities=18%  Similarity=0.178  Sum_probs=127.5

Q ss_pred             ChHHHHHHHHHHHhcC----CCCcCCcCCCCCCCccceeEecCCcEEEEEcCCCCcc------------------c----
Q 006055           30 LSSDRAALLALRSSVG----GRTLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALS------------------G----   83 (663)
Q Consensus        30 ~~~d~~all~~~~~~~----~~~~~w~~~~~~~c~w~gv~c~~~~v~~L~L~~~~l~------------------g----   83 (663)
                      ...++++|+++..++.    .....|......++.|.++.++..+++.|+|.+|++.                  +    
T Consensus       130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~~~  209 (727)
T 4b8c_D          130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDDI  209 (727)
T ss_dssp             --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred             cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccCcccc
Confidence            4568999999998874    2223465444446789999888777777766554433                  1    


Q ss_pred             ----ccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCC
Q 006055           84 ----QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIP  159 (663)
Q Consensus        84 ----~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  159 (663)
                          .+|++.|..+++|+.|+|++|.|. .+|..+.++++|++|+|++|.|+ .+|..|++|++|+.|+|++|+|+ .+|
T Consensus       210 ~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp  286 (727)
T 4b8c_D          210 ENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLP  286 (727)
T ss_dssp             ------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCC
T ss_pred             ccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccC
Confidence                134456788999999999999998 47888889999999999999999 88999999999999999999999 889


Q ss_pred             CCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCC----CCccCCcCCCCC
Q 006055          160 SGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGS----NSFLGNSLCGKP  227 (663)
Q Consensus       160 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~----~~~~~~~l~~~p  227 (663)
                      ..|++|++|++|+|++|.|+ .+|..|+.+++|+.|+|++|+|++.+|..+..+..    +.+.+|.+.+..
T Consensus       287 ~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~  357 (727)
T 4b8c_D          287 AELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPL  357 (727)
T ss_dssp             SSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_pred             hhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcC
Confidence            99999999999999999998 78888999999999999999999999987755432    223455565543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.73  E-value=3e-18  Score=182.82  Aligned_cols=156  Identities=21%  Similarity=0.193  Sum_probs=136.6

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|++++|.++ .+|..+|..+++|++|+|++|.|++..|..|.++++|++|+|++|.+++..|..|.++++|++|+
T Consensus        45 ~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  123 (390)
T 3o6n_A           45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  123 (390)
T ss_dssp             CCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence            46788999999998 89988889999999999999999998888999999999999999999998899999999999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCccCCcCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCG  225 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~l~~  225 (663)
                      |++|+++...+..|.++++|++|+|++|++++..|..+..+++|+.|++++|++++.....+..+..+.+.+|.+.+
T Consensus       124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~  200 (390)
T 3o6n_A          124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLST  200 (390)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSE
T ss_pred             CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccc
Confidence            99999995444457999999999999999998888899999999999999999997655556566555555555443

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.72  E-value=1.2e-17  Score=159.70  Aligned_cols=129  Identities=26%  Similarity=0.305  Sum_probs=117.1

Q ss_pred             EEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccc
Q 006055           73 MLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATN  152 (663)
Q Consensus        73 ~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N  152 (663)
                      .+++++|+++ .+|.++   .++|+.|+|++|+|+. +|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|
T Consensus        14 ~l~~~~~~l~-~ip~~~---~~~l~~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           14 VVRCSNKGLK-VLPKGI---PRDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             EEECTTSCCS-SCCSCC---CTTCCEEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEEcCCCCCC-cCCCCC---CCCCCEEECCCCcCch-hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            5677788888 888754   3789999999999985 7899999999999999999999888899999999999999999


Q ss_pred             cccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCC
Q 006055          153 NFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSI  206 (663)
Q Consensus       153 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~  206 (663)
                      +|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|++.+.-
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c  142 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC  142 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence            999888889999999999999999999777778999999999999999998643

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.72  E-value=5.6e-18  Score=167.85  Aligned_cols=137  Identities=17%  Similarity=0.171  Sum_probs=123.2

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCC-CCCCCCccccCCCCCceEEccc-ccccCchhhhhcCCccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNS-LTSQLPSDLASCSNLRNLYLQG-NHFSGEVPLFLVGLHHLVR  146 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~  146 (663)
                      ..++.|+|++|+++ .+|+..|+++++|+.|+|++|. +++..+..|.++++|++|+|++ |++++..+..|.++++|+.
T Consensus        31 ~~l~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~  109 (239)
T 2xwt_C           31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF  109 (239)
T ss_dssp             TTCCEEEEESCCCS-EECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred             CcccEEEEeCCcce-EECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence            57999999999999 6776678999999999999997 9887777899999999999999 9999777788999999999


Q ss_pred             cccccccccccCCCCCccccccc---ccccccc-cccCcCCCCCCCCCCCC-EEEeecCcCCCCCCcc
Q 006055          147 LNLATNNFSGEIPSGFKNLTKLK---TLFLENN-RLSGSIPGFDDVLPNLQ-QLNVSNNLLNGSIPKR  209 (663)
Q Consensus       147 L~l~~N~l~~~~p~~~~~l~~L~---~L~l~~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~  209 (663)
                      |+|++|++++ +|. |.++++|+   +|+|++| ++++..+..|..+++|+ .|++++|+++ .+|..
T Consensus       110 L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~  174 (239)
T 2xwt_C          110 LGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY  174 (239)
T ss_dssp             EEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTT
T ss_pred             EeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHh
Confidence            9999999995 776 88888888   9999999 99977777899999999 9999999999 55543

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.72  E-value=3.9e-18  Score=159.18  Aligned_cols=137  Identities=26%  Similarity=0.269  Sum_probs=121.5

Q ss_pred             CcEEEEEcCCCCcc-cccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccc
Q 006055           69 NRVTMLRLPGVALS-GQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        69 ~~v~~L~L~~~~l~-g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  147 (663)
                      .+++.|+|++|+++ |.+|. .+..+++|+.|+|++|.|++.  ..+..+++|++|+|++|++++.+|..+..+++|+.|
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  100 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEG-LTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL  100 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSS-CCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred             ccCCEEECCCCCCChhhHHH-HHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence            57999999999998 88987 479999999999999999985  789999999999999999998899988889999999


Q ss_pred             ccccccccccC-CCCCcccccccccccccccccCcCC---CCCCCCCCCCEEEeecCcCCCCCCcc
Q 006055          148 NLATNNFSGEI-PSGFKNLTKLKTLFLENNRLSGSIP---GFDDVLPNLQQLNVSNNLLNGSIPKR  209 (663)
Q Consensus       148 ~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p---~~~~~l~~L~~L~l~~N~l~g~~p~~  209 (663)
                      +|++|+|++.. +..+..+++|++|+|++|++++..+   ..+..+++|+.|++++|.+. .+|..
T Consensus       101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~  165 (168)
T 2ell_A          101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS  165 (168)
T ss_dssp             ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred             eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence            99999998642 2789999999999999999996555   47899999999999999987 55543

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.71  E-value=1.7e-17  Score=180.59  Aligned_cols=162  Identities=22%  Similarity=0.206  Sum_probs=119.1

Q ss_pred             cceeEecC-----------CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEccccc
Q 006055           61 WAGVECEQ-----------NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNH  129 (663)
Q Consensus        61 w~gv~c~~-----------~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  129 (663)
                      |..|.|..           .+++.|+|++|++++ +++..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+
T Consensus        56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~  134 (452)
T 3zyi_A           56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQM-IQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW  134 (452)
T ss_dssp             SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             CcEEEECCCCcCccCCCCCCCccEEECcCCcCce-ECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence            57888853           368999999999995 444578999999999999999999888899999999999999999


Q ss_pred             ccCchhhhhcCCccccccccccccccccCCCC-------------------------CcccccccccccccccccCcCCC
Q 006055          130 FSGEVPLFLVGLHHLVRLNLATNNFSGEIPSG-------------------------FKNLTKLKTLFLENNRLSGSIPG  184 (663)
Q Consensus       130 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-------------------------~~~l~~L~~L~l~~N~l~~~~p~  184 (663)
                      |++..+..|..+++|++|+|++|+|+...+..                         |.++++|++|+|++|+|++ +| 
T Consensus       135 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-  212 (452)
T 3zyi_A          135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-  212 (452)
T ss_dssp             CSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-
T ss_pred             CCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-
Confidence            99777777888999999999998887544433                         4445555555555565553 23 


Q ss_pred             CCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc---cCCcCCC
Q 006055          185 FDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF---LGNSLCG  225 (663)
Q Consensus       185 ~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~---~~~~l~~  225 (663)
                      .+..+++|+.|+|++|++++..|..|..++.+..   .+|.+.+
T Consensus       213 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~  256 (452)
T 3zyi_A          213 NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL  256 (452)
T ss_dssp             CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCE
T ss_pred             cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCce
Confidence            2456666777777777777666666666555443   4444443

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.71  E-value=1.6e-17  Score=180.95  Aligned_cols=138  Identities=23%  Similarity=0.268  Sum_probs=95.7

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      ..++.|+|++|++++.+|. .|+++++|+.|+|++|+|++..|..|.++++|++|+|++|.+++..|..|.++++|+.|+
T Consensus       275 ~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  353 (455)
T 3v47_A          275 SGVKTCDLSKSKIFALLKS-VFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLD  353 (455)
T ss_dssp             SCCCEEECCSSCCCEECTT-TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEE
T ss_pred             cCceEEEecCccccccchh-hcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEE
Confidence            3566777777777655443 566777777777777777766666677777777777777777666666677777777777


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP  207 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p  207 (663)
                      |++|++++..|..|.++++|++|+|++|+|++..+..+..+++|+.|+|++|++++..|
T Consensus       354 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          354 LSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            77777776666677777777777777777776555566677777777777777776666

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.71  E-value=2e-17  Score=194.09  Aligned_cols=166  Identities=22%  Similarity=0.193  Sum_probs=143.4

Q ss_pred             CccceeEecCCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCC-CccccCCCCCceEEcccccccCchhhh
Q 006055           59 CKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQL-PSDLASCSNLRNLYLQGNHFSGEVPLF  137 (663)
Q Consensus        59 c~w~gv~c~~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~  137 (663)
                      |.|..|.+-..+++.|+|++|.+++..| ..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|.+++..|..
T Consensus        14 ~~L~~vP~lp~~l~~LdLs~N~i~~i~~-~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~   92 (844)
T 3j0a_A           14 CNLTQVPQVLNTTERLLLSFNYIRTVTA-SSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA   92 (844)
T ss_dssp             CCSSCCCSSCTTCCEEEEESCCCCEECS-SSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred             CCCCCCCCCCCCcCEEECCCCcCCccCh-hHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence            5677777755789999999999995555 46899999999999999776666 788999999999999999999989999


Q ss_pred             hcCCccccccccccccccccCCCC--CcccccccccccccccccCcCC-CCCCCCCCCCEEEeecCcCCCCCCcccccC-
Q 006055          138 LVGLHHLVRLNLATNNFSGEIPSG--FKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVSNNLLNGSIPKRFQTF-  213 (663)
Q Consensus       138 ~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~-  213 (663)
                      |.++++|++|+|++|++++.+|..  |.++++|++|+|++|.+++..+ ..|+++++|++|+|++|++++..|..|..+ 
T Consensus        93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~  172 (844)
T 3j0a_A           93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ  172 (844)
T ss_dssp             SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHH
T ss_pred             ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccccc
Confidence            999999999999999999877765  9999999999999999998765 578999999999999999999988877544 


Q ss_pred             ----CCCCccCCcCCC
Q 006055          214 ----GSNSFLGNSLCG  225 (663)
Q Consensus       214 ----~~~~~~~~~l~~  225 (663)
                          ..+.+.+|.+.+
T Consensus       173 ~~~L~~L~L~~n~l~~  188 (844)
T 3j0a_A          173 GKTLSFFSLAANSLYS  188 (844)
T ss_dssp             HCSSCCCEECCSBSCC
T ss_pred             CCccceEECCCCcccc
Confidence                444445565554

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.71  E-value=2.1e-17  Score=179.24  Aligned_cols=156  Identities=31%  Similarity=0.285  Sum_probs=110.5

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEccccc-ccCchhhhhcCCcccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNH-FSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L  147 (663)
                      .+++.|+|++|+|+ .+|.+.|..+++|+.|+|++|.|++..+..|.++++|+.|+|++|+ +....+..|.++++|+.|
T Consensus       112 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L  190 (440)
T 3zyj_A          112 ANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYL  190 (440)
T ss_dssp             SSCCEEECCSSCCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEE
T ss_pred             ccCCEEECCCCcCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCee
Confidence            57999999999998 7777788999999999999999988767678888888888888744 443333467777777777


Q ss_pred             ccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc---cCCcCC
Q 006055          148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF---LGNSLC  224 (663)
Q Consensus       148 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~---~~~~l~  224 (663)
                      +|++|+|+ .+| .+..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..++.+..   .+|.+.
T Consensus       191 ~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  268 (440)
T 3zyj_A          191 NLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT  268 (440)
T ss_dssp             ECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCC
T ss_pred             cCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCC
Confidence            77777776 444 3666677777777777777666666666777777777777776666666555544433   444444


Q ss_pred             CCC
Q 006055          225 GKP  227 (663)
Q Consensus       225 ~~p  227 (663)
                      +.|
T Consensus       269 ~~~  271 (440)
T 3zyj_A          269 LLP  271 (440)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            433

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.70  E-value=6.2e-18  Score=171.38  Aligned_cols=158  Identities=25%  Similarity=0.266  Sum_probs=123.7

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|+++ .++...|.++++|++|+|++|.|++..|..|.++++|++|+|++|.+++..+..+..+++|+.|+
T Consensus        52 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  130 (276)
T 2z62_A           52 PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN  130 (276)
T ss_dssp             TTCSEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred             cCCcEEECCCCcCC-ccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEE
Confidence            57889999999888 55555788899999999999999887778888999999999999999877776788889999999


Q ss_pred             ccccccccc-CCCCCcccccccccccccccccCcCCCCCCCCCCCC----EEEeecCcCCCCCCccccc--CCCCCccCC
Q 006055          149 LATNNFSGE-IPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQ----QLNVSNNLLNGSIPKRFQT--FGSNSFLGN  221 (663)
Q Consensus       149 l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~----~L~l~~N~l~g~~p~~~~~--~~~~~~~~~  221 (663)
                      |++|++++. +|..|.++++|++|+|++|++++..+..+..+++|+    .|++++|++++..+..+..  +..+.+.+|
T Consensus       131 l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n  210 (276)
T 2z62_A          131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTN  210 (276)
T ss_dssp             CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSS
T ss_pred             CcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCC
Confidence            999998863 688888899999999999998877666676666666    7888888888665554442  333444556


Q ss_pred             cCCCCC
Q 006055          222 SLCGKP  227 (663)
Q Consensus       222 ~l~~~p  227 (663)
                      .+.+.|
T Consensus       211 ~l~~~~  216 (276)
T 2z62_A          211 QLKSVP  216 (276)
T ss_dssp             CCSCCC
T ss_pred             ceeecC
Confidence            555544

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.70  E-value=1.4e-17  Score=188.12  Aligned_cols=166  Identities=20%  Similarity=0.165  Sum_probs=142.9

Q ss_pred             cceeEecC-----------CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEccccc
Q 006055           61 WAGVECEQ-----------NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNH  129 (663)
Q Consensus        61 w~gv~c~~-----------~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  129 (663)
                      +.-|.|..           ..++.|+|++|.+++ +++..|+++++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus        14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~   92 (606)
T 3t6q_A           14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPT-IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP   92 (606)
T ss_dssp             TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSE-ECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             CceEECCCCCcccCcCCCCCcCcEEEccCCccCc-CChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence            45677843           478999999999995 544578999999999999999999889999999999999999999


Q ss_pred             ccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcc
Q 006055          130 FSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKR  209 (663)
Q Consensus       130 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~  209 (663)
                      +++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..+..+..+++|+.|++++|++++..|..
T Consensus        93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  172 (606)
T 3t6q_A           93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED  172 (606)
T ss_dssp             CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred             ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence            99999999999999999999999999877888999999999999999999754344445999999999999999888888


Q ss_pred             cccCCCCC-----ccCCcCCCCC
Q 006055          210 FQTFGSNS-----FLGNSLCGKP  227 (663)
Q Consensus       210 ~~~~~~~~-----~~~~~l~~~p  227 (663)
                      |..+..+.     +.+|.+.+.+
T Consensus       173 ~~~l~~L~~l~L~l~~n~l~~~~  195 (606)
T 3t6q_A          173 MSSLQQATNLSLNLNGNDIAGIE  195 (606)
T ss_dssp             HHTTTTCCSEEEECTTCCCCEEC
T ss_pred             hhhhcccceeEEecCCCccCccC
Confidence            87777655     3455555443

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.70  E-value=4.2e-18  Score=193.33  Aligned_cols=156  Identities=21%  Similarity=0.258  Sum_probs=139.9

Q ss_pred             CCcEEEEEcCCCCcccc-----------------cCccccC--CCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccc
Q 006055           68 QNRVTMLRLPGVALSGQ-----------------IPLGILG--NLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGN  128 (663)
Q Consensus        68 ~~~v~~L~L~~~~l~g~-----------------~p~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  128 (663)
                      ..+++.|+|++|.++|.                 +|.. ++  ++++|++|+|++|++.+.+|..|+++++|++|+|++|
T Consensus       205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~-l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n  283 (636)
T 4eco_A          205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED-LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN  283 (636)
T ss_dssp             CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTC
T ss_pred             ccCCCEEECcCCccccccccccccccccchhcccCchh-hhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCC
Confidence            36899999999999986                 9974 68  9999999999999999999999999999999999999


Q ss_pred             c-ccC-chhhhhcCC------ccccccccccccccccCCC--CCcccccccccccccccccCcCCCCCCCCCCCCEEEee
Q 006055          129 H-FSG-EVPLFLVGL------HHLVRLNLATNNFSGEIPS--GFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVS  198 (663)
Q Consensus       129 ~-l~~-~~p~~~~~l------~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~  198 (663)
                      + ++| .+|..++.+      ++|+.|+|++|+++ .+|.  .|+++++|++|+|++|+++|.+| .+..+++|+.|+|+
T Consensus       284 ~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~  361 (636)
T 4eco_A          284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLA  361 (636)
T ss_dssp             TTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECC
T ss_pred             CCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECC
Confidence            8 998 899999887      99999999999999 8998  89999999999999999999999 88999999999999


Q ss_pred             cCcCCCCCCcccccCCC-CCc---cCCcCCCCC
Q 006055          199 NNLLNGSIPKRFQTFGS-NSF---LGNSLCGKP  227 (663)
Q Consensus       199 ~N~l~g~~p~~~~~~~~-~~~---~~~~l~~~p  227 (663)
                      +|+++ .+|..+..+.. +..   .+|.+...|
T Consensus       362 ~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp  393 (636)
T 4eco_A          362 YNQIT-EIPANFCGFTEQVENLSFAHNKLKYIP  393 (636)
T ss_dssp             SSEEE-ECCTTSEEECTTCCEEECCSSCCSSCC
T ss_pred             CCccc-cccHhhhhhcccCcEEEccCCcCcccc
Confidence            99999 88888877666 543   566665444

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.70  E-value=2.7e-18  Score=177.34  Aligned_cols=137  Identities=23%  Similarity=0.245  Sum_probs=72.2

Q ss_pred             cEEEEEcCCCCcccccCcccc-CCCCCCCEEEccCCCCCCCCCccccCC-----CCCceEEcccccccCchhhhhcCCcc
Q 006055           70 RVTMLRLPGVALSGQIPLGIL-GNLTSLRTLSLRFNSLTSQLPSDLASC-----SNLRNLYLQGNHFSGEVPLFLVGLHH  143 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~  143 (663)
                      +++.|+|++|+++|.+|..++ +.+++|++|+|++|+|++. |..+..+     ++|++|+|++|++++..|..|+.+++
T Consensus        96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~  174 (312)
T 1wwl_A           96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA  174 (312)
T ss_dssp             CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred             CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence            455556666666555555432 5555566666666655554 5555544     55555555555555555555555555


Q ss_pred             cccccccccccccc--CCCCC--cccccccccccccccccC--cCC-CCCCCCCCCCEEEeecCcCCCCCC
Q 006055          144 LVRLNLATNNFSGE--IPSGF--KNLTKLKTLFLENNRLSG--SIP-GFDDVLPNLQQLNVSNNLLNGSIP  207 (663)
Q Consensus       144 L~~L~l~~N~l~~~--~p~~~--~~l~~L~~L~l~~N~l~~--~~p-~~~~~l~~L~~L~l~~N~l~g~~p  207 (663)
                      |+.|+|++|++.+.  +|..+  .++++|++|+|++|+|++  .++ ..+..+++|+.|+|++|++++.+|
T Consensus       175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  245 (312)
T 1wwl_A          175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG  245 (312)
T ss_dssp             CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCC
T ss_pred             CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccc
Confidence            55555555555443  12222  455555555555555552  111 223344555555555555555443

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.70  E-value=1.6e-17  Score=190.54  Aligned_cols=157  Identities=24%  Similarity=0.262  Sum_probs=138.1

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|+++ .+|+..|+++++|++|+|++|.+++..|..|.++++|++|+|++|.+++..+..|.++++|++|+
T Consensus        25 ~~l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~  103 (680)
T 1ziw_A           25 TNITVLNLTHNQLR-RLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH  103 (680)
T ss_dssp             TTCSEEECCSSCCC-CCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred             CCCcEEECCCCCCC-CcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence            47999999999999 56666789999999999999999999899999999999999999999976666899999999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccc-----cCCCCCccCCcC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQ-----TFGSNSFLGNSL  223 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-----~~~~~~~~~~~l  223 (663)
                      |++|++++..|..|+++++|++|+|++|.+++..|..+..+++|++|++++|++++..|..+.     .+..+.+.+|.+
T Consensus       104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l  183 (680)
T 1ziw_A          104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI  183 (680)
T ss_dssp             CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred             CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence            999999977778999999999999999999999999999999999999999999988776543     344455556665


Q ss_pred             CCC
Q 006055          224 CGK  226 (663)
Q Consensus       224 ~~~  226 (663)
                      .+.
T Consensus       184 ~~~  186 (680)
T 1ziw_A          184 KEF  186 (680)
T ss_dssp             CCB
T ss_pred             ccc
Confidence            543

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.70  E-value=1.3e-17  Score=188.51  Aligned_cols=157  Identities=24%  Similarity=0.181  Sum_probs=130.8

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCC-ccccCCCCCceEEcccccccCchhhhhcCCcccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLP-SDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  147 (663)
                      .+++.|+|++|.++ .+|. .+..+++|+.|+|++|.+++..| ..|.++++|++|+|++|.+++.+|..+.++++|+.|
T Consensus       376 ~~L~~L~L~~n~l~-~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  453 (606)
T 3vq2_A          376 NSLRHLDLSFNGAI-IMSA-NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTL  453 (606)
T ss_dssp             SCCCEEECCSCSEE-EECC-CCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred             CcccEeECCCCccc-cchh-hccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEE
Confidence            57888999999988 4664 57889999999999999988777 678889999999999999988888888889999999


Q ss_pred             ccccccccc-cCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc---cCCcC
Q 006055          148 NLATNNFSG-EIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF---LGNSL  223 (663)
Q Consensus       148 ~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~---~~~~l  223 (663)
                      +|++|++++ .+|..|.++++|++|+|++|++++.+|..+..+++|+.|+|++|++++.+|..|..++.+..   .+|.+
T Consensus       454 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l  533 (606)
T 3vq2_A          454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI  533 (606)
T ss_dssp             ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCC
T ss_pred             ECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcC
Confidence            999999887 47888888999999999999998888888888999999999999998888888877665544   55655


Q ss_pred             CCCC
Q 006055          224 CGKP  227 (663)
Q Consensus       224 ~~~p  227 (663)
                      ...|
T Consensus       534 ~~~p  537 (606)
T 3vq2_A          534 ETSK  537 (606)
T ss_dssp             CCEE
T ss_pred             cccC
Confidence            5433

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.69  E-value=4.9e-17  Score=171.44  Aligned_cols=162  Identities=22%  Similarity=0.242  Sum_probs=134.8

Q ss_pred             CCccceeEecCCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCcccc-CCCCCceEEcccccccCchhh
Q 006055           58 PCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLA-SCSNLRNLYLQGNHFSGEVPL  136 (663)
Q Consensus        58 ~c~w~gv~c~~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~  136 (663)
                      .|- ..-.|..   ..+++++++|+ .+|..+   .+.|+.|+|++|+|++..+..|. ++++|+.|+|++|+|++..|.
T Consensus        11 ~Cp-~~C~C~~---~~l~c~~~~l~-~iP~~~---~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~   82 (361)
T 2xot_A           11 SCP-ANCLCAS---NILSCSKQQLP-NVPQSL---PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSE   82 (361)
T ss_dssp             TCC-TTCEEET---TEEECCSSCCS-SCCSSC---CTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTT
T ss_pred             CCC-CCCEECC---CEEEeCCCCcC-ccCccC---CCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChh
Confidence            453 4556764   36899999998 799743   35689999999999998888887 999999999999999988888


Q ss_pred             hhcCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCccc---ccC
Q 006055          137 FLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRF---QTF  213 (663)
Q Consensus       137 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~---~~~  213 (663)
                      .|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|   ..+
T Consensus        83 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l  162 (361)
T 2xot_A           83 AFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKL  162 (361)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----C
T ss_pred             hccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccC
Confidence            99999999999999999997777789999999999999999998889999999999999999999996544444   334


Q ss_pred             CC---CCccCCcCCCCC
Q 006055          214 GS---NSFLGNSLCGKP  227 (663)
Q Consensus       214 ~~---~~~~~~~l~~~p  227 (663)
                      +.   +.+.+|.+...|
T Consensus       163 ~~L~~L~L~~N~l~~l~  179 (361)
T 2xot_A          163 PKLMLLDLSSNKLKKLP  179 (361)
T ss_dssp             TTCCEEECCSSCCCCCC
T ss_pred             CcCCEEECCCCCCCccC
Confidence            44   444566665544

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.69  E-value=1.3e-17  Score=193.19  Aligned_cols=164  Identities=20%  Similarity=0.247  Sum_probs=142.4

Q ss_pred             CccceeEe---cCCcEEEEEcCCCCccc-----------------ccCccccC--CCCCCCEEEccCCCCCCCCCccccC
Q 006055           59 CKWAGVEC---EQNRVTMLRLPGVALSG-----------------QIPLGILG--NLTSLRTLSLRFNSLTSQLPSDLAS  116 (663)
Q Consensus        59 c~w~gv~c---~~~~v~~L~L~~~~l~g-----------------~~p~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~  116 (663)
                      +...|+.-   ...+++.|+|++|.|+|                 .+|.+ ++  ++++|+.|+|++|++.+.+|..|.+
T Consensus       435 N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~-l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~  513 (876)
T 4ecn_A          435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEE-LSWSNLKDLTDVELYNCPNMTQLPDFLYD  513 (876)
T ss_dssp             CEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEESCTTCCSCCGGGGG
T ss_pred             CcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChh-hhhccCCCCCEEECcCCCCCccChHHHhC
Confidence            44455432   23689999999999998                 48985 45  9999999999999999999999999


Q ss_pred             CCCCceEEccccc-ccC-chhhhhcCCc-------cccccccccccccccCCC--CCcccccccccccccccccCcCCCC
Q 006055          117 CSNLRNLYLQGNH-FSG-EVPLFLVGLH-------HLVRLNLATNNFSGEIPS--GFKNLTKLKTLFLENNRLSGSIPGF  185 (663)
Q Consensus       117 l~~L~~L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~  185 (663)
                      +++|+.|+|++|+ |+| .+|..++.++       +|+.|+|++|+|+ .+|.  .|+++++|+.|+|++|+|+ .+| .
T Consensus       514 L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~  590 (876)
T 4ecn_A          514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-A  590 (876)
T ss_dssp             CSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-C
T ss_pred             CCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-h
Confidence            9999999999998 998 8998887776       9999999999999 8999  8999999999999999999 888 8


Q ss_pred             CCCCCCCCEEEeecCcCCCCCCcccccCCC-CC---ccCCcCCCCC
Q 006055          186 DDVLPNLQQLNVSNNLLNGSIPKRFQTFGS-NS---FLGNSLCGKP  227 (663)
Q Consensus       186 ~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~-~~---~~~~~l~~~p  227 (663)
                      +..+++|+.|+|++|+++ .+|..+..+.. +.   +.+|.+...|
T Consensus       591 ~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp  635 (876)
T 4ecn_A          591 FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIP  635 (876)
T ss_dssp             CCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCC
T ss_pred             hcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcCc
Confidence            999999999999999999 89988877666 54   4566665444

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.69  E-value=3.5e-17  Score=178.08  Aligned_cols=156  Identities=26%  Similarity=0.257  Sum_probs=112.8

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccc-cccCchhhhhcCCcccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGN-HFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L  147 (663)
                      .+++.|+|++|+|+ .+|++.|+++++|++|+|++|+|++..+..|.++++|+.|+|++| .+....+..|.++++|+.|
T Consensus       123 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L  201 (452)
T 3zyi_A          123 ASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYL  201 (452)
T ss_dssp             TTCCEEECCSSCCS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEE
T ss_pred             ccCCEEECCCCcCC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEE
Confidence            57999999999999 777778899999999999999999876667888888888888874 4443333457777777777


Q ss_pred             ccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc---cCCcCC
Q 006055          148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF---LGNSLC  224 (663)
Q Consensus       148 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~---~~~~l~  224 (663)
                      +|++|++++ +| .+..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..++.+..   .+|.+.
T Consensus       202 ~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  279 (452)
T 3zyi_A          202 NLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS  279 (452)
T ss_dssp             ECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             ECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCC
Confidence            777777763 33 4667777777777777777666667777777777777777777666666655554433   445554


Q ss_pred             CCC
Q 006055          225 GKP  227 (663)
Q Consensus       225 ~~p  227 (663)
                      +.|
T Consensus       280 ~~~  282 (452)
T 3zyi_A          280 SLP  282 (452)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            443

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.69  E-value=5.9e-17  Score=175.69  Aligned_cols=155  Identities=25%  Similarity=0.302  Sum_probs=133.9

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|+++ .++...|.++++|++|+|++|+|++..+..|.++++|++|+|++|.+++..+..|.++++|+.|+
T Consensus        88 ~~L~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  166 (440)
T 3zyj_A           88 RHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLD  166 (440)
T ss_dssp             SSCCEEECCSSCCC-EECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCcCC-ccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeC
Confidence            57999999999999 56667899999999999999999987777899999999999999999987778999999999999


Q ss_pred             cccccccccC-CCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc---cCCcCC
Q 006055          149 LATNNFSGEI-PSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF---LGNSLC  224 (663)
Q Consensus       149 l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~---~~~~l~  224 (663)
                      |++|+..+.+ +..|.++++|++|+|++|+|+ .+|. +..+++|+.|+|++|++++..|..|..++.+..   .+|.+.
T Consensus       167 l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~  244 (440)
T 3zyj_A          167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ  244 (440)
T ss_dssp             CCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCC-CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred             CCCCCCcceeCcchhhcccccCeecCCCCcCc-cccc-cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCcee
Confidence            9995544445 457999999999999999999 5664 789999999999999999988988887776654   556555


Q ss_pred             CC
Q 006055          225 GK  226 (663)
Q Consensus       225 ~~  226 (663)
                      +.
T Consensus       245 ~~  246 (440)
T 3zyj_A          245 VI  246 (440)
T ss_dssp             EE
T ss_pred             EE
Confidence            43

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.69  E-value=7.4e-18  Score=153.92  Aligned_cols=128  Identities=26%  Similarity=0.277  Sum_probs=112.5

Q ss_pred             CcEEEEEcCCCCcc-cccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccc
Q 006055           69 NRVTMLRLPGVALS-GQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        69 ~~v~~L~L~~~~l~-g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  147 (663)
                      .+++.|+|++|+++ |.+|. .++.+++|+.|+|++|.|++.  ..+.++++|++|+|++|.+++.+|..+..+++|+.|
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEG-LTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCS-CCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             ccCeEEEccCCcCChhHHHH-HHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            56899999999998 88886 678999999999999999885  779999999999999999998899988889999999


Q ss_pred             cccccccccc-CCCCCcccccccccccccccccCcCC---CCCCCCCCCCEEEeec
Q 006055          148 NLATNNFSGE-IPSGFKNLTKLKTLFLENNRLSGSIP---GFDDVLPNLQQLNVSN  199 (663)
Q Consensus       148 ~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p---~~~~~l~~L~~L~l~~  199 (663)
                      +|++|++++. .|..+.++++|++|++++|++++..+   ..+..+++|+.|++++
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            9999999863 34789999999999999999996655   4788899999998764

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.69  E-value=7.8e-18  Score=173.89  Aligned_cols=157  Identities=22%  Similarity=0.187  Sum_probs=129.5

Q ss_pred             CCcEEEEEcCCCCcccccCccccCCC-----CCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCc--hhhhh--
Q 006055           68 QNRVTMLRLPGVALSGQIPLGILGNL-----TSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGE--VPLFL--  138 (663)
Q Consensus        68 ~~~v~~L~L~~~~l~g~~p~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~--  138 (663)
                      ..+++.|+|++|++++. |. .++.+     ++|++|+|++|+|++..|..|+++++|++|+|++|++.+.  +|..+  
T Consensus       120 l~~L~~L~Ls~N~l~~~-~~-~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  197 (312)
T 1wwl_A          120 GPDLNILNLRNVSWATR-DA-WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP  197 (312)
T ss_dssp             SCCCSEEEEESCBCSSS-SS-HHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCT
T ss_pred             CCCccEEEccCCCCcch-hH-HHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHh
Confidence            46799999999999966 64 56776     9999999999999998889999999999999999998876  34455  


Q ss_pred             cCCccccccccccccccc--cCC-CCCcccccccccccccccccCcCC-CCCCCCCCCCEEEeecCcCCCCCCcccc-cC
Q 006055          139 VGLHHLVRLNLATNNFSG--EIP-SGFKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVSNNLLNGSIPKRFQ-TF  213 (663)
Q Consensus       139 ~~l~~L~~L~l~~N~l~~--~~p-~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~~  213 (663)
                      ..+++|++|+|++|+|++  .++ ..+.++++|++|+|++|+|++.+| ..+..+++|+.|+|++|+|+ .+|..+. ++
T Consensus       198 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~~~L  276 (312)
T 1wwl_A          198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKL  276 (312)
T ss_dssp             TSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCCSEE
T ss_pred             ccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhccCCc
Confidence            899999999999999983  222 334678999999999999998775 46677899999999999999 7787665 45


Q ss_pred             CCCCccCCcCCCCC
Q 006055          214 GSNSFLGNSLCGKP  227 (663)
Q Consensus       214 ~~~~~~~~~l~~~p  227 (663)
                      ..+.+.+|.+.+.|
T Consensus       277 ~~L~Ls~N~l~~~p  290 (312)
T 1wwl_A          277 SVLDLSYNRLDRNP  290 (312)
T ss_dssp             EEEECCSSCCCSCC
T ss_pred             eEEECCCCCCCCCh
Confidence            55666777776654

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.69  E-value=5.5e-17  Score=169.02  Aligned_cols=163  Identities=26%  Similarity=0.363  Sum_probs=126.5

Q ss_pred             CccceeEecC-----------CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEccc
Q 006055           59 CKWAGVECEQ-----------NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQG  127 (663)
Q Consensus        59 c~w~gv~c~~-----------~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  127 (663)
                      |.|..+.|..           .+++.|+|++|+++ .+++..|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus        33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  111 (332)
T 2ft3_A           33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK  111 (332)
T ss_dssp             EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred             ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCC-ccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence            6899998853           26788999999988 45555688899999999999999888788899999999999999


Q ss_pred             ccccCchhhhhcCCccccccccccccccccCCCCCccccccccccccccccc--CcCCCCCCCCCCCCEEEeecCcCCCC
Q 006055          128 NHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLS--GSIPGFDDVLPNLQQLNVSNNLLNGS  205 (663)
Q Consensus       128 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~L~l~~N~l~g~  205 (663)
                      |+++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|.++  +..|..+..+ +|+.|++++|++++ 
T Consensus       112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-  186 (332)
T 2ft3_A          112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-  186 (332)
T ss_dssp             SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-
T ss_pred             CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-
Confidence            9988 5665554  78888889888888655566888888888888888885  3667777777 88888888888885 


Q ss_pred             CCc-ccccCCCCCccCCcCCCCC
Q 006055          206 IPK-RFQTFGSNSFLGNSLCGKP  227 (663)
Q Consensus       206 ~p~-~~~~~~~~~~~~~~l~~~p  227 (663)
                      +|. .+.++..+.+.+|.+.+.+
T Consensus       187 l~~~~~~~L~~L~l~~n~i~~~~  209 (332)
T 2ft3_A          187 IPKDLPETLNELHLDHNKIQAIE  209 (332)
T ss_dssp             CCSSSCSSCSCCBCCSSCCCCCC
T ss_pred             cCccccCCCCEEECCCCcCCccC
Confidence            443 3345666666666665544

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.68  E-value=4.4e-17  Score=168.05  Aligned_cols=158  Identities=19%  Similarity=0.124  Sum_probs=114.8

Q ss_pred             CCcEEEEEcCCCCcccccCc---cccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCc--hh--hhhcC
Q 006055           68 QNRVTMLRLPGVALSGQIPL---GILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGE--VP--LFLVG  140 (663)
Q Consensus        68 ~~~v~~L~L~~~~l~g~~p~---~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p--~~~~~  140 (663)
                      ..+++.|+|++|.+++.+|.   ..+..+++|++|+|++|+|++..|..|.++++|++|+|++|++.+.  ++  ..+..
T Consensus       116 ~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~  195 (310)
T 4glp_A          116 GLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHK  195 (310)
T ss_dssp             CBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTS
T ss_pred             CCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhc
Confidence            35688888888888875551   2235688888888888888887778888888888888888887653  22  22367


Q ss_pred             CccccccccccccccccCCC----CCcccccccccccccccccCcCCCCCCCC---CCCCEEEeecCcCCCCCCccc-cc
Q 006055          141 LHHLVRLNLATNNFSGEIPS----GFKNLTKLKTLFLENNRLSGSIPGFDDVL---PNLQQLNVSNNLLNGSIPKRF-QT  212 (663)
Q Consensus       141 l~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~~~~p~~~~~l---~~L~~L~l~~N~l~g~~p~~~-~~  212 (663)
                      +++|++|+|++|+++ .+|.    .+.++++|++|+|++|+|++.+|..+..+   ++|++|+|++|+|+ .+|..+ .+
T Consensus       196 l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~  273 (310)
T 4glp_A          196 FPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAK  273 (310)
T ss_dssp             SCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSC
T ss_pred             CCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCC
Confidence            888888888888886 3333    24677888888888888887777766666   68888888888888 556544 34


Q ss_pred             CCCCCccCCcCCCCC
Q 006055          213 FGSNSFLGNSLCGKP  227 (663)
Q Consensus       213 ~~~~~~~~~~l~~~p  227 (663)
                      +..+.+.+|.+.+.|
T Consensus       274 L~~L~Ls~N~l~~~~  288 (310)
T 4glp_A          274 LRVLDLSSNRLNRAP  288 (310)
T ss_dssp             CSCEECCSCCCCSCC
T ss_pred             CCEEECCCCcCCCCc
Confidence            555555677776644

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.68  E-value=3.7e-17  Score=170.14  Aligned_cols=162  Identities=23%  Similarity=0.340  Sum_probs=122.3

Q ss_pred             CccceeEecC-----------CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEccc
Q 006055           59 CKWAGVECEQ-----------NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQG  127 (663)
Q Consensus        59 c~w~gv~c~~-----------~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  127 (663)
                      |.|..+.|..           ..++.|+|++|+++ .+|+..|+++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus        31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  109 (330)
T 1xku_A           31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK  109 (330)
T ss_dssp             EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CCCeEEEecCCCccccCccCCCCCeEEECCCCcCC-EeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence            6899999963           36889999999999 56666789999999999999999998899999999999999999


Q ss_pred             ccccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccccccC--cCCCCCCCCCCCCEEEeecCcCCCC
Q 006055          128 NHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSG--SIPGFDDVLPNLQQLNVSNNLLNGS  205 (663)
Q Consensus       128 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~g~  205 (663)
                      |+++ .+|..+.  ++|+.|++++|++++..+..|.++++|++|+|++|+++.  ..+..+..+++|+.|++++|+++. 
T Consensus       110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-  185 (330)
T 1xku_A          110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-  185 (330)
T ss_dssp             SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-
T ss_pred             CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-
Confidence            9988 5665543  677788888888776656667777777777777777753  566667777777777777777774 


Q ss_pred             CCcc-cccCCCCCccCCcCCC
Q 006055          206 IPKR-FQTFGSNSFLGNSLCG  225 (663)
Q Consensus       206 ~p~~-~~~~~~~~~~~~~l~~  225 (663)
                      +|.. +..+..+.+.+|.+.+
T Consensus       186 l~~~~~~~L~~L~l~~n~l~~  206 (330)
T 1xku_A          186 IPQGLPPSLTELHLDGNKITK  206 (330)
T ss_dssp             CCSSCCTTCSEEECTTSCCCE
T ss_pred             CCccccccCCEEECCCCcCCc
Confidence            3432 3344444444554443

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.68  E-value=3.7e-17  Score=183.26  Aligned_cols=147  Identities=20%  Similarity=0.202  Sum_probs=133.7

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|+++ .+++..|.++++|++|+|++|+|++..|..|.++++|++|+|++|.+++..|..|.++++|++|+
T Consensus        28 ~~l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (570)
T 2z63_A           28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV  106 (570)
T ss_dssp             SSCCEEECCSCCCC-EECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred             ccccEEEccCCccC-ccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence            47999999999999 45555789999999999999999998888999999999999999999988889999999999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccC-cCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSG-SIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSN  216 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~  216 (663)
                      |++|++++..+..|+++++|++|+|++|.+++ .+|..++++++|+.|++++|++++..|..+..+..+
T Consensus       107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  175 (570)
T 2z63_A          107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM  175 (570)
T ss_dssp             CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTC
T ss_pred             ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhcc
Confidence            99999996666679999999999999999997 579999999999999999999998888877766555

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.67  E-value=4.3e-17  Score=161.39  Aligned_cols=154  Identities=20%  Similarity=0.185  Sum_probs=129.6

Q ss_pred             CcEEEEEcCCCC-cccccCccccCCCCCCCEEEccC-CCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccc-
Q 006055           69 NRVTMLRLPGVA-LSGQIPLGILGNLTSLRTLSLRF-NSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLV-  145 (663)
Q Consensus        69 ~~v~~L~L~~~~-l~g~~p~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-  145 (663)
                      .+++.|+|++|. ++ .+|+..|.++++|++|+|++ |+|++..+..|.++++|++|+|++|.+++ +|. |..+++|+ 
T Consensus        55 ~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~  131 (239)
T 2xwt_C           55 PNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI  131 (239)
T ss_dssp             TTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred             CCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence            579999999997 77 77777889999999999999 99998777889999999999999999996 776 88888888 


Q ss_pred             --ccccccc-cccccCCCCCccccccc-ccccccccccCcCCC-CCCCCCCCCEEEeecCc-CCCCCCcccccC-CCCC-
Q 006055          146 --RLNLATN-NFSGEIPSGFKNLTKLK-TLFLENNRLSGSIPG-FDDVLPNLQQLNVSNNL-LNGSIPKRFQTF-GSNS-  217 (663)
Q Consensus       146 --~L~l~~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~-l~g~~p~~~~~~-~~~~-  217 (663)
                        .|++++| ++++..+..|.++++|+ +|+|++|+++ .+|. .+.. ++|+.|+|++|+ +++..+..|..+ +.+. 
T Consensus       132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~  209 (239)
T 2xwt_C          132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL  209 (239)
T ss_dssp             EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSE
T ss_pred             ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcE
Confidence              9999999 99977677799999999 9999999999 5555 4444 899999999995 987667777766 5544 


Q ss_pred             --ccCCcCCCCC
Q 006055          218 --FLGNSLCGKP  227 (663)
Q Consensus       218 --~~~~~l~~~p  227 (663)
                        +.+|.+.+.|
T Consensus       210 L~l~~N~l~~l~  221 (239)
T 2xwt_C          210 LDVSQTSVTALP  221 (239)
T ss_dssp             EECTTCCCCCCC
T ss_pred             EECCCCccccCC
Confidence              3556665544

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.67  E-value=3.4e-17  Score=185.11  Aligned_cols=158  Identities=19%  Similarity=0.165  Sum_probs=137.9

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCcc-ccCCCCCceEEcccccccCchhhhhcCCcccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSD-LASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  147 (663)
                      .+++.|+|++|.+.+..| ..|..+++|+.|+|++|.+++..|.. +.++++|++|+|++|.+++..|..+..+++|+.|
T Consensus       376 ~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  454 (606)
T 3t6q_A          376 SHLQSLNLSYNEPLSLKT-EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHL  454 (606)
T ss_dssp             TTCCEEECCSCSCEEECT-TTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEE
T ss_pred             CCCCEEECCCCcCCcCCH-HHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEE
Confidence            589999999999996555 46899999999999999999876654 8999999999999999999999999999999999


Q ss_pred             cccccccccc---CCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCC--ccCCc
Q 006055          148 NLATNNFSGE---IPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNS--FLGNS  222 (663)
Q Consensus       148 ~l~~N~l~~~---~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~--~~~~~  222 (663)
                      +|++|++++.   .+..+..+++|++|+|++|++++.+|..|..+++|+.|+|++|++++.+|..|..++.+.  +.+|.
T Consensus       455 ~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~L~L~~N~  534 (606)
T 3t6q_A          455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNH  534 (606)
T ss_dssp             ECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSCEEECCSSC
T ss_pred             ECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCcccccEEECcCCc
Confidence            9999999873   336689999999999999999988899999999999999999999999999998888762  25566


Q ss_pred             CCCCC
Q 006055          223 LCGKP  227 (663)
Q Consensus       223 l~~~p  227 (663)
                      +.+.+
T Consensus       535 l~~~~  539 (606)
T 3t6q_A          535 ISIIL  539 (606)
T ss_dssp             CCCCC
T ss_pred             ccccC
Confidence            66544

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.67  E-value=2.9e-17  Score=157.58  Aligned_cols=140  Identities=19%  Similarity=0.296  Sum_probs=113.7

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|+++ .+|.  +..+++|+.|+|++|.++.  +..+..+++|++|+|++|.+++..|..+..+++|+.|+
T Consensus        44 ~~L~~L~l~~n~i~-~l~~--l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~  118 (197)
T 4ezg_A           44 NSLTYITLANINVT-DLTG--IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD  118 (197)
T ss_dssp             HTCCEEEEESSCCS-CCTT--GGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred             CCccEEeccCCCcc-ChHH--HhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence            46888999999888 7773  6888999999999997764  44788889999999999999887888888899999999


Q ss_pred             cccccccccCCCCCccccccccccccccc-ccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNR-LSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNS  217 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~  217 (663)
                      |++|++++..|..+.++++|++|+|++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..++.+.
T Consensus       119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~  184 (197)
T 4ezg_A          119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLN  184 (197)
T ss_dssp             CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCC
T ss_pred             ecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCC
Confidence            99999988778888888999999999998 55 555 57888899999999999885 33 455555544

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.67  E-value=4.7e-17  Score=180.36  Aligned_cols=156  Identities=27%  Similarity=0.381  Sum_probs=125.2

Q ss_pred             CCcCCCCCCC-----cccee-EecCCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceE
Q 006055           50 LWNVYEASPC-----KWAGV-ECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNL  123 (663)
Q Consensus        50 ~w~~~~~~~c-----~w~gv-~c~~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  123 (663)
                      .|.. +.+||     .|.|+ .|..++++.|+|++|+|++ +|..+   +++|+.|+|++|+|+. +|   ..+++|++|
T Consensus        35 ~W~~-~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l---~~~L~~L~Ls~N~l~~-ip---~~l~~L~~L  105 (571)
T 3cvr_A           35 KWEK-QALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNL---PPQITVLEITQNALIS-LP---ELPASLEYL  105 (571)
T ss_dssp             HHHT-TCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCC---CTTCSEEECCSSCCSC-CC---CCCTTCCEE
T ss_pred             HHhc-cCCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhH---cCCCCEEECcCCCCcc-cc---cccCCCCEE
Confidence            3543 44578     79999 7988899999999999995 98754   3889999999999985 77   557999999


Q ss_pred             EcccccccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCC
Q 006055          124 YLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       124 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  203 (663)
                      +|++|+|++ +|. +.+  +|+.|+|++|+|++ +|.   .+++|++|+|++|+|++ +|.   .+++|+.|+|++|+|+
T Consensus       106 ~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~  173 (571)
T 3cvr_A          106 DACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLT  173 (571)
T ss_dssp             ECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS
T ss_pred             EccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCC
Confidence            999999997 777 665  89999999999996 776   67899999999999996 665   5788999999999998


Q ss_pred             CCCCcccc-cCCCCCccCCcCCCCCC
Q 006055          204 GSIPKRFQ-TFGSNSFLGNSLCGKPL  228 (663)
Q Consensus       204 g~~p~~~~-~~~~~~~~~~~l~~~p~  228 (663)
                      + +|. |. ++..+.+.+|.+...|.
T Consensus       174 ~-lp~-l~~~L~~L~Ls~N~L~~lp~  197 (571)
T 3cvr_A          174 F-LPE-LPESLEALDVSTNLLESLPA  197 (571)
T ss_dssp             C-CCC-CCTTCCEEECCSSCCSSCCC
T ss_pred             C-cch-hhCCCCEEECcCCCCCchhh
Confidence            6 666 43 44445556676665443

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.67  E-value=9.4e-17  Score=181.00  Aligned_cols=112  Identities=22%  Similarity=0.286  Sum_probs=101.0

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|.+++ +|+..|+++++|+.|+|++|.|++..|..|+++++|++|+|++|.|++..+..|+++++|+.|+
T Consensus        75 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~  153 (597)
T 3oja_B           75 RQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS  153 (597)
T ss_dssp             CCCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCcEEECCCCCCCC-CChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence            478999999999995 4445789999999999999999998888899999999999999999977777789999999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCc
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGS  181 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  181 (663)
                      |++|+|++..|..|+++++|++|+|++|.|++.
T Consensus       154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  186 (597)
T 3oja_B          154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV  186 (597)
T ss_dssp             CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred             eeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc
Confidence            999999988888999999999999999998854

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.66  E-value=3.1e-17  Score=169.18  Aligned_cols=158  Identities=20%  Similarity=0.179  Sum_probs=129.5

Q ss_pred             CcEEEEEcCCCCcccccCcccc-CCCCCCCEEEccCCCCCCCCC----ccccCCCCCceEEcccccccCchhhhhcCCcc
Q 006055           69 NRVTMLRLPGVALSGQIPLGIL-GNLTSLRTLSLRFNSLTSQLP----SDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH  143 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~-~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  143 (663)
                      .+++.|+|++|++++.+|..++ +.+++|++|+|++|.+++..|    ..+..+++|++|+|++|++++..|..|..+++
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~  170 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA  170 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence            3599999999999998887544 899999999999999998666    34567999999999999999988899999999


Q ss_pred             cccccccccccccc--C--CCCCcccccccccccccccccCcCCC----CCCCCCCCCEEEeecCcCCCCCCcccccC--
Q 006055          144 LVRLNLATNNFSGE--I--PSGFKNLTKLKTLFLENNRLSGSIPG----FDDVLPNLQQLNVSNNLLNGSIPKRFQTF--  213 (663)
Q Consensus       144 L~~L~l~~N~l~~~--~--p~~~~~l~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~g~~p~~~~~~--  213 (663)
                      |++|+|++|++.+.  +  +..++++++|++|+|++|+|+ .+|.    .+..+++|++|+|++|++++.+|..+..+  
T Consensus       171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  249 (310)
T 4glp_A          171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW  249 (310)
T ss_dssp             CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred             CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence            99999999998752  2  233578999999999999997 3333    35788999999999999999888776554  


Q ss_pred             ----CCCCccCCcCCCCC
Q 006055          214 ----GSNSFLGNSLCGKP  227 (663)
Q Consensus       214 ----~~~~~~~~~l~~~p  227 (663)
                          ..+...+|.+...|
T Consensus       250 ~~~L~~L~Ls~N~l~~lp  267 (310)
T 4glp_A          250 SSALNSLNLSFAGLEQVP  267 (310)
T ss_dssp             CTTCCCEECCSSCCCSCC
T ss_pred             cCcCCEEECCCCCCCchh
Confidence                33334566665433

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.66  E-value=9.4e-17  Score=175.99  Aligned_cols=149  Identities=24%  Similarity=0.219  Sum_probs=135.4

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|.+++..| ..|+++++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|..+++|+.|+
T Consensus        56 ~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~  134 (477)
T 2id5_A           56 PHLEELELNENIVSAVEP-GAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE  134 (477)
T ss_dssp             TTCCEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCccCEeCh-hhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence            589999999999996555 4789999999999999999987677799999999999999999998899999999999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF  218 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~  218 (663)
                      |++|++++..|..|.++++|++|+|++|++++..+..+..+++|+.|+|++|++++..+..|..+..+..
T Consensus       135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~  204 (477)
T 2id5_A          135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKV  204 (477)
T ss_dssp             ECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCE
T ss_pred             CCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccce
Confidence            9999999888999999999999999999999777777899999999999999999888878877766654

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.66  E-value=1.4e-16  Score=186.86  Aligned_cols=132  Identities=27%  Similarity=0.280  Sum_probs=114.4

Q ss_pred             cCCCCCCCEEEccCCCCCCCCCc-cccCCCCCceEEccccccc-----CchhhhhcCCccccccccccccccccCCCCCc
Q 006055           90 LGNLTSLRTLSLRFNSLTSQLPS-DLASCSNLRNLYLQGNHFS-----GEVPLFLVGLHHLVRLNLATNNFSGEIPSGFK  163 (663)
Q Consensus        90 ~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~  163 (663)
                      +.++++|+.|+|++|++++..+. .+..+++|+.|+|++|.++     +..|..|.++++|+.|+|++|+|++..|..|.
T Consensus       422 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  501 (844)
T 3j0a_A          422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS  501 (844)
T ss_dssp             HTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSS
T ss_pred             hhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHcc
Confidence            45789999999999999875443 4667899999999999997     45567789999999999999999988888999


Q ss_pred             ccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCccCCcC
Q 006055          164 NLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSL  223 (663)
Q Consensus       164 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~l  223 (663)
                      ++++|+.|+|++|+|++..|..+.  ++|+.|+|++|+|++.+|..|..+..+.+.+|++
T Consensus       502 ~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~  559 (844)
T 3j0a_A          502 HLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKF  559 (844)
T ss_dssp             SCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECC
T ss_pred             chhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCc
Confidence            999999999999999987777765  8999999999999999999988887777766653

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.66  E-value=1.2e-16  Score=153.35  Aligned_cols=129  Identities=18%  Similarity=0.250  Sum_probs=114.0

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|.++ .++  .+..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..+..+++|+.|+
T Consensus        66 ~~L~~L~l~~n~~~-~~~--~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~  142 (197)
T 4ezg_A           66 HNIKDLTINNIHAT-NYN--PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID  142 (197)
T ss_dssp             TTCSEEEEESCCCS-CCG--GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred             CCCCEEEccCCCCC-cch--hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence            57999999999776 444  479999999999999999988899999999999999999999998999999999999999


Q ss_pred             ccccc-ccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCC
Q 006055          149 LATNN-FSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNG  204 (663)
Q Consensus       149 l~~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g  204 (663)
                      |++|+ ++ .+| .+.++++|++|+|++|++++ ++ .+..+++|+.|++++|++.+
T Consensus       143 L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          143 LSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             CCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred             ccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence            99998 55 666 69999999999999999995 44 68899999999999999864

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.66  E-value=1.2e-16  Score=181.22  Aligned_cols=159  Identities=22%  Similarity=0.268  Sum_probs=138.1

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccc-cCchhhhhcCCcccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHF-SGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l-~~~~p~~~~~l~~L~~L  147 (663)
                      ..++.+++.+++.....+...|..+++|+.++++.|.+++..|..+..+++|+.|+|++|.+ .+.+|..|..+++|+.|
T Consensus       420 ~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L  499 (635)
T 4g8a_A          420 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL  499 (635)
T ss_dssp             TTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred             ccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEE
Confidence            46777888888887777777889999999999999999998899999999999999999984 45678889999999999


Q ss_pred             ccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccC-CCCCccCCcCCCC
Q 006055          148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTF-GSNSFLGNSLCGK  226 (663)
Q Consensus       148 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~-~~~~~~~~~l~~~  226 (663)
                      +|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+ +.+...  .+.++
T Consensus       500 ~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L--~L~~N  577 (635)
T 4g8a_A          500 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL--NLTQN  577 (635)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEE--ECTTC
T ss_pred             ECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEE--EeeCC
Confidence            999999999889999999999999999999998888899999999999999999999999988776 345432  35556


Q ss_pred             CCC
Q 006055          227 PLQ  229 (663)
Q Consensus       227 p~~  229 (663)
                      |+.
T Consensus       578 p~~  580 (635)
T 4g8a_A          578 DFA  580 (635)
T ss_dssp             CBC
T ss_pred             CCc
Confidence            665

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.66  E-value=1.2e-16  Score=179.14  Aligned_cols=145  Identities=25%  Similarity=0.246  Sum_probs=84.5

Q ss_pred             cEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCC-ccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           70 RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLP-SDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      +++.|+|++|.++ .+|.. +..+++|+.|+|++|.+++..| ..+.++++|++|+|++|.+++.+|..|.++++|+.|+
T Consensus       374 ~L~~L~l~~n~l~-~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  451 (570)
T 2z63_A          374 SLKYLDLSFNGVI-TMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK  451 (570)
T ss_dssp             CCCEEECCSCSEE-EEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred             ccCEEECCCCccc-ccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEE
Confidence            4555555555555 23332 4556666666666666655444 3455666666666666666655666666666666666


Q ss_pred             ccccccc-ccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCC
Q 006055          149 LATNNFS-GEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSN  216 (663)
Q Consensus       149 l~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~  216 (663)
                      |++|+++ +.+|..|..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..|..|..++.+
T Consensus       452 l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  520 (570)
T 2z63_A          452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSL  520 (570)
T ss_dssp             CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred             CcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCC
Confidence            6666665 4556666666666666666666665556666666666666666666665555555554444

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.65  E-value=2.1e-16  Score=168.46  Aligned_cols=112  Identities=22%  Similarity=0.293  Sum_probs=94.1

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|.++ .+++..|+.+++|++|+|++|.+++..|..|.++++|++|+|++|.++...+..|.++++|++|+
T Consensus        69 ~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~  147 (390)
T 3o6n_A           69 RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS  147 (390)
T ss_dssp             CCCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             ccCcEEECCCCccc-ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEE
Confidence            47888999999988 55555788899999999999999887788888999999999999999855555578899999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCc
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGS  181 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  181 (663)
                      |++|++++..|..|.++++|++|+|++|++++.
T Consensus       148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  180 (390)
T 3o6n_A          148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV  180 (390)
T ss_dssp             CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred             CCCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence            999999877777888889999999998888753

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.65  E-value=3.6e-16  Score=162.82  Aligned_cols=154  Identities=22%  Similarity=0.265  Sum_probs=102.9

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEccccccc--CchhhhhcCC-----
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS--GEVPLFLVGL-----  141 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l-----  141 (663)
                      .+++.|+|++|.++ .+|..++   ++|++|+|++|.|++..+..|.++++|+.|+|++|.++  +..|..+..+     
T Consensus       102 ~~L~~L~L~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L  177 (332)
T 2ft3_A          102 RKLQKLYISKNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYL  177 (332)
T ss_dssp             TTCCEEECCSSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCC
T ss_pred             CCCCEEECCCCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEE
Confidence            56788888888887 6776443   67777777777777655556777777777777777775  3455555544     


Q ss_pred             ---------------ccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCC
Q 006055          142 ---------------HHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSI  206 (663)
Q Consensus       142 ---------------~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~  206 (663)
                                     ++|+.|+|++|++++..|..|.++++|++|+|++|+|++..|..+..+++|+.|+|++|+++ .+
T Consensus       178 ~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l  256 (332)
T 2ft3_A          178 RISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RV  256 (332)
T ss_dssp             BCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BC
T ss_pred             ECcCCCCCccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ec
Confidence                           45666666666666555566777777777777777777666666777777777777777777 66


Q ss_pred             CcccccCCCCCc---cCCcCCCCC
Q 006055          207 PKRFQTFGSNSF---LGNSLCGKP  227 (663)
Q Consensus       207 p~~~~~~~~~~~---~~~~l~~~p  227 (663)
                      |..+..++.+..   .+|.+.+.+
T Consensus       257 p~~l~~l~~L~~L~l~~N~l~~~~  280 (332)
T 2ft3_A          257 PAGLPDLKLLQVVYLHTNNITKVG  280 (332)
T ss_dssp             CTTGGGCTTCCEEECCSSCCCBCC
T ss_pred             ChhhhcCccCCEEECCCCCCCccC
Confidence            666655554443   445554443

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.65  E-value=2.6e-16  Score=163.71  Aligned_cols=142  Identities=23%  Similarity=0.254  Sum_probs=76.6

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEccccccc--CchhhhhcCCcccc-
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS--GEVPLFLVGLHHLV-  145 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~-  145 (663)
                      .+++.|+|++|.++ .+|..++   ++|+.|+|++|.+++..+..|.++++|++|+|++|.++  +..+..+.++++|+ 
T Consensus       100 ~~L~~L~Ls~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~  175 (330)
T 1xku_A          100 VKLERLYLSKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY  175 (330)
T ss_dssp             TTCCEEECCSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCE
T ss_pred             CCCCEEECCCCcCC-ccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCE
Confidence            35667777777666 5554332   45555555555555544444555555555555555553  23444455554444 


Q ss_pred             --------------------ccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCC
Q 006055          146 --------------------RLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGS  205 (663)
Q Consensus       146 --------------------~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~  205 (663)
                                          .|+|++|++++..|..|.++++|++|+|++|++++..+..+..+++|+.|+|++|+++ .
T Consensus       176 L~l~~n~l~~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~  254 (330)
T 1xku_A          176 IRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-K  254 (330)
T ss_dssp             EECCSSCCCSCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-S
T ss_pred             EECCCCccccCCccccccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-c
Confidence                                4455555555444455555555555555555555554445555555555555555555 4


Q ss_pred             CCcccccCCC
Q 006055          206 IPKRFQTFGS  215 (663)
Q Consensus       206 ~p~~~~~~~~  215 (663)
                      +|..+..++.
T Consensus       255 lp~~l~~l~~  264 (330)
T 1xku_A          255 VPGGLADHKY  264 (330)
T ss_dssp             CCTTTTTCSS
T ss_pred             CChhhccCCC
Confidence            5554444443

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.64  E-value=5.7e-16  Score=173.41  Aligned_cols=134  Identities=23%  Similarity=0.278  Sum_probs=105.6

Q ss_pred             CCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccC--chhhhhcCCccccccccccccccccCCC-CCccccc
Q 006055           91 GNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSG--EVPLFLVGLHHLVRLNLATNNFSGEIPS-GFKNLTK  167 (663)
Q Consensus        91 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~  167 (663)
                      +.+++|++|+|++|++++.+|..+.++++|++|+|++|++++  .+|..+.++++|+.|+|++|++++.+|. .+..+++
T Consensus       350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~  429 (562)
T 3a79_B          350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES  429 (562)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred             cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence            677888899999999988888888888999999999998886  4567788888999999999998875655 4788888


Q ss_pred             ccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc---cCCcCCCCC
Q 006055          168 LKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF---LGNSLCGKP  227 (663)
Q Consensus       168 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~---~~~~l~~~p  227 (663)
                      |++|+|++|+|++.+|..+.  ++|+.|+|++|+|+ .+|..+..++.+..   .+|.+...|
T Consensus       430 L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~  489 (562)
T 3a79_B          430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVP  489 (562)
T ss_dssp             CCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCC
T ss_pred             CCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCC
Confidence            88888888888877776544  68888888888888 67766656655543   556665544

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.64  E-value=7.8e-17  Score=169.40  Aligned_cols=158  Identities=20%  Similarity=0.170  Sum_probs=132.8

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchh-hhhcCCcccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP-LFLVGLHHLVRL  147 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L  147 (663)
                      .+++.|+|++|++++ +++..|+++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+ ..|..+++|+.|
T Consensus        76 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L  154 (353)
T 2z80_A           76 VNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQIL  154 (353)
T ss_dssp             TTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred             CCCCEEECCCCccCc-cCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEE
Confidence            689999999999995 544578999999999999999998555559999999999999999995443 478999999999


Q ss_pred             ccccc-cccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcc-c---ccCCCCCccCCc
Q 006055          148 NLATN-NFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKR-F---QTFGSNSFLGNS  222 (663)
Q Consensus       148 ~l~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~---~~~~~~~~~~~~  222 (663)
                      ++++| .+++..|..|.++++|++|+|++|++++..|..+..+++|++|++++|+++ .+|.. +   .++..+.+.+|.
T Consensus       155 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~  233 (353)
T 2z80_A          155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTD  233 (353)
T ss_dssp             EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCB
T ss_pred             ECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCc
Confidence            99999 477666788999999999999999999999999999999999999999997 44543 2   334445556777


Q ss_pred             CCCCCC
Q 006055          223 LCGKPL  228 (663)
Q Consensus       223 l~~~p~  228 (663)
                      +.+.+.
T Consensus       234 l~~~~~  239 (353)
T 2z80_A          234 LDTFHF  239 (353)
T ss_dssp             CTTCCC
T ss_pred             cccccc
Confidence            766543

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.64  E-value=1.1e-16  Score=175.42  Aligned_cols=151  Identities=23%  Similarity=0.231  Sum_probs=78.4

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCc----------------cccCCCCCceEEcccccccC
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPS----------------DLASCSNLRNLYLQGNHFSG  132 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~----------------~~~~l~~L~~L~L~~N~l~~  132 (663)
                      .+++.|+|++|.+++.+|   |+.+++|+.|+|++|.|++..+.                ....+++|+.|+|++|.+++
T Consensus        58 ~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~  134 (487)
T 3oja_A           58 TKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITM  134 (487)
T ss_dssp             TTCCEEECTTSCCEEEEE---CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCCS
T ss_pred             CCCCEEEeeCCCCCCCcc---cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCCC
Confidence            355556666665554333   45555555555555544432110                00123445555555555555


Q ss_pred             chhhhhcCCccccccccccccccccCCCCCc-ccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccc
Q 006055          133 EVPLFLVGLHHLVRLNLATNNFSGEIPSGFK-NLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQ  211 (663)
Q Consensus       133 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~  211 (663)
                      ..|..|+.+++|+.|+|++|+|++.+|..+. ++++|++|+|++|.|++..+  +..+++|+.|+|++|+|++..| .|.
T Consensus       135 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~  211 (487)
T 3oja_A          135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQ  211 (487)
T ss_dssp             GGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGG
T ss_pred             CCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCH-hHc
Confidence            5555566666666666666666655555554 56666666666666664422  2246666666666666665333 344


Q ss_pred             cCCCCC---ccCCcCCC
Q 006055          212 TFGSNS---FLGNSLCG  225 (663)
Q Consensus       212 ~~~~~~---~~~~~l~~  225 (663)
                      .++.+.   +.+|.+++
T Consensus       212 ~l~~L~~L~Ls~N~l~~  228 (487)
T 3oja_A          212 SAAGVTWISLRNNKLVL  228 (487)
T ss_dssp             GGTTCSEEECTTSCCCE
T ss_pred             CCCCccEEEecCCcCcc
Confidence            443333   34454444

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.63  E-value=3.9e-16  Score=172.95  Aligned_cols=134  Identities=21%  Similarity=0.273  Sum_probs=110.9

Q ss_pred             CCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccC--chhhhhcCCccccccccccccccccCCC-CCccccc
Q 006055           91 GNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSG--EVPLFLVGLHHLVRLNLATNNFSGEIPS-GFKNLTK  167 (663)
Q Consensus        91 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~  167 (663)
                      ..+++|++|+|++|.+++.+|..+.++++|++|+|++|++++  .+|..+..+++|+.|+|++|++++.+|. .+..+++
T Consensus       321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  400 (520)
T 2z7x_B          321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS  400 (520)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred             hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence            678899999999999998888899999999999999999986  5678889999999999999999875665 4888899


Q ss_pred             ccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc---cCCcCCCCC
Q 006055          168 LKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF---LGNSLCGKP  227 (663)
Q Consensus       168 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~---~~~~l~~~p  227 (663)
                      |++|+|++|++++.+|..+.  ++|+.|+|++|+++ .+|..+..++.+..   .+|.+...|
T Consensus       401 L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~  460 (520)
T 2z7x_B          401 LLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVP  460 (520)
T ss_dssp             CCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCC
T ss_pred             CCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccC
Confidence            99999999999888776654  78999999999998 78877666666554   556665444

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.63  E-value=8.3e-16  Score=176.14  Aligned_cols=159  Identities=21%  Similarity=0.204  Sum_probs=107.5

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEccccccc--CchhhhhcCCccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS--GEVPLFLVGLHHLVR  146 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~  146 (663)
                      .+++.|+|++|.+++.+|...|.++++|+.|+|++|++++..+..|..+++|+.|+|++|.++  +.+|..|.++++|+.
T Consensus       405 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~  484 (680)
T 1ziw_A          405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI  484 (680)
T ss_dssp             TTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCE
T ss_pred             CCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCE
Confidence            356666666666666666556666677777777776666555555666666666666666655  456777788888888


Q ss_pred             cccccccccccCCCCCcccccccccccccccccCcCC--------CCCCCCCCCCEEEeecCcCCCCCCcccccCCCCC-
Q 006055          147 LNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIP--------GFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNS-  217 (663)
Q Consensus       147 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--------~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~-  217 (663)
                      |+|++|+|++..|..|.++++|++|+|++|++++..+        ..+..+++|+.|+|++|+++...+..|..++.+. 
T Consensus       485 L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~  564 (680)
T 1ziw_A          485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI  564 (680)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             EECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcce
Confidence            8888888887666678888888888888888875321        2367778888888888888743334566555544 


Q ss_pred             --ccCCcCCCCC
Q 006055          218 --FLGNSLCGKP  227 (663)
Q Consensus       218 --~~~~~l~~~p  227 (663)
                        +.+|.+.+.|
T Consensus       565 L~Ls~N~l~~l~  576 (680)
T 1ziw_A          565 IDLGLNNLNTLP  576 (680)
T ss_dssp             EECCSSCCCCCC
T ss_pred             eECCCCCCCcCC
Confidence              3556665544

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.63  E-value=3.6e-16  Score=173.29  Aligned_cols=146  Identities=27%  Similarity=0.300  Sum_probs=128.8

Q ss_pred             CCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCC--CCCccccCCCCCceEEcccccccCchhhh-hcCCccc
Q 006055           68 QNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTS--QLPSDLASCSNLRNLYLQGNHFSGEVPLF-LVGLHHL  144 (663)
Q Consensus        68 ~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L  144 (663)
                      ...++.|+|++|.+++.+|. .++++++|+.|+|++|+|++  .+|..+.++++|++|+|++|.+++.+|.. +..+++|
T Consensus       323 l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L  401 (520)
T 2z7x_B          323 ISPFLHLDFSNNLLTDTVFE-NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL  401 (520)
T ss_dssp             CCCCCEEECCSSCCCTTTTT-TCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred             CCcccEEEeECCccChhhhh-hhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC
Confidence            36799999999999988886 57999999999999999997  56778999999999999999999867764 8899999


Q ss_pred             cccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcc-cccCCCCCc
Q 006055          145 VRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKR-FQTFGSNSF  218 (663)
Q Consensus       145 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~~~~~~~  218 (663)
                      +.|+|++|++++.+|..+.  ++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+|.. |..++.+..
T Consensus       402 ~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~  472 (520)
T 2z7x_B          402 LSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQK  472 (520)
T ss_dssp             CEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCE
T ss_pred             CEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccE
Confidence            9999999999988887775  79999999999999 88887779999999999999999 56654 766666544

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.63  E-value=2.7e-16  Score=146.66  Aligned_cols=127  Identities=21%  Similarity=0.161  Sum_probs=111.6

Q ss_pred             CCCCCCCEEEccCCCCC-CCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCCCCccccccc
Q 006055           91 GNLTSLRTLSLRFNSLT-SQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLK  169 (663)
Q Consensus        91 ~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~  169 (663)
                      ...++|+.|+|++|.|+ +.+|..+..+++|++|+|++|.+++.  ..+..+++|+.|+|++|++++.+|..+.++++|+
T Consensus        21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   98 (168)
T 2ell_A           21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT   98 (168)
T ss_dssp             SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred             CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence            34588999999999998 77899999999999999999999965  7899999999999999999987888888899999


Q ss_pred             ccccccccccCcC-CCCCCCCCCCCEEEeecCcCCCCCC---cccccCCCCCcc
Q 006055          170 TLFLENNRLSGSI-PGFDDVLPNLQQLNVSNNLLNGSIP---KRFQTFGSNSFL  219 (663)
Q Consensus       170 ~L~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~g~~p---~~~~~~~~~~~~  219 (663)
                      +|+|++|+|++.. +..+..+++|+.|++++|++++..+   ..+..++.+...
T Consensus        99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L  152 (168)
T 2ell_A           99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL  152 (168)
T ss_dssp             EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEE
T ss_pred             EEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEe
Confidence            9999999999643 2778999999999999999996655   467777766553

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.62  E-value=5.3e-16  Score=148.12  Aligned_cols=120  Identities=27%  Similarity=0.327  Sum_probs=110.2

Q ss_pred             CccceeEecC-----------CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEccc
Q 006055           59 CKWAGVECEQ-----------NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQG  127 (663)
Q Consensus        59 c~w~gv~c~~-----------~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  127 (663)
                      |.|..+.|+.           ..++.|+|++|+++ .+|. .|.++++|+.|+|++|.|++..|..|.++++|++|+|++
T Consensus        10 C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~-~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~   87 (193)
T 2wfh_A           10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPK-ELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY   87 (193)
T ss_dssp             EETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCG-GGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             eCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHH-HhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence            6788888853           36899999999998 8985 789999999999999999998888999999999999999


Q ss_pred             ccccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccccccC
Q 006055          128 NHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSG  180 (663)
Q Consensus       128 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  180 (663)
                      |+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus        88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence            99999888899999999999999999996666679999999999999999974

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.62  E-value=8e-16  Score=172.20  Aligned_cols=155  Identities=27%  Similarity=0.316  Sum_probs=131.0

Q ss_pred             CCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCC--CCccccCCCCCceEEcccccccCchhh-hhcCCccc
Q 006055           68 QNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQ--LPSDLASCSNLRNLYLQGNHFSGEVPL-FLVGLHHL  144 (663)
Q Consensus        68 ~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L  144 (663)
                      ..+++.|+|++|.+++.+|. .++++++|+.|+|++|+|++.  +|..|.++++|++|+|++|++++.+|. .+..+++|
T Consensus       352 l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L  430 (562)
T 3a79_B          352 PSSFTFLNFTQNVFTDSVFQ-GCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI  430 (562)
T ss_dssp             CCCCCEEECCSSCCCTTTTT-TCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC
T ss_pred             CCCceEEECCCCccccchhh-hhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC
Confidence            36899999999999987886 579999999999999999973  356799999999999999999985665 58899999


Q ss_pred             cccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcc-cccCCCCCccCCcC
Q 006055          145 VRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKR-FQTFGSNSFLGNSL  223 (663)
Q Consensus       145 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~~~~~~~~~~~l  223 (663)
                      +.|+|++|++++.+|..+.  ++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+|.. |..++.+...  .+
T Consensus       431 ~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L--~l  504 (562)
T 3a79_B          431 LVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYI--WL  504 (562)
T ss_dssp             CEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCE--EC
T ss_pred             CEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEE--Ee
Confidence            9999999999988887765  79999999999999 77877779999999999999999 56655 7777666542  23


Q ss_pred             CCCCCC
Q 006055          224 CGKPLQ  229 (663)
Q Consensus       224 ~~~p~~  229 (663)
                      .++|+.
T Consensus       505 ~~N~~~  510 (562)
T 3a79_B          505 HDNPWD  510 (562)
T ss_dssp             CSCCBC
T ss_pred             cCCCcC
Confidence            444443

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.62  E-value=1e-16  Score=175.84  Aligned_cols=142  Identities=21%  Similarity=0.073  Sum_probs=120.9

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhc-CCcccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLV-GLHHLVRL  147 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L  147 (663)
                      ..++.|+|++|.+++..+    ..+++|+.|+|++|.|++..|..|+++++|+.|+|++|.|++.+|..+. .+++|+.|
T Consensus        99 ~~L~~L~L~~N~l~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L  174 (487)
T 3oja_A           99 PSIETLHAANNNISRVSC----SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL  174 (487)
T ss_dssp             TTCCEEECCSSCCCCEEE----CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred             CCcCEEECcCCcCCCCCc----cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEE
Confidence            568888888888885433    3568999999999999998899999999999999999999998888886 79999999


Q ss_pred             ccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc
Q 006055          148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF  218 (663)
Q Consensus       148 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~  218 (663)
                      +|++|.|++..+  +..+++|++|+|++|+|++.+| .+..+++|+.|+|++|+|++ +|..+..++.+..
T Consensus       175 ~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~  241 (487)
T 3oja_A          175 NLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEH  241 (487)
T ss_dssp             ECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCE
T ss_pred             ecCCCccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCE
Confidence            999999996633  4469999999999999996545 48899999999999999995 7777776665543

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.61  E-value=1e-16  Score=146.37  Aligned_cols=126  Identities=18%  Similarity=0.159  Sum_probs=111.9

Q ss_pred             CCCCCCCEEEccCCCCC-CCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCCCCccccccc
Q 006055           91 GNLTSLRTLSLRFNSLT-SQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLK  169 (663)
Q Consensus        91 ~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~  169 (663)
                      ...++|+.|+|++|.++ +.+|..+..+++|++|+|++|.+++.  ..+..+++|+.|+|++|++++.+|..+.++++|+
T Consensus        14 ~~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~   91 (149)
T 2je0_A           14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT   91 (149)
T ss_dssp             CCGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCC
T ss_pred             CCCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCC
Confidence            34588999999999998 78999999999999999999999976  7899999999999999999987888888899999


Q ss_pred             ccccccccccCc-CCCCCCCCCCCCEEEeecCcCCCCCC---cccccCCCCCc
Q 006055          170 TLFLENNRLSGS-IPGFDDVLPNLQQLNVSNNLLNGSIP---KRFQTFGSNSF  218 (663)
Q Consensus       170 ~L~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~g~~p---~~~~~~~~~~~  218 (663)
                      +|+|++|++++. .+..+..+++|+.|++++|++++..+   ..+..++.+..
T Consensus        92 ~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~  144 (149)
T 2je0_A           92 HLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTY  144 (149)
T ss_dssp             EEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCE
T ss_pred             EEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCccc
Confidence            999999999974 45789999999999999999997766   46777776654

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.61  E-value=8e-16  Score=161.43  Aligned_cols=167  Identities=17%  Similarity=0.194  Sum_probs=119.3

Q ss_pred             CccceeEecC-----------CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCC-ccccCCCCCce-EEc
Q 006055           59 CKWAGVECEQ-----------NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLP-SDLASCSNLRN-LYL  125 (663)
Q Consensus        59 c~w~gv~c~~-----------~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L  125 (663)
                      |.|..|.|+.           .+++.|+|++|+|+ .||+++|.++++|++|+|++|++.+.+| ..|.++++|++ +++
T Consensus         9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~   87 (350)
T 4ay9_X            9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   87 (350)
T ss_dssp             EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred             eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence            7899999963           36889999999999 8998889999999999999999977665 46788888765 667


Q ss_pred             ccccccCchhhhhcCCccccccccccccccccCCCCC-------------------------ccc-cccccccccccccc
Q 006055          126 QGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGF-------------------------KNL-TKLKTLFLENNRLS  179 (663)
Q Consensus       126 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-------------------------~~l-~~L~~L~l~~N~l~  179 (663)
                      +.|++++..|..|..+++|+.|++++|+|++..+..+                         ..+ ..|+.|+|++|+|+
T Consensus        88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~  167 (350)
T 4ay9_X           88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  167 (350)
T ss_dssp             EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence            7788987778888899999999999988874333222                         222 24667788888887


Q ss_pred             CcCCCCCCCCCCCCEEEeec-CcCCCCCC-cccccCCCCC---ccCCcCCCCCC
Q 006055          180 GSIPGFDDVLPNLQQLNVSN-NLLNGSIP-KRFQTFGSNS---FLGNSLCGKPL  228 (663)
Q Consensus       180 ~~~p~~~~~l~~L~~L~l~~-N~l~g~~p-~~~~~~~~~~---~~~~~l~~~p~  228 (663)
                       .+|.......+|+.|++++ |.++ .+| ..|..++.+.   +.+|.+...|.
T Consensus       168 -~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~lp~  219 (350)
T 4ay9_X          168 -EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPS  219 (350)
T ss_dssp             -EECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCCCCS
T ss_pred             -CCChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcCccCh
Confidence             3444333456677777764 4444 444 3455444433   35566655543

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.61  E-value=7.8e-16  Score=157.09  Aligned_cols=146  Identities=32%  Similarity=0.363  Sum_probs=104.4

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|++++ +++  +.++++|+.|+|++|.|++ +| .+.++++|++|+|++|++++.  ..+..+++|+.|+
T Consensus        68 ~~L~~L~L~~n~l~~-~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~  140 (291)
T 1h6t_A           68 PNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLY  140 (291)
T ss_dssp             TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEE
T ss_pred             CCCCEEEccCCccCC-Ccc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEE
Confidence            567888888888874 443  6788888888888888876 33 377888888888888888753  3577788888888


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc---cCCcCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF---LGNSLCG  225 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~---~~~~l~~  225 (663)
                      |++|++++.  ..+..+++|++|+|++|+|++..|  +..+++|+.|+|++|++++ +|. +..++.+..   .+|.+..
T Consensus       141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~~-l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGG-GTTCTTCSEEEEEEEEEEC
T ss_pred             ccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Chh-hccCCCCCEEECcCCcccC
Confidence            888888754  567788888888888888876555  7778888888888888875 342 555555443   4455544


Q ss_pred             CC
Q 006055          226 KP  227 (663)
Q Consensus       226 ~p  227 (663)
                      .|
T Consensus       215 ~~  216 (291)
T 1h6t_A          215 KP  216 (291)
T ss_dssp             CC
T ss_pred             Cc
Confidence            43

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.61  E-value=6.9e-16  Score=158.89  Aligned_cols=147  Identities=24%  Similarity=0.348  Sum_probs=117.6

Q ss_pred             CCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccc
Q 006055           68 QNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        68 ~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  147 (663)
                      ..+++.|+|++|+++ .++.  +..+++|+.|+|++|.|++ +| .+.++++|++|+|++|++++ +|. +..+++|+.|
T Consensus        62 l~~L~~L~L~~n~i~-~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L  134 (308)
T 1h6u_A           62 LNNLIGLELKDNQIT-DLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVL  134 (308)
T ss_dssp             CTTCCEEECCSSCCC-CCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEE
T ss_pred             cCCCCEEEccCCcCC-CChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEE
Confidence            467999999999998 5654  7899999999999999987 34 68899999999999999986 443 8899999999


Q ss_pred             ccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCC---CccCCcCC
Q 006055          148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSN---SFLGNSLC  224 (663)
Q Consensus       148 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~---~~~~~~l~  224 (663)
                      +|++|++++..+  +.++++|++|+|++|++++..+  +..+++|+.|+|++|++++..|  +..++.+   .+.+|.+.
T Consensus       135 ~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~  208 (308)
T 1h6u_A          135 YLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQIS  208 (308)
T ss_dssp             ECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCC
T ss_pred             ECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccC
Confidence            999999986544  8889999999999999986544  7889999999999999986544  4544444   34566665


Q ss_pred             CCC
Q 006055          225 GKP  227 (663)
Q Consensus       225 ~~p  227 (663)
                      +.+
T Consensus       209 ~~~  211 (308)
T 1h6u_A          209 DVS  211 (308)
T ss_dssp             BCG
T ss_pred             ccc
Confidence            543

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.61  E-value=1.5e-15  Score=156.45  Aligned_cols=145  Identities=24%  Similarity=0.379  Sum_probs=98.2

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|++++|+++ .+|.  +..+++|+.|+|++|.+++..+  +.++++|++|+|++|.+++ +| .+..+++|+.|+
T Consensus        41 ~~L~~L~l~~~~i~-~l~~--~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~  113 (308)
T 1h6u_A           41 DGITTLSAFGTGVT-TIEG--VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLD  113 (308)
T ss_dssp             HTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEE
T ss_pred             CCcCEEEeeCCCcc-Cchh--hhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEE
Confidence            46777777777776 5653  5777777777777777776433  7777777777777777774 33 577777777777


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCC---ccCCcCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNS---FLGNSLCG  225 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~---~~~~~l~~  225 (663)
                      |++|++++. |. +..+++|++|+|++|++++..+  +..+++|+.|+|++|++++..+  +..++.+.   +.+|.+.+
T Consensus       114 l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~  187 (308)
T 1h6u_A          114 LTSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD  187 (308)
T ss_dssp             CTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred             CCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCc
Confidence            777777753 32 7777777777777777775444  6677777777777777775333  44444433   34555544


Q ss_pred             C
Q 006055          226 K  226 (663)
Q Consensus       226 ~  226 (663)
                      .
T Consensus       188 ~  188 (308)
T 1h6u_A          188 I  188 (308)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.60  E-value=7.1e-16  Score=172.01  Aligned_cols=156  Identities=27%  Similarity=0.316  Sum_probs=135.0

Q ss_pred             eEecCCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcc
Q 006055           64 VECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH  143 (663)
Q Consensus        64 v~c~~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  143 (663)
                      ..|....+  .++++++++ .+|.++   .++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|.++++
T Consensus         2 ~~C~~~~~--c~~~~~~l~-~ip~~~---~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~   75 (549)
T 2z81_A            2 LSCDASGV--CDGRSRSFT-SIPSGL---TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS   75 (549)
T ss_dssp             CEECTTSE--EECTTSCCS-SCCSCC---CTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             ccCCCCce--EECCCCccc-cccccC---CCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhcccccc
Confidence            35766665  799999999 899854   389999999999999988999999999999999999999988899999999


Q ss_pred             ccccccccccccccCCCCCcccccccccccccccccC-cCCCCCCCCCCCCEEEeecCcCCCCCC-cccccCCCCCc---
Q 006055          144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSG-SIPGFDDVLPNLQQLNVSNNLLNGSIP-KRFQTFGSNSF---  218 (663)
Q Consensus       144 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~~~~~~~---  218 (663)
                      |++|+|++|++++..|..|+++++|++|+|++|++++ .+|..+..+++|++|++++|++.+.+| ..|..++.+..   
T Consensus        76 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L  155 (549)
T 2z81_A           76 LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEI  155 (549)
T ss_dssp             CCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEE
T ss_pred             CCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeec
Confidence            9999999999998777779999999999999999997 467889999999999999999666665 56777766554   


Q ss_pred             cCCcCCC
Q 006055          219 LGNSLCG  225 (663)
Q Consensus       219 ~~~~l~~  225 (663)
                      .+|.+.+
T Consensus       156 ~~n~l~~  162 (549)
T 2z81_A          156 KALSLRN  162 (549)
T ss_dssp             EETTCCE
T ss_pred             cCCcccc
Confidence            4555544

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.60  E-value=1.5e-15  Score=155.01  Aligned_cols=144  Identities=24%  Similarity=0.348  Sum_probs=123.0

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|++++|++. .+|.  +..+++|+.|+|++|+|++..|  +.++++|++|+|++|.+++ +|. +..+++|+.|+
T Consensus        46 ~~L~~L~l~~~~i~-~~~~--~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~  118 (291)
T 1h6t_A           46 NSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLS  118 (291)
T ss_dssp             HTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEE
T ss_pred             CcccEEEccCCCcc-cChh--HhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Chh-hccCCCCCEEE
Confidence            57999999999998 6664  7899999999999999998544  9999999999999999995 444 89999999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc---cCCcCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF---LGNSLCG  225 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~---~~~~l~~  225 (663)
                      |++|++++.  +.+.++++|++|+|++|++++.  ..+..+++|+.|+|++|++++..|  +..++.+..   .+|.+.+
T Consensus       119 L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~  192 (291)
T 1h6t_A          119 LEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD  192 (291)
T ss_dssp             CTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred             CCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC
Confidence            999999964  5689999999999999999965  568899999999999999997655  666665544   4555544

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.60  E-value=2.2e-15  Score=157.00  Aligned_cols=134  Identities=14%  Similarity=0.077  Sum_probs=96.3

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCccc---------------CHHH--------HHHHHHHhhcCCCCCcccce
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI---------------SERE--------FKDKIEGVGAVNHENLVPLR  431 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~---------------~~~~--------~~~e~~~l~~l~h~niv~l~  431 (663)
                      ...||+|++|.||+|...+|+.||||+++....               ....        ..+|...+.++.+..+.-..
T Consensus       100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~  179 (397)
T 4gyi_A          100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPE  179 (397)
T ss_dssp             EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCC
T ss_pred             cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCe
Confidence            568999999999999988999999998753210               0111        23455556666444332211


Q ss_pred             EEEEecCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCc-
Q 006055          432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYE-  510 (663)
Q Consensus       432 ~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~-  510 (663)
                       .+. ....++||||+++++|.++...           .....++.|++.+|.|||+.|  ||||||||.|||+++++. 
T Consensus       180 -p~~-~~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          180 -PIA-QSRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             -EEE-EETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEECS
T ss_pred             -eee-ccCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCCc
Confidence             111 1245899999999888765431           123467889999999999998  999999999999988773 


Q ss_pred             ---------eEEeccccccccC
Q 006055          511 ---------ARVSDFGLAHLVG  523 (663)
Q Consensus       511 ---------~kl~Dfg~a~~~~  523 (663)
                               +.|+||+-+....
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEETT
T ss_pred             ccccccccceEEEEeCCcccCC
Confidence                     8999999776543

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.60  E-value=4.6e-17  Score=186.87  Aligned_cols=143  Identities=24%  Similarity=0.241  Sum_probs=124.8

Q ss_pred             cCCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccc
Q 006055           67 EQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVR  146 (663)
Q Consensus        67 ~~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  146 (663)
                      ....++.|+|++|.+. .+|.++ .++++|+.|+|++|.|+ .+|..|.+|++|++|+|++|.|+ .+|..|++|++|++
T Consensus       222 ~l~~L~~L~Ls~n~l~-~l~~~~-~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~  297 (727)
T 4b8c_D          222 DDQLWHALDLSNLQIF-NISANI-FKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKY  297 (727)
T ss_dssp             CCCCCCEEECTTSCCS-CCCGGG-GGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSE
T ss_pred             cCCCCcEEECCCCCCC-CCChhh-cCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCE
Confidence            3468999999999998 899865 58999999999999999 68999999999999999999999 78999999999999


Q ss_pred             cccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCC-CCEEEeecCcCCCCCCcccccCC
Q 006055          147 LNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPN-LQQLNVSNNLLNGSIPKRFQTFG  214 (663)
Q Consensus       147 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~-L~~L~l~~N~l~g~~p~~~~~~~  214 (663)
                      |+|++|.|+ .+|..|++|++|++|+|++|.|++.+|..+..+.. +..|+|++|.++|.+|..+..+.
T Consensus       298 L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~l~  365 (727)
T 4b8c_D          298 FYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRFIE  365 (727)
T ss_dssp             EECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----
T ss_pred             EECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccceeE
Confidence            999999998 88999999999999999999999999987755432 23478999999999998776553

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.60  E-value=1e-16  Score=165.81  Aligned_cols=142  Identities=20%  Similarity=0.101  Sum_probs=107.6

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhc-CCcccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLV-GLHHLVRL  147 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L  147 (663)
                      ..++.|+|++|++++ ++.   ..+++|+.|+|++|+|++..|..+..+++|++|+|++|.+++..|..+. .+++|+.|
T Consensus        99 ~~L~~L~l~~n~l~~-~~~---~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L  174 (317)
T 3o53_A           99 PSIETLHAANNNISR-VSC---SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL  174 (317)
T ss_dssp             TTCCEEECCSSCCSE-EEE---CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred             CCcCEEECCCCccCC-cCc---cccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEE
Confidence            467777777777774 332   3467888899999988887777888888899999999888877777664 68888888


Q ss_pred             ccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc
Q 006055          148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF  218 (663)
Q Consensus       148 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~  218 (663)
                      +|++|+|++. |. ...+++|++|+|++|+|++ +|..+..+++|+.|+|++|+++ .+|..+..++.+..
T Consensus       175 ~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~  241 (317)
T 3o53_A          175 NLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEH  241 (317)
T ss_dssp             ECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCE
T ss_pred             ECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCE
Confidence            8888888854 33 3357888888888888884 4445778888888888888888 46766666555543

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.60  E-value=9.3e-16  Score=154.07  Aligned_cols=144  Identities=19%  Similarity=0.280  Sum_probs=108.8

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|+++ .+|  .++.+++|+.|+|++|+|++..|  +.++++|++|+|++|++++ +|... . ++|+.|+
T Consensus        41 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~L~  112 (263)
T 1xeu_A           41 SGVQNFNGDNSNIQ-SLA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSRLF  112 (263)
T ss_dssp             TTCSEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCEEE
T ss_pred             CcCcEEECcCCCcc-cch--HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCccc-c-CcccEEE
Confidence            56888888888887 677  36888888888998888887444  8888888888888888885 44432 3 8888888


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc---cCCcCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF---LGNSLCG  225 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~---~~~~l~~  225 (663)
                      |++|+|++. + .+.++++|+.|+|++|+|++. | .+..+++|+.|+|++|++++.  ..+..++.+..   .+|.+++
T Consensus       113 L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~  186 (263)
T 1xeu_A          113 LDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVN  186 (263)
T ss_dssp             CCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred             ccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence            888888853 3 588888888888888888854 3 577888888888888888865  44555555443   4555544


Q ss_pred             C
Q 006055          226 K  226 (663)
Q Consensus       226 ~  226 (663)
                      .
T Consensus       187 ~  187 (263)
T 1xeu_A          187 E  187 (263)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.60  E-value=4.4e-16  Score=146.44  Aligned_cols=129  Identities=18%  Similarity=0.215  Sum_probs=107.7

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|+++ .+|. +....++|+.|+|++|.|++.  ..|.++++|++|+|++|+|++..|..|..+++|+.|+
T Consensus        19 ~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~   94 (176)
T 1a9n_A           19 VRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI   94 (176)
T ss_dssp             TSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred             CCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence            57899999999998 6664 333344999999999999875  6789999999999999999966556668999999999


Q ss_pred             cccccccccCCC--CCcccccccccccccccccCcCCCC----CCCCCCCCEEEeecCcCC
Q 006055          149 LATNNFSGEIPS--GFKNLTKLKTLFLENNRLSGSIPGF----DDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       149 l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~----~~~l~~L~~L~l~~N~l~  203 (663)
                      |++|+|+ .+|.  .+.++++|+.|+|++|+++ .+|..    +..+++|+.|++++|.+.
T Consensus        95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            9999996 5665  7889999999999999998 56664    888999999999999875

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.60  E-value=1.8e-15  Score=169.48  Aligned_cols=150  Identities=31%  Similarity=0.367  Sum_probs=126.9

Q ss_pred             CCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccc
Q 006055           68 QNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        68 ~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  147 (663)
                      ..+++.|+|++|+|++ +|+  +..+++|+.|+|++|.|++ +| .+..|++|+.|+|++|+|++ +| .+..|++|+.|
T Consensus        64 l~~L~~L~Ls~N~l~~-~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L  136 (605)
T 1m9s_A           64 LPNVTKLFLNGNKLTD-IKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESL  136 (605)
T ss_dssp             CTTCCEEECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEE
T ss_pred             CCCCCEEEeeCCCCCC-Chh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEE
Confidence            4689999999999995 554  7899999999999999987 44 79999999999999999996 43 58899999999


Q ss_pred             ccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCC---ccCCcCC
Q 006055          148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNS---FLGNSLC  224 (663)
Q Consensus       148 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~---~~~~~l~  224 (663)
                      +|++|+|++.  ..|..|++|+.|+|++|+|++..|  +..+++|+.|+|++|+|++. | .+..++.|.   +.+|.++
T Consensus       137 ~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~  210 (605)
T 1m9s_A          137 YLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECL  210 (605)
T ss_dssp             ECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEE
T ss_pred             ECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCc
Confidence            9999999965  678999999999999999998777  88999999999999999964 4 455555544   4677777


Q ss_pred             CCCCCC
Q 006055          225 GKPLQD  230 (663)
Q Consensus       225 ~~p~~~  230 (663)
                      +.|...
T Consensus       211 ~~p~~~  216 (605)
T 1m9s_A          211 NKPINH  216 (605)
T ss_dssp             CCCCCC
T ss_pred             CCcccc
Confidence            766553

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.59  E-value=2.6e-15  Score=140.27  Aligned_cols=103  Identities=26%  Similarity=0.339  Sum_probs=56.0

Q ss_pred             EEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccc
Q 006055           73 MLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATN  152 (663)
Q Consensus        73 ~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N  152 (663)
                      .|++++|+|+ .+|.++   .++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|
T Consensus        13 ~l~~s~n~l~-~ip~~~---~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           13 TVDCSGKSLA-SVPTGI---PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             EEECTTSCCS-SCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEEeCCCCcC-ccCccC---CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            4566666666 566533   266666666666666655666666666666666666666544444455555555555555


Q ss_pred             cccccCCCCCccccccccccccccccc
Q 006055          153 NFSGEIPSGFKNLTKLKTLFLENNRLS  179 (663)
Q Consensus       153 ~l~~~~p~~~~~l~~L~~L~l~~N~l~  179 (663)
                      +|++..+..|.++++|++|+|++|.++
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence            554333333444444444444444333

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.57  E-value=3.2e-15  Score=140.58  Aligned_cols=114  Identities=29%  Similarity=0.363  Sum_probs=103.7

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      ..++.|+|++|+++ .+|...|+++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+
T Consensus        28 ~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  106 (177)
T 2o6r_A           28 SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELA  106 (177)
T ss_dssp             TTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCcEEEeCCCccc-EeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEE
Confidence            57999999999999 67767789999999999999999987777789999999999999999988888899999999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIP  183 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  183 (663)
                      |++|+|++..+..|.++++|++|+|++|.+++..|
T Consensus       107 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A          107 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            99999996666667899999999999999997665

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.57  E-value=1.5e-15  Score=156.95  Aligned_cols=148  Identities=20%  Similarity=0.147  Sum_probs=121.6

Q ss_pred             CCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccc
Q 006055           68 QNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        68 ~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  147 (663)
                      ..+++.|+|++|.++ .+|     ..++|+.|+|++|.|++..+..   +++|++|+|++|++++..|..+..+++|+.|
T Consensus        79 l~~L~~L~Ls~n~l~-~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  149 (317)
T 3o53_A           79 LSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYL  149 (317)
T ss_dssp             CTTCCEEECCSSEEE-EEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEE
T ss_pred             cCCCCEEECcCCccc-ccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEE
Confidence            468999999999998 444     3389999999999999865543   6789999999999998888899999999999


Q ss_pred             ccccccccccCCCCC-cccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc---cCCcC
Q 006055          148 NLATNNFSGEIPSGF-KNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF---LGNSL  223 (663)
Q Consensus       148 ~l~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~---~~~~l  223 (663)
                      +|++|++++..|..+ ..+++|++|+|++|+|++. |.. ..+++|+.|+|++|++++. |..+..++.+..   .+|.+
T Consensus       150 ~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~-~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l  226 (317)
T 3o53_A          150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQ-VVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKL  226 (317)
T ss_dssp             ECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECC-CCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCC
T ss_pred             ECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccc-cccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCcc
Confidence            999999998777777 4789999999999999965 433 3589999999999999954 555766665544   56666


Q ss_pred             CCCC
Q 006055          224 CGKP  227 (663)
Q Consensus       224 ~~~p  227 (663)
                      ...|
T Consensus       227 ~~l~  230 (317)
T 3o53_A          227 VLIE  230 (317)
T ss_dssp             CEEC
T ss_pred             cchh
Confidence            5433

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.56  E-value=8.7e-18  Score=161.38  Aligned_cols=146  Identities=23%  Similarity=0.309  Sum_probs=123.6

Q ss_pred             CcEEEEEcCCCCcccccCc-----cccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcc
Q 006055           69 NRVTMLRLPGVALSGQIPL-----GILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHH  143 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~-----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  143 (663)
                      .+++.++|+.+.++|.+|.     ..++.+++|+.|+|++|.|++ +| .+.++++|++|+|++|.++ .+|..+..+++
T Consensus        18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~   94 (198)
T 1ds9_A           18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT   94 (198)
T ss_dssp             TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred             ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence            4566777777777777774     247899999999999999998 67 8999999999999999999 68888888999


Q ss_pred             ccccccccccccccCCCCCcccccccccccccccccCcCC-CCCCCCCCCCEEEeecCcCCCCCCcc----------ccc
Q 006055          144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVSNNLLNGSIPKR----------FQT  212 (663)
Q Consensus       144 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~----------~~~  212 (663)
                      |+.|+|++|++++ +| .+.++++|++|+|++|+|++..+ ..+..+++|++|++++|++++.+|..          +..
T Consensus        95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~  172 (198)
T 1ds9_A           95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKR  172 (198)
T ss_dssp             CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHH
T ss_pred             CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHh
Confidence            9999999999996 55 68999999999999999995433 46889999999999999999877753          666


Q ss_pred             CCCCCcc
Q 006055          213 FGSNSFL  219 (663)
Q Consensus       213 ~~~~~~~  219 (663)
                      ++.+...
T Consensus       173 l~~L~~L  179 (198)
T 1ds9_A          173 LPNLKKL  179 (198)
T ss_dssp             CSSCSEE
T ss_pred             CCCcEEE
Confidence            6666553

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.56  E-value=6.2e-15  Score=138.16  Aligned_cols=104  Identities=27%  Similarity=0.402  Sum_probs=59.6

Q ss_pred             EEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccccccc
Q 006055           72 TMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLAT  151 (663)
Q Consensus        72 ~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~  151 (663)
                      +.+++++|+|+ .+|.++   .++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus        15 ~~l~~~~n~l~-~iP~~~---~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGI---PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SEEECCSSCCS-SCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             cEEEeCCCCCC-ccCCCc---CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            46777777775 677643   26677777777777766666666666666666666666654444445555555555555


Q ss_pred             ccccccCCCCCccccccccccccccccc
Q 006055          152 NNFSGEIPSGFKNLTKLKTLFLENNRLS  179 (663)
Q Consensus       152 N~l~~~~p~~~~~l~~L~~L~l~~N~l~  179 (663)
                      |+|++..+..|.++++|++|+|++|.+.
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCcc
Confidence            5555333323444444444444444443

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.56  E-value=7.3e-15  Score=137.16  Aligned_cols=109  Identities=28%  Similarity=0.320  Sum_probs=99.9

Q ss_pred             CCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCCCCccccccccccccc
Q 006055           96 LRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLEN  175 (663)
Q Consensus        96 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~  175 (663)
                      .+.|++++|+|+. +|..+.  ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus        11 ~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            4789999999987 777664  8999999999999998899999999999999999999977777789999999999999


Q ss_pred             ccccCcCCCCCCCCCCCCEEEeecCcCCCCCC
Q 006055          176 NRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP  207 (663)
Q Consensus       176 N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p  207 (663)
                      |+|++..+..|..+++|+.|+|++|++++..+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            99998878889999999999999999997654

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.55  E-value=3.7e-15  Score=165.91  Aligned_cols=107  Identities=31%  Similarity=0.328  Sum_probs=59.2

Q ss_pred             CCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCCCCccccccccccccc
Q 006055           96 LRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLEN  175 (663)
Q Consensus        96 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~  175 (663)
                      |+.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .|++|++|++|+|++
T Consensus       443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~  517 (567)
T 1dce_A          443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN  517 (567)
T ss_dssp             CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred             ceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence            5555555555554 343 555555555555555555 455555555555555555555553 44 455555555555555


Q ss_pred             ccccCcC-CCCCCCCCCCCEEEeecCcCCCCCC
Q 006055          176 NRLSGSI-PGFDDVLPNLQQLNVSNNLLNGSIP  207 (663)
Q Consensus       176 N~l~~~~-p~~~~~l~~L~~L~l~~N~l~g~~p  207 (663)
                      |+|++.+ |..+..+++|+.|+|++|+|++.+|
T Consensus       518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  550 (567)
T 1dce_A          518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG  550 (567)
T ss_dssp             SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence            5555444 5555555555555555555554433

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.54  E-value=4.9e-15  Score=165.89  Aligned_cols=145  Identities=24%  Similarity=0.364  Sum_probs=124.6

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+|+.|+|++|.+. .+|.  ++.+++|+.|+|++|+|++..|  +.+|++|+.|+|++|.|++ +| .+..+++|+.|+
T Consensus        43 ~~L~~L~l~~n~i~-~l~~--l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~  115 (605)
T 1m9s_A           43 NSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLS  115 (605)
T ss_dssp             TTCCCCBCTTCCCC-CCTT--GGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEE
T ss_pred             CCCCEEECcCCCCC-CChH--HccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEE
Confidence            57899999999998 6774  7999999999999999998555  9999999999999999995 44 689999999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCC---ccCCcCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNS---FLGNSLCG  225 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~---~~~~~l~~  225 (663)
                      |++|+|++ + +.+.+|++|+.|+|++|+|++.  ..+..+++|+.|+|++|+|++..|  +..++.|.   +.+|.+.+
T Consensus       116 Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~  189 (605)
T 1m9s_A          116 LEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD  189 (605)
T ss_dssp             CTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred             ecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC
Confidence            99999996 3 4699999999999999999965  568899999999999999998766  66665554   45666655


Q ss_pred             C
Q 006055          226 K  226 (663)
Q Consensus       226 ~  226 (663)
                      .
T Consensus       190 l  190 (605)
T 1m9s_A          190 L  190 (605)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.54  E-value=8.5e-15  Score=159.88  Aligned_cols=126  Identities=33%  Similarity=0.425  Sum_probs=80.5

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|+++ .++  .+..+++|+.|+|++|.+++..|  +..+++|+.|+|++|.+++..|  +..+++|+.|+
T Consensus       221 ~~L~~L~l~~n~l~-~~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~  293 (466)
T 1o6v_A          221 TNLDELSLNGNQLK-DIG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE  293 (466)
T ss_dssp             TTCCEEECCSSCCC-CCG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred             CCCCEEECCCCCcc-cch--hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEE
Confidence            45777777777776 343  35667777777777777766433  6666777777777777665443  56666666666


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGS  205 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~  205 (663)
                      |++|++++..|  +..+++|+.|+|++|++++..|  +..+++|+.|++++|++++.
T Consensus       294 L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~  346 (466)
T 1o6v_A          294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV  346 (466)
T ss_dssp             CCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred             cCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc
Confidence            66666665433  5666666666666666665554  45666666666666666643

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.54  E-value=1.1e-14  Score=146.27  Aligned_cols=126  Identities=24%  Similarity=0.311  Sum_probs=111.4

Q ss_pred             CCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccc
Q 006055           68 QNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        68 ~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  147 (663)
                      ..+++.|+|++|+++ .+|+  +.++++|+.|+|++|+|++ +|. +.. ++|+.|+|++|++++ +| .+..+++|+.|
T Consensus        62 l~~L~~L~L~~N~i~-~~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L  133 (263)
T 1xeu_A           62 FTNLKELHLSHNQIS-DLSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEIL  133 (263)
T ss_dssp             CTTCCEEECCSSCCC-CCGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEE
T ss_pred             CCCCCEEECCCCccC-CChh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEE
Confidence            368999999999999 5665  7999999999999999998 454 333 999999999999996 44 58999999999


Q ss_pred             ccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCC
Q 006055          148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGS  205 (663)
Q Consensus       148 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~  205 (663)
                      +|++|+|++. | .+..+++|++|+|++|+|++.  ..+..+++|+.|++++|++++.
T Consensus       134 ~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          134 SIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             ECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             ECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence            9999999964 4 699999999999999999976  6688999999999999999966

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.54  E-value=1.1e-14  Score=136.55  Aligned_cols=107  Identities=23%  Similarity=0.301  Sum_probs=97.2

Q ss_pred             CEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccc
Q 006055           97 RTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENN  176 (663)
Q Consensus        97 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N  176 (663)
                      +.+++++|+|+. +|..+.  ++|+.|+|++|+|++.+|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus        15 ~~l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLAS-VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCCc-cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            689999999975 787765  89999999999999988999999999999999999999766666899999999999999


Q ss_pred             cccCcCCCCCCCCCCCCEEEeecCcCCCCC
Q 006055          177 RLSGSIPGFDDVLPNLQQLNVSNNLLNGSI  206 (663)
Q Consensus       177 ~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~  206 (663)
                      +|++..+..|..+++|+.|+|++|+|....
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~  121 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCEC  121 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCccccc
Confidence            999777777999999999999999998543

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.53  E-value=1.5e-14  Score=160.38  Aligned_cols=136  Identities=29%  Similarity=0.351  Sum_probs=106.3

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|+|+ .+|    +.+++|+.|+|++|+|++ +|. |.+  +|++|+|++|+|++ +|.   .+++|+.|+
T Consensus        80 ~~L~~L~Ls~N~l~-~ip----~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~  146 (571)
T 3cvr_A           80 PQITVLEITQNALI-SLP----ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYIN  146 (571)
T ss_dssp             TTCSEEECCSSCCS-CCC----CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred             CCCCEEECcCCCCc-ccc----cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEe
Confidence            56899999999998 788    347899999999999988 777 665  89999999999986 666   678899999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccc-cC-------CCCCccC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQ-TF-------GSNSFLG  220 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~~-------~~~~~~~  220 (663)
                      |++|+|++ +|.   .+++|++|+|++|+|++ +|. |.  ++|+.|+|++|+|+ .+|. |. ++       ..+.+.+
T Consensus       147 Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~~L~~~~~~L~~L~Ls~  216 (571)
T 3cvr_A          147 ADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPVRNHHSEETEIFFRCRE  216 (571)
T ss_dssp             CCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC--------CCEEEECCS
T ss_pred             CCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHHhhhcccccceEEecCC
Confidence            99999985 666   57889999999999986 666 55  88999999999988 6666 43 33       3344455


Q ss_pred             CcCCCCC
Q 006055          221 NSLCGKP  227 (663)
Q Consensus       221 ~~l~~~p  227 (663)
                      |.+...|
T Consensus       217 N~l~~lp  223 (571)
T 3cvr_A          217 NRITHIP  223 (571)
T ss_dssp             SCCCCCC
T ss_pred             CcceecC
Confidence            6555443

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.53  E-value=6.3e-15  Score=154.29  Aligned_cols=146  Identities=27%  Similarity=0.319  Sum_probs=102.6

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|.+. .++.  +..+++|+.|++++|.+++..+  +..+++|+.|+|++|.+++..+  +..+++|+.|+
T Consensus       177 ~~L~~L~l~~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~  249 (347)
T 4fmz_A          177 TDLYSLSLNYNQIE-DISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLE  249 (347)
T ss_dssp             TTCSEEECTTSCCC-CCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             CCCCEEEccCCccc-cccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEE
Confidence            56888888888887 4553  5777888888888887776443  7777788888888887775444  77777778888


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc---cCCcCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF---LGNSLCG  225 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~---~~~~l~~  225 (663)
                      |++|++++.  +.+..+++|++|+|++|++++. | .+..+++|+.|++++|++++..|..|..++.+..   .+|.+.+
T Consensus       250 l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~  325 (347)
T 4fmz_A          250 IGTNQISDI--NAVKDLTKLKMLNVGSNQISDI-S-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD  325 (347)
T ss_dssp             CCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCC
T ss_pred             CCCCccCCC--hhHhcCCCcCEEEccCCccCCC-h-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcccc
Confidence            887777743  3577777777777777777753 2 4667777777777777777776666665555443   4454444

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.51  E-value=1.1e-14  Score=163.42  Aligned_cols=153  Identities=27%  Similarity=0.412  Sum_probs=111.0

Q ss_pred             CcCCCCCCCccceeE--------ecCCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCce
Q 006055           51 WNVYEASPCKWAGVE--------CEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRN  122 (663)
Q Consensus        51 w~~~~~~~c~w~gv~--------c~~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  122 (663)
                      |.. ..+||.|.|..        |...+++.|++++|+|+ .+|..+.   ++|+.|+|++|+|+. +|.   .+++|++
T Consensus        15 W~~-~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~---~~L~~L~L~~N~l~~-lp~---~l~~L~~   85 (622)
T 3g06_A           15 WRR-AAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLTS-LPA---LPPELRT   85 (622)
T ss_dssp             HHH-TCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC---TTCSEEEECSCCCSC-CCC---CCTTCCE
T ss_pred             HHh-cCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC---CCCcEEEecCCCCCC-CCC---cCCCCCE
Confidence            543 34588997653        33457899999999998 8987543   899999999999986 665   5789999


Q ss_pred             EEcccccccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcC
Q 006055          123 LYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLL  202 (663)
Q Consensus       123 L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l  202 (663)
                      |+|++|+|+ .+|.   .+++|++|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|..   +++|++|+|++|++
T Consensus        86 L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l  153 (622)
T 3g06_A           86 LEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQL  153 (622)
T ss_dssp             EEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCC
T ss_pred             EEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcC
Confidence            999999998 4665   67889999999999884 555   45778888888888874 5543   47777788888777


Q ss_pred             CCCCCcccccCCCCCccCCcCCC
Q 006055          203 NGSIPKRFQTFGSNSFLGNSLCG  225 (663)
Q Consensus       203 ~g~~p~~~~~~~~~~~~~~~l~~  225 (663)
                      ++ +|..+.++..+.+.+|.+.+
T Consensus       154 ~~-l~~~~~~L~~L~L~~N~l~~  175 (622)
T 3g06_A          154 AS-LPALPSELCKLWAYNNQLTS  175 (622)
T ss_dssp             SC-CCCCCTTCCEEECCSSCCSC
T ss_pred             CC-cCCccCCCCEEECCCCCCCC
Confidence            74 45445555544444444443

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.51  E-value=6e-14  Score=152.40  Aligned_cols=144  Identities=17%  Similarity=0.129  Sum_probs=110.7

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|++++ +|   ++.+++|+.|+|++|+|++. |  ++++++|++|+|++|+..+.+  .+..+++|+.|+
T Consensus       106 ~~L~~L~L~~N~l~~-l~---~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~  176 (457)
T 3bz5_A          106 TKLTYLNCDTNKLTK-LD---VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLD  176 (457)
T ss_dssp             TTCCEEECCSSCCSC-CC---CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEE
T ss_pred             CcCCEEECCCCcCCe-ec---CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEE
Confidence            579999999999985 65   68999999999999999883 3  888888888888888666666  377888888888


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCC---CccCCcCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSN---SFLGNSLCG  225 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~---~~~~~~l~~  225 (663)
                      |++|++++ +|  +..+++|+.|++++|+|++. +  +..+++|+.|++++|++++ +|  +..++.+   .+.+|.+.+
T Consensus       177 ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~--l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~  247 (457)
T 3bz5_A          177 CSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-D--LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTE  247 (457)
T ss_dssp             CCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC
T ss_pred             CCCCccce-ec--cccCCCCCEEECcCCcCCee-c--cccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCC
Confidence            88888885 45  77888888888888888854 3  6778888888888888886 45  4444443   346667776


Q ss_pred             CCCCC
Q 006055          226 KPLQD  230 (663)
Q Consensus       226 ~p~~~  230 (663)
                      .|...
T Consensus       248 ~~~~~  252 (457)
T 3bz5_A          248 LDVST  252 (457)
T ss_dssp             CCCTT
T ss_pred             cCHHH
Confidence            65443

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.51  E-value=5.1e-14  Score=152.84  Aligned_cols=120  Identities=23%  Similarity=0.380  Sum_probs=66.9

Q ss_pred             cEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccccc
Q 006055           70 RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL  149 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  149 (663)
                      +++.|+|++|+++ .+|.    ..++|++|+|++|++++ +| .|+++++|++|+|++|++++ +|..+   .+|++|++
T Consensus       112 ~L~~L~l~~n~l~-~l~~----~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L  180 (454)
T 1jl5_A          112 SLKSLLVDNNNLK-ALSD----LPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAA  180 (454)
T ss_dssp             TCCEEECCSSCCS-CCCS----CCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEEC
T ss_pred             CCcEEECCCCccC-cccC----CCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEEC
Confidence            4555555555554 2332    11466666666666665 55 46666666666666666664 44322   35666666


Q ss_pred             ccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCC
Q 006055          150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP  207 (663)
Q Consensus       150 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p  207 (663)
                      ++|++++ +| .++++++|++|++++|++++ +|...   ++|+.|++++|+++ .+|
T Consensus       181 ~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp  231 (454)
T 1jl5_A          181 GNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP  231 (454)
T ss_dssp             CSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC
T ss_pred             cCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc
Confidence            6666664 44 46666666666666666653 33321   35555555555555 444

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.50  E-value=7.3e-14  Score=151.72  Aligned_cols=148  Identities=19%  Similarity=0.124  Sum_probs=124.3

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|.+++ +|   ++++++|++|+|++|+|++ +|  ++++++|++|+|++|++++. |  ++.+++|+.|+
T Consensus        85 ~~L~~L~Ls~N~l~~-~~---~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~  154 (457)
T 3bz5_A           85 TNLTYLACDSNKLTN-LD---VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELD  154 (457)
T ss_dssp             TTCSEEECCSSCCSC-CC---CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEE
T ss_pred             CCCCEEECcCCCCce-ee---cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEE
Confidence            689999999999995 54   7899999999999999998 45  99999999999999999974 4  88999999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCccCCcCCCCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPL  228 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~l~~~p~  228 (663)
                      +++|+..+.+  .++.+++|++|+|++|+|++ +|  +..+++|+.|++++|++++..-..+.++..+.+.+|.+.+.|+
T Consensus       155 l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~~l~~l~~L~~L~Ls~N~l~~ip~  229 (457)
T 3bz5_A          155 CHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLTEIDV  229 (457)
T ss_dssp             CTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCCCCTTCTTCSEEECCSSCCSCCCC
T ss_pred             CCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCeeccccCCCCCEEECcCCcccccCc
Confidence            9999776676  48899999999999999996 56  7899999999999999997622223334444557788888775


Q ss_pred             CCC
Q 006055          229 QDC  231 (663)
Q Consensus       229 ~~c  231 (663)
                      ..|
T Consensus       230 ~~l  232 (457)
T 3bz5_A          230 TPL  232 (457)
T ss_dssp             TTC
T ss_pred             ccc
Confidence            443

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.50  E-value=1.4e-14  Score=161.09  Aligned_cols=133  Identities=26%  Similarity=0.342  Sum_probs=92.0

Q ss_pred             ccCCCCCCCEEE-ccCCCCCCCCCc------cccC--CCCCceEEcccccccCchhhhhcCCccccccccccccccccCC
Q 006055           89 ILGNLTSLRTLS-LRFNSLTSQLPS------DLAS--CSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIP  159 (663)
Q Consensus        89 ~~~~l~~L~~L~-L~~N~l~~~~p~------~~~~--l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  159 (663)
                      .++++++|+.|+ ++.|.+.. ++.      .+..  ...|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|
T Consensus       404 ~l~~l~~L~~L~~l~~n~~~~-L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp  479 (567)
T 1dce_A          404 TLQYFSTLKAVDPMRAAYLDD-LRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALP  479 (567)
T ss_dssp             HHHHHHHHHHHCGGGHHHHHH-HHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCC
T ss_pred             HHHHHHhcccCcchhhcccch-hhhhhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccc
Confidence            456677777777 45543321 110      0111  1257888888888885 565 788888888888888888 778


Q ss_pred             CCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCC-CcccccCCCCCc---cCCcCCCCC
Q 006055          160 SGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSI-PKRFQTFGSNSF---LGNSLCGKP  227 (663)
Q Consensus       160 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~-p~~~~~~~~~~~---~~~~l~~~p  227 (663)
                      ..|+++++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.+ |..|..++.+..   .+|.+++.|
T Consensus       480 ~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~  549 (567)
T 1dce_A          480 PALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE  549 (567)
T ss_dssp             GGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred             hhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence            888888888888888888885 56 6778888888888888888776 777776666543   556665544

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.49  E-value=4.5e-14  Score=154.11  Aligned_cols=146  Identities=33%  Similarity=0.391  Sum_probs=119.7

Q ss_pred             CCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccc
Q 006055           68 QNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        68 ~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  147 (663)
                      ..+++.|+|++|.+++..|   ++.+++|+.|+|++|++++.  ..+..+++|+.|+|++|.+++..|  +..+++|+.|
T Consensus       198 l~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L  270 (466)
T 1o6v_A          198 LTNLESLIATNNQISDITP---LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL  270 (466)
T ss_dssp             CTTCSEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEE
T ss_pred             CCCCCEEEecCCccccccc---ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEE
Confidence            3679999999999986544   57899999999999999873  468899999999999999997665  8899999999


Q ss_pred             ccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCC---CCccCCcCC
Q 006055          148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGS---NSFLGNSLC  224 (663)
Q Consensus       148 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~---~~~~~~~l~  224 (663)
                      +|++|++++..|  +..+++|+.|+|++|++++..|  +..+++|+.|+|++|++++..|  +..++.   +.+.+|.+.
T Consensus       271 ~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~  344 (466)
T 1o6v_A          271 KLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVS  344 (466)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCC
T ss_pred             ECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccC
Confidence            999999986544  8899999999999999997655  7889999999999999998766  444444   444666666


Q ss_pred             CC
Q 006055          225 GK  226 (663)
Q Consensus       225 ~~  226 (663)
                      +.
T Consensus       345 ~~  346 (466)
T 1o6v_A          345 DV  346 (466)
T ss_dssp             CC
T ss_pred             Cc
Confidence            54

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.49  E-value=1.2e-14  Score=136.43  Aligned_cols=124  Identities=19%  Similarity=0.108  Sum_probs=104.8

Q ss_pred             cCCCCCCCEEEccCCCCCCCCCccccCCC-CCceEEcccccccCchhhhhcCCccccccccccccccccCCCCCcccccc
Q 006055           90 LGNLTSLRTLSLRFNSLTSQLPSDLASCS-NLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKL  168 (663)
Q Consensus        90 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L  168 (663)
                      +.++++|+.|+|++|+|+. +|. +..+. +|++|+|++|.|++.  ..|..+++|+.|+|++|+|++..|..|..+++|
T Consensus        15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   90 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   90 (176)
T ss_dssp             EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence            5789999999999999996 454 55555 999999999999965  678999999999999999996544445999999


Q ss_pred             cccccccccccCcCCC--CCCCCCCCCEEEeecCcCCCCCCcc----cccCCCCCcc
Q 006055          169 KTLFLENNRLSGSIPG--FDDVLPNLQQLNVSNNLLNGSIPKR----FQTFGSNSFL  219 (663)
Q Consensus       169 ~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~g~~p~~----~~~~~~~~~~  219 (663)
                      ++|+|++|+|+ .+|.  .+..+++|+.|++++|+++ .+|..    +..++.+...
T Consensus        91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~L  145 (176)
T 1a9n_A           91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVL  145 (176)
T ss_dssp             CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEE
T ss_pred             CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCcccee
Confidence            99999999997 5665  7889999999999999998 55654    6777766553

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.48  E-value=3.8e-14  Score=148.30  Aligned_cols=144  Identities=24%  Similarity=0.346  Sum_probs=110.0

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|++++|.+. .++.  +..+++|+.|+|++|.+++..+  +..+++|+.|++++|.+++..+  +..+++|+.|+
T Consensus       155 ~~L~~L~l~~~~~~-~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~  227 (347)
T 4fmz_A          155 TGLNYLTVTESKVK-DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLK  227 (347)
T ss_dssp             TTCCEEECCSSCCC-CCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEE
T ss_pred             CCCcEEEecCCCcC-Cchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEE
Confidence            57888999988887 4443  6788899999999998887433  8888899999999998886555  78888999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCC---ccCCcCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNS---FLGNSLCG  225 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~---~~~~~l~~  225 (663)
                      |++|++++..+  +..+++|++|+|++|++++.  +.+..+++|+.|++++|++++. | .+..++.+.   +.+|.+.+
T Consensus       228 l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~L~~n~l~~  301 (347)
T 4fmz_A          228 IGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI-S-VLNNLSQLNSLFLNNNQLGN  301 (347)
T ss_dssp             CCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEEECCSSCCCG
T ss_pred             ccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC-h-hhcCCCCCCEEECcCCcCCC
Confidence            99998885443  88888999999999988853  3577888999999999988864 3 354444443   35555543

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.46  E-value=1.6e-13  Score=148.89  Aligned_cols=141  Identities=23%  Similarity=0.234  Sum_probs=102.3

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|.+++ +|.    .+++|+.|+|++|++++ +|..   .++|++|+|++|++++ +| .|+++++|++|+
T Consensus        91 ~~L~~L~l~~n~l~~-lp~----~~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~  159 (454)
T 1jl5_A           91 PHLESLVASCNSLTE-LPE----LPQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIID  159 (454)
T ss_dssp             TTCSEEECCSSCCSS-CCC----CCTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEE
T ss_pred             CCCCEEEccCCcCCc-ccc----ccCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEE
Confidence            567788888888875 664    23778888888888876 3322   1678888888888885 66 588888888888


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCccCCcCCCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKP  227 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~l~~~p  227 (663)
                      +++|++++ +|..+   .+|++|+|++|++++ +| .+..+++|+.|++++|++++ +|....++..+.+.+|.+...|
T Consensus       160 l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~~~L~~L~l~~n~l~~lp  231 (454)
T 1jl5_A          160 VDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLPLSLESIVAGNNILEELP  231 (454)
T ss_dssp             CCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCCTTCCEEECCSSCCSSCC
T ss_pred             CCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCcCcccEEECcCCcCCccc
Confidence            88888884 66544   478888888888885 56 47888888888888888885 5655556666666666655433

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.46  E-value=1.3e-15  Score=158.60  Aligned_cols=145  Identities=21%  Similarity=0.245  Sum_probs=94.8

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCC-CCccccCCCCCceEEcccccccCchhhhhcCCcccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQ-LPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  147 (663)
                      .+++.|+|++|.+.+..+.  +..+++|+.|+|++|.+++. +|..+..+++|++|+|++|.+++..|..+..+++|+.|
T Consensus        70 ~~l~~L~l~~n~l~~~~~~--~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L  147 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL  147 (336)
T ss_dssp             TTCSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEE
T ss_pred             ccceEEEcCCccccccchh--hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEE
Confidence            4577777777777765554  35677777777777777654 66667777777777777777776677777777777777


Q ss_pred             ccccc-ccccc-CCCCCcccccccccccccc-cccCc-CCCCCCCCC-CCCEEEeecC--cCC-CCCCcccccCCC
Q 006055          148 NLATN-NFSGE-IPSGFKNLTKLKTLFLENN-RLSGS-IPGFDDVLP-NLQQLNVSNN--LLN-GSIPKRFQTFGS  215 (663)
Q Consensus       148 ~l~~N-~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~-~L~~L~l~~N--~l~-g~~p~~~~~~~~  215 (663)
                      +|++| .+++. +|..+.++++|++|+|++| .+++. ++..+..++ +|+.|+|++|  .++ +.+|..+..++.
T Consensus       148 ~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~  223 (336)
T 2ast_B          148 NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPN  223 (336)
T ss_dssp             ECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTT
T ss_pred             ECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCC
Confidence            77777 56542 4555666777777777777 66643 455556666 6777777776  344 334444433333

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.45  E-value=6.5e-14  Score=146.60  Aligned_cols=108  Identities=25%  Similarity=0.237  Sum_probs=86.0

Q ss_pred             CccceeEecCCcEEEEEcCCC-CcccccCccccCCCCCCCEEEccC-CCCCCCCCccccCCCCCceEEcccccccCchhh
Q 006055           59 CKWAGVECEQNRVTMLRLPGV-ALSGQIPLGILGNLTSLRTLSLRF-NSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPL  136 (663)
Q Consensus        59 c~w~gv~c~~~~v~~L~L~~~-~l~g~~p~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  136 (663)
                      |.|..|.|.          ++ +|+ .||.  +..+++|+.|+|++ |.|++..|..|.+|++|+.|+|++|+|++.+|.
T Consensus         8 C~~~~v~~~----------~~n~l~-~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~   74 (347)
T 2ifg_A            8 HGSSGLRCT----------RDGALD-SLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD   74 (347)
T ss_dssp             SSSSCEECC----------SSCCCT-TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred             ccCCEEEcC----------CCCCCC-ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence            777777764          34 676 6886  78889999999986 999887778888999999999999999888888


Q ss_pred             hhcCCccccccccccccccccCCCCCcccccccccccccccccC
Q 006055          137 FLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSG  180 (663)
Q Consensus       137 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  180 (663)
                      .|.+|++|+.|+|++|+|++..+..|..++ |+.|+|++|.|..
T Consensus        75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c  117 (347)
T 2ifg_A           75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC  117 (347)
T ss_dssp             GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred             HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence            888888888888888888855555555555 7888888887763

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.44  E-value=1.3e-15  Score=158.65  Aligned_cols=139  Identities=17%  Similarity=0.184  Sum_probs=66.1

Q ss_pred             ccceeEecCCcEEEEEcCCCCcccccCccccCCC--CCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCc-hhh
Q 006055           60 KWAGVECEQNRVTMLRLPGVALSGQIPLGILGNL--TSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGE-VPL  136 (663)
Q Consensus        60 ~w~gv~c~~~~v~~L~L~~~~l~g~~p~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~  136 (663)
                      .|.++.|+...++.|+|+++.+.+    ..+..+  ++|+.|+|++|.+++..+. +.++++|++|+|++|.+++. +|.
T Consensus        38 ~W~~~~~~~~~~~~l~l~~~~~~~----~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~  112 (336)
T 2ast_B           38 RWYRLASDESLWQTLDLTGKNLHP----DVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHG  112 (336)
T ss_dssp             HHHHHHTCSTTSSEEECTTCBCCH----HHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHH
T ss_pred             HHHHHhcCchhheeeccccccCCH----HHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHH
Confidence            455554444444455555544431    123333  4555555555555443332 33445555555555555433 444


Q ss_pred             hhcCCccccccccccccccccCCCCCcccccccccccccc-cccC-cCCCCCCCCCCCCEEEeecC-cCC
Q 006055          137 FLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENN-RLSG-SIPGFDDVLPNLQQLNVSNN-LLN  203 (663)
Q Consensus       137 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~-~~p~~~~~l~~L~~L~l~~N-~l~  203 (663)
                      .+..+++|+.|+|++|++++..|..++++++|++|+|++| .+++ .+|..+..+++|++|+|++| .++
T Consensus       113 ~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~  182 (336)
T 2ast_B          113 ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFT  182 (336)
T ss_dssp             HHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCC
T ss_pred             HHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcC
Confidence            4555555555555555554444444444555555555555 3443 13333444555555555555 444

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.42  E-value=1.7e-13  Score=143.38  Aligned_cols=107  Identities=28%  Similarity=0.271  Sum_probs=97.5

Q ss_pred             CEEEccCC-CCCCCCCccccCCCCCceEEccc-ccccCchhhhhcCCccccccccccccccccCCCCCcccccccccccc
Q 006055           97 RTLSLRFN-SLTSQLPSDLASCSNLRNLYLQG-NHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLE  174 (663)
Q Consensus        97 ~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~  174 (663)
                      ..++++++ +|++ +|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|.+|++|++|+|+
T Consensus        11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            35799998 8987 788 99999999999996 99998888999999999999999999999889999999999999999


Q ss_pred             cccccCcCCCCCCCCCCCCEEEeecCcCCCCC
Q 006055          175 NNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSI  206 (663)
Q Consensus       175 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~  206 (663)
                      +|+|++..+..|..++ |+.|+|++|+|...-
T Consensus        89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c  119 (347)
T 2ifg_A           89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSC  119 (347)
T ss_dssp             SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCG
T ss_pred             CCccceeCHHHcccCC-ceEEEeeCCCccCCC
Confidence            9999977777777776 999999999998643

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.42  E-value=6.8e-15  Score=156.52  Aligned_cols=150  Identities=17%  Similarity=0.252  Sum_probs=98.9

Q ss_pred             CcEEEEEcCCC---CcccccCccc------cCCCCCCCEEEccCCCCCC----CCCccccCCCCCceEEcccccccCchh
Q 006055           69 NRVTMLRLPGV---ALSGQIPLGI------LGNLTSLRTLSLRFNSLTS----QLPSDLASCSNLRNLYLQGNHFSGEVP  135 (663)
Q Consensus        69 ~~v~~L~L~~~---~l~g~~p~~~------~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p  135 (663)
                      .+++.|+|++|   +++|.+|.++      |..+++|++|+|++|.|++    .+|..+.++++|++|+|++|.+++..+
T Consensus        60 ~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~  139 (386)
T 2ca6_A           60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG  139 (386)
T ss_dssp             TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred             CCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHH
Confidence            46777777774   4555566533      3677777777777777776    456667777777777777777764433


Q ss_pred             hhhc----CC---------cccccccccccccc-ccCC---CCCccccccccccccccccc--C---cCCCCCCCCCCCC
Q 006055          136 LFLV----GL---------HHLVRLNLATNNFS-GEIP---SGFKNLTKLKTLFLENNRLS--G---SIPGFDDVLPNLQ  193 (663)
Q Consensus       136 ~~~~----~l---------~~L~~L~l~~N~l~-~~~p---~~~~~l~~L~~L~l~~N~l~--~---~~p~~~~~l~~L~  193 (663)
                      ..+.    .+         ++|+.|+|++|+++ +.+|   ..+..+++|++|+|++|+|+  |   .+|..+..+++|+
T Consensus       140 ~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~  219 (386)
T 2ca6_A          140 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK  219 (386)
T ss_dssp             HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCC
T ss_pred             HHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCcc
Confidence            3333    33         77777777777776 3344   35566777777777777776  3   3454667777788


Q ss_pred             EEEeecCcCC----CCCCcccccCCCCCc
Q 006055          194 QLNVSNNLLN----GSIPKRFQTFGSNSF  218 (663)
Q Consensus       194 ~L~l~~N~l~----g~~p~~~~~~~~~~~  218 (663)
                      .|+|++|+++    +.+|..+..++.+..
T Consensus       220 ~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~  248 (386)
T 2ca6_A          220 VLDLQDNTFTHLGSSALAIALKSWPNLRE  248 (386)
T ss_dssp             EEECCSSCCHHHHHHHHHHHGGGCTTCCE
T ss_pred             EEECcCCCCCcHHHHHHHHHHccCCCcCE
Confidence            8888888775    456666655554443

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.40  E-value=4.2e-15  Score=158.12  Aligned_cols=136  Identities=22%  Similarity=0.306  Sum_probs=104.2

Q ss_pred             CcEEEEEcCCCCccc----ccCccccCCCCCCCEEEccCCCCCCCCCccc----cCC---------CCCceEEccccccc
Q 006055           69 NRVTMLRLPGVALSG----QIPLGILGNLTSLRTLSLRFNSLTSQLPSDL----ASC---------SNLRNLYLQGNHFS  131 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g----~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~----~~l---------~~L~~L~L~~N~l~  131 (663)
                      .+++.|+|++|.+++    .+|. .+.++++|++|+|++|.|++..+..+    ..+         ++|++|+|++|+++
T Consensus        94 ~~L~~L~Ls~n~l~~~~~~~l~~-~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~  172 (386)
T 2ca6_A           94 PKLHTVRLSDNAFGPTAQEPLID-FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE  172 (386)
T ss_dssp             TTCCEEECCSCCCCTTTHHHHHH-HHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCT
T ss_pred             CcccEEECCCCcCCHHHHHHHHH-HHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCC
Confidence            678888888888886    3664 46788888888888888864433333    333         78888888888887


Q ss_pred             -Cchh---hhhcCCcccccccccccccc--c---cCCCCCccccccccccccccccc----CcCCCCCCCCCCCCEEEee
Q 006055          132 -GEVP---LFLVGLHHLVRLNLATNNFS--G---EIPSGFKNLTKLKTLFLENNRLS----GSIPGFDDVLPNLQQLNVS  198 (663)
Q Consensus       132 -~~~p---~~~~~l~~L~~L~l~~N~l~--~---~~p~~~~~l~~L~~L~l~~N~l~----~~~p~~~~~l~~L~~L~l~  198 (663)
                       +.+|   ..+..+++|+.|+|++|+|+  |   .+|..+.++++|++|+|++|.|+    +.+|..+..+++|+.|+|+
T Consensus       173 ~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~  252 (386)
T 2ca6_A          173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN  252 (386)
T ss_dssp             GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECT
T ss_pred             cHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECC
Confidence             4555   46777888888888888887  3   45557888888888888888886    5677777888888888888


Q ss_pred             cCcCCCC
Q 006055          199 NNLLNGS  205 (663)
Q Consensus       199 ~N~l~g~  205 (663)
                      +|++++.
T Consensus       253 ~n~i~~~  259 (386)
T 2ca6_A          253 DCLLSAR  259 (386)
T ss_dssp             TCCCCHH
T ss_pred             CCCCchh
Confidence            8888765

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.39  E-value=9.2e-13  Score=147.73  Aligned_cols=94  Identities=29%  Similarity=0.369  Sum_probs=60.3

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|+|+ .+|.    .+++|++|+|++|+|++ +|.   .+++|++|+|++|.+++ +|.   .+++|+.|+
T Consensus        61 ~~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~  127 (622)
T 3g06_A           61 AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLW  127 (622)
T ss_dssp             TTCSEEEECSCCCS-CCCC----CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEE
T ss_pred             CCCcEEEecCCCCC-CCCC----cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEE
Confidence            46777888888777 6664    46777777777777775 554   56777777777777764 333   445666666


Q ss_pred             cccccccccCCCCCccccccccccccccccc
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLS  179 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  179 (663)
                      |++|+|++ +|..   +++|++|+|++|+|+
T Consensus       128 L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~  154 (622)
T 3g06_A          128 IFGNQLTS-LPVL---PPGLQELSVSDNQLA  154 (622)
T ss_dssp             CCSSCCSC-CCCC---CTTCCEEECCSSCCS
T ss_pred             CCCCCCCc-CCCC---CCCCCEEECcCCcCC
Confidence            66666653 4443   255556666666555

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.38  E-value=1.1e-14  Score=153.46  Aligned_cols=139  Identities=29%  Similarity=0.310  Sum_probs=87.9

Q ss_pred             CcEEEEEcCCCCcccccCc----cccCCCC-CCCEEEccCCCCCCCCCccccCC-----CCCceEEcccccccCchhhhh
Q 006055           69 NRVTMLRLPGVALSGQIPL----GILGNLT-SLRTLSLRFNSLTSQLPSDLASC-----SNLRNLYLQGNHFSGEVPLFL  138 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~  138 (663)
                      ..++.|+|++|.++ .++.    ..|..++ +|+.|+|++|.|++..+..|..+     ++|++|+|++|.+++..+..+
T Consensus        22 ~~L~~L~Ls~n~l~-~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l  100 (362)
T 3goz_A           22 HGVTSLDLSLNNLY-SISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL  100 (362)
T ss_dssp             TTCCEEECTTSCGG-GSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred             CCceEEEccCCCCC-hHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHH
Confidence            34777777777776 3443    3456666 77777777777776666666554     777777777777776665543


Q ss_pred             cC----C-ccccccccccccccccCCCCCc----c-cccccccccccccccCcC----CCCCCCCC-CCCEEEeecCcCC
Q 006055          139 VG----L-HHLVRLNLATNNFSGEIPSGFK----N-LTKLKTLFLENNRLSGSI----PGFDDVLP-NLQQLNVSNNLLN  203 (663)
Q Consensus       139 ~~----l-~~L~~L~l~~N~l~~~~p~~~~----~-l~~L~~L~l~~N~l~~~~----p~~~~~l~-~L~~L~l~~N~l~  203 (663)
                      ..    + ++|+.|+|++|+|++..+..+.    . .++|++|+|++|+|++..    +..+..++ +|+.|+|++|+++
T Consensus       101 ~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~  180 (362)
T 3goz_A          101 VKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA  180 (362)
T ss_dssp             HHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred             HHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCc
Confidence            33    3 6777777777777655443332    2 247777777777776422    22333444 7777777777777


Q ss_pred             CCCCc
Q 006055          204 GSIPK  208 (663)
Q Consensus       204 g~~p~  208 (663)
                      +..+.
T Consensus       181 ~~~~~  185 (362)
T 3goz_A          181 SKNCA  185 (362)
T ss_dssp             GSCHH
T ss_pred             hhhHH
Confidence            65553

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.38  E-value=9e-13  Score=138.11  Aligned_cols=144  Identities=14%  Similarity=0.157  Sum_probs=116.5

Q ss_pred             eEecCCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchh-hhhcCCc
Q 006055           64 VECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP-LFLVGLH  142 (663)
Q Consensus        64 v~c~~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~  142 (663)
                      -.|+..   .++-++++|+ .||.++   .++|+.|+|++|+|+.+.+..|.++++|++|+|++|++.+.+| ..|.+++
T Consensus         7 C~C~~~---~v~C~~~~Lt-~iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~   79 (350)
T 4ay9_X            7 CHCSNR---VFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP   79 (350)
T ss_dssp             SEEETT---EEEEESTTCC-SCCTTC---CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCT
T ss_pred             cEeeCC---EEEecCCCCC-ccCcCc---CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcch
Confidence            357653   4677899999 899754   4789999999999998666789999999999999999977676 4678898


Q ss_pred             cccc-cccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeec-CcCCCCCCcccccCC
Q 006055          143 HLVR-LNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSN-NLLNGSIPKRFQTFG  214 (663)
Q Consensus       143 ~L~~-L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~~~  214 (663)
                      +|+. +.+++|+|+...|..|.++++|++|++++|+|++..+..+....++..|++.+ |++....+..|..+.
T Consensus        80 ~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~  153 (350)
T 4ay9_X           80 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS  153 (350)
T ss_dssp             TCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB
T ss_pred             hhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcc
Confidence            8775 66778999988888999999999999999999977777777777888898876 566644445555543

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.38  E-value=3.2e-15  Score=143.38  Aligned_cols=128  Identities=23%  Similarity=0.275  Sum_probs=112.5

Q ss_pred             CCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccc
Q 006055           68 QNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRL  147 (663)
Q Consensus        68 ~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  147 (663)
                      ..+++.|+|++|++++ +|  .+.++++|+.|+|++|.|+. +|..+..+++|++|+|++|++++ +| .+..+++|+.|
T Consensus        47 l~~L~~L~ls~n~l~~-l~--~~~~l~~L~~L~l~~n~l~~-l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L  120 (198)
T 1ds9_A           47 LKACKHLALSTNNIEK-IS--SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVL  120 (198)
T ss_dssp             TTTCSEEECSEEEESC-CC--CHHHHTTCCEEEEEEEEECS-CSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEE
T ss_pred             CCCCCEEECCCCCCcc-cc--ccccCCCCCEEECCCCCccc-ccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEE
Confidence            4689999999999995 88  57999999999999999985 78888888999999999999996 66 68899999999


Q ss_pred             ccccccccccCC-CCCcccccccccccccccccCcCCCC----------CCCCCCCCEEEeecCcCC
Q 006055          148 NLATNNFSGEIP-SGFKNLTKLKTLFLENNRLSGSIPGF----------DDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       148 ~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~----------~~~l~~L~~L~l~~N~l~  203 (663)
                      +|++|++++..+ ..+..+++|++|+|++|++++.+|..          +..+++|+.||  +|.++
T Consensus       121 ~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          121 YMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             EESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             ECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence            999999985332 47889999999999999999887764          78899999987  77776

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.36  E-value=3e-14  Score=150.09  Aligned_cols=151  Identities=21%  Similarity=0.165  Sum_probs=119.7

Q ss_pred             EEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCC----ccccCCC-CCceEEcccccccCchhhhhcCC-----c
Q 006055           73 MLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLP----SDLASCS-NLRNLYLQGNHFSGEVPLFLVGL-----H  142 (663)
Q Consensus        73 ~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~  142 (663)
                      .++|+.|+++|.+|. .+...++|+.|+|++|.|++..+    ..|.+++ +|++|+|++|.+++..+..+..+     +
T Consensus         2 ~~~ls~n~~~~~~~~-~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~   80 (362)
T 3goz_A            2 NYKLTLHPGSNPVEE-FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA   80 (362)
T ss_dssp             EEECCCCTTCCHHHH-HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred             ccccccccchHHHHH-HHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence            367899999998886 56777779999999999998766    6788898 99999999999998888887775     9


Q ss_pred             cccccccccccccccCCCCCccc-----ccccccccccccccCcCCCC----CCC-CCCCCEEEeecCcCCCCCCccc--
Q 006055          143 HLVRLNLATNNFSGEIPSGFKNL-----TKLKTLFLENNRLSGSIPGF----DDV-LPNLQQLNVSNNLLNGSIPKRF--  210 (663)
Q Consensus       143 ~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~p~~----~~~-l~~L~~L~l~~N~l~g~~p~~~--  210 (663)
                      +|++|+|++|++++..+..+...     ++|++|+|++|+|++..+..    +.. .++|++|+|++|++++..+..+  
T Consensus        81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~  160 (362)
T 3goz_A           81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ  160 (362)
T ss_dssp             TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred             CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH
Confidence            99999999999997766655443     89999999999998765544    334 3699999999999996544332  


Q ss_pred             --c----cCCCCCccCCcCC
Q 006055          211 --Q----TFGSNSFLGNSLC  224 (663)
Q Consensus       211 --~----~~~~~~~~~~~l~  224 (663)
                        .    ++..+.+.+|.+.
T Consensus       161 ~l~~~~~~L~~L~Ls~n~l~  180 (362)
T 3goz_A          161 ILAAIPANVNSLNLRGNNLA  180 (362)
T ss_dssp             HHHTSCTTCCEEECTTSCGG
T ss_pred             HHhcCCccccEeeecCCCCc
Confidence              2    3444444555543

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.23  E-value=1.2e-13  Score=150.42  Aligned_cols=157  Identities=22%  Similarity=0.165  Sum_probs=117.5

Q ss_pred             CCcEEEEEcCCCCcccc----cCccccCCCCCCCEEEccCCCCCCC----CCccccCCCCCceEEcccccccCchhhhhc
Q 006055           68 QNRVTMLRLPGVALSGQ----IPLGILGNLTSLRTLSLRFNSLTSQ----LPSDLASCSNLRNLYLQGNHFSGEVPLFLV  139 (663)
Q Consensus        68 ~~~v~~L~L~~~~l~g~----~p~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  139 (663)
                      ..+++.|+|++|.+++.    +.+..+..+++|+.|+|++|.|+..    ++..+.++++|++|+|++|.+++..+..+.
T Consensus       226 ~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~  305 (461)
T 1z7x_W          226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC  305 (461)
T ss_dssp             CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHH
T ss_pred             CCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHH
Confidence            36799999999988753    2233455789999999999999864    577788899999999999999866555554


Q ss_pred             C-----Ccccccccccccccccc----CCCCCcccccccccccccccccCcCCCCCC-----CCCCCCEEEeecCcCCC-
Q 006055          140 G-----LHHLVRLNLATNNFSGE----IPSGFKNLTKLKTLFLENNRLSGSIPGFDD-----VLPNLQQLNVSNNLLNG-  204 (663)
Q Consensus       140 ~-----l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~l~~L~~L~l~~N~l~g-  204 (663)
                      .     .++|+.|+|++|.+++.    +|..+..+++|++|+|++|++++..+..+.     ..++|+.|+|++|++++ 
T Consensus       306 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~  385 (461)
T 1z7x_W          306 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS  385 (461)
T ss_dssp             HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHH
T ss_pred             HHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChh
Confidence            3     36899999999998865    566677789999999999998865443332     26789999999999986 


Q ss_pred             ---CCCcccccCCCCC---ccCCcCC
Q 006055          205 ---SIPKRFQTFGSNS---FLGNSLC  224 (663)
Q Consensus       205 ---~~p~~~~~~~~~~---~~~~~l~  224 (663)
                         .+|..+..++.+.   +.+|.+.
T Consensus       386 ~~~~l~~~l~~~~~L~~L~l~~N~i~  411 (461)
T 1z7x_W          386 SCSSLAATLLANHSLRELDLSNNCLG  411 (461)
T ss_dssp             HHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred             hHHHHHHHHHhCCCccEEECCCCCCC
Confidence               6777665555544   3455544

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.21  E-value=1.4e-13  Score=149.89  Aligned_cols=155  Identities=20%  Similarity=0.215  Sum_probs=120.9

Q ss_pred             CcEEEEEcCCCCcccc----cCccccCCCCCCCEEEccCCCCCCCC-----CccccCCCCCceEEcccccccCc----hh
Q 006055           69 NRVTMLRLPGVALSGQ----IPLGILGNLTSLRTLSLRFNSLTSQL-----PSDLASCSNLRNLYLQGNHFSGE----VP  135 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~----~p~~~~~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~L~~N~l~~~----~p  135 (663)
                      .+++.|+|++|++++.    ++. .+..+++|+.|+|++|.+++..     +..+..+++|++|+|++|.+++.    ++
T Consensus       199 ~~L~~L~L~~n~l~~~~~~~l~~-~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~  277 (461)
T 1z7x_W          199 CQLEALKLESCGVTSDNCRDLCG-IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC  277 (461)
T ss_dssp             CCCCEEECTTSCCBTTHHHHHHH-HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred             CCceEEEccCCCCcHHHHHHHHH-HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHH
Confidence            4899999999999853    554 5678999999999999987632     33344689999999999999964    78


Q ss_pred             hhhcCCccccccccccccccccCCCCCcc-----cccccccccccccccCc----CCCCCCCCCCCCEEEeecCcCCCCC
Q 006055          136 LFLVGLHHLVRLNLATNNFSGEIPSGFKN-----LTKLKTLFLENNRLSGS----IPGFDDVLPNLQQLNVSNNLLNGSI  206 (663)
Q Consensus       136 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~g~~  206 (663)
                      ..+..+++|+.|+|++|++++..+..+..     .++|++|+|++|.+++.    ++..+..+++|+.|+|++|++++..
T Consensus       278 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~  357 (461)
T 1z7x_W          278 RVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAG  357 (461)
T ss_dssp             HHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHH
T ss_pred             HHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccccc
Confidence            88888999999999999997554444433     36999999999999865    5666778899999999999998765


Q ss_pred             Ccccc--------cCCCCCccCCcCC
Q 006055          207 PKRFQ--------TFGSNSFLGNSLC  224 (663)
Q Consensus       207 p~~~~--------~~~~~~~~~~~l~  224 (663)
                      +..+.        ++..+.+.+|.+.
T Consensus       358 ~~~l~~~l~~~~~~L~~L~L~~n~i~  383 (461)
T 1z7x_W          358 VRELCQGLGQPGSVLRVLWLADCDVS  383 (461)
T ss_dssp             HHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred             HHHHHHHHcCCCCceEEEECCCCCCC
Confidence            54332        4444555555554

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.16  E-value=4.4e-11  Score=124.03  Aligned_cols=54  Identities=15%  Similarity=0.171  Sum_probs=39.0

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEE
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLY  124 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  124 (663)
                      .+++.|+|++ +++ .|+..+|.++++|+.|+|++|.++...+..|.++.++..|.
T Consensus       101 ~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~  154 (329)
T 3sb4_A          101 QTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIP  154 (329)
T ss_dssp             TTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEEC
T ss_pred             CCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEec
Confidence            5788899988 887 88888899999999999999987654444444444333333

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.13  E-value=1.4e-10  Score=116.13  Aligned_cols=134  Identities=14%  Similarity=0.024  Sum_probs=104.1

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCC-CCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      ..++.|+.+.||++... ++.+++|+..... .....+.+|+++++.+. +..+.++++++.+....++||||+++.+|.
T Consensus        20 ~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   98 (263)
T 3tm0_A           20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS   98 (263)
T ss_dssp             ECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred             eeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence            35777888999999855 7899999986531 22346888999998884 667788999998888899999999999998


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG-------------------------------------------  490 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-------------------------------------------  490 (663)
                      +.....          .....++.+++++|..||+..                                           
T Consensus        99 ~~~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (263)
T 3tm0_A           99 EEYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR  168 (263)
T ss_dssp             HHCCTT----------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred             hccCCc----------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence            764211          123467888999999999810                                           


Q ss_pred             --------------CcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          491 --------------PNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       491 --------------~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                                    +.++|+|++|.||+++++..+.|+||+.+.
T Consensus       169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                          238999999999999876556799998774

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=99.10  E-value=4.3e-13  Score=133.17  Aligned_cols=158  Identities=18%  Similarity=0.173  Sum_probs=106.6

Q ss_pred             CCccceeEecCC--cEEEEEcCC---CCcccccCccccCCCCCCCEEEccCCCCCCCCCc-cccCCCCCce--EEccccc
Q 006055           58 PCKWAGVECEQN--RVTMLRLPG---VALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPS-DLASCSNLRN--LYLQGNH  129 (663)
Q Consensus        58 ~c~w~gv~c~~~--~v~~L~L~~---~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~--L~L~~N~  129 (663)
                      .|.|.|+.|+.+  +|..+...+   ..+.|.++++.+..+..  .|...+|.-++.++- .|...+.|..  ++++.|+
T Consensus        77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~  154 (267)
T 3rw6_A           77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR  154 (267)
T ss_dssp             HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred             HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence            588999999754  777776655   45556666544444333  344455555554432 2555566666  7788885


Q ss_pred             cc---CchhhhhcCCccccccccccccccc--cCCCCCcccccccccccccccccCcCCCCCCCCC--CCCEEEeecCcC
Q 006055          130 FS---GEVPLFLVGLHHLVRLNLATNNFSG--EIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLP--NLQQLNVSNNLL  202 (663)
Q Consensus       130 l~---~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~--~L~~L~l~~N~l  202 (663)
                      ..   +.++....++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..+.  +|+.|+|++|++
T Consensus       155 ~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl  232 (267)
T 3rw6_A          155 RSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSL  232 (267)
T ss_dssp             HHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTT
T ss_pred             HHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcC
Confidence            43   3333334568899999999999987  5567777899999999999999864  2233344  899999999999


Q ss_pred             CCCCCc-------ccccCCCCCcc
Q 006055          203 NGSIPK-------RFQTFGSNSFL  219 (663)
Q Consensus       203 ~g~~p~-------~~~~~~~~~~~  219 (663)
                      ++.+|.       .+..++.+..+
T Consensus       233 ~~~~~~~~~y~~~il~~~P~L~~L  256 (267)
T 3rw6_A          233 CDTFRDQSTYISAIRERFPKLLRL  256 (267)
T ss_dssp             GGGCSSHHHHHHHHHHHCTTCCEE
T ss_pred             ccccCcchhHHHHHHHHCcccCeE
Confidence            987773       25566666554

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.09  E-value=2.1e-12  Score=135.98  Aligned_cols=134  Identities=20%  Similarity=0.230  Sum_probs=55.5

Q ss_pred             cEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccc-----cCCCCCceEEcccccccC----chhhhhcC
Q 006055           70 RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDL-----ASCSNLRNLYLQGNHFSG----EVPLFLVG  140 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~----~~p~~~~~  140 (663)
                      .++.|+|++|.++..-...+...+++|+.|+|++|.|+......+     ...++|++|+|++|.|+.    .++..+..
T Consensus       102 ~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~  181 (372)
T 3un9_A          102 ALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAG  181 (372)
T ss_dssp             CEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHT
T ss_pred             CceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhc
Confidence            455555555544322221122233444555555554443222222     123445555555555442    12333344


Q ss_pred             Ccccccccccccccccc----CCCCCcccccccccccccccccCc----CCCCCCCCCCCCEEEeecCcCC
Q 006055          141 LHHLVRLNLATNNFSGE----IPSGFKNLTKLKTLFLENNRLSGS----IPGFDDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       141 l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~  203 (663)
                      +++|++|+|++|+|+..    ++..+...++|++|+|++|.|+..    ++..+...++|++|+|++|+|+
T Consensus       182 ~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~  252 (372)
T 3un9_A          182 NTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS  252 (372)
T ss_dssp             CSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCC
T ss_pred             CCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCC
Confidence            44555555555554421    123333444455555555554421    1222223344555555555444

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.06  E-value=3.4e-10  Score=112.81  Aligned_cols=130  Identities=13%  Similarity=0.064  Sum_probs=96.8

Q ss_pred             ccc-cccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCC--cccceEEEEecCccEEEEEccCCCChh
Q 006055          377 VLG-KGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHEN--LVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       377 ~lg-~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .++ .|..+.||++...+|+.++||.....  ....+..|+.+++.+.+.+  +.+++++....+..++||||+++.+|.
T Consensus        26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~  103 (264)
T 1nd4_A           26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL  103 (264)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             ecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence            344 56669999998777889999997654  2245778888888886545  445888877777789999999998884


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG-------------------------------------------  490 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-------------------------------------------  490 (663)
                        ...        .+   ...++.++++.|..||+..                                           
T Consensus       104 --~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (264)
T 1nd4_A          104 --SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  170 (264)
T ss_dssp             --TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             --cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence              211        11   2256677788888888642                                           


Q ss_pred             -------------CcceecCCCCCCEEEcCCCceEEeccccccc
Q 006055          491 -------------PNVSHGNIKSSNILLTKSYEARVSDFGLAHL  521 (663)
Q Consensus       491 -------------~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~  521 (663)
                                   +.++|+|++|.||+++++..+.|+|||.+..
T Consensus       171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                         1299999999999998776677999998753

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.03  E-value=1.8e-10  Score=119.42  Aligned_cols=79  Identities=13%  Similarity=0.201  Sum_probs=59.6

Q ss_pred             CcEEEEEcCCCCcc----------c---------ccCccccCC--------CCCCCEEEccCCCCCCCCCccccCCCCCc
Q 006055           69 NRVTMLRLPGVALS----------G---------QIPLGILGN--------LTSLRTLSLRFNSLTSQLPSDLASCSNLR  121 (663)
Q Consensus        69 ~~v~~L~L~~~~l~----------g---------~~p~~~~~~--------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  121 (663)
                      .+++.|||++|++.          +         .||...|.+        +++|+.|+|++ +++.+-+..|.+|++|+
T Consensus        49 ~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~  127 (329)
T 3sb4_A           49 PSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLK  127 (329)
T ss_dssp             TTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCC
T ss_pred             ccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccc
Confidence            56888888887776          1         577788888        99999999999 89887778899999999


Q ss_pred             eEEcccccccCchhhhhcCCccccccc
Q 006055          122 NLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus       122 ~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .|+|++|.+....+..|.++.++..+.
T Consensus       128 ~l~l~~n~i~~i~~~aF~~~~~l~~l~  154 (329)
T 3sb4_A          128 ICQIRKKTAPNLLPEALADSVTAIFIP  154 (329)
T ss_dssp             EEEBCCSSCCEECTTSSCTTTCEEEEC
T ss_pred             eEEcCCCCccccchhhhcCCCceEEec
Confidence            999999987644444444444444333

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.98  E-value=3.2e-12  Score=134.60  Aligned_cols=136  Identities=22%  Similarity=0.195  Sum_probs=104.3

Q ss_pred             CcEEEEEcCCCCcccccCccccC-----CCCCCCEEEccCCCCCCCCCccc-cCCCCCceEEcccccccCchhhhh----
Q 006055           69 NRVTMLRLPGVALSGQIPLGILG-----NLTSLRTLSLRFNSLTSQLPSDL-ASCSNLRNLYLQGNHFSGEVPLFL----  138 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~-----~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~----  138 (663)
                      ..++.|+|++|.++..-.. .+.     +.++|+.|+|++|.|+......+ ..+++|+.|+|++|.|+......+    
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~-~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L  150 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCT-VVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL  150 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHH-HHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHH-HHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence            5799999999999743221 222     33799999999999975433333 356789999999999986555444    


Q ss_pred             -cCCccccccccccccccc----cCCCCCcccccccccccccccccCc----CCCCCCCCCCCCEEEeecCcCCCC
Q 006055          139 -VGLHHLVRLNLATNNFSG----EIPSGFKNLTKLKTLFLENNRLSGS----IPGFDDVLPNLQQLNVSNNLLNGS  205 (663)
Q Consensus       139 -~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~g~  205 (663)
                       ...++|+.|+|++|.|+.    .++..+..+++|++|+|++|+|+..    ++..+...++|+.|+|++|.|+..
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~  226 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDT  226 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHH
T ss_pred             HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHH
Confidence             356889999999999974    2445557789999999999999742    355567788999999999999853

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.96  E-value=2e-09  Score=112.91  Aligned_cols=138  Identities=15%  Similarity=0.179  Sum_probs=103.7

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEec--Ccc--cCHHHHHHHHHHhhcCCC--CCcccceEEEEec---CccEEEEEc
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLK--DVT--ISEREFKDKIEGVGAVNH--ENLVPLRAYYYSM---DEKLLVYDY  446 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~--~~~--~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~ey  446 (663)
                      +.|+.|.++.||+.... +..+++|+..  ...  .....+.+|..+++.+.+  ..+.+++.++.+.   ...++||||
T Consensus        44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            46899999999998876 4678888876  332  224568889999988864  4577888888765   347999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-------------------------------------
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ-------------------------------------  489 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-------------------------------------  489 (663)
                      +++..+.+...       ..++...+..++.++++.|..||+.                                     
T Consensus       123 v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          123 VSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             CCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             cCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            99977754211       2367888889999999999999973                                     


Q ss_pred             -------------------CCcceecCCCCCCEEEcCCCc--eEEeccccccc
Q 006055          490 -------------------GPNVSHGNIKSSNILLTKSYE--ARVSDFGLAHL  521 (663)
Q Consensus       490 -------------------~~~iiHrdlk~~Nill~~~~~--~kl~Dfg~a~~  521 (663)
                                         .+.++|+|+++.||+++.++.  +.|.||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               134899999999999997753  68999998864

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.81  E-value=1.3e-10  Score=130.62  Aligned_cols=137  Identities=16%  Similarity=0.196  Sum_probs=78.1

Q ss_pred             CcEEEEEcC-----------CCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccC-CCCCceEEcc----cccccC
Q 006055           69 NRVTMLRLP-----------GVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLAS-CSNLRNLYLQ----GNHFSG  132 (663)
Q Consensus        69 ~~v~~L~L~-----------~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~  132 (663)
                      .+++.|+|+           .+.+++.-...++..+++|+.|+|+.|.+++..+..+.. +++|+.|+|+    .|++++
T Consensus       342 ~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~  421 (592)
T 3ogk_B          342 KQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITD  421 (592)
T ss_dssp             TTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSS
T ss_pred             CCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccC
Confidence            457777776           244543322223345667777777666666655555544 6667777774    556665


Q ss_pred             c-----hhhhhcCCcccccccccc--ccccccCCCCCc-ccccccccccccccccC-cCCCCCCCCCCCCEEEeecCcCC
Q 006055          133 E-----VPLFLVGLHHLVRLNLAT--NNFSGEIPSGFK-NLTKLKTLFLENNRLSG-SIPGFDDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       133 ~-----~p~~~~~l~~L~~L~l~~--N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~  203 (663)
                      .     ++..+.++++|+.|+|++  |.+++..+..++ .+++|++|+|++|++++ .++..+..+++|+.|+|++|+++
T Consensus       422 ~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~  501 (592)
T 3ogk_B          422 LPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS  501 (592)
T ss_dssp             CCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCB
T ss_pred             chHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCc
Confidence            3     444555666677777653  234443333333 25666666776666654 33444456666677777766665


Q ss_pred             CC
Q 006055          204 GS  205 (663)
Q Consensus       204 g~  205 (663)
                      +.
T Consensus       502 ~~  503 (592)
T 3ogk_B          502 ER  503 (592)
T ss_dssp             HH
T ss_pred             HH
Confidence            43

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.74  E-value=8.7e-10  Score=123.76  Aligned_cols=128  Identities=14%  Similarity=0.105  Sum_probs=72.3

Q ss_pred             EEEEEcCCCC-ccc-ccCccccCCCCCCCEEEccCCCCCCC----CCccccCCCCCceEEccccccc----CchhhhhcC
Q 006055           71 VTMLRLPGVA-LSG-QIPLGILGNLTSLRTLSLRFNSLTSQ----LPSDLASCSNLRNLYLQGNHFS----GEVPLFLVG  140 (663)
Q Consensus        71 v~~L~L~~~~-l~g-~~p~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~----~~~p~~~~~  140 (663)
                      ++.|+|++|. ++. .++ .++.++++|++|+|++|.+++.    ++..+.++++|++|+|++|.++    +.++..+.+
T Consensus       140 L~~L~L~~~~~~~~~~l~-~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~  218 (592)
T 3ogk_B          140 LETLKLDKCSGFTTDGLL-SIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN  218 (592)
T ss_dssp             CCEEEEESCEEEEHHHHH-HHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred             CcEEECcCCCCcCHHHHH-HHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence            7777776665 211 111 1234567777777777766554    2333455667777777777765    344555566


Q ss_pred             CccccccccccccccccCCCCCccccccccccccccccc---CcCCCCCCCCCCCCEEEeecC
Q 006055          141 LHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLS---GSIPGFDDVLPNLQQLNVSNN  200 (663)
Q Consensus       141 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~---~~~p~~~~~l~~L~~L~l~~N  200 (663)
                      +++|+.|+|++|.+.+ +|..+.++++|++|+++++...   +..+..+..+++|+.|+++++
T Consensus       219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~  280 (592)
T 3ogk_B          219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYM  280 (592)
T ss_dssp             CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTC
T ss_pred             CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCcccc
Confidence            6777777777776663 4555666666666666543222   222334455555555555554

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.74  E-value=1.1e-10  Score=115.72  Aligned_cols=117  Identities=21%  Similarity=0.276  Sum_probs=82.4

Q ss_pred             CCCcccccCccccCCCCCCCE--EEccCCCCC---CCCCccccCCCCCceEEcccccccC--chhhhhcCCccccccccc
Q 006055           78 GVALSGQIPLGILGNLTSLRT--LSLRFNSLT---SQLPSDLASCSNLRNLYLQGNHFSG--EVPLFLVGLHHLVRLNLA  150 (663)
Q Consensus        78 ~~~l~g~~p~~~~~~l~~L~~--L~L~~N~l~---~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~  150 (663)
                      .|..++.++.+.|...+.|..  ++++.|...   +.++....++++|+.|+|++|+|++  .+|..+..+++|+.|+|+
T Consensus       125 yn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls  204 (267)
T 3rw6_A          125 YDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLS  204 (267)
T ss_dssp             EETTTTEEECTTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECT
T ss_pred             cchhccccCHHHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECC
Confidence            344444444444555666666  677777432   2222223567889999999999987  556777889999999999


Q ss_pred             cccccccCCCCCcccc--cccccccccccccCcCCC-------CCCCCCCCCEEE
Q 006055          151 TNNFSGEIPSGFKNLT--KLKTLFLENNRLSGSIPG-------FDDVLPNLQQLN  196 (663)
Q Consensus       151 ~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~p~-------~~~~l~~L~~L~  196 (663)
                      +|+|++.  ..+..+.  +|++|+|++|.+++.+|+       .+..+|+|+.||
T Consensus       205 ~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          205 GNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             TSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             CCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            9999865  3455555  899999999999887763       367789998876

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.71  E-value=6e-09  Score=106.53  Aligned_cols=180  Identities=19%  Similarity=0.200  Sum_probs=117.7

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCC-CCCc--ccceEEEEecC---ccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-HENL--VPLRAYYYSMD---EKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~~---~~~lv~ey~~~  449 (663)
                      +.++.|.+..||+..    ..+++|+.... .....+.+|.++++.+. +..+  .+++.+....+   ..++||||+++
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            458899999999853    56889986533 23467889999998873 3332  33443332222   24789999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG---------------------------------------  490 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~---------------------------------------  490 (663)
                      .++.+....       .++...+..++.++++.+..||+..                                       
T Consensus       101 ~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A          101 VPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             EECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             eECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            888653321       2566777778888888888888511                                       


Q ss_pred             -----------------CcceecCCCCCCEEEcC--CCceEEeccccccccCCCCC-----CC---CCc--------cc-
Q 006055          491 -----------------PNVSHGNIKSSNILLTK--SYEARVSDFGLAHLVGPSST-----PN---RVA--------GY-  534 (663)
Q Consensus       491 -----------------~~iiHrdlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~-----~~---~~~--------~y-  534 (663)
                                       +.++|+|++|.||++++  ...+.|+||+.+..-.+...     ..   ...        +| 
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                             24799999999999998  45678999999865433210     00   000        02 


Q ss_pred             -cC-ccccCCCCCCCcchhhhHHHHHHHHHhCCCCCc
Q 006055          535 -RA-PEVTDPCKVSQKADVYSFGVLLLELLTGKAPTH  569 (663)
Q Consensus       535 -~a-PE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~  569 (663)
                       .. |+....  .....+.|+++.+++.+.+|..+|-
T Consensus       254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence             11 111110  0112589999999999999988763

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=98.59  E-value=1.1e-07  Score=100.80  Aligned_cols=138  Identities=14%  Similarity=0.113  Sum_probs=104.1

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      ..++.+.|+. +++ .|+...|.++++|+.|+|..| ++.+-...|.+ .+|+.+.| .|.++..-+..|.++++|+.++
T Consensus       203 ~~L~~l~lp~-~l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~  277 (401)
T 4fdw_A          203 AGIEEVLLPV-TLK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVT  277 (401)
T ss_dssp             CCCSEEECCT-TCC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEE
T ss_pred             cccCEEEeCC-chh-eehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEE
Confidence            4678888884 466 888888999999999999875 66655667777 78889988 4556655677888888999998


Q ss_pred             ccccccc-----ccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccC
Q 006055          149 LATNNFS-----GEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTF  213 (663)
Q Consensus       149 l~~N~l~-----~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~  213 (663)
                      +.+|.+.     ..-+..|.+|++|+.++|. |.++..-...|.++++|+.|+|..| ++..-+.+|.++
T Consensus       278 l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~  345 (401)
T 4fdw_A          278 TYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT  345 (401)
T ss_dssp             EESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS
T ss_pred             eCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC
Confidence            8888765     3445678888889998888 4477555678888888999988555 654445566665

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.53  E-value=4.1e-09  Score=99.34  Aligned_cols=115  Identities=17%  Similarity=0.196  Sum_probs=81.6

Q ss_pred             ccCCCCCCCEEEccCC-CCCCC----CCccccCCCCCceEEcccccccCc----hhhhhcCCcccccccccccccccc--
Q 006055           89 ILGNLTSLRTLSLRFN-SLTSQ----LPSDLASCSNLRNLYLQGNHFSGE----VPLFLVGLHHLVRLNLATNNFSGE--  157 (663)
Q Consensus        89 ~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~--  157 (663)
                      .+...++|+.|+|++| .|...    +...+...++|++|+|++|.|...    +...+...++|++|+|++|.|+..  
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~  110 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI  110 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence            4567788888888888 77532    334456667888888888888632    344556667888888888888742  


Q ss_pred             --CCCCCccccccccccc--ccccccCc----CCCCCCCCCCCCEEEeecCcCC
Q 006055          158 --IPSGFKNLTKLKTLFL--ENNRLSGS----IPGFDDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       158 --~p~~~~~l~~L~~L~l--~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~  203 (663)
                        +...+...++|++|+|  ++|.|+..    +...+...++|+.|+|++|.+.
T Consensus       111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence              4556667778888888  77888642    3334555678999999988875

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.53  E-value=1.9e-09  Score=120.99  Aligned_cols=135  Identities=15%  Similarity=0.090  Sum_probs=77.9

Q ss_pred             CcEEEEEcC---------CCCcccccCccccCCCCCCCEEEccCCCCCCCCCcccc-CCCCCceEEcc--c----ccccC
Q 006055           69 NRVTMLRLP---------GVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLA-SCSNLRNLYLQ--G----NHFSG  132 (663)
Q Consensus        69 ~~v~~L~L~---------~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~--~----N~l~~  132 (663)
                      .+++.|+|.         .+.+++.....+...+++|+.|+++.|.+++..+..+. .+++|+.|+|+  +    |.+++
T Consensus       338 ~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~  417 (594)
T 2p1m_B          338 KDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL  417 (594)
T ss_dssp             TTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTC
T ss_pred             CCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccC
Confidence            457777772         23444322222223467777777777777654444443 46777777777  3    45542


Q ss_pred             -----chhhhhcCCccccccccccccccccCCCCCcc-cccccccccccccccCcCCCCC-CCCCCCCEEEeecCcCCC
Q 006055          133 -----EVPLFLVGLHHLVRLNLATNNFSGEIPSGFKN-LTKLKTLFLENNRLSGSIPGFD-DVLPNLQQLNVSNNLLNG  204 (663)
Q Consensus       133 -----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~g  204 (663)
                           .++..+..+++|+.|+|++ .+++..+..+.. +++|++|+|++|.+++..+..+ ..+++|+.|+|++|++++
T Consensus       418 ~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~  495 (594)
T 2p1m_B          418 EPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD  495 (594)
T ss_dssp             CCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred             CchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence                 2333355667777777765 555444444443 6667777777777654433322 456777777777777754

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=98.51  E-value=2.6e-07  Score=98.00  Aligned_cols=126  Identities=16%  Similarity=0.185  Sum_probs=66.5

Q ss_pred             EEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccc
Q 006055           71 VTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLA  150 (663)
Q Consensus        71 v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~  150 (663)
                      ++.+.|++ +++ .|+...|.++++|+.++|++|+++......|. +.+|+.+.|.+| ++..-..+|.++++|+.++|.
T Consensus       159 L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~  234 (401)
T 4fdw_A          159 VQEIVFPS-TLE-QLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP  234 (401)
T ss_dssp             CCEEECCT-TCC-EECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred             ceEEEeCC-Ccc-EehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence            44555543 444 45555555566666666665555543333443 455555555533 443444555566666666665


Q ss_pred             cccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCC
Q 006055          151 TNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       151 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  203 (663)
                      .| ++..-...|.+ .+|+.+.| .|.++...+..|.++++|+.+++.+|.+.
T Consensus       235 ~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~  284 (401)
T 4fdw_A          235 EN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN  284 (401)
T ss_dssp             TT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred             CC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence            53 33233334444 45555555 33444344556666666666666666554

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.44  E-value=2.1e-09  Score=120.58  Aligned_cols=153  Identities=12%  Similarity=0.113  Sum_probs=102.0

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEcc---------CCCCCCCCCcccc-CCCCCceEEcccccccCchhhhh
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLR---------FNSLTSQLPSDLA-SCSNLRNLYLQGNHFSGEVPLFL  138 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~---------~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~  138 (663)
                      .+++.|+|++| ++......+...+++|+.|+|+         .|.+++.....+. ++++|+.|+++.|.+++..+..+
T Consensus       314 ~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l  392 (594)
T 2p1m_B          314 PKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITI  392 (594)
T ss_dssp             TTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHH
T ss_pred             CCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHH
Confidence            57889999887 4432222344568999999983         3556543333333 48899999999999987777666


Q ss_pred             c-CCccccccccc--c----cccccc-----CCCCCcccccccccccccccccCcCCCCCCC-CCCCCEEEeecCcCCCC
Q 006055          139 V-GLHHLVRLNLA--T----NNFSGE-----IPSGFKNLTKLKTLFLENNRLSGSIPGFDDV-LPNLQQLNVSNNLLNGS  205 (663)
Q Consensus       139 ~-~l~~L~~L~l~--~----N~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~g~  205 (663)
                      . .+++|+.|+|+  +    |++++.     ++..+.++++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++.
T Consensus       393 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~  471 (594)
T 2p1m_B          393 ARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDL  471 (594)
T ss_dssp             HHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHH
T ss_pred             HhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHH
Confidence            5 58899999998  4    556521     112256778999999977 666544444444 78899999999998765


Q ss_pred             CCccc----ccCCCCCccCCcC
Q 006055          206 IPKRF----QTFGSNSFLGNSL  223 (663)
Q Consensus       206 ~p~~~----~~~~~~~~~~~~l  223 (663)
                      .+..+    .++..+.+.+|.+
T Consensus       472 ~~~~l~~~~~~L~~L~L~~n~~  493 (594)
T 2p1m_B          472 GMHHVLSGCDSLRKLEIRDCPF  493 (594)
T ss_dssp             HHHHHHHHCTTCCEEEEESCSC
T ss_pred             HHHHHHhcCCCcCEEECcCCCC
Confidence            54333    3444444455554

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.33  E-value=4.6e-08  Score=102.05  Aligned_cols=133  Identities=17%  Similarity=0.239  Sum_probs=82.2

Q ss_pred             CcEEEEEcCCCCcc---------cccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhc
Q 006055           69 NRVTMLRLPGVALS---------GQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLV  139 (663)
Q Consensus        69 ~~v~~L~L~~~~l~---------g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  139 (663)
                      .+++.|.+.++...         +.++ .++..+++|+.|+|++|.-. .++. + .+++|+.|+|..|.++......+.
T Consensus       139 ~~L~~L~l~~~~~e~~~is~~~~~~L~-~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~  214 (362)
T 2ra8_A          139 AHFEGLFWGDIDFEEQEISWIEQVDLS-PVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDIL  214 (362)
T ss_dssp             TTCSEEEECCCCTTTCCGGGCBCCBCH-HHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHH
T ss_pred             chhhheeecCcchhhcccccccccCHH-HHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHH
Confidence            47777877654321         1233 24567788888888877311 2333 3 378888888888887654444454


Q ss_pred             --CCcccccccccc--cccccc-----CCCCC--cccccccccccccccccCcCCCCC---CCCCCCCEEEeecCcCCCC
Q 006055          140 --GLHHLVRLNLAT--NNFSGE-----IPSGF--KNLTKLKTLFLENNRLSGSIPGFD---DVLPNLQQLNVSNNLLNGS  205 (663)
Q Consensus       140 --~l~~L~~L~l~~--N~l~~~-----~p~~~--~~l~~L~~L~l~~N~l~~~~p~~~---~~l~~L~~L~l~~N~l~g~  205 (663)
                        .+++|+.|+|+.  |...+.     +...+  ..+++|++|+|++|.+.+..+..+   ..+++|+.|+|+.|.|++.
T Consensus       215 ~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~  294 (362)
T 2ra8_A          215 GSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE  294 (362)
T ss_dssp             HSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred             HccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence              678888888753  222111     11112  346788888888888764332222   2467888888888888763

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.27  E-value=5e-08  Score=91.78  Aligned_cols=111  Identities=15%  Similarity=0.173  Sum_probs=86.6

Q ss_pred             CCcEEEEEcCCC-Ccccc----cCccccCCCCCCCEEEccCCCCCCC----CCccccCCCCCceEEcccccccCc----h
Q 006055           68 QNRVTMLRLPGV-ALSGQ----IPLGILGNLTSLRTLSLRFNSLTSQ----LPSDLASCSNLRNLYLQGNHFSGE----V  134 (663)
Q Consensus        68 ~~~v~~L~L~~~-~l~g~----~p~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~  134 (663)
                      ...++.|+|++| .+...    +. ..+...++|++|+|++|.|...    +...+...++|++|+|++|.|+..    +
T Consensus        35 ~~~L~~L~L~~n~~i~~~g~~~l~-~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l  113 (185)
T 1io0_A           35 DPDLEEVNLNNIMNIPVPTLKACA-EALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL  113 (185)
T ss_dssp             CTTCCEEECTTCTTCCHHHHHHHH-HHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred             CCCCCEEEecCCCCCCHHHHHHHH-HHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHH
Confidence            357999999999 88632    22 2456779999999999999742    334456668999999999999854    5


Q ss_pred             hhhhcCCcccccccc--cccccccc----CCCCCccccccccccccccccc
Q 006055          135 PLFLVGLHHLVRLNL--ATNNFSGE----IPSGFKNLTKLKTLFLENNRLS  179 (663)
Q Consensus       135 p~~~~~l~~L~~L~l--~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~  179 (663)
                      ...+...++|+.|+|  ++|.|...    +...+...++|++|+|++|.+.
T Consensus       114 ~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          114 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            667788889999999  88999743    3344556689999999999985

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.24  E-value=4.5e-06  Score=83.31  Aligned_cols=133  Identities=16%  Similarity=0.147  Sum_probs=90.6

Q ss_pred             ccccccce-EEEEEEec-CCcEEEEEEecCcccCHHHHHHHHHHhhcCC-CCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          377 VLGKGTFG-TAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       377 ~lg~G~~g-~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .+..|..| .||+.... ++..++||+-...  ....+.+|...++.+. +--+.++++++.+.+..++|||++++.++.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            34455555 68988744 4678999986543  2456788888888774 333667888888888999999999998876


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc--------------------------------------------
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ--------------------------------------------  489 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~--------------------------------------------  489 (663)
                      +......         .....++.+++..|..||..                                            
T Consensus       109 ~~~~~~~---------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          109 QVLEEYP---------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHCG---------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             ccccCCH---------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            6543211         11223344444444444421                                            


Q ss_pred             -------C-----CcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          490 -------G-----PNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       490 -------~-----~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                             -     +.++|+|+.+.||++++++.+-|+||+.+.
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                   1     127899999999999987777799999875

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.23  E-value=2.4e-07  Score=96.61  Aligned_cols=132  Identities=17%  Similarity=0.218  Sum_probs=87.6

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCcccc--CCCCCceEEccc--ccccCc-----hhhhh-
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLA--SCSNLRNLYLQG--NHFSGE-----VPLFL-  138 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~-----~p~~~-  138 (663)
                      .+++.|+|++|.-. .++.  +. +++|+.|+|..|.++......+.  .+++|+.|+|+.  |...+.     +...+ 
T Consensus       172 P~L~~L~L~g~~~l-~l~~--~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~  247 (362)
T 2ra8_A          172 PLLNNLKIKGTNNL-SIGK--KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS  247 (362)
T ss_dssp             TTCCEEEEECCBTC-BCCS--CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC
T ss_pred             CCCcEEEEeCCCCc-eecc--cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHh
Confidence            57888998877311 3443  33 78899999988887643323333  688899998863  222111     11222 


Q ss_pred             -cCCccccccccccccccccCCCCC---cccccccccccccccccCc----CCCCCCCCCCCCEEEeecCcCCC
Q 006055          139 -VGLHHLVRLNLATNNFSGEIPSGF---KNLTKLKTLFLENNRLSGS----IPGFDDVLPNLQQLNVSNNLLNG  204 (663)
Q Consensus       139 -~~l~~L~~L~l~~N~l~~~~p~~~---~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~g  204 (663)
                       ..+++|+.|+|++|.+.+..+..+   ..+++|++|+|+.|.|++.    ++..+..+++|+.|+|++|.++.
T Consensus       248 ~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d  321 (362)
T 2ra8_A          248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD  321 (362)
T ss_dssp             TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred             cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence             247889999999888864332222   2578899999999988753    44444567889999999888764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.21  E-value=6.5e-06  Score=83.89  Aligned_cols=134  Identities=19%  Similarity=0.134  Sum_probs=90.3

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCC---CcccceEEEE-ecCccEEEEEccCCCC
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHE---NLVPLRAYYY-SMDEKLLVYDYLTMGS  451 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~ey~~~gs  451 (663)
                      +.++.|....||+.    |..++||+-.. ......+.+|.+++..+.+.   .+.+.+.++. ..+..++||||+++..
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            45788888899987    67788888532 22345788999999998653   2445666654 3345789999999988


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG-----------------------------------------  490 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-----------------------------------------  490 (663)
                      +.+....       .++...+..++.++++.|..||+..                                         
T Consensus       100 l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A          100 LGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             CHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             Cchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            8663211       1233444444444544444444321                                         


Q ss_pred             -----------------CcceecCCCCCCEEEcC---CCc-eEEeccccccc
Q 006055          491 -----------------PNVSHGNIKSSNILLTK---SYE-ARVSDFGLAHL  521 (663)
Q Consensus       491 -----------------~~iiHrdlk~~Nill~~---~~~-~kl~Dfg~a~~  521 (663)
                                       +.++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                             24699999999999987   455 48999998754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.01  E-value=8e-06  Score=85.15  Aligned_cols=78  Identities=8%  Similarity=0.057  Sum_probs=53.9

Q ss_pred             ccc-ccccceEEEEEEec-------CCcEEEEEEecCcc---c-CHHHHHHHHHHhhcCCC---CCcccceEEEEec---
Q 006055          376 EVL-GKGTFGTAYKAVLE-------MGTIVAVKRLKDVT---I-SEREFKDKIEGVGAVNH---ENLVPLRAYYYSM---  437 (663)
Q Consensus       376 ~~l-g~G~~g~Vy~~~~~-------~g~~vavK~l~~~~---~-~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~---  437 (663)
                      +.| +.|....+|+....       +++.+++|+.....   . ....+.+|..+++.+..   -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            457 88999999998754       26788999865432   1 22457788888877742   2456677776554   


Q ss_pred             CccEEEEEccCCCChh
Q 006055          438 DEKLLVYDYLTMGSLS  453 (663)
Q Consensus       438 ~~~~lv~ey~~~gsL~  453 (663)
                      ...++||||+++..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            2468999999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.92  E-value=5.8e-05  Score=77.87  Aligned_cols=141  Identities=19%  Similarity=0.245  Sum_probs=79.4

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcC-----CCCCcccce-E--EEEecCccEEEEEcc
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAV-----NHENLVPLR-A--YYYSMDEKLLVYDYL  447 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~-~--~~~~~~~~~lv~ey~  447 (663)
                      +.|+.|..+.||+....+| .+++|+....   ...+..|..++..+     ..|.++... |  +....+..++||||+
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            3566678899999987655 4899988752   33444455555444     234444311 1  122455678999999


Q ss_pred             CCCChh--------------HhhccCCC----CC-----CCCCCHHHHH-------------------------------
Q 006055          448 TMGSLS--------------ALLHGNKG----AG-----RTPLNWEMRS-------------------------------  473 (663)
Q Consensus       448 ~~gsL~--------------~~l~~~~~----~~-----~~~l~~~~~~-------------------------------  473 (663)
                      ++..+.              ..+|....    ..     .....|....                               
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            986542              11221100    00     0112343211                               


Q ss_pred             HHHHHHHHHHHHHhh-----------cCCcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          474 LIALGAARGIEYLHA-----------QGPNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       474 ~i~~~ia~al~~LH~-----------~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                      .+...+..++.+|+.           ..+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            011123345667763           12459999999999999888899999999774

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.75  E-value=0.00012  Score=77.30  Aligned_cols=73  Identities=10%  Similarity=0.099  Sum_probs=48.0

Q ss_pred             cccccccceEEEEEEec-CCcEEEEEEecCcc--------cCHHHHHHHHHHhhcCCC--CCcc-cceEEEEecCccEEE
Q 006055          376 EVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVT--------ISEREFKDKIEGVGAVNH--ENLV-PLRAYYYSMDEKLLV  443 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~e~~~l~~l~h--~niv-~l~~~~~~~~~~~lv  443 (663)
                      +.||.|.++.||++... +++.++||......        .....+..|.+++..+..  +..+ +++.  .+.+..++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~--~d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE--EcCCccEEE
Confidence            57999999999999753 46889999764321        122346778888877632  3334 4443  345667899


Q ss_pred             EEccCCC
Q 006055          444 YDYLTMG  450 (663)
Q Consensus       444 ~ey~~~g  450 (663)
                      |||+++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999764

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.62  E-value=1.5e-05  Score=73.31  Aligned_cols=83  Identities=12%  Similarity=0.146  Sum_probs=43.5

Q ss_pred             CCCCEEEccCCCCCCCCCccccCCCCCceEEccccc-ccCchhhhhcCC----cccccccccccc-ccccCCCCCccccc
Q 006055           94 TSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNH-FSGEVPLFLVGL----HHLVRLNLATNN-FSGEIPSGFKNLTK  167 (663)
Q Consensus        94 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~p~~~~~l~~  167 (663)
                      -.|+.|||+++.|+..--..+.+|++|+.|+|+++. ++..--..+..+    ++|+.|+|+++. |+..--..+.++++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            356777777766654333445666777777777764 554333334443    246666665543 44221122344455


Q ss_pred             ccccccccc
Q 006055          168 LKTLFLENN  176 (663)
Q Consensus       168 L~~L~l~~N  176 (663)
                      |++|+|+++
T Consensus       141 L~~L~L~~c  149 (176)
T 3e4g_A          141 LKYLFLSDL  149 (176)
T ss_dssp             CCEEEEESC
T ss_pred             CCEEECCCC
Confidence            555555544

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=97.56  E-value=0.00013  Score=76.60  Aligned_cols=122  Identities=11%  Similarity=0.081  Sum_probs=63.0

Q ss_pred             ccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCCCCcccccc
Q 006055           89 ILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKL  168 (663)
Q Consensus        89 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L  168 (663)
                      .+....+|+.+.+..+ +.......|.++.+|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++..-...|.++++|
T Consensus       212 ~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L  288 (379)
T 4h09_A          212 GFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL  288 (379)
T ss_dssp             TTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC
T ss_pred             ccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccc
Confidence            3455556666665433 33333445556666666666554 33333445555666666665433 332333455666666


Q ss_pred             cccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCC
Q 006055          169 KTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFG  214 (663)
Q Consensus       169 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~  214 (663)
                      +.+.+.+|.++..-+..|.++.+|+.+.|..| ++..-..+|.++.
T Consensus       289 ~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~  333 (379)
T 4h09_A          289 TKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCK  333 (379)
T ss_dssp             CEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred             ccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCC
Confidence            66666666555444455666666666666433 3322233444433

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.52  E-value=1.3e-05  Score=73.71  Aligned_cols=91  Identities=10%  Similarity=0.027  Sum_probs=67.7

Q ss_pred             CccccCCCCCceEEcccccccCchhhhhcCCcccccccccccc-ccccCCCCCccc----cccccccccccc-ccCcCCC
Q 006055          111 PSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNN-FSGEIPSGFKNL----TKLKTLFLENNR-LSGSIPG  184 (663)
Q Consensus       111 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~p~  184 (663)
                      |.....--+|+.|||+++.++..--..+.++++|+.|+|+++. |+..--..+..+    ++|++|+|++|. |+..-=.
T Consensus        54 P~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~  133 (176)
T 3e4g_A           54 PTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGII  133 (176)
T ss_dssp             CCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHH
T ss_pred             CcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHH
Confidence            4433333579999999999986655668899999999999995 764322334443    479999999985 7743223


Q ss_pred             CCCCCCCCCEEEeecCc
Q 006055          185 FDDVLPNLQQLNVSNNL  201 (663)
Q Consensus       185 ~~~~l~~L~~L~l~~N~  201 (663)
                      .+..+++|+.|+|+++.
T Consensus       134 ~L~~~~~L~~L~L~~c~  150 (176)
T 3e4g_A          134 ALHHFRNLKYLFLSDLP  150 (176)
T ss_dssp             HGGGCTTCCEEEEESCT
T ss_pred             HHhcCCCCCEEECCCCC
Confidence            46789999999999985

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.49  E-value=0.00061  Score=68.40  Aligned_cols=73  Identities=18%  Similarity=0.248  Sum_probs=53.2

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCC---CcccceEEEEecCccEEEEEccCCCC
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHE---NLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      +.+|.|..+.||+.+..+|+.|.||+-.... .....|..|...|+.+.-.   .+.+++++    +..++||||++.+.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence            4689999999999999999999999865432 2234688899988877432   23344443    24589999998765


Q ss_pred             h
Q 006055          452 L  452 (663)
Q Consensus       452 L  452 (663)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            4

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=97.45  E-value=0.00011  Score=77.73  Aligned_cols=116  Identities=9%  Similarity=0.153  Sum_probs=90.9

Q ss_pred             ccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCCCCc
Q 006055           84 QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFK  163 (663)
Q Consensus        84 ~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~  163 (663)
                      .+....|.+.+.|+.+.+..+-. ..-...|.++++|+.+.+. +.++..-...|.++.+|+.++|..| ++..-...|.
T Consensus       255 ~i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~  331 (394)
T 4gt6_A          255 RIETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFA  331 (394)
T ss_dssp             EECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT
T ss_pred             EcccceeeecccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhh
Confidence            55666788999999999976543 3456678999999999996 4566455678899999999999865 6544467899


Q ss_pred             ccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCC
Q 006055          164 NLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       164 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  203 (663)
                      +|++|+.+.|.++ ++..-...|.++++|+.+++.+|...
T Consensus       332 ~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~  370 (394)
T 4gt6_A          332 GCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ  370 (394)
T ss_dssp             TCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred             CCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence            9999999999755 66455568999999999999887643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.38  E-value=0.0019  Score=65.48  Aligned_cols=138  Identities=18%  Similarity=0.150  Sum_probs=91.1

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCC---CCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN---HENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      +.|+.|....+|+.... +..++||+....  ....+..|.+.++.+.   ...+.+++.++...+..++||||+++..+
T Consensus        42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           42 EKLYSGEMNEIWLINDE-VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEECCSSSSEEEEEESS-SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EEeCCccceeeeEEEEC-CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            46899999999998864 678889986543  3567888988888773   35677888888777789999999998765


Q ss_pred             hH-----------hhccCCC---CC--------------CCCCCHHHHH---HHHHH----------------HH-HHHH
Q 006055          453 SA-----------LLHGNKG---AG--------------RTPLNWEMRS---LIALG----------------AA-RGIE  484 (663)
Q Consensus       453 ~~-----------~l~~~~~---~~--------------~~~l~~~~~~---~i~~~----------------ia-~al~  484 (663)
                      ..           .||....   -+              .-.-+|....   ++..+                +. ....
T Consensus       119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~  198 (312)
T 3jr1_A          119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD  198 (312)
T ss_dssp             CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred             CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence            21           2333211   00              0112565332   11111                11 1123


Q ss_pred             HHhh--cCCcceecCCCCCCEEEcCCCceEEeccc
Q 006055          485 YLHA--QGPNVSHGNIKSSNILLTKSYEARVSDFG  517 (663)
Q Consensus       485 ~LH~--~~~~iiHrdlk~~Nill~~~~~~kl~Dfg  517 (663)
                      .|..  ..|.++|+|+.+.|++++.++ +.|.||.
T Consensus       199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            3432  236799999999999999887 8899974

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=97.35  E-value=0.00045  Score=72.80  Aligned_cols=125  Identities=17%  Similarity=0.150  Sum_probs=62.6

Q ss_pred             cEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCc---------------------cccCCCCCceEEcccc
Q 006055           70 RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPS---------------------DLASCSNLRNLYLQGN  128 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~---------------------~~~~l~~L~~L~L~~N  128 (663)
                      .++.+.++.. ++ .|....|.+...|+.+.+..+..+ ....                     .|..+.+|+.+.+.++
T Consensus       231 ~l~~i~ip~~-~~-~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~~~F~~~~~L~~i~l~~~  307 (394)
T 4fs7_A          231 GVKNIIIPDS-FT-ELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPEKTFYGCSSLTEVKLLDS  307 (394)
T ss_dssp             CCCEEEECTT-CC-EECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECTTTTTTCTTCCEEEECTT
T ss_pred             CCceEEECCC-ce-ecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeeccccccccccccccccccc
Confidence            3455555432 22 344445555566666665544321 2223                     3445555555555443


Q ss_pred             cccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecC
Q 006055          129 HFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN  200 (663)
Q Consensus       129 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N  200 (663)
                       ++..-..+|.++.+|+.++|.++ ++..-...|.++++|+.+.|..| ++..-...|.++++|+.+++..|
T Consensus       308 -i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          308 -VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR  376 (394)
T ss_dssp             -CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred             -cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence             33233445555666666666433 44233445566666666666554 44333445666666666665543

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=97.27  E-value=0.00047  Score=72.20  Aligned_cols=126  Identities=15%  Similarity=0.174  Sum_probs=99.7

Q ss_pred             cEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCcccccccc
Q 006055           70 RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL  149 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  149 (663)
                      .++.+.+..+ +. .++...|.+...|+.+.+..+ ++..-...|.++.+|+.+.+..+ +...-...|.++.+|+.+.+
T Consensus       218 ~l~~i~~~~~-~~-~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l  293 (379)
T 4h09_A          218 NLKKITITSG-VT-TLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVM  293 (379)
T ss_dssp             SCSEEECCTT-CC-EECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEE
T ss_pred             ccceeeeccc-ee-EEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccc
Confidence            4666666543 44 577778889999999999876 66666778999999999999765 55455667899999999999


Q ss_pred             ccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecC
Q 006055          150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN  200 (663)
Q Consensus       150 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N  200 (663)
                      .+|.++..-...|.++.+|+.+.|.++ ++..-...|.++.+|+.+.+..|
T Consensus       294 ~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~  343 (379)
T 4h09_A          294 DNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS  343 (379)
T ss_dssp             CCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred             cccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence            999988555678999999999999765 66455668999999998876443

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=97.27  E-value=0.00045  Score=72.85  Aligned_cols=119  Identities=10%  Similarity=0.114  Sum_probs=83.6

Q ss_pred             CCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCCCCccccccccccc
Q 006055           94 TSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFL  173 (663)
Q Consensus        94 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l  173 (663)
                      ..+..+.+. +.++..-...|.++.+|+.+.+.++..+ .-...|.++++|+.+.+. +.++..-...|.++.+|+.++|
T Consensus       242 ~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~l  318 (394)
T 4gt6_A          242 REDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDI  318 (394)
T ss_dssp             CCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEEC
T ss_pred             cccceEEcC-CcceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEe
Confidence            344445443 3344444567888999999999877654 556778888999999886 4565444567889999999999


Q ss_pred             ccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCC
Q 006055          174 ENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNS  217 (663)
Q Consensus       174 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~  217 (663)
                      .+| ++..-...|.++.+|+.+.|..+ ++..-..+|.++.+|.
T Consensus       319 p~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~  360 (394)
T 4gt6_A          319 PEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALN  360 (394)
T ss_dssp             CTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCC
T ss_pred             CCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCC
Confidence            765 66455678889999999998654 6634346677766554

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.26  E-value=0.00065  Score=68.68  Aligned_cols=70  Identities=7%  Similarity=-0.001  Sum_probs=42.7

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcc-cceEEEEecCccEEEEEcc-CCCCh
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLV-PLRAYYYSMDEKLLVYDYL-TMGSL  452 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~ey~-~~gsL  452 (663)
                      +.|+.|....+|+.     ..+++|+............+|..+++.+....+. ++++  .+.+..++|+||+ ++.++
T Consensus        24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~--~~~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLH--VDPATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEE--ECTTTCCEEEECCTTCEEC
T ss_pred             eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEE--EECCCCEEEEeecCCCccC
Confidence            56888999999998     5688888754311111234577766666433333 4443  3455568999999 55444

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.24  E-value=0.0025  Score=65.02  Aligned_cols=142  Identities=13%  Similarity=0.049  Sum_probs=81.4

Q ss_pred             ccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCC--cccceEE-----EEecCccEEEEEccCC
Q 006055          377 VLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHEN--LVPLRAY-----YYSMDEKLLVYDYLTM  449 (663)
Q Consensus       377 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~ey~~~  449 (663)
                      .++ |....||+....+|+.+++|...........+..|..++..+....  +.+++..     ....+..++||||+++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G  111 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  111 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence            455 7778999988777888999998744445667777888777663222  3334332     1223455789999987


Q ss_pred             CChh-----Hh---------hcc----CCCCCCCCCCHHHH----HHH---------------HHHHHHHHHHHhh----
Q 006055          450 GSLS-----AL---------LHG----NKGAGRTPLNWEMR----SLI---------------ALGAARGIEYLHA----  488 (663)
Q Consensus       450 gsL~-----~~---------l~~----~~~~~~~~l~~~~~----~~i---------------~~~ia~al~~LH~----  488 (663)
                      ..+.     .+         +|.    .........++...    ..+               ...+...+..+..    
T Consensus       112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  191 (328)
T 1zyl_A          112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE  191 (328)
T ss_dssp             EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence            5432     11         121    11001112232211    000               0011122333321    


Q ss_pred             -cCCcceecCCCCCCEEEcCCCceEEeccccccc
Q 006055          489 -QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL  521 (663)
Q Consensus       489 -~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~  521 (663)
                       ..+.++|+|+++.||+++ + .+.++||+.+..
T Consensus       192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence             123489999999999999 4 899999987753

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.21  E-value=0.0014  Score=69.78  Aligned_cols=73  Identities=11%  Similarity=0.090  Sum_probs=45.7

Q ss_pred             CcceecCCCCCCEEEcCCCceEEeccccccccCCCCCCC-----CCccccCccccCCCC---CCCcchhhhHHHHHHHHH
Q 006055          491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN-----RVAGYRAPEVTDPCK---VSQKADVYSFGVLLLELL  562 (663)
Q Consensus       491 ~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~y~aPE~~~~~~---~~~~~Dv~slGvvl~ell  562 (663)
                      +.++|+|+++.||++++++ ++++||+.+..-.+.....     ....|.+|+......   .....++......+++..
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            3599999999999999876 9999999886543221000     012366666654211   111244556777777776


Q ss_pred             hC
Q 006055          563 TG  564 (663)
Q Consensus       563 tg  564 (663)
                      ++
T Consensus       311 ~~  312 (420)
T 2pyw_A          311 NK  312 (420)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=97.15  E-value=0.00072  Score=71.25  Aligned_cols=67  Identities=10%  Similarity=0.076  Sum_probs=41.9

Q ss_pred             ccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccc
Q 006055           84 QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATN  152 (663)
Q Consensus        84 ~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N  152 (663)
                      .|+..+|.++++|+.+.|.. .++.+-...|.+|++|+.++|.+| ++..-...|.++.+|+.+.+..+
T Consensus        61 sIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~  127 (394)
T 4fs7_A           61 SIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM  127 (394)
T ss_dssp             EECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred             EhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc
Confidence            46666677777777777753 365544556777777777777654 44334455666667766666543

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.95  E-value=5.9e-05  Score=70.61  Aligned_cols=114  Identities=13%  Similarity=0.135  Sum_probs=66.3

Q ss_pred             ccCCCCCCCEEEccCC-CCCCC----CCccccCCCCCceEEcccccccCc----hhhhhcCCcccccccccccccccc--
Q 006055           89 ILGNLTSLRTLSLRFN-SLTSQ----LPSDLASCSNLRNLYLQGNHFSGE----VPLFLVGLHHLVRLNLATNNFSGE--  157 (663)
Q Consensus        89 ~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~--  157 (663)
                      ++.+-+.|+.|+|++| +|...    +-..+..-+.|+.|+|++|+|...    +-..+..-+.|+.|+|++|.|...  
T Consensus        36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga  115 (197)
T 1pgv_A           36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL  115 (197)
T ss_dssp             HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred             HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence            3455677888888875 66421    223344556788888888887622    344455566788888888887632  


Q ss_pred             --CCCCCccccccccccccccc---ccC----cCCCCCCCCCCCCEEEeecCcC
Q 006055          158 --IPSGFKNLTKLKTLFLENNR---LSG----SIPGFDDVLPNLQQLNVSNNLL  202 (663)
Q Consensus       158 --~p~~~~~l~~L~~L~l~~N~---l~~----~~p~~~~~l~~L~~L~l~~N~l  202 (663)
                        +-..+..-+.|++|+|++|.   +..    .+-..+..-+.|+.|+++.|.+
T Consensus       116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence              22234444567777777542   221    1222334446677777766543

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.93  E-value=0.00084  Score=58.56  Aligned_cols=56  Identities=23%  Similarity=0.269  Sum_probs=38.2

Q ss_pred             EEEcCCCCcc-cccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEccccccc
Q 006055           73 MLRLPGVALS-GQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFS  131 (663)
Q Consensus        73 ~L~L~~~~l~-g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  131 (663)
                      .++.++++|+ ..+|.++   -++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~l---p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAF---PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCC---CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCC---CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            5666777775 4566532   246778888888887766666777777777777777664

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.90  E-value=0.0038  Score=63.50  Aligned_cols=143  Identities=11%  Similarity=0.091  Sum_probs=77.5

Q ss_pred             cccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCC-----CCCcccce-E--EEEecCccEEEEEcc
Q 006055          376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-----HENLVPLR-A--YYYSMDEKLLVYDYL  447 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~ey~  447 (663)
                      +.|+.|....+|+....+| .+++|..... .....+..|+.++..+.     -|.++... |  +....+..+++|+|+
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l  105 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL  105 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence            4577888899999987655 6889987652 12234556666666553     23333211 1  112234568999999


Q ss_pred             CCCChhH--------------hhccC----CCCC---CCCCCHHHHHH------------HHHHHHHHHHHHhhc---C-
Q 006055          448 TMGSLSA--------------LLHGN----KGAG---RTPLNWEMRSL------------IALGAARGIEYLHAQ---G-  490 (663)
Q Consensus       448 ~~gsL~~--------------~l~~~----~~~~---~~~l~~~~~~~------------i~~~ia~al~~LH~~---~-  490 (663)
                      ++..+..              .+|..    ....   .....|.....            +...+...+.++++.   . 
T Consensus       106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~  185 (322)
T 2ppq_A          106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL  185 (322)
T ss_dssp             CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred             CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence            8765321              12211    1000   00012332111            011234455666532   1 


Q ss_pred             -CcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          491 -PNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       491 -~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                       +.++|+|+.+.||+++++..+.|+||+.+.
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             248999999999999987666899998774

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.89  E-value=0.0027  Score=65.05  Aligned_cols=142  Identities=12%  Similarity=0.030  Sum_probs=70.8

Q ss_pred             ccccccceE-EEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCC--CcccceEEEEecCccEEEEEccCCCChh
Q 006055          377 VLGKGTFGT-AYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHE--NLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       377 ~lg~G~~g~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .|+.|.... +|+....+|..+++|.......  ..+..|+.++..+...  .+.+++.+.  .+..+++||++.+..+.
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~--~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g~ll~e~l~~~~l~  100 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG--GDTQPFVDLAQYLRNLDISAPEIYAEE--HARGLLLIEDLGDALFT  100 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTTT--CCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTTEEEECCCCSCBHH
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC--ccccHHHHHHHHHHhCCCCCCceeeec--CCCCEEEEeeCCCcchH
Confidence            465555554 6677654467777776543220  2334455655555322  244555542  33448899999776665


Q ss_pred             HhhccC---------------------CCCCCCCCCHHHHH---------H-----------HHHHHHHHHHHHh----h
Q 006055          454 ALLHGN---------------------KGAGRTPLNWEMRS---------L-----------IALGAARGIEYLH----A  488 (663)
Q Consensus       454 ~~l~~~---------------------~~~~~~~l~~~~~~---------~-----------i~~~ia~al~~LH----~  488 (663)
                      +++...                     .......++.....         .           ....+...+..+.    .
T Consensus       101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~  180 (333)
T 3csv_A          101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE  180 (333)
T ss_dssp             HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence            443211                     00000112111100         0           0011122233331    1


Q ss_pred             cCCcceecCCCCCCEEEcCC----CceEEecccccccc
Q 006055          489 QGPNVSHGNIKSSNILLTKS----YEARVSDFGLAHLV  522 (663)
Q Consensus       489 ~~~~iiHrdlk~~Nill~~~----~~~kl~Dfg~a~~~  522 (663)
                      ..+.++|||+.+.||+++.+    +.+.|+||+.+..-
T Consensus       181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            11359999999999999875    67999999988643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.80  E-value=0.0062  Score=63.46  Aligned_cols=142  Identities=13%  Similarity=0.094  Sum_probs=82.1

Q ss_pred             cccccccceEEEEEEec--------CCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCc-ccceEEEEecCccEEEEEc
Q 006055          376 EVLGKGTFGTAYKAVLE--------MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENL-VPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ey  446 (663)
                      +.|..|-...+|+....        +++.+++|+..........+.+|..+++.+.-..+ .++++++.+    .+||||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            45777888899998864        25789999864333345566788888887743333 455655432    399999


Q ss_pred             cCCCChhHh-----------------hccCCCCCCCCCC--HHHHHHHHHHHH-------------------HHHHHHh-
Q 006055          447 LTMGSLSAL-----------------LHGNKGAGRTPLN--WEMRSLIALGAA-------------------RGIEYLH-  487 (663)
Q Consensus       447 ~~~gsL~~~-----------------l~~~~~~~~~~l~--~~~~~~i~~~ia-------------------~al~~LH-  487 (663)
                      +++..|..-                 +|...-.......  |....++..++.                   ..+.+|. 
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            997655311                 2221111111222  444444443332                   1233332 


Q ss_pred             ---hcC--CcceecCCCCCCEEEcCC----CceEEeccccccc
Q 006055          488 ---AQG--PNVSHGNIKSSNILLTKS----YEARVSDFGLAHL  521 (663)
Q Consensus       488 ---~~~--~~iiHrdlk~~Nill~~~----~~~kl~Dfg~a~~  521 (663)
                         ...  ..++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               222  358999999999999876    6899999998753

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.77  E-value=0.0021  Score=56.04  Aligned_cols=57  Identities=25%  Similarity=0.348  Sum_probs=48.3

Q ss_pred             CEEEccCCCCC-CCCCccccCCCCCceEEcccccccCchhhhhcCCcccccccccccccc
Q 006055           97 RTLSLRFNSLT-SQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFS  155 (663)
Q Consensus        97 ~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  155 (663)
                      ..++.++++|+ ..+|..+.  ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            47899999997 24776543  57999999999999877888999999999999999875

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.58  E-value=0.019  Score=54.01  Aligned_cols=102  Identities=13%  Similarity=0.116  Sum_probs=67.4

Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCCC
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA-QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN  529 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  529 (663)
                      +|.++|....    .++++.+++.++.|.+.+|.-+-. ..+  ..+=+.|..|++..+|.+...+ ..+        ..
T Consensus        34 SL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s--------~~   98 (229)
T 2yle_A           34 SLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AAD--------DA   98 (229)
T ss_dssp             EHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             cHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-ccc--------cc
Confidence            7899998654    579999999999999998877621 111  1233456899999999988764 111        01


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCC
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPT  568 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~  568 (663)
                      ....+.|||... ...+++.=|||+|+++|..+--..|-
T Consensus        99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e  136 (229)
T 2yle_A           99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE  136 (229)
T ss_dssp             --------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence            122367888764 34567889999999999998755553

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.45  E-value=0.0039  Score=64.88  Aligned_cols=73  Identities=11%  Similarity=0.038  Sum_probs=42.5

Q ss_pred             cccccccceEEEEEEecC---------CcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcc-cceEEEEecCccEEEEE
Q 006055          376 EVLGKGTFGTAYKAVLEM---------GTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLV-PLRAYYYSMDEKLLVYD  445 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e  445 (663)
                      +.|+.|....+|+....+         +..+++|+.......-.....|.+++..+...+++ ++++..    ..++|||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~e  114 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIEE  114 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEEE
Confidence            457888888999988653         26888888654321111235677777766433433 555443    3478999


Q ss_pred             ccCCCCh
Q 006055          446 YLTMGSL  452 (663)
Q Consensus       446 y~~~gsL  452 (663)
                      |+++..+
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.37  E-value=0.014  Score=62.12  Aligned_cols=72  Identities=11%  Similarity=0.070  Sum_probs=48.8

Q ss_pred             cccccccceEEEEEEecC--------CcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCc-ccceEEEEecCccEEEEEc
Q 006055          376 EVLGKGTFGTAYKAVLEM--------GTIVAVKRLKDVTISEREFKDKIEGVGAVNHENL-VPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ey  446 (663)
                      +.|+.|....||+....+        +..+++|+.... .....+..|..++..+...++ .++++.+.    -.+|+||
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~----~g~v~e~  153 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEY  153 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC----CCEEEEE
Confidence            467888889999998653        578999987432 222455678888887754444 45666542    2489999


Q ss_pred             cCCCCh
Q 006055          447 LTMGSL  452 (663)
Q Consensus       447 ~~~gsL  452 (663)
                      +++.++
T Consensus       154 l~G~~l  159 (429)
T 1nw1_A          154 IPSRPL  159 (429)
T ss_dssp             CCEEEC
T ss_pred             eCCccc
Confidence            986443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.25  E-value=0.025  Score=60.50  Aligned_cols=73  Identities=7%  Similarity=0.025  Sum_probs=46.4

Q ss_pred             cccccccceEEEEEEecC-CcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcc-cceEEEEecCccEEEEEccCCCCh
Q 006055          376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLV-PLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      +.|+.|-...+|+....+ +..+++|+.......--....|..++..+...++. ++++++  .  ..+||||+++..|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~--~G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--T--NGRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--T--TEEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--C--CeEEEEeeCCccC
Confidence            468888899999998764 47888998743211111125788888887655554 566655  2  2469999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.24  E-value=0.013  Score=60.11  Aligned_cols=31  Identities=19%  Similarity=0.310  Sum_probs=27.3

Q ss_pred             CcceecCCCCCCEEEcCCCceEEeccccccc
Q 006055          491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHL  521 (663)
Q Consensus       491 ~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~  521 (663)
                      +.++|+|+.+.||++++++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4599999999999999888899999987754

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=95.97  E-value=0.0012  Score=61.74  Aligned_cols=88  Identities=15%  Similarity=0.163  Sum_probs=64.4

Q ss_pred             ccCCCCCceEEcccc-cccC----chhhhhcCCccccccccccccccccCC----CCCcccccccccccccccccCc---
Q 006055          114 LASCSNLRNLYLQGN-HFSG----EVPLFLVGLHHLVRLNLATNNFSGEIP----SGFKNLTKLKTLFLENNRLSGS---  181 (663)
Q Consensus       114 ~~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p----~~~~~l~~L~~L~l~~N~l~~~---  181 (663)
                      +.+-+.|++|+|++| +|..    .+-..+..-+.|+.|+|++|+|...-.    ..+..-+.|+.|+|++|+|+..   
T Consensus        37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~  116 (197)
T 1pgv_A           37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA  116 (197)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred             HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence            445578999999986 7762    245667778899999999999974332    3344557899999999999742   


Q ss_pred             -CCCCCCCCCCCCEEEeecCc
Q 006055          182 -IPGFDDVLPNLQQLNVSNNL  201 (663)
Q Consensus       182 -~p~~~~~l~~L~~L~l~~N~  201 (663)
                       +-..+..-+.|+.|+|++|.
T Consensus       117 ala~aL~~N~tL~~L~L~n~~  137 (197)
T 1pgv_A          117 RLLRSTLVTQSIVEFKADNQR  137 (197)
T ss_dssp             HHHHHTTTTCCCSEEECCCCS
T ss_pred             HHHHHHhhCCceeEEECCCCc
Confidence             22345556779999998763

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=94.62  E-value=0.013  Score=38.26  Aligned_cols=32  Identities=34%  Similarity=0.664  Sum_probs=23.2

Q ss_pred             cccCCceeehhHHHHHHHHHHHHHHhhhheec
Q 006055          258 KLSGGAIAGIVIGSVIGFLLILLILLILCRKK  289 (663)
Q Consensus       258 ~~~~~~i~giv~~~~~~~~~~~~i~~~~~~~r  289 (663)
                      .++.+.+.|+++++++++.+++.+.++++|||
T Consensus         7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~~rrr   38 (38)
T 2k1k_A            7 GLTGGEIVAVIFGLLLGAALLLGILVFRSRRA   38 (38)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_pred             CCCCCceeeeehHHHHHHHHHHHHHHHHeecC
Confidence            45567788999998888777776666665543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.52  E-value=0.27  Score=51.77  Aligned_cols=73  Identities=7%  Similarity=0.015  Sum_probs=46.1

Q ss_pred             cccccccceEEEEEEecC--------CcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCc-ccceEEEEecCccEEEEEc
Q 006055          376 EVLGKGTFGTAYKAVLEM--------GTIVAVKRLKDVTISEREFKDKIEGVGAVNHENL-VPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ey  446 (663)
                      +.+..|-...+|+....+        +..+++|+.......--+..+|..+++.+....+ .++++.+    ..++||||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ef  151 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEEF  151 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEEC
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEEE
Confidence            457778888999988653        5789999864432111123567777766643333 3455433    34889999


Q ss_pred             cCCCCh
Q 006055          447 LTMGSL  452 (663)
Q Consensus       447 ~~~gsL  452 (663)
                      +++..|
T Consensus       152 I~G~~l  157 (424)
T 3mes_A          152 IDGEPL  157 (424)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            998654

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=92.02  E-value=0.13  Score=34.66  Aligned_cols=31  Identities=19%  Similarity=0.339  Sum_probs=14.8

Q ss_pred             ceeehhHHHHHHHHHHHHHHhhhheecCCCC
Q 006055          263 AIAGIVIGSVIGFLLILLILLILCRKKSNRN  293 (663)
Q Consensus       263 ~i~giv~~~~~~~~~~~~i~~~~~~~r~~~~  293 (663)
                      .|.+.+++.+++++++++.+++++|+|+.++
T Consensus        12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~~   42 (44)
T 2ks1_B           12 SIATGMVGALLLLLVVALGIGLFMRRRHIVR   42 (44)
T ss_dssp             SSTHHHHHHHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             eEEeehhHHHHHHHHHHHHHHHHhhhhHhhc
Confidence            3444455544444444444455555554443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=89.73  E-value=0.2  Score=33.66  Aligned_cols=29  Identities=31%  Similarity=0.465  Sum_probs=13.0

Q ss_pred             eeehhHHHHHHHHHHHHHHhhhheecCCC
Q 006055          264 IAGIVIGSVIGFLLILLILLILCRKKSNR  292 (663)
Q Consensus       264 i~giv~~~~~~~~~~~~i~~~~~~~r~~~  292 (663)
                      +.+.+++.+++++++++..++++|+|+.+
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            44444444444444444444455544443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.65  E-value=1.1  Score=42.05  Aligned_cols=117  Identities=14%  Similarity=0.109  Sum_probs=78.4

Q ss_pred             CCCCcccceEEEEecCccEEEEEccCCC-ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCC
Q 006055          423 NHENLVPLRAYYYSMDEKLLVYDYLTMG-SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSS  501 (663)
Q Consensus       423 ~h~niv~l~~~~~~~~~~~lv~ey~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~  501 (663)
                      .||+++.. .+-.+.+...+.|+.-+.+ ++.. ++        ..+...+++++..|+....+++..    +|--|.|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik--------~~~~~eKlr~l~ni~~l~~~~~~r----~tf~L~P~  108 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK--------SFTKNEKLRYLLNIKNLEEVNRTR----YTFVLAPD  108 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG--------GSCHHHHHHHHHHGGGGGGGGGSS----EECCCSGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH--------hcCHHHHHHHHHHHHHHHHHhcCc----eEEEEecc
Confidence            57887765 3444445444445433322 2222 32        267899999999999877666543    68889999


Q ss_pred             CEEEcCCCceEEeccccccccCCCCCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccc
Q 006055          502 NILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHAL  571 (663)
Q Consensus       502 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~  571 (663)
                      |++++.++.+++.-.|+-..+.|..                  .++..=.-.+=+++..+++++..|+..
T Consensus       109 NL~f~~~~~p~i~~RGik~~l~P~~------------------~~ee~fL~qyKAliiall~~K~~Fe~l  160 (215)
T 4ann_A          109 ELFFTRDGLPIAKTRGLQNVVDPLP------------------VSEAEFLTRYKALVICAFNEKQSFDAL  160 (215)
T ss_dssp             GEEECTTSCEEESCCEETTTBSCCC------------------CCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred             eEEEcCCCCEEEEEccCccCCCCCC------------------CCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            9999999999999888755443321                  122222336788999999999998653

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=82.88  E-value=0.66  Score=31.10  Aligned_cols=26  Identities=19%  Similarity=0.478  Sum_probs=11.3

Q ss_pred             eeehhHHHHHHHHHHHHHHhhhheecC
Q 006055          264 IAGIVIGSVIGFLLILLILLILCRKKS  290 (663)
Q Consensus       264 i~giv~~~~~~~~~~~~i~~~~~~~r~  290 (663)
                      +.++++| ++.++++.++++++.|||+
T Consensus        14 Ia~~vVG-vll~vi~~l~~~~~~RRR~   39 (44)
T 2jwa_A           14 IISAVVG-ILLVVVLGVVFGILIKRRQ   39 (44)
T ss_dssp             HHHHHHH-HHHHHHHHHHHHHHHHHHC
T ss_pred             hHHHHHH-HHHHHHHHHHHHhheehhh
Confidence            5556666 3333333333334444443

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=82.20  E-value=3  Score=39.11  Aligned_cols=116  Identities=13%  Similarity=0.043  Sum_probs=77.7

Q ss_pred             CCCCcccceEEEEecCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHH-HHhhcCCcceecCCCCC
Q 006055          423 NHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIE-YLHAQGPNVSHGNIKSS  501 (663)
Q Consensus       423 ~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~-~LH~~~~~iiHrdlk~~  501 (663)
                      .||.+  -...-.+.+...+.|+.-+++.=...++        .++...+++++..|+.... +++.    -+|--|.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCc
Confidence            56776  3333345556666666543433333343        2678899999998887666 5544    468889999


Q ss_pred             CEEEcCCCceEEeccccccccCCCCCCCCCccccCccccCCCCCCCcchhh-hHHHHHHHHHhCCCCCccc
Q 006055          502 NILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPCKVSQKADVY-SFGVLLLELLTGKAPTHAL  571 (663)
Q Consensus       502 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~-slGvvl~elltg~~p~~~~  571 (663)
                      |+++|.++.+++.-.|+-..+.|.             -+     + ..|-| .+=+++..++.++..|+..
T Consensus       114 NL~f~~~~~p~i~hRGi~~~lpP~-------------e~-----~-ee~fl~qyKali~all~~K~~Fe~l  165 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKESLPPD-------------EW-----D-DERLLREVKATVLALTEGEYRFDEY  165 (219)
T ss_dssp             GEEECTTCCEEESCCEETTTBSSC-------------SC-----C-HHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred             eEEEeCCCcEEEEEcCCcccCCCC-------------CC-----C-HHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            999999999999988875444322             11     1 22333 6788899999999988653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	663
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-57
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-54
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-53
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-51
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-51
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-51
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-49
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-49
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-49
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-48
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-47
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-47
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-47
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-46
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-46
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-46
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-46
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-45
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-45
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-45
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-45
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-44
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-43
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-42
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-42
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-42
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-42
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-42
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-41
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-40
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-40
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-40
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-38
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-38
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-36
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-35
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-35
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-35
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-35
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-34
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-34
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-34
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-34
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-32
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-31
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-29
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-29
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-29
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-28
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-25
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-24
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-13
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	8e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-17
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-10
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-07
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-04
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-04
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-14
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-11
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-09
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-12
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-09
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-07
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	6e-07
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	3e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	6e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.004
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	9e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.003
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.002
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.003
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.002
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-05
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	2e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	7e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.002

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 8e-57
 Identities = 70/275 (25%), Positives = 129/275 (46%), Gaps = 27/275 (9%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           E LG G FG  +       T VAVK LK  ++S   F  +   +  + H+ LV L A   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 77

Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
           + +   ++ +Y+  GSL   L    G     L       +A   A G+ ++  +  N  H
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEER--NYIH 132

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA-----GYRAPEVTDPCKVSQKAD 550
            +++++NIL++ +   +++DFGLA L+  +    R        + APE  +    + K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192

Query: 551 VYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           V+SFG+LL E++T     +      G+  P  +Q++ +           ++R  N  EE+
Sbjct: 193 VWSFGILLTEIVTHGRIPY-----PGMTNPEVIQNLER--------GYRMVRPDNCPEEL 239

Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
            QL++L   C  + P++RP+   +   +E+   ++
Sbjct: 240 YQLMRL---CWKERPEDRPTFDYLRSVLEDFFTAT 271

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 5e-54
 Identities = 72/281 (25%), Positives = 122/281 (43%), Gaps = 33/281 (11%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISE---REFKDKIEGVGAVNHENLVPLRA 432
           + +G G+FGT YK        VAVK L     +    + FK+++  +    H N++    
Sbjct: 14  QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
           Y  +  +  +V  +    SL   LH  +              IA   A+G++YLHA+   
Sbjct: 72  YS-TAPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAKS-- 124

Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA------GYRAPEV---TDPC 543
           + H ++KS+NI L +    ++ DFGLA +    S  ++         + APEV    D  
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184

Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY 603
             S ++DVY+FG++L EL+TG+ P         ++    +  +V   + S          
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPY------SNINNRDQIIFMVGRGYLSPDLS---KVR 235

Query: 604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS 644
            N  + M +L+     C  +  D RP   +++  IE L  S
Sbjct: 236 SNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARS 273

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 3e-53
 Identities = 63/294 (21%), Positives = 113/294 (38%), Gaps = 35/294 (11%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           E +GKG FG  ++     G  VAVK            + +I     + HEN++   A   
Sbjct: 9   ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 67

Query: 436 SMDEKL----LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG- 490
             +       LV DY   GSL   L+      R  +  E    +AL  A G+ +LH +  
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 491 -----PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----TPNRVAG---YRAP 537
                P ++H ++KS NIL+ K+    ++D GLA     ++      PN   G   Y AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 538 EVTDPC------KVSQKADVYSFGVLLLELLTGKAPTHALLNEE----GVDLPRWVQSIV 587
           EV D        +  ++AD+Y+ G++  E+    +      + +     +         +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           +     +     +       E +  + ++  +C       R +   + K + +L
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 1e-51
 Identities = 62/272 (22%), Positives = 111/272 (40%), Gaps = 29/272 (10%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           + LG G FG            VA+K +K+ ++SE EF ++ + +  ++HE LV L     
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69

Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
                 ++ +Y+  G L   L   +         +    +       +EYL ++     H
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQ--FLH 123

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-----AGYRAPEVTDPCKVSQKAD 550
            ++ + N L+      +VSDFGL+  V      + V       +  PEV    K S K+D
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 183

Query: 551 VYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           +++FGVL+ E+ + GK P       E        + I +         L L R     E+
Sbjct: 184 IWAFGVLMWEIYSLGKMP------YERFTNSETAEHIAQ--------GLRLYRPHLASEK 229

Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           +  ++     C  +  D RP+   ++  I ++
Sbjct: 230 VYTIMYS---CWHEKADERPTFKILLSNILDV 258

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 2e-51
 Identities = 65/272 (23%), Positives = 116/272 (42%), Gaps = 29/272 (10%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           + +G G FG  +         VA+K +++  +SE +F ++ E +  ++H  LV L     
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70

Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
                 LV++++  G LS  L       R     E    + L    G+ YL      V H
Sbjct: 71  EQAPICLVFEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEAC--VIH 124

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA-----GYRAPEVTDPCKVSQKAD 550
            ++ + N L+ ++   +VSDFG+   V      +         + +PEV    + S K+D
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184

Query: 551 VYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           V+SFGVL+ E+ + GK P     N E V+       + K    S                
Sbjct: 185 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST--------------- 229

Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
              + Q+   C  + P++RP+ S +++++ E+
Sbjct: 230 --HVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 3e-51
 Identities = 64/268 (23%), Positives = 111/268 (41%), Gaps = 25/268 (9%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
           + +GKG FG         G  VAVK +K+   + + F  +   +  + H NLV L     
Sbjct: 13  QTIGKGEFGDVMLGDYR-GNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 436 SMDEKL-LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
                L +V +Y+  GSL   L      GR+ L  +     +L     +EYL        
Sbjct: 71  EEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN--FV 125

Query: 495 HGNIKSSNILLTKSYEARVSDFGLAHLVGPS-STPNRVAGYRAPEVTDPCKVSQKADVYS 553
           H ++ + N+L+++   A+VSDFGL      +  T      + APE     K S K+DV+S
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 185

Query: 554 FGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQL 613
           FG+LL E+ +     +       + L   V  + K          ++         + ++
Sbjct: 186 FGILLWEIYSFGRVPY-----PRIPLKDVVPRVEKGY--------KMDAPDGCPPAVYEV 232

Query: 614 LQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           ++    C       RPS  ++ +++E +
Sbjct: 233 MKN---CWHLDAAMRPSFLQLREQLEHI 257

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 1e-49
 Identities = 71/275 (25%), Positives = 117/275 (42%), Gaps = 27/275 (9%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYY 435
             LG+G FG  +       T VA+K LK  T+S   F  + + +  + HE LV L A   
Sbjct: 23  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 81

Query: 436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSH 495
           S +   +V +Y++ GSL   L G  G     L       +A   A G+ Y+        H
Sbjct: 82  SEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN--YVH 136

Query: 496 GNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA-----GYRAPEVTDPCKVSQKAD 550
            +++++NIL+ ++   +V+DFGLA L+  +    R        + APE     + + K+D
Sbjct: 137 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 196

Query: 551 VYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEM 610
           V+SFG+LL EL T     +  +    V     +  + +             R     E  
Sbjct: 197 VWSFGILLTELTTKGRVPYPGMVNREV-----LDQVERG-----------YRMPCPPECP 240

Query: 611 VQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS 645
             L  L   C  + P+ RP+   +   +E+   S+
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  172 bits (436), Expect = 2e-49
 Identities = 70/277 (25%), Positives = 125/277 (45%), Gaps = 27/277 (9%)

Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
             LG G +G  Y+ V  +    VAVK LK+ T+   EF  +   +  + H NLV L    
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 82

Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
                  ++ +++T G+L   L       R  ++  +   +A   +  +EYL     N  
Sbjct: 83  TREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEK--KNFI 137

Query: 495 HGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-----AGYRAPEVTDPCKVSQKA 549
           H ++ + N L+ +++  +V+DFGL+ L+   +            + APE     K S K+
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 197

Query: 550 DVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           DV++FGVLL E+ T     +      G+DL +  + + K        D  + R +   E+
Sbjct: 198 DVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEK--------DYRMERPEGCPEK 244

Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
           + +L++    C    P +RPS +E+ +  E +   S+
Sbjct: 245 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQESS 278

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 3e-49
 Identities = 68/279 (24%), Positives = 121/279 (43%), Gaps = 37/279 (13%)

Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLR 431
             +G+G+F T YK +  E    VA   L+D  +++ E   FK++ E +  + H N+V   
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 432 AYYYSMDEK----LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
             + S  +     +LV + +T G+L   L   K      +  ++         +G+++LH
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 129

Query: 488 AQGPNVSHGNIKSSNILLT-KSYEARVSDFGLAHLVGPSSTPNRV--AGYRAPEVTDPCK 544
            + P + H ++K  NI +T  +   ++ D GLA L   S     +    + APE+ +  K
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-K 188

Query: 545 VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ 604
             +  DVY+FG+ +LE+ T + P     N     + R V S VK     +V   E     
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSGVKPASFDKVAIPE----- 241

Query: 605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP 643
                   + ++   C  Q  D R S+ +++      H 
Sbjct: 242 --------VKEIIEGCIRQNKDERYSIKDLLN-----HA 267

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  169 bits (428), Expect = 4e-48
 Identities = 62/288 (21%), Positives = 125/288 (43%), Gaps = 41/288 (14%)

Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISE--REFKDKIEGVGAVNHENLVP 429
           +V+G G FG      L    +    VA+K LK     +  R+F  +   +G  +H N++ 
Sbjct: 32  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 91

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           L          +++ +++  GSL + L  N G             +  G A G++YL   
Sbjct: 92  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLADM 147

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA---------GYRAPEVT 540
                H ++ + NIL+  +   +VSDFGL+  +   ++               + APE  
Sbjct: 148 N--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205

Query: 541 DPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE 599
              K +  +DV+S+G+++ E+++ G+ P   + N++       + +I +D          
Sbjct: 206 QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD------VINAIEQD---------- 249

Query: 600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL--HPSS 645
             R     +    L QL +DC  +  ++RP   +++  ++++  +P+S
Sbjct: 250 -YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 296

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 1e-47
 Identities = 68/303 (22%), Positives = 124/303 (40%), Gaps = 41/303 (13%)

Query: 364 VFDLEDLLRASAEVLGKGTFGTAYKAVLEM---GTIVAVKRLKDVTISE--REFKDKIEG 418
               ++LL A  E LG G FG+  + V  M      VA+K LK  T      E   + + 
Sbjct: 4   FLKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62

Query: 419 VGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALG 478
           +  +++  +V L     +    +LV +    G L   L G +      +     + +   
Sbjct: 63  MHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQ 117

Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV------- 531
            + G++YL  +  N  H ++ + N+LL   + A++SDFGL+  +G   +           
Sbjct: 118 VSMGMKYLEEK--NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

Query: 532 AGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDE 590
             + APE  +  K S ++DV+S+GV + E L+ G+ P       + +  P  +  I + +
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY------KKMKGPEVMAFIEQGK 229

Query: 591 WTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH---PSSTQ 647
                    +        E+  L+     C     ++RP    V +R+   +    S  +
Sbjct: 230 --------RMECPPECPPELYALMSD---CWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278

Query: 648 GHH 650
           GHH
Sbjct: 279 GHH 281

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  167 bits (424), Expect = 2e-47
 Identities = 62/276 (22%), Positives = 113/276 (40%), Gaps = 36/276 (13%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE----FKDKIEGVGAVNHENLVPL 430
             +G G+FG  Y A  +    +VA+K++        E       ++  +  + H N +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
           R  Y       LV +Y    +   L    K     PL     + +  GA +G+ YLH+  
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHN 135

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEV---TDPCKVSQ 547
             + H ++K+ NILL++    ++ DFG A ++ P+++      + APEV    D  +   
Sbjct: 136 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDG 193

Query: 548 KADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE 607
           K DV+S G+  +EL   K P         ++    +  I ++E  +       L+  +  
Sbjct: 194 KVDVWSLGITCIELAERKPPLF------NMNAMSALYHIAQNESPA-------LQSGHWS 240

Query: 608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP 643
           E     +     C  + P +RP+   ++K     H 
Sbjct: 241 EYFRNFVD---SCLQKIPQDRPTSEVLLK-----HR 268

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 3e-47
 Identities = 66/302 (21%), Positives = 120/302 (39%), Gaps = 37/302 (12%)

Query: 364 VFDLEDLLRASAEVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISE--REFKDKIE 417
           V     L+    EV+G+G FG  Y   L          AVK L  +T      +F  +  
Sbjct: 21  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 80

Query: 418 GVGAVNHENLVPLRAYYYSMDEK-LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIA 476
            +   +H N++ L       +   L+V  Y+  G L   +             +      
Sbjct: 81  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFG 136

Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV----- 531
           L  A+G+++L ++     H ++ + N +L + +  +V+DFGLA  +      +       
Sbjct: 137 LQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194

Query: 532 ---AGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK 588
                + A E     K + K+DV+SFGVLL EL+T  AP +       V+       +++
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQ 249

Query: 589 DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQG 648
                      LL+ +   + + +++     C     + RPS SE++ RI  +  +    
Sbjct: 250 GR--------RLLQPEYCPDPLYEVMLK---CWHPKAEMRPSFSELVSRISAIFSTFIGE 298

Query: 649 HH 650
           H+
Sbjct: 299 HY 300

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (418), Expect = 8e-47
 Identities = 56/299 (18%), Positives = 116/299 (38%), Gaps = 51/299 (17%)

Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTIS--EREFKDKIEGVGAVNHENL 427
             +G+G FG  ++A        E  T+VAVK LK+   +  + +F+ +   +   ++ N+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKG-------------------AGRTPLN 468
           V L           L+++Y+  G L+  L                         G  PL+
Sbjct: 79  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138

Query: 469 WEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP---- 524
              +  IA   A G+ YL  +     H ++ + N L+ ++   +++DFGL+  +      
Sbjct: 139 CAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196

Query: 525 --SSTPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRW 582
                      +  PE     + + ++DV+++GV+L E+ +     +  +  E V     
Sbjct: 197 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV----- 251

Query: 583 VQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           +  +                    E   ++L  L   C ++ P +RPS   + + ++ +
Sbjct: 252 IYYVRDGN-----------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 2e-46
 Identities = 51/281 (18%), Positives = 103/281 (36%), Gaps = 36/281 (12%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE---FKDKIEGVGAVNHENLVPLR 431
             +G G++G   K      G I+  K L   +++E E      ++  +  + H N+V   
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 432 AYYYSMDEKLL--VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
                     L  V +Y   G L++++       R  L+ E    +       ++  H +
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKG-TKERQYLDEEFVLRVMTQLTLALKECHRR 128

Query: 490 G---PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP----SSTPNRVAGYRAPEVTDP 542
                 V H ++K +N+ L      ++ DFGLA ++      +        Y +PE  + 
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 188

Query: 543 CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR 602
              ++K+D++S G LL EL     P                  I + ++           
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPF------TAFSQKELAGKIREGKFRR--------I 234

Query: 603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP 643
                +E+ +++            +RPS+ E+++     +P
Sbjct: 235 PYRYSDELNEIIT---RMLNLKDYHRPSVEEILE-----NP 267

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 3e-46
 Identities = 64/299 (21%), Positives = 120/299 (40%), Gaps = 42/299 (14%)

Query: 358 FGNAARVFDLEDLLRASAEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE-FKDK 415
           + +  R  + ED        LG G FG  YKA   E   + A K +   +  E E +  +
Sbjct: 1   YEHVTRDLNPEDFWEII-GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE 59

Query: 416 IEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLI 475
           I+ + + +H N+V L   +Y  +   ++ ++   G++ A++   +     PL      ++
Sbjct: 60  IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVV 115

Query: 476 ALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR----V 531
                  + YLH     + H ++K+ NIL T   + +++DFG++     +          
Sbjct: 116 CKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT 173

Query: 532 AGYRAPEV-----TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSI 586
             + APEV     +       KADV+S G+ L+E+   + P H       ++  R +  I
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH------ELNPMRVLLKI 227

Query: 587 VKDEWTSEVFDLELLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
            K E         L +           L+  L  +      D R + S++++     HP
Sbjct: 228 AKSEP------PTLAQPSRWSSNFKDFLKKCLEKN-----VDARWTTSQLLQ-----HP 270

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 5e-46
 Identities = 70/303 (23%), Positives = 120/303 (39%), Gaps = 46/303 (15%)

Query: 363 RVFDLEDLLRASAEVLGKGTFGTAYKAVLEM---GTIVAVKRLKDVTISE---REFKDKI 416
           ++  LED      + LG G FGT  K   +M      VAVK LK+         E   + 
Sbjct: 6   KLLTLED------KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 59

Query: 417 EGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIA 476
             +  +++  +V +       +  +LV +   +G L+  L  N+      +  +    + 
Sbjct: 60  NVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELV 113

Query: 477 LGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA---- 532
              + G++YL        H ++ + N+LL   + A++SDFGL+  +       +      
Sbjct: 114 HQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171

Query: 533 ---GYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVK 588
               + APE  +  K S K+DV+SFGVL+ E  + G+ P   +   E          + K
Sbjct: 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEK 225

Query: 589 DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE-LHPSSTQ 647
            E         +        EM  L+ L   C     +NRP  + V  R+    +    +
Sbjct: 226 GE--------RMGCPAGCPREMYDLMNL---CWTYDVENRPGFAAVELRLRNYYYDVVNE 274

Query: 648 GHH 650
           GHH
Sbjct: 275 GHH 277

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 6e-46
 Identities = 67/275 (24%), Positives = 111/275 (40%), Gaps = 37/275 (13%)

Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPL 430
             LGKG FG  Y A   +   I+A+K L    +     E + + ++E    + H N++ L
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
             Y++      L+ +Y  +G++   L           + +  +      A  + Y H++ 
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR 126

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV--AGYRAPEVTDPCKVSQK 548
             V H +IK  N+LL  + E +++DFG +     S          Y  PE+ +     +K
Sbjct: 127 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 184

Query: 549 ADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE 608
            D++S GVL  E L GK P  A   +E       V+    D  T    DL          
Sbjct: 185 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL---------- 234

Query: 609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP 643
            + +LL+         P  RP + EV++     HP
Sbjct: 235 -ISRLLKHN-------PSQRPMLREVLE-----HP 256

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 1e-45
 Identities = 50/299 (16%), Positives = 111/299 (37%), Gaps = 42/299 (14%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK--DVTISEREFKDKIEGVGAVNHENLVPLRA 432
             LG G  G  +K      G ++A K +          +   +++ +   N   +V    
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
            +YS  E  +  +++  GSL  +L          +  ++   +++   +G+ YL  +   
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH-K 125

Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA--GYRAPEVTDPCKVSQKAD 550
           + H ++K SNIL+    E ++ DFG++  +  S   + V    Y +PE       S ++D
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 185

Query: 551 VYSFGVLLLELLTGKAPTHALLNEE------------GVDLPRWVQSIVKDEWTSEVFDL 598
           ++S G+ L+E+  G+ P      +E              + P   ++  +   +  +   
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSR 245

Query: 599 ELLRYQNVEEEMV--------------QLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP 643
             +    + + +V              +       C  + P  R  + +++      H 
Sbjct: 246 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV-----HA 299

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 2e-45
 Identities = 63/288 (21%), Positives = 116/288 (40%), Gaps = 38/288 (13%)

Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVTIS--EREFKDKIEGVGAVNHENLV 428
           +V+G G FG  YK +L     +    VA+K LK         +F  +   +G  +H N++
Sbjct: 13  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L          +++ +Y+  G+L   L    G      +      +  G A G++YL  
Sbjct: 73  RLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLAN 128

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA-------GYRAPEVTD 541
              N  H ++ + NIL+  +   +VSDFGL+ ++                  + APE   
Sbjct: 129 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186

Query: 542 PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL 601
             K +  +DV+SFG+++ E++T     +  L+         V   + D            
Sbjct: 187 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKAINDG----------F 230

Query: 602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL--HPSSTQ 647
           R     +    + QL + C  Q    RP  ++++  +++L   P S +
Sbjct: 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 2e-45
 Identities = 63/299 (21%), Positives = 117/299 (39%), Gaps = 45/299 (15%)

Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAV-NHEN 426
           + LG G FG   +A        +    VAVK LK             +++ +  + NH N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGA-------------GRTPLNWEMRS 473
           +V L          L++ +Y   G L   L   + +                 L+ E   
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 474 LIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-- 531
             +   A+G+ +L ++     H ++ + NILLT     ++ DFGLA  +   S       
Sbjct: 149 SFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 532 ----AGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIV 587
                 + APE    C  + ++DV+S+G+ L EL +  +  +      G+ +      ++
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-----PGMPVDSKFYKMI 261

Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST 646
           K+          +L  ++   EM  +++    C    P  RP+  ++++ IE+    ST
Sbjct: 262 KE-------GFRMLSPEHAPAEMYDIMKT---CWDADPLKRPTFKQIVQLIEKQISEST 310

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  162 bits (412), Expect = 3e-45
 Identities = 60/293 (20%), Positives = 123/293 (41%), Gaps = 36/293 (12%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE-FKDKIEGVGAVNHENLVPLRAY 433
           E LG G FG  ++      G   A K +     S++E  + +I+ +  + H  LV L   
Sbjct: 32  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91

Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
           +   +E +++Y++++ G L   +          ++ +          +G+ ++H      
Sbjct: 92  FEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHENN--Y 145

Query: 494 SHGNIKSSNILLT--KSYEARVSDFGLAHLVGPSS---TPNRVAGYRAPEVTDPCKVSQK 548
            H ++K  NI+ T  +S E ++ DFGL   + P          A + APEV +   V   
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 205

Query: 549 ADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE 608
            D++S GVL   LL+G +P        G +    ++++   +W      ++   +  + E
Sbjct: 206 TDMWSVGVLSYILLSGLSPFG------GENDDETLRNVKSCDWN-----MDDSAFSGISE 254

Query: 609 EMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQPDDLDN 659
           +    ++  L  D     P+ R ++ + ++     HP  T G+   +   + +
Sbjct: 255 DGKDFIRKLLLAD-----PNTRMTIHQALE-----HPWLTPGNAPGRDSQIPS 297

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 1e-44
 Identities = 59/286 (20%), Positives = 123/286 (43%), Gaps = 38/286 (13%)

Query: 376 EVLGKGTFGTAYKAVLE---MGTIVAVKRLKDVTISE--REFKDKIEGVGAV-NHENLVP 429
           +V+G+G FG   KA ++   +    A+KR+K+    +  R+F  ++E +  + +H N++ 
Sbjct: 16  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGN-----------KGAGRTPLNWEMRSLIALG 478
           L           L  +Y   G+L   L  +             +  + L+ +     A  
Sbjct: 76  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135

Query: 479 AARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YR 535
            ARG++YL        H ++ + NIL+ ++Y A+++DFGL+                 + 
Sbjct: 136 VARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 193

Query: 536 APEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEV 595
           A E  +    +  +DV+S+GVLL E+++     +      G+      + + +       
Sbjct: 194 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY-----CGMTCAELYEKLPQGY----- 243

Query: 596 FDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
               L +  N ++E+  L++    C  + P  RPS ++++  +  +
Sbjct: 244 ---RLEKPLNCDDEVYDLMRQ---CWREKPYERPSFAQILVSLNRM 283

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 7e-43
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 38/276 (13%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE-FKDKIEGVGAVNHENLVPLRAY 433
           E +G+G  GT Y A+ +  G  VA++++      ++E   ++I  +    + N+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
           Y   DE  +V +YL  GSL+ ++        T ++    + +     + +E+LH+    V
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSNQ--V 137

Query: 494 SHGNIKSSNILLTKSYEARVSDFGLAHLVGP----SSTPNRVAGYRAPEVTDPCKVSQKA 549
            H +IKS NILL      +++DFG    + P     ST      + APEV        K 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 550 DVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           D++S G++ +E++ G+ P          +  R +  I  +         EL   + +   
Sbjct: 198 DIWSLGIMAIEMIEGEPPYL------NENPLRALYLIATNGT------PELQNPEKLSAI 245

Query: 610 MVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
               L   L +D      + R S  E+++     H 
Sbjct: 246 FRDFLNRCLDMD-----VEKRGSAKELLQ-----HQ 271

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 1e-42
 Identities = 61/297 (20%), Positives = 111/297 (37%), Gaps = 50/297 (16%)

Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTISE--REFKDKIEGVGAV-NHEN 426
           +VLG G FG    A         +   VAVK LK+   S        +++ +  + +HEN
Sbjct: 43  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102

Query: 427 LVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKG------------------AGRTPLN 468
           +V L           L+++Y   G L   L   +                        L 
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162

Query: 469 WEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP 528
           +E     A   A+G+E+L  +     H ++ + N+L+T     ++ DFGLA  +   S  
Sbjct: 163 FEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 529 NRV------AGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRW 582
                      + APE       + K+DV+S+G+LL E+ +     +      G+ +   
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY-----PGIPVDAN 275

Query: 583 VQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE 639
              ++++         ++ +     EE+  ++Q    C A     RPS   +   + 
Sbjct: 276 FYKLIQN-------GFKMDQPFYATEEIYIIMQS---CWAFDSRKRPSFPNLTSFLG 322

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-42
 Identities = 61/281 (21%), Positives = 114/281 (40%), Gaps = 37/281 (13%)

Query: 376 EVLGKGTFGTAYKAVLEM----GTIVAVKRLKDVTISE----REFKDKIEGVGAVNHENL 427
           E LG G+FG   +   +        VAVK LK   +S+     +F  ++  + +++H NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           + L     +   K+ V +   +GSL   L  ++G           S  A+  A G+ YL 
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLE 128

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-------AGYRAPEVT 540
           ++     H ++ + N+LL      ++ DFGL   +  +     +         + APE  
Sbjct: 129 SKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL 600
                S  +D + FGV L E+ T            G++  + +  I K+          L
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPW-----IGLNGSQILHKIDKE-------GERL 234

Query: 601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
            R ++  +++  ++     C A  P++RP+   +   + E 
Sbjct: 235 PRPEDCPQDIYNVMVQ---CWAHKPEDRPTFVALRDFLLEA 272

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  154 bits (391), Expect = 2e-42
 Identities = 60/277 (21%), Positives = 113/277 (40%), Gaps = 36/277 (12%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRL-KDVTISEREFKDKIEGVGAVNHENLVPLRAY 433
           E LG G FG  ++ V    G +   K +     + +   K++I  +  ++H  L+ L   
Sbjct: 35  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94

Query: 434 YYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNV 493
           +    E +L+ ++L+ G L   +          ++          A  G++++H     +
Sbjct: 95  FEDKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEHS--I 148

Query: 494 SHGNIKSSNILLTKSYEARV--SDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVSQK 548
            H +IK  NI+      + V   DFGLA  + P            + APE+ D   V   
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFY 208

Query: 549 ADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE 608
            D+++ GVL   LL+G +P        G D    +Q++ + +W    FD +   + +V  
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFA------GEDDLETLQNVKRCDWE---FDEDA--FSSVSP 257

Query: 609 EMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
           E    ++  L  +     P  R ++ + ++     HP
Sbjct: 258 EAKDFIKNLLQKE-----PRKRLTVHDALE-----HP 284

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-42
 Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 41/280 (14%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRL--KDVTISEREFKDKIEGVGAVNHENLVPLRA 432
           + LG+G +G    AV       VAVK +  K         K +I     +NHEN+V    
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
           +    + + L  +Y + G L   +  + G     +              G+ YLH  G  
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGIG-- 123

Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTP---NRVAG---YRAPEVTDPCKV- 545
           ++H +IK  N+LL +    ++SDFGLA +   ++     N++ G   Y APE+    +  
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 546 SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN 605
           ++  DV+S G++L  +L G+       ++   +   W +                  ++ 
Sbjct: 184 AEPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSDWKEKKTYLN-----------PWKK 231

Query: 606 VEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
           ++   + LL   L  +     P  R ++ ++ K       
Sbjct: 232 IDSAPLALLHKILVEN-----PSARITIPDIKK-----DR 261

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 6e-42
 Identities = 60/292 (20%), Positives = 121/292 (41%), Gaps = 38/292 (13%)

Query: 376 EVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVTIS--EREFKDKIEGVGAVNHENL 427
             LG+G+FG  Y+ V       E  T VA+K + +        EF ++   +   N  ++
Sbjct: 26  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG-----RTPLNWEMRSLIALGAARG 482
           V L          L++ + +T G L + L   + A        P +      +A   A G
Sbjct: 86  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145

Query: 483 IEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV------AGYRA 536
           + YL+A      H ++ + N ++ + +  ++ DFG+   +  +    +         + +
Sbjct: 146 MAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203

Query: 537 PEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF 596
           PE       +  +DV+SFGV+L E+ T     +     +G+   + ++ +++        
Sbjct: 204 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----QGLSNEQVLRFVMEGGL----- 253

Query: 597 DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEE-LHPSSTQ 647
              L +  N  + + +L+++   C    P  RPS  E+I  I+E + P   +
Sbjct: 254 ---LDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 2e-41
 Identities = 63/301 (20%), Positives = 126/301 (41%), Gaps = 39/301 (12%)

Query: 376 EVLGKGTFGTAYKAVL-----EMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLV 428
           +VLG G FGT YK +      ++   VA+K L++ T   + +E  D+   + +V++ ++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L     +     L+   +  G L   +  +K      +  +      +  A+G+ YL  
Sbjct: 75  RLLGICLT-STVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLED 129

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG------YRAPEVTDP 542
           +   + H ++ + N+L+      +++DFGLA L+G         G      + A E    
Sbjct: 130 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187

Query: 543 CKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL 601
              + ++DV+S+GV + EL+T G  P   +   E       + SI++           L 
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEK-------GERLP 233

Query: 602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQPDDLDNIS 661
           +      ++  ++     C     D+RP   E+I    ++     Q +  +Q D+  ++ 
Sbjct: 234 QPPICTIDVYMIMVK---CWMIDADSRPKFRELIIEFSKM-ARDPQRYLVIQGDERMHLP 289

Query: 662 S 662
           S
Sbjct: 290 S 290

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 2e-40
 Identities = 56/277 (20%), Positives = 109/277 (39%), Gaps = 34/277 (12%)

Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISE--REFKDKIEGVGAVNHENLVP 429
             +G+G FG  ++ +          VA+K  K+ T      +F  +   +   +H ++V 
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           L     + +   ++ +  T+G L + L   K      L+     L A   +  + YL ++
Sbjct: 73  LIGVI-TENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESK 127

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG-----YRAPEVTDPCK 544
                H +I + N+L++ +   ++ DFGL+  +  S+      G     + APE  +  +
Sbjct: 128 R--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185

Query: 545 VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ 604
            +  +DV+ FGV + E+L            +GV     +  I   E         L    
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGE--------RLPMPP 232

Query: 605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           N    +  L+     C A  P  RP  +E+  ++  +
Sbjct: 233 NCPPTLYSLMTK---CWAYDPSRRPRFTELKAQLSTI 266

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 3e-40
 Identities = 61/296 (20%), Positives = 121/296 (40%), Gaps = 35/296 (11%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
           E LG+G FG  ++ V          K +K     +   K +I  +    H N++ L   +
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
            SM+E ++++++++   +   ++ +       LN              +++LH+    + 
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLHSHN--IG 124

Query: 495 HGNIKSSNILLTKSYEARV--SDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVSQKA 549
           H +I+  NI+      + +   +FG A  + P      +     Y APEV     VS   
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 550 DVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           D++S G L+  LL+G  P  A  N++       +++I+  E+T   FD E   ++ +  E
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEYT---FDEEA--FKEISIE 233

Query: 610 MVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQPDDLDNISSR 663
            +  +   L  +       +R + SE ++     HP   Q    +    +  +  R
Sbjct: 234 AMDFVDRLLVKE-----RKSRMTASEALQ-----HPWLKQKIERVSTKVIRTLKHR 279

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 4e-40
 Identities = 62/293 (21%), Positives = 115/293 (39%), Gaps = 44/293 (15%)

Query: 376 EVLGKGTFGTAYKAV------LEMGTIVAVKRLKDVTISE--REFKDKIEGVGAVNHENL 427
           + LG+G FG   +A             VAVK LK+       R    +++ +  + H   
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 428 VPLRAYYYSMDEK--LLVYDYLTMGSLSALLHGNKG-----------AGRTPLNWEMRSL 474
           V       +      +++ ++   G+LS  L   +              +  L  E    
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 475 IALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA-- 532
            +   A+G+E+L ++     H ++ + NILL++    ++ DFGLA  +       R    
Sbjct: 139 YSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196

Query: 533 ----GYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK 588
                + APE       + ++DV+SFGVLL E+ +  A  +      GV +       +K
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLK 251

Query: 589 DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           +            R +  +    ++ Q  +DC    P  RP+ SE+++ +  L
Sbjct: 252 EG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  145 bits (368), Expect = 5e-40
 Identities = 52/291 (17%), Positives = 94/291 (32%), Gaps = 51/291 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAV-----------N 423
           E+LG+G      + +        AVK +          ++  E   A             
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 424 HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
           H N++ L+  Y +     LV+D +  G L   L          L+ +    I       I
Sbjct: 69  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVI 123

Query: 484 EYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---------Y 534
             LH     + H ++K  NILL      +++DFG +  + P      V G          
Sbjct: 124 CALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181

Query: 535 RAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSE 594
                 +     ++ D++S GV++  LL G  P               ++ I+       
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW------HRKQMLMLRMIMSGN---- 231

Query: 595 VFDLELLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
            +      + +  + +  L+   L +      P  R +  E +      HP
Sbjct: 232 -YQFGSPEWDDYSDTVKDLVSRFLVVQ-----PQKRYTAEEALA-----HP 271

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 6e-40
 Identities = 61/281 (21%), Positives = 109/281 (38%), Gaps = 38/281 (13%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
           +VLG G  G   +          A+K L+D   + RE +       A    ++V +   Y
Sbjct: 18  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR---ASQCPHIVRIVDVY 74

Query: 435 YSMDEK----LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
            ++       L+V + L  G L + +      G         S I       I+YLH+  
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN 131

Query: 491 PNVSHGNIKSSNILLTKSYE---ARVSDFGLAHLVGPSSTPNRV---AGYRAPEVTDPCK 544
             ++H ++K  N+L T        +++DFG A      ++         Y APEV  P K
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 189

Query: 545 VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ 604
             +  D++S GV++  LL G  P ++       +    +   +K       ++     + 
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPPFYS-------NHGLAISPGMKTRIRMGQYEFPNPEWS 242

Query: 605 NVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
            V EE+  L++  L  +     P  R +++E +      HP
Sbjct: 243 EVSEEVKMLIRNLLKTE-----PTQRMTITEFMN-----HP 273

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 7e-39
 Identities = 61/294 (20%), Positives = 120/294 (40%), Gaps = 46/294 (15%)

Query: 376 EVLGKGTFGTAYKAVL--------EMGTIVAVKRLKDVTISE--REFKDKIEGVGAV-NH 424
           + LG+G FG    A             T VAVK LK     +   +   ++E +  +  H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 425 ENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAG-----------RTPLNWEMRS 473
           +N++ L           ++ +Y + G+L   L   +  G              L+ +   
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 474 LIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-- 531
             A   ARG+EYL ++     H ++ + N+L+T+    +++DFGLA  +       +   
Sbjct: 139 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196

Query: 532 ----AGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIV 587
                 + APE       + ++DV+SFGVLL E+ T     +  +  E       +  ++
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------ELFKLL 250

Query: 588 KDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
           K+          + +  N   E+  +++   DC    P  RP+  ++++ ++ +
Sbjct: 251 KE-------GHRMDKPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 294

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 1e-38
 Identities = 68/318 (21%), Positives = 124/318 (38%), Gaps = 42/318 (13%)

Query: 376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
           +V+G G+FG  Y+A L + G +VA+K++      +R    +++ +  ++H N+V LR ++
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKNRELQIMRKLDHCNIVRLRYFF 82

Query: 435 YSMDEK------LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
           YS  EK       LV DY+         H ++   +  L      L      R + Y+H+
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIHS 140

Query: 489 QGPNVSHGNIKSSNILLT-KSYEARVSDFGLAHLVGPSS---TPNRVAGYRAP-EVTDPC 543
            G  + H +IK  N+LL   +   ++ DFG A  +       +      YRAP  +    
Sbjct: 141 FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 198

Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHA---------LLNEEGVDLPRWVQSIVKDEW--- 591
             +   DV+S G +L ELL G+              ++   G      ++ +  +     
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258

Query: 592 --TSEVFDLELLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKR--IEELHPSS 645
               +      +       E + L    L        P  R +  E       +EL   +
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT-----PTARLTPLEACAHSFFDELRDPN 313

Query: 646 TQGHHGLQPDDLDNISSR 663
            +  +G     L N +++
Sbjct: 314 VKLPNGRDTPALFNFTTQ 331

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  142 bits (360), Expect = 1e-38
 Identities = 58/279 (20%), Positives = 110/279 (39%), Gaps = 39/279 (13%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE--FKDKIEGVGAVNHENLVPLRA 432
           +VLG G F     A       +VA+K +    +  +E   +++I  +  + H N+V L  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
            Y S     L+   ++ G L   +                S +       ++YLH     
Sbjct: 75  IYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDL--G 127

Query: 493 VSHGNIKSSNILLT---KSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPCKVS 546
           + H ++K  N+L     +  +  +SDFGL+ +  P S  +   G   Y APEV      S
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187

Query: 547 QKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV 606
           +  D +S GV+   LL G  P +        +  +  + I+K E     ++ +   + ++
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFY------DENDAKLFEQILKAE-----YEFDSPYWDDI 236

Query: 607 EEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
            +     ++  +  D     P+ R +  + ++     HP
Sbjct: 237 SDSAKDFIRHLMEKD-----PEKRFTCEQALQ-----HP 265

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 1e-38
 Identities = 55/282 (19%), Positives = 99/282 (35%), Gaps = 41/282 (14%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAV----NHENLVPL 430
           ++LG+G+F T   A  L      A+K L+   I +      +     V    +H   V L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
              +   ++      Y   G L   +           +              +EYLH   
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHG-- 126

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR------VAGYRAPEVTDPCK 544
             + H ++K  NILL +    +++DFG A ++ P S   R       A Y +PE+     
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186

Query: 545 VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ 604
             + +D+++ G ++ +L+ G  P          +     Q I+K E+            +
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFR------AGNEYLIFQKIIKLEYDFP---------E 231

Query: 605 NVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEEL-HP 643
               +   L++  L +D        R    E+        HP
Sbjct: 232 KFFPKARDLVEKLLVLD-----ATKRLGCEEMEGYGPLKAHP 268

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  137 bits (347), Expect = 3e-36
 Identities = 58/283 (20%), Positives = 107/283 (37%), Gaps = 41/283 (14%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDK-------IEGVGAVNHENL 427
            ++G+G FG  Y     + G + A+K L    I  ++ +         +  V   +   +
Sbjct: 10  RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           V +   +++ D+   + D +  G L   L  +        +       A     G+E++H
Sbjct: 70  VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMH 124

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV--AGYRAPEV-TDPCK 544
            +   V + ++K +NILL +    R+SD GLA           V   GY APEV      
Sbjct: 125 NRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVA 182

Query: 545 VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ 604
               AD +S G +L +LL G +P      ++  ++ R   ++  +               
Sbjct: 183 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP------------D 230

Query: 605 NVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEEL--HP 643
           +   E+  LL+  L  D      + R       +  +E+   P
Sbjct: 231 SFSPELRSLLEGLLQRD-----VNRRLGCLG--RGAQEVKESP 266

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (337), Expect = 1e-35
 Identities = 57/306 (18%), Positives = 102/306 (33%), Gaps = 37/306 (12%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
             +G G+FG  Y    +  G  VA+K    V     +   + +    +     +P   + 
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
            +  +  ++   L   SL  L +          + +   L+A      IEY+H++     
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKN--FI 125

Query: 495 HGNIKSSNILLT---KSYEARVSDFGLAHLVGPSSTPNRV-----------AGYRAPEVT 540
           H ++K  N L+    K     + DFGLA     + T   +           A Y +    
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL 600
              + S++ D+ S G +L+    G  P   L            Q   +         +E+
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT------KRQKYERISEKKMSTPIEV 239

Query: 601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQPDD---L 657
           L  +    E    L     C +   D++P  S + +     +    QG       D   L
Sbjct: 240 LC-KGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR--NLFHRQGFSYDYVFDWNML 293

Query: 658 DNISSR 663
              +SR
Sbjct: 294 KFGASR 299

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 4e-35
 Identities = 63/289 (21%), Positives = 104/289 (35%), Gaps = 28/289 (9%)

Query: 376 EVLGKGTFGTAYKA--VLEMGTIVAVKRLKDVTISEREFKDKIEGV------GAVNHENL 427
             +G+G +G  +KA  +   G  VA+KR++  T  E      I  V          H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLS-ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
           V L                L    +   L           +  E    +     RG+++L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDPC 543
           H+    V H ++K  NIL+T S + +++DFGLA +         V     YRAPEV    
Sbjct: 133 HSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 190

Query: 544 KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY 603
             +   D++S G +  E+   K       + + +     V  +  +E       L    +
Sbjct: 191 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 250

Query: 604 -----QNVEEEMVQLLQLAID----CSAQYPDNRPSMSEVIKRIEELHP 643
                Q +E+ +  + +L  D    C    P  R S    +      HP
Sbjct: 251 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS-----HP 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  131 bits (330), Expect = 6e-35
 Identities = 59/284 (20%), Positives = 117/284 (41%), Gaps = 38/284 (13%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE----REFKDKIEGVGAVNHENLVPL 430
           E+LG G     + A  L +   VAVK L+     +      F+ + +   A+NH  +V +
Sbjct: 13  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72

Query: 431 RAYYYSMDEKL----LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYL 486
                +         +V +Y+   +L  ++H        P+  +    +   A + + + 
Sbjct: 73  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFS 127

Query: 487 HAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-------AGYRAPEV 539
           H  G  + H ++K +NI+++ +   +V DFG+A  +  S             A Y +PE 
Sbjct: 128 HQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185

Query: 540 TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE 599
                V  ++DVYS G +L E+LTG+ P        G          V+++         
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSVAYQHVREDPI-----PP 234

Query: 600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRP-SMSEVIKRIEELH 642
             R++ +  ++  ++       A+ P+NR  + +E+   +  +H
Sbjct: 235 SARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADLVRVH 275

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 8e-35
 Identities = 56/297 (18%), Positives = 113/297 (38%), Gaps = 43/297 (14%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE--REFKDKIEGVGAVNHENLVPLRA 432
             +G+G +G    A        VA+K++         +    +I+ +    HEN++ +  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
              +   + +   YL    + A L+  K      L+ +          RG++Y+H+    
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLY--KLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 129

Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-------AGYRAPEV-TDPCK 544
           V H ++K SN+LL  + + ++ DFGLA +  P                YRAPE+  +   
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189

Query: 545 VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ 604
            ++  D++S G +L E+L+ +         + ++    +      E  + + +L+   Y 
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249

Query: 605 ----------------NVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
                           N + + + LL   L  +     P  R  + + +      HP
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN-----PHKRIEVEQALA-----HP 296

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  131 bits (330), Expect = 9e-35
 Identities = 57/287 (19%), Positives = 101/287 (35%), Gaps = 31/287 (10%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISE---REFKDKIEGVGAVNHENLVPLRA 432
           E +G+GT+G  YKA    G   A+K+++     E        +I  +  + H N+V L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 433 YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPN 492
             ++    +LV+++L       L           L         L    GI Y H +   
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDRR-- 120

Query: 493 VSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN----RVAGYRAPEV-TDPCKVSQ 547
           V H ++K  N+L+ +  E +++DFGLA   G              YRAP+V     K S 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 548 KADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE 607
             D++S G +  E++ G      +   + +     +      +    V +L         
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 608 EEMVQLLQLAIDCSAQY-----------PDNRPSMSEVIKRIEELHP 643
            E +                        P+ R +  + ++     H 
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE-----HA 282

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  131 bits (329), Expect = 1e-34
 Identities = 43/283 (15%), Positives = 92/283 (32%), Gaps = 34/283 (12%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYY 434
             +G+G+FG  ++   L     VA+K     + +  + +D+      +     +P   Y+
Sbjct: 11  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-QLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 435 YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVS 494
                  ++   L   SL  LL           + +  ++ A      ++ +H +   + 
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEKS--LV 123

Query: 495 HGNIKSSNILLTK-----SYEARVSDFGLAHLVGPSSTPNRV-----------AGYRAPE 538
           + +IK  N L+ +     +    V DFG+        T   +           A Y +  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 539 VTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                + S++ D+ + G + +  L G  P       +G+      Q   +     +   L
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPW------QGLKAATNKQKYERIGEKKQSTPL 237

Query: 599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL 641
             L      EE  + +           D  P    +     ++
Sbjct: 238 RELC-AGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKV 276

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 2e-34
 Identities = 68/280 (24%), Positives = 116/280 (41%), Gaps = 43/280 (15%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRL-KDVTISEREFKDKIEGV----GAVNHENLVP 429
           ++LGKG+FG  + A   +     A+K L KDV + + + +  +        A  H  L  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 430 LRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ 489
           +   + + +    V +YL  G L   +           +    +  A     G+++LH++
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK 122

Query: 490 GPNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPCKV 545
           G  + + ++K  NILL K    +++DFG+    +   +  N   G   Y APE+    K 
Sbjct: 123 G--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 546 SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN 605
           +   D +SFGVLL E+L G++P H      G D      SI  D              + 
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFH------GQDEEELFHSIRMDNPFYP---------RW 225

Query: 606 VEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
           +E+E   LL      +     P+ R  +   I++    HP
Sbjct: 226 LEKEAKDLLVKLFVRE-----PEKRLGVRGDIRQ----HP 256

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 2e-34
 Identities = 60/295 (20%), Positives = 110/295 (37%), Gaps = 44/295 (14%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE------REFKDKIEGVGAVNHENLV 428
           + LG+G F T YKA       IVA+K++K    SE      R    +I+ +  ++H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 429 PLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
            L   +       LV+D++       +   +       L         L   +G+EYLH 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQ 118

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV----AGYRAPEVTDPCK 544
               + H ++K +N+LL ++   +++DFGLA   G  +           YRAPE+    +
Sbjct: 119 H--WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176

Query: 545 V-SQKADVYSFGVLLLELLTGKAP-------------THALLNEEGVDLPRWVQSIVKDE 590
           +     D+++ G +L ELL                     L        P          
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 591 WTSEVFDLELLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
           + S         +    ++++ L+Q     +     P  R + ++ +K       
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN-----PCARITATQALK-----MK 281

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  130 bits (327), Expect = 5e-34
 Identities = 59/276 (21%), Positives = 107/276 (38%), Gaps = 35/276 (12%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE----REFKDKIEGVGAVNHENLVPL 430
             LG G+FG  +       G   A+K LK   +          D+   +  V H  ++ +
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
              +    +  ++ DY+  G L +LL              +    A      +EYLH++ 
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKD 124

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAGYRAPEVTDPCKVSQKA 549
             + + ++K  NILL K+   +++DFG A ++   + T      Y APEV      ++  
Sbjct: 125 --IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSI 182

Query: 550 DVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           D +SFG+L+ E+L G  P +        +  +  + I+  E                 E+
Sbjct: 183 DWWSFGILIYEMLAGYTPFY------DSNTMKTYEKILNAELR---------FPPFFNED 227

Query: 610 MVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
           +  LL   +  D S +  + +    +V       HP
Sbjct: 228 VKDLLSRLITRDLSQRLGNLQNGTEDVKN-----HP 258

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 6e-34
 Identities = 58/285 (20%), Positives = 111/285 (38%), Gaps = 45/285 (15%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLK-------DVTISEREFKDKIEGVGAVNHENL 427
           E LG G F    K      G   A K +K          +S  + + ++  +  + H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75

Query: 428 VPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
           + L   Y +  + +L+ + +  G L   L   +      L  E  +        G+ YLH
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLH 130

Query: 488 AQGPNVSHGNIKSSNILLTKSYEAR----VSDFGLAHLVGPSSTPNRVAG---YRAPEVT 540
           +    ++H ++K  NI+L      +    + DFGLAH +   +    + G   + APE+ 
Sbjct: 131 SL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188

Query: 541 DPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL 600
           +   +  +AD++S GV+   LL+G +P      +E                ++  ++ E 
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----------TLANVSAVNYEFED 237

Query: 601 LRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEELHP 643
             + N        ++  L  D     P  R ++ + ++     HP
Sbjct: 238 EYFSNTSALAKDFIRRLLVKD-----PKKRMTIQDSLQ-----HP 272

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 2e-33
 Identities = 59/288 (20%), Positives = 107/288 (37%), Gaps = 31/288 (10%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE---REFKDKIEGVGAVNHENLVPLR 431
           E +G+GT+G  YKA     G +VA+K+++  T +E        +I  +  +NH N+V L 
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
              ++ ++  LV+++L       +           +   +         +G+ + H+   
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCHSH-- 121

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNR----VAGYRAPEVTDPCK-VS 546
            V H ++K  N+L+      +++DFGLA   G              YRAPE+   CK  S
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181

Query: 547 QKADVYSFGVLLLELLTGKAP-------THALLNEEGVDLPRWVQSIVKDEWTSEVFDLE 599
              D++S G +  E++T +A                 +  P  V                
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241

Query: 600 LLRYQNVEEEMVQLLQLAID----CSAQYPDNRPSMSEVIKRIEELHP 643
               Q+  + +  L +             P+ R S    +      HP
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA-----HP 284

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 1e-32
 Identities = 64/291 (21%), Positives = 117/291 (40%), Gaps = 35/291 (12%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE---REFKDKIEGVGAVNHENLVPLR 431
           + +G G +G    AV    G  VA+K+L     SE   +    ++  +  + HEN++ L 
Sbjct: 24  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83

Query: 432 AYYYSMDEKLLVYDYLT----MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLH 487
             +   +      D+      MG+    L  ++      L  +    +     +G+ Y+H
Sbjct: 84  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIH 138

Query: 488 AQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVA-GYRAPEV-TDPCKV 545
           A G    H ++K  N+ + +  E ++ DFGLA       T   V   YRAPEV  +  + 
Sbjct: 139 AAGII--HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRY 196

Query: 546 SQKADVYSFGVLLLELLTGKAP---------THALLNEEGVDLPRWVQSIVKDEWTSEVF 596
           +Q  D++S G ++ E++TGK              ++   G     +VQ +  DE  + + 
Sbjct: 197 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256

Query: 597 DLELLRYQNVEEEMVQLLQLAID----CSAQYPDNRPSMSEVIKRIEELHP 643
            L  L  ++    +     LA++          + R +  E +      HP
Sbjct: 257 GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA-----HP 302

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 2e-32
 Identities = 56/282 (19%), Positives = 98/282 (34%), Gaps = 49/282 (17%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGA---------VNHE 425
            +LG G FG+ Y  + +     VA+K ++   IS+         V               
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
            ++ L  ++   D  +L+ +              +G     L  E+           + +
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRH 125

Query: 486 LHAQGPNVSHGNIKSSNILLTKS-YEARVSDFGLAHLVGPSSTPNRV--AGYRAPEVTDP 542
            H  G  V H +IK  NIL+  +  E ++ DFG   L+  +   +      Y  PE    
Sbjct: 126 CHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 183

Query: 543 CKV-SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL 601
            +   + A V+S G+LL +++ G  P                          E+   ++ 
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEH---------------------DEEIIRGQVF 222

Query: 602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP 643
             Q V  E   L++    C A  P +RP+  E+       HP
Sbjct: 223 FRQRVSSECQHLIRW---CLALRPSDRPTFEEIQN-----HP 256

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  123 bits (310), Expect = 1e-31
 Identities = 54/274 (19%), Positives = 107/274 (39%), Gaps = 31/274 (11%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE----FKDKIEGVGAVNHENLVPL 430
           + LG G+FG        E G   A+K L    + + +      ++   + AVN   LV L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
              +       +V +Y+  G + + L           +       A       EYLH+  
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD 161

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAGYRAPEVTDPCKVSQKA 549
             + + ++K  N+L+ +    +V+DFG A  + G + T        APE+      ++  
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAV 219

Query: 550 DVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE 609
           D ++ GVL+ E+  G  P  A    +  +     +      ++S++ DL           
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----------- 268

Query: 610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP 643
           +  LLQ  +D + ++ + +  ++++       H 
Sbjct: 269 LRNLLQ--VDLTKRFGNLKNGVNDIKN-----HK 295

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 1e-30
 Identities = 60/291 (20%), Positives = 113/291 (38%), Gaps = 30/291 (10%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE---REFKDKIEGVGAVNHENLVPLR 431
           E +G+GT+GT +KA   E   IVA+KR++     E        +I  +  + H+N+V L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
              +S  +  LV+++            N       L+ E+         +G+ + H++  
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRN- 121

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG----YRAPEVTDPCKV-S 546
            V H ++K  N+L+ ++ E ++++FGLA   G              YR P+V    K+ S
Sbjct: 122 -VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 547 QKADVYSFGVLLLELLTGKAPTHALLNE-EGVDLPRWVQSIVKDEWTSEVFDLELLRYQN 605
              D++S G +  EL     P     +  + +     +     +E    +  L   +   
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 606 VEEEMVQLLQLAIDCSAQY-----------PDNRPSMSEVIKR--IEELHP 643
           +      L+ +    +A             P  R S  E ++     +  P
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 2e-29
 Identities = 63/300 (21%), Positives = 114/300 (38%), Gaps = 30/300 (10%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE---REFKDKIEGVGAVNHENLVPLR 431
             +G G +G+   A   + G  VAVK+L     S    +    ++  +  + HEN++ L 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 432 AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
             +          D   +  L      N    +  L  +    +     RG++Y+H+   
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD- 141

Query: 492 NVSHGNIKSSNILLTKSYEARVSDFGLAHLVG-PSSTPNRVAGYRAPEVT-DPCKVSQKA 549
            + H ++K SN+ + +  E ++ DFGLA       +       YRAPE+  +    +Q  
Sbjct: 142 -IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 200

Query: 550 DVYSFGVLLLELLTGKAP---------THALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL 600
           D++S G ++ ELLTG+              +L   G      ++ I  +   + +  L  
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 260

Query: 601 LRYQNVEEEMVQLLQLAID----CSAQYPDNRPSMSEVIKRIEELHPSSTQGHHGLQPDD 656
           +   N     +    LA+D          D R + ++ +      H    Q H    PDD
Sbjct: 261 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA-----HAYFAQYH---DPDD 312

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 3e-29
 Identities = 56/303 (18%), Positives = 105/303 (34%), Gaps = 47/303 (15%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE---REFKDKIEGVGAVNHENLVPLR 431
             +G+GTFG  +KA   + G  VA+K++      E        +I+ +  + HEN+V L 
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 432 AYYYSMDEKLLVYD---YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA 488
               +            YL        L G                +      G+ Y+H 
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135

Query: 489 QGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV--------AGYRAPEVT 540
               + H ++K++N+L+T+    +++DFGLA     +                YR PE+ 
Sbjct: 136 N--KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193

Query: 541 DPCK-VSQKADVYSFGVLLLELLTGKAP--------THALLNEEGVDLPRWVQSIVKDEW 591
              +      D++  G ++ E+ T              AL+++    +   V   V +  
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253

Query: 592 TSEVFDL---------ELLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEE 640
             E  +L         + L+    +   + L+   L +D     P  R    + +     
Sbjct: 254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD-----PAQRIDSDDALN---- 304

Query: 641 LHP 643
            H 
Sbjct: 305 -HD 306

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  116 bits (291), Expect = 4e-29
 Identities = 50/302 (16%), Positives = 104/302 (34%), Gaps = 56/302 (18%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-HENLVPLRAY 433
             LG+G +   ++A+ +     V VK LK   + +++ K +I+ +  +    N++ L   
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILK--PVKKKKIKREIKILENLRGGPNIITLADI 98

Query: 434 YYSMDEKL--LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGP 491
                 +   LV++++       L           L             + ++Y H+ G 
Sbjct: 99  VKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG- 149

Query: 492 NVSHGNIKSSNILLT-KSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVT-DPCKVS 546
            + H ++K  N+++  +  + R+ D+GLA    P    N       ++ PE+  D     
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208

Query: 547 QKADVYSFGVLLLELLTGKAPTHALLNEEGVDL-----------------------PRWV 583
              D++S G +L  ++  K P     +     +                       PR+ 
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268

Query: 584 QSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEEL 641
             + +         +       V  E +  L   L  D       +R +  E ++     
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD-----HQSRLTAREAME----- 318

Query: 642 HP 643
           HP
Sbjct: 319 HP 320

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 3e-28
 Identities = 62/281 (22%), Positives = 103/281 (36%), Gaps = 42/281 (14%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISERE----FKDKIEGVGAVNHENLVPL 430
           ++LGKGTFG          G   A+K L+   I  ++       +   +    H  L  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 431 RAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG 490
           +  + + D    V +Y   G L   L   +         E            +EYLH++ 
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD 125

Query: 491 PNVSHGNIKSSNILLTKSYEARVSDFGLA-HLVGPSSTPNRVAG---YRAPEVTDPCKVS 546
             V + +IK  N++L K    +++DFGL    +   +T     G   Y APEV +     
Sbjct: 126 --VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183

Query: 547 QKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV 606
           +  D +  GV++ E++ G+ P +        D  R  + I+ +E             + +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY------NQDHERLFELILMEEIR---------FPRTL 228

Query: 607 EEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEEL--HP 643
             E   LL   L  D     P  R          +E+  H 
Sbjct: 229 SPEAKSLLAGLLKKD-----PKQRLGGGP--SDAKEVMEHR 262

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 4e-26
 Identities = 62/289 (21%), Positives = 105/289 (36%), Gaps = 46/289 (15%)

Query: 376 EVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVTISERE-----FKDKIEGVGAVNHE- 425
           +VLG G +G  +        + G + A+K LK  TI ++       + + + +  +    
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 426 NLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
            LV L   + +  +  L+ DY+  G L   L       R         +        +E+
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEH 144

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRV-----AGYRAPEV- 539
           LH  G  + + +IK  NILL  +    ++DFGL+       T           Y AP++ 
Sbjct: 145 LHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 540 -TDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL 598
                   +  D +S GVL+ ELLTG +P      +             + E +  +   
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-----------SQAEISRRILKS 251

Query: 599 ELLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSEVIKRIEEL--HP 643
           E    Q +      L+Q  L  D     P  R       +  +E+  H 
Sbjct: 252 EPPYPQEMSALAKDLIQRLLMKD-----PKKRLGCGP--RDADEIKEHL 293

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  104 bits (260), Expect = 5e-25
 Identities = 50/300 (16%), Positives = 98/300 (32%), Gaps = 32/300 (10%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRA-- 432
             LG G F T + A  +   T VA+K ++   +     +D+I+ +  VN  +     +  
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 433 ---------YYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGI 483
                    ++       +    +       LL   K      +       I+     G+
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 484 EYLHAQGPNVSHGNIKSSNILLTKS-YEARVSDFGLAHLVGPSSTPNRVA------GYRA 536
           +Y+H +   + H +IK  N+L+        +    +A L                  YR+
Sbjct: 139 DYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 537 PEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK-------- 588
           PEV         AD++S   L+ EL+TG                  +  I++        
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 257

Query: 589 ----DEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS 644
                ++T   F+   L     + +   L  +  +      D    +S+ +  + +L P 
Sbjct: 258 LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 1e-24
 Identities = 57/310 (18%), Positives = 107/310 (34%), Gaps = 62/310 (20%)

Query: 376 EVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTISE---REFKDKIEGVGAVNHENLVPLR 431
           + +G G  G    A    +   VA+K+L     ++   +    ++  +  VNH+N++ L 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 432 AYY------YSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEY 485
             +          +  LV + +       +            + E  S +      GI++
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLYQMLCGIKH 134

Query: 486 LHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPNRVAG---YRAPEVTDP 542
           LH+ G    H ++K SNI++      ++ DFGLA   G S           YRAPEV   
Sbjct: 135 LHSAGII--HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 192

Query: 543 CKVSQKADVYSFGVLLLELLTGKAP---------------------------THALLNEE 575
               +  D++S G ++ E++  K                                 +   
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252

Query: 576 GVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQ--LAIDCSAQYPDNRPSMSE 633
             + P++        +   +F  +    +    +   LL   L ID     P  R S+ +
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID-----PAKRISVDD 307

Query: 634 VIKRIEELHP 643
            ++     HP
Sbjct: 308 ALQ-----HP 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 81.7 bits (200), Expect = 2e-17
 Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 11/179 (6%)

Query: 32  SDRAALLALRSSVGGRTLL--WNVYEASPC--KWAGVECEQN----RVTMLRLPGVALSG 83
            D+ ALL ++  +G  T L  W       C   W GV C+ +    RV  L L G+ L  
Sbjct: 6   QDKQALLQIKKDLGNPTTLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64

Query: 84  QIPL-GILGNLTSLRTLSLRFN-SLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGL 141
             P+   L NL  L  L +    +L   +P  +A  + L  LY+   + SG +P FL  +
Sbjct: 65  PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124

Query: 142 HHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
             LV L+ + N  SG +P    +L  L  +  + NR+SG+IP        L      + 
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 68.6 bits (166), Expect = 3e-13
 Identities = 22/84 (26%), Positives = 28/84 (33%), Gaps = 21/84 (25%)

Query: 148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
           +L  N   G +P G   L  L +L +  N L G IP   + L        +NN       
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN-LQRFDVSAYANN------- 301

Query: 208 KRFQTFGSNSFLGNSLCGKPLQDC 231
                          LCG PL  C
Sbjct: 302 -------------KCLCGSPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 64.4 bits (155), Expect = 8e-12
 Identities = 23/67 (34%), Positives = 29/67 (43%), Gaps = 1/67 (1%)

Query: 117 CSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENN 176
             NL  L L+ N   G +P  L  L  L  LN++ NN  GEIP    NL +       NN
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANN 301

Query: 177 RLSGSIP 183
           +     P
Sbjct: 302 KCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 55.9 bits (133), Expect = 4e-09
 Identities = 18/87 (20%), Positives = 31/87 (35%), Gaps = 2/87 (2%)

Query: 50  LWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQ 109
             ++ + S     G       +  L L    + G +P G L  L  L +L++ FN+L  +
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQG-LTQLKFLHSLNVSFNNLCGE 283

Query: 110 LPSDLASCSNLRNLYLQGNHFSGEVPL 136
           +P    +           N      PL
Sbjct: 284 IPQ-GGNLQRFDVSAYANNKCLCGSPL 309

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 54.0 bits (128), Expect = 2e-08
 Identities = 16/59 (27%), Positives = 21/59 (35%), Gaps = 1/59 (1%)

Query: 101 LRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIP 159
           LR N +   LP  L     L +L +  N+  GE+P     L        A N      P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 81.6 bits (200), Expect = 4e-17
 Identities = 43/162 (26%), Positives = 65/162 (40%), Gaps = 29/162 (17%)

Query: 66  CEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYL 125
                +  L L G  L     +G L +LT+L  L L  N +++  P  L+  + L  L L
Sbjct: 216 GILTNLDELSLNGNQLKD---IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 270

Query: 126 QGNHFSGEVPLFLV--------------------GLHHLVRLNLATNNFSGEIPSGFKNL 165
             N  S   PL  +                     L +L  L L  NN S   P    +L
Sbjct: 271 GANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSL 328

Query: 166 TKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
           TKL+ LF  NN++S  +    + L N+  L+  +N ++   P
Sbjct: 329 TKLQRLFFANNKVSD-VSSLAN-LTNINWLSAGHNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 75.0 bits (183), Expect = 5e-15
 Identities = 35/144 (24%), Positives = 58/144 (40%), Gaps = 23/144 (15%)

Query: 74  LRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTS-----------------QLPSDLAS 116
           L L    +S   PL  L  LT L+  + + ++++                  +  S +++
Sbjct: 246 LDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305

Query: 117 CSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENN 176
             NL  L L  N+ S   P+    L  L RL  A N  S    S   NLT +  L   +N
Sbjct: 306 LKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361

Query: 177 RLSGSIPGFDDVLPNLQQLNVSNN 200
           ++S   P  +  L  + QL +++ 
Sbjct: 362 QISDLTPLAN--LTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 58.9 bits (141), Expect = 8e-10
 Identities = 21/94 (22%), Positives = 33/94 (35%), Gaps = 7/94 (7%)

Query: 59  CKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCS 118
            +          +T L L    +S   P+  L     L+ L    N ++    S LA+ +
Sbjct: 297 LEDISPISNLKNLTYLTLYFNNISDISPVSSLTK---LQRLFFANNKVSD--VSSLANLT 351

Query: 119 NLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATN 152
           N+  L    N  S   P  L  L  + +L L   
Sbjct: 352 NINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.9 bits (123), Expect = 1e-07
 Identities = 19/68 (27%), Positives = 30/68 (44%), Gaps = 4/68 (5%)

Query: 140 GLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSN 199
            L   ++  L   N +  +     +L ++ TL  +   +  SI G +  L NL Q+N SN
Sbjct: 20  ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGVEY-LNNLTQINFSN 75

Query: 200 NLLNGSIP 207
           N L    P
Sbjct: 76  NQLTDITP 83

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.5 bits (96), Expect = 2e-04
 Identities = 12/57 (21%), Positives = 20/57 (35%), Gaps = 4/57 (7%)

Query: 92  NLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN 148
           +L  + TL      + S     +   +NL  +    N  +   PL    L  LV + 
Sbjct: 42  DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITPLK--NLTKLVDIL 94

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 6e-04
 Identities = 15/83 (18%), Positives = 27/83 (32%), Gaps = 6/83 (7%)

Query: 118 SNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNR 177
           +      L   + +  V      L  +  L             G + L  L  +   NN+
Sbjct: 22  AEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQ 77

Query: 178 LSGSIPGFDDVLPNLQQLNVSNN 200
           L+   P  +  L  L  + ++NN
Sbjct: 78  LTDITPLKN--LTKLVDILMNNN 98

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 72.4 bits (176), Expect = 2e-14
 Identities = 39/208 (18%), Positives = 63/208 (30%), Gaps = 38/208 (18%)

Query: 59  CKWAGVECEQNR-----------VTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLT 107
           C    V+C                 +L L    ++  I  G   NL +L TL L  N ++
Sbjct: 10  CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKIS 68

Query: 108 SQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATN--------------- 152
              P   A    L  LYL  N            L  L                       
Sbjct: 69  KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128

Query: 153 --------NFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNG 204
                     SG     F+ + KL  + + +  ++ +IP    + P+L +L++  N +  
Sbjct: 129 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIP--QGLPPSLTELHLDGNKITK 185

Query: 205 SIPKRFQTFGSNSFLGNSLCGKPLQDCG 232
                 +   + + LG S       D G
Sbjct: 186 VDAASLKGLNNLAKLGLSFNSISAVDNG 213

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 62.4 bits (150), Expect = 4e-11
 Identities = 43/177 (24%), Positives = 69/177 (38%), Gaps = 9/177 (5%)

Query: 57  SPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLAS 116
              K       Q  V  L    +  SG    G    +  L  + +   ++T+ +P  L  
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSSGIEN-GAFQGMKKLSYIRIADTNITT-IPQGL-- 169

Query: 117 CSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENN 176
             +L  L+L GN  +      L GL++L +L L+ N+ S        N   L+ L L NN
Sbjct: 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 229

Query: 177 RLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGN----SLCGKPLQ 229
           +L     G  D    +Q + + NN ++      F   G N+   +    SL   P+Q
Sbjct: 230 KLVKVPGGLAD-HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 56.6 bits (135), Expect = 2e-09
 Identities = 35/160 (21%), Positives = 63/160 (39%), Gaps = 11/160 (6%)

Query: 50  LWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQ 109
           L      S     G      +++ +R+    ++  IP G+     SL  L L  N +T  
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP---PSLTELHLDGNKITKV 186

Query: 110 LPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLK 169
             + L   +NL  L L  N  S      L    HL  L+L  N    ++P G  +   ++
Sbjct: 187 DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQ 245

Query: 170 TLFLENNRLSG------SIPGFDDVLPNLQQLNVSNNLLN 203
            ++L NN +S         PG++    +   +++ +N + 
Sbjct: 246 VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 55.0 bits (131), Expect = 8e-09
 Identities = 31/112 (27%), Positives = 43/112 (38%), Gaps = 4/112 (3%)

Query: 115 ASCS-NLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFL 173
             C  +LR +         +VP  L        L+L  N  +      FKNL  L TL L
Sbjct: 6   FRCQCHLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLIL 62

Query: 174 ENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCG 225
            NN++S   PG    L  L++L +S N L     K  +T        N +  
Sbjct: 63  INNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITK 114

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 67.1 bits (163), Expect = 2e-13
 Identities = 18/159 (11%), Positives = 45/159 (28%), Gaps = 30/159 (18%)

Query: 376 EVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISER-----------EFKDKIEGVGAVNH 424
           +++G+G     +    E      VK  K    S +            F            
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 425 ENLVPLR----AYYYSMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAA 480
             L  L+       Y+ +   ++ + +                   +  E    +     
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKE------------LYRVRVENPDEVLDMIL 113

Query: 481 RGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLA 519
             +   + +   + HG++   N+L+++     + DF  +
Sbjct: 114 EEVAKFYHR--GIVHGDLSQYNVLVSE-EGIWIIDFPQS 149

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.8 bits (161), Expect = 1e-12
 Identities = 38/178 (21%), Positives = 56/178 (31%), Gaps = 2/178 (1%)

Query: 48  TLLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLT 107
             L            G+      +  L L   AL          +L +L  L L  N ++
Sbjct: 108 HTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPD-DTFRDLGNLTHLFLHGNRIS 166

Query: 108 SQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTK 167
           S          +L  L L  N  +   P     L  L+ L L  NN S         L  
Sbjct: 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226

Query: 168 LKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCG 225
           L+ L L +N           +   LQ+   S++ +  S+P+R           N L G
Sbjct: 227 LQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.4 bits (134), Expect = 3e-09
 Identities = 46/184 (25%), Positives = 71/184 (38%), Gaps = 9/184 (4%)

Query: 58  PCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASC 117
           PC      C          P   L   +P+GI     + + + L  N ++    +   +C
Sbjct: 1   PCP-GACVCYNEPKVTTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRAC 55

Query: 118 SNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEI-PSGFKNLTKLKTLFLENN 176
            NL  L+L  N  +        GL  L +L+L+ N     + P+ F  L +L TL L+  
Sbjct: 56  RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC 115

Query: 177 RLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFL---GNSLCGKPLQDCGT 233
            L    PG    L  LQ L + +N L       F+  G+ + L   GN +   P +    
Sbjct: 116 GLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG 175

Query: 234 KASL 237
             SL
Sbjct: 176 LHSL 179

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.2 bits (118), Expect = 3e-07
 Identities = 36/166 (21%), Positives = 50/166 (30%), Gaps = 26/166 (15%)

Query: 71  VTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNS------------------------- 105
              + L G  +S  +P        +L  L L  N                          
Sbjct: 34  SQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92

Query: 106 LTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNL 165
           L S  P+       L  L+L         P    GL  L  L L  N         F++L
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152

Query: 166 TKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQ 211
             L  LFL  NR+S         L +L +L +  N +    P  F+
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 54.3 bits (130), Expect = 1e-09
 Identities = 22/124 (17%), Positives = 33/124 (26%), Gaps = 27/124 (21%)

Query: 97  RTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLF------------------- 137
           R L L    LT      L     + +L L  N      P                     
Sbjct: 1   RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58

Query: 138 --LVGLHHLVRLNLATNNF-SGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDV---LPN 191
             +  L  L  L L  N            +  +L  L L+ N L       + +   LP+
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118

Query: 192 LQQL 195
           +  +
Sbjct: 119 VSSI 122

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 56.0 bits (133), Expect = 6e-09
 Identities = 22/92 (23%), Positives = 34/92 (36%), Gaps = 9/92 (9%)

Query: 124 YLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIP 183
               N  S E+         L  LN++ N    E+P+    L +L       N L+  +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVP 320

Query: 184 GFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGS 215
                  NL+QL+V  N L    P   ++   
Sbjct: 321 EL---PQNLKQLHVEYNPLR-EFPDIPESVED 348

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.2 bits (105), Expect = 1e-05
 Identities = 20/98 (20%), Positives = 33/98 (33%), Gaps = 11/98 (11%)

Query: 51  WNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQL 110
                AS  +   +      +  L +    L  ++P         L  L   FN L   +
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP----ALPPRLERLIASFNHLAE-V 319

Query: 111 PSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN 148
           P       NL+ L+++ N    E P     +  L R+N
Sbjct: 320 PELP---QNLKQLHVEYNPLR-EFPDIPESVEDL-RMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 43.3 bits (100), Expect = 7e-05
 Identities = 18/63 (28%), Positives = 30/63 (47%), Gaps = 8/63 (12%)

Query: 163 KNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNS 222
           +   +L+   L N  LS S+P   ++ P+L+ L  S N L   +P+  Q+  S     N+
Sbjct: 38  RQAHELE---LNNLGLS-SLP---ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNN 89

Query: 223 LCG 225
           L  
Sbjct: 90  LKA 92

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 37.9 bits (86), Expect = 0.003
 Identities = 18/73 (24%), Positives = 28/73 (38%), Gaps = 9/73 (12%)

Query: 65  ECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLY 124
           +C   +   L L  + LS  +P         L +L    NSLT  LP       +L++L 
Sbjct: 34  DCLDRQAHELELNNLGLS-SLP----ELPPHLESLVASCNSLTE-LPE---LPQSLKSLL 84

Query: 125 LQGNHFSGEVPLF 137
           +  N+      L 
Sbjct: 85  VDNNNLKALSDLP 97

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.4 bits (131), Expect = 1e-08
 Identities = 23/91 (25%), Positives = 35/91 (38%), Gaps = 9/91 (9%)

Query: 88  GILGNLTSLRTLSLRFNSLTSQ----LPSDLASCSNLRNLYLQGNHFSGEVPLFLV-GLH 142
           G+    + LR L L    ++      L + L +  +LR L L  N       L LV  + 
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 422

Query: 143 H----LVRLNLATNNFSGEIPSGFKNLTKLK 169
                L +L L    +S E+    + L K K
Sbjct: 423 QPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.0 bits (130), Expect = 2e-08
 Identities = 19/98 (19%), Positives = 30/98 (30%), Gaps = 12/98 (12%)

Query: 108 SQLPSDLASCSNLRNLYLQGNHFSGE----VPLFLVGLHHLVRLNLATNNFSGEIPSGF- 162
                     S LR L+L     S      +   L+  H L  L+L+ N           
Sbjct: 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418

Query: 163 ----KNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLN 196
               +    L+ L L +   S  +    D L  L++  
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEME---DRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.8 bits (127), Expect = 4e-08
 Identities = 14/90 (15%), Positives = 25/90 (27%), Gaps = 4/90 (4%)

Query: 71  VTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQ----LPSDLASCSNLRNLYLQ 126
           +  L +    LS      +L  L   + + L    LT      + S L     L  L L+
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 127 GNHFSGEVPLFLVGLHHLVRLNLATNNFSG 156
            N         ++         +   +   
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.9 bits (122), Expect = 1e-07
 Identities = 11/91 (12%), Positives = 28/91 (30%), Gaps = 5/91 (5%)

Query: 95  SLRTLSLRFNSLTSQLPSDLASC-SNLRNLYLQGNHFSGE----VPLFLVGLHHLVRLNL 149
            +++L ++   L+    ++L       + + L     +      +   L     L  LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSG 180
            +N              +  +  ++   L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.5 bits (121), Expect = 2e-07
 Identities = 16/80 (20%), Positives = 26/80 (32%), Gaps = 9/80 (11%)

Query: 142 HHLVRLNLATNNFSGE----IPSGFKNLTKLKTLFLENNRLSGSIP-----GFDDVLPNL 192
             L  L LA  + S      + +       L+ L L NN L  +               L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 193 QQLNVSNNLLNGSIPKRFQT 212
           +QL + +   +  +  R Q 
Sbjct: 429 EQLVLYDIYWSEEMEDRLQA 448

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 5e-06
 Identities = 13/72 (18%), Positives = 25/72 (34%), Gaps = 5/72 (6%)

Query: 144 LVRLNLATNNFSGE-IPSGFKNLTKLKTLFLENNRLSG----SIPGFDDVLPNLQQLNVS 198
           +  L++     S          L + + + L++  L+      I     V P L +LN+ 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 199 NNLLNGSIPKRF 210
           +N L        
Sbjct: 64  SNELGDVGVHCV 75

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.0 bits (116), Expect = 2e-07
 Identities = 24/116 (20%), Positives = 39/116 (33%), Gaps = 10/116 (8%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLF--LVGLHHLVRL 147
           L        L+ R +   + L     +   L +L L  N       +   +    +L  L
Sbjct: 38  LVAQNIDVVLNRRSSMAAT-LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96

Query: 148 NLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDD-------VLPNLQQLN 196
           NL+ N    E         KL+ L+L+ N LS +               P L +L+
Sbjct: 97  NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 48.3 bits (113), Expect = 6e-07
 Identities = 39/164 (23%), Positives = 62/164 (37%), Gaps = 12/164 (7%)

Query: 59  CKWAGVECEQNR-----------VTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLT 107
           C+   V+C                T L L    L      G+ G L  L  L L+ N LT
Sbjct: 8   CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 108 SQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTK 167
              P+     S+++ L L  N          +GLH L  LNL  N  S  +P  F++L  
Sbjct: 68  GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127

Query: 168 LKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQ 211
           L +L L +N  + +          L++ +++        P + +
Sbjct: 128 LTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSKVR 170

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 48.7 bits (114), Expect = 1e-06
 Identities = 14/92 (15%), Positives = 33/92 (35%), Gaps = 8/92 (8%)

Query: 95  SLRTLSLRFNSLTSQ----LPSDLASCSNLRNLYLQGNHFSGE----VPLFLVGLHHLVR 146
           S+   SL+ +++T++    + + L    +++ + L GN    E    +   +     L  
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 147 LNLATNNFSGEIPSGFKNLTKLKTLFLENNRL 178
              +            + L  L    L+  +L
Sbjct: 64  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.6 bits (98), Expect = 1e-04
 Identities = 19/93 (20%), Positives = 29/93 (31%), Gaps = 10/93 (10%)

Query: 51  WNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLGIL-----GNLTSLRTLSLRFNS 105
                      A        +  L L    LS +    ++          L+TL L++N 
Sbjct: 225 NTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNE 284

Query: 106 LTSQLPSDLAS-----CSNLRNLYLQGNHFSGE 133
           +       L +       +L  L L GN FS E
Sbjct: 285 IELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.4 bits (95), Expect = 2e-04
 Identities = 20/99 (20%), Positives = 37/99 (37%), Gaps = 17/99 (17%)

Query: 101 LRFNSLTSQLPSDLASC------SNLRNLYLQGNHFSGEVPLFLV-----GLHHLVRLNL 149
           L    L+++  + +           L+ L LQ N    +    L       +  L+ L L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 150 ATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDV 188
             N FS E       + +++ +F  + R  G +   DD+
Sbjct: 310 NGNRFSEEDDV----VDEIREVF--STRGRGELDELDDM 342

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.0 bits (94), Expect = 3e-04
 Identities = 10/86 (11%), Positives = 24/86 (27%), Gaps = 7/86 (8%)

Query: 146 RLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSG----SIPGFDDVLPNLQQLNVSNN- 200
           +L+  T      + +       +K + L  N +       +        +L+    S+  
Sbjct: 11  KLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF 70

Query: 201 --LLNGSIPKRFQTFGSNSFLGNSLC 224
              +   IP+  +           L 
Sbjct: 71  TGRVKDEIPEALRLLLQALLKCPKLH 96

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.2 bits (92), Expect = 6e-04
 Identities = 15/83 (18%), Positives = 24/83 (28%), Gaps = 15/83 (18%)

Query: 124 YLQGNHFSGEVP------LFLVGLHHLVRLNLATNNFSGEIPSG-----FKNLTKLKTLF 172
            L     S             +    L  L L  N    +          + +  L  L 
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 173 LENNRLSGSIPGFDDVLPNLQQL 195
           L  NR S      DDV+  ++++
Sbjct: 309 LNGNRFSEE----DDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.5 bits (90), Expect = 0.001
 Identities = 8/45 (17%), Positives = 16/45 (35%), Gaps = 4/45 (8%)

Query: 90  LGNLTSLRTLSLRFNSLT----SQLPSDLASCSNLRNLYLQGNHF 130
           L    S++ + L  N++       L  ++AS  +L          
Sbjct: 27  LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.9 bits (86), Expect = 0.003
 Identities = 16/93 (17%), Positives = 29/93 (31%), Gaps = 13/93 (13%)

Query: 142 HHLVRLNLATNNFSGEIPS------GFKNLTKLKTLFLENNRLSGSIP-----GFDDVLP 190
            +L  L L     S    +             L+TL L+ N +            D+ +P
Sbjct: 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 302

Query: 191 NLQQLNVSNNLLN--GSIPKRFQTFGSNSFLGN 221
           +L  L ++ N  +    +    +   S    G 
Sbjct: 303 DLLFLELNGNRFSEEDDVVDEIREVFSTRGRGE 335

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.7 bits (112), Expect = 1e-06
 Identities = 12/64 (18%), Positives = 27/64 (42%), Gaps = 4/64 (6%)

Query: 140 GLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSN 199
            L + +++    +N +  +     +L  + TL      ++ +I G    L NL  L + +
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQY-LNNLIGLELKD 72

Query: 200 NLLN 203
           N + 
Sbjct: 73  NQIT 76

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 6e-06
 Identities = 18/76 (23%), Positives = 29/76 (38%), Gaps = 4/76 (5%)

Query: 124 YLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIP 183
           YL   +        L  L  L  L    N  S   P    +L  L  + L+NN++S  + 
Sbjct: 155 YLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD-VS 211

Query: 184 GFDDVLPNLQQLNVSN 199
              +   NL  + ++N
Sbjct: 212 PLAN-TSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 1e-04
 Identities = 20/60 (33%), Positives = 28/60 (46%), Gaps = 4/60 (6%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNL 149
           L NL+ L TL    N ++    S LAS  NL  ++L+ N  S   PL      +L  + L
Sbjct: 169 LANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.004
 Identities = 16/46 (34%), Positives = 27/46 (58%), Gaps = 2/46 (4%)

Query: 162 FKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP 207
             NL+KL TL  ++N++S  I      LPNL ++++ NN ++   P
Sbjct: 169 LANLSKLTTLKADDNKISD-ISPLAS-LPNLIEVHLKNNQISDVSP 212

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.3 bits (105), Expect = 9e-06
 Identities = 6/43 (13%), Positives = 13/43 (30%)

Query: 83  GQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYL 125
            ++P  +    +    L +    + S     L +   LR    
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.9 bits (104), Expect = 1e-05
 Identities = 16/95 (16%), Positives = 25/95 (26%), Gaps = 10/95 (10%)

Query: 99  LSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEI 158
           L L  N +                     N+          G    V L+++        
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217

Query: 159 PSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQ 193
             G +NL KL+     N +           LP L+
Sbjct: 218 SYGLENLKKLRARSTYNLK----------KLPTLE 242

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.5 bits (103), Expect = 2e-05
 Identities = 16/86 (18%), Positives = 25/86 (29%), Gaps = 3/86 (3%)

Query: 122 NLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGS 181
            L+L  N           G           NN        F   +    L +   R+  S
Sbjct: 157 ILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-S 215

Query: 182 IPGFDDVLPNLQQLNVSNNLLNGSIP 207
           +P     L NL++L   +      +P
Sbjct: 216 LP--SYGLENLKKLRARSTYNLKKLP 239

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 4e-04
 Identities = 10/72 (13%), Positives = 21/72 (29%), Gaps = 14/72 (19%)

Query: 59  CKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCS 118
           C      C++++VT           +IP  +     +   L      L        +   
Sbjct: 8   CSNRVFLCQESKVT-----------EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFG 53

Query: 119 NLRNLYLQGNHF 130
           +L  + +  N  
Sbjct: 54  DLEKIEISQNDV 65

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.9 bits (91), Expect = 5e-04
 Identities = 13/64 (20%), Positives = 22/64 (34%), Gaps = 3/64 (4%)

Query: 95  SLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNF 154
           S R    + + +T  +PSDL    N   L                G   L ++ ++ N+ 
Sbjct: 9   SNRVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 155 SGEI 158
              I
Sbjct: 66  LEVI 69

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 0.003
 Identities = 11/63 (17%), Positives = 20/63 (31%), Gaps = 4/63 (6%)

Query: 111 PSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKT 170
              +  CSN R    Q +  + E+P  L    + + L              F     L+ 
Sbjct: 2   HHRICHCSN-RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57

Query: 171 LFL 173
           + +
Sbjct: 58  IEI 60

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.6 bits (104), Expect = 1e-05
 Identities = 12/65 (18%), Positives = 26/65 (40%), Gaps = 4/65 (6%)

Query: 140 GLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSN 199
                ++ NL   + +  +      L  +  +   N+ +  S+ G    LPN+ +L ++ 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQGIQY-LPNVTKLFLNG 77

Query: 200 NLLNG 204
           N L  
Sbjct: 78  NKLTD 82

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 2e-04
 Identities = 12/38 (31%), Positives = 18/38 (47%), Gaps = 2/38 (5%)

Query: 162 FKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSN 199
              LTKL+ L+L  N +S  +      L NL  L + +
Sbjct: 174 LAGLTKLQNLYLSKNHIS-DLRALAG-LKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.002
 Identities = 13/38 (34%), Positives = 16/38 (42%), Gaps = 2/38 (5%)

Query: 90  LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQG 127
           L  LT L+ L L  N ++      LA   NL  L L  
Sbjct: 174 LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.003
 Identities = 10/63 (15%), Positives = 23/63 (36%), Gaps = 4/63 (6%)

Query: 118 SNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNR 177
           +      L+    +  V      L+ + ++    ++       G + L  +  LFL  N+
Sbjct: 24  AETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGNK 79

Query: 178 LSG 180
           L+ 
Sbjct: 80  LTD 82

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.3 bits (103), Expect = 2e-05
 Identities = 23/76 (30%), Positives = 28/76 (36%), Gaps = 1/76 (1%)

Query: 103 FNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGF 162
            N L +  P  L     L  L L  N+ +      L GL +L  L L  N+    IP GF
Sbjct: 133 GNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGF 191

Query: 163 KNLTKLKTLFLENNRL 178
                L   FL  N  
Sbjct: 192 FGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.9 bits (102), Expect = 3e-05
 Identities = 29/95 (30%), Positives = 36/95 (37%), Gaps = 1/95 (1%)

Query: 106 LTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNL 165
           LTS     L     L+ LYL+GN      P  L     L +L+LA NN +         L
Sbjct: 112 LTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171

Query: 166 TKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
             L TL L+ N L     GF      L    +  N
Sbjct: 172 ENLDTLLLQENSLYTIPKGFFG-SHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.8 bits (99), Expect = 6e-05
 Identities = 43/214 (20%), Positives = 58/214 (27%), Gaps = 63/214 (29%)

Query: 64  VECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNL 123
           V C++  +T            +P  +         L L  N L +   + L   + L  L
Sbjct: 15  VNCDKRNLT-----------ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 124 YLQGN---------------------------------------------HFSGEVPLFL 138
            L                                                  +      L
Sbjct: 61  NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120

Query: 139 VGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVS 198
            GL  L  L L  N      P       KL+ L L NN L+    G  + L NL  L + 
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180

Query: 199 NNLLNGSIPKRFQTFGSNSFLGNSLCGKPLQ-DC 231
            N L  +IPK F       F    L G P   +C
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFA--FLHGNPWLCNC 211

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.2 bits (95), Expect = 2e-04
 Identities = 15/92 (16%), Positives = 27/92 (29%), Gaps = 27/92 (29%)

Query: 86  PLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLV 145
           P+  +  + S   ++    +LT+ LP DL    +   L+L  N                 
Sbjct: 2   PICEVSKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSEN----------------- 41

Query: 146 RLNLATNNFSGEIPSGFKNLTKLKTLFLENNR 177
                         +     T+L  L L+   
Sbjct: 42  -------LLYTFSLATLMPYTRLTQLNLDRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.5 bits (88), Expect = 0.002
 Identities = 11/57 (19%), Positives = 16/57 (28%), Gaps = 3/57 (5%)

Query: 144 LVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNN 200
            + +N    N +  +P           L L  N L             L QLN+   
Sbjct: 12  HLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (100), Expect = 2e-05
 Identities = 23/125 (18%), Positives = 33/125 (26%), Gaps = 4/125 (3%)

Query: 92  NLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLAT 151
           N    R L LR   +   + +  A+      +    N            L  L  L +  
Sbjct: 16  NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNN 72

Query: 152 NNFSGEIPSGFKNLTKLKTLFLENNRLSG-SIPGFDDVLPNLQQLNVSNNLLNGSIPKRF 210
           N          + L  L  L L NN L           L +L  L +  N +      R 
Sbjct: 73  NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132

Query: 211 QTFGS 215
                
Sbjct: 133 YVIYK 137

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 43.5 bits (101), Expect = 2e-05
 Identities = 29/162 (17%), Positives = 48/162 (29%), Gaps = 9/162 (5%)

Query: 67  EQNRVTMLRLPGVALSGQIPL-----GILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLR 121
           E+  V       V L G IP        L  L + + L+L  N++     S L+   NLR
Sbjct: 16  ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK--ISSLSGMENLR 73

Query: 122 NLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGS 181
              L       +    L  +   +     + N    +    K +         N   +  
Sbjct: 74  --ILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWG 131

Query: 182 IPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSL 223
                  L  L+ L ++ N L     +   T      +   L
Sbjct: 132 EIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRL 173

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.9 bits (89), Expect = 7e-04
 Identities = 16/75 (21%), Positives = 27/75 (36%), Gaps = 5/75 (6%)

Query: 49  LLWNVYEASPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTS 108
           L      ++             +  L      ++   PL    NLT+L  L +  N ++ 
Sbjct: 130 LNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLA---NLTTLERLDISSNKVSD 186

Query: 109 QLPSDLASCSNLRNL 123
              S LA  +NL +L
Sbjct: 187 --ISVLAKLTNLESL 199

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.7 bits (83), Expect = 0.002
 Identities = 25/177 (14%), Positives = 41/177 (23%), Gaps = 28/177 (15%)

Query: 57  SPCKWAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLAS 116
            P   +G+ C ++                   +     +L  L +        L      
Sbjct: 6   CPHGSSGLRCTRDGAL-----------DSLHHL-PGAENLTELYIENQQHLQHLELRDLR 53

Query: 117 -CSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLEN 175
               LRNL +  +      P        L RLNL+ N          + L+  + +   N
Sbjct: 54  GLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGN 113

Query: 176 N-RLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPLQDC 231
               S ++              V    L                    L   P   C
Sbjct: 114 PLHCSCALRWLQRWE-EEGLGGVPEQKLQCHGQ-------------GPLAHMPNASC 156

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	663
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.76
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.75
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.74
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.71
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.67
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.66
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.66
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.59
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.57
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.54
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.53
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.51
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.5
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.48
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.47
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.46
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.44
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.43
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.38
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.37
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.37
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.34
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.33
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.32
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.26
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.15
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.09
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.9
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.88
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.73
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.72
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.55
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.5
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.34
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.32
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.32
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.29
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.96
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.65
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.46
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.3
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.04
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.03
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.96
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.19
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.81
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	91.74

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-50  Score=404.99  Aligned_cols=247  Identities=23%  Similarity=0.363  Sum_probs=199.8

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|+||+||+|.+.+++.||||+++......++|.+|++++++++||||++++|+|.+.+..++||||+++|+|.+
T Consensus        10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~   89 (263)
T d1sm2a_          10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD   89 (263)
T ss_dssp             EEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred             EEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHH
Confidence            36799999999999999889999999998877778899999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-----CC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~~  529 (663)
                      ++....    ..++|..+..++.|||.||.|||+++  |+||||||+|||+++++.+||+|||+++.......     ..
T Consensus        90 ~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  163 (263)
T d1sm2a_          90 YLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK  163 (263)
T ss_dssp             HHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred             Hhhccc----cCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCCceeeccee
Confidence            987543    45899999999999999999999998  99999999999999999999999999987654322     33


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE  609 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  609 (663)
                      ++..|+|||++.+..++.++|||||||++|||+|+..|+...     ......+..+......           ..+...
T Consensus       164 gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~-----~~~~~~~~~i~~~~~~-----------~~p~~~  227 (263)
T d1sm2a_         164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-----RSNSEVVEDISTGFRL-----------YKPRLA  227 (263)
T ss_dssp             -CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-----CCHHHHHHHHHHTCCC-----------CCCTTS
T ss_pred             cCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC-----CCHHHHHHHHHhcCCC-----------CCcccc
Confidence            567799999999999999999999999999999965544321     2223333333222111           011122


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       610 ~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      ..++.+++.+||+.||++||||+||+++|+++.+
T Consensus       228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            3467889999999999999999999999999854

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=400.36  Aligned_cols=246  Identities=25%  Similarity=0.387  Sum_probs=203.3

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|+||+||+|.+++++.||||+++......+.|.+|++++++++|||||++++++. .+..++||||+++|+|.+
T Consensus        18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~   96 (272)
T d1qpca_          18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVD   96 (272)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHH
T ss_pred             eEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHHH
Confidence            4679999999999999988899999999877777889999999999999999999999875 456799999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-----CCC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----TPN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-----~~~  529 (663)
                      ++....   ...++|..++.|+.|||+||.|||+++  |+||||||+|||+++++.+||+|||+|+......     ...
T Consensus        97 ~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  171 (272)
T d1qpca_          97 FLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK  171 (272)
T ss_dssp             HTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCC
T ss_pred             HHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEccCCccccccccC
Confidence            886433   235899999999999999999999998  9999999999999999999999999998775432     234


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE  609 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  609 (663)
                      ++..|+|||++.+..++.++|||||||++|||+||..|+...     .........+......           ..+...
T Consensus       172 gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~-----~~~~~~~~~i~~~~~~-----------~~p~~~  235 (272)
T d1qpca_         172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-----MTNPEVIQNLERGYRM-----------VRPDNC  235 (272)
T ss_dssp             CCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-----CCHHHHHHHHHTTCCC-----------CCCTTC
T ss_pred             CcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC-----CCHHHHHHHHHhcCCC-----------CCcccC
Confidence            667799999999888999999999999999999976665432     1222233333222111           111223


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       610 ~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                      +.++.+++.+||+.||++||||+||++.|+++.
T Consensus       236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence            346788999999999999999999999998763

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.6e-49  Score=401.86  Aligned_cols=249  Identities=26%  Similarity=0.390  Sum_probs=207.7

Q ss_pred             hcccccccceEEEEEEec-CCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .+.||+|+||+||+|.+. +|+.||||+++......++|.+|++++++++|||||+++++|.+.+..++||||+++|+|.
T Consensus        22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~  101 (287)
T d1opja_          22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL  101 (287)
T ss_dssp             EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred             eeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchH
Confidence            468999999999999964 5899999999877777788999999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-----C
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----P  528 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~  528 (663)
                      +++....   ...+++..+..++.|||.||+|||+++  |+||||||+|||+++++.+||+|||+|+.......     .
T Consensus       102 ~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~  176 (287)
T d1opja_         102 DYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  176 (287)
T ss_dssp             HHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTE
T ss_pred             HHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccceeecCCCCceeeccc
Confidence            9997543   346899999999999999999999998  99999999999999999999999999987754432     1


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .++..|+|||++.+..++.++|||||||++|||++|..|+...     .+..... ..+......          ..+..
T Consensus       177 ~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~-----~~~~~~~-~~i~~~~~~----------~~~~~  240 (287)
T d1opja_         177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-----IDLSQVY-ELLEKDYRM----------ERPEG  240 (287)
T ss_dssp             EECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT-----CCHHHHH-HHHHTTCCC----------CCCTT
T ss_pred             cccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc-----chHHHHH-HHHhcCCCC----------CCCcc
Confidence            2456699999999999999999999999999999987776432     2222222 222222111          11122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      .+.++.+++.+||+.||++|||++||++.|+.+..+
T Consensus       241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            345688899999999999999999999999988654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.8e-49  Score=402.37  Aligned_cols=246  Identities=24%  Similarity=0.427  Sum_probs=193.9

Q ss_pred             hcccccccceEEEEEEec-CC---cEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MG---TIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .++||+|+||+||+|.++ +|   ..||||.+.....  ..+.|.+|++++++++|||||+++|+|.+.+..++||||++
T Consensus        31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~  110 (299)
T d1jpaa_          31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME  110 (299)
T ss_dssp             EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence            368999999999999964 23   3689998865422  34679999999999999999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-  527 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  527 (663)
                      +|+|.+++....    ..++|..+..++.|||+||.|||+++  |+||||||+|||++.++.+||+|||+++....... 
T Consensus       111 ~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~  184 (299)
T d1jpaa_         111 NGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD  184 (299)
T ss_dssp             TEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             CCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence            999999887543    35899999999999999999999998  99999999999999999999999999987654321 


Q ss_pred             --------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          528 --------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       528 --------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                              ..++..|+|||.+.+..++.++|||||||++|||+| |+.||....      ....+..+......      
T Consensus       185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~------~~~~~~~i~~~~~~------  252 (299)
T d1jpaa_         185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT------NQDVINAIEQDYRL------  252 (299)
T ss_dssp             -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTTCCC------
T ss_pred             ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCCC------
Confidence                    124567999999999999999999999999999998 899996532      22233333222111      


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                           +.+.+.+.++.+++.+||+.||++|||++||++.|+++..
T Consensus       253 -----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         253 -----PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                 1122334568889999999999999999999999998754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-49  Score=391.78  Aligned_cols=244  Identities=23%  Similarity=0.345  Sum_probs=206.6

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .++||+|+||+||+|++++++.||||.++.....+++|.+|+.++++++||||++++|+|.+.+..++||||+++|+|.+
T Consensus         9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~   88 (258)
T d1k2pa_           9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN   88 (258)
T ss_dssp             CCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHH
T ss_pred             eEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHH
Confidence            46899999999999999989999999999877788899999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-----CC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-----PN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~~  529 (663)
                      ++....    ..+++..+.+++.|+|+||.|||+.+  |+||||||+||+++.++.+||+|||+++.......     ..
T Consensus        89 ~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  162 (258)
T d1k2pa_          89 YLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK  162 (258)
T ss_dssp             HHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSC
T ss_pred             hhhccc----cCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCCceeecccC
Confidence            976543    35899999999999999999999998  99999999999999999999999999986644322     33


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      ++..|+|||.+.+..++.++|||||||++|||+| |+.||....      .......+..... .          ..+..
T Consensus       163 ~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~------~~~~~~~i~~~~~-~----------~~p~~  225 (258)
T d1k2pa_         163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT------NSETAEHIAQGLR-L----------YRPHL  225 (258)
T ss_dssp             CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC------HHHHHHHHHTTCC-C----------CCCTT
T ss_pred             CCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC------HHHHHHHHHhCCC-C----------CCccc
Confidence            5677999999999999999999999999999998 899996532      2223333322111 1          11112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                      ...++.+++.+||+.||++|||++|++++|.++
T Consensus       226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         226 ASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            334688999999999999999999999999764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-49  Score=397.32  Aligned_cols=249  Identities=29%  Similarity=0.406  Sum_probs=197.3

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||+||+|+++  ..||||+++...   ...+.|.+|++++++++|||||++++++.+ +..++||||+++|+
T Consensus        13 ~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~   89 (276)
T d1uwha_          13 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSS   89 (276)
T ss_dssp             CSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEE
T ss_pred             EEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCC
Confidence            468999999999999865  359999987542   234679999999999999999999998754 56899999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-----
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----  526 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-----  526 (663)
                      |.++++...    ..+++..+..++.|||+||+|||+++  |+||||||+|||++.++.+||+|||+|+......     
T Consensus        90 L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~  163 (276)
T d1uwha_          90 LYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF  163 (276)
T ss_dssp             HHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred             HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence            999997543    35899999999999999999999998  9999999999999999999999999998765322     


Q ss_pred             -CCCCCccccCccccCCC---CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          527 -TPNRVAGYRAPEVTDPC---KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~---~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                       ...+|+.|||||++.+.   .++.++|||||||++|||+||+.||.....      ...+...........    ... 
T Consensus       164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~------~~~~~~~~~~~~~~p----~~~-  232 (276)
T d1uwha_         164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN------RDQIIFMVGRGYLSP----DLS-  232 (276)
T ss_dssp             --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHHHHHTSCCC----CGG-
T ss_pred             cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh------HHHHHHHHhcCCCCC----cch-
Confidence             23467889999998643   478999999999999999999999965321      222222222222111    000 


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                       ......+.++.+++.+||+.||++|||++||+++|+.+...
T Consensus       233 -~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         233 -KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             -GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence             01122345788899999999999999999999999988654

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-49  Score=394.57  Aligned_cols=238  Identities=26%  Similarity=0.374  Sum_probs=200.7

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc----ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV----TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||+|.. .+|+.||+|++...    ......+.+|+++++.++|||||++++++.+.+..++||||+++
T Consensus        11 ~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~   90 (263)
T d2j4za1          11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL   90 (263)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence            57899999999999996 56899999998643    23467789999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--C
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--T  527 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--~  527 (663)
                      |+|.+++....     .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+|+......  .
T Consensus        91 g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~  163 (263)
T d2j4za1          91 GTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT  163 (263)
T ss_dssp             CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEE
T ss_pred             CcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCCcccc
Confidence            99999997533     5899999999999999999999998  9999999999999999999999999998765432  2


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..+|+.|+|||++.+..++.++|||||||++|||++|+.||...      +.......+.+....            .+.
T Consensus       164 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~------~~~~~~~~i~~~~~~------------~p~  225 (263)
T d2j4za1         164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN------TYQETYKRISRVEFT------------FPD  225 (263)
T ss_dssp             TTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHTTCCC------------CCT
T ss_pred             cCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC------CHHHHHHHHHcCCCC------------CCc
Confidence            35788899999999999999999999999999999999999642      233333333332211            111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....++.+++.+|++.||++|||++|+++|
T Consensus       226 ~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         226 FVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            123467788889999999999999999873

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-48  Score=392.33  Aligned_cols=240  Identities=25%  Similarity=0.356  Sum_probs=200.9

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCc-ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDV-TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||+||+|. ..+|+.||||+++.. ....+.+.+|+++++.++|||||++++++.+.+..++||||+++|+|
T Consensus        25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L  104 (293)
T d1yhwa1          25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL  104 (293)
T ss_dssp             CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcH
Confidence            3679999999999999 467999999998754 34467899999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----CC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----TP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~~  528 (663)
                      .+++...      .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++......    ..
T Consensus       105 ~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~  176 (293)
T d1yhwa1         105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (293)
T ss_dssp             HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred             HHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence            9988753      4899999999999999999999998  9999999999999999999999999998765432    33


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .+|+.|+|||++.+..++.++||||+||++|||++|+.||...      +....+..+........         ..+..
T Consensus       177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~------~~~~~~~~~~~~~~~~~---------~~~~~  241 (293)
T d1yhwa1         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE------NPLRALYLIATNGTPEL---------QNPEK  241 (293)
T ss_dssp             CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHHCSCCC---------SSGGG
T ss_pred             ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC------CHHHHHHHHHhCCCCCC---------CCccc
Confidence            4788899999999999999999999999999999999999642      22233333333221110         11122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...++.+++.+|++.||++|||++|+++|
T Consensus       242 ~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            33467788999999999999999999874

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-49  Score=394.47  Aligned_cols=240  Identities=23%  Similarity=0.280  Sum_probs=193.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||+||+|.. .+|+.||||++....  ...+.+.+|++++++++|||||++++++.+.+..++||||+++|+
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~   89 (271)
T d1nvra_          10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE   89 (271)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCc
Confidence            46899999999999995 579999999987542  234578999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC------
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS------  525 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~------  525 (663)
                      |.+++...     ..+++..+..++.||+.||+|||+++  |+||||||+|||+++++.+||+|||+|+.....      
T Consensus        90 L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~  162 (271)
T d1nvra_          90 LFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  162 (271)
T ss_dssp             GGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence            99999753     35899999999999999999999998  999999999999999999999999999875322      


Q ss_pred             CCCCCCccccCccccCCCCC-CCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          526 STPNRVAGYRAPEVTDPCKV-SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       526 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                      ....+|+.|||||++.+..+ +.++||||+||++|||++|+.||.......     .............          .
T Consensus       163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-----~~~~~~~~~~~~~----------~  227 (271)
T d1nvra_         163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----QEYSDWKEKKTYL----------N  227 (271)
T ss_dssp             CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-----HHHHHHHTTCTTS----------T
T ss_pred             cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-----HHHHHHhcCCCCC----------C
Confidence            23457889999999987765 678999999999999999999997543211     1111111111100          0


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      .......++.+++.+|++.||++|||++|+++
T Consensus       228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         228 PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            01112345678888999999999999999987

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=385.40  Aligned_cols=241  Identities=25%  Similarity=0.412  Sum_probs=194.0

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEec----CccEEEEEcc
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSM----DEKLLVYDYL  447 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~----~~~~lv~ey~  447 (663)
                      ++||+|+||+||+|.. .+++.||+|.+......   .+.+.+|++++++++|||||++++++.+.    ...++||||+
T Consensus        15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~   94 (270)
T d1t4ha_          15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM   94 (270)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred             eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence            4799999999999995 46889999998765433   35688999999999999999999998752    3468999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc-CCCceEEeccccccccCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT-KSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      ++|+|.+++....     .+++..+..++.||+.||+|||+++++|+||||||+|||++ +++.+||+|||+++......
T Consensus        95 ~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~  169 (270)
T d1t4ha_          95 TSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF  169 (270)
T ss_dssp             CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred             CCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc
Confidence            9999999997533     58999999999999999999999887799999999999996 57899999999998765432


Q ss_pred             --CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          527 --TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                        ...+|+.|+|||++.+ .++.++|||||||++|||++|+.||....     +.....+.+..... ...++       
T Consensus       170 ~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-----~~~~~~~~i~~~~~-~~~~~-------  235 (270)
T d1t4ha_         170 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVTSGVK-PASFD-------  235 (270)
T ss_dssp             BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHTTTCC-CGGGG-------
T ss_pred             cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-----cHHHHHHHHHcCCC-CcccC-------
Confidence              3457889999999876 58999999999999999999999996422     22222233222211 11110       


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                        .....++.+++.+||+.||++|||++|+++|
T Consensus       236 --~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         236 --KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             --GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --ccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence              1122357788899999999999999999874

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-48  Score=391.00  Aligned_cols=242  Identities=25%  Similarity=0.365  Sum_probs=197.9

Q ss_pred             ccccccceEEEEEEec---CCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          377 VLGKGTFGTAYKAVLE---MGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       377 ~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      +||+|+||+||+|.++   ++..||||.++...  ...+.|.+|++++++++|||||++++++.+ +..++||||+++|+
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~   94 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP   94 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence            4999999999999753   45689999997542  234679999999999999999999999864 56899999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-----
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----  526 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-----  526 (663)
                      |.+++....    ..+++..+..++.|||.||+|||+++  |+||||||+|||++.++.+||+|||+++......     
T Consensus        95 L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~  168 (285)
T d1u59a_          95 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  168 (285)
T ss_dssp             HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred             HHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhccccccccccc
Confidence            999986533    35899999999999999999999998  9999999999999999999999999998765432     


Q ss_pred             --CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          527 --TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                        ...++..|+|||++.+..++.++|||||||++|||+| |+.||.....      ......+..... .          
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~------~~~~~~i~~~~~-~----------  231 (285)
T d1u59a_         169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------PEVMAFIEQGKR-M----------  231 (285)
T ss_dssp             CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT------HHHHHHHHTTCC-C----------
T ss_pred             ccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCC-C----------
Confidence              1235677999999988899999999999999999998 9999975322      222222222211 1          


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                      ..+...+.++.+++.+||+.||++|||+.+|++.|+.+.
T Consensus       232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            111223457888999999999999999999999998653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-48  Score=390.49  Aligned_cols=249  Identities=27%  Similarity=0.363  Sum_probs=203.3

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChhH
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLSA  454 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~  454 (663)
                      .+.||+|+||+||+|.+++++.||||+++......+.|.+|+.++++++|||||+++++|. .++.++||||+++|+|..
T Consensus        22 ~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~  100 (285)
T d1fmka3          22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLD  100 (285)
T ss_dssp             EEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHH
T ss_pred             eeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhh
Confidence            5789999999999999988889999999887777889999999999999999999999985 466899999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-----CCC
Q 006055          455 LLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-----TPN  529 (663)
Q Consensus       455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-----~~~  529 (663)
                      ++....   ...++|..++.++.|||.||+|||+.+  |+||||||+|||+|.++.+||+|||+++......     ...
T Consensus       101 ~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  175 (285)
T d1fmka3         101 FLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK  175 (285)
T ss_dssp             HHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC--------------
T ss_pred             hhhhcc---cccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhccCCCceeecccc
Confidence            887532   235899999999999999999999998  9999999999999999999999999998765432     234


Q ss_pred             CCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHH
Q 006055          530 RVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEE  609 (663)
Q Consensus       530 ~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  609 (663)
                      ++..|+|||++....++.++|||||||++|||++|..|+...     ......+..+......           +.....
T Consensus       176 gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~-----~~~~~~~~~i~~~~~~-----------~~~~~~  239 (285)
T d1fmka3         176 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-----MVNREVLDQVERGYRM-----------PCPPEC  239 (285)
T ss_dssp             CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-----CCHHHHHHHHHTTCCC-----------CCCTTS
T ss_pred             ccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC-----CCHHHHHHHHHhcCCC-----------CCCccc
Confidence            677899999999999999999999999999999977776432     2233333333322111           111223


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          610 MVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       610 ~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                      ..++.+++.+||+.||++||++++|+++|++.....
T Consensus       240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            346788899999999999999999999999876553

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-48  Score=389.56  Aligned_cols=241  Identities=24%  Similarity=0.355  Sum_probs=195.5

Q ss_pred             cccccccceEEEEEEec---CCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVLE---MGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      ++||+|+||+||+|.++   .++.||||+++....+   .+.|.+|++++++++|||||+++++|.+ +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999854   3568999999754222   4679999999999999999999999854 567899999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC--
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST--  527 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--  527 (663)
                      |+|.++++...     .+++..+..++.|||.||+|||+++  |+||||||+|||++.++.+||+|||+++.......  
T Consensus        92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            99999998543     5899999999999999999999998  99999999999999999999999999987654322  


Q ss_pred             -----CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhh
Q 006055          528 -----PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL  601 (663)
Q Consensus       528 -----~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  601 (663)
                           ..+++.|+|||.+.+..++.++|||||||++|||+| |+.||....      .......+..... .        
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~------~~~~~~~i~~~~~-~--------  229 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK------GSEVTAMLEKGER-M--------  229 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHHHTTCC-C--------
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC------HHHHHHHHHcCCC-C--------
Confidence                 236678999999998889999999999999999998 899996532      2222222222211 1        


Q ss_pred             cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       602 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                        ..+...+.++.+++.+||+.||++|||++||++.|+..
T Consensus       230 --~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         230 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence              11122345688899999999999999999999988764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-48  Score=390.49  Aligned_cols=245  Identities=20%  Similarity=0.300  Sum_probs=189.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEe--cCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYS--MDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ey~~  448 (663)
                      .+.||+|+||+||+|.. .+|+.||||.+......   .+.+.+|++++++++|||||++++++.+  ....++||||++
T Consensus         9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~   88 (269)
T d2java1           9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE   88 (269)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCT
T ss_pred             eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCC
Confidence            36899999999999985 57999999999765443   3568899999999999999999999865  345789999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---CcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG---PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~---~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      +|+|.+++..... ....+++..++.++.|++.||.|||+++   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  167 (269)
T d2java1          89 GGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD  167 (269)
T ss_dssp             TEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred             CCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence            9999999864221 1245899999999999999999999875   35999999999999999999999999999877543


Q ss_pred             C----CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhh
Q 006055          526 S----TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELL  601 (663)
Q Consensus       526 ~----~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  601 (663)
                      .    ...+|+.|+|||++.+..++.++|||||||++|||+||+.||...      +.......+..... ..+      
T Consensus       168 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~------~~~~~~~~i~~~~~-~~~------  234 (269)
T d2java1         168 TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF------SQKELAGKIREGKF-RRI------  234 (269)
T ss_dssp             --------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHTCC-CCC------
T ss_pred             CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC------CHHHHHHHHHcCCC-CCC------
Confidence            2    245788899999999999999999999999999999999999643      22233333332221 110      


Q ss_pred             cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          602 RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       602 ~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                          +...+.++.+++.+||+.||++|||++|+++|
T Consensus       235 ----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         235 ----PYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----CcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                11223467888899999999999999999873

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-47  Score=393.23  Aligned_cols=240  Identities=23%  Similarity=0.367  Sum_probs=199.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC----HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS----EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||+|.. .+|+.||||+++.....    .+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus        20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~   99 (309)
T d1u5ra_          20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG   99 (309)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCC
Confidence            46799999999999984 57899999998765322    24688999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCCCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSSTPN  529 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  529 (663)
                      |+|..++...     ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+|+.........
T Consensus       100 g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~  172 (309)
T d1u5ra_         100 SASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV  172 (309)
T ss_dssp             EHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCC
T ss_pred             CchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCCCCccc
Confidence            9998776543     25899999999999999999999998  9999999999999999999999999999887777778


Q ss_pred             CCccccCccccCC---CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccCh
Q 006055          530 RVAGYRAPEVTDP---CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNV  606 (663)
Q Consensus       530 ~~~~y~aPE~~~~---~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  606 (663)
                      +|+.|||||++.+   ..|+.++|||||||++|||++|+.||...      +....+..+....... ..         .
T Consensus       173 GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~------~~~~~~~~i~~~~~~~-~~---------~  236 (309)
T d1u5ra_         173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQNESPA-LQ---------S  236 (309)
T ss_dssp             SCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHSCCCC-CS---------C
T ss_pred             cCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhCCCCC-CC---------C
Confidence            9999999999864   45889999999999999999999999642      2223333333332111 10         1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          607 EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       607 ~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .....++.+++.+||..||++|||++|+++|
T Consensus       237 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            1123467788889999999999999999874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=388.58  Aligned_cols=247  Identities=23%  Similarity=0.374  Sum_probs=195.6

Q ss_pred             hcccccccceEEEEEEecCC-----cEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVLEMG-----TIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g-----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .++||+|+||+||+|.++..     ..||||+++....  ...+|.+|++++++++|||||+++|++.+.+..++||||+
T Consensus        12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~   91 (283)
T d1mqba_          12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM   91 (283)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence            46899999999999996532     4799999875432  2457899999999999999999999999999999999999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST  527 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  527 (663)
                      .+|++.+++....    ..++|..+..++.|||.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......
T Consensus        92 ~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  165 (283)
T d1mqba_          92 ENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  165 (283)
T ss_dssp             TTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             ccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence            9999999887543    35899999999999999999999998  99999999999999999999999999987644321


Q ss_pred             -------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          528 -------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       528 -------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                             ..+|..|+|||++.+..++.++|||||||++|||++|..|+...     ......+..+.....         
T Consensus       166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~-----~~~~~~~~~i~~~~~---------  231 (283)
T d1mqba_         166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-----LSNHEVMKAINDGFR---------  231 (283)
T ss_dssp             --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-----CCHHHHHHHHHTTCC---------
T ss_pred             cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc-----CCHHHHHHHHhccCC---------
Confidence                   23567799999999999999999999999999999976665432     122222322222111         


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                        .+.+...+.++.+++.+||+.||++||||.||+++|+++..
T Consensus       232 --~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         232 --LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             --CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence              11112234568889999999999999999999999998754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=394.38  Aligned_cols=242  Identities=23%  Similarity=0.358  Sum_probs=198.7

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|++++++++|||||++++++.+.+..++||||+++|+|
T Consensus        17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L   96 (288)
T d2jfla1          17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred             eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcH
Confidence            46799999999999995 579999999997543 3346789999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC----CCC
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS----STP  528 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~----~~~  528 (663)
                      .+++....    ..+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+|+.....    ...
T Consensus        97 ~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~  170 (288)
T d2jfla1          97 DAVMLELE----RPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  170 (288)
T ss_dssp             HHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCC
T ss_pred             HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCccccccc
Confidence            99876432    35899999999999999999999998  999999999999999999999999999765332    345


Q ss_pred             CCCccccCccccC-----CCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          529 NRVAGYRAPEVTD-----PCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       529 ~~~~~y~aPE~~~-----~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                      .+|+.|+|||++.     ...++.++|||||||++|||++|+.||.....      ...+..+....... .        
T Consensus       171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~------~~~~~~i~~~~~~~-~--------  235 (288)
T d2jfla1         171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP------MRVLLKIAKSEPPT-L--------  235 (288)
T ss_dssp             CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG------GGHHHHHHHSCCCC-C--------
T ss_pred             ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCCC-C--------
Confidence            6888999999984     45578999999999999999999999975322      22233333332111 0        


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ..+.....++.+++.+||+.||++|||++|+++|
T Consensus       236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1112234467888899999999999999999874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-47  Score=394.26  Aligned_cols=247  Identities=23%  Similarity=0.360  Sum_probs=198.0

Q ss_pred             hcccccccceEEEEEEecC-C-----cEEEEEEecCcc--cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLEM-G-----TIVAVKRLKDVT--ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  445 (663)
                      .++||+|+||+||+|.... +     ..||||.+....  .....+.+|+.++.++ +|||||+++++|.+.+..++|||
T Consensus        42 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E  121 (325)
T d1rjba_          42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE  121 (325)
T ss_dssp             EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEE
Confidence            5789999999999998542 2     369999986542  2346789999999988 89999999999999999999999


Q ss_pred             ccCCCChhHhhccCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC
Q 006055          446 YLTMGSLSALLHGNKGA------------------GRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK  507 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~  507 (663)
                      |+++|+|.++++.....                  ....+++..++.++.||+.||+|||+++  |+||||||+|||++.
T Consensus       122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDlKp~Nill~~  199 (325)
T d1rjba_         122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTH  199 (325)
T ss_dssp             CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEEET
T ss_pred             cCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCchhcccccc
Confidence            99999999999764321                  1235899999999999999999999998  999999999999999


Q ss_pred             CCceEEeccccccccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChH
Q 006055          508 SYEARVSDFGLAHLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLP  580 (663)
Q Consensus       508 ~~~~kl~Dfg~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~  580 (663)
                      ++.+||+|||+|+.......      ..+|+.|||||++.+..++.++|||||||++|||+| |+.||......      
T Consensus       200 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~------  273 (325)
T d1rjba_         200 GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD------  273 (325)
T ss_dssp             TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS------
T ss_pred             CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH------
Confidence            99999999999987654332      224778999999999999999999999999999998 89999653221      


Q ss_pred             HHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 006055          581 RWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIE  639 (663)
Q Consensus       581 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~  639 (663)
                      ..+..++......          ..+...+.++.+++.+||+.||++|||++||+++|.
T Consensus       274 ~~~~~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         274 ANFYKLIQNGFKM----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHhcCCCC----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            2223333332211          111223446888999999999999999999999995

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-48  Score=397.49  Aligned_cols=190  Identities=22%  Similarity=0.356  Sum_probs=169.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .++||+|+||+||+|.. .+|+.||+|+++...  .....+.+|+.+++.++|||||+++++|.+..+.++||||+++|+
T Consensus        11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~   90 (322)
T d1s9ja_          11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS   90 (322)
T ss_dssp             EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCc
Confidence            36899999999999995 579999999987542  225678999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCcceecCCCCCCEEEcCCCceEEeccccccccCCC--CCC
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQ-GPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--STP  528 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~--~~~  528 (663)
                      |.++++...     .+++..+..++.|++.||.|||++ +  |+||||||+|||+++++.+||+|||+|+.....  .+.
T Consensus        91 L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~  163 (322)
T d1s9ja_          91 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  163 (322)
T ss_dssp             HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---
T ss_pred             HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCccccCCCccccc
Confidence            999997533     489999999999999999999974 7  999999999999999999999999999865432  345


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccc
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHAL  571 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~  571 (663)
                      .+|..|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus       164 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             cCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            6889999999999999999999999999999999999999753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.5e-47  Score=387.03  Aligned_cols=242  Identities=24%  Similarity=0.340  Sum_probs=186.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .+.||+|+||+||+|.. .+|+.||||++....  .....+.+|+++++.++|||||++++++.+.+..++||||+++|+
T Consensus        14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~   93 (307)
T d1a06a_          14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE   93 (307)
T ss_dssp             EEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence            46899999999999995 468999999987543  234568899999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc---CCCceEEeccccccccCCCC--
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT---KSYEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~---~~~~~kl~Dfg~a~~~~~~~--  526 (663)
                      |.+++....     .+++..+..++.||+.||+|||+++  |+||||||+||++.   +++.+||+|||+++......  
T Consensus        94 L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~  166 (307)
T d1a06a_          94 LFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL  166 (307)
T ss_dssp             HHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             HHHhhhccc-----CCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence            999997533     5899999999999999999999998  99999999999994   57899999999998765443  


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       +..+|+.|+|||++.+..++.++|||||||++|||++|+.||...      ........+........   .     ..
T Consensus       167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~~~~~~~i~~~~~~~~---~-----~~  232 (307)
T d1a06a_         167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE------NDAKLFEQILKAEYEFD---S-----PY  232 (307)
T ss_dssp             ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHTTCCCCC---T-----TT
T ss_pred             eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC------CHHHHHHHHhccCCCCC---C-----cc
Confidence             234788899999999999999999999999999999999999642      22233333333322111   0     01


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....+.++.+++.+|+..||++|||++|+++|
T Consensus       233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            11223467888899999999999999999984

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-47  Score=385.96  Aligned_cols=238  Identities=21%  Similarity=0.296  Sum_probs=198.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc----ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV----TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||+|.. .+|+.||||++...    ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus        13 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~g   92 (288)
T d1uu3a_          13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN   92 (288)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCC
Confidence            46899999999999995 57999999998643    23356799999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++....     .+++..+..++.|++.||+|||+.+  |+||||||+|||+++++.+||+|||+|+......   
T Consensus        93 g~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          93 GELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             CCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            99999987543     5899999999999999999999998  9999999999999999999999999998765322   


Q ss_pred             ---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          527 ---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       527 ---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                         ...||+.|+|||++.+..++.++||||+||++|||++|+.||...      +.......+......           
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~~~~~~~i~~~~~~-----------  228 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG------NEYLIFQKIIKLEYD-----------  228 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHTTCCC-----------
T ss_pred             ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc------CHHHHHHHHHcCCCC-----------
Confidence               234788999999999999999999999999999999999999642      233334444433210           


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                       .+.....++.+++.+|+..||++|||++|+.++
T Consensus       229 -~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         229 -FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             -CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             -CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence             011223467788899999999999999997554

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-46  Score=386.00  Aligned_cols=259  Identities=23%  Similarity=0.280  Sum_probs=198.4

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecC----ccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMD----EKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ey~~~g  450 (663)
                      .+.||+|+||+||+|++. |+.||||+++........++.|+..+..++||||++++++|.+.+    ..++||||+++|
T Consensus         8 ~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g   86 (303)
T d1vjya_           8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG   86 (303)
T ss_dssp             EEEEECCSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred             EEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCC
Confidence            467999999999999974 899999999765433333445666667889999999999998754    468999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQG------PNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~------~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      +|.++++..      .++|..+..++.|+|.||+|||+..      ++|+||||||+||||++++.+||+|||+++....
T Consensus        87 ~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~  160 (303)
T d1vjya_          87 SLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  160 (303)
T ss_dssp             BHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             CHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence            999999853      3899999999999999999999741      3599999999999999999999999999987643


Q ss_pred             CC--------CCCCCccccCccccCCCC------CCCcchhhhHHHHHHHHHhCCCCCccccCCCC--------CChHHH
Q 006055          525 SS--------TPNRVAGYRAPEVTDPCK------VSQKADVYSFGVLLLELLTGKAPTHALLNEEG--------VDLPRW  582 (663)
Q Consensus       525 ~~--------~~~~~~~y~aPE~~~~~~------~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~--------~~~~~~  582 (663)
                      ..        ...+|++|+|||++.+..      ++.++|||||||++|||+||..||........        ......
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T d1vjya_         161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE  240 (303)
T ss_dssp             TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred             CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH
Confidence            21        234788899999987643      56789999999999999999988754322111        011122


Q ss_pred             HHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCC
Q 006055          583 VQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPS  644 (663)
Q Consensus       583 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~  644 (663)
                      ........    ..++.+.......+....+.+++.+||..||++|||+.||+++|+++..+
T Consensus       241 ~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         241 MRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            22222211    11222212222334566788999999999999999999999999988643

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-47  Score=379.68  Aligned_cols=245  Identities=26%  Similarity=0.417  Sum_probs=193.1

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEe-cCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYS-MDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ey~~~gsL~  453 (663)
                      .++||+|+||.||+|.++ |+.||||+++... ..+.|.+|++++++++||||++++|+|.+ .+..++||||+++|+|.
T Consensus        12 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~   89 (262)
T d1byga_          12 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV   89 (262)
T ss_dssp             EEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred             eEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHH
Confidence            478999999999999985 8899999997643 45679999999999999999999999865 45689999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-CCCCCc
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-TPNRVA  532 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~  532 (663)
                      ++++...   ...++|..+++|+.||+.||.|||+.+  |+||||||+||+++.++.+|++|||+++...... ...++.
T Consensus        90 ~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~~  164 (262)
T d1byga_          90 DYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV  164 (262)
T ss_dssp             HHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC------------CCT
T ss_pred             HHHHhcC---CCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecCCCCccccccc
Confidence            9997532   235899999999999999999999998  9999999999999999999999999998765443 234567


Q ss_pred             cccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHHHHH
Q 006055          533 GYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEEEMV  611 (663)
Q Consensus       533 ~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  611 (663)
                      .|+|||++.+..++.++|||||||++|||+| |+.||....      .......+... ...+          .+.....
T Consensus       165 ~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~------~~~~~~~i~~~-~~~~----------~~~~~~~  227 (262)
T d1byga_         165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRVEKG-YKMD----------APDGCPP  227 (262)
T ss_dssp             TTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC------GGGHHHHHTTT-CCCC----------CCTTCCH
T ss_pred             cCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC------HHHHHHHHHcC-CCCC----------CCccCCH
Confidence            7999999988899999999999999999998 677775432      12222222221 1111          1122234


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          612 QLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       612 ~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      ++.+++.+||+.||++|||+.|++++|++++.
T Consensus       228 ~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         228 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            67888999999999999999999999998853

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-46  Score=384.11  Aligned_cols=250  Identities=22%  Similarity=0.365  Sum_probs=202.6

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||+||+|+.+      +++.||||+++....  ..++|.+|+++++.++||||++++++|......++||||
T Consensus        18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~   97 (301)
T d1lufa_          18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY   97 (301)
T ss_dssp             EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEe
Confidence            468999999999999854      457899999875432  246799999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC
Q 006055          447 LTMGSLSALLHGNKG-------------------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK  507 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~  507 (663)
                      +++|+|.++++....                   .....+++..+..|+.|+|.||+|||+++  |+||||||+|||+|.
T Consensus        98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDlKp~NILld~  175 (301)
T d1lufa_          98 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGE  175 (301)
T ss_dssp             CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECG
T ss_pred             cCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeEEcccceEECC
Confidence            999999999864321                   12345899999999999999999999998  999999999999999


Q ss_pred             CCceEEeccccccccCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCC-CCCccccCCCCCChH
Q 006055          508 SYEARVSDFGLAHLVGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGK-APTHALLNEEGVDLP  580 (663)
Q Consensus       508 ~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~-~p~~~~~~~~~~~~~  580 (663)
                      ++.+||+|||+++......      +..++..|+|||.+.+..++.++|||||||++|||++|. .||...      +..
T Consensus       176 ~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~------~~~  249 (301)
T d1lufa_         176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM------AHE  249 (301)
T ss_dssp             GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS------CHH
T ss_pred             CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC------CHH
Confidence            9999999999998654321      234567799999999999999999999999999999986 466432      223


Q ss_pred             HHHHHHHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          581 RWVQSIVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       581 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      +.+..+.... ...          .+...+.++.+++.+||+.||++||||.||+++|+++.+
T Consensus       250 e~~~~v~~~~-~~~----------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         250 EVIYYVRDGN-ILA----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             HHHHHHHTTC-CCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHHHHHcCC-CCC----------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            3333332222 111          112233468899999999999999999999999999864

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-46  Score=380.82  Aligned_cols=251  Identities=25%  Similarity=0.352  Sum_probs=200.2

Q ss_pred             cccccccceEEEEEEecCC----cEEEEEEecCcc--cCHHHHHHHHHHhhcCCCCCcccceEEEEec-CccEEEEEccC
Q 006055          376 EVLGKGTFGTAYKAVLEMG----TIVAVKRLKDVT--ISEREFKDKIEGVGAVNHENLVPLRAYYYSM-DEKLLVYDYLT  448 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~g----~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ey~~  448 (663)
                      ++||+|+||+||+|.+.++    ..||||+++...  ...++|.+|++++++++||||++++|++.+. ...++||||++
T Consensus        33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~  112 (311)
T d1r0pa_          33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK  112 (311)
T ss_dssp             EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred             eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence            6799999999999996432    368999997532  2246799999999999999999999998765 47899999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC-
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST-  527 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  527 (663)
                      +|+|.++++...    ..+++..+.+++.|+|.||.|||+.+  |+||||||+|||+++++.+||+|||+++....... 
T Consensus       113 ~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         113 HGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             cCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            999999988543    35788999999999999999999998  99999999999999999999999999987654321 


Q ss_pred             -------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          528 -------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       528 -------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                             ..++..|+|||.+.+..++.++||||||+++|||+||+.||.....     ...+...+.......       
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-----~~~~~~~i~~g~~~~-------  254 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLLQGRRLL-------  254 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTCCCC-------
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHcCCCCC-------
Confidence                   2356779999999999999999999999999999998888764322     112222222221111       


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCCCC
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSSTQG  648 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~~~  648 (663)
                          .+.....++.+++.+||+.||++||+|.||+++|+++......+
T Consensus       255 ----~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~  298 (311)
T d1r0pa_         255 ----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  298 (311)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             ----CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence                11122346788999999999999999999999999997654443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.8e-46  Score=388.35  Aligned_cols=243  Identities=21%  Similarity=0.335  Sum_probs=201.7

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc-CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI-SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||+||+|.. .+|+.||||++..... ..+.+.+|+.++++++|||||++++++.+.+..++||||+++|+|
T Consensus        31 ~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L  110 (350)
T d1koaa2          31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL  110 (350)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCH
Confidence            46899999999999995 5799999999976532 356789999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC--CCceEEeccccccccCCCCC---
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK--SYEARVSDFGLAHLVGPSST---  527 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~---  527 (663)
                      .+++....    ..+++..+..++.||+.||.|||+++  |+||||||+|||++.  ++.+||+|||+++.......   
T Consensus       111 ~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~  184 (350)
T d1koaa2         111 FEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV  184 (350)
T ss_dssp             HHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEE
T ss_pred             HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecccccccce
Confidence            99986433    35899999999999999999999998  999999999999964  67899999999988765433   


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..+|+.|||||++.+..++.++|||||||++|||++|+.||...      +....+..+........   ..     ...
T Consensus       185 ~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~------~~~~~~~~i~~~~~~~~---~~-----~~~  250 (350)
T d1koaa2         185 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE------NDDETLRNVKSCDWNMD---DS-----AFS  250 (350)
T ss_dssp             ECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCCSC---CG-----GGG
T ss_pred             ecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCCCC---cc-----ccc
Confidence            35788899999999999999999999999999999999999642      33344444443332111   00     011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....++.+++.+|+..||++|||++|+++|
T Consensus       251 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         251 GISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            223467788889999999999999999985

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.7e-46  Score=386.80  Aligned_cols=243  Identities=22%  Similarity=0.352  Sum_probs=201.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc-cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|++++++++|||||++++++.++...++||||+++|+|
T Consensus        34 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L  113 (352)
T d1koba_          34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL  113 (352)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChH
Confidence            46899999999999995 579999999987653 3356788999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc--CCCceEEeccccccccCCCCC---
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT--KSYEARVSDFGLAHLVGPSST---  527 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~--~~~~~kl~Dfg~a~~~~~~~~---  527 (663)
                      .+++....    ..+++..+..|+.||+.||.|||+++  |+||||||+|||++  .++.+||+|||+|+.......   
T Consensus       114 ~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~  187 (352)
T d1koba_         114 FDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV  187 (352)
T ss_dssp             HHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred             HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCCCceee
Confidence            98876432    35899999999999999999999998  99999999999998  678999999999998766533   


Q ss_pred             CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChH
Q 006055          528 PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVE  607 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  607 (663)
                      ..+++.|+|||++.+..++.++||||+||++|||++|+.||...      +....+..+........        .....
T Consensus       188 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~------~~~~~~~~i~~~~~~~~--------~~~~~  253 (352)
T d1koba_         188 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE------DDLETLQNVKRCDWEFD--------EDAFS  253 (352)
T ss_dssp             ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHHHHHCCCCCC--------SSTTT
T ss_pred             ccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCCCC--------ccccc
Confidence            35778899999999999999999999999999999999999642      22333334333321100        00111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          608 EEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       608 ~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ....++.+++.+|+..||++|||++|+++|
T Consensus       254 ~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         254 SVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            223467788899999999999999999884

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=376.16  Aligned_cols=242  Identities=21%  Similarity=0.343  Sum_probs=199.5

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc-------cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT-------ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||+||+|.. .+|+.||||+++...       ...+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus        15 ~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (293)
T d1jksa_          15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL   94 (293)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46899999999999995 579999999986431       2357899999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC----ceEEecccccccc
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY----EARVSDFGLAHLV  522 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~----~~kl~Dfg~a~~~  522 (663)
                      +++|+|.+++....     .+++..+..++.|++.||+|||+.+  |+||||||+||+++.++    .+|++|||+++..
T Consensus        95 ~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          95 VAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             CCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            99999999997533     5899999999999999999999998  99999999999998777    4999999999876


Q ss_pred             CCCC---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          523 GPSS---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       523 ~~~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                      ....   ...+++.|+|||++.+..++.++|||||||++|||++|+.||...      +.......+......   +...
T Consensus       168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~~~~~~~i~~~~~~---~~~~  238 (293)
T d1jksa_         168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD------TKQETLANVSAVNYE---FEDE  238 (293)
T ss_dssp             TTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHTTCCC---CCHH
T ss_pred             CCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC------CHHHHHHHHHhcCCC---CCch
Confidence            5432   345677899999999999999999999999999999999999653      222333333322211   0000


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .     ....+.++.+++.+||..||++|||++|+++|
T Consensus       239 ~-----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         239 Y-----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             H-----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             h-----cCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0     11223467788899999999999999999883

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-46  Score=381.68  Aligned_cols=244  Identities=23%  Similarity=0.395  Sum_probs=195.6

Q ss_pred             hcccccccceEEEEEEec-CCc----EEEEEEecCc--ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGT----IVAVKRLKDV--TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~  447 (663)
                      .++||+|+||+||+|.+. +|+    +||||+++..  ....++|.+|++++++++|||||+++++|.+ +..++++||+
T Consensus        14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~v~e~~   92 (317)
T d1xkka_          14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLM   92 (317)
T ss_dssp             EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeEEEEec
Confidence            378999999999999853 444    6899988654  3346789999999999999999999999976 4678889999


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST  527 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  527 (663)
                      .+|+|.+++....    ..+++..++.++.|||.||+|||+++  |+||||||+|||++.++.+||+|||+++.......
T Consensus        93 ~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~  166 (317)
T d1xkka_          93 PFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  166 (317)
T ss_dssp             TTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred             cCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence            9999999887543    45899999999999999999999998  99999999999999999999999999987654322


Q ss_pred             ------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhh
Q 006055          528 ------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLEL  600 (663)
Q Consensus       528 ------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  600 (663)
                            ..+|..|+|||++.+..++.++|||||||++|||+| |+.||+.....      ... ..+..+..        
T Consensus       167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~------~~~-~~i~~~~~--------  231 (317)
T d1xkka_         167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------EIS-SILEKGER--------  231 (317)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG------GHH-HHHHHTCC--------
T ss_pred             cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH------HHH-HHHHcCCC--------
Confidence                  235678999999999999999999999999999998 78888653221      111 12222110        


Q ss_pred             hcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          601 LRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       601 ~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                        ...+...+.++.+++.+||..||++|||+.|++++|+.+.
T Consensus       232 --~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         232 --LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             --CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence              1111223446788999999999999999999999998763

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.2e-45  Score=377.65  Aligned_cols=238  Identities=23%  Similarity=0.314  Sum_probs=201.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc----ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV----TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||+|+. .+|+.||||+++..    ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus         9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g   88 (316)
T d1fota_           9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG   88 (316)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCC
Confidence            46899999999999995 56999999998643    23357789999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-CC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-TP  528 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~  528 (663)
                      |+|..++....     .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+|+...... +.
T Consensus        89 g~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~  161 (316)
T d1fota_          89 GELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL  161 (316)
T ss_dssp             CBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCC
T ss_pred             ccccccccccc-----cccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEeccccccc
Confidence            99999987643     4788999999999999999999998  9999999999999999999999999998876543 35


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .+|+.|+|||++.+..++.++||||+||++|||++|+.||...      +.......+......            .+..
T Consensus       162 ~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~------~~~~~~~~i~~~~~~------------~p~~  223 (316)
T d1fota_         162 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS------NTMKTYEKILNAELR------------FPPF  223 (316)
T ss_dssp             CSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHCCCC------------CCTT
T ss_pred             cCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc------CHHHHHHHHHcCCCC------------CCCC
Confidence            6888999999999999999999999999999999999999642      333344444433211            0111


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                      ...++.+++.+|+..||++||     |++|+++|
T Consensus       224 ~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         224 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            233577888899999999996     89999875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=373.17  Aligned_cols=245  Identities=22%  Similarity=0.361  Sum_probs=190.9

Q ss_pred             hcccccccceEEEEEEecC----CcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLEM----GTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||+||+|.+..    +..||||.++....  ..+.|.+|++++++++||||+++++++. .+..++||||++
T Consensus        12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~   90 (273)
T d1mp8a_          12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT   90 (273)
T ss_dssp             EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEecc
Confidence            4789999999999998542    45799999865432  2467999999999999999999999985 567899999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--  526 (663)
                      +|+|.+++....    ..+++..++.++.||+.||.|||+++  |+||||||+||+++.++.+||+|||+++......  
T Consensus        91 ~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~  164 (273)
T d1mp8a_          91 LGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  164 (273)
T ss_dssp             TEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred             CCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence            999999876543    35899999999999999999999998  9999999999999999999999999998765432  


Q ss_pred             ---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhc
Q 006055          527 ---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLR  602 (663)
Q Consensus       527 ---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  602 (663)
                         ...+++.|+|||.+.+..++.++|||||||++|||++ |..||......      .....+......          
T Consensus       165 ~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~------~~~~~i~~~~~~----------  228 (273)
T d1mp8a_         165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGERL----------  228 (273)
T ss_dssp             ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------GHHHHHHTTCCC----------
T ss_pred             eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCCC----------
Confidence               1235677999999998899999999999999999998 88898754322      122222222111          


Q ss_pred             ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          603 YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       603 ~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                       +.+...+.++.+++.+||..||++|||++||+++|+.+.+
T Consensus       229 -~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         229 -PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence             1112234568889999999999999999999999998754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-45  Score=377.91  Aligned_cols=238  Identities=24%  Similarity=0.304  Sum_probs=199.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc----ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV----TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||+|+. .+|+.||||++++.    ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~g   89 (337)
T d1o6la_          10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG   89 (337)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCC
Confidence            46899999999999995 67999999999753    22357789999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC---
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      |+|.+++....     .+++..++.++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+|+......   
T Consensus        90 g~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~  162 (337)
T d1o6la_          90 GELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             Cchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccccCCccc
Confidence            99999998643     4889999999999999999999998  9999999999999999999999999998764432   


Q ss_pred             -CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccC
Q 006055          527 -TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQN  605 (663)
Q Consensus       527 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  605 (663)
                       ...||+.|+|||++.+..|+.++||||+||++|||++|+.||...      +.......+.....            ..
T Consensus       163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~------~~~~~~~~i~~~~~------------~~  224 (337)
T d1o6la_         163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHERLFELILMEEI------------RF  224 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCC------------CC
T ss_pred             ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc------CHHHHHHHHhcCCC------------CC
Confidence             234788899999999999999999999999999999999999653      22333333332221            01


Q ss_pred             hHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006055          606 VEEEMVQLLQLAIDCSAQYPDNRPS-----MSEVIKR  637 (663)
Q Consensus       606 ~~~~~~~l~~l~~~C~~~dP~~RPt-----~~ev~~~  637 (663)
                      +.....++.+++.+|+..||++||+     ++|+++|
T Consensus       225 p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            1122345778888999999999995     8888875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=379.11  Aligned_cols=253  Identities=23%  Similarity=0.366  Sum_probs=201.7

Q ss_pred             hcccccccceEEEEEEec-CCc--EEEEEEecCc--ccCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVLE-MGT--IVAVKRLKDV--TISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~-~g~--~vavK~l~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .++||+|+||+||+|.++ +|.  .||||+++..  ....+.|.+|++++.++ +|||||+++++|.+.+..++||||++
T Consensus        15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~   94 (309)
T d1fvra_          15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   94 (309)
T ss_dssp             EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence            578999999999999954 454  5788887643  22345799999999998 79999999999999999999999999


Q ss_pred             CCChhHhhccCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccc
Q 006055          449 MGSLSALLHGNK-----------GAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFG  517 (663)
Q Consensus       449 ~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg  517 (663)
                      +|+|.++++...           ......++|..+..++.|||.||.|||+.+  |+||||||+|||++.++.+||+|||
T Consensus        95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~~~~kl~DfG  172 (309)
T d1fvra_          95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFG  172 (309)
T ss_dssp             TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTT
T ss_pred             CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCCCceEEcccc
Confidence            999999997542           122356999999999999999999999998  9999999999999999999999999


Q ss_pred             cccccCCCCC---CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCC-CCccccCCCCCChHHHHHHHHhhcccc
Q 006055          518 LAHLVGPSST---PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKA-PTHALLNEEGVDLPRWVQSIVKDEWTS  593 (663)
Q Consensus       518 ~a~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (663)
                      +++.......   ..++..|+|||.+.+..++.++|||||||++|||++|.. ||..      .+.......+...... 
T Consensus       173 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~------~~~~~~~~~i~~~~~~-  245 (309)
T d1fvra_         173 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG------MTCAELYEKLPQGYRL-  245 (309)
T ss_dssp             CEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT------CCHHHHHHHGGGTCCC-
T ss_pred             ccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC------CCHHHHHHHHHhcCCC-
Confidence            9986654332   236778999999999999999999999999999999765 5643      2233333333222111 


Q ss_pred             cccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCCC
Q 006055          594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSST  646 (663)
Q Consensus       594 ~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~~  646 (663)
                                ..+...+.++.+++.+||+.||++||||+||+++|+++.+...
T Consensus       246 ----------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         246 ----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             ----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             ----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence                      1111233467888899999999999999999999999865543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-46  Score=372.76  Aligned_cols=244  Identities=25%  Similarity=0.378  Sum_probs=191.2

Q ss_pred             hcccccccceEEEEEEec--CC--cEEEEEEecCcc----cCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE--MG--TIVAVKRLKDVT----ISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~--~g--~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||+||+|+..  ++  ..||||+++...    ...+.|.+|++++++++||||++++|+|.+ ...++||||
T Consensus        13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~   91 (273)
T d1u46a_          13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL   91 (273)
T ss_dssp             EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeee
Confidence            467999999999999853  22  378999987542    123679999999999999999999999965 467899999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      +++|++.+++....    ..+++..+..++.|||.||.|||+++  |+||||||+||+++.++.+||+|||+++......
T Consensus        92 ~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_          92 APLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  165 (273)
T ss_dssp             CTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             ecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence            99999999876533    35899999999999999999999998  9999999999999999999999999998775442


Q ss_pred             C-------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          527 T-------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       527 ~-------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                      .       ..++..|+|||.+.+..++.++|||||||++|||+| |+.||...      +....+..+........    
T Consensus       166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~------~~~~~~~~i~~~~~~~~----  235 (273)
T d1u46a_         166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------NGSQILHKIDKEGERLP----  235 (273)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHTSCCCCC----
T ss_pred             CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc------CHHHHHHHHHhCCCCCC----
Confidence            2       224567999999999899999999999999999998 89999642      33334444443322111    


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEEL  641 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~  641 (663)
                            .+...+.++.+++.+||+.||++|||++||++.|++.
T Consensus       236 ------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         236 ------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                  1122334688899999999999999999999999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-45  Score=376.74  Aligned_cols=250  Identities=24%  Similarity=0.357  Sum_probs=188.6

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCccc--CHHHHHHHHHHhhcC-CCCCcccceEEEEecC-ccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVTI--SEREFKDKIEGVGAV-NHENLVPLRAYYYSMD-EKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~~lv~  444 (663)
                      .++||+|+||+||+|...      +++.||||+++....  ..+.+.+|...+.++ +|+||+.+++++.+.+ ..++||
T Consensus        18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~   97 (299)
T d1ywna1          18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV   97 (299)
T ss_dssp             EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred             eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence            478999999999999853      346899999875422  245677788777766 6889999999987654 579999


Q ss_pred             EccCCCChhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEE
Q 006055          445 DYLTMGSLSALLHGNKG-----------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARV  513 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl  513 (663)
                      ||+++|+|.++++....           .....+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||
T Consensus        98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NILl~~~~~~Kl  175 (299)
T d1ywna1          98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKI  175 (299)
T ss_dssp             ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEE
T ss_pred             EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCccceeECCCCcEEE
Confidence            99999999999975431           11345899999999999999999999998  999999999999999999999


Q ss_pred             eccccccccCCCC------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCC-CCCccccCCCCCChHHHHHHH
Q 006055          514 SDFGLAHLVGPSS------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGK-APTHALLNEEGVDLPRWVQSI  586 (663)
Q Consensus       514 ~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~  586 (663)
                      +|||+|+......      ...+|+.|+|||++.+..++.++|||||||++|||+||. .||....      ....+...
T Consensus       176 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~------~~~~~~~~  249 (299)
T d1ywna1         176 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK------IDEEFCRR  249 (299)
T ss_dssp             CC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------CSHHHHHH
T ss_pred             ccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC------HHHHHHHH
Confidence            9999998654432      224677899999999999999999999999999999975 5665322      12223333


Q ss_pred             HhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          587 VKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       587 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                      +..+.....          +...+.++.+++.+||+.||++|||++||+++|+++.
T Consensus       250 ~~~~~~~~~----------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         250 LKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             HHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhcCCCCCC----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            333221111          1123346888999999999999999999999999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-45  Score=374.47  Aligned_cols=243  Identities=23%  Similarity=0.357  Sum_probs=201.6

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCChh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .+.||+|+||+||+|.. .+|+.||||.++........+.+|+++++.++||||+++++++.+.+..++||||+++|+|.
T Consensus        10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~   89 (321)
T d1tkia_          10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF   89 (321)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHH
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHH
Confidence            46899999999999995 57899999999876655667899999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC--CceEEeccccccccCCCCC---C
Q 006055          454 ALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS--YEARVSDFGLAHLVGPSST---P  528 (663)
Q Consensus       454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~--~~~kl~Dfg~a~~~~~~~~---~  528 (663)
                      +++....    ..+++..+..++.||+.||+|||+++  |+||||||+|||++.+  ..+||+|||+++.......   .
T Consensus        90 ~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~  163 (321)
T d1tkia_          90 ERINTSA----FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL  163 (321)
T ss_dssp             HHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred             HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccCCccccc
Confidence            9997543    35899999999999999999999998  9999999999999854  4799999999987755432   3


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .+++.|+|||...+..++.++||||+||++|||++|+.||...      +....+..+......   ++...  +   ..
T Consensus       164 ~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~------~~~~~~~~i~~~~~~---~~~~~--~---~~  229 (321)
T d1tkia_         164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE------TNQQIIENIMNAEYT---FDEEA--F---KE  229 (321)
T ss_dssp             ESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHTCCC---CCHHH--H---TT
T ss_pred             ccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCC---CChhh--c---cC
Confidence            4677899999999999999999999999999999999999653      223344444433221   11110  0   11


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...++.+++.+|+..||++|||++|+++|
T Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         230 ISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            23457788889999999999999999985

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.5e-44  Score=365.60  Aligned_cols=247  Identities=24%  Similarity=0.351  Sum_probs=197.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCccc-C---HHHHHHHHHHhhcCCCCCcccceEEEEecCc----cEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI-S---EREFKDKIEGVGAVNHENLVPLRAYYYSMDE----KLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----~~lv~e  445 (663)
                      .+.||+|+||+||+|.. .+|+.||||.++.... .   ...+.+|+++++.++||||+++++++...+.    .++|||
T Consensus        12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE   91 (277)
T d1o6ya_          12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME   91 (277)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEE
Confidence            46899999999999994 6799999999976532 2   3468999999999999999999999877543    689999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+++|+|.+++....     .+++..+..++.||+.||+|||+++  |+||||||+|||++.++..+++|||.++.....
T Consensus        92 ~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          92 YVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADS  164 (277)
T ss_dssp             CCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred             CCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhhhccc
Confidence            999999999887543     5899999999999999999999998  999999999999999999999999998765432


Q ss_pred             C-------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccch
Q 006055          526 S-------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDL  598 (663)
Q Consensus       526 ~-------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  598 (663)
                      .       ...+|+.|+|||++.+..++.++|||||||++|||+||+.||...      +.......++.......    
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~------~~~~~~~~~~~~~~~~~----  234 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD------SPVSVAYQHVREDPIPP----  234 (277)
T ss_dssp             --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHCCCCCG----
T ss_pred             cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc------CHHHHHHHHHhcCCCCC----
Confidence            1       234678899999999999999999999999999999999999643      22333334443322110    


Q ss_pred             hhhcccChHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHhhC
Q 006055          599 ELLRYQNVEEEMVQLLQLAIDCSAQYPDNRP-SMSEVIKRIEELH  642 (663)
Q Consensus       599 ~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RP-t~~ev~~~L~~~~  642 (663)
                      .. .   ....+.++.+++.+|++.||++|| |++++.+.|.+++
T Consensus       235 ~~-~---~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         235 SA-R---HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             GG-T---SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ch-h---ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            00 0   112234677888899999999999 8999999998774

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-44  Score=376.98  Aligned_cols=238  Identities=21%  Similarity=0.228  Sum_probs=200.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc----ccCHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV----TISEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTM  449 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~  449 (663)
                      .+.||+|+||+||+|.. .+|+.||||++...    ....+.+.+|+++++.++|||||++++++.+....++||||+.+
T Consensus        46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~  125 (350)
T d1rdqe_          46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG  125 (350)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccc
Confidence            46899999999999995 57999999998643    22346789999999999999999999999999999999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC-CC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS-TP  528 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~  528 (663)
                      |+|.+++....     .+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+|+...... ..
T Consensus       126 g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~~  198 (350)
T d1rdqe_         126 GEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL  198 (350)
T ss_dssp             CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCC
T ss_pred             cchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccccccc
Confidence            99999987543     4899999999999999999999998  9999999999999999999999999998876443 34


Q ss_pred             CCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcccChHH
Q 006055          529 NRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQNVEE  608 (663)
Q Consensus       529 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  608 (663)
                      .+|+.|||||++.+..++.++|||||||++|||++|+.||...      +.......+......            .+..
T Consensus       199 ~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~------~~~~~~~~i~~~~~~------------~p~~  260 (350)
T d1rdqe_         199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD------QPIQIYEKIVSGKVR------------FPSH  260 (350)
T ss_dssp             EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC------------CCTT
T ss_pred             cCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc------CHHHHHHHHhcCCCC------------CCcc
Confidence            5788999999999999999999999999999999999999642      333334443332211            1112


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          609 EMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       609 ~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                      ...++.+++.+|+..||.+|+     |++|+++|
T Consensus       261 ~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            234677888899999999994     89999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=370.45  Aligned_cols=249  Identities=24%  Similarity=0.379  Sum_probs=195.4

Q ss_pred             hcccccccceEEEEEEec--------CCcEEEEEEecCccc--CHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEE
Q 006055          375 AEVLGKGTFGTAYKAVLE--------MGTIVAVKRLKDVTI--SEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLV  443 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  443 (663)
                      .+.||+|+||.||+|+..        ++..||||+++....  ...++.+|...+.++ +|||||+++++|.++...++|
T Consensus        18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v   97 (299)
T d1fgka_          18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI   97 (299)
T ss_dssp             EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence            478999999999999843        235799999976532  346788888888887 899999999999999999999


Q ss_pred             EEccCCCChhHhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceE
Q 006055          444 YDYLTMGSLSALLHGNKG-----------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEAR  512 (663)
Q Consensus       444 ~ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~k  512 (663)
                      |||+++|+|.+++.....           .....+++.+++.++.|||.||+|||+.+  |+||||||+|||++.++.+|
T Consensus        98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiLl~~~~~~k  175 (299)
T d1fgka_          98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMK  175 (299)
T ss_dssp             ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEE
T ss_pred             EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccceeecCCCCeE
Confidence            999999999999975432           12346899999999999999999999998  99999999999999999999


Q ss_pred             EeccccccccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHh-CCCCCccccCCCCCChHHHHHH
Q 006055          513 VSDFGLAHLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLT-GKAPTHALLNEEGVDLPRWVQS  585 (663)
Q Consensus       513 l~Dfg~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  585 (663)
                      |+|||+++.......      ..++..|+|||.+.+..++.++|||||||++|||++ |..||...      +..... .
T Consensus       176 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~------~~~~~~-~  248 (299)
T d1fgka_         176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------PVEELF-K  248 (299)
T ss_dssp             ECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------CHHHHH-H
T ss_pred             eccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC------CHHHHH-H
Confidence            999999987644321      235677999999999999999999999999999998 67787532      222222 2


Q ss_pred             HHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          586 IVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                      .+..+....          .+...+.++.+++.+||+.||++|||+.||++.|+++.
T Consensus       249 ~i~~~~~~~----------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         249 LLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             HHHTTCCCC----------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHcCCCCC----------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            222221111          11122346888999999999999999999999999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-45  Score=372.94  Aligned_cols=252  Identities=22%  Similarity=0.341  Sum_probs=204.1

Q ss_pred             hcccccccceEEEEEEec------CCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVLE------MGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .+.||+|+||+||+|.+.      +++.||||+++....  ....|.+|++++++++||||++++++|...+..++||||
T Consensus        25 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~  104 (308)
T d1p4oa_          25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL  104 (308)
T ss_dssp             EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEee
Confidence            578999999999999853      367899999975432  234689999999999999999999999999999999999


Q ss_pred             cCCCChhHhhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccc
Q 006055          447 LTMGSLSALLHGNKG-----AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL  521 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~  521 (663)
                      +++|+|.++++....     .....+++..+.+++.|+|+||.|||+++  |+||||||+|||+++++.+||+|||+++.
T Consensus       105 ~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~~~Kl~DFGla~~  182 (308)
T d1p4oa_         105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRD  182 (308)
T ss_dssp             CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCCEEECCTTCCCG
T ss_pred             cCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCceEEEeeccccee
Confidence            999999999864321     12345799999999999999999999998  99999999999999999999999999987


Q ss_pred             cCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCC-CCCccccCCCCCChHHHHHHHHhhccccc
Q 006055          522 VGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGK-APTHALLNEEGVDLPRWVQSIVKDEWTSE  594 (663)
Q Consensus       522 ~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (663)
                      ......      ..+++.|+|||.+.+..++.++||||||+++|||+||. .||..      .+.......+...... .
T Consensus       183 ~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~------~~~~~~~~~i~~~~~~-~  255 (308)
T d1p4oa_         183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG------LSNEQVLRFVMEGGLL-D  255 (308)
T ss_dssp             GGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT------SCHHHHHHHHHTTCCC-C
T ss_pred             ccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC------CCHHHHHHHHHhCCCC-C
Confidence            644322      23567799999999999999999999999999999985 56643      2333444443332211 1


Q ss_pred             ccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          595 VFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       595 ~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                                .+...+..+.+++.+||+.+|++|||++||+++|++..+..
T Consensus       256 ----------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         256 ----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             ----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence                      11123346888999999999999999999999999876543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.7e-44  Score=362.36  Aligned_cols=242  Identities=21%  Similarity=0.293  Sum_probs=197.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC----------HHHHHHHHHHhhcCC-CCCcccceEEEEecCccEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS----------EREFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLL  442 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~----------~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  442 (663)
                      .+.||+|+||+||+|.. .+|+.||||+++.....          .+.+.+|+.++++++ ||||+++++++.+.+..++
T Consensus         8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i   87 (277)
T d1phka_           8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL   87 (277)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence            47899999999999995 57999999998754221          235889999999997 9999999999999999999


Q ss_pred             EEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccccc
Q 006055          443 VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV  522 (663)
Q Consensus       443 v~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~  522 (663)
                      ||||+++|+|.++++...     .+++..+..++.||++||+|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        88 vmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          88 VFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchheeEc
Confidence            999999999999997533     5899999999999999999999998  999999999999999999999999999877


Q ss_pred             CCCC---CCCCCccccCccccCC------CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccc
Q 006055          523 GPSS---TPNRVAGYRAPEVTDP------CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTS  593 (663)
Q Consensus       523 ~~~~---~~~~~~~y~aPE~~~~------~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (663)
                      .+..   ...+|..|+|||++.+      ..++.++||||+||++|||++|+.||...      +.......+.......
T Consensus       161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~------~~~~~~~~i~~~~~~~  234 (277)
T d1phka_         161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR------KQMLMLRMIMSGNYQF  234 (277)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCCC
T ss_pred             cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC------CHHHHHHHHHhCCCCC
Confidence            6532   2346788999999743      35688999999999999999999999753      2223333333332211


Q ss_pred             cccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          594 EVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       594 ~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      .        .......+.++.+++.+|+..||++|||++||++|
T Consensus       235 ~--------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         235 G--------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             C--------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             C--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            0        01111233467788899999999999999999874

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=375.34  Aligned_cols=243  Identities=22%  Similarity=0.299  Sum_probs=191.7

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhc-CCCCCcccceEEEEe----cCccEEEEEccCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGA-VNHENLVPLRAYYYS----MDEKLLVYDYLTM  449 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~~lv~ey~~~  449 (663)
                      ++||+|+||+||+|.. .+|+.||||+++..    ..+.+|++++.+ .+|||||+++++|.+    ....++||||+++
T Consensus        18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g   93 (335)
T d2ozaa1          18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   93 (335)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             EEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence            5699999999999994 67999999998653    457789988654 589999999999875    3557999999999


Q ss_pred             CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC---CCceEEeccccccccCCCC
Q 006055          450 GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK---SYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~---~~~~kl~Dfg~a~~~~~~~  526 (663)
                      |+|.+++....   ...+++..+..++.||+.||+|||+.+  |+||||||+|||++.   ++.+||+|||+|+......
T Consensus        94 g~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~  168 (335)
T d2ozaa1          94 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN  168 (335)
T ss_dssp             EEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred             CcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHHcC--CccccccccccccccccccccccccccceeeeccCCC
Confidence            99999997532   346999999999999999999999998  999999999999985   4579999999998765543


Q ss_pred             ---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          527 ---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       527 ---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                         ...+|+.|+|||++.+..|+.++|||||||++|||+||+.||.+......   ...+..    ......++..   .
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~----~i~~~~~~~~---~  238 (335)
T d2ozaa1         169 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKT----RIRMGQYEFP---N  238 (335)
T ss_dssp             CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCCSCSSSCC---T
T ss_pred             ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHH----HHhcCCCCCC---C
Confidence               34578889999999999999999999999999999999999976432211   110000    0000001100   0


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ........++.+++.+|+..||++|||++|+++|
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            1112334578889999999999999999999985

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=371.51  Aligned_cols=251  Identities=23%  Similarity=0.379  Sum_probs=201.3

Q ss_pred             hcccccccceEEEEEEe------cCCcEEEEEEecCcc--cCHHHHHHHHHHhhcC-CCCCcccceEEEEecCccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL------EMGTIVAVKRLKDVT--ISEREFKDKIEGVGAV-NHENLVPLRAYYYSMDEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  445 (663)
                      .++||+|+||.||+|++      .+++.||||+++...  ....+|.+|+.++..+ +|||||+++++|.+....++|||
T Consensus        28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE  107 (311)
T d1t46a_          28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE  107 (311)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence            57899999999999985      346789999997643  2345789999999998 69999999999999999999999


Q ss_pred             ccCCCChhHhhccCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceE
Q 006055          446 YLTMGSLSALLHGNKG-------------AGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEAR  512 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~k  512 (663)
                      |+++|+|.++++....             .....+++..+..++.|||.||+|||+++  |+||||||+||+++.++.+|
T Consensus       108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~NIl~~~~~~~k  185 (311)
T d1t46a_         108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITK  185 (311)
T ss_dssp             CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEETTTEEE
T ss_pred             cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccccccccccccCccc
Confidence            9999999999976432             12346899999999999999999999998  99999999999999999999


Q ss_pred             EeccccccccCCCCC------CCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCC-CccccCCCCCChHHHHHH
Q 006055          513 VSDFGLAHLVGPSST------PNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAP-THALLNEEGVDLPRWVQS  585 (663)
Q Consensus       513 l~Dfg~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p-~~~~~~~~~~~~~~~~~~  585 (663)
                      ++|||.++.......      ..+++.|+|||.+.+..++.++|||||||++|||+|+..| |....      ....+..
T Consensus       186 i~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~------~~~~~~~  259 (311)
T d1t46a_         186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP------VDSKFYK  259 (311)
T ss_dssp             ECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC------SSHHHHH
T ss_pred             ccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC------HHHHHHH
Confidence            999999987654322      2356779999999989999999999999999999995544 43321      1122223


Q ss_pred             HHhhcccccccchhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCC
Q 006055          586 IVKDEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHP  643 (663)
Q Consensus       586 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~  643 (663)
                      ++..+....          .+...+.++.+++.+||+.||++|||++||+++|+++..
T Consensus       260 ~i~~~~~~~----------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         260 MIKEGFRML----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             HHHHTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhcCCCCC----------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            333222111          112233568889999999999999999999999987643

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.5e-44  Score=376.84  Aligned_cols=241  Identities=23%  Similarity=0.280  Sum_probs=192.1

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc----cCHHHHHHH---HHHhhcCCCCCcccceEEEEecCccEEEEEc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT----ISEREFKDK---IEGVGAVNHENLVPLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey  446 (663)
                      .++||+|+||+||+|.. .+|+.||||++....    .....+.+|   +.+++.++|||||++++++.+.+..++||||
T Consensus         9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~   88 (364)
T d1omwa3           9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL   88 (364)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence            46899999999999995 579999999986432    223334444   6677888999999999999999999999999


Q ss_pred             cCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC
Q 006055          447 LTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS  526 (663)
Q Consensus       447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  526 (663)
                      +++|+|.+++....     .+++..+..++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+|+......
T Consensus        89 ~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~  161 (364)
T d1omwa3          89 MNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  161 (364)
T ss_dssp             CCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred             cCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence            99999999997533     4789999999999999999999998  9999999999999999999999999998776543


Q ss_pred             --CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhcc
Q 006055          527 --TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRY  603 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  603 (663)
                        ...+|+.|+|||++.. ..++.++|||||||++|||+||+.||......   +.....+......    .        
T Consensus       162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~~~~~~~~~----~--------  226 (364)
T d1omwa3         162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---DKHEIDRMTLTMA----V--------  226 (364)
T ss_dssp             CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS---CHHHHHHHSSSCC----C--------
T ss_pred             ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcccCC----C--------
Confidence              3458889999999864 56899999999999999999999999764322   1211111111100    0        


Q ss_pred             cChHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006055          604 QNVEEEMVQLLQLAIDCSAQYPDNRPS-----MSEVIKR  637 (663)
Q Consensus       604 ~~~~~~~~~l~~l~~~C~~~dP~~RPt-----~~ev~~~  637 (663)
                      ..+.....++.+++.+|+..||++|||     ++|+++|
T Consensus       227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         227 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            001112346778888999999999999     6888764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-44  Score=371.07  Aligned_cols=237  Identities=24%  Similarity=0.340  Sum_probs=194.0

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCc----ccCHHHHHHHHHHhh-cCCCCCcccceEEEEecCccEEEEEccC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDV----TISEREFKDKIEGVG-AVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      .+.||+|+||+||+|+. .+|+.||||+++..    ....+.+..|..++. .++|||||++++++.+++..++||||++
T Consensus         7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~   86 (320)
T d1xjda_           7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN   86 (320)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence            46899999999999995 57999999999643    223455666766654 6899999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--  526 (663)
                      +|+|.++++...     .+++..+..++.||+.||+|||+++  |+||||||+|||+++++.+||+|||+++......  
T Consensus        87 ~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~  159 (320)
T d1xjda_          87 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  159 (320)
T ss_dssp             TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             CCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhccccccc
Confidence            999999997543     4889999999999999999999998  9999999999999999999999999998654332  


Q ss_pred             --CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchhhhccc
Q 006055          527 --TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLELLRYQ  604 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  604 (663)
                        ...+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.      +.......+.....            .
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~------~~~~~~~~i~~~~~------------~  221 (320)
T d1xjda_         160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ------DEEELFHSIRMDNP------------F  221 (320)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCC------------C
T ss_pred             ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC------CHHHHHHHHHcCCC------------C
Confidence              245788899999999999999999999999999999999999643      22233333322211            0


Q ss_pred             ChHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006055          605 NVEEEMVQLLQLAIDCSAQYPDNRPSMS-EVIK  636 (663)
Q Consensus       605 ~~~~~~~~l~~l~~~C~~~dP~~RPt~~-ev~~  636 (663)
                      .+.....++.+++.+|+..||++||++. |+++
T Consensus       222 ~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            1111234678888999999999999996 7764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-44  Score=369.15  Aligned_cols=249  Identities=24%  Similarity=0.278  Sum_probs=190.9

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcccC------HHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS------EREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLT  448 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~  448 (663)
                      ++||+|+||+||+|.. .+|+.||||+++.....      .+.+.+|+.+++.++|||||++++++.+.+..++||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            6899999999999994 57999999998654221      2468899999999999999999999999999999999999


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC--
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS--  526 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--  526 (663)
                      ++++..+....     ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++......  
T Consensus        84 ~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          84 TDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             EEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             chHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            98877776532     35788899999999999999999998  9999999999999999999999999998765432  


Q ss_pred             --CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh---cccccccch--
Q 006055          527 --TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD---EWTSEVFDL--  598 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d~--  598 (663)
                        ...+|..|+|||++.. ..++.++|||||||++|||++|+.||....+      ...+..+.+.   .......+.  
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~------~~~l~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD------LDQLTRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH------HHHHHHHHHhcCCCChhhccchhc
Confidence              2346788999999865 4579999999999999999999999965321      1222222211   000000000  


Q ss_pred             -------hhhcccCh----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          599 -------ELLRYQNV----EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       599 -------~~~~~~~~----~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                             ........    .....++.+++.+|+..||++|||++|+++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence                   00000000    1123467889999999999999999999884

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-43  Score=357.55  Aligned_cols=250  Identities=23%  Similarity=0.292  Sum_probs=190.6

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      +.||+|+||+||+|.. .+|+.||||+++....   ....+.+|++++++++|||||++++++.+....++||||+.++.
T Consensus         8 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~   87 (298)
T d1gz8a_           8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL   87 (298)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred             cEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCch
Confidence            6899999999999995 6799999999965432   24678999999999999999999999999999999999998654


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----C
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----T  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~  527 (663)
                      +.......    ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+|+......    .
T Consensus        88 ~~~~~~~~----~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~  161 (298)
T d1gz8a_          88 KKFMDASA----LTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH  161 (298)
T ss_dssp             HHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTC
T ss_pred             hhhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCccccee
Confidence            44333322    235899999999999999999999998  9999999999999999999999999998765432    2


Q ss_pred             CCCCccccCccccCCCC-CCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc-cccccch-------
Q 006055          528 PNRVAGYRAPEVTDPCK-VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW-TSEVFDL-------  598 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~-------  598 (663)
                      ..+++.|+|||.+.... ++.++||||+||++|+|++|+.||.....      ...+..+..... ..+....       
T Consensus       162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE------IDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH------HHHHHHHHHhcCCCchhhccccccccc
Confidence            35778899999876655 57899999999999999999999965321      122222211100 0000000       


Q ss_pred             ---hhhc--ccCh----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          599 ---ELLR--YQNV----EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       599 ---~~~~--~~~~----~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                         ....  ....    .....++.+++.+|+..||++|||++|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence               0000  0000    1123567888999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.6e-42  Score=352.54  Aligned_cols=250  Identities=22%  Similarity=0.271  Sum_probs=194.2

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      .++||+|+||+||+|..++|+.||||+++....   ..+.+.+|+.++++++||||+++++++.+.+..+++|||+.++.
T Consensus         7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~   86 (286)
T d1ob3a_           7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL   86 (286)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred             ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence            368999999999999999999999999965422   24689999999999999999999999999999999999999877


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCC----C
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSS----T  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----~  527 (663)
                      +..+.+..     ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+|++|||.+.......    .
T Consensus        87 ~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (286)
T d1ob3a_          87 KKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH  159 (286)
T ss_dssp             HHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             HHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCccccce
Confidence            77776543     35899999999999999999999998  9999999999999999999999999998765432    2


Q ss_pred             CCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhc---cccccc-------
Q 006055          528 PNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE---WTSEVF-------  596 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-------  596 (663)
                      ..+++.|+|||.+.+. .++.++||||+||++|||++|+.||.....      .....++....   ......       
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE------ADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH------HHHHHHHHHhhCCCChhhccchhhhhh
Confidence            3466779999998654 568999999999999999999999975321      12222221110   000000       


Q ss_pred             -chhhhc------ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          597 -DLELLR------YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       597 -d~~~~~------~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                       +.....      .........++.+++.+|+..||++|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             000000      00111223467788999999999999999999863

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=358.41  Aligned_cols=232  Identities=22%  Similarity=0.339  Sum_probs=188.4

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC-------HHHHHHHHHHhhcCC--CCCcccceEEEEecCccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS-------EREFKDKIEGVGAVN--HENLVPLRAYYYSMDEKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-------~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  444 (663)
                      .++||+|+||+||+|.. .+|+.||||+++.....       ...+.+|+.++++++  |||||++++++.+.+..++||
T Consensus         9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~   88 (273)
T d1xwsa_           9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL   88 (273)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred             eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEE
Confidence            46899999999999995 57999999998653211       234678999999886  899999999999999999999


Q ss_pred             EccCC-CChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCC-CceEEecccccccc
Q 006055          445 DYLTM-GSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKS-YEARVSDFGLAHLV  522 (663)
Q Consensus       445 ey~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~-~~~kl~Dfg~a~~~  522 (663)
                      ||+.+ +++.+++...     ..+++..+..++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+|+..
T Consensus        89 e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          89 ERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             ECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccceec
Confidence            99976 6788887643     25899999999999999999999998  9999999999999854 79999999999876


Q ss_pred             CCC--CCCCCCccccCccccCCCCC-CCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccchh
Q 006055          523 GPS--STPNRVAGYRAPEVTDPCKV-SQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFDLE  599 (663)
Q Consensus       523 ~~~--~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  599 (663)
                      ...  .+..+|..|+|||++.+..+ +.++||||+||++|||++|+.||....            .+.+....   +   
T Consensus       162 ~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~~~---~---  223 (273)
T d1xwsa_         162 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQVF---F---  223 (273)
T ss_dssp             CSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCCC---C---
T ss_pred             ccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhcccC---C---
Confidence            544  33457889999999977665 567899999999999999999996421            11111110   0   


Q ss_pred             hhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          600 LLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       600 ~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                            ....+.++.+++.+|+..||++|||++|+++|
T Consensus       224 ------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         224 ------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             ------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                  01123467788889999999999999999874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-42  Score=352.74  Aligned_cols=251  Identities=22%  Similarity=0.268  Sum_probs=187.4

Q ss_pred             hcccccccceEEEEEEe-cC-CcEEEEEEecCccc---CHHHHHHHHHHhhcC---CCCCcccceEEEEe-----cCccE
Q 006055          375 AEVLGKGTFGTAYKAVL-EM-GTIVAVKRLKDVTI---SEREFKDKIEGVGAV---NHENLVPLRAYYYS-----MDEKL  441 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~-g~~vavK~l~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~~~~  441 (663)
                      .+.||+|+||+||+|.. ++ ++.||||+++....   ....+.+|+.+++.+   +||||++++++|..     ....+
T Consensus        12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~   91 (305)
T d1blxa_          12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   91 (305)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred             EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence            36899999999999995 44 67899999864321   223456777766555   89999999999864     23578


Q ss_pred             EEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccc
Q 006055          442 LVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHL  521 (663)
Q Consensus       442 lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~  521 (663)
                      ++|||+.++++.......    ...+++.....++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus        92 ~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          92 LVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             EEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             EEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchhhhhh
Confidence            999999988776555432    235899999999999999999999998  99999999999999999999999999976


Q ss_pred             cCCC---CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhc-------c
Q 006055          522 VGPS---STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDE-------W  591 (663)
Q Consensus       522 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~  591 (663)
                      ....   ....+|+.|+|||++.+..++.++||||+||++|||++|+.||....      ....+..+....       +
T Consensus       166 ~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         166 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS------DVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCCCCGGGS
T ss_pred             hcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC------HHHHHHHHHHhhCCCchhcc
Confidence            5433   34557888999999999999999999999999999999999997532      122222222110       0


Q ss_pred             cccccchhhh--------cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          592 TSEVFDLELL--------RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       592 ~~~~~d~~~~--------~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ..........        ...........+.+++.+|++.||++|||++|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000000000        000011223456778889999999999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-41  Score=351.51  Aligned_cols=254  Identities=23%  Similarity=0.336  Sum_probs=188.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEecC------ccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSMD------EKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  444 (663)
                      .++||+|+||+||+|.. .+|+.||||+++.....   .+.+.+|+++|+.++|||||+++++|...+      +.++||
T Consensus        23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~  102 (346)
T d1cm8a_          23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM  102 (346)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEE
Confidence            36799999999999995 57999999999765433   356889999999999999999999997654      469999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+ +++|..+.+..      .+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+|++|||+++....
T Consensus       103 e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_         103 PFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             ECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccccccceeccCC
Confidence            999 45788877643      4899999999999999999999998  99999999999999999999999999988765


Q ss_pred             CCC-CCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcc--ccccc----
Q 006055          525 SST-PNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEW--TSEVF----  596 (663)
Q Consensus       525 ~~~-~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~----  596 (663)
                      ..+ ..++..|+|||.+.+ ..++.++||||+||++|||++|+.||.....      ...+........  ..+..    
T Consensus       174 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T d1cm8a_         174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH------LDQLKEIMKVTGTPPAEFVQRLQ  247 (346)
T ss_dssp             SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh------HHHHHHHHhccCCCcHHHHhhhc
Confidence            433 457788999999865 4568999999999999999999999965321      111111110000  00000    


Q ss_pred             -------chhhhc------ccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhCC
Q 006055          597 -------DLELLR------YQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR--IEELHP  643 (663)
Q Consensus       597 -------d~~~~~------~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~--L~~~~~  643 (663)
                             ...+..      .........++.+++.+|+..||++|||++|+++|  ++++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence                   000000      00011123456788899999999999999999996  666543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-41  Score=353.06  Aligned_cols=255  Identities=24%  Similarity=0.319  Sum_probs=188.0

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEEEEecC------ccEEEEEccC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAYYYSMD------EKLLVYDYLT  448 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ey~~  448 (663)
                      ++||+|+||+||+|+. .+|+.||||+++....   ...+|++++++++||||++++++|....      +.++||||++
T Consensus        26 k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~  102 (350)
T d1q5ka_          26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP  102 (350)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCS
T ss_pred             eEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccC
Confidence            6799999999999995 5799999999976432   2347999999999999999999986532      3689999998


Q ss_pred             CCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC-ceEEeccccccccCCCC-
Q 006055          449 MGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY-EARVSDFGLAHLVGPSS-  526 (663)
Q Consensus       449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~-  526 (663)
                      ++.+..+.+...  ....+++..++.++.||+.||+|||+++  |+||||||+|||++.++ .+||+|||+++...... 
T Consensus       103 ~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~  178 (350)
T d1q5ka_         103 ETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP  178 (350)
T ss_dssp             EEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred             CccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence            765444433111  1346899999999999999999999998  99999999999999775 89999999998765433 


Q ss_pred             --CCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh---cc-------cc
Q 006055          527 --TPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD---EW-------TS  593 (663)
Q Consensus       527 --~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~-------~~  593 (663)
                        +..++..|+|||.+.+ ..++.++||||+||++|||++|+.||.....      ...+..+.+.   ..       ..
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~------~~~l~~i~~~~g~~~~~~~~~~~~  252 (350)
T d1q5ka_         179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG------VDQLVEIIKVLGTPTREQIREMNP  252 (350)
T ss_dssp             CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH------HHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred             cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH------HHHHHHHHHHhCCChHHhhhhhcc
Confidence              3456778999998765 5689999999999999999999999965322      1111111110   00       00


Q ss_pred             cccchhhh-------cccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhCC
Q 006055          594 EVFDLELL-------RYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR--IEELHP  643 (663)
Q Consensus       594 ~~~d~~~~-------~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~--L~~~~~  643 (663)
                      ...+....       ..........++.+++.+|+..||++|||++|+++|  ++++..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            00000000       000011223467788899999999999999999985  566544

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-41  Score=348.78  Aligned_cols=252  Identities=20%  Similarity=0.286  Sum_probs=186.1

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCccc--CHHHHHHHHHHhhcCCCCCcccceEEEEecC----ccEEEEEcc
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTI--SEREFKDKIEGVGAVNHENLVPLRAYYYSMD----EKLLVYDYL  447 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ey~  447 (663)
                      .+.||+|+||+||+|. ..+|+.||||++.....  ..+.+.+|+++++.++||||+++++++....    ..+++++|+
T Consensus        13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~   92 (345)
T d1pmea_          13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL   92 (345)
T ss_dssp             EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred             EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEee
Confidence            3689999999999998 46899999999975432  2457889999999999999999999997653    235666778


Q ss_pred             CCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC--
Q 006055          448 TMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS--  525 (663)
Q Consensus       448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~--  525 (663)
                      .+|+|.+++...      .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++.....  
T Consensus        93 ~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          93 MGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             CCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             cCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            899999999743      4899999999999999999999998  999999999999999999999999999765432  


Q ss_pred             -----CCCCCCccccCccccCC-CCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccc---ccc
Q 006055          526 -----STPNRVAGYRAPEVTDP-CKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTS---EVF  596 (663)
Q Consensus       526 -----~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  596 (663)
                           ....++..|+|||++.. ..++.++||||+||++|||++|+.||......+   ...............   ...
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHTCC
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH---HHHHHhhhccCCChhhhhhhh
Confidence                 22346777999999854 467889999999999999999999996532111   000000000000000   000


Q ss_pred             chh-------hh--cccCh----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          597 DLE-------LL--RYQNV----EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       597 d~~-------~~--~~~~~----~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ...       ..  .....    .....++.+++.+|+..||++|||++|+++|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000       00  00000    0112367889999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6e-41  Score=341.56  Aligned_cols=253  Identities=16%  Similarity=0.169  Sum_probs=197.9

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCCC-CCcccceEEEEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNH-ENLVPLRAYYYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ey~~~gsL  452 (663)
                      .++||+|+||+||+|+. .+|+.||||.+.... ....+.+|++.+..++| +|++.+++++.+....++||||+ +++|
T Consensus        10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l   87 (293)
T d1csna_          10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL   87 (293)
T ss_dssp             EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCH
Confidence            46899999999999994 579999999886542 23457788888888866 89999999999999999999998 6799


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcC-----CCceEEeccccccccCCC--
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTK-----SYEARVSDFGLAHLVGPS--  525 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~-----~~~~kl~Dfg~a~~~~~~--  525 (663)
                      .++++...    ..+++..+..++.|++.||+|||+++  |+||||||+|||++.     ++.+||+|||+|+.....  
T Consensus        88 ~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (293)
T d1csna_          88 EDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT  161 (293)
T ss_dssp             HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred             HHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence            99887543    35899999999999999999999998  999999999999974     567999999999875432  


Q ss_pred             ---------CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccccccc
Q 006055          526 ---------STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVF  596 (663)
Q Consensus       526 ---------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  596 (663)
                               ....||+.|||||.+.+..++.++|||||||++|||++|+.||.......   .......+......   .
T Consensus       162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~---~~~~~~~i~~~~~~---~  235 (293)
T d1csna_         162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT---NKQKYERIGEKKQS---T  235 (293)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC---HHHHHHHHHHHHHH---S
T ss_pred             ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh---HHHHHHHHHhccCC---C
Confidence                     12347888999999999999999999999999999999999997543221   12222211111100   0


Q ss_pred             chhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhCCCC
Q 006055          597 DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELHPSS  645 (663)
Q Consensus       597 d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~~~~  645 (663)
                      ..+..    ....+.++.+++..|+..+|++||+++.+.+.|+++....
T Consensus       236 ~~~~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         236 PLREL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             CHHHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ChHHh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            00000    0112346788888999999999999999999998875443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-41  Score=347.23  Aligned_cols=253  Identities=19%  Similarity=0.241  Sum_probs=186.3

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcc---cCHHHHHHHHHHhhcCCCCCcccceEEEEe--------cCccEE
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVT---ISEREFKDKIEGVGAVNHENLVPLRAYYYS--------MDEKLL  442 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~~~~~l  442 (663)
                      .+.||+|+||+||+|.. .+|+.||||++....   .....+.+|+++++.++|||++++++++..        ....++
T Consensus        15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~i   94 (318)
T d3blha1          15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL   94 (318)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEE
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEE
Confidence            36899999999999995 679999999986442   234678899999999999999999999855        345789


Q ss_pred             EEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEecccccccc
Q 006055          443 VYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLV  522 (663)
Q Consensus       443 v~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~  522 (663)
                      ||||+.++.+.......     ..++......++.|++.||.|||+++  |+||||||+|||++.++.+||+|||+++..
T Consensus        95 v~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          95 VFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             EEECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEeccCCCccchhhhcc-----cccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecceeeec
Confidence            99999987776655432     34788999999999999999999998  999999999999999999999999999765


Q ss_pred             CCC--------CCCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccc-
Q 006055          523 GPS--------STPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT-  592 (663)
Q Consensus       523 ~~~--------~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  592 (663)
                      ...        ....+|..|+|||.+.+. .++.++||||+||++|||++|+.||....+.   .....+......... 
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLCGSITPE  244 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH---HHHHHHHHhcCCCChh
Confidence            432        123467889999998765 6899999999999999999999999643211   111111111111000 


Q ss_pred             --ccccch----hhh----cccChHH------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          593 --SEVFDL----ELL----RYQNVEE------EMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       593 --~~~~d~----~~~----~~~~~~~------~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                        ......    ...    ......+      ....+.+++.+|+..||++|||++|+++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence              000000    000    0001111      12356788999999999999999999983

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-40  Score=339.94  Aligned_cols=249  Identities=20%  Similarity=0.224  Sum_probs=188.2

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcccceEE-EEecCccEEEEEccCCCCh
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLVPLRAY-YYSMDEKLLVYDYLTMGSL  452 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~~~~lv~ey~~~gsL  452 (663)
                      .+.||+|+||+||+|.. .+|+.||||++.... ...++..|+++++.++|+|++..+.. +.+.+..++||||+. |++
T Consensus        12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l   89 (299)
T d1ckia_          12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSL   89 (299)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBH
T ss_pred             eEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cch
Confidence            46899999999999985 679999999876543 23457889999999988876665554 566677889999985 566


Q ss_pred             hHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEc---CCCceEEeccccccccCCCC---
Q 006055          453 SALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLT---KSYEARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~---~~~~~kl~Dfg~a~~~~~~~---  526 (663)
                      .+.+....    ..+++..+..++.|++.||+|||+++  |+||||||+|||++   .+..+||+|||+|+......   
T Consensus        90 ~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~  163 (299)
T d1ckia_          90 EDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  163 (299)
T ss_dssp             HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred             hhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence            66655332    35899999999999999999999998  99999999999986   35579999999998764322   


Q ss_pred             --------CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChH-HHHHHHHhhcccccccc
Q 006055          527 --------TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLP-RWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       527 --------~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~d  597 (663)
                              ...+|+.|+|||.+.+..++.++|||||||++|||++|+.||............ .+.......       .
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-------~  236 (299)
T d1ckia_         164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-------P  236 (299)
T ss_dssp             BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-------C
T ss_pred             ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-------C
Confidence                    234678899999999999999999999999999999999999765432211111 111000000       0


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhC
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKRIEELH  642 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~L~~~~  642 (663)
                      .+.    .....+.++.+++.+|++.+|++||+++++.+.|+.+.
T Consensus       237 ~~~----~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         237 IEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             HHH----HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             hhH----hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            000    01122356888899999999999999999999888763

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-40  Score=337.75  Aligned_cols=250  Identities=24%  Similarity=0.280  Sum_probs=195.4

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCccc---CHHHHHHHHHHhhcCCCCCcccceEEEEecCccEEEEEccCCCC
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTI---SEREFKDKIEGVGAVNHENLVPLRAYYYSMDEKLLVYDYLTMGS  451 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ey~~~gs  451 (663)
                      +.||+|+||+||+|+. .+|+.||||+++....   ....+.+|+.+++.++||||++++++|.+....++|+||+.+++
T Consensus         8 ~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~   87 (292)
T d1unla_           8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL   87 (292)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEH
T ss_pred             eEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccc
Confidence            6899999999999994 6789999999865432   24678999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCCCC----
Q 006055          452 LSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPSST----  527 (663)
Q Consensus       452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~----  527 (663)
                      +..+++...     .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||.++.......    
T Consensus        88 l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~  160 (292)
T d1unla_          88 KKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             HHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred             ccccccccc-----ccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence            988887543     5789999999999999999999998  99999999999999999999999999987755432    


Q ss_pred             CCCCccccCccccCCCC-CCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhccc--cccc--------
Q 006055          528 PNRVAGYRAPEVTDPCK-VSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWT--SEVF--------  596 (663)
Q Consensus       528 ~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~--------  596 (663)
                      ..++..|+|||.+.... ++.++||||+||++|||++|+.||...     .+.......+......  ....        
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG-----NDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC-----SSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC-----CCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence            23456699999987654 689999999999999999999997532     2233333332211110  0000        


Q ss_pred             -------chhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          597 -------DLELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       597 -------d~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                             ................+.+++.+|++.||++|||++|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   00000000111223457788889999999999999999884

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.9e-40  Score=339.78  Aligned_cols=248  Identities=18%  Similarity=0.264  Sum_probs=188.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCC-CCCcccceEEEEec--CccEEEEEccCCC
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-HENLVPLRAYYYSM--DEKLLVYDYLTMG  450 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ey~~~g  450 (663)
                      .++||+|+||+||+|+. .+|+.||||+++..  ..+.+.+|++++..++ ||||+++++++...  ...++||||+.+|
T Consensus        40 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~  117 (328)
T d3bqca1          40 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT  117 (328)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSC
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCC
Confidence            46899999999999995 67999999998753  3567899999999995 99999999998754  4588999999999


Q ss_pred             ChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCC-ceEEeccccccccCCCC---
Q 006055          451 SLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSY-EARVSDFGLAHLVGPSS---  526 (663)
Q Consensus       451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~---  526 (663)
                      +|..+.+        .+++..+..++.||+.||+|||+++  |+||||||+|||++.++ .+||+|||+++......   
T Consensus       118 ~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~  187 (328)
T d3bqca1         118 DFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN  187 (328)
T ss_dssp             BGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCC
T ss_pred             cHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccCCCccc
Confidence            9987653        3889999999999999999999998  99999999999998655 69999999998776543   


Q ss_pred             CCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHh---------hcccc---
Q 006055          527 TPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVK---------DEWTS---  593 (663)
Q Consensus       527 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~---  593 (663)
                      ...+|..|+|||.+.+. .++.++||||+||+++||++|+.||.......  +....+...+.         .....   
T Consensus       188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~--~~~~~i~~~~g~~~~~~~~~~~~~~~~~  265 (328)
T d3bqca1         188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYIDKYNIELDP  265 (328)
T ss_dssp             SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHHHTTCCCCG
T ss_pred             ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH--HHHHHHHHHHCCchhhhhhhhcccccCc
Confidence            23467789999998765 47999999999999999999999996532211  00000111110         00000   


Q ss_pred             cccc----------hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006055          594 EVFD----------LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIK  636 (663)
Q Consensus       594 ~~~d----------~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~  636 (663)
                      ...+          ..............++.+++.+|+..||++|||++|+++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             GGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000          000000111222356788899999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-40  Score=342.06  Aligned_cols=242  Identities=23%  Similarity=0.297  Sum_probs=192.0

Q ss_pred             hcccccccceEEEEEEe----cCCcEEEEEEecCcc-----cCHHHHHHHHHHhhcCCC-CCcccceEEEEecCccEEEE
Q 006055          375 AEVLGKGTFGTAYKAVL----EMGTIVAVKRLKDVT-----ISEREFKDKIEGVGAVNH-ENLVPLRAYYYSMDEKLLVY  444 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  444 (663)
                      .+.||+|+||+||+|..    .+|+.||||.++...     ...+.+.+|++++++++| |||+++++++.+....++||
T Consensus        29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~  108 (322)
T d1vzoa_          29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL  108 (322)
T ss_dssp             EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeee
Confidence            47899999999999984    258899999986432     234568899999999977 79999999999999999999


Q ss_pred             EccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCC
Q 006055          445 DYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGP  524 (663)
Q Consensus       445 ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~  524 (663)
                      ||+.+|+|.+++....     .+.......++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++....
T Consensus       109 e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         109 DYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             CCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             ecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            9999999999997643     3678888999999999999999998  99999999999999999999999999987643


Q ss_pred             CC-----CCCCCccccCccccCCC--CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccccccc
Q 006055          525 SS-----TPNRVAGYRAPEVTDPC--KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTSEVFD  597 (663)
Q Consensus       525 ~~-----~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  597 (663)
                      ..     ...++..|+|||.+.+.  .++.++||||+||++|||++|+.||......+  .............       
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~--~~~~i~~~~~~~~-------  252 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE-------  252 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHCC-------
T ss_pred             cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcccCC-------
Confidence            22     23466779999998654  46789999999999999999999997653322  1212122111111       


Q ss_pred             hhhhcccChHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006055          598 LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRP-----SMSEVIKR  637 (663)
Q Consensus       598 ~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RP-----t~~ev~~~  637 (663)
                           ...+.....++.+++.+|+..||++||     |++|+++|
T Consensus       253 -----~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         253 -----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -----CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                 011122345788888999999999999     47888874

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-39  Score=338.73  Aligned_cols=246  Identities=22%  Similarity=0.281  Sum_probs=182.6

Q ss_pred             cccccccceEEEEEEe-cCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEec------CccEEEEE
Q 006055          376 EVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSM------DEKLLVYD  445 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e  445 (663)
                      ++||+|+||+||+|.. .+|+.||||+++....+   ...+.+|+.+++.++||||++++++|...      .+.++|||
T Consensus        23 ~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~E  102 (355)
T d2b1pa1          23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME  102 (355)
T ss_dssp             EECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred             EEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEe
Confidence            6899999999999995 47999999999765433   34688999999999999999999998643      56799999


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+.++.+ +.++.       .+++..++.++.||+.||.|||+.|  |+||||||+|||++.++.+|++|||+++.....
T Consensus       103 y~~~~l~-~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~  172 (355)
T d2b1pa1         103 LMDANLC-QVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_dssp             CCSEEHH-HHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             ccchHHH-Hhhhc-------CCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhccccc
Confidence            9977544 44432       3789999999999999999999998  999999999999999999999999998766543


Q ss_pred             C---CCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHH---------------
Q 006055          526 S---TPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIV---------------  587 (663)
Q Consensus       526 ~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---------------  587 (663)
                      .   ...+|..|+|||++.+..++.++||||+||+++||++|+.||....      .......+.               
T Consensus       173 ~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~------~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD------YIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC------HHHHHHHHHHhccCCCHHHHHHhh
Confidence            2   2346778999999999999999999999999999999999996432      111111111               


Q ss_pred             -------hhccccc------ccchhhhcc--cChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          588 -------KDEWTSE------VFDLELLRY--QNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       588 -------~~~~~~~------~~d~~~~~~--~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                             .......      .+.......  ........++.+++.+|+..||++|||++|+++|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                   1100000      000000000  0122345678899999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-39  Score=340.10  Aligned_cols=249  Identities=22%  Similarity=0.294  Sum_probs=186.9

Q ss_pred             hcccccccceEEEEEE-ecCCcEEEEEEecCcccC---HHHHHHHHHHhhcCCCCCcccceEEEEec-----CccEEEEE
Q 006055          375 AEVLGKGTFGTAYKAV-LEMGTIVAVKRLKDVTIS---EREFKDKIEGVGAVNHENLVPLRAYYYSM-----DEKLLVYD  445 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e  445 (663)
                      .++||+|+||+||+|. ..+|+.||||+++....+   .+.+.+|+++++.++|||+|++++++...     ...+++++
T Consensus        23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~  102 (348)
T d2gfsa1          23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  102 (348)
T ss_dssp             EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEE
Confidence            3689999999999999 467999999999765433   35688999999999999999999998643     33477788


Q ss_pred             ccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEeccccccccCCC
Q 006055          446 YLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSDFGLAHLVGPS  525 (663)
Q Consensus       446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~  525 (663)
                      |+.+|+|.++++..      .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+|++|||++......
T Consensus       103 ~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~  174 (348)
T d2gfsa1         103 HLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE  174 (348)
T ss_dssp             ECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred             eecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhcccCcc
Confidence            88999999999643      4899999999999999999999998  999999999999999999999999999766543


Q ss_pred             -CCCCCCccccCccccCCC-CCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhhcccc--cc----cc
Q 006055          526 -STPNRVAGYRAPEVTDPC-KVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKDEWTS--EV----FD  597 (663)
Q Consensus       526 -~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~----~d  597 (663)
                       ....++..|+|||...+. .++.++||||+||++|+|++|+.||.....      ......+.......  +.    ..
T Consensus       175 ~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~  248 (348)
T d2gfsa1         175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH------IDQLKLILRLVGTPGAELLKKISS  248 (348)
T ss_dssp             GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred             cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHHhcCCCChHHhhhccc
Confidence             234466779999987665 468899999999999999999999965321      11112221111000  00    00


Q ss_pred             hh-------hhc--ccCh----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          598 LE-------LLR--YQNV----EEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       598 ~~-------~~~--~~~~----~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                      ..       ...  ....    .....++.+++.+|+..||++|||++|+++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            00       000  0000    0123457788999999999999999999984

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.7e-36  Score=314.70  Aligned_cols=259  Identities=20%  Similarity=0.258  Sum_probs=185.8

Q ss_pred             hcccccccceEEEEEEe-cCCcEEEEEEecCcccCHHHHHHHHHHhhcCC-----------CCCcccceEEEEec--Ccc
Q 006055          375 AEVLGKGTFGTAYKAVL-EMGTIVAVKRLKDVTISEREFKDKIEGVGAVN-----------HENLVPLRAYYYSM--DEK  440 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~~--~~~  440 (663)
                      .++||+|+||+||+|+. .+|+.||||+++......+.+.+|+.+++.++           |+||+++++++...  ...
T Consensus        18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~   97 (362)
T d1q8ya_          18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV   97 (362)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccce
Confidence            47899999999999995 67999999999876555567788888887764           57899999987653  455


Q ss_pred             EEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCcceecCCCCCCEEEcCCCc------eEE
Q 006055          441 LLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHA-QGPNVSHGNIKSSNILLTKSYE------ARV  513 (663)
Q Consensus       441 ~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~iiHrdlk~~Nill~~~~~------~kl  513 (663)
                      +++++++..+..........  ....+++..+..++.||+.||+|||+ .+  |+||||||+|||++.++.      +++
T Consensus        98 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~~~~~kl  173 (362)
T d1q8ya_          98 HVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKI  173 (362)
T ss_dssp             EEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred             eeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccccceeeE
Confidence            66777665554333222111  13458899999999999999999998 66  999999999999986653      999


Q ss_pred             eccccccccCCC-CCCCCCccccCccccCCCCCCCcchhhhHHHHHHHHHhCCCCCccccCCCCCChHHHHHHHHhh--c
Q 006055          514 SDFGLAHLVGPS-STPNRVAGYRAPEVTDPCKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLPRWVQSIVKD--E  590 (663)
Q Consensus       514 ~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~  590 (663)
                      +|||.+...... ....++..|+|||++.+..++.++||||+||+++||++|+.||.....................  .
T Consensus       174 ~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~  253 (362)
T d1q8ya_         174 ADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE  253 (362)
T ss_dssp             CCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCS
T ss_pred             eecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCC
Confidence            999999865543 3345788899999999989999999999999999999999999764332222211111111100  0


Q ss_pred             ----------ccccccc------------------hhhhcccChHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006055          591 ----------WTSEVFD------------------LELLRYQNVEEEMVQLLQLAIDCSAQYPDNRPSMSEVIKR  637 (663)
Q Consensus       591 ----------~~~~~~d------------------~~~~~~~~~~~~~~~l~~l~~~C~~~dP~~RPt~~ev~~~  637 (663)
                                .....++                  ..............++.+++.+|+..||++|||++|+++|
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             CCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             CCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                      0000000                  0001122335667789999999999999999999999986

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=3e-31  Score=272.57  Aligned_cols=201  Identities=35%  Similarity=0.571  Sum_probs=151.4

Q ss_pred             CChHHHHHHHHHHHhcCCC--CcCCcCCCCCCC--ccceeEecC----CcEEEEEcCCCCccc--ccCccccCCCCCCCE
Q 006055           29 DLSSDRAALLALRSSVGGR--TLLWNVYEASPC--KWAGVECEQ----NRVTMLRLPGVALSG--QIPLGILGNLTSLRT   98 (663)
Q Consensus        29 ~~~~d~~all~~~~~~~~~--~~~w~~~~~~~c--~w~gv~c~~----~~v~~L~L~~~~l~g--~~p~~~~~~l~~L~~   98 (663)
                      |.++|++||++||+++.+.  ..+|+. ++|||  .|.||+|+.    .||+.|+|++|+++|  .+|+ .+++|++|++
T Consensus         3 c~~~e~~aLl~~k~~~~~~~~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~-~l~~L~~L~~   80 (313)
T d1ogqa_           3 CNPQDKQALLQIKKDLGNPTTLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLNF   80 (313)
T ss_dssp             SCHHHHHHHHHHHHHTTCCGGGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCSE
T ss_pred             CCHHHHHHHHHHHHHCCCCCcCCCCCC-CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCCh-HHhcCccccc
Confidence            7899999999999999754  347874 56899  599999975    379999999999998  5777 5799999999


Q ss_pred             EEccC-CCCCCCCCccccCCCCCceEEcccccccCchh------------------------hhhcCCcccccccccccc
Q 006055           99 LSLRF-NSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP------------------------LFLVGLHHLVRLNLATNN  153 (663)
Q Consensus        99 L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p------------------------~~~~~l~~L~~L~l~~N~  153 (663)
                      |+|++ |+++|.+|..|++|++|++|+|++|+|.+..|                        ..+.++++|+.+++++|.
T Consensus        81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~  160 (313)
T d1ogqa_          81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR  160 (313)
T ss_dssp             EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred             cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence            99986 89999999999999999999999998876544                        344455555555555555


Q ss_pred             ccccCCCC-----------------------------------------------------------------------C
Q 006055          154 FSGEIPSG-----------------------------------------------------------------------F  162 (663)
Q Consensus       154 l~~~~p~~-----------------------------------------------------------------------~  162 (663)
                      +++.+|..                                                                       +
T Consensus       161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~  240 (313)
T d1ogqa_         161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV  240 (313)
T ss_dssp             CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGC
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            54333322                                                                       2


Q ss_pred             cccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcc--cccCCCCCccCCc-CCCCCCCCC
Q 006055          163 KNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKR--FQTFGSNSFLGNS-LCGKPLQDC  231 (663)
Q Consensus       163 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~~~~~~~~~~~-l~~~p~~~c  231 (663)
                      +.+++|+.|+|++|+|+|.+|..++++++|++|+|++|+|+|.+|..  +.++..+.+.+|+ +||.|+..|
T Consensus       241 ~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c  312 (313)
T d1ogqa_         241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC  312 (313)
T ss_dssp             CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred             ccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCC
Confidence            22345667777777777777777777888888888888888777752  3445555555554 777777666

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=8.4e-23  Score=193.02  Aligned_cols=159  Identities=14%  Similarity=0.124  Sum_probs=116.7

Q ss_pred             hcccccccceEEEEEEecCCcEEEEEEecCcccC-------------------HHHHHHHHHHhhcCCCCCcccceEEEE
Q 006055          375 AEVLGKGTFGTAYKAVLEMGTIVAVKRLKDVTIS-------------------EREFKDKIEGVGAVNHENLVPLRAYYY  435 (663)
Q Consensus       375 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-------------------~~~~~~e~~~l~~l~h~niv~l~~~~~  435 (663)
                      +++||+|+||+||+|...+|+.||||+++....+                   ......|...+.++.|.+++..+++. 
T Consensus         5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~-   83 (191)
T d1zara2           5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE-   83 (191)
T ss_dssp             EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE-
T ss_pred             CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec-
Confidence            5789999999999999889999999987532100                   12345678889999999998877653 


Q ss_pred             ecCccEEEEEccCCCChhHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCcceecCCCCCCEEEcCCCceEEec
Q 006055          436 SMDEKLLVYDYLTMGSLSALLHGNKGAGRTPLNWEMRSLIALGAARGIEYLHAQGPNVSHGNIKSSNILLTKSYEARVSD  515 (663)
Q Consensus       436 ~~~~~~lv~ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~iiHrdlk~~Nill~~~~~~kl~D  515 (663)
                         ..+++|||++++.+.++            +......++.|+++|+.|||+++  |+||||||+|||++++ .++|+|
T Consensus        84 ---~~~lvme~~~~~~~~~l------------~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          84 ---GNAVLMELIDAKELYRV------------RVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             ---TTEEEEECCCCEEGGGC------------CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEECC
T ss_pred             ---CCEEEEEeeccccccch------------hhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEEE
Confidence               45899999988655432            22334678999999999999998  9999999999999965 589999


Q ss_pred             cccccccCCCCCCCCCccccCc------cccCCCCCCCcchhhhHHHH
Q 006055          516 FGLAHLVGPSSTPNRVAGYRAP------EVTDPCKVSQKADVYSFGVL  557 (663)
Q Consensus       516 fg~a~~~~~~~~~~~~~~y~aP------E~~~~~~~~~~~Dv~slGvv  557 (663)
                      ||.|+........    .|...      |.+ .+.|..++|+||..--
T Consensus       146 FG~a~~~~~~~~~----~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         146 FPQSVEVGEEGWR----EILERDVRNIITYF-SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CTTCEETTSTTHH----HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred             CCCcccCCCCCcH----HHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence            9999766533211    11110      111 2456778899996543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.76  E-value=8.7e-20  Score=172.17  Aligned_cols=131  Identities=28%  Similarity=0.323  Sum_probs=115.7

Q ss_pred             EEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCC-CccccCCCCCceEEcccccccCchhhhhcCCcccccccccc
Q 006055           73 MLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQL-PSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLAT  151 (663)
Q Consensus        73 ~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~  151 (663)
                      .++.++++|+ .||.++   .+++++|+|++|+|++.+ +..|.++++|+.|+|++|.+.+.++..|..+++|++|+|++
T Consensus        12 ~v~Cs~~~L~-~iP~~l---p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_          12 TVDCTGRGLK-EIPRDI---PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             EEECTTSCCS-SCCSCC---CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             EEEEeCCCcC-ccCCCC---CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence            3455667787 899754   378999999999998744 56789999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCC
Q 006055          152 NNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP  207 (663)
Q Consensus       152 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p  207 (663)
                      |+|+...|..|.++++|++|+|++|+|++..|+.|..+++|++|+|++|++.+..+
T Consensus        88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~  143 (192)
T d1w8aa_          88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence            99998778889999999999999999998888899999999999999999986544

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.75  E-value=1.8e-18  Score=163.05  Aligned_cols=164  Identities=24%  Similarity=0.325  Sum_probs=138.9

Q ss_pred             CccceeEecC-----------CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEccc
Q 006055           59 CKWAGVECEQ-----------NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQG  127 (663)
Q Consensus        59 c~w~gv~c~~-----------~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  127 (663)
                      |.|..|.|+.           ..++.|+|++|.|++.++...|+++++|+.|+|++|.+++..+..|..+++|++|+|++
T Consensus         8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_           8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence            6799999963           36899999999999788888899999999999999999999999999999999999999


Q ss_pred             ccccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCC
Q 006055          128 NHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIP  207 (663)
Q Consensus       128 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p  207 (663)
                      |+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|.+....+.. .-...|+.+.+..|.+++..|
T Consensus        88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~p  166 (192)
T d1w8aa_          88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCSS
T ss_pred             ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCCC
Confidence            9999888889999999999999999999888889999999999999999998543321 112346667788899988888


Q ss_pred             cccccCCCCCccCCcC
Q 006055          208 KRFQTFGSNSFLGNSL  223 (663)
Q Consensus       208 ~~~~~~~~~~~~~~~l  223 (663)
                      ..+.++.-..+..|.+
T Consensus       167 ~~l~~~~l~~L~~n~l  182 (192)
T d1w8aa_         167 SKVRDVQIKDLPHSEF  182 (192)
T ss_dssp             TTTTTSBGGGSCTTTC
T ss_pred             hhhcCCEeeecCHhhC
Confidence            8777665444444443

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=4.4e-18  Score=169.12  Aligned_cols=144  Identities=26%  Similarity=0.307  Sum_probs=104.3

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      ..++.|+|++|+|+ .+|.+.|.++++|+.|+|++|+|+. +| .++.+++|++|+|++|++++ +|..+.++++|+.|+
T Consensus        31 ~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~  106 (266)
T d1p9ag_          31 KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLD  106 (266)
T ss_dssp             TTCCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEE
T ss_pred             cCCCEEECcCCcCC-CcCHHHhhccccccccccccccccc-cc-cccccccccccccccccccc-ccccccccccccccc
Confidence            36889999999998 6777778899999999999999985 44 36788889999999998884 566777888888888


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSN  216 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~  216 (663)
                      +++|.+.+..+..+..+.+|++|++++|.++...+..+..+++|+.|++++|+|++..|..|..++.+
T Consensus       107 l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L  174 (266)
T d1p9ag_         107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENL  174 (266)
T ss_dssp             CCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTC
T ss_pred             ccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCcccccccccc
Confidence            88777776555566666666666666666665555555666666666666666665555555444443

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.71  E-value=1.8e-17  Score=164.60  Aligned_cols=154  Identities=32%  Similarity=0.325  Sum_probs=117.8

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|+|+ .+|.  ++.+++|++|+|++|+|++ .|..+.++++|+.|+|++|.+.+..+..+..+.+|+.|+
T Consensus        55 ~~L~~L~L~~N~l~-~l~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~  130 (266)
T d1p9ag_          55 TRLTQLNLDRAELT-KLQV--DGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY  130 (266)
T ss_dssp             TTCCEEECTTSCCC-EEEC--CSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred             cccccccccccccc-cccc--ccccccccccccccccccc-cccccccccccccccccccccceeecccccccccccccc
Confidence            56888888888887 6664  5678888888888888876 466778888888888888888877777777888888888


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCccCCcCCCCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPL  228 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~l~~~p~  228 (663)
                      +++|.++...+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+..+...  .+.|+|+
T Consensus       131 l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L--~L~~Np~  207 (266)
T d1p9ag_         131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFA--FLHGNPW  207 (266)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEE--ECCSCCB
T ss_pred             ccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEE--EecCCCC
Confidence            8888888666667777888888888888888777777888888888888888888 777776666655543  3556665


Q ss_pred             C
Q 006055          229 Q  229 (663)
Q Consensus       229 ~  229 (663)
                      .
T Consensus       208 ~  208 (266)
T d1p9ag_         208 L  208 (266)
T ss_dssp             C
T ss_pred             C
Confidence            5

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.67  E-value=1.1e-16  Score=160.31  Aligned_cols=147  Identities=24%  Similarity=0.264  Sum_probs=102.7

Q ss_pred             cEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCC-------------------------ccccCCCCCceEE
Q 006055           70 RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLP-------------------------SDLASCSNLRNLY  124 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p-------------------------~~~~~l~~L~~L~  124 (663)
                      .++.|+|++|+|+ .+|+..|.++++|++|++++|+|....+                         ..|.++++|++|+
T Consensus        33 ~~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~  111 (284)
T d1ozna_          33 ASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (284)
T ss_dssp             TCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCEEECcCCcCC-CCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence            5789999999998 7888789999999999999998765433                         3455566666666


Q ss_pred             cccccccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCC
Q 006055          125 LQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNG  204 (663)
Q Consensus       125 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g  204 (663)
                      |++|.+....+..+..+.+|+.+++++|+|++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|++++|++++
T Consensus       112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~  191 (284)
T d1ozna_         112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (284)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence            66666665555566666666666666666665545566666666666666666666666666666666666666666666


Q ss_pred             CCCcccccCCCCC
Q 006055          205 SIPKRFQTFGSNS  217 (663)
Q Consensus       205 ~~p~~~~~~~~~~  217 (663)
                      ..|..|..++++.
T Consensus       192 i~~~~f~~l~~L~  204 (284)
T d1ozna_         192 VHPHAFRDLGRLM  204 (284)
T ss_dssp             ECTTTTTTCTTCC
T ss_pred             cChhHhhhhhhcc
Confidence            6666666555443

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.66  E-value=1.5e-16  Score=161.11  Aligned_cols=156  Identities=26%  Similarity=0.374  Sum_probs=112.3

Q ss_pred             CccceeEecC-----------CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEccc
Q 006055           59 CKWAGVECEQ-----------NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQG  127 (663)
Q Consensus        59 c~w~gv~c~~-----------~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  127 (663)
                      |.|.+|.|+.           ..++.|+|++|+|+ .+|+..|.++++|+.|++++|.+....|..|.++++|+.|+|++
T Consensus        10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~   88 (305)
T d1xkua_          10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK   88 (305)
T ss_dssp             EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence            6899999964           36889999999998 88887899999999999999999998888999999999999999


Q ss_pred             ccccCchh------------------------------------------------hhhcCCccccccccccccc-----
Q 006055          128 NHFSGEVP------------------------------------------------LFLVGLHHLVRLNLATNNF-----  154 (663)
Q Consensus       128 N~l~~~~p------------------------------------------------~~~~~l~~L~~L~l~~N~l-----  154 (663)
                      |+++. +|                                                ..+..+++|+.+++++|++     
T Consensus        89 n~l~~-l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~  167 (305)
T d1xkua_          89 NQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ  167 (305)
T ss_dssp             SCCSB-CCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCS
T ss_pred             CccCc-CccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCc
Confidence            98863 22                                                1133344455555555544     


Q ss_pred             ----------------cccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCC
Q 006055          155 ----------------SGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNS  217 (663)
Q Consensus       155 ----------------~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~  217 (663)
                                      ++..+..|.+++.++.|++++|++++..+..+.++++|++|+|++|+|+ .+|..|..++.+.
T Consensus       168 ~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~  245 (305)
T d1xkua_         168 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQ  245 (305)
T ss_dssp             SCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCC
T ss_pred             ccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCC
Confidence                            4444455555566666666666666555666666666666666666666 4555555555444

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.66  E-value=1e-16  Score=160.71  Aligned_cols=144  Identities=24%  Similarity=0.253  Sum_probs=129.0

Q ss_pred             ccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCCCCc
Q 006055           84 QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFK  163 (663)
Q Consensus        84 ~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~  163 (663)
                      .+++..|.++++|+.|+|++|.+....+..+..+.+|+.+++++|+|++..+..|..+++|+.|+|++|+|++..+..|.
T Consensus        95 ~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~  174 (284)
T d1ozna_          95 SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR  174 (284)
T ss_dssp             CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred             cccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhc
Confidence            56666789999999999999999988888899999999999999999987788899999999999999999988888999


Q ss_pred             ccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCccCCcCCCCCCC
Q 006055          164 NLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSFLGNSLCGKPLQ  229 (663)
Q Consensus       164 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~~~~~l~~~p~~  229 (663)
                      ++++|++|++++|++++..|..|..+++|++|++++|++++..|..|..+..+...  .+.++|+.
T Consensus       175 ~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L--~l~~N~l~  238 (284)
T d1ozna_         175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL--RLNDNPWV  238 (284)
T ss_dssp             TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEE--ECCSSCEE
T ss_pred             cccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEE--EecCCCCC
Confidence            99999999999999999999999999999999999999998888888887776653  34455554

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.59  E-value=3.2e-16  Score=159.27  Aligned_cols=123  Identities=32%  Similarity=0.494  Sum_probs=116.5

Q ss_pred             CCCCEEEccCCCCCC--CCCccccCCCCCceEEccc-ccccCchhhhhcCCccccccccccccccccCCCCCcccccccc
Q 006055           94 TSLRTLSLRFNSLTS--QLPSDLASCSNLRNLYLQG-NHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKT  170 (663)
Q Consensus        94 ~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~  170 (663)
                      .+++.|+|++|.++|  .+|+.+++|++|++|+|++ |+++|.+|..|++|++|++|+|++|+|.+..|..+.++..|+.
T Consensus        50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence            478999999999998  5889999999999999997 8999999999999999999999999999999999999999999


Q ss_pred             cccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCC
Q 006055          171 LFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSN  216 (663)
Q Consensus       171 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~  216 (663)
                      +++++|.+.+.+|..+..+++|+.+++++|.++|.+|..+..+..+
T Consensus       130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l  175 (313)
T d1ogqa_         130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL  175 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT
T ss_pred             cccccccccccCchhhccCcccceeecccccccccccccccccccc
Confidence            9999999999999999999999999999999999999988877665

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.57  E-value=1.1e-15  Score=132.18  Aligned_cols=101  Identities=27%  Similarity=0.290  Sum_probs=67.4

Q ss_pred             EEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccc
Q 006055           73 MLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATN  152 (663)
Q Consensus        73 ~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N  152 (663)
                      .|+|++|+++ .++.  ++.+++|++|+|++|.|+. +|..|..+++|+.|+|++|+|++ +| .+..+++|+.|++++|
T Consensus         2 ~L~Ls~n~l~-~l~~--l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           2 VLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             EEECTTSCCS-SCCC--GGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             EEEcCCCCCC-CCcc--cccCCCCCEEECCCCccCc-chhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            4677777776 5553  5677777777777777764 56667777777777777777763 44 3667777777777777


Q ss_pred             cccccC-CCCCccccccccccccccccc
Q 006055          153 NFSGEI-PSGFKNLTKLKTLFLENNRLS  179 (663)
Q Consensus       153 ~l~~~~-p~~~~~l~~L~~L~l~~N~l~  179 (663)
                      +|+... ...+..+++|++|++++|+++
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            776332 134666667777777777765

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.54  E-value=2.7e-15  Score=129.77  Aligned_cols=103  Identities=32%  Similarity=0.359  Sum_probs=91.3

Q ss_pred             CEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCCCCcccccccccccccc
Q 006055           97 RTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENN  176 (663)
Q Consensus        97 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N  176 (663)
                      +.|+|++|+|+. +| .+..+++|++|+|++|+|+ .+|..|+.+++|+.|++++|+|++ +| .+.++++|++|++++|
T Consensus         1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            589999999985 45 4999999999999999999 678889999999999999999994 44 5999999999999999


Q ss_pred             cccCcCC-CCCCCCCCCCEEEeecCcCCC
Q 006055          177 RLSGSIP-GFDDVLPNLQQLNVSNNLLNG  204 (663)
Q Consensus       177 ~l~~~~p-~~~~~l~~L~~L~l~~N~l~g  204 (663)
                      +|+.... ..+..+++|+.|++++|+++.
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence            9995432 468899999999999999984

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=1.6e-15  Score=137.88  Aligned_cols=110  Identities=20%  Similarity=0.133  Sum_probs=61.1

Q ss_pred             cCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCCCCccccccc
Q 006055           90 LGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLK  169 (663)
Q Consensus        90 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~  169 (663)
                      |.+...|+.|+|++|+|+. +|..+..+++|+.|+|++|+|+ .++ .|..+++|+.|+|++|+++...+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence            3455556666666666654 3444455566666666666665 332 355566666666666666533333344566666


Q ss_pred             ccccccccccCcCC--CCCCCCCCCCEEEeecCcCC
Q 006055          170 TLFLENNRLSGSIP--GFDDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       170 ~L~l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~  203 (663)
                      .|+|++|+|+. ++  ..+..+++|++|++++|+++
T Consensus        91 ~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          91 ELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             EEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             cceeccccccc-cccccccccccccchhhcCCCccc
Confidence            66666666652 22  23555666666666666665

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.51  E-value=3.3e-15  Score=135.78  Aligned_cols=122  Identities=18%  Similarity=0.209  Sum_probs=105.2

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .++.+|+|++|+|+ .||. .+..+++|+.|+|++|+|+. ++ .|..+++|++|+|++|+++...+..+..+++|+.|+
T Consensus        18 ~~lr~L~L~~n~I~-~i~~-~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~   93 (162)
T d1a9na_          18 VRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI   93 (162)
T ss_dssp             TSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred             CcCcEEECCCCCCC-ccCc-cccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccccce
Confidence            46899999999998 7874 67889999999999999986 44 589999999999999999966666677899999999


Q ss_pred             cccccccccCC--CCCcccccccccccccccccCcCCC----CCCCCCCCCEEE
Q 006055          149 LATNNFSGEIP--SGFKNLTKLKTLFLENNRLSGSIPG----FDDVLPNLQQLN  196 (663)
Q Consensus       149 l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~  196 (663)
                      |++|+|+. ++  ..+..+++|++|++++|.++ ..|.    .+..+|+|++||
T Consensus        94 L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          94 LTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred             eccccccc-cccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence            99999984 33  46889999999999999998 4554    477889999887

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.50  E-value=2.4e-14  Score=135.01  Aligned_cols=126  Identities=29%  Similarity=0.387  Sum_probs=85.0

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|++++|+++ .++.  ++.+++|++|+|++|+|++..|  +.++++|++|++++|.+.. +| .+.++++|+.|+
T Consensus        40 ~~l~~L~l~~~~i~-~l~~--l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~  112 (199)
T d2omxa2          40 DQVTTLQADRLGIK-SIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLT  112 (199)
T ss_dssp             TTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred             cCCCEEECCCCCCC-Cccc--cccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-cccccccccccc
Confidence            45677777777776 5542  5677777777777777776332  7777777777777777763 33 266777777777


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGS  205 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~  205 (663)
                      +++|.+...  ..+.++++|+.|++++|++.. +| .+..+++|+.|++++|++++.
T Consensus       113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l  165 (199)
T d2omxa2         113 LFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDL  165 (199)
T ss_dssp             CCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC
T ss_pred             ccccccccc--cccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccccCC
Confidence            777776643  236667777777777777763 33 356677777777777777643

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.48  E-value=3.2e-14  Score=135.36  Aligned_cols=136  Identities=33%  Similarity=0.380  Sum_probs=80.8

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|.+++ +++  ++++++|+.|+|++|+|++ +| .+.++++|+.|++++|.+.. ++ .+..+++|+.++
T Consensus        68 ~~L~~L~L~~n~i~~-l~~--~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~~-~l~~l~~l~~l~  140 (210)
T d1h6ta2          68 PNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLY  140 (210)
T ss_dssp             TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-CG-GGGGCTTCCEEE
T ss_pred             CCCCEEeCCCccccC-ccc--cccCccccccccccccccc-cc-cccccccccccccccccccc-cc-cccccccccccc
Confidence            456666666666663 442  4566666666666666665 33 36666666666666666652 22 355666666666


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNS  217 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~  217 (663)
                      +++|.+++  +..+.++++|+++++++|++++..+  +.++++|+.|+|++|+++. +| .|..++++.
T Consensus       141 ~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~  203 (210)
T d1h6ta2         141 LGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLD  203 (210)
T ss_dssp             CCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCS
T ss_pred             cccccccc--ccccccccccccccccccccccccc--ccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCC
Confidence            66666653  2345566667777777777764322  5666777777777777663 33 355554443

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.47  E-value=5.9e-14  Score=132.29  Aligned_cols=142  Identities=29%  Similarity=0.384  Sum_probs=117.0

Q ss_pred             cceeEecCCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcC
Q 006055           61 WAGVECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVG  140 (663)
Q Consensus        61 w~gv~c~~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  140 (663)
                      +.|+. .-.+++.|+|++|++++ +++  ++++++|+.|++++|.+.. ++ .+.++++|+.|++++|.+....  .+..
T Consensus        55 l~~l~-~l~nL~~L~Ls~N~l~~-~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~~--~~~~  126 (199)
T d2omxa2          55 IDGVE-YLNNLTQINFSNNQLTD-ITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDID--PLKN  126 (199)
T ss_dssp             CTTGG-GCTTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCG--GGTT
T ss_pred             ccccc-cCCCcCcCccccccccC-ccc--ccCCccccccccccccccc-cc-cccccccccccccccccccccc--ccch
Confidence            44442 23689999999999994 554  7999999999999999986 34 4899999999999999998543  4789


Q ss_pred             CccccccccccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCC
Q 006055          141 LHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSN  216 (663)
Q Consensus       141 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~  216 (663)
                      +++|+.|++++|++.. ++ .+..+++|++|++++|++++..+  +.++++|+.|++++|+++. +| .+..++.+
T Consensus       127 l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~~--l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L  196 (199)
T d2omxa2         127 LTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD-IS-VLAKLTNL  196 (199)
T ss_dssp             CTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGGGCTTC
T ss_pred             hhhhHHhhhhhhhhcc-cc-cccccccccccccccccccCCcc--ccCCCCCCEEECCCCCCCC-Cc-cccCCCCC
Confidence            9999999999999973 43 58899999999999999996533  7899999999999999985 44 45555554

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.46  E-value=6.6e-14  Score=141.31  Aligned_cols=131  Identities=25%  Similarity=0.357  Sum_probs=83.9

Q ss_pred             cEEEEEcCCCCccc-ccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           70 RVTMLRLPGVALSG-QIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        70 ~v~~L~L~~~~l~g-~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      ....++...|.... ......+..+++|+.+++++|.++. +|..+  +++|+.|++++|.+++..+..|.+++.++.|+
T Consensus       125 ~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~  201 (305)
T d1xkua_         125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLG  201 (305)
T ss_dssp             TCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEE
T ss_pred             cccccccccccccccCCCccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccc
Confidence            34445555443221 1222345666777777777777664 44332  46677777777777766667777777777777


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNG  204 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g  204 (663)
                      +++|.+++..+..|.++++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+.
T Consensus       202 ~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~  256 (305)
T d1xkua_         202 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA  256 (305)
T ss_dssp             CCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred             cccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCc
Confidence            7777777666666777777777777777776 556666677777777777777764

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=8.9e-14  Score=135.27  Aligned_cols=96  Identities=16%  Similarity=0.243  Sum_probs=78.4

Q ss_pred             CccceeEecC-----------CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCC-CccccCCCCCceEEcc
Q 006055           59 CKWAGVECEQ-----------NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQL-PSDLASCSNLRNLYLQ  126 (663)
Q Consensus        59 c~w~gv~c~~-----------~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~  126 (663)
                      |.+..|.|..           ..++.|+|++|.++ .+|...|.++++|++|+|++|.+...+ +..|.+++++++|++.
T Consensus         8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~   86 (242)
T d1xwdc1           8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   86 (242)
T ss_dssp             ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred             CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence            6788889952           26889999999998 888888999999999999999987754 4467888888888876


Q ss_pred             c-ccccCchhhhhcCCcccccccccccccc
Q 006055          127 G-NHFSGEVPLFLVGLHHLVRLNLATNNFS  155 (663)
Q Consensus       127 ~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~  155 (663)
                      . |++....+..|.++++|+.|++++|++.
T Consensus        87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~  116 (242)
T d1xwdc1          87 KANNLLYINPEAFQNLPNLQYLLISNTGIK  116 (242)
T ss_dssp             CCTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred             ccccccccccccccccccccccccchhhhc
Confidence            4 6677677777888888888888888775

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.43  E-value=1.3e-13  Score=131.09  Aligned_cols=143  Identities=24%  Similarity=0.361  Sum_probs=116.8

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      ..++.|++++|.++ .++.  +..+++|++|+|++|+|++. + .+.++++|+.|+|++|++++ +| .+..+++|+.|+
T Consensus        46 ~~L~~L~l~~~~i~-~l~~--l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~  118 (210)
T d1h6ta2          46 NSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS  118 (210)
T ss_dssp             HTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred             cCccEEECcCCCCC-Cchh--HhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-cccccccccccc
Confidence            46899999999998 5653  68999999999999999984 4 37899999999999999994 66 488999999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCC---ccCCcCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNS---FLGNSLC  224 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~---~~~~~l~  224 (663)
                      +++|.+.. + ..+.++++|+.+++++|.+++..  .+..+++|+.+++++|++++..|  +.+++.+.   +.+|.+.
T Consensus       119 l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~~--~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~  191 (210)
T d1h6ta2         119 LEHNGISD-I-NGLVHLPQLESLYLGNNKITDIT--VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS  191 (210)
T ss_dssp             CTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCCG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             cccccccc-c-ccccccccccccccccccccccc--ccccccccccccccccccccccc--ccCCCCCCEEECCCCCCC
Confidence            99999873 3 46889999999999999998533  46789999999999999996433  55554443   4455443

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.38  E-value=3.5e-13  Score=140.13  Aligned_cols=124  Identities=34%  Similarity=0.429  Sum_probs=74.9

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|++++|.++ .+|  .+..+++|+.|++++|.+++..|  +..+++|+.|++++|.+++..|  +..++.++.++
T Consensus       219 ~~L~~L~l~~n~l~-~~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~  291 (384)
T d2omza2         219 TNLDELSLNGNQLK-DIG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE  291 (384)
T ss_dssp             TTCCEEECCSSCCC-CCG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred             CCCCEEECCCCCCC-Ccc--hhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCc--ccccccccccc
Confidence            45677777777776 444  35677788888888887776433  6777778888887777775433  33444444444


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  203 (663)
                      ++.|++++.  ..+..+++++.|+|++|+|++..|  +..+++|+.|++++|+|+
T Consensus       292 ~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~  342 (384)
T d2omza2         292 LNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS  342 (384)
T ss_dssp             CCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCC
T ss_pred             ccccccccc--cccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCC
Confidence            444444421  234455555666666666654332  455566666666666655

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.37  E-value=4.7e-13  Score=128.79  Aligned_cols=125  Identities=27%  Similarity=0.378  Sum_probs=57.6

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|.+++ +++  +..+++|+.|++++|.++. ++ .+.++++|+.|++++|...+..+  +...+.++.+.
T Consensus        63 ~~L~~L~ls~n~i~~-~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~~--~~~~~~~~~l~  135 (227)
T d1h6ua2          63 NNLIGLELKDNQITD-LAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLY  135 (227)
T ss_dssp             TTCCEEECCSSCCCC-CGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCGG--GTTCTTCCEEE
T ss_pred             CCCcEeecCCceeec-ccc--ccccccccccccccccccc-cc-cccccccccccccccccccccch--hccccchhhhh
Confidence            345555555555442 221  3445555555555554443 22 24445555555555544443221  11222222222


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNG  204 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g  204 (663)
                      ++++.+...  ..+.++++|++|++++|.+++..+  +.++++|+.|+|++|++++
T Consensus       136 ~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~Ls~n~l~~  187 (227)
T d1h6ua2         136 LDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD  187 (227)
T ss_dssp             CCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred             chhhhhchh--hhhccccccccccccccccccchh--hcccccceecccCCCccCC
Confidence            222222211  124455566666666666653332  5566666666666666664

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.37  E-value=1.1e-13  Score=124.74  Aligned_cols=98  Identities=22%  Similarity=0.136  Sum_probs=54.5

Q ss_pred             CCCcccccCccccCCCCCCCEEEccCC-CCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccc
Q 006055           78 GVALSGQIPLGILGNLTSLRTLSLRFN-SLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSG  156 (663)
Q Consensus        78 ~~~l~g~~p~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  156 (663)
                      ++++. .+|.. +..+++|+.|+|++| .|+...+..|.++++|+.|+|++|+|+...|..|..+++|++|+|++|+|+ 
T Consensus        17 ~~~~~-~~p~~-l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-   93 (156)
T d2ifga3          17 RDGAL-DSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-   93 (156)
T ss_dssp             SSCCC-TTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-
T ss_pred             CCCCc-cCccc-ccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-
Confidence            34444 44542 456666777777554 366555555666666666666666666555555666666666666666665 


Q ss_pred             cCCCCCcccccccccccccccc
Q 006055          157 EIPSGFKNLTKLKTLFLENNRL  178 (663)
Q Consensus       157 ~~p~~~~~l~~L~~L~l~~N~l  178 (663)
                      .+|.......+|+.|+|++|.+
T Consensus        94 ~l~~~~~~~~~l~~L~L~~Np~  115 (156)
T d2ifga3          94 SLSWKTVQGLSLQELVLSGNPL  115 (156)
T ss_dssp             CCCSTTTCSCCCCEEECCSSCC
T ss_pred             ccChhhhccccccccccCCCcc
Confidence            3333222222455555555544

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.34  E-value=4.4e-15  Score=139.78  Aligned_cols=114  Identities=23%  Similarity=0.325  Sum_probs=96.6

Q ss_pred             ccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCCCCcccccc
Q 006055           89 ILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKL  168 (663)
Q Consensus        89 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L  168 (663)
                      .++.|++|++|+|++|+|+. ++ .|.+|++|+.|+|++|+|+ .+|..+..+++|+.|++++|+|+. ++ .+.++++|
T Consensus        43 sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L  117 (198)
T d1m9la_          43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL  117 (198)
T ss_dssp             HHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHS
T ss_pred             HHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccc
Confidence            47889999999999999986 44 5899999999999999998 577666777899999999999984 43 48899999


Q ss_pred             cccccccccccCcCC-CCCCCCCCCCEEEeecCcCCCCCC
Q 006055          169 KTLFLENNRLSGSIP-GFDDVLPNLQQLNVSNNLLNGSIP  207 (663)
Q Consensus       169 ~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~g~~p  207 (663)
                      +.|+|++|+|+.... ..+..+++|+.|+|++|+++...+
T Consensus       118 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  157 (198)
T d1m9la_         118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             SEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred             cccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence            999999999984322 457899999999999999875544

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.33  E-value=1.6e-12  Score=116.89  Aligned_cols=110  Identities=23%  Similarity=0.182  Sum_probs=94.0

Q ss_pred             CCCCCEEEccCCCCCCCCCccccCCCCCceEEcccc-cccCchhhhhcCCccccccccccccccccCCCCCccccccccc
Q 006055           93 LTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGN-HFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTL  171 (663)
Q Consensus        93 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L  171 (663)
                      ....+.++.+++++.. .|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...|..|.++++|++|
T Consensus         7 c~~~~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L   85 (156)
T d2ifga3           7 PHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL   85 (156)
T ss_dssp             CSSSSCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred             cCCCCeEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence            3445678999999876 6888999999999999876 4887777889999999999999999997778889999999999


Q ss_pred             ccccccccCcCCCCCCCCCCCCEEEeecCcCCC
Q 006055          172 FLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNG  204 (663)
Q Consensus       172 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g  204 (663)
                      +|++|+|+...+..|.. .+|+.|+|++|+|..
T Consensus        86 ~Ls~N~l~~l~~~~~~~-~~l~~L~L~~Np~~C  117 (156)
T d2ifga3          86 NLSFNALESLSWKTVQG-LSLQELVLSGNPLHC  117 (156)
T ss_dssp             ECCSSCCSCCCSTTTCS-CCCCEEECCSSCCCC
T ss_pred             eccCCCCcccChhhhcc-ccccccccCCCcccC
Confidence            99999999555555554 479999999999963

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.32  E-value=9.8e-13  Score=136.70  Aligned_cols=137  Identities=28%  Similarity=0.339  Sum_probs=115.7

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      ..++.|++.+|.+++ +++  ++.+++|+.|++++|.+++..  .+.++..++.++++.|.+++.  ..+..+++++.|+
T Consensus       241 ~~L~~L~l~~n~l~~-~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~  313 (384)
T d2omza2         241 TNLTDLDLANNQISN-LAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLT  313 (384)
T ss_dssp             TTCSEEECCSSCCCC-CGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEE
T ss_pred             cccchhccccCccCC-CCc--ccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEE
Confidence            578999999999995 443  688999999999999999743  388899999999999999863  3478899999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF  218 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~  218 (663)
                      +++|++++..  .+..+++|++|+|++|+|++ ++ .+.++++|++|+|++|+|++..|  +.+++++..
T Consensus       314 ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~  377 (384)
T d2omza2         314 LYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQ  377 (384)
T ss_dssp             CCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSE
T ss_pred             CCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCE
Confidence            9999999654  38899999999999999984 44 58899999999999999997655  666665543

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.26  E-value=2e-14  Score=135.20  Aligned_cols=122  Identities=25%  Similarity=0.299  Sum_probs=102.3

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++|+|+ .++.  |..+++|+.|+|++|.|+. +|..+..+++|+.|++++|+++. ++ .+..+++|+.|+
T Consensus        48 ~~L~~L~Ls~n~I~-~i~~--l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~  121 (198)
T d1m9la_          48 KACKHLALSTNNIE-KISS--LSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY  121 (198)
T ss_dssp             TTCCEEECSEEEES-CCCC--HHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEE
T ss_pred             cccceeECcccCCC-Cccc--ccCCccccChhhccccccc-ccccccccccccccccccccccc-cc-cccccccccccc
Confidence            68999999999998 7763  7899999999999999986 67666667899999999999994 54 478899999999


Q ss_pred             cccccccccCC-CCCcccccccccccccccccCcCCCC----------CCCCCCCCEEE
Q 006055          149 LATNNFSGEIP-SGFKNLTKLKTLFLENNRLSGSIPGF----------DDVLPNLQQLN  196 (663)
Q Consensus       149 l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~----------~~~l~~L~~L~  196 (663)
                      |++|+|+.... ..+..+++|++|+|++|++....+..          +..+|+|+.||
T Consensus       122 L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             ESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred             cccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence            99999984321 46889999999999999998655543          45688888876

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.15  E-value=3.4e-11  Score=115.47  Aligned_cols=137  Identities=31%  Similarity=0.457  Sum_probs=112.5

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|++++|.++ .++.  +..+++|+.|++++|.+.+.  ..+...+.++.+.++++.+....+  +.++++|+.|+
T Consensus        85 ~~l~~l~~~~n~~~-~i~~--l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~~L~~L~  157 (227)
T d1h6ua2          85 TKITELELSGNPLK-NVSA--IAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLS  157 (227)
T ss_dssp             CSCCEEECCSCCCS-CCGG--GTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEE
T ss_pred             cccccccccccccc-cccc--cccccccccccccccccccc--chhccccchhhhhchhhhhchhhh--hcccccccccc
Confidence            57889999999988 6763  78999999999999998864  347788999999999999985443  67889999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCCCCc
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGSNSF  218 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~~~~  218 (663)
                      +++|++++..  .++++++|+.|+|++|++++ +|. +..+++|++|+|++|++++..|  +.+++.+..
T Consensus       158 l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~  221 (227)
T d1h6ua2         158 IGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFI  221 (227)
T ss_dssp             CCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCE
T ss_pred             ccccccccch--hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCCCcc--cccCCCCCE
Confidence            9999997543  38899999999999999985 443 7899999999999999995433  566665544

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.09  E-value=1.3e-10  Score=112.30  Aligned_cols=143  Identities=15%  Similarity=0.179  Sum_probs=112.1

Q ss_pred             eEecCCcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchh-hhhcCCc
Q 006055           64 VECEQNRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVP-LFLVGLH  142 (663)
Q Consensus        64 v~c~~~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~  142 (663)
                      -.|+.   +.++.++.+++ .+|.+++   +++++|+|++|+|+...+..|.++++|++|+|++|.+...+| ..|.+++
T Consensus         6 C~C~~---~~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~   78 (242)
T d1xwdc1           6 CHCSN---RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP   78 (242)
T ss_dssp             EEECS---SEEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCT
T ss_pred             CCCcC---CEEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccc
Confidence            34543   35677888898 8997553   689999999999998666689999999999999999886554 5688999


Q ss_pred             ccccccccc-ccccccCCCCCcccccccccccccccccCcCC-CCCCCCCCCCEEEeecCcCCCCCCcccccC
Q 006055          143 HLVRLNLAT-NNFSGEIPSGFKNLTKLKTLFLENNRLSGSIP-GFDDVLPNLQQLNVSNNLLNGSIPKRFQTF  213 (663)
Q Consensus       143 ~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~  213 (663)
                      +++.|.+.. |++....+..|.++++|++|++++|++....+ ..+..+..|..+..+++++....+..|..+
T Consensus        79 ~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~  151 (242)
T d1xwdc1          79 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL  151 (242)
T ss_dssp             TCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTS
T ss_pred             ccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccc
Confidence            999999864 78887888889999999999999999984433 234556677777777878875555555544

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.90  E-value=1.5e-09  Score=110.29  Aligned_cols=116  Identities=27%  Similarity=0.377  Sum_probs=89.0

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLN  148 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  148 (663)
                      .+++.|+|++++|+ .+|+    .+++|++|+|++|+|+. +|..+   .+|+.|++++|+++ .++..   .+.|++|+
T Consensus        38 ~~l~~LdLs~~~L~-~lp~----~~~~L~~L~Ls~N~l~~-lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~  104 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPE----LPPHLESLVASCNSLTE-LPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLG  104 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCS----CCTTCSEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEE
T ss_pred             cCCCEEEeCCCCCC-CCCC----CCCCCCEEECCCCCCcc-cccch---hhhhhhhhhhcccc-hhhhh---cccccccc
Confidence            56889999999998 7985    25789999999999985 67654   57999999999998 44431   14699999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCCCCCCCCCCEEEeecCcCC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGFDDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  203 (663)
                      |++|.++ .+|. ++++++|+.|++++|.++...+ .   ...+..+.+.++...
T Consensus       105 L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~-~---~~~l~~l~~~~~~~~  153 (353)
T d1jl5a_         105 VSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPD-L---PPSLEFIAAGNNQLE  153 (353)
T ss_dssp             CCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCC-C---CTTCCEEECCSSCCS
T ss_pred             ccccccc-cccc-hhhhccceeecccccccccccc-c---cccccchhhcccccc
Confidence            9999998 5664 6889999999999999874332 2   344555555555443

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.88  E-value=6.5e-11  Score=117.52  Aligned_cols=150  Identities=25%  Similarity=0.301  Sum_probs=97.7

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccc-cccCc-hhhhhcCCccccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGN-HFSGE-VPLFLVGLHHLVR  146 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~  146 (663)
                      .+++.|+|+++.+++.....++.++++|++|+|++|.+++..+..+..+++|++|+|+++ .++.. +...+.++++|++
T Consensus        46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~  125 (284)
T d2astb2          46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE  125 (284)
T ss_dssp             BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred             CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence            478999999988875544457888999999999999998877788888999999999984 56632 3344567889999


Q ss_pred             cccccc-ccccc-CCCCCcc-cccccccccccc--cccC-cCCCCCCCCCCCCEEEeecC-cCCCCCCcccccCCCCCc
Q 006055          147 LNLATN-NFSGE-IPSGFKN-LTKLKTLFLENN--RLSG-SIPGFDDVLPNLQQLNVSNN-LLNGSIPKRFQTFGSNSF  218 (663)
Q Consensus       147 L~l~~N-~l~~~-~p~~~~~-l~~L~~L~l~~N--~l~~-~~p~~~~~l~~L~~L~l~~N-~l~g~~p~~~~~~~~~~~  218 (663)
                      |+|+++ +++.. +...+.. .++|+.|+++++  .++. .+...+..+++|++|++++| .+++..+..+..++.+..
T Consensus       126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~  204 (284)
T d2astb2         126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH  204 (284)
T ss_dssp             EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred             cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCE
Confidence            999884 44321 1111222 346666666643  2332 12223345666777777664 355555555555554443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.73  E-value=1.2e-08  Score=103.51  Aligned_cols=107  Identities=25%  Similarity=0.315  Sum_probs=84.7

Q ss_pred             CCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCchhhhhcCCccccccccccccccccCCCCCccccccccccc
Q 006055           94 TSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGEVPLFLVGLHHLVRLNLATNNFSGEIPSGFKNLTKLKTLFL  173 (663)
Q Consensus        94 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l  173 (663)
                      .+|+.|||++|+|+. +|+.   +++|++|+|++|+|+ .+|..   +.+|+.|++++|+++ .++. +.  +.|++|+|
T Consensus        38 ~~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-lp--~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-LP--PLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-CC--TTCCEEEC
T ss_pred             cCCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-hc--cccccccc
Confidence            468899999999986 7854   578999999999999 77865   457899999999998 4443 21  46999999


Q ss_pred             ccccccCcCCCCCCCCCCCCEEEeecCcCCCCCCcccccCCC
Q 006055          174 ENNRLSGSIPGFDDVLPNLQQLNVSNNLLNGSIPKRFQTFGS  215 (663)
Q Consensus       174 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~~~  215 (663)
                      ++|.++ .+|. ++.+++|+.|++++|.++. .|.....+..
T Consensus       106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~~~~l~~  144 (353)
T d1jl5a_         106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDLPPSLEF  144 (353)
T ss_dssp             CSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCCCTTCCE
T ss_pred             cccccc-cccc-hhhhccceeeccccccccc-cccccccccc
Confidence            999999 5665 5789999999999999984 4444444433

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.72  E-value=6.7e-10  Score=110.06  Aligned_cols=149  Identities=22%  Similarity=0.203  Sum_probs=93.2

Q ss_pred             CcEEEEEcCCCCcccccCccccCCCCCCCEEEccCC-CCCCC-CCccccCCCCCceEEcccc-cccCc-hhhhhcC-Ccc
Q 006055           69 NRVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFN-SLTSQ-LPSDLASCSNLRNLYLQGN-HFSGE-VPLFLVG-LHH  143 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~-l~~  143 (663)
                      .+++.|+|+++.+++..+. .++.+++|+.|+|+++ .++.. +..-+.++++|++|+|+++ .++.. ++..+.. .++
T Consensus        71 ~~L~~L~L~~~~l~~~~~~-~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~  149 (284)
T d2astb2          71 SKLQNLSLEGLRLSDPIVN-TLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET  149 (284)
T ss_dssp             CCCSEEECTTCBCCHHHHH-HHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTT
T ss_pred             CCcccccccccCCCcHHHH-HHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccc
Confidence            4688888988888766665 4678888999998884 56531 2223456788888888874 44421 2233333 357


Q ss_pred             ccccccccc--ccccc-CCCCCcccccccccccccc-cccCcCCCCCCCCCCCCEEEeec-CcCCCCCCcccccCCCCCc
Q 006055          144 LVRLNLATN--NFSGE-IPSGFKNLTKLKTLFLENN-RLSGSIPGFDDVLPNLQQLNVSN-NLLNGSIPKRFQTFGSNSF  218 (663)
Q Consensus       144 L~~L~l~~N--~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~~~~~~~  218 (663)
                      |+.|++++.  .++.. +..-+.++++|++|+|++| .+++.....+..+++|++|+|++ +.+++.....+..++.+..
T Consensus       150 L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~  229 (284)
T d2astb2         150 ITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT  229 (284)
T ss_dssp             CCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred             cchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCE
Confidence            777777753  33321 2222345677777777765 46656666667777777777777 3566555555555555443

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.55  E-value=7e-10  Score=99.95  Aligned_cols=42  Identities=29%  Similarity=0.321  Sum_probs=17.6

Q ss_pred             hcCCcccccccccccccccc--CCCCCccccccccccccccccc
Q 006055          138 LVGLHHLVRLNLATNNFSGE--IPSGFKNLTKLKTLFLENNRLS  179 (663)
Q Consensus       138 ~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~  179 (663)
                      +..+++|++|+|++|+|+..  ++..+..+++|+.|+|++|+|+
T Consensus        61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~  104 (162)
T d1koha1          61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK  104 (162)
T ss_dssp             HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred             HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence            33444444444444444421  1122334444444444444444

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.50  E-value=5e-09  Score=94.17  Aligned_cols=124  Identities=23%  Similarity=0.212  Sum_probs=85.7

Q ss_pred             EEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCCCCCccccCCCCCceEEcccccccCc--hhhhhcCCccccccc
Q 006055           71 VTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTSQLPSDLASCSNLRNLYLQGNHFSGE--VPLFLVGLHHLVRLN  148 (663)
Q Consensus        71 v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~  148 (663)
                      ...|+|+++...   +  .+..+..+..|++.+|.+. .++..+..+++|++|+|++|+|+..  ++..+..+++|+.|+
T Consensus        24 ~~~Ldls~l~~~---~--~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~   97 (162)
T d1koha1          24 QQALDLKGLRSD---P--DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN   97 (162)
T ss_dssp             SCCBCCCCCSSC---T--TTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred             hCeeecccCCCC---c--hhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence            455666655432   2  1344555555555555443 3454556799999999999999954  356678899999999


Q ss_pred             cccccccccCCCCCcccccccccccccccccCcCCCC-------CCCCCCCCEEEeecCcC
Q 006055          149 LATNNFSGEIPSGFKNLTKLKTLFLENNRLSGSIPGF-------DDVLPNLQQLNVSNNLL  202 (663)
Q Consensus       149 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-------~~~l~~L~~L~l~~N~l  202 (663)
                      |++|+|+..-+-.+....+|+.|+|++|.++......       +..+|+|+.||  ++++
T Consensus        98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v  156 (162)
T d1koha1          98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL  156 (162)
T ss_dssp             CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred             cccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence            9999998433323334467899999999998665532       56789999875  5554

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.34  E-value=1.2e-08  Score=107.30  Aligned_cols=108  Identities=24%  Similarity=0.351  Sum_probs=52.6

Q ss_pred             CCEEEccCCCCCCCC-CccccCCCCCceEEcccccccC----chhhhhcCCcccccccccccccccc----CCCCCc-cc
Q 006055           96 LRTLSLRFNSLTSQL-PSDLASCSNLRNLYLQGNHFSG----EVPLFLVGLHHLVRLNLATNNFSGE----IPSGFK-NL  165 (663)
Q Consensus        96 L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~-~l  165 (663)
                      |+.|||++|+|++.. ..-+..+++|+.|+|++|.++.    .+...+..+++|++|||++|+|+..    +...+. ..
T Consensus         4 l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~   83 (460)
T d1z7xw1           4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPS   83 (460)
T ss_dssp             EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTT
T ss_pred             CCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCC
Confidence            444444444444311 1123334445555555554441    2333444555555555555555311    111121 12


Q ss_pred             ccccccccccccccCc----CCCCCCCCCCCCEEEeecCcCC
Q 006055          166 TKLKTLFLENNRLSGS----IPGFDDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       166 ~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~  203 (663)
                      .+|++|+|++|+++..    ++..+..+++|+.|+|++|+++
T Consensus        84 ~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          84 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence            3566666766666532    3445566677777777777765

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.32  E-value=1.3e-08  Score=103.56  Aligned_cols=137  Identities=20%  Similarity=0.139  Sum_probs=88.2

Q ss_pred             CCcEEEEEcCCCCcc--------cccC----ccccCCCCCCCEEEccCCCCCCC----CCccccCCCCCceEEccccccc
Q 006055           68 QNRVTMLRLPGVALS--------GQIP----LGILGNLTSLRTLSLRFNSLTSQ----LPSDLASCSNLRNLYLQGNHFS  131 (663)
Q Consensus        68 ~~~v~~L~L~~~~l~--------g~~p----~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~  131 (663)
                      ...++.|+|++|.+.        ..+.    .......+.|+.|++++|.++..    +...+..++.|+.|+|++|+++
T Consensus       120 ~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~  199 (344)
T d2ca6a1         120 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR  199 (344)
T ss_dssp             CTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCC
T ss_pred             cccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhccccccccccc
Confidence            357888899888652        0010    01123567788888888887632    2233456678888888888876


Q ss_pred             Cc-----hhhhhcCCcccccccccccccccc----CCCCCcccccccccccccccccCcCCC----CCC--CCCCCCEEE
Q 006055          132 GE-----VPLFLVGLHHLVRLNLATNNFSGE----IPSGFKNLTKLKTLFLENNRLSGSIPG----FDD--VLPNLQQLN  196 (663)
Q Consensus       132 ~~-----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~----~~~--~l~~L~~L~  196 (663)
                      ..     +...+..+++|+.|+|++|.++..    +...+..+++|++|+|++|.|++.-..    .+.  ..+.|+.|+
T Consensus       200 ~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~  279 (344)
T d2ca6a1         200 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLR  279 (344)
T ss_dssp             HHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEE
T ss_pred             ccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEE
Confidence            32     334466778888888888887532    344566778888888888888643111    111  235688888


Q ss_pred             eecCcCCC
Q 006055          197 VSNNLLNG  204 (663)
Q Consensus       197 l~~N~l~g  204 (663)
                      +++|+++.
T Consensus       280 ls~N~i~~  287 (344)
T d2ca6a1         280 LQYNEIEL  287 (344)
T ss_dssp             CCSSCCBH
T ss_pred             CCCCcCCh
Confidence            88888764

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.32  E-value=1.4e-08  Score=106.86  Aligned_cols=111  Identities=23%  Similarity=0.257  Sum_probs=86.7

Q ss_pred             cEEEEEcCCCCcccccCccccCCCCCCCEEEccCCCCCC----CCCccccCCCCCceEEcccccccCc----hhhhhc-C
Q 006055           70 RVTMLRLPGVALSGQIPLGILGNLTSLRTLSLRFNSLTS----QLPSDLASCSNLRNLYLQGNHFSGE----VPLFLV-G  140 (663)
Q Consensus        70 ~v~~L~L~~~~l~g~~p~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~-~  140 (663)
                      +|+.||+++|++++.-=...+..+++|+.|+|++|+|+.    .++..+..+++|++|||++|.|+..    +...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            589999999999853212356778999999999999973    3455678899999999999998632    223332 2


Q ss_pred             Ccccccccccccccccc----CCCCCcccccccccccccccccC
Q 006055          141 LHHLVRLNLATNNFSGE----IPSGFKNLTKLKTLFLENNRLSG  180 (663)
Q Consensus       141 l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~  180 (663)
                      ..+|+.|+|++|+++..    ++..+..+++|++|+|++|.++.
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence            35799999999999743    45667889999999999999874

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.29  E-value=1.9e-08  Score=102.28  Aligned_cols=135  Identities=17%  Similarity=0.183  Sum_probs=76.5

Q ss_pred             CcEEEEEcCCCCccc---ccCc------cccCCCCCCCEEEccCCCCCCC----CCccccCCCCCceEEcccccccCchh
Q 006055           69 NRVTMLRLPGVALSG---QIPL------GILGNLTSLRTLSLRFNSLTSQ----LPSDLASCSNLRNLYLQGNHFSGEVP  135 (663)
Q Consensus        69 ~~v~~L~L~~~~l~g---~~p~------~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p  135 (663)
                      .+++.|+|+++.+..   ..|.      ..+...++|+.|+|++|.++..    +...+..+++|+.|+|++|.++..-.
T Consensus        59 ~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~  138 (344)
T d2ca6a1          59 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG  138 (344)
T ss_dssp             TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred             CCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheeccccccccccc
Confidence            567777777654321   1111      1245567777777777777653    22234456777777777776642111


Q ss_pred             h-------------hhcCCcccccccccccccccc----CCCCCcccccccccccccccccCc-----CCCCCCCCCCCC
Q 006055          136 L-------------FLVGLHHLVRLNLATNNFSGE----IPSGFKNLTKLKTLFLENNRLSGS-----IPGFDDVLPNLQ  193 (663)
Q Consensus       136 ~-------------~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~-----~p~~~~~l~~L~  193 (663)
                      .             .....+.|+.|++++|+++..    +...+..++.|++|+|++|+|+..     +...+..+++|+
T Consensus       139 ~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~  218 (344)
T d2ca6a1         139 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK  218 (344)
T ss_dssp             HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCC
T ss_pred             ccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhc
Confidence            1             112455677777777766421    222344556677777777776531     334455667777


Q ss_pred             EEEeecCcCC
Q 006055          194 QLNVSNNLLN  203 (663)
Q Consensus       194 ~L~l~~N~l~  203 (663)
                      .|+|++|+++
T Consensus       219 ~L~Ls~N~i~  228 (344)
T d2ca6a1         219 VLDLQDNTFT  228 (344)
T ss_dssp             EEECCSSCCH
T ss_pred             cccccccccc
Confidence            7777777764

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.96  E-value=1.7e-05  Score=76.27  Aligned_cols=129  Identities=15%  Similarity=0.048  Sum_probs=84.0

Q ss_pred             ccceEEEEEEecCCcEEEEEEecCc-ccCHHHHHHHHHHhhcCC-CCCcccceEEEEecCccEEEEEccCCCChhHhhcc
Q 006055          381 GTFGTAYKAVLEMGTIVAVKRLKDV-TISEREFKDKIEGVGAVN-HENLVPLRAYYYSMDEKLLVYDYLTMGSLSALLHG  458 (663)
Q Consensus       381 G~~g~Vy~~~~~~g~~vavK~l~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ey~~~gsL~~~l~~  458 (663)
                      ++.+.||+.... ++.++||+.... ......+.+|..++..+. +--+.+++.+..+++..++||+++++..+.+....
T Consensus        25 ~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~  103 (263)
T d1j7la_          25 MSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED  103 (263)
T ss_dssp             CSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred             CCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence            334689988754 566788887644 223345677888776663 33356677887778888999999999887654321


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------------------
Q 006055          459 NKGAGRTPLNWEMRSLIALGAARGIEYLHAQG------------------------------------------------  490 (663)
Q Consensus       459 ~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~------------------------------------------------  490 (663)
                      ..       .   ...++.++++.+..||+..                                                
T Consensus       104 ~~-------~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (263)
T d1j7la_         104 EQ-------S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF  173 (263)
T ss_dssp             CS-------C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHH
T ss_pred             cc-------c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHH
Confidence            10       1   1122333334444444211                                                


Q ss_pred             ---------CcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          491 ---------PNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       491 ---------~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                               +.++|+|+.|.||++++++.+-|.||+.+.
T Consensus       174 l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         174 LKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                     126799999999999987667799999875

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.65  E-value=2.5e-06  Score=76.30  Aligned_cols=111  Identities=14%  Similarity=0.099  Sum_probs=59.5

Q ss_pred             CCCCCCCEEEccCC-CCCCC----CCccccCCCCCceEEcccccccCc----hhhhhcCCcccccccccccccccc----
Q 006055           91 GNLTSLRTLSLRFN-SLTSQ----LPSDLASCSNLRNLYLQGNHFSGE----VPLFLVGLHHLVRLNLATNNFSGE----  157 (663)
Q Consensus        91 ~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----  157 (663)
                      .+.++|+.|+|+++ .++..    +-..+...++|++|+|++|.+...    +...+...+.|+.|+|++|.|+..    
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence            44566777777653 34321    112344556677777777766522    223344456677777777766532    


Q ss_pred             CCCCCcccccccccccccccccCc-------CCCCCCCCCCCCEEEeecCc
Q 006055          158 IPSGFKNLTKLKTLFLENNRLSGS-------IPGFDDVLPNLQQLNVSNNL  201 (663)
Q Consensus       158 ~p~~~~~l~~L~~L~l~~N~l~~~-------~p~~~~~l~~L~~L~l~~N~  201 (663)
                      +-..+...++|++|+|++|.+...       +...+...++|+.|+++.+.
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence            122344456667777766654421       22233345667777765553

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.46  E-value=0.00037  Score=66.09  Aligned_cols=142  Identities=15%  Similarity=0.067  Sum_probs=84.1

Q ss_pred             ccccccc-eEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCC--CCcccceEEEEecCccEEEEEccCCCChh
Q 006055          377 VLGKGTF-GTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNH--ENLVPLRAYYYSMDEKLLVYDYLTMGSLS  453 (663)
Q Consensus       377 ~lg~G~~-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~ey~~~gsL~  453 (663)
                      .+..|.. +.||+....++..++||.-.....  ..+..|...++.+..  -.+.+++.+..+.+..++||+|+++.++.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT--SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH--hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            3445553 689999988888899998654432  246667777766533  23556787777778889999999876553


Q ss_pred             Hh-----------------hccCCCC-CCCCCCHHHHHHHHH--------------------HHHHHHHHHhhcC-----
Q 006055          454 AL-----------------LHGNKGA-GRTPLNWEMRSLIAL--------------------GAARGIEYLHAQG-----  490 (663)
Q Consensus       454 ~~-----------------l~~~~~~-~~~~l~~~~~~~i~~--------------------~ia~al~~LH~~~-----  490 (663)
                      +.                 ||..... ....-.+.....-..                    .....+..+....     
T Consensus        95 ~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  174 (255)
T d1nd4a_          95 SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGED  174 (255)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCC
T ss_pred             cccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCC
Confidence            21                 1110000 000001111100000                    0112233343322     


Q ss_pred             CcceecCCCCCCEEEcCCCceEEecccccc
Q 006055          491 PNVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       491 ~~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                      +.++|+|+.|.||+++++..+-|+||+.+.
T Consensus       175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         175 LVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            137999999999999987667899999875

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.30  E-value=0.00071  Score=68.67  Aligned_cols=74  Identities=9%  Similarity=0.113  Sum_probs=45.9

Q ss_pred             cccccccceEEEEEEecC-CcEEEEEEecCc--------ccCHHHHHHHHHHhhcC-CC-C-CcccceEEEEecCccEEE
Q 006055          376 EVLGKGTFGTAYKAVLEM-GTIVAVKRLKDV--------TISEREFKDKIEGVGAV-NH-E-NLVPLRAYYYSMDEKLLV  443 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~--------~~~~~~~~~e~~~l~~l-~h-~-niv~l~~~~~~~~~~~lv  443 (663)
                      +.||.|....||+....+ ++.|+||.-...        .........|.+.++.+ .+ | .+.+++  +.+.+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~--~~d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVF--YSDTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEE--EEETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEE--EEcCCCCEEE
Confidence            468999999999998544 678999964211        11222344577776655 22 2 333444  3456778999


Q ss_pred             EEccCCCC
Q 006055          444 YDYLTMGS  451 (663)
Q Consensus       444 ~ey~~~gs  451 (663)
                      |||+.+..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.04  E-value=0.0025  Score=62.65  Aligned_cols=136  Identities=12%  Similarity=0.079  Sum_probs=79.4

Q ss_pred             eEEEEEEecCCcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCc-----ccce--EEEEecCccEEEEEccCCCChh---
Q 006055          384 GTAYKAVLEMGTIVAVKRLKDVTISEREFKDKIEGVGAVNHENL-----VPLR--AYYYSMDEKLLVYDYLTMGSLS---  453 (663)
Q Consensus       384 g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~ni-----v~l~--~~~~~~~~~~lv~ey~~~gsL~---  453 (663)
                      -.||++..++|+.|++|.......+.+++..|...+..|....+     +..-  ..+......+.+++|++|..+.   
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~  115 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN  115 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence            47999999999999999987766678889999988877642221     1111  1123455678899988764321   


Q ss_pred             --Hh---------h----ccCCCCCCCCCCHHH-------------------HHHHHHHHHHHHHHHhhc---C--Ccce
Q 006055          454 --AL---------L----HGNKGAGRTPLNWEM-------------------RSLIALGAARGIEYLHAQ---G--PNVS  494 (663)
Q Consensus       454 --~~---------l----~~~~~~~~~~l~~~~-------------------~~~i~~~ia~al~~LH~~---~--~~ii  494 (663)
                        .+         +    +......+...++..                   +..+...+.+.++.+...   .  ..+|
T Consensus       116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li  195 (325)
T d1zyla1         116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL  195 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred             HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence              11         1    111111112222221                   111222222333333321   1  3489


Q ss_pred             ecCCCCCCEEEcCCCceEEeccccccc
Q 006055          495 HGNIKSSNILLTKSYEARVSDFGLAHL  521 (663)
Q Consensus       495 Hrdlk~~Nill~~~~~~kl~Dfg~a~~  521 (663)
                      |+|+.+.|||++++  ..+.||+-+..
T Consensus       196 HgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         196 HGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             cCCCCcccEEEeCC--ceEEechhccc
Confidence            99999999999754  45899998753

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.03  E-value=5.6e-05  Score=67.19  Aligned_cols=89  Identities=16%  Similarity=0.179  Sum_probs=66.2

Q ss_pred             cCCCCCceEEcccc-cccCc----hhhhhcCCccccccccccccccccCC----CCCcccccccccccccccccCc----
Q 006055          115 ASCSNLRNLYLQGN-HFSGE----VPLFLVGLHHLVRLNLATNNFSGEIP----SGFKNLTKLKTLFLENNRLSGS----  181 (663)
Q Consensus       115 ~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p----~~~~~l~~L~~L~l~~N~l~~~----  181 (663)
                      .+.++|++|+|+++ .++..    +-..+...+.|+.|+|++|.+...-.    ..+...+.|++|+|++|.|+..    
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence            35688999999974 56532    33456778899999999999974322    2344568899999999999742    


Q ss_pred             CCCCCCCCCCCCEEEeecCcCC
Q 006055          182 IPGFDDVLPNLQQLNVSNNLLN  203 (663)
Q Consensus       182 ~p~~~~~l~~L~~L~l~~N~l~  203 (663)
                      +-..+...++|+.|+|++|.+.
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSC
T ss_pred             HHHHHHhCCcCCEEECCCCcCC
Confidence            2234567788999999999776

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.96  E-value=2.7e-05  Score=69.26  Aligned_cols=113  Identities=15%  Similarity=0.161  Sum_probs=70.3

Q ss_pred             cCCCCCCCEEEccC-CCCCCC----CCccccCCCCCceEEcccccccCc----hhhhhcCCcccccccccccccccc---
Q 006055           90 LGNLTSLRTLSLRF-NSLTSQ----LPSDLASCSNLRNLYLQGNHFSGE----VPLFLVGLHHLVRLNLATNNFSGE---  157 (663)
Q Consensus        90 ~~~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~---  157 (663)
                      ..+.++|+.|+|++ |.|+..    +-..+...++|++|+|++|.++..    +-..+...+.|+.|++++|.+...   
T Consensus        13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~   92 (166)
T d1io0a_          13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL   92 (166)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred             HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence            35667788888876 456421    122345667788888888877633    223455567788888888877532   


Q ss_pred             -CCCCCcccccccc--cccccccccC----cCCCCCCCCCCCCEEEeecCcC
Q 006055          158 -IPSGFKNLTKLKT--LFLENNRLSG----SIPGFDDVLPNLQQLNVSNNLL  202 (663)
Q Consensus       158 -~p~~~~~l~~L~~--L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l  202 (663)
                       +...+...++|+.  |++++|.+..    .+...+...++|+.|+++.|..
T Consensus        93 ~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          93 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence             2344566677775  4445666643    2334455678888888876654

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.19  E-value=0.00018  Score=63.64  Aligned_cols=111  Identities=14%  Similarity=0.142  Sum_probs=77.2

Q ss_pred             CcEEEEEcCC-CCcccccC---ccccCCCCCCCEEEccCCCCCCCC----CccccCCCCCceEEcccccccCc----hhh
Q 006055           69 NRVTMLRLPG-VALSGQIP---LGILGNLTSLRTLSLRFNSLTSQL----PSDLASCSNLRNLYLQGNHFSGE----VPL  136 (663)
Q Consensus        69 ~~v~~L~L~~-~~l~g~~p---~~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~----~p~  136 (663)
                      ..++.|+|++ +.++...=   ...+...++|+.|+|++|.++...    -..+...+.|+.|++++|.++..    +-.
T Consensus        17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~   96 (166)
T d1io0a_          17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE   96 (166)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred             CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence            5789999987 44542110   023467899999999999986532    23455678999999999998733    335


Q ss_pred             hhcCCccccc--cccccccccc----cCCCCCccccccccccccccccc
Q 006055          137 FLVGLHHLVR--LNLATNNFSG----EIPSGFKNLTKLKTLFLENNRLS  179 (663)
Q Consensus       137 ~~~~l~~L~~--L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~  179 (663)
                      .+...++|+.  |++++|.+..    .+...+...++|+.|+|+.|...
T Consensus        97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~  145 (166)
T d1io0a_          97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  145 (166)
T ss_dssp             GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence            5677788886  4556777753    34455667889999999877653

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.81  E-value=0.016  Score=58.40  Aligned_cols=72  Identities=11%  Similarity=0.051  Sum_probs=48.3

Q ss_pred             cccccccceEEEEEEecC--------CcEEEEEEecCcccCHHHHHHHHHHhhcCCCCCcc-cceEEEEecCccEEEEEc
Q 006055          376 EVLGKGTFGTAYKAVLEM--------GTIVAVKRLKDVTISEREFKDKIEGVGAVNHENLV-PLRAYYYSMDEKLLVYDY  446 (663)
Q Consensus       376 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~ey  446 (663)
                      +.|+.|-.=.+|++...+        ++.|.+++.- .....-...+|..+++.+.-.++. ++++++.    -.+|+||
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ef  122 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEY  122 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEE
Confidence            468888888999988654        3456666654 333344567788888877434554 6666652    3789999


Q ss_pred             cCCCCh
Q 006055          447 LTMGSL  452 (663)
Q Consensus       447 ~~~gsL  452 (663)
                      +++-.+
T Consensus       123 i~g~~l  128 (395)
T d1nw1a_         123 IPSRPL  128 (395)
T ss_dssp             CCEEEC
T ss_pred             eccccC
Confidence            987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=91.74  E-value=0.25  Score=47.24  Aligned_cols=29  Identities=21%  Similarity=0.292  Sum_probs=26.0

Q ss_pred             cceecCCCCCCEEEcCCCceEEecccccc
Q 006055          492 NVSHGNIKSSNILLTKSYEARVSDFGLAH  520 (663)
Q Consensus       492 ~iiHrdlk~~Nill~~~~~~kl~Dfg~a~  520 (663)
                      .+||+|+.+.||+++++...-|.||+.+.
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccCCcchhhhhcccccceeEecccccc
Confidence            49999999999999988777899999874